PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cherry, J; Jones, H; Karschner, VA; Pekala, PH				Cherry, Joy; Jones, Heath; Karschner, Vesna A.; Pekala, Phillip H.			Post-transcriptional Control of CCAAT/Enhancer-binding Protein beta (C/EBP beta) Expression FORMATION OF A NUCLEAR HuR-C/EBP beta mRNA COMPLEX DETERMINES THE AMOUNT OF MESSAGE REACHING THE CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; 3'-UNTRANSLATED REGION; PPAR-GAMMA; GENE; ELEMENT; ALPHA; STABILIZATION; CELL; DIFFERENTIATION; ADIPOGENESIS	In 3T3-L1 cells, HuR is constitutively expressed and prior to induction of differentiation localized predominantly to the nucleus. Within minutes of induction of differentiation, nuclear HuR binds to its target ligand mRNAs, and the complexes appear to move to the cytosol. One ligand mRNA is the CCAAT/enhancer-binding protein beta (C/EBP beta) message. To examine the function and importance of the HuR-C/EBP beta interaction, retroviral expression constructs were created in which the HuR binding site was altered by deletion (beta del) or deletion and substitution (beta d/s). Expression of these constructs in murine embryonic fibroblasts resulted in significant adipose conversion relative to those cells expressing wild type C/EBP beta. C/EBP beta protein content was increased markedly in both beta del and beta d/s, which correlated with the acquisition of the adipocyte phenotype. Analysis of the beta d/s cell line demonstrated a robust expression of C/EBP alpha coincident with peroxisome proliferator-activated receptor gamma expression. Total C/EBP beta mRNA accumulation indicated no difference between cells harboring either the wild type C/EBP beta cDNA or beta d/s construct. However, cytosolic C/EBP beta mRNA in the cells expressing the beta d/s construct was maintained at levels between 2- and 7-fold greater than in the cells expressing the wild type construct. Alteration in mRNA half-life was not responsible for the increased accumulation. Mechanistically, these data suggest that HuR binding results in nuclear retention of the C/EBP beta mRNA and is consistent with HuR control, at least in part, of mRNA processing.	[Cherry, Joy; Jones, Heath; Karschner, Vesna A.; Pekala, Phillip H.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Pekala, PH (corresponding author), E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	pekalap@ecu.edu			National Institutes of Health [DK55169]; American Diabetes Association [7-03-RA-76]; Brody Brothers Foundation [MT7753]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Brody Brothers Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant DK55169. This work was also supported by American Diabetes Association Grant 7-03-RA-76 and Brody Brothers Foundation Grant MT7753. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FORD LP, 2001, EMBO J, V20, P1134; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gantt K, 2005, J BIOL CHEM, V280, P24768, DOI 10.1074/jbc.M502011200; Gantt KR, 2006, J CELL BIOCHEM, V99, P565, DOI 10.1002/jcb.20950; Gantt KR, 2004, BIOCHEM BIOPH RES CO, V313, P619, DOI 10.1016/j.bbrc.2003.11.162; Goldberg-Cohen I, 2002, J BIOL CHEM, V277, P13635, DOI 10.1074/jbc.M108703200; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; Jones H, 2007, BIOCHEM BIOPH RES CO, V355, P217, DOI 10.1016/j.bbrc.2007.01.136; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; King PH, 2000, GENE, V242, P125, DOI 10.1016/S0378-1119(99)00537-5; Kirigiti P, 2001, MOL PHARMACOL, V60, P1308, DOI 10.1124/mol.60.6.1308; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Loflin P, 2001, FEBS LETT, V509, P267, DOI 10.1016/S0014-5793(01)03176-3; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; STEPHENS JM, 1993, MOL CELL BIOCHEM, V123, P63, DOI 10.1007/BF01076476; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	40	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30812	30820		10.1074/jbc.M805659200	http://dx.doi.org/10.1074/jbc.M805659200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18678862	Green Published, hybrid			2022-12-25	WOS:000260544800036
J	Satoh, Y; Matsumura, I; Tanaka, H; Ezoe, S; Fukushima, K; Tokunaga, M; Yasumi, M; Shibayama, H; Mizuki, M; Era, T; Okuda, T; Kanakura, Y				Satoh, Yusuke; Matsumura, Itaru; Tanaka, Hirokazu; Ezoe, Sachiko; Fukushima, Kentaro; Tokunaga, Masahiro; Yasumi, Masato; Shibayama, Hirohiko; Mizuki, Masao; Era, Takumi; Okuda, Tsukasa; Kanakura, Yuzuru			AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; MULTIPLE CHROMOSOMAL TRANSLOCATIONS; FAMILIAL PLATELET DISORDER; FETAL LIVER HEMATOPOIESIS; BINDING-FACTOR-BETA; MYELODYSPLASTIC SYNDROME; POINT MUTATIONS; TRANSCRIPTION FACTOR; AML1/PEBP2-ALPHA-B GENE	In this study, we analyzed the roles for AML1/RUNX1 in the regulation of the c-mpl promoter. Wild-type AML1 activated the c-mpl promoter through the proximal AML-binding site in luciferase assays using 293T and HeLa cells. In accord with this result, electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that AML1 bound to this site. Next, we analyzed the function of AML1 using a mutant of AML1 lacking the C terminus (AML1dC), which was originally found in a patient with myelodysplastic syndromes. AML1dC dominant-negatively suppressed transcriptional activity of wild-type AML1. However, unexpectedly, AML1dC-transduced murine c-Kit(+)Sca1(+)Lineage(-) cells expressed c-mpl mRNA and c-Mpl protein more abundantly than mock-transduced cells, which led to the enhanced thrombopoietin-mediated proliferation. Moreover, when AML1dC was induced to express during the development of hematopoietic cells from embryonic stem (ES) cells, AML1dC augmented the c-Mpl expression on hematopoietic stem/progenitor cells. Furthermore, we found that early hematopoietic cells that derived from AML1(-/-) ES cells expressed c-Mpl more intensely than those that developed from wild-type ES cells. In contrast, AML1dC hardly affected c-Mpl expression and maturation of megakaryocytes. As for the mechanism of the different roles of AML1 in the regulation of the c-mpl promoter, we found that AML1 forms a complex with a transcription repressor mSin3A on the c-mpl promoter in hematopoietic stem/progenitor cells, although it forms a complex with a transcription activator p300 on the same promoter in megakaryocytic cells. Together, these data indicate that AML1 can regulate the c-mpl promoter both positively and negatively by changing the binding partner according to cell types.	[Satoh, Yusuke; Matsumura, Itaru; Tanaka, Hirokazu; Ezoe, Sachiko; Fukushima, Kentaro; Tokunaga, Masahiro; Yasumi, Masato; Shibayama, Hirohiko; Mizuki, Masao; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Era, Takumi] Kumamoto Univ, Div Mol Neurobiol, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Okuda, Tsukasa] Kyoto Prefectural Univ Med, Dept Biochem & Mol Biol, Kyoto 6028566, Japan	Osaka University; Kumamoto University; Kyoto Prefectural University of Medicine	Matsumura, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	matumura@bldon.med.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture and Technology of Japan; Sankyo Foundation of Life Science	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan and the Sankyo Foundation of Life Science.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; CAMERON S, 1994, BLOOD, V83, P2851, DOI 10.1182/blood.V83.10.2851.2851; Elagib KE, 2007, CRIT REV EUKAR GENE, V17, P271, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.20; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Heller PG, 2005, BLOOD, V105, P4664, DOI 10.1182/blood-2005-01-0050; Hirai H, 2003, JPN J CLIN ONCOL, V33, P153, DOI 10.1093/jjco/hyg037; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jalvy S, 2007, CIRC RES, V100, P1292, DOI 10.1161/01.RES.0000266609.28312.de; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakata S, 2004, J BIOL CHEM, V279, P55578, DOI 10.1074/jbc.M408238200; Niki M, 1997, P NATL ACAD SCI USA, V94, P5697, DOI 10.1073/pnas.94.11.5697; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 2000, MOL CELL BIOL, V20, P319, DOI 10.1128/MCB.20.1.319-328.2000; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osato M, 2001, INT J HEMATOL, V74, P245, DOI 10.1007/BF02982056; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Quesnel B, 1998, BLOOD, V91, P2985, DOI 10.1182/blood.V91.8.2985.2985_2985_2990; RUSSELL M, 1994, BLOOD, V84, P1243, DOI 10.1182/blood.V84.4.1243.bloodjournal8441243; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Shimizu K, 2000, BLOOD, V96, P288, DOI 10.1182/blood.V96.1.288.013k05_288_296; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; SUGIMOTO K, 1993, BLOOD, V81, P3022; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Uchida T, 1997, BLOOD, V90, P1403, DOI 10.1182/blood.V90.4.1403.1403_1403_1409; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; YonedaKato N, 1996, ONCOGENE, V12, P265; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	57	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30045	30056		10.1074/jbc.M804768200	http://dx.doi.org/10.1074/jbc.M804768200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687690	Green Published, hybrid			2022-12-25	WOS:000260366900049
J	Comini, MA; Rettig, J; Dirdjaja, N; Hanschmann, EM; Berndt, C; Krauth-Siegel, RL				Comini, Marcelo A.; Rettig, Jochen; Dirdjaja, Natalie; Hanschmann, Eva-Maria; Berndt, Carsten; Krauth-Siegel, R. Luise			Monothiol glutaredoxin-1 is an essential iron-sulfur protein in the mitochondrion of African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; RNA INTERFERENCE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BRUCEI; CLUSTERS; EXPRESSION; GRX5; GLUTATHIONYLATION; GLYCOSOMES	African trypanosomes encode three monothiol glutaredoxins (1-C-Grx). 1-C-Grx1 occurs exclusively in the mitochondrion, and 1-C-Grx2 and -3 are predicted to be mitochondrial and cytosolic proteins, respectively. All three 1-C-Grx are expressed in both the mammalian bloodstream and the insect procyclic form of Trypanosoma brucei, with the highest levels found in stationary phase and starving parasites. In the rudimentary mitochondrion of bloodstream cells, 1-C-Grx1 reaches concentrations above 200 mu M/subunit. Recombinant T. brucei 1-C-Grx1 exists as a noncovalent homodimer, whereas 1-C-Grx2 and 1-C-Grx3 are monomeric proteins. In vitro, dimeric 1-C-Grx1 coordinated an H2O2-sensitive [2Fe-2S] cluster that required GSH as an additional ligand. Both bloodstream and procyclic trypanosomes were refractory to down-regulation of 1-C-Grx1 expression by RNA interference. In procyclic parasites, the 1-c-grx1 alleles could only be deleted if an ectopic copy of the gene was expressed. A 5-10-fold overexpression of 1-C-Grx1 in both parasite forms did not yield a growth phenotype under optimal culture conditions. However, exposure of these cells to the iron chelator deferoxamine or H2O2, but not to iron or menadione, impaired cell growth. Treatment of wild-type bloodstream parasites with deferoxamine and H2O2 caused a 2-fold down- and up-regulation of 1-C-Grx1, respectively. The results point to an essential role of the mitochondrial 1-C-Grx1 in the iron metabolism of these parasites.	[Comini, Marcelo A.; Rettig, Jochen; Dirdjaja, Natalie; Krauth-Siegel, R. Luise] Heidelberg Univ, Ctr Biochem, D-69120 Heidelberg, Germany; [Hanschmann, Eva-Maria; Berndt, Carsten] Karolinska Inst, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Berndt, Carsten] Univ Marburg, Dept Clin Cytobiol & Cytopathol, D-35037 Marburg, Germany	Ruprecht Karls University Heidelberg; Karolinska Institutet; Philipps University Marburg	Comini, MA (corresponding author), Inst Pasteur Montevideo, Mataojo 2020, Montevideo 11400, Uruguay.	mcomini@pasteur.edu.uy	Hanschmann, Eva-Maria/AAS-9261-2021; Berndt, Carsten/X-6260-2018	Berndt, Carsten/0000-0001-8583-7966; Comini, Marcelo/0000-0001-5000-1333	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases [B3]; Karolinska Institutet; Swedish Cancer Society;  [BE 3259/1]	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases(German Research Foundation (DFG)); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); 	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases," project B3) and Research Fellowship BE 3259/1 (to C. B.), the Karolinska Institutet, and the Swedish Cancer Society (Cancerfonden, to Arne Holmgren). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Breidbach T, 2002, INT J PARASITOL, V32, P473, DOI 10.1016/S0020-7519(01)00310-1; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; CAMASCHELLA C, 2007, BLOOD, V725, P1; Cevallos AM, 2005, FEMS MICROBIOL LETT, V246, P259, DOI 10.1016/j.femsle.2005.04.017; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Deponte M, 2005, BIOL CHEM, V386, P33, DOI 10.1515/BC.2005.005; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; HERRERO E, 2007, CELL MOL LIFE SCI, V655, P1; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Kim HG, 2005, MOL CELLS, V20, P43; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; McAmis WC, 2003, BBA-MOL CELL RES, V1641, P43, DOI 10.1016/S0167-4889(03)00063-6; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; MESHNICK SR, 1978, J EXP MED, V148, P569, DOI 10.1084/jem.148.2.569; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Ochatt CM, 1999, MOL BIOCHEM PARASIT, V103, P35, DOI 10.1016/S0166-6851(99)00111-5; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Selzer PM, 1996, EUR J CELL BIOL, V69, P173; Shi HF, 2004, EUKARYOT CELL, V3, P1445, DOI 10.1128/EC.3.6.1445-1453.2004; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887	49	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27785	27798		10.1074/jbc.M802010200	http://dx.doi.org/10.1074/jbc.M802010200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669638	hybrid			2022-12-25	WOS:000259719200050
J	Kitagawa, H; Tsutsumi, K; Ikegami-Kuzuhara, A; Nadanaka, S; Goto, F; Ogawa, T; Sugahara, K				Kitagawa, Hiroshi; Tsutsumi, Kae; Ikegami-Kuzuhara, Akemi; Nadanaka, Satomi; Goto, Fumitaka; Ogawa, Tomoya; Sugahara, Kazuyuki			Sulfation of the galactose residues in the glycosaminoglycan-protein linkage region by recombinant human chondroitin 6-O-sulfotransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; HEPARAN-SULFATE; SHARK CARTILAGE; PROTEOGLYCANS; EXPRESSION; BIOSYNTHESIS; 4-SULFATE; BRAIN	6-O-Sulfated galactose residues have been demonstrated in the glycosaminoglycan-protein linkage region GlcUA beta 1-3Gal beta 1-3Gal-4Xyl beta 1-O-Ser isolated from shark cartilage chondroitin 6-sulfate (Sugahara, K., Ohi, Y., Harada, T., de Waard, P., and Vliegenthart, J. F. G. ( 1992) J. Biol. Chem. 267, 6027-6035). In this study, we investigated whether a recombinant human chondroitin 6-sulfotransferase-1 (C6ST-1) catalyzes the sulfation of C6 on both galactose residues in the linkage region using structurally defined acceptor substrates. The C6ST-1 was expressed as a soluble protein A chimeric form in COS-1 cells and purified using IgG-Sepharose. The purified C6ST-1 utilized the linkage tri-, tetra-, penta-, and hexasaccharide-serines and hexasaccharide alditols, including GlcUA beta 1-3GalNAc(4-O-sulfate)beta 1-4GlcUA beta 1-3Gal(4-O-sulfate) beta 1-3Gal beta 1-4Xy1 beta 1-O-Ser and Delta GlcUA beta 1-3Gal-NAc(6-O-sulfate)beta 1-4GlcUA beta 1-3Gal beta 1-3Gal(6-O-sulfate)beta 1-4Xyl-ol. Identification of the reaction products obtained with the linkage tetra-, penta-, and hexasaccharideserines revealed that the C6ST-1 catalyzed the sulfation of C6 on both galactose residues in the linkage region. Notably, the linkage tetrasaccharide-peptide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-(Gly)Ser-(Gly-Glu) was a good acceptor substrate for the C6ST-1, suggesting that the sulfation of the galactose residues can occur before the transfer of the first N-acetylhexosamine residue to the linkage tetrasaccharide. In contrast, no incorporation was observed into Delta GlcUA beta 1 3GalNAc(4-O-sulfate)beta 1-4GlcUA beta 1-3Gal(4-O-sulfate)beta 1-3Gal beta 1-4Xyl-ol, indicating that an intact xylose is necessary for the transfer of a sulfate to the second sugar residue Gal from the reducing end. These findings clearly demonstrated that the recombinant C6ST-1 catalyzes the sulfation of C6 on both galactose residues in the linkage region in vitro. This is the first identification of the sulfotransferase responsible for the sulfation of galactose residues in the glycosaminoglycan-protein linkage region.	[Kitagawa, Hiroshi; Tsutsumi, Kae; Ikegami-Kuzuhara, Akemi; Nadanaka, Satomi; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Goto, Fumitaka; Ogawa, Tomoya] RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan	Kobe Pharmaceutical University; RIKEN; Hokkaido University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp; k-sugar@sci.hokudai.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation [19390025, 18390030]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [14082207]; Takeda Science Foundation; Japan Science and Technology Agency; MEXT	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported in part by the Scientific Research Promotion Fund from the Japan Private School Promotion Foundation, Grants-in-aid for Scientific Research-B 19390025 (to H. K.) and 18390030 (to K. S.), and Grant-in-aid for Scientific Research on Priority Areas 14082207 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Takeda Science Foundation (to H. K.), the Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency (to H. K. and K. S.), and a National Project "Knowledge Cluster Initiative" (2nd Stage "Sapporo Bio-cluster Bio-S") from MEXT. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; DEWAARD P, 1992, J BIOL CHEM, V267, P6036; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; GOTO F, 1992, TETRAHEDRON LETT, V33, P6841, DOI 10.1016/S0040-4039(00)61790-2; GOTO F, 1992, TETRAHEDRON LETT, V33, P5099, DOI 10.1016/S0040-4039(00)61200-5; GOTO F, 1993, PURE APPL CHEM, V65, P793, DOI 10.1351/pac199365040793; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Moses J, 1999, EUR J BIOCHEM, V260, P879, DOI 10.1046/j.1432-1327.1999.00228.x; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1994, GLYCOBIOLOGY, V4, P535, DOI 10.1093/glycob/4.4.535; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugumaran G, 1998, BIOCHEM J, V329, P203, DOI 10.1042/bj3290203; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; Uchimura K, 1998, GLYCOBIOLOGY, V8, P489, DOI 10.1093/glycob/8.5.489; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; van Roij MHH, 2008, AM J MED GENET A, V146A, P2376, DOI 10.1002/ajmg.a.32482	30	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27438	27443		10.1074/jbc.M803279200	http://dx.doi.org/10.1074/jbc.M803279200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697746	hybrid			2022-12-25	WOS:000259719200013
J	Alpadi, K; Magupalli, VG; Kappel, S; Koblitz, L; Schwarz, K; Seigel, GM; Sung, CH; Schmitz, F				Alpadi, Kannan; Magupalli, Venkat Giri; Kaeppel, Stefanie; Koeblitz, Louise; Schwarz, Karin; Seigel, Gail M.; Sung, Ching-Hwa; Schmitz, Frank			RIBEYE recruits munc119, a mammalian ortholog of the Caenorhabditis elegans protein unc119, to synaptic ribbons of photoreceptor Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR; PDE-DELTA; HRG4; BINDING; IDENTIFICATION; ACTIVATOR; CTBP	Munc119 (also denoted as RG4) is a mammalian ortholog of the Caenorhabditis elegans protein unc119 and is essential for vision and synaptic transmission at photoreceptor ribbon synapses by unknown molecular mechanisms. Munc119/RG4 is related to the prenyl-binding protein PrBP/delta and expressed at high levels in photoreceptor ribbon synapses. Synaptic ribbons are presynaptic specializations in the active zone of these tonically active synapses and contain RIBEYE as a unique and major component. In the present study, we identified Munc119 as a RIBEYE-interacting protein at photoreceptor ribbon synapses using five independent approaches. The PrBP/delta homology domain of Munc119 is essential for the interaction with the NADH binding region of RIBEYE(B) domain. But RIBEYE-Munc119 interaction does not depend on NADH binding. A RIBEYE point mutant (RE(B) E844Q) that no longer interacted with Munc119 still bound NADH, arguing that binding of Munc119 and NADH to RIBEYE are independent from each other. Our data indicate that Munc119 is a synaptic ribbon-associated component. Weshow that Munc119 can be recruited to synaptic ribbons via its interaction with RIBEYE. Our data suggest that the RIBEYE-Munc119 interaction is essential for synaptic transmission at the photoreceptor ribbon synapse.	[Alpadi, Kannan; Magupalli, Venkat Giri; Kaeppel, Stefanie; Koeblitz, Louise; Schwarz, Karin; Schmitz, Frank] Univ Saarland, Med Sch Homburg Saar, Inst Anat & Cell Biol, Dept Neuroanat, D-66421 Homburg, Germany; [Seigel, Gail M.] SUNY Buffalo, Dept Ophthalmol Physiol & Biophys, Buffalo, NY 14214 USA; [Sung, Ching-Hwa] Cornell Univ, Weill Med Coll, Margaret M Dyson Vis Res Inst, Dept Ophthalmol Cell & Dev Biol, New York, NY 10021 USA	Saarland University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cornell University	Schmitz, F (corresponding author), Univ Saarland, Med Sch Homburg Saar, Inst Anat & Cell Biol, Dept Neuroanat, Bldg 61, D-66421 Homburg, Germany.	frank.schmitz@uniklinikum-saarland.de	Schwarz, Karin/AAO-2819-2020	Magupalli, Venkat/0000-0003-4638-3062; Schwarz, Karin/0000-0002-7328-1427	Sonderforschungsbereich 530 (SFB530) [TPC11]; HOMFOR; NATIONAL EYE INSTITUTE [R01EY011307] Funding Source: NIH RePORTER	Sonderforschungsbereich 530 (SFB530)(German Research Foundation (DFG)); HOMFOR; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Sonderforschungsbereich 530 (SFB530) (TPC11) and by HOMFOR (to F. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai C, 1996, METHOD ENZYMOL, V273, P331; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Haeseleer F, 2008, INVEST OPHTH VIS SCI, V49, P2366, DOI 10.1167/iovs.07-1166; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; HARPER JW, 1993, CELL, V75, P805; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Helmuth M, 2001, ANAL BIOCHEM, V293, P149, DOI 10.1006/abio.2001.5107; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; James P, 1996, GENETICS, V144, P1425; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; KOBAYASHI A, 2000, INVESTIG OPHTHALMOL, V11, P3268; Kubota S, 2002, INVEST OPHTH VIS SCI, V43, P308; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Li N, 1998, GENOMICS, V49, P76, DOI 10.1006/geno.1998.5210; Mori N, 2006, INVEST OPHTH VIS SCI, V47, P1281, DOI 10.1167/iovs.05-0493; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 1996, J NEUROSCI, V16, P7109; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Seigel GM, 2004, CURR EYE RES, V28, P257, DOI 10.1076/ceyr.28.4.257.27831; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	36	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26461	26467		10.1074/jbc.M801625200	http://dx.doi.org/10.1074/jbc.M801625200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18664567	Green Published, hybrid			2022-12-25	WOS:000259341600021
J	Woodard-Grice, AV; McBrayer, AC; Wakefield, JK; Zhuo, Y; Bellis, SL				Woodard-Grice, Alencia V.; McBrayer, Alexis C.; Wakefield, John K.; Zhuo, Ya; Bellis, Susan L.			Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha 4 beta 1 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MYELOID FIBRONECTIN RECEPTORS; ALZHEIMERS BETA-SECRETASE; CELL-ADHESION; DIFFERENTIAL GLYCOSYLATION; ACTIVATED RECEPTOR; KNOCKOUT MICE; BINDING-SITE; HL60 CELLS; N-GLYCANS	Differentiation of monocytes into macrophages is accompanied by increased cell adhesiveness, due in part to the activation of alpha 4 beta 1 integrins. Here we report that the sustained alpha 4 beta 1 activation associated with macrophage differentiation results from expression of beta 1 integrin subunits that lack alpha 2-6-linked sialic acids, a carbohydrate modification added by the ST6Gal-I sialyltransferase. During differentiation of U937 monocytic cells and primary human CD14(+) monocytes, ST6Gal-I is down-regulated, leading to beta 1 hyposialylation and enhanced alpha 4 beta 1-dependent VCAM-1 binding. Importantly, ST6Gal-I down-regulation results from cleavage by the BACE1 secretase, which we show is dramatically up-regulated during macrophage differentiation. BACE1 up-regulation, ST6Gal-I shedding, beta 1 hyposialylation, and alpha 4 beta 1-dependent VCAM-1 binding are all temporally correlated and share the same signaling mechanism (protein kinase C/Ras/ERK). Preventing ST6Gal-I down-regulation (and therefore integrin hyposialylation), through BACE1 inhibition or ST6Gal-I constitutive overexpression, eliminates VCAM-1 binding. Similarly, preventing integrin hyposialylation inhibits a differentiation-induced increase in the expression of an activation-dependent conformational epitope on the beta 1 subunit. Collectively, these results describe a novel mechanism for alpha 4 beta 1 regulation and further suggest an unanticipated role for BACE1 in macrophage function.	[Woodard-Grice, Alencia V.; Zhuo, Ya; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [McBrayer, Alexis C.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Wakefield, John K.] Tranzyme Pharma, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama, Dept Physiol & Biophys, Rm 982A MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@physiology.uab.edu			NCI NIH HHS [R01CA84248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Brennan PJ, 2006, INT IMMUNOL, V18, P627, DOI 10.1093/intimm/dxh344; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Chen C, 1999, J IMMUNOL, V162, P1084; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; FEHR J, 1977, J EXP MED, V146, P641, DOI 10.1084/jem.146.3.641; Feigelson S, 2001, J BIOL CHEM, V276, P13891, DOI 10.1074/jbc.M004939200; Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019; GILBERT HS, 1978, METABOLISM, V27, P889, DOI 10.1016/0026-0495(78)90132-4; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; He HC, 1999, CELL GROWTH DIFFER, V10, P307; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2004, GLYCOCONJUGATE J, V21, P25, DOI 10.1023/B:GLYC.0000043743.21735.ff; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LIU Y, 2008, PROTEINS IN PRESS; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; Miranda MB, 2002, LEUKEMIA, V16, P683, DOI 10.1038/sj.leu.2402400; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; PAWLOWSKI NA, 1988, J EXP MED, V168, P1865, DOI 10.1084/jem.168.5.1865; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sastre M, 2003, J NEUROSCI, V23, P9796; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smith JW, 1997, MATRIX BIOL, V16, P173, DOI 10.1016/S0945-053X(97)90005-6; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Villavicencio-Lorini P, 2002, J MOL MED-JMM, V80, P671, DOI 10.1007/s00109-002-0382-y; Weber C, 2003, J MOL MED, V81, P4, DOI 10.1007/s00109-002-0391-x; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yang GX, 2003, MED RES REV, V23, P369, DOI 10.1002/med.10044; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001	60	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26364	26373		10.1074/jbc.M800836200	http://dx.doi.org/10.1074/jbc.M800836200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650447	hybrid, Green Published			2022-12-25	WOS:000259341600010
J	Chung, HJ; Steplewski, A; Chung, KY; Uitto, J; Fertala, A				Chung, Hye Jin; Steplewski, Andrzej; Chung, Kee Yang; Uitto, Jouni; Fertala, Andrzej			Collagen fibril formation - A new target to limit fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; BONE MORPHOGENETIC PROTEIN-1; ALZHEIMERS-DISEASE; PREVENTION; INHIBITION; METALLOPROTEINASES; MONOMERS; CLEAVAGE; POSITION; DRIVEN	We present a concept for reducing formation of fibrotic deposits by inhibiting self-assembly of collagen molecules into fibrils, a main component of fibrotic lesions. Employing monoclonal antibodies that bind to the telopeptide region of a collagen molecule, we found that blocking telopeptide-mediated collagen/collagen interactions reduces the amount of collagen fibrils accumulated in vitro and in keloid-like organotypic constructs. We conclude that inhibiting extracellular steps of the fibrotic process provides a novel approach to limit fibrosis in a number of tissues and organs.	[Chung, Hye Jin; Steplewski, Andrzej; Uitto, Jouni; Fertala, Andrzej] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Chung, Kee Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 120752, South Korea; [Chung, Kee Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul 120752, South Korea	Jefferson University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Fertala, A (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, BLSB,Rm 424,233 S 10th St, Philadelphia, PA 19107 USA.	andrzej.fertala@jefferson.edu		Chung, Hye Jin/0000-0003-0204-4085; Chung, Kee Yang/0000-0003-3257-0297	National Institutes of Health [R01AR048544, R01AR049537, R01AR41439]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041439, R01AR048544, R01AR049537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR048544 and R01AR049537 (to A. F.) and R01AR41439 (to J.U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADDICKS EM, 1983, ARCH OPHTHALMOL-CHIC, V101, P795; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; CHANG K, 1980, DIABETES, V29, P778, DOI 10.2337/diabetes.29.10.778; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; ELLIOTT BW, 1986, J BIOL CHEM, V261, P1259; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864; FERTALA A, 1994, J BIOL CHEM, V269, P11584; FIEDLERNAGY C, 1981, ARCH BIOCHEM BIOPHYS, V212, P668, DOI 10.1016/0003-9861(81)90411-2; Fish PV, 2007, J MED CHEM, V50, P3442, DOI 10.1021/jm061010z; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354; FLEISCHMAJER R, 1981, P NATL ACAD SCI-BIOL, V78, P7360, DOI 10.1073/pnas.78.12.7360; GELMAN RA, 1979, J BIOL CHEM, V254, P180; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Lansbury PT, 1997, CURR OPIN CHEM BIOL, V1, P260, DOI 10.1016/S1367-5931(97)80018-X; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Ovens A, 2000, J PEPT SCI, V6, P489, DOI 10.1002/1099-1387(200009)6:9<489::AID-PSC282>3.3.CO;2-B; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RILEY DJ, 1980, J CLIN INVEST, V65, P643, DOI 10.1172/JCI109709; ROMANIC AM, 1991, J BIOL CHEM, V266, P12703; Roseborough IE, 2004, J NATL MED ASSOC, V96, P108; Sanders KW, 2005, ARCH FACIAL PLAST S, V7, P172, DOI 10.1001/archfaci.7.3.172; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SHAH M, 1995, J CELL SCI, V108, P985; Steplewski A, 2004, J STRUCT BIOL, V148, P326, DOI 10.1016/j.jsb.2004.07.006; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Wang HJ, 2003, TISSUE ENG, V9, P909, DOI 10.1089/107632703322495556; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	41	51	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25879	25886		10.1074/jbc.M804272200	http://dx.doi.org/10.1074/jbc.M804272200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650436	Green Published, hybrid			2022-12-25	WOS:000259200100015
J	Suzuki, M; Lee, DY; Inyamah, N; Stadtman, TC; Tjandra, N				Suzuki, Motoshi; Lee, Duck-Yeon; Inyamah, Nwakaego; Stadtman, Thressa C.; Tjandra, Nico			Solution NMR structure of selenium-binding protein from Methanococcus vannielii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIENTED MACROMOLECULES; C-13; SPECTROSCOPY; ENHANCEMENT; METABOLISM; COUPLINGS; N-15	Selenium is an important nutrient. The lack of selenium will suppress expression of various enzymes that will lead to cell abnormality and diseases. However, high concentrations of free selenium are toxic to the cell because it adversely affects numerous cell metabolic pathways. In Methanonoccus vannielii, selenium transport in the cell is established by the selenium-binding protein, SeBP. SeBP sequesters selenium during transport, thus regulating the level of free selenium in the cell, and delivers it specifically to the selenophosphate synthase enzyme. In solution, SeBP is an oligomer of 8.8-kDa subunits. It is a symmetric pentamer. The solution structure of SeBP was determined by NMR spectroscopy. Each subunit of SeBP is composed of an alpha-helix on top of a 4-stranded twisted beta-sheet. The stability of the five subunits stems mainly from hydrophobic interactions and supplemented by hydrogen bond interactions. The loop containing Cys(59) has been shown to be important for selenium binding, is flexible, and adopts multiple conformations. However, the cysteine accessibility is restricted in the structure, reducing the possibility of the binding of free selenium readily. Therefore, a different selenium precursor or other factors might be needed to facilitate opening of this loop to expose Cys(59) for selenium binding.	[Suzuki, Motoshi; Tjandra, Nico] NIH, Lab Mol Biophys, Bethesda, MD 20892 USA; [Lee, Duck-Yeon; Inyamah, Nwakaego; Stadtman, Thressa C.] NHLBI, NIH, Biochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Stadtman, TC (corresponding author), 50 South Dr,Bldg 50,Rm 3503,MSC-8012, Bethesda, MD 20892 USA.	stadtmat@nhlbi.nih.gov; tjandran@nhlbi.nih.gov		Suzuki, Motoshi/0000-0002-4346-7677	Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001048, ZIAHL001048, Z01HL000205] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bock A, 1988, Biofactors, V1, P245; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Haratake M, 2005, BBA-GEN SUBJECTS, V1723, P215, DOI 10.1016/j.bbagen.2005.02.002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horn MJ, 1941, J BIOL CHEM, V139, P649; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; Lacourciere GM, 2002, P NATL ACAD SCI USA, V99, P9150, DOI 10.1073/pnas.142291199; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; LEINFELDER W, 1988, J BACTERIOL, V170, P540, DOI 10.1128/jb.170.2.540-546.1988; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ogasawara Y, 2005, P NATL ACAD SCI USA, V102, P1012, DOI 10.1073/pnas.0409042102; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Patteson KG, 2005, P NATL ACAD SCI USA, V102, P12029, DOI 10.1073/pnas.0505650102; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Self WT, 2004, IUBMB LIFE, V56, P501, DOI 10.1080/15216540400010818; Stadtman TC, 2004, IUBMB LIFE, V56, P427, DOI 10.1080/15216540400008911; STADTMAN TC, 1974, SCIENCE, V183, P915, DOI 10.1126/science.183.4128.915; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; VERES Z, 1992, P NATL ACAD SCI USA, V89, P2975, DOI 10.1073/pnas.89.7.2975; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	36	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25936	25943		10.1074/jbc.M803773200	http://dx.doi.org/10.1074/jbc.M803773200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650445	hybrid, Green Published			2022-12-25	WOS:000259200100021
J	Coesel, S; Obornik, M; Varela, J; Falciatore, A; Bowler, C				Coesel, Sacha; Obornik, Miroslav; Varela, Joao; Falciatore, Angela; Bowler, Chris			Evolutionary Origins and Functions of the Carotenoid Biosynthetic Pathway in Marine Diatoms	PLOS ONE			English	Article							VIOLAXANTHIN DE-EPOXIDASE; XANTHOPHYLL-CYCLE; DIADINOXANTHIN CYCLE; GENE-EXPRESSION; LIGHT; PH; ARABIDOPSIS; ALGAE; PHOTOSYNTHESIS; IDENTIFICATION	Carotenoids are produced by all photosynthetic organisms, where they play essential roles in light harvesting and photoprotection. The carotenoid biosynthetic pathway of diatoms is largely unstudied, but is of particular interest because these organisms have a very different evolutionary history with respect to the Plantae and are thought to be derived from an ancient secondary endosymbiosis between heterotrophic and autotrophic eukaryotes. Furthermore, diatoms have an additional xanthophyll-based cycle for dissipating excess light energy with respect to green algae and higher plants. To explore the origins and functions of the carotenoid pathway in diatoms we searched for genes encoding pathway components in the recently completed genome sequences of two marine diatoms. Consistent with the supplemental xanthophyll cycle in diatoms, we found more copies of the genes encoding violaxanthin de-epoxidase (VDE) and zeaxanthin epoxidase (ZEP) enzymes compared with other photosynthetic eukaryotes. However, the similarity of these enzymes with those of higher plants indicates that they had very probably diversified before the secondary endosymbiosis had occurred, implying that VDE and ZEP represent early eukaryotic innovations in the Plantae. Consequently, the diatom chromist lineage likely obtained all paralogues of ZEP and VDE genes during the process of secondary endosymbiosis by gene transfer from the nucleus of the algal endosymbiont to the host nucleus. Furthermore, the presence of a ZEP gene in Tetrahymena thermophila provides the first evidence for a secondary plastid gene encoded in a heterotrophic ciliate, providing support for the chromalveolate hypothesis. Protein domain structures and expression analyses in the pennate diatom Phaeodactylum tricornutum indicate diverse roles for the different ZEP and VDE isoforms and demonstrate that they are differentially regulated by light. These studies therefore reveal the ancient origins of several components of the carotenoid biosynthesis pathway in photosynthetic eukaryotes and provide information about how they have diversified and acquired new functions in the diatoms.	[Coesel, Sacha; Falciatore, Angela; Bowler, Chris] Stazione Zool Anton Dohrn, Cell Signalling Lab, Naples, Italy; [Obornik, Miroslav] Univ S Bohemia, Acad Sci Czech Republic, Fac Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Varela, Joao] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Bowler, Chris] Ecole Normale Superieure, Dept Biol, CNRS UMR8186, Paris, France	Stazione Zoologica Anton Dohrn di Napoli; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Universidade do Algarve; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Coesel, S (corresponding author), Stazione Zool Anton Dohrn, Cell Signalling Lab, Naples, Italy.	cbowler@biologie.ens.fr	Obornik, Miroslav/G-9350-2014; Varela, João/M-4223-2013; Falciatore, Angela/Q-6161-2018; Coesel, Sacha/AAX-5588-2021; Bowler, Chris/AAC-6256-2019	Varela, João/0000-0003-3101-693X; Coesel, Sacha/0000-0001-9422-8388; Bowler, Chris/0000-0003-3835-6187; Falciatore, Angela/0000-0003-3318-9578	EU-funded FP6 Diatomics project [LSHG-CT-2004-512035]; EU-FP6 Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; CNRS; Agence Nationale de la Recherche (France); Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/BD/4839/2001]; Academy of Sciences of the Czech Republic [IAA500220502]; HFSP-CDA [0014/2006]; US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396];  [ATIP "Blanche"]	EU-funded FP6 Diatomics project; EU-FP6 Marine Genomics Network of Excellence(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); HFSP-CDA; US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); 	Funding for this work was obtained from the EU-funded FP6 Diatomics project (LSHG-CT-2004-512035), the EU-FP6 Marine Genomics Network of Excellence (GOCE-CT-2004-505403), an ATIP "Blanche" grant from CNRS, and the Agence Nationale de la Recherche (France) to CB, the Fundacao para a Ciencia e a Tecnologia (Portugal) to SC (SFRH/BD/4839/2001), the Grant Agency of the Academy of Sciences of the Czech Republic to MO (IAA500220502), and the HFSP-CDA (0014/2006) to AF. Diatom genome sequencing at the Joint Genome Institute (Walnut Creek, CA, USA) was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. P. tricornutum ESTs were generated at Genoscope (Evry, Paris).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Bohne F, 2002, BBA-GENE STRUCT EXPR, V1579, P26, DOI 10.1016/S0167-4781(02)00500-6; Bouvier F, 1996, J BIOL CHEM, V271, P28861, DOI 10.1074/jbc.271.46.28861; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Goss R, 2003, PLANTA, V217, P801, DOI 10.1007/s00425-003-1044-1; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Guillard R.R.L., 1975, CULTURE PHYTOPLANKTO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kooistra, 2007, ORIGIN EVOLUTION DIA; Kooistra WHCF, 2003, PROG MOLEC, V33, P59; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lavaud J, 2003, BIOCHEMISTRY-US, V42, P5802, DOI 10.1021/bi027112i; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Maheswari U, 2005, NUCLEIC ACIDS RES, V33, pD344, DOI 10.1093/nar/gki121; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Marquardt J, 2004, EUR J PHYCOL, V39, P285, DOI 10.1080/09670260410001712572; Mewes H, 2002, PLANT PHYSIOL, V130, P1527, DOI 10.1104/pp.006775; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nakamura Y, 2003, DNA RES, V10, P181, DOI 10.1093/dnares/10.4.181; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; PFUNDEL EE, 1994, PLANT PHYSIOL, V106, P1647, DOI 10.1104/pp.106.4.1647; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Salier JP, 2000, BBA-PROTEIN STRUCT M, V1482, P25, DOI 10.1016/S0167-4838(00)00144-8; Schubert N, 2006, J PHYCOL, V42, P1208, DOI 10.1111/j.1529-8817.2006.00274.x; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; STRANSKY H, 1970, ARCH MIKROBIOL, V73, P315, DOI 10.1007/BF00412298; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; YAMAMOTO HY, 1972, PLANT PHYSIOL, V49, P224, DOI 10.1104/pp.49.2.224; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	73	104	108	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2896	10.1371/journal.pone.0002896	http://dx.doi.org/10.1371/journal.pone.0002896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682837	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600052
J	Han, YX; Wang, XJ; Dang, Y; Zheng, YH				Han, Yanxing; Wang, Xiaojun; Dang, Ying; Zheng, Yong-Hui			Demonstration of a Novel HIV-1 Restriction Phenotype from a Human T Cell Line	PLOS ONE			English	Article								Background: Although retroviruses may invade host cells, a productive infection can be established only after the virus counteracts inhibition from different types of host restriction factors. Fv1, APOBEC3G/F, TRIM5 alpha, ZAP, and CD317 inhibit the replication of different retroviruses by interfering with viral uncoating, reverse transcription, nuclear import, RNA stability, and release. In humans, although APOBEC3G/3F and CD317 block HIV-1 replication, their antiviral activities are neutralized by viral proteins Vif and Vpu. So far, no human gene has been found to effectively block wild type HIV-1 replication under natural condition. Thus, identification of such a gene product would be of great medical importance for the development of HIV therapies. Method and Findings: In this study, we discovered a new type of host restriction against the wild type HIV-1 from a CD4/CXCR4 double-positive human T cell line. We identified a CEM-derived cell line (CEM.NKR) that is highly resistant to productive HIV-1 infection. Viral production was reduced by at least 1000-fold when compared to the other permissive human T cell lines such as H9, A3.01, and CEM-T4. Importantly, this resistance was evident at extremely high multiplicity of infection. Further analyses demonstrated that HIV-1 could finish the first round of replication in CEM.NKR cells, but the released virions were poorly infectious. These virions could enter the target cells, but failed to initiate reverse transcription. Notably, this restriction phenotype was also present in CEM.NKR and 293T heterokaryons. Conclusions: These results clearly indicate that CEM.NKR cells express a HIV inhibitory gene(s). Further characterization of this novel gene product(s) will reveal a new antiretroviral mechanism that directly inactivates wild type HIV-1.	[Han, Yanxing; Wang, Xiaojun; Dang, Ying; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.ed	Han, Yanxing/GRO-5138-2022	Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI080225, R56AI063944, R01AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant AI063944 from the National Institutes of Health to Y.-H.Z.	Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bour S, 2000, Adv Pharmacol, V48, P75; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; HOWELL DN, 1985, J IMMUNOL, V134, P971; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JOLICOEUR P, 1980, J VIROL, V33, P183, DOI 10.1128/JVI.33.1.183-195.1980; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kozak CA, 1996, VIROLOGY, V225, P300, DOI 10.1006/viro.1996.0604; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; LILLY F, 1967, SCIENCE, V155, P461, DOI 10.1126/science.155.3761.461; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Malyguine AM, 1998, IMMUNOL LETT, V61, P67, DOI 10.1016/S0165-2478(97)00164-8; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; ROWE WP, 1973, J EXP MED, V137, P850, DOI 10.1084/jem.137.3.850; SCOTT JE, 1995, J IMMUNOL, V155, P143; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Spenlehauer C, 2001, VIROLOGY, V280, P292, DOI 10.1006/viro.2000.0780; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YANG WK, 1980, P NATL ACAD SCI-BIOL, V77, P2994, DOI 10.1073/pnas.77.5.2994; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2796	10.1371/journal.pone.0002796	http://dx.doi.org/10.1371/journal.pone.0002796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665212	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300015
J	Hansson, B; Hasselquist, D; Tarka, M; Zehtindjiev, P; Bensch, S				Hansson, Bengt; Hasselquist, Dennis; Tarka, Maja; Zehtindjiev, Pavel; Bensch, Staffan			Postglacial Colonisation Patterns and the Role of Isolation and Expansion in Driving Diversification in a Passerine Bird	PLOS ONE			English	Article								Pleistocene glacial cycles play a major role in diversification and speciation, although the relative importance of isolation and expansion in driving diversification remains debated. We analysed mitochondrial DNA sequence data from 15 great reed warbler (Acrocephalus arundinaceus) populations distributed over the vast Eurasian breeding range of the species, and revealed unexpected postglacial expansion patterns from two glacial refugia. There were 58 different haplotypes forming two major clades, A and B. Clade A dominated in Western Europe with declining frequencies towards Eastern Europe and the Middle East, but showed a surprising increase in frequency in Western and Central Asia. Clade B dominated in the Middle East, with declining frequencies towards north in Central and Eastern Europe and was absent from Western Europe and Central Asia. A parsimonious explanation for these patterns is independent postglacial expansions from two isolated refugia, and mismatch distribution analyses confirmed this suggestion. Gene flow analyses showed that clade A colonised both Europe and Asia from a refugium in Europe, and that clade B expanded much later and colonised parts of Europe from a refugium in the Middle East. Great reed warblers in the eastern parts of the range have slightly paler plumage than western birds (sometimes treated as separate subspecies; A. a. zarudnyi and A. a. arundinaceus, respectively) and our results suggest that the plumage diversification took place during the easterly expansion of clade A. This supports the postglacial expansion hypothesis proposing that postglacial expansions drive diversification in comparatively short time periods. However, there is no indication of any (strong) reproductive isolation between clades and our data show that the refugia populations became separated during the last glaciation. This is in line with the Pleistocene speciation hypothesis invoking that much longer periods of time in isolation are needed for speciation to occur.	[Hansson, Bengt; Hasselquist, Dennis; Tarka, Maja; Bensch, Staffan] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Zehtindjiev, Pavel] Bulgarian Acad Sci, Inst Zool, Sofia, Bulgaria	Lund University; Bulgarian Academy of Sciences	Hansson, B (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.	bengt.hansson@zooekol.lu.se	Hansson, Bengt/L-8874-2013; Tarka, Maja/L-8065-2013; Hasselquist, Dennis/M-5223-2014; Zehtidiev, Pavel/K-3236-2012	Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101; Hasselquist, Dennis/0000-0002-0056-6616; Zehtidiev, Pavel/0000-0002-9786-3974	Swedish Research Council; Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society; Crafoordska Stiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society(National Geographic Society); Crafoordska Stiftelsen	The work was supported by grants from the Swedish Research Council (VR), the Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the National Swedish Environment Protection Board, the Carl Tryggers stiftelse, the Royal Swedish Academy of Science (the K. and A. Wallenbergs, the J.A. Ahlstrand, and the Hierta-Retzius Foundations), the Lunds Djurskyddsfond, the Magn Bergvalls Stiftelse, the National Geographic Society and the Crafoordska Stiftelsen.	[Anonymous], 1992, HDB BIRDS EUROPE MID; Baker Allan J., 1997, P51, DOI 10.1016/B978-012498315-1/50005-4; Ben-Shlomo R, 2007, MAMM GENOME, V18, P164, DOI 10.1007/s00335-007-9001-0; BENSCH S, 1991, J ANIM ECOL, V60, P857, DOI 10.2307/5418; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; Bensch S, 1999, BIOL J LINN SOC, V66, P171, DOI 10.1006/bijl.1998.0261; Bensch S, 1999, EVOLUTION, V53, P1925, DOI 10.1111/j.1558-5646.1999.tb04573.x; Coyne JA, 2004, SPECIATION, V37; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; De Roo A., 1969, Gerfaut, V59, P260; del Hoyo J., 2006, HDB BIRDS WORLD; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, OECOLOGIA, V130, P536, DOI 10.1007/s00442-001-0831-2; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hansson B, 2003, MOL ECOL, V12, P631, DOI 10.1046/j.1365-294X.2003.01772.x; Hansson B, 2000, ECOLOGY, V81, P319, DOI 10.2307/177429; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hansson B, 2002, J AVIAN BIOL, V33, P311, DOI 10.1034/j.1600-048X.2002.330314.x; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUDSON RR, 1992, GENETICS, V132, P583; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; ILES MM, 1998, AM J HUM GENET, V63, pA42; Johnson NK, 2004, EVOLUTION, V58, P1122; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; NYLANDER JAA, 2004, MRMODELTEST2; Odeen A, 2003, MOL ECOL, V12, P2113, DOI 10.1046/j.1365-294X.2003.01883.x; OTTVALL R, 2002, AVIAN SCI, V4, P237; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saetre GP, 1997, NATURE, V387, P589; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SEUTIN G, 1995, EVOLUTION, V49, P962, DOI 10.1111/j.1558-5646.1995.tb02331.x; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SPENCER HG, 1986, AM NAT, V128, P241, DOI 10.1086/284557; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wenink PW, 1996, EVOLUTION, V50, P318, DOI 10.1111/j.1558-5646.1996.tb04495.x; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; [No title captured]	59	46	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2794	10.1371/journal.pone.0002794	http://dx.doi.org/10.1371/journal.pone.0002794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665223	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300013
J	Ospina-Alvarez, N; Piferrer, F				Ospina-Alvarez, Natalia; Piferrer, Francesc			Temperature-Dependent Sex Determination in Fish Revisited: Prevalence, a Single Sex Ratio Response Pattern, and Possible Effects of Climate Change	PLOS ONE			English	Article								Background: In gonochoristic vertebrates, sex determination mechanisms can be classified as genotypic (GSD) or temperature-dependent (TSD). Some cases of TSD in fish have been questioned, but the prevalent view is that TSD is very common in this group of animals, with three different response patterns to temperature. Methodology/Principal Findings: We analyzed field and laboratory data for the 59 fish species where TSD has been explicitly or implicitly claimed so far. For each species, we compiled data on the presence or absence of sex chromosomes and determined if the sex ratio response was obtained within temperatures that the species experiences in the wild. If so, we studied whether this response was statistically significant. We found evidence that many cases of observed sex ratio shifts in response to temperature reveal thermal alterations of an otherwise predominately GSD mechanism rather than the presence of TSD. We also show that in those fish species that actually have TSD, sex ratio response to increasing temperatures invariably results in highly male-biased sex ratios, and that even small changes of just 1-2 degrees C can significantly alter the sex ratio from 1:1 (males:females) up to 3:1 in both freshwater and marine species. Conclusions/Significance: We demonstrate that TSD in fish is far less widespread than currently believed, suggesting that TSD is clearly the exception in fish sex determination. Further, species with TSD exhibit only one general sex ratio response pattern to temperature. However, the viability of some fish populations with TSD can be compromised through alterations in their sex ratios as a response to temperature fluctuations of the magnitude predicted by climate change.	[Ospina-Alvarez, Natalia; Piferrer, Francesc] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Ospina-Alvarez, N (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	piferrer@icm.csic.es	Piferrer, Francesc/A-5634-2012; Ospina-Alvarez, Natalia/B-8067-2010	Piferrer, Francesc/0000-0003-0903-4736; Ospina-Alvarez, Natalia/0000-0001-8916-9934	Spanish Ministry of Education and Science; Government of Catalonia	Spanish Ministry of Education and Science(Spanish Government); Government of Catalonia(Generalitat de Catalunya)	Work supported by a Spanish Ministry of Education and Science grant ("Sexratio") to F.P. N.O.A. was supported by a scholarship from the aquaculture network (XRAq) from the Government of Catalonia.	Aida S, 1998, FISHERIES SCI, V64, P989, DOI 10.2331/fishsci.64.989; Azuma T, 2004, AQUACULTURE, V234, P461, DOI 10.1016/j.aquaculture.2003.11.023; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; BEAMISH FW, 1993, CAN J FISH AQUAT SCI, V50, P1299, DOI 10.1139/f93-147; Bezault E, 2007, AQUACULTURE, V272, pS3, DOI 10.1016/j.aquaculture.2007.07.227; Biro PA, 2007, P NATL ACAD SCI USA, V104, P9715, DOI 10.1073/pnas.0701638104; Bull J. J., 1983, EVOLUTION SEX DETERM; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Conover David O., 2004, P11; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1987, COPEIA, P732, DOI 10.2307/1445667; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CONOVER DO, 1992, EVOLUTION, V46, P1722, DOI 10.1111/j.1558-5646.1992.tb01164.x; CORNEJO AM, 2003, BIOL ACUAT, V20, P19; Craig JK, 1996, CAN J FISH AQUAT SCI, V53, P141, DOI 10.1139/cjfas-53-1-141; CREWS D, 1994, J ENDOCRINOL, V142, P1, DOI 10.1677/joe.0.1420001; DAVIS KB, 1990, GEN COMP ENDOCR, V78, P218, DOI 10.1016/0016-6480(90)90008-A; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; FROESE R, 2008, FISHBASE; Fujioka Y, 2001, J FISH BIOL, V59, P851, DOI 10.1006/jfbi.2001.1700; HARRINGTON RW, 1967, BIOL BULL-US, V132, P174, DOI 10.2307/1539887; Harvey SC, 2003, CYTOGENET GENOME RES, V101, P314, DOI 10.1159/000074355; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; HOSTACHE G, 1995, CAN J ZOOL, V73, P1239, DOI 10.1139/z95-148; IPCC, 2007, CLIM CHANG 2007 PHYS; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Janzen Fredric J., 2004, P121; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; Kamel SJ, 2006, ECOL APPL, V16, P923, DOI 10.1890/1051-0761(2006)016[0923:DROSRD]2.0.CO;2; KRAAK SBM, 1993, NETH J ZOOL, V43, P260; Krueger WH, 1999, ENVIRON BIOL FISH, V55, P381, DOI 10.1023/A:1007575600789; Luckenbach JA, 2003, AQUACULTURE, V216, P315, DOI 10.1016/S0044-8486(02)00407-6; MAIR GC, 1991, THEOR APPL GENET, V82, P153, DOI 10.1007/BF00226206; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; NANDA I, 1993, J EXP ZOOL, V265, P301, DOI 10.1002/jez.1402650311; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nelson JS, 1984, FISHES WORLD; Nomura T, 1998, FISHERIES SCI, V64, P753, DOI 10.2331/fishsci.64.753; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; PANDIAN TJ, 1990, J EXP ZOOL, V255, P88, DOI 10.1002/jez.1402550112; PARKER K, 1980, FISH B-NOAA, V78, P541; Patino R, 1996, J EXP ZOOL, V276, P209, DOI 10.1002/(SICI)1097-010X(19961015)276:3&lt;209::AID-JEZ5&gt;3.0.CO;2-R; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Piferrer F, 2005, GEN COMP ENDOCR, V142, P102, DOI 10.1016/j.ygcen.2005.02.011; PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Romer U, 1996, J FISH BIOL, V48, P714, DOI 10.1111/j.1095-8649.1996.tb01467.x; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Strussmann C.A., 1999, ENCY REPROD; SULLIVAN JA, 1986, EVOLUTION, V40, P152, DOI 10.1111/j.1558-5646.1986.tb05726.x; TABATA K, 1995, FISHERIES SCI, V61, P199, DOI 10.2331/fishsci.61.199; TABATA K, 1991, NIPPON SUISAN GAKK, V57, P845; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; UEDA T, 1984, B JPN SOC SCI FISH, V50, P1495; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Yamamoto E, 1999, AQUACULTURE, V173, P235, DOI 10.1016/S0044-8486(98)00448-7; YAMAMOTO TO, 1968, J EXP ZOOL, V168, P215, DOI 10.1002/jez.1401680209; Zar JH., 1999, BIOSTAT ANAL	60	358	379	11	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2837	10.1371/journal.pone.0002837	http://dx.doi.org/10.1371/journal.pone.0002837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665231	Green Submitted, gold, Green Published			2022-12-25	WOS:000264304300056
J	Ostrom, M; Loffler, KA; Edfalk, S; Selander, L; Dahl, U; Ricordi, C; Jeon, J; Correa-Medina, M; Diez, J; Edlund, H				Ostrom, Maria; Loffler, Kelly A.; Edfalk, Sara; Selander, Lars; Dahl, Ulf; Ricordi, Camillo; Jeon, Jongmin; Correa-Medina, Mayrin; Diez, Juan; Edlund, Helena			Retinoic Acid Promotes the Generation of Pancreatic Endocrine Progenitor Cells and Their Further Differentiation into beta-Cells	PLOS ONE			English	Article							EMBRYONIC PANCREAS; MOTOR-NEURONS; INSULIN GENE; NEUROGENIN3; EXPRESSION; EMBRYOGENESIS; REQUIREMENT; ACTIVATION; MECHANISMS; MESODERM	The identification of secreted factors that can selectively stimulate the generation of insulin producing beta-cells from stem and/or progenitor cells represent a significant step in the development of stem cell-based beta-cell replacement therapy. By elucidating the molecular mechanisms that regulate the generation of beta-cells during normal pancreatic development such putative factors may be identified. In the mouse, beta-cells increase markedly in numbers from embryonic day (e) 14.5 and onwards, but the extra-cellular signal(s) that promotes the selective generation of beta-cells at these stages remains to be identified. Here we show that the retinoic acid (RA) synthesizing enzyme Raldh1 is expressed in developing mouse and human pancreas at stages when beta-cells are generated. We also provide evidence that RA induces the generation of Ngn3(+) endocrine progenitor cells and stimulates their further differentiation into beta-cells by activating a program of cell differentiation that recapitulates the normal temporal program of beta-cell differentiation.	[Ostrom, Maria; Loffler, Kelly A.; Edfalk, Sara; Selander, Lars; Dahl, Ulf] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Ricordi, Camillo; Jeon, Jongmin; Correa-Medina, Mayrin; Diez, Juan; Edlund, Helena] Univ Miami, Leonard M Miller Sch Med, Diabetes Res Inst, Miami, FL USA	Umea University; University of Miami	Ostrom, M (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	helena.edlund@ucmm.umu.se	RICORDI, CAMILLO/AAA-4740-2019	Edlund, Helena/0000-0002-3553-7348; Loffler, Kelly/0000-0003-3302-5995; Ricordi, Camillo/0000-0001-8092-7153	Swedish Research Council; Juvenile Diabetes Research Foundation; Diabetes Research Institute Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Research Institute Foundation	This work was supported by grants from the Swedish Research Council, Juvenile Diabetes Research Foundation, and the Diabetes Research Institute Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; BRISCOE J, 2007, PHIL T R SOC B  0205; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Diez del Corral R, 2003, NEURON, V40, P65; Dumonteil E, 1996, DIABETES METAB, V22, P164; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Esni F, 2001, DEV BIOL, V238, P202, DOI 10.1006/dbio.2001.0405; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Li ZX, 2004, DEV BIOL, V269, P252, DOI 10.1016/j.ydbio.2004.01.043; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Pictet R., 1972, HDB PHYSL, P25; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Selander L, 2002, MECH DEVELOP, V113, P189, DOI 10.1016/S0925-4773(02)00023-0; Shen CN, 2007, DIFFERENTIATION, V75, P62, DOI 10.1111/j.1432-0436.2006.00116.x; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tulachan SS, 2003, DIABETES, V52, P76, DOI 10.2337/diabetes.52.1.76; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772	41	96	130	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2841	10.1371/journal.pone.0002841	http://dx.doi.org/10.1371/journal.pone.0002841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665267	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300060
J	Gortazar, C; Torres, MJ; Vicente, J; Acevedo, P; Reglero, M; de la Fuente, J; Negro, JJ; Aznar-Martin, J				Gortazar, Christian; Torres, Maria Jose; Vicente, Joaquin; Acevedo, Pelayo; Reglero, Manuel; de la Fuente, Jose; Negro, Juan Jose; Aznar-Martin, Javier			Bovine Tuberculosis in Donana Biosphere Reserve: The Role of Wild Ungulates as Disease Reservoirs in the Last Iberian Lynx Strongholds	PLOS ONE			English	Article							MANDIBULAR LYMPH-NODES; DEER CERVUS-ELAPHUS; BOAR SUS-SCROFA; MYCOBACTERIUM-BOVIS; RED DEER; OROPHARYNGEAL TONSILS; HOME-RANGE; DAMA-DAMA; 4 AREAS; EPIDEMIOLOGY	Donana National Park (DNP) in southern Spain is a UNESCO Biosphere Reserve where commercial hunting and wildlife artificial feeding do not take place and traditional cattle husbandry still exists. Herein, we hypothesized that Mycobacterium bovis infection prevalence in wild ungulates will depend on host ecology and that variation in prevalence will reflect variation in the interaction between hosts and environmental risk factors. Cattle bTB reactor rates increased in DNP despite compulsory testing and culling of infected animals. In this study, 124 European wild boar, 95 red deer, and 97 fallow deer were sampled from April 2006 to April 2007 and analyzed for M. bovis infection. Modelling and GIS were used to identify risk factors and intra and inter-species relationships. Infection with M. bovis was confirmed in 65 (52.4%) wild boar, 26 (27.4%) red deer and 18 (18.5%) fallow deer. In the absence of cattle, wild boar M. bovis prevalence reached 92.3% in the northern third of DNP. Wild boar showed more than twice prevalence than that in deer (p<0.001). Modelling revealed that M. bovis prevalence decreased from North to South in wild boar (p<0.001) and red deer (p<0.01), whereas no spatial pattern was evidenced for fallow deer. Infection risk in wild boar was dependent on wild boar M. bovis prevalence in the buffer area containing interacting individuals (p<0.01). The prevalence recorded in this study is among the highest reported in wildlife. Remarkably, this high prevalence occurs in the absence of wildlife artificial feeding, suggesting that a feeding ban alone would have a limited effect on wildlife M. bovis prevalence. In DNP, M. bovis transmission may occur predominantly at the intra-species level due to ecological, behavioural and epidemiological factors. The results of this study allow inferring conclusions on epidemiological bTB risk factors in Mediterranean habitats that are not managed for hunting purposes. Our results support the need to consider wildlife species for the control of bTB in cattle and strongly suggest that bTB may affect animal welfare and conservation.	[Gortazar, Christian; Vicente, Joaquin; Acevedo, Pelayo; Reglero, Manuel; de la Fuente, Jose] UCLM, JCCM, CSIC, IREC Natl Wildlife Res Inst, Ciudad Real, Spain; [Torres, Maria Jose] Univ Seville, Dept Microbiol, Seville, Spain; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK USA; [Negro, Juan Jose] CSIC, Estacion Biol Donana, Dept Evolutionary Ecol, Seville, Spain; [Aznar-Martin, Javier] HH UU Virgen Rocio, Serv Microbiol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Sevilla; Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gortazar, C (corresponding author), UCLM, JCCM, CSIC, IREC Natl Wildlife Res Inst, Ciudad Real, Spain.	christian.gortazar@uclm.es	de la Fuente, José/AAU-1197-2020; Torres, Maria/GVU-3391-2022; Acevedo, Pelayo/L-6737-2013; Negro, Juan Jose/I-2653-2015; IBIS, TUBERCULOSIS/O-9334-2015; Gortazar, Christian/E-7918-2012; Vicente, Joaquín/K-7822-2013	de la Fuente, José/0000-0001-7383-9649; Acevedo, Pelayo/0000-0002-3509-7696; Negro, Juan Jose/0000-0002-8697-5647; Gortazar, Christian/0000-0003-0012-4006; Vicente, Joaquín/0000-0001-8416-3672; Aznar Martin, Javier/0000-0001-7285-9728	Consejeria de Medio Ambiente, Junta de Andalucia; CICYT [AGL2005-07401]; INIA; Principado de Asturias; Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA); Grupo Santander - Fundacion Marcelino Botin	Consejeria de Medio Ambiente, Junta de Andalucia(Junta de Andalucia); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); INIA(Instituto de Investigacion Agropecuaria (INIA)); Principado de Asturias(Principality of Asturias); Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA); Grupo Santander - Fundacion Marcelino Botin	The study was funded by Consejeria de Medio Ambiente, Junta de Andalucia. This is a contribution to CICYT - MEC research grant AGL2005-07401. Studies on diseases shared between domestics and wildlife are also supported by grants and contracts from INIA, Principado de Asturias, Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA), and Grupo Santander - Fundacion Marcelino Botin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; BELTRAN JF, 1985, P 17 C INT UN GAM BI, P961; BRAZA F, 1986, ACTA THERIOL, V31, P467, DOI 10.4098/AT.arch.86-42; CALDERON J, VACA MOSTRE IN PRESS; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; Clifton-Hadley RS, 2005, CATTLE PRACT, V13, P369; Davini S, 2004, ACTA THERIOL, V49, P393, DOI 10.1007/BF03192537; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; de Mera IGF, 2008, DEV COMP IMMUNOL, V32, P85, DOI 10.1016/j.dci.2007.05.001; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; GARCIA MAG, 1999, INFORM PRELIMI UNPUB; Gil-Sanchez JM, 2006, ACTA THERIOL, V51, P85, DOI 10.1007/BF03192659; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2003, VET REC, V152, P779, DOI 10.1136/vr.152.25.779; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Griffin JFT, 2004, TUBERCULOSIS, V84, P293, DOI 10.1016/j.tube.2003.11.001; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Lugton IW, 1998, NEW ZEAL VET J, V46, P147, DOI 10.1080/00480169.1998.36079; Machackova M, 2003, VET MED-CZECH, V48, P51, DOI 10.17221/5750-VETMED; Martin S. W, 1987, VET EPIDEMIOLOGY, P48; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; MIGNONE W, 1996, RICER BIOL SELV S, V24, P619; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; MUNRO R, 1986, MANAGEMENT DISEASES, P157; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Naranjo Victoria, 2007, Animal Health Research Reviews, V8, P81, DOI 10.1017/S1466252307001260; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Naranjo V, 2007, PROTEOMICS, V7, P220, DOI 10.1002/pmic.200600527; Naranjo V, 2006, VET MICROBIOL, V116, P224, DOI 10.1016/j.vetmic.2006.03.013; Nishi JS, 2002, ANN NY ACAD SCI, V969, P236, DOI 10.1111/j.1749-6632.2002.tb04385.x; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; Olea-Popelka FJ, 2003, PREV VET MED, V59, P103, DOI 10.1016/S0167-5877(03)00055-2; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Perez J, 2001, VET REC, V148, P414, DOI 10.1136/vr.148.13.414; Pfeiffer DU, 1995, NEW ZEAL VET J, V43, P272, DOI 10.1080/00480169./1995.35906; RHYAN JC, 1995, VET PATHOL, V32, P215, DOI 10.1177/030098589503200301; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Serraino A, 1999, J CLIN MICROBIOL, V37, P2766, DOI 10.1128/JCM.37.9.2766-2771.1999; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; VIZCAINO LL, 1990, 32 INT S ERKR ZOO WI; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	57	122	124	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2776	10.1371/journal.pone.0002776	http://dx.doi.org/10.1371/journal.pone.0002776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648665	Green Published, gold			2022-12-25	WOS:000264302900046
J	Danielian, PS; Friesenhahn, LB; Faust, AM; West, JC; Caron, AM; Bronson, RT; Lees, JA				Danielian, P. S.; Friesenhahn, L. B.; Faust, A. M.; West, J. C.; Caron, A. M.; Bronson, R. T.; Lees, J. A.			E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity	ONCOGENE			English	Article						E2f3; Arf; cell cycle; E2f1	HUMAN BLADDER-CANCER; CELLULAR PROLIFERATION; TRANSCRIPTION FACTOR; OVEREXPRESSION; AMPLIFICATION; EXPRESSION; IDENTIFICATION; SPECIFICITY; REPRESSION; APOPTOSIS	The E2f transcription factors are key downstream targets of the retinoblastoma protein tumor suppressor that control cell proliferation. E2F3 has garnered particular attention because it is amplified in various human tumors. E2f3 mutant mice typically die around birth and E2f3-deficient cells have a proliferation defect that correlates with impaired E2f target gene activation and also induction of p19(Arf) and p53. The E2f3 locus encodes two isoforms, E2f3a and E2f3b, which differ in their N-termini. However, it is unclear how E2f3a versus E2f3b contributes to E2f3's requirement in either proliferation or development. To address this, we use E2f3a- and E2f3b-specific knockouts. We show that inactivation of E2f3a results in a low penetrance proliferation defect in vitro whereas loss of E2f3b has no effect. This proliferation defect appears insuficient to disrupt normal development as E2f3a and E2f3b mutant mice are both fully viable and have no detectable defects. However, when combined with E2f1 mutation, inactivation of E2f3a, but not E2f3b, causes significant proliferation defects in vitro, neonatal lethality and also a striking cartilage defect. Thus, we conclude that E2f3a and E2f3b have largely overlapping functions in vivo and that E2f3a can fully substitute for E2f1 and E2f3 in most murine tissues.	[Danielian, P. S.; Friesenhahn, L. B.; Faust, A. M.; West, J. C.; Caron, A. M.; Lees, J. A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Bronson, R. T.] Tufts Cummings Sch Vet Med, North Grafton, MA USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Mass Ave,E17-517B, Cambridge, MA 02139 USA.	jalees@mit.edu		Danielian, Paul/0000-0003-2651-0386	NIH [CA118757]; NATIONAL CANCER INSTITUTE [R01CA118757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Aurora Burds Connor and the MIT Fannie E Rippel transgenic facility; the KI Flow Cytometry facility for technical assistance; Donald Court, Neal Copeland, Nancy Jenkins and Lili Yamasaki for reagents and mouse strains and Keara Lane, Daniel Garcia, GuangJun Zhang and Lees laboratory members for helpful suggestions. This work was supported by an NIH grant to JAL (CA118757). JAL is a Ludwig Scholar.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Berthet C, 2007, ONCOGENE, V26, P4469, DOI 10.1038/sj.onc.1210243; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; Danielian PS, 2007, DEV BIOL, V305, P564, DOI 10.1016/j.ydbio.2007.02.037; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Humbert PO, 2000, GENE DEV, V14, P690; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Oeggerli M, 2006, ONCOGENE, V25, P6538, DOI 10.1038/sj.onc.1209946; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	27	43	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 30	2008	27	51					6561	6570		10.1038/onc.2008.253	http://dx.doi.org/10.1038/onc.2008.253			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18663357	Green Submitted, Green Accepted			2022-12-25	WOS:000260501700003
J	Larade, K; Jiang, ZG; Zhang, YZ; Wang, WF; Bonner-Weir, S; Zhu, H; Bunn, HF				Larade, Kevin; Jiang, Zhigang; Zhang, Yongzhao; Wang, WenFang; Bonner-Weir, Susan; Zhu, Hao; Bunn, H. Franklin			Loss of Ncb5or Results in Impaired Fatty Acid Desaturation, Lipoatrophy, and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; COENZYME-A DESATURASE; BREAST-CANCER CELLS; FACTOR-KAPPA-B; CONGENITAL METHEMOGLOBINEMIA; CYTOCHROME-B5 REDUCTASE; GENERALIZED DEFICIENCY; MENTAL-RETARDATION	Targeted ablation of the novel flavoheme reductase Ncb5or knock-out (KO) results in progressive loss of pancreatic beta-cells and white adipose tissue over time. Lipoatrophy persisted in KO animals in which the confounding metabolic effects of diabetes were eliminated by islet transplantation (transplanted knockout (TKO)). Lipid profiles in livers prepared from TKO animals were markedly deficient in triglycerides and diacylglycerides. Despite enhanced expression of stearoyl-Co-A desaturase-1, levels of palmitoleic and oleic acids (Delta 9 fatty acid desaturation) were decreased in TKO relative to wild type controls. Treatment of KO hepatocytes with palmitic acid reduced cell viability and increased apoptosis, a response blunted by coincubation with oleic acid. The results presented here support the hypothesis that Ncb5or supplies electrons for fatty acid desaturation, offer new insight into the regulation of a crucial step in fatty acid biosynthesis, and provide a plausible explanation for both the diabetic and the lipoatrophic phenotype in Ncb5or(-/-) mice.	[Larade, Kevin; Jiang, Zhigang; Zhang, Yongzhao; Bunn, H. Franklin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Sch Allied Hlth, Kansas City, KS 66160 USA; [Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Bunn, HF (corresponding author), CHRB 5-215,75 Francis St, Boston, MA 02115 USA.	hfbunn@rics.bwh.harvard.edu		Bonner-Weir, Susan/0000-0003-4682-0656	National Institutes of Health [DK067355, AI56374]; Juvenile Diabetes Research Foundation [1-2005-121, 3-2005-232]; American Diabetes Association [7-04-RA-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067355 and AI56374. This work was also supported by Juvenile Diabetes Research Foundation Grants 1-2005-121 and 3-2005-232 and American Diabetes Association Grant 7-04-RA-15. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bulbarelli A, 1998, BLOOD, V92, P310, DOI 10.1182/blood.V92.1.310.413k24_310_319; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; GIORDANO SJ, 1991, BIOCHEM BIOPH RES CO, V178, P38, DOI 10.1016/0006-291X(91)91776-9; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; HIRONO H, 1984, LIPIDS, V19, P60, DOI 10.1007/BF02534610; HIRONO H, 1980, LIPIDS, V15, P272, DOI 10.1007/BF02535839; HIRONO H, 1983, TOHOKU J EXP MED, V140, P391, DOI 10.1620/tjem.140.391; HOLLOWAY PW, 1972, BIOCHEMISTRY-US, V11, P3689, DOI 10.1021/bi00770a005; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; KIMURA S, 1984, FEBS LETT, V169, P143, DOI 10.1016/0014-5793(84)80306-3; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Leonard AE, 2000, BIOCHEM J, V347, P719, DOI 10.1042/0264-6021:3470719; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PIETRINI G, 1992, J CELL BIOL, V117, P975, DOI 10.1083/jcb.117.5.975; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sperling P, 2001, EUR J LIPID SCI TECH, V103, P158, DOI 10.1002/1438-9312(200103)103:3<158::AID-EJLT158>3.0.CO;2-1; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; VIEIRA LM, 1994, EUR J BIOCHEM, V220, P729, DOI 10.1111/j.1432-1033.1994.tb18673.x; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	52	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29285	29291		10.1074/jbc.M804645200	http://dx.doi.org/10.1074/jbc.M804645200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682384	Green Published, hybrid			2022-12-25	WOS:000260179900055
J	Mark, JK; Aubin, RA; Smith, S; Hefford, MA				Mark, John K.; Aubin, Remy A.; Smith, Sophie; Hefford, Mary Alice			Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASE PHOSPHATASE; SECONDARY STRUCTURE; CATALYTIC ACTIVATION; DOMAIN; MKP3; EXPRESSION; ERK2; MECHANISM; PYST1/MKP3; DICHROWEB	Mitogen-activated protein (MAP) kinase phosphatase 3 (MKP3) is a cytoplasmic dual specificity phosphatase that functions to attenuate signaling via dephosphorylation and subsequent deactivation of its substrate and allosteric regulator, extracellular signal-regulated protein kinase 2 (ERK2). Expression of MKP3 has been shown to be under the control of ERK2, thus providing an elegant feedback mechanism for regulating the rate and duration of proliferative signals. Previously published studies suggest that MKP3 might serve as a tumor suppressor; however, significantly elevated, rather than reduced, levels of this protein have been reported in early lesions. Because overexpression of this phosphatase is counterintuitive to a proposed tumor suppressor function, the observed cellular tolerance suggested a self-inactivation mechanism. Using surface plasmon resonance, we have provided direct evidence of physical interaction between the N-and C-terminal domains. Kinetic analysis using dimethyl sulfoxide to activate the C-terminal fragment in the absence of ERK2 showed that the isolated C-terminal domain had higher catalytic efficiency than the similarly activated full-length protein. Furthermore, when the isolated N-terminal domain was added to the activated C-terminal domain, a dose-dependant inhibition of catalytic activity was observed. The similarity between the K-I and K-D values obtained indicate that interdomain binding stabilizes the inactive conformation of the catalytic site and implies that the N-terminal domain functions as an allosteric inhibitor of phosphatase activity. Finally, we have provided evidence for oligomerization of MKP3 in pancreatic cancer cells expressing elevated levels of this phosphatase.	[Mark, John K.; Aubin, Remy A.; Smith, Sophie; Hefford, Mary Alice] Hlth Canada, Biol Res Ctr, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada	Hefford, MA (corresponding author), Hlth Canada, Biol Res Ctr, Biol & Genet Therapies Directorate, 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0L2, Canada.	Mary_Hefford@hc-sc.gc.ca						BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; Echevarria D, 2005, DEV BIOL, V277, P114, DOI 10.1016/j.ydbio.2004.09.011; Evans DRH, 1998, NATURE, V394, P23, DOI 10.1038/27782; Farooq A, 2001, J BIOMOL NMR, V19, P195, DOI 10.1023/A:1008344405731; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Furukawa T, 2006, ONCOGENE, V25, P4831, DOI 10.1038/sj.onc.1209494; Furukawa T, 2006, CANCER SCI, V97, P1, DOI 10.1111/j.1349-7006.2005.00134.x; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Furukawa T, 2004, PANCREAS, V28, P253, DOI 10.1097/00006676-200404000-00007; Furukawa T, 1998, CYTOGENET CELL GENET, V82, P156, DOI 10.1159/000015091; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Itoh M, 1998, J HUM GENET, V43, P9, DOI 10.1007/s100380050030; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Mark JK, 2007, PROTEIN EXPRES PURIF, V54, P253, DOI 10.1016/j.pep.2007.03.004; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD85, DOI 10.2741/mustelin; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rigas JD, 2001, BIOCHEMISTRY-US, V40, P4398, DOI 10.1021/bi002951v; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Theodosiou A, 2002, GENOME BIOL, V3; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wang J, 1997, BIOCHEMISTRY-US, V36, P2993, DOI 10.1021/bi9611873; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Yoshida E, 2004, MOL BRAIN RES, V131, P33, DOI 10.1016/j.molbrainres.2004.08.023; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	43	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28574	28583		10.1074/jbc.M801747200	http://dx.doi.org/10.1074/jbc.M801747200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694935	Green Published, hybrid			2022-12-25	WOS:000259969300060
J	Monk, CE; Pearson, BM; Mulholland, F; Smith, HK; Poole, RK				Monk, Claire E.; Pearson, Bruce M.; Mulholland, Francis; Smith, Holly K.; Poole, Robert K.			Oxygen- and NssR-dependent globin expression and enhanced iron acquisition in the response of Campylobacter to nitrosative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CULTURED ESCHERICHIA-COLI; SINGLE-DOMAIN HEMOGLOBIN; NITRIC-OXIDE; GENE-EXPRESSION; TRUNCATED HEMOGLOBIN; S-NITROSOGLUTATHIONE; HELICOBACTER-PYLORI; TRANSCRIPTIONAL RESPONSES; FUNCTIONAL-PROPERTIES	Pathogenic bacteria experience nitrosative stress from NO generated in the host and from nitrosating species such as S-nitrosoglutathione. The food-borne pathogen Campylobacter jejuni responds by activating gene expression from a small regulon under the control of the NO-sensitive regulator, NssR. Here, we describe the full extent of the S-nitrosoglutathione response using transcriptomic and proteomic analysis of batch- and chemostat-cultured C. jejuni. In addition to the NssR regulon, which includes two hemoglobins (Cgb and Ctb), we identify more than 90 other up-regulated genes, notably those encoding heat shock proteins and proteins involved in oxidative stress tolerance and iron metabolism/transport. Up-regulation of a subset of these genes, including cgb, is also elicited by NO-releasing compounds. Mutation of the iron-responsive regulator Fur results in insensitivity of growth to NO, suggesting that derepression of iron-regulated genes and augmentation of iron acquisition is a physiological response to nitrosative damage. We describe the effect of oxygen availability on nitrosative stress tolerance; cells cultured at higher rates of oxygen diffusion have elevated levels of hemoglobins, are more resistant to inhibition by NO of both growth and respiration, and consume NO more rapidly. The oxygen response is mediated by NssR. Thus, in addition to NO detoxification catalyzed by the hemoglobins Cgb and possibly Ctb, C. jejuni mounts an extensive stress response. We suggest that inhibition of respiration by NO may increase availability of oxygen for Cgb synthesis and function.	[Monk, Claire E.; Smith, Holly K.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Pearson, Bruce M.; Mulholland, Francis] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Sheffield; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk		Pearson, Bruce/0000-0002-9223-7712	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Biotechnology and Biological Sciences Research Council [BB/E010504/1, BBS/E/F/00042291] Funding Source: researchfish; BBSRC [BB/E010504/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan E, 2001, MICROBIOL-SGM, V147, P2285, DOI 10.1099/00221287-147-8-2285; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Donzelli S, 2006, FREE RADICAL BIO MED, V40, P1056, DOI 10.1016/j.freeradbiomed.2005.10.058; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Friedman C.R., 2000, CAMPYLOBACTER, P121; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; GOODHEW CF, 1988, BIOCHIM BIOPHYS ACTA, V933, P114, DOI 10.1016/0005-2728(88)90061-8; Guerry P, 1997, J BACTERIOL, V179, P3997, DOI 10.1128/jb.179.12.3997-4002.1997; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hernandez-Urzua E, 2007, ARCH MICROBIOL, V187, P67, DOI 10.1007/s00203-006-0175-8; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Homuth G, 2000, J BACTERIOL, V182, P4257, DOI 10.1128/JB.182.15.4257-4263.2000; HUGHES MN, 1991, J GEN MICROBIOL, V137, P725, DOI 10.1099/00221287-137-4-725; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Iovine NM, 2008, INFECT IMMUN, V76, P986, DOI 10.1128/IAI.01063-07; Janvier B, 1998, RES MICROBIOL, V149, P95, DOI 10.1016/S0923-2508(98)80025-9; Jarboe LR, 2008, J BIOL CHEM, V283, P5148, DOI 10.1074/jbc.M706018200; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Lai Y, 2005, J NEUROCHEM, V94, P360, DOI 10.1111/j.1471-4159.2005.03212.x; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olczak AA, 2003, INFECT IMMUN, V71, P580, DOI 10.1128/IAI.71.1.580-583.2003; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PIRT SJ, 1985, PRINCIPLES MICROBE C, P81; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pullan ST, 2008, METHOD ENZYMOL, V437, P499, DOI 10.1016/S0076-6879(07)37025-0; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Raphael BH, 2003, CAN J MICROBIOL, V49, P727, DOI 10.1139/W03-086; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Roos V, 2006, INFECT IMMUN, V74, P3565, DOI 10.1128/IAI.01959-05; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; THORUPANDERSEN M, 2005, MICROBIOLOGY, V151, P905; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; van Vliet AHM, 2000, FEMS MICROBIOL LETT, V188, P115, DOI 10.1016/S0378-1097(00)00222-6; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Velayudhan J, 2004, INFECT IMMUN, V72, P260, DOI 10.1128/IAI.72.1.260-268.2004; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k; Wainwright LM, 2005, MICROBIOL-SGM, V151, P4079, DOI 10.1099/mic.0.28266-0; Wan XY, 1997, FEBS LETT, V407, P32, DOI 10.1016/S0014-5793(97)00302-5; Weaver J, 2005, BBA-GEN SUBJECTS, V1726, P302, DOI 10.1016/j.bbagen.2005.08.012; Yu H, 1997, FEBS LETT, V409, P161, DOI 10.1016/S0014-5793(97)00494-8	87	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28413	28425		10.1074/jbc.M801016200	http://dx.doi.org/10.1074/jbc.M801016200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682395	Green Published, hybrid			2022-12-25	WOS:000259969300043
J	Green, CJ; Goransson, O; Kular, GS; Leslie, NR; Gray, A; Alessi, DR; Sakamoto, K; Hundal, HS				Green, Charlotte J.; Goransson, Olga; Kular, Gursant S.; Leslie, Nick R.; Gray, Alexander; Alessi, Dario R.; Sakamoto, Kei; Hundal, Harinder S.			Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; PLECKSTRIN-HOMOLOGY-DOMAIN; GROWTH-FACTOR-I; GLYCOGEN-SYNTHASE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; GLUT4 VESICLES; B-ALPHA; TRANSPORT; ACTIVATION; MEMBRANE	Protein kinase B (PKB)/Akt has been strongly implicated in the insulin-dependent stimulation of GLUT4 translocation and glucose transport in skeletal muscle and fat cells. Recently an allosteric inhibitor of PKB (Akti) that selectively targets PKB alpha and -beta was reported, but as yet its precise mechanism of action or ability to suppress key insulin-regulated events such as glucose and amino acid uptake and glycogen synthesis in muscle cells has not been reported. We show here that Akti ablates the insulin-dependent regulation of these processes in L6 myotubes at submicromolar concentrations and that inhibition correlates tightly with loss of PKB activation/phosphorylation. Similar findings were obtained using 3T3-L1 adipocytes. Akti did not inhibit IRS1 tyrosine phosphorylation, phosphatidylinositol 3-kinase signaling, or activation of Erks, ribosomal S6 kinase, or atypical protein kinases C but significantly impaired regulation of downstream PKB targets glycogen synthase kinase-3 and AS160. Akti-mediated inhibition of PKB requires an intact kinase pleckstrin homology domain but does not involve suppression of 3-phosphoinositide binding to this domain. Importantly, we have discovered that Akti inhibition is critically dependent upon a solvent-exposed tryptophan residue (Trp-80) that is present within the pleckstrin homology domain of all three PKB isoforms and whose mutation to an alanine (PKBW80A) yields an Akti-resistant kinase. Cellular expression of PKBW80A antagonized the Akti-mediated inhibition of glucose and amino acid uptake. Our findings support a critical role for PKB in the hormonal regulation of glucose and system A amino acid uptake and indicate that use of Akti and expression of the drug-resistant kinase will be valuable tools in delineating cellular PKB functions.	[Green, Charlotte J.; Leslie, Nick R.; Gray, Alexander; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Kular, Gursant S.; Alessi, Dario R.; Sakamoto, Kei] Univ Dundee, Coll Life Sci, James Black Ctr, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Goransson, Olga] Lund Univ, Biomed Ctr, Dept Expt Med Sci, S-22184 Lund, Sweden	University of Dundee; University of Dundee; Lund University	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	GREEN, Charlotte/B-9742-2014; Hundal, Hari/A-8990-2008; sakamoto, kei/C-8806-2019; Leslie, Nicholas/D-2699-2009	GREEN, Charlotte/0000-0003-1631-3186; Hundal, Hari/0000-0002-7621-4932; sakamoto, kei/0000-0001-8839-5980; LESLIE, Nicholas/0000-0001-5131-0541; Gray, Alexander/0000-0001-9227-0363; Goransson, Olga/0000-0002-7209-8022; Alessi, Dario/0000-0002-2140-9185	Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Pfizer; Swedish Wenner-Gren Foundations; European Commission [LSHM-CT-20004-005272]; Diabetes Research and Wellness Foundation; Merck KGaA; Diabetes UK; Medical Research Council [MC_U127088492, MC_U127015387, G9403619] Funding Source: researchfish; MRC [G9403619, MC_U127015387, MC_U127088492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Swedish Wenner-Gren Foundations; European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes Research and Wellness Foundation; Merck KGaA; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to K. S. and D. R. A.), pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Merck KGaA, and Pfizer), The Swedish Wenner-Gren Foundations (to O. G.), European Commission Contract LSHM-CT-20004-005272 (to H. S. H.), and the Diabetes Research and Wellness Foundation (to H. S. H.) and Diabetes UK(to K. S. and H. S. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Batty IH, 2004, BIOCHEM J, V379, P641, DOI 10.1042/BJ20031700; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Dowler S., 2002, SCI STKE, V2002, P16; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GUMA A, 1988, BIOCHEM J, V253, P625, DOI 10.1042/bj2530625; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HUNDAL HS, 1994, BIOCHEM J, V297, P289, DOI 10.1042/bj2970289; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LAWRENCE JC, 1977, J BIOL CHEM, V252, P444; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McDowell HE, 1998, FEBS LETT, V441, P15, DOI 10.1016/S0014-5793(98)01508-7; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; Tsuru M, 2002, AM J PHYSIOL-ENDOC M, V283, pE338, DOI 10.1152/ajpendo.00457.2001; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Zhou QL, 2004, BIOCHEM SOC T, V32, P817, DOI 10.1042/BST0320817	45	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27653	27667		10.1074/jbc.M802623200	http://dx.doi.org/10.1074/jbc.M802623200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669636	hybrid			2022-12-25	WOS:000259719200037
J	Lee, CB; Swatek, KN; McClure, B				Lee, Christopher B.; Swatek, Kirby N.; McClure, Bruce			Pollen proteins bind to the C-terminal domain of Nicotiana alata pistil arabinogalactan proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBE GROWTH; SELF-INCOMPATIBILITY; S-RNASE; UBIQUITIN LIGASE; IN-VITRO; 120-KDA GLYCOPROTEIN; SIGNALING PATHWAYS; IDENTIFICATION; SYNAPTOTAGMIN; ENDOCYTOSIS	Pollen tube growth is influenced by interaction between pollen proteins and the pistil extracellular matrix. The transmitting tract-specific glycoprotein (NaTTS) and 120-kDa glycoprotein (120K) are two pistil arabinogalactan proteins (AGPs) that share a conserved C-terminal domain (CTD) and directly influence pollen tubes in Nicotiana alata. 120K and other extracellular matrix proteins are taken up and transported to vacuoles of growing pollen tubes. We hypothesize that signaling and trafficking processes inside pollen tubes are important for controlling pollen tube growth. We performed a yeast two-hybrid screen of pollen cDNAs using sequences from 120K and NaTTS as baits. We found that an S-RNase-binding protein (SBP1), a C2 domain-containing protein (NaPCCP), and a putative cysteine protease bound to the AGP baits. SBP1 from Petunia hybrida and Solanum chacoense is a putative E3 ubiquitin ligase that binds to S-RNase and other proteins. C2 domain-containing proteins bind lipids and can regulate myriad cellular processes. Cysteine proteases are often associated with the degradation of vacuolar proteins. Expression analysis revealed that transcripts for these proteins are expressed in mature pollen. NaPCCP and NaSBP1 were characterized further because of their potential roles in signaling and trafficking. In vitro pull-down assays verified binding between maltose-binding protein (MBP) fusions, MBP:: NaPCCP or MBP:: NaSBP1 and glutathione S-transferase (GST), GST:: AGP CTD fusions. NaSBP1 binds to the AGP CTDs through its helical and RING domains. NaPCCP binds through its C-terminal region. Binding between NaPCCP and NaSBP1 and the pistil AGPs may contribute to signaling and trafficking inside pollen tubes growing in planta.	[Swatek, Kirby N.; McClure, Bruce] Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Lee, Christopher B.] Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	McClure, B (corresponding author), Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, 240A Life Sci Ctr,1201 E Rollins St, Columbia, MO 65211 USA.	mcclureb@missouri.edu			National Science Foundation [IOB 0614962]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOB 0614962. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEECHER BS, 1999, THESIS U MISSOURI CO; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Camacho L, 2003, J EXP BOT, V54, P83, DOI 10.1093/jxb/54.380.83; Cheung AY, 2007, J EXP BOT, V58, P75, DOI 10.1093/jxb/erl122; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Cheung AY, 2000, ANN BOT-LONDON, V85, P29, DOI 10.1006/anbo.1999.1016; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CORNISH EC, 1987, NATURE, V326, P99, DOI 10.1038/326099a0; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; DAMER CK, 1994, J BIOL CHEM, V269, P31115; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Gu Y, 2003, J EXP BOT, V54, P93, DOI 10.1093/jxb/54.380.93; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Johnson ML, 2006, PROCESSING AND FABRICATION OF ADVANCED MATERIALS XV, P223, DOI 10.1007/7089_051; JORGENSEN L, 1995, BIOTECHNOL TECH, V9, P477, DOI 10.1007/BF00159561; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Lai EC, 2001, P NATL ACAD SCI USA, V98, P5637, DOI 10.1073/pnas.101135498; Li ST, 2007, PLANT PHYSIOL, V145, P236, DOI 10.1104/pp.107.101741; Lind JL, 1996, SEX PLANT REPROD, V9, P75, DOI 10.1007/BF02153054; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2004, SEX PLANT REPROD, V17, P81, DOI 10.1007/s00497-004-0218-8; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Sze H, 2006, PLANT CELL MONOGR, V3, P71, DOI 10.1007/7089_044; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	57	36	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26965	26973		10.1074/jbc.M804410200	http://dx.doi.org/10.1074/jbc.M804410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678868	hybrid			2022-12-25	WOS:000259586600017
J	Shimizu, A; Mammoto, A; Italiano, JE; Pravda, E; Dudley, AC; Ingber, DE; Klagsbrun, M				Shimizu, Akio; Mammoto, Akiko; Italiano, Joseph E., Jr.; Pravda, Elke; Dudley, Andrew C.; Ingber, Donald E.; Klagsbrun, Michael			ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P190 RHOGAP; GROWTH; ABL; ACTIN; BRAIN; GUIDANCE; FAMILY; SUBSTRATE; PROTEIN; SEMAPHORINS	Class three semaphorins (SEMAs) were originally shown to be mediators of axon guidance that repelled axons and collapsed growth cones, but it is now evident that SEMA3F, for example, has similar effects on tumor cells and endothelial cells (EC). In both human U87MG glioma cells and human umbilical vein EC, SEMA3F induced rapid cytoskeletal collapse, suppressed cell contractility, decreased phosphorylation of cofilin, and inhibited cell migration in culture. Analysis of the signaling pathways showed that SEMA3F formed a complex with NRP2 (neuropilin2) and plexin A1. These interactions eventually led to inactivation of the small GTPase, RhoA, which is necessary for stress fiber formation and cytoskeleton integrity. A novel upstream RhoA mediator was shown to be ABL2, also known as ARG, a membrane- anchored nonreceptor tyrosine kinase. Within minutes after the addition of SEMA3F, ABL2 directly bound plexin A1 but not to a plexin A1 mutant lacking the cytoplasmic domain. In addition, ABL2 phosphorylated and thereby activated p190RhoGAP, which inactivated RhoA (GTP to GDP), resulting in cytoskeleton collapse and inhibition of cell migration. On the other hand, cells overexpressing an ABL2 inactive kinase mutant or treated with ABL2 small interfering RNA did not inactivate RhoA. Cells treated with p190RhoGAP small interfering RNA also did not inactivate RhoA. Together, these results suggested that ABL2/ARG is a novel mediator of SEMA3F- induced RhoA inactivation and collapsing activity.	[Ingber, Donald E.; Klagsbrun, Michael] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; [Klagsbrun, Michael] Harvard Univ, Childrens Hosp Boston, Sch Med, Vasc Biol Program,Dept Surg,Karp Family Res Labs, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Klagsbrun, M (corresponding author), Harvard Univ, Childrens Hosp Boston, Sch Med, Vasc Biol Program,Dept Surg,Karp Family Res Labs, 12-210,300 Longwood Ave, Boston, MA 02115 USA.	michael.klagsbrun@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019		National Institutes of Health [CA37392, CA45548]; NATIONAL CANCER INSTITUTE [P01CA045548, R37CA037392, R01CA037392, R56CA037392, S15CA058833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA37392 (to M. K.), CA45548 (to M. K. and D. I.), CA58833 (to D. I.), and HL068130 (to J. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jin Z, 1997, J NEUROSCI, V17, P6256; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; PEACOCK JG, 2007, J MOL BIOL; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xue F, 2008, HEPATOL RES, V38, P810, DOI 10.1111/j.1872-034X.2008.00333.x; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zalutsky MR, 2005, J NUCL MED, V46, p151S	57	78	85	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27230	27238		10.1074/jbc.M804520200	http://dx.doi.org/10.1074/jbc.M804520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18660502	Green Published, hybrid			2022-12-25	WOS:000259586600043
J	Song, KS; Lee, TJ; Kim, K; Chung, KC; Yoon, JH				Song, Kyoung Seob; Lee, Tae-Jin; Kim, Kyubo; Chung, Kwang Chul; Yoon, Joo-Heon			cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURINERGIC RECEPTORS; DNA-BINDING; ACTIVATION; ETS-1; MUCIN; INTERLEUKIN-1-BETA; NUCLEOTIDES; RELEASE; DOMAIN; CELLS	Exogenous ATP activates purinoreceptors on the cell surface that regulate diverse cellular functions, including mucous cell secretion in the respiratory epithelium. In this study, ATP increased MUC5AC mRNA in primary human nasal epithelial cells and in NCI-H292 pulmonary adenocarcinoma cells in vitro. ATP-induced MUC5AC mRNA was mediated by phospholipase C beta 3. Adominant-negative mutation in the PDZ binding domain of PLC beta 3 inhibited ATP-induced MUC5AC gene expression. ATP sequentially activated the phosphorylation of Akt, ERK1/2, p38, RSK1, and cAMP-responding element-binding protein (CREB) in a protein kinase C-independent manner. ATP-induced MUC5AC mRNA levels were regulated by CREB via direct interaction with c-Ets1 on the MUC5AC gene promoter (located - 938 to - 930). Effects of CREB and c-Ets1 were additive. Inhibition of either CREB or c-Ets1 inhibited ATP-induced MUC5AC gene expression. Stimulation with ATP caused the direct binding of CREB and c-Ets1 to the MUC5AC promoter, increasing the phosphorylation of c-Ets1. Chromatin immunoprecipitation assays demonstrated that in the presence of ATP, both c-Ets1 and CREB bound to the MUC5AC promoter. The effects of exogenous ATP on MUC5AC gene expression are mediated by a complex regulatory cascade controlling interactions between CREB and c-Ets1 that bind to a promoter element in the MUC5AC gene enhancing MUC5AC gene transcription. ATP-dependent activation of MUC5AC gene expression via CREB-c-Ets1 may contribute to mucous cell hypersecretion associated with common respiratory disorders.	[Song, Kyoung Seob; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul 120752, South Korea; [Kim, Kyubo; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Brain Korea Med Sci 21, Seoul 120752, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea; [Lee, Tae-Jin] Yeungnam Univ, Coll Med, Dept Anat, Taegu 705717, South Korea; [Chung, Kwang Chul] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yeungnam University; Yonsei University	Yoon, JH (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	jhyoon@yuhs.ac	Yoon, Joo-Heon/E-5781-2016; rchnds, rchnds/D-7595-2016	Yoon, Joo-Heon/0000-0003-2404-7156	Korea Science and Engineering Foundation [R11-2007-040-02001-0]; Korea Research Foundation [KRF-2005-050-C00005]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by Korea Science and Engineering Foundation Grant R11-2007-040-02001-0 funded by the Korean Government (MOST) (to J.H.Y.) and Korea Research Foundation Grant KRF-2005-050-C00005 (to K. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Cowley DO, 2000, GENE DEV, V14, P366; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; Feng YM, 2004, GENE, V330, P75, DOI 10.1016/j.gene.2004.01.006; Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kim CH, 2004, AM J PHYSIOL-LUNG C, V287, pL835, DOI 10.1152/ajplung.00285.2003; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Song KS, 2003, J BIOL CHEM, V278, P34890, DOI 10.1074/jbc.M303911200; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Tang XW, 2002, J BIOL CHEM, V277, P338, DOI 10.1074/jbc.M108927200; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	31	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26869	26878		10.1074/jbc.M802507200	http://dx.doi.org/10.1074/jbc.M802507200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676374	hybrid, Green Published			2022-12-25	WOS:000259586600006
J	Good, DW; George, T; Watts, BA				Good, David W.; George, Thampi; Watts, Bruns A., III			Nerve growth factor inhibits Na+/H+ exchange and HCO3- absorption through parallel phosphatidylinositol 3-kinase-mTOR and ERK pathways in thick ascending limb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN HOMOLOGOUS PROTEIN; NA-H EXCHANGE; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; APICAL MEMBRANE; S6 KINASE; PHOSPHATASE 2A; CELL-GROWTH; RAT-KIDNEY; NHE1	In the medullary thick ascending limb, inhibiting the basolateral NHE1 Na+/H+ exchanger with nerve growth factor (NGF) induces actin cytoskeleton remodeling that secondarily inhibits apical NHE3 and transepithelial HCO3- absorption. The inhibition by NGF is mediated 50% through activation of extracellular signal-regulated kinase (ERK). Here we examined the signaling pathway responsible for the remainder of the NGF-induced inhibition. Inhibition of HCO3- absorption was reduced 45% by the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin or LY294002 and 50% by rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR), a downstream effector of PI3K. The combination of a PI3K inhibitor plus rapamycin did not cause a further reduction in the inhibition by NGF. In contrast, the combination of a PI3K inhibitor plus the MEK/ERK inhibitor U0126 completely eliminated inhibition by NGF. Rapamycin decreased NGF-induced inhibition of basolateral NHE1 by 45%. NGF induced a 2-fold increase in phosphorylation of Akt, a PI3K target linked to mTOR activation, and a 2.2-fold increase in the activity of p70 S6 kinase, a downstream effector of mTOR. p70 S6 kinase activation was blocked by wortmannin and rapamycin, consistent with PI3K, mTOR, and p70 S6 kinase in a linear pathway. Rapamycin-sensitive inhibition of NHE1 by NGF was associated with an increased level of phosphorylated mTOR in the basolateral membrane domain. These findings indicate that NGF inhibits HCO3- absorption in the medullary thick ascending limb through the parallel activation of PI3K-mTOR and ERK signaling pathways, which converge to inhibit NHE1. The results identify a role for mTOR in the regulation of Na+/H+ exchange activity and implicate NHE1 as a possible downstream effector contributing to mTOR's effects on cell growth, proliferation, survival, and tumorigenesis.	[Good, David W.] Univ Texas Galveston, Med Branch, Dept Med, Galveston, TX 77555 USA; Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Good, DW (corresponding author), Univ Texas Galveston, Med Branch, Dept Med, 4-200 John Sealy Annex,301 Univ Blvd, Galveston, TX 77555 USA.	dgood@utmb.edu			National Institutes of Health [R01 DK-038217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-038217. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper SL, 1997, AM J PHYSIOL-RENAL, V273, pF601, DOI 10.1152/ajprenal.1997.273.4.F601; Alpern RJ, 2000, KIDNEY, P455; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buhaescu I, 2006, THER DRUG MONIT, V28, P577, DOI 10.1097/01.ftd.0000245377.93401.39; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Good DW, 1999, AM J PHYSIOL-RENAL, V276, pF726, DOI 10.1152/ajprenal.1999.276.5.F726; Good DW, 2006, AM J PHYSIOL-CELL PH, V290, pC757, DOI 10.1152/ajpcell.00391.2005; Good DW, 2004, AM J PHYSIOL-RENAL, V287, pF1244, DOI 10.1152/ajprenal.00176.2004; Good DW, 1996, AM J PHYSIOL-RENAL, V270, pF691, DOI 10.1152/ajprenal.1996.270.4.F691; Good DW, 1998, AM J PHYSIOL-CELL PH, V274, pC931, DOI 10.1152/ajpcell.1998.274.4.C931; GOOD DW, 1993, SEMIN NEPHROL, V13, P225; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; Good DW, 2000, AM J PHYSIOL-CELL PH, V279, pC1443, DOI 10.1152/ajpcell.2000.279.5.C1443; Good DW, 1995, P NATL ACAD SCI USA, V92, P12525, DOI 10.1073/pnas.92.26.12525; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Kenerson HL, 2002, CANCER RES, V62, P5645; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lagana A, 2000, J CELL SCI, V113, P3649; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Liu Y, 2006, KIDNEY INT, V69, P1925, DOI 10.1038/sj.ki.5001543; MA YH, 1994, J BIOL CHEM, V269, P30734; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Watts BA, 2005, J BIOL CHEM, V280, P11439, DOI 10.1074/jbc.M410719200; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 1998, AM J PHYSIOL-RENAL, V275, pF478, DOI 10.1152/ajprenal.1998.275.4.F478; Watts BA, 1999, J CLIN INVEST, V104, P1593, DOI 10.1172/JCI7332; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Watts BA, 1999, J BIOL CHEM, V274, P7841, DOI 10.1074/jbc.274.12.7841; WATTS BA, 2005, AM J PHYSIOL, V291, pF1005; WATTS BA, 2006, J AM SOC NEPHROL, V17; Wee S, 2008, CURR OPIN ONCOL, V20, P77, DOI 10.1097/CCO.0b013e3282f3111e; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Woods TC, 2004, ANNU REV MED, V55, P169, DOI 10.1146/annurev.med.55.091902.105243; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; YANO H, 1993, J BIOL CHEM, V268, P25846	62	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26602	26611		10.1074/jbc.M803019200	http://dx.doi.org/10.1074/jbc.M803019200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660503	Green Published, hybrid			2022-12-25	WOS:000259341600036
J	Jasiak, AJ; Hartmann, H; Karakasili, E; Kalocsay, M; Flatley, A; Kremmer, E; Strasser, K; Martin, DE; Soding, J; Cramer, P				Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Kalocsay, Marian; Flatley, Andrew; Kremmer, Elisabeth; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick			Genome-associated RNA polymerase II includes the dissociable Rpb4/7 subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT RPB4; TRANSCRIPTION; INITIATION; RECRUITMENT; ELONGATION; RESOLUTION; STRESS	Yeast RNA polymerase (Pol) II consists of a 10-subunit core enzyme and the Rpb4/7 subcomplex, which is dispensable for catalytic activity and dissociates in vitro. To investigate whether Rpb4/7 is an integral part of DNA-associated Pol II in vivo, we used chromatin immunoprecipitation coupled to high resolution tiling microarray analysis. We show that the genome-wide occupancy profiles for Rpb7 and the core subunit Rpb3 are essentially identical. Thus, the complete Pol II associates with DNA in vivo, consistent with functional roles of Rpb4/7 throughout the transcription cycle.	[Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Kalocsay, Marian] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Flatley, Andrew; Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Söding, Johannes/A-3341-2013; Kalocsay, Marian/ABH-5959-2020	Söding, Johannes/0000-0001-9642-8244; Kalocsay, Marian/0000-0002-4187-5829; Strasser, Katja/0000-0003-3533-5516	Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich [SFB646]; Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern; Transregio 5 Chromatin; Chemischen Industrie	Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich(German Research Foundation (DFG)); Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern(Department of Science & Technology (India)); Transregio 5 Chromatin; Chemischen Industrie	This work was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern, the Transregio 5 Chromatin, and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	APARICIO O, 2005, CURR PROT MOL BIOL, V21; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Do JH, 2006, MOL CELLS, V22, P254; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Mitsuzawa H, 2003, NUCLEIC ACIDS RES, V31, P4696, DOI 10.1093/nar/gkg688; Miyao T, 2001, J BIOL CHEM, V276, P46408, DOI 10.1074/jbc.M107012200; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Sakurai H, 1999, MOL CELL BIOL, V19, P7511; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	23	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26423	26427		10.1074/jbc.M803237200	http://dx.doi.org/10.1074/jbc.M803237200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667430	Green Published, hybrid			2022-12-25	WOS:000259341600016
J	Fanshawe, TR; Lynch, AG; Ellis, IO; Green, AR; Hanka, R				Fanshawe, Thomas R.; Lynch, Andrew G.; Ellis, Ian O.; Green, Andrew R.; Hanka, Rudolf			Assessing Agreement between Multiple Raters with Missing Rating Information, Applied to Breast Cancer Tumour Grading	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; LOW KAPPA; INDEX; MODEL	Background: We consider the problem of assessing inter-rater agreement when there are missing data and a large number of raters. Previous studies have shown only 'moderate' agreement between pathologists in grading breast cancer tumour specimens. We analyse a large but incomplete data-set consisting of 24177 grades, on a discrete 1-3 scale, provided by 732 pathologists for 52 samples. Methodology/Principal Findings: We review existing methods for analysing inter-rater agreement for multiple raters and demonstrate two further methods. Firstly, we examine a simple non-chance-corrected agreement score based on the observed proportion of agreements with the consensus for each sample, which makes no allowance for missing data. Secondly, treating grades as lying on a continuous scale representing tumour severity, we use a Bayesian latent trait method to model cumulative probabilities of assigning grade values as functions of the severity and clarity of the tumour and of rater-specific parameters representing boundaries between grades 1-2 and 2-3. We simulate from the fitted model to estimate, for each rater, the probability of agreement with the majority. Both methods suggest that there are differences between raters in terms of rating behaviour, most often caused by consistent over- or under-estimation of the grade boundaries, and also considerable variability in the distribution of grades assigned to many individual samples. The Bayesian model addresses the tendency of the agreement score to be biased upwards for raters who, by chance, see a relatively 'easy' set of samples. Conclusions/Significance: Latent trait models can be adapted to provide novel information about the nature of inter-rater agreement when the number of raters is large and there are missing data. In this large study there is substantial variability between pathologists and uncertainty in the identity of the 'true' grade of many of the breast cancer tumours, a fact often ignored in clinical studies.	[Fanshawe, Thomas R.] Univ Lancaster, Dept Med, Lancaster, England; [Lynch, Andrew G.] Univ Cambridge, Cambridge Res Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge, England; [Ellis, Ian O.] Univ Nottingham, Nottingham, England; [Green, Andrew R.] Univ Nottingham, Sch Mol Med Sci, Div Pathol, Nottingham, England; [Hanka, Rudolf] Univ Cambridge, Wolfson Coll, Cambridge, England	Lancaster University; CRUK Cambridge Institute; University of Cambridge; University of Nottingham; University of Nottingham; University of Cambridge	Fanshawe, TR (corresponding author), Univ Lancaster, Dept Med, Lancaster, England.	t.fanshawe@lancaster.ac.uk	Green, Andrew/AAF-1991-2020	Green, Andrew/0000-0002-0488-5913; Lynch, Andy/0000-0002-7876-7338; Ellis, Ian/0000-0001-5292-8474	University of Cambridge, Cancer Research UK [C14303/A8646]; Hutchison Whampoa Limited; NHS Breast Screening Program	University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Hutchison Whampoa Limited; NHS Breast Screening Program	AGL would like to acknowledge the funding support of The University of Cambridge, Cancer Research UK (CUK grant number C14303/A8646) and Hutchison Whampoa Limited. The data files were provided by the the National External Quality Assurance (EQA) Scheme for Breast Screening Histopathology, funded by the NHS Breast Screening Program.	AGRESTI A, 1993, BIOMETRICS, V49, P131, DOI 10.2307/2532608; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Altaye M, 2001, BIOMETRICS, V57, P584, DOI 10.1111/j.0006-341X.2001.00584.x; Castellan NJ, 1988, NONPARAMETRIC STAT B; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P46; Ellis I. O., 1995, P635; Ellis IO, 2006, J CLIN PATHOL, V59, P138, DOI 10.1136/jcp.2004.025551; ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Formann A K, 1996, Stat Methods Med Res, V5, P179, DOI 10.1177/096228029600500205; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; GUGGENMOOSHOLZMANN I, 1993, STAT MED, V12, P2191, DOI 10.1002/sim.4780122305; HARTMANN WH, 1984, CANCER, V53, P681, DOI 10.1002/1097-0142(19840201)53:3+<681::AID-CNCR2820531315>3.0.CO;2-3; JAMES IR, 1983, BIOMETRICS, V39, P651, DOI 10.2307/2531092; LANDIS JR, 1977, BIOMETRICS, V33, P671, DOI 10.2307/2529465; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; LANDIS JR, 1977, BIOMETRICS, V33, P174; LANGEHEINE R, 1988, LATENT TRAIT LATENT; MARTIN A, 2004, BRIT J MATH STAT PSY, V57, P1; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; Nelson JC, 2000, STAT METHODS MED RES, V9, P475, DOI 10.1191/096228000701555262; Pepe M. S., 2003, STAT EVALUATION MED; R Development Core Team, 2005, R LANG ENV STAT COMP; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Rogel A, 1998, STAT MED, V17, P489, DOI 10.1002/(SICI)1097-0258(19980228)17:4<489::AID-SIM751>3.0.CO;2-9; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; UEBERSAX JS, 1990, STAT MED, V9, P559, DOI 10.1002/sim.4780090509; UEBERSAX JS, 1993, BIOMETRICS, V49, P823, DOI 10.2307/2532202; UEBERSAX JS, 1993, J AM STAT ASSOC, V88, P421, DOI 10.2307/2290320; Yang I, 1997, BIOMETRICS, V53, P948, DOI 10.2307/2533555; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2925	10.1371/journal.pone.0002925	http://dx.doi.org/10.1371/journal.pone.0002925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698346	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000264412600011
J	Bittar, F; Richet, H; Dubus, JC; Reynaud-Gaubert, M; Stremler, N; Sarles, J; Raoult, D; Rolain, JM				Bittar, Fadi; Richet, Herve; Dubus, Jean-Christophe; Reynaud-Gaubert, Martine; Stremler, Nathalie; Sarles, Jacques; Raoult, Didier; Rolain, Jean-Marc			Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients	PLOS ONE			English	Article								Background: There is strong evidence that culture-based methods detect only a small proportion of bacteria present in the respiratory tracts of cystic fibrosis (CF) patients. Methodology/Principal Findings: Standard microbiological culture and phenotypic identification of bacteria in sputa from CF patients have been compared to molecular methods by the use of 16S rDNA amplification, cloning and sequencing. Twenty-five sputa from CF patients were cultured that yield 33 isolates (13 species) known to be pathogens during CF. For molecular cloning, 760 clones were sequenced (7.2 +/- 3.9 species/sputum), and 53 different bacterial species were identified including 16 species of anaerobes (30%). Discrepancies between culture and molecular data were numerous and demonstrate that accurate identification remains challenging. New or emerging bacteria not or rarely reported in CF patients were detected including Dolosigranulum pigrum, Dialister pneumosintes, and Inquilinus limosus. Conclusions/Significance: Our results demonstrate the complex microbial community in sputa from CF patients, especially anaerobic bacteria that are probably an underestimated cause of CF lung pathology. Metagenomic analysis is urgently needed to better understand those complex communities in CF pulmonary infections.	[Bittar, Fadi; Richet, Herve; Raoult, Didier; Rolain, Jean-Marc] Univ Aix Marseille 2, Fac Med & Pharm, CNRS IRD, URMITE,UMR 6236, Marseille, France; [Dubus, Jean-Christophe; Stremler, Nathalie; Sarles, Jacques] Hop La Timone, Ctr Ressources Competences Mucoviscidose Enfants, Dept Maladies Respiratoires, Marseille, France; [Reynaud-Gaubert, Martine] Hop St Marguerite, Ctr Ressources Competences Mucoviscidose Adultes, Dept Maladies Respiratoires, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bittar, F (corresponding author), Univ Aix Marseille 2, Fac Med & Pharm, CNRS IRD, URMITE,UMR 6236, Marseille, France.	jean-marc.rolain@univmed.fr	RAOULT, Didier/A-8434-2008; Dubus, Jean-Christophe/P-8242-2016; Reynaud-Gaubert, Martine LM/P-6958-2016; Bittar, Fadi/F-2037-2018; Rolain, Jean-Marc/Y-3788-2019	RAOULT, Didier/0000-0002-0633-5974; Bittar, Fadi/0000-0003-4052-344X; Rolain, Jean-Marc/0000-0002-2402-4467	French Association Vaincre La Mucoviscidose (VLM); Programme Hospitalier de Recherche Clinique 2006	French Association Vaincre La Mucoviscidose (VLM); Programme Hospitalier de Recherche Clinique 2006	The research for this article was supported in part by the French Association Vaincre La Mucoviscidose (VLM) and by Programme Hospitalier de Recherche Clinique 2006.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bittar F, 2008, EMERG INFECT DIS, V14, P993, DOI 10.3201/eid1406.071355; Chaparro C, 2001, AM J RESP CRIT CARE, V163, P43, DOI 10.1164/ajrccm.163.1.9811076; Chiron R, 2005, J CLIN MICROBIOL, V43, P3938, DOI 10.1128/JCM.43.8.3938-3943.2005; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cooke RFD, 2007, BRIT J BIOMED SCI, V64, P127, DOI 10.1080/09674845.2007.11732772; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Fenollar F, 2006, J CLIN MICROBIOL, V44, P1018, DOI 10.1128/JCM.44.3.1018-1028.2006; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoedemaekers A, 2006, J CLIN MICROBIOL, V44, P3461, DOI 10.1128/JCM.01050-06; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Hutter G, 2003, MICROBIOL-SGM, V149, P67, DOI 10.1099/mic.0.25791-0; JEWES LA, 1990, J MED MICROBIOL, V31, P271, DOI 10.1099/00222615-31-4-271; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; LaClaire L, 2000, ANTIMICROB AGENTS CH, V44, P2001, DOI 10.1128/AAC.44.7.2001-2003.2000; Lecuyer H, 2007, J CLIN MICROBIOL, V45, P3474, DOI 10.1128/JCM.01373-07; McMenamin JD, 2000, CHEST, V117, P1661, DOI 10.1378/chest.117.6.1661; MORIO F, 2007, ANTIMICROB AGENTS CH; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pitulle C, 1999, J CLIN MICROBIOL, V37, P3851, DOI 10.1128/JCM.37.12.3851-3855.1999; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rolph HJ, 2001, J CLIN MICROBIOL, V39, P3282, DOI 10.1128/JCM.39.9.3282-3289.2001; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Saito D, 2006, J MED MICROBIOL, V55, P101, DOI 10.1099/jmm.0.46212-0; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Schmoldt S, 2006, J MED MICROBIOL, V55, P1425, DOI 10.1099/jmm.0.46466-0; SHAKIL S, 2007, J BIOMED SCI; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van Belkum A, 2000, FEMS IMMUNOL MED MIC, V27, P51, DOI 10.1111/j.1574-695X.2000.tb01411.x; Vaudaux P, 2006, CLIN INFECT DIS, V43, P968, DOI 10.1086/507643; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Wellinghausen N, 2005, EMERG INFECT DIS, V11, P457, DOI 10.3201/eid1103.041078; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	42	169	171	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2908	10.1371/journal.pone.0002908	http://dx.doi.org/10.1371/journal.pone.0002908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682840	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600064
J	Glaberman, S; Du Pasquier, L; Caccone, A				Glaberman, Scott; Du Pasquier, Louis; Caccone, Adalgisa			Characterization of a Nonclassical Class I MHC Gene in a Reptile, the Galapagos Marine Iguana (Amblyrhynchus cristatus)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-G MOLECULES; T-CELL; EVOLUTION; POLYADENYLATION; CLONING; EXPRESSION; DIVERSITY; APOPTOSIS; PATTERNS	Squamates are a diverse order of vertebrates, representing more than 7,000 species. Yet, descriptions of full-length major histocompatibility complex (MHC) genes in this group are nearly absent from the literature, while the number of MHC studies continues to rise in other vertebrate taxa. The lack of basic information about MHC organization in squamates inhibits investigation into the relationship between MHC polymorphism and disease, and leaves a large taxonomic gap in our understanding of amniote MHC evolution. Here, we use both cDNA and genomic sequence data to characterize a class I MHC gene (Amcr-UA) from the Galapagos marine iguana, a member of the squamate subfamily Iguaninae. Amcr-UA appears to be functional since it is expressed in the blood and contains many of the conserved peptide-binding residues that are found in classical class I genes of other vertebrates. In addition, comparison of Amcr-UA to homologous sequences from other iguanine species shows that the antigen-binding portion of this gene is under purifying selection, rather than balancing selection, and therefore may have a conserved function. A striking feature of Amcr-UA is that both the cDNA and genomic sequences lack the transmembrane and cytoplasmic domains that are necessary to anchor the class I receptor molecule into the cell membrane, suggesting that the product of this gene is secreted and consequently not involved in classical class I antigen-presentation. The truncated and conserved character of Amcr-UA lead us to define it as a nonclassical gene that is related to the few available squamate class I sequences. However, phylogenetic analysis placed Amcr-UA in a basal position relative to other published classical MHC genes from squamates, suggesting that this gene diverged near the beginning of squamate diversification.	[Glaberman, Scott; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, Basel, Switzerland	Yale University; University of Basel	Glaberman, S (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	scott.glaberman@gmail.com	Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Glaberman, Scott/0000-0003-0594-4732	Yale Institute for Biospheric Studies (YIBS)	Yale Institute for Biospheric Studies (YIBS)	Funding for this project was provided by the Yale Institute for Biospheric Studies (YIBS). Work was also supported by pilot study funds from the YIBS Center for Field Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, GENE, V353, P31, DOI 10.1016/j.gene.2005.03.045; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flajnik M, 2004, TISSUE ANTIGENS, V64, P328; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Glaberman S, 2008, IMMUNOGENETICS, V60, P371, DOI 10.1007/s00251-008-0298-y; GRIMHOLT U, 1993, IMMUNOGENETICS, V37, P469, DOI 10.1007/BF00222473; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; HUGHES AL, 1989, MOL BIOL EVOL, V6, P559; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; KOLLER BH, 1985, J IMMUNOL, V134, P2727; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; MELLOR AL, 1984, CELL, V36, P139, DOI 10.1016/0092-8674(84)90082-5; Miller HC, 2006, MOL BIOL EVOL, V23, P949, DOI 10.1093/molbev/msj099; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nylander J. A. A., 2004, MRMODELTEST V2; Pauws E, 2001, NUCLEIC ACIDS RES, V29, P1690, DOI 10.1093/nar/29.8.1690; Plant MH, 1999, BIOCHEM J, V344, P677, DOI 10.1042/0264-6021:3440677; Ploegh H, 1998, CURR OPIN IMMUNOL, V10, P57, DOI 10.1016/S0952-7915(98)80032-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POTTS WK, 1990, TRENDS ECOL EVOL, V5, P181, DOI 10.1016/0169-5347(90)90207-T; RADA C, 1990, P NATL ACAD SCI USA, V87, P2167, DOI 10.1073/pnas.87.6.2167; Radtkey RR, 1996, P ROY SOC B-BIOL SCI, V263, P1023, DOI 10.1098/rspb.1996.0151; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Rebmann V, 1999, TISSUE ANTIGENS, V53, P14, DOI 10.1034/j.1399-0039.1999.530102.x; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Sambrook J., 2001, MOL CLONING LAB MANU; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; STIERNBERG J, 1987, J IMMUNOL, V138, P3877; Stroynowski I, 1996, RES IMMUNOL, V147, P290, DOI 10.1016/0923-2494(96)89642-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Timon M, 1998, IMMUNOGENETICS, V47, P170; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wiens JJ, 2000, SYST BIOL, V49, P143, DOI 10.1080/10635150050207447; Zappacosta F, 2000, J IMMUNOL, V164, P1906, DOI 10.4049/jimmunol.164.4.1906	52	23	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2859	10.1371/journal.pone.0002859	http://dx.doi.org/10.1371/journal.pone.0002859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682845	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600015
J	Rube, CE; Palm, J; Erren, M; Fleckenstein, J; Konig, J; Remberger, K; Rube, C				Ruebe, Claudia E.; Palm, Jan; Erren, Michael; Fleckenstein, Jochen; Koenig, Jochem; Remberger, Klaus; Ruebe, Christian			Cytokine Plasma Levels: Reliable Predictors for Radiation Pneumonitis?	PLOS ONE			English	Article								Background: Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinical reports proposed that cytokine plasma levels measured during RT allow to estimate the individual risk of patients to develop RP. The identification of such cytokine risk profiles would facilitate tailoring radiotherapy to maximize treatment efficacy and to minimize radiation toxicity. However, cytokines are produced not only in normal lung tissue after irradiation, but are also over-expressed in tumour cells of NSCLC specimens. This tumour-derived cytokine production may influence circulating plasma levels in NSCLC patients. The aim of the present study was to investigate the prognostic value of TNF-alpha, IL-1 beta, IL-6 and TGF-beta 1 plasma levels to predict radiation pneumonitis and to evaluate the impact of tumour-derived cytokine production on circulating plasma levels in patients irradiated for NSCLC. Methodology/Principal Findings: In 52 NSCLC patients (stage I-III) cytokine plasma levels were investigated by ELISA before and weekly during RT, during follow-up (1/3/6/9 months after RT), and at the onset of RP. Tumour biopsies were immunohistochemically stained for IL-6 and TGF-beta 1, and immunoreactivity was quantified (grade 1-4). RP was evaluated according to LENT-SOMA scale. Tumour response was assessed according to RECIST criteria by chest-CT during follow-up. In our clinical study 21 out of 52 patients developed RP (grade I/II/III/IV: 11/3/6/1 patients). Unexpectedly, cytokine plasma levels measured before and during RT did not correlate with RP incidence. In most patients IL-6 and TGF-beta 1 plasma levels were already elevated before RT and correlated significantly with the IL-6 and TGF-beta 1 production in corresponding tumour biopsies. Moreover, IL-6 and TGF-beta 1 plasma levels measured during follow-up were significantly associated with the individual tumour responses of these patients. Conclusions/Significance: The results of this study did not confirm that cytokine plasma levels, neither their absolute nor any relative values, may identify patients at risk for RP. In contrast, the clear correlations of IL-6 and TGF-beta 1 plasma levels with the cytokine production in corresponding tumour biopsies and with the individual tumour responses suggest that the tumour is the major source of circulating cytokines in patients receiving RT for advanced NSCLC.	[Ruebe, Claudia E.; Palm, Jan; Fleckenstein, Jochen; Ruebe, Christian] Univ Saarland, Dept Radiotherapy & Radiooncol, D-6650 Homburg, Germany; [Erren, Michael] Univ Munster, Inst Clin Chem & Lab Med, Munster, Germany; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Remberger, Klaus] Saarland Univ, Dept Pathol, Homburg, Germany	Saarland University; University of Munster; Johannes Gutenberg University of Mainz; Universitatsklinikum des Saarlandes	Rube, CE (corresponding author), Univ Saarland, Dept Radiotherapy & Radiooncol, D-6650 Homburg, Germany.	claudia.ruebe@uniklinik-saarland.de	König, Jochem/T-3500-2019	König, Jochem/0000-0003-4683-0360; Palm, Jan/0000-0003-1122-1557	Saarland University [HOMFOR A/2003/19]	Saarland University	This study was supported by grant HOMFOR A/2003/19 from Saarland University.	Albain KS, 2002, J CLIN ONCOL, V20, P3454, DOI 10.1200/JCO.2002.03.055; Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Anscher MS, 1997, INT J RADIAT ONCOL, V37, P253, DOI 10.1016/S0360-3016(96)00529-9; Anscher MS, 2003, INT J RADIAT ONCOL, V56, P988, DOI 10.1016/S0360-3016(03)00184-6; Anscher MS, 2001, J CLIN ONCOL, V19, P3758, DOI 10.1200/JCO.2001.19.17.3758; Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Asakura S, 1999, HUM PATHOL, V30, P195, DOI 10.1016/S0046-8177(99)90275-7; Asselin-Paturel C, 1998, INT J CANCER, V77, P7, DOI 10.1002/(SICI)1097-0215(19980703)77:1<7::AID-IJC2>3.0.CO;2-Y; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bennett WP, 1998, CLIN CANCER RES, V4, P1499; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; CALIGIURI MAL, 2007, CYTOKINES GENESIS TR, P482; Chang KT, 2005, AM J PHYSIOL-LUNG C, V289, pL438, DOI 10.1152/ajplung.00033.2005; Chen YY, 2005, INT J RADIAT ONCOL, V62, P260, DOI 10.1016/j.ijrobp.2005.01.041; Chen YY, 2001, INT J RADIAT ONCOL, V49, P641, DOI 10.1016/S0360-3016(00)01445-0; Conze D, 2001, CANCER RES, V61, P8851; De Jaeger K, 2004, INT J RADIAT ONCOL, V58, P1378, DOI 10.1016/j.ijrobp.2003.09.078; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Haura EB, 2006, CLIN LUNG CANCER, V7, P273, DOI 10.3816/CLC.2006.n.006; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Ito M, 2006, J IMMUNOL, V176, P5637, DOI 10.4049/jimmunol.176.9.5637; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kaminska J, 2006, ONCOLOGY-BASEL, V70, P115, DOI 10.1159/000093002; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kayacan O, 2006, AM J CLIN ONCOL-CANC, V29, P328, DOI 10.1097/01.coc.0000221300.72657.e0; Kong FM, 1996, LUNG CANCER-J IASLC, V16, P47, DOI 10.1016/S0169-5002(96)00611-3; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Lee CB, 2006, CLIN LUNG CANCER, V8, P195, DOI 10.3816/CLC.2006.n.047; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nestle U, 2000, INT J RADIAT ONCOL, V48, P95, DOI 10.1016/S0360-3016(00)00607-6; Novakova-Jiresova A, 2004, RADIOTHER ONCOL, V71, P183, DOI 10.1016/j.radonc.2004.01.019; Pantsulaia I, 2004, CALCIFIED TISSUE INT, V74, P47, DOI 10.1007/s00223-003-0046-0; Rube CE, 2005, INT J RADIAT ONCOL, V61, P1482, DOI 10.1016/j.ijrobp.2004.12.072; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Rube CE, 2004, RADIOTHER ONCOL, V72, P231, DOI 10.1016/j.radonc.2004.05.004; Rube CE, 2003, INT J RADIAT ONCOL, V56, P1414, DOI 10.1016/S0360-3016(03)00418-8; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Rube CE, 2002, RADIOTHER ONCOL, V64, P177, DOI 10.1016/S0167-8140(02)00077-4; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Schallenkamp JM, 2007, INT J RADIAT ONCOL, V67, P410, DOI 10.1016/j.ijrobp.2006.09.030; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; To Y, 2002, AM J RESP CELL MOL, V27, P220, DOI 10.1165/ajrcmb.27.2.4804; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Trott KR, 2004, INT J RADIAT ONCOL, V58, P463, DOI 10.1016/j.ijrobp.2003.09.045; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; Vokes EE, 2002, J CLIN ONCOL, V20, P4191, DOI 10.1200/JCO.2002.03.054; Vujaskovic Z, 2000, INT J RADIAT BIOL, V76, P511, DOI 10.1080/095530000138510; Wang JY, 2002, INT J RADIAT ONCOL, V54, P735, DOI 10.1016/S0360-3016(02)02994-2; Yamaji H, 2004, CANCER IMMUNOL IMMUN, V53, P786, DOI 10.1007/s00262-004-0533-9; Yang K, 2007, INT J RADIAT BIOL, V83, P665, DOI 10.1080/09553000701558977; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; INT J RAD ONCOL BIOL, V31, P1049	69	61	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2898	10.1371/journal.pone.0002898	http://dx.doi.org/10.1371/journal.pone.0002898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682839	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600054
J	Sharot, T; Davidson, ML; Carson, MM; Phelps, EA				Sharot, Tali; Davidson, Matthew L.; Carson, Meredith M.; Phelps, Elizabeth A.			Eye Movements Predict Recollective Experience	PLOS ONE			English	Article							MEMORY; EMOTION; EVENTS	Previously encountered stimuli can bring to mind a vivid memory of the episodic context in which the stimulus was first experienced ("remembered'' stimuli), or can simply seem familiar ("known'' stimuli). Past studies suggest that more attentional resources are required to encode stimuli that are subsequently remembered than known. However, it is unclear if the attentional resources are distributed differently during encoding and recognition of remembered and known stimuli. Here, we record eye movements while participants encode photos, and later while indicating whether the photos are remembered, known or new. Eye fixations were more clustered during both encoding and recognition of remembered photos relative to known photos. Thus, recognition of photos that bring to mind a vivid memory for the episodic context in which they were experienced is associated with less distributed overt attention during encoding and recognition. The results suggest that remembering is related to encoding of a few distinct details of a photo rather than the photo as a whole. In turn, during recognition remembering may be trigged by enhanced memory for the salient details of the photos.	[Sharot, Tali] UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England; [Davidson, Matthew L.] Columbia Univ, Dept Psychol, New York, NY USA; [Carson, Meredith M.] Drexel Univ, Dept Psychol, Philadelphia, PA USA; [Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY USA	University of London; University College London; Columbia University; Drexel University; New York University	Sharot, T (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England.	liz.phelps@nyu.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [MH62104]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institutes of Health, MH62104 to EAP.	ALTHOFF RR, 1999, J EXPT PSYCHOL LEARN, V25, P1; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CHRISTIANSON SA, 1991, COGNITION EMOTION, V5, P81, DOI 10.1080/02699939108411027; Curran T, 2004, NEUROPSYCHOLOGIA, V42, P1088, DOI 10.1016/j.neuropsychologia.2003.12.011; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Gardiner JM, 2006, MEM COGNITION, V34, P227, DOI 10.3758/BF03193401; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Lang J.P., 1999, A4 U FLOR CTR RES PS; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wessel I, 2000, MEMORY, V8, P97; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; YONELINAS AP, 1994, CAN J EXP PSYCHOL, V48, P516, DOI 10.1037/1196-1961.48.4.516	19	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2884	10.1371/journal.pone.0002884	http://dx.doi.org/10.1371/journal.pone.0002884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682731	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600040
J	Cao, H; Yang, CS; Rana, TM				Cao, Hong; Yang, Chao-Shun; Rana, Tariq M.			Evolutionary Emergence of microRNAs in Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; ES CELLS; DIFFERENTIATION; LINES; PLURIPOTENCY; EXPRESSION; NANOG; MORPHOGENESIS; ENHANCER; OCT-3/4	Human embryonic stem (hES) cells have unique abilities to divide indefinitely without differentiating and potential to differentiate into more than 200 cell types. These properties make hES cells an ideal model system for understanding early human development and for regenerative medicine. Molecular mechanisms including cellular signaling and transcriptional regulation play important roles in hES cell differentiation. However, very little information is available on posttranscriptional regulation of hES cell pluripotency, self-renewal, and early decisions about cell fate. microRNAs ( miRNAs), 22-nt long noncoding small RNAs found in plants and animals, regulate gene expression by targeting mRNAs for cleavage or translation repression. In hES cells we found that 276 miRNAs were expressed; of these, a set of 30 miRNAs had significantly changed expression during differentiation. Using a representative example, miR-302b, we show that miRNAs in human ES cells assemble into a bona fide RISC that contains Ago2 and can specifically cleave perfectly matched target RNA. Our results demonstrate that human ES cell differentiation is accompanied by changes in the expression of a unique set of miRNAs, providing a glimpse of a new molecular circuitry that may regulate early development in humans. Chromosomes 19 and X contained 98 and 40 miRNA genes, respectively, indicating that majority of miRNA genes in hES cells were expressed from these two chromosomes. Strikingly, distribution analysis of miRNA gene loci across six species including dog, rat, mouse, rhesus, chimpanzee, and human showed that miRNA genes encoded in chromosome 19 were drastically increased in chimpanzees and humans while miRNA gene loci on other chrosmomes were decreased as compared with dog, rat, and mouse. Comparative genomic studies showed 99% conservation of chromosome 19 miRNA genes between chimpanzees and humans. Together, these findings reveal the evolutionary emergence, similar to 5 million years ago, of miRNAs involved in regulating early human development. One could imagine that this burst of miRNA gene clusters at specific chromosomes was part of an evolutionary event during species divergence.	[Cao, Hong; Yang, Chao-Shun; Rana, Tariq M.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Cao, H (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	tariq.rana@umassmed.edu		Yang, Chao-Shun/0000-0002-1532-3377				Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	27	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2820	10.1371/journal.pone.0002820	http://dx.doi.org/10.1371/journal.pone.0002820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665260	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300039
J	De Feyter, HM; Lenaers, E; Houten, SM; Schrauwen, P; Hesselink, MK; Wanders, RJA; Nicolay, K; Prompers, JJ				De Feyter, Henk M.; Lenaers, Ellen; Houten, Sander M.; Schrauwen, Patrick; Hesselink, Matthijs K.; Wanders, Ronald J. A.; Nicolay, Klaas; Prompers, Jeanine J.			Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes	FASEB JOURNAL			English	Article						rat; NMR spectroscopy; In vivo NMR; insulin resistance; PCr recovery	INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; ZUCKER RATS; FATTY RATS; FIBER TYPE; DYSFUNCTION; OBESITY; HUMANS; DIET; SPECTROSCOPY	Currently inherited or acquired skeletal muscle mitochondrial dysfunction is linked to dysregulated fatty acid metabolism, resulting in increased levels of intramyocellular lipids (IMCLs) and lipid intermediates, inducing insulin resistance. The present study aimed to clarify the order of changes in IMCL levels and skeletal muscle mitochondrial function during the development of type 2 diabetes in Zucker diabetic fatty (ZDF) rats. IMCL levels and skeletal muscle oxidative capacity were determined in vivo, using localized H-1 magnetic resonance spectroscopy (MRS) and dynamic P-31 MRS, respectively. In parallel, in vitro activities were measured from enzymes involved in fatty acid oxidation, the tricarboxylic acid cycle and the electron transport chain. Fa/fa ZDF rats were studied at 3 different ages corresponding to different stages of type 2 diabetes, whereas fa/+ rats served as controls. Fa/fa ZDF rats had higher IMCL contents than controls throughout the duration of the study. In vivo muscle oxidative capacity was not different in fa/fa animals compared to controls, and in vitro enzyme activity data suggested improved functionality of enzymes involved in fat oxidation in type 2 diabetic animals. Accordingly, we can conclude that in the ZDF rat model, type 2 diabetes develops in the absence of skeletal muscle mitochondrial dysfunction. -De Feyter, H. M., Lenaers, E., Houten, S. M., Schrauwen, P., Hesselink, M. K., Wanders, R. J. A., Nicolay, K., Prompers, J. J. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J. 22, 3947-3955 (2008)	[De Feyter, Henk M.; Nicolay, Klaas; Prompers, Jeanine J.] Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Lenaers, Ellen; Hesselink, Matthijs K.] Maastricht Univ, Dept Human Movement Sci, Nutr & Toxicol Res Inst, Maastricht, Netherlands; [Schrauwen, Patrick] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst, Maastricht, Netherlands; [Houten, Sander M.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	De Feyter, HM (corresponding author), Yale Univ, MRRC, TAC N 136,300 Cedar St,POB 208043, New Haven, CT 06520 USA.	henk.defeyter@yale.edu	Houten, Sander/Y-3599-2019; De Feyter, Henk/B-8107-2008; Nicolay, Klaas/F-4192-2010	Houten, Sander/0000-0002-6167-9147; De Feyter, Henk/0000-0001-6111-0316; Nicolay, Klaas/0000-0002-4179-616X; schrauwen, patrick/0000-0002-0973-847X; Prompers, Jeanine/0000-0002-4756-4474	VIDI [917.66.359]	VIDI(Netherlands Organization for Scientific Research (NWO))	We express our appreciation to Stephan Majoor and Larry de Graaf for their assistance with the in vivo experiments and for technical support, respectively. We thank Jos P. N. Ruiter for technical assistance with the enzyme assays and Robin A. de Graaf for help with the implementation of the LASER pulse sequence. M. K. H. is supported by a VIDI grant for innovative research (917.66.359).	Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BOSKA M, 1994, MAGN RESON MED, V32, P1, DOI 10.1002/mrm.1910320102; BRINDLE KM, 1989, BIOCHEMISTRY-US, V28, P4887, DOI 10.1021/bi00437a054; Chanseaume E, 2007, OBESITY, V15, P50, DOI 10.1038/oby.2007.511; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; De Feyter HMML, 2006, MAGN RESON MED, V56, P19, DOI 10.1002/mrm.20924; de Graaf RA, 1998, MAGNET RESON MED, V40, P690, DOI 10.1002/mrm.1910400508; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KLEIN M, 1994, AM J PHYSIOL, V266, pE410, DOI 10.1152/ajpendo.1994.266.3.E410; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138; Kulhmann J, 2005, MAGN RESON MED, V53, P1275, DOI 10.1002/mrm.20501; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; QUISTORFF B, 1993, BIOCHEM J, V291, P681, DOI 10.1042/bj2910681; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102; Sanderson AL, 1996, CLIN SCI, V91, P691, DOI 10.1042/cs0910691; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Taylor D J, 1983, Mol Biol Med, V1, P77; TAYLOR DJ, 1986, MAGNET RESON MED, V3, P44, DOI 10.1002/mrm.1910030107; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	51	59	60	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3947	3955		10.1096/fj.08-112318	http://dx.doi.org/10.1096/fj.08-112318			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18653763	Green Submitted			2022-12-25	WOS:000260503000023
J	Grimsey, N; Han, GS; O'Hara, L; Rochford, JJ; Carman, GM; Siniossoglou, S				Grimsey, Neil; Han, Gil-Soo; O'Hara, Laura; Rochford, Justin J.; Carman, George M.; Siniossoglou, Symeon			Temporal and Spatial Regulation of the Phosphatidate Phosphatases Lipin 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; ADIPOCYTE DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; GENE; LIPODYSTROPHY; EXPRESSION; ADIPOGENESIS; BIOGENESIS; PROTEINS; PATHWAY	Lipins are the founding members of a novel family of Mg2+-dependent phosphatidate phosphatases (PAP1 enzymes) that play key roles in fat metabolism and lipid biosynthesis. Despite their importance, there is still little information on how their activity is regulated. Here we demonstrate that the functions of lipin 1 and 2 are evolutionarily conserved from unicellular eukaryotes to mammals. The two lipins display distinct intracellular localization in HeLa M cells, with a pool of lipin 2 exhibiting a tight membrane association. Small interfering RNA-mediated silencing of lipin 1 leads to a dramatic decrease of the cellular PAP1 activity in HeLaM cells, whereas silencing of lipin 2 leads to an increase of lipin 1 levels and PAP1 activity. Consistent with their distinct functions in HeLa M cells, lipin 1 and 2 exhibit reciprocal patterns of protein expression in differentiating 3T3-L1 adipocytes. Lipin 2 levels increase in lipin 1-depleted 3T3-L1 cells without rescuing the adipogenic defects, whereas depletion of lipin 2 does not inhibit adipogenesis. Finally, we show that the PAP1 activity of both lipins is inhibited by phosphorylation during mitosis, leading to a decrease in the cellular PAP1 activity during cell division. We propose that distinct and non-redundant functions of lipin 1 and 2 regulate lipid production during the cell cycle and adipocyte differentiation.	[Grimsey, Neil; O'Hara, Laura; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Rochford, Justin J.] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	University of Cambridge; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Siniossoglou, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ss560@cam.ac.uk	Grimsey, Neil/B-1634-2015; Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Grimsey, Neil/0000-0002-0481-4920; O'Hara, Laura/0000-0001-7790-9261; Rochford, Justin/0000-0002-5020-4939	National Institutes of Health [GM-28140]; Wellcome Trust; United States Public Health Service; British Heart Foundation; MRC [G0701446] Funding Source: UKRI; Medical Research Council [G0701446] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.). This work was also supported by a Wellcome Trust career development fellowship (to S. S.), by the United States Public Health Service, and by a British Heart Foundation intermediate fellowship (to J. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; WALTON PA, 1984, BIOCHIM BIOPHYS ACTA, V796, P364, DOI 10.1016/0005-2760(84)90139-5; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	25	85	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29166	29174		10.1074/jbc.M804278200	http://dx.doi.org/10.1074/jbc.M804278200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694939	Green Published, hybrid			2022-12-25	WOS:000260179900044
J	Cailhier, JF; Sirois, I; Laplante, P; Lepage, S; Raymond, MA; Brassard, N; Prat, A; Iozzo, RV; Pshezhetsky, AV; Hebert, MJ				Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Prat, Alexandre; Iozzo, Renato V.; Pshezhetsky, Alexey V.; Hebert, Marie-Josee			Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELL APOPTOSIS; ABDOMINAL AORTIC-ANEURYSM; BCL-X; PERITUBULAR CAPILLARIES; REDUCES ATHEROSCLEROSIS; CYSTEINE PROTEASES; EXPRESSION; DEATH; RECEPTOR	Proteolysis of extracellular matrix components and the production of cryptic bioactive factors play key roles in vascular remodeling. We showed previously that extracellular matrix proteolysis is triggered by the apoptosis of endothelial cells (EC), resulting in the release of an anti-apoptotic C-terminal fragment of endorepellin (LG3). Here, we characterize the endorepellin-cleaving proteases released by apoptotic EC using a multifaceted proteomics strategy. Cathepsin L (CathL), a cysteine protease known to be associated with cardiovascular disease progression in animal models and humans, was isolated from medium conditioned by apoptotic EC. CathL cleaved recombinant endorepellin in vitro, leading to LG3 release. Inhibition of CathL activity in EC exposed to pro-apoptotic stimuli prevented LG3 release without modulating the development of apoptosis in EC. Inhibition of caspase-3 activation in EC with the biochemical inhibitor DEVD-fluoromethyl ketone or small interfering RNAs concomitantly prevented CathL release by EC, LG3 production, and the development of paracrine anti-apoptotic activity. These data demonstrate that caspase-3 activation is a novel pathway of importance for triggering extracellular CathL release and the cleavage of extracellular matrix components.	[Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Hebert, Marie-Josee] CRCHUM, Montreal, PQ H2L 4M1, Canada; [Prat, Alexandre] Univ Montreal, CHUM, Res Ctr, Neuroimmunol Res Lab, Montreal, PQ H2L 4M1, Canada; [Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Hebert, Marie-Josee] Univ Montreal, CHUM, Res Ctr, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Pshezhetsky, Alexey V.] Univ Montreal, Ctr Hosp Univ St Justine, Dept Med Genet, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Jefferson University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hebert, MJ (corresponding author), CRCHUM, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	marie-josee.hebert.chum@ssss.gouv.qc.ca	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; A, Pshezhetsky/0000-0002-6612-1062	Canadian Institutes of Health Research [MOP-15447]; Fonds de la Recherche en Sante du Que bec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Que bec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grants MOP-15447 ( to M.- J. H.) and MOP-66980 (to A. V. P.) and a grant from the Fonds de la Recherche en Sante du Que bec (Interdisciplinary group grant on predictors of rejection (to M.- J. H.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Choy JC, 2005, AM J TRANSPLANT, V5, P494, DOI 10.1111/j.1600-6143.2004.00710.x; Choy JC, 2004, AM J PATHOL, V165, P127, DOI 10.1016/S0002-9440(10)63281-6; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dimmeler S, 1997, CIRCULATION, V95, P1760; Du XL, 1998, DIABETOLOGIA, V41, P249, DOI 10.1007/s001250050900; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Gacko M, 1998, CLIN CHIM ACTA, V271, P171, DOI 10.1016/S0009-8981(97)00246-5; Gacko M, 1998, CLIN CHEM LAB MED, V36, P449, DOI 10.1515/CCLM.1998.075; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Hamet P, 2001, CAN J CARDIOL, V17, p26A; Heermeier K, 1999, KIDNEY INT, V56, P1310, DOI 10.1046/j.1523-1755.1999.00685.x; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ishii Y, 2005, KIDNEY INT, V67, P321, DOI 10.1111/j.1523-1755.2005.00085.x; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Keeling W Brent, 2005, Vasc Endovascular Surg, V39, P457, DOI 10.1177/153857440503900601; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Pshezhetsky AV, 2007, PROTEOMICS, V7, P2201, DOI 10.1002/pmic.200600956; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Raymond MA, 2003, FASEB J, V17, P515, DOI 10.1096/fj.02-0500fje; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Saxena A, 2002, J PATHOL, V196, P335, DOI 10.1002/path.1040; Shimizu A, 2000, KIDNEY INT, V58, P2546, DOI 10.1046/j.1523-1755.2000.00440.x; Shimizu A, 2002, KIDNEY INT, V61, P1867, DOI 10.1046/j.1523-1755.2002.00309.x; Shimizu A, 2000, J AM SOC NEPHROL, V11, P2371, DOI 10.1681/ASN.V11122371; Sukhova GK, 2006, ANN NY ACAD SCI, V1085, P161, DOI 10.1196/annals.1383.028; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Suzuki J, 2000, CARDIOVASC RES, V45, P783, DOI 10.1016/S0008-6363(99)00356-9; Vogt CJ, 2001, MICROCIRCULATION, V8, P129, DOI 10.1080/713774024; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	55	90	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27220	27229		10.1074/jbc.M801164200	http://dx.doi.org/10.1074/jbc.M801164200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18658137	hybrid			2022-12-25	WOS:000259586600042
J	Dodd, R; Peracchia, C; Stolady, D; Torok, K				Dodd, Ryan; Peracchia, Camillo; Stolady, Daniel; Torok, Katalin			Calmodulin association with connexin32-derived peptides suggests trans-domain interaction in chemical gating of gap junction channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; BINDING; ACTIVATION; MECHANISMS; CA2+/CALMODULIN; PERMEABILITY; CONDUCTANCE; DIVERSITY; PROTEINS; KINASE	Calmodulin plays a key role in the chemical gating of gap junction channels. Two calmodulin-binding regions have previously been identified in connexin32 gap junction protein, one in the N-terminal and another in the C-terminal cytoplasmic tail of the molecule. The aim of this study was to better understand how calmodulin interacts with the connexin32-binding domains. Lobe-specific interactions of calmodulin with connexin32 peptides were studied by stopped flow kinetics, using Ca2+ binding-deficient mutants. Peptides corresponding to the N-terminal tail (residues 1-22) of connexin32 engaged both the N- and C-terminal lobes (N- and C-lobes) of calmodulin, binding with higher affinity to the C-lobe of calmodulin (Ca2+ dissociation rate constants k(3,4), 1.7 +/- 0.5 s(-1)) than to the N-lobe (k(1,2), 10.8 +/- 1.3 s(-1)). In contrast, peptides representing the C-terminal tail domain (residues 208 - 227) of connexin32 bound either the Cor the N- lobe but only one calmodulin lobe at a time (k(3,4), 2.6 +/- 0.1 s(-1) or k(1), 13.8 +/- 0.5 s(-1) and k(2), 1000 s(-1)). The calmodulin-binding domains of the N- and C-terminal tails of connexin32 were best defined as residues 1 - 21 and 216 - 227, respectively. Our data, showing separate functions of the N- and C-lobes of calmodulin in the interactions with connexin32, suggest trans-domain or trans-subunit bridging by calmodulin as a possible mechanism of gap junction gating.	[Dodd, Ryan; Stolady, Daniel; Torok, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England; [Peracchia, Camillo] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14627 USA	University of London; University of Rochester	Torok, K (corresponding author), SGUL, BMS, Cranmer Terrace, London SW17 0RE, England.	k.torok@sgul.ac.uk		Peracchia, Camillo/0000-0001-7405-1271; Torok, Katalin/0000-0002-3107-4534	National Institutes of Health [GM20113]; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM20113. This work was also supported by long term support of research in the laboratory on CaM probes and stopped flow kinetics from the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alan R., 1988, GAP JUNCTIONS, V7, P267; [Anonymous], 1996, CIRCULAR DICHROISM C; Bennett M V, 1992, Semin Cell Biol, V3, P29; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 1997, BIOPHYS J, V72, P2137, DOI 10.1016/S0006-3495(97)78856-8; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; PERACCHIA C, 1983, PFLUG ARCH EUR J PHY, V399, P152, DOI 10.1007/BF00663912; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Peracchia C., 2000, GAP JUNCTIONS MOL BA, P271; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; SPRAY DC, 1985, AM J PHYSIOL, V248, pH753, DOI 10.1152/ajpheart.1985.248.6.H753; Torok K, 1997, BIOCHEM J, V326, P479; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; WANG X, 1997, BIOPHYS J, V271, pC1743; Wang XG, 1996, PFLUG ARCH EUR J PHY, V431, P844; WERNER R, 1991, P ROY SOC B-BIOL SCI, V243, P5, DOI 10.1098/rspb.1991.0002; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	33	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26911	26920		10.1074/jbc.M801434200	http://dx.doi.org/10.1074/jbc.M801434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676375	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000259586600011
J	Rigbers, O; Li, SM				Rigbers, Ole; Li, Shu-Ming			Ergot alkaloid biosynthesis in Aspergillus fumigatus - Overproduction and biochemical characterization of a 4-dimethylallyltryptophan N-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRENYLATED INDOLE-DERIVATIVES; FUNGUS CLAVICEPS-PURPUREA; FUMIGACLAVINE-C; DIMETHYLALLYLTRYPTOPHAN SYNTHASE; CHEMOENZYMATIC SYNTHESIS; DNA METHYLATION; GENE-CLUSTER; EVOLUTION; TOOLS; STEP	The putative gene fgaMT was identified in the biosynthetic gene cluster of fumigaclavines in Aspergillus fumigatus. The coding region of fgaMT was amplified by PCR from a cDNA library, cloned into pQE60, and overexpressed in Escherichia coli. FgaMT comprises 339 amino acids with a molecular mass of about 38.1 kDa. The soluble dimeric His(6)-FgaMT was purified to near homogeneity and characterized biochemically. FgaMT was found to catalyze the N-methylation of 4-dimethylallyltryptophan in the presence of S-adenosylmethionine, resulting in the formation of 4-dimethylallyl-L-abrine, which was identified by NMR and mass spectrometry analysis. Therefore, FgaMT represents the second pathway-specific enzyme in the biosynthesis of ergot alkaloids. The enzyme did not require metal ions for its enzymatic reaction and showed a relatively high specificity toward the prenyl moiety at position C-4 of the indole ring. 4-Dimethylallyltryptophan derivatives with modification at the indole ring were also accepted by FgaMT as substrates. Km values for 4-dimethylallyltryptophan and S-adenosylmethionine were determined at 0.12 and 2.4 mM, respectively. The turnover number was 2.0 s(-1).	[Li, Shu-Ming] Univ Dusseldorf, Inst Pharmazeut Biol & Biotechnol, D-40225 Dusseldorf, Germany; Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany	Heinrich Heine University Dusseldorf; Philipps University Marburg	Li, SM (corresponding author), Univ Dusseldorf, Inst Pharmazeut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.	shu-ming.li@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to S.-M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Coyle CM, 2005, APPL ENVIRON MICROB, V71, P3112, DOI 10.1128/AEM.71.6.3112-3118.2005; Ding YS, 2008, J BIOL CHEM, V283, P16068, DOI 10.1074/jbc.M801991200; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; FLOSS HG, 1976, TETRAHEDRON, V32, P873, DOI 10.1016/0040-4020(76)85047-8; Galm U, 2004, CHEM BIOL, V11, P173, DOI 10.1016/j.chembiol.2004.01.012; Groger D., 1998, ALKALOIDS CHEM PHARM, V50, P171; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Haarmann T, 2006, CHEMBIOCHEM, V7, P645, DOI 10.1002/cbic.200500487; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kodama Y, 2008, BIOCHIMIE, V90, P547, DOI 10.1016/j.biochi.2007.10.001; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Langenhan JM, 2005, J NAT PROD, V68, P1696, DOI 10.1021/np0502084; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Lorenz N, 2007, APPL ENVIRON MICROB, V73, P7185, DOI 10.1128/AEM.01040-07; Ma HY, 2006, PLANTA MED, V72, P387, DOI 10.1055/s-2005-916235; Markert A, 2008, PLANT PHYSIOL, V147, P296, DOI 10.1104/pp.108.116699; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; OTSUKA H, 1980, PLANTA MED, V40, P109, DOI 10.1055/s-2008-1074947; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Riederer B, 1996, J BIOL CHEM, V271, P27524, DOI 10.1074/jbc.271.44.27524; Rohde B, 2008, PLANT J, V53, P541, DOI 10.1111/j.1365-313X.2007.03360.x; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Sambrook J, 2001, MOL CLONING LAB MANU; Schardl CL, 2006, ALKALOIDS-CHEM BIOL, V63, P45, DOI 10.1016/S1099-4831(06)63002-2; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Sulewska A, 2007, FOLIA HISTOCHEM CYTO, V45, P149; Teuber M, 2007, PLANT MOL BIOL, V63, P787, DOI 10.1007/s11103-006-9126-7; TSAI HF, 1995, BIOCHEM BIOPH RES CO, V216, P119, DOI 10.1006/bbrc.1995.2599; Tudzynski P, 1999, MOL GEN GENET, V261, P133, DOI 10.1007/s004380050950; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walzel B, 1997, CHEM BIOL, V4, P223, DOI 10.1016/S1074-5521(97)90292-1; Wang JH, 2004, FUNGAL GENET BIOL, V41, P189, DOI 10.1016/j.fgb.2003.10.002; Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004; Weist S, 2005, APPL MICROBIOL BIOT, V68, P141, DOI 10.1007/s00253-005-1891-8; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Wu XF, 2005, INT IMMUNOPHARMACOL, V5, P1543, DOI 10.1016/j.intimp.2005.04.014; Zhao Y, 2004, J PHARM PHARMACOL, V56, P775, DOI 10.1211/0022357023592	51	56	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26859	26868		10.1074/jbc.M804979200	http://dx.doi.org/10.1074/jbc.M804979200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678866	hybrid			2022-12-25	WOS:000259586600005
J	Katsuno, Y; Hanyu, A; Kanda, H; Ishikawa, Y; Akiyama, F; Iwase, T; Ogata, E; Ehata, S; Miyazono, K; Imamura, T				Katsuno, Y.; Hanyu, A.; Kanda, H.; Ishikawa, Y.; Akiyama, F.; Iwase, T.; Ogata, E.; Ehata, S.; Miyazono, K.; Imamura, T.			Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway	ONCOGENE			English	Article						TGF-beta; BMP; breast cancer; metastasis; invasion	TUMOR-SUPPRESSOR; BETA; GROWTH; EXPRESSION; OVEREXPRESSION; PROGRESSION; TRANSITION; MEMBRANE; MELANOMA; SKI	Transforming growth factor (TGF)-beta is known to promote tumor invasion and metastasis. Although bone morphogenetic proteins ( BMPs), members of the TGF-beta family, are expressed in a variety of human carcinoma cell lines, their roles in tumor progression have not been fully clarified. In this study, we sought to determine the roles of BMPs in the progression of breast cancer bone metastasis using human breast cancer samples and a mouse xenograft model. Immunohistochemical analysis of samples from breast cancer patients as well as a mouse xenograft model of MDA-231-D, highly metastatic human breast cancer cells, revealed phospho-Smad2 and phospho-Smad1/5/8 staining in the nuclei of cancer cells in primary tumor and/or bone metastasis. Using a functional in vivo bioluminescence imaging system, we showed that TGF-beta- and BMP-induced transcriptional pathways are active in bone metastatic lesions in vivo. In addition, both TGF-beta 3 and BMP-2 promoted the motility and invasiveness of the MDA-231-D cells in vitro. Moreover, expression of dominant-negative receptors for TGF-beta and/or BMPs in the MDA-231-D cells inhibited invasiveness in vitro and bone metastasis in the xenograft model. These results suggest that BMPs as well as TGF-beta promote invasion and bone metastasis of breast cancer.	[Katsuno, Y.; Hanyu, A.; Miyazono, K.; Imamura, T.] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Katsuno, Y.; Ehata, S.; Miyazono, K.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo, Japan; [Kanda, H.; Ishikawa, Y.; Akiyama, F.] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Koto Ku, Tokyo 1358550, Japan; [Iwase, T.] Canc Inst Hosp, Dept Breast Oncol, Koto Ku, Tokyo, Japan; [Ogata, E.] Japanese Fdn Canc Res, Canc Inst Hosp, Koto Ku, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research; University of Tokyo; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp		Ehata, Shogo/0000-0002-6740-9391	Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr H Miyoshi (RIKEN, Tsukuba) for the lentivirus system, and K Nomura, E Kobayashi, N Kaneniwa and Y Yuuki (The Cancer Institute) for technical assistance. This research was supported by KAKENHI (Grants-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. TI was supported by the Naito Foundation.	Arwert E, 2007, CANCER RES, V67, P7335, DOI 10.1158/0008-5472.CAN-07-0077; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; HATAKEYAMA S, 1993, BIOCHEM BIOPH RES CO, V190, P695, DOI 10.1006/bbrc.1993.1105; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Helms MW, 2005, J PATHOL, V206, P366, DOI 10.1002/path.1785; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katagiri Takenobu, 2008, P121; Kim IY, 2000, CANCER RES, V60, P2840; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Rothhammer T, 2005, CANCER RES, V65, P448; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	42	181	193	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	49					6322	6333		10.1038/onc.2008.232	http://dx.doi.org/10.1038/onc.2008.232			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18663362				2022-12-25	WOS:000260263400002
J	Zuo, PY; Picher, M; Okada, SF; Lazarowski, ER; Button, B; Boucher, RC; Elston, TC				Zuo, Peiying; Picher, Maryse; Okada, Seiko F.; Lazarowski, Eduardo R.; Button, Brian; Boucher, Richard C.; Elston, Timothy C.			Mathematical model of nucleotide regulation on airway epithelia - Implications for airway homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EXTRACELLULAR ADENINE-NUCLEOTIDES; P2Y(2) RECEPTOR AGONIST; SURFACE LIQUID VOLUME; SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; ATP RELEASE; ALKALINE-PHOSPHATASE; ENDOTHELIAL-CELLS; ADENYLATE KINASE	In the airways, adenine nucleotides support a complex signaling network mediating host defenses. Released by the epithelium into the airway surface liquid (ASL) layer, they regulate mucus clearance through P2 (ATP) receptors, and following surface metabolism through P1 (adenosine; Ado) receptors. The complexity of ASL nucleotide regulation provides an ideal subject for biochemical network modeling. A mathematical model was developed to integrate nucleotide release, the ectoenzymes supporting the dephosphorylation of ATP into Ado, Ado deamination into inosine (Ino), and nucleoside uptake. The model also includes ecto-adenylate kinase activity and feed-forward inhibition of Ado production by ATP and ADP. The parameters were optimized by fitting the model to experimental data for the steady-state and transient concentration profiles generated by adding ATP to polarized primary cultures of human bronchial epithelial (HBE) cells. The model captures major aspects of ATP and Ado regulation, including their > 4-fold increase in concentration induced by mechanical stress mimicking normal breathing. The model also confirmed the independence of steady-state nucleotide concentrations on the ASL volume, an important regulator of airway clearance. An interactive approach between simulations and assays revealed that feed-forward inhibition is mediated by selective inhibition of ecto5 '-nucleotidase. Importantly, the model identifies ecto-adenylate kinase as a key regulator of ASL ATP and proposes novel strategies for the treatment of airway diseases characterized by impaired nucleotide-mediated clearance. These new insights into the biochemical processes supporting ASL nucleotide regulation illustrate the potential of this mathematical model for fundamental and clinical research.	[Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Elston, Timothy C.] Univ N Carolina, Virtual Lung Grp, Chapel Hill, NC 27599 USA; [Zuo, Peiying] Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; [Picher, Maryse; Okada, Seiko F.; Lazarowski, Eduardo R.; Button, Brian; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	telston@med.unc.edu	Zuo, Peiying/AAF-2856-2020	Zuo, Peiying/0000-0003-4621-8526	National Institutes of Health [PPG-P01-HL034332, P30 DK065988, SCOR 1-P50-HL060280, SCCOR 1-P50-HL084934, R01-GM079271]; Cystic Fibrosis Foundation [BUTTON06G0, OKADA0610, PICHER0710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL034332, P50HL084934, P50HL060280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PPG-P01-HL034332, P30 DK065988, SCOR 1-P50-HL060280, SCCOR 1-P50-HL084934, and R01-GM079271. This work was also supported by Cystic Fibrosis Foundation Grants BUTTON06G0, OKADA0610, and PICHER0710. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1796, DOI 10.1164/ajrccm.153.6.8665037; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; CHRISTOFORIDIS S, 1995, EUR J BIOCHEM, V234, P66, DOI 10.1111/j.1432-1033.1995.066_c.x; Davis CW, 2002, NOVART FDN SYMP, V248, P113; Demenis MA, 2003, BBA-PROTEINS PROTEOM, V1646, P216, DOI 10.1016/S1570-9639(03)00021-9; Deterding R, 2005, PEDIATR PULM, V39, P339, DOI 10.1002/ppul.20192; Dixon M., 1979, ENZYMES, Vthird; Donaldson SH, 2002, AM J RESP CELL MOL, V26, P209, DOI 10.1165/ajrcmb.26.2.4650; Donaldson SH, 2000, MOL MED, V6, P969, DOI 10.1007/BF03401831; DONALDSON SH, 1998, P2 NUCLEOTIDE RECEPT, P413; Eltzschig HK, 2006, METH MOL B, V341, P73; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fabre ACS, 2006, CELL MOL LIFE SCI, V63, P2829, DOI 10.1007/s00018-006-6325-y; Fadini GP, 2007, ATHEROSCLEROSIS, V193, P241, DOI 10.1016/j.atherosclerosis.2007.05.015; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FLEETWOOD G, 1989, AM J PHYSIOL, V256, pH1565, DOI 10.1152/ajpheart.1989.256.6.H1565; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gayle S, 2005, CELL TISSUE RES, V319, P27, DOI 10.1007/s00441-004-0979-2; GORDON EL, 1986, J BIOL CHEM, V261, P5496; GORDON EL, 1989, J BIOL CHEM, V264, P18986; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; Hazama A, 1998, PFLUG ARCH EUR J PHY, V437, P31, DOI 10.1007/s004240050742; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hirsh AJ, 2007, BIOCHEMISTRY-US, V46, P10373, DOI 10.1021/bi7009647; Hourani SMO, 1996, J AUTON PHARMACOL, V16, P349, DOI 10.1111/j.1474-8673.1996.tb00051.x; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; IKEHARA Y, 1978, J BIOCHEM, V83, P1471, DOI 10.1093/oxfordjournals.jbchem.a132057; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim CH, 2004, AM J PHYSIOL-LUNG C, V287, pL835, DOI 10.1152/ajplung.00285.2003; Knight GE, 2002, AM J PHYSIOL-RENAL, V282, pF281, DOI 10.1152/ajprenal.00293.2000; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; LEHIR M, 1989, ENZYME, V41, P87, DOI 10.1159/000469058; Marcet B, 2006, PHARMACOL THERAPEUT, V112, P719, DOI 10.1016/j.pharmthera.2006.05.010; Matharu AL, 2001, J BIOL CHEM, V276, P30199, DOI 10.1074/jbc.M010650200; MEGHJI P, 1995, BIOCHEM J, V308, P725, DOI 10.1042/bj3080725; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Munkonda MN, 2007, BIOCHEM PHARMACOL, V74, P1524, DOI 10.1016/j.bcp.2007.07.033; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; PEARSON JD, 1980, BIOCHEM J, V190, P421, DOI 10.1042/bj1900421; Picher M, 2000, AM J RESP CELL MOL, V23, P255, DOI 10.1165/ajrcmb.23.2.4088; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Picher M, 2003, J BIOL CHEM, V278, P11256, DOI 10.1074/jbc.M208071200; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Picher M, 2001, DRUG DEVELOP RES, V52, P66, DOI 10.1002/ddr.1099; PICHER M, 2006, PURINERG SIGNAL, V2, P399; PIZAURO JM, 1993, BIOCHIM BIOPHYS ACTA, V1202, P22, DOI 10.1016/0167-4838(93)90058-Y; SAY JC, 1991, BIOCHIM BIOPHYS ACTA, V1074, P256, DOI 10.1016/0304-4165(91)90161-9; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; SEARGEANT LE, 1979, CAN J BIOCHEM CELL B, V57, P1000, DOI 10.1139/o79-124; Shaver Sammy R, 2005, Purinergic Signal, V1, P183, DOI 10.1007/s11302-005-0648-2; SLAKEY LL, 1986, J BIOL CHEM, V261, P5505; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Spicuzza L, 2003, CURR OPIN ALLERGY CL, V3, P65, DOI 10.1097/01.all.0000053270.39029.86; STEFANOVIC V, 1988, RENAL PHYSIOL BIOCH, V11, P89; SUNDERMAN FW, 1990, ANN CLIN LAB SCI, V20, P123; Takemura H, 2003, JPN J PHYSIOL, V53, P319, DOI 10.2170/jjphysiol.53.319; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Taylor AL, 1999, J CLIN INVEST, V104, P875, DOI 10.1172/JCI7270; Valero E, 2006, FEBS J, V273, P3598, DOI 10.1111/j.1742-4658.2006.05366.x; VANBELLE H, 1976, CLIN CHEM, V22, P972; Vaughan RP, 2006, TOXICOL SCI, V93, P411, DOI 10.1093/toxsci/kfl061; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Yerxa BR, 2002, J PHARMACOL EXP THER, V302, P871, DOI 10.1124/jpet.102.035485; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	82	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26805	26819		10.1074/jbc.M801516200	http://dx.doi.org/10.1074/jbc.M801516200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662982	Green Published, hybrid			2022-12-25	WOS:000259341600052
J	Correa, LGG; Riano-Pachon, DM; Schrago, CG; dos Santos, RV; Mueller-Roeber, B; Vincentz, M				Guedes Correa, Luiz Gustavo; Riano-Pachon, Diego Mauricio; Schrago, Carlos Guerra; dos Santos, Renato Vicentini; Mueller-Roeber, Bernd; Vincentz, Michel			The Role of bZIP Transcription Factors in Green Plant Evolution: Adaptive Features Emerging from Four Founder Genes	PLOS ONE			English	Article							MADS-BOX GENES; SIGNAL-TRANSDUCTION PATHWAY; RETICULUM STRESS-RESPONSE; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; FAMILY EVOLUTION; LAND PLANTS; RICE GENOME; EUKARYOTIC TRANSCRIPTION; PHYLOGENETIC ANALYSES	Background: Transcription factors of the basic leucine zipper (bZIP) family control important processes in all eukaryotes. In plants, bZIPs are regulators of many central developmental and physiological processes including photomorphogenesis, leaf and seed formation, energy homeostasis, and abiotic and biotic stress responses. Here we performed a comprehensive phylogenetic analysis of bZIP genes from algae, mosses, ferns, gymnosperms and angiosperms. Methodology/Principal Findings: We identified 13 groups of bZIP homologues in angiosperms, three more than known before, that represent 34 Possible Groups of Orthologues (PoGOs). The 34 PoGOs may correspond to the complete set of ancestral angiosperm bZIP genes that participated in the diversification of flowering plants. Homologous genes dedicated to seed-related processes and ABA-mediated stress responses originated in the common ancestor of seed plants, and three groups of homologues emerged in the angiosperm lineage, of which one group plays a role in optimizing the use of energy. Conclusions/Significance: Our data suggest that the ancestor of green plants possessed four bZIP genes functionally involved in oxidative stress and unfolded protein responses that are bZIP-mediated processes in all eukaryotes, but also in light-dependent regulations. The four founder genes amplified and diverged significantly, generating traits that benefited the colonization of new environments.	[Guedes Correa, Luiz Gustavo; dos Santos, Renato Vicentini; Vincentz, Michel] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Guedes Correa, Luiz Gustavo; Riano-Pachon, Diego Mauricio; Mueller-Roeber, Bernd] Univ Potsdam, Dept Mol Biol, Potsdam, Germany; [Guedes Correa, Luiz Gustavo; Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, Cooperat Res Grp, Potsdam, Germany; [Riano-Pachon, Diego Mauricio] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, GabiPD Team, Potsdam, Germany; [Schrago, Carlos Guerra] Univ Fed Rio de Janeiro, Dept Genet, Lab Biodivers Mol, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Potsdam; Max Planck Society; Max Planck Society; Universidade Federal do Rio de Janeiro	Correa, LGG (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil.	mgavince@unicamp.br	Riaño-Pachón, Diego M/A-1755-2010; Mueller-Roeber, Bernd/Z-4052-2019; Vicentini, Renato/C-5967-2012; Schrago, Carlos/E-4612-2012; Riaño-Pachón, Diego Mauricio/B-4891-2014	Riaño-Pachón, Diego M/0000-0001-9803-3465; Schrago, Carlos/0000-0001-6257-8906; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Vicentini, Renato/0000-0002-0527-1083; vincentz, michel/0000-0002-9850-1772	DAAD [A/04/34814, D/04/01336]; BMBF [FKZ 0315046]; Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies; DAAD/DFG International PhD Programme Integrative Plant Science; Fonds der Chemischen Industrie [0164389]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF)); Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies; DAAD/DFG International PhD Programme Integrative Plant Science(Deutscher Akademischer Austausch Dienst (DAAD)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	L.G.G.C. thanks the DAAD for providing a scholarship (A/04/34814). D.M.R.P. acknowledges financial support from the BMBF (FKZ 0315046). This work was supported in part by grants from the Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (to L.G.G.C and M.V.), the University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies (to B.M.-R.), the DAAD/DFG International PhD Programme Integrative Plant Science (DAAD D/04/01336; to B.M-R.), and the Fonds der Chemischen Industrie (N 0164389; to B.M.-R.).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Beckett D, 2001, J MOL BIOL, V314, P335, DOI 10.1006/jmbi.2001.5134; Bennetzen J, 2002, SCIENCE, V296, P60, DOI 10.1126/science.1071402; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carlini LE, 1999, PLANT MOL BIOL, V41, P339, DOI 10.1023/A:1006338727053; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; CORREA LGG, 2004, THESIS U ESTADUAL CA; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, P301; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Demuth JP, 2007, GENETICA, V129, P37, DOI 10.1007/s10709-006-0031-4; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Fassler J, 2002, GENOME RES, V12, P1190, DOI 10.1101/gr.67902; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finkelstein RR, 2000, PLANT PHYSIOL, V122, P1179, DOI 10.1104/pp.122.4.1179; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hsia CC, 2003, CURR OPIN GENET DEV, V13, P199, DOI 10.1016/S0959-437X(03)00017-0; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Irish VF, 2003, BIOESSAYS, V25, P637, DOI 10.1002/bies.10292; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kamisugi Y, 2005, PLANT MOL BIOL, V59, P723, DOI 10.1007/s11103-005-0909-z; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lara P, 2003, J BIOL CHEM, V278, P21003, DOI 10.1074/jbc.M210538200; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Lawton-Rauh A, 2003, MOL PHYLOGENET EVOL, V29, P396, DOI 10.1016/j.ympev.2003.07.004; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nei M., 2000, MOL EVOLUTION PHYLOG; Nieva C, 2005, PLANT MOL BIOL, V58, P899, DOI 10.1007/s11103-005-8407-x; Niggeweg R, 2000, PLANT MOL BIOL, V42, P775, DOI 10.1023/A:1006319113205; Niggeweg R, 2000, J BIOL CHEM, V275, P19897, DOI 10.1074/jbc.M909267199; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pennacchio LA, 2003, MAMM GENOME, V14, P429, DOI 10.1007/s00335-002-4001-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pontier D, 2001, PLANT J, V27, P529, DOI 10.1046/j.1365-313X.2001.01086.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Shigyo M, 2007, PLANT CELL PHYSIOL, V48, P179, DOI 10.1093/pcp/pcl044; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Silveira AB, 2007, PLANT SCI, V172, P1148, DOI 10.1016/j.plantsci.2007.03.003; Singer SD, 2007, PLANT CELL REP, V26, P1155, DOI 10.1007/s00299-007-0312-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanabe Y, 2005, P NATL ACAD SCI USA, V102, P2436, DOI 10.1073/pnas.0409860102; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vettore AL, 1998, PLANT MOL BIOL, V36, P249, DOI 10.1023/A:1005995806897; Vincentz M, 2004, PLANT PHYSIOL, V134, P951, DOI 10.1104/pp.103.033878; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Walsh J, 1998, GENE DEV, V12, P208, DOI 10.1101/gad.12.2.208; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Warren AJ, 2002, CURR OPIN STRUC BIOL, V12, P107, DOI 10.1016/S0959-440X(02)00296-8; Wellmer F, 1999, J BIOL CHEM, V274, P29476, DOI 10.1074/jbc.274.41.29476; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZHANG B, 1993, PLANT J, V4, P711, DOI 10.1046/j.1365-313X.1993.04040711.x; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	124	192	218	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2944	10.1371/journal.pone.0002944	http://dx.doi.org/10.1371/journal.pone.0002944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698409	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600030
J	Lee, REC; Puente, LG; Kaern, M; Megeney, LA				Lee, Robin E. C.; Puente, Lawrence G.; Kaern, Mads; Megeney, Lynn A.			A Non-Death Role of the Yeast Metacaspase: Yca1p Alters Cell Cycle Dynamics	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; APOPTOSIS; CASPASE; PROTEINS; GENE; DIFFERENTIATION; IDENTIFICATION; TRANSITION; ARREST; PHASE	Caspase proteases are a conserved protein family predominantly known for engaging and executing apoptotic cell death. Nevertheless, in higher eukaryotes, caspases also influence a variety of cell behaviors including differentiation, proliferation and growth control. S. cerevisiae expresses a primordial caspase, yca1, and exhibits apoptosis-like death under certain stresses; however, the benefit of a dedicated death program to single cell organisms is controversial. In the absence of a clear rationale to justify the evolutionary retention of a death only pathway, we hypothesize that yca1 also influences non-apoptotic events. We report that genetic ablation and/or catalytic inactivation of Yca1p leads to a longer G1/S transition accompanied by slower growth in fermentation conditions. Downregulation of Yca1p proteolytic activity also results in failure to arrest during nocodazole treatment, indicating that Yca1p participates in the G2/M mitotic checkpoint. 20s proteasome activity and ROS staining of the Delta yca1 strain is indistinguishable from its isogenic control suggesting that putative regulation of the oxidative stress response by Yca1p does not instigate the cell cycle phenotype. Our results demonstrate multiple non-death roles for yca1 in the cell cycle.	[Lee, Robin E. C.; Puente, Lawrence G.; Megeney, Lynn A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Lee, Robin E. C.; Kaern, Mads; Megeney, Lynn A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Kaern, Mads; Megeney, Lynn A.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1N 6N5, Canada; [Kaern, Mads] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Lee, REC (corresponding author), Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	lmegeney@ohri.ca	Lee, Robin/X-6718-2019; Kaern, Mads/GVU-6867-2022	Kaern, Mads/0000-0002-9371-666X; Megeney, Lynn/0000-0002-6824-8569; Lee, Robin/0000-0001-7209-3929	Canadian Insitutes of Health Research; Ontario Graduate Scholarship	Canadian Insitutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This study was supported by grants from the Canadian Insitutes of Health Research to L.A.M., R.E.C.L. was supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Brachmann CB, 1998, YEAST, V14, P115; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Coquelle A, 2006, BIOCHEM PHARMACOL, V72, P1396, DOI 10.1016/j.bcp.2006.04.014; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Gilot D, 2005, CARCINOGENESIS, V26, P2086, DOI 10.1093/carcin/bgi187; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Koren A, 2006, IUBMB LIFE, V58, P203, DOI 10.1080/15216540600719606; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Sattler M, 1999, BLOOD, V93, P2928; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vachova L, 2007, FEMS YEAST RES, V7, P12, DOI 10.1111/j.1567-1364.2006.00137.x; Verdoodt B, 1999, MUTAGENESIS, V14, P513, DOI 10.1093/mutage/14.5.513; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Wysocki R, 2004, J CELL BIOL, V166, P311, DOI 10.1083/jcb.200405016	33	75	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2956	10.1371/journal.pone.0002956	http://dx.doi.org/10.1371/journal.pone.0002956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698411	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600042
J	Gaillard, C; Borde, C; Gozlan, J; Marechal, V; Strauss, F				Gaillard, Claire; Borde, Chloe; Gozlan, Joel; Marechal, Vincent; Strauss, Francois			A High-Sensitivity Method for Detection and Measurement of HMGB1 Protein Concentration by High-Affinity Binding to DNA Hemicatenanes	PLOS ONE			English	Article								Background: Protein HMGB1, an abundant nuclear non-histone protein that interacts with DNA and has an architectural function in chromatin, was strikingly shown some years ago to also possess an extracellular function as an alarmin and a mediator of inflammation. This extracellular function has since been actively studied, both from a fundamental point of view and in relation to the involvement of HMGB1 in inflammatory diseases. A prerequisite for such studies is the ability to detect HMGB1 in blood or other biological fluids and to accurately measure its concentration. Methodology/Principal Findings: In addition to classical techniques (western blot, ELISA) that make use of specific anti-HMGB1 antibodies, we present here a new, extremely sensitive technique that is based on the fact that hemicatenated DNA loops (hcDNA) bind HMGB1 with extremely high affinity, higher than the affinity of specific antibodies, similar in that respect to DNA aptamers. DNA-protein complexes formed between HMGB1 and radiolabeled hcDNA are analyzed by electrophoresis on nondenaturing polyacrylamide gels using the band-shift assay method. In addition, using a simple and fast protocol to purify HMGB1 on the basis of its solubility in perchloric acid allowed us to increase the sensitivity by suppressing any nonspecific background. The technique can reliably detect HMGB1 at a concentration of 1 pg per microliter in complex fluids such as serum, and at much lower concentrations in less complex samples. It compares favorably with ELISA in terms of sensitivity and background, and is less prone to interference from masking proteins in serum. Conclusion: The new technique, which illustrates the potential of DNA nanoobjects and aptamers to form high-affinity complexes with selected proteins, should provide a valuable tool to further investigate the extracellular functions of HMGB1 and its involvement in inflammatory pathologies.	[Gaillard, Claire; Borde, Chloe; Gozlan, Joel; Marechal, Vincent; Strauss, Francois] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Gaillard, C (corresponding author), Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France.	francois.strauss@crc.jussieu.fr	marechal, vincent/P-7719-2017; GOZLAN, Joël/P-6014-2017	Strauss, Francois/0000-0003-4327-6827	Sidaction; ANRS; Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement Superieur et de la Recherche [fellowship]	Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	This work was made possible in part by grants from Sidaction and ANRS. C.G. and F.S. are members of the Centre National de la Recherche Scientifique (CNRS). C.B. is the recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	ADACHI Y, 1990, J CHROMATOGR-BIOMED, V530, P39, DOI 10.1016/S0378-4347(00)82300-2; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P46, DOI 10.1189/jlb.1306200; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; GAILLARD C, 1994, SCIENCE, V264, P433, DOI 10.1126/science.8153633; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2006, J THEOR BIOL, V243, P604, DOI 10.1016/j.jtbi.2006.07.001; Gaillard Claire, 2002, BMC Struct Biol, V2, P7, DOI 10.1186/1472-6807-2-7; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Jiang WW, 2005, J LEUKOCYTE BIOL, V78, P930, DOI 10.1189/jlb.0405208; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lyubchenko YL, 2002, NUCLEIC ACIDS RES, V30, P4902, DOI 10.1093/nar/gkf626; MARKHAM AE, 1941, J AM CHEM SOC, V63, P874; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; Raucci A, 2007, AUTOIMMUNITY, V40, P285, DOI 10.1080/08916930701356978; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Scopes RK, 1993, PROTEIN PURIFICATION, V3rd; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Ugrinova I, 2007, BIOCHEMISTRY-US, V46, P2111, DOI 10.1021/bi0614479; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; WAGNER JP, 1995, J BIOL CHEM, V270, P7394, DOI 10.1074/jbc.270.13.7394; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Waterer GW, 2007, CRIT CARE MED, V35, P1205, DOI 10.1097/01.CCM.0000259171.54501.B2; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Yamada S, 2003, CLIN CHEM, V49, P1535, DOI 10.1373/49.9.1535; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yamada S, 2006, CLIN CHIM ACTA, V372, P173, DOI 10.1016/j.cca.2006.04.016; Zimmermann K, 2004, INFLAMMATION, V28, P221, DOI 10.1023/B:IFLA.0000049047.61014.e3	49	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2855	10.1371/journal.pone.0002855	http://dx.doi.org/10.1371/journal.pone.0002855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682735	gold, Green Submitted, Green Published			2022-12-25	WOS:000264366600011
J	Li, YH; Meissle, M; Romeis, J				Li, Yunhe; Meissle, Michael; Romeis, Joerg			Consumption of Bt Maize Pollen Expressing Cry1Ab or Cry3Bb1 Does Not Harm Adult Green Lacewings, Chrysoperla carnea (Neuroptera: Chrysopidae)	PLOS ONE			English	Article								Adults of the common green lacewing, Chrysoperla carnea (Stephens) (Neuroptera: Chrysopidae), are prevalent pollen-consumers in maize fields. They are therefore exposed to insecticidal proteins expressed in the pollen of insect-resistant, genetically engineered maize varieties expressing Cry proteins derived from Bacillus thuringiensis (Bt). Laboratory experiments were conducted to evaluate the impact of Cry3Bb1 or Cry1Ab-expressing transgenic maize (MON 88017, Event Bt176) pollen on fitness parameters of adult C. carnea. Adults were fed pollen from Bt maize varieties or their corresponding near isolines together with sucrose solution for 28 days. Survival, pre-oviposition period, fecundity, fertility and dry weight were not different between Bt or non-Bt maize pollen treatments. In order to ensure that adults of C. carnea are not sensitive to the tested toxins independent from the plant background and to add certainty to the hazard assessment, adult C. carnea were fed with artificial diet containing purified Cry3Bb1 or Cry1Ab at about a 10 times higher concentration than in maize pollen. Artificial diet containing Galanthus nivalis agglutinin (GNA) was included as a positive control. No differences were found in any life-table parameter between Cry protein containing diet treatments and control diet. However, the pre-oviposition period, daily and total fecundity and dry weight of C. carnea were significantly negatively affected by GNA-feeding. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources as well as the uptake by C. carnea was confirmed. These results show that adults of C. carnea are not affected by Bt maize pollen and are not sensitive to Cry1Ab and Cry3Bb1 at concentrations exceeding the levels in pollen. Consequently, Bt maize pollen consumption will pose a negligible risk to adult C. carnea.	[Li, Yunhe; Meissle, Michael; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Li, YH (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	joerg.romeis@art.admin.ch	Meissle, Michael/C-3127-2009; Romeis, Joerg/J-5360-2013	Meissle, Michael/0000-0002-5391-7715; Romeis, Joerg/0000-0003-3652-8360	National Center of Competence in Research (NCCR); Swiss National Science Foundation	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the National Center of Competence in Research (NCCR) Plant Survival, research program of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2006, J ECON ENTOMOL, V99, P1085, DOI 10.1603/0022-0493-99.4.1085; Bigler F., 1984, BIOL CHRYSOPIDAE, P233; Blumel S., 2000, GUIDELINES EVALUATE; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Corey D, 1998, J KANSAS ENTOMOL SOC, V71, P11; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; GOSS JA, 1968, BOT REV, V34, P333, DOI 10.1007/BF02985391; HAGEN KS, 1970, CAN ENTOMOL, V120, P806; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; Hellmich RL, 2001, P NATL ACAD SCI USA, V98, P11925, DOI 10.1073/pnas.211297698; Hilbeck A, 1998, ENVIRON ENTOMOL, V27, P1255, DOI 10.1093/ee/27.5.1255; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; JONES SL, 1977, ANN ENTOMOL SOC AM, V70, P43, DOI 10.1093/aesa/70.1.43; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Lang A, 2006, BASIC APPL ECOL, V7, P296, DOI 10.1016/j.baae.2005.10.003; Lawo NC, 2008, BIOL CONTROL, V44, P389, DOI 10.1016/j.biocontrol.2007.12.002; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; McEwen PK, 2001, LACEWINGS CROP ENV; *MONS CO, 2003, SAF ASS YIELDGARD RO; *MONS CO, 2004, PET DET NONR STAT MO; NEW TR, 1975, T ROY ENT SOC LONDON, V127, P115; Oberhauser KS, 2001, P NATL ACAD SCI USA, V98, P11913, DOI 10.1073/pnas.211234298; Obrist LB, 2006, EXP APPL ACAROL, V38, P125, DOI 10.1007/s10493-006-0008-0; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; PRINCIPI MM, 1984, BIOL CHRYSOPIDAE, P76; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; Rodrigo-Simon A, 2006, APPL ENVIRON MICROB, V72, P1595, DOI 10.1128/AEM.72.2.1595-1603.2006; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2004, J INSECT PHYSIOL, V50, P175, DOI 10.1016/j.jinsphys.2003.11.004; Romeis Joerg, 2008, V5, P87, DOI 10.1007/978-1-4020-8373-0_4; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Roulston TH, 2000, EVOL ECOL RES, V2, P627; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; SHELDON J K, 1971, Psyche (Cambridge), V78, P107; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; SUNDBY R A, 1967, Entomophaga, V12, P475, DOI 10.1007/BF02376933; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; TREU R, 2000, POLLEN DISPERSAL CRO; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Vogt H., 2000, Guidelines to evaluate side-effects of plant protection products to non-target arthropods, P27; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; ZEMEK R, 2008, IOBC WPRS B IN PRESS, V33	50	53	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2909	10.1371/journal.pone.0002909	http://dx.doi.org/10.1371/journal.pone.0002909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682800	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600065
J	Faigle, M; Seessle, J; Zug, S; El Kasmi, KC; Eltzschig, HK				Faigle, Marion; Seessle, Jessica; Zug, Stephanie; El Kasmi, Karim C.; Eltzschig, Holger K.			ATP Release from Vascular Endothelia Occurs Across Cx43 Hemichannels and Is Attenuated during Hypoxia	PLOS ONE			English	Article							PROTEIN-KINASE-C; CONNEXIN MIMETIC PEPTIDES; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE RECEPTORS; EXTRACELLULAR ATP; TISSUE-DAMAGE; PROTECTION; GAP; ECTONUCLEOTIDASES; CARDIOPROTECTION	Background: Extracellular ATP is an important signaling molecule for vascular adaptation to limited oxygen availability (hypoxia). Here, we pursued the contribution of vascular endothelia to extracellular ATP release under hypoxic conditions. Methodology, Principal Findings: We gained first insight from studying ATP release from endothelia (HMEC-1) pre-exposed to hypoxia. Surprisingly, we found that ATP release was significantly attenuated following hypoxia exposure (2% oxygen, 22 +/- 3% after 48 h). In contrast, intracellular ATP was unchanged. Similarly, lactate-dehydrogenase release into the supernatants was similar between normoxic or hypoxic endothelia, suggesting that differences in lytic ATP release between normoxia or hypoxia are minimal. Next, we used pharmacological strategies to study potential mechanisms for endothelial-dependent ATP release (eg, verapamil, dipyridamole, 18-alpha-glycyrrhetinic acid, anandamide, connexin-mimetic peptides). These studies revealed that endothelial ATP release occurs-at least in part-through connexin 43 (Cx43) hemichannels. A real-time RT-PCR screen of endothelial connexin expression showed selective repression of Cx43 transcript and additional studies confirmed time-dependent Cx43 mRNA, total and surface protein repression during hypoxia. In addition, hypoxia resulted in Cx43-serine368 phosphorylation, which is known to switch Cx43 hemi-channels from an open to a closed state. Conclusions/Significance: Taken together, these studies implicate endothelial Cx43 in hypoxia-associated repression of endothelial ATP release.	[Faigle, Marion; Seessle, Jessica; Zug, Stephanie; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesia & Intens Care Med, Tubingen, Germany; [El Kasmi, Karim C.; Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Eltzschig, HK (corresponding author), Univ Tubingen Hosp, Dept Anesthesia & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu			German Research Foundation (DFG) [EL274/1, EL274/4]; Foundation for Anesthesia Research and Education	German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation for Anesthesia Research and Education	This work was supported by grants from the German Research Foundation (DFG) (EL274/1 and EL274/4 to (H.K.E.) and the Foundation for Anesthesia Research and Education (H.K.E.).	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Baiu DC, 2008, FASEB J, V22; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; ECKLE T, 2007, BLOOD; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Erlinge D, 2004, AM J PHYSIOL-CELL PH, V287, pC260, DOI 10.1152/ajpcell.00217.2004; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; HART ML, 2008, ARTERIOSCLER THROMB; HART ML, 2008, AM J PHYSL GASTROINT; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Linden J, 2006, SCIENCE, V314, P1689, DOI 10.1126/science.1137190; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; MOROTEGARCIA JC, 2008, BLOOD; Novak I, 2003, NEWS PHYSIOL SCI, V18, P12, DOI 10.1152/nips.01409.2002; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Weissmuller Thomas, 2005, Purinergic Signal, V1, P229, DOI 10.1007/s11302-005-6323-9	51	114	115	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2801	10.1371/journal.pone.0002801	http://dx.doi.org/10.1371/journal.pone.0002801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665255	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300020
J	Schmieder, AH; Caruthers, SD; Zhang, H; Williams, TA; Robertson, JD; Wickline, SA; Lanza, GM				Schmieder, Anne H.; Caruthers, Shelton D.; Zhang, Huiying; Williams, Todd A.; Robertson, J. David; Wickline, Samuel A.; Lanza, Gregory M.			Three-dimensional MR mapping of angiogenesis with alpha(5)beta(1)(alpha(v)beta(3))-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model	FASEB JOURNAL			English	Article						magnetic resonance imaging; fumagillin; cancer; molecular imaging; antiangiogenic	VX-2 RABBIT TUMORS; IN-VIVO; BREAST-CANCER; INTEGRIN ALPHA(5)BETA(1); INHIBITOR TNP-470; CONTRAST AGENT; PHASE-I; ALPHA(V)BETA(3); AG-013736; ANTIBODY	Our objectives were 1) to characterize angiogenesis in the MDA-MB-435 xenograft mouse model with three-dimensional (3D) MR molecular imaging using alpha(5)beta(1)(RGD)- or irrelevant RGS-targeted paramagnetic nanoparticles and 2) to use MR molecular imaging to assess the antiangiogenic effectiveness of alpha(5)beta(1)(alpha(v)beta(3))- vs. alpha(v)beta(3)-targeted fumagillin (50 mu g/kg) nanoparticles. Tumor-bearing mice were imaged with MR before and after administration of either alpha(5)beta(1)(RGD) or irrelevant RGS-paramagnetic nanoparticles. In experiment 2, mice received saline or alpha(5)beta(1)(alpha(v)beta(3))- or alpha(v)beta(3)-targeted fumagillin nanoparticles on days 7, 11, 15, and 19 posttumor implant. On day 22, MRI was performed using alpha(5)beta(1)(alpha(v)beta(3))-targeted paramagnetic nanoparticles to monitor the antiangiogenic response. 3D reconstructions of alpha(5)beta(1)(RGD)-signal enhancement revealed a sparse, asymmetrical pattern of angiogenesis along the tumor periphery, which occupied < 2.0% tumor surface area. alpha(5)beta(1)-targeted rhodamine nanoparticles colocalized with FITC-lectin corroborated the peripheral neovascular signal. alpha(5)beta(1)(alpha(v)beta(3))-fumagillin nanoparticles decreased neovasculature to negligible levels relative to control; alpha(v)beta(3)-targeted fumagillin nanoparticles were less effective (P > 0.05). Reduction of angiogenesis in MDA-MB-435 tumors from low to negligible levels did not decrease tumor volume. MR molecular imaging may be useful for characterizing tumors with sparse neovasculature that are unlikely to have a reduced growth response to targeted antiangiogenic therapy.	[Schmieder, Anne H.; Caruthers, Shelton D.; Zhang, Huiying; Williams, Todd A.; Wickline, Samuel A.; Lanza, Gregory M.] Washington Univ, Sch Med, St Louis, MO 63108 USA; [Caruthers, Shelton D.] Philips Healthcare, Andover, MA USA; [Robertson, J. David] Univ Missouri Res Reactor, Columbia, MO USA	Washington University (WUSTL); Philips; Philips Healthcare; University of Missouri System; University of Missouri Columbia	Lanza, GM (corresponding author), Washington Univ, Sch Med, Campus Box 8215,4320 Forest Pk Ave, St Louis, MO 63108 USA.	greg@cvu.wustl.edu		Robertson, John/0000-0002-6675-8469	National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and BioEngineering [HL-78631, HL-73646, CA-119342]; NATIONAL CANCER INSTITUTE [U54CA119342, U54CA136398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646, R01HL078631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and BioEngineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kereos, Inc. for the gift of the peptidomimetic integrin antagonists, Grace Hu for assistance with formulation chemistry, and John S. Allen and Cordelia Caradine for support of the animal studies. A.H.S., T.W., H.Z., S.A.W., and G. L. are supported by the National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and BioEngineering (HL-78631, HL-73646, and CA-119342); and Philips Healthcare. S.A.W. and G.M.L. are scientific cofounders of Kereos, Inc. S.D.C. is employed by Philips Healthcare.	Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Boudreau NJ, 2004, J BIOL CHEM, V279, P4862, DOI 10.1074/jbc.M305190200; Cai WB, 2006, CANCER RES, V66, P9673, DOI 10.1158/0008-5472.CAN-06-1480; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Castronovo V, 1996, EUR J CANCER, V32A, P2520, DOI 10.1016/S0959-8049(96)00388-7; Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403; Cue D, 2000, P NATL ACAD SCI USA, V97, P2858, DOI 10.1073/pnas.050587897; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Flacke S, 2001, CIRCULATION, V104, P1280, DOI 10.1161/hc3601.094303; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Frias JC, 2004, J AM CHEM SOC, V126, P16316, DOI 10.1021/ja044911a; Giles FJ, 2006, LEUKEMIA RES, V30, P801, DOI 10.1016/j.leukres.2005.10.024; Harris TD, 2003, CANCER BIOTHER RADIO, V18, P627, DOI 10.1089/108497803322287727; Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055; Hu G, 2007, INT J CANCER, V120, P1951, DOI 10.1002/ijc.22581; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Izzedine H, 2007, AM J KIDNEY DIS, V50, P203, DOI 10.1053/j.ajkd.2007.04.025; Janssen M, 2004, CANCER BIOTHER RADIO, V19, P399, DOI 10.1089/cbr.2004.19.399; Jayson GC, 2002, J NATL CANCER I, V94, P1484, DOI 10.1093/jnci/94.19.1484; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Kong G, 2000, CANCER RES, V60, P4440; Konno H, 1996, CANCER-AM CANCER SOC, V77, P1736; Kudelka AP, 1998, NEW ENGL J MED, V338, P991, DOI 10.1056/NEJM199804023381412; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Li LY, 2004, INT J RADIAT ONCOL, V58, P1215, DOI 10.1016/j.ijrobp.2003.10.057; Liu G, 2005, J CLIN ONCOL, V23, P5464, DOI 10.1200/JCO.2005.04.143; Liu S, 2007, BIOCONJUGATE CHEM, V18, P438, DOI 10.1021/bc0603081; Logothetis CJ, 2001, CLIN CANCER RES, V7, P1198; Meoli DF, 2004, J CLIN INVEST, V113, P1684, DOI 10.1172/JCI200420352; Mulder WJM, 2005, FASEB J, V19, P2008, DOI 10.1096/fj.05-4145fje; Offodile R, 1999, TUMORI, V85, P51, DOI 10.1177/030089169908500111; Parsons-Wingerter P, 2005, AM J PATHOL, V167, P193, DOI 10.1016/S0002-9440(10)62965-3; Sadeghi MM, 2004, CIRCULATION, V110, P84, DOI 10.1161/01.CIR.0000133319.84326.70; Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391; Shusterman S, 2001, CLIN CANCER RES, V7, P977; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Weissleder R, 2001, BIOCONJUGATE CHEM, V12, P213, DOI 10.1021/bc000091p; Wilmes LJ, 2007, MAGN RESON IMAGING, V25, P319, DOI 10.1016/j.mri.2006.09.041; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Winter PM, 2003, CANCER RES, V63, P5838; Zakarija A, 2005, CURR OPIN ONCOL, V17, P578, DOI 10.1097/01.cco.0000183672.15133.ab; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zitzmann S, 2002, CANCER RES, V62, P5139	49	104	105	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4179	4189		10.1096/fj.08-112060	http://dx.doi.org/10.1096/fj.08-112060			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18697838	Green Published			2022-12-25	WOS:000261254800017
J	Mahajan, B; Selvapandiyan, A; Gerald, NJ; Majam, V; Zheng, H; Wickramarachchi, T; Tiwari, J; Fujioka, H; Moch, JK; Kumar, N; Aravind, L; Nakhasi, HL; Kumar, S				Mahajan, Babita; Selvapandiyan, Angamuthu; Gerald, Noel J.; Majam, Victoria; Zheng, Hong; Wickramarachchi, Thilan; Tiwari, Jawahar; Fujioka, Hisashi; Moch, J. Kathleen; Kumar, Nirbhay; Aravind, L.; Nakhasi, Hira L.; Kumar, Sanjai			Centrins, Cell Cycle Regulation Proteins in Human Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; BODY DUPLICATION; MURINE CENTRIN; GENE; CENTROSOME; LOCALIZATION; EXPRESSION; ULTRASTRUCTURE	Molecules and cellular mechanisms that regulate the process of cell division in malaria parasites remain poorly understood. In this study we isolate and characterize the four Plasmodium falciparum centrins (PfCENs) and, by growth complementation studies, provide evidence for their involvement in cell division. Centrins are cytoskeleton proteins with key roles in cell division, including centrosome duplication, and possess four Ca2+-binding EF hand domains. By means of phylogenetic analysis, we were able to decipher the evolutionary history of centrins in eukaryotes with particular emphasis on the situation in apicomplexans and other alveolates. Plasmodium possesses orthologs of four distinct centrin paralogs traceable to the ancestral alveolate, including two that are unique to alveolates. By real time PCR and/or immunofluorescence, we determined the expression of PfCEN mRNA or protein in sporozoites, asexual blood forms, gametocytes, and in the oocysts developing inside mosquito mid-gut. Immunoelectron microscopy studies showed that centrin is expressed in close proximity with the nucleus of sporozoites and asexual schizonts. Furthermore, confocal and widefield microscopy using the double staining with alpha-tubulin and centrin antibodies strongly suggested that centrin is associated with the parasite centrosome. Following the episomal expression of the four PfCENs in a centrin knock-out Leishmania donovani parasite line that exhibited a severe growth defect, one of the PfCENs was able to partially restore Leishmania growth rate and overcome the defect in cytokinesis in such mutant cell line. To our knowledge, this study is the first characterization of a Plasmodium molecule that is involved in the process of cell division. These results provide the opportunity to further explore the role of centrins in cell division in malaria parasites and suggest novel targets to construct genetically modified, live attenuated malaria vaccines.	[Kumar, Sanjai] US FDA, CBER, DETTD, OBRR, Rockville, MD 20852 USA; [Tiwari, Jawahar] US FDA, Ctr Biol Evaluat & Res, Div Biostat, Rockville, MD 20852 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Moch, J. Kathleen] Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA; [Kumar, Nirbhay] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Aravind, L.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Case Western Reserve University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kumar, S (corresponding author), US FDA, CBER, DETTD, OBRR, 1401 Rockville Pike HFM-313, Rockville, MD 20852 USA.	sanjai.kumar@fda.hhs.gov	Selvapandiyan, Angamuthu/AAY-2556-2021; Selvapandiyan, Angamuthu/AAA-8602-2021	Selvapandiyan, Angamuthu/0000-0002-2194-1534; Aravind, L/0000-0003-0771-253X				AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; BARON AT, 1991, CELL MOTIL CYTOSKEL, V18, P1, DOI 10.1002/cm.970180102; BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Gerald NJ, 2007, MOL MICROBIOL, V63, P962, DOI 10.1111/j.1365-2958.2006.05487.x; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; Hart PE, 2001, GENE, V264, P205, DOI 10.1016/S0378-1119(01)00342-0; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; JAIKARIA NS, 1993, MOL BIOCHEM PARASIT, V57, P269, DOI 10.1016/0166-6851(93)90203-A; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Koblenz B, 2003, J CELL SCI, V116, P2635, DOI 10.1242/jcs.00497; Kramer A, 2002, LEUKEMIA, V16, P767, DOI 10.1038/sj.leu.2402454; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; KUCHKA MR, 1982, J CELL BIOL, V92, P170, DOI 10.1083/jcb.92.1.170; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; KUMAR N, 1988, P NATL ACAD SCI USA, V85, P6277, DOI 10.1073/pnas.85.17.6277; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Nguyen TV, 2001, J BIOL CHEM, V276, P26724, DOI 10.1074/jbc.M103375200; PIELOU E C, 1969, P286; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; SCHREVEL J, 1977, J ULTRA MOL STRUCT R, V59, P332, DOI 10.1016/S0022-5320(77)90043-0; Selvapandiyan A, 2004, J BIOL CHEM, V279, P25703, DOI 10.1074/jbc.M402794200; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VAVRA J, 1969, J PROTOZOOL, V16, P745, DOI 10.1111/j.1550-7408.1969.tb02338.x; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903	64	43	44	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31871	31883		10.1074/jbc.M800028200	http://dx.doi.org/10.1074/jbc.M800028200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18693242	hybrid			2022-12-25	WOS:000260760800070
J	Schar, CR; Jensen, JK; Christensen, A; Blouse, GE; Andreasen, PA; Peterson, CB				Schar, Christine R.; Jensen, Jan K.; Christensen, Anni; Blouse, Grant E.; Andreasen, Peter A.; Peterson, Cynthia B.			Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE CENTER; CELL-MIGRATION; S-PROTEIN; TYPE-1; MECHANISM; SERPIN; FIBRINOLYSIS; EPITOPE; LATENT	Vitronectin and plasminogen activator inhibitor-1 (PAI-1) are proteins that interact in the circulatory system and pericellular region to regulate fibrinolysis, cell adhesion, and migration. The interactions between the two proteins have been attributed primarily to binding of the somatomedin B (SMB) domain, which comprises the N-terminal 44 residues of vitronectin, to the flexible joint region of PAI-1, including residues Arg-103, Met-112, and Gln-125 of PAI-1. A strategy for deletion mutagenesis that removes the SMB domain demonstrates that this mutant form of vitronectin retains PAI-1 binding Schar, C. R., Blouse, G. E., Minor, K. M., and Peterson, C. B. (2008) J. Biol. Chem. 283, 10297-10309). In the current study, the complementary binding site on PAI-1 was mapped by testing for the ability of a battery of PAI-1 mutants to bind to the engineered vitronectin lacking the SMB domain. This approach identified a second, separate site for interaction between vitronectin and PAI-1. The binding of PAI-1 to this site was defined by a set of mutations in PAI-1 distinct from the mutations that disrupt binding to the SMB domain. Using the mutations in PAI-1 to map the second site suggested interactions between alpha-helices D and E in PAI-1 and a site in vitronectin outside of the SMB domain. The affinity of this second interaction exhibited a K-D value similar to 100-fold higher than that of the PAI-1-somatomedin B interaction. In contrast to the PAI-1-somatomedin B binding, the second interaction had almost the same affinity for active and latent PAI-1. We hypothesize that, together, the two sites form an extended binding area that may promote assembly of higher order vitronectin-PAI-1 complexes.	[Schar, Christine R.; Peterson, Cynthia B.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Jensen, Jan K.; Christensen, Anni; Blouse, Grant E.; Andreasen, Peter A.] Univ Aarhus, Dept Mol & Struct Biol, Lab Cellular Protein Sci, DK-8000 Aarhus, Denmark	University of Tennessee System; University of Tennessee Knoxville; Aarhus University	Peterson, CB (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, M407 Walters Life Sci Bldg, Knoxville, TN 37996 USA.	cynthia_peterson@utk.edu			NHLBI [HL50676]; Danish Cancer Society; Danish Research Agency; University of Aarhus; European Commission; Carlsberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL050676, R01HL050676] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Danish Cancer Society(Danish Cancer Society); Danish Research Agency; University of Aarhus; European Commission(European CommissionEuropean Commission Joint Research Centre); Carlsberg Foundation(Carlsberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL50676 from NHLBI (to C. B. P.). This work was also supported by grants from the Danish Cancer Society, the Danish Research Agency, the University of Aarhus, and the European Commission (to P. A. A.) and by a grant from the Carlsberg Foundation ( to G. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; Arteel GE, 2008, J GASTROEN HEPATOL, V23, pS54, DOI 10.1111/j.1440-1746.2007.05285.x; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Bijnens AP, 2001, THROMB HAEMOSTASIS, V85, P866; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Bodker JS, 2003, EUR J BIOCHEM, V270, P1672, DOI 10.1046/j.1432-1033.2003.03523.x; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; De Prada NA, 2002, EUR J BIOCHEM, V269, P184, DOI 10.1046/j.0014-2956.2002.02639.x; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Demiralp DO, 2008, CLIN APPL THROMB-HEM, V14, P438, DOI 10.1177/1076029607305081; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112; Gorlatova NV, 2003, J BIOL CHEM, V278, P16329, DOI 10.1074/jbc.M208420200; Hansen M, 2001, EUR J BIOCHEM, V268, P6274, DOI 10.1046/j.0014-2956.2001.02582.x; Jensen JK, 2004, FEBS LETT, V556, P175, DOI 10.1016/S0014-5793(03)01405-4; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kamikubo Y, 2004, BIOCHEMISTRY-US, V43, P6519, DOI 10.1021/bi049647c; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Li XQ, 2007, J BIOL CHEM, V282, P5318, DOI 10.1074/jbc.M611396200; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; Mathiasen L, 2008, MOL PHARMACOL, V74, P641, DOI 10.1124/mol.108.046417; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Minor KH, 2002, J BIOL CHEM, V277, P10337, DOI 10.1074/jbc.M109564200; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; PADMANABHAN J, 1995, THROMB HAEMOSTASIS, V73, P829; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Rich RL, 2001, J MOL RECOGNIT, V14, P223, DOI 10.1002/jmr.535; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; VANMEIJER M, 1994, FEBS LETT, V352, P342, DOI 10.1016/0014-5793(94)00990-2; Wanhainen A, 2007, J VASC SURG, V45, P1109, DOI 10.1016/j.jvs.2007.02.001; Wind T, 2001, EUR J BIOCHEM, V268, P1095, DOI 10.1046/j.1432-1327.2001.2680041095.x; WUN TC, 1989, J BIOL CHEM, V264, P7862; Zhou AW, 2007, PROTEIN SCI, V16, P1502, DOI 10.1110/ps.072819107; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	50	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28487	28496		10.1074/jbc.M804257200	http://dx.doi.org/10.1074/jbc.M804257200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658131	hybrid, Green Published			2022-12-25	WOS:000259969300051
J	Vaidya, KS; Harihar, S; Phadke, PA; Stafford, LJ; Hurst, DR; Hicks, DG; Casey, G; DeWald, DB; Welch, DR				Vaidya, Kedar S.; Harihar, Sitaram; Phadke, Pushkar A.; Stafford, Lewis J.; Hurst, Douglas R.; Hicks, David G.; Casey, Graham; DeWald, Daryll B.; Welch, Danny R.			Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GENE-EXPRESSION; CARCINOMA CELLS; BRMS1; ACTIVATION; AKT/PKB; TISSUES; LINE	That metastatic tumor cells grow in selective non-native environments suggests an ability to differentially respond to local microenvironments. BRMS1, like other metastasis suppressors, halts ectopic growth (metastasis) without blocking orthotopic tumor formation. BRMS1-expressing tumor cells reach secondary sites but do not colonize distant tissues, compelling the hypothesis that BRMS1 selectively restricts the ability of tumor cells to respond to exogenous regulators in different tissues. Here we report that BRMS1 expression in metastatic human breast cancer cells leads to a selective reduction in epidermal growth factor receptor expression and downstream (AKT) signaling. Signaling through another receptor tyrosine kinase, hepatocyte growth factor receptor (c-Met), remains unaltered despite reduced levels of the signaling intermediate phosphatidylinositol (4,5)-bisphosphate. Interestingly, reduced downstream calcium signaling is observed following treatment with platelet-derived growth factor, consistent with decreased phosphatidylinositol (4,5)-bisphosphate. However, platelet-derived growth factor receptor expression is unaltered. Thus, BRMS1 differentially attenuates cellular responses to mitogenic signals, not only dependent upon the specific signal received, but at varying steps within the same signaling cascade. Specific modulation of signaling responses received from the microenvironment may ultimately dictate which environments are permissive/restrictive for tumor cell growth and provide insights into the biology underlying metastasis.	[Vaidya, Kedar S.; Phadke, Pushkar A.; Stafford, Lewis J.; Hurst, Douglas R.; Welch, Danny R.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Natl Fdn Canc Res Ctr Metastasis Res, Birmingham, AL 35294 USA; [Harihar, Sitaram; DeWald, Daryll B.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Hicks, David G.; Casey, Graham] Cleveland Clin, Lerner Sch Med, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; Utah State University; Case Western Reserve University; Cleveland Clinic Foundation	Welch, DR (corresponding author), Univ Alabama, Dept Pathol, G-019 Volker Hall,1670 Univ Blvd, Birmingham, AL 35294 USA.	DanWelch@uab.edu	Welch, Danny R/B-7310-2009; Hurst, Douglas R/B-7341-2009; vaidya, kedar/B-7339-2009; Harihar, Sitaram/Q-4088-2016; harihar, sitaram/AAO-1476-2020	Welch, Danny R/0000-0002-1951-4947; Harihar, Sitaram/0000-0003-4953-7282; harihar, sitaram/0000-0003-4953-7282; Hurst, Douglas/0000-0002-1296-2210; Vaidya, Kedar/0000-0001-6600-2648	United States Public Health Service [R01-CA87728]; United States Army Medical Research and Materiel Command [DAMD-17-02-1-0541]; National Foundation for Cancer Research Center for Metastasis Research; NATIONAL CANCER INSTITUTE [F32CA113037, R01CA087728] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Foundation for Cancer Research Center for Metastasis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by United States Public Health Service Grant R01-CA87728, United States Army Medical Research and Materiel Command Grant DAMD-17-02-1-0541, and the National Foundation for Cancer Research Center for Metastasis Research (to D. R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Blanquicett C, 2002, ANAL BIOCHEM, V303, P209, DOI 10.1006/abio.2001.5570; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DeWald DB, 2005, CANCER RES, V65, P713; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Gschwantler-Kaulich D, 2005, ONCOL REP, V14, P305; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; IRVINE RF, 2002, SCI STKE, pRE13; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Nishi H, 2003, INT J MOL MED, V11, P49; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Reardon DB, 1999, ONCOGENE, V18, P4756, DOI 10.1038/sj.onc.1202849; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Seraj MJ, 2000, CANCER RES, V60, P2764; Vaidya KS, 2007, J MAMMARY GLAND BIOL, V12, P175, DOI 10.1007/s10911-007-9049-1; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	31	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28354	28360		10.1074/jbc.M710068200	http://dx.doi.org/10.1074/jbc.M710068200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664570	Green Published, hybrid			2022-12-25	WOS:000259969300037
J	Gjymishka, A; Palii, SS; Shan, J; Kilberg, MS				Gjymishka, Altin; Palii, Stela S.; Shan, Jixiu; Kilberg, Michael S.			Despite increased ATF4 binding at the C/EBP-ATF composite site following activation of the unfolded protein response, system A transporter 2 (SNAT2) transcription activity is repressed in HepG2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEPRIVATION; ASPARAGINE SYNTHETASE GENE; TRANSLATIONAL CONTROL; MASTER REGULATOR; EXPRESSION; ELEMENT; KINASE; REINITIATION; ATF6-ALPHA; RESISTANCE	The activated amino acid response (AAR) and unfolded protein response (UPR) stress signaling pathways converge at the phosphorylation of translation initiation factor eIF2 alpha. This eIF2 alpha modification suppresses global protein synthesis but enhances translation of selected mRNAs such as that for activating transcription factor 4 (ATF4). An ATF4 target gene, SNAT2 (systemAsodium-dependent neutral amino acid transporter 2), contains a C/EBP-ATF site that binds ATF4 and triggers increased transcription during the AAR. However, the present studies show that despite increased ATF4 binding to the SNAT2 gene during UPR activation in HepG2 human hepatoma cells, transcription activity was not enhanced. Hyperacetylation of histone H3 and recruitment of the general transcription factors at the HepG2 SNAT2 promoter occurred in response to the AAR but not the UPR. In contrast, the UPR did enhance transcription from a plasmid-based reporter gene driven by a SNAT2 genomic fragment containing the C/EBP-ATF site. Simultaneous activation of the AAR and the UPR pathways revealed that the UPR actually suppressed the increased SNAT2 transcription by the AAR pathway, demonstrating that the UPR pathway generates a repressive signal that acts downstream of ATF4 binding.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu			National Institutes of Health [DK-59315, DK-52064]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK059315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59315 and DK-52064 (NIDDK) (to M. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Bain PJ, 2002, J NUTR, V132, P3023, DOI 10.1093/jn/131.10.3023; BARBER EF, 1982, J BIOL CHEM, V257, P4960; Barbosa-Tessmann IP, 1999, BIOCHEM J, V339, P151, DOI 10.1042/0264-6021:3390151; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; den Boer ML, 1998, BLOOD, V91, P2092, DOI 10.1182/blood.V91.6.2092.2092_2092_2098; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fraser P, 2006, GENE DEV, V20, P1379, DOI 10.1101/gad.1438106; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; HUTSON RG, 1994, BIOCHEM J, V304, P745, DOI 10.1042/bj3040745; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 1993, ANNU REV NUTR, V13, P137, DOI 10.1146/annurev.nu.13.070193.001033; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SAIER MH, 1988, J MEMBRANE BIOL, V104, P1, DOI 10.1007/BF01871898; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sood R, 2000, GENETICS, V154, P787; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhong C, 2003, BIOCHEM J, V372, P603, DOI 10.1042/BJ20030076	54	30	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27736	27747		10.1074/jbc.M803781200	http://dx.doi.org/10.1074/jbc.M803781200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697751	hybrid, Green Published			2022-12-25	WOS:000259719200045
J	Reynolds, PJ; Simms, JR; Duronio, RJ				Reynolds, Patrick J.; Simms, Jeffrey R.; Duronio, Robert J.			Identifying Determinants of Cullin Binding Specificity Among the Three Functionally Different Drosophila melanogaster Roc Proteins via Domain Swapping	PLOS ONE			English	Article								Background: Cullin-dependent E3 ubiquitin ligases (CDL) are key regulators of protein destruction that participate in a wide range of cell biological processes. The Roc subunit of CDL contains an evolutionarily conserved RING domain that binds ubiquitin charged E2 and is essential for ubiquitylation. Drosophila melanogaster contains three highly related Roc proteins: Roc1a and Roc2, which are conserved in vertebrates, and Roc1b, which is specific to Drosophila. Our previous genetic data analyzing Roc1a and Roc1b mutants suggested that Roc proteins are functionally distinct, but the molecular basis for this distinction is not known. Methodology/Principal Findings: Using co-immunoprecipitation studies we show that Drosophila Roc proteins bind specific Cullins: Roc1a binds Cul1-4, Roc1b binds Cul3, and Roc2 binds Cul5. Through domain swapping experiments, we demonstrate that Cullin binding specificity is strongly influenced by the Roc NH(2)-terminal domain, which forms an intermolecular beta sheet with the Cullin. Substitution of the Roc1a RING domain with that of Roc1b results in a protein with similar Cullin binding properties to Roc1a that is active as an E3 ligase but cannot complement Roc1a mutant lethality, indicating that the identity of the RING domain can be an important determinant of CDL function. In contrast, the converse chimeric protein with a substitution of the Roc1b RING domain with that of Roc1a can rescue the male sterility of Roc1b mutants, but only when expressed from the endogenous Roc1b promoter. We also identified mutations of Roc2 and Cul5 and show that they cause no overt developmental phenotype, consistent with our finding that Roc2 and Cul5 proteins are exclusive binding partners, which others have observed in human cells as well. Conclusions: The Drosophila Roc proteins are highly similar, but have diverged during evolution to bind a distinct set of Cullins and to utilize RING domains that have overlapping, but not identical, function in vivo.	[Reynolds, Patrick J.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Simms, Jeffrey R.; Duronio, Robert J.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC USA; [Duronio, Robert J.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Reynolds, PJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	duronio@med.unc.edu		Duronio, Robert/0000-0001-6469-6965	American Cancer Society [RSG-04-179-01-DDC]	American Cancer Society(American Cancer Society)	This study was supported by American Cancer Society grant RSG-04-179-01-DDC. ACS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Aso T, 2000, BIOCHEM BIOPH RES CO, V276, P355, DOI 10.1006/bbrc.2000.3451; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Dadgostar H, 1998, J BIOL CHEM, V273, P24775, DOI 10.1074/jbc.273.38.24775; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Donaldson TD, 2004, MOL BIOL CELL, V15, P4892, DOI 10.1091/mbc.E04-03-0180; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; HU J, 2008, GENES DEV IN PRESS; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Liu HL, 2007, BIOTECHNOL PROGR, V23, P1231, DOI 10.1021/bp0701665; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sasagawa Y, 2007, FEBS LETT, V581, P145, DOI 10.1016/j.febslet.2006.12.009; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; von Arnim AG, 2003, CURR OPIN PLANT BIOL, V6, P520, DOI 10.1016/j.pbi.2003.09.006; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	50	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2918	10.1371/journal.pone.0002918	http://dx.doi.org/10.1371/journal.pone.0002918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698375	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600006
J	Surolia, I; Sinha, S; Sarkar, DP; Reddy, PY; Reddy, GB; Surolia, A				Surolia, Ira; Sinha, Sharmistha; Sarkar, Debi Prasad; Reddy, P. Yadagiri; Reddy, G. Bhanuprakash; Surolia, Avadhesha			Concurrence of Danish Dementia and Cataract: Insights from the Interactions of Dementia Associated Peptides with Eye Lens alpha-Crystallin	PLOS ONE			English	Article								Familial Danish Dementia (FDD) is an autosomal disease, which is distinguished by gradual loss of vision, deafness, progressive ataxia and dementia. Cataract is the first manifestation of the disease. In this article, we demonstrate a specific correlation between the poisoning of the chaperone activity of the rat eye lens alpha-crystallins, loss of lens transparency in organ culture by the pathogenic form of the Danish dementia peptide, i.e. the reduced Danish dementia peptide (redADan peptide), by a combination of ex vivo, in vitro, biophysical and biochemical techniques. The interaction of redADan peptide and lens crystallins are very specific when compared with another chaperone, HSP-70, underscoring the specificity of the pathogenic form of Danish dementia peptide, redADan, for the early onset of cataract in this disease.	[Surolia, Ira; Sarkar, Debi Prasad] Univ Delhi, Dept Biochem, New Delhi, India; [Sinha, Sharmistha; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [Reddy, P. Yadagiri; Reddy, G. Bhanuprakash] Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi, India	University of Delhi; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Surolia, I (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	surolia@nii.res.in	Reddy, G Bhanuprakash/AAJ-3494-2020	Reddy, G Bhanuprakash/0000-0003-4787-3944; Sinha, Sharmistha/0000-0003-2459-650X; Sarkar, Debi P/0000-0002-8886-8415	Dept. of Biotechnology, Government of India; Department of Science and Technology, Government of India	Dept. of Biotechnology, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work is supported by grants from the Dept. of Biotechnology, Government of India, and from the Department of Science and Technology, Government of India, to AS.	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bek T, 2000, BRIT J OPHTHALMOL, V84, P1298, DOI 10.1136/bjo.84.11.1298; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Gibson G, 2004, J NEUROCHEM, V88, P281, DOI 10.1046/j.1471-4159.2003.02134.x; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Harding J J, 1991, Lens Eye Toxic Res, V8, P245; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; KLEMENZ R, 1991, MOL CELL BIOL, V11, P803, DOI 10.1128/MCB.11.2.803; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rao G, 2008, MOL VIS, V14, P666; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; STROMGREN E, 1970, ACTA NEUROL SCAN S43, V46; SUROLIA I, 2008, BIOCH BIOPH IN PRESS; Surolia I, 2006, J NEUROCHEM, V99, P537, DOI 10.1111/j.1471-4159.2006.04072.x; Suryanarayana P, 2004, MOL VIS, V10, P148; SWAMY MS, 1987, INVEST OPHTH VIS SCI, V28, P1693; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097	33	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2927	10.1371/journal.pone.0002927	http://dx.doi.org/10.1371/journal.pone.0002927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698348	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600013
J	Chang, YM; Kong, QM; Shan, X; Tian, GL; Ilieva, H; Cleveland, DW; Rothstein, JD; Borchelt, DR; Wong, PC; Lin, CLG				Chang, Yueming; Kong, Qiongman; Shan, Xiu; Tian, Guilian; Ilieva, Hristelina; Cleveland, Don W.; Rothstein, Jeffrey D.; Borchelt, David R.; Wong, Philip C.; Lin, Chien-liang Glenn			Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS	PLOS ONE			English	Article								Background: Accumulating evidence indicates that RNA oxidation is involved in a wide variety of neurological diseases and may be associated with neuronal deterioration during the process of neurodegeneration. However, previous studies were done in postmortem tissues or cultured neurons. Here, we used transgenic mice to demonstrate the role of RNA oxidation in the process of neurodegeneration. Methodology/Principal Findings: We demonstrated that messenger RNA (mRNA) oxidation is a common feature in amyotrophic lateral sclerosis (ALS) patients as well as in many different transgenic mice expressing familial ALS-linked mutant copper-zinc superoxide dismutase (SOD1). In mutant SOD1 mice, increased mRNA oxidation primarily occurs in the motor neurons and oligodendrocytes of the spinal cord at an early, pre-symptomatic stage. Identification of oxidized mRNA species revealed that some species are more vulnerable to oxidative damage, and importantly, many oxidized mRNA species have been implicated in the pathogenesis of ALS. Oxidative modification of mRNA causes reduced protein expression. Reduced mRNA oxidation by vitamin E restores protein expression and partially protects motor neurons. Conclusion/Significance: These findings suggest that mRNA oxidation is an early event associated with motor neuron deterioration in ALS, and may be also a common early event preceding neuron degeneration in other neurological diseases.	[Chang, Yueming; Kong, Qiongman; Shan, Xiu; Tian, Guilian; Lin, Chien-liang Glenn] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Chang, Yueming; Tian, Guilian; Lin, Chien-liang Glenn] Ohio State Univ, Ohio State Biochem Program, Columbus, OH USA; [Ilieva, Hristelina; Cleveland, Don W.] Univ Calif San Diego, Dept Med & Neurosci, San Diego, CA USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA; [Borchelt, David R.] Univ Florida, Dept Neurosci, Gainesville, FL USA; [Wong, Philip C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Johns Hopkins University; State University System of Florida; University of Florida; Johns Hopkins University	Chang, YM (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	lin.492@osu.edu	Lin, Chien-liang G/E-3513-2011; Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013	Cleveland, Don/0000-0002-1934-3682	ALS Association; NIH [AG17317]; Neuroscience Education and Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG017317] Funding Source: NIH RePORTER	ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Education and Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by ALS Association, NIH (grant AG17317), and the Neuroscience Education and Research Foundation.	Andrus PK, 1998, J NEUROCHEM, V71, P2041; Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; BANIK NL, 1987, NEUROCHEM PATHOL, V7, P57, DOI 10.1007/BF02834292; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Ekegren T, 2006, J PROTEOME RES, V5, P2364, DOI 10.1021/pr060237f; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; FIALA ES, 1989, CANCER RES, V49, P5518; Gard AL, 2001, MICROSC RES TECHNIQ, V52, P709, DOI 10.1002/jemt.1055; Gong YH, 2000, EXP NEUROL, V162, P27, DOI 10.1006/exnr.2000.7323; Graf M, 2005, J NEURAL TRANSM, V112, P649, DOI 10.1007/s00702-004-0220-1; Guentchev M, 2002, NEUROBIOL DIS, V9, P275, DOI 10.1006/nbdi.2002.0477; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hayashi M, 2002, J CHILD NEUROL, V17, P725, DOI 10.1177/08830738020170101101; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nunomura A, 1999, ANN NY ACAD SCI, V893, P362, DOI 10.1111/j.1749-6632.1999.tb07855.x; Nunomura A, 2004, NEUROBIOL DIS, V17, P108, DOI 10.1016/j.nbd.2004.06.003; Nunomura A, 2002, NEUROREPORT, V13, P2035, DOI 10.1097/00001756-200211150-00009; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Shan X, 2006, NEUROBIOL AGING, V27, P657, DOI 10.1016/j.neurobiolaging.2005.03.022; Shan X, 2003, J NEUROSCI, V23, P4913; Shan X, 2007, FASEB J, V21, P2753, DOI 10.1096/fj.07-8200com; Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Wamer WG, 1997, FREE RADICAL BIO MED, V23, P851, DOI 10.1016/S0891-5849(97)00068-3; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yamamoto Y, 1999, EUR J NEUROSCI, V11, P847, DOI 10.1046/j.1460-9568.1999.00490.x; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	54	152	155	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2849	10.1371/journal.pone.0002849	http://dx.doi.org/10.1371/journal.pone.0002849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682740	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600005
J	Lyon, JA; Angov, E; Fay, MP; Sullivan, JS; Girourd, AS; Robinson, SJ; Bergmann-Leitner, ES; Duncan, EH; Darko, CA; Collins, WE; Long, CA; Barnwell, JW				Lyon, Jeffrey A.; Angov, Evelina; Fay, Michael P.; Sullivan, Joann S.; Girourd, Autumn S.; Robinson, Sally J.; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Darko, Christian A.; Collins, William E.; Long, Carole A.; Barnwell, John W.			Protection Induced by Plasmodium falciparum MSP1(42) Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; CARBOXYL-TERMINAL FRAGMENT; MALARIA PARASITE; AOTUS-NANCYMAI; MURINE MALARIA; IMMUNIZATION; INVASION; VACCINE; GROWTH; CHALLENGE	Vaccination with Plasmodium falciparum MSP1(42)/complete Freund's adjuvant (FA) followed by MSP1(42)/incomplete FA is the only known regimen that protects Aotus nancymaae monkeys against infection by erythrocytic stage malaria parasites. The role of adjuvant is not defined; however complete FA cannot be used in humans. In rodent models, immunity is strain-specific. We vaccinated Aotus monkeys with the FVO or 3D7 alleles of MSP1(42) expressed in Escherichia coli or with the FVO allele expressed in baculovirus (bv) combined with complete and incomplete FA, Montanide ISA-720 (ISA-720) or AS02A. Challenge with FVO strain P. falciparum showed that suppression of cumulative day 11 parasitemia was strain-specific and could be induced by E. coli expressed MSP1(42) in combination with FA or ISA-720 but not with AS02A. The coli42-FVO antigen induced a stronger protective effect than the bv42-FVO antigen, and FA induced a stronger protective effect than ISA-720. ELISA antibody (Ab) responses at day of challenge (DOC) were strain-specific and correlated inversely with c-day 11 parasitemia (r = -0.843). ELISA Ab levels at DOC meeting a titer of at least 115,000 ELISA Ab units identified the vaccinees not requiring treatment (noTx) with a true positive rate of 83.3% and false positive rate of 14.3%. Correlation between functional growth inhibitory Ab levels (GIA) and cumulative day 11 parasitemia was weaker (r = -0.511), and was not as predictive for a response of noTx. The lowest false positive rate for GIA was 30% when requiring a true positive rate of 83.3%. These inhibition results along with those showing that antigen/FA combinations induced a stronger protective immunity than antigen/ISA-720 or antigen/AS02 combinations are consistent with protection as ascribed to MSP1-specific cytophilic antibodies. Development of an effective MSP1(42) vaccine against erythrocytic stage P. falciparum infection will depend not only on antigen quality, but also upon the selection of an optimal adjuvant component.	[Lyon, Jeffrey A.; Angov, Evelina; Girourd, Autumn S.; Robinson, Sally J.; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Darko, Christian A.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA; [Fay, Michael P.] NIAID, NIH, Biostat Res Branch, Bethesda, MD USA; [Sullivan, Joann S.; Collins, William E.; Barnwell, John W.] CDC, Natl Ctr Zoonot, Vector Borne & Enter Dis, Div Parasit Dis, Malaria Branch, Atlanta, GA USA; [Long, Carole A.] NIAID, NIH, Dept Malaria & Vector Res, Bethesda, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lyon, JA (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA.	evelina.angov@us.army.mil	Bergmann-Leitner, Elke/I-5431-2019; Bergmann-Leitner, Elke S./B-3548-2011; Fay, Michael P/A-2974-2008	Bergmann-Leitner, Elke/0000-0002-8571-8956; Bergmann-Leitner, Elke S./0000-0002-8571-8956; Fay, Michael P/0000-0002-8643-9625	U.S. Agency for International Development [936?6001, AAG-P- 00-98-00006, AAG-P-00-98-00005]; National Institutes of Health and Centers for Disease Control and Prevention [NIAID YIAI-0438-03/ CDC C100-042]; United States Army Medical Research and Materiel Command; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, Z01AI001020] Funding Source: NIH RePORTER	U.S. Agency for International Development(United States Agency for International Development (USAID)); National Institutes of Health and Centers for Disease Control and Prevention; United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Agency for International Development under project number 936?6001, award number AAG-P- 00-98-00006, and award number AAG-P-00-98-00005, by the National Institutes of Health and Centers for Disease Control and Prevention Interagency Agreement under grant number NIAID YIAI-0438-03/ CDC C100-042, and by the United States Army Medical Research and Materiel Command.	Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bergmann-Leitner ES, 2008, AM J TROP MED HYG, V78, P468, DOI 10.4269/ajtmh.2008.78.468; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Brunham KP., 2002, MODEL SELECTION MULT; BURNS JM, 1989, J IMMUNOL, V143, P2670; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHAPPEL JA, 1993, MOL BIOCHEM PARASIT, V60, P303, DOI 10.1016/0166-6851(93)90141-J; CHULAY JD, 1981, J INFECT DIS, V144, P270, DOI 10.1093/infdis/144.3.270; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DIGGS CL, 1993, PARASITOL TODAY, V9, P300, DOI 10.1016/0169-4758(93)90130-8; FARLEY PJ, 1995, EXP PARASITOL, V80, P328, DOI 10.1006/expr.1995.1040; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; HALDAR K, 1985, J BIOL CHEM, V260, P4969; Hirunpetcharat C, 2003, VACCINE, V21, P2923, DOI 10.1016/S0264-410X(03)00132-4; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; HOLDER AA, 1994, PARASITOLOGY, V108, pS5, DOI 10.1017/S0031182000075673; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Janeway C.A., 2004, IMMUNOBIOLOGY IMMUNE; JIN B, 2007, IMMUNOLOGY; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Ling IT, 1997, VACCINE, V15, P1562, DOI 10.1016/S0264-410X(97)00076-5; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; LYON JA, 1987, J IMMUNOL, V138, P895; MAJARIAN WR, 1984, J IMMUNOL, V132, P3131; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; PERKINS ME, 1988, J IMMUNOL, V141, P3190; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Rotman HL, 1998, J IMMUNOL, V161, P1908; Sachdeva S, 2006, VACCINE, V24, P2007, DOI 10.1016/j.vaccine.2005.11.041; Sachdeva S, 2004, INFECT IMMUN, V72, P5775, DOI 10.1128/IAI.72.10.5775-5782.2004; Segal BM, 2000, J IMMUNOL, V164, P5683, DOI 10.4049/jimmunol.164.11.5683; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Yip HC, 1999, J IMMUNOL, V162, P3942	52	65	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2830	10.1371/journal.pone.0002830	http://dx.doi.org/10.1371/journal.pone.0002830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665258	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300049
J	Ahmed, KM; Fan, M; Nantajit, D; Cao, N; Li, JJ				Ahmed, K. M.; Fan, M.; Nantajit, D.; Cao, N.; Li, J. J.			Cyclin D1 in low-dose radiation-induced adaptive resistance	ONCOGENE			English	Article						radiation resistance; cyclin D1; 14-3-3; Bax; human keratinocytes; adaptive response	FACTOR-KAPPA-B; IONIZING-RADIATION; GENOMIC INSTABILITY; APOPTOTIC RESPONSE; HUMAN-LYMPHOCYTES; GENE-EXPRESSION; CANCER CELLS; X-RAYS; PROTEIN; BAX	Cyclin D1 is involved in cell-cycle arrest in DNA-damage response. This study tested the hypothesis that cyclin D1 regulates mitochondrial apoptosis. Cycl in D1 was induced by low-dose ionizing radiation (LDIR; 10-cGy X-ray) in human keratinocytes with an adaptive radioresistance that can be inhibited by short interfering RNA (siRNA)mediated cyclin D1 inhibition. Cyclin D1 was found to form complex with chaperon 14-3-3 zeta in unstressed cells and mutation of 14-3-3 zeta Ser-58 to Asp (S58D) significantly impaired 14-3-3 zeta binding to cyclin D1. The formation of cyclin D1/14-3-3 zeta complex was differently regulated by exposure to low (10-cGy X-ray) versus high (5-Gy gamma-ray) doses of radiation. Unlike exposure to 5-Gy that predominantly enhanced cyclin D1 nuclear accumulation, LDIR induced the dissociation of the cyclin D1/14-3-3 zeta complex without nuclear translocation, indicating that cytosolic accumulation of cyclin D1 was required for LDIR-induced adaptive response. Further studies revealed a direct interaction of cyclin D1 with proapoptotic Bax and an improved mitochondrial membrane potential (Delta psi(m)) in LDIR-treated cells. Consistently, blocking cyclin D1/Bax formation by cyclin D1 siRNA reversed Delta psi(m) and inhibited the LDIR-associated antiapoptotic response. These results demonstrate the evidence that cytosolic cyclin D1 is able to regulate apoptosis by interaction with Bax in LDIR-induced adaptive resistance.	[Ahmed, K. M.; Fan, M.; Nantajit, D.; Cao, N.; Li, J. J.] Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, W Lafayette, IN 47907 USA; [Ahmed, K. M.; Fan, M.; Nantajit, D.; Cao, N.; Li, J. J.] Purdue Univ, Sch Hlth Sci, Grad Program Radiat & Canc Biol, W Lafayette, IN 47907 USA; [Li, J. J.] Purdue Canc Ctr, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Li, JJ (corresponding author), Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, 550 Stadium Mall Dr, W Lafayette, IN 47907 USA.	jjli@purdue.edu	Cao, Ning/F-9480-2013; Nantajit, Danupon/CAF-7353-2022; Cao, Ning/I-3094-2013	Cao, Ning/0000-0002-3929-8604	NIH NCI [RO1 101990]; Department of Energy [DE-FG02-03ER63634]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy(United States Department of Energy (DOE))	We thank Dr N Colburn (National Cancer Institute, NIH) for providing human keratinocytes HK18 cells, Dr S Liu (Purdue University School of Health Sciences) for invaluable help with animal experiments. This work was supported by NIH NCI grant RO1 101990 and the Department of Energy grant DE-FG02-03ER63634 to JJL.	Ahmed KM, 2006, MOL CANCER RES, V4, P945, DOI 10.1158/1541-7786.MCR-06-0291; Biliran H, 2005, CLIN CANCER RES, V11, P6075, DOI 10.1158/1078-0432.CCR-04-2419; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen XF, 2002, CANCER RES, V62, P1213; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Daosukho C, 2002, ONCOGENE, V21, P3603, DOI 10.1038/sj.onc.1205448; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Feinendegen LE, 1996, MUTAT RES-FUND MOL M, V358, P199, DOI 10.1016/S0027-5107(96)00121-2; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; KELSEY KT, 1991, MUTAT RES, V263, P197, DOI 10.1016/0165-7992(91)90001-K; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Limoli CL, 2001, FREE RADICAL BIO MED, V31, P10, DOI 10.1016/S0891-5849(01)00542-1; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oyama T, 1998, CANCER RES, V58, P2876; Pandey BN, 2006, ANTIOXID REDOX SIGN, V8, P1253, DOI 10.1089/ars.2006.8.1253; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; SHADLEY JD, 1987, RADIAT RES, V111, P511, DOI 10.2307/3576936; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Ulsh BA, 2004, J ENVIRON RADIOACTIV, V74, P73, DOI 10.1016/j.jenvrad.2004.01.005; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	32	41	45	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6738	6748		10.1038/onc.2008.265	http://dx.doi.org/10.1038/onc.2008.265			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18695676	Green Accepted			2022-12-25	WOS:000260866200004
J	Andre, H; Pereira, TS				Andre, Helder; Pereira, Teresa S.			Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; HIPPEL-LINDAU PROTEIN; FACTOR-ALPHA; FACTOR 1-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA HIF-1-ALPHA; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; DIRECT BINDING; HIF-ALPHA	The hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of the cellular response to decreased oxygen levels. This transcription factor is highly unstable at normal oxygen concentrations and is rapidly stabilized by hypoxia. At normoxia two specific proline residues (Pro(402) and Pro(563)) of mHIF-1 alpha are hydroxylated and recognized by the von Hippel-Lindau E3 ubiquitin ligase (pVHL) complex, which upon binding mediates degradation of the protein. Previous studies have demonstrated that these two proline residues are critical for high affinity binding to pVHL. We have performed a detailed analysis of a mutant form of HIF-1 alpha, where both these proline residues have been mutated, and we have uncovered a novel degradation pathway, to which the HIF-1 alpha mutant protein is not resistant. Our results show that the HIF-1 alpha double proline mutant undergoes ubiquitination and proteasome-dependent degradation, and retains the ability to be stabilized in response to hypoxia and CoCl2 treatment. However in contrast to the wild-type protein, stabilization of the mutant was only observed within short periods of hypoxia exposure (1-2 h). Degradation assays in the presence of the expressed prolyl hydroxylases (PHDs) 1-3 showed that, unlike the wild-type protein, the HIF-1 alpha mutant was resistant to these hydroxylases. However, experiments knocking-down expression of pVHL by RNA interference showed that the HIF-1 alpha mutant is degraded and ubiquitinated by a pVHL-mediated mechanism. In conclusion, we show the first evidence of a novel mechanism of degradation of HIF-1 alpha at normoxia that involves pVHL but is not mediated by PHDs 1-3 or by degradation boxes surrounding Pro(402) and Pro(563).	[Andre, Helder; Pereira, Teresa S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Pereira, TS (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	teresa.pereira@ki.se	Pereira, Teresa/AAP-8197-2020; Andre, Helder/AAC-5220-2019	Pereira, Teresa/0000-0001-8654-2385; Andre, Helder/0000-0002-2926-2376	Swedish Medical Research Council; the Swedish Cancer Society; the European Union; Karolinska Institutet	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); the Swedish Cancer Society(Swedish Cancer Society); the European Union(European Commission); Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Society, the European Union, and Karolinska Institutet. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Haase VH, 2005, SEMIN CELL DEV BIOL, V16, P564, DOI 10.1016/j.semcdb.2005.03.006; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	37	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29375	29384		10.1074/jbc.M805919200	http://dx.doi.org/10.1074/jbc.M805919200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694926	Green Published, hybrid			2022-12-25	WOS:000260179900064
J	Oku, T; Kaneko, Y; Murofushi, K; Seyama, Y; Toyoshima, S; Tsuji, T				Oku, Teruaki; Kaneko, Yutaka; Murofushi, Koki; Seyama, Yoshiyuki; Toyoshima, Satoshi; Tsuji, Tsutomu			Phorbol Ester-dependent Phosphorylation Regulates the Association of p57/Coronin-1 with the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER MOTIF; PROTEIN-KINASE-C; BINDING-PROTEIN; CORONIN FAMILY; MYCOBACTERIUM-TUBERCULOSIS; TRANSIENT ASSOCIATION; CELL MOTILITY; DICTYOSTELIUM; PHAGOSOMES; DYNAMICS	The p57/coronin-1 protein is a member of the coronin family of actin-binding proteins, which are characterized by the presence of WD (tryptophan/aspartic acid) repeats and a coiled-coil motif in the molecule. It is selectively expressed in immune cells and has been suggested to play crucial roles in leukocyte functions, including cell migration and phagocytosis. In this study we examined the effects of p57/coronin-1 phosphorylation on the association of the protein with actin. Treatment of HL60 human leukemic cells or p57/coronin-1-transfected HEK293 cells with phorbol 12-myristate 13-acetate (PMA) reduced the association of p57/coronin-1 with the actin cytoskeleton, as indicated by cell fractionation experiments and by fluorescence microscopic observation. Two-dimensional gel electrophoresis of HL60 cell lysate revealed that p57/coronin-1 was phosphorylated upon PMA stimulation of the cells, giving two major and two minor spots of phosphorylated forms, each with distinct isoelectric points. The p57/coronin-1 molecules associated with the cytoskeleton in PMA-treated HL60 cells were phosphorylated at lower levels than those recovered in the cytosolic fraction. In addition, p57/coronin-1 co-sedimented with F-actin polymerized in vitro had lower phosphorylation levels than the molecules remaining in the supernatant. By affinity chromatographic analysis using anti-p57/coronin-1 antibody-conjugated Sepharose, p57/coronin-1 derived from PMA-treated HL60 cells showed lower affinity for actin than that from untreated cells. Finally, recovery of p57/coronin-1 in the actin cytoskeleton-rich fraction from neutrophil-like differentiated HL60 cells decreased during phagocytosis, concomitant with enhanced phosphorylation of p57/coronin-1. These results strongly suggest that the phosphorylation of p57/coronin-1 down-regulates its association with actin and modulates the reorganization of actin-containing cytoskeleton.	[Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428501, Japan; [Seyama, Yoshiyuki] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Clin Chem, Tokyo 1428501, Japan; [Toyoshima, Satoshi] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan	Hoshi University; Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	tsuji@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Open Research Center Project	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Open Research Center Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Open Research Center Project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L; Fukui Y, 1997, BIOL BULL, V193, P224, DOI 10.1086/BBLv193n2p224; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Hacker U, 1997, J CELL SCI, V110, P105; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769	24	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28918	28925		10.1074/jbc.M709990200	http://dx.doi.org/10.1074/jbc.M709990200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18693254	hybrid, Green Published			2022-12-25	WOS:000260179900017
J	Colomina, N; Ferrezuelo, F; Wang, HY; Aldea, M; Gari, E				Colomina, Neus; Ferrezuelo, Francisco; Wang, Hongyin; Aldea, Marti; Gari, Eloi			Whi3, a developmental regulator of budding yeast, binds a large set of mRNAs functionally related to the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN CLN3; PROTEIN; GENE; IDENTIFICATION; LOCALIZATION; TRANSCRIPTION; COMPLEX; ER; COORDINATION; DEPRIVATION	Whi3 is an RNA-binding protein associated with the endoplasmic reticulum (ER) that binds the CLN3 mRNA and plays a key role in the efficient retention of cyclin Cln3 at the ER. In the present work, we have identified new Whi3-associated mRNAs by a genomic approach. A large and significant number of these Whi3 targets encode for membrane and exocytic proteins involved in processes such as transport and cell wall biogenesis. Consistent with the genomic data, we have observed that cell wall integrity is compromised in Whi3-deficient cells and found strong genetic interactions between WHI3 and the cell integrity pathway. Whi3-associated mRNAs are enriched in clusters of the tetranucleotide GCAU, and mutation of the GCAU clusters in the CLN3 mRNA caused a reduction in its association to Whi3, suggesting that these sequences may act as cis-determinants for binding. Our data suggest that Whi3 is involved in the regulation and/or localization of a large subset of mRNAs functionally related to the ER and, since it is important for different molecular processes such as cytoplasmic retention or exocytic traffic of proteins, we propose that Whi3 is a general modulator of protein fate in budding yeast.	[Colomina, Neus; Ferrezuelo, Francisco; Wang, Hongyin; Aldea, Marti; Gari, Eloi] Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Inst Recerca Biomed Lleida, Lleida 25008, Catalunya, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Gari, E (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Inst Recerca Biomed Lleida, Montserrat Roig 2, Lleida 25008, Catalunya, Spain.	eloi.gari@cmb.udl.cat	Aldea, Marti/K-3962-2014; Colomina Gabarrella, Neus/C-4449-2011; Colomina, Neus/ABF-7179-2021; Garí, Eloi/A-5996-2010; Aldea, Marti/A-9721-2010; Ferrezuelo, Francisco/E-7511-2010	Aldea, Marti/0000-0002-8710-5336; Colomina Gabarrella, Neus/0000-0002-1986-1199; Colomina, Neus/0000-0002-1986-1199; Garí, Eloi/0000-0002-3505-4901; Ferrezuelo, Francisco/0000-0001-9403-0355	Ministry of Education and Science of Spain; Fundacio La Caixa; European Union	Ministry of Education and Science of Spain(Spanish Government); Fundacio La Caixa(La Caixa FoundationEuropean Commission); European Union(European Commission)	This work was funded by grants from the Ministry of Education and Science of Spain (Consolider-Ingenio 2010), the Fundacio La Caixa, and the European Union (Fondos FEDER). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de la Torre-Ruiz MA, 2002, J BIOL CHEM, V277, P33468, DOI 10.1074/jbc.M203515200; DERISI J, 2002, DNA MICROARRAYS MOL, P187; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Jin QW, 2003, EUKARYOT CELL, V2, P510, DOI 10.1128/EC.2.3.510-520.2003; Karagiannis J, 2002, GENETICS, V162, P45; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mosch HU, 1997, GENETICS, V145, P671; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nash RS, 2001, GENETICS, V157, P1469; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Sengupta DJ, 1999, RNA, V5, P596, DOI 10.1017/S1355838299002113; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	53	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28670	28679		10.1074/jbc.M804604200	http://dx.doi.org/10.1074/jbc.M804604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667435	Green Published, hybrid			2022-12-25	WOS:000259969300069
J	Shi, JH; Zhang, TY; Zhou, CL; Chohan, MO; Gu, XS; Wegiel, J; Zhou, JH; Hwang, YW; Iqbal, K; Grundke-Iqbal, I; Gong, CX; Liu, F				Shi, Jianhua; Zhang, Tianyi; Zhou, Chunlei; Chohan, Muhammad Omar; Gu, Xiaosong; Wegiel, Jerzy; Zhou, Jianhua; Hwang, Yu-Wen; Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei			Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PRE-MESSENGER-RNA; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PROTEIN-KINASE; INTRANUCLEAR DISTRIBUTION; NEUROFIBRILLARY TANGLES; FACTOR ASF/SF2; HUMAN BRAIN; PHOSPHORYLATION	Two groups of tau, 3R-and 4R-tau, are generated by alternative splicing of tau exon 10. Normal adult human brain expresses equal levels of them. Disruption of the physiological balance is a common feature of several tauopathies. Very early in their life, individuals with Down syndrome (DS) develop Alzheimer-type tau pathology, the molecular basis for which is not fully understood. Here, we demonstrate that Dyrk1A, a kinase encoded by a gene in the DS critical region, phosphorylates alternative splicing factor (ASF) at Ser-227, Ser-234, and Ser-238, driving it into nuclear speckles and preventing it from facilitating tau exon 10 inclusion. The increased dosage of Dyrk1A in DS brain due to trisomy of chromosome 21 correlates to an increase in 3R-tau level, which on abnormal hyperphosphorylation and aggregation of tau results in neurofibrillary degeneration. Imbalance of 3R-and 4R-tau in DS brain by Dyrk1A-induced dysregulation of alternative splicing factor-mediated alternative splicing of tau exon 10 represents a novel mechanism of neurofibrillary degeneration and may help explain early onset tauopathy in individuals with DS.	[Shi, Jianhua; Zhang, Tianyi; Zhou, Chunlei; Gu, Xiaosong; Liu, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Chohan, Muhammad Omar; Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY 10314 USA; [Wegiel, Jerzy] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, New York, NY 10314 USA; [Hwang, Yu-Wen] New York State Inst Basic Res Dev Disabil, Dept Mol Biol, New York, NY 10314 USA; [Zhou, Jianhua] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Zhou, Jianhua] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01605 USA	Nantong University; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Liu, F (corresponding author), 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Chohan, Muhammad/ABG-1163-2021; Shi, Jianhua/L-8463-2016	Chohan, Muhammad/0000-0003-4542-4651; Shi, Jianhua/0000-0002-5351-406X	National Institutes of Health Grant [AG027429, AG019158, HD43960]; Nantong University; New York State Office of Mental Retardation and Developmental Disabilities; University of Massachusetts Medical School; National Natural Science Foundation of China [30572076, 30770468]; Alzheimer's Association [NIRG-08-91126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027429, R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nantong University; New York State Office of Mental Retardation and Developmental Disabilities; University of Massachusetts Medical School; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Association(Alzheimer's Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants AG027429 (to C.- X. G.), AG019158 (to K. I.), and HD43960 (to J. W.). This work was also supported by grants from Nantong University, the New York State Office of Mental Retardation and Developmental Disabilities, and the University of Massachusetts Medical School and by grants from the National Natural Science Foundation of China (Grants 30572076 and 30770468 to F. L.) and Alzheimer's Association (NIRG-08-91126 to F. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonso AD, 2001, J BIOL CHEM, V276, P37967; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; LIU F, 2008, FASEB J IN PRESS; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; Stanford PM, 2003, BRAIN, V126, P814, DOI 10.1093/brain/awg090; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x	52	117	120	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28660	28669		10.1074/jbc.M802645200	http://dx.doi.org/10.1074/jbc.M802645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658135	Green Published, hybrid			2022-12-25	WOS:000259969300068
J	Fedrizzi, L; Lim, D; Carafoli, E; Brini, M				Fedrizzi, Laura; Lim, Dmitry; Carafoli, Ernesto; Brini, Marisa			Interplay of the Ca2+-binding protein DREAM with presenilin in neuronal Ca2+ signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CALSENILIN; MUTATIONS; MODULATION; APOPTOSIS; CHANNELS; CELLS; ENTRY	The Ca2+ binding protein DREAM regulates gene transcription and Kv potassium channels in neurons but has also been claimed to interact with presenilins, which are involved in the generation of beta-amyloid and in the regulation of the Ca2+ content in the endoplasmic reticulum. The role of DREAM in Ca2+ homeostasis was thus explored in SH-SY5Y cells stably or transiently overexpressing DREAM or a Ca2+ -insensitive mutant of it. The overexpression of DREAM had transcriptional and post-transcriptional effects. Endoplasmic reticulum Ca2+ and capacitative Ca2+ influx were reduced in stably expressing cells. The previously shown down-regulation of Na+/Ca2+ exchanger 3 expression was confirmed; it could cause a local increase of sub-plasma membrane Ca2+ and thus inhibit capacitative Ca2+ influx. DREAM up-regulated the expression of the inositol 1,4,5-trisphosphate receptor and could thus increase the unstimulated release of Ca2+ through it. The transient coexpression of DREAM and presenilin potentiated the decrease of endoplasmic reticulum Ca2+ observed in presenilin-overexpressing cells. This could be due to a direct effect of DREAM on presenilin as the two proteins interacted in a Ca2+ -independent fashion.	[Fedrizzi, Laura; Lim, Dmitry; Carafoli, Ernesto; Brini, Marisa] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Fedrizzi, Laura; Brini, Marisa] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Lim, Dmitry; Carafoli, Ernesto] Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Brini, M (corresponding author), Univ Padua, Dept Biochem, Viale G Colombo 3, I-35131 Padua, Italy.	marisa.brini@unipd.it	Brini, Marisa/K-5189-2016; Lim, Dmitry/H-9101-2012; Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094; Brini, Marisa/0000-0001-5141-0243	Telethon Foundation [GGP04169]; Italian Ministry of University and Research [PRIN 2003]; European Union FP6 Integrated Projects NeuroNe;  [LSH-2003-2.1.3-3]	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Union FP6 Integrated Projects NeuroNe(European Commission); 	The work was supported by Telethon Foundation Project GGP04169 (to M. B.), Italian Ministry of University and Research Grant PRIN 2003 and 2005 (to M. B.), and FP6 program of the European Union FP6 Integrated Projects NeuroNe and LSH-2003-2.1.3-3 (to E. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 at ISI, Thomson Scientific on October 6, 2008 www. jbc. org Downloaded from	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dettbarn C, 1998, J PHARMACOL EXP THER, V285, P739; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GATTO C, 1995, BIOCHEMISTRY-US, V34, P965, DOI 10.1021/bi00003a031; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jo DG, 2004, J NEUROCHEM, V88, P604, DOI 10.1046/j.1471-4159.2003.02159.x; Jo DG, 2001, FASEB J, V15, P589; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Penner R, 1993, Curr Opin Neurobiol, V3, P368, DOI 10.1016/0959-4388(93)90130-Q; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Scsucova S, 2005, NUCLEIC ACIDS RES, V33, P2269, DOI 10.1093/nar/gki503; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Smith IF, 2002, BRAIN RES, V949, P105, DOI 10.1016/S0006-8993(02)02970-0; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vito P, 1996, J BIOL CHEM, V271, P31025, DOI 10.1074/jbc.271.49.31025; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002	49	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27494	27503		10.1074/jbc.M804152200	http://dx.doi.org/10.1074/jbc.M804152200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664571	hybrid			2022-12-25	WOS:000259719200020
J	Johnson, ET; Schmidt-Dannert, C				Johnson, Ethan T.; Schmidt-Dannert, Claudia			Characterization of three homologs of the large subunit of the magnesium chelatase from Chlorobaculum tepidum and interaction with the magnesium protoporphyrin IX methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-SULFUR BACTERIUM; COMPLETE GENOME SEQUENCE; ADENOSYL-L-METHIONINE; CHLOROPHYLL BIOSYNTHESIS; CHLOROBIUM-TEPIDUM; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; RHODOPSEUDOMONAS-SPHEROIDES; SYNECHOCYSTIS PCC6803; ATPASE ACTIVITY	Green bacteria synthesize several types of (bacterio) chlorophylls for the assembly of functional photosynthetic reaction centers and antenna complexes. A distinctive feature of green bacteria compared with other photosynthetic microbes is that their genomes contain multiple homologs of the large subunit (BchH) of the magnesium chelatase which is a three-subunit enzyme complex (BchH, BchD, and BchI) that inserts magnesium into protoporphyrin IX as the first committed step of (bacterio) chlorophyll biosynthesis. There is speculation that the additional BchH homologs may regulate the biosynthesis of each type of chlorophyll, although the biochemical properties of the different magnesium chelatase complexes from a single species of green bacteria have not yet been compared. In this study, we investigated the activities of all three chelatase complexes from the green sulfur bacterium Chlorobaculum tepidum and interactions with the next enzyme in the pathway, magnesium protoporphyrin IX methyltransferase (BchM). Although all three chelatase complexes insert magnesium into protoporphyrin IX, the activities range by a factor of 10(5). Further, there are differences in the interactions between the BchH homologs and BchM; two of the subunits increase the methyltransferase activity by 30-60%, and the third decreases it by 30%. Expression of the chelatase complexes alone and together with BchM in Escherichia coli overproducing protoporphyrin IX suggests that the chelatase is the rate-limiting enzyme. We observed that BchM uses protoporphyrin IX without bound metal as a substrate. Our results conflict with expectations generated by previous gene inactivation studies and suggest a complex regulation of chlorophyll biosynthesis in green bacteria.	[Johnson, Ethan T.; Schmidt-Dannert, Claudia] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Schmidt-Dannert, C (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 1479 Gortner Ave, St Paul, MN 55108 USA.	schmi232@umn.edu			David and Lucile Packard Foundation; University of Minnesota; National Science Foundation [CBET-0756296]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); University of Minnesota(University of Minnesota System); National Science Foundation(National Science Foundation (NSF))	This research was supported by the David and Lucile Packard Foundation, the Institute on the Environment of the University of Minnesota, and National Science Foundation Grant CBET-0756296. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; Balaban TS, 2005, TOP CURR CHEM, V258, P1, DOI 10.1007/b137480; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Borrego CM, 1999, PHOTOSYNTH RES, V59, P159, DOI 10.1023/A:1006161302838; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; FALK JE, 1964, PORPHYRINS METALLOPO; Frigaard NU, 2004, ARCH MICROBIOL, V182, P265, DOI 10.1007/s00203-004-0718-9; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Geck MK, 1999, BIOCHEMISTRY-US, V38, P8032, DOI 10.1021/bi983029c; GIBSON KD, 1963, BIOCHEM J, V88, P325, DOI 10.1042/bj0880325; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; GORCHEIN A, 1972, BIOCHEM J, V127, P97, DOI 10.1042/bj1270097; GRANICK S, 1961, J BIOL CHEM, V236, P1168; GUNTER EW, 1989, CLIN CHEM, V35, P1601; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kwon SJ, 2003, APPL ENVIRON MICROB, V69, P4875, DOI 10.1128/AEM.69.8.4875-4883.2003; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Milani M, 2003, BIOCHEM MOL BIOL EDU, V31, P228, DOI 10.1002/bmb.2003.494031040239; OHHAMA T, 1982, BIOCHEM BIOPH RES CO, V105, P647, DOI 10.1016/0006-291X(82)91483-8; Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x; Petersen BL, 1998, J BACTERIOL, V180, P699, DOI 10.1128/JB.180.3.699-704.1998; PORRA RJ, 1983, EUR J BIOCHEM, V130, P509, DOI 10.1111/j.1432-1033.1983.tb07179.x; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Sambrook J, 2001, MOL CLONING LAB MANU; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WAHLUND TM, 1991, ARCH MICROBIOL, V156, P81, DOI 10.1007/BF00290978; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	45	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27776	27784		10.1074/jbc.M804486200	http://dx.doi.org/10.1074/jbc.M804486200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693239	hybrid			2022-12-25	WOS:000259719200049
J	Schauwienold, D; Sastre, AP; Genzel, N; Schaefer, M; Reusch, HP				Schauwienold, Dag; Sastre, Alejandra Perez; Genzel, Nadine; Schaefer, Michael; Reusch, H. Peter			The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE; ANGIOTENSIN-II; EGF RECEPTOR; CELLS; ACTIVATION; CALCIUM; BINDING; PHOSPHORYLATION	G protein-coupled receptors such as proteinase-activated receptor 1 induce phosphorylation of mitogen-activated protein kinases through multiple pathways including transactivation of receptor tyrosine kinases. In vascular smooth muscle cells, both matrix-metalloproteinase-dependent extracellular shedding of membrane-bound epidermal growth factor (EGF) receptor ligands and activation of the nonreceptor tyrosine kinases Pyk2 and Src contributed to the thrombin-induced ERK1/2 phosphorylation. Surprisingly, disruption of the HB-EGF-mediated extracellular mode of EGF receptor transactivation also prevented the phosphorylation of the nonreceptor tyrosine kinases Pyk2 and Src, locating these kinases downstream of the transactivated EGF receptor. The ionomycin-induced Pyk2 phosphorylation was partially sensitive to AG1478, heparin, or the matrix-metalloproteinase inhibitor BB2116, and the ionomycin-induced EGF receptor phosphorylation was almost completely blocked by these inhibitors of extracellular transactivation. Coimmunoprecipitation experiments revealed that, upon thrombin stimulation, a signaling complex consisting of Pyk2 and Src assembles at the EGF receptor. Reconstitution of the signaling molecules in HEK293 or vascular smooth muscle cells and subsequent determination of the EGF-induced Src kinase activity applying fluorescent sensor proteins demonstrated that a Ca2+-independent mode of Pyk2 activation is critical for the activation of Src downstream of the EGF receptor.	[Schauwienold, Dag; Reusch, H. Peter] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44780 Bochum, Germany; [Sastre, Alejandra Perez; Genzel, Nadine; Schaefer, Michael] Charite Univ Med Berlin, Neurowissensch Forshungszentrum Mol Pharmacol & C, D-14195 Berlin, Germany; [Genzel, Nadine] ImaGenes GmbH, D-13125 Berlin, Germany	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de			Forschergruppe 341; Graduiertenkolleg 276; 865 of the Deutsche Forschungsgemeinschaft	Forschergruppe 341; Graduiertenkolleg 276(German Research Foundation (DFG)); 865 of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Forschergruppe 341 and Graduiertenkolleg 276 and 865 of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Bobe R, 2003, AM J PHYSIOL-HEART C, V285, pH745, DOI 10.1152/ajpheart.01042.2002; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kalmes A, 2000, CIRC RES, V87, P92, DOI 10.1161/01.RES.87.2.92; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Touyz RM, 2002, HYPERTENSION, V39, P479, DOI 10.1161/hy02t2.102909; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	29	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27748	27756		10.1074/jbc.M801431200	http://dx.doi.org/10.1074/jbc.M801431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667434	hybrid			2022-12-25	WOS:000259719200046
J	Schwarzer, C; Fu, Z; Fischer, H; Machen, TE				Schwarzer, Christian; Fu, Zhu; Fischer, Horst; Machen, Terry E.			Redox-independent activation of NF-kappa B by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEIN INDICATORS; TNF-ALPHA; EXPRESSION; FLAGELLIN; INHIBITION; RESPONSES; ACID; LOCALIZATION; INFLAMMATION; GLUTATHIONE	The roles of the Pseudomonas aeruginosa-derived pigment pyocyanin (PYO) as an oxidant and activator of the proinflammatory transcription factor NF-kappa B were tested in a cystic fibrosis (CF) airway epithelial cell line, CF15.100 mu M PYO on its own had no effect or only small effects to activate NF-kappa B (< 1.5-fold), but PYO synergized with the TLR5 agonist flagellin. Flagellin activated NF-kappa B 4-20-fold, and PYO increased these activations > 2.5- fold. PYO could have synergized with flagellin to activate NF-kappa B by redox cycling with NADPH, generating superoxide (O-2(.-).), hydrogen peroxide (H2O2), and hydroxyl radical (HO center dot). Cytosol-targeted, redox-sensitive roGFP1 and imaging microscopy showed that 1-100 mu M PYO oxidized CF15 cytosol redox potential (psi(cyto)) from -325mV(control) to -285 mV. O-2(.-) (derived from KO2.- or xanthine + xanthine oxidase) or H2O2 oxidized psi(cyto) dose-dependently but did not activate NF-kappa B, even in the presence of flagellin, and 400 mu M H2O2 inhibited NF-kappa B. Overexpressing intracellular catalase decreased effects of PYO and H2O2 on psi(cyto) but did not affect flagellin + PYO-activated NF-kappa B. Catalase also reversed the inhibitory effects of H2O2 on NF-kappa B. The HO center dot scavenger DMSO did not alter the effects of PYO on psi(cyto) and NF-kappa B. The synergistic NF-kappa B activation was calcium-independent. Thus, in the presence of flagellin, PYO activated NF-kappa B through a redox and calcium-independent effect.	[Schwarzer, Christian; Fu, Zhu; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Fischer, Horst] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu			National Institutes of Health [R01 DK51799]; Cystic Fibrosis Foundation [MACH03, MACH07, FISCHE07, SCHWA01]; Cystic Fibrosis Research Inc., and the Hawn Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Research Inc., and the Hawn Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK51799. This work was also supported by Cystic Fibrosis Foundation Grants MACH03, MACH07, FISCHE07, and SCHWA01, Cystic Fibrosis Research Inc., and the Hawn Fund (University of California, Berkeley). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Denning GM, 1998, AM J PHYSIOL-LUNG C, V274, pL893, DOI 10.1152/ajplung.1998.274.6.L893; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hughes G, 2005, BIOCHEM J, V389, P83, DOI 10.1042/bj20050078; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; JEFFERSON DM, 1990, AM J PHYSIOL, V259, pL496, DOI 10.1152/ajplung.1990.259.6.L496; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Na HJ, 2006, INT IMMUNOPHARMACOL, V6, P1597, DOI 10.1016/j.intimp.2006.06.004; O'Malley YQ, 2004, FREE RADICAL BIO MED, V36, P90, DOI 10.1016/j.freeradbiomed.2003.09.021; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; O'Malley YXQ, 2003, AM J PHYSIOL-LUNG C, V285, pL1077, DOI 10.1152/ajplung.00198.2003; Olson JC, 1999, INFECT IMMUN, V67, P2847, DOI 10.1128/IAI.67.6.2847-2854.1999; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pan NY, 2006, RESP MED, V100, P1614, DOI 10.1016/j.rmed.2005.12.003; Pederson KJ, 1999, MOL MICROBIOL, V32, P393, DOI 10.1046/j.1365-2958.1999.01359.x; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwarzer C, 2007, FREE RADICAL BIO MED, V43, P300, DOI 10.1016/j.freeradbiomed.2007.04.015; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; WASIL M, 1987, BIOCHEM J, V243, P867, DOI 10.1042/bj2430867; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27144	27153		10.1074/jbc.M709693200	http://dx.doi.org/10.1074/jbc.M709693200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682396	Green Published, hybrid			2022-12-25	WOS:000259586600035
J	Agarwal, R; Swaminathan, S				Agarwal, Rakhi; Swaminathan, Subramanyam			SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; LIGHT-CHAIN; ANGSTROM RESOLUTION; STRUCTURAL-ANALYSIS; POTENT INHIBITORS; CRYSTAL-STRUCTURE; SEROTYPE-F; RECOGNITION; PROTEASE; PURIFICATION	Clostridium botulinum neurotoxins are the most potent toxins to humans. The recognition and cleavage of SNAREs are prime evente in exhibiting their toxicity. We report here the crystal structure of the catalytically active full-length botulinum serotype E catalytic domain (BoNT E) in complex with SNAP-25 (a SNARE protein) substrate peptide Arg(180)-Ile(181)-Met(182)-Glu(183) (P1-P3'). It is remarkable that the peptide spanning the scissile bond binds to but bypasses cleavage by the enzyme and inhibits the catalysis fairly with K-i similar to 69 mu M. The inhibitory peptide occupies the active site of BoNT E and shows well defined electron density. The catalytic zinc and the conserved key residue Tyr(350) of the enzyme facilitate the docking of Arg(180) (P1) by interacting with its carbonyl oxygen that displaces the nucleophilic water. The general base Glu(212) side chain interacts with the main chain amino group of P1 and P1'. Conserved Arg(347) of BoNT E stabilizes the proper docking of the Ile(181) (P1') main chain, whereas the hydrophobic pockets stabilize the side chains of Ile181 (P1') and Met(182) (P2'), and the 250 loop stabilizes Glu(183) (P3'). Structural and functional analysis revealed an important role for the P1' residue and S1' pocket in driving substrate recognition and docking at the active site. This study is the first of its kind and rationalizes the substrate cleavage strategy of BoNT E. Also, our complex structure opens up an excellent opportunity of structure-based drug design for this fast acting and extremely toxic high priority BoNT E.	[Agarwal, Rakhi; Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Swaminathan, S (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	swami@bnl.gov			National Institutes of Health [1R56Al058175]; Department of Energy Prime [DEAC02-98CH10886];  [DAMD1702-2];  [DTRA BO742081]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Prime(United States Department of Energy (DOE)); ; 	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56Al058175. This work was also supported by Grants DAMD1702-2 and DTRA BO742081 under Department of Energy Prime Contract DEAC02-98CH10886 with the Brookhaven National Laboratory. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler M, 1998, FEBS LETT, V429, P234, DOI 10.1016/S0014-5793(98)00492-X; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Agarwal R, 2004, PROTEIN EXPRES PURIF, V34, P95, DOI 10.1016/j.pep.2003.10.017; Anne C, 2005, CHEMBIOCHEM, V6, P1375, DOI 10.1002/cbic.200400398; Anne C, 2003, J MED CHEM, V46, P4648, DOI 10.1021/jm0300680; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; Blommaert A, 2004, BIOORGAN MED CHEM, V12, P3055, DOI 10.1016/j.bmc.2004.03.006; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2005, BIOORGAN MED CHEM, V13, P333, DOI 10.1016/j.bmc.2004.10.026; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; DASGUPTA BR, 1983, TOXICON, V21, P566, DOI 10.1016/0041-0101(83)90136-8; DASGUPTA BR, 1983, TOXICON, V21, P535, DOI 10.1016/0041-0101(83)90131-9; DeLano WL, 2002, PYMOL USERS MANUAL; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Johnson SL, 2008, CHEM BIOL DRUG DES, V71, P131, DOI 10.1111/j.1747-0285.2007.00617.x; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461; SATHYAMOORTHY V, 1985, BIOCHEM BIOPH RES CO, V127, P768, DOI 10.1016/S0006-291X(85)80009-7; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8	38	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25944	25951		10.1074/jbc.M803756200	http://dx.doi.org/10.1074/jbc.M803756200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658150	Green Published, hybrid			2022-12-25	WOS:000259200100022
J	Chen, HQ; Ma, YY; Yang, J; O'Brien, CJ; Lee, SL; Mazurkiewicz, JE; Haataja, S; Yan, JH; Gao, GF; Zhang, JR				Chen, Huaiqing; Ma, Yueyun; Yang, Jun; O'Brien, Christopher J.; Lee, Scott L.; Mazurkiewicz, Joseph E.; Haataja, Sauli; Yan, Jing-Hua; Gao, George F.; Zhang, Jing-Ren			Genetic Requirement for Pneumococcal Ear Infection	PLOS ONE			English	Article								Background: Ear infection or otitis media (OM) accounts for most bacterial respiratory infections in children in both developed and developing nations. Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis are the major OM pathogens. However, little is known about the genetic basis of bacterial OM largely due to practical difficulties in conducting research in ear infection models and genetically manipulating clinical isolates. Here, we report the first genome-scale in vivo screen for bacterial genes required for ear infection in a chinchilla model by signature tagged mutagenesis (STM), a high throughput mutant screen technique. Methodology/Principal Findings: STM strains were constructed with a multi-drug resistant OM isolate ST556 (serotype 19F) and screened in a chinchilla OM model. Out of 5,280 mutants tested, 248 mutants were substantially underrepresented in the mutant pools recovered from the middle ear fluids of the infected chinchillas, indicating the impaired ability to survive and replicate in the middle ears due to genetic disruptions in the chromosome of strain ST556. Further DNA sequencing analysis mapped the mutations to 169 pneumococcal genes. Surprisingly, only 52 of these genes were required for pneumococcal nasopharyngeal colonization in a murine model. This infection site-specific gene requirement was verified by targeted mutagenesis in the selected genes. Conclusions/Significance: These findings suggest that there are a subset of pneumococcal genes required for ear infection and that these may be distinct from those required for nasal colonization. Our data thus provide comprehensive gene targets for mechanistic understanding of pneumococcal ear infection. Finally, this study has also developed a model for future genome-scale search for virulence determinants in other pathogens associated with ear infections.	[Chen, Huaiqing; Ma, Yueyun; Yang, Jun; O'Brien, Christopher J.; Zhang, Jing-Ren] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Lee, Scott L.] Albany Med Coll, Div Otolaryngol Head & Neck Surg, Albany, NY 12208 USA; [Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Haataja, Sauli] Univ Turku, Dept Med Biochem & Mol Biol, SF-20500 Turku, Finland; [Ma, Yueyun] Fourth Mil Med Univ, Xijing Hosp, Ctr Clin Mol Biol, Xian, Peoples R China; [Yan, Jing-Hua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Ctr Mol Immunol, Beijing 100864, Peoples R China	Albany Medical College; Albany Medical College; Albany Medical College; University of Turku; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Chen, HQ (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	zhangj@mail.amc.edu	ma, yue/GXE-9897-2022; Gao, George Fu/ABD-5229-2021; Haataja, Sauli/AAR-5103-2020		NIH/NIDCD [DC006917]; China Natural Sciences Foundation (NSFC) [30728014]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006917] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); China Natural Sciences Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant (to J.-R.Z.) from NIH/NIDCD (DC006917). Collaboration between J.-R.Z. and G.F.G. was supported by a grant from the China Natural Sciences Foundation (NSFC) (Grant No. 30728014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguedas A, 1998, PEDIATR INFECT DIS J, V17, P680, DOI 10.1097/00006454-199808000-00004; AUSTRIAN R, 1986, CHEMOTHERAPY, V18, pS35; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Barenkamp SJ, 2005, ANN OTO RHINOL LARYN, V114, P60, DOI 10.1177/00034894051140S109; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Chen S, 2005, FEMS MICROBIOL LETT, V253, P151, DOI 10.1016/j.femsle.2005.09.052; Chiang SL, 1999, ANNU REV MICROBIOL, V53, P129, DOI 10.1146/annurev.micro.53.1.129; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Freid V M, 1998, Vital Health Stat 13, P1; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; GIEBINK GS, 1978, ANNU REV MED, V29, P285, DOI 10.1146/annurev.me.29.020178.001441; Giebink GS, 2001, NEW ENGL J MED, V345, P1177, DOI 10.1056/NEJMra010462; GIEBINK GS, 1976, J INFECT DIS, V134, P595, DOI 10.1093/infdis/134.6.595; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lim DJ, 2005, ANN OTO RHINOL LARYN, V114, P31; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Novotny LA, 2005, INFECT IMMUN, V73, P609, DOI 10.1128/IAI.73.1.609-611.2005; Pallova P, 2007, BIOCHEM BIOPH RES CO, V355, P526, DOI 10.1016/j.bbrc.2007.01.184; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; PATON JC, GRAM POSITIVE PATHOG, P241; Pettigrew MM, 2005, INFECT IMMUN, V73, P2805, DOI 10.1128/IAI.73.5.2805-2811.2005; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Ren B, 2004, J IMMUNOL, V173, P7506, DOI 10.4049/jimmunol.173.12.7506; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Smith BL, 2000, J INFECT DIS, V182, P497, DOI 10.1086/315722; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 1999, MICROB PATHOGENESIS, V26, P111, DOI 10.1006/mpat.1998.0257; Tong HH, 2000, INFECT IMMUN, V68, P921, DOI 10.1128/IAI.68.2.921-924.2000; Tuomanen EI, 2000, VACCINE, V19, pS38, DOI 10.1016/S0264-410X(00)00276-0; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	52	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2950	10.1371/journal.pone.0002950	http://dx.doi.org/10.1371/journal.pone.0002950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18670623	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600036
J	Jabbi, M; Bastiaansen, J; Keysers, C				Jabbi, Mbemba; Bastiaansen, Jojanneke; Keysers, Christian			A Common Anterior Insula Representation of Disgust Observation, Experience and Imagination Shows Divergent Functional Connectivity Pathways	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; OLD-WORLD MONKEY; MOTOR IMAGERY; EMPATHY; PERCEPTION; ACTIVATION; MECHANISMS; BRAIN; ORGANIZATION; RECOGNITION	Similar brain regions are involved when we imagine, observe and execute an action. Is the same true for emotions? Here, the same subjects were scanned while they (a) experience, (b) view someone else experiencing and (c) imagine experiencing gustatory emotions (through script-driven imagery). Capitalizing on the fact that disgust is repeatedly inducible within the scanner environment, we scanned the same participants while they (a) view actors taste the content of a cup and look disgusted (b) tasted unpleasant bitter liquids to induce disgust, and (c) read and imagine scenarios involving disgust and their neutral counterparts. To reduce habituation, we inter-mixed trials of positive emotions in all three scanning experiments. We found voxels in the anterior Insula and adjacent frontal operculum to be involved in all three modalities of disgust, suggesting that simulation in the context of social perception and mental imagery of disgust share a common neural substrates. Using effective connectivity, this shared region however was found to be embedded in distinct functional circuits during the three modalities, suggesting why observing, imagining and experiencing an emotion feels so different.	[Jabbi, Mbemba] NIMH, Sect Integrat Neuroimaging, Cognit Brain Disorders Branch, Bethesda, MD 20892 USA; [Jabbi, Mbemba; Bastiaansen, Jojanneke; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Social Brain Lab, Groningen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Groningen	Jabbi, M (corresponding author), NIMH, Sect Integrat Neuroimaging, Cognit Brain Disorders Branch, Bethesda, MD 20892 USA.	jabbim@mail.nih.gov; c.m.keysers@rug.nl	Keysers, Christian/H-6251-2013; Bastiaansen, Jojanneke/F-4849-2013	Keysers, Christian/0000-0002-2845-5467; Bastiaansen, Jojanneke/0000-0003-4831-6402; Lauwereyns, Jan/0000-0003-0551-2550; Jabbi, Mbemba/0000-0001-5263-5321	European Marie Curie Excellence; Nederlands Wetenschappelijk Organisatie NWO; Dutch science foundation; VIDI	European Marie Curie Excellence; Nederlands Wetenschappelijk Organisatie NWO; Dutch science foundation(Netherlands Organization for Scientific Research (NWO)); VIDI(Netherlands Organization for Scientific Research (NWO))	This work has been funded by the European Marie Curie Excellence and the Nederlands Wetenschappelijk Organisatie (NWO; Dutch science foundation) VIDI grants to Christian Keysers. However, the funding bodies have no further role in any part of this work or the decision to submit the manuscript to PloS ONE.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bonthius DJ, 2005, J NEUROPATH EXP NEUR, V64, P910, DOI 10.1097/01.jnen.0000182983.87106.d1; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chikama M, 1997, J NEUROSCI, V17, P9686; Craig A. D., 2008, HDB EMOTIONS, P272; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A. R., 2003, LOOKING SPINOZA JOY; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fudge JL, 2005, J COMP NEUROL, V490, P101, DOI 10.1002/cne.20660; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; HESS U, 1999, SOCIAL CONTEXT NONVE; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kikuchi S, 2005, NEUROREPORT, V16, P281, DOI 10.1097/00001756-200502280-00016; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Porro CA, 1996, J NEUROSCI, V16, P7688; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	60	216	223	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2939	10.1371/journal.pone.0002939	http://dx.doi.org/10.1371/journal.pone.0002939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698355	gold, Green Submitted, Green Published			2022-12-25	WOS:000264412600025
J	Adamo, A; Pinney, JW; Kunova, A; Westhead, DR; Meyer, P				Adamo, Alessio; Pinney, John W.; Kunova, Andrea; Westhead, David R.; Meyer, Peter			Heat Stress Enhances the Accumulation of Polyadenylated Mitochondrial Transcripts in Arabidopsis thaliana	PLOS ONE			English	Article							COEXPRESSION TOOL ACT; MESSENGER-RNA; GENE; DEGRADATION; POLY(A); CHROMOSOME-2; CHLOROPLAST; CORDYCEPIN; NUCLEUS	Background: Polyadenylation of RNA has a decisive influence on RNA stability. Depending on the organisms or subcellular compartment, it either enhances transcript stability or targets RNAs for degradation. In plant mitochondria, polyadenylation promotes RNA degradation, and polyadenylated mitochondrial transcripts are therefore widely considered to be rare and unstable. We followed up a surprising observation that a large number of mitochondrial transcripts are detectable in microarray experiments that used poly(A)-specific RNA probes, and that these transcript levels are significantly enhanced after heat treatment. Methodology/Principal Findings: As the Columbia genome contains a complete set of mitochondrial genes, we had to identify polymorphisms to differentiate between nuclear and mitochondrial copies of a mitochondrial transcript. We found that the affected transcripts were uncapped transcripts of mitochondrial origin, which were polyadenylated at multiple sites within their 39region. Heat-induced enhancement of these transcripts was quickly restored during a short recovery period. Conclusions/Significance: Our results show that polyadenylated transcripts of mitochondrial origin are more stable than previously suggested, and that their steady-state levels can even be significantly enhanced under certain conditions. As many microarrays contain mitochondrial probes, due to the frequent transfer of mitochondrial genes into the genome, these effects need to be considered when interpreting microarray data.	[Adamo, Alessio; Kunova, Andrea; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Pinney, John W.; Westhead, David R.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Adamo, A (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Kunova, Andrea/AAB-8717-2022; Kunova, Andrea/F-3769-2016	Kunova, Andrea/0000-0002-9210-4792; Kunova, Andrea/0000-0002-9210-4792; Westhead, David/0000-0002-0519-3820	BBSRC [studentship, BB/C52101X/1]; Epigenome Network of Excellence; MRC [studentship]; Biotechnology and Biological Sciences Research Council [BB/C52101X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Epigenome Network of Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A.A. and A.K. were supported by BBSRC studentships and by the Epigenome Network of Excellence. JWP was supported by an MRC studentship and DRW acknowledges a BBSRC Research Development Fellowship (BB/C52101X/1).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2001, GENETICS, V158, P1289; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; HIRSCH M, 1974, J MOL BIOL, V83, P131, DOI 10.1016/0022-2836(74)90384-2; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; Huang CY, 2005, PLANT PHYSIOL, V138, P1723, DOI 10.1104/pp.105.060327; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Kudla J, 1996, EMBO J, V15, P7137, DOI 10.1002/j.1460-2075.1996.tb01105.x; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupold DS, 1999, PLANT CELL, V11, P1565, DOI 10.1105/tpc.11.8.1565; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Perez-Martinez X, 2000, J BIOL CHEM, V275, P30144, DOI 10.1074/jbc.M003940200; Rikhvanov EG, 2007, PLANT J, V52, P763, DOI 10.1111/j.1365-313X.2007.03275.x; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P703, DOI 10.1007/s00280-007-0533-5; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479	28	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2889	10.1371/journal.pone.0002889	http://dx.doi.org/10.1371/journal.pone.0002889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682831	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600045
J	Ruhwald, M; Petersen, J; Kofoed, K; Nakaoka, H; Cuevas, LE; Lawson, L; Squire, SB; Eugen-Olsen, J; Ravn, P				Ruhwald, Morten; Petersen, Janne; Kofoed, Kristian; Nakaoka, Hiroshi; Cuevas, Luis Eduardo; Lawson, Lovett; Squire, Stephen Bertil; Eugen-Olsen, Jesper; Ravn, Pernille			Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; IFN-GAMMA; SKIN-TEST; RESPONSES; CHEMOKINES; CHILDREN	Background: There is a need for simple tools such as the M. tuberculosis specific IFN-gamma release assays (IGRA) to improve diagnosis of M. tuberculosis-infection in children. The aim of the study was to evaluate the performance of an IP-10 and IL-2 based tests for the diagnosis of M. tuberculosis-infection in recently exposed children from Nigeria. Methodology and Principal Findings: Samples were obtained from 59 children at high risk of infection with M. tuberculosis (contacts of adults with smear and culture-positive tuberculosis) and 61 at low risk (contacts of smear-negative/culture-positive tuberculosis or community controls). IP-10 and IL-2 was measured in plasma after stimulation of whole-blood with M. tuberculosis specific antigens and mitogen. Previously developed criteria for positive IP-10 and IL-2 tests were used and the diagnostic performances of the IP-10 and IL-2 tests were compared with the Quantiferon In-Tube (QFT-IT) and the Tuberculin Skin Tests (TST). In response to M. tuberculosis specific antigens, the high-risk children expressed significantly higher levels of IP-10 (1358 pg/ml[IQR 278-2535 pg/ml]) and IL-2 (164 pg/ml[11-590 pg/ml]) than low risk groups 149 pg/ml( 25-497 pg/ml), and 0 pg/ml(0-3 pg/ml), respectively. There was excellent agreement (>89%, k>0.80) between IP-10, IL-2 tests and QFT-IT, better than with TST (>74%, k>0.49). The IP-10 and IL-2 responses were strongly associated with M. tuberculosis exposure and with grade of infectiousness of the index cases (p<0.0001). IP-10, IL-2, and TST but not QFT-IT was associated with age of the child in the low risk groups (p<0.02). Conclusions/Significance: IP-10 is expressed in high levels and results of the IP-10 test were comparable to the QFT-IT. IL-2 was released in low amounts in response to the antigens and not in response to the mitogen therefore IL-2 seems a less useful marker. We have demonstrated that IP-10 and possibly IL-2 could be alternative or adjunct markers to IFN-gamma in the diagnosis infection with M. tuberculosis.	[Ruhwald, Morten] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis 144, DK-2650 Hvidovre, Denmark; [Ruhwald, Morten; Petersen, Janne; Kofoed, Kristian; Eugen-Olsen, Jesper; Ravn, Pernille] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr 136, Hvidovre, Denmark; [Nakaoka, Hiroshi; Cuevas, Luis Eduardo; Squire, Stephen Bertil] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Lawson, Lovett] Zankli Med Ctr, Abuja, Nigeria; [Ravn, Pernille] Univ Copenhagen, Herlev Hosp, Dept Internal Med, Infect Dis Unit, Herlev, Denmark	University of Copenhagen; University of Copenhagen; Liverpool School of Tropical Medicine; University of Copenhagen; Herlev & Gentofte Hospital	Ruhwald, M (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis 144, DK-2650 Hvidovre, Denmark.	mruhwald@mail.dk	Ruhwald, Morten/E-5757-2012; Cuevas, Luis E/I-3697-2015	Cuevas, Luis E/0000-0002-6581-0587; Eugen-Olsen, Jesper/0000-0002-4630-4275; Petersen, Janne/0000-0001-7323-2548; Lawson, Lovett/0000-0001-9019-7537; Squire, Stephen/0000-0001-7173-9038	Danish Lung Association; The Copenhagen University Hospital, Hvidovre; AugustinusFonden; Aase and Einar Danielsens Foundation; The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen; Capital Region of Denmark	Danish Lung Association; The Copenhagen University Hospital, Hvidovre; AugustinusFonden; Aase and Einar Danielsens Foundation; The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen; Capital Region of Denmark	This work was supported by the Danish Lung Association; The Copenhagen University Hospital, Hvidovre, Annual Research Grant; AugustinusFonden, Aase and Einar Danielsens Foundation, The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen. MR is a PhD candidate receiving a Scholarship from the Capital Region of Denmark.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berktas M, 2004, J INT MED RES, V32, P324, DOI 10.1177/147323000403200313; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Connell TG, 2006, EXPERT REV MOL DIAGN, V6, P663, DOI 10.1586/14737159.6.5.663; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kibiki GS, 2007, CLIN EXP IMMUNOL, V148, P254, DOI 10.1111/j.1365-2249.2007.03330.x; Lawson L, 2005, INT J TUBERC LUNG D, V9, P933; LUETKEMEYER AF, 2007, AM J RESP CRIT CARE; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; NAKAOKA H, 2006, EMERGING INFECT DIS; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; PAI M, 2008, ANN INTERN MED; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; SCHAUF V, 1993, J INFECT DIS, V168, P1056, DOI 10.1093/infdis/168.4.1056; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; *WHO, 2006, GLOB TUB CONTR SURV	35	86	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2858	10.1371/journal.pone.0002858	http://dx.doi.org/10.1371/journal.pone.0002858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682747	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600014
J	Vieira, OV; Hartmann, DO; Cardoso, CMP; Oberdoerfer, D; Baptista, M; Santos, MAS; Almeida, L; Ramalho-Santos, J; Vaz, WLC				Vieira, Otilia V.; Hartmann, Diego O.; Cardoso, Carla M. P.; Oberdoerfer, Daniel; Baptista, Marta; Santos, Manuel A. S.; Almeida, Luis; Ramalho-Santos, Joao; Vaz, Winchil L. C.			Surfactants as Microbicides and Contraceptive Agents: A Systematic In Vitro Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHOSPHATIDYLCHOLINE BILAYERS; CONTROLLED-TRIAL; NONOXYNOL 9; HIV; C31G; SOLUBILIZATION; DELIVERY; INCREASE; SULFATE	Background: The urgent need for cheap and easy-to-use protection against both unwanted pregnancies and sexually transmitted diseases has stimulated considerable interest in the use of surfactants as microbicides, anti-viral, and contraceptive agents in recent years. In the present study we report a systematic in vitro evaluation of the microbicidal, antiviral and contraceptive potential of cationic, anionic, zwitterionic, and non-ionic surfactants. Methodology/Principal Findings: Toxicity was evaluated in mammalian columnar epithelial (MDCK) cells, human sperm cells, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Streptococcus agalactiae and Enterococcus faecalis. The inhibition of adenovirus and lentivirus infection of MDCK cells was also tested. A homologous series of cationic surfactants, alkyl-N,N,N-trimethylammonium bromides (C(n)TAB), with varying alkyl chains were shown to be bactericidal and fungicidal at doses that were related to the surfactant critical micelle concentrations (CMC), all of them at concentrations significantly below the CMC. In general, bacteria were more susceptible to this surfactant group than C. albicans and this organism, in turn, was more susceptible than MDCK cells. This suggests that the C(n)TAB may be useful as vaginal disinfectants only in so far as bacterial and fungal infections are concerned. None of the surfactants examined, including those that have been used in pre-clinical studies, showed inhibition of adenovirus or lentivirus infection of MDCK cells or spermicidal activity at doses that were sub-toxic to MDCK cells. Conclusions/Significance: The results of this study lead us to propose that systematic analysis of surfactant toxicity, such as we report in the present work, be made a mandatory pre-condition for the use of these substances in pre-clinical animal and/or human studies.	[Vieira, Otilia V.; Hartmann, Diego O.; Cardoso, Carla M. P.; Oberdoerfer, Daniel; Baptista, Marta; Almeida, Luis; Ramalho-Santos, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Santos, Manuel A. S.] Univ Aveiro, Dept Biol, CESAM, Aveiro, Portugal; [Almeida, Luis] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Coimbra, Dept Zool, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Hosp Coimbra, Dept Maternal Fetal Med, Genet & Human Reproduct, Coimbra, Portugal; [Vaz, Winchil L. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Universidade de Coimbra; Universidade de Aveiro; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Vieira, OV (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	vieira@cnc.cj.uc.pt	Santos, Manuel/E-6704-2010; Santos, João/HHZ-5595-2022; Hartmann, Diego O/E-6904-2013; Vaz, Winchil/N-4320-2013; Vieira, Otilia V/O-8660-2017; Ramalho-Santos, João/F-8641-2012; de Almeida, Luis Pereira/O-8196-2019; de Almeida, Luis Pereira/A-4605-2009; Vieira, O V/C-4860-2013	Santos, Manuel/0000-0002-0437-1146; Hartmann, Diego O/0000-0002-6399-5020; Vaz, Winchil/0000-0002-3797-4330; Vieira, Otilia V/0000-0003-4924-1780; Ramalho-Santos, João/0000-0002-1172-4018; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Cardoso, Carla/0000-0002-0985-7487	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education [PTDC/SAU-MII/66285/2006, SFRH/BPD/34713/2007]	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education	Research grant PTDC/SAU-MII/66285/2006 from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT). CMPC is a holder of a post-doctoral fellowship (ref.: SFRH/BPD/34713/2007) from the FCT.	Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x; Ahlstrom B, 1997, ANTIMICROB AGENTS CH, V41, P544, DOI 10.1128/AAC.41.3.544; Ahyayauch H, 2006, BBA-BIOMEMBRANES, V1758, P190, DOI 10.1016/j.bbamem.2006.01.016; Bergmeyer H.U., 1974, UV ASSAY PYRUVATE NA, P574; BRITO RMM, 1986, ANAL BIOCHEM, V152, P250, DOI 10.1016/0003-2697(86)90406-9; Catalone BJ, 2005, ANTIMICROB AGENTS CH, V49, P1509, DOI 10.1128/AAC.49.4.1509-1520.2005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; GARNER DL, 1994, J ANDROL, V15, P620; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Krebs FC, 1999, ANTIVIR RES, V43, P157, DOI 10.1016/S0166-3542(99)00044-3; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; Sander F. V., 1941, HUM FERTIL, V6, P134; Schnitzer E, 2005, CHEM PHYS LIPIDS, V135, P69, DOI 10.1016/j.chemphyslip.2005.02.002; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanford C., 1991, HYDROPHOBIC EFFECT F, pix; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	32	50	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2913	10.1371/journal.pone.0002913	http://dx.doi.org/10.1371/journal.pone.0002913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682796	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600068
J	Wegner, KM				Wegner, K. Mathias			Clustering of Drosophila melanogaster Immune Genes in Interplay with Recombination Rate	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NATURAL-SELECTION; LINKAGE-DISEQUILIBRIUM; EVOLUTIONARY DYNAMICS; RED QUEEN; ADAPTATION; ORGANIZATION; ARCHITECTURE; POLYMORPHISM; EXPRESSION	Background: Gene order in eukaryotic chromosomes is not random and has been linked to coordination of gene expression, chromatin structure and also recombination rate. The evolution of recombination rate is especially relevant for genes involved in immunity because host-parasite co-evolution could select for increased recombination rate (Red Queen hypothesis). To identify patterns left by the intimate interaction between hosts and parasites, I analysed the genomic parameters of the immune genes from 24 gene families/groups of Drosophila melanogaster. Principal Findings: Immune genes that directly interact with the pathogen (i.e. recognition and effector genes) clustered in regions of higher recombination rates. Out of these, clustered effector genes were transcribed fastest indicating that transcriptional control might be one major cause for cluster formation. The relative position of clusters to each other, on the other hand, cannot be explained by transcriptional control per se. Drosophila immune genes that show epistatic interactions can be found at an average distance of 15.44 +/- 2.98 cM, which is considerably closer than genes that do not interact (30.64 +/- 1.95 cM). Conclusions: Epistatically interacting genes rarely belong to the same cluster, which supports recent models of optimal recombination rates between interacting genes in antagonistic host-parasite co-evolution. These patterns suggest that formation of local clusters might be a result of transcriptional control, but that in the condensed genome of D. melanogaster relative position of these clusters may be a result of selection for optimal rather than maximal recombination rates between these clusters.	[Wegner, K. Mathias] ETH, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wegner, KM (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	mathias.wegner@env.ethz.ch	Wegner, Mathias/B-6674-2009; Wegner, K. Mathias/P-1149-2015	Wegner, K. Mathias/0000-0002-2410-8898				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Durand D, 2003, J COMPUT BIOL, V10, P453, DOI 10.1089/10665270360688129; Fischer O, 2005, BIOL LETTERS, V1, P193, DOI 10.1098/rsbl.2005.0296; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hey J, 2002, GENETICS, V160, P595; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Kouyos RD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-211; Kover PX, 2001, MOL ECOL, V10, P1, DOI 10.1046/j.1365-294X.2001.01124.x; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; NEI M, 1967, GENETICS, V57, P625; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Schlenke TA, 2005, GENETICS, V169, P2013, DOI 10.1534/genetics.104.035337; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2835	10.1371/journal.pone.0002835	http://dx.doi.org/10.1371/journal.pone.0002835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665272	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300054
J	Demene, H; Ducat, T; De Guillen, K; Birck, C; Aymerich, S; Kochoyan, M; Declerck, N				Demene, Helene; Ducat, Thierry; De Guillen, Karine; Birck, Catherine; Aymerich, Stephane; Kochoyan, Michel; Declerck, Nathalie			Structural Mechanism of Signal Transduction between the RNA-binding Domain and the Phosphotransferase System Regulation Domain of the LicT Antiterminator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM; BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATOR; SECONDARY STRUCTURE; RESPONSE REGULATOR; SPECIFICITY DETERMINANTS; CATABOLITE REPRESSION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	LicT belongs to a family of bacterial transcriptional antiterminators, which control the expression of sugar-metabolizing operons in response to phosphorylations by the phosphoenolpyruvate: sugar phosphotransferase system (PTS). Previous studies of LicT have revealed the structural basis of RNA recognition by the dimeric N-terminal co-antiterminator (CAT) domain on the one hand and the conformational changes undergone by the duplicated regulation domain (PRD1 and PRD2) upon activation on the other hand. To investigate the mechanism of signal transduction between the effector and regulation modules, we have undertaken the characterization of a fragment, including the CAT and PRD1 domains and the linker in-between. Comparative experiments, including RNA binding assays, NMR spectroscopy, limited proteolysis, analytical ultracentrifugation, and circular dichroism, were conducted on native CAT-PRD1 and on a constitutively active CAT-PRD1 mutant carrying a D99N substitution in PRD1. We show that in the native state, CAT-PRD1 behaves as a rather unstable RNA-binding deficient dimer, in which the CAT dimer interface is significantly altered and the linker region is folded as a trypsin-resistant helix. In the activated mutant form, the CAT-PRD1 linker becomes protease-sensitive, and the helix content decreases, and the CAT module adopts the same dimeric conformation as in isolated CAT, thereby restoring the affinity for RNA. From these results, we propose that a helix-to-coil transition in the linker acts as the structural relay triggered by the regulatory domain for remodeling the effector dimer interface. In essence, the structural mechanism modulating the LicT RNA antitermination activity is thus similar to that controlling the DNA binding activity of dimeric transcriptional regulators.	[Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] Univ Montpellier I, Ctr Biochim Struct, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] Univ Montpellier 2, Ctr Biochim Struct, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] INSERM, U554, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] CNRS, UMR 5048, F-34090 Montpellier, France; [Birck, Catherine] Univ Strasbourg 1, Dept Biol & Genet Struct, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Cu Strasbourg, France; [Birck, Catherine] INSERM, U596, F-67404 Illkirch Cu Strasbourg, France; [Aymerich, Stephane] INRA, UMR1238, F-78850 Thiverval Grignon, France; [Aymerich, Stephane] CNRS, UMR2585, F-78850 Thiverval Grignon, France; [Aymerich, Stephane] AgroParisTech, F-78850 Thiverval Grignon, France; [Birck, Catherine] CNRS, UMR 7104, F-67404 Illkirch Cu Strasbourg, France	Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Demene, H (corresponding author), Univ Montpellier I, Ctr Biochim Struct, 29 Rue Navacelles, F-34090 Montpellier, France.	helene.demene@cbs.cnrs.fr	Déméné, Hélène/AAZ-1691-2021	Déméné, Hélène/0000-0002-7531-4309; de Guillen, Karine/0000-0002-5037-2115; Declerck, Nathalie/0000-0003-1551-1607				ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; AYMERICH S, 1992, P NATL ACAD SCI USA, V89, P10410, DOI 10.1073/pnas.89.21.10410; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Ben-Zeev E, 2005, J MOL BIOL, V347, P693, DOI 10.1016/j.jmb.2005.01.068; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Declerck N, 2001, J MOL BIOL, V314, P671, DOI 10.1006/jmbi.2001.5185; Declerck N, 1999, J MOL BIOL, V294, P389, DOI 10.1006/jmbi.1999.3256; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Ducat T, 2002, J BIOMOL NMR, V23, P325, DOI 10.1023/A:1020264611438; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Graille M, 2005, J BIOL CHEM, V280, P14780, DOI 10.1074/jbc.M414642200; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kumarevel T, 2005, NATURE, V434, P183, DOI 10.1038/nature03355; Lindner C, 2002, J BACTERIOL, V184, P4819, DOI 10.1128/JB.184.17.4819-4828.2002; Lindner C, 1999, MOL MICROBIOL, V31, P995, DOI 10.1046/j.1365-2958.1999.01262.x; MAHADEVAN S, 1987, CELL, V50, P485, DOI 10.1016/0092-8674(87)90502-2; Manival X, 1997, EMBO J, V16, P5019, DOI 10.1093/emboj/16.16.5019; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; MINTON AP, 1994, CONSERVATION SIGNAL; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; ROYER CA, 1992, METHOD ENZYMOL, V210, P481; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schilling O, 2006, NUCLEIC ACIDS RES, V34, P6102, DOI 10.1093/nar/gkl733; Schnetz K, 1996, J BACTERIOL, V178, P1971, DOI 10.1128/jb.178.7.1971-1979.1996; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Sreerama N, 1999, PROTEIN SCI, V8, P370; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; Tortosa P, 2001, MOL MICROBIOL, V41, P1381, DOI 10.1046/j.1365-2958.2001.02608.x; van Tilbeurgh H, 2001, EMBO J, V20, P3789, DOI 10.1093/emboj/20.14.3789; vanTilbeurgh H, 1997, EMBO J, V16, P5030, DOI 10.1093/emboj/16.16.5030; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang YS, 2002, EMBO J, V21, P1987, DOI 10.1093/emboj/21.8.1987; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	50	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30838	30849		10.1074/jbc.M805955200	http://dx.doi.org/10.1074/jbc.M805955200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18682383	Green Published, hybrid			2022-12-25	WOS:000260544800039
J	Elorza, A; Hyde, B; Mikkola, HK; Collins, S; Shirihai, OS				Elorza, Alvaro; Hyde, Brigham; Mikkola, Hanna K.; Collins, Sheila; Shirihai, Orian S.			UCP2 Modulates Cell Proliferation through the MAPK/ERK Pathway during Erythropoiesis and Has No Effect on Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; REACTIVE OXYGEN; ERYTHROID-DIFFERENTIATION; SUPEROXIDE-DISMUTASE; INSULIN-SECRETION; SIGNALING PATHWAYS; PROGENITOR CELLS; BETA-CELLS; LIFE-SPAN	UCP2, an inner membrane mitochondrial protein, has been implicated in bioenergetics and reactive oxygen species (ROS) modulation. High levels of UCP2 mRNA were recently found in erythroid cells where UCP2 is hypothesized to function as a facilitator of heme synthesis and iron metabolism by reducing ROS production. We examined UCP2 protein expression and role in mice erythropoiesis in vivo. UCP2 was mainly expressed at early stages of erythroid maturation when cells are not fully committed in heme synthesis. Iron incorporation into heme was unaltered in reticulocytes from UCP2-deficient mice. Although heme synthesis was not influenced by UCP2 deficiency, mice lacking UCP2 had a delayed recovery from chemically induced hemolytic anemia. Analysis of progenitor cells from bone marrow and fetal liver both in vitro and in vivo revealed that UCP2 deficiency results in a significant decrease in cell proliferation at the erythropoietin-dependent phase of erythropoiesis. This was accompanied by reduction in the phosphorylated form of ERK, a ROS-dependent cytosolic regulator of cell proliferation. Analysis of ROS in UCP2 null erythroid cells revealed altered distribution of ROS, resulting in decreased cytosolic and increased mitochondrial ROS. Restoration of the cytosol oxidative state of erythroid progenitor cells by the pro-oxidant Paraquat reversed the effect of UCP2 deficiency on cell proliferation in in vitro differentiation assays. Together, these results indicate that UCP2 is a regulator of erythropoiesis and suggests that inhibition of UCP2 function may contribute to the development of anemia.	[Elorza, Alvaro; Hyde, Brigham; Shirihai, Orian S.] Boston Univ, Evans Biomed Res Ctr, Boston, MA 02118 USA; [Elorza, Alvaro; Hyde, Brigham; Shirihai, Orian S.] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Mikkola, Hanna K.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Mikkola, Hanna K.; Collins, Sheila] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA	Boston University; Tufts University; University of California System; University of California Los Angeles; The Hamner Institutes for Health Sciences	Shirihai, OS (corresponding author), Boston Univ, Evans Biomed Res Ctr, 650 Albany St, Boston, MA 02118 USA.	Shirihai@bu.edu		Shirihai, Orian/0000-0002-9502-2661; Elorza, Alvaro A./0000-0003-1570-9832	National Institutes of Health [1-R01-DK-074778-01, 5-R01-HL-071629-03, R01-DK-54024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054024, R01DK074778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-R01-DK-074778-01 and 5-R01-HL-071629-03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant 5-R01-HL-071629-03.; Supported by National Institutes of Health Grant R01-DK-54024.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Beauchemin H, 2004, J BIOL CHEM, V279, P19471, DOI 10.1074/jbc.M309989200; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bugarski D, 2007, EXP BIOL MED, V232, P156; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; DE BF, 2004, J NEUROCHEM, V89, P1283; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Flachs P, 2007, FEBS LETT, V581, P1093, DOI 10.1016/j.febslet.2007.02.012; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; KOURY MJ, 1988, J CELL PHYSIOL, V137, P65, DOI 10.1002/jcp.1041370108; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217; MARTINEZ.J, 1972, BIOCHIM BIOPHYS ACTA, V264, P272, DOI 10.1016/0304-4165(72)90291-7; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NAGRESALVAYRE A, 1997, FASEB J, V11, P809; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Nishio K, 2005, J MOL HISTOL, V36, P35, DOI 10.1007/s10735-004-2915-x; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Polonsky KS, 2001, CELL, V105, P705, DOI 10.1016/S0092-8674(01)00389-0; Richard D, 2001, BIOCHEM SOC T, V29, P812, DOI 10.1042/BST0290812; Ricquier D., 2000, INT J OBES RELAT S2, V24, P86; Rooke HM, 2006, BLOOD, V107, P3527, DOI 10.1182/blood-2005-10-4309; Rossi R, 2006, BLOOD CELL MOL DIS, V37, P180, DOI 10.1016/j.bcmd.2006.09.003; Rubiolo C, 2006, BLOOD, V108, P152, DOI 10.1182/blood-2005-09-3866; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sattler M, 1999, BLOOD, V93, P2928; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Suh YH, 2004, J ENDOCRINOL, V183, P133, DOI 10.1677/joe.1.05675; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; VESGUERRA MC, 2003, J BIOL CHEM, V278, P42307; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; Zhang AS, 2005, BLOOD, V105, P368, DOI 10.1182/blood-2004-06-2226; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	64	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30461	30470		10.1074/jbc.M805400200	http://dx.doi.org/10.1074/jbc.M805400200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18687678	Green Published, hybrid			2022-12-25	WOS:000260544800004
J	Zhu, PX; Hata, RJ; Cao, F; Gu, F; Hanakawa, Y; Hashimoto, K; Sakanaka, M				Zhu, Pengxiang; Hata, Ryuji; Cao, Fang; Gu, Feng; Hanakawa, Yasushi; Hashimoto, Koji; Sakanaka, Masahiro			Ramified microglial cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function	FASEB JOURNAL			English	Article						neurogenesis; NSC; SOCS3; AG490; notch	FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ASTROCYTIC DIFFERENTIATION; STEM/PROGENITOR CELLS; PRECURSOR CELLS; ADULT BRAIN; NEUROGENESIS; EXPRESSION; NOTCH; SOX9	The differentiation and proliferation of neural stem cells (NSCs) are regulated by a combination of their intrinsic properties (e.g., transcription factors, epigenetic factors, and microRNA regulation) and cell-extrinsic properties from the microenvironment around NSC (e.g., cytokines, growth factors, and cell-cell contact). Recently, there has been a great interest in clarifying the mechanism of the influence of the microenvironment on NSCs, especially cell-cell contact between NSCs and other types of cells nearby. In this study, we investigated whether microglial (Mi) cells influence the fate of NSCs. Coculture study showed that ramified Mi cells promoted astrogliogenesis and maintenance of NSCs through their paracrine effects. This microglia-induced astrogliogenesis was inhibited by AG490 and by overexpression of the dominant-negative form of Stat3 and SOCS3. Promoter assay revealed transactivation of Stat3 function in NSCs by Mi cells. Gene expression study revealed that mRNA of Notch family members (notch1-3) and sox9 in NSCs was significantly upregulated by Mi cells, and this up-regulation was inhibited by AG490. These results demonstrated that ramified Mi cells promoted astrogliogenesis and maintenance of NSCs by activating Stat3 function and via notch and sox9 signaling pathways. -Zhu, P., Hata, R., Cao, F., Gu, F., Hanakawa, Y., Hashimoto, K., Sakanaka, M. Ramified microglial cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function. FASEB J. 22, 3866-3877 (2008)	[Zhu, Pengxiang; Hata, Ryuji; Cao, Fang; Gu, Feng; Sakanaka, Masahiro] Ehime Univ, Grad Sch Med, Dept Funct Histol, Toon, Ehime 7910295, Japan; [Hanakawa, Yasushi; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan	Ehime University; Ehime University	Hata, RJ (corresponding author), Ehime Univ, Grad Sch Med, Dept Funct Histol, Toon, Ehime 7910295, Japan.	hata@m.ehime-u.ac.jp		Zhu, Pengxiang/0000-0002-7770-5178				Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cao F, 2006, J NEUROCHEM, V98, P459, DOI 10.1111/j.1471-4159.2006.03890.x; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Rajan P, 1998, J NEUROSCI, V18, P3620; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	38	37	39	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3866	3877		10.1096/fj.08-105908	http://dx.doi.org/10.1096/fj.08-105908			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18685078				2022-12-25	WOS:000260503000015
J	Foy, RL; Song, IY; Chitalia, VC; Cohen, HT; Saksouk, N; Cayrou, C; Vaziri, C; Cote, J; Panchenko, MV				Foy, Rebecca L.; song, Ihn Young; Chitalia, Vipul C.; Cohen, Herbert T.; Saksouk, Nehme; Cayrou, Christelle; Vaziri, Cyrus; Cote, Jacques; Panchenko, Maria V.			Role of Jade-1 in the Histone Acetyltransferase (HAT) HBO1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; TUMOR-SUPPRESSOR; DNA-REPLICATION; LYSINE-4 METHYLATION; HOMEODOMAIN PROTEIN; H4 ACETYLATION; ZINC-FINGER; CHROMATIN; DOMAIN; TRANSCRIPTION	Regulation of global chromatin acetylation is important for chromatin remodeling. A small family of Jade proteins includes Jade-1L, Jade-2, and Jade-3, each bearing two mid-molecule tandem plant homology domain (PHD) zinc fingers. We previously demonstrated that the short isoform of Jade-1L protein, Jade-1, is associated with endogenous histone acetyltransferase (HAT) activity. It has been found that Jade-1L/2/3 proteins co-purify with a novel HAT complex, consisting of HBO1, ING4/5, and Eaf6. We investigated a role for Jade-1/1L in the HBO1 complex. When overexpressed individually, neither Jade-1/1L nor HBO1 affected histone acetylation. However, co-expression of Jade1/1L and HBO1 increased acetylation of the bulk of endogenous histone H4 in epithelial cells in a synergistic manner, suggesting that Jade1/1L positively regulates HBO1 HAT activity. Conversely, small interfering RNA-mediated depletion of endogenous Jade resulted in reduced levels of H4 acetylation. Moreover, HBO1-mediated H4 acetylation activity was enhanced severalfold by the presence of Jade-1/1L in vitro. The removal of PHD fingers affected neither binding nor mutual Jade-1-HBO1 stabilization but completely abrogated the synergistic Jade-1/1L- and HBO1-mediated histone H4 acetylation in live cells and in vitro with reconstituted oligonucleosome substrates. Therefore, PHDs are necessary for Jade-1/1L- induced acetylation of nucleosomal histones by HBO1. In contrast to Jade-1/1L, the PHD zinc finger protein ING4/5 failed to synergize with HBO1 to promote histone acetylation. The physical interaction of ING4/5 with HBO1 occurred in the presence of Jade-1L or Jade-3 but not with the Jade-1 short isoform. In summary, this study demonstrates that Jade-1/1L are crucial co-factors for HBO1-mediated histone H4 acetylation.	[song, Ihn Young; Vaziri, Cyrus; Panchenko, Maria V.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Foy, Rebecca L.; Chitalia, Vipul C.; Cohen, Herbert T.; Panchenko, Maria V.] Boston Univ, Sch Med, Dept Med, Nephrol Sect, Boston, MA 02118 USA; [song, Ihn Young; Vaziri, Cyrus; Panchenko, Maria V.] Evans Biomed Res Ctr, Med Ctr, Boston, MA 02118 USA; [Saksouk, Nehme; Cayrou, Christelle; Cote, Jacques] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ G1R 2J6, Canada	Boston University; Boston University; Laval University	Panchenko, MV (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St,Rm 416, Boston, MA 02118 USA.	mpanch@bu.edu	SAKSOUK, NEHME/ABA-4057-2021; Cote, Jacques/I-8901-2014	SAKSOUK, NEHME/0000-0001-5592-6298; Cote, Jacques/0000-0001-6751-555X; Panchenko, Maria/0000-0001-6247-6598; Cayrou, Christelle/0000-0002-6910-8023; Chitalia, Vipul/0000-0002-6663-6058; Cohen, Herbert/0000-0003-1900-8718	American Heart Association [SDG 0535485T]; American Cancer Society [IRG-72-001-32-IRG]; NIEHS [RO1 ES12917, R01 CA79830, R01 DK67569]; NATIONAL CANCER INSTITUTE [R01CA079830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067569, K08DK080946, R01DK087910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012917] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by American Heart Association Grant SDG 0535485T and American Cancer Society Grant IRG-72-001-32-IRG (to M. V. P.). This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES12917 from the NIEHS ( to C. V.) and Grants R01 CA79830 and R01 DK67569 ( to H. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carruthers LM, 2007, BIOCHEM J, V405, P541, DOI 10.1042/BJ20061347; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Panchenko MV, 2004, J BIOL CHEM, V279, P56032, DOI 10.1074/jbc.M410487200; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szelci J, 2000, J STEROID BIOCHEM, V72, P89, DOI 10.1016/S0960-0760(00)00025-X; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tzouanacou E, 2003, MOL CELL BIOL, V23, P8553, DOI 10.1128/MCB.23.23.8553-8562.2003; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Verreault A, 2000, GENE DEV, V14, P1430; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	52	50	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28817	28826		10.1074/jbc.M801407200	http://dx.doi.org/10.1074/jbc.M801407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18684714	hybrid, Green Published			2022-12-25	WOS:000260179900006
J	Carlson, CB; Gunderson, KA; Mosher, DF				Carlson, C. Britt; Gunderson, Kristin A.; Mosher, Deane F.			Mutations targeting intermodular interfaces or calcium binding destabilize the thrombospondin-2 signature domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; PSEUDOACHONDROPLASIA CHONDROCYTES; ENDOPLASMIC-RETICULUM; TYPE-3 REPEATS; CA2+ BINDING; CELL-DEATH; COMP; EXPRESSION; APOPTOSIS	Thrombospondins (THBSs) are a family of secreted calcium-binding glycoproteins with roles in angiogenesis, cell motility, apoptosis, cytoskeletal organization, and extracellular matrix organization. The THBS-2 signature domain (three epidermal growth factor (EGF)-like modules, a wire module with 13 calcium-binding repeats, and a lectin-like module) binds 30 calcium ions and forms extensive interactions among its parts. We explored the significance of these structural elements by examining the impact of 10 different mutations known to result in pseudoachondrodysplasia or multiple epiphyseal dysplasia when found in the homologous wire and lectin-like modules of thrombospondin-5 (THBS-5). A variety of observations indicate that the mutations result in unstable THBS-5 proteins that aggregate in the endoplasmic reticulum. We introduced the mutations into homologous sites of a THBS-2 construct, for which the crystal structure is known, and determined the effects of the mutations on structure as assayed by differential scanning calorimetry and expression of the epitope for the 4B6.13 conformation-sensitive antibody. Abnormalities were found in one or more of several readouts: stability of interactions between the wire and lectin-like modules, stabilities of the EGF-like and wire modules, expression of the 4B6.13 epitope in soluble protein, and expression of the 4B6.13 epitope in substrate-adsorbed protein at different calcium concentrations. The patterns of abnormalities support the idea that the EGF-like, wire, and lectin-like modules constitute a dynamic and interactive calcium-sensitive structure in which a distortion at one site is transmitted to distal sites, leading to global changes in the protein.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [HL54462, HL07899]; University of Wisconsin-Madison Biophysics Instrumentation Facility [S10 RR13790]; National Science Foundation [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Biophysics Instrumentation Facility; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54462 (to D.F.M.) and S10 RR13790 (to the University of Wisconsin-Madison Biophysics Instrumentation Facility). This work was also supported by National Science Foundation Grant BIR-9512577 (to the University of Wisconsin-Madison Biophysics Instrumentation Facility). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Supported by National Institutes of Health Training Grant HL07899.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Chen TLL, 2008, J CELL BIOCHEM, V103, P778, DOI 10.1002/jcb.21445; Delano W.L., 2002, DELANO SCI; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; Duke J, 2003, APOPTOSIS, V8, P191, DOI 10.1023/A:1022926811397; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Merritt TM, 2006, J ORTHOP RES, V24, P700, DOI 10.1002/jor.20100; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, CELL MOL LIFE SCI, V65, P687, DOI 10.1007/s00018-007-7485-0; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Weirich C, 2007, MATRIX BIOL, V26, P314, DOI 10.1016/j.matbio.2007.01.004	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27089	27099		10.1074/jbc.M803842200	http://dx.doi.org/10.1074/jbc.M803842200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682400	Green Published, hybrid			2022-12-25	WOS:000259586600030
J	Dai, RP; Yu, FX; Goh, SR; Chng, HW; Tan, YL; Fu, JL; Zheng, L; Luo, Y				Dai, Ru-Ping; Yu, Fa-Xing; Goh, Shuang-Ru; Chng, Hsiao-Wee; Tan, Ya-Li; Fu, Jian-Lin; Zheng, Lei; Luo, Yan			Histone 2B (H2B) expression is confined to a proper NAD(+)/NADH redox status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-CYCLE REGULATION; COACTIVATOR OCA-B; GENE-TRANSCRIPTION; METABOLIC ENZYMES; PHOSPHORYLATION; DEGENERATION; ACTIVATION; COMPLEX; PROTEIN	S-phase transcription of the histone 2B (H2B) gene is dependent on Octamer-binding factor 1 (Oct-1) and Oct-1 Co-Activator in S-phase (OCA-S), a protein complex comprising glyceraldehyde-3-phosphate dehydrogenase and lactate dehydrogenase (p38/GAPDH and p36/LDH) along with other components. H2B transcription in vitro is modulated by NAD(H). This potentially links the cellular redox status to histone expression. Here, we show that H2B transcription requires a proper NAD(+)/NADH redox status in vitro and in vivo. Therefore, perturbing a properly balanced redox impairs H2B transcription. A redox-modulated direct p38/GAPDH-Oct-1 interaction nucleates the occupancy of the H2B promoter by the OCA-S complex, in which p36/LDH plays a critical role in the hierarchical organization of the complex. As for p38/GAPDH, p36/LDH is essential for the OCA-S function in vivo, and OCA-S-associated p36/LDH possesses an LDH enzyme activity that impacts H2B transcription. These studies suggest that the cellular redox status (metabolic states) can directly feedback to gene switching in higher eukaryotes as is commonly observed in prokaryotes.	[Zheng, Lei] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21230 USA; [Dai, Ru-Ping; Yu, Fa-Xing; Goh, Shuang-Ru; Chng, Hsiao-Wee; Tan, Ya-Li; Fu, Jian-Lin; Luo, Yan] Inst Mol & Cell Biol, Singapore 138673, Singapore	Johns Hopkins University; Johns Hopkins Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zheng, L (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 186, Baltimore, MD 21230 USA.	lzheng6@jhmi.edu; yluo@imcb.a-star.edu.sg	Fu, Jianlin/T-6132-2019	Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology, and Research (A* STAR), Singapore	Agency for Science, Technology, and Research (A* STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A* STAR), Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; McKnight S, 2003, CELL, V114, P150, DOI 10.1016/S0092-8674(03)00563-4; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P85; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Svedruzic ZM, 2006, PROTEINS, V63, P501, DOI 10.1002/prot.20862; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	28	56	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26894	26901		10.1074/jbc.M804307200	http://dx.doi.org/10.1074/jbc.M804307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682386	hybrid			2022-12-25	WOS:000259586600009
J	Ding, Q; Gladson, CL; Wu, HJ; Hayasaka, H; Olman, MA				Ding, Qiang; Gladson, Candece L.; Wu, Hongju; Hayasaka, Haurko; Olman, Mitchell A.			Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH MUSCLE ACTIN; IDIOPATHIC PULMONARY FIBROSIS; GROWTH-FACTOR-BETA; TYROSINE PHOSPHORYLATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; CELL-PROLIFERATION; GLIOBLASTOMA CELLS; LATENT TGF-BETA-1	Transforming growth factor (TGF)-beta 1 induces fibroblast transdifferentiation to myofibroblasts, a process that requires the involvement of integrin-mediated signaling and focal adhesion kinase (FAK). FAK-related non-kinase (FRNK) is known for its role in inhibiting integrin-mediated cell migration; however, its role in myofibroblast differentiation has not been defined. Here, we report that FRNK abrogates TGF-beta 1-induced myofibroblast differentiation in vitro and in vivo. TGF-beta 1 can induce alpha-smooth muscle actin (alpha-SMA) expression in the presence or absence of FAK; however, TGF-beta 1-induced alpha-SMA expression is reduced (similar to 73%) in FAK-deficient fibroblasts. Although both ERK and p38 MAPK activation is required for maximal TGF-beta 1-induced alpha-SMA expression, ERK is the major signaling intermediate in cells that express FAK. In contrast, p38 MAPK is the dominant mediator of TGF-beta 1-induced alpha-SMA expression in FAK-deficient cells. FRNK overexpression blocks TGF-beta 1-induced ERK or p38 MAPK activation in the presence, and surprisingly, in the absence of FAK. The loss of FRNK was tested in vivo during experimentally induced pulmonary fibrosis in mice. FRNK knock-out mice have a greater increase in alpha-SMA-expressing cells in response to a pulmonary fibrotic stimulus in vivo, as compared with congenic wild type mice. This is the first time that FRNK loss has been shown to modify the pathobiology in any animal disease model. Together, the data demonstrate that FRNK negatively regulates myofibroblast differentiation in vitro and in vivo. These data further suggest that modulation FRNK expression may be a novel avenue for therapeutic intervention in tissue fibrosis.	[Ding, Qiang; Olman, Mitchell A.] Univ Alabama Birmingham, Dept Med, Div Pulm & Crit Care Med, Birmingham, AL 35294 USA; [Gladson, Candece L.; Olman, Mitchell A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wu, Hongju] Univ Alabama Birmingham, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Hayasaka, Haurko] Osaka Univ, Dept Microbiol, Suita, Osaka 5650871, Japan; [Hayasaka, Haurko] Osaka Univ, Dept Immunol, Suita, Osaka 5650871, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University; Osaka University	Ding, Q (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm & Crit Care Med, 1900 Univ Blvd,422 THT, Birmingham, AL 35294 USA.	qding@uab.edu			National Institutes of Health [HL085324, HL58655]; American Heart Association; Veterans Affairs merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085324, R01HL058655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085324 (to Q. D.) and HL58655 (to M. A. O.). This work was also supported by a grant from the American Heart Association (to Q. D.) and a Veterans Affairs merit award (to M. A. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Dugina V, 1998, EXP CELL RES, V238, P481, DOI 10.1006/excr.1997.3868; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Hagood JS, 2007, AM J RESP CELL MOL, V37, P503, DOI 10.1165/rcmb.2007-0005ED; Hagood JS, 1996, BLOOD, V87, P3749, DOI 10.1182/blood.V87.9.3749.bloodjournal8793749; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Haskell H, 2003, CLIN CANCER RES, V9, P2157; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hauck CR, 2001, CANCER RES, V61, P7079; Hayasaka H, 2005, J CELL BIOCHEM, V95, P1248, DOI 10.1002/jcb.20501; Hayasaka H, 2007, J CELL BIOCHEM, V102, P947, DOI 10.1002/jcb.21329; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; King Jr TE, 2000, AM J RESP CRIT CARE, V161, P646; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kutz SM, 2001, J CELL SCI, V114, P3905; LAZO JS, 1990, PHARMACOL THERAPEUT, V47, P347, DOI 10.1016/0163-7258(90)90061-6; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Olman MA, 1996, AM J PHYSIOL-LUNG C, V271, pL519, DOI 10.1152/ajplung.1996.271.4.L519; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Olman MA, 2003, ACUTE RESP DISTRESS, P313; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Sieg DJ, 1999, J CELL SCI, V112, P2677; Simmons WL, 1998, AM J RESP CELL MOL, V18, P307, DOI 10.1165/ajrcmb.18.3.2892; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; UNDERWOOD DC, 2001, AM J PHYSIOL, V279, pL895; Walker HA, 2003, MOL BIOL CELL, V14, P1941, DOI 10.1091/mbc.E02-08-0508; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Williams JC, 1998, TRENDS BIOCHEM SCI, V23, P179, DOI 10.1016/S0968-0004(98)01202-X; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; ZHANG K, 1994, AM J PATHOL, V145, P114	78	75	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26839	26849		10.1074/jbc.M803645200	http://dx.doi.org/10.1074/jbc.M803645200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669633	Green Published, hybrid			2022-12-25	WOS:000259586600003
J	Du, M; Rambhadran, A; Jayaraman, V				Du, Mei; Rambhadran, Anu; Jayaraman, Vasanthi			Luminescence resonance energy transfer investigation of conformational changes in the ligand binding domain of a kainate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; ION CHANNELS; PROTEIN INTERACTIONS; NMR-SPECTROSCOPY; AMPA RECEPTORS; DOMOIC ACID; CORE; ACTIVATION; AGONIST	The apo state structure of the isolated ligand binding domain of the GluR6 subunit and the conformational changes induced by agonist binding to this protein have been investigated by luminescence resonance energy transfer (LRET) measurements. The LRET-based distances show that agonist binding induces cleft closure, and the extent of cleft closure is proportional to the extent of activation over a wide range of activations, thus establishing that the cleft closure conformational change is one of the mechanisms by which the agonist mediates receptor activation. The LRET distances also provide insight into the apo state structure, for which there is currently no crystal structure available. The distance change between the glutamate-bound state and the apo state is similar to that observed between the glutamate-bound and antagonist UBP-310-bound form of the GluR5 ligand binding domain, indicating that the cleft for the apo state of the GluR6 ligand binding domain should be similar to the UBP-310-bound form of GluR5. This observation implies that the apo state of GluR6 undergoes a cleft closure of 29-30 degrees upon binding full agonists, one of the largest observed in the glutamate receptor family.	[Du, Mei; Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, MSB 4-106,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102]; National Science Foundation [MCB-0444352]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102. This work was also supported by National Science Foundation Grant MCB-0444352. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2004, J BIOL CHEM, V279, P26346, DOI 10.1074/jbc.M403111200; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; Deming D, 2003, J BIOL CHEM, V278, P17589, DOI 10.1074/jbc.C300105200; Dingledine R, 1999, PHARMACOL REV, V51, P7; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hald H, 2007, J BIOL CHEM, V282, P25726, DOI 10.1074/jbc.M700137200; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; Li G, 2003, BIOCHEMISTRY-US, V42, P12367, DOI 10.1021/bi034797t; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madden DR, 2001, J BIOL CHEM, V276, P37821; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a	35	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27074	27078		10.1074/jbc.M805040200	http://dx.doi.org/10.1074/jbc.M805040200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18658129	Green Published, hybrid			2022-12-25	WOS:000259586600028
J	Tenhumberg, S; Waetzig, GH; Chalaris, A; Rabe, B; Seegert, D; Scheller, J; Rose-John, S; Grotzinger, J				Tenhumberg, Stephanie; Waetzig, Georg H.; Chalaris, Athena; Rabe, Bjoern; Seegert, Dirk; Scheller, Juergen; Rose-John, Stefan; Groetzinger, Joachim			Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE RECEPTORS; RHEUMATOID-ARTHRITIS; IN-VIVO; GP130; CYTOKINES; INFLAMMATION; FAMILY; MEMBRANE; COMPLEX; SYSTEM	Binding of interleukin-6 (IL-6) to its specific receptor IL-6R is a prerequisite for the activation of the signal-transducing receptor glycoprotein 130 (gp130). A soluble form of the IL-6R (sIL-6R) in complex with IL-6 can activate cells lacking membrane-bound IL-6R (trans-signaling). IL-6-trans-signaling is counterbalanced by a naturally occurring, soluble form of gp130 (sgp130), whereby signaling via the membrane-bound IL-6R is not affected. Many inflammatory and neoplastic disorders are driven by IL-6 trans-signaling. By analysis of the three-dimensional structure of gp130 in complex with IL-6 and sIL-6R, we identified amino acid side chains in gp130 as candidates for the generation of sgp130 muteins with increased binding affinity to IL-6/sIL-6R. In addition, with information from modeling and NMR analysis of the membrane proximal domain of gp130, we generated a more stable variant of sgp130Fc. Proteins were tested for binding to the IL-6/sIL-6R-complex, for inhibition of IL-6/sIL-6R-induced cell proliferation and of acute phase gene expression. Several mutations showed an additive effect in improving the binding affinity of human sgp130 toward human IL-6/sIL-6R. Finally, we demonstrate the species specificity of these mutations in the optimal triple mutein ( T102Y/Q113F/N114L) both in vitro and in a mouse model of acute inflammation.	[Rose-John, Stefan] Univ Kiel, Dept Biochem, Inst Biochem, D-24098 Kiel, Germany; [Waetzig, Georg H.; Seegert, Dirk] CONARIS Res Inst AG, D-24118 Kiel, Germany	University of Kiel	Rose-John, S (corresponding author), Univ Kiel, Dept Biochem, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	rosejohn@biochem.uni-kiel.de	Seegert, Dirk/B-8826-2011; Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021; Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279	Hensel-Stiftung; Deutsche Forschungsgemeinschaft	Hensel-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Hensel-Stiftung (to S. T.) and the Deutsche Forschungsgemeinschaft (SFB 415, to S. R. J., J. G., and J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Boe A, 1999, CYTOKINE, V11, P1057, DOI 10.1006/cyto.1999.0502; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P946; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; FISCHER M, 1997, NAT BIOTECHNOL, V15, P145; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hibi M, 1996, J MOL MED-JMM, V74, P1, DOI 10.1007/BF00202068; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Oppmann B, 1996, J IMMUNOL METHODS, V195, P153, DOI 10.1016/0022-1759(96)00110-X; PACHTA M, 2004, THESIS U KIEL KIEL; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Peters M, 1998, J IMMUNOL, V161, P3575; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rose-John Stefan, 2007, V174, P57; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; Scheller J, 2006, SIGNAL TRANSDUCTION, V6, P240, DOI [DOI 10.1002/SITA.200600086, 10.1002/sita.200600086]; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WAXMAN E, 1993, ANAL BIOCHEM, V210, P425, DOI 10.1006/abio.1993.1220	43	51	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27200	27207		10.1074/jbc.M803694200	http://dx.doi.org/10.1074/jbc.M803694200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650419	hybrid			2022-12-25	WOS:000259586600040
J	Bijl, J; Krosl, J; Lebert-Ghali, CE; Vacher, J; Mayotte, N; Sauvageau, G				Bijl, J.; Krosl, J.; Lebert-Ghali, C-E; Vacher, J.; Mayotte, N.; Sauvageau, G.			Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia	ONCOGENE			English	Article						Hoxb4; E2A-PBX1; collaborator oncogenes; T-ALL	ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; TRANSGENIC MICE; PRE-B; TRANSCRIPTIONAL ACTIVATOR; TRANSLOCATION PROTEIN; HOMEODOMAIN PROTEIN	Using murine Moloney leukemia virus (MMLV)-based proviral insertional mutagenesis, we previously showed a preferential targeting of a small region in the Hoxa gene locus in E2A-PBX1-induced lymphoid leukemia resulting in the overexpression of several Hoxa genes including Hoxa10, Hoxa9 and Hoxa7. This observation suggested a functional interaction between Hox gene overexpression and E2A-PBX1-induced lymphoid tumors. To further explore this possibility, we generated a series of compound E2A-PBX1 x Hox transgenic mice and tested the genetic interaction between these genes in the generation of lymphoid leukemia in vivo. Results presented in this report show that the onset of T-cell leukemia is significantly ccelerated in E2A-PBX1 x Hoxb4 compound transgenic animals when compared with control E2A-PBX1 or Hoxb4 littermates. Hoxa9 appears less potent than Hoxb4 to accelerate E2A-PBX1-induced T-cell leukemia in mice. E2A-PBX1-induced T-cell leukemias express much higher levels of Hoxa genes than MMLV-induced counterparts, possibly suggesting a contribution of these genes to T-cell transformation by E2A-PBX1. Collectively, these data provide the first genetic evidence showing oncogenic collaboration between E2A-PBX1 and a Hox gene in lymphoid malignancies in vivo and document the specific deregulation of a subgroup of Hoxa genes in these leukemias.	[Bijl, J.; Krosl, J.; Sauvageau, G.] Univ Montreal, Inst Res Immunol & Canc IRIC, Lab Mol Genet Hematopoiet Stem Cells, Montreal, PQ, Canada; [Bijl, J.; Lebert-Ghali, C-E; Sauvageau, G.] Hop Maison Neuve Rosemont, Res Ctr, Div Hematol, Montreal, PQ H1T 2M4, Canada; [Bijl, J.; Sauvageau, G.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Vacher, J.] Clin Res Inst Montreal, Sect Cellular Interact & Dev, Montreal, PQ H2W 1R7, Canada; [Sauvageau, G.] Hop Maison Neuve Rosemont, Leukemia Cell Bank Quebec, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Bijl, J (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech Hop, 5415 Boul Lassompt, Montreal, PQ H1T 2M4, Canada.	jbijl.hmr@ssss.gouv.qc.ca		Sauvageau, Guy/0000-0002-4333-7266	Institute for Clinical Research of Montreal (IRCM); Canadian Cancer Society [018478]; Canada Research Chair	Institute for Clinical Research of Montreal (IRCM); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank Melanie Frechette for assistance with the animal care and transplantation experiments, and to the personnel from the transgenic animal facility at the Institute for Clinical Research of Montreal (IRCM) for the generation of Hoxb4 and Hoxa9 transgenic lines. We also thank Eric Massicotte and Martine Dupuis from the flow cytometry service of IRCM, and Danielle Gagne from the. ow cytometry service of IRIC for assistance in FACS analysis. Dr Alex Thompson (Queen's University, Belfast, UK) is thanked for critically reading the manuscript. This work was supported by funds from the Canadian Cancer Society through a NCIC grant to GS(no. 018478) and the Canada Research Chair program also to GS.	Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Azpiazu N, 1998, GENE DEV, V12, P261, DOI 10.1101/gad.12.2.261; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bergeron J, 2006, LEUKEMIA, V20, P1184, DOI 10.1038/sj.leu.2404187; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; Cauwelier B, 2007, LEUKEMIA, V21, P121, DOI 10.1038/sj.leu.2404410; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Chang CP, 1997, MOL CELL BIOL, V17, P81, DOI 10.1128/MCB.17.1.81; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; Dik WA, 2005, LEUKEMIA, V19, P1948, DOI 10.1038/sj.leu.2403891; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; HOGAN B, 1983, NATURE, V306, P313, DOI 10.1038/306313a0; HOUGH MR, 1994, J EXP MED, V179, P177, DOI 10.1084/jem.179.1.177; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krosl J, 2000, ONCOGENE, V19, P5134, DOI 10.1038/sj.onc.1203897; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; LEBRUN DP, 1994, ONCOGENE, V9, P1641; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; LU Q, 1994, MOL CELL BIOL, V14, P3938, DOI 10.1128/MCB.14.6.3938; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Medina-Martinez O, 2003, DEV BIOL, V264, P77, DOI 10.1016/j.ydbio.2003.07.020; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Sauvageau G, 2001, BLOOD, V98, p836A; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Speleman F, 2005, LEUKEMIA, V19, P358, DOI 10.1038/sj.leu.2403657; Su X, 2006, GENE CHROMOSOME CANC, V45, P846, DOI 10.1002/gcc.20348; Taghon T, 2002, BLOOD, V99, P1197, DOI 10.1182/blood.V99.4.1197; Taghon T, 2003, LEUKEMIA, V17, P1157, DOI 10.1038/sj.leu.2402947; Thompson A, 2003, BLOOD, V101, P1558, DOI 10.1182/blood.V101.4.1558; Thorsteinsdottir U, 1999, MOL CELL BIOL, V19, P6355; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; TROUSSARD X, 1995, BRIT J HAEMATOL, V89, P516, DOI 10.1111/j.1365-2141.1995.tb08357.x; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; VANDIJK MA, 1993, P NATL ACAD SCI USA, V90, P6061, DOI 10.1073/pnas.90.13.6061; VANDIJK MA, 1995, MECH DEVELOP, V52, P99, DOI 10.1016/0925-4773(95)00394-G; Zhang XB, 2008, J CLIN INVEST, V118, P1502, DOI 10.1172/JCI34371	45	15	16	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	49					6356	6364		10.1038/onc.2008.233	http://dx.doi.org/10.1038/onc.2008.233			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18679416				2022-12-25	WOS:000260263400005
J	Costa, R; Ferreira-da-Silva, F; Saraiva, MJ; Cardoso, I				Costa, Rita; Ferreira-da-Silva, Frederico; Saraiva, Maria J.; Cardoso, Isabel			Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor	PLOS ONE			English	Article								Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of amyloid beta-peptide (A-Beta) in the brain. Transthyretin (TTR) is a tetrameric protein of about 55 kDa mainly produced in the liver and choroid plexus of the brain. The known physiological functions of TTR are the transport of thyroid hormone T-4 and retinol, through binding to the retinol binding protein. TTR has also been established as a cryptic protease able to cleave ApoA-I in vitro. It has been described that TTR is involved in preventing A-Beta fibrilization, both by inhibiting and disrupting A-Beta fibrils, with consequent abrogation of toxicity. We further characterized the nature of the TTR/A-Beta interaction and found that TTR, both recombinant or isolated from human sera, was able to proteolytically process A-Beta, cleaving the peptide after aminoacid residues 1, 2, 3, 10, 13, 14,16, 19 and 27, as determined by mass spectrometry, and reversed phase chromatography followed by N-terminal sequencing. A-Beta peptides (1-14) and (15-42) showed lower amyloidogenic potential than the full length counterpart, as assessed by thioflavin binding assay and ultrastructural analysis by transmission electron microscopy. A-Beta cleavage by TTR was inhibited in the presence of an alpha APP peptide containing the Kunitz Protease Inhibitor (KPI) domain but not in the presence of the secreted alpha APP derived from the APP isoform 695 without the KPI domain. TTR was also able to degrade aggregated forms of A-Beta peptide. Our results confirmed TTR as a protective molecule in AD, and prompted A-Beta proteolysis by TTR as a protective mechanism in this disease. TTR may prove to be a useful therapeutic agent for preventing or retarding the cerebral amyloid plaque formation implicated in AD pathology.	[Costa, Rita; Saraiva, Maria J.; Cardoso, Isabel] IBMC Inst Biol Mol & Celular, Oporto, Portugal; [Ferreira-da-Silva, Frederico] IBMC Inst Biol Mol & Celular, Protein Product & Purificat Unit, Oporto, Portugal; [Saraiva, Maria J.] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Costa, R (corresponding author), IBMC Inst Biol Mol & Celular, Oporto, Portugal.	icardoso@ibmc.up.pt	Costa, Ana Rita AR/G-6341-2016; Cardoso, Isabel/K-3903-2013; Silva, Frederico F/K-3820-2013; Saraiva, Maria João/K-3907-2013	Costa, Ana Rita AR/0000-0002-2855-0472; Cardoso, Isabel/0000-0003-2472-7055; Silva, Frederico F/0000-0002-8890-4228; Saraiva, Maria João/0000-0002-3360-6899	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/57761/2004, PTDC/SAU-NEU/64593/2006]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) through POCI/SAU-NEU/57761/2004 and PTDC/SAU-NEU/64593/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Caswell MD, 1999, EUR J BIOCHEM, V266, P509, DOI 10.1046/j.1432-1327.1999.00886.x; Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; FURUYA H, 1991, BIOCHEMISTRY-US, V30, P2415, DOI 10.1021/bi00223a017; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Ho LB, 1996, J BIOL CHEM, V271, P30929, DOI 10.1074/jbc.271.48.30929; Lansbury PT, 2000, CHEM BIOL, V7, pR9, DOI 10.1016/S1074-5521(00)00068-5; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALITO E, 2008, CELL MOL LI IN PRESS; Menendez-Gonzalez M, 2005, NEURODEGENER DIS, V2, P277, DOI 10.1159/000092315; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Palha JA, 1996, NEUROSCI LETT, V204, P212, DOI 10.1016/0304-3940(96)12334-X; Rago JV, 2000, INFECT IMMUN, V68, P2366, DOI 10.1128/IAI.68.4.2366-2368.2000; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SHIRAHAMA T, 1982, AM J PATHOL, V107, P41; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; Sparks DL, 2007, CURR ALZHEIMER RES, V4, P165; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Stein TD, 2002, J NEUROSCI, V22, P7380; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; VETRIVEL KS, 2008, J BIOL CHEM IN PRESS; Vidal R, 1999, NATURE, V399, P776; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; WOEBER KA, 1968, J CLIN INVEST, V47, P1710, DOI 10.1172/JCI105861	44	90	93	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2899	10.1371/journal.pone.0002899	http://dx.doi.org/10.1371/journal.pone.0002899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682830	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600055
J	Monahan, PJ; de Souza, K; Idsardi, WJ				Monahan, Philip J.; de Souza, Kevin; Idsardi, William J.			Neuromagnetic Evidence for Early Auditory Restoration of Fundamental Pitch	PLOS ONE			English	Article							EVOKED M100; PERCEPTION; REPRESENTATION; REFLECTIONS; LATENCY; CORTEX	Background: Understanding the time course of how listeners reconstruct a missing fundamental component in an auditory stimulus remains elusive. We report MEG evidence that the missing fundamental component of a complex auditory stimulus is recovered in auditory cortex within 100 ms post stimulus onset. Methodology: Two outside tones of four-tone complex stimuli were held constant (1200 Hz and 2400 Hz), while two inside tones were systematically modulated (between 1300 Hz and 2300 Hz), such that the restored fundamental (also knows as "virtual pitch'') changed from 100 Hz to 600 Hz. Constructing the auditory stimuli in this manner controls for a number of spectral properties known to modulate the neuromagnetic signal. The tone complex stimuli only diverged on the value of the missing fundamental component. Principal Findings: We compared the M100 latencies of these tone complexes to the M100 latencies elicited by their respective pure tone (spectral pitch) counterparts. The M100 latencies for the tone complexes matched their pure sinusoid counterparts, while also replicating the M100 temporal latency response curve found in previous studies. Conclusions: Our findings suggest that listeners are reconstructing the inferred pitch by roughly 100 ms after stimulus onset and are consistent with previous electrophysiological research suggesting that the inferential pitch is perceived in early auditory cortex.	[Monahan, Philip J.; de Souza, Kevin; Idsardi, William J.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Idsardi, William J.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Monahan, PJ (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	pmonahan@umd.edu		Lauwereyns, Jan/0000-0003-0551-2550; Idsardi, William/0000-0003-4461-2685; Monahan, Philip/0000-0001-8637-1889	NIH [R01 05660]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH R01 05660 to David Poeppel and William J. Idsardi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Boersma P, 2001, GLOT INT, V5, P341; Cedolin L, 2005, J NEUROPHYSIOL, V94, P347, DOI 10.1152/jn.01114.2004; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Fujioka T, 2003, EUR J NEUROSCI, V18, P432, DOI 10.1046/j.1460-9568.2003.02769.x; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; Gage N, 1998, BRAIN RES, V814, P236, DOI 10.1016/S0006-8993(98)01058-0; Gage NM, 2000, NEUROREPORT, V11, P2723, DOI 10.1097/00001756-200008210-00023; GOLDSTEIN JL, 1973, J ACOUST SOC AM, V54, P1496, DOI 10.1121/1.1914448; HEFFNER H, 1976, J ACOUST SOC AM, V59, P915, DOI 10.1121/1.380951; Matsuwaki Y, 2004, AURIS NASUS LARYNX, V31, P208, DOI 10.1016/j.anl.2004.03.016; Meddis R, 2006, J ACOUST SOC AM, V120, P3861, DOI 10.1121/1.2372595; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Roberts TPL, 1996, NEUROREPORT, V7, P1138, DOI 10.1097/00001756-199604260-00007; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; Shamma S, 2000, J ACOUST SOC AM, V107, P2631, DOI 10.1121/1.428649; SMOORENBURG GF, 1970, J ACOUST SOC AM, V48, P924, DOI 10.1121/1.1912232; Smoorenburg GF., 1970, FREQUENCY ANAL PERIO, P41; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; TOMLINSON RWW, 1988, J ACOUST SOC AM, V84, P560, DOI 10.1121/1.396833; Winkler I, 1997, J ACOUST SOC AM, V102, P1072, DOI 10.1121/1.419860	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2900	10.1371/journal.pone.0002900	http://dx.doi.org/10.1371/journal.pone.0002900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682843	Green Submitted, gold, Green Published			2022-12-25	WOS:000264366600056
J	Facella, P; Lopez, L; Carbone, F; Galbraith, DW; Giuliano, G; Perrotta, G				Facella, Paolo; Lopez, Loredana; Carbone, Fabrizio; Galbraith, David W.; Giuliano, Giovanni; Perrotta, Gaetano			Diurnal and Circadian Rhythms in the Tomato Transcriptome and Their Modulation by Cryptochrome Photoreceptors	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; CLOCK-CONTROLLED GENE; FLOWERING TIME; ARABIDOPSIS; EXPRESSION; PHYTOCHROME; GIGANTEA; PROTEIN; ELF3; RESPONSES	Background: Circadian clocks are internal molecular time-keeping mechanisms that provide living organisms with the ability to adjust their growth and physiology and to anticipate diurnal environmental changes. Circadian clocks, without exception, respond to light and, in plants, light is the most potent and best characterized entraining stimulus. The capacity of plants to respond to light is achieved through a number of photo-perceptive proteins including cryptochromes and phytochromes. There is considerable experimental evidence demonstrating the roles of photoreceptors in providing light input to the clock. Methodology: In order to identify genes regulated by diurnal and circadian rhythms, and to establish possible functional relations between photoreceptors and the circadian clock in tomato, we monitored the temporal transcription pattern in plants entrained to long-day conditions, either by large scale comparative profiling, or using a focused approach over a number of photosensory and clock-related genes by QRT-PCR. In parallel, focused transcription analyses were performed in cry1a-and in CRY2-OX tomato genotypes. Conclusions: We report a large series of transcript oscillations that shed light on the complex network of interactions among tomato photoreceptors and clock-related genes. Alteration of cryptochrome gene expression induced major changes in the rhythmic oscillations of several other gene transcripts. In particular, over-expression of CRY2 had an impact not only on day/night fluctuations but also on rhythmicity under constant light conditions. Evidence was found for widespread diurnal oscillations of transcripts encoding specific enzyme classes (e. g. carotenoid biosynthesis enzymes) as well as for post-transcriptional diurnal and circadian regulation of the CRY2 transcript.	[Facella, Paolo; Lopez, Loredana; Carbone, Fabrizio; Perrotta, Gaetano] ENEA, Trisaia Res Ctr, Rotondella, MT, Italy; [Giuliano, Giovanni] ENEA, Casaccia Res Ctr, Rome, Italy; [Galbraith, David W.] Univ Arizona, BIO5 Inst Collaborative Biores, Dept Plant Sci, Tucson, AZ USA	Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Arizona	Perrotta, G (corresponding author), ENEA, Trisaia Res Ctr, Rotondella, MT, Italy.	gaetano.perrotta@trisaia.enea.it	Giuliano, Giovanni/A-2701-2012; Galbraith, David/AAG-8891-2021; Carbone, Fabrizio/O-2443-2017; Facella, Paolo/HHC-1895-2022; Carbone, Fabrizio/AAE-1065-2019	Giuliano, Giovanni/0000-0002-2486-0510; Carbone, Fabrizio/0000-0002-0393-7099; Facella, Paolo/0000-0001-9076-3754; Carbone, Fabrizio/0000-0002-0393-7099; Perrotta, Gaetano/0000-0003-2037-1063	Italian Ministry of Research [GEPROT DM1570]; EU	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	Work supported by the Italian Ministry of Research Project GEPROT DM1570, and by the EU (EUSOL project).	Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Casal JJ, 2005, INT J DEV BIOL, V49, P501, DOI 10.1387/ijdb.051973jc; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Facella P, 2006, FEBS LETT, V580, P4618, DOI 10.1016/j.febslet.2006.07.044; FOLTA KM, 2007, J EXP BOT, V146, P227; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hauser BA, 1998, PLANT J, V14, P431, DOI 10.1046/j.1365-313X.1998.00144.x; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Ledger S, 2001, PLANT J, V26, P14; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Millar AJ, 1999, NEW PHYTOL, V141, P175, DOI 10.1046/j.1469-8137.1999.00349.x; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Neff MM, 2000, GENE DEV, V14, P257; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Paltiel J, 2006, PLANTA, V224, P1255, DOI 10.1007/s00425-006-0305-1; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perrotta G, 2000, PLANT MOL BIOL, V42, P765, DOI 10.1023/A:1006371130043; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Weller JL, 2001, PLANT J, V25, P427, DOI 10.1046/j.1365-313x.2001.00978.x; Yanovsky MJ, 2000, CURR BIOL, V10, P1013, DOI 10.1016/S0960-9822(00)00651-5; ZERR DM, 1990, J NEUROSCI, V10, P2749	69	50	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2798	10.1371/journal.pone.0002798	http://dx.doi.org/10.1371/journal.pone.0002798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665253	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300017
J	Gohar, M; Faegri, K; Perchat, S; Ravnum, S; Okstad, OA; Gominet, M; Kolsto, AB; Lereclus, D				Gohar, Michel; Faegri, Karoline; Perchat, Stephane; Ravnum, Solveig; Okstad, Ole Andreas; Gominet, Myriam; Kolsto, Anne-Brit; Lereclus, Didier			The PlcR Virulence Regulon of Bacillus cereus	PLOS ONE			English	Article								PlcR is a Bacillus cereus transcriptional regulator, which activates gene expression by binding to a nucleotidic sequence called the 'PlcR box'. To build a list of all genes included in the PlcR regulon, a consensus sequence was identified by directed mutagenesis. The reference strain ATCC14579 sequenced genome was searched for occurrences of this consensus sequence to produce a virtual regulon. PlcR control of these genes was confirmed by comparing gene expression in the reference strain and its isogenic Delta-plcR strain using DNA microarrays, lacZ fusions and proteomics methods. The resulting list included 45 genes controlled by 28 PlcR boxes. Forty of the PlcR controlled proteins were exported, of which 22 were secreted in the extracellular medium and 18 were bound or attached to cell wall structures (membrane or peptidoglycan layer). The functions of these proteins were related to food supply (phospholipases, proteases, toxins), cell protection (bacteriocins, toxins, transporters, cell wall biogenesis) and environment-sensing (two-component sensors, chemotaxis proteins, GGDEF family regulators). Four genes coded for cytoplasmic regulators. The PlcR regulon appears to integrate a large range of environmental signals, including food deprivation and self cell-density, and regulate the transcription of genes designed to overcome obstacles that hinder B. cereus growth within the host: food supply, host barriers, host immune defenses, and competition with other bacterial species. PlcR appears to be a key component in the efficient adaptation of B. cereus to its host environment.	[Gohar, Michel; Perchat, Stephane; Lereclus, Didier] INRA, Genet Microbienne & Environm, Guyancourt, France; [Gohar, Michel] INRA, Microbiol Genet Mol, Thiverval Grignon, France; [Faegri, Karoline; Ravnum, Solveig; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Dept Pharm Biosci, Oslo, Norway; [Gominet, Myriam] Inst Pasteur, Paris, France	INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gohar, M (corresponding author), INRA, Genet Microbienne & Environm, Guyancourt, France.	michel.gohar@jouy.inra.fr	Lereclus, Didier/AAD-8293-2019; Okstad, Ole Andreas/ABE-4202-2020	Lereclus, Didier/0000-0001-9047-9104; Okstad, Ole Andreas/0000-0001-9351-8535	ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine [ANR-05-PNRA-013]	ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine(French National Research Agency (ANR))	This work was carried out with the financial support of the ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine , project ANR-05-PNRA-013, B.CEREUS .	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Beecher DJ, 2000, MICROBIOL-UK, V146, P3033, DOI 10.1099/00221287-146-12-3033; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Brillard J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-52; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; DALHAMMAR G, 1984, EUR J BIOCHEM, V139, P247, DOI 10.1111/j.1432-1033.1984.tb08000.x; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Fedhila S, 2003, J BACTERIOL, V185, P2820, DOI 10.1128/JB.185.9.2820-2825.2003; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fouet A, 2000, J BACTERIOL, V182, P5036, DOI 10.1128/JB.182.18.5036-5045.2000; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; Hajaij-Ellouze M, 2006, FEMS MICROBIOL LETT, V260, P9, DOI 10.1111/j.1574-6968.2006.00289.x; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lereclus D, 2000, INT J MED MICROBIOL, V290, P295, DOI 10.1016/S1438-4221(00)80024-7; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McGann P, 2007, APPL ENVIRON MICROB, V73, P2919, DOI 10.1128/AEM.02664-06; Miao L, 2007, BIOCHEM BIOPH RES CO, V357, P641, DOI 10.1016/j.bbrc.2007.03.171; Mignot T, 2001, ENVIRON MICROBIOL, V3, P493, DOI 10.1046/j.1462-2920.2001.00220.x; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; R Development Core Team, 2005, R LANG ENV STAT COMP; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003	50	201	209	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2793	10.1371/journal.pone.0002793	http://dx.doi.org/10.1371/journal.pone.0002793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665214	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300012
J	Kaye, TG; Gaugler, G; Sawlowicz, Z				Kaye, Thomas G.; Gaugler, Gary; Sawlowicz, Zbigniew			Dinosaurian Soft Tissues Interpreted as Bacterial Biofilms	PLOS ONE			English	Article							CELLULAR PRESERVATION	A scanning electron microscope survey was initiated to determine if the previously reported findings of "dinosaurian soft tissues'' could be identified in situ within the bones. The results obtained allowed a reinterpretation of the formation and preservation of several types of these "issues'' and their content. Mineralized and non-mineralized coatings were found extensively in the porous trabecular bone of a variety of dinosaur and mammal species across time. They represent bacterial biofilms common throughout nature. Biofilms form endocasts and once dissolved out of the bone, mimic real blood vessels and osteocytes. Bridged trails observed in biofilms indicate that a previously viscous film was populated with swimming bacteria. Carbon dating of the film points to its relatively modern origin. A comparison of infrared spectra of modern biofilms with modern collagen and fossil bone coatings suggests that modern biofilms share a closer molecular make-up than modern collagen to the coatings from fossil bones. Blood cell size iron-oxygen spheres found in the vessels were identified as an oxidized form of formerly pyritic framboids. Our observations appeal to a more conservative explanation for the structures found preserved in fossil bone.	[Kaye, Thomas G.] Burke Museum Nat Hist, Dept Paleontol, Seattle, WA USA; [Gaugler, Gary] Microtechnics Inc, Granite Bay, CA USA; [Sawlowicz, Zbigniew] Jagiellonian Univ, Dept Geol, Krakow, Poland	Jagiellonian University	Kaye, TG (corresponding author), Burke Museum Nat Hist, Dept Paleontol, Seattle, WA USA.	tomkaye@u.washington.edu		Sawlowicz, Zbigniew/0000-0001-8372-8205; Kaye, Thomas/0000-0001-7996-618X				Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; FLORA JRV, 1995, BIOTECHNOL BIOENG, V46, P43, DOI 10.1002/bit.260460107; Fratesi SE, 2004, J SEDIMENT RES, V74, P858, DOI 10.1306/042604740858; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Higby Schweitzer Mary, 1999, Annales de Paleontologie, V85, P179, DOI 10.1016/S0753-3969(99)80013-5; Konhauser KO, 1997, FEMS MICROBIOL REV, V20, P315, DOI 10.1016/S0168-6445(97)00014-4; LEDFORD H, 2007, DINOSAUR PROTEIN SEQ, DOI DOI 10.1038/NEWS070409-070411; Martill DM, 1997, PALAEONTOLOGY, V40, P619; Ohfuji H, 2005, EARTH-SCI REV, V71, P147, DOI 10.1016/j.earscirev.2005.02.001; RASMUSSEN M, 2003, J BIOL CHEM; ROBINSON RW, 1984, APPL ENVIRON MICROB, V48, P127, DOI 10.1128/AEM.48.1.127-136.1984; Sawlowicz Z., 2000, MINERAL WORK, V88, P1; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; SCHAECHTER M, 2004, DESK ENCY MICROBIOLO, P1152; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Strassberg D, 2005, EDN, V50, P24; SUK D, 1990, NATURE, V345, P611, DOI 10.1038/345611a0; Yuan XL, 2001, PRECAMBRIAN RES, V107, P253, DOI 10.1016/S0301-9268(00)00144-3	21	69	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2808	10.1371/journal.pone.0002808	http://dx.doi.org/10.1371/journal.pone.0002808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665236	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300027
J	Fujimoto, K; Ishihara, S; Kaneko, K				Fujimoto, Koichi; Ishihara, Shuji; Kaneko, Kunihiko			Network Evolution of Body Plans	PLOS ONE			English	Article								One of the major goals in evolutionary developmental biology is to understand the relationship between gene regulatory networks and the diverse morphologies and their functionalities. Are the diversities solely triggered by random events, or are they inevitable outcomes of an interplay between evolving gene networks and natural selection? Segmentation in arthropod embryogenesis represents a well-known example of body plan diversity. Striped patterns of gene expression that lead to the future body segments appear simultaneously or sequentially in long and short germ-band development, respectively. Moreover, a combination of both is found in intermediate germ-band development. Regulatory genes relevant for stripe formation are evolutionarily conserved among arthropods, therefore the differences in the observed traits are thought to have originated from how the genes are wired. To reveal the basic differences in the network structure, we have numerically evolved hundreds of gene regulatory networks that produce striped patterns of gene expression. By analyzing the topologies of the generated networks, we show that the characteristics of stripe formation in long and short germ-band development are determined by Feed-Forward Loops (FFLs) and negative Feed-Back Loops (FBLs) respectively, and those of intermediate germ-band development are determined by the interconnections between FFL and negative FBL. Network architectures, gene expression patterns and knockout responses exhibited by the artificially evolved networks agree with those reported in the fly Drosophila melanogaster and the beetle Tribolium castaneum. For other arthropod species, principal network architectures that remain largely unknown are predicted. Our results suggest that the emergence of the three modes of body segmentation in arthropods is an inherent property of the evolving networks.	[Fujimoto, Koichi; Kaneko, Kunihiko] Japan Sci & Technol Agcy, ERATO Complex Syst Biol Project, Tokyo, Japan; [Fujimoto, Koichi; Ishihara, Shuji; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Tokyo, Japan; [Ishihara, Shuji] Natl Inst Basic Biol, Div Theoretical Biol, Okazaki, Aichi, Japan	Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Fujimoto, K (corresponding author), Japan Sci & Technol Agcy, ERATO Complex Syst Biol Project, Tokyo, Japan.	fujimoto@complex.c.u-tokyo.ac.jp	Fujimoto, Koichi/J-8454-2013	Fujimoto, Koichi/0000-0001-6473-7990	ERATO Complex Systems Biology Project, JST	ERATO Complex Systems Biology Project, JST(Japan Science & Technology Agency (JST))	This work was supported by ERATO Complex Systems Biology Project, JST.	Alon U., 2006, INTRO SYSTEMS BIOL D; ARTHUR W, 1998, ORIGIN ANIMAL BODY P; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Brown SJ, 1996, SEMIN CELL DEV BIOL, V7, P553, DOI 10.1006/scdb.1996.0069; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Cerny AC, 2005, DEVELOPMENT, V132, P5353, DOI 10.1242/dev.02154; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Copf T, 2003, DEVELOPMENT, V130, P5915, DOI 10.1242/dev.00835; Cordero OX, 2006, MOL BIOL EVOL, V23, P1931, DOI 10.1093/molbev/msl060; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; Darcy, 2003, 2003 OFFSHORE TECHNO; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davis GK, 2005, DEV BIOL, V285, P169, DOI 10.1016/j.ydbio.2005.06.014; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Davis GK, 2001, DEVELOPMENT, V128, P3445; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dearden PK, 2001, DEVELOPMENT, V128, P3435; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; ISHIHARA S, 2008, J THEOR BIOL; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaynes JB, 2004, DEV BIOL, V269, P609, DOI 10.1016/j.ydbio.2004.03.001; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kauffman S.A., 1993, ORIGINS ORDER; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Lau KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051907; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu PZ, 2005, EVOL DEV, V7, P629, DOI 10.1111/j.1525-142X.2005.05066.x; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Liu PZ, 2004, DEVELOPMENT, V131, P4567, DOI 10.1242/dev.01311; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H., 1982, MODELS BIOL PATTERN; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mito T, 2006, DEV BIOL, V294, P471, DOI 10.1016/j.ydbio.2005.12.057; Monod J., 1972, CHANCE NECESSITY; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Salazar-Ciudad I, 2001, EVOL DEV, V3, P95, DOI 10.1046/j.1525-142x.2001.003002095.x; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; SOMMER RJ, 1993, NATURE, V361, P448, DOI 10.1038/361448a0; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wittkopp PJ, 2007, J EXP BIOL, V210, P1567, DOI 10.1242/jeb.002592	75	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2772	10.1371/journal.pone.0002772	http://dx.doi.org/10.1371/journal.pone.0002772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648662	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900042
J	Weinlander, K; Naschberger, E; Lehmann, MH; Tripal, P; Paster, W; Stockinger, H; Hohenadl, C; Sturzl, M				Weinlaender, Kristina; Naschberger, Elisabeth; Lehmann, Michael H.; Tripal, Philipp; Paster, Wolfgang; Stockinger, Hannes; Hohenadl, Christine; Stuerzl, Michael			Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha(4) expression	FASEB JOURNAL			English	Article						angiogenesis; inflammation; integrins; large GTPase	MAMMARY EPITHELIAL-CELLS; TUMOR ANGIOGENESIS; GROWTH-FACTOR; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; INFLAMMATORY CYTOKINES; NUCLEOTIDE-BINDING; GENE PROMOTER; FIBRONECTIN; INTERFERON	Human guanylate binding protein-1 (GBP-1) is a large GTPase that is induced by inflammatory cytokines and acts antiangiogenically through the inhibition of endothelial cell proliferation and migration. In this study, we detected that GBP-1-expressing cells show a significantly reduced spreading and migration on fibronectin matrices. Investigating possible mechanisms of these effects, we found that integrin alpha(4) (ITGA4) was consistently up-regulated at both the RNA and protein level in GBP-1-expressing cell cultures. Inhibition of cell spreading and migration by GBP-1 was dependent on the binding of ITGA4 to fibronectin. The inflammatory cytokines IL-1 beta and TNF-alpha induced ITGA4 expression in HUVECs and inhibited spreading and migration. Knockdown of GBP-1 by shRNA abrogated inflammatory cytokine induced ITGA4 expression and restored spreading and migration capabilities of the cells. These results show that inhibition of endothelial cell spreading and migration by inflammatory cytokines is mediated by GBP-1 through induction of ITGA4 expression. Endothelial cell migration is a key process during angiogenesis. Therefore, ITGA4 may be a novel molecular target to modulate angiogenesis in human disease.	[Weinlaender, Kristina; Naschberger, Elisabeth; Lehmann, Michael H.; Tripal, Philipp; Stuerzl, Michael] Univ Erlangen Nurnberg, Div Mol & Expt Surg, Dept Surg, D-91054 Erlangen, Germany; [Paster, Wolfgang; Stockinger, Hannes] Med Univ Vienna, Dept Mol Immunol, Ctr Physiol Pathophysiol & Immunol, Vienna, Austria; [Hohenadl, Christine] Univ Vet Med, Dept Pathobiol, Inst Virol, Vienna, Austria	University of Erlangen Nuremberg; Medical University of Vienna; University of Veterinary Medicine Vienna	Sturzl, M (corresponding author), Univ Erlangen Nurnberg, Div Mol & Expt Surg, Dept Surg, Schwabachanlage 10, D-91054 Erlangen, Germany.	michael.stuerzl@uk-erlangen.de	Stockinger, Hannes/E-5173-2011; Lehmann, Michael H./A-1983-2013; Naschberger, Elisabeth/AAV-5289-2021; Stürzl, Michael/B-3019-2015	Stockinger, Hannes/0000-0001-6404-4430; Lehmann, Michael H./0000-0002-1037-8600; Naschberger, Elisabeth/0000-0003-1291-622X; Stürzl, Michael/0000-0002-9276-2824; Paster, Wolfgang/0000-0002-5537-2886; Tripal, Philipp/0000-0003-0568-1725	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft [STU 317/2-1, DFG-GK 1071, DFG SPP 1130]	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Melanie Nurtsch, Gertrud Hoffmann, and Mahimaidos Manoharan for excellent technical assistance, Susanne Reed and Matthew Miller for reading the manuscript (Division of Molecular and Experimental Surgery, University of Erlangen), and Ludger Klein-Hitpass (Institute for Cell Biology, University of Essen) for Affymetrix GeneChip hybridization and partial analysis. We also thank Dr. Christoph Garlichs (Department of Medicine II, Cardiology and Angiology, University of Erlangen) for kindly providing the FACSCalibur. We are very grateful to Werner Hohenberger (Director of the Department of Surgery, University of Erlangen) for his generous support. This work was supported by grants from the Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg and the Deutsche Forschungsgemeinschaft (STU 317/2-1, DFG-GK 1071, DFG SPP 1130) to M.S. The authors have no conflicting financial interests.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Boyer L, 2004, MOL BIOL CELL, V15, P1124, DOI 10.1091/mbc.E03-05-0301; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Brezinschek RI, 1996, AM J PATHOL, V149, P1651; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; COZZOLINO F, 1990, P NATL ACAD SCI USA, V87, P6487, DOI 10.1073/pnas.87.17.6487; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; DIATLOFFZITO C, 1995, GENE, V163, P301, DOI 10.1016/0378-1119(95)00275-B; Dow JK, 2000, UROLOGY, V55, P800, DOI 10.1016/S0090-4295(00)00457-X; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; FRIESEL R, 1987, J CELL BIOL, V104, P689, DOI 10.1083/jcb.104.3.689; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Hernandez-Perera O, 2000, CIRC RES, V87, P616, DOI 10.1161/01.RES.87.7.616; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ignatoski KMW, 2000, BRIT J CANCER, V82, P666, DOI 10.1054/bjoc.1999.0979; Jia YF, 2004, CANCER RES, V64, P8674, DOI 10.1158/0008-5472.CAN-04-0069; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kirschner KM, 2006, J BIOL CHEM, V281, P31930, DOI 10.1074/jbc.M602668200; Kraynack NC, 2002, AM J PHYSIOL-LUNG C, V283, pL604, DOI 10.1152/ajplung.00459.2001; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lehmann MH, 2002, BIOTECHNIQUES, V33, P766, DOI 10.2144/02334bm10; Lehmann MH, 2001, IMMUNOL LETT, V76, P111, DOI 10.1016/S0165-2478(01)00178-X; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Livant DL, 2000, J CLIN INVEST, V105, P1537, DOI 10.1172/JCI8527; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mantovani A, 1998, TRANSPLANT P, V30, P4239, DOI 10.1016/S0041-1345(98)01402-X; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Naschberger E, 2004, BIOCHEM J, V379, P409, DOI 10.1042/BJ20031873; Naschberger E, 2006, AM J PATHOL, V169, P1088, DOI 10.2353/ajpath.2006.060244; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; Ruegg C, 2003, CELL MOL LIFE SCI, V60, P1135, DOI 10.1007/s00018-003-2297-3; Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003; Schellerer VS, 2007, LAB INVEST, V87, P1159, DOI 10.1038/labinvest.3700671; Schubert SW, 2008, J BIOL CHEM, V283, P5460, DOI 10.1074/jbc.M710110200; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P997, DOI 10.1016/0006-291X(87)90350-0; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Veikkola T, 2000, CANCER RES, V60, P203; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; White ES, 2001, J IMMUNOL, V167, P5362, DOI 10.4049/jimmunol.167.9.5362; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zaniolo K, 2004, INVEST OPHTH VIS SCI, V45, P1692, DOI 10.1167/iovs.03-0908; Zhang Y, 2004, EXP CELL RES, V295, P48, DOI 10.1016/j.yexcr.2003.12.011; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	75	54	55	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4168	4178		10.1096/fj.08-107524	http://dx.doi.org/10.1096/fj.08-107524			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18697840				2022-12-25	WOS:000261254800016
J	Doebber, M; Bordignon, E; Klare, JP; Holterhues, J; Martell, S; Mennes, N; Li, L; Engelhard, M; Steinhoff, HJ				Doebber, Meike; Bordignon, Enrica; Klare, Johann P.; Holterhues, Julia; Martell, Swetlana; Mennes, Nadine; Li, Lin; Engelhard, Martin; Steinhoff, Heinz-Juergen			Salt-driven equilibrium between two conformations in the HAMP domain from Natronomonas pharaonis - The language of signal transfer?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-LABELED PROTEINS; SENSORY-RHODOPSIN; SIDE-CHAINS; STRUCTURAL DETERMINANTS; HISTIDINE KINASE; NITROXIDE MOTION; COMPLEX; BACTERIORHODOPSIN; PHOTOTRANSDUCER; PHOBORHODOPSIN	HAMP domains (conserved in histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatases) perform their putative function as signal transducing units in diversified environments in a variety of protein families. Here the conformational changes induced by environmental agents, namely salt and temperature, on the structure and function of a HAMP domain of the phototransducer from Natronomonas pharaonis (NpHtrII) in complex with sensory rhodopsin II (NpSRII) were investigated by site-directed spin labeling electron paramagnetic resonance. A series of spin labeled mutants were engineered in NpHtrII(157), a truncated analog containing only the first HAMP domain following the transmembrane helix 2. This truncated transducer is shown to be a valid model system for a signal transduction domain anchored to the transmembrane light sensor NpSRII. The HAMP domain is found to be engaged in a "two-state" equilibrium between a highly dynamic (dHAMP) and a more compact (cHAMP) conformation. The structural properties of the cHAMP as proven by mobility, accessibility, and intra-transducer-dimer distance data are in agreement with the four helical bundle NMR model of the HAMP domain from Archaeoglobus fulgidus.	[Doebber, Meike; Bordignon, Enrica; Klare, Johann P.; Holterhues, Julia; Steinhoff, Heinz-Juergen] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Martell, Swetlana; Mennes, Nadine; Li, Lin; Engelhard, Martin] Univ Osnabruck, Fachbereich Phys, D-49076 Osnabruck, Germany	Max Planck Society; University Osnabruck	Engelhard, M (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	martin.engelhard@mpi-dortmund.mpg.de; hsteinho@uos.de	Steinhoff, Heinz-Juergen/H-3791-2014; Klare, Johann P./C-1428-2009	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Klare, Johann P./0000-0002-5761-5968; Bordignon, Enrica/0000-0003-2450-5161	Deutsche Forschungsgemeinschaft Grants [SFB 431/P18, EN87/14-2]; Max Planck Society	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 431/P18 (to J. P. K. and H. J. S.) and EN87/14-2 (to M. E.) and the Max Planck Society (to M. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; [Anonymous], 1976, SPIN LABELING THEORY, DOI DOI 10.1016/B978-0-12-092350-2.50008-4; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BAYLEY ST, 1978, CRC CR REV MICROBIOL, V6, P151, DOI 10.3109/10408417809090622; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Borrok MJ, 2008, ACS CHEM BIOL, V3, P101, DOI 10.1021/cb700211s; Brutlach H, 2006, APPL MAGN RESON, V30, P359, DOI 10.1007/BF03166206; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; John E., 2007, CRC HDB CHEM PHYS; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kamada K, 2006, BIOCHEMISTRY-US, V45, P4859, DOI 10.1021/bi060047i; KATES M, 1982, METHOD ENZYMOL, V88, P98; KIM SH, 1994, PROTEIN SCI, V3, P159; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Klare JP, 2004, FEBS LETT, V564, P219, DOI 10.1016/S0014-5793(04)00193-0; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mennes N, 2007, FEBS LETT, V581, P1487, DOI 10.1016/j.febslet.2007.03.005; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pfeiffer M, 1999, J MOL BIOL, V287, P163, DOI 10.1006/jmbi.1998.2593; Plato M, 2002, MOL PHYS, V100, P3711, DOI 10.1080/00268970210166246; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; Rodriguez-Valera Francisco, 1993, P1; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; STEINHOFF HJ, 1989, Z NATURFORSCH C, V44, P280; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312	53	34	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28691	28701		10.1074/jbc.M801931200	http://dx.doi.org/10.1074/jbc.M801931200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697747	hybrid, Green Published			2022-12-25	WOS:000259969300071
J	Li, H; Koshiba, S; Hayashi, F; Tochio, N; Tomizawa, T; Kasai, T; Yabuki, T; Motoda, Y; Harada, T; Watanabe, S; Inoue, M; Hayashizaki, Y; Tanaka, A; Kigawa, T; Yokoyama, S				Li, Hua; Koshiba, Seizo; Hayashi, Fumiaki; Tochio, Naoya; Tomizawa, Tadashi; Kasai, Takuma; Yabuki, Takashi; Motoda, Yoko; Harada, Takushi; Watanabe, Satoru; Inoue, Makoto; Hayashizaki, Yoshihide; Tanaka, Akiko; Kigawa, Takanori; Yokoyama, Shigeyuki			Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; PTB DOMAIN; NMR STRUCTURE; FUNCTIONAL ANNOTATION; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; PROGRAM; PHOSPHORYLATION; MUTAGENESIS; RECOGNITION	Fe65L1, a member of the Fe65 family, is an adaptor protein that interacts with the cytoplasmic domain of Alzheimer amyloid precursor protein (APP) through its C-terminal phosphotyrosine interaction/phosphotyrosine binding (PID/PTB) domain. In the present study, the solution structures of the C-terminal PID domain of mouse Fe65L1, alone and in complex with a 32-mer peptide (DAAVTPEERHLSKMQQNGYENPTYKFFEQMQN) derived from the cytoplasmic domain of APP, were determined using NMR spectroscopy. The C-terminal PID domain of Fe65L1 alone exhibits a canonical PID/PTB fold, whereas the complex structure reveals a novel mode of peptide binding. In the complex structure, the NPTY motif forms a type-I beta-turn, and the residues immediately N-terminal to the NPTY motif form an antiparallel beta-sheet with the beta 5 strand of the PID domain, the binding mode typically observed in the PID/PTB center dot peptide complex. On the other hand, the N-terminal region of the peptide forms a 2.5- turn alpha-helix and interacts extensively with the C-terminal alpha-helix and the peripheral regions of the PID domain, representing a novel mode of peptide binding that has not been reported previously for the PID/PTB center dot peptide complex. The indispensability of the N-terminal region of the peptide for the high affinity of the PID-peptide interaction is consistent with NMR titration and isothermal calorimetry data. The extensive binding features of the PID domain of Fe65L1 with the cytoplasmic domain of APP provide a framework for further understanding of the function, trafficking, and processing of APP modulated by adapter proteins.	[Li, Hua; Koshiba, Seizo; Hayashi, Fumiaki; Tochio, Naoya; Tomizawa, Tadashi; Kasai, Takuma; Yabuki, Takashi; Motoda, Yoko; Harada, Takushi; Watanabe, Satoru; Inoue, Makoto; Tanaka, Akiko; Kigawa, Takanori; Yokoyama, Shigeyuki] RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Om Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; Tokyo Institute of Technology; University of Tokyo	Kigawa, T (corresponding author), RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kigawa@jota.gsc.riken.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Kigawa, Takanori/A-7679-2010; Hayashizaki, Yoshihide/N-6590-2015; watanabe, satoru s/E-9501-2012; Yokoyama, Shigeyuki/N-6911-2015	Kigawa, Takanori/0000-0003-0146-9719; watanabe, satoru s/0000-0001-5329-9278; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kasai, Takuma/0000-0002-0089-533X	RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Geyer JP, 2005, J MOL BIOL, V348, P711, DOI 10.1016/j.jmb.2005.02.033; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; McLoughlin DM, 1996, FEBS LETT, V397, P197; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SIMEONE A, 1994, DEV NEUROSCI-BASEL, V16, P53, DOI 10.1159/000112088; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	54	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27165	27178		10.1074/jbc.M803892200	http://dx.doi.org/10.1074/jbc.M803892200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650440	hybrid			2022-12-25	WOS:000259586600037
J	Caunt, CJ; Armstrong, SP; Rivers, CA; Norman, MR; McArdle, CA				Caunt, Christopher J.; Armstrong, Stephen P.; Rivers, Caroline A.; Norman, Michael R.; McArdle, Craig A.			Spatiotemporal regulation of ERK2 by dual specificity phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; OF-FUNCTION MUTATION; EARLY GENE-PRODUCTS; MAP KINASE; CELL-CYCLE; IN-VIVO; DIFFERENTIAL REGULATION; TYROSINE PHOSPHATASES; NUCLEAR TRANSLOCATION; MOLECULAR-CLONING	Although many stimuli activate extracellular signal-regulated kinases 1 and 2 (ERK1/2), the kinetics and compartmentalization of ERK1/2 signals are stimulus-dependent and dictate physiological consequences. ERKscan be inactivated by dual specificity phosphatases (DUSPs), notably the MAPK phosphatases (MKPs) and atypical DUSPs, that can both dephosphorylate and scaffold ERK1/2. Using a cell imaging model (based on knockdown of endogenous ERKs and add-back of wild-type or mutated ERK2-GFP reporters), we explored possible effects of DUSPs on responses to transient or sustained ERK2 activators (epidermal growth factor and phorbol 12,13-dibutyrate, respectively). For both stimuli, a D319N mutation (which impairs DUSP binding) increased ERK2 activity and reduced nuclear accumulation. These stimuli also increased mRNA levels for eight DUSPs. In a short inhibitory RNA screen, 12 of 16 DUSPs influenced ERK2 responses. These effects were evident among nuclear inducible MKP, cytoplasmic ERK MKP, JNK/p38 MKP, and atypical DUSP subtypes and, with the exception of the nuclear inducible MKPs, were paralleled by corresponding changes in Egr-1 luciferase activation. Simultaneous removal of all JNK/p38 MKPs or nuclear inducible MKPs revealed them as positive and negative regulators of ERK2 signaling, respectively. The effects of JNK/p38 MKP short inhibitory RNAs were not dependent on protein neosynthesis but were reversed in the presence of JNK and p38 kinase inhibitors, indicating DUSP-mediated cross-talk between MAPK pathways. Overall, our data reveal that a large number of DUSPs influence ERK2 signaling. Together with the known tissue-specific expression of DUSPs and the importance of ERK1/2 in cell regulation, our data support the potential value of DUSPs as targets for drug therapy.	[Caunt, Christopher J.; Armstrong, Stephen P.; Rivers, Caroline A.; Norman, Michael R.; McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England	University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bris.ac.uk	McArdle, Craig/AAQ-5660-2021	McArdle, Craig/0000-0003-4836-5351	Wellcome Trust Project and Equipment [062918, 076557, 078407]	Wellcome Trust Project and Equipment(Wellcome Trust)	This work was supported by Wellcome Trust Project and Equipment Grants 062918, 076557, and 078407. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1993, ONCOGENE, V8, P2015; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dowd S, 1998, J CELL SCI, V111, P3389; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lazo JS, 2006, BIOORGAN MED CHEM, V14, P5643, DOI 10.1016/j.bmc.2006.04.036; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Usui T, 2001, CHEM BIOL, V8, P1209, DOI 10.1016/S1074-5521(01)00089-8; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Vogt A, 2003, CHEM BIOL, V10, P733, DOI 10.1016/S1074-5521(03)00170-4; Volmat V, 2001, J CELL SCI, V114, P3433; Wu Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2714, DOI 10.2741/2001; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	46	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26612	26623		10.1074/jbc.M801500200	http://dx.doi.org/10.1074/jbc.M801500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650424	Green Published, hybrid			2022-12-25	WOS:000259341600037
J	Bracamontes, JR; Steinbach, JH				Bracamontes, John R.; Steinbach, Joe Henry			Multiple modes for conferring surface expression of homomeric beta 1 GABA(A) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA SUBUNITS; AMINOBUTYRIC ACID(A) RECEPTORS; LIGAND-BINDING DOMAIN; GABA(A) RECEPTORS; ION CHANNELS; A RECEPTORS; ALPHA-SUBUNITS; IDENTIFICATION; RESIDUES; PHARMACOLOGY	The gamma-aminobutyric acid typeA (GABA(A)) receptor assembles from individual subunits to form ligand-gated ion channels. Human (h) beta 3 subunits assemble to form homomeric surface receptors in somatic cells, but h beta 1 subunits do not. We have identified three distinct sets of amino acid residues in the N-terminal extracellular domain of the h beta 1 subunit, which when mutated to the homologous residue in h beta 3 allow expression as a functional homomeric receptor. The three sets likely result in three modes of assembly. Mode 1 expression results from a single amino acid change at residue h beta 1 Asp-37. Mode 2 expression results from mutations of residues between positions 44 and 73 together with residues between positions 169 and 173. Finally, mode 3 results from the mutations A45V and K196R. Examination of homology-based structural models indicates that many of the residues are unlikely to be involved in physical inter-subunit interactions, suggesting that a major alteration is stabilization of an assembly competent form of the subunit. These mutations do not, however, have a major effect on the surface expression of heteromeric receptors which include the alpha 1 subunit.	[Bracamontes, John R.; Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anaesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Bracamontes, JR (corresponding author), Washington Univ, Sch Med, Dept Anaesthesiol, 660 S Euclid Ave,Campus Box 8054, St Louis, MO 63110 USA.	john@morpheus.wustl.edu			National Institutes of Health [P01 GM47969, NS22356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 GM47969 and NS22356. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amin J, 1996, P ROY SOC B-BIOL SCI, V263, P273, DOI 10.1098/rspb.1996.0042; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; AUSUBEL FM, 1992, SHORT PROTOCOLS MOL, P9; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cestari IN, 2000, J NEUROCHEM, V74, P827, DOI 10.1046/j.1471-4159.2000.740827.x; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Enz R, 1999, BRAIN RES, V846, P177, DOI 10.1016/S0006-8993(99)02008-9; Enz R, 1998, VISION RES, V38, P1431, DOI 10.1016/S0042-6989(97)00277-0; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Li P, 2006, MOL PHARMACOL, V69, P2015, DOI 10.1124/mol.106.022590; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; SANNA E, 1995, MOL PHARMACOL, V47, P213; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto I, 2002, NEUROPHARMACOLOGY, V43, P482, DOI 10.1016/S0028-3908(02)00160-0; Sarto-Jackson I, 2006, J NEUROCHEM, V96, P983, DOI 10.1111/j.1471-4159.2005.03626.x; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Srinivasan S, 1999, J BIOL CHEM, V274, P26633, DOI 10.1074/jbc.274.38.26633; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Ueno S, 1996, MOL PHARMACOL, V50, P931; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; Xue H, 2000, J MOL BIOL, V296, P739, DOI 10.1006/jmbi.2000.3502	38	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26128	26136		10.1074/jbc.M801292200	http://dx.doi.org/10.1074/jbc.M801292200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650446	hybrid, Green Published			2022-12-25	WOS:000259200100041
J	Cladel, NM; Hu, JF; Balogh, KK; Christensen, ND				Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.			CRPV Genomes with Synonymous Codon Optimizations in the CRPV E7 Gene Show Phenotypic Differences in Growth and Altered Immunity upon E7 Vaccination	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MESSENGER-RNA STABILITY; PROTEIN EXPRESSION; COTTONTAIL RABBIT; IN-VITRO; PROTECTIVE IMMUNITY; DNA VACCINATION; MUTATIONS; USAGE; BIAS	Papillomaviruses use rare codons relative to their hosts. Recent studies have demonstrated that synonymous codon changes in viral genes can lead to increased protein production when the codons are matched to those of cells in which the protein is being expressed. We theorized that the immunogenicity of the virus would be enhanced by matching codons of selected viral genes to those of the host. We report here that synonymous codon changes in the E7 oncogene are tolerated in the context of the cottontail rabbit papillomavirus (CRPV) genome. Papilloma growth rates differ depending upon the changes made indicating that synonymous codons are not necessarily neutral. Immunization with wild type E7 DNA yielded significant protection from subsequent challenge by both wild type and codon-modified genomes. The reduction in growth was most dramatic with the genome containing the greatest number of synonymous codon changes.	[Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.] Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA; [Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cladel, NM (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA.	ndc1@psu.edu			NCI [CA47622]; National Institutes of Health; Jake Gittlen Memorial Golf Tournament; NATIONAL CANCER INSTITUTE [R01CA047622] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jake Gittlen Memorial Golf Tournament; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA47622 from the National Institutes of Health, and the Jake Gittlen Memorial Golf Tournament.	Alunni-Fabbroni M, 2000, ONCOGENE, V19, P2277, DOI 10.1038/sj.onc.1203570; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Carlini DB, 2004, J EVOLUTION BIOL, V17, P779, DOI 10.1111/j.1420-9101.2004.00725.x; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CHEN L, 1999, P NATL ACAD SCI USA, V88, P110; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Embers ME, 2002, J VIROL, V76, P9798, DOI 10.1128/JVI.76.19.9798-9805.2002; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gu WY, 2007, NUCLEIC ACIDS RES, V35, P4820, DOI 10.1093/nar/gkm496; Gu WY, 2004, NUCLEIC ACIDS RES, V32, P4448, DOI 10.1093/nar/gkh748; Hallez S, 2004, CANCER IMMUNOL IMMUN, V53, P642, DOI 10.1007/s00262-004-0501-4; Han R, 2000, J VIROL, V74, P9712, DOI 10.1128/JVI.74.20.9712-9716.2000; Han RC, 1999, J VIROL, V73, P7039, DOI 10.1128/JVI.73.8.7039-7043.1999; Hu JF, 2002, J VIROL, V76, P6453, DOI 10.1128/JVI.76.13.6453-6459.2002; Hu JF, 2007, VIROLOGY, V358, P384, DOI 10.1016/j.virol.2006.08.045; Hu JF, 2006, J IMMUNOL, V177, P8037, DOI 10.4049/jimmunol.177.11.8037; Kim TG, 2004, IMMUNOLOGY, V112, P117, DOI 10.1111/j.1365-2567.2004.01851.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Leachman SA, 2002, J VIROL, V76, P7616, DOI 10.1128/JVI.76.15.7616-7624.2002; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Liu WJ, 2002, VIROLOGY, V301, P43, DOI 10.1006/viro.2002.1584; Mossadegh N, 2004, VIROLOGY, V326, P57, DOI 10.1016/j.virol.2004.04.050; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Samorski R, 2006, IMMUNOL LETT, V107, P41, DOI 10.1016/j.imlet.2006.07.003; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	43	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2947	10.1371/journal.pone.0002947	http://dx.doi.org/10.1371/journal.pone.0002947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698362	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600033
J	Felicisimo, AM; Munoz, J; Gonzalez-Solis, J				Felicisimo, Angel M.; Munoz, Jesus; Gonzalez-Solis, Jacob			Ocean Surface Winds Drive Dynamics of Transoceanic Aerial Movements	PLOS ONE			English	Article								Global wind patterns influence dispersal and migration processes of aerial organisms, propagules and particles, which ultimately could determine the dynamics of colonizations, invasions or spread of pathogens. However, studying how wind-mediated movements actually happen has been hampered so far by the lack of high resolution global wind data as well as the impossibility to track aerial movements. Using concurrent data on winds and actual pathways of a tracked seabird, here we show that oceanic winds define spatiotemporal pathways and barriers for large-scale aerial movements. We obtained wind data from NASA SeaWinds scatterometer to calculate wind cost ( impedance) models reflecting the resistance to the aerial movement near the ocean surface. We also tracked the movements of a model organism, the Cory's shearwater (Calonectris diomedea), a pelagic bird known to perform long distance migrations. Cost models revealed that distant areas can be connected through "wind highways'' that do not match the shortest great circle routes. Bird routes closely followed the low-cost "wind-highways'' linking breeding and wintering areas. In addition, we found that a potential barrier, the near surface westerlies in the Atlantic sector of the Intertropical Convergence Zone (ITCZ), temporally hindered meridional trans-equatorial movements. Once the westerlies vanished, birds crossed the ITCZ to their winter quarters. This study provides a novel approach to investigate wind-mediated movements in oceanic environments and shows that large-scale migration and dispersal processes over the oceans can be largely driven by spatiotemporal wind patterns.	[Felicisimo, Angel M.] Univ Extremadura, Escuela Politecn, Caceres, Spain; [Munoz, Jesus] Real Jardin Botanico CSIC, Madrid, Spain; [Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Barcelona	Felicisimo, AM (corresponding author), Univ Extremadura, Escuela Politecn, Caceres, Spain.	jmunoz@rjb.csic.es	Felicisimo, Angel/B-4138-2008; Gonzalez-Solis, Jacob/C-3942-2008; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/AAZ-5338-2021; Munoz, Jesus/B-7809-2008	Felicisimo, Angel/0000-0002-9953-8614; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Munoz, Jesus/0000-0002-9266-2268	Spanish Ministry of Education and Research [BOS2003-01960, CGL2006-01315/BOS, CGL2007-60247/BOS]; Fundacion Banco Bilbao Vizcaya Argentaria; Generalitat de Catalunya [2005-SGR00744-GEN.CATA]	Spanish Ministry of Education and Research(Spanish Government); Fundacion Banco Bilbao Vizcaya Argentaria; Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by the Spanish Ministry of Education and Research grants BOS2003-01960 and CGL2006-01315/BOS (JG-S), CGL2007-60247/BOS (AMF), the Fundacion Banco Bilbao Vizcaya Argentaria (AMF, JM, JG-S), and the 2005-SGR00744-GEN.CATA grant from the Generalitat de Catalunya (JG-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Alerstam T, 1990, BIRD MIGRATION; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; BROOKE M, 1990, MANX SHEARWATER; Gauthreaux Sidney A. Jr, 2005, P182; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Greene DF, 2008, ECOLOGY, V89, P118, DOI 10.1890/06-0781.1; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Grodsky SA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017867; Grodsky SA, 2003, J CLIMATE, V16, P723, DOI 10.1175/1520-0442(2003)016<0723:TICZIT>2.0.CO;2; Grodsky SA, 2001, GEOPHYS RES LETT, V28, P1503, DOI 10.1029/2000GL012601; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Jenni L, 2003, AVIAN MIGRATION, P155; *JET PROP LAB, 2006, QUIKSCAT SCI DAT PRO; Jet Propulsion Laboratory, 2001, SEAWINDS QUIKSCAT LE; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Levin DA, 2006, SYST BOT, V31, P443, DOI 10.1600/036364406778388692; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Murray MD, 2003, EMU, V103, P111, DOI 10.1071/MU01068; Murray MD, 2003, EMU, V103, P59, DOI 10.1071/MU01011; Murray MD, 2002, EMU, V102, P377, DOI 10.1071/MU01010; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nicholls DG, 1997, EMU, V97, P240; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Reinke K, 1998, AUST J ZOOL, V46, P171, DOI 10.1071/ZO97046; Ritchie SA, 2001, EMERG INFECT DIS, V7, P900; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Serventy D. L., 1954, Proceedings 7th Pacific Science Congress, V4, P394; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Weber TP, 2000, J THEOR BIOL, V205, P95, DOI 10.1006/jtbi.2000.2047; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241	34	106	111	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2928	10.1371/journal.pone.0002928	http://dx.doi.org/10.1371/journal.pone.0002928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698354	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600014
J	Alirezaei, M; Kiosses, WB; Flynn, CT; Brady, NR; Fox, HS				Alirezaei, Mehrdad; Kiosses, William B.; Flynn, Claudia T.; Brady, Nathan R.; Fox, Howard S.			Disruption of Neuronal Autophagy by Infected Microglia Results in Neurodegeneration	PLOS ONE			English	Article								There is compelling evidence to support the idea that autophagy has a protective function in neurons and its disruption results in neurodegenerative disorders. Neuronal damage is well-documented in the brains of HIV-infected individuals, and evidence of inflammation, oxidative stress, damage to synaptic and dendritic structures, and neuronal loss are present in the brains of those with HIV-associated dementia. We investigated the role of autophagy in microglia-induced neurotoxicity in primary rodent neurons, primate and human models. We demonstrate here that products of simian immunodeficiency virus (SIV)-infected microglia inhibit neuronal autophagy, resulting in decreased neuronal survival. Quantitative analysis of autophagy vacuole numbers in rat primary neurons revealed a striking loss from the processes. Assessment of multiple biochemical markers of autophagic activity confirmed the inhibition of autophagy in neurons. Importantly, autophagy could be induced in neurons through rapamycin treatment, and such treatment conferred significant protection to neurons. Two major mediators of HIV-induced neurotoxicity, tumor necrosis factor-alpha and glutamate, had similar effects on reducing autophagy in neurons. The mRNA level of p62 was increased in the brain in SIV encephalitis and as well as in brains from individuals with HIV dementia, and abnormal neuronal p62 dot structures immunoreactivity was present and had a similar pattern with abnormal ubiquitinylated proteins. Taken together, these results identify that induction of deficits in autophagy is a significant mechanism for neurodegenerative processes that arise from glial, as opposed to neuronal, sources, and that the maintenance of autophagy may have a pivotal role in neuroprotection in the setting of HIV infection.	[Alirezaei, Mehrdad; Flynn, Claudia T.; Fox, Howard S.] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA USA; [Brady, Nathan R.] BIOQUANT, Deutsches Krebsforschungszentrum, Heidelberg, Germany	Scripps Research Institute; Scripps Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Alirezaei, M (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	hfox@unmc.edu	Brady, Nathan/H-2452-2013	Fox, Howard/0000-0003-2032-374X	NIH [F32 NS048767, DA024467, MH073490, MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545, P30MH062261, R01MH073490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS048767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH NRSA F32 NS048767 (to MA), and DA024467, MH073490 and MH062261 (to HSF).	Alirezaei M, 2007, J NEUROSCI, V27, P11047, DOI 10.1523/JNEUROSCI.2733-07.2007; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Gelman BB, 2004, J NEUROVIROL, V10, P98, DOI 10.1080/13550280490279816; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; GRAY F, 1991, ACTA NEUROPATHOL, V82, P229, DOI 10.1007/BF00294450; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; HANADA T, 2007, J BIOL CHEM; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LANE TE, 1995, VIROLOGY, V212, P458, DOI 10.1006/viro.1995.1503; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marcondes MCG, 2007, J IMMUNOL, V178, P5812, DOI 10.4049/jimmunol.178.9.5812; Marcondes MCG, 2001, J IMMUNOL, V167, P5429, DOI 10.4049/jimmunol.167.9.5429; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Tan JM, 2007, AUTOPHAGY, V4; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; WATRY D, 1995, AM J PATHOL, V146, P914; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	55	119	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2906	10.1371/journal.pone.0002906	http://dx.doi.org/10.1371/journal.pone.0002906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682838	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600062
J	Atijosan, O; Rischewski, D; Simms, V; Kuper, H; Linganwa, B; Nuhi, A; Foster, A; Lavy, C				Atijosan, Oluwarantimi; Rischewski, Dorothea; Simms, Victoria; Kuper, Hannah; Linganwa, Bonaventure; Nuhi, Assuman; Foster, Allen; Lavy, Chris			A National Survey of Musculoskeletal Impairment in Rwanda: Prevalence, Causes and Service Implications	PLOS ONE			English	Article								Background: Accurate information on the prevalence and causes of musculoskeletal impairment (MSI) is lacking in low income countries. We present a new survey methodology that is based on sound epidemiological principles and is linked to the World Health Organisation's International Classification of Functioning. Methods: Clusters were selected with probability proportionate to size. Households were selected within clusters through compact segment sampling. 105 clusters of 80 people (all ages) were included. All participants were screened for MSI by a physiotherapist and medical assistant. Possible cases plus a random sample of 10% of non-MSI cases were examined further to ascertain diagnosis, aetiology, quality of life, and treatment needs. Findings: 6757 of 8368 enumerated individuals (80.8%) were screened. There were 352 cases, giving an overall prevalence for MSI of 5.2%. (95% CI 4.5-5.9) The prevalence of MSI increased with age and was similar in men and women. Extrapolating these estimates, there are approximately 488,000 MSI diagnoses in Rwanda. Only 8.2% of MSI cases were severe, while the majority were moderate (43.7%) or mild (46.3%). Diagnostic categories comprised 11.5% congenital, 31.3% trauma, 3.8% infection, 9.0% neurological, and 44.4% non-traumatic non infective acquired. The most common individual diagnoses were joint disease (13.3%), angular limb deformity (9.7%) and fracture mal- and non-union (7.2%). 96% of all cases required further treatment. Interpretation: This survey demonstrates a large burden of MSI in Rwanda, which is mostly untreated. The survey methodology will be useful in other low income countries, to assist with planning services and monitoring trends.	[Atijosan, Oluwarantimi; Rischewski, Dorothea; Simms, Victoria; Kuper, Hannah; Foster, Allen; Lavy, Chris] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Linganwa, Bonaventure; Nuhi, Assuman] CBMI, Kigali, Rwanda; [Lavy, Chris] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Atijosan, O (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	christopher.lavy@ndos.ox.ac.uk	Simms, Victoria/C-3278-2009; Simms, Victoria/AAU-4134-2021	Simms, Victoria/0000-0002-4897-458X; Foster, Allen/0000-0003-2368-4436	CBMI	CBMI	CBMI was the main funder of this study, but was not involved in the work or writing of the paper.	[Anonymous], 1999, PREJUDICE DIGNITY IN; Atijosan O, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-30; Biritwum R B, 2001, West Afr J Med, V20, P249; Chopra A, 2004, J RHEUMATOL, V31, P2320; DISLER PB, 1986, S AFR MED J, V69, P349; *GOV RWAND, 2003, 3 GEN CENS POP HOUS; McLaren P A, 1987, Int Rehabil Med, V8, P98; *MIN REH INT SOC H, 1995, EN NAT AMPL HAND RWA; MKANDAWIRE NC, 2004, E CENTRAL AFRICAN J, V2, P2; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Tamrat G, 2001, DISABIL REHABIL, V23, P799; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *UN, 2008, HUM FUNCT DIS; WHO, 2001, WHO INT CLASS FUNCT; World Health Organisation, 2002, DIS REH FUT TRENDS C	15	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2851	10.1371/journal.pone.0002851	http://dx.doi.org/10.1371/journal.pone.0002851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682849	Green Published, Green Accepted, gold			2022-12-25	WOS:000264366600007
J	Dzbek, J; Korzeniewski, B				Dzbek, Jaroslaw; Korzeniewski, Bernard			Control Over the Contribution of the Mitochondrial Membrane Potential (Delta psi) and Proton Gradient (Delta pH) to the Protonmotive Force (Delta p) IN SILICO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC-CONTROL ANALYSIS; OXIDATIVE-PHOSPHORYLATION; INNER MEMBRANE; ENERGY-METABOLISM; MODEL; CONDUCTANCE; RESPIRATION; TRANSPORT; MUSCLE; HEPATOCYTES	The protonmotive force across the inner mitochondrial membrane (Delta p) has two components: membrane potential (Delta Psi) and the gradient of proton concentration (Delta pH). The computer model of oxidative phosphorylation developed previously by Korzeniewski et al. (Korzeniewski, B., Noma, A., and Matsuoka, S. (2005) Biophys. Chem. 116, 145-157) was modified by including the K+ uniport, K+/H+ exchange across the inner mitochondrial membrane, and membrane capacitance to replace the fixed Delta Psi/Delta pH ratio used previously with a variable one determined mechanistically. The extended model gave good agreement with experimental results. Computer simulations showed that the contribution of Delta Psi and Delta pH to Delta p is determined by the ratio of the rate constants of the K+ uniport and K+/H+ exchange and not by the absolute values of these constants. The value of Delta p is mostly controlled by ATP usage. The metabolic control over the Delta Psi/Delta pH ratio is exerted mostly by K+ uniport and K+/H+ exchange in the presence of these processes, and by the ATP usage, ATP/ADP carrier, and phosphate carrier in the absence of them. The K+ circulation across the inner mitochondrial membrane is controlled mainly by K+ uniport and K+/H+ exchange, whereas H+ circulation by ATP usage. It is demonstrated that the secondary K+ ion transport is not necessary for maintaining the physiological Delta Psi/Delta pH ratio.	[Dzbek, Jaroslaw; Korzeniewski, Bernard] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University	Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	benio@mol.uj.edu.pl						Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BROWN G, 1994, BIOCHEM J, V197, P115; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; CZYZ A, 1995, BIOCHEM BIOPH RES CO, V210, P98, DOI 10.1006/bbrc.1995.1632; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; DUSZYNSKI J, 1984, BIOCHIM BIOPHYS ACTA, V767, P540, DOI 10.1016/0005-2728(84)90053-7; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; GROEN AK, 1982, J BIOL CHEM, V257, P2754; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; KACSER H, 1973, RATE CONTROL BIOL PR, P65; KORZENIEWSKI B, 1991, BIOCHIM BIOPHYS ACTA, V1060, P210, DOI 10.1016/S0005-2728(09)91009-X; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143; KRISHNAMOORTHY G, 1984, BIOCHEMISTRY-US, V23, P1640, DOI 10.1021/bi00303a009; KUNZ W, 1988, FEBS LETT, V233, P17, DOI 10.1016/0014-5793(88)81347-4; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Nicholls D., 2002, BIOENERGETICS, V3; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2005, BBA-BIOENERGETICS, V1710, P63, DOI 10.1016/j.bbabio.2005.09.002; NOBES CD, 1990, J BIOL CHEM, V265, P12903; OUHABI R, 1991, BIOCHIM BIOPHYS ACTA, V1060, P293, DOI 10.1016/S0005-2728(05)80319-6; RAIS B, 1993, MODERN TRENDS IN BIOTHERMOKINETICS, P269; REICH JG, 1983, BIOMED BIOCHIM ACTA, V42, P37; RIGOULET M, 1990, BIOCHIM BIOPHYS ACTA, V1018, P91, DOI 10.1016/0005-2728(90)90114-J; Schuster S, 1998, BIOELECTROCH BIOENER, V45, P181, DOI 10.1016/S0302-4598(98)00092-0; SCHUSTER S, 1993, MODERN TRENDS IN BIOTHERMOKINETICS, P39; SEJERSTED OM, 2000, PHYSIOL REV, V80, P1422; Wallace D C, 1987, Birth Defects Orig Artic Ser, V23, P137; WISNIEWSKI E, 1995, EUR J BIOCHEM, V230, P549	37	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33232	33239		10.1074/jbc.M802404200	http://dx.doi.org/10.1074/jbc.M802404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18694940	Green Published, hybrid			2022-12-25	WOS:000261183700026
J	Leeman, JR; Weniger, MA; Barth, TF; Gilmore, TD				Leeman, J. R.; Weniger, M. A.; Barth, T. F.; Gilmore, T. D.			Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL	ONCOGENE			English	Article						c-Rel; NF-kappa B; alternative splicing; lymphoma; transactivation; inhibition	TRANSCRIPTION FACTOR REL; C-REL; V-REL; PHOSPHORYLATION; INDUCTION; CELLS; PROLIFERATION; STIMULATION; RESIDUES; DEFECTS	Misregulation of REL, a nuclear factor-kappa B family transcription factor, has been implicated in several human lymphoid malignancies. REL has a conserved N-terminal DNA-binding/dimerization domain called the Rel homology domain (RHD) and a C-terminal transactivation domain (TAD). Here, we define the sequences (amino acids (aa) 323-422) between the RHD and TAD as a REL inhibitory domain (RID) because deletion of these sequences increases both REL transactivation and DNA binding. Furthermore, we have characterized two REL mRNA splice variants that encode proteins with alterations near RID: one lacking exon 9 sequences (aa 308-330; RELD9) and one with an exonized Alu fragment insertion of 32 aa after aa 307 (REL + Alu). Deletion of RID or exon 9-encoded sequences increases transactivation by GAL4-REL by approximately threefold. Moreover, deletion of RID or exon 9 sequences increases transactivation by full-length REL from certain kappa B site-containing promoters and increases DNA binding by REL. Deletion of RID does not affect REL's ability to transform chicken spleen cells. Reverse transcriptase-polymerase chain reaction analysis of mRNA from both primary lymphoma samples and several transformed tissue culture cell lines indicates that the RELD9 splice variant is preferentially expressed in lymphoma, suggesting that the REL transcript lacking exon 9 could serve as a marker for certain types of lymphoid tumors.	[Leeman, J. R.; Gilmore, T. D.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Weniger, M. A.; Barth, T. F.] Univ Ulm, Dept Pathol, Ulm, Germany	Boston University; Ulm University	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu			NIH [CA47763]; Deutsche Krebshilfe [108060]; NATIONAL CANCER INSTITUTE [R01CA047763, R29CA047763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Mike Garbati, Melanie Herscovitch, Daniel Starczynowski and Francis Wolenski for helpful discussions, and Michaela Buck, Karola Dorsch, Iwona Nerbas and Ingo Melzner for technical assistance. This work was supported by NIH Grant CA47763 (TDG) and a grant from Deutsche Krebshilfe (108060; TFB).	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; BROWNELL E, 1989, ONCOGENE, V4, P935; Bundesarztekammer ZEbd, 2003, DTSCH ARZTEBL, V100, pA1632; Epinat JC, 2000, ONCOGENE, V19, P599, DOI 10.1038/sj.onc.1203376; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Kalaitzidis D, 2002, ONCOGENE, V21, P8759, DOI 10.1038/sj.onc.1206033; Kalaitzidis D, 2002, GENE CHROMOSOME CANC, V34, P129, DOI 10.1002/gcc.10051; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LEEMAN JR, 2008, GENE IN PRESS; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; SCHATZLE JD, 1995, J VIROL, V69, P5383, DOI 10.1128/JVI.69.9.5383-5390.1995; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Starczynowski DT, 2007, ONCOGENE, V26, P2685, DOI 10.1038/sj.onc.1210089; Starczynowski DT, 2005, ONCOGENE, V24, P7355, DOI 10.1038/sj.onc.1208902; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Stoilov P, 2002, DNA CELL BIOL, V21, P803, DOI 10.1089/104454902320908450; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	31	18	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6770	6781		10.1038/onc.2008.284	http://dx.doi.org/10.1038/onc.2008.284			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18695674	Green Accepted			2022-12-25	WOS:000260866200007
J	Tagscherer, KE; Fassl, A; Campos, B; Farhadi, M; Kraemer, A; Bock, BC; Macher-Goeppinger, S; Radlwimmer, B; Wiestler, OD; Herold-Mende, C; Roth, W				Tagscherer, K. E.; Fassl, A.; Campos, B.; Farhadi, M.; Kraemer, A.; Boeck, B. C.; Macher-Goeppinger, S.; Radlwimmer, B.; Wiestler, O. D.; Herold-Mende, C.; Roth, W.			Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins	ONCOGENE			English	Article						apoptosis; brain tumors; glioma; ABT-737; Bcl-2 inhibitor	HUMAN-MALIGNANT GLIOMA; BH3 MIMETIC ABT-737; ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; IN-VIVO; STEM-CELLS; IMMUNOHISTOCHEMICAL ANALYSIS; CHEMOTHERAPEUTIC-AGENTS; DOWN-REGULATION	Defects in the apoptotic signaling cascades contribute to the poor therapeutic response of malignant gliomas. As glioblastomas are characterized by high expression levels of anti-apoptotic Bcl-2 family proteins, we studied the effects of the novel Bcl-2 inhibitor, ABT-737, on malignant glioma cells. ABT-737 treatment released the pro-apoptotic Bax protein from its binding partner Bcl-2 and potently induced apoptotic cell death in glioblastoma cells in vitro and in vivo. The local administration of ABT-737 prolonged the survival in an intracranial glioma xenograft model. Downregulation of Mcl-1 and overexpression of Bcl-2 sensitized the cells to ABT-737mediated apoptosis. Moreover, ABT-737 potentiated the cytotoxicity of the chemotherapeutic drugs vincristine and etoposide, and of the death ligand TRAIL. As glioma stem cells may play a crucial role for the tumor progression and the resistance to treatment in glioblastomas, we investigated the effects of ABT-737 on the subpopulation of glioma cells exhibiting stem cell characteristics. Inhibition of proliferation and induction of apoptosis by ABT-737 were less efficient in glioma stem cells than in non-stem cell-like glioma cells. As the resistance of glioma stem cells was associated with high Mcl-1 expression levels, ABT-737 treatment combined with downregulation of Mcl-1 could represent a promising novel approach in glioblastoma treatment.	[Roth, W.] German Canc Res Ctr, DKFZ, D-69120 Heidelberg, Germany; [Campos, B.; Farhadi, M.; Herold-Mende, C.] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, Heidelberg, Germany; [Macher-Goeppinger, S.; Roth, W.] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Radlwimmer, B.] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Roth, W (corresponding author), German Canc Res Ctr, DKFZ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	W.Roth@dkfz.de	Radlwimmer, Bernhard F/I-3229-2013; Fassl, Anne/AAA-5249-2022; Tagscherer, Katrin/AAS-3809-2021	Radlwimmer, Bernhard F/0000-0002-4553-7800; Tagscherer, Katrin/0000-0002-0657-6399	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant from the Deutsche Krebshilfe to WR (German Cancer Aid, Max Eder Program). We thank Ilona Demir, Monika Frank-Stohr and Sarah MeBnard for expert technical assistance. We thank Manfred Jugold (Molecular Imaging, German Cancer Research Center) for performing magnetic resonance imaging of animals.	Adams JM, 2005, COLD SH Q B, V70, P469, DOI 10.1101/sqb.2005.70.009; Ahmadi R, 2006, FREE RADICAL BIO MED, V40, P763, DOI 10.1016/j.freeradbiomed.2005.09.031; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; CAMPOS B, 2008, DIFFERENTIATIO UNPUB; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Del Bufalo D, 2001, J CELL BIOCHEM, V83, P473, DOI 10.1002/jcb.1245; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dictus C, 2007, J NEUROSCI METH, V161, P250, DOI 10.1016/j.jneumeth.2006.11.012; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Glaser T, 1999, ONCOGENE, V18, P5044, DOI 10.1038/sj.onc.1202882; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Kajiwara Y, 2003, CANCER-AM CANCER SOC, V97, P1077, DOI 10.1002/cncr.11122; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Karcher S, 2006, INT J CANCER, V118, P2182, DOI 10.1002/ijc.21648; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krajewski S, 1997, AM J PATHOL, V150, P805; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Kraus JA, 2001, J NEURO-ONCOL, V52, P263, DOI 10.1023/A:1010684203704; Letai A, 2006, CANCER CELL, V10, P343, DOI 10.1016/j.ccr.2006.10.014; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nagane M, 2000, CANCER RES, V60, P847; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Olejniczak ET, 2007, MOL CANCER RES, V5, P331, DOI 10.1158/1541-7786.MCR-06-0367; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pollack IF, 2001, CLIN CANCER RES, V7, P1362; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sinicrope FA, 2004, CLIN CANCER RES, V10, P8284, DOI 10.1158/1078-0432.CCR-04-1289; Stupp R, 2007, NAT BIOTECHNOL, V25, P193, DOI 10.1038/nbt0207-193; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wagenknecht B, 1999, CELL DEATH DIFFER, V6, P370, DOI 10.1038/sj.cdd.4400503; Webb JL, 1963, ENZYMES METABOL INH, V1, P487; Weiler M, 2006, CELL DEATH DIFFER, V13, P1156, DOI 10.1038/sj.cdd.4401786; WELLER M, 1995, J CLIN INVEST, V95, P2633, DOI 10.1172/JCI117965; Zangemeister-Wittke U, 2003, ANN NY ACAD SCI, V1002, P90, DOI 10.1196/annals.1281.019	55	169	171	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6646	6656		10.1038/onc.2008.259	http://dx.doi.org/10.1038/onc.2008.259			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18663354				2022-12-25	WOS:000260638800003
J	Schneider, S; Sandalova, T; Schneider, G; Sprenger, GA; Samland, AK				Schneider, Sarah; Sandalova, Tatyana; Schneider, Gunter; Sprenger, Georg A.; Samland, Anne K.			Replacement of a Phenylalanine by a Tyrosine in the Active Site Confers Fructose-6-phosphate Aldolase Activity to the Transaldolase of Escherichia coli and Human Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE INTERMEDIATE; CLASS-I ALDOLASE; SATURATION MUTAGENESIS; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; EXPRESSION; DEFICIENCY; CLONING; INACTIVATION; EFFICIENT	Based on a structure-assisted sequence alignment we designed 11 focused libraries at residues in the active site of transaldolase B from Escherichia coli and screened them for their ability to synthesize fructose 6-phosphate from dihydroxyacetone and glyceraldehyde 3-phosphate using a newly developed color assay. We found one positive variant exhibiting a replacement of Phe(178) to Tyr. This mutant variant is able not only to transfer a dihydroxyacetone moiety from a ketose donor, fructose 6-phosphate, onto an aldehyde acceptor, erythrose 4-phosphate (14 units/mg), but to use it as a substrate directly in an aldolase reaction (7 units/mg). With a single amino acid replacement the fructose-6-phosphate aldolase activity was increased considerably (> 70-fold compared with wild-type). Structural studies of the wild-type and mutant protein suggest that this is due to a different H-bond pattern in the active site leading to a destabilization of the Schiff base intermediate. Furthermore, we show that a homologous replacement has a similar effect in the human transaldolase Taldo1 (aldolase activity, 14 units/mg). We also demonstrate that both enzymes TalB and Taldo1 are recognized by the same polyclonal antibody.	[Schneider, Sarah; Sprenger, Georg A.; Samland, Anne K.] Univ Stuttgart, Inst Microbiol, D-70550 Stuttgart, Germany; [Sandalova, Tatyana; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Struct Biol, S-17177 Stockholm, Sweden	University of Stuttgart; Karolinska Institutet	Samland, AK (corresponding author), Allmandring 31, D-70550 Stuttgart, Germany.	anne.samland@imb.uni-stuttgart.de	Sprenger, Georg A./E-2384-2011	Sprenger, Georg A./0000-0002-7879-8978; Schneider, Gunter/0000-0003-0622-5713; Sandalova, Tatyana/0000-0002-7694-6420	Deutsche Forschungsgemeinschaft [SPP1170/Sp503/4-2]; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP1170/Sp503/4-2 (to G. Sprenger) and a grant from the Swedish Research Council (to G. Schneider). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiss TJ, 2007, PROTEIN SCI, V16, P2350, DOI 10.1110/ps.073119507; Ang EL, 2007, FEBS J, V274, P928, DOI 10.1111/j.1742-4658.2007.05638.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANKI K, 1994, J BIOL CHEM, V269, P2847; Banki K, 1996, FEBS LETT, V378, P161, DOI 10.1016/0014-5793(95)01446-2; BANKI K, 1994, J EXP MED, V180, P1649, DOI 10.1084/jem.180.5.1649; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito M, 1999, J IMMUNOL, V163, P4027; Fujii K, 2005, APPL ENVIRON MICROB, V71, P5823, DOI 10.1128/AEM.71.10.5823-5827.2005; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; GEORGESCU R, 2003, DIRECTED EVOLUTION L; Grossman CE, 2004, BIOCHEM J, V382, P725, DOI 10.1042/BJ20040413; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; INOUE T, 2006, THESIS U STUTTGART S; Jager SAW, 2008, J BIOTECHNOL, V133, P18, DOI 10.1016/j.jbiotec.2007.08.039; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; Jia J, 1997, PROTEIN SCI, V6, P119; Kohler U, 1996, PLANT MOL BIOL, V30, P213, DOI 10.1007/BF00017817; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novy R., 2001, INNOVATIONS, V12, P1; Parikh MR, 2005, J MOL BIOL, V352, P621, DOI 10.1016/j.jmb.2005.07.020; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Perl A, 2006, P NATL ACAD SCI USA, V103, P14813, DOI 10.1073/pnas.0602678103; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; Schneider G, 2002, METHOD ENZYMOL, V354, P197; Schorken U, 1998, FEBS LETT, V441, P247, DOI 10.1016/S0014-5793(98)01521-X; Schorken U, 2001, EUR J BIOCHEM, V268, P2408, DOI 10.1046/j.1432-1327.2001.02128.x; Schurmann M, 2002, J MOL CATAL B-ENZYM, V19, P247, DOI 10.1016/S1381-1177(02)00174-1; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; SPRENGER GA, 1995, J BACTERIOL, V177, P5930, DOI 10.1128/jb.177.20.5930-5936.1995; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; TSOLAS O, 1972, ENZYMES; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valayannopoulos V, 2006, J PEDIATR-US, V149, P713, DOI 10.1016/j.jpeds.2006.08.016; Verhoeven NM, 2005, J INHERIT METAB DIS, V28, P169, DOI 10.1007/s10545-005-5261-6; Verhoeven NM, 2001, AM J HUM GENET, V68, P1086, DOI 10.1086/320108; Williams GJ, 2005, PROTEIN ENG DES SEL, V18, P239, DOI 10.1093/protein/gzi027	46	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30064	30072		10.1074/jbc.M803184200	http://dx.doi.org/10.1074/jbc.M803184200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687684	hybrid, Green Published			2022-12-25	WOS:000260366900051
J	Rebillard, A; Rioux-Leclercq, N; Muller, C; Bellaud, P; Jouan, F; Meurette, O; Jouan, E; Vernhet, L; Le Quement, C; Carpinteiro, A; Schenck, M; Lagadic-Gossmann, D; Gulbins, E; Dimanche-Boitrel, MT				Rebillard, A.; Rioux-Leclercq, N.; Muller, C.; Bellaud, P.; Jouan, F.; Meurette, O.; Jouan, E.; Vernhet, L.; Le Quement, C.; Carpinteiro, A.; Schenck, M.; Lagadic-Gossmann, D.; Gulbins, E.; Dimanche-Boitrel, M. T.			Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage	ONCOGENE			English	Article						acid sphingomyelinase; cisplatin; small intestine; endothelial cells; p53	RADIATION-INDUCED APOPTOSIS; COLON-CANCER CELLS; MICE; ACTIVATION; TOXICITY; CERAMIDE; ANALOGS; DRUGS	Cisplatin is one of the most effectively used chemotherapeutic agents for cancer treatment. However, in humans, important cytotoxic side effects are observed including dose-limiting renal damage and profound gastrointestinal symptomatology. The toxic responses to cisplatin in mice are similar to those in human patients. Here, we evaluated whether the acid sphingomyelinase (Asm) mediates at least some of the toxic in vivo effects of cisplatin. To this end, we determined the toxic effects of a single intraperitoneal dose of cisplatin (27 mg/kg) in wild type (Asm(+/+)) and Asm-deficient mice (Asm(-/-)). Tissue injury and apoptosis were determined histologically on hematox-ylin-eosin and TUNEL ( terminal deoxynucleotidyl transferase (TdT)-mediated nick end labeling) stainings 3, 12, 36 and 72 h after treatment. Our results revealed severe toxicity of cisplatin in Asm(+/+) mice with increased numbers of apoptotic cells in the thymus and small intestine. In marked contrast, Asm(-/-) mice were resistant to cisplatin and no apoptosis was observed in these organs after treatment. Moreover, cisplatin treatment primarily triggered apoptosis of endothelial cells in microvessels of intestine and thymus, an effect that was absent in mice lacking Asm. The data thus suggest that at least some toxic effects of cisplatin are mediated by the Asm in vivo resulting in early death of endothelial cells and consecutive organ damage.	[Rebillard, A.; Muller, C.; Meurette, O.; Jouan, E.; Vernhet, L.; Le Quement, C.; Lagadic-Gossmann, D.; Dimanche-Boitrel, M. T.] INSERM, UMR620, IFR GFAS 140, Rennes, France; [Rebillard, A.; Meurette, O.; Jouan, E.; Vernhet, L.; Le Quement, C.; Lagadic-Gossmann, D.; Dimanche-Boitrel, M. T.] Univ Rennes, UPRES EA SeRAIC, Rennes, France; [Rioux-Leclercq, N.; Bellaud, P.] Rennes Univ, Dept Pathol, Rennes, France; [Rioux-Leclercq, N.; Jouan, F.] Rennes Univ, CNRS, UMR6061, Rennes, France; [Carpinteiro, A.; Schenck, M.; Gulbins, E.] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of Duisburg Essen	Dimanche-Boitrel, MT (corresponding author), Univ Rennes 1, INSERM, UMR620, Fac Pharm, 2 Av Pr Leon Bernard, F-35043 Rennes, France.	marie-therese.boitrel@rennes.inserm.fr	LAGADIC-GOSSMANN, Dominique/I-5079-2015; VERNHET, Laurent/K-3364-2015; Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Gulbins, Erich/L-6989-2014	LAGADIC-GOSSMANN, Dominique/0000-0002-4888-236X; Gulbins, Erich/0000-0002-3117-1342; Dimanche-Boitrel, Marie-Therese/0000-0002-8038-7780; Vernhet, Laurent/0000-0001-6476-7583	Ligue Nationale Contre le Cancer; Region Bretagne [DFG-10-2238-Gu2]	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Bretagne(Region Bretagne)	We thank F Paris, M Le Vee and I Guenon. This study was supported by grants from the Ligue Nationale Contre le Cancer ( the Cote d'Armor, Ille et Vilaine and Loire-Atlantique Committees), Rennes Metropole, the Region Bretagne and DFG-10-2238-Gu2.	ALLAN SG, 1986, BRIT J CANCER, V53, P355, DOI 10.1038/bjc.1986.59; Bezombes C, 2004, BLOOD, V104, P1166, DOI 10.1182/blood-2004-01-0277; GRUNICKE H, 1992, PHARMACOL THERAPEUT, V55, P1, DOI 10.1016/0163-7258(92)90027-W; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Gulbins E, 2002, BBA-MOL CELL BIOL L, V1585, P139, DOI 10.1016/S1388-1981(02)00334-7; Harrison S D Jr, 1981, Fundam Appl Toxicol, V1, P382, DOI 10.1093/toxsci/1.5.382; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; PRESTAYKO AW, 1979, CANCER TREAT REP, V63, P1503; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; Sansom OJ, 2002, ONCOGENE, V21, P5934, DOI 10.1038/sj.onc.1205760; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Tamaki T, 2003, J INT MED RES, V31, P6, DOI 10.1177/147323000303100102; Vasey PA, 1996, MOL PHARMACOL, V50, P1536	19	30	32	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2008	27	51					6590	6595		10.1038/onc.2008.257	http://dx.doi.org/10.1038/onc.2008.257			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18679423				2022-12-25	WOS:000260501700006
J	Asiedu, M; Wu, D; Matsumura, F; Wei, QZ				Asiedu, Michael; Wu, Di; Matsumura, Fumio; Wei, Qize			Phosphorylation of MyoGEF on Thr-574 by Plk1 promotes MyoGEF localization to the central spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; CULTURED EPITHELIAL-CELLS; SMALL-MOLECULE INHIBITOR; BOX DOMAIN; CONTRACTILE RING; CYTOKINESIS; RHOA; ECT2; ACTIVATION; POLO-LIKE-KINASE-1	We reported previously that a guanine nucleotide exchange factor, MyoGEF, localizes to the central spindle, activates RhoA, and is required for cytokinesis. In this study, we have found that Plk1 (polo-like kinase 1) can phosphorylate MyoGEF, thereby recruiting MyoGEF to the central spindle as well as enhancing MyoGEF activity toward RhoA. The in vitro kinase assay shows that Plk1 can phosphorylate MyoGEF on threonine 574. Immunoprecipitation/immunoblot analysis demonstrates that mutation of threonine 574 to alanine dramatically decreases threonine phosphorylation of MyoGEF in transfected HeLa cells, suggesting that threonine 574 is phosphorylated in vivo. Consistent with these observations, immunofluorescence shows that Plk1 and MyoGEF colocalize at the spindle pole and central spindle during mitosis and cytokinesis. Importantly, RNA interference-mediated depletion of Plk1 interferes with the localization of MyoGEF at the spindle pole and central spindle. Moreover, mutation of threonine 574 to alanine in MyoGEF or depletion of Plk1 by RNA interference leads to a decrease in MyoGEF activity toward RhoA in HeLa cells. Therefore, our results suggest that Plk1 can regulate MyoGEF activity and localization, contributing to the regulation of cytokinesis.	[Asiedu, Michael; Wu, Di; Wei, Qize] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Matsumura, Fumio] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Kansas State University; Rutgers State University New Brunswick	Wei, QZ (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	weiq@ksu.edu		Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health [k22 HL071542, P20 RR17708, P20 RR15563]; Johnson Center for Basic Cancer Research; Kansas Agricultural Experiment Station [08-296-J]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR015563] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL071542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Center for Basic Cancer Research; Kansas Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants k22 HL071542 (to Q. W.) and P20 RR17708 and P20 RR15563. This work was also supported by a fund from the Terry C. Johnson Center for Basic Cancer Research (to Q. W.). This is contribution 08-296-J from the Kansas Agricultural Experiment Station (Manhattan, KS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Dai BN, 2007, CELL PROLIFERAT, V40, P550, DOI 10.1111/j.1365-2184.2007.00447.x; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	41	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28392	28400		10.1074/jbc.M801801200	http://dx.doi.org/10.1074/jbc.M801801200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694934	hybrid, Green Published			2022-12-25	WOS:000259969300041
J	Monterroso, B; Saiz, JL; Garcia, P; Garcia, JL; Menendez, M				Monterroso, Begona; Saiz, Jose Luis; Garcia, Pedro; Garcia, Jose Luis; Menendez, Margarita			Insights into the structure-function relationships of pneumococcal cell wall lysozymes, LytC and Cpl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; CHOLINE-BINDING; PHOSPHORYLCHOLINE ESTERASE; SCANNING CALORIMETRY; AUTOLYTIC LYSOZYME; CIRCULAR-DICHROISM; MUREIN HYDROLASES; PHAGE CP-1; PROTEINS	The LytC lysozyme belongs to the autolytic system of Streptococcus pneumoniae and carries out a slow autolysis with optimum activity at 30 C. Like all pneumococcal murein hydrolases, LytC is a modular enzyme. Its mature form comprises a catalytic module belonging to the GH25 family of glycosyl-hydrolases and a cell wall binding module (CBM), made of 11 sequence repeats, that is essential for activity and specifically targets choline residues present in pneumococcal lipoteichoic and teichoic acids. Here we show that the catalytic module is natively folded, and its thermal denaturation takes place at 45.4 degrees C. However, the CBM is intrinsically unstable, and the ultimate folding and stabilization of the active, monomeric form of LytC relies on choline binding. The complex formation proceeds in a rather slow way, and all sites (8.0 +/- 0.5 sites/monomer) behave as equivalent (K-d = 2.7 +/- 0.3 mM). The CBM stabilization is, nevertheless, marginal, and irreversible denaturation becomes measurable at 37 C even at high choline concentration, compromising LytC activity. In contrast, the Cpl-1 lysozyme, a homologous endolysin encoded by pneumococcal Cp-1 bacteriophage, is natively folded in the absence of choline and has maximum activity at 37 degrees C. Choline binding is fast and promotes Cpl-1 dimerization. Coupling between choline binding and folding of the CBM of LytC indicates a high conformational plasticity that could correlate with the unusual alternation of short and long choline-binding repeats present in this enzyme. Moreover, it can contribute to regulate LytC activity by means of a tight, complementary binding to the pneumococcal envelope, a limited motility, and a moderate resistance to thermal denaturation that could also account for its activity versus temperature profile.	[Monterroso, Begona; Saiz, Jose Luis; Menendez, Margarita] Consejo Super Invest Cient, Inst Quim Fis Rocasolano, Madrid 28006, Spain; [Saiz, Jose Luis; Garcia, Pedro; Menendez, Margarita] Consejo Super Invest Cient, CIBER Enfermedades Resp, Madrid 28040, Spain; [Garcia, Pedro; Garcia, Jose Luis] Consejo Super Invest Cient, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Menendez, M (corresponding author), Consejo Super Invest Cient, Inst Quim Fis Rocasolano, Serrano 119, Madrid 28006, Spain.	mmenendez@iqfr.csic.es	Menendez, Margarita/AAD-2043-2020; García, Pedro/L-2808-2017; Monterroso, Begoña/J-9748-2014; Menendez, Margarita/M-1795-2014; Garcia Lopez, Jose Luis/G-9139-2015	Menendez, Margarita/0000-0002-6590-7960; García, Pedro/0000-0001-6717-8717; Monterroso, Begoña/0000-0003-2538-084X; Menendez, Margarita/0000-0002-3267-4443; Garcia Lopez, Jose Luis/0000-0002-9238-2485	Direccion General de Investigacion Cientifica y Tecnica [BIO2003-01952, BFU2006-10288, SAF2006-00390]; COMBACT [S-BIO-0260/ 2006]; CIBER of Respiratory Diseases (CIBERES)	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); COMBACT; CIBER of Respiratory Diseases (CIBERES)	This work was supported by Direccion General de Investigacion Cientifica y Tecnica Grants BIO2003-01952, BFU2006-10288, and SAF2006-00390. Additional funding was provided by the COMBACT program (S-BIO-0260/ 2006) of the Comunidad de Madrid, the CIBER of Respiratory Diseases (CIBERES), an initiative of the ISCIII, and the Glycodynamics Network (FP6-UE and MCTN-CT-2005-019561). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAINS G, 1992, BIOCHEMISTRY-US, V31, P12624, DOI 10.1021/bi00165a012; BRANDTS JF, 1989, BIOCHEMISTRY-US, V28, P8588, DOI 10.1021/bi00447a048; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eftink M., 1980, BIOL MICROCALORIM, P343; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Garcia JL, 2000, STREPTOCOCCUS PNEUMO, P231; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473; GILL SJ, 1990, BINDING LINKAGE, P80; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HOLTJE JV, 1991, J GEN MICROBIOL, V137, P441, DOI 10.1099/00221287-137-3-441; Lagartera L, 2005, PROTEIN SCI, V14, P3013, DOI 10.1110/ps.051575005; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Martin AC, 1998, J BACTERIOL, V180, P210; MARTINEZBUEY R, 2007, J MOL BIOL, V365, P411; Medrano FJ, 1996, J BIOL CHEM, V271, P29152, DOI 10.1074/jbc.271.46.29152; Monterroso B, 2005, BIOCHEM J, V391, P41, DOI 10.1042/BJ20050612; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Saiz JL, 2002, PROTEIN SCI, V11, P1788, DOI 10.1110/ps.4680102; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANZ JM, 1993, J BIOL CHEM, V268, P6125; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; Severin A, 1997, MICROB DRUG RESIST, V3, P391, DOI 10.1089/mdr.1997.3.391; Shockman GD., 1994, BACTERIAL CELL WALL, P131, DOI 10.1016/S0167-7306(08)60410-X; STRICKLA.EH, 1969, BIOCHEMISTRY-US, V8, P3205, DOI 10.1021/bi00836a012; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1968, P NATL ACAD SCI USA, V59, P86, DOI 10.1073/pnas.59.1.86; Usobiaga P, 1996, J BIOL CHEM, V271, P6832, DOI 10.1074/jbc.271.12.6832; Varea J, 2004, J BIOL CHEM, V279, P43697, DOI 10.1074/jbc.M407067200; Varea J, 2000, J BIOL CHEM, V275, P26842; VELAZQUEZCAMPOY A, 2004, CURR PROTEIN CELL BI, V23	42	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28618	28628		10.1074/jbc.M802808200	http://dx.doi.org/10.1074/jbc.M802808200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667432	Green Published, hybrid			2022-12-25	WOS:000259969300064
J	Shrivastava, IH; Jiang, J; Amara, SG; Bahar, I				Shrivastava, Indira H.; Jiang, Jie; Amara, Susan G.; Bahar, Ivet			Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; STEERED MOLECULAR-DYNAMICS; NORMAL-MODE ANALYSIS; REENTRANT LOOP; INDIVIDUAL SUBUNITS; POTASSIUM CHANNEL; ALLOSTERIC MODEL; UNBOUND STATE; EAAC1; TRANSLOCATION	Glutamate transporters, also referred to as excitatory amino acid transporters (EAATs), are membrane proteins that regulate glutamatergic signal transmission by clearing excess glutamate after its release at synapses. A structure-based understanding of their molecular mechanisms of function has been elusive until the recent determination of the x-ray structure of an archaeal transporter, Glt(Ph). Glt(Ph) exists as a trimer, with each subunit containing a core region that mediates substrate translocation. In the present study a series of molecular dynamics simulations have been conducted and analyzed in light of new experimental data on substrate binding properties of EAATs. The simulations provide for the first time a full atomic description of the time-resolved events that drive the recognition and binding of substrate. The core region of each subunit exhibits an intrinsic tendency to open the helical hairpin HP2 loop, the extracellular gate, within tens of nanoseconds exposing conserved polar residues that serve as attractors for substrate binding. The NMDGT motif on the partially unwound part of the transmembrane helix TM7 and the residues Asp-390 and Asp-394 on TM8 are also distinguished by their important role in substrate binding and close interaction with mediating water molecules and/or sodium ions. The simulations reveal a Na+ binding site comprised in part of Leu-303 on TM7 and Asp-405 on TM8 and support a role for sodium ions in stabilizing substrate-bound conformers. The functional importance of Leu-303 or its counterpart Leu-391 inhuman EAAT1(hEAAT1) is confirmed by site-directed mutagenesis and Na+ dependence assays conducted with hEAAT1 mutants L391C and L391A.	[Shrivastava, Indira H.; Bahar, Ivet] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15213 USA; [Jiang, Jie; Amara, Susan G.] Univ Pittsburgh, Dept Neurobiol, Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Biomed Sci Tower 3,Rm 3073,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020	Amara, Susan/0000-0001-8914-1106	National Institutes of Health [R33 GM068400, MH080726]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM068400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R33 GM068400 (to I. B.) and MH080726 (to S. G. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Capener CE, 2000, BIOPHYS J, V78, P2929, DOI 10.1016/S0006-3495(00)76833-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	52	80	80	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28680	28690		10.1074/jbc.M800889200	http://dx.doi.org/10.1074/jbc.M800889200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678877	Green Published, hybrid			2022-12-25	WOS:000259969300070
J	Bhatia, B; Jiang, M; Suraneni, M; Patrawala, L; Badeaux, M; Schneider-Broussard, R; Multani, AS; Jeter, CR; Calhoun-Davis, T; Hu, LM; Hu, JH; Tsavachidis, S; Zhang, W; Chang, S; Hayward, SW; Tang, DG				Bhatia, Bobby; Jiang, Ming; Suraneni, Mahipal; Patrawala, Lubna; Badeaux, Mark; Schneider-Broussard, Robin; Multani, Asha S.; Jeter, Collene R.; Calhoun-Davis, Tammy; Hu, Limei; Hu, Jianhua; Tsavachidis, Spiridon; Zhang, Wei; Chang, Sandy; Hayward, Simon W.; Tang, Dean G.			Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CELLULAR SENESCENCE; CANCER-CELLS; 15-LIPOXYGENASE-2 15-LOX2; REPLICATIVE SENESCENCE; DIFFERENTIATION; BENIGN; GROWTH; HYPERPLASIA; POPULATION	Normal human prostate (NHP) epithelial cells undergo senescence in vitro and in vivo, but the underlying molecular mechanisms remain obscure. Here we show that the senescence of primary NHP cells, which are immunophenotyped as intermediate basal-like cells expressing progenitor cell markers CD44, alpha 2 beta 1, p63, hTERT, and CK5/CK18, involves loss of telomerase expression, up-regulation of p16, and activation of p53. Using genetically defined manipulations of these three signaling pathways, we show that p16 is the primary determinant of the NHP cell proliferative capacity and that hTERT is required for unlimited proliferative life span. Hence, suppression of p16 significantly extends NHP cell life span, but both p16 inhibition and hTERT are required to immortalize NHP cells. Importantly, immortalized NHP cells retain expression of most progenitor markers, demonstrate gene expression profiles characteristic of proliferating progenitor cells, and possess multilineage differentiation potential generating functional prostatic glands. Our studies shed important light on the molecular mechanisms regulating the proliferative life span of NHP progenitor cells.	[Bhatia, Bobby; Suraneni, Mahipal; Patrawala, Lubna; Badeaux, Mark; Schneider-Broussard, Robin; Jeter, Collene R.; Calhoun-Davis, Tammy; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; [Jiang, Ming; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN 37232 USA; [Multani, Asha S.; Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Hu, Limei; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hu, Jianhua; Tsavachidis, Spiridon] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, POB 389, Smithville, TX 78957 USA.	dtang@mdanderson.org	Jiang, Ming/F-2060-2011; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Hayward, Simon/0000-0002-6059-6550; Jiang, Ming/0000-0002-1927-5667; Jiang, Ming/0000-0003-3361-9881; Jeter, Collene/0000-0002-9627-4529	National Institutes of Health [R01-AG023374, R01-ES015888, R21-ES015893-01A1]; American Cancer Society [RSG MGO-105961]; Department of Defense [W81XWH-07-1-0616, PC073751]; Prostate Cancer Foundation; Elsa Pardee Foundation; two Center [CCSG-5 P30 CA166672, ES07784]; NATIONAL CANCER INSTITUTE [R01CA166672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, P30ES007784, R01ES015888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Elsa Pardee Foundation; two Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG023374, R01-ES015888, and R21-ES015893-01A1. This work was also supported by American Cancer Society Grant RSG MGO-105961, Department of Defense Grants W81XWH-07-1-0616 and PC073751, the Prostate Cancer Foundation, the Elsa Pardee Foundation (to D. G. T.), and two Center Grants, CCSG-5 P30 CA166672 and ES07784. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bhatia B, 2005, ONCOGENE, V24, P3583, DOI 10.1038/sj.onc.1208406; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Bhatia B, 2008, INT J CANCER, V122, P1483, DOI 10.1002/ijc.23222; Bright RK, 1997, CANCER RES, V57, P995; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Chopra DP, 1996, J CELL PHYSIOL, V169, P269, DOI 10.1002/(SICI)1097-4652(199611)169:2<269::AID-JCP6>3.0.CO;2-M; Collins AT, 2001, J CELL SCI, V114, P3865; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Jarrard DF, 1999, CANCER RES, V59, P2957; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Konishi N, 2002, AM J PATHOL, V160, P1207, DOI 10.1016/S0002-9440(10)62547-3; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Mitchell PJ, 2003, MOL CELL BIOL, V23, P2530, DOI 10.1128/MCB.23.7.2530-2542.2003; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PEEHL DM, 1986, IN VITRO CELL DEV B, V22, P82; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Sandhu C, 2000, CANCER RES, V60, P2616; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Stern M, 1996, AM J PATHOL, V149, P911; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Yasunaga Y, 2001, CANCER RES, V61, P5969; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005	58	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27957	27972		10.1074/jbc.M803467200	http://dx.doi.org/10.1074/jbc.M803467200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662989	Green Published, hybrid			2022-12-25	WOS:000259719200066
J	Galloux, M; Vitrac, H; Montagner, C; Raffestin, S; Popoff, MR; Chenal, A; Forge, V; Gillet, D				Galloux, Marie; Vitrac, Heidi; Montagner, Caroline; Raffestin, Stephanie; Popoff, Michel R.; Chenal, Alexandre; Forge, Vincent; Gillet, Daniel			Membrane interaction of botulinum neurotoxin A translocation (T) domain - The belt region is a regulatory loop for membrane interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN; PROTEIN-RECEPTOR; PORE FORMATION; BINDING; LIGHT; IDENTIFICATION; TETANUS; FUSION; PHASE; STEPS	The translocation of the catalytic domain through the membrane of the endosome to the cell cytoplasm is a key step of intoxication by botulinum neurotoxin (BoNT). This step is mediated by the translocation (T) domain upon endosome acidification, although the mechanism of interaction of the T domain with the membrane is still poorly understood. Using physicochemical approaches and spectroscopic methods, we studied the interaction of the BoNT/A T domain with the membrane as a function of pH. We found that the interaction with membranes does not involve major secondary or tertiary structural changes, as reported for other toxins like diphtheria toxin. The T domain becomes insoluble around its pI value and then penetrates into the membrane. At that stage, the T domain becomes able to permeabilize lipid vesicles. This occurs for pH values lower than 5.5, in agreement with the pH encountered by the toxin within endosomes. Electrostatic interactions are also important for the process. The role of the so-called belt region was investigated with four variant proteins presenting different lengths of the N-extremity of the T domain. We observed that this part of the T domain, which contains numerous negatively charged residues, limits the protein-membrane interaction. Indeed, interaction with the membrane of the protein deleted of this extremity takes place for higher pH values than for the entire T domain. Overall, the data suggest that acidification eliminates repulsive electrostatic interactions between the T domain and the membrane, allowing its penetration into the membrane without triggering detectable structural changes.	[Forge, Vincent] CEA, iRTSV, LCBM, UMR CNRS UJF 5249, F-38054 Grenoble, France; [Galloux, Marie; Raffestin, Stephanie; Gillet, Daniel] CEA, Inst Biol & Technol Saclay, SIMOPRO, F-91191 Gif Sur Yvette, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Chenal, Alexandre] Dept Biol Struct & Chim, URA CNRS 2185, Unite Biochim Interact Mol, F-75724 Paris 15, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Forge, V (corresponding author), CEA, iRTSV, LCBM, UMR CNRS UJF 5249, F-38054 Grenoble, France.	vincent.forge@cea.fr; daniel.gillet@cea.fr	Chenal, Alexandre/C-2240-2009; Gillet, Daniel/C-5592-2008; Vitrac, Heidi/R-7117-2018	Chenal, Alexandre/0000-0002-4959-1003; Gillet, Daniel/0000-0003-0477-3599; Vitrac, Heidi/0000-0002-8858-4914				Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BINZ T, 1990, J BIOL CHEM, V265, P9153; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cai SW, 2001, BIOCHEMISTRY-US, V40, P15327, DOI 10.1021/bi011350g; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; Couesnon A, 2006, MICROBIOL-SGM, V152, P759, DOI 10.1099/mic.0.28561-0; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Nizard P, 1998, FEBS LETT, V433, P83, DOI 10.1016/S0014-5793(98)00890-4; Oh KJ, 1999, P NATL ACAD SCI USA, V96, P8467, DOI 10.1073/pnas.96.15.8467; Parikh S, 2007, PROTEIN J, V26, P19, DOI 10.1007/s10930-006-9040-5; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; RIGAUD JL, 1983, BIOCHEM BIOPH RES CO, V111, P373, DOI 10.1016/0006-291X(83)90316-9; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	36	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27668	27676		10.1074/jbc.M802557200	http://dx.doi.org/10.1074/jbc.M802557200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693250	hybrid			2022-12-25	WOS:000259719200038
J	Mylonis, I; Chachami, G; Paraskeva, E; Simos, G				Mylonis, Ilias; Chachami, Georgia; Paraskeva, Efrosyni; Simos, George			Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1 alpha by MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; HIF HYDROXYLASES; HIF-1-ALPHA; OXYGEN; PHOSPHORYLATION; LOCALIZATION; RECEPTOR; ACCUMULATION; DEGRADATION	Hypoxia-inducible factor 1 (HIF-1) is the key transcriptional activator of hypoxia-inducible genes and an important anti-cancer target. Its regulated subunit, HIF-1 alpha, is controlled by oxygen levels and major signaling pathways. We reported previously that phosphorylation of Ser(641/643) by p42/44 MAPK is essential for HIF-1 alpha nuclear accumulation and activity. We now show that a fragment of HIF-1 alpha (amino acids 616-658), termed MAPK target domain, contains a nuclear export signal (NES), which has atypical hydrophobic residue spacing. Localization, reporter gene, and co-immunoprecipitation assays demonstrate that the identified NES interacts with CRM1 in a phosphorylation-sensitive manner. Furthermore, disruption of the NES (I637A/L638A/I639A) restores nuclear localization and activity of nonphosphorylated HIF-1 alpha and renders it largely resistant to inhibition of MAPK, an effect reproduced by a phosphomimetic mutation (S641E). As these data predict, overexpression of wildtype or mutant (S641A/S643A) MAPK target domain in HeLa cells modulates the activity and subcellular distribution of endogenous HIF-1 alpha. Wesuggest that control of HIF-1 alpha nuclear transport represents an important MAPK-dependent regulatory mechanism.	[Mylonis, Ilias; Chachami, Georgia; Simos, George] Univ Thessaly, Dept Med, Biochem Lab, Mezourlo 41110, Larissa, Greece; [Mylonis, Ilias; Chachami, Georgia; Paraskeva, Efrosyni; Simos, George] Inst Biomed Res & Technol BIOMED, Mezourlo 41110, Larissa, Greece	University of Thessaly	Simos, G (corresponding author), Univ Thessaly, Dept Med, Biochem Lab, POB 1400, Mezourlo 41110, Larissa, Greece.	simos@med.uth.gr	Paraskeva, Efrosyni/E-6449-2015; Simos, George/AAH-2596-2021	Paraskeva, Efrosyni/0000-0002-1312-0322; Simos, George/0000-0001-5453-3185; Mylonis, Ilias/0000-0002-0893-6618; Chachami, Georgia/0000-0002-4771-4196	European Social Fund and National Resources; EPEAEK II-PYTHAGORAS; Greek Ministry of National Education and Religious Affairs	European Social Fund and National Resources(European Social Fund (ESF)); EPEAEK II-PYTHAGORAS; Greek Ministry of National Education and Religious Affairs	This work was supported in part by a grant co-funded by the European Social Fund and National Resources, EPEAEK II-PYTHAGORAS, from the Greek Ministry of National Education and Religious Affairs (to G. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; Chachami G, 2005, BIOCHEM BIOPH RES CO, V331, P464, DOI 10.1016/j.bbrc.2005.03.193; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kietzmann T, 2005, SEMIN CELL DEV BIOL, V16, P474, DOI 10.1016/j.semcdb.2005.03.010; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Lyberopoulou A, 2007, CELL PHYSIOL BIOCHEM, V20, P995, DOI 10.1159/000110460; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Triantafyllou A, 2008, FREE RADICAL BIO MED, V44, P657, DOI 10.1016/j.freeradbiomed.2007.10.050; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	31	73	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27620	27627		10.1074/jbc.M803081200	http://dx.doi.org/10.1074/jbc.M803081200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687685	hybrid			2022-12-25	WOS:000259719200033
J	Randhawa, VK; Ishikura, S; Talior-Volodarsky, I; Cheng, AWP; Patel, N; Hartwig, JH; Klip, A				Randhawa, Varinder K.; Ishikura, Shuhei; Talior-Volodarsky, Ilana; Cheng, Alex W. P.; Patel, Nish; Hartwig, John H.; Klip, Amira			GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; INSULIN-STIMULATED PHOSPHORYLATION; PLASMA-MEMBRANE; GLUCOSE-UPTAKE; SKELETAL-MUSCLE; L6 MYOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; CORTICAL ACTIN; ADIPOSE-CELLS	Insulin increases glucose uptake into muscle by enhancing the surface recycling of GLUT4 transporters. In myoblasts, insulin signals bifurcate downstream of phosphatidylinositol 3-kinase into separate Akt and Rac/actin arms. Akt-mediated Rab-GAP AS160 phosphorylation and Rac/actin are required for net insulin gain of GLUT4, but the specific steps (vesicle recruitment, docking or fusion) regulated by Rac, actin dynamics, and AS160 target Rab8A are unknown. In L6 myoblasts expressing GLUT4myc, blocking vesicle fusion by tetanus toxin cleavage of VAMP2 impeded GLUT4myc membrane insertion without diminishing its build-up at the cell periphery. Conversely, actin disruption by dominant negative Rac or Latrunculin B abolished insulin-induced surface and submembrane GLUT4myc accumulation. Expression of non-phosphorylatable AS160 (AS1604P) abrogated membrane insertion of GLUT4myc and partially reduced its cortical build-up, an effect magnified by selective Rab8A knockdown. We propose that insulin-induced actin dynamics participates in GLUT4myc vesicle retention beneath the membrane, whereas AS160 phosphorylation is essential for GLUT4myc vesicle-membrane docking/fusion and also contributes to GLUT4myc cortical availability through Rab8A.	[Randhawa, Varinder K.; Ishikura, Shuhei; Talior-Volodarsky, Ilana; Cheng, Alex W. P.; Patel, Nish; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Randhawa, Varinder K.; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Hartwig, John H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by Grant MOP-7307 (to A. K.) from the Canadian Institutes of Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; ANTONESCU CN, 2008, DISSECTING GLUT 4 TR; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Chabrillat ML, 2005, MOL BIOL CELL, V16, P1640, DOI 10.1091/mbc.e04-09-0770; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; ISHIKAWA H, 1969, J CELL BIOL, V43, P312; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kaddai V, 2008, ACTA PHYSIOL, V192, P75, DOI 10.1111/j.1748-1716.2007.01787.x; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; KARNIELI E, 1993, ENDOCRINOLOGY, V133, P2943, DOI 10.1210/en.133.6.2943; Khayat ZA, 2000, J CELL SCI, V113, P279; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lang Thorsten, 2008, V184, P107; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Oatey PB, 1997, BIOCHEM J, V327, P637; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Patel N, 2006, PFLUG ARCH EUR J PHY, V451, P499, DOI 10.1007/s00424-005-1475-6; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Regazzi R, 1996, EMBO J, V15, P6951, DOI 10.1002/j.1460-2075.1996.tb01087.x; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Sweeney G, 2004, J BIOL CHEM, V279, P32233, DOI 10.1074/jbc.M402897200; TALIORVOLODARSK.I, 2008, J BIOL CHEM     0710; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	70	91	94	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27208	27219		10.1074/jbc.M804282200	http://dx.doi.org/10.1074/jbc.M804282200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650435	hybrid			2022-12-25	WOS:000259586600041
J	Wei, S; Yang, HC; Chuang, HC; Yang, J; Kulp, SK; Lu, PJ; Lai, MD; Chen, CS				Wei, Shuo; Yang, Hsiao-Ching; Chuang, Hsiao-Ching; Yang, Jian; Kulp, Samuel K.; Lu, Pei-Jung; Lai, Ming-Derg; Chen, Ching-Shih			A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; KAPPA-B; DEPENDENT UBIQUITINATION; TRANSFORMED PHENOTYPE; INHIBITS GROWTH; SOMATIC WEE1; PHOSPHORYLATION; ANTISENSE; EXPRESSION; KINASE	This study identifies a novel mechanism by which thiazolidinediones mediate cyclin D1 repression in prostate cancer cells. Based on the finding that the thiazolidinedione family of peroxisome proliferator-activated receptor gamma(PPAR gamma) agonists mediatedPPAR gamma-independent cyclin D1 degradation, we developed a novel PPAR gamma-inactive troglitazone derivative, STG28, with high potency in cyclin D1 ablation. STG28-mediated cyclin D1 degradation was preceded by Thr-286 phosphorylation and nuclear export, which however, were independent of glycogen synthase kinase 3 beta. Mutational analysis further confirmed the pivotal role of Thr-286 phosphorylation in STG28-induced nuclear export and proteolysis. Of several kinases examined, inhibition of I kappa B kinase alpha blocked STG28-mediated cytoplasmic sequestration and degradation of cyclin D1. Pulldown of ectopically expressed Cul1, the scaffold protein of the Skp-Cullin-F- box E3 ligase, in STG28-treated cells revealed an increased association of cyclin D1 with beta-TrCP, whereas no specific binding was noted with other F-box proteins examined, including Skp2, Fbw7, Fbx4, and Fbxw8. This finding represents the first evidence that cyclin D1 is targeted by beta-TrCP. Moreover, beta-TrCP expression was up-regulated in response to STG28, and ectopic expression and small interfering RNA-mediated knockdown of beta-TrCP enhanced and protected against STG28-facilitated cyclin D1 degradation, respectively. Because cyclin D1 lacks the DSG destruction motif, mutational and modeling analyses indicate that cyclin D1 was targeted by beta-TrCP through an unconventional recognition site, (279)EEVDLACpT(286), reminiscent to that of Wee1. Moreover, we obtained evidence that this beta-TrCP-dependent degradation takes part in controlling cyclin D1 turnover when cancer cells undergo glucose starvation, which endows physiological relevance to this novel mechanism.	[Wei, Shuo; Chuang, Hsiao-Ching; Yang, Jian; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Yang, Hsiao-Ching] Fu Jen Catholic Univ, Dept Chem, Taipei 24205, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Tainan 704, Taiwan; [Lai, Ming-Derg] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 704, Taiwan	University System of Ohio; Ohio State University; Fu Jen Catholic University; National Cheng Kung University; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Yang, Jian/B-9451-2012; Lai, Ming-Derg/M-8028-2014	Yang, Hsiao-Ching/0000-0002-7970-1357	National Institutes of Health Public Health Service [CA112250]; Ohio State University Medical Center; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Ohio State University Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA112250 (NCI). This work was also supported by the Lucius A. Wing Endowed Chair Fund from The Ohio State University Medical Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-8; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arber N, 1997, CANCER RES, V57, P1569; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen B, 1999, WORLD J GASTROENTERO, V5, P18; Chung DC, 2004, ANN NY ACAD SCI, V1014, P209, DOI 10.1196/annals.1294.022; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Huang JW, 2006, J MED CHEM, V49, P4684, DOI 10.1021/jm060057h; Huang JW, 2005, MOL PHARMACOL, V67, P1342, DOI 10.1124/mol.104.007732; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Kwak YT, 2005, J BIOL CHEM, V280, P33945, DOI 10.1074/jbc.M506206200; Langenfeld J, 1997, P NATL ACAD SCI USA, V94, P12070, DOI 10.1073/pnas.94.22.12070; Lapillonne H, 2003, CANCER RES, V63, P5926; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Qin CH, 2004, MOL CANCER THER, V3, P247; Qin CH, 2003, CANCER RES, V63, P958; Sauter ER, 2002, CANCER RES, V62, P3200; Sauter ER, 2000, CLIN CANCER RES, V6, P654; Schrump DS, 1996, CANCER GENE THER, V3, P131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Wang CG, 2001, MOL CELL BIOL, V21, P3057, DOI 10.1128/MCB.21.9.3057-3070.2001; Wang Chenguang, 2004, Cancer Treat Res, V119, P217; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wei S, 2007, MOL PHARMACOL, V72, P725, DOI 10.1124/mol.107.035287; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang CC, 2007, CANCER RES, V67, P3229, DOI 10.1158/0008-5472.CAN-06-2759; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; ZHOU P, 1995, ONCOGENE, V11, P571	45	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26759	26770		10.1074/jbc.M802160200	http://dx.doi.org/10.1074/jbc.M802160200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650423	Green Published, hybrid			2022-12-25	WOS:000259341600048
J	Giles, TN; Graham, DE				Giles, Teresa N.; Graham, David E.			Crenarchaeal arginine decarboxylase evolved from an S-adenosylmethionine decarboxylase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION-MASS SPECTROMETRY; COVALENTLY BOUND PYRUVATE; METHANOCOCCUS-JANNASCHII; POLYAMINE BIOSYNTHESIS; EXTREME THERMOPHILE; ESCHERICHIA-COLI; SULFOLOBUS-SOLFATARICUS; CALDARIELLA-ACIDOPHILA; THERMUS-THERMOPHILUS; AMINO-ACIDS	The crenarchaeon Sulfolobus solfataricus uses arginine to produce putrescine for polyamine biosynthesis. However, genome sequences from S. solfataricus and most crenarchaea have no known homologs of the previously characterized pyridoxal 5'-phosphate or pyruvoyl-dependent arginine decarboxylases that catalyze the first step in this pathway. Instead they have two paralogs of the S-adenosylmethionine decarboxylase (AdoMetDC). The gene at locus SSO0585 produces an AdoMetDC enzyme, whereas the gene at locus SSO0536 produces a novel arginine decarboxylase (ArgDC). Both thermostable enzymes self-cleave at conserved serine residues to form amino-terminal beta-domains and carboxyl-terminal alpha-domains with reactive pyruvoyl cofactors. The ArgDC enzyme specifically catalyzed arginine decarboxylation more efficiently than previously studied pyruvoyl enzymes. alpha-Difluoromethylarginine significantly reduced the ArgDC activity of purified enzyme, and treating growing S. solfataricus cells with this inhibitor reduced the cells' ratio of spermidine to norspermine by decreasing the putrescine pool. The crenarchaeal ArgDC had no AdoMetDC activity, whereas its AdoMetDC paralog had no ArgDC activity. A chimeric protein containing the beta-subunit of SSO0536 and the alpha-subunit of SSO0585 had ArgDC activity, implicating residues responsible for substrate specificity in the amino-terminal domain. This crenarchaeal ArgDC is the first example of alternative substrate specificity in the AdoMetDC family. ArgDC activity has evolved through convergent evolution at least five times, demonstrating the utility of this enzyme and the plasticity of amino acid decarboxylases.	[Giles, Teresa N.; Graham, David E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Giles, Teresa N.; Graham, David E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Graham, DE (corresponding author), 1 Univ Stn A5300, Austin, TX 78712 USA.	degraham@mail.utexas.edu	Graham, David E/F-8578-2010	Graham, David E/0000-0001-8968-7344	National Institutes of Health; NIAID; Public Health Service [AI064444]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant, NIAID, Public Health Service Grant AI064444. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson AF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r99; BEY P, 1979, J ORG CHEM, V44, P2732, DOI 10.1021/jo01329a029; BLETHEN SL, 1968, J BIOL CHEM, V243, P1671; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; CACCIAPUOTI G, 1986, EUR J BIOCHEM, V161, P263, DOI 10.1111/j.1432-1033.1986.tb10442.x; CACCIAPUOTI G, 1991, EUR J BIOCHEM, V199, P395, DOI 10.1111/j.1432-1033.1991.tb16136.x; Cacciapuoti G, 2007, J BACTERIOL, V189, P6057, DOI 10.1128/JB.00151-07; DEROSA M, 1976, BIOCHEM BIOPH RES CO, V69, P253, DOI 10.1016/S0006-291X(76)80300-2; DEROSA M, 1978, BIOCHEM J, V176, P1; Gaboriau F, 2003, ANAL BIOCHEM, V318, P212, DOI 10.1016/S0003-2697(03)00214-8; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Goda S, 2005, BBA-PROTEINS PROTEOM, V1748, P110, DOI 10.1016/j.bbapap.2004.12.010; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Graham DE, 2000, J BIOL CHEM, V275, P4055, DOI 10.1074/jbc.275.6.4055; HAMANA K, 1994, MICROBIOS, V79, P109; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kezmarsky ND, 2005, BBA-GEN SUBJECTS, V1722, P175, DOI 10.1016/j.bbagen.2004.12.003; Kim AD, 2000, J BACTERIOL, V182, P6667, DOI 10.1128/JB.182.23.6667-6672.2000; Lord PW, 2002, BIOINFORMATICS, V18, P1402, DOI 10.1093/bioinformatics/18.10.1402; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; NICOLAUS B, 1988, SYST APPL MICROBIOL, V10, P215, DOI 10.1016/S0723-2020(88)80003-1; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohnuma M, 2005, J BIOL CHEM, V280, P30073, DOI 10.1074/jbc.M413332200; POULIN R, 1992, J BIOL CHEM, V267, P150; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; RILEY WD, 1968, BIOCHEMISTRY-US, V7, P3520, DOI 10.1021/bi00850a029; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; SHIPE JR, 1979, CLIN CHEM, V25, P1564; Snider MJ, 2000, J AM CHEM SOC, V122, P11507, DOI 10.1021/ja002851c; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Tolbert WD, 2001, BIOCHEMISTRY-US, V40, P9484, DOI 10.1021/bi010735w; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; WU WH, 1973, J BIOL CHEM, V248, P1687; Zabinski RF, 2001, J AM CHEM SOC, V123, P193, DOI 10.1021/ja0026354	41	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25829	25838		10.1074/jbc.M802674200	http://dx.doi.org/10.1074/jbc.M802674200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650422	Green Published, hybrid			2022-12-25	WOS:000259200100009
J	Wang, L; Gao, J; Dai, W; Lu, L				Wang, Ling; Gao, Jie; Dai, Wei; Lu, Luo			Activation of polo-like kinase 3 by hypoxic stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL EPITHELIAL-CELLS; POLO-LIKE KINASE; C-JUN; INDUCIBLE FACTOR; SERINE/THREONINE KINASE; DOWN-REGULATION; CYCLE ARREST; DNA-DAMAGE; BOX DOMAIN; KAPPA-B	Hypoxia/reoxygenation stress induces the activation of specific signaling proteins and activator protein 1 (AP-1) to regulate cell cycle regression and apoptosis. In the present study, we report that hypoxia/reoxygenation stress activates AP-1 by increasing c-Jun phosphorylation and DNA binding activity through activation of Polo-like-kinase 3 (Plk3) resulting in apoptosis. The specific effect of hypoxia/reoxygenation stress on Plk3 activation resulting in c-Jun phosphorylation was the opposite of UV irradiation-induced responses that are meanly independent on activation of the stress-induced JNK signaling pathway in human corneal epithelial (HCE) cells. The effect of hypoxia/reoxygenation stress-induced Plk3 activation on increased c-Jun phosphorylation and apoptosis was also mimicked by exposure of cells to CoCl2. Hypoxia/reoxygenation activated Plk3 in HCE cells to directly phosphorylate c-Jun proteins at phosphorylation sites Ser-63 and Ser-73, and to increase DNA binding activity of c-Jun, detected by EMSA. Further evidence demonstrated that Plk3 and phospho-c-Jun were immunocolocalized in the nuclear compartment of hypoxia/reoxygenation stress-induced cells. Increased Plk3 activity by overexpression of wild-type and dominantly positive Plk3 enhanced the effect of hypoxia/reoxygenation on c-Jun phosphorylation and cell death. In contrast, knocking-down Plk3 mRNA suppressed hypoxia-induced c-Jun phosphorylation. Our results provide a new mechanism indicating that hypoxia/reoxygenation induces Plk3 activation instead of the JNK effect to directly phosphorylate and activate c-Jun, subsequently contributing to apoptosis in HCE cells.	[Wang, Ling; Gao, Jie; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] New York Univ, Sch Med, Dept Environm Med, New York, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,C-2, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY12953, CA074229]; NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY12953 (to L. L.) and CA074229 (to W. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS PJ, 1995, MUTAT RES-DNA REPAIR, V336, P169, DOI 10.1016/0921-8777(94)00049-C; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Conn CW, 2000, CANCER RES, V60, P6826; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Li W, 2001, TRANSPLANTATION, V72, P1423, DOI 10.1097/00007890-200110270-00016; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nishi H, 2002, CANCER RES, V62, P827; Ruan YW, 2003, BRAIN RES, V982, P228, DOI 10.1016/S0006-8993(03)03021-X; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singh N, 2005, INVEST OPHTH VIS SCI, V46, P1647, DOI 10.1167/iovs.04-1172; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Smirnova IS, 2001, CELL BIOL INT, V25, P1101, DOI 10.1006/cbir.2001.0709; Wang L, 1999, J BIOL CHEM, V274, P3678, DOI 10.1074/jbc.274.6.3678; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	43	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25928	25935		10.1074/jbc.M801326200	http://dx.doi.org/10.1074/jbc.M801326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650425	Green Published, hybrid			2022-12-25	WOS:000259200100020
J	He, F; Wu, DD; Kong, QP; Zhang, YP				He, Fang; Wu, Dong-Dong; Kong, Qing-Peng; Zhang, Ya-Ping			Intriguing Balancing Selection on the Intron 5 Region of LMBR1 in Human Population	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE ANALYSES; RANGE SHH ENHANCER; MOLECULAR EVOLUTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; TRIPHALANGEAL THUMB; STATISTICAL-METHOD; SONIC-HEDGEHOG; HUMAN GENOME; GENE	Background: The intron 5 of gene LMBR1 is the cis-acting regulatory module for the sonic hedgehog (SHH) gene. Mutation in this non-coding region is associated with preaxial polydactyly, and may play crucial roles in the evolution of limb and skeletal system. Methodology/Principal Findings: We sequenced a region of the LMBR1 gene intron 5 in East Asian human population, and found a significant deviation of Tajima's D statistics from neutrality taking human population growth into account. Data from HapMap also demonstrated extended linkage disequilibrium in the region in East Asian and European population, and significantly low degree of genetic differentiation among human populations. Conclusion/Significance: We proposed that the intron 5 of LMBR1 was presumably subject to balancing selection during the evolution of modern human.	[He, Fang; Wu, Dong-Dong; Kong, Qing-Peng; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Ya-Ping] Yunnan Univ, Laboratory for Conservat & Utilizat Bio Resource, Kunming, Peoples R China; [He, Fang; Wu, Dong-Dong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, F (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp1@263.net.cn	Wu, Dong-Dong/AAR-5615-2020		Key State Research Program of China [2006CB943900]; Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China	Key State Research Program of China; Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key State Research Program of China (2006CB943900), Science and Technology Committee of Yunnan Province and the National Natural Science Foundation of China.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allerston CK, 2007, PHARMACOGENET GENOM, V17, P827, DOI 10.1097/FPC.0b013e328256b198; Armelagos GJ, 2005, EVOL ANTHROPOL, V14, P68, DOI 10.1002/evan.20047; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Clark RM, 2001, GENETICS, V159, P715; Dorus S, 2006, HUM MOL GENET, V15, P2031, DOI 10.1093/hmg/ddl123; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2005, ANN HUM GENET, V69, P389, DOI 10.1046/j.1529-8817.2005.00163.x; Grigorova M, 2007, ANN HUM GENET, V71, P18, DOI 10.1111/j.1469-1809.2006.00299.x; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Koda Y, 2003, HUM GENET, V113, P534, DOI 10.1007/s00439-003-1013-6; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; LEWONTIN RC, 1964, GENETICS, V49, P49; Nakajima T, 2005, GENES IMMUN, V6, P398, DOI 10.1038/sj.gene.6364215; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Soejima M, 2005, ANN HUM GENET, V69, P239, DOI 10.1046/j.1529-8817.2005.00165.x; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wooding S, 2002, GENETICS, V161, P1641	41	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2948	10.1371/journal.pone.0002948	http://dx.doi.org/10.1371/journal.pone.0002948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698406	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600034
J	Hoffmann, M; Chang, HH; Huang, S; Ingber, DE; Loeffler, M; Galle, J				Hoffmann, Martin; Chang, Hannah H.; Huang, Sui; Ingber, Donald E.; Loeffler, Markus; Galle, Joerg			Noise-Driven Stem Cell and Progenitor Population Dynamics	PLOS ONE			English	Article								Background: The balance between maintenance of the stem cell state and terminal differentiation is influenced by the cellular environment. The switching between these states has long been understood as a transition between attractor states of a molecular network. Herein, stochastic fluctuations are either suppressed or can trigger the transition, but they do not actually determine the attractor states. Methodology/Principal Findings: We present a novel mathematical concept in which stem cell and progenitor population dynamics are described as a probabilistic process that arises from cell proliferation and small fluctuations in the state of differentiation. These state fluctuations reflect random transitions between different activation patterns of the underlying regulatory network. Importantly, the associated noise amplitudes are state-dependent and set by the environment. Their variability determines the attractor states, and thus actually governs population dynamics. This model quantitatively reproduces the observed dynamics of differentiation and dedifferentiation in promyelocytic precursor cells. Conclusions/Significance: Consequently, state-specific noise modulation by external signals can be instrumental in controlling stem cell and progenitor population dynamics. We propose follow-up experiments for quantifying the imprinting influence of the environment on cellular noise regulation.	[Hoffmann, Martin; Galle, Joerg] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Chang, Hannah H.; Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Pathol & Surg, Vasc Biol Program, Boston, MA USA; [Chang, Hannah H.] Harvard Univ, Program Biophys, Boston, MA USA; [Chang, Hannah H.] Harvard Med Sch, MD PhD Program, Boston, MA USA; [Huang, Sui] Univ Calgary, Inst Biocomplexity & Informat, Calgary, AB, Canada; [Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Leipzig University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; University of Calgary; Leipzig University	Hoffmann, M (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.	hoffmann@izbi.uni-leipzig.de	Ingber, Donald E/AAC-5894-2019		German Research Foundation [AU 132/3-1, BIZ-6 1/1]; Federal Ministry of Education and Research of Germany [0313836]; Air Force Office of Scientific Research [F49550-05-1-0078]; National Institutes of Health (NIH) [R21CA123284, CA55833]; DoD Breast Cancer Innovator Award; Harvard University [Ashford Fellowship]; NATIONAL CANCER INSTITUTE [R21CA123284, R01CA055833] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Breast Cancer Innovator Award(United States Department of Defense); Harvard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a joint grant from the German Research Foundation (DFG; AU 132/3-1, IZBI). MH was supported by the Federal Ministry of Education and Research of Germany through grant 0313836 (MS CartPro). JG was supported by DFG-grant BIZ-6 1/1. SH was supported by grant F49550-05-1-0078 from the Air Force Office of Scientific Research and grant R21CA123284 from the National Institutes of Health (NIH). DEI was supported by NIH grant CA55833 and a DoD Breast Cancer Innovator Award. HHC was supported by the Presidential Scholarship and the Ashford Fellowship of Harvard University.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ao P, 2007, COMPLEXITY, V12, P19, DOI 10.1002/cplx.20171; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Brown G, 2002, EXP CELL RES, V281, P28, DOI 10.1006/excr.2002.5654; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Drayson MT, 2001, EXP CELL RES, V266, P126, DOI 10.1006/excr.2001.5200; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gibbs JD, 2007, CELL CYCLE, V6, P1205, DOI 10.4161/cc.6.10.4258; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; GOSH K, 2007, MICROMECHANICAL CONT; GOSH K, 2007, ADV DRUG DELIV REV; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kitajima K, 2001, BIOCHEM BIOPH RES CO, V288, P1182, DOI 10.1006/bbrc.2001.5892; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leon K, 2004, J THEOR BIOL, V229, P455, DOI 10.1016/j.jtbi.2004.04.011; Loeffler M, 2004, CURR OPIN HEMATOL, V11, P81, DOI 10.1097/01.moh.0000133648.83991.af; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Press W. H., 1992, ART SCI COMPUTING; Quesenberry PJ, 2005, STEM CELL REV, V1, P29, DOI 10.1385/SCR:1:1:029; Rando OJ, 2006, DEV CELL, V11, P134, DOI 10.1016/j.devcel.2006.07.012; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Roeder I, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/84656; Roeder I, 2006, STEM CELL REV, V2, P171, DOI 10.1007/s12015-006-0045-4; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tabaka M, 2008, J MOL BIOL, V377, P1002, DOI 10.1016/j.jmb.2008.01.060; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; van Kampen N., 2004, STOCHASTIC PROCESSES; Viswanathan S, 2005, BIOTECHNOL APPL BIOC, V42, P119, DOI 10.1042/BA20040207; Waddington C.H., 1956, PRINCIPLES EMBRYOLOG; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zwaka TP, 2006, CELL, V127, P1301, DOI 10.1016/j.cell.2006.12.011	65	81	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2922	10.1371/journal.pone.0002922	http://dx.doi.org/10.1371/journal.pone.0002922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698344	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600008
J	Pamonsinlapatham, P; Hadj-Slimane, R; Raynaud, F; Bickle, M; Corneloup, C; Barthelaix, A; Lepelletier, Y; Mercier, P; Schapira, M; Samson, J; Mathieu, AL; Hugo, N; Moncorge, O; Mikaelian, I; Dufour, S; Garbay, C; Colas, P				Pamonsinlapatham, Perayot; Hadj-Slimane, Reda; Raynaud, Francoise; Bickle, Marc; Corneloup, Claudine; Barthelaix, Audrey; Lepelletier, Yves; Mercier, Perrine; Schapira, Matthieu; Samson, Jerome; Mathieu, Anne-Laure; Hugo, Nicolas; Moncorge, Olivier; Mikaelian, Ivan; Dufour, Sylvie; Garbay, Christiane; Colas, Pierre			A RasGAP SH3 Peptide Aptamer Inhibits RasGAP-Aurora Interaction and Induces Caspase-Independent Tumor Cell Death	PLOS ONE			English	Article								The Ras GTPase-activating protein RasGAP catalyzes the conversion of active GTP-bound Ras into inactive GDP-bound Ras. However, RasGAP also acts as a positive effector of Ras and exerts an anti-apoptotic activity that is independent of its GAP function and that involves its SH3 (Src homology) domain. We used a combinatorial peptide aptamer approach to select a collection of RasGAP SH3 specific ligands. We mapped the peptide aptamer binding sites by performing yeast two-hybrid mating assays against a panel of RasGAP SH3 mutants. We examined the biological activity of a peptide aptamer targeting a pocket delineated by residues D295/7, L313 and W317. This aptamer shows a caspase-independent cytotoxic activity on tumor cell lines. It disrupts the interaction between RasGAP and Aurora B kinase. This work identifies the above-mentioned pocket as an interesting therapeutic target to pursue and points its cognate peptide aptamer as a promising guide to discover RasGAP small-molecule drug candidates.	[Pamonsinlapatham, Perayot; Hadj-Slimane, Reda; Raynaud, Francoise; Samson, Jerome; Garbay, Christiane] Univ Paris 05, UFR Biomed, INSERM, Lab Pharmacochim Mol & Cellulaire,U648, Paris, France; [Bickle, Marc; Corneloup, Claudine; Barthelaix, Audrey; Mercier, Perrine; Schapira, Matthieu; Mathieu, Anne-Laure; Hugo, Nicolas; Moncorge, Olivier; Mikaelian, Ivan; Colas, Pierre] Aptanomics, Lyon, France; [Lepelletier, Yves] Univ Paris 05, Hop Necker, CNRS, UMR 8147, Paris, France; [Dufour, Sylvie] Inst Curie, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Pamonsinlapatham, P (corresponding author), Univ Paris 05, UFR Biomed, INSERM, Lab Pharmacochim Mol & Cellulaire,U648, Paris, France.	christiane.garbay@univ-paris5.fr	Moncorge, Olivier/E-3233-2017; DUFOUR, Sylvie/G-2253-2019; lepelletier, yves/AAF-1546-2020	Moncorge, Olivier/0000-0003-0512-1824; lepelletier, yves/0000-0001-7746-5170; Dufour, Sylvie/0000-0002-6663-0676; Colas, Pierre/0000-0001-7436-3718; Mathieu, Anne-Laure/0000-0002-2893-7001	French Ministry of Research [02L0521]; "Ligue Nationale Contre le Cancer", Equipe Labellisee	French Ministry of Research(Ministry of Research, FranceEuropean Commission); "Ligue Nationale Contre le Cancer", Equipe Labellisee(Ligue nationale contre le cancer)	This work was funded by the French Ministry of Research (AC2002 "Molecules et cibles therapeutiques" -n 02L0521). INSERM U648 is supported by the "Ligue Nationale Contre le Cancer", Equipe Labellisee 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed N, 2007, MOL CELL PROTEOMICS, V6, P2110, DOI 10.1074/mcp.M700105-MCP200; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goto S, 2002, J TURBUL, V3; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hoppe-Seyler F, 2004, CURR MOL MED, V4, P529, DOI 10.2174/1566524043360519; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Leblanc V, 1999, ONCOGENE, V18, P4884, DOI 10.1038/sj.onc.1202855; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Parker F, 1996, MOL CELL BIOL, V16, P2561; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tomai E, 2006, J BIOL CHEM, V281, P21345, DOI 10.1074/jbc.M604258200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x	25	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2902	10.1371/journal.pone.0002902	http://dx.doi.org/10.1371/journal.pone.0002902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682833	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600058
J	Dani, FR; Francese, S; Mastrobuoni, G; Felicioli, A; Caputo, B; Simard, F; Pieraccini, G; Moneti, G; Coluzzi, M; della Torre, A; Turillazzi, S				Dani, Francesca R.; Francese, Simona; Mastrobuoni, Guido; Felicioli, Antonio; Caputo, Beniamino; Simard, Frederic; Pieraccini, Giuseppe; Moneti, Gloriano; Coluzzi, Mario; della Torre, Alessandra; Turillazzi, Stefano			Exploring Proteins in Anopheles gambiae Male and Female Antennae through MALDI Mass Spectrometry Profiling	PLOS ONE			English	Article								MALDI profiling and imaging mass spectrometry (IMS) are novel techniques for direct analysis of peptides and small proteins in biological tissues. In this work we applied them to the study of Anopheles gambiae antennae, with the aim of analysing expression of soluble proteins involved in olfaction perireceptor events. MALDI spectra obtained by direct profiling on single antennae and by the analysis of extracts, showed similar profiles, although spectra obtained through profiling had a richer ion population and higher signal to noise ratio. Male and female antennae showed distinct protein profiles. MALDI imaging experiments were also performed and differences were observed in the localization of some proteins. Two proteins were identified through high resolution measurement and top-down MS/MS experiments. A 8 kDa protein only present in the male antennae matched with an unannotated sequence of the An. gambiae genome, while the presence of odorant binding protein 9 (OBP-9) was confirmed through experiments of 2-DE, followed by MS and MS/MS analysis of digested spots. This work shows that MALDI MS profiling is a technique suitable for the analysis of proteins of small and medium MW in insect appendices, and allows obtaining data for several specimens which can be investigated for differences between groups. Proteins of interest can be identified through other complementary MS approaches.	[Dani, Francesca R.; Francese, Simona; Mastrobuoni, Guido; Pieraccini, Giuseppe; Moneti, Gloriano; Turillazzi, Stefano] Univ Florence, Ctr Interdipartimentale Spettrometria Massa, Florence, Italy; [Felicioli, Antonio] Univ Pisa, Dipartimento Anatom, Biochim Fisiol Vet, Pisa, Italy; [Caputo, Beniamino; Coluzzi, Mario; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sezione Parassitol, Rome, Italy; [Simard, Frederic] Inst Rech Dev, Montpellier, France; [Simard, Frederic] Org Coordinat Lutte Endemies Afrique, Yaounde, Cameroon	University of Florence; University of Pisa; Sapienza University Rome; Institut de Recherche pour le Developpement (IRD)	Dani, FR (corresponding author), Univ Florence, Ctr Interdipartimentale Spettrometria Massa, Florence, Italy.	francescaromana.dani@unifi.it	Caputo, Beniamino/I-2880-2015; mastrobuoni, guido/J-3660-2012; Felicioli, Antonio/AAT-2167-2021; Dani, Francesca Romana/O-9120-2018; Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016	Caputo, Beniamino/0000-0002-5650-8773; Dani, Francesca Romana/0000-0002-2939-2103; Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Mastrobuoni, Guido/0000-0003-4509-1295; Pieraccini, Giuseppe/0000-0003-3103-3924	Italian Ministry for University and Research; PRIN 2006 programme; Ente Cassa di Risparmio di Firenze	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN 2006 programme(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	Financial support was provided by Italian Ministry for University and Research, PRIN 2006 programme, and by the Ente Cassa di Risparmio di Firenze (within the grants 2003 and 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], [No title captured]; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Campbell PM, 2005, SYST ENTOMOL, V30, P186, DOI 10.1111/j.1365-3113.2004.00279.x; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Clynen E, 2001, EUR J BIOCHEM, V268, P1929, DOI 10.1046/j.1432-1327.2001.02067.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Perera MR, 2005, ENTOMOL EXP APPL, V117, P243, DOI 10.1111/j.1570-7458.2005.00353.x; Rubakhin SS, 2003, ANAL CHEM, V75, P5374, DOI 10.1021/ac034498+; Rubakhin SS, 2000, NAT BIOTECHNOL, V18, P172, DOI 10.1038/72622; Scarselli R, 2005, PROTEOMICS, V5, P769, DOI 10.1002/pmic.200401149; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; SEELEY EH, 2008, J AM SOC MA IN PRESS; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Turillazzi S, 2007, J MASS SPECTROM, V42, P199, DOI 10.1002/jms.1152; Verhaert PD, 2007, INT J MASS SPECTROM, V260, P177, DOI 10.1016/j.ijms.2006.11.008; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yew JY, 2003, RAPID COMMUN MASS SP, V17, P2693, DOI 10.1002/rcm.1240; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	24	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2822	10.1371/journal.pone.0002822	http://dx.doi.org/10.1371/journal.pone.0002822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665262	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300041
J	Li, NYK; Verdolini, K; Clermont, G; Mi, Q; Rubinstein, EN; Hebda, PA; Vodovotz, Y				Li, Nicole Y. K.; Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Rubinstein, Elaine N.; Hebda, Patricia A.; Vodovotz, Yoram			A Patient-Specific in silico Model of Inflammation and Healing Tested in Acute Vocal Fold Injury	PLOS ONE			English	Article							CLINICAL-TRIALS; LIGAMENT; MARKERS; IMMOBILIZATION; MOBILIZATION; NEUTROPHILS; VALIDATION; COMPLEXITY; SECRETIONS; DISORDERS	The development of personalized medicine is a primary objective of the medical community and increasingly also of funding and registration agencies. Modeling is generally perceived as a key enabling tool to target this goal. Agent-Based Models (ABMs) have previously been used to simulate inflammation at various scales up to the whole-organism level. We extended this approach to the case of a novel, patient-specific ABM that we generated for vocal fold inflammation, with the ultimate goal of identifying individually optimized treatments. ABM simulations reproduced trajectories of inflammatory mediators in laryngeal secretions of individuals subjected to experimental phonotrauma up to 4 hrs post-injury, and predicted the levels of inflammatory mediators 24 hrs post-injury. Subject-specific simulations also predicted different outcomes from behavioral treatment regimens to which subjects had not been exposed. We propose that this translational application of computational modeling could be used to design patient-specific therapies for the larynx, and will serve as a paradigm for future extension to other clinical domains.	[Li, Nicole Y. K.; Verdolini, Katherine; Hebda, Patricia A.; Vodovotz, Yoram] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA; [Verdolini, Katherine; Hebda, Patricia A.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Verdolini, Katherine] Univ Pittsburgh, Univ Pittsburgh Voice Ctr, Pittsburgh, PA USA; [Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, Dept Critical Care Med, Pittsburgh, PA USA; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Hebda, Patricia A.; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Rubinstein, Elaine N.] Univ Pittsburgh, Office Measurement & Evaluat Teach, Pittsburgh, PA USA; [Hebda, Patricia A.] Childrens Hosp Pittsburgh, Otolaryngol Wound Heal Lab, Pittsburgh, PA USA; [Hebda, Patricia A.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Verdolini, K (corresponding author), Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA.	kittie@csd.pitt.edu		Li-Jessen, Nicole/0000-0003-2963-4763	National Institutes of Health [R01-DC-005643, R01-DC-008290]; National Institute on Deafness and Other Communication Disorders; National Institute of General Medical Sciences [P50-GM-53789-09]; National Institute for Disability Rehabilitation Research [H133E070024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008290, R01DC005643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Disability Rehabilitation Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported in part by the National Institutes of Health grants R01-DC-005643 and R01-DC-008290 to K. Verdolini from the National Institute on Deafness and Other Communication Disorders; grant P50-GM-53789-09 (Project V) from the National Institute of General Medical Sciences to Y. Vodovotz and G. Clermont, and grant H133E070024 (Developmental Project 1) from the National Institute for Disability Rehabilitation Research to Y. Vodovotz and Q. Mi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2005, CRIT CARE MED, V33, P253, DOI 10.1097/01.CCM.0000150753.86953.10; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Branski RC, 2004, ANN OTO RHINOL LARYN, V113, P23, DOI 10.1177/000348940411300105; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105; BRANSKI RC, 2006, J VOICE; BRANSKI RC, 2005, THESIS U PITTSBURGH, P1; BURROUGHS P, 1990, AM J SPORT MED, V18, P376, DOI 10.1177/036354659001800407; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Calvin M, 1998, WOUNDS, V10, P12; Catten M, 1998, OTOLARYNG HEAD NECK, V118, P663, DOI 10.1177/019459989811800516; Chong HY, 1999, J CELL PHYSIOL, V178, P275, DOI 10.1002/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.3.CO;2-H; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CLARK RAF, 1988, PROG DERMATOL, V22, P1; Clark RAF, 1998, MOL CELLULAR BIOL WO; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; COCKBILL S, 2002, HOSP PHARM, V9, P255; Courey MS, 1996, ANN OTO RHINOL LARYN, V105, P525, DOI 10.1177/000348949610500706; DAY J, 2006, J THEOR BIOL; de Melo ECM, 2003, LARYNGOSCOPE, V113, P2187; EIFF MP, 1994, AM J SPORT MED, V22, P83, DOI 10.1177/036354659402200115; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; GRAY S, 1988, ANN OTO RHINOL LARYN, V97, P381, DOI 10.1177/000348948809700410; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; GRAY SD, 1995, ANN OTO RHINOL LARYN, V104, P13, DOI 10.1177/000348949510400103; GRAY SD, 1987, J VOICE, V1, P109; GRAY SD, 2000, OTOLARYNGOLOGIC CLIN; GRAY SD, 1991, BASEMENT MEMBRANE ZO, P1; Gunter HE, 2004, J BIOMECH, V37, P1119, DOI 10.1016/j.jbiomech.2003.11.007; Gunter HE, 2003, J ACOUST SOC AM, V113, P994, DOI 10.1121/1.1534100; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311; HARDY MA, 1989, PHYS THER, V69, P1014, DOI 10.1093/ptj/69.12.1014; Hart J, 2002, J Wound Care, V11, P245; Hart J, 2002, J Wound Care, V11, P205; Hirschi SD, 2002, J VOICE, V16, P310, DOI 10.1016/S0892-1997(02)00102-9; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jiang JJ, 1998, ANN OTO RHINOL LARYN, V107, P603, DOI 10.1177/000348949810700711; Kerkhoffs G.M.M.J., 2002, COCHRANE DB SYST REV, pCD002938, DOI [10.1002/14651858.CD002938, DOI 10.1002/14651858.CD002938]; Kerkhoffs GMMJ, 2003, ACTA ORTHOP SCAND, V74, P69, DOI 10.1080/00016470310013699; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; KUMAR R, MATH SIMULA IN PRESS; Kvist J, 2004, SPORTS MED, V34, P269, DOI 10.2165/00007256-200434040-00006; LI NYK, 2006, SIMULATING ACUTE PHO; Ma EPM, 2001, J SPEECH LANG HEAR R, V44, P511, DOI 10.1044/1092-4388(2001/040); Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MI Q, WOUND REPAI IN PRESS; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Morrison M, 1994, MANAGEMENT VOICE DIS; MULLIGAN B, 1995, MANUAL THERAPY NAGS, P78; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NEVES BMJ, 2004, BRAZILLIAN J OTOLARY, V70, P439; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Paungmali A, 2003, PHYS THER, V83, P374, DOI 10.1093/ptj/83.4.374; PETERSON KL, 1994, ANN OTO RHINOL LARYN, V103, P335, DOI 10.1177/000348949410300501; Pijnenburg ACM, 2000, J BONE JOINT SURG AM, V82A, P761, DOI 10.2106/00004623-200006000-00002; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Raaijmakers MF, 1998, FOLIA PHONIATR LOGO, V50, P71, DOI 10.1159/000021452; Railsback Steven F., 2001, Natural Resource Modeling, V14, P465; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; REYNOLDS A, 2006, J THEOR BIOL; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; Robson MC, 2001, CURR PROB SURG, V38, P65; SALTER RB, 1994, HAND CLIN, V10, P211; Salter RB, 1996, HAND CLIN, V12, P1; SATALOFF RT, 1997, VOICE REST, P453; Smallwood RH, 2004, J MOL HISTOL, V35, P659; Smith E., 1996, J MED SPEECH-LANG PA, V4, P223; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-1; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P469, DOI 10.1177/000348940611500612; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Thibeault SL, 2003, J VOICE, V17, P377, DOI 10.1067/S0892-1997(03)00064-X; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P302, DOI 10.1177/000348940211100404; Thomson SL, 2005, J ACOUST SOC AM, V118, P1689, DOI 10.1121/1.2000787; Thornton GM, 2003, J ORTHOPAED RES, V21, P716, DOI 10.1016/S0736-0266(03)00051-2; THRELKELD AJ, 1992, MANUAL THERAPY AM PH, P59; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007; Toumi H, 2006, J ANAT, V208, P459, DOI 10.1111/j.1469-7580.2006.00543.x; Verdolini K, 1998, J VOICE, V12, P315, DOI 10.1016/S0892-1997(98)80021-0; Verdolini K, 2003, ANN OTO RHINOL LARYN, V112, P1021, DOI 10.1177/000348940311201205; VERDOLINI K, 2000, CASE STUDY RESONANT, P46; VERDOLINI K, EFFECT TARGETE UNPUB; VERDOLINI K, EFFECT RESONAN UNPUB; VERDOLINIMARSTON K, 1995, J VOICE, V9, P74, DOI 10.1016/S0892-1997(05)80225-5; Visser NA, 1998, CONNECT TISSUE RES, V37, P295, DOI 10.3109/03008209809002446; Vodovotz Y, 2006, SHOCK, V25, P39, DOI 10.1097/00024382-200606001-00118; Vodovotz Y, 1999, CANCER RES, V59, P2142; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Walter J.B., 1987, GEN PATHOLOGY, V6th; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Whitcomb DC, 2005, DIGEST DIS SCI, V50, P2195, DOI 10.1007/s10620-005-3033-7; WILLIAMS JM, 1994, CLIN ORTHOP RELAT R, V304, P252; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1	106	65	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2789	10.1371/journal.pone.0002789	http://dx.doi.org/10.1371/journal.pone.0002789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665229	gold, Green Published, Green Accepted			2022-12-25	WOS:000264304300008
J	Sadikovic, B; Yoshimoto, M; Al-Romaih, K; Maire, G; Zielenska, M; Squire, JA				Sadikovic, Bekim; Yoshimoto, Maisa; Al-Romaih, Khaldoun; Maire, Georges; Zielenska, Maria; Squire, Jeremy A.			In Vitro Analysis of Integrated Global High-Resolution DNA Methylation Profiling with Genomic Imbalance and Gene Expression in Osteosarcoma	PLOS ONE			English	Article								Genetic and epigenetic changes contribute to deregulation of gene expression and development of human cancer. Changes in DNA methylation are key epigenetic factors regulating gene expression and genomic stability. Recent progress in microarray technologies resulted in developments of high resolution platforms for profiling of genetic, epigenetic and gene expression changes. OS is a pediatric bone tumor with characteristically high level of numerical and structural chromosomal changes. Furthermore, little is known about DNA methylation changes in OS. Our objective was to develop an integrative approach for analysis of high-resolution epigenomic, genomic, and gene expression profiles in order to identify functional epi/genomic differences between OS cell lines and normal human osteoblasts. A combination of Affymetrix Promoter Tilling Arrays for DNA methylation, Agilent array-CGH platform for genomic imbalance and Affymetrix Gene 1.0 platform for gene expression analysis was used. As a result, an integrative high-resolution approach for interrogation of genome-wide tumour-specific changes in DNA methylation was developed. This approach was used to provide the first genomic DNA methylation maps, and to identify and validate genes with aberrant DNA methylation in OS cell lines. This first integrative analysis of global cancer-related changes in DNA methylation, genomic imbalance, and gene expression has provided comprehensive evidence of the cumulative roles of epigenetic and genetic mechanisms in deregulation of gene expression networks.	[Sadikovic, Bekim; Zielenska, Maria] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Sadikovic, Bekim; Zielenska, Maria] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON, Canada; [Sadikovic, Bekim; Yoshimoto, Maisa; Al-Romaih, Khaldoun; Maire, Georges; Squire, Jeremy A.] UHN, OCI, Dept Res, Div Cellular & Mol Biol, Toronto, ON, Canada; [Squire, Jeremy A.] Queens Univ, Richardson Labs, Dept Pathol & Mol Med, Kingston, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Queens University - Canada	Sadikovic, B (corresponding author), Hosp Sick Children, Dept Pediat Lab Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	squirej@queensu.ca	Squire, Jeremy A/F-4437-2012; Squire, Jeremy A/A-9352-2012	Squire, Jeremy A/0000-0002-9863-468X	National Cancer Institute of Canada [16215]; Canadian Cancer Society; Terry Fox Foundation [Post Doctoral Fellowship]; Hospital for Sick Children, Toronto, Canada [Restracomp Fellowship]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Hospital for Sick Children, Toronto, Canada	This work was funded by the National Cancer Institute of Canada grant #16215 with funds from the Canadian Cancer Society. BS is a recipient of the Post Doctoral Fellowship form the Terry Fox Foundation, and the National Cancer Institute of Canada and the Restracomp Fellowship from The Hospital for Sick Children, Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Batanian JR, 2002, J CLIN PATHOL-MOL PA, V55, P389, DOI 10.1136/mp.55.6.389; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; BEDFORD MT, 1987, CANCER RES, V47, P5274; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; DiNardo DNM, 2001, ONCOGENE, V20, P5331, DOI 10.1038/sj.onc.1204697; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P15, DOI 10.1002/gcc.2870140104; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2002, ONCOGENE, V21, P4345, DOI 10.1038/sj.onc.1205446; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jurgens B, 1996, CANCER RES, V56, P5698; KIM YI, 1994, CANCER, V74, P893, DOI 10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; Kindich R, 2006, EUR UROL, V49, P169, DOI 10.1016/j.eururo.2005.09.012; Lim G, 2005, GENE CHROMOSOME CANC, V42, P392, DOI 10.1002/gcc.20157; Lim G, 2004, CANCER GENET CYTOGEN, V153, P158, DOI 10.1016/j.cancergencyto.2004.01.016; Lin CH, 2001, CANCER RES, V61, P4238; Lock GSH, 1998, T CAN SOC MECH ENG, V22, P207; Maire G, 2003, GENE CHROMOSOME CANC, V37, P389, DOI 10.1002/gcc.10223; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Ozaki T, 2003, CANCER GENET CYTOGEN, V140, P145, DOI 10.1016/S0165-4608(02)00685-4; Papaggeli P C, 2003, J BUON, V8, P341; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Ryhanen S, 1997, J CELL BIOCHEM, V66, P404, DOI 10.1002/(SICI)1097-4644(19970901)66:3<404::AID-JCB12>3.0.CO;2-E; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Selvarajah S, 2007, CANCER GENET CYTOGEN, V179, P52, DOI 10.1016/j.cancergencyto.2007.08.003; SHANN YJ, 2008, GENOME RES; SINGH VP, 1993, J SOC INF DISPLAY, V1, P135; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Sugihara T, 2007, NEC TECH J, V2, P26; Tarkkanen M, 1999, INT J CANCER, V84, P114, DOI 10.1002/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q; TSUKAMOTO N, 1992, EXP HEMATOL, V20, P1061; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; WAHLFORS J, 1992, BLOOD, V80, P2074; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zielenska M, 2004, CYTOGENET GENOME RES, V107, P77, DOI 10.1159/000079574; Zielenska M, 2001, CANCER GENET CYTOGEN, V130, P14, DOI 10.1016/S0165-4608(01)00461-7	55	61	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2834	10.1371/journal.pone.0002834	http://dx.doi.org/10.1371/journal.pone.0002834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18698372	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300053
J	Fukuda, T; Kohda, M; Kanomata, K; Nojima, J; Nakamura, A; Kamizono, J; Noguchi, Y; Iwakiri, K; Kondo, T; Kurose, J; Endo, K; Awakura, T; Fukushi, J; Nakashima, Y; Chiyonobu, T; Kawara, A; Nishida, Y; Wada, I; Akita, M; Komori, T; Nakayama, K; Nanba, A; Maruki, Y; Yoda, T; Tomoda, H; Yu, PB; Shore, EM; Kaplan, FS; Miyazono, K; Matsuoka, M; Ikebuchi, K; Ohtake, A; Oda, H; Jimi, E; Owan, I; Okazaki, Y; Katagiri, T				Fukuda, Toru; Kohda, Masakazu; Kanomata, Kazuhiro; Nojima, Junya; Nakamura, Atsushi; Kamizono, Jyunji; Noguchi, Yasuo; Iwakiri, Kiyofumi; Kondo, Takeo; Kurose, Junichi; Endo, Ken-ichi; Awakura, Takeshi; Fukushi, Junichi; Nakashima, Yasuharu; Chiyonobu, Tomohiro; Kawara, Akira; Nishida, Yoshihiro; Wada, Ikuo; Akita, Masumi; Komori, Tetsuo; Nakayama, Konosuke; Nanba, Akira; Maruki, Yuichi; Yoda, Tetsuya; Tomoda, Hiroshi; Yu, Paul B.; Shore, Eileen M.; Kaplan, Frederick S.; Miyazono, Kohei; Matsuoka, Masaru; Ikebuchi, Kenji; Ohtake, Akira; Oda, Hiromi; Jimi, Eijiro; Owan, Ichiro; Okazaki, Yasushi; Katagiri, Takenobu			Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RECEPTORS; HETEROTOPIC OSSIFICATION; NATURAL-HISTORY; MESSENGER-RNA; ACTIVIN-A; IDENTIFICATION; DIFFERENTIATION; PATHWAY; DYSREGULATION; INJECTION	Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by congenital malformation of the great toes and by progressive heterotopic bone formation in muscle tissue. Recently, a mutation involving a single amino acid substitution in a bone morphogenetic protein (BMP) type I receptor, ALK2, was identified in patients with FOP. We report here that the identical mutation, R206H, was observed in 19 Japanese patients with sporadic FOP. This mutant receptor, ALK2(R206H), activates BMP signaling without ligand binding. Moreover, expression of Smad1 and Smad5 was up-regulated in response to muscular injury. ALK2(R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or dorsomorphin. Taken together, these findings suggest that the heterotopic bone formation in FOP may be induced by a constitutively activated BMP receptor signaling through Smad1 or Smad5. Gene transfer of Smad7 or inhibition of type I receptors with dorsomorphin may represent strategies for blocking the activity induced by ALK2(R206H) in FOP.	[Fukuda, Toru; Kanomata, Kazuhiro; Nojima, Junya; Nakamura, Atsushi; Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, Hidaka, Saitama 3501241, Japan; [Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Saitama 3501241, Japan; [Fukuda, Toru; Akita, Masumi; Komori, Tetsuo; Nakayama, Konosuke; Nanba, Akira; Maruki, Yuichi; Yoda, Tetsuya; Tomoda, Hiroshi; Miyazono, Kohei; Ikebuchi, Kenji; Ohtake, Akira; Oda, Hiromi; Jimi, Eijiro; Owan, Ichiro; Okazaki, Yasushi; Katagiri, Takenobu] Saitama Med Univ, Project Clin & Basic Res FOP, Hidaka, Saitama 3501241, Japan; [Kamizono, Jyunji] Kitakyusyu City Yahata Hosp, Dept Pediat Emergency, Yahatahigashi Ku, Kitakyushu, Fukuoka 8058534, Japan; [Noguchi, Yasuo] Saga Prefectural Hosp Koseikan, Dept Orthoped Surg, Saga 8408571, Japan; [Iwakiri, Kiyofumi] Nagayoshi Orthoped Clin, Miyazaki 8800951, Japan; [Kondo, Takeo] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Aoba Ku, Sendai, Miyagi 9808474, Japan; [Kurose, Junichi] Senjyudo Hosp, Dept Orthoped Surg, Gifu 5008862, Japan; [Endo, Ken-ichi] Endo Clin, Kodaira, Tokyo 1870035, Japan; [Awakura, Takeshi] Awakura Clin, Wajima, Ishiwawa 9280246, Japan; [Fukushi, Junichi; Nakashima, Yasuharu] Kyushu Univ, Fac Med, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan; [Chiyonobu, Tomohiro] Akashi Municipal Hosp, Dept Pediat, Akashi, Hyogo 6738501, Japan; [Kawara, Akira] Kawara Clin, Higashinada Ku, Kobe, Hyogo 6580051, Japan; [Nishida, Yoshihiro] Nagoya Univ, Grad Sch, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishida, Yoshihiro] Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Wada, Ikuo] Nagoya City Univ Hosp, Dept Rehabil, Mizuho Ku, Nagoya, Aichi 4678602, Japan; [Nojima, Junya; Yoda, Tetsuya] Saitama Med Univ, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Nanba, Akira] Saitama Med Univ, Dept Obstet & Gynecol, Moroyama, Saitama 3500495, Japan; [Nakayama, Konosuke] Saitama Med Univ, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan; [Komori, Tetsuo] Saitama Med Univ, Dept Neurol, Moroyama, Saitama 3500495, Japan; [Oda, Hiromi] Saitama Med Univ, Dept Orthoped Surg, Moroyama, Saitama 3500495, Japan; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Moroyama, Saitama 3500495, Japan; [Matsuoka, Masaru; Ikebuchi, Kenji] Saitama Med Univ, Dept Lab Med, Moroyama, Saitama 3500495, Japan; [Akita, Masumi] Saitama Med Univ, Biomed Res Ctr, Div Morphol Sci, Moroyama, Saitama 3500495, Japan; [Maruki, Yuichi] Saitama Neuropsychiat Inst, Dept Neurol, Chuo Ku, Saitama 3388577, Japan; [Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tomoda, Hiroshi] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1080023, Japan; [Yu, Paul B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA 02129 USA; [Yu, Paul B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Dept Med, Boston, MA 02129 USA; [Shore, Eileen M.; Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Orthoped Surg, Ctr Res Fibrodysplasia Ossificans Progress & Rela, Philadelphia, PA 19104 USA; [Jimi, Eijiro] Kyushu Dent Coll, Dept Biosci, Div Mol Signaling & Biochem, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Owan, Ichiro] Univ Ryukyus, Fac Med, Dept Orthoped Surg, Nishihara, Okinawa 9030215, Japan; [Nakashima, Yasuharu] Minist Hlth Labour & Welf, Res Comm Fibrodysplasia Ossificans Progress, Bunkyo Ku, Tokyo 1138655, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Tohoku University; Kyushu University; Nagoya University; Nagoya City University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; University of Tokyo; Kitasato University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Kyushu Dental University; University of the Ryukyus	Katagiri, T (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	katagiri@saitama-med.ac.jp	Shore, Eileen/D-2593-2009; Nishida, Yoshihiro/I-7354-2014; Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Okazaki, Yasushi/0000-0003-3241-5502; Ohtake, Akira/0000-0003-1147-3113; Kaplan, Frederick/0000-0003-1277-5420; Chiyonobu, Tomohiro/0000-0001-6678-060X	NHLBI NIH HHS [K08 HL079943, K08 HL079943-04] Funding Source: Medline; NIAMS NIH HHS [R01-AR41916] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Aoki H, 2001, J CELL SCI, V114, P1483; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Davies MR, 2005, J AM SOC NEPHROL, V16, P917, DOI 10.1681/ASN.2004100835; Fiori JL, 2006, J BONE MINER RES, V21, P902, DOI 10.1359/JBMR.060215; Gannon FH, 1997, HUM PATHOL, V28, P339, DOI 10.1016/S0046-8177(97)90133-7; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kaplan FS, 2008, J BONE MINER METAB, V26, P521, DOI 10.1007/s00774-008-0879-8; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Kaplan FS, 2006, ANN NY ACAD SCI, V1068, P54, DOI 10.1196/annals.1346.008; KAPLAN FS, 1990, CALCIFIED TISSUE INT, V47, P117, DOI 10.1007/BF02555995; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P1214, DOI 10.2106/00004623-199308000-00011; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Katagiri Takenobu, 2008, P121; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; LANCHONEY TF, 1995, J PEDIATR-US, V126, P762, DOI 10.1016/S0022-3476(95)70408-6; Link BA, 1997, EXP CELL RES, V233, P350, DOI 10.1006/excr.1997.3575; Luchetti W, 1996, ORAL SURG ORAL MED O, V81, P21, DOI 10.1016/S1079-2104(96)80141-7; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakajima M, 2007, J HUM GENET, V52, P473, DOI 10.1007/s10038-007-0128-3; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Souchelnytskyi S, 1996, EMBO J, V15, P6231, DOI 10.1002/j.1460-2075.1996.tb01013.x; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; TENDIJKE P, 1993, ONCOGENE, V8, P2879; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	42	153	162	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7149	7156		10.1074/jbc.M801681200	http://dx.doi.org/10.1074/jbc.M801681200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	18684712	hybrid, Green Published			2022-12-25	WOS:000263919000062
J	Chiu, HJ; Fischman, DA; Hammerling, U				Chiu, Haw-Jyh; Fischman, Donald A.; Hammerling, Ulrich			Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation	FASEB JOURNAL			English	Article						lymphocytes; mitochondrion; reactive oxygen species; bioenergetics	PROTEIN-KINASE-C; APOPTOSIS INDUCING FACTOR; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; RETRO-RETINOIDS; COMPLEX-III; DNA-REPAIR; ANHYDRORETINOL; GROWTH; PARP	A significant unresolved question is how vitamin A deprivation causes, and why retinoic acid fails to reverse, immunodeficiency. When depleted of vitamin A, T cells undergo programmed cell death (PCD), which is enhanced by the natural competitor of retinol, anhydroretinol. PCD does not happen by apoptosis, despite the occurrence of shared early events, including mitochondrial membrane depolarization, permeability transition pore opening, and cytochrome c release. It also lacks caspase-3 activation, chromatin condensation, and endonuclease-mediated DNA degradation, hallmarks of apoptosis. PCD following vitamin A deprivation exhibits increased production of reactive oxygen species (ROS), drastic reductions in ATP and NAD(+) levels, and activation of poly-(ADP-ribose) polymerase (PARP) -1. These latter steps are causative because neutralizing ROS, imposing hypoxic conditions, or inhibiting PARP-1 by genetic or pharmacologic approaches prevents energy depletion and PCD. The data highlight a novel regulatory role of vitamin A in mitochondrial energy homeostasis. -Chiu, H.-J., Fischman, D. A., Hammerling, U. Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP1-dependent energy deprivation. FASEB J. 22, 3878-3887 (2008)	[Chiu, Haw-Jyh; Hammerling, Ulrich] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Fischman, Donald A.] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Hammerling, U (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10065 USA.	u-hammerling@ski.mskcc.org			National Institutes of Health [CA 089362, DK 069348]; NATIONAL CANCER INSTITUTE [R01CA089362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are indebted to Dr. Valina Dawson (Johns Hopkins University School of Medicine, Baltimore, MD, USA) for sharing PARP-1<SUP>-/-</SUP> MEFs. This work was supported by grants from the National Institutes of Health, CA 089362 and DK 069348.	ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569; Asumendi A, 2002, BRIT J CANCER, V86, P1951, DOI 10.1038/sj.bjc.6600356; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen YQ, 1999, CANCER RES, V59, P3985; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; DE LUCA LM, 1991, FASEB J, V5, P2924; DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359; DERGUINI F, 1995, J BIOL CHEM, V270, P18875, DOI 10.1074/jbc.270.32.18875; DERGUINI F, 1994, BIOCHEMISTRY-US, V33, P623, DOI 10.1021/bi00169a001; Dmitrovsky E, 2004, J NATL CANCER I, V96, P1264, DOI 10.1093/jnci/djh268; Eguchi Y, 1997, CANCER RES, V57, P1835; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; EPPINGER TM, 1993, J EXP MED, V178, P1995, DOI 10.1084/jem.178.6.1995; Faderl S, 2003, LEUKEMIA RES, V27, P259, DOI 10.1016/S0145-2126(02)00162-5; Farivar AS, 2005, ANN THORAC SURG, V80, P950, DOI 10.1016/j.athoracsur.2005.02.035; Fossati S, 2007, NEUROCHEM INT, V50, P203, DOI 10.1016/j.neuint.2006.08.009; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GARBE A, 1992, J EXP MED, V176, P109, DOI 10.1084/jem.176.1.109; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Hoyos B, 2002, J BIOL CHEM, V277, P23949, DOI 10.1074/jbc.M110750200; Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835; Imam A, 2001, FASEB J, V15, P28; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Korichneva I, 2003, J PHARMACOL EXP THER, V305, P426, DOI 10.1124/jpet.103.048900; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Korichneva I, 1999, J CELL SCI, V112, P2521; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Morales MC, 2005, ANTICANCER RES, V25, P1945; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OConnell MJ, 1996, J EXP MED, V184, P549, DOI 10.1084/jem.184.2.549; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pieper AA, 2000, MOL MED, V6, P271, DOI 10.1007/BF03401936; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Shah GM, 1996, BBA-MOL CELL RES, V1312, P1, DOI 10.1016/0167-4889(96)00004-3; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008	62	50	53	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3878	3887		10.1096/fj.08-112375	http://dx.doi.org/10.1096/fj.08-112375			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18676402	Green Published			2022-12-25	WOS:000260503000016
J	Ido, H; Ito, S; Taniguchi, Y; Hayashi, M; Sato-Nishiuchi, R; Sanzen, N; Hayashi, Y; Futaki, S; Sekiguchi, K				Ido, Hiroyuki; Ito, Shunsuke; Taniguchi, Yukimasa; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Sanzen, Noriko; Hayashi, Yoshitaka; Futaki, Sugiko; Sekiguchi, Kiyotoshi			Laminin isoforms containing the gamma 3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma 1 and gamma 2 chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN-BINDING; CELL-ADHESION; GLOBULAR DOMAIN; LG MODULES; BASEMENT-MEMBRANES; SULFATIDE BINDING; SPLICE VARIANTS; EXPRESSION; RECOMBINANT; MIGRATION	Laminins are the major cell adhesive proteins in basement membranes, and consist of three subunits termed alpha, beta, and gamma. Recently, we found that the Glu residue at the third position from the C termini of the gamma 1 and gamma 2 chains is critically involved in integrin binding by laminins. However, the gamma 3 chain lacks this Glu residue, suggesting that laminin isoforms containing the gamma 3 chain may be unable to bind to integrins. To address this possibility, we expressed the E8 fragment of laminin-213 and found that it was incapable of binding to integrins. Similarly, the E8 fragment of laminin-113 was expressed and also found to be inactive in binding to integrins, confirming the distinction between the integrin binding activities of gamma 3 chain-containing isoforms and those containing the gamma 1 or gamma 2 chain. To further address the importance of the Glu residue, we swapped the C-terminal four amino acids of the gamma 3 chain with the C-terminal nine amino acids of the gamma 1 chain, which contain the Glu residue. The resulting chimeric E8 fragment of laminin-213 became fully active in integrin binding, whereas replacement with the nine amino acids of the gamma 1 chain after substitution of Gln for the conserved Glu residue failed to restore the integrin binding activity. These results provide both loss-of-function and gain-of-function evidence that laminin isoforms containing the gamma 3 chain are unable to bind to integrins due to the absence of the conserved Glu residue, which should play a critical role in integrin binding by laminins.	[Ido, Hiroyuki; Ito, Shunsuke; Taniguchi, Yukimasa; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Sanzen, Noriko; Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan	Osaka University; Nagoya University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Sanzen, Noriko/0000-0001-6518-403X	New Energy and Industrial Technology Development Organization [17082005, 18370044]	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by Grants-in-Aid for Scientific Research (17082005 and 18370044 to K. S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Airenne T, 1996, GENOMICS, V32, P54, DOI 10.1006/geno.1996.0076; Airenne T, 2000, CELL TISSUE RES, V300, P129, DOI 10.1007/s004410050054; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cserhalmi-Friedman PB, 2001, BIOCHEM BIOPH RES CO, V280, P39, DOI 10.1006/bbrc.2000.4086; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Navdaev Alexei, 2008, Exp Cell Res, V314, P489, DOI 10.1016/j.yexcr.2007.10.027; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sterk LMT, 2002, J CELL SCI, V115, P1161; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500	53	39	40	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28149	28157		10.1074/jbc.M803553200	http://dx.doi.org/10.1074/jbc.M803553200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697739	hybrid, Green Published			2022-12-25	WOS:000259969300017
J	Zhang, WT; Chen, YF; Swift, MR; Tassi, E; Stylianou, DC; Gibby, KA; Riegel, AT; Wellstein, A				Zhang, Wentao; Chen, Yifan; Swift, Matthew R.; Tassi, Elena; Stylianou, Dora C.; Gibby, Krissa A.; Riegel, Anna T.; Wellstein, Anton			Effect of FGF-binding protein 3 on vascular permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-BINDING-PROTEIN; HEPARIN-LIKE MOLECULES; CRYSTAL-STRUCTURE; SKIN CARCINOGENESIS; FACTOR RECEPTORS; STRUCTURAL BASIS; HUMAN CANCER; FGF ACTIVITY; CELL	Fibroblast growth factor-binding protein 1 (FGF-BP1 is BP1) is involved in the regulation of embryonic development, tumor growth, and angiogenesis by mobilizing endogenous FGFs from their extracellular matrix storage. Here we describe a new member of the FGF-BP family, human BP3. We show that the hBP3 protein is secreted from cells, binds to FGF2 in vitro and in intact cells, and inhibits FGF2 binding to heparin. To determine the function of hBP3 in vivo, hBP3 was transiently expressed in chicken embryos and resulted in > 50% lethality within 24 h because of vascular leakage. The onset of vascular permeability was monitored by recording the extravasation kinetics of FITC-labeled 40-kDa dextran microperfused into the vitelline vein of 3-day-old embryos. Vascular permeability increased as early as 8 h after expression of hBP3. The increased vascular permeability caused by hBP3 was prevented by treatment of embryos with PD173074, a selective FGFR kinase inhibitor. Interestingly, a C-terminal 66-amino acid fragment (C66) of hBP3, which contains the predicted FGF binding domain, still inhibited binding of FGF2 to heparin similar to full-length hBP3. However, expression of the C66 fragment did not increase vascular permeability on its own, but required the administration of exogenous FGF2 protein. We conclude that the FGF binding domain and the heparin binding domain are necessary for the hBP3 interaction with endogenous FGF and the activation of FGFR signaling in vivo.	[Zhang, Wentao; Chen, Yifan; Swift, Matthew R.; Tassi, Elena; Stylianou, Dora C.; Gibby, Krissa A.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA	Georgetown University	Wellstein, A (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Res Bldg E311,3970 Reservoir Rd, Washington, DC 20057 USA.	wellstea@georgetown.edu	Stylianou, Dora/J-2697-2016; Stylianou, Dora/AAT-1074-2020; Chen, Yifan/K-1235-2019; Tassi, Enrico/K-3958-2015	Stylianou, Dora/0000-0003-4167-1380; Stylianou, Dora/0000-0003-4167-1380; Chen, Yifan/0000-0003-1388-9200; Wellstein, Anton/0000-0002-0570-4950	National Institutes of Health [R01 CA71508]; NCI [P30 CA51008]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008, R01CA071508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA71508 (to A. W.) and P30 CA51008 from the NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aigner A, 2000, GROWTH FACTORS, V18, P51, DOI 10.3109/08977190009003233; Aigner A, 2001, INT J CANCER, V92, P510, DOI 10.1002/1097-0215(20010515)92:4<510::AID-IJC1227>3.0.CO;2-H; Ballinger MD, 1999, NAT BIOTECHNOL, V17, P1199, DOI 10.1038/70746; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; CZUBAYKO F, 1994, J BIOL CHEM, V269, P28243; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Kurtz A, 1997, ONCOGENE, V14, P2671, DOI 10.1038/sj.onc.1201117; Kurtz A, 2004, NEOPLASIA, V6, P595, DOI 10.1593/neo.04214; Lametsch R, 2000, J BIOL CHEM, V275, P19469, DOI 10.1074/jbc.M002550200; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; McDonnell K, 2005, LAB INVEST, V85, P747, DOI 10.1038/labinvest.3700269; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Ogura K, 1999, J BIOMOL NMR, V13, P11, DOI 10.1023/A:1008330622467; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rak J, 1997, NAT MED, V3, P1083, DOI 10.1038/nm1097-1083; Ray PE, 2006, AM J PHYSIOL-REG I, V290, pR105, DOI 10.1152/ajpregu.00492.2005; Ray R, 2003, CANCER RES, V63, P8085; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Tassi E, 2006, CANCER RES, V66, P1191, DOI 10.1158/0008-5472.CAN-05-2926; Tassi E, 2001, J BIOL CHEM, V276, P40247, DOI 10.1074/jbc.M104933200; Tassi E, 2007, AM J PHYSIOL-REG I, V293, pR775, DOI 10.1152/ajpregu.00737.2006; VLODAVSKY I, 1991, ANN NY ACAD SCI, V638, P207; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; WU DQ, 1991, J BIOL CHEM, V266, P16778; Xie B, 2006, J BIOL CHEM, V281, P1137, DOI 10.1074/jbc.M510754200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487	45	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28329	28337		10.1074/jbc.M802144200	http://dx.doi.org/10.1074/jbc.M802144200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669637	hybrid, Green Published			2022-12-25	WOS:000259969300035
J	Burgess, BR; Dobson, RCJ; Bailey, MF; Atkinson, SC; Griffin, MDW; Jameson, GB; Parker, MW; Gerrard, JA; Perugini, MA				Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Jameson, Geoffrey B.; Parker, Michael W.; Gerrard, Juliet A.; Perugini, Matthew A.			Structure and evolution of a novel dimeric enzyme from a clinically important bacterial pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; INHIBITION; DIFFRACTION; RESOLUTION	Dihydrodipicolinate synthase (DHDPS) catalyzes the first committed step of the lysine biosynthetic pathway. The tetrameric structure of DHDPS is thought to be essential for enzymatic activity, as isolated dimeric mutants of Escherichia coli DHDPS possess less than 2.5% that of the activity of the wildtype tetramer. It has recently been proposed that the dimeric form lacks activity due to increased dynamics. Tetramerization, by buttressing two dimers together, reduces dynamics in the dimeric unit and explains why all active bacterial DHDPS enzymes to date have been shown to be homo-tetrameric. However, in this study we demonstrate for the first time that DHDPS from methicillin-resistant Staphylococcus aureus (MRSA) exists in a monomer-dimer equilibrium in solution. Fluorescence-detected analytical ultracentrifugation was employed to show that the dimerization dissociation constant of MRSA-DHDPS is 33 nM in the absence of substrates and 29 nM in the presence of (S)-aspartate semialdehyde (ASA), but is 20-fold tighter in the presence of the substrate pyruvate (1.6 nM). The MRSA-DHDPS dimer exhibits a ping-pong kinetic mechanism (k(cat) = 70 +/- 2 s(-1), K-m(Pyruvate) = 0.11 +/- 0.01 mM, and K-m(ASA) = 0.22 +/- 0.02 mM) and shows ASA substrate inhibition with a K-si(ASA) of 2.7 +/- 0.9 mM. We also demonstrate that unlike the E. coli tetramer, the MRSA-DHDPS dimer is insensitive to lysine inhibition. The near atomic resolution (1.45 angstrom) crystal structure confirms the dimeric quaternary structure and reveals that the dimerization interface of the MRSA enzyme is more extensive in buried surface area and noncovalent contacts than the equivalent interface in tetrameric DHDPS enzymes from other bacterial species. These data provide a detailed mechanistic insight into DHDPS catalysis and the evolution of quaternary structure of this important bacterial enzyme.	[Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Perugini, Matthew A.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia; [Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Struct Biol Ctr, Palmerston North 4442, New Zealand; [Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Gerrard, Juliet A.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	University of Melbourne; University of Melbourne; Massey University; St. Vincent's Institute of Medical Research; University of Canterbury	Perugini, MA (corresponding author), Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia.	perugini@unimelb.edu.au	Dobson, Renwick/A-9188-2011; Dobson, Renwick/AAZ-7020-2021; Parker, Michael W/F-9069-2013	Dobson, Renwick/0000-0002-5506-4939; Parker, Michael W/0000-0002-3101-1138; Perugini, Matthew/0000-0001-8052-5584; Griffin, Michael/0000-0001-9845-7735; Jameson, Geoffrey/0000-0003-4839-0784; Atkinson, Sarah/0000-0002-3518-9785	Defense Threat Reduction Agency [W911NF-07-1-0105]; Australian Research Council [DP0770888, LX0776388]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Australian Research Council(Australian Research Council)	This work was supported by Defense Threat Reduction Agency Contract W911NF-07-1-0105 and Australian Research Council Grants DP0770888 and LX0776388 for providing funding, an Australian postdoctoral fellowship (to M. A. P.) and a Federation fellowship (to M. W. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Burgess BR, 2008, ACTA CRYSTALLOGR F, V64, P659, DOI 10.1107/S1744309108016746; CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Coulter CV, 1999, PESTIC SCI, V55, P887, DOI 10.1002/(SICI)1096-9063(199909)55:9&lt;887::AID-PS36&gt;3.0.CO;2-B; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, BIOCHIMIE, V86, P311, DOI 10.1016/j.biochi.2004.03.008; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dobson RCJ, 2004, BIOCHEM J, V377, P757, DOI 10.1042/bj20031389; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Sambrook J, 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SNOWDEN MA, 1990, EUR J BIOCHEM, V191, P373, DOI 10.1111/j.1432-1033.1990.tb19132.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; *UK HLTH PROT AG, 2004, STAPH AUR BACT LAB R; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	40	77	78	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27598	27603		10.1074/jbc.M804231200	http://dx.doi.org/10.1074/jbc.M804231200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18684709	hybrid			2022-12-25	WOS:000259719200030
J	Geach, TJ; Dale, L				Geach, Timothy J.; Dale, Leslie			Molecular determinants of Xolloid action in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; PROCOLLAGEN C-PROTEINASE; MINIMAL DOMAIN-STRUCTURE; SPEMANN ORGANIZER; TWISTED GASTRULATION; VENTRALIZING FACTOR; DROSOPHILA EMBRYO; CHORDIN; MESODERM; CLEAVAGE	Xld (Xolloid) is a member of the Tolloid family of metalloproteases found in embryos of the frog Xenopus laevis. It cleaves Chordin, an inhibitory binding protein for BMP2/4, releasing fragments with reduced affinity for these important ventralizing signals. As a consequence, increasing Xld activity ventralizes Xenopus embryos. We have used this phenotype as an assay to determine the requirement for the C-terminal, nonprotease component of Xld for in vivo activity. This part of the protein is composed of five complement C1r/C1s-sea urchin epidermal growth factor-BMP1 (CUB) and two epidermal growth factor domains, which are thought to be involved in protein-protein interactions and may confer substrate specificity. Our results show that the protease coupled to CUB1 and CUB2 is the minimum domain structure required to ventralize Xenopus embryos and to block the dorsal axis-inducing activity of Chordin. Xld-CUB1-CUB2 cleaves Chordin, and a protease-inactive version co-precipitates Chordin. Our results indicate that the first and second CUB domains bind Chordin and present it to the protease domain. Protease-inactive Xld blocks the cleavage of Chordin by wild-type Xld and dorsalizes injected Xenopus embryos. We find that protease-inactive Xld-CUB1-CUB2 does not share this activity and that all of the C-terminal domains are required to generate the dorsalized phenotype.	[Geach, Timothy J.; Dale, Leslie] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Dale, L (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	l.dale@ucl.ac.uk	Dale, Leslie/C-6709-2008		Biotechnology and Biological Sciences Research Council [BBS/B/0661X]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council project Grant BBS/B/0661X. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Canty EG, 2006, J BIOL CHEM, V281, P13258, DOI 10.1074/jbc.M510483200; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHILDS SR, 1994, DEV BIOL, V162, P209, DOI 10.1006/dbio.1994.1079; Dale L, 1999, SEMIN CELL DEV BIOL, V10, P319, DOI 10.1006/scdb.1999.0308; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dosch R, 1997, DEVELOPMENT, V124, P2325; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; FINELLI AL, 1994, DEVELOPMENT, V120, P861; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hintze V, 2006, BIOCHEMISTRY-US, V45, P6741, DOI 10.1021/bi060228k; JONES CM, 1992, DEVELOPMENT, V115, P639; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Larrain J, 2001, DEVELOPMENT, V128, P4439; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Reynolds SD, 2000, GENE, V248, P233, DOI 10.1016/S0378-1119(00)00114-1; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Spemann H., 1938, EMBRYONIC DEV INDUCT; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Wardle FC, 1999, MECH DEVELOP, V86, P75, DOI 10.1016/S0925-4773(99)00114-8; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	49	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27057	27063		10.1074/jbc.M804232200	http://dx.doi.org/10.1074/jbc.M804232200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18664565	hybrid			2022-12-25	WOS:000259586600026
J	Takeda, Y; He, P; Tachibana, I; Zhou, B; Miyado, K; Kaneko, H; Suzuki, M; Minami, S; Iwasaki, T; Goya, S; Kijima, T; Kumagai, T; Yoshida, M; Osaki, T; Komori, T; Mekada, E; Kawase, I				Takeda, Yoshito; He, Ping; Tachibana, Isao; Zhou, Bo; Miyado, Kenji; Kaneko, Hideshi; Suzuki, Mayumi; Minami, Seigo; Iwasaki, Takeo; Goya, Sho; Kijima, Takashi; Kumagai, Toru; Yoshida, Mitsuhiro; Osaki, Tadashi; Komori, Toshihisa; Mekada, Eisuke; Kawase, Ichiro			Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; ALVEOLAR MACROPHAGES; HISTONE DEACETYLASE; ANIMAL-MODELS; GROWTH-FACTOR; LACKING CD81; EMPHYSEMA; LUNG; MECHANISMS; MULTIPLE	CD9 and CD81 are closely related tetraspanins that regulate cell motility and signaling by facilitating the organization of multimolecular membrane complexes, including integrins. We show that CD9 and CD81 are down-regulated in smoking-related inflammatory response of a macrophage line, RAW264.7. When functions of CD9 and CD81 were ablated with monoclonal antibody treatment, small interfering RNA transfection, or gene knock-out, macrophages were less motile and produced larger amounts of matrix metalloproteinase (MMP)-2 and MMP-9 than control cells in vitro. In line with this, CD9/CD81 double-knock-out mice spontaneously developed pulmonary emphysema, a major pathological component of chronic obstructive pulmonary disease ( COPD). The mutant lung contained an increased number of alveolar macrophages with elevated activities of MMP-2 and MMP-9 and progressively displayed enlarged airspace and disruption of elastic fibers in the alveoli. Secretory cell metaplasia, a finding similar to goblet cell metaplasia in cigarette smokers, was also observed in the epithelium of terminal bronchioles. With aging, the double-knock-out mice showed extrapulmonary phenotypes, including weight loss, kyphosis, and osteopenia. These results suggest that the tetraspanins CD9 and CD81 regulate cell motility and protease production of macrophages and that their dysfunction may underlie the progression of COPD.	[Takeda, Yoshito; He, Ping; Tachibana, Isao; Zhou, Bo; Suzuki, Mayumi; Minami, Seigo; Iwasaki, Takeo; Goya, Sho; Kijima, Takashi; Kumagai, Toru; Yoshida, Mitsuhiro; Osaki, Tadashi; Komori, Toshihisa; Kawase, Ichiro] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [He, Ping] Xian Jiaotong Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Xian 71004, Peoples R China; [Miyado, Kenji; Mekada, Eisuke] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kaneko, Hideshi] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Pharmacol & Safety Res Dept, Tokyo 1918512, Japan	Osaka University; Xi'an Jiaotong University; Osaka University; Teijin Pharma Limited	Tachibana, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	itachi02@imed3.med.osaka-u.ac.jp	MIYADO, KENJI/E-6568-2013	Miyado, Kenji/0000-0002-8339-6738; Mekada, Eisuke/0000-0001-8858-4781	Takeda Science Foundation, Osaka, Japan; "Kansai Biomedical Cluster" Project in Saito, Japan	Takeda Science Foundation, Osaka, Japan(Takeda Science Foundation (TSF)); "Kansai Biomedical Cluster" Project in Saito, Japan	This work was supported by a grant from Takeda Science Foundation, Osaka, Japan (to I.T.), and a grant from "Kansai Biomedical Cluster" Project in Saito, Japan, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan ( to I.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM; AMY RWM, 1977, J ANAT, V124, P131; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Brusselle GG, 2006, PULM PHARMACOL THER, V19, P155, DOI 10.1016/j.pupt.2005.06.001; Cawston T, 2001, NOVART FDN SYMP, V234, P205; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Finlay GA, 1996, AM J PATHOL, V149, P1405; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Gross N J, 2001, Curr Opin Pulm Med, V7, P84, DOI 10.1097/00063198-200103000-00006; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoshino S, 2005, BIOCHEM BIOPH RES CO, V329, P58, DOI 10.1016/j.bbrc.2005.01.095; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lind PM, 2001, BONE, V29, P265, DOI 10.1016/S8756-3282(01)00576-2; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Lucattelli M, 2003, EUR RESPIR J, V22, P728, DOI 10.1183/09031936.03.00047603; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Ohnishi K, 1998, LAB INVEST, V78, P1077; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Park GY, 2003, CHEST, V123, P475, DOI 10.1378/chest.123.2.475; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Saito Y, 2006, CANCER RES, V66, P9557, DOI 10.1158/0008-5472.CAN-06-1131; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shibata Y, 2001, BLOOD, V98, P2845, DOI 10.1182/blood.V98.9.2845; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tohami T, 2007, FASEB J, V21, P691, DOI 10.1096/fj.06-6610com; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	48	53	54	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26089	26097		10.1074/jbc.M801902200	http://dx.doi.org/10.1074/jbc.M801902200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18662991	hybrid, Green Published			2022-12-25	WOS:000259200100037
J	Morrell, NT; Leucht, P; Zhao, LD; Kim, JB; ten Berge, D; Ponnusamy, K; Carre, AL; Dudek, H; Zachlederova, M; McElhaney, M; Brunton, S; Gunzner, J; Callow, M; Polakis, P; Costa, M; Zhang, XM; Helms, JA; Nusse, R				Morrell, Nathan T.; Leucht, Philipp; Zhao, Ludan; Kim, Jae-Beom; ten Berge, Derk; Ponnusamy, Karthik; Carre, A. Lyonel; Dudek, Henryk; Zachlederova, Marie; McElhaney, Michael; Brunton, Shirley; Gunzner, Janet; Callow, Marinella; Polakis, Paul; Costa, Mike; Zhang, Xiaoyan M.; Helms, Jill A.; Nusse, Roel			Liposomal Packaging Generates Wnt Protein with In Vivo Biological Activity	PLOS ONE			English	Article							BETA-CATENIN; REGENERATION; WINGLESS; HEDGEHOG; GROWTH; CELLS	Wnt signals exercise strong cell-biological and regenerative effects of considerable therapeutic value. There are, however, no specific Wnt agonists and no method for in vivo delivery of purified Wnt proteins. Wnts contain lipid adducts that are required for activity and we exploited this lipophilicity by packaging purified Wnt3a protein into lipid vesicles. Rather than being encapsulated, Wnts are tethered to the liposomal surface, where they enhance and sustain Wnt signaling in vitro. Molecules that effectively antagonize soluble Wnt3a protein but are ineffective against the Wnt3a signal presented by a cell in a paracrine or autocrine manner are also unable to block liposomal Wnt3a activity, suggesting that liposomal packaging mimics the biological state of active Wnts. When delivered subcutaneously, Wnt3a liposomes induce hair follicle neogenesis, demonstrating their robust biological activity in a regenerative context.	[Morrell, Nathan T.; Leucht, Philipp; Zhao, Ludan; Kim, Jae-Beom; Ponnusamy, Karthik; Carre, A. Lyonel; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [ten Berge, Derk; Nusse, Roel] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA USA; [Dudek, Henryk; Zachlederova, Marie; McElhaney, Michael; Zhang, Xiaoyan M.] Curis Inc, Cambridge, MA USA; [Brunton, Shirley] Evotec Ltd, Abingdon, Oxon, England; [Gunzner, Janet] Genentech Inc, Dept Med Chem, San Francisco, CA USA; [Callow, Marinella; Polakis, Paul; Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA USA	Stanford University; Stanford University; Evotec; Roche Holding; Genentech; Roche Holding; Genentech	Morrell, NT (corresponding author), Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	jhelms@stanford.edu; rnusse@stanford.edu	Berge, Derk ten/C-1967-2012; Berge, Derk ten/ABF-2591-2020; Leucht, Philipp/H-7238-2019	Berge, Derk ten/0000-0002-5863-0860; Leucht, Philipp/0000-0002-8409-8513; Helms, Jill/0000-0002-0463-396X; Zachlederova, Marie/0000-0003-4929-0275	NIH [RO1 PA-02-011]; Air Force Office of Research [FOS-2004-0025A]; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	NIH RO1 PA-02-011 and Air Force Office of Research FOS-2004-0025A (JAH); R. Nusse is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2001, J BIOMATER APPL, V16, P3, DOI 10.1106/RA7U-1V9C-RV7C-8QXL; Cattel L, 2004, J CHEMOTHERAPY, V16, P94, DOI 10.1179/joc.2004.16.Supplement-1.94; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Koning GA, 2006, ARTHRITIS RHEUM-US, V54, P1198, DOI 10.1002/art.21719; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Park JW, 2002, BREAST CANCER RES, V4, P93; Ponce AM, 2006, FUTURE LIPIDOL, V1, P25, DOI 10.2217/17460875.1.1.25; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schiffelers R, 2001, J ANTIMICROB CHEMOTH, V48, P333, DOI 10.1093/jac/48.3.333; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; ZHANG Q, 2007, P NATL ACAD SCI US	33	59	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2930	10.1371/journal.pone.0002930	http://dx.doi.org/10.1371/journal.pone.0002930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698373	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600016
J	Shiffman, D; Kane, JP; Louie, JZ; Arellano, AR; Ross, DA; Catanese, JJ; Malloy, MJ; Ellis, SG; Devlin, JJ				Shiffman, Dov; Kane, John P.; Louie, Judy Z.; Arellano, Andre R.; Ross, David A.; Catanese, Joseph J.; Malloy, Mary J.; Ellis, Stephen G.; Devlin, James J.			Analysis of 17,576 Potentially Functional SNPs in Three Case-Control Studies of Myocardial Infarction	PLOS ONE			English	Article								Myocardial infarction (MI) is a common complex disease with a genetic component. While several single nucleotide polymorphisms (SNPs) have been reported to be associated with risk of MI, they do not fully explain the observed genetic component of MI. We have been investigating the association between MI and SNPs that are located in genes and have the potential to affect gene function or expression. We have previously published studies that tested about 12,000 SNPs for association with risk of MI, early-onset MI, or coronary stenosis. In the current study we tested 17,576 SNPs that could affect gene function or expression. In order to use genotyping resources efficiently, we staged the testing of these SNPs in three case -control studies of MI. In the first study (762 cases, 857 controls) we tested 17,576 SNPs and found 1,949 SNPs that were associated with MI (P<0.05). We tested these 1,949 SNPs in a second study (579 cases and 1159 controls) and found that 24 SNPs were associated with MI (1-sided P<0.05) and had the same risk alleles in the first and second study. Finally, we tested these 24 SNPs in a third study (475 cases and 619 controls) and found that 5 SNPs in 4 genes (ENO1, FXN (2 SNPs), HLA-DPB2, and LPA) were associated with MI in the third study (1-sided P<0.05), and had the same risk alleles in all three studies. The false discovery rate for this group of 5 SNPs was 0.23. Thus, we have identified 5 SNPs that merit further examination for their potential association with MI. One of these SNPs (in LPA), has been previously shown to be associated with risk of cardiovascular disease in other studies.	[Shiffman, Dov; Kane, John P.; Louie, Judy Z.; Arellano, Andre R.; Ross, David A.; Catanese, Joseph J.; Devlin, James J.] Celera, Alameda, CA USA; [Malloy, Mary J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Ellis, Stephen G.] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH USA	University of California System; University of California San Francisco; Cleveland Clinic Foundation	Shiffman, D (corresponding author), Celera, Alameda, CA USA.	dov.shiffman@celera.com			University of California; State of California; Celera; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	University of California(University of California System); State of California; Celera; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from the University of California Discovery Grant Program, which is jointly funded by the University of California and the State of California with matching funds from Celera.	Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; *AM HEART ASS, 2002, HEART DIS STROK STAT; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2006, CURR OPIN MOL THER, V8, P493; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910	19	30	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2895	10.1371/journal.pone.0002895	http://dx.doi.org/10.1371/journal.pone.0002895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682748	Green Published, gold			2022-12-25	WOS:000264366600051
J	Smith, JN; Dyszel, JL; Soares, JA; Ellermeier, CD; Altier, C; Lawhon, SD; Adams, LG; Konjufca, V; Curtiss, R; Slauch, JM; Ahmer, BMM				Smith, Jenee N.; Dyszel, Jessica L.; Soares, Jitesh A.; Ellermeier, Craig D.; Altier, Craig; Lawhon, Sara D.; Adams, L. Garry; Konjufca, Vjollca; Curtiss, Roy, III; Slauch, James M.; Ahmer, Brian M. M.			SdiA, an N-Acylhomoserine Lactone Receptor, Becomes Active during the Transit of Salmonella enterica through the Gastrointestinal Tract of Turtles	PLOS ONE			English	Article								Background: LuxR-type transcription factors are typically used by bacteria to determine the population density of their own species by detecting N-acylhomoserine lactones (AHLs). However, while Escherichia and Salmonella encode a LuxR-type AHL receptor, SdiA, they cannot synthesize AHLs. In vitro, it is known that SdiA can detect AHLs produced by other bacterial species. Methodology/Principal Findings: In this report, we tested the hypothesis that SdiA detects the AHL-production of other bacterial species within the animal host. SdiA did not detect AHLs during the transit of Salmonella through the gastrointestinal tract of a guinea pig, a rabbit, a cow, 5 mice, 6 pigs, or 12 chickens. However, SdiA was activated during the transit of Salmonella through turtles. All turtles examined were colonized by the AHL-producing species Aeromonas hydrophila. Conclusions/Significance: We conclude that the normal gastrointestinal microbiota of most animal species do not produce AHLs of the correct type, in an appropriate location, or in sufficient quantities to activate SdiA. However, the results obtained with turtles represent the first demonstration of SdiA activity in animals.	[Smith, Jenee N.; Dyszel, Jessica L.; Soares, Jitesh A.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ellermeier, Craig D.; Slauch, James M.] Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL USA; [Altier, Craig] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Lawhon, Sara D.; Adams, L. Garry] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX USA; [Konjufca, Vjollca; Curtiss, Roy, III] Washington Univ, Dept Biol, St Louis, MO USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Washington University (WUSTL)	Smith, JN (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010; Lawhon, Sara D./G-5147-2011	Ahmer, Brian M. M./0000-0002-4267-7322; Lawhon, Sara D./0000-0001-9154-8909; Konjufca, Vjollca/0000-0002-7736-5097; Ellermeier, Craig/0000-0002-8953-5081; Slauch, James/0000-0003-4634-9702	Public Health Service [AI0500002, AI073971, AI63230, 5K08AI060933-02, AI24533]; Roy J. Carver Charitable Trust [00-25]; USDA NRICGP [2002-35204-11624]; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2005-35201-16270]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063230, K08AI060933, R01AI024533, R01AI050002, R01AI073971] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Roy J. Carver Charitable Trust; USDA NRICGP(United States Department of Agriculture (USDA)); National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.M.M.A. was supported by Public Health Service grants AI0500002 and AI073971. J.M.S. and C.D.E. were supported by grant 00-25 from the Roy J. Carver Charitable Trust and by Public Health Service grant AI63230. S.D.L was supported by Public Health Service grant 5K08AI060933-02. L.G.A. was supported by USDA NRICGP grant 2002-35204-11624. C.A. was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant number 2005-35201-16270. R.C. was supported by Public Health Service grant AI24533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Baumler AJ, 1996, INFECT IMMUN, V64, P61; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; CAMILLI A, 1994, P NATL ACAD SCI USA, V91, P2634, DOI 10.1073/pnas.91.7.2634; *CDC CFDC, 1999, SALM SURV ANN TAB SU; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CIPRIANO RC, 2001, 68 US DEP INT FISH W; Cirillo DM, 1996, INFECT IMMUN, V64, P2019, DOI 10.1128/IAI.64.6.2019-2023.1996; Crago AM, 1999, FEMS MICROBIOL LETT, V176, P495, DOI 10.1111/j.1574-6968.1999.tb13703.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong YH, 2005, J MICROBIOL, V43, P101; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Erickson DL, 2002, CAN J MICROBIOL, V48, P374, DOI 10.1139/w02-022; FRIEDRICH MJ, 1993, MOL MICROBIOL, V8, P543, DOI 10.1111/j.1365-2958.1993.tb01599.x; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 1999, CELL-CELL SIGNALING IN BACTERIA, P211; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; HACKETT J, 1987, J INFECT DIS, V155, P540, DOI 10.1093/infdis/155.3.540; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1992, J CLIN INVEST, V90, P953, DOI 10.1172/JCI115972; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kirke DF, 2004, FEMS MICROBIOL LETT, V241, P109, DOI 10.1016/j.femsle.2004.10.011; Kodjo A, 1997, J VET MED B, V44, P625, DOI 10.1111/j.1439-0450.1997.tb01016.x; Kozinska A, 2007, J FISH DIS, V30, P293, DOI 10.1111/j.1365-2761.2007.00813.x; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Maloy SR., 1996, GENETIC ANAL PATHOGE; MCGAREY DJ, 1991, EXPERIENTIA, V47, P441; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; Milton DL, 2001, J BACTERIOL, V183, P3537, DOI 10.1128/JB.183.12.3537-3547.2001; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Pasmans F, 2002, VET REC, V150, P692, DOI 10.1136/vr.150.22.692; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Roche DM, 2004, MICROBIOL-SGM, V150, P2023, DOI 10.1099/mic.0.26977-0; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Sen K, 2007, CAN J MICROBIOL, V53, P261, DOI 10.1139/W06-095; SHANE SM, 1990, EPIDEMIOL INFECT, V105, P307, DOI 10.1017/S0950268800047907; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slauch JM, 2000, METHOD ENZYMOL, V326, P73; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Swift S, 1999, CELL-CELL SIGNALING IN BACTERIA, P291; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2000, J BACTERIOL, V182, P1779, DOI 10.1128/JB.182.7.1779-1787.2000; Wang YJ, 2005, APPL ENVIRON MICROB, V71, P1291, DOI 10.1128/AEM.71.3.1291-1299.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041	61	75	79	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2826	10.1371/journal.pone.0002826	http://dx.doi.org/10.1371/journal.pone.0002826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665275	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300045
J	Winter, J; Roepcke, S; Krause, S; Muller, EC; Otto, A; Vingron, M; Schweiger, S				Winter, Jennifer; Roepcke, Stefan; Krause, Sven; Mueller, Eva-Christina; Otto, Albrecht; Vingron, Martin; Schweiger, Susann			Comparative 3 ' UTR Analysis Allows Identification of Regulatory Clusters that Drive Eph/ephrin Expression in Cancer Cell Lines	PLOS ONE			English	Article								Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ephrins, they fulfill multiple biological functions. Aberrant expression of Ephs/ephrins leading to increased Eph receptor to ephrin ligand ratios is a critical factor in tumorigenesis, indicating that tight regulation of Eph and ephrin expression is essential for normal cell behavior. The 3'-untranslated regions (3'UTRs) of transcripts play an important yet widely underappreciated role in the control of protein expression. Based on the assumption that paralogues of large gene families might exhibit a conserved organization of regulatory elements in their 3'UTRs we applied a novel bioinformatics/molecular biology approach to the 3'UTR sequences of Eph/ephrin transcripts. We identified clusters of motifs consisting of cytoplasmic polyadenylation elements (CPEs), AU-rich elements (AREs) and HuR binding sites. These clusters bind multiple RNA-stabilizing and destabilizing factors, including HuR. Surprisingly, despite its widely accepted role as an mRNA-stabilizing protein, we further show that binding of HuR to these clusters actually destabilizes Eph/ephrin transcripts in tumor cell lines. Consequently, knockdown of HuR greatly modulates expression of multiple Ephs/ephrins at both the mRNA and protein levels. Together our studies suggest that overexpression of HuR as found in many progressive tumors could be causative for disarranged Eph receptor to ephrin ligand ratios leading to a higher degree of tissue invasiveness.	[Winter, Jennifer; Roepcke, Stefan; Krause, Sven; Vingron, Martin; Schweiger, Susann] Max Planck Inst Mol Genet, Berlin, Germany; [Mueller, Eva-Christina; Otto, Albrecht] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schweiger, Susann] Charite Hosp, Dept Dermatol, Berlin, Germany; [Schweiger, Susann] Univ Dundee, Coll Med, Dept Neurosci & Pathol, Dundee, Scotland	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Dundee	Winter, J (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	winter@immunbio.mpg.de			Deutsche Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 577, A6]	Deutsche Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by the Deutsche Volkswagenstiftung and the Deutsche Forschungsgemeinschaft (SFB 577, project A6 to SS).	Akhmedov AT, 2000, NUCLEIC ACIDS RES, V28, P3022, DOI 10.1093/nar/28.16.3022; Bajenova O, 2003, EXP CELL RES, V291, P228, DOI 10.1016/S0014-4827(03)00373-2; Bajenova OV, 2001, J BIOL CHEM, V276, P31067, DOI 10.1074/jbc.M104093200; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Carosa E, 2002, J BIOL CHEM, V277, P656, DOI 10.1074/jbc.M107004200; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dobi A, 2006, J BIOL CHEM, V281, P28889, DOI 10.1074/jbc.M511858200; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Drescher U, 2002, CURR OPIN GENET DEV, V12, P397, DOI 10.1016/S0959-437X(02)00316-7; Du L, 2005, RNA, V11, P1340, DOI 10.1261/rna.2870505; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Enokizono Yoshiaki, 2003, Nucleic Acids Res Suppl, P231; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; HARIHARAN N, 1989, GENE DEV, V3, P1789, DOI 10.1101/gad.3.11.1789; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang YS, 2007, METHOD ENZYMOL, V431, P143, DOI 10.1016/S0076-6879(07)31008-2; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Jackson AP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-137; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Kafasla P, 2002, BIOCHEM J, V363, P793, DOI 10.1042/0264-6021:3630793; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kozmik Z, 2008, EVOL DEV, V10, P52, DOI 10.1111/j.1525-142X.2007.00213.x; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118; Rehbein M, 2002, J NEUROCHEM, V82, P1039, DOI 10.1046/j.1471-4159.2002.01058.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Shim S, 2007, MOL CELL BIOL, V27, P1614, DOI 10.1128/MCB.01429-06; Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Theil T, 1998, DEVELOPMENT, V125, P443; Zelinski DP, 2002, J CELL BIOCHEM, V85, P714, DOI 10.1002/jcb.10186; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2780	10.1371/journal.pone.0002780	http://dx.doi.org/10.1371/journal.pone.0002780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648668	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000264302900050
J	Zhuang, D; Mannava, S; Grachtchouk, V; Tang, WH; Patil, S; Wawrzyniak, JA; Berman, AE; Giordano, TJ; Prochownik, EV; Soengas, MS; Nikiforov, MA				Zhuang, D.; Mannava, S.; Grachtchouk, V.; Tang, W-H; Patil, S.; Wawrzyniak, J. A.; Berman, A. E.; Giordano, T. J.; Prochownik, E. V.; Soengas, M. S.; Nikiforov, M. A.			C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells	ONCOGENE			English	Article						C-MYC; melanoma; senescence	MALIGNANT-MELANOMA; CELLULAR SENESCENCE; TUMOR-SUPPRESSOR; BRAF MUTATIONS; P53; ONCOPROTEIN; CANCER; CYCLE; NEVI; TRANSFORMATION	Malignant melanomas often harbor activating mutations in BRAF (V600E) or, less frequently, in NRAS (Q61R). Intriguingly, the same mutations have been detected at higher incidences in benign nevi, which are largely composed of senescent melanocytes. Overexpression of BRAF(V600E) or NRAS(Q61R) in human melanocytes in vitro has been shown to induce senescence, although via different mechanisms. How oncogene-induced senescence is overcome during melanoma progression remains unclear. Here, we report that in the majority of analysed BRAF(V600E)- or NRAS(Q61R)-expressing melanoma cells, C-MYC depletion induced different yet overlapping sets of senescence phenotypes that are characteristic of normal melanocytes undergoing senescence due to overexpression of BRAF(V600E) or NRAS(Q61R), respectively. These senescence phenotypes were p16(INK4A)- or p53-independent, however, several of them were suppressed by genetic or pharmacological inhibition of BRAF(V600E) or phosphoinositide 3-kinase pathways, including rapamycin-mediated inhibition of mTOR-raptor in NRAS(Q61R)-expressing melanoma cells. Reciprocally, overexpression of C-MYC in normal melanocytes suppressed BRAF(V600E)-induced senescence more efficiently than NRAS(Q61R)-induced senescence, which agrees with the generally higher rates of activating mutations in BRAF than NRAS gene in human cutaneous melanomas. Our data suggest that one of the major functions of C-MYC overexpression in melanoma progression is to continuous suppress BRAF(V600E)- or NRAS(Q61R)-dependent senescence programs.	[Zhuang, D.; Mannava, S.; Grachtchouk, V.; Wawrzyniak, J. A.; Nikiforov, M. A.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Zhuang, D.; Mannava, S.; Grachtchouk, V.; Tang, W-H; Patil, S.; Soengas, M. S.; Nikiforov, M. A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Zhuang, D.; Mannava, S.; Grachtchouk, V.; Tang, W-H; Patil, S.; Giordano, T. J.; Soengas, M. S.; Nikiforov, M. A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Berman, A. E.] RAMS, Inst Biomed Chem, Moscow, Russia; [Giordano, T. J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Prochownik, E. V.] Childrens Hosp Pittsburgh, Rangos Res Ctr, Hematol Oncol Sect, Pittsburgh, PA 15213 USA	Roswell Park Cancer Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nikiforov, MA (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Elm & Carlton St,L3-317, Buffalo, NY 14263 USA.	mikhail.nikiforov@roswellpark.org	EBerman, Albert/F-5042-2017; Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Giordano, Thomas/0000-0003-0641-8873	NIH [R01 CA120244, CA107237]; University of Michigan's Cancer Center [NIH 5 P30 CA46592]; Melanoma Research Foundation Scholar; NATIONAL CANCER INSTITUTE [R01CA120244, R01CA107237, P30CA046592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); Melanoma Research Foundation Scholar; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Michelle Vinco for assistance with the human tissue work. This work was supported by Grants NIH R01 CA120244 (MAN), CA107237 (MSS), and, in part, by the University of Michigan's Cancer Center Support Grant (NIH 5 P30 CA46592). MAN is a Melanoma Research Foundation Scholar.	Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Biroccio A, 2003, J BIOL CHEM, V278, P35693, DOI 10.1074/jbc.M304597200; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goding C R, 2000, Forum (Genova), V10, P176; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Greulich KM, 2000, CANCER, V89, P97, DOI 10.1002/1097-0142(20000701)89:1<97::AID-CNCR14>3.0.CO;2-0; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Ross DA, 1998, BRIT J SURG, V85, P46; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	50	151	158	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6623	6634		10.1038/onc.2008.258	http://dx.doi.org/10.1038/onc.2008.258			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18679422	Green Accepted			2022-12-25	WOS:000260638800001
J	Gong, KZ; Li, ZJ; Xu, M; Du, JH; Lv, ZZ; Zhang, YY				Gong, Kaizheng; Li, Zijian; Xu, Ming; Du, Jianhai; Lv, Zhizhen; Zhang, Youyi			A Novel Protein Kinase A-independent, beta-Arrestin-1-dependent Signaling Pathway for p38 Mitogen-activated Protein Kinase Activation by beta(2)-Adrenergic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN RECRUITMENT; NF-KAPPA-B; NADPH OXIDASE; COUPLED RECEPTORS; MAPK ACTIVATION; ANGIOTENSIN-II; PHOSPHORYLATION; P38-ALPHA; APOPTOSIS; RAC1	A growing body of evidence has demonstrated that p38 mitogen-activated protein kinase (MAPK) has a crucial role in various physiological and pathological processes mediated by beta(2)-adrenergic receptors (beta(2)-ARs). However, the detailed mechanism of beta(2)-ARs-induced p38 MAPK activation has not yet been fully defined. The present study demonstrates a novel kinetic model of p38 MAPK activation induced by beta(2)-ARs in human embryonic kidney 293A cells. The beta(2)-AR agonist isoproterenol induced a time-dependent biphasic phosphorylation of p38 MAPK: the early phase peaked at 10 min, and was followed by a delayed phase that appeared at 90 min and was sustained for 6 h. Interestingly, inhibition of the cAMP/protein kinase A (PKA) pathway failed to affect the early phosphorylation but abolished the delayed activation. By contrast, silencing of beta-arrestin-1 expression by small interfering RNA inhibited the early phase activation of p38 MAPK. Furthermore, the NADPH oxidase complex is a downstream target of beta-arrestin-1, as evidenced by the fact that isoproterenol-induced Rac1 activation was also suppressed by beta-arrestin-1 knockdown. In addition, early phase activation of p38 MAPK was prevented by inactivation of Rac1 and NADPH oxidase by pharmacological inhibitors, overexpression of a dominant negative mutant of Rac1, and p47(phox) knockdown by RNA interference. Of note, we demonstrated that only early activation of p38 MAPK is involved in isoproterenol-induced F-actin rearrangement. Collectively, these data suggest that the classic cAMP/PKA pathway is responsible for the delayed activation, whereas a beta-arrestin-1/Rac1/NADPH oxidase-dependent signaling is a heretofore unrecognized mechanism for beta(2)-AR-mediated early activation of p38 MAPK.	Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100191, Peoples R China; Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University	Zhang, YY (corresponding author), Huayuan Bei Rd 49, Beijing 100191, Peoples R China.	zhangyy@bjmu.edu.cn	Du, Jianhai/J-6197-2014	Du, Jianhai/0000-0002-5612-4091	People's Republic of China [G2006CB503806]; Natural Science Foundation of China [30672466, 30570716]	People's Republic of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of the People's Republic of China Grant G2006CB503806 and Natural Science Foundation of China Grants 30672466 and 30570716. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Chi David S., 2004, BMC Immunology, V5; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gerlo S, 2006, CELL MOL LIFE SCI, V63, P92, DOI 10.1007/s00018-005-5433-4; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Magne S, 2001, J BIOL CHEM, V276, P39539, DOI 10.1074/jbc.M100954200; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okada T, 2005, AM J PHYSIOL-HEART C, V289, pH2310, DOI 10.1152/ajpheart.00462.2005; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Pomerance M, 2000, J BIOL CHEM, V275, P40539, DOI 10.1074/jbc.M002097200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Siow YL, 2006, BIOCHEM J, V398, P73, DOI 10.1042/BJ20051810; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vogt A, 2007, CELL SIGNAL, V19, P1229, DOI 10.1016/j.cellsig.2007.01.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Yin F, 2003, J BIOL CHEM, V278, P21070, DOI 10.1074/jbc.M211028200; Zhao M, 2004, J BIOL CHEM, V279, P49259, DOI 10.1074/jbc.M405118200; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	58	55	58	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29028	29036		10.1074/jbc.M801313200	http://dx.doi.org/10.1074/jbc.M801313200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18678875	Green Published, hybrid			2022-12-25	WOS:000260179900029
J	Gupta, N; Ragsdale, SW				Gupta, Nirupama; Ragsdale, Stephen W.			Dual roles of an essential cysteine residue in activity of a redox-regulated bacterial transcriptional activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; DNA-BINDING DOMAIN; DEHALORESPIRATION; DEHALOGENATION; EXPRESSION; REDUCTION; VECTORS; CLUSTER; CPRK1	CprK from Desulfitobacterium dehalogenans is the first characterized transcriptional regulator of anaerobic dehalorespiration and is controlled at two levels: redox and effector binding. In the reduced state and in the presence of chlorinated aromatic compounds, CprK positively regulates expression of the cpr gene cluster. One of the products of the cpr gene cluster is CprA, which catalyzes the reductive dehalogenation of chlorinated aromatic compounds. Redox regulation of CprK occurs through a thiol/ disulfide redox switch, which includes two classes of cysteine residues. Under oxidizing conditions, Cys(11) and Cys(200) form an intermolecular disulfide bond, whereas Cys(105) and Cys(111) form an intramolecular disulfide. Here, we report that Cys(11) is involved in redox inactivation in vivo. Upon replacement of Cys(11) with serine, alanine, or aspartate, CprK loses its DNA binding activity. C11A is unstable; however, circular dichroism studies demonstrate that the stability and overall secondary structures of CprK and the C11S and C11D variants are similar. Furthermore, effector binding remains intact in the C11S and C11D variants. However, fluorescence spectroscopic results reveal that the tertiary structures of the C11S and C11D variants differ from that of the wild type protein. Thus, Cys(11) plays a dual role as a redox switch and in maintaining the correct tertiary structure that promotes DNA binding.	[Gupta, Nirupama; Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	gupta, nirupama/H-2297-2012		National Institutes of Health [1P20RR17675]; National Science Foundation [GM 39451]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P20RR17675. This work was also supported by National Science Foundation Grant GM 39451 (to S. W. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Gabor K, 2006, J BACTERIOL, V188, P2604, DOI 10.1128/JB.188.7.2604-2613.2006; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; GIESE NA, 1987, SCIENCE, V236, P1315, DOI 10.1126/science.3035718; Grossel MJ, 1996, J VIROL, V70, P7264, DOI 10.1128/JVI.70.10.7264-7269.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Joyce MG, 2006, J BIOL CHEM, V281, P28318, DOI 10.1074/jbc.M602654200; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Krasotkina J, 2001, J BIOL CHEM, V276, P40991, DOI 10.1074/jbc.M106217200; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lambert C, 2007, J BIOL CHEM, V282, P19666, DOI 10.1074/jbc.M611527200; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Mazon H, 2007, J BIOL CHEM, V282, P11281, DOI 10.1074/jbc.M611177200; MCBRIDE AA, 1992, P NATL ACAD SCI USA, V89, P7531, DOI 10.1073/pnas.89.16.7531; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Nath MD, 2001, ARCH BIOCHEM BIOPHYS, V392, P287, DOI 10.1006/abbi.2001.2449; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; PAJARES MA, 1991, BIOCHEM J, V274, P225, DOI 10.1042/bj2740225; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rotrekl V, 1999, EUR J BIOCHEM, V266, P1056, DOI 10.1046/j.1432-1327.1999.00948.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Smidt H, 2000, J BACTERIOL, V182, P5683, DOI 10.1128/JB.182.20.5683-5691.2000; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; UTKIN I, 1994, INT J SYST BACTERIOL, V44, P612, DOI 10.1099/00207713-44-4-612; Villemur R, 2006, FEMS MICROBIOL REV, V30, P706, DOI 10.1111/j.1574-6976.2006.00029.x; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; WATERMAN MR, 1974, BIOCHIM BIOPHYS ACTA, V371, P159, DOI 10.1016/0005-2795(74)90165-2; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; Wiegel J, 1999, APPL ENVIRON MICROB, V65, P2217; Yang YK, 2007, AM J PHYSIOL-REG I, V293, pR1120, DOI 10.1152/ajpregu.00240.2007; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	44	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28721	28728		10.1074/jbc.M800630200	http://dx.doi.org/10.1074/jbc.M800630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687692	Green Published, hybrid			2022-12-25	WOS:000259969300074
J	Yamashita, A; Nijo, N; Pospisil, P; Morita, N; Takenaka, D; Aminaka, R; Yamamoto, Y; Yamamoto, Y				Yamashita, Amu; Nijo, Nobuyoshi; Pospisil, Pavel; Morita, Noriko; Takenaka, Daichi; Aminaka, Ryota; Yamamoto, Yoko; Yamamoto, Yasusi			Quality control of photosystem II - Reactive oxygen species are responsible for the damage to photosystem II under moderate heat stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D1 PROTEIN; THYLAKOID MEMBRANES; SPINACH THYLAKOIDS; SINGLET OXYGEN; ACCEPTOR-SIDE; ANTENNA SIZE; PHOTOINHIBITION; TEMPERATURE; TURNOVER; INACTIVATION	Moderate heat stress (40 degrees C for 30 min) on spinach thylakoid membranes induced cleavage of the reaction center-binding D1 protein of photosystem II, aggregation of the D1 protein with the neighboring polypeptides D2 and CP43, and release of three extrinsic proteins, PsbO, -P, and -Q. These heat-induced events were suppressed under anaerobic conditions or by the addition of sodium ascorbate, a general scavenger of reactive oxygen species. In accordance with this, singlet oxygen and hydroxyl radicals were detected in spinach photosystem II membranes incubated at 40 C for 30 min with electron paramagnetic resonance spin-trapping spectroscopy. The moderate heat stress also induced significant lipid peroxidation under aerobic conditions. We suggest that the reactive oxygen species are generated by heat-induced inactivation of a water-oxidizing manganese complex and through lipid peroxidation. Although occurring in the dark, the damages caused by the moderate heat stress to photosystem II are quite similar to those induced by excessive illumination where reactive oxygen species are involved.	[Yamashita, Amu; Nijo, Nobuyoshi; Morita, Noriko; Takenaka, Daichi; Aminaka, Ryota; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Pospisil, Pavel] Palacky Univ, Biophys Lab, Dept Expt Phys, Fac Sci, Olomouc 77146, Czech Republic; [Yamamoto, Yoko] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	Okayama University; Palacky University Olomouc; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [18570042, 20570039]; Ministry of Education, Youth and Sports of the Czech Republic [6198959215]; Grant Agency of the Czech Republic [522/06/0979]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by Grants-in-aid for Scientific Research 18570042 and 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. Y.), Ministry of Education, Youth and Sports of the Czech Republic Grant MSM 6198959215, and Grant Agency of the Czech Republic Grant 522/06/0979 ( to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson B, 1997, PHYSIOL PLANTARUM, V100, P780, DOI 10.1034/j.1399-3054.1997.1000405.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; CAO J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P180, DOI 10.1016/0005-2728(90)90018-Y; ENAMI I, 1994, BBA-BIOENERGETICS, V1186, P52, DOI 10.1016/0005-2728(94)90134-1; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Gutteridge J M, 1983, J Appl Biochem, V5, P293; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HIDEG E, 1993, PHOTOCHEM PHOTOBIOL, V58, P280, DOI 10.1111/j.1751-1097.1993.tb09562.x; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; MISHRA RK, 1992, PLANT PHYSIOL, V99, P1; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; MIYAO M, 1994, BIOCHEMISTRY-US, V33, P9722, DOI 10.1021/bi00198a043; NASH D, 1985, BIOCHIM BIOPHYS ACTA, V807, P127, DOI 10.1016/0005-2728(85)90115-X; OHAD I, 1984, J CELL BIOL, V270, P14919; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2003, BIOPHYS J, V84, P1370, DOI 10.1016/S0006-3495(03)74952-2; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; SUNDBY C, 1986, BIOCHIM BIOPHYS ACTA, V851, P475, DOI 10.1016/0005-2728(86)90084-8; THOMPSON LK, 1989, BIOCHEMISTRY-US, V28, P6686, DOI 10.1021/bi00442a023; Wydrzynski T, 1996, PHYSIOL PLANTARUM, V96, P342, DOI 10.1111/j.1399-3054.1996.tb00224.x; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; Yamamoto Y, 1998, BIOCHEMISTRY-US, V37, P1565, DOI 10.1021/bi9707640; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; YAMAMOTO Y, 1983, OXYGEN EVOLVING SYST, P229; Yamane Y, 1998, PHOTOSYNTH RES, V57, P51, DOI 10.1023/A:1006019102619; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200	45	75	81	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28380	28391		10.1074/jbc.M710465200	http://dx.doi.org/10.1074/jbc.M710465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664569	Green Published, hybrid			2022-12-25	WOS:000259969300040
J	Das, B; Gupta, S; Vasanji, A; Xu, Z; Misra, S; Sen, S				Das, Biswajit; Gupta, Sudhiranjan; Vasanji, Amit; Xu, Zhen; Misra, Saurav; Sen, Subha			Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth - Regulation by myotrophin hairpin loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANKYRIN REPEAT PROTEIN; CARDIAC-HYPERTROPHY; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; CAPPING PROTEIN; ANGIOTENSIN-II; ACTIVATION; GENE; EXPRESSION	Myotrophin, a 12-kDa ankyrin repeat protein, stimulates protein synthesis and cardiomyocyte growth to initiate cardiac hypertrophy by activating the NF-kappa B signaling cascade. We found that, after internalization into myocytes, myotrophin co-translocates into the nucleus with p65 to stimulate myocyte growth. We used structure-based mutations on the hairpin loops of myotrophin to determine the effect of the loops on myotrophin and p65 localization, induction of protein synthesis, and cardiac hypertrophy. Loop mutants, most prominently glutamic acid 33 -> alanine (E33A), stimulated protein synthesis much less than wild type. Myotrophin-E33A internalized into myocytes but did not translocate into the nucleus and failed to promote nuclear translocation of p65. In addition, two cardiac hypertrophy marker genes, atrial natriuretic factor and beta-myosin heavy chain, were not up-regulated in E33A-treated cells. Myotrophin-induced myocyte growth and initiation of hypertrophy thus require nuclear co-translocation of myotrophin and p65, in a manner that depends crucially on the myotrophin hairpin loops.	[Das, Biswajit; Gupta, Sudhiranjan; Xu, Zhen; Misra, Saurav; Sen, Subha] Cleveland Clin, Dept Mol Cardiol, LRI, Cleveland, OH 44195 USA; [Vasanji, Amit] Cleveland Clin, Image Proc & Anal Ctr, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sen, S (corresponding author), Cleveland Clin, Dept Mol Cardiol, LRI, NB-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	sens@ccf.org		Misra, Saurav/0000-0002-1385-8554	National Institutes of Health [HL R01 47794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL R01 47794 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson KM, 1999, J MOL CELL CARDIOL, V31, P705, DOI 10.1006/jmcc.1998.0903; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Brigelus-Flohe R, 1995, BIOFACTORS, V5, P169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goddard T. D., 2006, SPARKY; Gupta S, 2005, AM J PHYSIOL-HEART C, V289, pH20, DOI 10.1152/ajpheart.00082.2005; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jones W Keith, 2003, Cardiovasc Toxicol, V3, P229, DOI 10.1385/CT:3:3:229; Kalra D, 2000, CIRCULATION, V102, P1302, DOI 10.1161/01.CIR.102.11.1302; Khan SQ, 2007, CLIN SCI, V112, P251, DOI 10.1042/CS20060191; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Kobayashi S, 2005, GENES CELLS, V10, P253, DOI 10.1111/j.1365-2443.2005.00835.x; Lowe AR, 2007, J MOL BIOL, V365, P1245, DOI 10.1016/j.jmb.2006.10.060; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Mosavi LK, 2002, J MOL BIOL, V320, P165, DOI 10.1016/S0022-2836(02)00441-2; MUKHERJEE DP, 1993, HYPERTENSION, V21, P142, DOI 10.1161/01.HYP.21.2.142; O'Brien RJ, 2003, J AM COLL CARDIOL, V42, P719, DOI 10.1016/S0735-1097(03)00755-1; Purcell NH, 2003, CIRCULATION, V108, P638, DOI 10.1161/01.CIR.0000085362.40608.DD; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Qin J, 2006, ACTA PHARMACOL SIN, V27, P1159, DOI 10.1111/j.1745-7254.2006.00370.x; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rouet-Benzineb P, 2000, J MOL CELL CARDIOL, V32, P1767, DOI 10.1006/jmcc.2000.1211; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; SEN S, 1990, J BIOL CHEM, V265, P16635; Sil P, 1998, CIRC RES, V82, P1173, DOI 10.1161/01.RES.82.11.1173; Sil P, 2004, MOL CELL BIOCHEM, V262, P79, DOI 10.1023/B:MCBI.0000038219.46896.a4; SIL P, 1993, CIRC RES, V73, P98, DOI 10.1161/01.RES.73.1.98; Sivasubramanian N, 1996, J BIOL CHEM, V271, P2812, DOI 10.1074/jbc.271.5.2812; TAOKA M, 1994, J BIOL CHEM, V269, P9946; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Wong SCY, 1998, CIRCULATION, V98, P100, DOI 10.1161/01.CIR.98.2.100; Yamakuni T, 2002, BIOCHEM BIOPH RES CO, V298, P793, DOI 10.1016/S0006-291X(02)02529-9; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Yang YW, 1997, PROTEIN SCI, V6, P1347, DOI 10.1002/pro.5560060625	41	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27947	27956		10.1074/jbc.M801210200	http://dx.doi.org/10.1074/jbc.M801210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693253	hybrid, Green Published			2022-12-25	WOS:000259719200065
J	Hsieh, MCF; Das, D; Sambandam, N; Zhang, MQ; Nahle, Z				Hsieh, Michael C. F.; Das, Debopriya; Sambandam, Nandakumar; Zhang, Michael Q.; Nahle, Zaher			Regulation of the PDK4 isozyme by the Rb-E2F1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE KINASE; CELL-CYCLE PROGRESSION; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; CANCER-CELLS; TRANSCRIPTIONAL REGULATION; MUSCLE-CELLS; E2F FAMILY; S-PHASE; INACTIVATION	Loss of the transcription factor E2F1 elicits a complex metabolic phenotype in mice underscored by reduced adiposity and protection from high fat diet-induced diabetes. Here, we demonstrate that E2F1 directly regulates the gene encoding PDK4 (pyruvate dehydrogenase kinase 4), a key nutrient sensor and modulator of glucose homeostasis that is chronically elevated in obesity and diabetes and acutely induced under the metabolic stress of starvation or fasting. We show that loss of E2F1 in vivo blunts PDK4 expression and improves myocardial glucose oxidation. The absence of E2F1 also corresponds to lower blood glucose levels, improved plasma lipid profile, and increased sensitivity to insulin stimulation. Consistently, enforced E2F1 expression up-regulates PDK4 levels and suppresses glucose oxidation in C2C12 myoblasts. Furthermore, inactivation of Rb, the repressor of E2F-dependent transcription, markedly induces PDK4 and triggers the enrichment of E2F1 occupancy onto the PDK4 promoter as detected by chromatin immunoprecipitation analysis. Two overlapping E2F binding sites were identified on this promoter. Transactivation assays later verified E2F1 responsiveness of this promoter element in C2C12 myoblasts and IMR90 fibroblasts, an effect that was completely abrogated following mutation of the E2F sites. Taken together, our data illustrate how the E2F1 mitogen directly regulates PDK4 levels and influences cellular bioenergetics, namely mitochondrial glucose oxidation. These results are relevant to the pathophysiology of chronic diseases like obesity and diabetes, where PDK4 is dysregulated and could have implications pertinent to the etiology of tumor metabolism, especially in cancers with Rb pathway defects.	[Hsieh, Michael C. F.; Sambandam, Nandakumar; Nahle, Zaher] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Das, Debopriya] Ernest O Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94270 USA; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Cold Spring Harbor Laboratory	Nahle, Z (corresponding author), Weill Cornell Med Coll, Dept Cardiothorac Surg, Div Thorac Surg, 1300 York Ave,69th St,A Bldg, New York, NY 10065 USA.	znahle@DOM.wustl.edu			American Heart Association [0760028Z]	American Heart Association(American Heart Association)	This work was supported by American Heart Association beginning Grant-in-Aid 0760028Z (to Z.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x; Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Darville MI, 1997, NUCLEIC ACIDS RES, V25, P2759, DOI 10.1093/nar/25.14.2759; DARVILLE MI, 1995, ONCOGENE, V11, P1509; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; XUAN Z, 2005, GENOME BIOL, V6; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	45	81	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27410	27417		10.1074/jbc.M802418200	http://dx.doi.org/10.1074/jbc.M802418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667418	hybrid			2022-12-25	WOS:000259719200009
J	Tu, SL; Chen, HC; Ku, LW				Tu, Shih-Long; Chen, Hsiu-Chen; Ku, Li-Wen			Mechanistic studies of the phytochromobilin synthase HY2 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOCYANOBILIN-FERREDOXIN OXIDOREDUCTASE; CYANOBACTERIAL PHYCOCYANOBILIN; CHROMOPHORE BIOSYNTHESIS; CRYSTAL-STRUCTURE; BILIVERDIN; BINDING; COMPLEX; DEFICIENT; PCYA; REDUCTION	Phytochromobilin (P Phi B) is an open chain tetrapyrrole molecule that functions as the chromophore of light-sensing phytochromes in plants. Derived from heme, P Phi B is synthesized through an open chain tetrapyrrole intermediate, biliverdin IX alpha (BV), in the biosynthesis pathway. BV is subsequently reduced by the P Phi B synthase HY2 in plants. HY2 is a ferredoxin-dependent bilin reductase that catalyzes the reduction of the A-ring 2,3,3(1),3(2)-diene system to produce an ethylidene group for assembly with apophytochromes. In this study, we sought to determine the catalytic mechanism of HY2. Data from UV-visible and EPR spectroscopy showed that the HY2-catalyzed BV reaction proceeds via a transient radical intermediate. Site-directed mutagenesis showed several ionizable residues that are involved in the catalytic steps. Detailed analysis of these site-directed mutants highlighted a pair of aspartate residues central to proton donation and substrate positioning. A mechanistic prediction for the HY2 reaction is proposed. These results support the hypothesis that ferredoxin-dependent bilin reductases reduce BV through a radical mechanism, but their double bond specificity is decided by strategic placement of different proton-donating residues surrounding the bilin substrate in the active sites.	[Tu, Shih-Long; Chen, Hsiu-Chen; Ku, Li-Wen] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tu, SL (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	tsl@gate.sinica.edu.tw	Tu, Shih-Long/ABF-5446-2021	Tu, Shih-Long/0000-0001-9436-278X	National Science Council [96-2311-B-001019-MY2]; Academia Sinica of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 96-2311-B-001019-MY2 (to S.-L.T.) and Academia Sinica of Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; CHORY J, 1989, PLANT CELL, V1, P867, DOI 10.1105/tpc.1.9.867; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Dose MM, 1997, PLANT PHYSIOL, V114, P1047, DOI 10.1104/pp.114.3.1047; ELICH TD, 1989, J BIOL CHEM, V264, P183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falk H., 1989, CHEM LINEAR OLIGOPYR; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2006, FEBS LETT, V580, P3823, DOI 10.1016/j.febslet.2006.05.075; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KROIS D, 1995, MONATSH CHEM, V126, P349, DOI 10.1007/BF00816104; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P17680, DOI 10.1021/bi981718i; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; SCHLUCHTER WM, 1994, THESIS PENNSYLVANIA; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2006, J BIOL CHEM, V281, P3127, DOI 10.1074/jbc.M510126200; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z	26	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27555	27564		10.1074/jbc.M803761200	http://dx.doi.org/10.1074/jbc.M803761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658149	hybrid			2022-12-25	WOS:000259719200026
J	Witola, WH; El Bissati, K; Pessi, G; Xie, C; Roepe, PD; Ben Mamoun, C				Witola, William Harold; El Bissati, Kamal; Pessi, Gabriella; Xie, Changan; Roepe, Paul D.; Ben Mamoun, Choukri			Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRANSFERASE; PHOSPHOCHOLINE BIOSYNTHESIS; PARASITES; METHYLATION; CLONING; YEAST	Biochemical studies in the human malaria parasite, Plasmodium falciparum, indicated that in addition to the pathway for synthesis of phosphatidylcholine from choline (CDP-choline pathway), the parasite synthesizes this major membrane phospholipid via an alternative pathway named the serine-decarboxylasephosphoethanolamine-methyltransferase (SDPM) pathway using host serine and ethanolamine as precursors. However, the role the transmethylation of phosphatidylethanolamine plays in the biosynthesis of phosphatidylcholine and the importance of the SDPM pathway in the parasite's growth and survival remain unknown. Here, we provide genetic evidence that knock-out of the PfPMT gene encoding the phosphoethanolamine methyltransferase enzyme completely abrogates the biosynthesis of phosphatidylcholine via the SDPM pathway. Lipid analysis in knock-out parasites revealed that unlike in mammalian and yeast cells, methylation of phosphatidylethanolamine to phosphatidylcholine does not occur in P. falciparum, thus making the SDPM and CDP-choline pathways the only routes for phosphatidylcholine biosynthesis in this organism. Interestingly, loss of PfPMT resulted in significant defects in parasite growth, multiplication, and viability, suggesting that this gene plays an important role in the pathogenesis of intraerythrocytic Plasmodium parasites.	[Witola, William Harold; El Bissati, Kamal; Pessi, Gabriella; Ben Mamoun, Choukri] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Xie, Changan; Roepe, Paul D.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Xie, Changan; Roepe, Paul D.] Georgetown Univ, Dept Biochem Cellular & Mol Biol, Washington, DC 20057 USA	University of Connecticut; Georgetown University; Georgetown University	Ben Mamoun, C (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	choukri@up.uchc.edu	Witola, WIlliam Harold/AAD-6647-2020; Pessi, Gabriella/AGW-2342-2022	EL BISSATI, KAMAL/0000-0001-9341-4162; Pessi, Gabriella/0000-0002-8138-5541	National Institutes of Health [AI51507, AI51962]; Department of Defense [PR033005]; Burroughs Wellcome Fund [1006267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI51507 and AI51962. This research was also supported by Department of Defense Grant PR033005 as well as by Burroughs Wellcome Fund Award 1006267 (to C. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; BRENDZA KM, 2007, BIOCH J; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Gligorijevic B, 2008, MOL BIOCHEM PARASIT, V159, P7, DOI 10.1016/j.molbiopara.2007.12.014; Gligorijevic B, 2006, BIOCHEMISTRY-US, V45, P12400, DOI 10.1021/bi061033f; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Krishna S, 1997, BMJ-BRIT MED J, V315, P730, DOI 10.1136/bmj.315.7110.730; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; SUMMERS EF, 1988, GENETICS, V120, P909; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; WHO Expert Committee on Malaria, 2000, WHO TECH REP SER, V892, P1; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07; ZEISEL SH, 1980, NEUROLOGY, V30, P1226, DOI 10.1212/WNL.30.11.1226; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976	32	59	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27636	27643		10.1074/jbc.M804360200	http://dx.doi.org/10.1074/jbc.M804360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694927	Green Published, hybrid			2022-12-25	WOS:000259719200035
J	Zhang, HS; Kruk, JA; Reese, JC				Zhang, Hesheng; Kruk, Jennifer A.; Reese, Joseph C.			Dissection of coactivator requirement at RNR3 reveals unexpected contributions from TFIID and SAGA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; GENERAL TRANSCRIPTION MACHINERY; UPSTREAM ACTIVATING SEQUENCES; TBP-ASSOCIATED FACTORS; RNA-POLYMERASE-II; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CORE PROMOTER; YEAST; RECRUITMENT	The gene encoding ribonucleotide reductase 3 (RNR3)is strongly induced in response to DNA damage. Its expression is strictly dependent upon the TAF(II) subunits of TFIID, which are required for the recruitment of SWI/SNF and nucleosome remodeling. However, full activation of RNR3 also requires GCN5, the catalytic subunit of the SAGA histone acetyltransferase complex. Thus, RNR3 is dependent upon both TFIID and SAGA, two complexes that deliver TATA-binding protein (TBP) to promoters. Furthermore, unlike the majority of TFIID-dominated genes, RNR3 contains a consensus TATA-box, a feature of SAGA-regulated core promoters. Although a large fraction of the genome can be characterized as either TFIID-or SAGA-dominant, it is expected that many genes utilize both. The mechanism of activation and the relative contributions of SAGA and TFIID at genes regulated by both complexes have not been examined. Here we delineated the role of SAGA in the regulation of RNR3 and contrast it to that of TFIID. We find that SAGA components fulfill distinct functions in the regulation of RNR3. The core promoter of RNR3 is SAGA-dependent, and we provide evidence that SAGA, not TAF(II)s within TFIID, are largely responsible for TBP recruitment. This taken together with our previous work provides evidence that SAGA recruits TBP, whereas TFIID mediates chromatin remodeling. Thus, we described an unexpected shift in the division of labor between these two complexes and provide the first characterization of a gene that requires both SAGA and TFIID.	[Zhang, Hesheng; Kruk, Jennifer A.; Reese, Joseph C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reese, JC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, 203 Althouse Lab, University Pk, PA 16802 USA.	Jcr8@psu.edu			National Institutes of Health [GM58672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58672 (to J. C. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Brachmann CB, 1998, YEAST, V14, P115; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Durso RJ, 2001, MOL CELL BIOL, V21, P7331, DOI 10.1128/MCB.21.21.7331-7344.2001; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li B, 2000, EMBO J, V19, P4091, DOI 10.1093/emboj/19.15.4091; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reese JC, 2000, J BIOL CHEM, V275, P17391, DOI 10.1074/jbc.M001635200; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Tomar RS, 2008, EMBO J, V27, P1575, DOI 10.1038/emboj.2008.93; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yu YX, 2003, MOL CELL BIOL, V23, P1910, DOI 10.1128/MCB.23.6.1910-1921.2003; Zhang HS, 2007, P NATL ACAD SCI USA, V104, P8833, DOI 10.1073/pnas.0701666104; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227; Zhang Zhengjian, 2006, Methods Mol Biol, V313, P245	55	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27360	27368		10.1074/jbc.M803831200	http://dx.doi.org/10.1074/jbc.M803831200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682387	Green Published, hybrid			2022-12-25	WOS:000259719200004
J	Khidr, L; Wu, GK; Davila, A; Procaccio, V; Wallace, D; Lee, WH				Khidr, Lily; Wu, Guikai; Davila, Antonio; Procaccio, Vincent; Wallace, Douglas; Lee, Wen-Hwa			Role of SUV3 helicase in maintaining mitochondrial Homeostasis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA DEGRADOSOME; ESCHERICHIA-COLI; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION-FACTOR; RNA/DNA HELICASE; INNER MEMBRANE; DNA NUCLEOIDS; BOX PROTEIN	In yeast mitochondria, RNA degradation takes place through the coordinated activities of ySuv3 helicase and yDss1 exoribonuclease (mtEXO), whereas in bacteria, RNA is degraded via RNaseE, Rh1B, PNPase, and enolase. Yeast lacking the Suv3 component of the mtEXO form petits and undergo a toxic accumulation of omega intron RNAs. Mammalian mitochondria resemble their prokaryotic origins by harboring a polyadenylation-dependent RNA degradation mechanism, but whether SUV3 participates in regulating RNA turnover in mammalian mitochondria is unclear. We found that lack of hSUV3 in mammalian cells subsequently yielded an accumulation of shortened polyadenylated mtRNA species and impaired mitochondrial protein synthesis. This suggests that SUV3 may serve in part as a component of an RNA degradosome, resembling its yeast ancestor. Reduction in the expression levels of oxidative phosphorylation components correlated with an increase in reactive oxygen species generation, whereas membrane potential and ATP production were decreased. These cumulative defects led to pleiotropic effects in mitochondria such as decreased mtDNA copy number and a shift in mitochondrial morphology from tubular to granular, which eventually manifests in cellular senescence or cell death. Thus, our results suggest that SUV3 is essential for maintaining proper mitochondrial function, likely through a conserved role in mitochondrial RNA regulation.	[Khidr, Lily; Wu, Guikai; Davila, Antonio; Procaccio, Vincent; Wallace, Douglas; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Davila, Antonio; Procaccio, Vincent; Wallace, Douglas] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014	procaccio, Vincent/0000-0002-1537-4684	National Institutes of Health [R01-AG027877, AG24373, AG13154, NS41850, DK73691, NS21328]; Donald Bren Endowment; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041850, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, R01AG027877, R01AG013154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald Bren Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG027877 (to W.-H.L.) and AG24373, AG13154, NS41850, DK73691, and NS21328 (to D.W.). It was also supported by the Donald Bren Endowment (to W.-H.L. and D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Attardi G, 1979, Methods Enzymol, V56, P66; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; BOGENHAGEN DF, 2007, J BIOL CHEM; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Carpousis AJ, 2001, METHOD ENZYMOL, V342, P333, DOI 10.1016/S0076-6879(01)42556-0; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; CHRZANOWSKALIGHTOWLERS ZMA, 1994, J BIOL CHEM, V269, P27322; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, FASEB J, V6, P3186, DOI 10.1096/fasebj.6.13.1397840; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; FORABOSCO A, 1972, B SOC ITAL BIOL SPER, V48, P33; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Gebauer D, 1996, INT J DEV BIOL, V40, P239; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUKAT A, 2008, NUCL ACIDS IN PRESS; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Margossian SP, 1996, TRENDS BIOCHEM SCI, V21, P392, DOI 10.1016/S0968-0004(96)90129-2; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Minczuk M, 2005, BBA-GENE STRUCT EXPR, V1729, P81, DOI 10.1016/j.bbaexp.2005.04.005; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; MORAIS R, 1988, IN VITRO CELL DEV B, V24, P649, DOI 10.1007/BF02623602; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; Pereira M, 2007, MECH AGEING DEV, V128, P609, DOI 10.1016/j.mad.2007.09.001; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Regonesi ME, 2004, NUCLEIC ACIDS RES, V32, P1006, DOI 10.1093/nar/gkh268; Rodriguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wu GK, 2003, CANCER RES, V63, P2589; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	65	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27064	27073		10.1074/jbc.M802991200	http://dx.doi.org/10.1074/jbc.M802991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678873	Green Published, hybrid			2022-12-25	WOS:000259586600027
J	Lightcap, CM; Sun, S; Lear, JD; Rodeck, U; Polenova, T; Williams, JC				Lightcap, Christine M.; Sun, Shangjin; Lear, James D.; Rodeck, Ulrich; Polenova, Tatyana; Williams, John C.			Biochemical and structural characterization of the Pak1-LC8 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NITRIC-OXIDE SYNTHASE; PROTEIN INHIBITOR; INTRINSIC DISORDER; PHOSPHORYLATION; IDENTIFICATION; LIGHT-CHAIN-1; LOCALIZATION; BINDING; PIN	Pak1 (p21-activated kinase-1) and the dynein light chain, LC8, are overexpressed in breast cancer, and their direct interaction has been proposed to regulate tumor cell survival. These effects have been attributed in part to Pak1-mediated phosphorylation of LC8 at serine 88. However, LC8 is homodimeric, which renders Ser(88) inaccessible. Moreover, Pak1 does not contain a canonical LC8 binding sequence compared with other characterized LC8 binding sequences. Together, these observations raise the question whether the Pak1/LC8 interaction is distinct (i. e. enabled by a unique interface independent of LC8 dimerization). Herein, we present results from biochemical, NMR, and crystallographic studies that show that Pak1 (residues 212-222) binds to LC8 along the same groove as canonical LC8 interaction partners (e. g. nNOS and BimL). Using LC8 point mutants K36P and T67A, we were able to differentiate Pak1 from canonical LC8 binding sequences and identify a key hydrogen bond network that compensates for the loss of the conserved glutamine in the consensus sequence. We also show that the target binding interface formed through LC8 dimerization is required to bind to Pak1 and precludes phosphorylation of LC8 at Ser88. Consistent with this observation, in vitro phosphorylation assays using activated Pak1 fail to phosphorylate LC8. Although these results define structural details of the Pak1/LC8 interaction and suggest a hierarchy of target binding affinities, they do not support the current model whereby Pak1 binds to and subsequently phosphorylates LC8 to promote anchorage-independent growth. Rather, they suggest that LC8 binding modulates Pak1 activity and/or nuclear localization.	[Lightcap, Christine M.; Williams, John C.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lightcap, Christine M.; Rodeck, Ulrich; Williams, John C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol, Philadelphia, PA 19107 USA; [Sun, Shangjin; Polenova, Tatyana] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Lear, James D.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19109 USA	Jefferson University; Jefferson University; Jefferson University; University of Delaware; University of Pennsylvania	Williams, JC (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Bluemle Life Sci Bldg,Rm 826,233 S 10th St, Philadelphia, PA 19107 USA.	jwilliam@mail.jci.tju.edu	Sun, Shangjin/E-8054-2012		National Institutes of Health (National Center for Research Resources) [S10-RR022316]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022316] Funding Source: NIH RePORTER	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health (National Center for Research Resources) Grant S10-RR022316 (to J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkin M, 2001, ANAL BIOCHEM, V299, P98, DOI 10.1006/abio.2001.5396; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472; GODDARD TD, 2006, SPARKY3; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; Kharakoz DP, 1997, BIOCHEMISTRY-US, V36, P10276, DOI 10.1021/bi961781c; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCauley SD, 2007, LIFE SCI, V80, P959, DOI 10.1016/j.lfs.2006.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; ZWART PH, 2007, CCP4 NEWSLETTER WINT, V7	50	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27314	27324		10.1074/jbc.M800758200	http://dx.doi.org/10.1074/jbc.M800758200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650427	Green Published, hybrid			2022-12-25	WOS:000259586600050
J	Perez-Jimenez, R; Wiita, AP; Rodriguez-Larrea, D; Kosuri, P; Gavira, JA; Sanchez-Ruiz, JM; Fernandez, JM				Perez-Jimenez, Raul; Wiita, Arun P.; Rodriguez-Larrea, David; Kosuri, Pallav; Gavira, Jose A.; Sanchez-Ruiz, Jose M.; Fernandez, Julio M.			Force-clamp spectroscopy detects residue co-evolution in enzyme catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; PROTEIN DISULFIDE-ISOMERASE; SINGLE-PROTEIN; ACTIVE-SITE; ELECTROSTATIC INTERACTIONS; CORRELATED MUTATIONS; EVOLUTION; NETWORK; ACTIVATION; MOLECULE	Understanding how the catalytic mechanisms of enzymes are optimized through evolution remains a major challenge in molecular biology. The concept of co-evolution implicates that compensatory mutations occur to preserve the structure and function of proteins. We have combined statistical analysis of protein sequences with the sensitivity of single molecule force-clamp spectroscopy to probe how catalysis is affected by structurally distant correlated mutations in Escherichia coli thioredoxin. Our findings show that evolutionary anti-correlated mutations have an inhibitory effect on enzyme catalysis, whereas positively correlated mutations rescue the catalytic activity. We interpret these results in terms of an evolutionary tuning of both the enzyme-substrate binding process and the chemistry of the active site. Our results constitute a direct observation of distant residue co-evolution in enzyme catalysis.	[Perez-Jimenez, Raul; Wiita, Arun P.; Kosuri, Pallav; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Wiita, Arun P.] Columbia Univ, Grad Program Neurobiol & Behav, New York, NY 10027 USA; [Rodriguez-Larrea, David; Sanchez-Ruiz, Jose M.] Univ Granada, Dept Quim Fis, Fac Ciencias, E-18071 Granada, Spain; [Kosuri, Pallav] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Gavira, Jose A.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Lab Estudios Cristalograf, Granada 18100, Spain	Columbia University; Columbia University; University of Granada; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, 1011A Fairchild Ctr,1212 Amsterdam Ave,MC 2449, New York, NY 10027 USA.	jfernandez@columbia.edu	Kosuri, Pallav/J-8279-2012; Rodriguez-Larrea, David/ABH-3171-2020; Sanchez-Ruiz, Jose/H-2849-2015; Gavira, Jose A./C-2491-2009; Perez-Jimenez, Raul/C-3085-2017	Kosuri, Pallav/0000-0002-7025-3543; Rodriguez-Larrea, David/0000-0002-5580-7413; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Gavira, Jose A./0000-0002-7386-6484; Perez-Jimenez, Raul/0000-0001-7094-6799	National Institutes of Health [HL66030, HL61228]; Spanish Ministry of Education and Science, FEDER Funds [BIO2006- 07332]; Junta de Andalucia [CVI-771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science, FEDER Funds(Spanish Government); Junta de Andalucia(Junta de Andalucia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66030 and HL61228 (to J.M.F.). This work was also supported by Grant BIO2006- 07332 from the Spanish Ministry of Education and Science, FEDER Funds, and Grant CVI-771 from Junta de Andalucia (to J.M.S.-R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Choi SS, 2005, NAT GENET, V37, P1367, DOI 10.1038/ng1685; Dillet V, 1998, BIOCHEMISTRY-US, V37, P10298, DOI 10.1021/bi980333x; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Masip L, 2008, J BIOL CHEM, V283, P840, DOI 10.1074/jbc.M705147200; Mateu MG, 1999, P NATL ACAD SCI USA, V96, P3595, DOI 10.1073/pnas.96.7.3595; Mossner E, 1998, PROTEIN SCI, V7, P1233; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PATTHY L, 1999, PROTEIN EVOLUTION, P80; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Perez-Jimenez R, 2006, BIOPHYS CHEM, V119, P240, DOI 10.1016/j.bpc.2005.09.010; Pritchard L, 2000, J THEOR BIOL, V202, P77, DOI 10.1006/jtbi.1999.1043; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; SLABY I, 1975, J BIOL CHEM, V250, P1340; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; WILSON KP, 1992, J BIOL CHEM, V267, P10842; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199	56	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27121	27129		10.1074/jbc.M803746200	http://dx.doi.org/10.1074/jbc.M803746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18687682	hybrid, Green Published			2022-12-25	WOS:000259586600033
J	Xu, J; Li, Y; Wang, Y; Liu, HX; Lei, L; Yang, HL; Liu, GQ; Ren, DT				Xu, Juan; Li, Yuan; Wang, Ying; Liu, Hongxia; Lei, Lei; Yang, Hailian; Liu, Guoqin; Ren, Dongtao			Activation of MAPK kinase 9 induces ethylene and camalexin biosynthesis and enhances sensitivity to salt stress in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MAP KINASE; DISEASE RESISTANCE; SALICYLIC-ACID; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; THALIANA; DEFENSE; CASCADE; GENE; PATHWAY	Mitogen-activated protein kinase (MAPK) cascades play important roles in regulating plant growth, development, and responses to various environmental stimuli. We demonstrate that MKK9, an MKK, is an upstream activator of the MPKs MPK3 and MPK6 both in vitro and in planta. Expression of active MKK9 protein in transgenic plants induces the synthesis of ethylene and camalexin through the activation of the endogenous MPK3 and MPK6 kinases. As a consequence, transcription of multiple genes responsible for ethylene biosynthesis, ethylene responses, and camalexin biosynthesis is coordinately up-regulated. The activation of MKK9 inhibits hypocotyl elongation in the etiolated seedlings. MKK9-mediated effects on hypocotyl elongation were blocked by the ethylene biosynthesis inhibitor, aminoethoxyvinylglycine, and ethylene receptor antagonist, Ag+. Expression of active MKK9 protein enhances the sensitivity of transgenic seedlings to salt stress, whereas loss of MKK9 activity reduces salt sensitivity indicating a role for MKK9 in the salt stress response. The results reported here reveal that the MKK9-MPK3/MPK6 cascade participates in the regulation of the biosynthesis of ethylene and camalexin and may be an important axis in the stress responses of Arabidopsis.	[Xu, Juan; Li, Yuan; Wang, Ying; Liu, Hongxia; Lei, Lei; Yang, Hailian; Liu, Guoqin; Ren, Dongtao] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Ren, DT (corresponding author), 2 W Yuanmingyuan Rd, Beijing 100094, Peoples R China.	ren@cau.edu.cn			National Natural Science Foundation of China [30421002, 30770203, 30771124]; New Century Excellence Talents in University [04-0131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellence Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China Grants 30421002 and 30770203, New Century Excellence Talents in University Grant 04-0131 (to D.R.), and National Natural Science Foundation of China Grant 30771124 (to H.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alzwiy IA, 2007, PLANT SCI, V173, P302, DOI 10.1016/j.plantsci.2007.06.007; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Calderini O, 2001, J BIOL CHEM, V276, P18139, DOI 10.1074/jbc.M010621200; Cardinale F, 2002, PLANT CELL, V14, P703, DOI 10.1105/tpc.010256; Chae HS, 2005, TRENDS PLANT SCI, V10, P291, DOI 10.1016/j.tplants.2005.04.006; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; DELAAT AMM, 1983, PHYSIOL PLANT PATHOL, V22, P261; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kim CY, 2003, PLANT CELL, V15, P2707, DOI 10.1105/tpc.011411; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; Liu HX, 2008, CELL RES, V18, P422, DOI 10.1038/cr.2008.29; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; SPANU P, 1994, PLANT PHYSIOL, V106, P529, DOI 10.1104/pp.106.2.529; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; TSUJI J, 1993, PHYSIOL MOL PLANT P, V43, P221, DOI 10.1006/pmpp.1993.1052; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang X, 2007, PLANT J, V52, P1066, DOI 10.1111/j.1365-313X.2007.03294.x; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	57	233	258	7	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26996	27006		10.1074/jbc.M801392200	http://dx.doi.org/10.1074/jbc.M801392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18693252	hybrid			2022-12-25	WOS:000259586600020
J	Malik, SB; Pightling, AW; Stefaniak, LM; Schurko, AM; Logsdon, JM				Malik, Shehre-Banoo; Pightling, Arthur W.; Stefaniak, Lauren M.; Schurko, Andrew M.; Logsdon, John M., Jr.			An Expanded Inventory of Conserved Meiotic Genes Provides Evidence for Sex in Trichomonas vaginalis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; PHYLOGENETIC ANALYSIS; RIBOSOMAL-RNA; GENOME SEQUENCE; TRANSPOSABLE ELEMENTS; MOLECULAR PHYLOGENY; TRYPANOSOMA-BRUCEI; CROSSOVER CONTROL	Meiosis is a defining feature of eukaryotes but its phylogenetic distribution has not been broadly determined, especially among eukaryotic microorganisms (i.e. protists)-which represent the majority of eukaryotic 'supergroups'. We surveyed genomes of animals, fungi, plants and protists for meiotic genes, focusing on the evolutionarily divergent parasitic protist Trichomonas vaginalis. We identified homologs of 29 components of the meiotic recombination machinery, as well as the synaptonemal and meiotic sister chromatid cohesion complexes. T. vaginalis has orthologs of 27 of 29 meiotic genes, including eight of nine genes that encode meiosis-specific proteins in model organisms. Although meiosis has not been observed in T. vaginalis, our findings suggest it is either currently sexual or a recent asexual, consistent with observed, albeit unusual, sexual cycles in their distant parabasalid relatives, the hypermastigotes. T. vaginalis may use meiotic gene homologs to mediate homologous recombination and genetic exchange. Overall, this expanded inventory of meiotic genes forms a useful "meiosis detection toolkit''. Our analyses indicate that these meiotic genes arose, or were already present, early in eukaryotic evolution; thus, the eukaryotic cenancestor contained most or all components of this set and was likely capable of performing meiotic recombination using near-universal meiotic machinery.	[Malik, Shehre-Banoo; Pightling, Arthur W.; Stefaniak, Lauren M.; Schurko, Andrew M.; Logsdon, John M., Jr.] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol, Iowa City, IA USA	University of Iowa	Malik, SB (corresponding author), Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol, Iowa City, IA USA.	john-logsdon@uiowa.edu	PIGHTLING, ARTHUR/AAD-6621-2020; Logsdon, John M/B-7812-2009	Malik, Shehre-Banoo/0000-0003-0833-0648	National Science Foundation [MCB-0437442, 0216702]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB-0437442/ 0216702 to JML.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN RA, 2000, SOC PROTOZOOLOGISTS; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Arisue N, 2005, MOL BIOL EVOL, V22, P409, DOI 10.1093/molbev/msi023; Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Arkhipova IR, 2005, CYTOGENET GENOME RES, V110, P372, DOI 10.1159/000084969; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bhui-Kaur A, 1998, MOL CELL BIOL, V18, P1436, DOI 10.1128/MCB.18.3.1436; Birky CW, 2005, CURR BIOL, V15, pR56, DOI 10.1016/j.cub.2004.12.055; Birky CW, 1996, GENETICS, V144, P427; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; BUTTERFIELD NJ, 1990, SCIENCE, V250, P104, DOI 10.1126/science.11538072; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Cavalier-Smith T, 2002, HEREDITY, V88, P125, DOI 10.1038/sj.hdy.6800034; Chen CB, 2005, PLANT J, V43, P321, DOI 10.1111/j.1365-313X.2005.02461.x; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chuma I, 2003, CURR GENET, V43, P191, DOI 10.1007/s00294-003-0390-7; CLEVELAND LR, 1947, SCIENCE, V105, P287, DOI 10.1126/science.105.2724.287; CLEVELAND LR, 1951, J MORPHOL, V88, P385, DOI 10.1002/jmor.1050880302; CLEVELAND LR, 1956, J PROTOZOOL, V3, P161, DOI 10.1111/j.1550-7408.1956.tb02452.x; CLEVELAND LR, 1947, SCIENCE, V105, P16, DOI 10.1126/science.105.2714.16; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Dacks JB, 2008, PARASITOL INT, V57, P97, DOI 10.1016/j.parint.2007.11.004; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Drmota T, 1997, EUR J PROTISTOL, V33, P131, DOI 10.1016/S0932-4739(97)80030-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HAIG D, 1993, J THEOR BIOL, V163, P15, DOI 10.1006/jtbi.1993.1104; Hampl V, 2006, INT J SYST EVOL MICR, V56, P305, DOI 10.1099/ijs.0.63754-0; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hampl V, 2004, MOL PHYLOGENET EVOL, V32, P711, DOI 10.1016/j.ympev.2004.03.005; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Hampl V, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-11; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HONIGBERG BM, 1989, TRICHOMONADS PARASIT, P5; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Logsdon JM, 2008, CURR BIOL, V18, pR66, DOI 10.1016/j.cub.2007.11.019; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lyons EJ, 2004, TRENDS PARASITOL, V20, P204, DOI 10.1016/j.pt.2004.03.005; MacLeod A, 2005, MOL BIOCHEM PARASIT, V143, P12, DOI 10.1016/j.molbiopara.2005.04.009; MADDISON WP, 2005, MACCLADE 4 07; Malik SB, 2007, MOL BIOL EVOL, V24, P2827, DOI 10.1093/molbev/msm217; Marcon E, 2005, BIOESSAYS, V27, P795, DOI 10.1002/bies.20264; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merino ST, 2000, P NATL ACAD SCI USA, V97, P10477, DOI 10.1073/pnas.190346097; MOCHIZUKI K, 2008, J CELL SCI; Moreau S, 1999, MOL CELL BIOL, V19, P556; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nassonova ES, 2005, EUR J PROTISTOL, V41, P175, DOI 10.1016/j.ejop.2005.02.001; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Ohkuma M, 2005, MOL PHYLOGENET EVOL, V35, P646, DOI 10.1016/j.ympev.2005.02.013; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pereira-Neves A, 2003, PROTIST, V154, P313, DOI 10.1078/143446103322454095; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; RAIKOV IB, 1995, EUR J PROTISTOL, V31, P1, DOI 10.1016/S0932-4739(11)80349-4; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ribeiro KC, 2000, J EUKARYOT MICROBIOL, V47, P481, DOI 10.1111/j.1550-7408.2000.tb00077.x; Richard GF, 2005, MOL BIOL EVOL, V22, P1011, DOI 10.1093/molbev/msi083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Schwebke JR, 2006, ANTIMICROB AGENTS CH, V50, P4209, DOI 10.1128/AAC.00814-06; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Laan R, 2000, GENOMICS, V69, P86, DOI 10.1006/geno.2000.6220; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; Wang F, 2003, MOL CELL BIOL, V23, P7698, DOI 10.1128/MCB.23.21.7698-7707.2003; Watkins RF, 2008, PROTIST, V159, P269, DOI 10.1016/j.protis.2007.12.001; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wolfe K, 2004, CURR BIOL, V14, pR392, DOI 10.1016/j.cub.2004.05.015; Xu HL, 2004, EMBO REP, V5, P378, DOI 10.1038/sj.embor.7400121; Yidiz O, 2004, GENETICS, V167, P263, DOI 10.1534/genetics.167.1.263	127	159	162	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2879	10.1371/journal.pone.0002879	http://dx.doi.org/10.1371/journal.pone.0002879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18663385	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600035
J	Salam, N; Gupta, S; Sharma, S; Pahujani, S; Sinha, A; Saxena, RK; Natarajan, K				Salam, Nasir; Gupta, Shashank; Sharma, Sachin; Pahujani, Shweta; Sinha, Aprajita; Saxena, Rajiv K.; Natarajan, Krishnamurthy			Protective Immunity to Mycobacterium tuberculosis Infection by Chemokine and Cytokine Conditioned CFP-10 Differentiated Dendritic Cells	PLOS ONE			English	Article								Background: Dendritic cells (DCs) play major roles in mediating immune responses to mycobacteria. A crucial aspect of this is the priming of T cells via chemokines and cytokines. In this study we investigated the roles of chemokines RANTES and IP-10 in regulating protective responses from Mycobacterium tuberculosis (M. tb) 10 kDa Culture Filtrate Protein-10 (CFP-10) differentiated DCs (CFP10-DCs). Methods and Findings: Infection of CFP10-DCs with mycobacteria down-modulated RANTES and IP-10 levels. Pathway specific microarray analyses showed that in addition to RANTES and IP-10, mycobacteria infected CFP10-DCs showed reduced expression of many Th1 promoting chemokines and chemokine receptors. Importantly, T cells co-cultured with RANTES and IP-10 conditioned CFP10-DCs mediated killing of mycobacteria from infected macrophages. Similarly, T cells recruited by RANTES and IP-10 conditioned CFP10-DCs mediated significant killing of mycobacteria from infected macrophages. IFN-gamma treatment of CFP10-DCs restored RANTES and IP-10 levels and T cells activated by these DCs mediated significant killing of virulent M. tb inside macrophages. Adoptive transfer of either RANTES and IP-10 or IL-12 and IFN-gamma conditioned CFP10-DCs cleared an established M. tb infection in mice. The extent of clearance was similar to that obtained with drug treatment. Conclusions: These results indicate that chemokine and cytokine secretion by DCs differentiated by M. tb antigens such as CFP-10 play major roles in regulating protective immune responses at sites of infection.	[Salam, Nasir; Gupta, Shashank; Sharma, Sachin; Pahujani, Shweta; Sinha, Aprajita; Natarajan, Krishnamurthy] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Salam, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi, India.	natrajan@icgeb.res.in	Salam, Nasir/C-8049-2015; Gupta, Shashank/E-7382-2016	Salam, Nasir/0000-0001-9133-1304; Gupta, Shashank/0000-0003-0445-5195	Department of Biotechnology Government of India; Tropical Diseases Research of WHO	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India); Tropical Diseases Research of WHO	This work was funded by grants from the Department of Biotechnology Government of India and the Tropical Diseases Research of WHO to KN.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Azouaou N, 1997, IMMUNOLOGY, V91, P414, DOI 10.1046/j.1365-2567.1997.00282.x; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkhi MY, 2004, J INFECT DIS, V189, P1598, DOI 10.1086/383328; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; Dheenadhayalan V, 2001, INFECT IMMUN, V69, P5635, DOI 10.1128/IAI.69.9.5635-5642.2001; Dieli F, 2000, SCAND J IMMUNOL, V52, P96; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Fahy OL, 2006, INFECT IMMUN, V74, P6885, DOI 10.1128/IAI.01065-06; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujii H, 2004, J DERMATOL SCI, V35, P43, DOI 10.1016/j.jdermsci.2004.03.001; Ghosh S, 2004, EXP MOL MED, V36, P387, DOI 10.1038/emm.2004.51; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Marei A, 2005, INT IMMUNOL, V17, P1439, DOI 10.1093/intimm/dxh322; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; McRae BL, 1998, J IMMUNOL, V160, P4298; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Nagayama H, 2000, J IMMUNOL, V165, P59, DOI 10.4049/jimmunol.165.1.59; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nikonenko BV, 2004, ANTIMICROB AGENTS CH, V48, P4550, DOI 10.1128/AAC.48.12.4550-4555.2004; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Ohrui T, 2000, CLIN EXP IMMUNOL, V122, P13, DOI 10.1046/j.1365-2249.2000.01291.x; Park MK, 2001, INFECT IMMUN, V69, P6755, DOI 10.1128/IAI.69.11.6755-6768.2001; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; ROOK GAW, 1994, IMMUNOBIOLOGY, V191, P478, DOI 10.1016/S0171-2985(11)80454-7; Rubakova E, 2007, TUBERCULOSIS, V87, P134, DOI 10.1016/j.tube.2006.06.002; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Skwor TA, 2004, J LEUKOCYTE BIOL, V76, P1229, DOI 10.1189/jlb.0704414; Somoskovi A, 1999, EUR CYTOKINE NETW, V10, P135; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinman R. M, 1999, FUNDAMENTAL IMMUNOLO, P547; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088; *WHO, 2002, WHO FACT SHEET; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Wiley RE, 2001, J IMMUNOL, V166, P2750, DOI 10.4049/jimmunol.166.4.2750; Wilsher M. L., 1999, Tubercle and Lung Disease, V79, P371, DOI 10.1054/tuld.1999.0223	51	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2869	10.1371/journal.pone.0002869	http://dx.doi.org/10.1371/journal.pone.0002869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682728	gold, Green Submitted, Green Published			2022-12-25	WOS:000264366600025
J	Voss, M; Ingram, JN; Wolpert, DM; Haggard, P				Voss, Martin; Ingram, James N.; Wolpert, Daniel M.; Haggard, Patrick			Mere Expectation to Move Causes Attenuation of Sensory Signals	PLOS ONE			English	Article								When a part of the body moves, the sensation evoked by a probe stimulus to that body part is attenuated. Two mechanisms have been proposed to explain this robust and general effect. First, feedforward motor signals may modulate activity evoked by incoming sensory signals. Second, reafferent sensation from body movements may mask the stimulus. Here we delivered probe stimuli to the right index finger just before a cue which instructed subjects to make left or right index finger movements. When left and right cues were equiprobable, we found attenuation for stimuli to the right index finger just before this finger was cued (and subsequently moved). However, there was no attenuation in the right finger just before the left finger was cued. This result suggests that the movement made in response to the cue caused 'postdictive' attenuation of a sensation occurring prior to the cue. In a second experiment, the right cue was more frequent than the left. We now found attenuation in the right index finger even when the left finger was cued and moved. This attenuation linked to a movement that was likely but did not in fact occur, suggests a new expectation-based mechanism, distinct from both feedforward motor signals and postdiction. Our results suggest a new mechanism in motor-sensory interactions in which the motor system tunes the sensory inputs based on expectations about future possible actions that may not, in fact, be implemented.	[Voss, Martin; Ingram, James N.; Wolpert, Daniel M.] Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England; [Voss, Martin] Humboldt Univ, Charite Univ Hosp, St Hedwig Hosp, Dept Psychiat, Berlin, Germany; [Ingram, James N.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Cambridge, England; [Haggard, Patrick] Inst Cognitive Neurosci, Dept Psychol, London, England	University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; University of London; University College London	Voss, M (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	martin.voss@charite.de	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X; Wolpert, Daniel/0000-0003-2011-2790; Voss, Martin/0000-0002-5221-4647; Lauwereyns, Jan/0000-0003-0551-2550	Human Frontiers Science Programme; Wellcome Trust; RIKEN Institute; German Academic Exchange Programme (DAAD); ESRC [RES-000-23-1571] Funding Source: UKRI; Economic and Social Research Council [RES-000-23-1571] Funding Source: researchfish	Human Frontiers Science Programme(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); RIKEN Institute; German Academic Exchange Programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Human Frontiers Science Programme, the Wellcome Trust and the RIKEN Institute. M. Voss was funded by a grant from the German Academic Exchange Programme (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; CHAPMAN CE, 1988, EXP BRAIN RES, V72, P316; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; de Jong R, 2006, BRAIN RES, V1105, P73, DOI 10.1016/j.brainres.2006.03.030; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Kida T, 2006, EXP BRAIN RES, V175, P609, DOI 10.1007/s00221-006-0578-4; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Walsh E, 2007, EXP BRAIN RES, V183, P405, DOI 10.1007/s00221-007-1128-4; Wasaka T, 2003, NEUROIMAGE, V20, P1830, DOI 10.1016/S1053-8119(03)00442-7; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968	18	75	75	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2866	10.1371/journal.pone.0002866	http://dx.doi.org/10.1371/journal.pone.0002866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682736	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600022
J	McGuire, AM; Galagan, JE				McGuire, Abigail Manson; Galagan, James E.			Conserved Secondary Structures in Aspergillus	PLOS ONE			English	Article							NONCODING RNA GENES; PRE-MESSENGER-RNA; COMPARATIVE GENOMICS; CODING REGIONS; COMPUTATIONAL IDENTIFICATION; CAENORHABDITIS-ELEGANS; PREDICTION; SEQUENCES; HUMAN-CHROMOSOME-21; TRANSCRIPTOME	Background: Recent evidence suggests that the number and variety of functional RNAs (ncRNAs as well as cis-acting RNA elements within mRNAs) is much higher than previously thought; thus, the ability to computationally predict and analyze RNAs has taken on new importance. We have computationally studied the secondary structures in an alignment of six Aspergillus genomes. Little is known about the RNAs present in this set of fungi, and this diverse set of genomes has an optimal level of sequence conservation for observing the correlated evolution of base-pairs seen in RNAs. Methodology/Principal Findings: We report the results of a whole-genome search for evolutionarily conserved secondary structures, as well as the results of clustering these predicted secondary structures by structural similarity. We find a total of 7450 predicted secondary structures, including a new predicted,60 bp long hairpin motif found primarily inside introns. We find no evidence for microRNAs. Different types of genomic regions are over-represented in different classes of predicted secondary structures. Exons contain the longest motifs ( primarily long, branched hairpins), 59 UTRs primarily contain groupings of short hairpins located near the start codon, and 39 UTRs contain very little secondary structure compared to other regions. There is a large concentration of short hairpins just inside the boundaries of exons. The density of predicted intronic RNAs increases with the length of introns, and the density of predicted secondary structures within mRNA coding regions increases with the number of introns in a gene. Conclusions/Sigificance: There are many conserved, high-confidence RNAs of unknown function in these Aspergillus genomes, as well as interesting spatial distributions of predicted secondary structures. This study increases our knowledge of secondary structure in these aspergillus organisms.	[McGuire, Abigail Manson; Galagan, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McGuire, AM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	amcguire@broad.mit.edu; jgalag@mit.edu	Manson, Abigail/B-7132-2016	Manson, Abigail/0000-0002-3800-0714; Galagan, James/0000-0003-0542-3291	NSF [MCB-0450812]; NIAID [HHSN26620040001C]	NSF(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding sources for this study were NSF grant for Comparative Fungal Genomics (MCB-0450812) and an NIAID Contract for Microbial Genome Centers (HHSN26620040001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; di Bernardo D, 2003, BIOINFORMATICS, V19, P1606, DOI 10.1093/bioinformatics/btg229; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kreahling JM, 2005, MOL CELL BIOL, V25, P10251, DOI 10.1128/MCB.25.23.10251-10260.2005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McCutcheon JP, 2003, NUCLEIC ACIDS RES, V31, P4119, DOI 10.1093/nar/gkg438; Meyer IM, 2005, NUCLEIC ACIDS RES, V33, P6338, DOI 10.1093/nar/gki923; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Missal K, 2006, J EXP ZOOL PART B, V306B, P379, DOI 10.1002/jez.b.21086; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; PARKIN NT, 1992, J VIROL, V66, P5147, DOI 10.1128/JVI.66.8.5147-5151.1992; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Walczak R, 1996, RNA, V2, P367; Washietl S, 2004, J MOL BIOL, V342, P19, DOI 10.1016/j.jmb.2004.07.018; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Weile C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-244; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	62	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2812	10.1371/journal.pone.0002812	http://dx.doi.org/10.1371/journal.pone.0002812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665251	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300031
J	Bruce, MC; Macheso, A; Kelly-Hope, LA; Nkhoma, S; McConnachie, A; Molyneux, ME				Bruce, Marian C.; Macheso, Allan; Kelly-Hope, Louise A.; Nkhoma, Standwell; McConnachie, Alex; Molyneux, Malcolm E.			Effect of Transmission Setting and Mixed Species Infections on Clinical Measures of Malaria in Malawi	PLOS ONE			English	Article								Background: In malaria endemic regions people are commonly infected with multiple species of malaria parasites but the clinical impact of these Plasmodium co-infections is unclear. Differences in transmission seasonality and transmission intensity between endemic regions have been suggested as important factors in determining the effect of multiple species co-infections. Principal Findings: In order to investigate the impact of multiple-species infections on clinical measures of malaria we carried out a cross-sectional community survey in Malawi, in 2002. We collected clinical and parasitological data from 2918 participants aged >6 months, and applied a questionnaire to measure malaria morbidity. We examined the effect of transmission seasonality and intensity on fever, history of fever, haemoglobin concentration ([Hb]) and parasite density, by comparing three regions: perennial transmission (PT), high intensity seasonal transmission (HIST) and low intensity seasonal transmission (LIST). These regions were defined using multi-level modelling of PCR prevalence data and spatial and geoclimatic measures. The three Plasmodium species (P. falciparum, P. malariae and P. ovale) were randomly distributed amongst all children but not adults in the LIST and PT regions. Mean parasite density in children was lower in the HIST compared with the other two regions. Mixed species infections had lower mean parasite density compared with single species infections in the PT region. Fever rates were similar between transmission regions and were unaffected by mixed species infections. A history of fever was associated with single species infections but only in the HIST region. Reduced mean [Hb] and increased anaemia was associated with perennial transmission compared to seasonal transmission. Children with mixed species infections had higher [Hb] in the HIST region. Conclusions: Our study suggests that the interaction of Plasmodium co-infecting species can have protective effects against some clinical outcomes of malaria but that this is dependent on the seasonality and intensity of malaria transmission.	[Bruce, Marian C.] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland; [Macheso, Allan] Gov Malawi, Minist Hlth & Populat, Lilongwe, Malawi; [Kelly-Hope, Louise A.; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Nkhoma, Standwell; Molyneux, Malcolm E.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi; [McConnachie, Alex] Glasgow Univ, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Glasgow	Bruce, MC (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland.	m.bruce@bio.gla.ac.uk			Wellcome Trust Junior Biodiversity Fellowship [060446]	Wellcome Trust Junior Biodiversity Fellowship(Wellcome Trust)	This research was funded by a Wellcome Trust Junior Biodiversity Fellowship to Marian Bruce, Reference 060446.	Alifrangis M, 1999, PARASITOLOGY, V119, P337, DOI 10.1017/S0031182099004825; Binka F, 2006, CURR MOL MED, V6, P261, DOI 10.2174/156652406776055203; BLACK J, 1994, LANCET, V343, P1095, DOI 10.1016/S0140-6736(94)90203-8; Bowie C, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-49; Brabin BJ, 2004, ANN TROP MED PARASIT, V98, P71, DOI 10.1179/000349804225003055; Bruce MC, 2007, PARASITOLOGY, V134, P637, DOI 10.1017/S0031182006001958; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Bruce MC, 2003, TRENDS PARASITOL, V19, P271, DOI 10.1016/S1471-4922(03)00116-8; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Fraser-Hurt N, 1999, T ROY SOC TROP MED H, V93, pS47, DOI 10.1016/S0035-9203(99)90327-9; Garnham PCC, 1966, MALARIA PARASITES OT; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; *GOV MAL DEP SURV, 1984, NAT ATL MAL; HAWLEY W, 1992, MALARIA VECTOR ASSES; Haworth J., 1988, P1379; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; JANOVY J, 1995, ECOL MODEL, V77, P189, DOI 10.1016/0304-3800(93)E0087-J; Kawamoto F, 1999, PARASITOL TODAY, V15, P422, DOI 10.1016/S0169-4758(99)01511-2; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Maguire JD, 2002, LANCET, V360, P58, DOI 10.1016/S0140-6736(02)09336-4; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; May J, 2000, T ROY SOC TROP MED H, V94, P399, DOI 10.1016/S0035-9203(00)90119-6; McKenzie FE, 2002, AM J TROP MED HYG, V67, P411, DOI 10.4269/ajtmh.2002.67.411; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; Mehlotra RK, 2002, AM J TROP MED HYG, V67, P555, DOI 10.4269/ajtmh.2002.67.555; *MIN HLTH POP, 2004, HIV AIDS MAL TB 5 5; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; MZILAHOWA T, 2005, THESIS U LIVERPOOL; NORTHRUP N, 1986, INT J AFR HIST STUD, V19, P59, DOI 10.2307/218695; PELLETIER DL, 1991, SOC SCI MED, V32, P887, DOI 10.1016/0277-9536(91)90244-7; Peragallo MS, 1997, T ROY SOC TROP MED H, V91, P343, DOI 10.1016/S0035-9203(97)90101-2; PHILLIPS RE, 1986, Q J MED, V58, P305; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Richter J, 2004, T ROY SOC TROP MED H, V98, P751, DOI 10.1016/j.trstmh.2004.06.004; RITCHIE TL, 1988, PARASITOLOGY, V96, P607; Rosenberg R, 2007, TRENDS PARASITOL, V23, P193, DOI 10.1016/j.pt.2007.02.009; Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; SMITH T, 1995, AM J TROP MED HYG, V52, P306, DOI 10.4269/ajtmh.1995.52.306; Smith T, 1999, T ROY SOC TROP MED H, V93, pS53, DOI 10.1016/S0035-9203(99)90328-0; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; Tanomsing N, 2007, ANTIMICROB AGENTS CH, V51, P3523, DOI 10.1128/AAC.00234-07; Thorold Alan, 1993, MUSLIM IDENTITY SOCI, P79; Tobian AAR, 2000, J INFECT DIS, V182, P558, DOI 10.1086/315729	56	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2775	10.1371/journal.pone.0002775	http://dx.doi.org/10.1371/journal.pone.0002775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648666	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000264302900045
J	Noh, YW; Lim, YT; Chung, BH				Noh, Young-Woock; Lim, Yong Taik; Chung, Bong Hyun			Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals	FASEB JOURNAL			English	Article						immunotherapeutic cells; quantum dots; in vivo imaging; fluorescent probes	MESENCHYMAL STEM-CELLS; MOUSE BONE-MARROW; CDTE QUANTUM DOTS; IN-VIVO; CANCER-IMMUNOTHERAPY; MELANOMA PATIENTS; LIVE CELLS; TRACKING; VACCINES; DIAGNOSTICS	Effective tracking of immunotherapeutic cells is essential for monitoring the migration of injected cells to the target tissue. Here we report the use of near-infrared (NIR) -emitting fluorescent semiconductor nanocrystals, called quantum dots (QDs), for noninvasive in vivo tracking of dendritic cell ( DC) migration into lymph nodes. The effect of QDs on DC viability and maturation was systematically investigated using MTT assays and FACS analysis. We found that the labeling of DCs with QDs had no effect on DC phenotype or maturation potential. Cytokine and migration assays revealed that there were no significant changes in either cytokine production or chemokine-dependent migration of QD-labeled DCs relative to unlabeled cells; in both labeled and unlabeled cells, cytokine production and migratory capacity was increased by stimulation with lipopolysaccharide. Furthermore, QDs did not influence allogenic naive T cell activation or uptake of exogenous antigens. Notably, we also demonstrated that it was possible to track QD-labeled DCs injected into the footpad into popliteal and inguinal lymph nodes using NIR fluorescence. Taken together, our protocols establish the potential of noninvasive in vivo imaging of NIR-emitting QDs for tracking immunotherapeutic cells. -Noh, Y.- W., Lim, Y. T., Chung, B. H. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J. 22, 3908-3918 (2008)	[Noh, Young-Woock; Lim, Yong Taik; Chung, Bong Hyun] Korea Res Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lim, YT (corresponding author), Korea Res Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, POB 115, Taejon 305333, South Korea.	yongtaik@kribb.re.kr; chungbh@kribb.re.kr			Korea government (MEST); KRIBB Research Initiative Program	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KRIBB Research Initiative Program	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) and KRIBB Research Initiative Program. We thank Dr. Chong Kil Lee (Chungbuk National University, Cheongju, South Korea) for providing cell lines.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Azzazy HME, 2007, CLIN BIOCHEM, V40, P917, DOI 10.1016/j.clinbiochem.2007.05.018; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baumjohann D, 2006, IMMUNOBIOLOGY, V211, P587, DOI 10.1016/j.imbio.2006.05.011; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Byrne SJ, 2006, J MATER CHEM, V16, P2896, DOI 10.1039/b605333e; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Cho SJ, 2007, LANGMUIR, V23, P1974, DOI 10.1021/la060093j; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; de Vries IJM, 2003, CANCER RES, V63, P12; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Eggert AAO, 2003, IMMUNOL LETT, V89, P17, DOI 10.1016/S0165-2478(03)00105-6; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Gaponik N, 2003, NANO LETT, V3, P369, DOI 10.1021/nl0259333; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hoshino A, 2004, BIOCHEM BIOPH RES CO, V314, P46, DOI 10.1016/j.bbrc.2003.11.185; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kim SW, 2005, J AM CHEM SOC, V127, P10526, DOI 10.1021/ja0434331; KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Lesterhuis WJ, 2004, ANN ONCOL, V15, P145, DOI 10.1093/annonc/mdh919; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Olasz EB, 2002, J IMMUNOL METHODS, V260, P137, DOI 10.1016/S0022-1759(01)00528-2; Parungo CP, 2005, CHEST, V127, P1799, DOI 10.1378/chest.127.5.1799; Pozzolini M, 2003, ANAL BIOCHEM, V313, P338, DOI 10.1016/S0003-2697(02)00631-0; Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schimmelpfennig CH, 2005, AM J PATHOL, V167, P1321, DOI 10.1016/S0002-9440(10)61219-9; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shah LS, 2007, NANO LETT, V7, P3071, DOI 10.1021/nl071547f; Shen ZH, 1997, J IMMUNOL, V158, P2723; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Verdijk P, 2007, INT J CANCER, V120, P978, DOI 10.1002/ijc.22385; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684	45	62	62	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3908	3918		10.1096/fj.08-112896	http://dx.doi.org/10.1096/fj.08-112896			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18682573				2022-12-25	WOS:000260503000019
J	Chudakova, DA; Zeidan, YH; Wheeler, BW; Yu, J; Novgorodov, SA; Kindy, MS; Hannun, YA; Gudz, TI				Chudakova, Daria A.; Zeidan, Youssef H.; Wheeler, Brian W.; Yu, Jin; Novgorodov, Sergei A.; Kindy, Mark S.; Hannun, Yusuf A.; Gudz, Tatyana I.			Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; OLIGODENDROCYTE PROGENITOR MIGRATION; CYTOPLASMIC DOMAIN; CEREBRAL-ISCHEMIA; TYROSINE KINASES; SALVAGE PATHWAY; FACTOR RECEPTOR; BRAIN-INJURY; C-DELTA; CERAMIDE	Integrins govern cellular adhesion and transmit signals leading to activation of intracellular signaling pathways aimed to prevent apoptosis. Herein we report that attachment of oligodendrocytes (OLs) to fibronectin via alpha(v)beta(3) integrin receptors rendered the cells more resistant to apoptosis than the cells attached to laminin via alpha(6)beta(1) integrins. Investigation of molecular mechanisms involved in alpha(v)beta(3) integrin-mediated cell survival revealed that ligation of the integrin with fibronectin results in higher expression of activated Lyn kinase. Both in OLs and in the mouse brain, Lyn selectively associates with alpha(v)beta(3) integrin, not with alpha(v)beta(5) integrin, leading to suppression of acid sphingomyelinase activity and preventing ceramide-mediated apoptosis. In OLs, knockdown of Lyn with small interfering RNA resulted in OL apoptosis with concomitant accumulation of C-16-ceramide due to activation of acid sphingomyelinase (ASMase) and sphingomyelin hydrolysis. Knocking down ASMase partially protected OLs from apoptosis. In the brain, ischemia/reperfusion (IR) triggered rearrangements in the alpha(v)beta(3) integrin-Lyn kinase complex leading to disruption of Lyn kinase-mediated suppression of ASMase activity. Thus, co-immunoprecipitation studies revealed an increased association of alpha(v)beta(3) integrin-Lyn kinase complex with ionotropic glutamate receptor subunits, GluR2 and GluR4, after cerebral IR. Sphingolipid analysis of the brain demonstrated significant accumulation of ceramide and sphingomyelin hydrolysis. The data suggest a novel mechanism for regulation of ASMase activity during cell adhesion in which Lyn acts as a key upstream kinase that may play a critical role in cerebral IR injury.	[Chudakova, Daria A.; Wheeler, Brian W.; Yu, Jin; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kindy, Mark S.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Novgorodov, Sergei A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Zeidan, Youssef H.; Novgorodov, Sergei A.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Gudz, TI (corresponding author), Med Univ S Carolina, Dept Neurosci, 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Chudakova, Daria/ABB-3032-2020; Zeidan, Youssef H./H-7578-2019	Zeidan, Youssef H./0000-0002-1951-8585	National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology [P20 RR 17677-04]; National Institutes of Health [P01-CA97132, AG16583]; National Science Foundation EPSCOR [EPS0132573]; Veterans Affairs Merit Awards; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCOR(National Science Foundation (NSF)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology Grant P20 RR 17677-04 (to T. I. G.) and National Institutes of Health Grant P01-CA97132 (to Y.A.H.). This work was also supported by National Science Foundation EPSCOR Grant EPS0132573 (to M. S. K.), and Veterans Affairs Merit Awards (to T. I. G. and M. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant AG16583.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Bates RC, 2001, CANCER RES, V61, P5275; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Cui QL, 2006, NEUROCHEM INT, V48, P383, DOI 10.1016/j.neuint.2005.11.014; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Erdreich-Epstein A, 2005, BLOOD, V105, P4353, DOI 10.1182/blood-2004-08-3098; Ferlinz K, 1999, CHEM PHYS LIPIDS, V102, P35, DOI 10.1016/S0009-3084(99)00073-0; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grazide S, 2002, FASEB J, V16, P1685, DOI 10.1096/fj.01-0794fje; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Gudz TI, 2002, J NEUROSCI, V22, P7398; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herr I, 1999, BRAIN RES, V826, P210, DOI 10.1016/S0006-8993(99)01288-3; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Kabuyama Y, 2002, EUR J BIOCHEM, V269, P664, DOI 10.1046/j.0014-2956.2001.02698.x; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kubota M, 1996, NEUROL RES, V18, P337; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Liu SC, 2000, J CELL SCI, V113, P3563; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; MILNER R, 1994, DEVELOPMENT, V120, P3497; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nakane M, 2000, NEUROSCI LETT, V296, P89, DOI 10.1016/S0304-3940(00)01655-4; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Qin SF, 1998, FEBS LETT, V427, P139, DOI 10.1016/S0014-5793(98)00383-4; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Testai FD, 2004, J NEUROSCI RES, V75, P66, DOI 10.1002/jnr.10816; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Umemori H, 1999, J NEUROSCI, V19, P1393; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	63	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28806	28816		10.1074/jbc.M803301200	http://dx.doi.org/10.1074/jbc.M803301200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682390	Green Published, hybrid			2022-12-25	WOS:000260179900005
J	O'Donoghue, AJ; Mahon, CS; Goetz, DH; O'Malley, JM; Gallagher, DM; Zhou, M; Murray, PG; Craik, CS; Tuohy, MG				O'Donoghue, Anthony J.; Mahon, Cathal S.; Goetz, David H.; O'Malley, James M.; Gallagher, Denise M.; Zhou, Min; Murray, Patrick G.; Craik, Charles S.; Tuohy, Maria G.			Inhibition of a Secreted Glutamic Peptidase Prevents Growth of the Fungus Talaromyces emersonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIGER; ASPERGILLOGLUTAMIC PEPTIDASE; SCYTALIDIUM-LIGNICOLUM; SCYTALIDOGLUTAMIC PEPTIDASE; CRYPHONECTRIA-PARASITICA; PENICILLIUM-MARNEFFEI; SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; CARBOXYL PROTEINASE; ANTIFUNGAL PROTEINS	secretes a variety of hydrolytic enzymes that are of interest for processing of biomass into fuel. Many carbohydrases have been isolated and characterized from this fungus, but no studies had been performed on peptidases. In this study, two acid-acting endopeptidases were isolated and characterized from the culture filtrate of T. emersonii. One of these enzymes was identified as a member of the recently classified glutamic peptidase family and was subsequently named T. emersonii glutamic peptidase 1 (TGP1). The second enzyme was identified as an aspartyl peptidase (PEP1). TGP1 was cloned and sequenced and shown to exhibit 64 and 47% protein identity to peptidases from Aspergillus niger and Scytalidium ligno-colum, respectively. Substrate profiling of 16 peptides determined that TGP1 has broad specificity with a preference for large residues in the P1 site, particularly Met, Gln, Phe, Lys, Glu, and small amino acids at P1' such as Ala, Gly, Ser, or Thr. This enzyme efficiently cleaves an internally quenched fluorescent substrate containing the zymogen activation sequence (k(cat)/K-m = 2 x 10(5) M-1 s(-1)). Maximum hydrolysis occurs at pH 3.4 and 50 degrees C. The reaction is strongly inhibited by a transition state peptide analog, TA1 (K-i = 1.5 nM), as well as a portion of the propeptide sequence, PT1 (K-i = 32 nM). Ex vivo studies show that hyphal extension of T. emersonii in complex media is unaffected by the aspartyl peptidase inhibitor pepstatin but is inhibited by TA1 and PT1. This study provides insight into the functional role of the glutamic peptidase TGP1 for growth of T. emersonii.	[O'Donoghue, Anthony J.; Goetz, David H.; O'Malley, James M.; Zhou, Min; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [O'Donoghue, Anthony J.; Mahon, Cathal S.; O'Malley, James M.; Gallagher, Denise M.; Murray, Patrick G.; Tuohy, Maria G.] Natl Univ Ireland, Dept Biochem, Galway, Ireland	University of California System; University of California San Francisco; Ollscoil na Gaillimhe-University of Galway	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Mail Code 2280,600th 16th St, San Francisco, CA 94158 USA.	craik@cgl.ucsf.edu		Murray, Patrick/0000-0001-6349-7761	National Institutes of Health [GM082250]; Irish Research Council for Science, Engineering, and Technology; Enterprise Ireland; County Cork Vocational Education Committee; National University of Ireland Galway; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland; County Cork Vocational Education Committee; National University of Ireland Galway; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082250 (to C. S. C.). This work was also supported in part by Enterprise Ireland Research Innovation and Higher Education Authority pre-PRTLI, PRTLI awards (to M. G. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of post-graduate funding awards from Irish Research Council for Science, Engineering, and Technology, Enterprise Ireland, County Cork Vocational Education Committee, and National University of Ireland Galway and an education abroad program fellowship from National University of Ireland Galway.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown RS, 1997, INT J MASS SPECTROM, V169, P1, DOI 10.1016/S0168-1176(97)00217-6; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Cooper J. B., 2004, HDB PROTEOLYTIC ENZY, P104; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Dash C, 2001, ANTIMICROB AGENTS CH, V45, P2008, DOI 10.1128/AAC.45.7.2008-2017.2001; Fianchi L, 2004, MYCOSES, V47, P163, DOI 10.1111/j.1439-0507.2004.00960.x; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Heneghan MN, 2007, ENZYME MICROB TECH, V41, P677, DOI 10.1016/j.enzmictec.2007.05.014; HOFMANN T, 2004, HDB PROTEOLYTIC ENZY, P99; Huang XP, 2000, J BIOL CHEM, V275, P26607, DOI 10.1074/jbc.M910243199; ICHISHIMA E, 2004, HDB PROTEOLYTIC ENZY, P92; IIO K, 1976, BIOCHIM BIOPHYS ACTA, V429, P912, DOI 10.1016/0005-2744(76)90336-3; Jara P, 1996, MOL GEN GENET, V250, P97, DOI 10.1007/BF02191829; JARAI G, 1994, GENE, V145, P171, DOI 10.1016/0378-1119(94)90002-7; Kataoka Y, 2005, FEBS LETT, V579, P2991, DOI 10.1016/j.febslet.2005.04.050; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Kubota K, 2005, J BIOL CHEM, V280, P999, DOI 10.1074/jbc.M410852200; Lee BR, 2003, BIOCHEM J, V371, P541, DOI 10.1042/BJ20021691; LORITO M, 1994, MOL PLANT MICROBE IN, V7, P525, DOI 10.1094/MPMI-7-0525; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Moon JL, 2006, BIOL CHEM, V387, P985, DOI 10.1515/BC.2006.122; Murray PG, 2003, BIOCHEM BIOPH RES CO, V301, P280, DOI 10.1016/S0006-291X(02)03025-5; Murray PG, 2001, ENZYME MICROB TECH, V29, P90, DOI 10.1016/S0141-0229(01)00354-4; Nishii W, 2003, BIOCHEM BIOPH RES CO, V301, P1023, DOI 10.1016/S0006-291X(03)00083-4; ODA K, 1976, AGR BIOL CHEM TOKYO, V40, P1221, DOI 10.1080/00021369.1976.10862184; ODA K, 1987, BIOCHIM BIOPHYS ACTA, V923, P463, DOI 10.1016/0304-4165(87)90055-9; ODA K, 2004, HDB PROTEOLYTIC ENZY, P219; Oda N, 1998, BIOSCI BIOTECH BIOCH, V62, P1637, DOI 10.1271/bbb.62.1637; Pillai B, 2007, J MOL BIOL, V365, P343, DOI 10.1016/j.jmb.2006.09.058; Poussereau N, 2001, MICROBIOL-UK, V147, P717, DOI 10.1099/00221287-147-3-717; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; RAZANAMPARANY V, 1992, CURR GENET, V21, P455, DOI 10.1007/BF00351655; ROBERTS WK, 1986, BIOCHIM BIOPHYS ACTA, V880, P161, DOI 10.1016/0304-4165(86)90076-0; Sasaki H, 2005, P JPN ACAD B-PHYS, V81, P441, DOI 10.2183/pjab.81.441; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; TAKAHASHI K, 2004, HDB PROTEOLYTIC ENZY, P221; TUOHY MG, 1993, BIOCHEM J, V290, P515, DOI 10.1042/bj2900515; Tuohy MG, 2002, BBA-PROTEIN STRUCT M, V1596, P366, DOI 10.1016/S0167-4838(01)00308-9; Ustianowski AP, 2008, CURR OPIN INFECT DIS, V21, P31, DOI 10.1097/QCO.0b013e3282f406ae; VandenHombergh JPTW, 1997, EUR J BIOCHEM, V247, P605; Vernekar JV, 1999, BIOCHEM BIOPH RES CO, V262, P702, DOI 10.1006/bbrc.1999.1269; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Yabuki Y, 2004, FEBS LETT, V569, P161, DOI 10.1016/j.febslet.2004.05.041; Yang XY, 2006, PEPTIDES, V27, P1726, DOI 10.1016/j.peptides.2006.01.020	50	19	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29186	29195		10.1074/jbc.M802366200	http://dx.doi.org/10.1074/jbc.M802366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18687686	hybrid, Green Published			2022-12-25	WOS:000260179900046
J	Zhou, LY; Qi, XP; Potashkin, JA; Abdul-Karim, FW; Gorodeski, GI				Zhou, Lingyin; Qi, Xiaoping; Potashkin, Judith A.; Abdul-Karim, Fadi W.; Gorodeski, George I.			MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X(7) receptor by activation of instability sites at the 3 '-untranslated region of the gene that decrease steady-state levels of the transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; CANCER-CELLS; DETERMINANTS; INHIBITION; RELEASE; NEURONS; PROFILE; MIRNAS; GROWTH	The P2X(7) receptor regulates cell growth through mediation of apoptosis. P2X(7) levels are lower in cancer epithelial cells than in normal cells, and previous studies showed that expression of P2X(7) was regulated post-transcriptionally. The objective of the study was to understand regulation of P2X(7) mRNA stability. Overexpression of a reporter containing the full-length human P2X(7) 3'-untranslated region (3'-UTR) or reporters containing parts of the 3'-UTR-P2X(7) were associated with increased abundance of the construct in normal cells and decreased abundance in cancer epithelial cells. Sequences within the 3'-UTR-P2X(7), which are putative target sites for the microRNAs, miR-186 (middle segment) and miR-150 (distal segment), decreased the abundance of the P2X(7) transcript. Overexpression in cancer cells of mutated miR-186 and miR-150 target sites was associated with lower levels of the reporter genes. In normal cells overexpression of the mutated miR-186 target site was associated with marked increased concentration, but overexpression of the miR-150 target site reporters, wild-type and mutant, did not change over time. Levels of miR-186 and miR-150 were higher in cancer than in normal cells, and treatment with miR-186 and miR-150 inhibitors increased P2X(7) mRNA. In human embryonic kidney-293 cells heterologously expressing the full-length 3'-UTR-P2X(7) luciferase reporter, miR-186 and miR-150 inhibitors increased luciferase activity, whereas miR-186 and miR-150 mimics decreased luciferase activity after actinomycin D treatment. These data suggest that increased expression of miR-186 and miR-150 in cancer epithelial cells decreases P2X(7) mRNA by activation of miR-186 and miR-150 instability target sites located at the 3'-UTR-P2X(7).	[Zhou, Lingyin; Qi, Xiaoping; Gorodeski, George I.] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA; [Abdul-Karim, Fadi W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Gorodeski, George I.] Case Western Reserve Univ, Dept Oncol, Cleveland, OH 44106 USA; [Gorodeski, George I.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Chicago Medical School; Rosalind Franklin University Medical & Science	Gorodeski, GI (corresponding author), Case Western Reserve Univ Hosp, Med Ctr, Dept Obstet & Gynecol, Univ Hosp MacDonald Womens Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.	gig@cwru.edu			National Institutes of Health [AG15955]; CytoCore Inc.; NATIONAL INSTITUTE ON AGING [R01AG015955, R55AG015955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CytoCore Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15955. This work was also supported by an unrestricted grant by CytoCore Inc. (to G. I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; Buell GN, 1998, RECEPTOR CHANNEL, V5, P347; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng YH, 2005, AM J PHYSIOL-CELL PH, V288, pC1342, DOI 10.1152/ajpcell.00315.2004; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; GORODESKI GI, 1994, DIFFERENTIATION, V56, P107, DOI 10.1046/j.1432-0436.1994.56120107.x; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Guglielmelli P, 2007, EXP HEMATOL, V35, P1708, DOI 10.1016/j.exphein.2007.08.020; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Henriksen KL, 2003, CELL PHYSIOL BIOCHEM, V13, P93, DOI 10.1159/000070253; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kujoth GC, 2006, CANCER RES, V66, P7386, DOI 10.1158/0008-5472.CAN-05-4670; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GH, 2000, J BIOL CHEM, V275, P29107, DOI 10.1074/jbc.M910277199; LI X, 2006, CANCER EPIDEM BIOMAR, V15, P1, DOI DOI 10.1158/1055-9965.EPI-05-0923; Li X, 2007, GYNECOL ONCOL, V106, P233, DOI 10.1016/j.ygyno.2007.03.032; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodriguez-Nieto S, 2006, CURR PHARM DESIGN, V12, P4411, DOI 10.2174/138161206779010495; Soto F, 1997, J MEMBRANE BIOL, V160, P91, DOI 10.1007/s002329900298; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wang LQ, 2005, ENDOCRINOLOGY, V146, P164, DOI 10.1210/en.2004-1026; Wang QF, 2004, ENDOCRINOLOGY, V145, P5568, DOI 10.1210/en.2004-0807; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	55	112	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28274	28286		10.1074/jbc.M802663200	http://dx.doi.org/10.1074/jbc.M802663200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682393	Green Published, hybrid			2022-12-25	WOS:000259969300029
J	Lamanna, WC; Frese, MA; Balleininger, M; Dierks, T				Lamanna, William C.; Frese, Marc-Andre; Balleininger, Martina; Dierks, Thomas			Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; IN-VIVO; DOMAIN-STRUCTURE; SPECIFICITY; EXPRESSION; BINDING; PROTEIN; QSULF1; 6-O-ENDOSULFATASES; GLYCOSAMINOGLYCANS	Sulf1 and Sulf2 are two heparan sulfate 6-O-endosulfatases that regulate the activity of multiple growth factors, such as fibroblast growth factor and Wnt, and are essential for mammalian development and survival. In this study, the mammalian Sulfs were functionally characterized using overexpressing cell lines, in vitro enzyme assays, and in vivo Sulf knock-out cell models. Analysis of subcellular Sulf localization revealed significant differences in enzyme secretion and detergent solubility between the human isoforms and their previously characterized quail orthologs. Further, the activity of the Sulfs toward their native heparan sulfate substrates was determined in vitro, demonstrating restricted specificity for S-domain-associated 6S disaccharides and an inability to modify transition zone-associated UA-GlcNAc( 6S). Analysis of heparan sulfate composition from different cell surface, shed, glycosylphosphatidylinositol- anchored and extracellular matrix proteoglycan fractions of Sulf knock-out cell lines established differential effects of Sulf1 and/or Sulf2 loss on nonsubstrate N-, 2-O-, and 6-O-sulfate groups. These findings indicate a dynamic influence of Sulf deficiency on the HS biosynthetic machinery. Real time PCR analysis substantiated differential expression of the Hs2st and Hs6st heparan sulfate sulfotransferase enzymes in the Sulf knock-out cell lines. Functionally, the changes in heparan sulfate sulfation resulting from Sulf loss were shown to elicit significant effects on fibroblast growth factor signaling. Taken together, this study implicates that the Sulfs are involved in a potential cellular feed-back mechanism, in which they edit the sulfation of multiple heparan sulfate proteoglycans, thereby regulating cellular signaling and modulating the expression of heparan sulfate biosynthetic enzymes.	[Lamanna, William C.; Frese, Marc-Andre; Dierks, Thomas] Univ Bielefeld, Fak Chem Biochem 1, D-33615 Bielefeld, Germany; [Balleininger, Martina] Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem Biochem 1, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Shire Human Genetic Therapies Inc. (Cambridge, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Shire Human Genetic Therapies Inc. (Cambridge, MA)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and Shire Human Genetic Therapies Inc. (Cambridge, MA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Edgren G, 1997, GLYCOBIOLOGY, V7, P103, DOI 10.1093/glycob/7.1.103; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grobe K, 2002, J BIOL CHEM, V277, P30699, DOI 10.1074/jbc.M111904200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HEREMANS A, 1988, J BIOL CHEM, V263, P4731; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	49	113	114	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27724	27735		10.1074/jbc.M802130200	http://dx.doi.org/10.1074/jbc.M802130200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687675	hybrid			2022-12-25	WOS:000259719200044
J	Lan, F; Cacicedo, JM; Ruderman, N; Ido, Y				Lan, Fan; Cacicedo, Jose M.; Ruderman, Neil; Ido, Yasuo			SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 - Possible role in AMP-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; PHOSPHORYLATION; DEACETYLASE; METABOLISM	SIRT1, a histone/protein deacetylase, and AMP-activated protein kinase (AMPK) are key enzymes responsible for longevity and energy homeostasis. We examined whether a mechanistic connection exists between these molecules that involves the major AMPK kinase LKB1. Initial studies demonstrated that LKB1 is acetylated in cultured (HEK293T) cells, mouse white adipose tissue, and rat liver. In the 293T cells, SIRT1 overexpression diminished lysine acetylation of LKB1 and concurrently increased its activity, cytoplasmic/nuclear ratio, and association with the LKB1 activator STRAD. In contrast, short hairpin RNA for SIRT1, where studied, had opposite effects on these parameters. Mass spectrometric analysis established that acetylation of LKB1 occurs on multiple, but specific, lysine residues; however, only mutation of lysine 48 to arginine, which mimics deacetylation, reproduced all of the effects of activated SIRT1. SIRT1 also affected downstream targets of LKB1. Thus its overexpression increased AMPK and acetyl-CoA carboxylase phosphorylation, and conversely, RNA interference-mediated SIRT1 knockdown reduced AMPK phosphorylation and that of another LKB1 target MARK1. Consistent with the results in cultured cells, total LKB1 lysine acetylation was decreased by 60% in the liver of 48-h starved rats compared with starved-refed rats, and this was associated with modest but significant increases in both LKB1 and AMPK activities. These results suggest that LKB1 deacetylation is regulated by SIRT1 and that this in turn influences its intracellular localization, association with STRAD, kinase activity, and ability to activate AMPK.	[Lan, Fan; Cacicedo, Jose M.; Ruderman, Neil; Ido, Yasuo] Boston Univ, Sch Med, Diabet & Metab Res Unit, Dept Med,Sect Endocrinol, Boston, MA 02118 USA; [Cacicedo, Jose M.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Ido, Y (corresponding author), 650 Albany St,Rm 820, Boston, MA 02118 USA.	yido@bu.edu		/0000-0001-8417-9754; Ido, Yasuo/0000-0002-3036-9971; Ruderman, Neil/0000-0002-6589-6587	National Institutes of Health [P01 HL08758, DK19514]; Kilo Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kilo Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL08758 and DK19514 (to N. R.). This work was also supported by grants from the Kilo Diabetes Foundation (to Y. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Suzuki K, 2007, BIOCHEM BIOPH RES CO, V359, P665, DOI 10.1016/j.bbrc.2007.05.164; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	21	584	617	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27628	27635		10.1074/jbc.M805711200	http://dx.doi.org/10.1074/jbc.M805711200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687677	Green Published, hybrid			2022-12-25	WOS:000259719200034
J	Zimmer, SM; Liu, J; Clayton, JL; Stephens, DS; Snyder, JP				Zimmer, Shanta M.; Liu, Jin; Clayton, Jaime L.; Stephens, David S.; Snyder, James P.			Paclitaxel binding to human and murine MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE MIMETIC ACTION; LIPID-A; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; BETA-TUBULIN; MOUSE MD-2; TAXOL; PROTEIN	Paclitaxel (PTX) is an important cancer chemotherapeutic agent that binds to beta-tubulin and prevents mitosis through microtubule overstabilization. Recent evidence also implicates PTX in the induction of apoptosis of cancer cells via the TLR4 innate immune pathway. The TLR4 accessory protein, MD-2, is an essential component for the species-specific proinflammatory activity of PTX on murine cells. However, whether PTX binds to human MD-2 and how MD-2 and TLR4 interact with PTX are not well defined. Recombinant human MD-2 (rhMD-2) was produced in a Pichia pastoris expression system, and the interaction between rhMD-2 and PTX was assessed by an enzyme-linked immunosorbent assay to show that PTX binds rhMD-2. Formation of the latter complex was found to be dose-dependent and inhibited by anti-MD-2 antibody but not by an isotype control antibody. As measured by human tumor necrosis factor alpha production, human THP-1 monocytes expressing TLR4 and MD-2 were poorly responsive to the addition of PTX, but murine macrophages expressing TLR4 and MD-2 responded in a dose-dependent manner. Human embryonic kidney (HEK293) cells transfected with both human TLR4 and human MD-2 or human MD-2 and murine TLR4 were also poorly responsive to PTX (10 mu M). However, HEK293 cells transfected with murine MD-2 and human TLR4 or murine MD-2 and murine TLR4 were highly responsive to PTX (10 mu M), indicating that the murine MD-2/ PTX interaction is required for TLR4 activation. To further define the structural differences for MD-2/ TLR4 activation, crystal structures of both murine and human MD-2 were subjected to PTX docking by computational methods. These models indicate that PTX binds in the pocket of both human and mouse MD-2 structures. The species-specific difference between human and murine MD-2 activation of TLR4 by PTX can be explained by alterations of surface charge distribution (i.e. electrostatic potential), binding pocket size, and the locus of PTX binding within the MD-2 pocket, which results in reorganization of the 123-130 amino acid loop. In particular, Phe(126) appears to operate as a bridge for TLR4.MD-2 dimerization in the mouse but not the human protein.	[Zimmer, Shanta M.; Stephens, David S.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Liu, Jin; Clayton, Jaime L.; Snyder, James P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Zimmer, SM (corresponding author), Vet Affairs Med Ctr, Res Serv 151, 1670 Clairmont Rd, Decatur, GA 30033 USA.		Stephens, David S/A-8788-2012		National Institutes of Health [K08 AI060966-03, R01 AI033517-10, R01 CA-69571]; NATIONAL CANCER INSTITUTE [R01CA069571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033517, K08AI060966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 AI060966-03 (to S. M. Z.), R01 AI033517-10 (to D. S. S.), and R01 CA-69571 (to J. P. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bertoni C, 1997, MAMM GENOME, V8, P90, DOI 10.1007/s003359900364; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fishman MN, 2006, CLIN CANCER RES, V12, P523, DOI 10.1158/1078-0432.CCR-05-0928; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Ganesh T, 2004, P NATL ACAD SCI USA, V101, P10006, DOI 10.1073/pnas.0403459101; Ganesh T, 2007, J MED CHEM, V50, P713, DOI 10.1021/jm061071x; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; HORWITZ SB, 1986, ANN NY ACAD SCI, V466, P733, DOI 10.1111/j.1749-6632.1986.tb38455.x; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kawasaki K, 2001, J IMMUNOL, V166, P11, DOI 10.4049/jimmunol.166.1.11; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; MANTHEY CL, 1994, J IMMUNOL, V152, P825; MANTHEY CL, 1992, J IMMUNOL, V149, P2459; MANTHEY CL, 1993, J EXP MED, V178, P695, DOI 10.1084/jem.178.2.695; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MEDZHITOV R, 1997, NATURE, V388, P397; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moses JW, 2005, J AM COLL CARDIOL, V45, P1165, DOI 10.1016/j.jacc.2004.10.074; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Okamoto Masato, 2003, Journal of Medical Investigation, V50, P9; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Rahman MM, 1998, CARBOHYD RES, V307, P311; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Snyder JP, 2000, J AM CHEM SOC, V122, P724, DOI 10.1021/ja9930115; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Vogel S, 2001, J ENDOTOXIN RES, V7, P237, DOI 10.1177/09680519010070030801; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang J, 2002, BRIT J HAEMATOL, V118, P638, DOI 10.1046/j.1365-2141.2002.03645.x; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Zaks-Zilberman M, 2001, CYTOKINE, V15, P156, DOI 10.1006/cyto.2001.0935; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	60	67	70	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27916	27926		10.1074/jbc.M802826200	http://dx.doi.org/10.1074/jbc.M802826200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650420	Green Published, hybrid			2022-12-25	WOS:000259719200062
J	Beltrami, A; Rossmann, M; Fiorillo, MT; Paladini, F; Sorrentino, R; Saenger, W; Kumar, P; Ziegler, A; Uchanska-Ziegler, B				Beltrami, Alessandra; Rossmann, Maxim; Fiorillo, Maria Teresa; Paladini, Fabiana; Sorrentino, Rosa; Saenger, Wolfram; Kumar, Pravin; Ziegler, Andreas; Uchanska-Ziegler, Barbara			Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; ANKYLOSING-SPONDYLITIS; CUTTING EDGE; PROTEINS; DISEASE; RECOGNITION; ANTIBODIES; ANTIGEN; AUTOANTIBODIES; CONFORMATION	Inflammatory processes are accompanied by the posttranslational modification of certain arginine residues within proteins to yield citrulline, although it is largely unknown how this modification influences antigen presentation. We employed crystallographic and functional studies to investigate whether the exchange of arginine to citrulline affects the display of a peptide by two human major histocompatibility antigen class I subtypes, HLA-B* 2705 and HLA-B* 2709. Both differ only in residue 116 within the peptide binding groove despite their differential association with ankylosing spondylitis, an inflammatory rheumatic disorder. The crystal structures described here show that a modified self-peptide, pVIPR-U5(RRKWURWHL; U = citrulline), is presented by the two HLA-B27 molecules in distinct conformations. These binding modes differ not only drastically from each other but also from the conformations exhibited by the non-citrullinated peptide in a given subtype. The differential reactivity of HLA-B27-restricted cytotoxic T cells with modified or unmodified pVIPR supports the structural findings and shows that the presentation of citrullinated peptides has the potential to influence immune responses.	[Beltrami, Alessandra; Ziegler, Andreas; Uchanska-Ziegler, Barbara] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany; [Rossmann, Maxim; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Fiorillo, Maria Teresa; Paladini, Fabiana; Sorrentino, Rosa] Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, I-00185 Rome, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Sapienza University Rome	Ziegler, A (corresponding author), Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Campus Benjamin Franklin,Thielallee 73, D-14195 Berlin, Germany.	andreas.ziegler@charite.de	Sorrentino, Rosa/G-5472-2012	Sorrentino, Rosa/0000-0002-9632-2383; Rossmann, Maxim/0000-0001-8811-3277; Paladini, Fabiana/0000-0003-1040-452X; FIORILLO, Maria Teresa/0000-0002-6859-5851	Deutsche Forschungsgemeinschaft [SFB 449]; VolkswagenStiftung [1/79 983]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen)	This work was financially supported by Deutsche Forschungsgemeinschaft (SFB 449, B6), VolkswagenStiftung (1/79 983), Berliner Krebsgesellschaft (Ernst von Leyden fellowship to A. B.), Senate of Berlin (NaFoG fellowship to P. K.), Sonnenfeld-Stiftung, Berlin, and Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bizzaro N, 2007, CLIN CHEM LAB MED, V45, P150, DOI 10.1515/CCLM.2007.027; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; BREWERTON DA, 1973, LANCET, V1, P904; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; DeLano W, 2002, PYMOL 0 99; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fearon WR, 1939, BIOCHEM J, V33, P902, DOI 10.1042/bj0330902; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; FIORILLO MT, 2008, MOL MECH SPONDYLOART; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Ireland J, 2006, J IMMUNOL, V177, P1421, DOI 10.4049/jimmunol.177.3.1421; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miley MJ, 2004, J EXP MED, V200, P1445, DOI 10.1084/jem.20040217; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Rehm A, 2000, HUM IMMUNOL, V61, P408, DOI 10.1016/S0198-8859(99)00176-7; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma AK, 2001, J BIOL CHEM, V276, P21443, DOI 10.1074/jbc.M010791200; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER., 2004, CLIN APPL IMMUNOL RE, V4, P239, DOI [DOI 10.1016/j.cair.2003.11.001, 10.1016/j.cair.2003.11.001, DOI 10.1016/J.CAIR.2003.11.001]; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97; ZIEGLER A, 2008, MOL MECH SPONDYLOART	57	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27189	27199		10.1074/jbc.M802818200	http://dx.doi.org/10.1074/jbc.M802818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650441	hybrid			2022-12-25	WOS:000259586600039
J	Basso, E; Petronilli, V; Forte, MA; Bernardi, P				Basso, Emy; Petronilli, Valeria; Forte, Michael A.; Bernardi, Paolo			Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC-PHOSPHATE; INNER MEMBRANE; UBIQUINONE ANALOGS; HEART-MITOCHONDRIA; CALCIUM-UPTAKE; LIVER; MATRIX; RESPIRATION; DYSFUNCTION; MODULATION	Energized mouse liver mitochondria displayed the same calcium retention capacity (a sensitive measure of the propensity of the permeability transition pore (PTP) to open) irrespective of whether phosphate, arsenate, or vanadate was the permeating anion. Unexpectedly, however, phosphate was specifically required for PTP desensitization by cyclosporin A (CsA) or by genetic inactivation of cyclophilin D (CyP-D). Indeed, when phosphate was replaced by arsenate, vanadate, or bicarbonate, the inhibitory effects of CsA and of CyP-D ablation on the PTP disappeared. After loading with the same amount of Ca2+ in the presence of arsenate or vanadate but in the absence of phosphate, the sensitivity of the PTP to a variety of inducers was identical in mitochondria from wild-type mice, CyP-D-null mice, and wild-type mice treated with CsA. These findings call for a reassessment of conclusions on the role of the PTP in cell death that are based on the effects of CsA or of CyP-D ablation.	[Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; University of Padua; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015; Basso, Emy/F-7687-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404; Basso, Emy/0000-0003-2962-7213	United States Public Health Service [GM69883]; Ministero per l'Universita e la Ricerca, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ministero per l'Universita e la Ricerca, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69883 from the United States Public Health Service (to M. A. F. and P. B.). This work was also supported by the Ministero per l'Universita e la Ricerca, Italy (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; AZZONE GF, 1977, FEBS LETT, V78, P21, DOI 10.1016/0014-5793(77)80264-0; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1982, FEBS LETT, V139, P9, DOI 10.1016/0014-5793(82)80475-4; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CARAFOLI E, 1964, J BIOL CHEM, V239, P3055; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; CROMPTON M, 1988, BIOCHEM J, V255, P357; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HARRIS EJ, 1977, FEBS LETT, V79, P284, DOI 10.1016/0014-5793(77)80804-1; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KATZ LA, 1988, AM J PHYSIOL, V255, pH189, DOI 10.1152/ajpheart.1988.255.1.H189; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390	45	133	138	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26307	26311		10.1074/jbc.C800132200	http://dx.doi.org/10.1074/jbc.C800132200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18684715	Green Published, hybrid			2022-12-25	WOS:000259341600003
J	Filipp, D; Moemeni, B; Ferzoco, A; Kathirkamathamby, K; Zhang, J; Ballek, O; Davidson, D; Veillette, A; Julius, M				Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Ballek, Ondrej; Davidson, Dominique; Veillette, Andre; Julius, Michael			Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; T-CELL-RECEPTOR; SRC-FAMILY KINASES; TCR-ALPHA-BETA; SIGNAL-TRANSDUCTION; SH2 DOMAIN; TRANSMEMBRANE ADAPTER; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; HORMONE RECEPTOR	Mechanisms regulating the activation and delivery of function of Lck and Fyn are central to the generation of the most proximal signaling events emanating from the T cell antigen receptor (TcR) complex. Recent results demonstrate that lipid rafts (LR) segregate Lck and Fyn and play a fundamental role in the temporal and spatial coordination of their activation. Specifically, TcR-CD4 co-aggregation-induced Lck activation outside LR results in Lck translocation to LR where the activation of LR-resident Fyn ensues. Here we report a structure-function analysis toward characterizing the mechanism supporting Lck partitioning to LR and its capacity to activate co-localized Fyn. Using NIH 3T3 cells ectopically expressing FynT, we demonstrate that only LR-associated, kinase-active (Y505F)Lck reciprocally co-immunoprecipitates with and activates Fyn. Mutational analyses revealed a profound reduction in the formation of Lck-Fyn complexes and Fyn activation, using kinase domain mutants K273R and Y394F of (Y505F)Lck, both of which have profoundly compromised kinase activity. The only kinase-active Lck mutants tested that revealed impaired physical and enzymatic engagement with Fyn were those involving truncation of the C-terminal sequence YQPQP. Remarkably, sequential truncation of YQPQP resulted in an increasing reduction of kinase-active Lck partitioning to LR, in both fibroblasts and T cells. This in turn correlated with an ablation of the capacity of these truncates to enhance TcR-mediated interleukin-2 production. Thus, Lck-dependent Fyn activation is predicated by proximity-mediated transphosphorylation of the Fyn kinase domain, and targeting kinase-active Lck to LR is dependent on the C-terminal sequence QPQP.	[Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Julius, Michael] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Julius, Michael] Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Filipp, Dominik; Ballek, Ondrej] Inst Mol Genet AS CR, Immunol Lab, Prague 14220 4, Czech Republic; [Davidson, Dominique; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Davidson, Dominique; Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3A 1A1, Canada; [Davidson, Dominique; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3T 1J4, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Julius, M (corresponding author), Univ Toronto, Sunnybrook Res Inst, Rm A3-33,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	michael.julius@sri.utoronto.ca	Filipp, Dominik/G-4395-2014	Filipp, Dominik/0000-0003-2506-9330	Canadian Institutes of Health Research [FRN9735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant FRN9735 from the Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Bonnard M, 1997, CELL IMMUNOL, V175, P1, DOI 10.1006/cimm.1996.1044; Bougeret C, 1996, J BIOL CHEM, V271, P7465, DOI 10.1074/jbc.271.13.7465; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; DAVIDSON D, 1994, J BIOL CHEM, V269, P10956; Doro U, 1996, MOL CELL BIOL, V16, P4996; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Filipp D, 2004, MOL IMMUNOL, V41, P645, DOI 10.1016/j.molimm.2004.04.011; Filipp D, 2004, J IMMUNOL, V172, P4266, DOI 10.4049/jimmunol.172.7.4266; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Heck E, 2006, J VIROL, V80, P9934, DOI 10.1128/JVI.01112-06; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; JULIUS M, 1993, IMMUNOL TODAY, V14, P177; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kjellen P, 2002, VIROLOGY, V297, P281, DOI 10.1006/viro.2002.1419; KUBO RT, 1989, J IMMUNOL, V142, P2736; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Leung BL, 1999, J IMMUNOL, V163, P1334; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MAROUN CR, 1994, EUR J IMMUNOL, V24, P959, DOI 10.1002/eji.1830240427; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Mendieta J, 2004, J MOL GRAPH MODEL, V23, P189, DOI 10.1016/j.jmgm.2004.06.001; Miller CE, 2004, BIOPHYS J, V86, P3700, DOI 10.1529/biophysj.103.032508; Mitchell JL, 2007, J MOL BIOL, V366, P1282, DOI 10.1016/j.jmb.2006.12.026; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Navratil AM, 2006, BIOL REPROD, V74, P788, DOI 10.1095/biolreprod.105.048157; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; Pawson AJ, 2003, ENDOCRINOLOGY, V144, P3860, DOI 10.1210/en.2003-0028; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; RESKEKUNZ AB, 1985, EUR J IMMUNOL, V15, P1048, DOI 10.1002/eji.1830151017; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; SUGIMOTO Y, 1985, J BIOL CHEM, V260, P3838; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TSYGANKOV AY, 1994, J BIOL CHEM, V269, P7792; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yeh E T, 1994, Semin Immunol, V6, P73, DOI 10.1006/smim.1994.1011; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	83	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26409	26422		10.1074/jbc.M710372200	http://dx.doi.org/10.1074/jbc.M710372200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660530	Green Published, hybrid			2022-12-25	WOS:000259341600015
J	Maeda, A; Maeda, T; Golczak, M; Palczewski, K				Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Palczewski, Krzysztof			Retinopathy in mice induced by disrupted all-trans-retinal clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR RHODOPSIN; MACULAR DEGENERATION; VISUAL CYCLE; PIGMENT EPITHELIUM; STARGARDT-DISEASE; MOUSE MODEL; LIGHT DAMAGE; GENE ABCR; IN-VIVO; A2E	The visual (retinoid) cycle is a fundamental metabolic process in vertebrate retina responsible for production of 11-cis-retinal, the chromophore of rhodopsin and cone pigments. 11-cis-Retinal is bound to opsins, forming visual pigments, and when the resulting visual chromophore 11-cis-retinylidene is photoisomerized to all-trans-retinylidene, all-trans-retinal is released from these receptors. Toxic byproducts of the visual cycle formed from all-trans-retinal often are associated with lipofuscin deposits in the retinal pigmented epithelium (RPE), but it is not clear whether aberrant reactions of the visual cycle participate in RPE atrophy, leading to a rapid onset of retinopathy. Here we report that mice lacking both the ATP-binding cassette transporter 4 (Abca4) and enzyme retinol dehydrogenase 8 (Rdh8), proteins critical for all-trans-retinal clearance from photoreceptors, developed severe RPE/photoreceptor dystrophy at an early age. This phenotype includes lipofuscin, drusen, and basal laminar deposits, Bruch's membrane thickening, and choroidal neovascularization. Importantly, the severity of visual dysfunction and retinopathy was exacerbated by light but attenuated by treatment with retinylamine, a visual cycle inhibitor that slows the flow of all-trans-retinal through the visual cycle. These findings provide direct evidence that aberrant production of toxic condensation byproducts of the visual cycle in mice can lead to rapid, progressive retinal degeneration.	[Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Sch Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY09339, P30 EY11373, EY08123]; NATIONAL EYE INSTITUTE [R01EY008123, P30EY011373, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY09339, P30 EY11373, and EY08123. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; ELDRED GE, 1993, NATURE, V364, P396; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Haines JL, 2007, P NATL ACAD SCI USA, V104, P16725, DOI 10.1073/pnas.0708151104; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4540, DOI 10.1167/iovs.06-0215; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; NILSSON SEG, 1977, ACTA OPHTHALMOL, V55, P994; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verdegem PJE, 1997, TETRAHEDRON LETT, V38, P5355, DOI 10.1016/S0040-4039(97)01171-4; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035	40	210	216	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26684	26693		10.1074/jbc.M804505200	http://dx.doi.org/10.1074/jbc.M804505200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658157	Green Published, hybrid			2022-12-25	WOS:000259341600042
J	Ma, DZ; Bai, XC; Guo, SG; Jiang, Y				Ma, Dongzhu; Bai, Xiaochun; Guo, Shuguang; Jiang, Yu			The switch I region of Rheb is critical for its interaction with FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; SIGNALING NETWORK; RAPAMYCIN MTOR; CELL-GROWTH; LOCALIZATION; ACTIVATION; APOPTOSIS; PATHWAY; INSULIN	The Ras-like small GTPase Rheb is an upstream activator of the mammalian target of rapamycin (mTOR). It has recently been shown that Rheb activates mTOR by binding to its endogenous inhibitor FKBP38 and preventing it from association with mTOR. The interaction of Rheb with FKBP38 is controlled by its guanine nucleotide binding states, which are responsive to growth factor and amino acid conditions. In this study, we show that Rheb interacts with FKBP38 through a section within its switch I region that is equivalent to the effector domain of other Ras-like small GTPases. We find that the ability for Rheb to interact with FKBP38 correlates with its activity for mTOR activation. Our findings suggest that FKBP38 is a bona fide effector of Rheb and that the ability to interact with FKBP38 is important for Rheb as an activator of mTOR.	[Ma, Dongzhu; Guo, Shuguang; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bai, Xiaochun] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	yuj5@pitt.edu			National Institutes of Health [GM068832, CA129821]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole by National Institutes of Health Grants GM068832 and CA129821 (to Y.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Harrar Y, 2001, TRENDS PLANT SCI, V6, P426, DOI 10.1016/S1360-1385(01)02044-1; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Portier BP, 2006, J BIOL CHEM, V281, P40493, DOI 10.1074/jbc.M606181200; Proud CG, 2007, SCIENCE, V318, P926, DOI 10.1126/science.1150653; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	36	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25963	25970		10.1074/jbc.M802356200	http://dx.doi.org/10.1074/jbc.M802356200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658153	Green Published, hybrid			2022-12-25	WOS:000259200100024
J	Brookes, RH; Hill, PC; Owiafe, PK; Ibanga, HB; Jeffries, DJ; Donkor, SA; Fletcher, HA; Hammond, AS; Lienhardt, C; Adegbola, RA; McShane, H; Hill, AVS				Brookes, Roger H.; Hill, Philip C.; Owiafe, Patrick K.; Ibanga, Hannah B.; Jeffries, David J.; Donkor, Simon A.; Fletcher, Helen A.; Hammond, Abdulrahman S.; Lienhardt, Christian; Adegbola, Richard A.; McShane, Helen; Hill, Adrian V. S.			Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; VIRUS ANKARA; SKIN-TEST; ENHANCED IMMUNOGENICITY; PROTECTIVE EFFICACY; CLINICAL-TRIALS; BCG VACCINATION; INFECTION; IMMUNITY	Background: Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers. Methods and Findings: We vaccinated 21 healthy adult male subjects (11 BCG scar negative and 10 BCG scar positive) with MVA85A after screening for evidence of prior exposure to mycobacteria. We monitored them over six months, observing for clinical, haematological and biochemical adverse events, together with assessment of the vaccine induced cellular immune response using ELISPOT and flow cytometry. MVA85A was well tolerated with no significant adverse events. Mild local and systemic adverse events were consistent with previous UK trials. Marked immunogenicity was found whether individuals had a previous BCG scar or not. There was not enhanced immunogenicity in those with a BCG scar, and induced T cell responses were better maintained in apparently BCG-naive Gambians than previously studied BCG-naive UK vaccinees. Although responses were predominantly attributable to CD4+ T cells, we also identified antigen specific CD8+ T cell responses, in subjects who were HLA B-35 and in whom enough blood was available for more detailed immunological analysis. Conclusions: These data on the safety and immunogenicity of MVA85A in West Africa support its accelerated development as a promising booster vaccine for tuberculosis.	[Brookes, Roger H.; Hill, Philip C.; Owiafe, Patrick K.; Ibanga, Hannah B.; Jeffries, David J.; Donkor, Simon A.; Hammond, Abdulrahman S.; Adegbola, Richard A.] MRC Labs, TB Div, Bacterial Dis Programme, Banjul, Gambia; [Fletcher, Helen A.; McShane, Helen; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lienhardt, Christian] Inst Rech Dev, Paris, France; [Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	MRC Laboratory Molecular Biology; University of Oxford; Institut de Recherche pour le Developpement (IRD); University of Oxford; Wellcome Centre for Human Genetics	Brookes, RH (corresponding author), MRC Labs, TB Div, Bacterial Dis Programme, Banjul, Gambia.	helen.mcshane@ndm.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Hammond, Abdulrahman/F-1541-2011; Fletcher, Helen/D-1470-2011	Lienhardt, Christian/0000-0003-0233-893X; Brookes, Roger/0000-0002-5361-0617; Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142; Kwasi Owiafe, Patrick/0000-0002-4287-3577	Medical Research Council (UK); European Commission [AFTBVAC-ICA4-CT-2002-10052]; Medical Research Council [MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (UK) and the European Commission (AFTBVAC-ICA4-CT-2002-10052). Neither funder had any role in the design of the study or the preparation of the manuscript.	Ahmed RKS, 2005, SCAND J IMMUNOL, V61, P63, DOI 10.1111/j.0300-9475.2005.01530.x; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Klein MR, 2001, J INFECT DIS, V183, P928, DOI 10.1086/319267; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LEE SP, 1995, EUR J IMMUNOL, V25, P102, DOI 10.1002/eji.1830250119; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; YOUNG TK, 1992, TUBERCLE LUNG DIS, V73, P94, DOI 10.1016/0962-8479(92)90062-O	34	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2921	10.1371/journal.pone.0002921	http://dx.doi.org/10.1371/journal.pone.0002921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698342	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000264412600007
J	Hashimoto, T; Hussien, R; Cho, HS; Kaufer, D; Brooks, GA				Hashimoto, Takeshi; Hussien, Rajaa; Cho, Hyung-Sook; Kaufer, Daniela; Brooks, George A.			Evidence for the Mitochondrial Lactate Oxidation Complex in Rat Neurons: Demonstration of an Essential Component of Brain Lactate Shuttles	PLOS ONE			English	Article								To evaluate the presence of components of a putative Intracellular Lactate Shuttle (ILS) in neurons, we attempted to determine if monocarboxylate ( e. g. lactate) transporter isoforms (MCT1 and -2) and lactate dehydrogenase (LDH) are coexpressed in neuronal mitochondria of rat brains. Immunohistochemical analyses of rat brain cross-sections showed MCT1, MCT2, and LDH to colocalize with the mitochondrial inner membrane marker cytochrome oxidase ( COX) in cortical, hippocampal, and thalamic neurons. Immunoblotting after immunoprecipitation (IP) of mitochondria from brain homogenates supported the histochemical observations by demonstrating that COX coprecipitated MCT1, MCT2, and LDH. Additionally, using primary cultures from rat cortex and hippocampus as well as immunohistochemistry and immunocoprecipitation techniques, we demonstrated that MCT2 and LDH are coexpressed in mitochondria of cultured neurons. These findings can be interpreted to mean that, as in skeletal muscle, neurons contain a mitochondrial lactate oxidation complex (mLOC) that has the potential to facilitate both intracellular and cell-cell lactate shuttles in brain.	[Hashimoto, Takeshi; Hussien, Rajaa; Cho, Hyung-Sook; Kaufer, Daniela; Brooks, George A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hashimoto, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	gbrooks@berkeley.edu		Brooks, George A./0000-0002-1389-1629	NIH [R01 AR050459]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH R01 AR050459	ABILOVA G A, 1991, Byulleten' Eksperimental'noi Biologii i Meditsiny, V111, P462; Atlante A, 2007, BBA-BIOENERGETICS, V1767, P1285, DOI 10.1016/j.bbabio.2007.08.003; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Bliss TM, 2004, J NEUROSCI, V24, P6202, DOI 10.1523/JNEUROSCI.0805-04.2004; BRANDT RB, 1987, ARCH BIOCHEM BIOPHYS, V259, P412, DOI 10.1016/0003-9861(87)90507-8; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; BROOKS GA, 1991, J APPL PHYSIOL, V71, P333, DOI 10.1152/jappl.1991.71.1.333; BROOKS GA, 1985, GLYCOLYTIC END PRODU, P202; Brooks GEA, 2007, J PHYSIOL-LONDON, V584, P705, DOI 10.1113/jphysiol.2007.142992; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; de Bari L, 2004, BIOCHEM J, V380, P231, DOI 10.1042/BJ20031981; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; FRIEDMAN L, 1987, NEUROSCI LETT, V79, P65, DOI 10.1016/0304-3940(87)90673-2; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/MSS.0b013e31815fcb04, 10.1249/mss.0b013e31815fcb04]; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Laughton JD, 2000, NEUROSCIENCE, V96, P619, DOI 10.1016/S0306-4522(99)00580-1; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Richardson RS, 1998, J APPL PHYSIOL, V85, P627, DOI 10.1152/jappl.1998.85.2.627; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; SCHURR A, 1988, BRAIN RES, V438, P311, DOI 10.1016/0006-8993(88)91354-6; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Valenti D, 2002, BIOCHEM J, V364, P101, DOI 10.1042/bj3640101; WILSON EJ, 1987, NEUROCHEM RES, V12, P831; Wimmer VC, 2006, J NEUROSCI, V26, P109, DOI 10.1523/JNEUROSCI.3268-05.2006	41	122	131	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2915	10.1371/journal.pone.0002915	http://dx.doi.org/10.1371/journal.pone.0002915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698340	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600003
J	Shrivastava, S; Mande, SS				Shrivastava, Sakshi; Mande, Sharmila S.			Identification and Functional Characterization of Gene Components of Type VI Secretion System in Bacterial Genomes	PLOS ONE			English	Article							PROTEIN SECRETION	A new secretion system, called the Type VI Secretion system (T6SS), was recently reported in Vibrio cholerae, Pseudomonas aeruginosa and Burkholderia mallei. A total of 18 genes have been identified to be belonging to this secretion system in V. cholerae. Here we attempt to identify presence of T6SS in other bacterial genomes. This includes identification of orthologous sequences, conserved motifs, domains, families, 3D folds, genomic islands containing T6SS components, phylogenetic profiles and protein-protein association of these components. Our analysis indicates presence of T6SS in 42 bacteria and its absence in most of their non-pathogenic species, suggesting the role of T6SS in imparting pathogenicity to an organism. Analysis of genomic regions containing T6SS components, phylogenetic profiles and protein-protein association of T6SS components indicate few additional genes which could be involved in this secretion system. Based on our studies, functional annotations were assigned to most of the components. Except one of the genes, we could group all the other genes of T6SS into those belonging to the puncturing device, and those located in the outer membrane, transmembrane and inner membrane. Based on our analysis, we have proposed a model of T6SS and have compared the same with the other bacterial secretion systems.	[Shrivastava, Sakshi; Mande, Sharmila S.] Tata Consultancy Serv, Adv Technol Ctr, Biosci Div, Madhapur, Andhra Pradesh, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Shrivastava, S (corresponding author), Tata Consultancy Serv, Adv Technol Ctr, Biosci Div, Madhapur, Andhra Pradesh, India.	sharmila@atc.tcs.com						Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Zusman T, 2004, INFECT IMMUN, V72, P3398, DOI 10.1128/IAI.72.6.3398-3409.2004	16	123	135	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2955	10.1371/journal.pone.0002955	http://dx.doi.org/10.1371/journal.pone.0002955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698408	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600041
J	Miles, DJC; van der Sande, M; Jeffries, D; Kaye, S; Ojuola, O; Sanneh, M; Cox, M; Palmero, MS; Touray, ES; Waight, P; Rowland-Jones, S; Whittle, H; Marchant, A				Miles, David J. C.; van der Sande, Marianne; Jeffries, David; Kaye, Steve; Ojuola, Olubukola; Sanneh, Mariama; Cox, Momodou; Palmero, Melba S.; Touray, Ebrima S.; Waight, Pauline; Rowland-Jones, Sarah; Whittle, Hilton; Marchant, Arnaud			Maintenance of Large Subpopulations of Differentiated CD8 T-Cells Two Years after Cytomegalovirus Infection in Gambian Infants	PLOS ONE			English	Article							LYMPHOCYTE SUBPOPULATIONS; GAMMA-INTERFERON; PROTEIN PP65; 1ST YEAR; MEMORY; CD4(+); ASSOCIATION; FREQUENCIES; EXPRESSION; EFFECTOR	Background: In a previously published study, we found that large differentiated subpopulations of CD8 T-cells emerged rapidly after CMV infection in young infants and persisted throughout the following year. Here we describe a follow-up study conducted on the same infants to establish whether the differentiated subpopulations continued through the second year post-infection. Methodology/Principal Findings: CMV-specific cells identified using tetramers remained more activated and differentiated than the overall CD8 population. The large subpopulation of differentiated cytotoxic (CD28(-)CD62L(-)Bcl-2(low)CD95(+)perforin(+)) cells that emerged rapidly after infection remained stable after two years. No similar subpopulation was found in CMV-uninfected infants indicating that two years after infection, CMV remained a major factor in driving CD8 T-cell differentiation. Although markers of activation (CD45R0 and HLA-D) declined throughout the first year, HLA-D expression continued to decline during the second year and CD45R0 expression increased slightly. The age-related increase in IFN gamma response observed during the first year continued but was non-significant during the second year, indicating that the rate of functional improvement had slowed substantially. Conclusions/Significance: The large differentiated subpopulations of CD8 T-cells that had emerged immediately after CMV infection persisted through the second year post-infection, while levels of activation and functional capacity remained fairly constant.	[Miles, David J. C.; Jeffries, David; Sanneh, Mariama; Cox, Momodou; Palmero, Melba S.; Touray, Ebrima S.; Rowland-Jones, Sarah; Whittle, Hilton] MRC Labs Gambia, Banjul, Gambia; [van der Sande, Marianne] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Kaye, Steve] Imperial Coll London, Jefferiss Trust Lab, London, England; [Ojuola, Olubukola] Bronx Lebanon Hosp Ctr, Dept Pediat, Bronx, NY USA; [Waight, Pauline] Hlth Protect Agcy Ctr Infect, Immunisat Dept, London, England; [Marchant, Arnaud] Free Univ Brussels, Inst Med Immunol, Charleroi, Belgium	Netherlands National Institute for Public Health & the Environment; Imperial College London; BronxCare Health System; Health Protection Agency	Miles, DJC (corresponding author), MRC Labs Gambia, Banjul, Gambia.	djcm1@liverpool.ac.uk		van der Sande, Marianne AB/0000-0002-4778-6739	GSK Biologicals; Medical Research Council; Fonds National de la Recherche Scientifique, Belgium; MRC [MC_U190081978, MC_U190085854] Funding Source: UKRI; Medical Research Council [MC_U190081978, MC_U190085854] Funding Source: researchfish	GSK Biologicals(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by GSK Biologicals and the Medical Research Council. Arnaud Marchant is a senior research associate at the Fonds National de la Recherche Scientifique, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1993, J EXP MED, V178, P427, DOI 10.1084/jem.178.2.427; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Chen SF, 2004, J INFECT DIS, V189, P1619, DOI 10.1086/383249; de Vries E, 2000, PEDIATR RES, V47, P528, DOI 10.1203/00006450-200004000-00019; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; GAVIN MA, 1993, J IMMUNOL, V151, P3971; GERDES J, 1984, J IMMUNOL, V133, P1710; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; GRATAMA JW, 1987, BLOOD, V70, P516; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, IMMUNOL TODAY, V20, P177, DOI 10.1016/S0167-5699(99)01444-9; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Jaimes MC, 2002, J VIROL, V76, P4741, DOI 10.1128/JVI.76.10.4741-4749.2002; JEFFRIES D, CYTOMETRY IN PRESS; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAYE S, 2008, J INFECT DIS, P197; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Komatsu Haruki, 2006, Immun Ageing, V3, P11, DOI 10.1186/1742-4933-3-11; Kuijpers TW, 2003, J IMMUNOL, V170, P4342, DOI 10.4049/jimmunol.170.8.4342; Lohman BL, 2005, J VIROL, V79, P8121, DOI 10.1128/JVI.79.13.8121-8130.2005; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Olsson J, 2000, MECH AGEING DEV, V121, P187; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Solache A, 1999, J IMMUNOL, V163, P5512; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; UTZ U, 1992, J IMMUNOL, V149, P214; van Leeuwen EMM, 2006, J IMMUNOL, V177, P4998, DOI 10.4049/jimmunol.177.8.4998; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	45	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2905	10.1371/journal.pone.0002905	http://dx.doi.org/10.1371/journal.pone.0002905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682836	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600061
J	Toh, SY; Gong, JY; Du, GL; Li, JZ; Yang, SQ; Ye, J; Yao, HL; Zhang, YX; Xue, BF; Li, Q; Yang, HY; Wen, ZL; Li, P				Toh, Shen Yon; Gong, Jingyi; Du, Guoli; Li, John Zhong; Yang, Shuqun; Ye, Jing; Yao, Huilan; Zhang, Yinxin; Xue, Bofu; Li, Qing; Yang, Hongyuan; Wen, Zilong; Li, Peng			Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice	PLOS ONE			English	Article								Fsp27, a member of the Cide family proteins, was shown to localize to lipid droplet and promote lipid storage in adipocytes. We aimed to understand the biological role of Fsp27 in regulating adipose tissue differentiation, insulin sensitivity and energy balance. Fsp27(-/-) mice and Fsp27/lep double deficient mice were generated and we examined the adiposity, whole body metabolism, BAT and WAT morphology, insulin sensitivity, mitochondrial activity, and gene expression changes in these mouse strains. Furthermore, we isolated mouse embryonic fibroblasts (MEFs) from wildtype and Fsp27(-/-) mice, followed by their differentiation into adipocytes in vitro. We found that Fsp27 is expressed in both brown adipose tissue (BAT) and white adipose tissue (WAT) and its levels were significantly elevated in the WAT and liver of leptin-deficient ob/ob mice. Fsp27(-/-) mice had increased energy expenditure, lower levels of plasma triglycerides and free fatty acids. Furthermore, Fsp27(-/-) and Fsp27/lep double-deficient mice are resistant to diet-induced obesity and display increased insulin sensitivity. Moreover, white adipocytes in Fsp27(-/-) mice have reduced triglycerides accumulation and smaller lipid droplets, while levels of mitochondrial proteins, mitochondrial size and activity are dramatically increased. We further demonstrated that BAT-specific genes and key metabolic controlling factors such as FoxC2, PPAR and PGC1 alpha were all markedly upregulated. In contrast, factors inhibiting BAT differentiation such as Rb, p107 and RIP140 were down-regulated in the WAT of Fsp27(-/-) mice. Remarkably, Fsp27(-/-) MEFs differentiated in vitro show many brown adipocyte characteristics in the presence of the thyroid hormone triiodothyronine (T3). Our data thus suggest that Fsp27 acts as a novel regulator in vivo to control WAT identity, mitochondrial activity and insulin sensitivity.	[Toh, Shen Yon] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Toh, Shen Yon; Gong, Jingyi; Du, Guoli; Li, John Zhong; Yang, Shuqun; Ye, Jing; Yao, Huilan; Zhang, Yinxin; Li, Peng] Tsinghua Univ, Dept Biol Sci & Biotechnol, Protein Sci Lab Minist Ed, Beijing, Peoples R China; [Toh, Shen Yon; Li, John Zhong; Xue, Bofu] Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Peoples R China; [Ye, Jing; Li, Qing] Fourth Mil Med Univ, Dept Pathol, Xian, Peoples R China; [Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wen, Zilong] Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Tsinghua University; Hong Kong University of Science & Technology; Air Force Military Medical University; University of New South Wales Sydney; Hong Kong University of Science & Technology	Toh, SY (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	li-peng@mail.tsinghua.edu.cn	zhang, yinxin/D-8896-2013; Li, Zhong/U-2157-2017; Yang, Hongyuan/AAR-1326-2020; Li, John Zhong/S-2118-2019; Zhang, Yinxin/I-9996-2019	Yang, Hongyuan/0000-0002-8482-6031; Li, John Zhong/0000-0003-4991-9563; Zhang, Yinxin/0000-0001-5909-3676; Wen, Zilong/0000-0002-4260-7682; Toh, Shen Yon/0000-0002-6421-0862	Ministry of Education of China [704002]; National Natural Science Foundation of China [30530350]; National Basic Research program of China [2006CB503900, 2007CB914404]; Ministry of Science and Technology of China	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (704002 to PL) from Ministry of Education of China; (30530350 to PL) from National Natural Science Foundation of China; and National Basic Research program of China (2006CB503900, 2007CB914404) from Ministry of Science and Technology of China. PL is a Cheung Kong Scholar of the Ministry of Education of China. This work was also supported by Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education in China.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; BOUILLAUD F, 1984, J BIOL CHEM, V259, P1583; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brock DA, 2003, EUKARYOT CELL, V2, P788, DOI 10.1128/EC.2.4.788-797.2003; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; DANESCH U, 1992, J BIOL CHEM, V267, P7185; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FERRE P, 2004, DIABETES METAB, V53; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; LIN J, 2005, CELL METABOLISM, V1; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCIME A, 2005, CELL METAB, V2, P107; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; VONRAALTE DH, 2004, PHARM RES, V21; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yoshida T, 1998, AM J PHYSIOL-ENDOC M, V274, pE469, DOI 10.1152/ajpendo.1998.274.3.E469; ZHOU Z, 2003, NATURE GENETICS, V35	45	209	221	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2890	10.1371/journal.pone.0002890	http://dx.doi.org/10.1371/journal.pone.0002890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682832	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600046
J	Vleeshouwers, VGAA; Rietman, H; Krenek, P; Champouret, N; Young, C; Oh, SK; Wang, MQ; Bouwmeester, K; Vosman, B; Visser, RGF; Jacobsen, E; Govers, F; Kamoun, S; Van der Vossen, EAG				Vleeshouwers, Vivianne G. A. A.; Rietman, Hendrik; Krenek, Pavel; Champouret, Nicolas; Young, Carolyn; Oh, Sang-Keun; Wang, Miqia; Bouwmeester, Klaas; Vosman, Ben; Visser, Richard G. F.; Jacobsen, Evert; Govers, Francine; Kamoun, Sophien; Van der Vossen, Edwin A. G.			Effector Genomics Accelerates Discovery and Functional Profiling of Potato Disease Resistance and Phytophthora Infestans Avirulence Genes	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; LATE BLIGHT RESISTANCE; SOLANUM-BULBOCASTANUM; IPIO GENE; PLANT; DNA; ORGANIZATION; RECOGNITION; PROTEINS; SERIES	Potato is the world's fourth largest food crop yet it continues to endure late blight, a devastating disease caused by the Irish famine pathogen Phytophthora infestans. Breeding broad-spectrum disease resistance (R) genes into potato (Solanum tuberosum) is the best strategy for genetically managing late blight but current approaches are slow and inefficient. We used a repertoire of effector genes predicted computationally from the P. infestans genome to accelerate the identification, functional characterization, and cloning of potentially broad-spectrum R genes. An initial set of 54 effectors containing a signal peptide and a RXLR motif was profiled for activation of innate immunity (avirulence or Avr activity) on wild Solanum species and tentative Avr candidates were identified. The RXLR effector family IpiO induced hypersensitive responses (HR) in S. stoloniferum, S. papita and the more distantly related S. bulbocastanum, the source of the R gene Rpi-blb1. Genetic studies with S. stoloniferum showed cosegregation of resistance to P. infestans and response to IpiO. Transient co-expression of IpiO with Rpi-blb1 in a heterologous Nicotiana benthamiana system identified IpiO as Avr-blb1. A candidate gene approach led to the rapid cloning of S. stoloniferum Rpi-sto1 and S. papita Rpi-pta1, which are functionally equivalent to Rpi-blb1. Our findings indicate that effector genomics enables discovery and functional profiling of late blight R genes and Avr genes at an unprecedented rate and promises to accelerate the engineering of late blight resistant potato varieties.	[Vleeshouwers, Vivianne G. A. A.; Rietman, Hendrik; Krenek, Pavel; Champouret, Nicolas; Wang, Miqia; Vosman, Ben; Visser, Richard G. F.; Jacobsen, Evert; Van der Vossen, Edwin A. G.] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Young, Carolyn; Oh, Sang-Keun; Kamoun, Sophien] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH USA; [Bouwmeester, Klaas; Govers, Francine] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands; [Kamoun, Sophien] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England	Wageningen University & Research; University System of Ohio; Ohio State University; Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Vleeshouwers, VGAA (corresponding author), Wageningen UR Plant Breeding, Wageningen, Netherlands.	Vivianne.Vleeshouwers@wur.nl	Govers, Francine/A-5616-2009; Visser, Richard GF/B-3423-2012; Young, Carolyn Anne/Q-2963-2019; Vleeshouwers, Vivianne/AAF-2965-2020; Bouwmeester, Klaas/A-4081-2011; Vosman, Ben/C-5494-2013; Kamoun, Sophien/B-3529-2009; Bouwmeester, Klaas/AAF-3647-2020	Govers, Francine/0000-0001-5311-929X; Visser, Richard GF/0000-0002-0213-4016; Young, Carolyn Anne/0000-0003-0406-8398; Bouwmeester, Klaas/0000-0002-8141-3880; Vosman, Ben/0000-0003-4942-8342; Kamoun, Sophien/0000-0002-0290-0315; Bouwmeester, Klaas/0000-0002-8141-3880; Vleeshouwers, Vivianne/0000-0002-8160-4556; Krenek, Pavel/0000-0002-0206-4978	WUR Plant Breeding, Wageningen; Czech University of Agriculture; Center of Biosystems Genomics (CBSG); NSF Plant Genome Research Program [DBI-0211659]; Gatsby Charitable Foundation	WUR Plant Breeding, Wageningen; Czech University of Agriculture; Center of Biosystems Genomics (CBSG); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Gatsby Charitable Foundation	This research was financed by WUR Plant Breeding, Wageningen. The Czech University of Agriculture has financially supported PK, and the Center of Biosystems Genomics (CBSG) has financially supported the retrieving of resistant germplasm. CY and SKO were funded by NSF Plant Genome Research Program grant DBI-0211659. SK was supported by the Gatsby Charitable Foundation.	*APPL GM FIELD TRI, 2005, POT IMPR RES PHYT IN; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; HAWKES JG, 1990, POTATO EVOLUTION BIO; HOEKEMA A, 1989, BIO-TECHNOL, V7, P273, DOI 10.1038/nbt0389-273; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Huang S, 2005, PLANT DIS, V89, P1263, DOI 10.1094/PD-89-1263; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jacobsen E, 2006, POTATO DEV CHANGING, P46; Jacobsen E, 2007, TRENDS BIOTECHNOL, V25, P219, DOI 10.1016/j.tibtech.2007.03.008; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; MCKEE RK, 1962, EUPHYTICA, V11, P42, DOI 10.1007/BF00044803; MULLER K. O., 1952, Zeitschrift fur Pflanzenzuchtung, V31, P305; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Spooner DM, 1997, AM J BOT, V84, P671, DOI 10.2307/2445904; SPOONER DM, 2004, SYSTEMIC BOT MONOGRA; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vleeshouwers VGAA, 1999, EUR J PLANT PATHOL, V105, P241, DOI 10.1023/A:1008710700363; Vleeshouwers VGAA, 2006, MOL PLANT PATHOL, V7, P499, DOI 10.1111/j.1364-3703.2006.00355.X; Wang M, 2008, THEOR APPL GENET, V116, P933, DOI 10.1007/s00122-008-0725-3; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593	42	260	284	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2875	10.1371/journal.pone.0002875	http://dx.doi.org/10.1371/journal.pone.0002875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682852	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600031
J	Walls, JR; Coultas, L; Rossant, J; Henkelman, RM				Walls, Johnathon R.; Coultas, Leigh; Rossant, Janet; Henkelman, R. Mark			Three-Dimensional Analysis of Vascular Development in the Mouse Embryo	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; RECEPTOR TYROSINE KINASES; BLOOD-VESSELS; NEURAL CREST; ARTERIOVENOUS-MALFORMATIONS; SIGNALING PATHWAY; SONIC HEDGEHOG; VEGF; ANGIOGENESIS; EXPRESSION	Key vasculogenic (de-novo vessel forming) and angiogenic (vessel remodelling) events occur in the mouse embryo between embryonic days (E) 8.0 and 10.0 of gestation, during which time the vasculature develops from a simple circulatory loop into a complex, fine structured, three-dimensional organ. Interpretation of vascular phenotypes exhibited by signalling pathway mutants has historically been hindered by an inability to comprehensively image the normal sequence of events that shape the basic architecture of the early mouse vascular system. We have employed Optical Projection Tomography (OPT) using frequency distance relationship (FDR)-based deconvolution to image embryos immunostained with the endothelial specific marker PECAM-1 to create a high resolution, three-dimensional atlas of mouse vascular development between E8.0 and E10.0 (5 to 30 somites). Analysis of the atlas has provided significant new information regarding normal development of intersomitic vessels, the perineural vascular plexus, the cephalic plexus and vessels connecting the embryonic and extraembryonic circulation. We describe examples of vascular remodelling that provide new insight into the mechanisms of sprouting angiogenesis, vascular guidance cues and artery/vein identity that directly relate to phenotypes observed in mouse mutants affecting vascular development between E8.0 and E10.0. This atlas is freely available at http://www.mouseimaging.ca/research/mouse_atlas.html and will serve as a platform to provide insight into normal and abnormal vascular development.	[Walls, Johnathon R.; Henkelman, R. Mark] Hosp Sick Children, Toronto Ctr Phenogenom, Mouse Imaging Ctr MICe, Toronto, ON M5G 1X8, Canada; [Walls, Johnathon R.; Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Coultas, Leigh; Rossant, Janet] Hosp Sick Children, Res Inst, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Walls, JR (corresponding author), Hosp Sick Children, Toronto Ctr Phenogenom, Mouse Imaging Ctr MICe, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mhenkel@phenogenomics.ca	HENKELMAN, MARK/W-6847-2019		Canadian Foundation for Innovation; Ontario Research and Development Challenge Fund; National Cancer Institute of Canada Terry Fox Foundation; Canada Research Chair in Imaging; Canadian Institutes of Health Research [distinguished investigator]; National Health and Medical Research Council (Canberra) [C.J. Martin postdoctoral fellow]; Hospital for Sick Children [Restracomp Scholarship]	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research and Development Challenge Fund(General Electric); National Cancer Institute of Canada Terry Fox Foundation; Canada Research Chair in Imaging(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (Canberra)(National Health and Medical Research Council (NHMRC) of Australia); Hospital for Sick Children	This work was supported by grants from Canadian Foundation for Innovation, the Ontario Research and Development Challenge Fund and the National Cancer Institute of Canada Terry Fox Foundation. RMH holds a Canada Research Chair in Imaging, JR is a distinguished investigator of the Canadian Institutes of Health Research, LC is a C.J. Martin postdoctoral fellow of the National Health and Medical Research Council (Canberra), and JRW is funded with a Hospital for Sick Children Restracomp Scholarship.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; BURKE AC, 1995, DEVELOPMENT, V121, P333; Byrd N, 2002, DEVELOPMENT, V129, P361; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chaturvedi K, 2006, NEUROENDOCRINOLOGY, V83, P387, DOI 10.1159/000096049; Childs S, 2002, DEVELOPMENT, V129, P973; COFFIN JD, 1988, DEVELOPMENT, V102, P735; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; COULY G, 1995, MECH DEVELOP, V53, P97, DOI 10.1016/0925-4773(95)00428-9; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Evans HM, 1909, ANAT REC, V3, P498, DOI 10.1002/ar.1090030903; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hajihosseini MK, 2008, MOL CELL NEUROSCI, V37, P857, DOI 10.1016/j.mcn.2008.01.008; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krull CE, 2001, MECH DEVELOP, V105, P37, DOI 10.1016/S0925-4773(01)00395-1; Kuan CYK, 2004, MECH DEVELOP, V121, P1055, DOI 10.1016/j.mod.2004.05.001; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; Mu JW, 2006, AM J PHYSIOL-HEART C, V291, pH1421, DOI 10.1152/ajpheart.00031.2006; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; NAKAO T, 1988, ANAT RECORD, V221, P663, DOI 10.1002/ar.1092210212; NIESSEN K, 2007, AM J PHYSIOL-CELL PH, V293, P1; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Slaney M., 1988, PRINCIPLES COMPUTERI; Sorensen LK, 2003, DEV BIOL, V261, P235, DOI 10.1016/S0012-1606(03)00158-1; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tucker RP, 1999, DEV DYNAM, V214, P312, DOI 10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Walls JR, 2007, PHYS MED BIOL, V52, P2775, DOI 10.1088/0031-9155/52/10/010; Walls JR, 2005, PHYS MED BIOL, V50, P4645, DOI 10.1088/0031-9155/50/19/015; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; WILTING J, 1995, DEV DYNAM, V202, P165, DOI 10.1002/aja.1002020208; Wood HB, 1997, BLOOD, V90, P2300; XIA WS, 1995, IEEE T MED IMAGING, V14, P100, DOI 10.1109/42.370406; Zhang XQ, 2001, BLOOD, V98, P1028, DOI 10.1182/blood.V98.4.1028; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	93	152	155	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2853	10.1371/journal.pone.0002853	http://dx.doi.org/10.1371/journal.pone.0002853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682734	gold, Green Published			2022-12-25	WOS:000264366600009
J	Ahn, SM; Byun, K; Cho, K; Kim, JY; Yoo, JS; Kim, D; Paek, SH; Kim, SU; Simpson, RJ; Lee, B				Ahn, Sung-Min; Byun, Kyunghee; Cho, Kun; Kim, Jin Young; Yoo, Jong Shin; Kim, Deokhoon; Paek, Sun Ha; Kim, Seung U.; Simpson, Richard J.; Lee, Bonghee			Human Microglial Cells Synthesize Albumin in Brain	PLOS ONE			English	Article								Albumin, an abundant plasma protein with multifunctional properties, is mainly synthesized in the liver. Albumin has been implicated in Alzheimer's disease (AD) since it can bind to and transport amyloid beta (A beta), the causative agent of AD; albumin is also a potent inhibitor of A beta polymerization. Despite evidence of non-hepatic transcription of albumin in many tissues including kidney and pancreas, non-hepatic synthesis of albumin at the protein level has been rarely confirmed. In a pilot phase study of Human Brain Proteome Project, we found evidence that microglial cells in brain may synthesize albumin. Here we report, for the first time, the de novo synthesis of albumin in human microglial cells in brain. Furtherore, we demonstrate that the synthesis and secretion of albumin from microglial cells is enhanced upon microgial activation by A beta(1-42)- or lipopolysaccharide (LPS)-treatment. These data indicate that microglial cells may play a beneficial role in AD by secreting albumin that not only inhibits A beta polymerization but also increases its clearance.	[Ahn, Sung-Min; Byun, Kyunghee; Kim, Deokhoon; Lee, Bonghee] Gachon Univ Med & Sci, Ctr Genom & Prote, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Cho, Kun; Kim, Jin Young; Yoo, Jong Shin; Kim, Deokhoon] Korea Basic Sci Inst, Mass Spectrometry Anal Grp, Taejon, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea; [Kim, Seung U.] Gachon Univ Med & Sci, Gachon Inst Regenerat Med, Inchon, South Korea; [Simpson, Richard J.] Walter & Eliza Hall Inst Med Res, Ludwig Inst Canc Res, Joint Proteomics Lab, Melbourne, Vic, Australia; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	Gachon University; Korea Basic Science Institute (KBSI); Seoul National University (SNU); Seoul National University Hospital; Gachon University; Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute; University of British Columbia	Ahn, SM (corresponding author), Gachon Univ Med & Sci, Ctr Genom & Prote, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	Richard.simpson@ludwig.edu.au; bhlee@gachon.ac.kr	Paek, Sun Ha/J-2760-2012; Simpson, Richard/A-6947-2012; Cho, Kun/B-9319-2012	Cho, Kun/0000-0003-1154-4065; Ahn, Sung-Min/0000-0002-5031-1929; Simpson, Richard/0000-0002-9834-0796	Korea Science and Engineering Foundation [2006-04090]; 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council [280912]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Korea Science and Engineering Foundation grant (#2006-04090), 21ST frontier science program SC-2110 of Korea stem cell research center, and a National Health & Medical Research Council Program Grant (#280912, R.J.S).	Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; DEVIJLDER JJM, 1992, ENDOCRINOLOGY, V131, P578, DOI 10.1210/en.131.2.578; DZIARSKI R, 1994, J BIOL CHEM, V269, P20431; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Interewicz B, 2004, LYMPHOLOGY, V37, P65; Kalaria R N, 1999, Curr Opin Hematol, V6, P15, DOI 10.1097/00062752-199901000-00004; Kim JY, 2005, PROTEOMICS, V5, P3376, DOI 10.1002/pmic.200401220; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; MURRARY RK, 1999, HARPERS BIOCH; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Peters Theodore Jr., 1996; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROEPSTORFF P, 1994, BIOCHEM SOC T, V22, P533, DOI 10.1042/bst0220533; Schenk DB, 2002, NEUROBIOL AGING, V23, P677, DOI 10.1016/S0197-4580(02)00034-9; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Yamaguchi M, 2003, J CELL BIOCHEM, V89, P356, DOI 10.1002/jcb.10510; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	29	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2829	10.1371/journal.pone.0002829	http://dx.doi.org/10.1371/journal.pone.0002829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665237	Green Published, gold			2022-12-25	WOS:000264304300048
J	Masuhiro, Y; Kayama, K; Fukushima, A; Baba, K; Soutsu, M; Kamiya, Y; Gotoh, M; Yamaguchi, N; Hanazawa, S				Masuhiro, Yoshikazu; Kayama, Kenichi; Fukushima, Akie; Baba, Koji; Soutsu, Makio; Kamiya, Yoshiaki; Gotoh, Michio; Yamaguchi, Noboru; Hanazawa, Shigemasa			SOCS-3 Inhibits E2F/DP-1 Transcriptional Activity and Cell Cycle Progression via Interaction with DP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION STATUS; BOX MOTIF; E2F; GENE; SUPPRESSOR; FAMILY; GROWTH; HYPERMETHYLATION; DIFFERENTIATION; COMPLEX	Recent studies using SOCS family knock-out mice have suggested that SOCS proteins have multiple biological functions in addition to their role as negative regulators of JAK-STAT signaling. To explore these other functions of this family of proteins, we used yeast two-hybrid screening to find proteins interacting with human SOCS-3. We identified the transcriptional factor DP-1 as a SOCS-3-interacting protein involved in regulation of the cell cycle. Immunoprecipitation-Western blot assay showed that this interaction between these endogenous proteins occurred in cells both in vitro and in vivo. SOCS-3 interacted with the C-terminal region of DP-1, and amino acids 156 172 of SOCS-3 were required for this interaction. Confocal microscopy revealed that SOCS-3 and DP-1 were primarily colocalized in the cytoplasm. SOCS-3 inhibited E2F/DP-1 transcriptional activity under the cyclin-E promoter and actually inhibited cell cycle progression and cell growth under E2F/DP-1 control. In contrast, DP-1 almost completely eliminated the inhibitory action of SOCS-3 on LIF-stimulated STAT-3 transcriptional activity in JAK-STAT signaling. Interestingly, the alternative regulatory action of SOCS-3 and DP-1 was dramatically eliminated by each siRNA. Taken together, these findings demonstrate that SOCS-3 acts as a negative regulator of the cell cycle progression under E2F/DP-1 control by interfering with heterodimer formation between DP-1 and E2F and also that DP-1 plays an important role in controlling JAK-STAT signaling.	[Hanazawa, Shigemasa] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Lab Mol & Cellular Physiol, Fujisawa, Kanagawa 2528510, Japan; [Masuhiro, Yoshikazu; Hanazawa, Shigemasa] Nihon Univ, Adv Res Inst Sci & Humanities, Chiyoda Ku, Tokyo 1020073, Japan; [Yamaguchi, Noboru] Kyushu Univ, Fac Dent Sci, Dept Prevent Dent, Higashi Ku, Fukuoka 8128582, Japan; [Fukushima, Akie] Kyushu Univ, Fac Dent Sci, Dept Oral Infect Dis & Immunol, Higashi Ku, Fukuoka 8128582, Japan	Nihon University; Nihon University; Kyushu University; Kyushu University	Hanazawa, S (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Lab Mol & Cellular Physiol, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.	hanazawa@brs.nihon-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; OSAKA Cancer Research Foundation; Nihon University	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OSAKA Cancer Research Foundation; Nihon University	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and by the OSAKA Cancer Research Foundation. Additional support came from a Nihon University Individual Research Grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Allen KE, 1997, J CELL SCI, V110, P2819; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Chan MWY, 2004, BIOTECHNOL LETT, V26, P1289, DOI 10.1023/B:BILE.0000044922.43572.2d; Datta A, 2005, MOL CELL BIOL, V25, P8024, DOI 10.1128/MCB.25.18.8024-8036.2005; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; GIRLING R, 1993, NATURE, V365, P468, DOI 10.1038/365468d0; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; Hatirnaz M, 2007, AM J HEMATOL, V82, P729, DOI 10.1002/ajh.20886; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Inaba M, 2005, BIOCHEM BIOPH RES CO, V328, P953, DOI 10.1016/j.bbrc.2005.01.046; Inoue Hiromasa, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008348; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Magae J, 1996, J CELL SCI, V109, P1717; Magae J, 1999, ONCOGENE, V18, P593, DOI 10.1038/sj.onc.1202345; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; Miyoshi H, 2004, J GASTROENTEROL, V39, P563, DOI 10.1007/s00535-003-1343-0; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okochi O, 2003, CLIN CANCER RES, V9, P5295; Orr SJ, 2007, BLOOD, V109, P1061, DOI 10.1182/blood-2006-05-023556; Oshimo Y, 2004, INT J CANCER, V112, P1003, DOI 10.1002/ijc.20521; Ozaki A, 2005, J IMMUNOL, V175, P5489, DOI 10.4049/jimmunol.175.8.5489; Qiao H, 2007, J BIOL CHEM, V282, P454, DOI 10.1074/jbc.M606169200; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Sorensen TS, 1996, MOL CELL BIOL, V16, P5888; Spangenburg EE, 2005, J BIOL CHEM, V280, P10749, DOI 10.1074/jbc.M410604200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Tokita T, 2007, INT J ONCOL, V30, P689; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; WU CL, 1995, MOL CELL BIOL, V15, P2536; Yamada M, 2002, CYTOKINE, V17, P91, DOI 10.1006/cyto.2001.0992; ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	47	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31575	31583		10.1074/jbc.M800328200	http://dx.doi.org/10.1074/jbc.M800328200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18687693	hybrid, Green Published			2022-12-25	WOS:000260760800037
J	Wang, XM; Fonseca, BD; Tang, H; Liu, R; Elia, A; Clemens, MJ; Bommer, UA; Proud, CG				Wang, Xuemin; Fonseca, Bruno D.; Tang, Hua; Liu, Rui; Elia, Androulla; Clemens, Michael J.; Bommer, Ulrich-Axel; Proud, Christopher G.			Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-CHAIN INITIATION; NUCLEOTIDE-EXCHANGE FACTOR; TRANSFER-RNA-SYNTHETASES; SMALL GTPASE RHEB; AMINO-ACIDS; TRANSLATIONAL CONTROL; S6 KINASE; PROTEIN; PHOSPHORYLATION; FKBP38	Signaling through mammalian target of rapamycin complex 1 (mTORC1) is stimulated by amino acids and insulin. Insulin inactivates TSC1/2, the GTPase-activator complex for Rheb, and Rheb.GTP activates mTORC1. It is not clear how amino acids regulate mTORC1. FKBP38 (immunophilin FK506-binding protein, 38 kDa), was recently reported to exert a negative effect on mTORC1 function that is relieved by its binding to Rheb.GTP. We confirm that Rheb binds wild type FKBP38, but inactive Rheb mutants showed contrasting abilities to bind FKBP38. We were unable to observe any regulation of FKBP38/mTOR binding by amino acids or insulin. Furthermore, FKBP38 did not inhibit mTORC1 signaling. The translationally controlled tumor protein (TCTP) in Drosophila was recently reported to act as the guanine nucleotide-exchange factor for Rheb. We have studied the role of TCTP in mammalian TORC1 signaling and its control by amino acids. Reducing TCTP levels did not reproducibly affect mTORC1 signaling in amino acid-replete/insulin-stimulated cells. Moreover, overexpressing TCTP did not rescue mTORC1 signaling in amino acid-starved cells. In addition, we were unable to see any stable interaction between TCTP and Rheb or mTORC1. Accumulation of uncharged tRNA has been previously proposed to be involved in the inhibition of mTORC1 signaling during amino acid starvation. To test this hypothesis, we used a Chinese hamster ovary cell line containing a temperature-sensitive mutation in leucyl-tRNA synthetase. Leucine deprivation markedly inhibited mTORC1 signaling in these cells, but shifting the cells to the nonpermissive temperature for the synthetase did not. These data indicate that uncharged tRNALeu does not switch off mTORC1 signaling and suggest that mTORC1 is controlled by a distinct pathway that senses the availability of amino acids. Our data also indicate that, in the mammalian cell lines tested here, neither TCTP nor FKBP38 regulates mTORC1 signaling.	[Wang, Xuemin; Fonseca, Bruno D.; Tang, Hua; Liu, Rui; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Elia, Androulla] St Georges Univ London, Div Basic Med Sci, London SW17 0RE, England; [Clemens, Michael J.] Univ Sussex, Sch Life Sci, Dept Biochem, Brighton BN1 9QG, E Sussex, England; [Bommer, Ulrich-Axel] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia	University of British Columbia; St Georges University London; University of Sussex; University of Wollongong	Proud, CG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	C.G.Proud@soton.ac.uk	Elia, Androulla/AAE-6854-2021; LIU, RUI/P-1991-2019	Proud, Christopher/0000-0003-0704-6442; Bommer, Ulrich/0000-0003-1110-7615	Canadian Institutes of Health Research; Ajinomoto Amino Acid Research Program; University of British Columbia; Wellcome Trust; Ralph Bates Cancer Research Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ajinomoto Amino Acid Research Program; University of British Columbia; Wellcome Trust(Wellcome TrustEuropean Commission); Ralph Bates Cancer Research Fund	This work was supported by grants from the Canadian Institutes of Health Research, the Ajinomoto Amino Acid Research Program, and the University of British Columbia (to C. G. P.), from the Wellcome Trust (to U. A. B., A. E., and M. J. C.), and from the Ralph Bates Cancer Research Fund (to A. E. and M. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUSTIN SA, 1986, EUR J BIOCHEM, V157, P39, DOI 10.1111/j.1432-1033.1986.tb09635.x; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; CLEMENS MJ, 1987, J BIOL CHEM, V262, P767; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Erdmann F, 2007, FEBS LETT, V581, P5709, DOI 10.1016/j.febslet.2007.11.037; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gachet Y, 1999, J CELL SCI, V112, P1257; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; MOORE PA, 1977, J BIOL CHEM, V252, P7427; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; Pham PTT, 2000, J CELL BIOCHEM, V79, P427, DOI 10.1002/1097-4644(20001201)79:3<427::AID-JCB80>3.0.CO;2-0; POLLARD JW, 1989, EUR J BIOCHEM, V182, P1, DOI 10.1111/j.1432-1033.1989.tb14793.x; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sood R, 2000, GENETICS, V154, P787; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; THOMPSON LH, 1973, P NATL ACAD SCI USA, V70, P3094, DOI 10.1073/pnas.70.11.3094; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	55	116	135	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30482	30492		10.1074/jbc.M803348200	http://dx.doi.org/10.1074/jbc.M803348200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18676370	Green Published, hybrid			2022-12-25	WOS:000260544800006
J	Shiono, M; Kobayashi, T; Takahashi, R; Sun, G; Abe, M; Zhang, D; Wang, L; Piao, X; Takagi, Y; Mineki, R; Taka, H; Tada, N; Sonobe, S; Momose, S; Ueda, M; Hino, O				Shiono, M.; Kobayashi, T.; Takahashi, R.; Sun, G.; Abe, M.; Zhang, D.; Wang, L.; Piao, X.; Takagi, Y.; Mineki, R.; Taka, H.; Tada, N.; Sonobe, S.; Momose, S.; Ueda, M.; Hino, O.			The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition	ONCOGENE			English	Article						tuberous sclerosis; tumor suppressor gene; Tsc2; transgenic rat; mTOR	RAPAMYCIN ANALOG CCI-779; RENAL-CARCINOMA; MOUSE MODEL; TSC2; PHOSPHORYLATION; COMPLEX; GENE; HAMARTIN; TARGET; GAP	Tuberin, a tumor-suppressor protein produced by the tuberous sclerosis gene TSC2, downregulates the Rheb-mTOR-S6K pathway (mTOR axis). Comparison of the effects of human tuberin mutations, such as G1556S, suggests that pathways other than the mTOR axis might also be involved in the pathogenesis of tuberous sclerosis. Here we test this possibility using the rat G1556S-type mutation (GSM) and a transgenic Eker (Tsc2 mutant) rat system. Cells expressing GSM-tuberin failed to downregulate the mTOR axis. GSM-tuberin had an altered localization, which underlie its reduced ability to form a complex with hamartin, and a site-specific alteration in phosphorylation status indicating diverse regulation by Akt. GSM-transgenic (GSM-Tg) rats exhibited suppression of macroscopic renal tumors following N-ethyl-N-nitrosourea treatment. Intriguingly, rats with weaker GSM-Tg expression showed microscopic cystic and pre-tumorous lesions that were restricted in size and expansion, although they had hyper-phosphorylation of ribosomal protein S6. These results highlight a novel pathway involving tuberin that regulates tumor suppression independently of the mTOR inhibitory function. Identification of such a novel pathway will provide clear implications for generation of new therapeutic targets in the treatment of these tumors.	[Hino, O.] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, Tokyo 1138421, Japan; [Mineki, R.; Taka, H.] Juntendo Univ, Sch Med, Div Prote & BioMol Sci, Tokyo 1138421, Japan; [Tada, N.] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan; [Sonobe, S.] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 1138421, Japan; [Momose, S.] Saitama Med Univ, Saitama Med Ctr, Dept Pathol, Saitama, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Saitama Medical University	Hino, O (corresponding author), Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ohino@juntendo.ac.jp	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a Grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science and the Ministry of Health, Labour and Welfare of Japan. We also thank Ms N Otsuji (Department of Pathology and Oncology), Mr R Tsukada, Mr F Kanai, Ms T Hidano ( Center for Biomedical Research Resources), Mr M Yoshida, Mr J Nakamoto ( Division of Ultrastructural Research), Mr Y Watanabe, Mr K Matsunami, Ms K Ochiai ( Division of Radioisotope Research), Dr T Fujimura ( Division of Proteomics and BioMolecular Science), Ms Y Kojima, Dr H Kurihara ( Division of Biomedical Imaging Research), Dr T Seki ( Department of Developmental Neurobiology), Dr T Ueno and Dr E Kominami ( Department of Biochemistry), all of Juntendo University, for their support.	Aicher LD, 2001, J BIOL CHEM, V276, P21017, DOI 10.1074/jbc.C100136200; Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Fukuda T, 1998, JPN J CANCER RES, V89, P1104, DOI 10.1111/j.1349-7006.1998.tb00503.x; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327; HINO O, 1994, BIOCHEM BIOPH RES CO, V203, P1302, DOI 10.1006/bbrc.1994.2324; HINO O, 1993, CANCER RES, V53, P5856; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jansen AC, 2006, ANN NEUROL, V60, P528, DOI 10.1002/ana.21037; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kenerson HL, 2002, CANCER RES, V62, P5645; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P3990, DOI 10.1073/pnas.94.8.3990; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Kobayashi T, 2003, P JPN ACAD B-PHYS, V79, P22, DOI 10.2183/pjab.79B.22; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lee L, 2006, GENE CHROMOSOME CANC, V45, P933, DOI 10.1002/gcc.20357; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mayer K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010835; Momose S, 2002, HUM MOL GENET, V11, P2997, DOI 10.1093/hmg/11.24.2997; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Nellist M, 2001, HUM MOL GENET, V10, P2889, DOI 10.1093/hmg/10.25.2889; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Shah OJ, 2004, J BIOL CHEM, V279, P20816, DOI 10.1074/jbc.M400957200; Sun GD, 2007, BIOCHEM BIOPH RES CO, V360, P181, DOI 10.1016/j.bbrc.2007.06.021; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413	41	6	6	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6690	6697		10.1038/onc.2008.283	http://dx.doi.org/10.1038/onc.2008.283			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18695678				2022-12-25	WOS:000260638800007
J	Cabib, E; Farkas, V; Kosik, O; Blanco, N; Arroyo, J; McPhie, P				Cabib, Enrico; Farkas, Vladimir; Kosik, Ondrej; Blanco, Noelia; Arroyo, Javier; McPhie, Peter			Assembly of the Yeast Cell Wall Crh1p AND Crh2p ACT AS TRANSGLYCOSYLASES IN VIVO AND IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHITIN; PROTEINS; POROSITY; BETA-1,6-GLUCAN; ENDOCHITINASE; BIOSYNTHESIS; LOCALIZATION; PURIFICATION; ARCHITECTURE	The cross-linking of polysaccharides to assemble new cell wall in fungi requires mechanisms by which a preexisting linkage is broken for each new one made, to allow for the absence of free energy sources outside the plasma membrane. Previous work showed that Crh1p and Crh2p, putative transglycosylases, are required for the linkage of chitin to beta(1-3) glucose branches of beta(1-6) glucan in the cell wall of budding yeast. To explore the linking reaction in vivo and in vitro, we used fluorescent sulfor-hodamine-linked laminari-oligosaccharides as artificial chitin acceptors. In vivo, fluorescence was detected in bud scars and at a lower level in the cell contour, both being dependent on the CRH genes. The linking reaction was also shown in digitonin-permeabilized cells, with UDP-N-acetylglucosamine as the substrate for nascent chitin production. Both the nucleotide and the Crh proteins were required here. A gas1 mutant that overexpresses Crh1p showed very high fluorescence both in intact and permeabilized cells. In the latter, fluorescence was still incorporated in patches in the absence of UDP-GlcNAc. Isolated cell walls of this strain, when incubated with sulforhodamine-oligosaccharide, also showed Crhp-dependent fluorescence in patches, which were identified as bud scars. In all three systems, binding of the fluorescent material to chitin was verified by chitinase digestion. Moreover, the cell wall reaction was inhibited by chitooligosaccharides. These results demonstrate that the Crh proteins act by transferring chitin chains to beta(1-6) glucan, with a newly observed high activity in the bud scar. The importance of transglycosylation for cell wall assembly is thus firmly established.	[Cabib, Enrico; McPhie, Peter] NIDDK, Lab Biochem & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Farkas, Vladimir; Kosik, Ondrej] Slovak Acad Sci, Ctr Excellence GLYCOBIOS, Inst Chem, Bratislava 84538, Slovakia; [Blanco, Noelia; Arroyo, Javier] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Slovak Academy of Sciences; Complutense University of Madrid	Cabib, E (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Dept Hlth & Human Serv, Bldg 8,Rm 403, Bethesda, MD 20892 USA.	enricoc@bdg10.niddk.nih.gov	Arroyo, Javier/E-9308-2016; Kosik, Ondrej/AAR-1206-2021	Arroyo, Javier/0000-0002-1971-1721; Kosik, Ondrej/0000-0003-3117-0224; Farkas, Vladimir/0000-0002-8219-4288	National Institutes of Health; European Commission [MRTN-CT-2004-512265]; Scientific Grant Agency VEGA, Slovakia [2/3158/25]; MEC (Spanish Government) [BIO2007-67821]; Comunidad de Madrid [S-SAL-0246/2006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024945, ZIADK024964, ZIADK024945, Z01DK024964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Scientific Grant Agency VEGA, Slovakia(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); MEC (Spanish Government)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant (Intramural Research Program, NIDDK). This work was also supported by Grant MRTN-CT-2004-512265 from the 6FP of the European Commission, by Grant 2/3158/25 from the Scientific Grant Agency VEGA, Slovakia, and by Projects BIO2007-67821 from the MEC (Spanish Government) and S-SAL-0246/2006 from Comunidad de Madrid. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; BORASTON AB, 2004, BIOCHEM J, V382, P921; CABIB E, 1983, P NATL ACAD SCI-BIOL, V80, P3318, DOI 10.1073/pnas.80.11.3318; Cabib E, 2005, J BIOL CHEM, V280, P9170, DOI 10.1074/jbc.M414005200; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; CABIB E, 1988, MICROBIOL SCI, V5, P370; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; CHOI WJ, 1994, ANAL BIOCHEM, V219, P368, DOI 10.1006/abio.1994.1278; CORREA JU, 1982, J BIOL CHEM, V257, P1392; Coutinho PM, 1999, ROY SOC CH, P3; Crotti LB, 2001, ANAL BIOCHEM, V292, P8, DOI 10.1006/abio.2001.5051; DEITS T, 1984, J BIOL CHEM, V259, P3525; DENOBEL JG, 1990, YEAST, V6, P483, DOI 10.1002/yea.320060605; FERNANDEZ MP, 1982, J BACTERIOL, V152, P1255; Gomez-Esquer F, 2004, MICROBIOL-SGM, V150, P3269, DOI 10.1099/mic.0.27314-0; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kosik O, 2008, ANAL BIOCHEM, V375, P232, DOI 10.1016/j.ab.2007.11.025; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MOHAND FA, 2006, CARBOHYD RES, V46, P478; MOLANO J, 1979, J BIOL CHEM, V254, P4901; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; PARK JT, 1949, J BIOL CHEM, V181, P149; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; ROBERTS RL, 1982, ANAL BIOCHEM, V127, P402, DOI 10.1016/0003-2697(82)90194-4; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHERRER R, 1974, J BACTERIOL, V118, P534, DOI 10.1128/JB.118.2.534-540.1974; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; SIKORSKI RS, 1989, GENETICS, V122, P19; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wiederhold NP, 2003, EXPERT OPIN INV DRUG, V12, P1313, DOI 10.1517/13543784.12.8.1313; Yin QY, 2007, FEMS YEAST RES, V7, P887, DOI 10.1111/j.1567-1364.2007.00272.x; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	40	73	73	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29859	29872		10.1074/jbc.M804274200	http://dx.doi.org/10.1074/jbc.M804274200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18694928	hybrid, Green Published			2022-12-25	WOS:000260366900030
J	Rickman, DS; Millon, R; De Reynies, A; Thomas, E; Wasylyk, C; Muller, D; Abecassis, J; Wasylyk, B				Rickman, D. S.; Millon, R.; De Reynies, A.; Thomas, E.; Wasylyk, C.; Muller, D.; Abecassis, J.; Wasylyk, B.			Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays	ONCOGENE			English	Article						HNSCC; distant metastasis; prognosis; intrinsic groups; differentiation	LYMPH-NODE METASTASIS; HUMAN-PAPILLOMAVIRUS; BREAST-CANCER; EXPRESSION; CLASSIFICATION; IDENTIFICATION; GENES; SIGNATURE; RECEPTOR; ALCOHOL	Propensity for subsequent distant metastasis in head and neck squamous-cell carcinoma (HNSCC) was analysed using 186 primary tumours from patients initially treated by surgery that developed ( M) or did not develop (NM) metastases as the first recurrent event. Transcriptome (Affymetrix HGU133_ Plus2, QRT-PCR) and array-comparative genomic hybridization data were collected. Non-supervised hierarchical clustering based on Affymetrix data distinguished tumours differing in pathological differentiation, and identified associated functional changes. Propensity for metastasis was not associated with these subgroups. Using QRT-PCR data we identified a four-gene model (PSMD10, HSD17B12, FLOT2 and KRT17) that predicts M/NM status with 77% success in a separate 79-sample validation group of HNSCC samples. This prediction is independent of clinical criteria ( age, lymph node status, stage, differentiation and localization). The most significantlyalte red transcripts in M versus NM were significantly associated to metastasis-related functions, including adhesion, mobility and cell survival. Several genomic modi. cations were significantly associated with M/NM status ( most notably gains at 4q11-22 and Xq12-28; losses at 11q14-24 and 17q11 losses) and partly linked to transcription modi. cations. This work yields a basis for the development of prognostic molecular signatures, markers and therapeutic targets for HNSCC metastasis.	[Wasylyk, C.; Wasylyk, B.] IGBMC, CNRS, INSERM, ULP, F-67404 Illkirch Graffenstaden, France; [Rickman, D. S.; De Reynies, A.; Thomas, E.] Ligue Natl Contre Canc, Paris, France; [Millon, R.; Muller, D.; Abecassis, J.] Ctr Reg Lutte Contre Canc Paul Strauss, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Centre Paul Strauss	Wasylyk, B (corresponding author), IGBMC, CNRS, INSERM, ULP, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	boh@igbmc.u-strasbg.fr	Wasylyk, Bohdan/ABG-6778-2020; de Reyniès, Aurélien/Q-8640-2017	Wasylyk, Bohdan/0000-0002-1718-1237; de Reyniès, Aurélien/0000-0002-1328-5290; Thomas, Emilie/0000-0002-8313-7218	Ligues Nationale et Regionales; CNRS; INSERM	Ligues Nationale et Regionales; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Financial support: Ligues Nationale et Regionales (Bas et Haut Rhin) contre le Cancer, CNRS, INSERM.	Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Braakhuis BJM, 2006, J CLIN PATHOL, V59, P1254, DOI 10.1136/jcp.2005.035451; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Han CY, 2005, NUCLEIC ACIDS RES, V33, P6555, DOI 10.1093/nar/gki964; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Ioannidis JPA, 2007, ONCOLOGIST, V12, P301, DOI 10.1634/theoncologist.12-3-301; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Kaklamani Virginia G, 2006, Curr Treat Options Oncol, V7, P123, DOI 10.1007/s11864-006-0047-0; Le Tourneau C, 2005, HEAD NECK-J SCI SPEC, V27, P801, DOI 10.1002/hed.20254; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ragin CCR, 2006, BRIT J CANCER, V95, P1432, DOI 10.1038/sj.bjc.6603394; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Roepman P, 2006, CANCER RES, V66, P2361, DOI 10.1158/0008-5472.CAN-05-3960; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Schlecht NF, 2007, J PATHOL, V213, P283, DOI 10.1002/path.2227; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Song D, 2006, J STEROID BIOCHEM, V101, P136, DOI 10.1016/j.jsbmb.2006.06.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	42	118	122	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2008	27	51					6607	6622		10.1038/onc.2008.251	http://dx.doi.org/10.1038/onc.2008.251			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18679425				2022-12-25	WOS:000260501700009
J	Averna, M; Stifanese, R; De Tullio, R; Passalacqua, M; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; Stifanese, Roberto; De Tullio, Roberta; Passalacqua, Mario; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Functional Role of HSP90 Complexes with Endothelial Nitric-oxide Synthase (eNOS) and Calpain on Nitric Oxide Generation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SIGNAL-TRANSDUCTION; ATP-BINDING; RAT; TRAFFICKING; DYSFUNCTION; CALMODULIN; ACTIVATION; EXPRESSION; CAVEOLINS	Although several reports have indicated that eNOS is a highly sensitive calpain substrate, the occurrence of a concomitant Ca2(+)-dependent activation of the synthase and of the protease has never been analyzed in specific direct experiments. In this study, we have explored in vivo how eNOS can undergo Ca2(+)-dependent translocation and activation, protected against degradation by activated calpain. Here we demonstrate that following a brief exposure to Ca2(+)-loading, the cytosolic eNOS-HSP90 complex recruits calpain in a form in which the chaperone and the synthase are almost completely resistant to digestion by the protease. Furthermore, in the presence of the HSP90 inhibitor geldanamycin, a significant decrease in NO production and an extensive degradation of eNOS protein occurs, indicating that dissociation from membranes and association with the chaperone is correlated to the protection of the synthase. Experiments with isolated membrane preparations confirm the primary role of HSP90 in dissociation of eNOS from caveolae. Prolonged exposure of cells to Ca2+-loading resulted in an extensive degradation of both eNOS and HSP90, accompanied by a large suppression of NO production. We propose that the protective effect exerted by HSP90 on eNOS degradation mediated by calpain represents a novel and critical mechanism that assures the reversibility of the intracellular trafficking and activation of the synthase.	[Melloni, Edon] Univ Genoa, DIMES, Biochem Sect, I-16132 Genoa, Italy; Univ Genoa, CEBR, I-16132 Genoa, Italy	University of Genoa; University of Genoa	Melloni, E (corresponding author), Univ Genoa, DIMES, Biochem Sect, Viale Benedetto XV, I-16132 Genoa, Italy.	melloni@unige.it	Passalacqua, Mario/W-1973-2019; AVERNA, MONICA/R-5719-2019	Passalacqua, Mario/0000-0003-2779-6259; AVERNA, MONICA/0000-0002-9463-7533; DE TULLIO, ROBERTA/0000-0001-6925-3207	University of Genoa	University of Genoa	This work was supported in part by grants from MIUR, FIRB, and PRIN projects, and from the University of Genoa. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Averna M, 2008, FEBS J, V275, P2501, DOI 10.1111/j.1742-4658.2008.06394.x; Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Bae Y, 2007, J CONTROL RELEASE, V122, P16, DOI 10.1016/j.jconrel.2007.06.005; Bloch W, 2001, NITRIC OXIDE-BIOL CH, V5, P317, DOI 10.1006/niox.2000.0339; Blunt BC, 2007, AM J PHYSIOL-HEART C, V293, pH1518, DOI 10.1152/ajpheart.00269.2006; Chaubourt E, 2002, J PHYSIOLOGY-PARIS, V96, P43, DOI 10.1016/S0928-4257(01)00079-1; De Tullio R, 1999, BIOCHEM J, V343, P467; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Goligorsky MS, 2002, AM J PHYSIOL-RENAL, V283, pF1, DOI 10.1152/ajprenal.00377.2001; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Husain K, 2007, CELL MOL BIOL, V53, P70, DOI 10.1170/T777; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu XY, 2008, CARDIOVASC RES, V79, P500, DOI 10.1093/cvr/cvn091; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Mitchell Brett M., 2007, V139, P105; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Ortiz PA, 2003, ACTA PHYSIOL SCAND, V179, P107, DOI 10.1046/j.1365-201X.2003.01207.x; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; PALEJWALA S, 1992, P NATL ACAD SCI USA, V89, P4202, DOI 10.1073/pnas.89.9.4202; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; PONTREMOLI S, 1988, J BIOL CHEM, V263, P1915; Pott C, 2006, AM J PHYSIOL-CELL PH, V290, pC1437, DOI 10.1152/ajpcell.00005.2005; Scheibel T, 1997, J BIOL CHEM, V272, P18608, DOI 10.1074/jbc.272.30.18608; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smith AR, 2006, ARCH BIOCHEM BIOPHYS, V454, P100, DOI 10.1016/j.abb.2006.02.017; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Stalker TJ, 2003, FASEB J, V17, P1511, DOI 10.1096/fj.02-1213fje; Stifanese R, 2006, ARCH BIOCHEM BIOPHYS, V456, P48, DOI 10.1016/j.abb.2006.09.022; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Wu WC, 2007, EXP EYE RES, V85, P721, DOI 10.1016/j.exer.2007.08.005; Wunderlich C, 2008, PULM PHARMACOL THER, V21, P507, DOI 10.1016/j.pupt.2007.11.005; Xu Y, 2002, J BIOL CHEM, V277, P21474, DOI 10.1074/jbc.M111689200; Yetik-Anacak G, 2006, AM J PHYSIOL-HEART C, V291, pH260, DOI 10.1152/ajpheart.01027.2005	62	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29069	29076		10.1074/jbc.M803638200	http://dx.doi.org/10.1074/jbc.M803638200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682401	Green Published, hybrid			2022-12-25	WOS:000260179900034
J	Doan, N; Gettins, PGW				Doan, Ninh; Gettins, Peter G. W.			alpha-macroglobulins are present in some Gram-negative bacteria - Characterization of the alpha(2)-macroglobulin from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; COMPLEMENT COMPONENT C3; RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-2-MACROGLOBULIN; CONFORMATIONAL-CHANGES; SULFHYDRYL-GROUPS; BAIT REGION; BINDING; MEMBER; FORMS	alpha-Macroglobulins (alpha Ms) are large glycoproteins that have been identified in a wide range of vertebrate and invertebrate species and are mostly thiol ester containing proteinase inhibitors. A recent analysis of bacterial genomes (Budd, A., Blandin, S., Levashina, E. A., and Gibson, T. J. (2004) Genome Biol. 5, R38) identified many alpha-macroglobulin-like sequences that appear to have been acquired by Gram-negative bacteria from their metazoan hosts. We report the first expression and characterization of such a bacterial alpha-macroglobulin, that from Escherichia coli. This is also the first alpha-macroglobulin to be characterized that is predicted to be membrane-anchored. We found that the 183-kDa protein contains an intact thiol ester, is monomeric, and is localized to the periplasmic space. Reaction with proteinase results in limited cleavage within a bait region, rapid activation of the thiol ester, cross-linking to the attacking proteinase or other available nucleophiles, and partial protection of the proteinase against macromolecular substrates. Given these properties and the co-occurrence of the alpha M gene with one for a repair transglycosylase, this suggests a possible role for bacterial alpha Ms in cell defense following host attack. Such a role would make bacterial alpha Ms appropriate novel targets for antibiotic drugs.	[Doan, Ninh; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [R01 GM54414]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022361, S10RR015958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54414. The MicroCal VP differential scanning calorimeter and the Beckman XL-1 analytical ultracentrifuge were purchased through National Institutes of Health Grants S10 RR15958 and S10 RR22361, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Alekshun MN, 2006, BIOCHEM PHARMACOL, V71, P893, DOI 10.1016/j.bcp.2005.12.040; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Armstrong PB, 1996, J INSECT PHYSIOL, V42, P53, DOI 10.1016/0022-1910(95)00082-8; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BJORK I, 1984, BIOCHEM J, V217, P303; BJORK I, 1982, BIOCHEM J, V207, P347; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; CHU CT, 1994, LAB INVEST, V71, P792; CUNNINGHAM LW, 1990, BIOCHEMISTRY-US, V29, P1638, DOI 10.1021/bi00458a040; DANGOTT LJ, 1982, BIOCHEM BIOPH RES CO, V107, P1243, DOI 10.1016/S0006-291X(82)80131-9; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Godehardt AW, 2004, BIOCHEM J, V381, P877, DOI 10.1042/BJ20030919; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; LARSSON LJ, 1987, BIOCHEM J, V243, P47, DOI 10.1042/bj2430047; LARSSON LJ, 1984, BIOCHEMISTRY-US, V23, P2802, DOI 10.1021/bi00307a041; Li ZF, 2004, GENOMICS, V83, P1083, DOI 10.1016/j.ygeno.2003.12.005; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Onara DF, 2008, DEV COMP IMMUNOL, V32, P339, DOI 10.1016/j.dci.2007.06.007; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, ANNU REV BIOPH BIOM, V25, P113, DOI 10.1146/annurev.bb.25.060196.000553; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SAND O, 1985, J BIOL CHEM, V260, P5723; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; SOTTRUPJENSEN J, 1989, J BIOL CHEM, V264, P11539; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; SOTTRUPJENSEN L, 1981, FEBS LETT, V127, P167, DOI 10.1016/0014-5793(81)80197-4; STRICKLAND DK, 1984, BIOCHEMISTRY-US, V23, P3115, DOI 10.1021/bi00309a002; Toppel AW, 2003, J INFECT DIS, V187, P1694, DOI 10.1086/375029; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6	49	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28747	28756		10.1074/jbc.M803127200	http://dx.doi.org/10.1074/jbc.M803127200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697741	Green Published, hybrid			2022-12-25	WOS:000259969300077
J	Pietroni, P; von Hippel, PH				Pietroni, Paola; von Hippel, Peter H.			Multiple ATP binding is required to stabilize the "Activated" (clamp open) clamp loader of the T4 DNA replication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN COMPLEX; POLYMERASE-III HOLOENZYME; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; SLIDING CLAMP; GAMMA-COMPLEX; FACTOR-C; CRYSTAL-STRUCTURE; MECHANISM; SYSTEM	Most DNA replication systems include a sliding clamp that encircles the genomic DNA and links the polymerase to the template to control polymerase processivity. A loading complex is required to open the clamp and place it onto the DNA. In phage T4 this complex consists of a trimeric clamp of gp45 subunits and a pentameric loader assembly of four gp44 and one gp62 subunit(s), with clamp loading driven by ATP binding. We measure this binding as a function of input ligand concentration and show that four ATPs bind to the gp44/62 complex with equal affinity. In contrast, the ATPase rate profile of the clamp-clamp loader complex exhibits a marked peak at an input ATP concentration close to the overall K-d (similar to 30 mu M), with further increases in bound ATP decreasing the ATPase rate to a much lower level. Thus the progressive binding of the four ATPs triggers a conformational change in the complex that markedly inhibits ATPase activity. This inhibition is related to ring opening by using a clamp that is covalently cross-linked across its subunit interfaces and thus rendered incapable of opening. Binding of this clamp abolishes substrate inhibition of the ATPase but leaves ATP binding unchanged. We show that four ATP ligands must bind to the T4 clamp loader before the loader can be fully "activated" and the clamp opened, and that ATP hydrolysis is required only for release of the loader complex after clamp loading onto the replication fork has been completed.	[von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	National Institutes of Health [GM-15792, GM-29158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029158, R01GM015792, R37GM015792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-15792 and GM-29158. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUANG CC, 1981, J BIOL CHEM, V256, P4087; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Latham GJ, 1999, P NATL ACAD SCI USA, V96, P12448, DOI 10.1073/pnas.96.22.12448; MAKI S, 1988, J BIOL CHEM, V263, P6561; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Neuwald AF, 1999, GENOME RES, V9, P27; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; RUSH J, 1989, J BIOL CHEM, V264, P10943; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Young MC, 1996, J MOL BIOL, V264, P440, DOI 10.1006/jmbi.1996.0652	32	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28338	28353		10.1074/jbc.M804371200	http://dx.doi.org/10.1074/jbc.M804371200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18676368	Green Published, hybrid			2022-12-25	WOS:000259969300036
J	Cheng, TF; Hu, XP; Gnatt, A; Brooks, PJ				Cheng, Tsu-Fan; Hu, Xiaopeng; Gnatt, Averell; Brooks, Philip J.			Differential blocking effects of the acetaldehyde-derived DNA lesion N-2-ethyl-2 '-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; NUCLEOSIDE TRIPHOSPHATES; TRANSLESION SYNTHESIS; ELONGATION COMPLEXES; ALLOSTERIC BINDING; ADDUCTS; MECHANISM; BACTERIAL; CLEAVAGE; BYPASS	Acetaldehyde, the first metabolite of ethanol, reacts with DNA to form adducts, including N-2-ethyl-2'-deoxyguanosine (N-2-Et-dG). Although the effects of N-2-Et-dG on DNA polymerases have been well studied, nothing is known about possible effects of this lesion on transcription by RNA polymerases (RNAPs). Using primer extension assays in vitro, we found that a single N-2-Et-dG lesion is a strong block to both mammalian RNAPII and two other multisubunit RNAPs, (yeast RNAPII and Escherichia coli RNAP), as well as to T7 RNAP. However, the mechanism of transcription blockage appears to differ between the multisubunit RNAPs and T7 RNAP. Specifically, all three of the multisubunit RNAPs can incorporate a single rNTP residue opposite the lesion, whereas T7 RNAP is essentially unable to do so. Using the mammalian RNAPII, we found that CMP is exclusively incorporated opposite the N-2-Et-dG lesion. In addition, we also show that the accessory transcription factor TFIIS does not act as a lesion bypass factor, as it does for other nonbulky DNA lesions; instead, it stimulates the polymerase to remove the CMP incorporated opposite the lesion by mammalian RNAPII. We also include models of the N-2-Et-dG within the active site of yeast RNAPII, which are compatible with our observations.	[Cheng, Tsu-Fan; Brooks, Philip J.] NIAAA, Mol Neurobiol Sect, Neurogenet Lab, Bethesda, MD 20892 USA; [Hu, Xiaopeng; Gnatt, Averell] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University System of Maryland; University of Maryland Baltimore	Brooks, PJ (corresponding author), NIAAA, Mol Neurobiol Sect, Neurogenet Lab, 5625 Fishers Ln,Rm 3S-32, Rockville, MD 20852 USA.	pjbrooks@mail.nih.gov			Division of Clinical and Intramural Research; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000083, ZIAAA000083] Funding Source: NIH RePORTER	Division of Clinical and Intramural Research; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Division of Clinical and Intramural Research, National Institute on Alcohol Abuse and Alcoholism. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; DELLARCO VL, 1988, MUTAT RES, V195, P1, DOI 10.1016/0165-1110(88)90013-9; Dimitri A, 2008, J MOL BIOL, V375, P353, DOI 10.1016/j.jmb.2007.10.057; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; FANG JL, 1997, CARCINOGENESIS, V18, P632; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; FRAENKELCONRAT H, 1988, P NATL ACAD SCI USA, V85, P3758, DOI 10.1073/pnas.85.11.3758; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; Hecht SS, 2001, TOXICOLOGY, V166, P31, DOI 10.1016/S0300-483X(01)00436-X; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Inagaki S, 2004, BIOL PHARM BULL, V27, P273, DOI 10.1248/bpb.27.273; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; Matsuda T, 2006, CHEM RES TOXICOL, V19, P1374, DOI 10.1021/tx060113h; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Ogawa H, 2000, INT J BIOCHEM CELL B, V32, P289, DOI 10.1016/S1357-2725(99)00113-2; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; VACA CE, 1995, CHEM-BIOL INTERACT, V98, P51, DOI 10.1016/0009-2797(95)03632-V; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Wang MY, 2006, CHEM RES TOXICOL, V19, P319, DOI 10.1021/tx0502948; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	52	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27820	27828		10.1074/jbc.M804086200	http://dx.doi.org/10.1074/jbc.M804086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669632	Green Published, hybrid			2022-12-25	WOS:000259719200053
J	Delelis, O; Carayon, K; Guiot, E; Leh, H; Tauc, P; Brochon, JC; Mouscadet, JF; Deprez, E				Delelis, Olivier; Carayon, Kevin; Guiot, Elvire; Leh, Herve; Tauc, Patrick; Brochon, Jean-Claude; Mouscadet, Jean-Francois; Deprez, Eric			Insight into the integrase-DNA recognition mechanism - A specific DNA-binding mode revealed by an enzymatically labeled integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESOLVED FLUORESCENCE ANISOTROPY; CARBOXYL-TERMINAL DOMAINS; MAXIMUM-ENTROPY METHOD; HIV-1 INTEGRASE; VIRAL-DNA; IN-VITRO; NUCLEOCAPSID PROTEIN; CATALYTIC CORE; REPLICATION	Integration catalyzed by integrase (IN) is a key process in the retrovirus life cycle. Many biochemical or structural human immunodeficiency virus, type 1 (HIV-1) IN studies have been severely impeded by its propensity to aggregate. We characterized a retroviral IN (primate foamy virus (PFV-1)) that displays a solubility profile different from that of HIV-1 IN. Using various techniques, including fluorescence correlation spectroscopy, time-resolved fluorescence anisotropy, and size exclusion chromatography, we identified a monomer-dimer equilibrium for the protein alone, with a half-transition concentration of 20-30 mu M. We performed specific enzymatic labeling of PFV-1 IN and measured the fluorescence resonance energy transfer between carboxytetramethylrhodamine-labeled IN and fluorescein-labeled DNA substrates. FRET and fluorescence anisotropy highlight the preferential binding of PFV-1 IN to the 3'-end processing site. Sequence-specific DNA binding was not observed with HIV-1 IN, suggesting that the intrinsic ability of retroviral INs to bind preferentially to the processing site is highly underestimated in the presence of aggregates. IN is in a dimeric state for 3'-processing on short DNA substrates, whereas IN polymerization, mediated by nonspecific contacts at internal DNA positions, occurs on longer DNAs. Additionally, aggregation, mediated by nonspecific IN-IN interactions, occurs preferentially with short DNAs at high IN/DNA ratios. The presence of either higher order complex is detrimental for specific activity. Ionic strength favors catalytically competent over higher order complexes by selectively disrupting nonspecific IN-IN interactions. This counteracting effect was not observed with polymerization. The synergic effect on the selection of specific/competent complexes, obtained by using short DNA substrates under high salt conditions, may have important implications for further structural studies in IN.DNA complexes.	[Delelis, Olivier; Carayon, Kevin; Guiot, Elvire; Leh, Herve; Tauc, Patrick; Brochon, Jean-Claude; Mouscadet, Jean-Francois; Deprez, Eric] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Inst Alembert, F-94235 Cachan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Deprez, E (corresponding author), Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Inst Alembert, 61 Ave President Wilson, F-94235 Cachan, France.	deprez@lbpa.ens-cachan.fr			TrioH European Project [FP6 503480]; Agence Nationale de la Recherche [06-PCVI-0015]; CNRS; Institut d'Alembert	TrioH European Project; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut d'Alembert	This work was supported by TrioH European Project Grant FP6 503480, Agence Nationale de la Recherche Grant 06-PCVI-0015, and grants from CNRS and Institut d'Alembert. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Enssle J, 1999, J GEN VIROL, V80, P1445, DOI 10.1099/0022-1317-80-6-1445; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Harding SE, 1999, BIOPHYS J, V76, P2432, DOI 10.1016/S0006-3495(99)77398-4; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Laboulais C, 2001, BIOPHYS J, V81, P473, DOI 10.1016/S0006-3495(01)75715-3; LAKOWICS J, 2006, PRINCIPLES FLUORESCE; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Lee HS, 2005, MOL CELLS, V19, P246; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; LINDEN J, 1982, J CYCLIC NUCL PROT, V8, P163; Marchand C, 2003, MOL PHARMACOL, V64, P600, DOI 10.1124/mol.64.3.600; Moebes A, 1997, J VIROL, V71, P7305, DOI 10.1128/JVI.71.10.7305-7311.1997; Oh YT, 1999, BIOCHEM MOL BIOL INT, V47, P621; PAHL A, 1995, J BIOL CHEM, V270, P2957, DOI 10.1074/jbc.270.7.2957; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; Taki M, 2004, PROTEIN ENG DES SEL, V17, P119, DOI 10.1093/protein/gzh015; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Yu SF, 1999, J VIROL, V73, P1565, DOI 10.1128/JVI.73.2.1565-1572.1999; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou HX, 1995, BIOPHYS J, V69, P2298, DOI 10.1016/S0006-3495(95)80100-1	45	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27838	27849		10.1074/jbc.M803257200	http://dx.doi.org/10.1074/jbc.M803257200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697740	hybrid			2022-12-25	WOS:000259719200055
J	Li, XK; Barkho, BZ; Luo, YP; Smrt, RD; Santistevan, NJ; Liu, CM; Kuwabara, T; Gage, FH; Zhao, XY				Li, Xuekun; Barkho, Basam Z.; Luo, Yuping; Smrt, Richard D.; Santistevan, Nicholas J.; Liu, Changmei; Kuwabara, Tomoko; Gage, Fred H.; Zhao, Xinyu			Epigenetic regulation of the stem cell mitogen Fgf-2 by Mbd1 in adult neural stem/progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; METHYL-CPG BINDING-PROTEIN-1; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; PROLIFERATION; BRAIN; DIFFERENTIATION; NEUROGENESIS	Whether and how mechanisms intrinsic to stem cells modulate their proliferation and differentiation are two central questions in stem cell biology. Although exogenous basic fibroblast growth factor 2 (FGF-2/Fgf-2) is commonly used to expand adult neural stem/progenitor cells (NSPCs) in vitro, we do not yet understand the functional significance or the molecular regulation of Fgf-2 expressed endogenously by adult NSPCs. We previously demonstrated that methylated CpG binding protein 1 (MBD1/Mbd1) is a transcriptional repressor of Fgf-2 and is enriched in adult brains. Mbd1 deficiency in mice selectively affected adult neurogenesis and the differentiation of NSPCs. Here we show that an Mbd1 and DNA methylation-mediated epigenetic mechanism regulated the expression of stem cell mitogen Fgf-2 in adult NSPCs. Mbd1 bound to the Fgf-2 promoter and regulates its expression in adult NSPCs. In the absence of functional Mbd1, the Fgf-2 promoter was hypomethylated, and treatment with a DNA methylation inhibitor resulted in increased Fgf-2 expression in adult NSPCs. We further demonstrated that both acute knockdown of Mbd1 or overexpression of Fgf-2 in adult NSPCs inhibited their neuronal differentiation, which could be responsible for the neurogenic deficits observed in Mbd1-deficient mice. These data indicate that intrinsic epigenetic mechanisms play critical roles in the regulation of adult NSPC functions.	[Li, Xuekun; Barkho, Basam Z.; Luo, Yuping; Smrt, Richard D.; Santistevan, Nicholas J.; Liu, Changmei; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Kuwabara, Tomoko; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of New Mexico; Salk Institute	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@salud.unm.edu	Santistevan, Nicholas/L-3233-2015; Liu, Changmei/H-9600-2012	Santistevan, Nicholas/0000-0002-4657-6860; 	National Institutes of Health [MH080434, MH078972]; Oxnard Foundation; International Rett Syndrome Foundation; University of New Mexico School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxnard Foundation; International Rett Syndrome Foundation; University of New Mexico School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH080434 and MH078972. This work was also supported in part by the Oxnard Foundation, International Rett Syndrome Foundation, and University of New Mexico School of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Care A, 1996, MOL CELL BIOL, V16, P4842; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Decker L, 2002, J NEUROSCI RES, V69, P763, DOI 10.1002/jnr.10411; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Lillien L, 2000, DEVELOPMENT, V127, P4993; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Raballo R, 2000, J NEUROSCI, V20, P5012; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Ueba T, 1999, J BIOL CHEM, V274, P10382, DOI 10.1074/jbc.274.15.10382; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	34	80	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27644	27652		10.1074/jbc.M804899200	http://dx.doi.org/10.1074/jbc.M804899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18689796	Green Published, hybrid			2022-12-25	WOS:000259719200036
J	Olivier, NB; Imperiali, B				Olivier, Nelson B.; Imperiali, Barbara			Crystal structure and catalytic mechanism of PglD from Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; GENERAL PROTEIN GLYCOSYLATION; ESCHERICHIA-COLI; ACTIVE-SITE; SERINE ACETYLTRANSFERASE; ANTECEDENT INFECTIONS; LINKED GLYCAN; BETA-HELIX; BIOSYNTHESIS; IDENTIFICATION	The carbohydrate 2,4-diacetamido-2,4,6-trideoxy-alpha-D-glucopyranose (BacAc(2)) is found in a variety of eubacterial pathogens. In Campylobacter jejuni, PglD acetylates the C4 amino group on UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucopyranose (UDP-4-amino-sugar) to form UDP-BacAc2. Sequence analysis predicts PglD to be a member of the left-handed beta helix family of enzymes. However, poor sequence homology between PglD and left-handed beta helix enzymes with existing structural data precludes unambiguous identification of the active site. The co-crystal structures of PglD in the presence of citrate, acetyl coenzyme A, or the UDP-4-amino-sugar were solved. The biological assembly is a trimer with one active site formed between two protomers. Residues lining the active site were identified, and results from functional assays on alanine mutants suggest His-125 is critical for catalysis, whereas His-15 and His-134 are involved in substrate binding. These results are discussed in the context of implications for proteins homologous to PglD in other pathogens.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Imperiali, B (corresponding author), MIT, 77 Massachusetts Ave,18-590, Cambridge, MA 02090 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health [F32GM075415, GM39334]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075415, R01GM039334, R29GM039334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Post-doctoral Fellowship F32GM075415 (NIGMS; to N. B. O.) and Grant GM39334 (to B. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; BOUDAVARI S, 1996, MERCK INDEX, P636; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; DICKER IB, 1992, MOL MICROBIOL, V6, P817, DOI 10.1111/j.1365-2958.1992.tb01532.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Field RA, 2003, BIOCHEMISTRY-US, V42, P7637, DOI 10.1021/bi0345079; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Johnson CM, 2004, BIOCHEMISTRY-US, V43, P15534, DOI 10.1021/bi048450h; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Sugantino M, 2002, BIOCHEMISTRY-US, V41, P2209, DOI 10.1021/bi011991b; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Tian Y, 1997, PROTEINS, V28, P298; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZEHAVI U, 1973, J BIOL CHEM, V248, P433	50	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27937	27946		10.1074/jbc.M801207200	http://dx.doi.org/10.1074/jbc.M801207200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667421	hybrid, Green Published			2022-12-25	WOS:000259719200064
J	Tremp, AZ; Khater, EI; Dessens, JT				Tremp, Annie Z.; Khater, Emad I.; Dessens, Johannes T.			IMC1b is a putative membrane skeleton protein involved in cell shape, mechanical strength, motility, and infectivity of malaria ookinetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-BERGHEI; TOXOPLASMA-GONDII; GLIDING MOTILITY; MOSQUITO MIDGUT; PARASITE; INVASION; OOCYST; CTRP; TRANSFORMATION; CYTOSKELETON	Membrane skeletons are cytoskeletal elements that have important roles in cell development, shape, and structural integrity. Malaria parasites encode a conserved family of putative membrane skeleton proteins related to articulins. One member, IMC1a, is expressed in sporozoites and localizes to the pellicle, a unique membrane complex believed to form a scaffold onto which the ligands and glideosome are arranged to mediate parasite motility and invasion. IMC1b is a closely related structural paralogue of IMC1a, fostering speculation that it could be functionally homologous but in a different invasive life stage. Here we have generated genetically modified parasites that express IMC1b tagged with green fluorescent protein, and we show that it is targeted exclusively to the pellicle of ookinetes. Wealso show that IMC1b-deficient ookinetes display abnormal cell shape, reduced gliding motility, decreased mechanical strength, and reduced infectivity. These findings are consistent with a membrane skeletal role of IMC1b and provide strong experimental support for the view that membrane skeletons form an integral part of the pellicle of apicomplexan zoites and function to provide rigidity to the pellicular membrane complex. The similarities observed between the loss-of-function phenotypes of IMC1a and IMC1b show that membrane skeletons of ookinetes and sporozoites function in an overall similar way. However, the fact that ookinetes and sporozoites do not use the same IMC1 protein implies that different mechanical properties are required of their respective membrane skeletons, likely reflecting the distinct environments in which these life stages must operate.	[Tremp, Annie Z.; Dessens, Johannes T.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; [Khater, Emad I.] Ain Shams Univ, Dept Entomol, Cairo 11566, Egypt	University of London; London School of Hygiene & Tropical Medicine; Egyptian Knowledge Bank (EKB); Ain Shams University	Dessens, JT (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England.	Johannes.Dessens@lshtm.ac.uk	Khater, Emad I. M./D-4248-2009; Khater, Dr, Emad I. M./AAV-7158-2020	Khater, Emad I. M./0000-0002-7510-6294; Khater, Dr, Emad I. M./0000-0002-7510-6294; Dessens, Johannes/0000-0002-2070-6073; Tremp, Annie/0000-0003-4042-9074	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Carter V, 2007, INT J PARASITOL, V37, P1221, DOI 10.1016/j.ijpara.2007.03.005; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GARNHAM PCC, 1969, T ROY SOC TROP MED H, V63, P187, DOI 10.1016/0035-9203(69)90145-X; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Heintzelman MB, 2003, CURR BIOL, V13, pR57, DOI 10.1016/S0960-9822(02)01428-8; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Pumplin David W., 1993, Trends in Cell Biology, V3, P113, DOI 10.1016/0962-8924(93)90173-X; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Vernick KD, 1999, EXP PARASITOL, V91, P362, DOI 10.1006/expr.1998.4388; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	31	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27604	27611		10.1074/jbc.M801302200	http://dx.doi.org/10.1074/jbc.M801302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650444	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000259719200031
J	Park, PH; Huang, HL; McMullen, MR; Mandal, P; Sun, L; Nagy, LE				Park, Pil-Hoon; Huang, Honglian; McMullen, Megan R.; Mandal, Palash; Sun, Lei; Nagy, Laura E.			Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; AU-RICH ELEMENTS; HUMAN MONOCYTIC CELLS; TNF-ALPHA; CHRONIC ETHANOL; EGR-1 EXPRESSION; ANTIINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSES	Adiponectin is an adipokine with potent anti-inflammatory properties. Treatment of macrophages with adiponectin results in a suppression of lipopolysaccharide (LPS)-stimulated cytokine production. Here we investigated the transcriptional and post-transcriptional mechanisms by which adiponectin suppresses LPS-stimulated tumor necrosis factor (TNF)-alpha production. Treatment of RAW 264.7 macrophages with LPS increased TNF-alpha promoter-driven luciferase activity (TNF-alpha promoter/Luc activity) by 20-fold over basal. After culture with 1 mu g/ml globular adiponectin (gAcrp) for 18 h, TNF-alpha promoter/Luc activity was increased even in the absence of LPS; further challenge with LPS only increased TNF-alpha promoter/Luc activity by 1.4-fold. Treatment with gAcrp decreased LPS-stimulated ERK1/2 phosphorylation and I kappa B degradation and suppressed the ability of LPS to increase the DNA binding activity of Egr-1 and p65. gAcrp also suppressed LPS-mediated stabilization of TNF-alpha mRNA. In controls cells, the half-life of TNF-alpha mRNA was increased from similar to 30 min at base line to similar to 80 min in response to LPS. After treatment with gAcrp for 18 h, LPS failed to increase TNF-alpha mRNA stability. This gAcrp-mediated loss of stimulus-induced stabilization of TNF-alpha mRNA required the presence of the TNF-alpha 3 '-untranslated region and was associated with an increase in expression and RNA binding activity of tristetraprolin, an mRNA-binding protein that destabilizes TNF-alpha mRNA. In summary, these data characterize the complex transcriptional and post-transcriptional effects of gAcrp on LPS-stimulated TNF-alpha expression in macrophages. gAcrp treatment profoundly suppressed the ability of LPS to increase TNF-alpha transcription and reduced the stimulus-induced stabilization of TNF-alpha mRNA in response to LPS.	[Park, Pil-Hoon; Huang, Honglian; McMullen, Megan R.; Mandal, Palash; Sun, Lei; Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nagy, LE (corresponding author), Cleveland Clin Fdn, LRI NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	laura.nagy@case.edu	huang, Honglian/E-8679-2010; MANDAL, PALASH/I-5238-2019; Huang, H/E-9490-2010	MANDAL, PALASH/0000-0001-6612-3773; 	National Institutes of Health [AA011975, AA013868]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011975, R56AA011975, R01AA013868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA011975 and AA013868 (to L.E.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; BEUTLER B, 1995, J INVEST MED, V43, P227; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brinkman BMN, 1999, J BIOL CHEM, V274, P30882, DOI 10.1074/jbc.274.43.30882; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hel Z, 1996, MOL CELL BIOL, V16, P5579; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Jacob CO, 1996, J IMMUNOL, V156, P3043; JACOB CO, 1992, IMMUNOL TODAY, V13, P122, DOI 10.1016/0167-5699(92)90107-I; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchant A, 1996, J INFLAMM, V46, P114; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Steer JH, 2000, J BIOL CHEM, V275, P18432, DOI 10.1074/jbc.M906304199; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang FZ, 2005, MED HYPOTHESES, V65, P1082, DOI 10.1016/j.mehy.2005.05.047; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	60	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26850	26858		10.1074/jbc.M802787200	http://dx.doi.org/10.1074/jbc.M802787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678874	Green Published, hybrid			2022-12-25	WOS:000259586600004
J	He, LH; Aleksandrov, AA; Serohijos, AWR; Hegedus, T; Aleksandrov, LA; Cui, L; Dokholyan, NV; Riordan, JR				He, Lihua; Aleksandrov, Andrei A.; Serohijos, Adrian W. R.; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Dokholyan, Nikolay V.; Riordan, John R.			Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; DISEASE-ASSOCIATED MUTATIONS; MULTIDRUG ABC TRANSPORTER; CHLORIDE CHANNEL; DELTA-F508 MUTATION; CRYSTAL-STRUCTURE; ATP-BINDING; PROTEIN; LOOP; PHOSPHORYLATION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique ATP-binding cassette (ABC) ion channel mutated in patients with cystic fibrosis. The most common mutation, deletion of phenylalanine 508 (Delta F508) and many other disease-associated mutations occur in the nucleotide binding domains (NBD) and the cytoplasmic loops (CL) of the membrane-spanning domains (MSD). A recently constructed computational model of the CFTR three-dimensional structure, supported by experimental data (Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 3256-3261) revealed that several of these mutations including Delta F508 disrupted interfaces between these domains. Here we have used cysteine cross-linking experiments to verify all NBD/CL interfaces predicted by the structural model and observed that their cross-linking has a variety of different effects on channel gating. The interdomain contacts comprise aromatic clusters important for stabilization of the interfaces and also involve the Q-loops and X-loops that are in close proximity to the ATP binding sites. Cross-linking of all domain-swapping contacts between NBDs and MSD cytoplasmic loops in opposite halves of the protein rapidly and reversibly arrest single channel gating while those in the same halves have lesser impact. These results reinforce the idea that mediation of regulatory signals between cytoplasmic- and membrane-integrated domains of the CFTR channel apparently relies on an array of precise but highly dynamic interdomain structural joints.	[He, Lihua; Serohijos, Adrian W. R.; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Dokholyan, Nikolay V.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Aleksandrov, Andrei A.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Serohijos, Adrian W. R.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Serohijos, Adrian W. R.; Dokholyan, Nikolay V.] Univ N Carolina, Mol & Cellular Phys Program, Chapel Hill, NC 27599 USA; [He, Lihua; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Riordan, John R.] Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Riordan, JR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	jack_riordan@med.unc.edu	Hegedus, Tamas/P-8625-2015; Serohijos, Adrian/G-4607-2011; Dokholyan, Nikolay/D-8081-2018; Dokholyan, Nikolay/B-2238-2009	Hegedus, Tamas/0000-0002-5195-749X; Dokholyan, Nikolay/0000-0002-8225-4025; Dokholyan, Nikolay/0000-0002-8225-4025; Serohijos, Adrian/0000-0001-8369-982X	National Institutes of Health [DK051619]; Cystic Fibrosis Foundation [DOKHOL07I0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619, R01DK051870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051619 (to J. R. R.). This work was also supported by Cystic Fibrosis Foundation Grant DOKHOL07I0 ( to N. V. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; BAKER J, 2006, PEDS PULMONOL S, V29, P97; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; THIBODEAU PH, 2004, PED PULMONOL S, V27, P189; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	38	96	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26383	26390		10.1074/jbc.M803894200	http://dx.doi.org/10.1074/jbc.M803894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658148	Green Published, hybrid			2022-12-25	WOS:000259341600012
J	Wang, Y; Rogers, PM; Su, C; Varga, G; Stayrook, KR; Burris, TP				Wang, Yongjun; Rogers, Pamela M.; Su, Chen; Varga, Gabor; Stayrook, Keith R.; Burris, Thomas P.			Regulation of cholesterologenesis by the oxysterol receptor, LXR alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; SQUALENE SYNTHASE INHIBITOR; HMG-COA REDUCTASE; RESPONSE ELEMENTS; GENE-EXPRESSION; METABOLISM; PROMOTER; PATHWAY; LANOSTEROL; ACTIVATORS	Cholesterol is required for normal cellular and physiological function, yet dysregulation of cholesterol metabolism is associated with diseases such as atherosclerosis. Cholesterol biosynthesis is regulated by end product negative feedback inhibition where the levels of sterols and oxysterols regulate the expression of cholesterologenic enzymes. Sterol regulatory element-binding protein-2 is responsive to both sterols and oxysterols and has been shown to mediate the transcriptional response of the cholesterologenic enzymes to these lipids. Here, we show that the nuclear hormone receptor for oxysterols, the liver X receptor alpha (LXR alpha), regulates cholesterol biosynthesis by directly silencing the expression of two key cholesterologenic enzymes ( lanosterol 14 alpha-demethylase (CYP51A1), and squalene synthase (farnesyl diphosphate farnesyl transferase 1)) via novel negative LXR DNA response elements (nLXREs) located in each of these genes. Examination of the CYP51A1 gene revealed that both the SRE and nLXRE are required for normal oxysterol-dependent repression of this gene. Thus, these data suggest that LXR alpha plays an important role in the regulation of cholesterol biosynthesis.	[Wang, Yongjun; Rogers, Pamela M.; Burris, Thomas P.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA; [Su, Chen; Varga, Gabor; Stayrook, Keith R.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Eli Lilly	Burris, TP (corresponding author), Scripps Res Inst, 5353 Parkside Dr, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011; Varga, Gábor/O-8858-2017	Burris, Thomas P/0000-0003-2922-4449; 	National Institutes of Health [DK080201]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 (to T. P. B.). This work was also supported by an award from the American Heart Association (to T. P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; Amin D, 1997, J PHARMACOL EXP THER, V281, P746; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; BURRIS TP, 1995, BIOCHEM BIOPH RES CO, V214, P576, DOI 10.1006/bbrc.1995.2324; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Halder SK, 2002, MOL ENDOCRINOL, V16, P1853, DOI 10.1210/me.2001-0262; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Michael LF, 2005, MINI-REV MED CHEM, V5, P729, DOI 10.2174/1389557054553767; MIETTINEN TA, 1988, J LIPID RES, V29, P43; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Takahashi S, 1999, J BACTERIOL, V181, P1256, DOI 10.1128/JB.181.4.1256-1263.1999; Ugawa T, 2000, BRIT J PHARMACOL, V131, P63, DOI 10.1038/sj.bjp.0703545; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	28	97	106	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26332	26339		10.1074/jbc.M804808200	http://dx.doi.org/10.1074/jbc.M804808200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676367	hybrid, Green Published			2022-12-25	WOS:000259341600006
J	Esteve-Lanao, J; Lucia, A; Dekoning, JJ; Foster, C				Esteve-Lanao, Jonathan; Lucia, Alejandro; dekoning, Jos J.; Foster, Carl			How Do Humans Control Physiological Strain during Strenuous Endurance Exercise?	PLOS ONE			English	Article							ENERGY-EXPENDITURE; OXYGEN-UPTAKE; HEART-RATE; NEURAL REGULATION; DISTANCE; FATIGUE; PERFORMANCE; ACCUMULATION; INTENSITY; RUNNERS	Background: Distance running performance is a viable model of human locomotion. Methodology/Principal Findings: To evaluate the physiologic strain during competitions ranging from 5-100 km, we evaluated heart rate (HR) records of competitive runners (n=211). We found evidence that: 1) physiologic strain (% of maximum HR (% HRmax)) increased in proportional manner relative to distance completed, and was regulated by variations in running pace; 2) the % HRmax achieved decreased with relative distance; 3) slower runners had similar % HRmax response within a racing distance compared to faster runners, and despite differences in pace, the profile of % HRmax during a race was very similar in runners of differing ability; and 4) in cases where there was a discontinuity in the running performance, there was evidence that physiologic effort was maintained for some time even after the pace had decreased. Conclusions/Significance: The overall results suggest that athletes are actively regulating their relative physiologic strain during competition, although there is evidence of poor regulation in the case of competitive failures.	[Esteve-Lanao, Jonathan; Lucia, Alejandro] European Univ Madrid, Dept Exercise Physiol, Madrid, Spain; [dekoning, Jos J.] Vrije Univ Amsterdam, Fac MOVE, Amsterdam, Netherlands; [Foster, Carl] Univ Wisconsin, Dept Exercise & Sport Sci, La Crosse, WI USA	European University of Madrid; Vrije Universiteit Amsterdam; University of Wisconsin System	Esteve-Lanao, J (corresponding author), European Univ Madrid, Dept Exercise Physiol, Madrid, Spain.	alejandro.lucia@uem.es	Lucia, Alejandro/M-2759-2014; Rodríguez, Ferran A. A/H-4892-2011	Lucia, Alejandro/0000-0002-3025-2060; Rodríguez, Ferran A. A/0000-0002-2280-8962; Lucia, Alejandro/0000-0002-5565-0997; de Koning, Jos J/0000-0002-5596-0282				AMANN M, 2007, J PHYSL         1025; Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; AMMAN M, 2007, J PHYSL, V581, P389; AMMAN M, 2008, J PHYSL, V586, P161; Ansley L, 2004, MED SCI SPORT EXER, V36, P309, DOI 10.1249/01.MSS.0000113474.31529.C6; Banister EW, 1999, EUR J APPL PHYSIOL O, V79, P182, DOI 10.1007/s004210050493; Banister EW, 1991, PHYSL TESTING ELITE, P403; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Billat VL, 2006, J PHYSIOL SCI, V56, P103, DOI 10.2170/physiolsci.R2028; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Calbet JAL, 2006, J PHYSIOL-LONDON, V575, P688, DOI 10.1113/jphysiol.2006.116087; COSTILL DL, 1973, MED SCI SPORT EXER, V5, P248; Cottin F, 2002, EUR J APPL PHYSIOL, V87, P17, DOI 10.1007/s00421-002-0582-8; de Koning JJ, 2005, J APPL PHYSIOL, V98, P227, DOI 10.1152/japplphysiol.01095.2003; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048; Eston R, 2007, PSYCHOPHYSIOLOGY, V44, P779, DOI 10.1111/j.1469-8986.2007.00558.x; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Foster C, 2005, MED SCI SPORT EXER, V37, P670, DOI 10.1249/01.MSS.0000158183.64465.BF; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; FOSTER C, 1978, EUR J APPL PHYSIOL O, V39, P73, DOI 10.1007/BF00421711; Gibson ASC, 2007, SPORTS MED, V37, P1029; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Gilman MB, 1996, SPORTS MED, V21, P73, DOI 10.2165/00007256-199621020-00001; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Lieberman DE, 2007, SPORTS MED, V37, P288, DOI 10.2165/00007256-200737040-00004; Lucia A, 1999, INT J SPORTS MED, V20, P167, DOI 10.1055/s-2007-971112; Lucia A, 2003, SCAND J MED SCI SPOR, V13, P275, DOI 10.1034/j.1600-0838.2003.00345.x; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; MARON MB, 1976, J APPL PHYSIOL, V40, P836, DOI 10.1152/jappl.1976.40.5.836; Martin DT, 2001, SPORTS MED, V31, P469, DOI 10.2165/00007256-200131070-00002; MENDEZVILLANUEV.A, 2008, EUR J APPL PHYS 0327; Mujika I, 2001, SPORTS MED, V31, P479, DOI 10.2165/00007256-200131070-00003; Noakes TD, 2005, BRIT J SPORT MED, V39, P120, DOI 10.1136/bjsm.2003.010330; Pollock M L, 1977, Ann N Y Acad Sci, V301, P310, DOI 10.1111/j.1749-6632.1977.tb38209.x; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Spencer MR, 2001, MED SCI SPORT EXER, V33, P157; Stevinson CD, 1998, BRIT J SPORT MED, V32, P229, DOI 10.1136/bjsm.32.3.229; Thomas C, 2005, INT J SPORTS MED, V26, P268, DOI 10.1055/s-2004-820998; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Wike Jeffrey, 2005, Curr Sports Med Rep, V4, P76; XU F, 1999, SPORTS MED, V2, P14	45	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2943	10.1371/journal.pone.0002943	http://dx.doi.org/10.1371/journal.pone.0002943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698405	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600029
J	Rodriguez, JJ; Jones, VC; Tabuchi, M; Allan, SM; Knight, EM; LaFerla, FM; Oddo, S; Verkhratsky, A				Rodriguez, Jose J.; Jones, Victoria C.; Tabuchi, Masashi; Allan, Stuart M.; Knight, Elysse M.; LaFerla, Frank M.; Oddo, Salvatore; Verkhratsky, Alexei			Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article								It has become generally accepted that new neurones are added and integrated mainly in two areas of the mammalian CNS, the subventricular zone and the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus, which is of central importance in learning and memory. The newly generated cells display neuronal morphology, are able to generate action potentials and receive functional synaptic inputs, i.e. their properties are similar to those found in mature neurones. Alzheimer's disease ( AD) is the primary and widespread cause of dementia and is an age-related, progressive and irreversible neurodegenerative disease that deteriorates cognitive functions. Here, we have used male and female triple transgenic mice (3xTg-AD) harbouring three mutant genes (beta-amyloid precursor protein, presenilin-1 and tau) and their respective non-transgenic (non-Tg) controls at 2, 3, 4, 6, 9 and 12 months of age to establish the link between AD and neurogenesis. Using immunohistochemistry we determined the area density of proliferating cells within the SGZ of the DG, measured by the presence of phosphorylated Histone H3 (HH3), and their possible co-localisation with GFAP to exclude a glial phenotype. Less than 1% of the HH3 labeled cells co-localised with GFAP. Both non-Tg and 3xTg-AD showed an age-dependent decrease in neurogenesis. However, male 3xTg-AD mice demonstrated a further reduction in the production of new neurones from 9 months of age (73% decrease) and a complete depletion at 12 months, when compared to controls. In addition, female 3xTg-AD mice showed an earlier but equivalent decrease in neurogenesis at 4 months (reduction of 63%) with an almost inexistent rate at 12 months (88% decrease) compared to controls. This reduction in neurogenesis was directly associated with the presence of beta-amyloid plaques and an increase in the number of beta-amyloid containing neurones in the hippocampus; which in the case of 3xgTg females was directly correlated. These results suggest that 3xTg-AD mice have an impaired ability to generate new neurones in the DG of the hippocampus, the severity of which increases with age and might be directly associated with the known cognitive impairment observed from 6 months of age onwards. The earlier reduction of neurogenesis in females, from 4 months, is in agreement with the higher prevalence of AD in women than in men. Thus it is conceivable to speculate that a recovery in neurogenesis rates in AD could help to rescue cognitive impairment.	[Rodriguez, Jose J.; Jones, Victoria C.; Tabuchi, Masashi; Allan, Stuart M.; Knight, Elysse M.; Verkhratsky, Alexei] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [LaFerla, Frank M.; Oddo, Salvatore] Univ Calif Irvine, Dept Neurobiol & Behaviour, Irvine, CA USA; [Verkhratsky, Alexei] ASCR, Inst Expt Med, Prague, Czech Republic	University of Manchester; University of California System; University of California Irvine; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Rodriguez, JJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Jose.Rodriguez-arellano@manchester.ac.uk	Verkhratsky, Alexei/J-4527-2013; Jones, Vicky/J-2958-2017; Allan, Stuart/AAL-1245-2020	Verkhratsky, Alexei/0000-0003-2592-9898; Jones, Vicky/0000-0001-8401-5223; knight, Elysse/0000-0001-8372-1214; Allan, Stuart/0000-0001-9646-4456; Oddo, Salvatore/0000-0001-7304-7430; Tabuchi, Masashi/0000-0002-8734-6922	Alzheimer's Research Trust Programme [ART/PG2004A/1]	Alzheimer's Research Trust Programme	Alzheimer's Research Trust Programme Grant (ART/PG2004A/1) to JJR and AV.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P580; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Manly JJ, 2000, NEUROLOGY, V54, P833, DOI 10.1212/WNL.54.4.833; Mayo W, 2005, NEUROBIOL AGING, V26, P103, DOI 10.1016/j.neurobiolaging.2004.03.013; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Price D L, 1986, Res Publ Assoc Res Nerv Ment Dis, V64, P209; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; *RAM CAJ S, 1913, EST DEG REG SIST NER; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Webber KM, 2005, ALZ DIS ASSOC DIS, V19, P95, DOI 10.1097/01.wad.0000165512.90864.3f; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	254	259	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2935	10.1371/journal.pone.0002935	http://dx.doi.org/10.1371/journal.pone.0002935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698410	Green Published, gold, Green Accepted			2022-12-25	WOS:000264412600021
J	Su, HR; He, M; Li, HM; Liu, Q; Wang, J; Wang, YQ; Gao, WW; Zhou, L; Liao, JY; Young, AA; Wang, MW				Su, Haoran; He, Min; Li, Hongmei; Liu, Qing; Wang, Jia; Wang, Yiqian; Gao, Weiwei; Zhou, Ling; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei			Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice	PLOS ONE			English	Article							ACTING RELEASE FORMULATION; INSULIN SENSITIVITY; BODY-WEIGHT; ZUCKER RATS; FOOD-INTAKE; GLUCOSE; EXENDIN-4; EXENATIDE; GLP-1; DB/DB	Background: Our recent discovery of the substituted cyclobutane Boc5, one of the first non-peptidic agonists at glucagon-like peptide-1 receptors, offers the potential of combining oral availability with full agonism capable of eliciting antidiabetic and antiobesity effects. The present study was aimed at determining the in vivo pharmacologic properties of Boc5 in both normal and diabetic mice following chronic administration, with emphasis on glycemic control and weight loss. Methodology/Principal Findings: C57BL/6J and db/db mice were treated daily with Boc5 for 4 weeks and a range of pharmacologic parameters, including hemoglobin A1c, intraperitoneal glucose tolerance, insulin tolerance, fasting insulin and leptin levels, food intake, body weight and fat mass, were assessed before and after the treatment. Effects on food intake, gastric emptying, and insulinogenic index were also investigated in animals acutely administered with Boc5. Boc5 (3 mg) was able to induce a durable restoration of glycemic control (normalization of both hemoglobin A1c and intraperitoneal glucose tolerance) in db/db mice, following 4 weeks of daily administration. As with peptidic glucagon-like peptide-1 receptor agonists, its glycemic benefit and weight (fat) loss were associated with dose-dependent effects that included reduction in food intake, slowing of gastric emptying (both of which reduce nutrient-drive at beta-cells), stimulation of insulin secretion (which was glucose-dependent), and elevation in insulin sensitivity. There was little effect on normal mice treated in the same manner. Conclusions/Significance: Our findings suggest that Boc5 is the only non-peptidic molecule reported thus far to simultaneously activate this spectrum of antidiabetic effects.	[Su, Haoran; He, Min; Li, Hongmei; Liu, Qing; Wang, Jia; Wang, Yiqian; Gao, Weiwei; Zhou, Ling; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Liu, Qing; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Su, HR (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.	wangmw@mail.shcnc.ac.cn	Liu, Qing/AAO-8151-2020	Liu, Qing/0000-0003-1825-6760	Ministry of Science and Technology [2004CB518902]; Chinese Academy of Sciences [KSCX1-YW-02-2, KSCX2-YW-R-17]; Natural Science Foundation of China [30628024]; Shanghai Science and Technology Development Fund [074319114]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund	This work was supported in part by grants from the Ministry of Science and Technology (2004CB518902), the Chinese Academy of Sciences (KSCX1-YW-02-2 and KSCX2-YW-R-17), the Natural Science Foundation of China (30628024) and Shanghai Science and Technology Development Fund (074319114).	Ahren B, 1999, AM J PHYSIOL-ENDOC M, V277, pE996, DOI 10.1152/ajpendo.1999.277.6.E996; Ahren B, 2007, REGUL PEPTIDES, V143, P97, DOI 10.1016/j.regpep.2007.03.008; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BERGER W, 1986, SCHWEIZ MED WSCHR, V116, P145; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Carey DG, 2002, OBES RES, V10, P1008, DOI 10.1038/oby.2002.137; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Han GC, 2007, J AGR FOOD CHEM, V55, P10641, DOI 10.1021/jf0722598; Harris RBS, 1999, ENDOCRINOLOGY, V140, P138, DOI 10.1210/en.140.1.138; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Irwin N, 2006, EXP GERONTOL, V41, P151, DOI 10.1016/j.exger.2005.11.006; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Macdonald IA, 1996, DIABETIC MED, V13, pS11; Maggs D, 2006, DIABETOLOGIA, V49, P3; Mizuno A, 1997, METABOLISM, V46, P745, DOI 10.1016/S0026-0495(97)90117-7; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Nielsen L, 2007, DIABETES, V56, pA149; Orskov L, 1996, DIABETOLOGIA, V39, P1227, DOI 10.1007/BF02658511; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Parkes D, 2005, DIABETES, V54, pA368; PEDERSON RA, 1975, CAN J PHYSIOL PHARM, V53, P217, DOI 10.1139/y75-032; RABINOVITCH A, 1975, DIABETES, V24, P1094, DOI 10.2337/diabetes.24.12.1094; Rachman J, 1997, DIABETOLOGIA, V40, P205, DOI 10.1007/s001250050664; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SCHEPP W, 1994, EUR J PHARM-MOLEC PH, V269, P183, DOI 10.1016/0922-4106(94)90085-X; STONEHOUSE A, 2007, OBESITY          SPR; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; TANGCHRISTENSEN E, 2002, 7755 SOC NEUR; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; WELBORN TA, 1966, LANCET, V1, P1336; YOUNG A, 2007, PEPTIDE DRUG DISCOVE, P272; Young AA, 1996, METABOLISM, V45, P1, DOI 10.1016/S0026-0495(96)90192-4; Young AA, 2002, FRONT ANIM DIAB RES, V5, P235; YOUNG AA, 1995, DIABETOLOGIA, V38, P642, DOI 10.1007/BF00401833; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Young Andrew, 2005, Adv Pharmacol, V52, P67, DOI 10.1016/S1054-3589(05)52004-0; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	54	34	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2892	10.1371/journal.pone.0002892	http://dx.doi.org/10.1371/journal.pone.0002892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682834	Green Published, gold			2022-12-25	WOS:000264366600048
J	Crewther, SG; Murphy, MJ; Crewther, DP				Crewther, Sheila G.; Murphy, Melanie J.; Crewther, David P.			Potassium Channel and NKCC Cotransporter Involvement in Ocular Refractive Control Mechanisms	PLOS ONE			English	Article								Myopia affects well over 30% of adult humans globally. However, the underlying physiological mechanism is little understood. This study tested the hypothesis that ocular growth and refractive compensation to optical defocus can be controlled by manipulation of potassium and chloride ion-driven transretinal fluid movements to the choroid. Chicks were raised with +/- 10D or zero power optical defocus rendering the focal plane of the eye in front of, behind, or at the level of the retinal photoreceptors respectively. Intravitreal injections of barium chloride, a non-specific inhibitor of potassium channels in the retina and RPE or bumetanide, a selective inhibitor of the sodium-potassium-chloride cotransporter were made, targeting fluid control mechanisms. Comparison of refractive compensation to 5mM Ba2+ and 10(-5) M bumetanide compared with control saline injected eyes shows significant change for both positive and negative lens defocus for Ba2+ but significant change only for negative lens defocus with bumetanide (Rx(SAL)(-10D) = -8.6 +/-.9D; Rx(Ba2+)(-10D) = -2.9 +/-.9D; Rx(Bum)(-10D) = -2.9 +/-.9D; Rx(SAL)(+10D) = +8.2 +/-.9D; Rx(Ba2+)(+10D) = +2.8 +/- 1.3D; Rx(Bum)(+10D) = +8.0 +/-.7D). Vitreous chamber depths showed a main effect for drug conditions with less depth change in response to defocus shown for Ba2+ relative to Saline, while bumetanide injected eyes showed a trend to increased depth without a significant interaction with applied defocus. The results indicate that both K channels and the NKCC cotransporter play a role in refractive compensation with NKCC blockade showing far more specificity for negative, compared with positive, lens defocus. Probable sites of action relevant to refractive control include the apical retinal pigment epithelium membrane and the photoreceptor/ON bipolar synapse. The similarities between the biometric effects of NKCC inhibition and biometric reports of the blockade of the retinal ON response, suggest a possible common mechanism. The selective inhibition of refractive compensation to negative lens in chick by loop diuretics such as bumetanide suggests that these drugs may be effective in the therapeutic management of human myopia.	[Crewther, Sheila G.; Murphy, Melanie J.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia	La Trobe University; Swinburne University of Technology	Crewther, SG (corresponding author), La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	s.crewther@latrobe.edu.au	Crewther, Sheila G/A-2165-2008; Murphy, Melanie/S-8805-2018	Murphy, Melanie/0000-0002-5145-4593	NHMRC Australia	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the receipt of a Development Grant from the NHMRC Australia. This is a national competitive granting process in Australia, with the source of funding the National Health and Medical Research Council of Australia. No private funding was received nor inputs to the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADORANTE JS, 1990, J GEN PHYSIOL, V96, P1153, DOI 10.1085/jgp.96.6.1153; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Bello RA, 1998, J GEN PHYSIOL, V111, P343, DOI 10.1085/jgp.111.2.343; Beresford JA, 2001, OPTOMETRY VISION SCI, V78, P40, DOI 10.1097/00006324-200101010-00013; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Crewther DP, 2002, NEUROREPORT, V13, P1029, DOI 10.1097/00001756-200206120-00010; Crewther DP, 2000, PROG RETIN EYE RES, V19, P421, DOI 10.1016/S1350-9462(00)00004-5; Crewther SG, 2003, NEUROREPORT, V14, P1233, DOI 10.1097/00001756-200307010-00009; Crewther SG, 2006, P NATL ACAD SCI USA, V103, P15663, DOI 10.1073/pnas.0607241103; Curtin BJ, 1985, THE MYOPIAS, V1; Dmitriev AV, 2007, VISUAL NEUROSCI, V24, P635, DOI 10.1017/S0952523807070629; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC957, DOI 10.1152/ajpcell.1994.266.4.C957; Ehrlich D, 1990, CIBA F SYMP, V155, P84; Gabelt BT, 1997, INVEST OPHTH VIS SCI, V38, P1700; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; Hamann S, 2002, INT REV CYTOL, V215, P395; Junghans BM, 1996, AUST NZ J OPHTHALMOL, V24, P47, DOI 10.1111/j.1442-9071.1996.tb00993.x; Junghans BM, 1999, OPTOMETRY VISION SCI, V76, P796, DOI 10.1097/00006324-199911000-00028; Krupin T, 1996, EXP EYE RES, V62, P231, DOI 10.1006/exer.1996.0028; Lei B, 1999, VISUAL NEUROSCI, V16, P743, DOI 10.1017/S0952523899164137; LI JD, 1994, INVEST OPHTH VIS SCI, V35, P2700; Liang H, 2004, INVEST OPHTH VIS SCI, V45, P2463, DOI 10.1167/iovs.03-1009; Marmor M.F., 1998, RETINAL PIGMENT EPIT, P103; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pardue MT, 2008, INVEST OPHTH VIS SCI, V49, P706, DOI 10.1167/iovs.07-0643; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; SHIMAZAKI H, 1986, J GEN PHYSIOL, V87, P633, DOI 10.1085/jgp.87.4.633; SHIMAZAKI H, 1984, J GEN PHYSIOL, V84, P475, DOI 10.1085/jgp.84.3.475; STEINBERG RH, 1980, J NEUROPHYSIOL, V44, P897, DOI 10.1152/jn.1980.44.5.897; Vardi N, 2000, J NEUROSCI, V20, P7657; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Walter SJ, 2001, EXP PHYSIOL, V86, P469, DOI 10.1113/eph8602210; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002	44	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2839	10.1371/journal.pone.0002839	http://dx.doi.org/10.1371/journal.pone.0002839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665233	Green Published, gold			2022-12-25	WOS:000264304300058
J	Ge, JQ; Han, SH				Ge, Jianqiao; Han, Shihui			Distinct Neurocognitive Strategies for Comprehensions of Human and Artificial Intelligence	PLOS ONE			English	Article							NEURAL BASIS; SELF; MIND; BRAIN; PERSPECTIVE; DEACTIVATE; SIMULATION; THINKING; AUTISM; OTHERS	Although humans have inevitably interacted with both human and artificial intelligence in real life situations, it is unknown whether the human brain engages homologous neurocognitive strategies to cope with both forms of intelligence. To investigate this, we scanned subjects, using functional MRI, while they inferred the reasoning processes conducted by human agents or by computers. We found that the inference of reasoning processes conducted by human agents but not by computers induced increased activity in the precuneus but decreased activity in the ventral medial prefrontal cortex and enhanced functional connectivity between the two brain areas. The findings provide evidence for distinct neurocognitive strategies of taking others' perspective and inhibiting the process referenced to the self that are specific to the comprehension of human intelligence.	[Ge, Jianqiao; Han, Shihui] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Han, Shihui] Peking Univ, Funct Imaging Ctr, Beijing, Peoples R China; [Han, Shihui] Peking Univ, Key Lab Machine Percept, Beijing, Peoples R China	Peking University; Peking University; Peking University	Han, SH (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	shan@pku.edu.cn		Lauwereyns, Jan/0000-0003-0551-2550	National Natural Science Foundation of China [30630025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project 30630025).	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Franklin S., 1999, ARTIFICIAL MINDS; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gardner H., 1993, MULTIPLE INTELLIGENC; Goel V, 2004, J COGNITIVE NEUROSCI, V16, P654, DOI 10.1162/089892904323057362; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Han SH, 2005, NEUROIMAGE, V24, P928, DOI 10.1016/j.neuroimage.2004.09.046; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Knauff M, 2002, COGNITIVE BRAIN RES, V13, P203, DOI 10.1016/S0926-6410(01)00116-1; LYCAN W, 1996, 20 QUESTIONS INTRO P, P201; Meltzoff A. N., 2001, INTENTIONS INTENTION, P171; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Murray D. K. C., 1997, AUTISM LEARNING GUID, P100; Perner J., 2005, OTHER MINDS HUMANS B, P174; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Searle J., 1984, MINDS BRAINS SCI; STERNBERG RJ, 1986, INTELLIGENCE, V10, P281, DOI 10.1016/0160-2896(86)90001-2; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Von Neumann J., 2012, COMPUTER BRAIN; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2797	10.1371/journal.pone.0002797	http://dx.doi.org/10.1371/journal.pone.0002797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665211	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300016
J	Hong, S; Optican, LM				Hong, Simon; Optican, Lance M.			Interaction between Purkinje Cells and Inhibitory Interneurons May Create Adjustable Output Waveforms to Generate Timed Cerebellar Output	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR; NICTITATING-MEMBRANE RESPONSES; CONDITIONED EYELID RESPONSE; INFERIOR OLIVE; REVERSIBLE INACTIVATIONS; INTERPOSITUS NUCLEUS; DECEREBRATE FERRET; NEURONAL-ACTIVITY; CLIMBING FIBERS	We develop a new model that explains how the cerebellum may generate the timing in classical delay eyeblink conditioning. Recent studies show that both Purkinje cells (PCs) and inhibitory interneurons (INs) have parallel signal processing streams with two time scales: an AMPA receptor-mediated fast process and a metabotropic glutamate receptor (mGluR)-mediated slow process. Moreover, one consistent finding is an increased excitability of PC dendrites (in Larsell's lobule HVI) in animals when they acquire the classical delay eyeblink conditioning naturally, in contrast to in vitro studies, where learning involves long-term depression (LTD). Our model proposes that the delayed response comes from the slow dynamics of mGluR-mediated IP3 activation, and the ensuing calcium concentration change, and not from LTP/LTD. The conditioned stimulus (tone), arriving on the parallel fibers, triggers this slow activation in INs and PC spines. These excitatory (from PC spines) and inhibitory (from INs) signals then interact at the PC dendrites to generate variable waveforms of PC activation. When the unconditioned stimulus (puff), arriving on the climbing fibers, is coupled frequently with this slow activation the waveform is amplified (due to an increased excitability) and leads to a timed pause in the PC population. The disinhibition of deep cerebellar nuclei by this timed pause causes the delayed conditioned response. This suggested PC-IN interaction emphasizes a richer role of the INs in learning and also conforms to the recent evidence that mGluR in the cerebellar cortex may participate in slow motor execution. We show that the suggested mechanism can endow the cerebellar cortex with the versatility to learn almost any temporal pattern, in addition to those that arise in classical conditioning.	[Hong, Simon; Optican, Lance M.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hong, S (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	LanceOptican@nih.gov			Intramural Research Program of the National Eye Institute, NIH, DHHS; NATIONAL EYE INSTITUTE [ZIAEY000302, Z01EY000302] Funding Source: NIH RePORTER	Intramural Research Program of the National Eye Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Eye Institute, NIH, DHHS. No role of sponsor in any aspect of this work.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; AKSENOV D, 2005, SOC NEUR 35 ANN M WA; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1966, J PHYSIOL-LONDON, V187, P553, DOI 10.1113/jphysiol.1966.sp008108; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; BATINI C, 1985, EXP BRAIN RES, V59, P404; BILLARD JM, 1988, NEUROSCI LETT, V88, P21, DOI 10.1016/0304-3940(88)90309-6; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BULLOCK D, 1994, NEURAL NETWORKS, V7, P1101, DOI 10.1016/S0893-6080(05)80161-3; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chen ZH, 2000, J CENT SOUTH UNIV T, V7, P201, DOI 10.1007/s11771-000-0054-4; Choi JS, 2003, BEHAV NEUROSCI, V117, P1211, DOI 10.1037/0735-7044.117.6.1211; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; DESMOND JE, 1988, BIOL CYBERN, V58, P405, DOI 10.1007/BF00361347; DESPERATI C, 1993, NEUROSCIENCE, V53, P139, DOI 10.1016/0306-4522(93)90292-N; DETWEILER K, 2005, SOC NEUR 35 ANN M WA; DeZeeuw CI, 1997, NEUROSCIENCE, V80, P981; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Fiala JC, 1996, J NEUROSCI, V16, P3760; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GELLMAN R, 1983, J COMP NEUROL, V215, P228, DOI 10.1002/cne.902150210; Gibson AR, 2004, CEREBELLUM, V3, P212, DOI 10.1080/14734220410018995; Gibson AR, 2002, ANN NY ACAD SCI, V978, P219, DOI 10.1111/j.1749-6632.2002.tb07569.x; Gould TJ, 1996, NEUROBIOL LEARN MEM, V65, P17, DOI 10.1006/nlme.1996.0003; Green JT, 2005, LEARN MEMORY, V12, P260, DOI 10.1101/lm.89505; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hamori J, 1996, ACTA BIOL HUNG, V47, P181; Hardiman MJ, 1996, EXP BRAIN RES, V110, P235; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heck D, 2003, NEUROSCI LETT, V341, P79, DOI 10.1016/S0304-3940(03)00132-0; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HOANG C, 2005, SOC NEUR 35 ANN M WA; HOEHLER FK, 1976, PAVLOVIAN J BIOL SCI, V11, P180; HONG S, 2008, PROGR BRAIN IN PRESS; HORN KM, 2005, SOC NEUR WASH DC; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Karakossian MH, 2004, J NEUROPHYSIOL, V92, P1558, DOI 10.1152/jn.00300.2004; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; Kotani S, 2006, BRAIN RES, V1068, P70, DOI 10.1016/j.brainres.2005.10.090; Kotani S, 2003, BRAIN RES, V994, P193, DOI 10.1016/j.brainres.2003.09.036; Kreiner L, 2004, CEREBELLUM, V3, P112, DOI 10.1080/14734220410031990; Krupa DJ, 2003, J NEUROSCI, V23, P10577; KRUPA DJ, 1995, P NATL ACAD SCI USA, V92, P5097, DOI 10.1073/pnas.92.11.5097; LAVOND DG, 1989, BEHAV BRAIN RES, V33, P113, DOI 10.1016/S0166-4328(89)80047-6; LAVOND DG, 1987, EXP BRAIN RES, V67, P569; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rhodes BJ, 2002, APPL INTELL, V17, P35, DOI 10.1023/A:1015736004189; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; SCHEIBEL ME, 1954, J COMP NEUROL, V101, P733, DOI 10.1002/cne.901010305; SCHNEIDERMAN N, 1962, SCIENCE, V136, P650, DOI 10.1126/science.136.3516.650; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; SCHREURS BG, 1991, BRAIN RES, V548, P18, DOI 10.1016/0006-8993(91)91100-F; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P86, DOI 10.1152/jn.1997.77.1.86; Schweighofer N, 2004, P NATL ACAD SCI USA, V101, P4655, DOI 10.1073/pnas.0305966101; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; Schweighofer N, 1999, J NEUROPHYSIOL, V82, P804, DOI 10.1152/jn.1999.82.2.804; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Shinkman PG, 1996, BEHAV NEUROSCI, V110, P914, DOI 10.1037/0735-7044.110.5.914; Shinoda Y, 1997, PROG BRAIN RES, V114, P193; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; STEINMETZ JE, 1990, PSYCHOL SCI, V1, P378, DOI 10.1111/j.1467-9280.1990.tb00245.x; STEINMETZ JE, 1986, BEHAV NEUROSCI, V100, P878, DOI 10.1037/0735-7044.100.6.878; Steuber V, 2004, J COMPUT NEUROSCI, V17, P149, DOI 10.1023/B:JCNS.0000037678.26155.b5; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Svensson P, 2006, EXP BRAIN RES, V168, P241, DOI 10.1007/s00221-005-0086-y; Svensson P, 1997, LEARN MEMORY, V4, P105, DOI 10.1101/lm.4.1.105; Svensson P, 1999, EUR J NEUROSCI, V11, P4333, DOI 10.1046/j.1460-9568.1999.00862.x; Takehara K, 2003, J NEUROSCI, V23, P9897; THOMPSON RF, 1990, PHILOS T ROY SOC B, V329, P161, DOI 10.1098/rstb.1990.0161; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; WETMORE DZ, 2007, LOCK AND KEY MECH CE; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; WOODRUFFPAK DS, 1985, BRAIN RES, V348, P249, DOI 10.1016/0006-8993(85)90443-3; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022	105	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2770	10.1371/journal.pone.0002770	http://dx.doi.org/10.1371/journal.pone.0002770			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648667	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900040
J	Hamidouche, Z; Hay, E; Vaudin, P; Charbord, P; Schule, R; Marie, PJ; Fromigue, O				Hamidouche, Zahia; Haye, Eric; Vaudin, Pascal; Charbord, Pierre; Schuele, Roland; Marie, Pierre J.; Fromigue, Olivia			FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression	FASEB JOURNAL			English	Article						osteogenesis; signaling; cell therapy	LIM-ONLY PROTEIN; OSTEOGENIC DIFFERENTIATION; STEM-CELLS; GLUCOCORTICOIDS INHIBIT; STROMAL CELLS; BONE MASS; MARROW; COACTIVATOR; DISRUPTION; INTERACTS	The differentiation of bone marrow mesenchymal stem cells (MSCs) into osteoblasts is a crucial step in bone formation. However, the mechanisms involved in the early stages of osteogenic differentiation are not well understood. In this study, we identified FHL2, a member of the LIM-only subclass of the LIM protein superfamily, that is up-regulated during early osteoblast differentiation induced by dexamethasone in murine and human MSCs. Gain-of-function studies showed that FHL2 promotes the expression of the osteoblast transcription factor Runx2, alkaline phosphatase, type I collagen, as well as in vitro extracellular matrix mineralization in murine and human mesenchymal cells. Knocking down FHL2 using sh-RNA reduces basal and dexamethasone-induced osteoblast marker gene expression in MSCs. We demonstrate that FHL2 interacts with beta-catenin, a key player involved in bone formation induced by Wnt signaling. FHL2-beta-catenin interaction potentiates beta-catenin nuclear translocation and TCF/LEF transcription, resulting in increased Runx2 and alkaline phosphatase expression, which was inhibited by the Wnt inhibitor DKK1. Reduction of Runx2 transcriptional activity using a mutant Runx2 results in inhibition of FHL2-induced alkaline phosphatase expression in MSCs. These findings reveal that FHL2 acts as an endogenous activator of mesenchymal cell differentiation into osteoblasts and mediates osteogenic differentiation induced by dexamethasone in MSCs through activation of Wnt/beta-catenin signaling-dependent Runx2 expression.-Hamidouche, Z., Hay, E., Vaudin, P., Charbord, P., Schule, R., Marie, P. J., and Fromigue, O. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J. 22, 3813-3822 (2008)	[Marie, Pierre J.] Hop Lariboisiere, INSERM, U606, F-75475 Paris 10, France; [Hamidouche, Zahia; Haye, Eric; Marie, Pierre J.; Fromigue, Olivia] Univ Paris 07, Paris, France; [Vaudin, Pascal] Univ Tours, Tours, France; [Charbord, Pierre] INSERM ESPRI, Tours, France; [Schuele, Roland] Univ Frauenklin, Freiburg, Germany; [Schuele, Roland] Zentrum Klin Forsch, Freiburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Vaudin, Pascal/J-1870-2014; Fromigue, Olivia/B-8225-2013	Fromigue, Olivia/0000-0002-3050-6155; charbord, pierre/0000-0002-2254-3300; Hay, Eric/0000-0002-0131-9983	INSERM; Etablissement Francais du Sang, France [2004-08, 2005.11]; Integrated Project of the European Commission FP6 [LSHB-CT-2003-503161]; Association Rhumatisme et Travail, Hopital Lariboisiere, Paris, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Etablissement Francais du Sang, France; Integrated Project of the European Commission FP6(European Commission); Association Rhumatisme et Travail, Hopital Lariboisiere, Paris, France	The authors thank Dr. J. Dennis (Case Western Reserve University, Cleveland, OH, USA) for providing the BMC10 cell line, Biopredic (Rennes, France) for the hMSCs, and Dr. G. Karsenty (Department of Genetics and Development, Columbia University, New York, NY, USA) for the gift of mutant Runx2 cDNA. This work was funded in part by INSERM, the Etablissement Francais du Sang (EFS, Scientific Council No. 2004-08 and 2005.11, France), the Integrated Project of the European Commission FP6 research funding program (contract LSHB-CT-2003-503161 GENOSTEM) and Association Rhumatisme et Travail, Hopital Lariboisiere, Paris, France.	Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; BELLOWS CG, 1987, ENDOCRINOLOGY, V121, P1985, DOI 10.1210/endo-121-6-1985; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Delorme Bruno, 2007, V140, P67; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Fromigue O, 2000, J BONE MINER RES, V15, P2211, DOI 10.1359/jbmr.2000.15.11.2211; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Genini M, 1997, DNA CELL BIOL, V16, P433, DOI 10.1089/dna.1997.16.433; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Govoni KE, 2006, CALCIFIED TISSUE INT, V79, P112, DOI 10.1007/s00223-006-0074-7; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Kimelman N, 2006, REGEN MED, V1, P549, DOI 10.2217/17460751.1.4.549; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lai CF, 2006, J BONE MINER RES, V21, P17, DOI 10.1359/JBMR.050915; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lian JB, 2003, CALCIFIED TISSUE INT, V72, P631, DOI 10.1007/s00223-002-1058-x; Lian JB, 1998, BIOCHEM SOC T, V26, P14, DOI 10.1042/bst0260014; Luppen CA, 2003, J BONE MINER RES, V18, P1186, DOI 10.1359/jbmr.2003.18.7.1186; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; OWEN M, 1988, J CELL SCI, P63; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Shibamoto S, 1998, GENES CELLS, V3, P659; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang FS, 2005, ENDOCRINOLOGY, V146, P2415, DOI 10.1210/en.2004-1050; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	56	127	131	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3813	3822		10.1096/fj.08-106302	http://dx.doi.org/10.1096/fj.08-106302			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18653765				2022-12-25	WOS:000260503000010
J	Kirkland, SC; Ying, HJ				Kirkland, Susan C.; Ying, Huijun			alpha 2 beta 1 integrin regulates lineage commitment in multipotent human colorectal cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; EXTRACELLULAR-MATRIX; MULTILINEAGE DIFFERENTIATION; INTEGRIN ALPHA-2-BETA-1; SIGNALING PATHWAYS; I COLLAGEN; ADHESION; GROWTH; RECEPTOR; BETA-1-INTEGRINS	The human colorectal epithelium is maintained by multipotent stem cells that give rise to absorptive, mucous, and endocrine lineages. Recent evidence suggests that human colorectal cancers are likewise maintained by a minority population of so-called cancer stem cells. We have previously established a human colorectal cancer cell line with multipotent characteristics (HRA-19) and developed a serum-free medium that induces endocrine, mucous and absorptive lineage commitment by HRA-19 cells in vitro. In this study, we investigate the role of the beta 1 integrin family of cell surface extracellular matrix receptors in multilineage differentiation by these multipotent human colorectal cancer cells. We show that endocrine and mucous lineage commitment is blocked in the presence of function-blocking antibodies to beta 1 integrin. Function-blocking antibodies to alpha 2 integrin also blocked both HRA-19 endocrine lineage commitment and enterocytic differentiation by Caco-2 human colon cancer cells; both effects being abrogated by the MEK inhibitor, PD98059, suggesting a role for ERK signaling in alpha 2-mediated regulation of colorectal cancer cell differentiation. To further explore the role of alpha 2 integrin in multilineage differentiation, we established multipotent cells expressing high levels of wild-type alpha 2 integrin or a non-signaling chimeric alpha 2 integrin. Overexpression of wild-type alpha 2 integrin in HRA-19 cells significantly enhanced endocrine and mucous lineage commitment, while cells expressing the non-signaling chimeric alpha 2 integrin had negligible ability for either endocrine or mucous lineage commitment. This study indicates that the collagen receptor alpha 2 beta 1 integrin is a regulator of cell fate in human multipotent colorectal cancer cells.	[Kirkland, Susan C.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Fac Med, London W12 ONN, England	Imperial College London	Kirkland, SC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Fac Med, DuCane Rd, London W12 ONN, England.	s.kirkland@imperial.ac.uk			The Wellcome Trust [060688]	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Grant 060688 from The Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Crook MF, 2002, J VASC RES, V39, P221, DOI 10.1159/000063687; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; Fabbri M, 1996, TISSUE ANTIGENS, V48, P47, DOI 10.1111/j.1399-0039.1996.tb02604.x; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fujimoto K, 2002, GASTROENTEROLOGY, V123, P1941, DOI 10.1053/gast.2002.37065; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; HEINO J, 1989, J BIOL CHEM, V264, P380; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Henderson K, 1996, DIFFERENTIATION, V60, P259, DOI 10.1046/j.1432-0436.1996.6040259.x; Hers I, 2000, EUR J BIOCHEM, V267, P2088, DOI 10.1046/j.1432-1327.2000.01214.x; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jiang FX, 2001, MOL MED, V7, P107, DOI 10.1007/BF03401944; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Kirkland SC, 2001, J CELL SCI, V114, P2055; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Ni HY, 1998, CELL ADHES COMMUN, V5, P257, DOI 10.3109/15419069809040296; Ning Y, 2007, J BIOL CHEM, V282, P6380, DOI 10.1074/jbc.M610915200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rohwedel J, 1998, DEV BIOL, V201, P167, DOI 10.1006/dbio.1998.9002; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sawhney RS, 2003, J BIOL CHEM, V278, P19861, DOI 10.1074/jbc.M213162200; Scartozzi M, 2006, EXPERT OPIN THER TAR, V10, P281, DOI 10.1517/14728222.10.2.281; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Whittard JD, 2002, MATRIX BIOL, V21, P525, DOI 10.1016/S0945-053X(02)00037-9; Yu X, 2000, J CELL SCI, V113, P2139; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	54	27	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27612	27619		10.1074/jbc.M802932200	http://dx.doi.org/10.1074/jbc.M802932200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664572	Green Published, hybrid			2022-12-25	WOS:000259719200032
J	Kumari, A; Minko, IG; Harbut, MB; Finkel, SE; Goodman, MF; Lloyd, RS				Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Finkel, Steven E.; Goodman, Myron F.; Lloyd, R. Stephen			Replication bypass of interstrand cross-link intermediates by Escherichia coli DNA polymerase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; POL-KAPPA; REPAIR; ACROLEIN; ADDUCT; FIDELITY; EXCISION; RECOMBINATION; PURIFICATION; MUTATIONS	Repair of interstrand DNA cross-links (ICLs) in Escherichia coli can occur through a combination of nucleotide excision repair (NER) and homologous recombination. However, an alternative mechanism has been proposed in which repair is initiated by NER followed by translesion DNA synthesis (TLS) and completed through another round of NER. Using site-specifically modified oligodeoxynucleotides that serve as a model for potential repair intermediates following incision by E. coli NER proteins, the ability of E. coli DNA polymerases (pol) II and IV to catalyze TLS past N-2-N-2-guanine ICLs was determined. No biochemical evidence was found suggesting that pol II could bypass these lesions. In contrast, pol IV could catalyze TLS when the nucleotides that are 5' to the cross-link were removed. The efficiency of TLS was further increased when the nucleotides 3' to the cross-linked site were also removed. The correct nucleotide, C, was preferentially incorporated opposite the lesion. When E. coli cells were transformed with a vector carrying a site-specific N-2- N-2- guanine ICL, the transformation efficiency of a pol II-deficient strain was indistinguishable from that of the wild type. However, the ability to replicate the modified vector DNA was nearly abolished in a pol IV-deficient strain. These data strongly suggest that pol IV is responsible for TLS past N-2-N-2- guanine ICLs.	[Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Finkel, Steven E.; Goodman, Myron F.] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Oregon Health & Science University; Oregon Health & Science University; University of Southern California; University of Southern California	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health [ES05355, R37 GM21244, ES012259]; Center Grant [ES000267]; National Science Foundation Career Award [MCB-0237975]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259, P30ES000267, P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center Grant; National Science Foundation Career Award(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES05355 (to R. S. L.) and Center Grant ES000267 and National Institutes of Health Grants R37 GM21244 and ES012259 (to M. F. G.). This work was also supported by National Science Foundation Career Award MCB-0237975 (to S. E. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. at ISI, Thomson Scientific on October 6, 2008 www. jbc. org Downloaded from	Berardini M, 1999, J BACTERIOL, V181, P2878, DOI 10.1128/JB.181.9.2878-2882.1999; Berardini M, 1997, BIOCHEMISTRY-US, V36, P3506, DOI 10.1021/bi962778w; Cai H, 1995, METHOD ENZYMOL, V262, P13; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; Gerlach VL, 2001, J BIOL CHEM, V276, P92, DOI 10.1074/jbc.M004413200; Kanuri M, 2005, DNA REPAIR, V4, P1374, DOI 10.1016/j.dnarep.2005.08.011; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kim HYH, 2002, J AM CHEM SOC, V124, P9324, DOI 10.1021/ja020333r; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Lee CH, 2006, J MOL GRAPH MODEL, V25, P87, DOI 10.1016/j.jmgm.2005.10.009; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIYA M, 1988, P NATL ACAD SCI USA, V85, P1586, DOI 10.1073/pnas.85.5.1586; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; VANHOUTEN B, 1986, P NATL ACAD SCI USA, V83, P8077; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	21	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27433	27437		10.1074/jbc.M801237200	http://dx.doi.org/10.1074/jbc.M801237200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697749	Green Published, hybrid			2022-12-25	WOS:000259719200012
J	Palle, K; Pattarello, L; van der Merwe, M; Losasso, C; Benedetti, P; Bjornsti, MA				Palle, Komaraiah; Pattarello, Luca; van der Merwe, Marie; Losasso, Carmen; Benedetti, Piero; Bjornsti, Mary-Ann			Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the n terminus in clamp closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMPTOTHECIN RESISTANCE; CATALYTIC-ACTIVITY; FUNCTIONAL LINKER; CELL LETHALITY; SLIDING CLAMP; MECHANISM; DOMAIN; RELAXATION; SENSITIVITY; YEAST	In eukaryotes, DNA topoisomerase I (Top1) catalyzes the relaxation of supercoiled DNA by a conserved mechanism of transient DNA strand breakage, rotation, and religation. The unusual architecture of the monomeric human enzyme comprises a conserved protein clamp, which is tightly wrapped about duplex DNA, and an extended coiled-coil linker domain that appropriately positions the C-terminal active site tyrosine domain against the Top1 core to form the catalytic pocket. A structurally undefined N-terminal domain, dispensable for enzyme activity, mediates protein-protein interactions. Previously, reversible disulfide bonds were designed to assess whether locking the Top1 clamp around duplex DNA would restrict DNA strand rotation within the covalent Top1-DNA intermediate. The active site proximal disulfide bond in full-length Top1-clamp(534) restricted DNA rotation ( Woo, M. H., Losasso, C., Guo, H., Pattarello, L., Benedetti, P., and Bjornsti, M. A. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 13767-13772), whereas the more distal disulfide bond of the N-terminally truncated Topo70-clamp(499) did not (Carey, J. F., Schultz, S. J., Sisson, L., Fazzio, T. G., and Champoux, J. J. ( 2003) Proc. Natl. Acad. Sci. U. S. A. 100, 5640-5645). To assess the contribution of the N-terminal domain to the dynamics of Top1 clamping of DNA, the same disulfide bonds were engineered into full-length Top1 and truncated Topo70, and the activities of these proteins were assessed in vitro and in yeast. Here we report that the N terminus impacts the opening and closing of the Top1 protein clamp. We also show that the architecture of yeast and human Top1 is conserved in so far as cysteine substitutions of the corresponding residues suffice to lock the Top1-clamp. However, the composition of the divergent N-terminal/linker domains impacts Top1-clamp activity and stability in vivo.	[Pattarello, Luca; Losasso, Carmen; Benedetti, Piero; Bjornsti, Mary-Ann] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Palle, Komaraiah; van der Merwe, Marie; Bjornsti, Mary-Ann] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38015 USA	University of Padua; St Jude Children's Research Hospital	Benedetti, P (corresponding author), Univ Padua, Dept Biol, Via Bassi 58-B, I-35131 Padua, Italy.	pietro.benedetti@unipd.it; ann.bjornsti@stjude.org	Losasso, Carmen/AAC-9734-2022; losasso, carmen/C-2928-2013; Losasso, Carmen/AAC-9790-2022	Losasso, Carmen/0000-0002-8234-1292; losasso, carmen/0000-0002-8234-1292; Losasso, Carmen/0000-0002-8234-1292	National Institutes of Health [CA58755, CA111542]; National Institutes of Health; NCI; Cancer Center Core [CA21765]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento; NATIONAL CANCER INSTITUTE [R01CA058755, P30CA021765, R01CA111542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core; Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA58755 and CA111542 (to M.-A. B.) and National Institutes of Health, NCI, Cancer Center Core Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities and grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento 2005-2007 and Ministero della Salute (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALSNER J, 1992, J BIOL CHEM, V267, P12408; BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Dionne I, 2008, MOL MICROBIOL, V68, P216, DOI 10.1111/j.1365-2958.2008.06150.x; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2004, J MOL BIOL, V336, P93, DOI 10.1016/j.jmb.2003.12.007; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Frohlich RF, 2007, NUCLEIC ACIDS RES, V35, P6170, DOI 10.1093/nar/gkm669; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Haluska P, 1998, ADV ENZYME REGUL, V38, P253, DOI 10.1016/S0065-2571(97)00008-3; Jacquiau HR, 2005, J BIOL CHEM, V280, P23566, DOI 10.1074/jbc.M500947200; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Kaiser C., 1994, METHODS YEAST GENETI; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Mo YY, 2000, J BIOL CHEM, V275, P41107, DOI 10.1074/jbc.M003135200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	46	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27767	27775		10.1074/jbc.M804826200	http://dx.doi.org/10.1074/jbc.M804826200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693244	Green Published, hybrid			2022-12-25	WOS:000259719200048
J	Wright, NT; Prosser, BL; Varney, KM; Zimmer, DB; Schneider, MF; Weber, DJ				Wright, Nathan T.; Prosser, Benjamin L.; Varney, Kristen M.; Zimmer, Danna B.; Schneider, Martin F.; Weber, David J.			S100A1 and calmodulin compete for the same binding site on ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; 3-DIMENSIONAL SOLUTION STRUCTURE; CA2+-BINDING PROTEIN S100A1; DIPOLAR COUPLINGS; REGULATORY DOMAIN; NMR STRUCTURE; APOCALMODULIN; COMPLEX; ACTIVATION; REGION	In heart and skeletal muscle an S100 protein family member, S100A1, binds to the ryanodine receptor (RyR) and promotes Ca2+ release. Using competition binding assays, we further characterized this system in skeletal muscle and showed that Ca2+-S100A1 competes with Ca2+-calmodulin (CaM) for the same binding site on RyR1. In addition, the NMR structure was determined for Ca2+-S100A1 bound to a peptide derived from this CaM/S100A1 binding domain, a region conserved in RyR1 and RyR2 and termed RyRP12 (residues 3616-3627 in human RyR1). Examination of the S100A1-RyRP12 complex revealed residues of the helical RyRP12 peptide (Lys-3616, Trp-3620, Lys-3622, Leu-3623, Leu-3624, and Lys-3626) that are involved in favorable hydrophobic and electrostatic interactions with Ca2+-S100A1. These same residues were shown previously to be important for RyR1 binding to Ca2+-CaM. A model for regulating muscle contraction is presented in which Ca2+-S100A1 and Ca2+-CaM compete directly for the same binding site on the ryanodine receptor.	[Wright, Nathan T.; Prosser, Benjamin L.; Varney, Kristen M.; Schneider, Martin F.; Weber, David J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zimmer, Danna B.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station	Weber, DJ (corresponding author), 108 N Greene St, Baltimore, MD 21201 USA.	dweber@umaryland.edu	Weber, David J/B-5349-2011; Tuluc, Petronel/C-2527-2011	Weber, David J/0000-0002-8824-1110; Wright, Nathan/0000-0003-0177-6129; Prosser, Benjamin/0000-0003-3696-9131	National Institutes of Health [GM58888, CA107331, AR055099]; Shared Instrumentation [S10 RR10441, S10 RR15741, S10 RR16812, S10 RR23447]; National Institutes of Health; DBI [0115795]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016812, S10RR031729, S10RR015741, S10RR010441, S10RR023447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR055099, R01AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBI; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58888 and CA107331 (to D. J. W.) and AR055099 (to M. F. S.). The NMR spectrometers used in these studies were purchased, in part, by Shared Instrumentation Grants S10 RR10441, S10 RR15741, S10 RR16812, and S10 RR23447 (to D. J. W.) from the National Institutes of Health and DBI 0115795 from the National Science Foundation (to D. J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAX A, 1994, J MAGN RESON SER A, V106, P269, DOI 10.1006/jmra.1994.1038; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; BRUNGER AT, 1993, X PLOR VERSION 3 1; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1999, PROTEIN SCI, V8, P800; Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; ODriscoll S, 1996, BIOCHEM J, V319, P421, DOI 10.1042/bj3190421; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Rodney GG, 2003, BIOPHYS J, V85, P921, DOI 10.1016/S0006-3495(03)74531-7; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; RODNEY GG, 2008, AM J PHYSIOL, V294, P1288; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	38	90	98	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26676	26683		10.1074/jbc.M804432200	http://dx.doi.org/10.1074/jbc.M804432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650434	hybrid, Green Published			2022-12-25	WOS:000259341600041
J	Michael, E; Malecela, MN; Zervos, M; Kazura, JW				Michael, Edwin; Malecela, Mwele N.; Zervos, Mihail; Kazura, James W.			Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI INFECTION; PAPUA-NEW-GUINEA; MASS TREATMENT; MATHEMATICAL-MODELS; COST-EFFECTIVENESS; VENOUS-BLOOD; 4 STRATEGIES; DIETHYLCARBAMAZINE; PREVALENCE; THRESHOLD	The ultimate goal of the global programme against lymphatic filariasis is eradication through irrevocable cessation of transmission using 4 to 6 years of annual single dose mass drug administration. The costs of eradication, managerial impediments to executing national control programmes, and scientific uncertainty about transmission endpoints, are challenges to the success of this effort, especially in areas of high endemicity where financial resources are limited. We used a combined analysis of empirical community data describing the association between infection and chronic disease prevalence, mathematical modelling, and economic analyses to identify and evaluate the feasibility of setting an infection target level at which the chronic pathology attributable to lymphatic filariasis - lymphoedema of the extremities and hydroceles - becomes negligible in the face of continuing transmission as a first stage option in achieving the elimination of this parasitic disease. The results show that microfilaria prevalences below a threshold of 3.55% at a blood sampling volume of 1 ml could constitute readily achievable and sustainable targets to control lymphatic filarial disease. They also show that as a result of the high marginal cost of curing the last few individuals to achieve elimination, maximal benefits can occur at this threshold. Indeed, a key finding from our coupled economic and epidemiological analysis is that when initial uncertainty regarding eradication occurs and prospects for resolving this uncertainty over time exist, it is economically beneficial to adopt a flexible, sequential, eradication strategy based on controlling chronic disease initially.	[Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Malecela, Mwele N.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Zervos, Mihail] London Sch Econom & Polit Sci, Math Dept, London, England; [Kazura, James W.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH USA	Imperial College London; National Institute of Medical Research; University of London; London School Economics & Political Science; Case Western Reserve University	Michael, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	jxk14@case.edu	Michael, Edwin/D-3388-2014		United States Public Health Service NIH [R01 AI69387-01A1, U19 AI065717]; British Council Higher Education Link Programme; United States Public Health Service NIH ICIDR [U19 AI33061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI033061, R01AI069387, U19AI065717] Funding Source: NIH RePORTER	United States Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); British Council Higher Education Link Programme; United States Public Health Service NIH ICIDR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.M. gratefully acknowledges the financial support of a United States Public Health Service NIH grant R01 AI69387-01A1 for facilitating this work. E.M. and M.N.M. are grateful to the British Council Higher Education Link Programme for supporting research collaboration in carrying out this study. Collaboration between E.M. and J.W.K. was made possible by a United States Public Health Service NIH ICIDR grant U19 AI33061. Contributions by J.W.K. were in part also supported by the United States Public Health Service NIH grant U19 AI065717. The funders are not responsible for any statements in the manuscript.	ARROW KJ, 1974, Q J ECON, V88, P312, DOI 10.2307/1883074; Barrett S, 2004, B WORLD HEALTH ORGAN, V82, P683; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Burkot T, 2002, TRENDS PARASITOL, V18, P109, DOI 10.1016/S1471-4922(01)02221-8; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; Chen H-T, 1990, THEORY DRIVEN EVALUA; DAWSON S, 1992, ANAL ORG; DESOWITZ R S, 1973, Southeast Asian Journal of Tropical Medicine and Public Health, V4, P329; Dixit A.K., 1994, INVESTMENT UNCERTAIN, DOI DOI 10.1515/9781400830176; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Dreyer G, 1996, TROP MED INT HEALTH, V1, P264; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Gallopin GC, 2001, INT SOC SCI J, V53, P219, DOI 10.1111/1468-2451.00311; Geoffard PY, 1997, AM ECON REV, V87, P222; Gersovitz M, 2003, WORLD BANK RES OBSER, V18, P129, DOI 10.1093/wbro/lkg011; Gollier C, 2003, J RISK UNCERTAINTY, V27, P77, DOI 10.1023/A:1025576823096; *GOV TANZ NAT BUR, 2002, UN REP TANZ 2002 POP; Hunt DL, 2005, J APPL TOXICOL, V25, P435, DOI 10.1002/jat.1092; Krishnamoorthy K, 2002, ANN TROP MED PARASIT, V96, pS77, DOI 10.1179/000349802125002428; Krishnamoorthy K, 2000, INDIAN J MED RES, V111, P81; Lindsey JK, 2001, NONLINEAR MODELS MED; LIPSEY RG, 1956, REV ECON STUD, V24, P11, DOI 10.2307/2296233; Little MP, 2004, J INFECT DIS, V189, P1932, DOI 10.1086/383326; Mataika JU, 1998, B WORLD HEALTH ORGAN, V76, P575; MCMAHON JE, 1979, ANN TROP MED PARASIT, V73, P457, DOI 10.1080/00034983.1979.11687285; Meyrowitsch DW, 1996, T ROY SOC TROP MED H, V90, P423, DOI 10.1016/S0035-9203(96)90534-9; Michael E, 1996, TROP MED INT HEALTH, V1, P414, DOI 10.1046/j.1365-3156.1996.d01-82.x; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; MOULIAPELAT JP, 1992, TROP MED PARASITOL, V43, P146; NG NK, 1983, WELFARE EC INTRO DEV; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; Oh Y., 1995, INT ECON J, V9, P89; Onapa AW, 2001, ACTA TROP, V78, P171, DOI 10.1016/S0001-706X(00)00185-6; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ramaiah KD, 2004, TRENDS PARASITOL, V20, P499, DOI 10.1016/j.pt.2004.08.010; Ramaiah KD, 2002, TROP MED INT HEALTH, V7, P767, DOI 10.1046/j.1365-3156.2002.00935.x; Ramzy Reda M R, 2005, Filaria J, V4, P7, DOI 10.1186/1475-2883-4-7; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; SABRY M, 1991, T ROY SOC TROP MED H, V85, P506, DOI 10.1016/0035-9203(91)90237-S; SCOTT B, 2004, B WORLD HEALTH ORGAN, V82, P683; Sculpher M., 2005, HLTH POLICY EC OPPOR, P8; Seim A R, 1999, Rev Soc Bras Med Trop, V32, P325, DOI 10.1590/S0037-86821999000300022; Simonsen PE, 2004, AM J TROP MED HYG, V70, P63, DOI 10.4269/ajtmh.2004.70.63; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7; Thylefors B, 2004, TROP MED INT HEALTH, V9, pA1, DOI 10.1111/j.1365-3156.2004.01226.x; ULM K, 1991, STAT MED, V10, P341, DOI 10.1002/sim.4780100306; van der Werf MJ, 2002, ACTA TROP, V82, P127, DOI 10.1016/S0001-706X(02)00007-4; Vaqas Babar, 2003, Filaria J, V2, P4, DOI 10.1186/1475-2883-2-4; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Whitehead N, 2002, AM J EPIDEMIOL, V155, P117, DOI 10.1093/aje/155.2.117	56	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2936	10.1371/journal.pone.0002936	http://dx.doi.org/10.1371/journal.pone.0002936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698350	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600022
J	Andreasen, CH; Mogensen, MS; Borch-Johnsen, K; Sandbaek, A; Lauritzen, T; Sorensen, TIA; Hansen, L; Almind, K; Jorgensen, T; Pedersen, O; Hansen, T				Andreasen, Camilla H.; Mogensen, Mette S.; Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten; Sorensen, Thorkild I. A.; Hansen, Lars; Almind, Katrine; Jorgensen, Torben; Pedersen, Oluf; Hansen, Torben			Non-Replication of Genome-Wide Based Associations between Common Variants in INSIG2 and PFKP and Obesity in Studies of 18,014 Danes	PLOS ONE			English	Article							BODY-MASS INDEX; FTO GENE; FAT MASS; ADIPOCYTE DIFFERENTIATION; EXTREME OBESITY; POLYMORPHISM; CHILDHOOD; RS7566605; ADULT; OVERWEIGHT	Background: The INSIG2 rs7566605 and PFKP rs6602024 polymorphisms have been identified as obesity gene variants in genome-wide association (GWA) studies. However, replication has been contradictory for both variants. The aims of this study were to validate these obesity-associations through case-control studies and analyses of obesity-related quantitative traits. Moreover, since environmental and genetic factors may modulate the impact of a genetic variant, we wanted to perform such interaction analyses. We focused on physical activity as an environmental risk factor, and on the GWA identified obesity variants in FTO (rs9939609) and near MC4R (rs17782313) as genetic risk factors. Materials and Methods: The four variants were genotyped in a combined study sample comprising a total of 18,014 subject ascertained from, the population-based Inter99 cohort (n = 6,514), the ADDITION screening cohort (n = 8,662), a population-based study sample (n = 680) and a type 2 diabetic patient group (n = 2,158) from Steno Diabetes Center. Results: No association with overweight, obesity or obesity-related measures was shown for either the INSIG2 rs7566605 or the PFKP rs6602024 variants. However, an interaction between the INSIG2 rs7566605 variant and the level of self-reported physical activity (p(Int) = 0.004) was observed. A BMI difference of 0.53 (SE 0.42) kg/m(2) was found when comparing physically passive homozygous C-allele carriers with physically passive G-allele carriers. No interactions between the two variants and FTO rs9939609 and MC4R rs17782313 were observed. Conclusions: The INSIG2 rs7566605 and PFKP rs6602024 polymorphisms play no apparent role in the development of common forms of obesity in the Danish population. However, if replicated, the INSIG2 rs7566605 may influence the level of BMI in combination with the level of physical activity.	[Andreasen, Camilla H.; Mogensen, Mette S.; Borch-Johnsen, Knut; Pedersen, Oluf; Hansen, Torben] Steno Diabet Ctr, Copenhagen, Denmark; [Andreasen, Camilla H.; Almind, Katrine] Novo Nordisk A S, Med & Sci Dev Projects, Bagsvaerd, Denmark; [Borch-Johnsen, Knut; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Hansen, Lars] Bristol Myers Squibb Co, Princeton, NJ USA; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	Steno Diabetes Center; Novo Nordisk; University of Copenhagen; Aarhus University; Aarhus University; Bristol-Myers Squibb; University of Copenhagen	Andreasen, CH (corresponding author), Steno Diabet Ctr, Copenhagen, Denmark.	cila@novonordisk.com	Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830	Danish Medical Research Council; Danish Diabetes Association; Gerda and Aage Haensch Foundation; A.P. Moller Foundation for the Advancement of Medical Science; University of Copenhagen; Velux Foundation; European Commission [LSHM-CT-2005-018734]; The Danish Obesity Research centre; The Danish Council for Strategic Research [2101-06-0005]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Diabetes Association; Gerda and Aage Haensch Foundation; A.P. Moller Foundation for the Advancement of Medical Science; University of Copenhagen; Velux Foundation(Velux Fonden); European Commission(European CommissionEuropean Commission Joint Research Centre); The Danish Obesity Research centre; The Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Danish Medical Research Council, the Danish Diabetes Association, the Gerda and Aage Haensch Foundation, the A.P. Moller Foundation for the Advancement of Medical Science, University of Copenhagen, and the Velux Foundation. This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP www.hepadip.org), which is supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734). The study also received support from The Danish Obesity Research centre (DanORC; www.danorc.dk), which is supported by The Danish Council for Strategic Research (Grant No 2101-06-0005).	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; BELFIORE F, 1976, METABOLISM, V25, P483, DOI 10.1016/0026-0495(76)90001-9; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Feng Y, 2007, HUM GENET, V120, P743, DOI 10.1007/s00439-006-0258-2; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Kuzuya M, 2007, OBESITY, V15, P2531, DOI 10.1038/oby.2007.301; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Price RA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-4; R Core Team, 2022, R LANG ENV STAT COMP; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Tabara Y, 2008, OBESITY, V16, P211, DOI 10.1038/oby.2007.25; World Health Organization, 1999, WHONCDNCS992	36	42	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2872	10.1371/journal.pone.0002872	http://dx.doi.org/10.1371/journal.pone.0002872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682847	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600028
J	Franqueville, L; Henning, P; Magnusson, M; Vigne, E; Schoehn, G; Blair-Zajdel, ME; Habib, N; Lindholm, L; Blair, GE; Hong, SS; Boulanger, P				Franqueville, Laure; Henning, Petra; Magnusson, Maria; Vigne, Emmanuelle; Schoehn, Guy; Blair-Zajdel, Maria E.; Habib, Nagy; Lindholm, Leif; Blair, G. Eric; Hong, Saw See; Boulanger, Pierre			Protein Crystals in Adenovirus Type 5-Infected Cells: Requirements for Intranuclear Crystallogenesis, Structural and Functional Analysis	PLOS ONE			English	Article								Intranuclear crystalline inclusions have been observed in the nucleus of epithelial cells infected with Adenovirus serotype 5 (Ad5) at late steps of the virus life cycle. Using immuno-electron microscopy and confocal microscopy of cells infected with various Ad5 recombinants modified in their penton base or fiber domains, we found that these inclusions represented crystals of penton capsomers, the heteromeric capsid protein formed of penton base and fiber subunits. The occurrence of protein crystals within the nucleus of infected cells required the integrity of the fiber knob and part of the shaft domain. In the knob domain, the region overlapping residues 489-492 in the FG loop was found to be essential for crystal formation. In the shaft, a large deletion of repeats 4 to 16 had no detrimental effect on crystal inclusions, whereas deletion of repeats 8 to 21 abolished crystal formation without altering the level of fiber protein expression. This suggested a crucial role of the five penultimate repeats in the crystallisation process. Chimeric pentons made of Ad5 penton base and fiber domains from different serotypes were analyzed with respect to crystal formation. No crystal was found when fiber consisted of shaft (S) from Ad5 and knob (K) from Ad3 (heterotypic S5-K3 fiber), but occurred with homotypic S3K3 fiber. However, less regular crystals were observed with homotypic S35-K35 fiber. TB5, a monoclonal antibody directed against the Ad5 fiber knob was found by immunofluorescence microscopy to react with high efficiency with the intranuclear protein crystals in situ. Data obtained with Ad fiber mutants indicated that the absence of crystalline inclusions correlated with a lower infectivity and/or lower yields of virus progeny, suggesting that the protein crystals might be involved in virion assembly. Thus, we propose that TB5 staining of Ad-infected 293 cells can be used as a prognostic assay for the viability and productivity of fiber-modified Ad5 vectors.	[Franqueville, Laure; Hong, Saw See; Boulanger, Pierre] Univ Lyon 1, Fac Med Laennec, Lab Virol & Pathol Humaine, CNRS,FRE 3011, F-69365 Lyon, France; [Henning, Petra; Magnusson, Maria] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Henning, Petra; Magnusson, Maria; Lindholm, Leif] Got A Gene AB, Kullavik, Sweden; [Vigne, Emmanuelle] Ctr Rech Vitry, Sanofi Avantis, Vitry Sur Seine, France; [Schoehn, Guy] Univ Grenoble Joseph Fourier UJF, Inst Biol Structurale Jean Pierre Ebel, Unit Virus Host Cell Interact, UMR 5233 UJF EMBL CNRS, Grenoble, France; [Blair-Zajdel, Maria E.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield, S Yorkshire, England; [Habib, Nagy] Imperial Coll, Dept Surg Oncol & Technol, London, England; [Blair, G. Eric] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Boulanger, Pierre] Hosp Civils Lyon, Ctr Biol Pathol Est, Lab Virol Med, Bron, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Gothenburg; Sanofi-Aventis; Sanofi France; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Sheffield Hallam University; Imperial College London; University of Leeds; CHU Lyon	Franqueville, L (corresponding author), Univ Lyon 1, Fac Med Laennec, Lab Virol & Pathol Humaine, CNRS,FRE 3011, F-69365 Lyon, France.	Pierre.Boulanger@sante.univ-lyon1.fr	Blair, George Eric/A-5906-2008; Hong, Saw See/M-9818-2017; Boulanger, Pierre/AFV-2750-2022	Blair, George Eric/0000-0003-0440-1795; Hong, Saw See/0000-0001-8871-0901; Schoehn, Guy/0000-0002-1459-3201; Magnusson, Maria/0000-0002-8888-4968; Henning, Petra/0000-0002-9330-6265	Centre National de la Recherche Scientifique; French Foundation for Research on Cystic Fibrosis [TG0702]; Association Francaise contre les Myopathies [MNM2 D-2006-12155]; European Community [QLK3-CT-1999-01262, GIANT]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Foundation for Research on Cystic Fibrosis; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Community(European Commission)	The work in Lyon was supported in part by the Centre National de la Recherche Scientifique and by grants from the French Foundation for Research on Cystic Fibrosis ("Vaincre la Mucoviscidose", VLM Contract TG0702) and from the Association Francaise contre les Myopathies (AFM Contract N MNM2 D-2006-12155). The work in Goteborg was supported by the European Community (Contracts N QLK3-CT-1999-01262 and GIANT).	Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; BOUDIN ML, 1983, EMBO J, V2, P1921, DOI 10.1002/j.1460-2075.1983.tb01680.x; BOUDIN ML, 1982, VIROLOGY, V116, P589, DOI 10.1016/0042-6822(82)90151-9; BOUDIN ML, 1979, VIROLOGY, V92, P125, DOI 10.1016/0042-6822(79)90219-8; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Boulanger P A, 1974, Intervirology, V2, P56; BOULANGER PA, 1970, J GEN VIROL, V6, P329, DOI 10.1099/0022-1317-6-2-329; Cauet G, 2005, BIOCHEMISTRY-US, V44, P5453, DOI 10.1021/bi047702b; CEPKO CL, 1982, CELL, V31, P407, DOI 10.1016/0092-8674(82)90134-9; CHROBOCZEL K, 1995, MOL REPERTOIRE ADENO, P163; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Coulibaly F, 2007, NATURE, V446, P97, DOI 10.1038/nature05628; Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414; DHALLUIN JC, 1995, MOL REPERTOIRE ADENO, P47; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaden F, 2004, J VIROL, V78, P7227, DOI 10.1128/JVI.78.13.7227-7247.2004; Galfre G, 1981, Methods Enzymol, V73, P3; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henning P, 2005, GENE THER, V12, P211, DOI 10.1038/sj.gt.3302408; Henning P, 2002, HUM GENE THER, V13, P1427, DOI 10.1089/10430340260185067; Henning P, 2006, J GEN VIROL, V87, P3151, DOI 10.1099/vir.0.81992-0; HENRY CJ, 1971, VIROLOGY, V44, P215, DOI 10.1016/0042-6822(71)90167-X; HENRY CJ, 1971, J VIROL, V8, P842, DOI 10.1128/JVI.8.6.842-849.1971; HONG JS, 1991, VIROLOGY, V185, P758; Hong JS, 1996, J VIROL, V70, P7071, DOI 10.1128/JVI.70.10.7071-7078.1996; Hong SS, 1999, VIROLOGY, V262, P163, DOI 10.1006/viro.1999.9864; Hong SS, 2005, J MOL BIOL, V352, P125, DOI 10.1016/j.jmb.2005.06.070; Hong SS, 2003, MOL THER, V7, P692, DOI 10.1016/S1525-0016(03)00067-4; HONG SS, 1995, EMBO J, V14, P4714, DOI 10.1002/j.1460-2075.1995.tb00153.x; HORWITZ MS, 1986, FUNDAMENTAL VIROLOGY, P563; Huvent I, 1998, J GEN VIROL, V79, P1069, DOI 10.1099/0022-1317-79-5-1069; Karayan L, 1997, J VIROL, V71, P8678, DOI 10.1128/JVI.71.11.8678-8689.1997; KARAYAN L, 1994, VIROLOGY, V202, P782, DOI 10.1006/viro.1994.1400; Kirby I, 1999, J VIROL, V73, P9508, DOI 10.1128/JVI.73.11.9508-9514.1999; Kovacs GM, 2004, J GEN VIROL, V85, P2799, DOI 10.1099/vir.0.80225-0; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Legrand V, 1999, J VIROL, V73, P907, DOI 10.1128/JVI.73.2.907-919.1999; Leissner P, 2001, GENE THER, V8, P49, DOI 10.1038/sj.gt.3301343; Li JL, 2006, J VIROL, V80, P12324, DOI 10.1128/JVI.01331-06; LIFCHITZ A, 1975, ACTA CRYSTALLOGR B, V31, P441, DOI 10.1107/S0567740875002981; Magnusson MK, 2007, CANCER GENE THER, V14, P468, DOI 10.1038/sj.cgt.7701027; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MARTIN GR, 1978, J GEN VIROL, V41, P303, DOI 10.1099/0022-1317-41-2-303; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; MARUSYK R, 1972, J GEN VIROL, V14, P261, DOI 10.1099/0022-1317-14-3-261; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373; NEUMANN R, 1988, GENE, V69, P153, DOI 10.1016/0378-1119(88)90389-7; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NOVELLI A, 1991, J BIOL CHEM, V266, P9299; NOVELLI A, 1991, VIROLOGY, V185, P365, DOI 10.1016/0042-6822(91)90784-9; Puvion-Dutilleul F, 1999, BIOL CELL, V91, P617, DOI 10.1016/S0248-4900(00)88526-3; Rey FA, 2007, NATURE, V446, P35, DOI 10.1038/446035a; RUIGROK RWH, 1990, J MOL BIOL, V215, P589, DOI 10.1016/S0022-2836(05)80170-6; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; Souquere-Besse S, 2002, MICROSC RES TECHNIQ, V56, P465, DOI 10.1002/jemt.10060; Vigne E, 2003, GENE THER, V10, P153, DOI 10.1038/sj.gt.3301845; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Waszak P, 2007, MOL THER, V15, P2008, DOI 10.1038/sj.mt.6300254; WEBER J, 1969, CAN J MICROBIOL, V15, P841, DOI 10.1139/m69-150; WEBER J, 1978, CAN J MICROBIOL, V24, P1381, DOI 10.1139/m78-221; WILLS EJ, 1973, J GEN VIROL, V20, P407, DOI 10.1099/0022-1317-20-3-407; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; Zubieta C, 2006, FEBS J, V273, P4336, DOI 10.1111/j.1742-4658.2006.05430.x	73	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2894	10.1371/journal.pone.0002894	http://dx.doi.org/10.1371/journal.pone.0002894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682854	gold, Green Published, Green Accepted			2022-12-25	WOS:000264366600050
J	Ong, CT; Sedy, JR; Murphy, KM; Kopan, R				Ong, Chin-Tong; Sedy, John R.; Murphy, Kenneth M.; Kopan, Raphael			Notch and Presenilin Regulate Cellular Expansion and Cytokine Secretion but Cannot Instruct Th1/Th2 Fate Acquisition	PLOS ONE			English	Article								Recent reports suggested that Delta1, 4 and Jagged1, 2 possessed the ability to instruct CD4(+) T cell into selection of Th1 or Th2 fates, respectively, although the underlying mechanism endowing the cleaved Notch receptor with memory of ligand involved in its activation remains elusive. To examine this, we prepared artificial antigen-presenting cells expressing either DLL1 or Jag1. Although both ligands were efficient in inducing Notch2 cleavage and activation in CD4(+) T or reporter cells, the presence of Lunatic Fringe in CD4(+) T cells inhibited Jag1 activation of Notch1 receptor. Neither ligand could induce Th1 or Th2 fate choice independently of cytokines or redirect cytokine-driven Th1 or Th2 development. Instead, we find that Notch ligands only augment cytokine production during T cell differentiation in the presence of polarizing IL-12 and IL-4. Moreover, the differentiation choices of naive CD4(+) T cells lacking gamma-secretase, RBP-J, or both in response to polarizing cytokines revealed that neither presenilin proteins nor RBP-J were required for cytokine-induced Th1/Th2 fate selection. However, presenilins facilitate cellular proliferation and cytokine secretion in an RBP-J ( and thus, Notch) independent manner. The controversies surrounding the role of Notch and presenilins in Th1/Th2 polarization may reflect their role as genetic modifiers of T-helper cells differentiation.	[Ong, Chin-Tong; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Sedy, John R.; Murphy, Kenneth M.] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol, St Louis, MO USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO USA; [Kopan, Raphael] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Ong, CT (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA.	kmurphy@wustl.edu; kopan@beckermail.wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Ong, Chin-Tong/0000-0002-5450-4760; Kopan, Raphael/0000-0002-0350-2730; Sedy, John/0000-0002-6428-1054	National Institutes of Health [GM55479, HD044056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health GM55479 (R.K.) and HD044056 (C.T.O), and Howard Hughes Medical Institute (K.M.M. and J.R.S).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014; DE SB, 1999, NATURE, V398, P518; Dong C, 2003, IMMUNOL RES, V28, P39, DOI 10.1385/IR:28:1:39; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; GORDON WR, 2007, NAT STRUCT MOL BIOL; GRIDLEY T, 2007, DEVELOPMENT; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2006, CHEM IMMUNOL ALLERGY, V90, P65, DOI 10.1159/000088881; Khandelwal A, 2007, P NATL ACAD SCI USA, V104, P13337, DOI 10.1073/pnas.0702038104; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Minato Y, 2005, INT J HEMATOL, V82, P302, DOI 10.1532/IJH97.05095; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; O'Garra A, 2004, ADV IMMUNOL, V83, P133; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reinhardt RL, 2006, CURR OPIN IMMUNOL, V18, P271, DOI 10.1016/j.coi.2006.03.003; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas MD, 2006, CELL IMMUNOL, V239, P92, DOI 10.1016/j.cellimm.2006.04.007; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	95	76	78	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2823	10.1371/journal.pone.0002823	http://dx.doi.org/10.1371/journal.pone.0002823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665263	Green Published, gold			2022-12-25	WOS:000264304300042
J	Derangeon, M; Bourmeyster, N; Plaisance, I; Pinet-Charvet, C; Chen, Q; Duthe, F; Popoff, MR; Sarrouilhe, D; Herve, JC				Derangeon, Mickael; Bourmeyster, Nicolas; Plaisance, Isabelle; Pinet-Charvet, Caroline; Chen, Qian; Duthe, Fabien; Popoff, Michel R.; Sarrouilhe, Denis; Herve, Jean-Claude			RhoA GTPase and F-actin Dynamically Regulate the Permeability of Cx43-made Channels in Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; PROTEIN-KINASE; VENTRICULAR MYOCYTES; ZONULA OCCLUDENS-1; PLASMA-MEMBRANE; CULTURED ASTROCYTES; EPITHELIAL BARRIER; OSTEOBLASTIC CELLS; CA2+ CURRENT; CONNEXIN43	Gap junctions are clusters of transmembrane channels allowing a passive diffusion of ions and small molecules between adjacent cells. Connexin43, the main channel-forming protein expressed in ventricular myocytes, can associate with zonula occludens-1, a scaffolding protein linked to the actin cytoskeleton and to signal transduction molecules. The possible influence of Rho GTPases, major regulators of cellular junctions and of the actin cytoskeleton, in the modulation of gap junctional intercellular communication ( GJIC) was examined. The activation of RhoA by cytoxic necrotizing factor 1 markedly enhanced GJIC, whereas its specific inhibition by the Clostridium botulinum C3 exoenzyme significantly reduced it. RhoA activity affects GJIC without major cellular redistribution of junctional plaques or changes in the Cx43 phosphorylation pattern. As these GTPases frequently act via the cortical cytoskeleton, the importance of F-actin in the modulation of GJIC was investigated by means of agents interfering with actin polymerization. Cytoskeleton stabilization by phalloidin slowed down the kinetics of channel rundown in the absence of ATP, whereas its disruption by cytochalasin D rapidly and markedly reduced GJIC despite ATP presence. Cytoskeleton stabilization by phalloidin markedly reduced the consequences of RhoA activation or inactivation. This mechanism appears to be the first described capable to both up- or down-regulate GJIC through RhoA activation or, conversely, inhibition. The inhibition of Rho downstream kinase effectors had no effect on GJIC. The present results provide further insight into the gating and regulation of junctional channels and identify a new downstream target for the small G-protein RhoA.	[Derangeon, Mickael; Bourmeyster, Nicolas; Plaisance, Isabelle; Pinet-Charvet, Caroline; Chen, Qian; Duthe, Fabien; Sarrouilhe, Denis; Herve, Jean-Claude] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, UMR 6187, F-86022 Poitiers, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Herve, JC (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, UMR 6187, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Jean.Claude.Herve@univ-poitiers.fr	derangeon, mickael/D-3606-2015	pinet, caroline/0000-0002-8440-0292; Bourmeyster, Nicolas/0000-0002-9563-5142	European Community Research and Technological Development Action [QLG1-CT-1999-00516]	European Community Research and Technological Development Action	This work was supported in part by grants from the European Community Research and Technological Development Action QLG1-CT-1999-00516. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Barker RJ, 2001, CELL COMMUN ADHES, V8, P205, DOI 10.3109/15419060109080724; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOURMEYSTER N, 1992, BIOCHEMISTRY-US, V31, P12863, DOI 10.1021/bi00166a022; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Czyz J, 2005, INT J DEV BIOL, V49, P33, DOI 10.1387/ijdb.041835jc; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Deleze J, 2001, METH MOL B, V154, P313; DERANGEON M, 2007, ARCH MAL COEUR VAISS, V100, P313; Duthe F, 2001, AM J PHYSIOL-CELL PH, V281, pC1648, DOI 10.1152/ajpcell.2001.281.5.C1648; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Grounds HR, 2005, J CELL BIOCHEM, V95, P529, DOI 10.1002/jcb.20441; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Herve JC, 2006, PROG BIOPHYS MOL BIO, V90, P225, DOI 10.1016/j.pbiomolbio.2005.06.005; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; HUANG KP, 1982, J BIOL CHEM, V257, P3236; Hughes BA, 1998, AM J PHYSIOL-CELL PH, V275, pC1372, DOI 10.1152/ajpcell.1998.275.5.C1372; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kamouchi M, 1997, J PHYSIOL-LONDON, V504, P545, DOI 10.1111/j.1469-7793.1997.545bd.x; KANTER HL, 1992, CIRC RES, V70, P438, DOI 10.1161/01.RES.70.2.438; Kim JH, 2007, BIOCHEM BIOPH RES CO, V352, P503, DOI 10.1016/j.bbrc.2006.11.051; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laing JG, 2007, CARDIOVASC PATHOL, V16, P159, DOI 10.1016/j.carpath.2007.01.004; Laing JG, 2005, J CELL SCI, V118, P2167, DOI 10.1242/jcs.02329; Laing JG, 2001, J BIOL CHEM, V276, P23051, DOI 10.1074/jbc.M100303200; Lampe PD, 2001, AM J PHYSIOL-CELL PH, V281, pC1211, DOI 10.1152/ajpcell.2001.281.4.C1211; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Matsuda T, 2006, J MOL CELL CARDIOL, V40, P495, DOI 10.1016/j.yjmcc.2005.12.010; MCNICHOLAS CM, 1994, P NATL ACAD SCI USA, V91, P8077, DOI 10.1073/pnas.91.17.8077; Mironov SL, 1999, EUR J NEUROSCI, V11, P1831, DOI 10.1046/j.1460-9568.1999.00584.x; Nagy JI, 1997, EXP CELL RES, V236, P127, DOI 10.1006/excr.1997.3716; Piccoli G, 2004, J NEUROSCI, V24, P10918, DOI 10.1523/JNEUROSCI.4020-04.2004; Plaisance I, 2003, PFLUG ARCH EUR J PHY, V447, P181, DOI 10.1007/s00424-003-1158-0; Postma FR, 1998, J CELL BIOL, V140, P1199, DOI 10.1083/jcb.140.5.1199; Rajashree R, 2005, AM J PHYSIOL-HEART C, V289, pH1736, DOI 10.1152/ajpheart.00318.2004; Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x; Sarrouilhe D, 1998, BBA-MOL CELL RES, V1403, P199, DOI 10.1016/S0167-4889(98)00038-X; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shumilina EV, 2003, FEBS LETT, V547, P27, DOI 10.1016/S0014-5793(03)00663-X; SUGIURA H, 1990, CIRC RES, V66, P1095, DOI 10.1161/01.RES.66.4.1095; TADVALKAR G, 1983, J CELL BIOL, V96, P1279, DOI 10.1083/jcb.96.5.1279; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Verrecchia F, 1997, PFLUG ARCH EUR J PHY, V434, P113, DOI 10.1007/s004240050370; Verrecchia F, 1999, J PHYSIOL-LONDON, V516, P447, DOI 10.1111/j.1469-7793.1999.0447v.x; Verrecchia F, 1997, AM J PHYSIOL-CELL PH, V272, pC875, DOI 10.1152/ajpcell.1997.272.3.C875; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WANG YJ, 1995, J CELL SCI, V108, P3501; Wang ZR, 2004, AM J PHYSIOL-HEART C, V286, pH749, DOI 10.1152/ajpheart.00398.2003; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wherlock M, 2002, J CELL SCI, V115, P239; Yamane Y, 2002, NEUROSCIENCE, V112, P593, DOI 10.1016/S0306-4522(02)00095-7; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; ZANDOMENI R, 1984, J BIOL CHEM, V259, P4804; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhu C, 2005, MICROSC MICROANAL, V11, P244, DOI 10.1017/S143192760505049X	80	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30754	30765		10.1074/jbc.M801556200	http://dx.doi.org/10.1074/jbc.M801556200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18667438	Green Published, hybrid			2022-12-25	WOS:000260544800030
J	Klootwijk, RD; Savelkoul, PJM; Ciccone, C; Manoli, I; Caplen, NJ; Krasnewich, DM; Gahl, WA; Huizing, M				Klootwijk, Riko D.; Savelkoul, Paul J. M.; Ciccone, Carla; Manoli, Irini; Caplen, Natasha J.; Krasnewich, Donna M.; Gahl, William A.; Huizing, Marjan			Allele-specific silencing of the dominant disease allele in sialuria by RNA interference	FASEB JOURNAL			English	Article						real-time PCR; feedback inhibition; sialic acid; UDP-GlcNAc 2-epimerase/ManNAc kinase; siRNA; allosteric site	N-ACETYLGLUCOSAMINE 2-EPIMERASE; AMYOTROPHIC-LATERAL-SCLEROSIS; IN-VIVO; PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE; REGULATORY MUTATIONS; MOUSE MODEL; GENE; DELIVERY; SUPERACTIVITY; PURIFICATION	Dominant disease alleles are attractive therapeutic targets for allele-specific gene silencing by small interfering RNA ( siRNA). Sialuria is a dominant disorder caused by missense mutations in the allosteric site of GNE, coding for the rate-limiting enzyme of sialic acid biosynthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase. The resultant loss of feedback inhibition of GNE-epimerase activity by CMP-sialic acid causes excessive production of free sialic acid. For this study we employed synthetic siRNAs specifically targeting the dominant GNE mutation c. 797G > A (p.R266Q) in sialuria fibroblasts. We demonstrated successful siRNA-mediated down-regulation of the mutant allele by allele-specific real-time PCR. Importantly, mutant allele-specific silencing resulted in a significant decrease of free sialic acid, to within the normal range. Feedback inhibition of GNE-epimerase activity by CMP-sialic acid recovered after silencing demonstrating specificity of this effect. These findings indicate that allele-specific silencing of a mutated allele is a viable therapeutic strategy for autosomal dominant diseases, including sialuria.-Klootwijk, R. D., Savelkoul, P. J. M., Ciccone, C., Manoli, I., Caplen, N. J., Krasnewich, D. M., Gahl, W. A., Huizing, M. Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J. 22, 3846-3852 (2008)	[Klootwijk, Riko D.; Savelkoul, Paul J. M.; Ciccone, Carla; Manoli, Irini; Krasnewich, Donna M.; Gahl, William A.; Huizing, Marjan] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Caplen, Natasha J.] NCI, Gene Silencing Sect, Genet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Gahl, William A.] NIH, Off Rare Dis, Intramural Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Huizing, M (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1851, Bethesda, MD 20892 USA.	mhuizing@mail.nih.gov	Huizing, Marjan/AAR-8860-2020; Caplen, Natasha J/H-2768-2016	Caplen, Natasha J/0000-0002-0001-9460; Manoli, Irini/0000-0003-1543-2941	National Human Genome Research Institute; National Cancer Institute; National Institutes of Health, Bethesda, MD, USA; NATIONAL CANCER INSTITUTE [ZIABC010613, Z01BC010613] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIAHG200322, Z01HG200322] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Intramural Research programs of the National Human Genome Research Institute and the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.	Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Abdelgany A, 2003, HUM MOL GENET, V12, P2637, DOI 10.1093/hmg/ddg280; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; Birchall J, 2007, EXPERT OPIN DRUG DEL, V4, P575, DOI 10.1517/17425247.4.6.575; Cashman SM, 2005, GENE THER, V12, P1223, DOI 10.1038/sj.gt.3302512; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Enns GM, 2001, J INHERIT METAB DIS, V24, P328, DOI 10.1023/A:1010588115479; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; Ferreira H, 1999, MOL GENET METAB, V67, P131, DOI 10.1006/mgme.1999.2852; Gaither LA, 2007, EXPERT REV PROTEOMIC, V4, P411, DOI 10.1586/14789450.4.3.411; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Helip-Wooley Amanda, 2007, P499, DOI 10.1007/978-0-387-70909-3_31; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Huizing M., 2005, DRUG DISCOV TODAY DI, V2, P519, DOI [10.1016/j.ddmec.2005.11.003, DOI 10.1016/J.DDMEC.2005.11.003]; Kawasumi M, 2007, J INVEST DERMATOL, V127, P1577, DOI 10.1038/sj.jid.5700853; KRASNEWICH DM, 1993, BIOCHEM MED METAB B, V49, P90, DOI 10.1006/bmmb.1993.1010; Lemyre E, 1999, AM J MED GENET, V82, P385, DOI 10.1002/(SICI)1096-8628(19990219)82:5<385::AID-AJMG6>3.3.CO;2-V; Leroy JG, 2001, AM J HUM GENET, V68, P1419, DOI 10.1086/320598; Livak K. J., 1997, ABI PRISM 7700 SEQUE, V2; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1066, DOI 10.1152/ajplung.00067.2004; Maxwell MM, 2004, P NATL ACAD SCI USA, V101, P3178, DOI 10.1073/pnas.0308726100; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; MONTREUIL J, 1967, CR ACAD SCI D NAT, V265, P97; Nakai N, 2007, GENE THER, V14, P357, DOI 10.1038/sj.gt.3302868; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; SEPPALA R, 1991, J BIOL CHEM, V266, P7456; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sparks SE, 2005, GLYCOBIOLOGY, V15, P1102, DOI 10.1093/glycob/cwi100; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Suda T, 2003, INT J MOL MED, V12, P243; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WEISS P, 1989, J BIOL CHEM, V264, P17635; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019	43	13	13	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3846	3852		10.1096/fj.08-110890	http://dx.doi.org/10.1096/fj.08-110890			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18653764	Green Published			2022-12-25	WOS:000260503000013
J	Oudhoff, MJ; Bolscher, JGM; Nazmi, K; Kalay, H; van't Hof, W; Amerongen, AVN; Veerman, ECI				Oudhoff, Menno J.; Bolscher, Jan G. M.; Nazmi, Kamran; Kalay, Hakan; van't Hof, Wim; Amerongen, Arie V. Nieuw; Veerman, Enno C. I.			Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay	FASEB JOURNAL			English	Article						cell migration; ERK1/2; antimicrobial peptides; epithelial cells; Candida albicans	EPIDERMAL-GROWTH-FACTOR; ANTIMICROBIAL PEPTIDES; FACTOR RECEPTOR; ORAL KERATINOCYTES; SUBMAXILLARY GLAND; MIGRATION; MOUSE; LL-37; PROLIFERATION; ACTIVATION	Wounds in the oral cavity heal much faster than skin lesions. Among other factors, saliva is generally assumed to be of relevance to this feature. Rodent saliva contains large amounts of growth factors such as epidermal growth factor (EGF) and nerve growth factor (NGF). In humans, however, the identity of the involved compounds has remained elusive, especially since EGF and NGF concentrations are similar to 100,000 times lower than those in rodent saliva. Using an in vitro model for wound closure, we examined the properties of human saliva and the fractions that were obtained from saliva by high-performance liquid chromotography (HPLC) separation. We identified histatin 1 (Hst1) and histatin 2 (Hst2) as major wound-closing factors in human saliva. In contrast, the D-enantiomer of Hst2 did not induce wound closure, indicating stereospecific activation. Furthermore, histatins were actively internalized by epithelial cells and specifically used the extracellular signal-regulated kinases 1/2 (ERK1/2) pathway, thereby enhancing epithelial migration. This study demonstrates that members of the histatin family, which up to now were implicated in the antifungal weaponry of saliva, exert a novel function that likely is relevant for oral wound healing.-Oudhoff, M. J., Bolscher, J. G. M., Nazmi, K., Kalay, H., van 't Hof, W., Nieuw Amerongen, A. V., Veerman, E. C. I. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 22, 3805-3812 (2008)	[Oudhoff, Menno J.; Bolscher, Jan G. M.; Nazmi, Kamran; van't Hof, Wim; Amerongen, Arie V. Nieuw; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1081 BT Amsterdam, Netherlands; [Oudhoff, Menno J.; Bolscher, Jan G. M.; Nazmi, Kamran; van't Hof, Wim; Amerongen, Arie V. Nieuw; Veerman, Enno C. I.] Vrije Univ Amsterdam, Dept Oral Biochem, NL-1081 BT Amsterdam, Netherlands; [Kalay, Hakan] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Oudhoff, MJ (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	mj.oudhoff@vumc.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164; Oudhoff, Menno/0000-0002-1180-8975	VU Medical Center, Amsterdam, The Netherlands [U0126, SB203580]; Netherlands Institute for Dental Sciences (IOT)	VU Medical Center, Amsterdam, The Netherlands(Netherlands Government); Netherlands Institute for Dental Sciences (IOT)	We thank F. Faulhaber, T. Duin, and D. M. Pegtel for excellent technical assistance. We also thank S. I. Gringhuis (VU Medical Center, Amsterdam, The Netherlands) for the kind gift of the inhibitors U0126 and SB203580. This work was supported by the Netherlands Institute for Dental Sciences (IOT).	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; Bercier JG, 1999, J ORAL PATHOL MED, V28, P26, DOI 10.1111/j.1600-0714.1999.tb01990.x; BODNER L, 1993, ARCH ORAL BIOL, V38, P17, DOI 10.1016/0003-9969(93)90149-G; Bolscher JGM, 2006, PEPTIDES, V27, P1, DOI 10.1016/j.peptides.2005.06.012; COHEN S, 1963, J INVEST DERMATOL, V40, P1; COHEN S, 1962, J BIOL CHEM, V237, P1555; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Engeland CG, 2006, ARCH SURG-CHICAGO, V141, P1193, DOI 10.1001/archsurg.141.12.1193; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Groschl M, 2005, J MOL ENDOCRINOL, V34, P353, DOI 10.1677/jme.1.01658; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; HUTSON JM, 1979, NATURE, V279, P793, DOI 10.1038/279793a0; Jagla W, 1999, CELL TISSUE RES, V298, P161, DOI 10.1007/s004419900087; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KONTUREK SJ, 1988, GASTROENTEROLOGY, V94, P1300, DOI 10.1016/0016-5085(88)90667-1; MATTHAY MA, 1993, J CELL SCI, V106, P869; MURPHY RA, 1980, J HISTOCHEM CYTOCHEM, V28, P890, DOI 10.1177/28.8.6969274; Nam JW, 2007, ORAL DIS, V13, P187, DOI 10.1111/j.1601-0825.2006.01265.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Ohshima M, 2002, EUR J ORAL SCI, V110, P130, DOI 10.1034/j.1600-0722.2002.11179.x; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Storesund T, 2008, EUR J ORAL SCI, V116, P135, DOI 10.1111/j.1600-0722.2007.00516.x; THESLEFF I, 1988, LIFE SCI, V43, P13, DOI 10.1016/0024-3205(88)90231-7; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072; VANSETTEN GB, 1995, LARYNGOSCOPE, V105, P610, DOI 10.1288/00005537-199506000-00009; Veerman ECI, 1996, EUR J ORAL SCI, V104, P346, DOI 10.1111/j.1600-0722.1996.tb00090.x; Veerman ECI, 2007, J BIOL CHEM, V282, P18831, DOI 10.1074/jbc.M610555200; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301	36	154	159	2	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3805	3812		10.1096/fj.08-112003	http://dx.doi.org/10.1096/fj.08-112003			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18650243				2022-12-25	WOS:000260503000009
J	Exposito, JY; Larroux, C; Cluzel, C; Valcourt, U; Lethias, C; Degnan, BM				Exposito, Jean-Yves; Larroux, Claire; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire; Degnan, Bernard M.			Demosponge and sea anemone fibrillar collagen diversity reveals the early emergence of A/C clades and the maintenance of the modular structure of type V/XI collagens from sponge to human	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V COLLAGEN; SEQUENCE ALIGNMENT; GENE; VERTEBRATE; EVOLUTION; ORIGIN; EXPRESSION; INSIGHTS; GENOME; IDENTIFICATION	Collagens are often considered a metazoan hallmark, with the fibril-forming fibrillar collagens present from sponges to human. From evolutionary studies, three fibrillar collagen clades (named A, B, and C) have been defined and shown to be present in mammals, whereas the emergence of the A and B clades predates the protostome/deuterostome split. Moreover, several C clade fibrillar collagen chains are present in some invertebrate deuterostome genomes but not in protostomes whose genomes have been sequenced. The newly sequenced genomes of the choanoflagellate Monosiga brevicollis, the demosponge Amphimedon queenslandica, and the cnidarians Hydra magnipapillata (Hydra) and Nematostella vectensis (sea anemone) allow us to have a better understanding of the origin and evolution of fibrillar collagens. Analysis of these genomes suggests that an ancestral fibrillar collagen gene arose at the dawn of the Metazoa, before the divergence of sponge and eumetazoan lineages. The duplication events leading to the formation of the three fibrillar collagen clades (A, B, and C) occurred before the eumetazoan radiation. Interestingly, only the B clade fibrillar collagens preserved their characteristic modular structure from sponge to human. This observation is compatible with the suggested primordial function of type V/XI fibrillar collagens in the initiation of the formation of the collagen fibrils.	[Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] IBCP, CNRS, UMR 5086, F-69367 Lyon, France; [Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] Univ Lyon 1, IFR 128, F-69365 Lyon, France; [Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] Univ Lyon, Lyon, France; [Larroux, Claire; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Queensland	Exposito, JY (corresponding author), IBCP, CNRS, UMR 5086, 7 Passage Vercors, F-69367 Lyon, France.	jy.exposito@ibcp.fr	VALCOURT, Ulrich/ABB-3943-2021; Larroux, Claire/U-7981-2017	VALCOURT, Ulrich/0000-0002-1727-4409; Larroux, Claire/0000-0002-3503-4150; Degnan, Bernard/0000-0001-7573-8518; Cluzel, Caroline/0000-0001-8946-3439; Exposito, Jean-Yves/0000-0002-4926-4942				Aouacheria A, 2004, J BIOL CHEM, V279, P47711, DOI 10.1074/jbc.M408950200; Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cluzel C, 2004, J BIOL CHEM, V279, P9811, DOI 10.1074/jbc.M311803200; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; Exposito JY, 2000, MATRIX BIOL, V19, P275, DOI 10.1016/S0945-053X(00)00067-6; EXPOSITO JY, 1990, P NATL ACAD SCI USA, V87, P6669, DOI 10.1073/pnas.87.17.6669; EXPOSITO JY, 1993, J MOL EVOL, V37, P254, DOI 10.1007/BF00175502; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; OLSEN BR, 1982, NEW TRENDS BASEMENT, P225; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sicot FX, 1997, EUR J BIOCHEM, V246, P50, DOI 10.1111/j.1432-1033.1997.00050.x; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200	54	52	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28226	28235		10.1074/jbc.M804573200	http://dx.doi.org/10.1074/jbc.M804573200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697744	Green Published, hybrid			2022-12-25	WOS:000259969300024
J	Hasan, NM; Longacre, MJ; Stoker, SW; Boonsaen, T; Jitrapakdee, S; Kendrick, MA; Wallace, JC; MacDonald, MJ				Hasan, Noaman M.; Longacre, Melissa J.; Stoker, Scott W.; Boonsaen, Thirajit; Jitrapakdee, Sarawut; Kendrick, Mindy A.; Wallace, John C.; MacDonald, Michael J.			Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL PHOSPHATE DEHYDROGENASE; GLUCOSE-REGULATED ANAPLEROSIS; NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELL; ATP-CITRATE LYASE; MALIC ENZYME; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MITOCHONDRIAL METABOLISM; METHYL SUCCINATE; INS-1 CELLS	Anaplerosis, the synthesis of citric acid cycle intermediates, by pancreatic beta cell mitochondria has been proposed to be as important for insulin secretion as mitochondrial energy production. However, studies designed to lower the rate of anaplerosis in the beta cell have been inconclusive. To test the hypothesis that anaplerosis is important for insulin secretion, we lowered the activity of pyruvate carboxylase ( PC), the major enzyme of anaplerosis in the beta cell. Stable transfection of short hairpin RNA was used to generate a number of INS-1 832/13-derived cell lines with various levels of PC enzyme activity that retained normal levels of control enzymes, insulin content, and glucose oxidation. Glucose-induced insulin release was decreased in proportion to the decrease in PC activity. Insulin release in response to pyruvate alone, 2-aminobicyclo[ 2,2,1] heptane-2-carboxylic acid (BCH) plus glutamine, or methyl succinate plus beta-hydroxybutyrate was also decreased in the PC knockdown cells. Consistent with a block at PC, the most PC-deficient cells showed a metabolic crossover point at PC with increased basal and/or glucose-stimulated pyruvate plus lactate and decreased malate and citrate. In addition, in BCH plus glutamine-stimulated PC knockdown cells, pyruvate plus lactate was increased, whereas citrate was severely decreased, and malate and aspartate were slightly decreased. The incorporation of C-14 into lipid from [U-14C] glucose was decreased in the PC knockdown cells. The results confirm the central importance of PC and anaplerosis to generate metabolites from glucose that support insulin secretion and even suggest PC insulin secretion stimulated by noncarbohydrate insulin secretagogues.	[Hasan, Noaman M.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy A.; MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA; [Boonsaen, Thirajit; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Wisconsin System; University of Wisconsin Madison; Mahidol University; University of Adelaide	MacDonald, MJ (corresponding author), 3459 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	mjmacdon@wisc.edu	, John/AAP-5150-2020	MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Oscar C. Rennebohm Foundation; Faculty of Science, Mahidol University); Thailand Research Fund [4680002]; Australian Research Council [DP0346807]; medical scholar program (Mahidol University, Thailand); Department of Education, Science, and Training, Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK028348, R01DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oscar C. Rennebohm Foundation; Faculty of Science, Mahidol University); Thailand Research Fund(Thailand Research Fund (TRF)); Australian Research Council(Australian Research Council); medical scholar program (Mahidol University, Thailand); Department of Education, Science, and Training, Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by a grant from the Oscar C. Rennebohm Foundation (to M. J. M.); a Career Development Grant (Faculty of Science, Mahidol University) and Thailand Research Fund RSA Grant 4680002 ( to S. J.); and Australian Research Council Grant DP0346807 (to J. C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by an M. D./Ph. D. medical scholar program (Mahidol University, Thailand) and the Endeavour Asia-Australia postgraduate research fellowship from the Department of Education, Science, and Training, Australia.	Antinozzi PA, 2006, P NATL ACAD SCI USA, V103, P3698, DOI 10.1073/pnas.0510521103; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGMEYER HU, 1985, METHOD ENZYMAT AN, V7, P261; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; HEDESKOV CJ, 1984, BIOCHIM BIOPHYS ACTA, V791, P37, DOI 10.1016/0167-4838(84)90278-4; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 1998, J BIOL CHEM, V273, P34422, DOI 10.1074/jbc.273.51.34422; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; LOUIS NA, 1992, J BIOL CHEM, V267, P2287; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P118, DOI 10.1016/j.abb.2006.01.019; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2004, MOL CELL BIOCHEM, V258, P201, DOI 10.1023/B:MCBI.0000012856.31929.91; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1981, ENDOCRINOLOGY, V108, P1899, DOI 10.1210/endo-108-5-1899; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MACDONALD MJ, 1991, J BIOL CHEM, V266, P22392; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Samid D, 2000, CLIN CANCER RES, V6, P933; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Shack S, 1996, CLIN CANCER RES, V2, P865; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200	56	64	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28048	28059		10.1074/jbc.M804170200	http://dx.doi.org/10.1074/jbc.M804170200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697738	Green Published, hybrid			2022-12-25	WOS:000259969300006
J	Joshi, MC; Sharma, A; Kant, S; Birah, A; Gupta, GP; Khan, SR; Bhatnagar, R; Banerjee, N				Joshi, Mohan Chandra; Sharma, Animesh; Kant, Sashi; Birah, Ajanta; Gupta, Gorakh Prasad; Khan, Sharik R.; Bhatnagar, Rakesh; Banerjee, Nirupama			An insecticidal GroEL protein with chitin binding activity from Xenorhabdus nematophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; MOLECULAR-BIOLOGY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PILIN SUBUNIT; RECOGNITION; STABILITY; MEMBRANE; RESIDUES; GROWTH	Xenorhabdus nematophila secretes insecticidal proteins to kill its larval prey. We have isolated an similar to 58-kDa GroEL homolog, secreted in the culture medium through outer membrane vesicles. The protein was orally insecticidal to the major crop pest Helicoverpa armigera with an LC50 of similar to 3.6 mu g/g diet. For optimal insecticidal activity all three domains of the protein, apical, intermediate, and equatorial, were necessary. The apical domain alone was able to bind to the larval gut membranes and manifest low level insecticidal activity. At equimolar concentrations, the apical domain contained approximately one-third and the apical-intermediate domain approximately one-half bioactivity of that of the full-length protein. Interaction of the protein with the larval gut membrane was specifically inhibited by N-acetylglucosamine and chito-oligosaccharides. Treatment of the larval gut membranes with chitinase abolished protein binding. Based on the three-dimensional structural model, mutational analysis demonstrated that surface-exposed residues Thr-347 and Ser-356 in the apical domain were crucial for both binding to the gut epithelium and insecticidal activity. Double mutant T347A,S356A was 80% less toxic (p < 0.001) than the wild type protein. The GroEL homolog showed alpha-chitin binding activity with K-d similar to 0.64 mu M and B-max similar to 4.68 mu mol/g chitin. The variation in chitin binding activity of the mutant proteins was in good agreement with membrane binding characteristics and insecticidal activity. The less toxic double mutant XnGroEL showed an similar to 8-fold increase of K-d in chitin binding assay. Our results demonstrate that X. nematophila secretes an insecticidal GroEL protein with chitin binding activity.	[Joshi, Mohan Chandra; Kant, Sashi; Khan, Sharik R.; Banerjee, Nirupama] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Sharma, Animesh] Fuzzylife, Open Source Bioinformat Educ, New Delhi 110091, India; [Birah, Ajanta; Gupta, Gorakh Prasad] Indian Agr Res Inst, Div Entomol, New Delhi 110012, India; [Joshi, Mohan Chandra; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Jawaharlal Nehru University, New Delhi	Banerjee, N (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India.		Kant, Sashi/V-3864-2019	Kant, Sashi/0000-0002-9015-8383; Joshi, Mohan/0000-0002-1808-771X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Department of Biotechnology, Government of India. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akhurst R., 2012, PARASITES PATHOGENS, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bochkareva E, 1999, J BIOL CHEM, V274, P20756, DOI 10.1074/jbc.274.30.20756; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bonet J, 2006, PROTEINS, V63, P65, DOI 10.1002/prot.20791; Braig K, 1998, CURR OPIN STRUC BIOL, V8, P159, DOI 10.1016/S0959-440X(98)80033-X; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CIOFFI M, 1983, TISSUE CELL, V15, P781, DOI 10.1016/0040-8166(83)90050-2; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V829, P397, DOI 10.1016/0167-4838(85)90250-X; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Fares MA, 2002, MOL BIOL EVOL, V19, P1162, DOI 10.1093/oxfordjournals.molbev.a004174; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762, DOI 10.1128/JB.175.18.5762-5768.1993; Guo XF, 2002, J CARBOHYD CHEM, V21, P149, DOI 10.1081/CAR-120003746; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Khandelwal P, 2004, BIOCHEM BIOPH RES CO, V314, P943, DOI 10.1016/j.bbrc.2003.12.187; Khandelwal P, 2004, J BACTERIOL, V186, P6465, DOI 10.1128/JB.186.19.6465-6476.2004; Khandelwal P, 2003, APPL ENVIRON MICROB, V69, P2032, DOI 10.1128/AEM.69.4.2032-2037.2003; KONI PA, 1994, MICROBIOL-SGM, V140, P1869, DOI 10.1099/13500872-140-8-1869; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Ranford JC, 2002, J CLIN PATHOL-MOL PA, V55, P209, DOI 10.1136/mp.55.4.209; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; SIGLER PB, 1995, PHILOS T ROY SOC B, V348, P113, DOI 10.1098/rstb.1995.0052; Singh J, 1998, PROTEIN SCI, V7, P1124, DOI 10.1002/pro.5560070506; Surin AK, 1999, BIOORG KHIM+, V25, P358; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; WARD ES, 1988, J MOL BIOL, V202, P527, DOI 10.1016/0022-2836(88)90283-5; Yoshida N, 2001, NATURE, V411, P44, DOI 10.1038/35075148; Zeltins A, 1997, EUR J BIOCHEM, V246, P557, DOI 10.1111/j.1432-1033.1997.t01-1-00557.x; Zhang SX, 2007, J COMPUT AID MOL DES, V21, P97, DOI 10.1007/s10822-007-9102-6	46	38	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28287	28296		10.1074/jbc.M804416200	http://dx.doi.org/10.1074/jbc.M804416200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667427	Green Published, hybrid			2022-12-25	WOS:000259969300030
J	Joshi, P; Carrington, EA; Wang, L; Ketel, CS; Miller, EL; Jones, RS; Simon, JA				Joshi, Preeti; Carrington, Elizabeth A.; Wang, Liangjun; Ketel, Carrie S.; Miller, Ellen L.; Jones, Richard S.; Simon, Jeffrey A.			Dominant alleles identify SET domain residues required for histone methyltransferase of polycomb repressive complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROTEIN LYSINE METHYLTRANSFERASES; DROSOPHILA-MELANOGASTER; GROUP GENE; CHROMATIN-STRUCTURE; TARGET GENES; IN-VIVO; DEVELOPMENTAL REGULATORS; CAENORHABDITIS-ELEGANS; PRODUCT SPECIFICITY	Polycomb gene silencing requires histone methyltransferase activity of Polycomb repressive complex 2 (PRC2), which methylates lysine 27 of histone H3. Information on how PRC2 works is limited by lack of structural data on the catalytic subunit, Enhancer of zeste (E(Z)), and the paucity of E(z) mutant alleles that alter its SET domain. Here we analyze missense alleles of Drosophila E(z), selected for molecular study because of their dominant genetic effects. Four missense alleles identify key E(Z) SET domain residues, and a fifth is located in the adjacent CXC domain. Analysis of mutant PRC2 complexes in vitro, and H3-K27 methylation in vivo, shows that each SET domain mutation disrupts PRC2 histone methyltransferase. Based on known SET domain structures, the mutations likely affect either the lysine-substrate binding pocket, the binding site for the adenosylmethionine methyl donor, or a critical tyrosine predicted to interact with the substrate lysine epsilon-amino group. In contrast, the CXC mutant retains catalytic activity, Lys-27 specificity, and trimethylation capacity. Deletion analysis also reveals a functional requirement for a conserved E(Z) domain N-terminal to CXC and SET. These results identify critical SET domain residues needed for PRC2 enzyme function, and they also emphasize functional inputs from outside the SET domain.	[Carrington, Elizabeth A.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Joshi, Preeti; Wang, Liangjun; Ketel, Carrie S.; Miller, Ellen L.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Southern Methodist University; University of Minnesota System; University of Minnesota Twin Cities	Jones, RS (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	rjones@mail.smu.edu; simon004@umn.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to J. S. and R. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bajusz I, 2001, GENETICS, V159, P1135; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birve A, 2001, DEVELOPMENT, V128, P3371; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chen S, 2008, MOL GENET GENOMICS, V279, P159, DOI 10.1007/s00438-007-0304-3; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fanti L, 2008, CHROMOSOMA, V117, P25, DOI 10.1007/s00412-007-0123-7; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Holdeman R, 1998, DEVELOPMENT, V125, P2457; HULSKAMP M, 1991, BIOESSAYS, V13, P261, DOI 10.1002/bies.950130602; Jones CA, 1998, MOL CELL BIOL, V18, P2825, DOI 10.1128/MCB.18.5.2825; JONES RS, 1990, GENETICS, V126, P185; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; KALISCH WE, 1974, HEREDITAS, V78, P97; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PELEGRI F, 1994, GENETICS, V136, P1341; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; PHILLIPS MD, 1990, GENETICS, V125, P91; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1992, DEVELOPMENT, V114, P493; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tie F, 1998, DEVELOPMENT, V125, P3483; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; WU CT, 1989, MOL GEN GENET, V218, P559, DOI 10.1007/BF00332424; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu L, 2001, P NATL ACAD SCI USA, V98, P5061, DOI 10.1073/pnas.081016198; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	85	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27757	27766		10.1074/jbc.M804442200	http://dx.doi.org/10.1074/jbc.M804442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693240	Green Published, hybrid			2022-12-25	WOS:000259719200047
J	Rougemaille, M; Shankar, S; Braun, S; Rowley, M; Madhani, HD				Rougemaille, Mathieu; Shankar, Smita; Braun, Sigurd; Rowley, Margot; Madhani, Hiten D.			Ers1, a rapidly diverging protein essential for RNA interference-dependent heterochromatic silencing in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; RITS; LOCALIZATION; METHYLATION	Centromeric silencing and heterochromatin formation in Schizosaccharomyces pombe require the RNA interference (RNAi) machinery. Three factors that mediate this mechanism have been identified: 1) the RNA-dependent RNA polymerase complex RdRC, 2) the Argonaute-containing RITS (RNA-induced initiation of transcriptional silencing) complex, and 3) the endoribonuclease Dicer ortholog Dcr1. S. pombe mutants lacking a new factor described here, Ers1, are completely defective in RNAi-dependent silencing of centromeric regions but, importantly, not in RNAi-independent silencing at the mat3M or tel2R loci. ers1 Delta cells likewise fail to convert centromeric pre-small interfering RNA transcripts into small interfering RNAs, are defective in histone H3Lys(9) methylation, and are unable to recruit the RITS complex to centromeric sequences. Surprisingly, Ers1 lacks obvious orthologs outside of the genus Schizosaccharomyces. Within this group, it is diverging rapidly, raising the possibility that it is coevolving with target RNA elements.	[Rougemaille, Mathieu; Shankar, Smita; Braun, Sigurd; Rowley, Margot; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Braun, Sigurd/0000-0001-6399-8574; Rougemaille, Mathieu/0000-0002-9675-3888; Madhani, Hiten/0000-0001-7400-6657	National Institutes of Health [R01GM063670]; Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM063670 (to H. D. M.). This work was also supported by an Opportunity grant from the Sandler Foundation (to H. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; LUMBSCH HT, 2007, MYCONET, V13, P1403; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; UZAWA S, 1992, J CELL SCI, V101, P267; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	14	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25770	25773		10.1074/jbc.C800140200	http://dx.doi.org/10.1074/jbc.C800140200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658154	Green Published, hybrid			2022-12-25	WOS:000259200100002
J	Gounaris, E; Tung, CH; Restaino, C; Maehr, R; Kohler, R; Joyce, JA; Plough, HL; Barrett, TA; Weissleder, R; Khazaie, K				Gounaris, Elias; Tung, Ching H.; Restaino, Clifford; Maehr, Rene; Kohler, Rainer; Joyce, Johanna A.; Plough, Hidde L.; Barrett, Terrence A.; Weissleder, Ralph; Khazaie, Khashayarsha			Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth	PLOS ONE			English	Article							INTESTINAL ADENOMAS; TARGET; CANCER; APC; PROTEASES; MODELS; ROLES; CELLS	It has been estimated that up to 30% of detectable polyps in patients regress spontaneously. One major challenge in the evaluation of effective therapy of cancer is the readout for tumor regression and favorable biological response to therapy. Inducible near infra-red (NIR) fluorescent probes were utilized to visualize intestinal polyps of mice hemizygous for a novel truncation of the Adenomatous Polyposis coli (APC) gene. Laser Scanning Confocal Microscopy in live mice allowed visualization of cathepsin activity in richly vascularized benign dysplastic lesions. Using biotinylated suicide inhibitors we quantified increased activities of the Cathepsin B & Z in the polyps. More than 3/4 of the probe signal was localized in CD11b(+)Gr1(+) myeloid derived suppressor cells (MDSC) and CD11b(+)F4/80(+) macrophages infiltrating the lesions. Polyposis was attenuated through genetic ablation of cathepsin B, and suppressed by neutralization of TNF alpha in mice. In both cases, diminished probe signal was accounted for by loss of MDSC. Thus, in vivo NIR imaging of focal cathepsin activity reveals inflammatory reactions etiologically linked with cancer progression and is a suitable approach for monitoring response to therapy.	[Gounaris, Elias; Tung, Ching H.; Restaino, Clifford; Kohler, Rainer; Weissleder, Ralph; Khazaie, Khashayarsha] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Gounaris, Elias; Barrett, Terrence A.; Khazaie, Khashayarsha] Northwestern Univ, Robert Lurie Comprehensive Canc Ctr, Feinberg Sch Med, Div Gastroenterol, Chicago, IL USA; [Joyce, Johanna A.] Memorial Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY USA; [Plough, Hidde L.] MIT, Whitehead Inst, Cambridge, MA USA; [Tung, Ching H.] Weill Cornell Med Coll, Methodist Hosp Res Inst, Houston, TX USA; [Maehr, Rene] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Maehr, Rene] Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Harvard University; Howard Hughes Medical Institute	Gounaris, E (corresponding author), Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA.	khazaie@northwestern.edu	Gounaris, Elias/B-3184-2011; Tung, Ching-Hsuan/AHC-5070-2022; Tung, Ching-Hsuan/AIE-6009-2022	Tung, Ching-Hsuan/0000-0001-6648-6195; Tung, Ching-Hsuan/0000-0001-6648-6195; Gounaris, Elias/0000-0001-8679-9711; Barrett, Terrence/0000-0001-6428-3271; /0000-0003-0828-4143	NIH [R01 CA104547-03, R01-CA125162]; American Cancer Society [113422]; NATIONAL CANCER INSTITUTE [R01CA104547, R01CA125162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH R01 CA104547-03 (KK), and American Cancer Society Research Scholar Grant, 113422 RSG (KK), NIH R01-CA125162 (JAJ).	Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161; Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Bertagnolli MM, 1999, ANN NY ACAD SCI, V889, P32, DOI 10.1111/j.1749-6632.1999.tb08721.x; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Carothers AM, 2006, CANCER RES, V66, P6432, DOI 10.1158/0008-5472.CAN-06-0992; Chen Wei-Tsung, 2005, Mol Imaging, V4, P67; Choo-Kang BSW, 2005, TRENDS IMMUNOL, V26, P518, DOI 10.1016/j.it.2005.07.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; FUVONIC M, 2003, MOL IMAGING, V2, P350; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hang HC, 2006, ACS CHEM BIOL, V1, P713, DOI 10.1021/cb600431a; Jacoby RF, 1996, CANCER RES, V56, P710; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Tung CH, 2000, CANCER RES, V60, P4953; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463	32	91	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2916	10.1371/journal.pone.0002916	http://dx.doi.org/10.1371/journal.pone.0002916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698347	Green Published, gold			2022-12-25	WOS:000264412600004
J	Mardulyn, P; Vaesen, MA; Milinkovitch, MC				Mardulyn, Patrick; Vaesen, Marie-Anne; Milinkovitch, Michel C.			Controlling Population Evolution in the Laboratory to Evaluate Methods of Historical Inference	PLOS ONE			English	Article							MIGRATION RATES; CONSERVATION GENETICS; MAXIMUM-LIKELIHOOD; SIZE; POLYMORPHISM; PERFORMANCE; BOTTLENECKS; DROSOPHILA; EXPANSION; FLOW	Natural populations of known detailed past demographic history are extremely valuable to evaluate methods of historical inference, yet are extremely rare. As an alternative approach, we have generated multiple replicate microsatellite data sets from laboratory-cultured populations of a gonochoric free-living nematode, Caenorhabditis remanei, that were constrained to pre-defined demographic histories featuring different levels of migration among populations or bottleneck events of different magnitudes. These data sets were then used to evaluate the performances of two recently developed population genetics methods, BAYESASS+, that estimates recent migration rates among populations, and BOTTLENECK, that detects the occurrence of recent bottlenecks. Migration rates inferred by BAYESASS+ were generally over-estimates, although these were often included within the confidence interval. Analyses of data sets simulated in-silico, using a model mimicking the laboratory experiments, produced less biased estimates of the migration rates, and showed increased efficiency of the program when the number of loci and sampled genotypes per population was higher. In the replicates for which the prebottleneck laboratory-cultured populations did not significantly depart from a mutation/drift equilibrium, an important assumption of the program BOTTLENECK, only a portion of the bottleneck events were detected. This result was confirmed by in-silico simulations mirroring the laboratory bottleneck experiments. More generally, our study demonstrates the feasibility, and highlights some of the limits, of the approach that consists in generating molecular genetic data sets by controlling the evolution of laboratory-reared nematode populations, for the purpose of validating methods inferring population history.	[Mardulyn, Patrick; Vaesen, Marie-Anne; Milinkovitch, Michel C.] Free Univ Brussels, Lab Evolutionary Genet, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Mardulyn, P (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	pmarduly@ulb.ac.be		Milinkovitch, Michel/0000-0002-2553-0724				Abdo ZAID, 2004, MOL ECOL, V13, P837, DOI 10.1111/j.1365-294X.2004.02132.x; BAIRD SE, 1992, EVOLUTION, V46, P585, DOI [10.2307/2409629, 10.1111/j.1558-5646.1992.tb02067.x]; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2002, GENETICS, V162, P2025; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Caldicott IM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P398; Cornuet JM, 1996, GENETICS, V144, P2001; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Frankham R, 1999, HEREDITAS, V130, P195, DOI 10.1111/j.1601-5223.1999.00195.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Graustein A, 2002, GENETICS, V161, P99; Hahn MW, 2002, GENETICS, V161, P11; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Nei M., 1987, MOL EVOLUTIONARY GEN; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Wang JL, 2003, GENETICS, V163, P429; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; WOODWORTH LM, 1994, MOL ECOL, V3, P393, DOI 10.1111/j.1365-294X.1994.tb00079.x; Wright S, 1931, GENETICS, V16, P0097	34	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2960	10.1371/journal.pone.0002960	http://dx.doi.org/10.1371/journal.pone.0002960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698364	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600045
J	Neena, J; Rachel, J; Praveen, V; Murthy, GVS				Neena, John; Rachel, Jose; Praveen, Vashist; Murthy, Gudlavalleti V. S.		RAAB India Study Grp	Rapid Assessment of Avoidable Blindness in India	PLOS ONE			English	Article							CATARACT BLINDNESS; EYE SURVEY; VISUAL IMPAIRMENT; VISION IMPAIRMENT; OLDER ADULTS; DISTRICT; POPULATION; PREVALENCE	Background: Rapid assessment of avoidable blindness provides valid estimates in a short period of time to assess the magnitude and causes of avoidable blindness. The study determined magnitude and causes of avoidable blindness in India in 2007 among the 50+ population. Methods and Findings: Sixteen randomly selected districts where blindness surveys were undertaken 7 to 10 years earlier were identified for a follow up survey. Stratified cluster sampling was used and 25 clusters (20 rural and 5 urban) were randomly picked in each district.. After a random start, 100 individuals aged 50+ were enumerated and examined sequentially in each cluster. All those with presenting vision <6/18 were dilated and examined by an ophthalmologist. 42722 individuals aged >=50 years were enumerated, and 94.7% examined. Based on presenting vision,, 4.4% (95% Confidence Interval[CI]: 4.1,4.8) were severely visually impaired (vision <6/60 to 3/60 in the better eye) and 3.6% (95% CI: 3.3,3.9) were blind (vision<3/60 in the better eye). Prevalence of low vision (< 6/18 to 6/60 in the better eye) was 16.8% (95% CI: 16.0,17.5). Prevalence of blindness and severe visual impairment (<6/60 in the better eye) was higher among rural residents (8.2%; 95% CI: 7.9,8.6) compared to urban (7.1%; 95% CI: 5.0, 9.2), among females (9.2%; 95% CI: 8.6,9.8) compared to males (6.5%; 95% CI: 6.0,7.1) and people above 70 years (20.6%; 95% CI: 19.1,22.0) compared to people aged 50-54 years (1.3%; 95% CI: 1.1,1.6). Of all blindness, 88.2% was avoidable. of which 81.9% was due to cataract and 7.1% to uncorrected refractive errors/uncorrected aphakia. Conclusions: Cataract and refractive errors are major causes of blindness and low vision and control strategies should prioritize them. Most blindness and low vision burden is avoidable.	[Neena, John; Praveen, Vashist; Murthy, Gudlavalleti V. S.] All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, Community Ophthalmol Unit, New Delhi, India; [Rachel, Jose] Gov India, Minist Hlth & Family Welfare, Hlth Serv, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Neena, J (corresponding author), All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, Community Ophthalmol Unit, New Delhi, India.	gvsmurthy2000@yahoo.com			National Programme for Control of Blindness; Ministry of Health and Family Welfare; Government of India	National Programme for Control of Blindness; Ministry of Health and Family Welfare; Government of India	The survey was funded by the National Programme for Control of Blindness, Ministry of Health and Family Welfare, Government of India.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; [Anonymous], 1998, Health Millions, V24, P20; Bachani D, 2000, Indian J Public Health, V44, P82; BANTHIA JK, 2004, CENSUS INDIA 2001 FI; Beltranena F, 2007, OPHTHALMOLOGY, V114, P1558, DOI 10.1016/j.ophtha.2006.11.015; Chandrashekhar TS, 2007, TROP DOCT, V37, P18, DOI 10.1258/004947507779952113; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Jose R, 1995, Indian J Ophthalmol, V43, P35; Kuper Hannah, 2006, Community Eye Health, V19, P68; Kuper H, 2006, PLOS MED, V3, P2192, DOI 10.1371/journal.pmed.0030476; Limburg H, 1998, Ophthalmic Epidemiol, V5, P211, DOI 10.1076/opep.5.4.211.4193; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Limburg Hans, 1996, Indian Journal of Ophthalmology, V44, P241; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; MOHAN M, 1987, COLLABORATIVE STUDY; Mohan M., 1989, NATL SURVEY BLINDNES; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Prakash Indira Jai, 2003, J Aging Soc Policy, V15, P85, DOI 10.1300/J031v15n02_06; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Thulasiraj RD, 2003, OPHTHALMOLOGY, V110, P1491, DOI 10.1016/S0161-6420(03)00565-7; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P299, DOI 10.1076/opep.9.5.299.10334; Venkata G, 2005, BRIT J OPHTHALMOL, V89, P257, DOI 10.1136/bjo.2004.056937; Vijaya L, 2006, BRIT J OPHTHALMOL, V90, P407, DOI 10.1136/bjo.2005.081406; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu Min, 2007, Community Eye Health, V20, P10	32	113	113	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2867	10.1371/journal.pone.0002867	http://dx.doi.org/10.1371/journal.pone.0002867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682738	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000264366600023
J	Phiri, KS; Calis, JCJ; Faragher, B; Nkhoma, E; Ng'oma, K; Mangochi, B; Molyneux, ME; van Hensbroek, MB				Phiri, Kamija S.; Calis, Job C. J.; Faragher, Brian; Nkhoma, Ernest; Ng'oma, Kondwani; Mangochi, Bridget; Molyneux, Malcolm E.; van Hensbroek, Michael Boele			Long Term Outcome of Severe Anaemia in Malawian Children	PLOS ONE			English	Article								Background: Severe anaemia is a common, frequently fatal, condition in African children admitted to hospital, but its long term outcome is unknown. Early reports that survivors may be at risk of additional late morbidity and mortality may have significant implications for child survival in Africa. We assessed the short and long term outcome of severe anaemia in Malawian children and identified potential risk factors for death and further severe anaemia. Methodology and Findings: For 18 months, we followed up children (6-60 months old) presenting to hospital with severe anaemia (haemoglobin <= 5g/dl) and their hospital and community controls with the aim to compare all cause mortality and severe anaemia recurrence rates between the groups, and to identify risk factors for these adverse outcomes. A total of 377 cases, 377 hospital controls and 380 community controls were recruited. Among cases, the in-hospital mortality was 6.4% and post-discharge all cause mortality was 12.6%, which was significantly greater than in hospital controls (2.9%) or community controls (1.4%) (Log rank test, p<0.001). The incidence of recurrence of severe anaemia among the cases was 0.102 per child-year (95% Confidence Interval 0.075-0.138), and was significantly higher than the 0.007 per child-year (95% CI 0.003-0.015) in the combined controls (p<0.0001). HIV was the most important risk factor both for post-discharge mortality (Hazard Ratio 10.5, 95% CI 4.0-27.2) and for recurrence of severe anaemia (HR 5.6, 95% CI 1.6-20.1). Conclusions: Severe anaemia carries a high 'hidden' morbidity and mortality occurring in the months after initial diagnosis and treatment. Because severe anaemia is very common, this is likely to contribute importantly to overall under-five mortality. If not adequately addressed, severe anaemia may be an obstacle to achievement of the Millennium development goal No. 4 on child survival. Strategies to diagnose and properly treat HIV infected children early most likely will reduce the high post-discharge mortality in severe anaemia.	[Phiri, Kamija S.; Calis, Job C. J.; Nkhoma, Ernest; Ng'oma, Kondwani; Mangochi, Bridget; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Calis, Job C. J.; van Hensbroek, Michael Boele] Univ Amsterdam, Emma Childrens Hosp AMC, Amsterdam, Netherlands; [Faragher, Brian; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine	Phiri, KS (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kamijaphiri@gmail.com		Phiri, Kamija/0000-0003-1753-2727; Boele van Hensbroek, Michael/0000-0003-1907-5427	Wellcome Trust [064772]; Numico and Ter Meulen foundation; Gates Malaria Partnership	Wellcome Trust(Wellcome TrustEuropean Commission); Numico and Ter Meulen foundation(Danone NutriciaRoyal Numico N.V.); Gates Malaria Partnership	The study was supported by a grant from the Wellcome Trust (Career Development Fellowship 064772 to Dr M. Boele van Hensbroek). There were further contributions from Numico and Ter Meulen foundation (for J. Calis) and Gates Malaria Partnership (for K. Phiri). The sponsor of the study had no role in the study design, data collection, data analysis, data interpretations, or writing of this report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Bojang KA, 1997, T ROY SOC TROP MED H, V91, P557, DOI 10.1016/S0035-9203(97)90025-0; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee, 2008, AIDS, V22, P97; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-128; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; PHILLIPS J, 1998, PAEDIAT HDB MALAWI; PHIRI KS, 2006, THESIS U LIVERPOOL L; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; World Health Organization, 2001, IR DEF ASS PREV CONT	27	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2903	10.1371/journal.pone.0002903	http://dx.doi.org/10.1371/journal.pone.0002903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682797	Green Submitted, gold, Green Published			2022-12-25	WOS:000264366600059
J	Trouw, LA; Okroj, M; Kupreishvili, K; Landberg, G; Johansson, B; Niessen, HWM; Blom, AM				Trouw, Leendert A.; Okroj, Marcin; Kupreishvili, Koba; Landberg, Goeran; Johansson, Bengt; Niessen, Hans W. M.; Blom, Anna M.			C4b-Binding Protein Is Present in Affected Areas of Myocardial Infarction during the Acute Inflammatory Phase and Covers a Larger Area than C3	PLOS ONE			English	Article								Background: During myocardial infarction reduced blood flow in the heart muscle results in cell death. These dying/dead cells have been reported to bind several plasma proteins such as IgM and C-reactive protein (CRP). In the present study we investigated whether fluid-phase complement inhibitor C4b-binding protein (C4BP) would also bind to the infarcted heart tissue. Methods and Findings: Initial studies using immunohistochemistry on tissue arrays for several cardiovascular disorders indicated that C4BP can be found in heart tissue in several cardiac diseases but that it is most abundantly found in acute myocardial infarction (AMI). This condition was studied in more detail by analyzing the time window and extent of C4BP positivity. The binding of C4BP correlates to the same locations as C3b, a marker known to correlate to the patterns of IgM and CRP staining. Based on criteria that describe the time after infarction we were able to pinpoint that C4BP binding is a relatively early marker of tissue damage in myocardial infarction with a peak of binding between 12 hours and 5 days subsequent to AMI, the phase in which infiltration of neutrophilic granulocytes in the heart is the most extensive. Conclusions: C4BP, an important fluid-phase inhibitor of the classical and lectin pathway of complement activation binds to jeopardized cardiomyocytes early after AMI and co-localizes to other well known markers such as C3b.	[Trouw, Leendert A.; Okroj, Marcin; Blom, Anna M.] Lund Univ, Dept Lab Med Med Protein Chem, Malmo, Sweden; [Kupreishvili, Koba; Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands; [Landberg, Goeran] Lund Univ, Dept Pathol, Malmo, Sweden; [Johansson, Bengt] Umea Univ, Norrlands Univ Hosp, Dept Cardiol, Umea, Sweden; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	Lund University; Vrije Universiteit Amsterdam; Lund University; Umea University; Vrije Universiteit Amsterdam	Trouw, LA (corresponding author), Lund Univ, Dept Lab Med Med Protein Chem, Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Trouw, Leendert/AGK-5202-2022	Blom, Anna/0000-0002-1348-1734; Trouw, Leendert/0000-0001-5186-2290; Niessen, Hans/0000-0001-9404-9822	Foundations of Tore Nilsson; Royal Physiographic Society in Lund; Swedish Foundation for Strategic Research (INGVAR); Swedish Research Council; Foundations of Kock; US Immunodeficiency Network; Cancerfonden; University Hospital in Malmo; Wenner-Gren Foundation; Anna-Greta Crafoord Foundation; NWO	Foundations of Tore Nilsson; Royal Physiographic Society in Lund; Swedish Foundation for Strategic Research (INGVAR)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Kock; US Immunodeficiency Network; Cancerfonden(Swedish Cancer Society); University Hospital in Malmo; Wenner-Gren Foundation; Anna-Greta Crafoord Foundation; NWO(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge the financial support of Foundations of Tore Nilsson and the Royal Physiographic Society in Lund (L.T.), Swedish Foundation for Strategic Research (INGVAR), Swedish Research Council and Foundations of Kock, ysterlund, King Gustav V's 80th anniversary, US Immunodeficiency Network, Cancerfonden and a research grant from the University Hospital in Malmo (A.B.), LT was a recipient of postdoctoral stipends from foundations of Wenner-Gren, and Anna-Greta Crafoord and is currently supported by a NWO Zon-MW VENI-grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; ENTMAN ML, 1991, FASEB J, V5, P2529, DOI 10.1096/fasebj.5.11.1868978; FARB A, 1993, J AM COLL CARDIOL, V21, P1245, DOI 10.1016/0735-1097(93)90253-W; Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134; JIANG H, 1992, J EXP MED, V175, P1373, DOI 10.1084/jem.175.5.1373; Krijnen PAJ, 2005, J CLIN PATHOL, V58, P382, DOI 10.1136/jcp.2004.022988; Krijnen PAJ, 2002, J CLIN PATHOL, V55, P801, DOI 10.1136/jcp.55.11.801; Krijnen Paul A. J., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P113; Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Niessen HWM, 1999, CARDIOVASC RES, V41, P603, DOI 10.1016/S0008-6363(98)00236-3; Nijmeijer R, 2003, AM J PATHOL, V163, P269, DOI 10.1016/S0002-9440(10)63650-4; Nijmeijer R, 2003, AM J PHYSIOL-HEART C, V285, pH2218, DOI 10.1152/ajpheart.00887.2002; Nijmeijer R, 2001, INT IMMUNOPHARMACOL, V1, P403, DOI 10.1016/S1567-5769(00)00044-8; Oksjoki R, 2003, ARTERIOSCL THROM VAS, V23, P630, DOI 10.1161/01.ATV.0000057808.91263.A4; Oksjoki R, 2007, ATHEROSCLEROSIS, V192, P40, DOI 10.1016/j.atherosclerosis.2006.06.013; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Saraste A, 1997, CIRCULATION, V95, P320; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Webb JH, 2003, BLOOD COAGUL FIBRIN, V14, P355, DOI 10.1097/00001721-200306000-00006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Wolbink GJ, 1998, J INFECT DIS, V177, P81, DOI 10.1086/513803; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2886	10.1371/journal.pone.0002886	http://dx.doi.org/10.1371/journal.pone.0002886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682851	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600042
J	Wahls, WP; Siegel, ER; Davidson, MK				Wahls, Wayne P.; Siegel, Eric R.; Davidson, Mari K.			Meiotic Recombination Hotspots of Fission Yeast Are Directed to Loci that Express Non-Coding RNA	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOT-SPOT; BINDING PROTEIN; HIS4 LOCUS; HYPERSENSITIVE SITES; DNA REVEALS; ADE6 GENE; R-LOOPS; MEIOSIS; TRANSCRIPTION	Background: Polyadenylated, mRNA-like transcripts with no coding potential are abundant in eukaryotes, but the functions of these long non-coding RNAs (ncRNAs) are enigmatic. In meiosis, Rec12 (Spo11) catalyzes the formation of dsDNA breaks (DSBs) that initiate homologous recombination. Most meiotic recombination is positioned at hotspots, but knowledge of the mechanisms is nebulous. In the fission yeast genome DSBs are located within 194 prominent peaks separated on average by 65-kbp intervals of DNA that are largely free of DSBs. Methodology/Principal Findings: We compared the genome-wide distribution of DSB peaks to that of polyadenylated ncRNA molecules of the prl class. DSB peaks map to ncRNA loci that may be situated within ORFs, near the boundaries of ORFs and intergenic regions, or most often within intergenic regions. Unconditional statistical tests revealed that this colocalization is non-random and robust (P <= 5.5x18(-8)). Furthermore, we tested and rejected the hypothesis that the ncRNA loci and DSB peaks localize preferentially, but independently, to a third entity on the chromosomes. Conclusions/Significance: Meiotic DSB hotspots are directed to loci that express polyadenylated ncRNAs. This reveals an unexpected, possibly unitary mechanism for what directs meiotic recombination to hotspots. It also reveals a likely biological function for enigmatic ncRNAs. We propose specific mechanisms by which ncRNA molecules, or some aspect of RNA metabolism associated with ncRNA loci, help to position recombination protein complexes at DSB hotspots within chromosomes.	[Wahls, Wayne P.; Davidson, Mari K.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Wahls, WP (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	wahlswaynep@uams.edu		Siegel, Eric/0000-0001-9824-6612	National Institute of General Medical Sciences [GM81766]; National Institute of Environmental Health Sciences [ES13787]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081766] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support provided by the National Institute of General Medical Sciences (GM81766 to WPW) and National Institute of Environmental Health Sciences (ES13787 to MKD). The sponsors had no role in the design and conduct of the study.	Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cho YS, 2005, BIOL REPROD, V73, P840, DOI 10.1095/biolreprod.105.042788; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Gao J, 2008, NUCLEIC ACIDS RES, V36, P2838, DOI 10.1093/nar/gkn037; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; GRIMM C, 1991, MOL CELL BIOL, V11, P289, DOI 10.1128/MCB.11.1.289; GROMIE GA, 2007, PLOS GENET, V3, pE141; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Jolivet S, 2006, GENES CELLS, V11, P615, DOI 10.1111/j.1365-2443.2006.00972.x; Kasama T, 2006, EUKARYOT CELL, V5, P1301, DOI 10.1128/EC.00099-06; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maleki S, 2004, CELL, V118, P404, DOI 10.1016/j.cell.2004.08.008; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Mizuno K, 1996, MAMM GENOME, V7, P490, DOI 10.1007/s003359900149; Molnar M, 2001, GENETICS, V157, P519; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Nilsen TW, 2007, MOL CELL, V28, P715, DOI 10.1016/j.molcel.2007.11.017; Nishant KT, 2006, BIOESSAYS, V28, P45, DOI 10.1002/bies.20349; Nishant KT, 2004, MOL CELL BIOL, V24, P5620, DOI 10.1128/MCB.24.12.5620-5634.2004; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; SCHAR P, 1994, EMBO J, V13, P5212, DOI 10.1002/j.1460-2075.1994.tb06852.x; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; Watanabe T, 2002, DNA RES, V9, P209, DOI 10.1093/dnares/9.6.209; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; WHITE MA, 1991, P NATL ACAD SCI USA, V88, P9755, DOI 10.1073/pnas.88.21.9755; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZAHNZABAL M, 1995, GENETICS, V140, P469	55	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2887	10.1371/journal.pone.0002887	http://dx.doi.org/10.1371/journal.pone.0002887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682829	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600043
J	Diekmann, K; Hodkinson, TR; Fricke, E; Barth, S				Diekmann, Kerstin; Hodkinson, Trevor R.; Fricke, Evelyn; Barth, Susanne			An Optimized Chloroplast DNA Extraction Protocol for Grasses (Poaceae) Proves Suitable for Whole Plastid Genome Sequencing and SNP Detection	PLOS ONE			English	Article							RESISTANCE; EVOLUTIONARY; DIVERSITY	Background: Obtaining chloroplast genome sequences is important to increase the knowledge about the fundamental biology of plastids, to understand evolutionary and ecological processes in the evolution of plants, to develop biotechnological applications (e.g. plastid engineering) and to improve the efficiency of breeding schemes. Extraction of pure chloroplast DNA is required for efficient sequencing of chloroplast genomes. Unfortunately, most protocols for extracting chloroplast DNA were developed for eudicots and do not produce sufficiently pure yields for a shotgun sequencing approach of whole plastid genomes from the monocot grasses. Methodology/Principal Findings: We have developed a simple and inexpensive method to obtain chloroplast DNA from grass species by modifying and extending protocols optimized for the use in eudicots. Many protocols for extracting chloroplast DNA require an ultracentrifugation step to efficiently separate chloroplast DNA from nuclear DNA. The developed method uses two more centrifugation steps than previously reported protocols and does not require an ultracentrifuge. Conclusions/Significance: The described method delivered chloroplast DNA of very high quality from two grass species belonging to highly different taxonomic subfamilies within the grass family (Lolium perenne, Pooideae; Miscanthus x giganteus, Panicoideae). The DNA from Lolium perenne was used for whole chloroplast genome sequencing and detection of SNPs. The sequence is publicly available on EMBL/GenBank.	[Diekmann, Kerstin; Fricke, Evelyn; Barth, Susanne] Teagasc Crops Res Ctr, Carlow, Ireland; [Diekmann, Kerstin; Hodkinson, Trevor R.] Univ Dublin, Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland	Teagasc; Trinity College Dublin	Diekmann, K (corresponding author), Teagasc Crops Res Ctr, Carlow, Ireland.	susanne.barth@teagasc.ie	Barth, Susanne/P-3366-2014; Hodkinson, Trevor/F-6850-2014	Barth, Susanne/0000-0002-4104-5964; Hodkinson, Trevor/0000-0003-1384-7270	Teagasc Walsh Fellowship Schema; Teagasc Vision programme	Teagasc Walsh Fellowship Schema; Teagasc Vision programme	KD was financed under the Teagasc Walsh Fellowship Schema. Project funding was obtained from the Teagasc Vision programme.	BOFFEY SA, 1982, PLANT PHYSIOL, V69, P1387, DOI 10.1104/pp.69.6.1387; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chung SM, 2007, GENOME, V50, P215, DOI 10.1139/G07-003; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Gray JC, 2005, ANNU PLANT REV, V13, P237; GRAY MW, 2004, MOL BIOL BIOTECHNOLO, P87; HALLDEN C, 1993, PLANT BREEDING, V111, P185, DOI 10.1111/j.1439-0523.1993.tb00628.x; Hodkinson TR, 2007, SYST ASSOC SPEC VOL, V72, P275; Hodkinson TR, 2007, J PLANT RES, V120, P17, DOI 10.1007/s10265-006-0059-7; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Khan MS, 1999, NAT BIOTECHNOL, V17, P910, DOI 10.1038/12907; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Lee SJ, 2006, NEPHROL DIAL TRANSPL, V21, P3; MARGULIS L, 1970, P349; McGrath S, 2007, HEREDITY, V99, P531, DOI 10.1038/sj.hdy.6801030; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; SANDBRINK JM, 1989, BIOCHEM SYST ECOL, V17, P45, DOI 10.1016/0305-1978(89)90041-0; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6	24	40	106	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2813	10.1371/journal.pone.0002813	http://dx.doi.org/10.1371/journal.pone.0002813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665252	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300032
J	Dubbelink, KTEO; Felius, A; Verbunt, JPA; van Dijk, BW; Berendse, HW; Stam, CJ; de Waal, HAV				Dubbelink, Kim T. E. Olde; Felius, Abraham; Verbunt, Jeroen P. A.; van Dijk, Bob W.; Berendse, Henk W.; Stam, Cornelis J.; Delemarre-van de Waal, Henriette A.			Increased Resting-State Functional Connectivity in Obese Adolescents; A Magnetoencephalographic Pilot Study	PLOS ONE			English	Article							BODY-MASS INDEX; GENERALIZED SYNCHRONIZATION; LABILE BRAIN; FOLLOW-UP; RISK; OVERWEIGHT; EEG; TRANSIENTS; LIKELIHOOD; ADIPOSITY	Background: Obesity is not only associated with metabolic abnormalities, but also with cognitive dysfunction and changes in the central nervous system. The present pilot study was carried out to investigate functional connectivity in obese and non-obese adolescents using magnetoencephalography (MEG). Methodology/Principal Findings: Magnetoencephalographic recordings were performed in 11 obese (mean BMI 38.8 +/- 4.6 kg/m(2)) and 8 lean ( mean BMI 21.0 +/- 1.5 kg/m(2)) female adolescents (age 12-19 years) during an eyes-closed resting-state condition. From these recordings, the synchronization likelihood (SL), a common method that estimates both linear and non-linear interdependencies between MEG signals, was calculated within and between brain regions, and within standard frequency bands (delta, theta, alpha1, alpha2, beta and gamma). The obese adolescents had increased synchronization in delta (0.5-4 Hz) and beta (13-30 Hz) frequency bands compared to lean controls (P-delta (total) = 0.001; P-beta (total) = 0.002). Conclusions/Significance: This study identified increased resting-state functional connectivity in severe obese adolescents. Considering the importance of functional coupling between brain areas for cognitive functioning, the present findings strengthen the hypothesis that obesity may have a major impact on human brain function. The cause of the observed excessive synchronization is unknown, but might be related to disturbed motivational pathways, the recently demonstrated increase in white matter volume in obese subjects or altered metabolic processes like hyperinsulinemia. The question arises whether the changes in brain structure and communication are a dynamic process due to weight gain and whether these effects are reversible or not.	[Dubbelink, Kim T. E. Olde; Felius, Abraham; Delemarre-van de Waal, Henriette A.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat Endocrinol, Amsterdam, Netherlands; [Verbunt, Jeroen P. A.; van Dijk, Bob W.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [Dubbelink, Kim T. E. Olde; Berendse, Henk W.; Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Inst Clin & Expt Neurosci, Dept Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Dubbelink, KTEO (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Paediat Endocrinol, Amsterdam, Netherlands.	a.felius@lumc.nl		Berendse, Henk/0000-0002-9189-3662; Stam, Cornelis/0000-0001-9163-7274				Abbott RD, 2002, NEUROLOGY, V59, P1051, DOI 10.1212/WNL.59.7.1051; Baba R, 2007, CIRC J, V71, P722, DOI 10.1253/circj.71.722; BUZSAKI G, 2008, RYTHMS BRAIN; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Coutin-Churchman P, 2006, CLIN NEUROPHYSIOL, V117, P740, DOI 10.1016/j.clinph.2005.12.021; de Bruin EA, 2004, CLIN NEUROPHYSIOL, V115, P2048, DOI 10.1016/j.clinph.2004.04.010; Del Parigi A, 2002, ANN NY ACAD SCI, V967, P389; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Friston KJ, 2000, PHILOS T ROY SOC B, V355, P237, DOI 10.1098/rstb.2000.0561; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Green MC, 2005, POLIT PSYCHOL, V26, P1, DOI 10.1111/j.1467-9221.2005.00407.x; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Haltia LT, 2007, J CLIN ENDOCR METAB, V92, P3278, DOI 10.1210/jc.2006-2495; Herning RI, 1997, BIOL PSYCHIAT, V41, P1087, DOI 10.1016/S0006-3223(96)00258-2; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LAPPALAINEN R, 1994, PHYSIOL BEHAV, V56, P393, DOI 10.1016/0031-9384(94)90212-7; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lee L, 2003, NEUROIMAGE, V19, P457, DOI 10.1016/S1053-8119(03)00062-4; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; STOFFERS D, 2008, NEUROIMAGE IN PRESS; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Vega G L, 2004, Minerva Endocrinol, V29, P47; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065	41	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2827	10.1371/journal.pone.0002827	http://dx.doi.org/10.1371/journal.pone.0002827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665257	Green Published, gold			2022-12-25	WOS:000264304300046
J	Sauer, S; Freiwald, A; Maier, T; Kube, M; Reinhardt, R; Kostrzewa, M; Geider, K				Sauer, Sascha; Freiwald, Anja; Maier, Thomas; Kube, Michael; Reinhardt, Richard; Kostrzewa, Markus; Geider, Klaus			Classification and Identification of Bacteria by Mass Spectrometry and Computational Analysis	PLOS ONE			English	Article								Background: In general, the definite determination of bacterial species is a tedious process and requires extensive manual labour. Novel technologies for bacterial detection and analysis can therefore help microbiologists in minimising their efforts in developing a number of microbiological applications. Methodology: We present a robust, standardized procedure for automated bacterial analysis that is based on the detection of patterns of protein masses by MALDI mass spectrometry. We particularly applied the approach for classifying and identifying strains in species of the genus Erwinia. Many species of this genus are associated with disastrous plant diseases such as fire blight. Using our experimental procedure, we created a general bacterial mass spectra database that currently contains 2800 entries of bacteria of different genera. This database will be steadily expanded. To support users with a feasible analytical method, we developed and tested comprehensive software tools that are demonstrated herein. Furthermore, to gain additional analytical accuracy and reliability in the analysis we used genotyping of single nucleotide polymorphisms by mass spectrometry to unambiguously determine closely related strains that are difficult to distinguish by only relying on protein mass pattern detection. Conclusions: With the method for bacterial analysis, we could identify fire blight pathogens from a variety of biological sources. The method can be used for a number of additional bacterial genera. Moreover, the mass spectrometry approach presented allows the integration of data from different biological levels such as the genome and the proteome.	[Sauer, Sascha; Freiwald, Anja; Kube, Michael; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Maier, Thomas; Kostrzewa, Markus] Bruker Daltonik GmbH, Leipzig, Germany; [Geider, Klaus] Julius Kuehn Inst Plant Protect Fruit Crops, Dossenheim, Germany	Max Planck Society; Bruker Corporation; Bruker Daltonik GmbH; Julius Kuhn-Institut	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	sauer@molgen.mpg.de		Reinhardt, Richard/0000-0001-9376-2132	German Ministry of Education and Research; European Union; Max-Planck Society	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Ministry of Education and Research, the European Union and the Max-Planck Society.	Chong BE, 1997, RAPID COMMUN MASS SP, V11, P1900, DOI 10.1002/(SICI)1097-0231(199711)11:17<1900::AID-RCM95>3.0.CO;2-K; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; CROSSE JE, 1958, NATURE, V182, P1530, DOI 10.1038/1821530a0; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; Jock S, 2004, ENVIRON MICROBIOL, V6, P480, DOI 10.1111/j.1462-2920.2004.00583.x; JUKES T H, 1969, P21; Kim WS, 1999, INT J SYST BACTERIOL, V49, P899, DOI 10.1099/00207713-49-2-899; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sauer S, 2006, CLIN CHIM ACTA, V363, P95, DOI 10.1016/j.cccn.2005.05.040; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Sauer S, 2006, NAT PROTOC, V1, P1761, DOI 10.1038/nprot.2006.257; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; STARR MP, 1972, ANNU REV MICROBIOL, V26, P389, DOI 10.1146/annurev.mi.26.100172.002133	16	231	247	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2843	10.1371/journal.pone.0002843	http://dx.doi.org/10.1371/journal.pone.0002843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665227	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000264304300062
J	Wu, QF; Kim, YC; Lu, J; Xuan, ZY; Chen, J; Zheng, YL; Zhou, T; Zhang, MQ; Wu, CI; Wang, SM				Wu, Qingfa; Kim, Yeong C.; Lu, Jian; Xuan, Zhenyu; Chen, Jun; Zheng, Yonglan; Zhou, Tom; Zhang, Michael Q.; Wu, Chung-I; Wang, San Ming			Poly A- Transcripts Expressed in HeLa Cells	PLOS ONE			English	Article							MESSENGER-RNA; SEQUENCES; GENES; IDENTIFICATION; METABOLISM; COMPLEXITY; NUCLEI; GENOME	Background: Transcripts expressed in eukaryotes are classified as poly A+ transcripts or poly A- transcripts based on the presence or absence of the 3' poly A tail. Most transcripts identified so far are poly A+ transcripts, whereas the poly A- transcripts remain largely unknown. Methodology/Principal Findings: We developed the TRD (Total RNA Detection) system for transcript identification. The system detects the transcripts through the following steps: 1) depleting the abundant ribosomal and small-size transcripts; 2) synthesizing cDNA without regard to the status of the 3' poly A tail; 3) applying the 454 sequencing technology for massive 3' EST collection from the cDNA; and 4) determining the genome origins of the detected transcripts by mapping the sequences to the human genome reference sequences. Using this system, we characterized the cytoplasmic transcripts from HeLa cells. Of the 13,467 distinct 3' ESTs analyzed, 24% are poly A-, 36% are poly A+, and 40% are bimorphic with poly A+ features but without the 3' poly A tail. Most of the poly A-3' ESTs do not match known transcript sequences; they have a similar distribution pattern in the genome as the poly A+ and bimorphic 3' ESTs, and their mapped intergenic regions are evolutionarily conserved. Experiments confirmed the authenticity of the detected poly A- transcripts. Conclusion/Significance: Our study provides the first large-scale sequence evidence for the presence of poly A- transcripts in eukaryotes. The abundance of the poly A-transcripts highlights the need for comprehensive identification of these transcripts for decoding the transcriptome, annotating the genome and studying biological relevance of the poly A-transcripts.	[Wu, Qingfa; Kim, Yeong C.; Chen, Jun; Zheng, Yonglan; Zhou, Tom; Wang, San Ming] Northwestern Univ, Feinberg Sch Med, ENH Res Inst, Dept Med,Ctr Funct Genom,Div Med Genet, Chicago, IL 60611 USA; [Lu, Jian; Wu, Chung-I] Univ Chicago, Dept Ecol & Evolution, Chicago, IL USA; [Xuan, Zhenyu; Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Wang, San Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehensive Canc Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Chicago; Cold Spring Harbor Laboratory; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Wang, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, ENH Res Inst, Dept Med,Ctr Funct Genom,Div Med Genet, Chicago, IL 60611 USA.	swang1@northwestern.edu	Zheng, Yonglan/O-4112-2019; , san ming wang/ABG-4910-2020; Zheng, Yonglan/C-4236-2011	Zheng, Yonglan/0000-0001-6597-7072; Zhou, Tom/0000-0001-7416-5594; Xuan, Zhenyu/0000-0001-9344-8493	NIH [R01HG002600]; Daniel F. and Ada L. Rice Foundation; Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daniel F. and Ada L. Rice Foundation; Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by NIH grant R01HG002600, the Daniel F. and Ada L. Rice Foundation, Mazza Foundation, and the Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust.	Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Chen J, 2008, GENOME RES, V18, P751, DOI 10.1101/gr.068304.107; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DETKE S, 1978, NUCLEIC ACIDS RES, V5, P1515, DOI 10.1093/nar/5.5.1515; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; DUNCAN R, 1984, DIFFERENTIATION, V28, P24, DOI 10.1111/j.1432-0436.1984.tb00262.x; GALAU GA, 1981, J BIOL CHEM, V256, P2551; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRADY LJ, 1978, NUCLEIC ACIDS RES, V5, P697, DOI 10.1093/nar/5.3.697; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Lee S, 2002, GENOMICS, V79, P598, DOI 10.1006/geno.2002.6730; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; MOFFETT RB, 1981, BIOCHIM BIOPHYS ACTA, V652, P177, DOI 10.1016/0005-2787(81)90221-5; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; NAKAZATO H, 1974, P NATL ACAD SCI USA, V71, P200, DOI 10.1073/pnas.71.1.200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; VANNESS J, 1979, CELL, V18, P1341, DOI 10.1016/0092-8674(79)90244-7; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; ZIMMERMAN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3148, DOI 10.1073/pnas.79.10.3148; ZIMMERMAN JL, 1980, GENETICS, V95, P673	28	68	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2803	10.1371/journal.pone.0002803	http://dx.doi.org/10.1371/journal.pone.0002803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665230	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000264304300022
J	Quenet, D; Gasser, V; Fouillen, L; Cammas, F; Sanglier-Cianferani, S; Losson, R; Dantzer, F				Quenet, Delphine; Gasser, Veronique; Fouillen, Laetitia; Cammas, Florence; Sanglier-Cianferani, Sarah; Losson, Regine; Dantzer, Francoise			The histone subcode: poly(ADP-ribose) polymerase-1 (Parp-1) and Parp-2 control cell differentiation by regulating the transcriptional intermediary factor TIF1 beta and the heterochromatin protein HP1 alpha	FASEB JOURNAL			English	Article						epigenetics; pericentric heterochromatin; post-translational modification; protein interactions	ZINC FINGER PROTEINS; FUNCTIONAL INTERACTION; DNA-REPAIR; HP1; EXPRESSION; INTERACTS; CHROMATIN; FAMILY; CONTRIBUTES; MAINTENANCE	Recent advances reveal emerging unique functions of poly(ADP-ribose) polymerase-1 (Parp-1) and Parp-2 in heterochromatin integrity and cell differentiation. However, the chromatin-mediated molecular and cellular events involved remain elusive. Here we describe specific physical and functional interactions of Parp-1 and Parp-2 with the transcriptional intermediary factor (TIF1 beta) and the heterochromatin proteins (HP1) that affect endodermal differentiation. We show that Parp-2 binds to TIF1 beta with high affinity both directly and through HP1 alpha. Both partners colocalize at pericentric heterochromatin in primitive endoderm-like cells. Parp-2 also binds to HP1 beta but not to HP1 gamma. In contrast Parp-1 binds weakly to TIF1 beta and HP1 beta only. Both Parps selectively poly(ADP-ribosyl) ate HP1 alpha. Using shRNA approaches, we provide evidence for distinct participation of both Parps in endodermal differentiation. Whereas Parp-2 and its activity are required for the relocation of TIF1 beta to heterochromatic foci during primitive endodermal differentiation, Parp-1 and its activity modulate TIF1 beta-HP1 alpha association with consequences on parietal endodermal differentiation. Both Parps control TIF1 beta transcriptional activity. In addition, this work identifies both Parps as new modulators of the HP1-mediated subcode histone. -Quenet, D., Gasser, V., Fouillen, L., Cammas, F., Sanglier-Cianferani, S., Losson, R., Dantzer, F. The histone subcode: poly(ADP-ribose) polymerase-1 (Parp-1) and Parp-2 control cell differentiation by regulating the transcriptional intermediary factor TIF1 beta and the heterochromatin protein HP1 alpha. FASEB J. 22, 3853-3865 (2008)	[Quenet, Delphine; Gasser, Veronique; Dantzer, Francoise] ESBS, Dept IDG, UMR7175, F-67412 Illkirch Graffenstaden, France; [Cammas, Florence; Losson, Regine] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Fouillen, Laetitia; Sanglier-Cianferani, Sarah] Ecole Chim Polymeres & Mat, Lab Spectrometrie Masse Bioorgan, UMR7178, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3)	Dantzer, F (corresponding author), ESBS, Dept IDG, UMR7175, Bld S Brant, F-67412 Illkirch Graffenstaden, France.	fdantzer@esbs.u-strasbg.fr	Dantzer, Françoise/O-2126-2016; Cammas, florence m/D-1823-2017; FOUILLEN, Laetitia/AAV-9710-2020	Cammas, florence m/0000-0003-4117-8182; FOUILLEN, Laetitia/0000-0002-1204-9296; Dantzer, Francoise/0000-0003-0945-8483; Cianferani, Sarah/0000-0003-4013-4129	Association pour la Recherche Contre le Cancer; Ligue Nationale Contre le Cancer et Comite Regional; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche	Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer et Comite Regional(Ligue nationale contre le cancer); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank V. Schreiber for critical reading of the manuscript and A. van Dorsselear for access to the proteomic platform. This work was supported by Association pour la Recherche Contre le Cancer, Ligue Nationale Contre le Cancer et Comite Regional, Centre National de la Recherche Scientifique, and Agence Nationale de la Recherche.	Aldinucci A, 2007, J IMMUNOL, V179, P305, DOI 10.4049/jimmunol.179.1.305; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bai P, 2007, J BIOL CHEM, V282, P37738, DOI 10.1074/jbc.M701021200; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; LE DB, 1996, EMBO J, V15, P6701; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nusinow DA, 2007, J BIOL CHEM, V282, P12851, DOI 10.1074/jbc.M610502200; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; SCHULTZ MJ, 2001, RRD IMMUNOL 1, V3, P1; Singh PB, 2002, J STRUCT BIOL, V140, P10, DOI 10.1016/S1047-8477(02)00536-1; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; Weber P, 2002, DEVELOPMENT, V129, P2329; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	43	50	50	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3853	3865		10.1096/fj.08-113464	http://dx.doi.org/10.1096/fj.08-113464			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18676401	Green Submitted			2022-12-25	WOS:000260503000014
J	Yabu, T; Imamura, S; Yamashita, M; Okazaki, T				Yabu, Takeshi; Imamura, Shintaro; Yamashita, Michiaki; Okazaki, Toshiro			Identification of Mg2+-dependent Neutral Sphingomyelinase 1 as a Mediator of Heat Stress-induced Ceramide Generation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL ALKALINE SPHINGOMYELINASE; TUMOR-NECROSIS-FACTOR; SUBCELLULAR-LOCALIZATION; ACID SPHINGOMYELINASE; CELL-DIFFERENTIATION; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; BACILLUS-CEREUS; HL-60 CELLS; RAT-LIVER	Neutral sphingomyelinases (SMases) are involved in the induction of ceramide-mediated proapoptotic signaling under heat stress conditions. Although ceramide is an important mediator of apoptosis, the neutral SMase that is activated under heat stress has not been identified. In this study, we cloned an Mg2+-dependent neutral SMase from a zebrafish embryonic cell cDNA library using an Escherichia coli expression-cloning vector. Screening of the clones using an SMase activity assay with C-6-7-nitro-2-1,3-benzoxadiazol-4-yl-sphingomyelin as the substrate resulted in the isolation of one neutral SMase cDNA clone. This cDNA encoded a polypeptide of 420 amino acids (putative molecular weight: 46,900) containing two predicted transmembrane domains in its C-terminal region. The cloned neutral SMase 1 acted as a mediator of stress-induced apoptosis. Bacterially expressed recombinant neutral SMase 1 hydrolyzed [choline-methyl-C-14] sphingomyelin optimally at pH 7.5 in the presence of an Mg2+ ion. In zebrafish embryonic cells, the endogenous SMase enzyme was localized in the microsomal fraction. In FLAG-tagged SMase-overexpressing cells, neutral SMase 1 colocalized with a Golgi marker in a cytochemical analysis. Inactivation of the enzyme by an antisense phosphorothioate oligonucleotide repressed the induction of ceramide generation, caspase-3 activation, and apoptotic cell death by heat stress. Thus, neutral SMase 1 participates in an inducible ceramide-mediating, proapoptotic signaling pathway that operates in heat-induced apoptosis in zebrafish embryonic cells.	[Yabu, Takeshi; Imamura, Shintaro; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan; [Okazaki, Toshiro] Tottori Univ, Dept Hematol, Clin Lab Med, Sch Med, Tottori 6838504, Japan	Japan Fisheries Research & Education Agency (FRA); Tottori University	Yabu, T (corresponding author), Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Kanagawa 2368648, Japan.	tyabu@fra.affrc.go.jp			Japan Science and Technology Corporation; Japan Society for the Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Japan Science and Technology Corporation, the Japan Society for the Promotion of Science, and the Ministry of Agriculture, Forestry, and Fisheries of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrieu N, 1996, EUR J BIOCHEM, V236, P738, DOI 10.1111/j.1432-1033.1996.00738.x; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Bevers EM, 1998, LUPUS, V7, pS126, DOI 10.1177/096120339800700228; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2003, J LIPID RES, V44, P1241, DOI 10.1194/jlr.M300037-JLR200; DUAN RD, 1995, BBA-LIPID LIPID MET, V1259, P49, DOI 10.1016/0005-2760(95)00137-2; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; Fujii S, 1998, J BIOCHEM-TOKYO, V124, P1178, DOI 10.1093/oxfordjournals.jbchem.a022236; Fujii S, 1999, J BIOCHEM-TOKYO, V126, P90, DOI 10.1093/oxfordjournals.jbchem.a022441; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; GATT S, 1976, BIOCHEM BIOPH RES CO, V68, P235, DOI 10.1016/0006-291X(76)90034-6; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HELLER M, 1966, BIOCHEM J, V98, P763, DOI 10.1042/bj0980763; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; HOSTETLER KY, 1979, J LIPID RES, V20, P456; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Kondo T, 2000, J BIOL CHEM, V275, P8872, DOI 10.1074/jbc.275.12.8872; Kronke M, 1999, CHEM PHYS LIPIDS, V102, P157, DOI 10.1016/S0009-3084(99)00084-5; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; Nyberg L, 1996, BBA-LIPID LIPID MET, V1300, P42, DOI 10.1016/0005-2760(95)00245-6; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OBEID LM, 2003, SCI AGING KNOWLEDGE, P27; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9; RAO BG, 1976, J LIPID RES, V17, P506; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Stoffel W, 1999, CHEM PHYS LIPIDS, V102, P107, DOI 10.1016/S0009-3084(99)00079-1; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Tepper AD, 1997, J BIOL CHEM, V272, P24308, DOI 10.1074/jbc.272.39.24308; Tepper AD, 2001, BIOCHEM BIOPH RES CO, V280, P634, DOI 10.1006/bbrc.2000.4166; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yabu T, 2003, FISHERIES SCI, V69, P1218, DOI 10.1111/j.0919-9268.2003.00748.x; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	62	40	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29971	29982		10.1074/jbc.M805402200	http://dx.doi.org/10.1074/jbc.M805402200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18678863	Green Published, hybrid			2022-12-25	WOS:000260366900042
J	Brellier, F; Bergoglio, V; Valin, A; Barnay, S; Chevallier-Lagente, O; Vielh, P; Spatz, A; Gorry, P; Avril, MF; Magnaldo, T				Brellier, F.; Bergoglio, V.; Valin, A.; Barnay, S.; Chevallier-Lagente, O.; Vielh, P.; Spatz, A.; Gorry, P.; Avril, M-F; Magnaldo, T.			Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures	ONCOGENE			English	Article						PATCHED; skin; keratinocyte; basal cell carcinoma; organotypic cultures; Gorlin syndrome	SONIC HEDGEHOG; CYCLE PROGRESSION; NEVUS SYNDROME; HUMAN HOMOLOG; MICE; GLI2; PTCH; KERATINOCYTES; ACTIVATION; SPECTRUM	Basal cell carcinoma of the skin is the most common type of cancer in humans. The majority of these tumors displays aberrant activation of the SONIC HEDGEHOG (SHH)/PATCHED pathway, triggered by mutations in the PATCHED tumor suppressor gene, which encodes a transmembrane receptor of SHH. In this study, we took advantage of the natural genotype (PATCHED(+/-)) of healthy keratinocytes expanded from patients with the nevoid basal cell carcinoma or Gorlin syndrome to mimic heterozygous somatic mutations thought to occur in the PATCHED gene early upon basal cell carcinoma development in the general population. PATCHED(+/-) epidermis developed on a dermal equivalent containing wild-type (WT) PATCHED(+/+). fibroblasts exhibited striking invasiveness and hyperproliferation, as well as marked differentiation impairment. Deciphering the phenotype of PATCHED(+/-) keratinocytes revealed slight increases of the transcriptional activators GLI1 and GLI2-the latter known to provoke basal cell carcinoma-like tumors when overexpressed in transgenic mice. PATCHED(+/-) keratinocytes also showed a substantial increase of the cell cycle regulator cyclin D1. These data show for the first time the physiological impact of constitutive heterozygous PATCHED mutations in primary human keratinocytes and strongly argue for a yet elusive mechanism of haploinsufficiency leading to cancer proneness.	[Bergoglio, V.; Valin, A.; Barnay, S.; Chevallier-Lagente, O.; Magnaldo, T.] Inst Gustave Roussy, FRE 2939, F-94805 Villejuif 05, France; [Brellier, F.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Vielh, P.; Spatz, A.] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif 05, France; [Gorry, P.] CHU Pellegrin Enfants, Serv Genet, Bordeaux, France; [Avril, M-F] Univ Paris 05, Serv Dermatol, Paris, France	UNICANCER; Gustave Roussy; Friedrich Miescher Institute for Biomedical Research; UNICANCER; Gustave Roussy; CHU Bordeaux; UDICE-French Research Universities; Universite Paris Cite	Magnaldo, T (corresponding author), Inst Gustave Roussy, FRE 2939, Rue Camille Desmoulins, F-94805 Villejuif 05, France.	marie-francoise.avril@cch.aphp.fr; magnaldo@igr.fr	SPATZ, ALAN/B-8645-2009; , GORRY/I-9725-2019; Bergoglio, Valérie VB/P-1624-2014	SPATZ, ALAN/0000-0003-3020-1420; , GORRY/0000-0002-5497-8069; Bergoglio, Valérie VB/0000-0003-2773-3178; Brellier, Florence/0000-0002-0143-472X; Barnay-Verdier, Stephanie/0000-0002-4615-3059	CNRS; ARC [9500]; Fondation de l'Avenir; SFD; AFM	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council); Fondation de l'Avenir; SFD; AFM(Association Francaise contre les Myopathies)	VB, AV, SB, have contributed equally to this work. FB and AV were recipients of PhD fellowships from the CNRS and Ligue Nationale contre le Cancer, and MESR, respectively. SB was an IGR post-doctoral fellow. We gratefully thank Dr Francoise Bernerd, Dr Howard Green, Ms Valerie Velasco, Virginie Marty, Dr Rune Toftgard, Dr Paule Opolon, and Marianne Brown-Luedi for their kind help. This work was supported by the CNRS, the ARC ( no. 9500), the Fondation de l'Avenir, the SFD and the AFM.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Boutet N, 2003, J INVEST DERMATOL, V121, P478, DOI 10.1046/j.1523-1747.2003.12423.x; BRELLIER F, 2008, BR J DERMATOL   0528; Chidambaram A, 1996, ADV CANCER RES, V70, P49, DOI 10.1016/S0065-230X(08)60871-4; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Evans T, 2000, HUM MUTAT, V16, P43, DOI 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.3.CO;2-Z; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pruvost-Balland C, 2006, ANN DERMATOL VENER, V133, P117, DOI 10.1016/S0151-9638(06)70861-4; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Unden AB, 1997, CANCER RES, V57, P2336	29	9	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2008	27	51					6601	6606		10.1038/onc.2008.260	http://dx.doi.org/10.1038/onc.2008.260			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18679421				2022-12-25	WOS:000260501700008
J	Shim, JH; Choi, HS; Pugliese, A; Lee, SY; Chae, JI; Choi, BY; Bode, AM; Dong, Z				Shim, Jung-Hyun; Choi, Hong Seok; Pugliese, Angelo; Lee, Sung-Young; Chae, Jung-Il; Choi, Bu Young; Bode, Ann M.; Dong, Zigang			(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-TYROSINE KINASE; GREEN TEA; MASS-SPECTROMETRY; ZETA-CHAIN; IN-VITRO; ACTIVATION; PHOSPHORYLATION; EXPRESSION; APOPTOSIS	The zeta chain-associated 70-kDa protein (ZAP-70) of tyrosine kinase plays a critical role in T cell receptor-mediated signal transduction and the immune response. A high level of ZAP-70 expression is observed in leukemia, which suggests ZAP-70 as a logical target for immunomodulatory therapies. (-)-Epigallocatechin gallate (EGCG) is one of the major green tea catechins that is suggested to have a role as a preventive agent in cancer, obesity, diabetes, and cardiovascular disease. Here we identified ZAP-70 as an important and novel molecular target of EGCG in leukemia cells. ZAP-70 and EGCG displayed high binding affinity (K-d = 0.6207 mu mol/liter), and additional results revealed that EGCG effectively suppressed ZAP-70, linker for the activation of T cells, phospholipase C gamma 1, extracellular signaling-regulated kinase, and MAPK kinase activities in CD3-activated T cell leukemia. Furthermore, the activation of activator protein-1 and interleukin-2 induced by CD3 was dose-dependently inhibited by EGCG treatment. Notably, EGCG dose-dependently induced caspase-mediated apoptosis in P116.cl39 ZAP-70-expressing leukemia cells, whereas P116 ZAP-70-deficient cells were resistant to EGCG treatment. Molecular docking studies, supported by site-directed mutagenesis experiments, showed that EGCG could form a series of intermolecular hydrogen bonds and hydrophobic interactions within the ATP binding domain, which may contribute to the stability of the ZAP-70-EGCG complex. Overall, these results strongly indicated that ZAP-70 activity was inhibited specifically by EGCG, which contributed to suppressing the CD3-mediated T cell-induced pathways in leukemia cells.	[Shim, Jung-Hyun; Choi, Hong Seok; Pugliese, Angelo; Lee, Sung-Young; Choi, Bu Young; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Chae, Jung-Il] Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305806, South Korea	University of Minnesota System; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	pugliese, angelo/C-1729-2008	Shim, Jung-Hyun/0000-0002-4062-4016	National Institutes of Health [CA81064, CA77646, CA111536, CA120388]; The Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, R01CA077646, R37CA081064, R01CA081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA81064, CA77646, CA111536, and CA120388. This work was also supported by The Hormel Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Asano Y, 1996, LIFE SCI, V60, P135, DOI 10.1016/S0024-3205(96)00603-0; Bene MC, 2006, CYTOM PART B-CLIN CY, V70B, P204, DOI 10.1002/cyto.b.20124; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buggins AGS, 1998, BRIT J HAEMATOL, V100, P784; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gibbs G, 2007, INT J LAB HEMATOL, V29, P225, DOI 10.1111/j.1751-553X.2006.00869.x; Hamblin TJ, 2007, BEST PRACT RES CL HA, V20, P455, DOI 10.1016/j.beha.2007.02.001; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Iwashima M, 2003, IMMUNOL REV, V191, P196, DOI 10.1034/j.1600-065X.2003.00024.x; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Khan IH, 2006, MOL CELL PROTEOMICS, V5, P758, DOI 10.1074/mcp.T500032-MCP200; Li HC, 2000, JPN J CANCER RES, V91, P34, DOI 10.1111/j.1349-7006.2000.tb00857.x; Lin J, 2001, J CELL SCI, V114, P243; Martelli MP, 2000, BLOOD, V96, P2181; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Nakagawa H, 2004, CARCINOGENESIS, V25, P1567, DOI 10.1093/carcin/bgh168; Nakazato T, 2005, HAEMATOLOGICA, V90, P317; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Shim JH, 2005, PROTEOMICS, V5, P2112, DOI 10.1002/pmic.200401106; SUZUSHIMA H, 1991, CANCER RES, V51, P6084; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; VANDONGEN JJM, 1987, J IMMUNOL, V138, P1260; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang DJ, 2006, J CHROMATOGR A, V1119, P277, DOI 10.1016/j.chroma.2005.12.031; Zanotti R, 2007, LEUKEMIA, V21, P102, DOI 10.1038/sj.leu.2404458; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	55	81	83	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28370	28379		10.1074/jbc.M802200200	http://dx.doi.org/10.1074/jbc.M802200200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687687	Green Published, hybrid			2022-12-25	WOS:000259969300039
J	Chen, CL; Chen, JF; Rawale, S; Varadharaj, S; Kaumaya, PPT; Zweier, JL; Chen, YR				Chen, Chwen-Lih; Chen, Jingfeng; Rawale, Sharad; Varadharaj, Saradhadevi; Kaumaya, Pravin P. T.; Zweier, Jay L.; Chen, Yeong-Renn			Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial Complex II in the post-ischemic myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; CYTOCHROME-C-REDUCTASE; OXYGEN-FREE RADICALS; NITRIC-OXIDE; SUCCINATE-UBIQUINONE; ENDOTHELIAL DYSFUNCTION; QUINONE OXIDOREDUCTASES; SUPEROXIDE GENERATION; NADH DEHYDROGENASE; HEART	Increased O-2(-) and NO production is a key mechanism of mitochondrial dysfunction in myocardial ischemia/reperfusion injury. A crucial segment of the mitochondrial electron transport chain is succinate ubiquinone reductase (SQR or Complex II). In SQR, oxidative impairment and deglutathionylation of the 70-kDa flavin protein occurs in the post-ischemic heart (Chen, Y. R., Chen, C. L., Pfeiffer, D. R., and Zweier, J. L. (2007) J. Biol. Chem. 282, 32640 -32654). To gain insights into the oxidative modification of the 70-kDa protein in the post-ischemic myocardium, we used the identified S-glutathionylated peptide ((77)AAFGLSEAGFNTA (C) under bar VTK93) of the 70-kDa protein as a chimeric epitope incorporating a "promiscuous" T cell epitope to generate a high titer polyclonal antibody, AbGSC90. Purified AbGSC90 showed a high binding affinity to isolated SQR. Antibodies of AbGSC90 moderately inhibited the electron transfer and superoxide generation activities of SQR. To test for protein nitration, rats were subjected to 30 min of coronary ligation followed by 24 h of reperfusion. Tissue homogenates were immunoprecipitated with AbGSC90 and probed with antibodies against 3-nitrotyrosine. Enhancement of protein tyrosine nitration was detected in the post-ischemic myocardium. Isolated SQR was subjected to in vitro protein nitration with peroxynitrite, leading to site-specific nitration at the 70-kDa polypeptide and impairment of SQR electron transfer activity. Protein nitration of SQR further impaired its protein-protein interaction with Complex III. Liquid chromatography/tandem mass spectrometry analysis indicated that Tyr-56 and Tyr-142 were involved in protein tyrosine nitration. When the isolated SQR was subjected to in vitro S-glutathionylation, oxidative modification and impairment mediated by peroxynitrite were significantly decreased, thus confirming the protective effect of S-glutathionylation from the oxidative damage of nitration.	[Chen, Chwen-Lih; Chen, Jingfeng; Varadharaj, Saradhadevi; Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Davis Heart & Lung Res Inst, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA; [Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Dept Mol & Cellular Biochem, Coll Med, Columbus, OH 43210 USA; [Rawale, Sharad; Kaumaya, Pravin P. T.] Ohio State Univ, Dept Obstet & Gynecol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 607, 473 W 12th Ave, Columbus, OH 43210 USA.	yeong-renn.chen@osumc.edu	Kaumaya, Pravin T. P/E-3354-2011		National Institutes of Health [HL83237, HL63744, HL38324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R01HL063744, R29HL038324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL83237 (to Y.-R. C.) and HL63744 and HL38324 (to J. L. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Aulak KS, 2004, AM J PHYSIOL-HEART C, V286, pH30, DOI 10.1152/ajpheart.00743.2003; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FERRARI R, 1995, AM J CARDIOL, V76, pB17; FERRARI R, 1994, ADV EXP MED BIOL, V366, P99; FERRARI R, 1991, AM J CLIN NUTR, V53, pS215, DOI 10.1093/ajcn/53.1.215S; FERRARI R, 1998, AM J CARDIOL, V82, P2; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guo Y, 1998, AM J PHYSIOL, V275, P1375; GWAK SH, 1986, BIOCHEMISTRY-US, V25, P7675, DOI 10.1021/bi00371a059; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Han ZS, 2007, AM J PHYSIOL-CELL PH, V292, pC1103, DOI 10.1152/ajpcell.00389.2006; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hatefi Y, 1978, Methods Enzymol, V53, P11; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOBSCONRAD S, 1993, J BIOL CHEM, V268, P25285; Koeck T, 2005, BIOCHEM SOC T, V33, P1399, DOI 10.1042/BST0331399; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Liu PT, 1997, AM J PHYSIOL-HEART C, V272, pH2327, DOI 10.1152/ajpheart.1997.272.5.H2327; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; TSAO PS, 1990, AM J PHYSIOL, V259, pH1660, DOI 10.1152/ajpheart.1990.259.6.H1660; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VERCESI A, 1978, J BIOL CHEM, V253, P6379; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1; YU L, 1982, J BIOL CHEM, V257, P2016; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; Zhao X, 2007, AM J PHYSIOL-HEART C, V292, pH1541, DOI 10.1152/ajpheart.00264.2006; Zhu XH, 2007, AM J PHYSIOL-HEART C, V293, pH1442, DOI 10.1152/ajpheart.00256.2007; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	48	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27991	28003		10.1074/jbc.M802691200	http://dx.doi.org/10.1074/jbc.M802691200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682392	Green Published, hybrid			2022-12-25	WOS:000259719200069
J	Li, Y; Wang, Z; Kong, D; Li, R; Sarkar, SH				Li, Yiwei; Wang, Zhiwei; Kong, Dejuan; Li, Ran; Sarkar, Sanila H.			Regulation of Akt/FOXO3a/GSK-3 beta/AR signaling network by isoflavone in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FACTOR-KAPPA-B; ANDROGEN RECEPTOR; BETA-CATENIN; SOY ISOFLAVONES; AKT; APOPTOSIS; INHIBITION; GENISTEIN; PATHWAY	We have previously shown that genistein could inhibit Akt activation and down-regulate AR (androgen receptor) and PSA (prostate-specific antigen) expression in prostate cancer (PCa) cells. However, pure genistein showed increased lymph node metastasis in an animal model, but such an adverse effect was not seen with isoflavone, suggesting that further mechanistic studies are needed for elucidating the role of isoflavone in PCa. It is known that FOXO3a and GSK-3 beta, targets of Akt, regulate cell proliferation and apoptosis. Moreover, FOXO3a, GSK-3 beta, and Src are AR regulators and regulate transactivation of AR, mediating the development and progression of PCa. Therefore, we investigated the molecular effects of isoflavone on the Akt/FOXO3a/GSK-3 beta/AR signaling network in hormone-sensitive LNCaP and hormone- insensitive C4-2B PCa cells. We found that isoflavone inhibited the phosphorylation of Akt and FOXO3a, regulated the phosphorylation of Src, and increased the expression of GSK-3 beta, leading to the down-regulation of AR and its target gene PSA. We also found that isoflavone inhibited AR nuclear translocation and promoted FOXO3a translocation to the nucleus. By electrophoretic mobility shift assay and chromatin immunoprecipitation assay, we found that isoflavone inhibited FOXO3a binding to the promoter of AR and increased FOXO3a binding to the p27(KIP1) promoter, resulting in the alteration of AR and p27KIP1 expression, the inhibition of cell proliferation, and the induction of apoptosis in both androgen-sensitive and -insensitive PCa cells. These results suggest that isoflavone-induced inhibition of cell proliferation and induction of apoptosis are partly mediated through the regulation of the Akt/FOXO3a/GSK-3 beta/AR signaling network. In conclusion, our data suggest that isoflavone could be useful for the prevention and/or treatment of PCa.	[Li, Yiwei; Wang, Zhiwei; Kong, Dejuan; Li, Ran; Sarkar, Sanila H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol,Hudson Webber Canc Res Ctr, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, SH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol,Hudson Webber Canc Res Ctr 740, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu			National Institutes of Health; NCI [5R01CA083695, 5R01CA101870]; Puschelberg Foundation; NATIONAL CANCER INSTITUTE [R01CA101870, R01CA083695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Puschelberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants 5R01CA083695 and 5R01CA101870 (to F. H. S.). This work was also supported by the Puschelberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davis JN, 2002, MOL CARCINOGEN, V34, P91, DOI 10.1002/mc.10053; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; El Touny LH, 2007, CARCINOGENESIS, V28, P1710, DOI 10.1093/carcin/bgm103; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hillman GG, 2004, MOL CANCER THER, V3, P1271; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li BY, 2007, CARCINOGENESIS, V28, P572, DOI 10.1093/carcin/bgl193; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; Li YW, 2002, CLIN CANCER RES, V8, P2369; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raffoul JJ, 2007, INT J CANCER, V120, P2491, DOI 10.1002/ijc.22548; Rannikko A, 2006, PROSTATE, V66, P82, DOI 10.1002/pros.20315; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Truica CI, 2000, CANCER RES, V60, P4709; Wen Y, 2000, CANCER RES, V60, P6841; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200	46	90	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27707	27716		10.1074/jbc.M802759200	http://dx.doi.org/10.1074/jbc.M802759200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687691	hybrid, Green Published			2022-12-25	WOS:000259719200042
J	Rabu, C; Wipf, P; Brodsky, JL; High, S				Rabu, Catherine; Wipf, Peter; Brodsky, Jeffrey L.; High, Stephen			A precursor-specific role for Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MOLECULAR CHAPERONES; MEMBRANE INSERTION; ATPASE ACTIVITY; TRANSLOCATION; PATHWAY; YEAST; IDENTIFICATION; MECHANISMS; INHIBITOR	Tail-anchored (TA) protein synthesis at the endoplasmic reticulum (ER) represents a distinct and novel process that provides a paradigm for understanding post-translational membrane insertion in eukaryotes. The major route for delivering TA proteins to the ER requires both ATP and one or more cytosolic factors that facilitate efficient membrane insertion. Until recently, the identity of these cytosolic components was elusive, but two candidates have now been suggested to promote ATP-dependent TA protein integration. The first is the cytosolic chaperone complex of Hsp40/Hsc70, and the second is a novel ATPase denoted Asna-1 or TRC40. In this study we focus on the role of the Hsp40/Hsc70 complex in promoting TA protein biogenesis at the ER. We show that the membrane integration of most TA proteins is stimulated by Hsp40/Hsc70 when using purified components and a reconstituted system. In contrast, when both Hsp40/Hsc70 and Asna-1/TRC40 are provided as a complete system, small molecule inhibition of Hsp40/Hsc70 indicates that only a subset of TA proteins are obligatory clients for this chaperone-mediated delivery route. We show that the hydrophobicity of the TA region dictates whether a precursor is delivered to the ER via the Hsp40/Hsc70 or Asna-1/TRC40-dependent route, and we conclude that these distinct cytosolic ATPases are responsible for two different ATP-dependent pathways of TA protein biogenesis.	[Rabu, Catherine; High, Stephen] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	High, S (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	stephen.high@manchester.ac.uk	Rabu, Catherine/K-7369-2015; Wipf, Peter/AAG-1771-2021	Rabu, Catherine/0000-0001-8405-2809; Wipf, Peter/0000-0001-7693-5863; High, Stephen/0000-0002-4532-8152	National Institutes of Health [P50-GM067082]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D007879/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER; BBSRC [BB/D007879/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant P50-GM067082 from the NIGMS for support of the P50 Chemical Methodologies and Library Development Program at the University of Pittsburgh (to P. W.). This work was also supported by a Biotechnology and Biological Sciences Research Council project grant (to S. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GILMORE R, 1993, CELL, V75, P589, DOI 10.1016/0092-8674(93)90476-7; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; King C, 1999, BIOCHEMISTRY-US, V38, P12452, DOI 10.1021/bi9902788; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Rabu C, 2007, CURR BIOL, V17, pR472, DOI 10.1016/j.cub.2007.04.031; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wright CM, 2008, BIOORGAN MED CHEM, V16, P3291, DOI 10.1016/j.bmc.2007.12.014; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	38	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27504	27513		10.1074/jbc.M804591200	http://dx.doi.org/10.1074/jbc.M804591200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667436	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000259719200021
J	Hegde, ML; Theriot, CA; Das, A; Hegde, PM; Guo, ZG; Gary, RK; Hazra, TK; Shen, BH; Mitra, S				Hegde, Muralidhar L.; Theriot, Corey A.; Das, Aditi; Hegde, Pavana M.; Guo, Zhigang; Gary, Ronald K.; Hazra, Tapas K.; Shen, Binghui; Mitra, Sankar			Physical and functional interaction between human oxidized base-specific DNA glycosylase NEIL1 and flap endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; PURIFIED HUMAN PROTEINS; EXCISION-REPAIR; MAMMALIAN-CELLS; REPLICATION FORK; STRUCTURAL BASIS; POLYMERASE-BETA; WRN HELICASE; FEN-1; PCNA	The S phase-specific activation of NEIL1 and not of the other DNA glycosylases responsible for repairing oxidatively damaged bases in mammalian genomes and the activation of NEIL1 by proliferating cell nuclear antigen (PCNA) suggested preferential action by NEIL1 in oxidized base repair during DNA replication. Here we show that NEIL1 interacts with flap endonuclease 1 (FEN-1), an essential component of the DNA replication. FEN-1 is present in the NEIL1 immunocomplex isolated from human cell extracts, and the two proteins colocalize in the nucleus. FEN-1 stimulates the activity of NEIL1 in vitro in excising 5-hydroxyuracil from duplex, bubble, forked, and single-stranded DNA substrates by up to 5-fold. The disordered region near the C terminus of NEIL1, which is dispensable for activity, is necessary and sufficient for high affinity binding to FEN-1 (K-D congruent to 0.2 mu M). The interacting interface of FEN-1 is localized in its disordered C-terminal region uniquely present in mammalian orthologs. Fine structure mapping identified several Lys and Arg residues in this region that form salt bridges with Asp and Glu residues in NEIL1. NEIL1 was previously shown to initiate single nucleotide excision repair, which does not require FEN-1 or PCNA. The present study shows that NEIL1 could also participate in strand displacement repair synthesis (long patch repair (LP-BER)) mediated by FEN-1 and stimulated by PCNA. Interaction between NEIL1 and FEN-1 is essential for efficient NEIL1-initiated LP-BER. These studies strongly implicate NEIL1 in a distinct subpathway of LP-BER in replicating genomes.	[Hegde, Muralidhar L.; Theriot, Corey A.; Das, Aditi; Hegde, Pavana M.; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Guo, Zhigang; Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, Duarte, CA 91010 USA; [Guo, Zhigang; Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA; [Gary, Ronald K.] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA	University of Texas System; University of Texas Medical Branch Galveston; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Mitra, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	samitra@utmb.edu	Classen, Scott/AAY-8176-2020; Gary, Ronald K/A-8650-2008	Gary, Ronald K/0000-0001-5079-1953; Shen, Binghui/0000-0002-4408-407X; Hegde, Muralidhar/0000-0001-7333-8123; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health United States Public Health Service Research [P01 CA092584, R01 CA81063, R01 CA53791, P30 ES06676, R01 CA102271, R01 CA073764]; NATIONAL CANCER INSTITUTE [R01CA081063, R01CA073764, P01CA092584, R01CA102271, R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Research Grants P01 CA092584, R01 CA81063, R01 CA53791, and P30 ES06676 (to S. M.); R01 CA102271 (to T. K. H.); and R01 CA073764 (to B. H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3	45	80	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27028	27037		10.1074/jbc.M802712200	http://dx.doi.org/10.1074/jbc.M802712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662981	Green Published, hybrid			2022-12-25	WOS:000259586600023
J	Pajonk, S; Kwon, C; Clemens, N; Panstruga, R; Schulze-Lefert, P				Pajonk, Simone; Kwon, Chian; Clemens, Natascha; Panstruga, Ralph; Schulze-Lefert, Paul			Activity determinants and functional specialization of Arabidopsis PEN1 syntaxin in innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; 25 KDA SNAP-25; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; PENETRATION RESISTANCE; SYNAPTIC-TRANSMISSION; NONHOST RESISTANCE; POWDERY MILDEW; C-TERMINUS; RESPONSES	In eukaryotes, proteins of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family are believed to have a general role for the fusion of intracellular transport vesicles with acceptor membranes. Arabidopsis thaliana PEN1 syntaxin resides in the plasma membrane and was previously shown to act together with its partner SNAREs, the adaptor protein SNAP33, and endomembrane-anchored VAMP721/722 in the execution of secretory immune responses against powdery mildew fungi. We conducted a structure-function analysis of PEN1 and show that N-terminal phospho-mimicking and non-phosphorylatable variants neither affected binary nor ternary SNARE complex formation with cognate partners in vitro. However, expression of these syntaxin variants at native protein levels in a pen1 mutant background suggests that phosphorylation is required for full resistance activity in planta. All tested site-directed substitutions of SNARE domain or "linker region" residues reduced PEN1 defense activity. Two of the variants failed to form ternary complexes with the partner SNAREs in vitro, possibly explaining their diminished in planta activity. However, impaired pathogen defense in plants expressing a linker region variant is likely because of PEN1 destabilization. Although Arabidopsis PEN1 and SYP122 syntaxins share overlapping functions in plant growth and development, PEN1 activity in disease resistance is apparently the result of a complete functional specialization. Our findings are consistent with the hypothesis that PEN1 acts in plant defense through the formation of ternary SNARE complexes and point to the existence of unknown regulatory factors. Our data indirectly support structural inferences that the four-helical coiled coil bundle in ternary SNARE complexes is formed in a sequential order from the N- to C-terminal direction.	[Pajonk, Simone; Kwon, Chian; Clemens, Natascha; Panstruga, Ralph; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany	Max Planck Society	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Bruening, Stefan/B-8505-2011; Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957	Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1212, SFB670]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society and Deutsche Forschungsgemeinschaft Grants SPP1212 (to C.K. and P.S.-L.) and SFB670 (to R.P. and P.S.-L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Assaad FF, 2001, J CELL BIOL, V152, P531, DOI 10.1083/jcb.152.3.531; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; Douchkov D, 2005, MOL PLANT MICROBE IN, V18, P755, DOI 10.1094/MPMI-18-0755; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Elliott C, 2005, BIOCHEM J, V385, P243, DOI 10.1042/BJ20040993; Fergestad T, 2001, J NEUROSCI, V21, P9142, DOI 10.1523/JNEUROSCI.21-23-09142.2001; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Heese A, 2005, PLANT PHYSIOL, V138, P2406, DOI 10.1104/pp.105.063032; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Nonet ML, 1998, J NEUROSCI, V18, P70; Nuhse TS, 2003, J BIOL CHEM, V278, P45248, DOI 10.1074/jbc.M307443200; Rao SS, 2001, EMBO J, V20, P6761, DOI 10.1093/emboj/20.23.6761; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizo J, 2006, TRENDS CELL BIOL, V16, P549; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sanderfoot A, 2007, PLANT PHYSIOL, V144, P6, DOI 10.1104/pp.106.092973; Shen QH, 2007, EMBO J, V26, P4293, DOI 10.1038/sj.emboj.7601854; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x	47	54	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26974	26984		10.1074/jbc.M805236200	http://dx.doi.org/10.1074/jbc.M805236200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678865	hybrid, Green Published			2022-12-25	WOS:000259586600018
J	Zahn, C; Jaschke, A; Weiske, J; Hommel, A; Hesse, D; Augustin, R; Lu, L; Hong, WJ; Florian, S; Scheepers, A; Joost, HG; Huber, O; Schurmann, A				Zahn, Claudia; Jaschke, Alexander; Weiske, Joerg; Hommel, Angela; Hesse, Deike; Augustin, Robert; Lu, Lei; Hong, Wanjin; Florian, Simone; Scheepers, Andrea; Joost, Hans-Georg; Huber, Otmar; Schuermann, Annette			ADP-ribosylation factor-like GTPase ARFRP1 is required for trans-golgi to plasma membrane trafficking of E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; CELL-ADHESION; N-CADHERIN; GENE-EXPRESSION; PROTEIN SYS1P; MOUSE EMBRYOS; GRIP DOMAINS; BETA-CATENIN; COMPLEX; FAMILY	ADP-ribosylation factor-related protein 1 (ARFRP1) plays a specific role in Golgi function controlling recruitment of GRIP domain proteins and ARL1 to the trans-Golgi. Deletion of the mouse Arfrp1 gene causes embryonic lethality during early gastrulation, because epiblast cells detach from the ectodermal cell layer and do not differentiate to mesodermal tissue. Here we show that in Arfrp1(-/-) embryos E-cadherin is mistargeted to intracellular compartments, whereas in control embryos it is present at the cell surface of trophectodermal and ectodermal cells. In enterocytes of intestine-specific Arfrp1 null mutants (Arfrp1vil(-/-)), E-cadherin is associated with intracellular membranes, partially colocalizing with the cis-Golgi marker GM130 or with punctae close to the cell surface. In contrast, in control enterocytes E-cadherin is exclusively located in the lateral membranes. In addition, ARL1 is dislocated from Golgi membranes to the cytosol of Arfrp1vil(-/-) enterocytes. Depletion of endogenous ARFRP1 by RNA interference leads to a dislocation of E-cadherin from the cell surface in HeLa cells and to a reduced cell aggregation in Ltk(-) Ecad cells. ARFRP1 was coimmunoprecipitated in a complex with E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and p120(ctn) from lysates of Madin-Darby canine kidney cells stably expressing myc-ARFRP1. These data indicate that knock-out of Arfrp1 disrupts the trafficking of E-cadherin through the Golgi and suggest an essential role of the GTPase in trans-Golgi network function.	[Zahn, Claudia; Jaschke, Alexander; Hommel, Angela; Hesse, Deike; Augustin, Robert; Scheepers, Andrea; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, D-14558 Nuthetal, Germany; [Weiske, Joerg; Huber, Otmar] Charite Univ Med Berlin, Cent Dept, Lab Med & Pathobiochem, D-12200 Berlin, Germany; [Lu, Lei; Hong, Wanjin] Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 138673, Singapore; [Florian, Simone] German Inst Human Nutr Potsdam Rehbrucke, Dept Toxicol, D-14558 Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schurmann, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	schuermann@dife.de	Hesse, Deike/F-5716-2018; Huber, Otmar/AAA-4548-2021; Joost, Hans-Georg/J-4462-2013; HONG, Wanjin/E-9927-2010; Lu, Lei/A-2225-2011	Hesse, Deike/0000-0001-5915-8003; Huber, Otmar/0000-0003-4359-1747; Joost, Hans-Georg/0000-0002-5860-606X; Lu, Lei/0000-0002-8192-1471; Schurmann, Annette/0000-0002-4113-4377	Deutsche Forschungsgemeinschaft [750/5-2, 750/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants Schu 750/5-2 and Schu 750/5-3 (to A.S.) and the Sonnenfeld-Stiftung (to O.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Angres B, 2001, DEV DYNAM, V221, P182, DOI 10.1002/dvdy.1146; Angst BD, 2001, J CELL SCI, V114, P625; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; DUBAND JL, 1988, DEVELOPMENT, V103, P325; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Huber O, 1999, J CELL SCI, V112, P4415; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 2003, PROTEINS CELL REGULA; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; KASPER M, 1995, HISTOCHEM CELL BIOL, V104, P383, DOI 10.1007/BF01458132; KLINOWSKA TCM, 1994, DIFFERENTIATION, V57, P7, DOI 10.1046/j.1432-0436.1994.5710007.x; Leckband D, 2002, STRUCTURE, V10, P739, DOI 10.1016/S0969-2126(02)00783-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lowe SL, 1996, J CELL SCI, V109, P209; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mueller AG, 2002, MOL CELL BIOL, V22, P1488, DOI 10.1128/MCB.22.5.1488-1494.2002; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Schurmann A, 1999, J BIOL CHEM, V274, P9744, DOI 10.1074/jbc.274.14.9744; Schurmann A, 1995, J BIOL CHEM, V270, P30657, DOI 10.1074/jbc.270.51.30657; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Wang B, 2005, AM J PHYSIOL-CELL PH, V288, pC1411, DOI 10.1152/ajpcell.00533.2004; WEILAND M, 1990, BIOCHEM J, V270, P331, DOI 10.1042/bj2700331; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zahn C, 2006, MOL MEMBR BIOL, V23, P475, DOI 10.1080/09687860600840100; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8	53	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27179	27188		10.1074/jbc.M802108200	http://dx.doi.org/10.1074/jbc.M802108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662990	hybrid			2022-12-25	WOS:000259586600038
J	Harada, K; Ogai, A; Takahashi, T; Kitakaze, M; Matsubara, H; Oh, H				Harada, Koichiro; Ogai, Akiko; Takahashi, Tomosaburo; Kitakaze, Masafumi; Matsubara, Hiroaki; Oh, Hidemasa			Crossveinless-2 controls bone morphogenetic protein signaling during early cardiomyocyte differentiation in P19 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY CARDIOMYOGENESIS; BMP INDUCTION; MESODERM; ENDODERM; HEART; GASTRULATION; INHIBITION; EXPRESSION; GROWTH; PLAYS	Increasing evidence indicates that bone morphogenetic proteins (BMPs) are crucial for cardiac induction, specification, and development. Although signaling of BMPs is tightly regulated through soluble BMP-binding proteins, how they regulate BMP signaling during cardiac differentiation remains unknown. To identify molecules responsible for BMP signaling during early cardiomyocyte differentiation of P19 cells, cDNA subtraction was performed. We found a bimodal expression of the BMP-binding protein Crossveinless-2 (Cv2) during cardiomyocyte differentiation; Cv2 is temporally expressed earlier than cardiac transcription factors such as Nkx2.5 and Tbx5 and acts as a suppressor for BMP signaling in P19 cells. We established a P19 clonal cell line harboring a cardiac alpha-myosin heavy chain promoter-driven enhanced green fluorescent protein gene to monitor cardiac differentiation by flow cytometry. Treatment with BMP2 during the first 2 days of differentiation suppressed cardiomyocyte differentiation through activation of downstream targets Smad1/5/8 protein and Id1 gene, whereas treatment with Cv2 conversely inhibited Smad1/5/8 activation and Id1 expression, leading to increased generation of cardiac cells. RNA interference-mediated knockdown (KD) of endogenous Cv2 showed increased Smad1/5/8 activation and impaired cardiomyocyte differentiation. Expression of cardiac mesoderm markers was reduced, whereas expression of Id1 and endoderm markers such as Sox7, Hnf4, and E-cadherin was induced in Cv2-kinase dead cells. These phenotypes were rescued by the addition of Cv2 protein to the culture media during the first 2 days of differentiation or co-culture with parental cells. These data suggest that Cv2 may specify cardiac mesodermal lineage through inhibition of BMP signaling at early stage of cardiogenesis.	[Harada, Koichiro; Takahashi, Tomosaburo; Matsubara, Hiroaki; Oh, Hidemasa] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 6068507, Japan; [Takahashi, Tomosaburo; Matsubara, Hiroaki] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto 6028566, Japan; [Harada, Koichiro; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Osaka 5658565, Japan; [Ogai, Akiko] Natl Cardiovasc Ctr, Res Inst, Dept Epidemiol, Osaka 5658565, Japan	Kyoto University; Kyoto Prefectural University of Medicine; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Harada, K (corresponding author), 5-7-1 Fujishiro Dai, Osaka 5658565, Japan.	kharada_kuhp@yahoo.co.jp			Japan Cardiovascular Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Japan Cardiovascular Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from Japan Cardiovascular Research Foundation, grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Coffinier C, 2002, MECH DEVELOP, V119, pS179, DOI 10.1016/S0925-4773(03)00113-8; Coles E, 2004, DEVELOPMENT, V131, P5309, DOI 10.1242/dev.01419; Conley CA, 2000, DEVELOPMENT, V127, P3947; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 1997, DEVELOPMENT, V124, P2325; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Norton JD, 2000, J CELL SCI, V113, P3897; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Saga Y, 1996, DEVELOPMENT, V122, P2769; SATER AK, 1989, DEVELOPMENT, V105, P821; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zhang HB, 1996, DEVELOPMENT, V122, P2977	38	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26705	26713		10.1074/jbc.M801485200	http://dx.doi.org/10.1074/jbc.M801485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662983	Green Published, hybrid			2022-12-25	WOS:000259341600044
J	Tsai, CY; Chou, CK; Yang, CW; Lai, YC; Liang, CC; Chen, CM; Tsai, TF				Tsai, Ching-Yen; Chou, Chen-Kung; Yang, Chu-Wen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen			Hurp deficiency in mice leads to female infertility caused by an implantation defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYO IMPLANTATION; SPINDLE CHECKPOINT; MOUSE MODELS; AURORA-A; KINETOCHORE; RAN; RECEPTOR	First revealed in cancer studies, HURP ( hepatoma up-regulated protein) is a cell cycle-associated gene with elevated expression in the G(2)/M phase. Cell culture studies have revealed that HURP is an essential factor required for spindle formation and chromosome congression during mitosis. However, the function of HURP in an in vivo context has not been explored. Wegenerated a Hurp knock-out (Hurp(-/-)) mouse to investigate the role of HURP in development under normal physiological conditions. Hurp(-/-) mice develop normally and are indistinguishable from their wild-type littermates. Interestingly, breeding experiments revealed that Hurp(-/-) females are completely infertile, whereas the males reproduce normally. Ovulation, fertilization, and pre-implantation embryo development are normal; however, the Hurp(-/-) females are unable to form implantation sites due to an inability to undergo the decidual reaction. This is caused by a defect in endometrial stromal proliferation that leads to implantation failure. Additionally, HURP expression in the uterus coincides with the implantation stage and can be induced by estrogen treatment. Our results demonstrate for the first time that HURP affects endometrial stromal proliferation during implantation but is dispensable during normal development in mice; specifically, HURP has an essential function in uterine biology.	[Tsai, Ching-Yen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Tsai, Ching-Yen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan 333, Taiwan; [Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 111, Taiwan; [Tsai, Ting-Fen] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 350, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Soochow University; National Health Research Institutes - Taiwan	Tsai, TF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.	tftsai@ym.edu.tw	Tsai, Ching-Yen/AEX-9366-2022	Tsai, Ching-Yen/0000-0001-7964-6661; Chen, Chun-Ming/0000-0001-8873-7602	National Research Program for Genomic Medicine [95HC007, NSC96-2752-B-010-004-PAE, CMRPD160471]; National Science Council [NSC96-2320-B-031-001-MY2]; Ministry of Education "Aim for the Top University Plan."; National Yang-Ming University Genome Research Center; National Science Council	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education "Aim for the Top University Plan."(Ministry of Education, Taiwan); National Yang-Ming University Genome Research Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Research Program for Genomic Medicine Grants 95HC007 and NSC96-2752-B-010-004-PAE (to T.-F.T.), CMRPD160471 (to C.-K.C.), and NSC96-2320-B-031-001-MY2 (to C.-W.Y.) from the National Science Council and by a grant from the Ministry of Education "Aim for the Top University Plan." Work performed in the Microarray and Gene Expression Analysis Core Facility of the National Yang-Ming University Genome Research Center was supported by the National Research Program for Genomic Medicine, National Science Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Chen RH, 2007, J BIOMED SCI, V14, P475, DOI 10.1007/s11373-007-9157-3; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hogan B, 1994, MANIPULATING MOUSE E; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wilde A, 2006, J CELL BIOL, V173, P829, DOI 10.1083/jcb.200605150; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	24	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26302	26306		10.1074/jbc.C800117200	http://dx.doi.org/10.1074/jbc.C800117200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676373	Green Published, hybrid			2022-12-25	WOS:000259341600002
J	Camats, M; Guil, S; Kokolo, M; Bach-Elias, M				Camats, Maria; Guil, Sonia; Kokolo, Mariette; Bach-Elias, Montse			P68 RNA Helicase (DDX5) Alters Activity of Cis- and Trans-Acting Factors of the Alternative Splicing of H-Ras	PLOS ONE			English	Article								Background: H-Ras pre-mRNA undergoes an alternative splicing process to render two proteins, namely p21 H-Ras and p19 H-Ras, due to either the exclusion or inclusion of the alternative intron D exon (IDX), respectively. p68 RNA helicase ( p68) is known to reduce IDX inclusion. Principal Findings: Here we show that p68 unwinds the stem-loop IDX-rasISS1 structure and prevents binding of hnRNP H to IDX-rasISS1. We also found that p68 alters the dynamic localization of SC35, a splicing factor that promotes IDX inclusion. The knockdown of hnRNP A1, FUS/TLS and hnRNP H resulted in upregulation of the expression of the gene encoding the SC35-binding protein, SFRS2IP. Finally, FUS/TLS was observed to upregulate p19 expression and to stimulate IDX inclusion, and in vivo RNAi-mediated depletion of hnRNP H decreased p19 H-Ras abundance. Significance: Taken together, p68 is shown to be an essential player in the regulation of H-Ras expression as well as in a vital transduction signal pathway tied to cell proliferation and many cancer processes.	[Camats, Maria; Guil, Sonia; Kokolo, Mariette; Bach-Elias, Montse] CSIC, Inst Invest Biomed, Unidad Splicing, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Camats, M (corresponding author), CSIC, Inst Invest Biomed, Unidad Splicing, Barcelona, Spain.	mbebmc@cid.csic.es	Guil, Sonia/M-8036-2015	Guil, Sonia/0000-0002-2257-3331	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC) [BFU2005-00701]; BEFI; FPU	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC)(Spanish Government); BEFI; FPU(Spanish Government)	This work was supported by Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA) and by the Plan Nacional (MEC) BFU2005-00701. M.C., S.G and M.K. were recipients of a Fmed MMA, BEFI (Carlos III) and FPU (MEC) fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; Dereure O, 2006, ANN DERMATOL VENER, V133, P731, DOI 10.1016/S0151-9638(06)71003-1; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971; Enukashvily N, 2005, J CELL SCI, V118, P611, DOI 10.1242/jcs.01605; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Guil S, 2003, CANCER RES, V63, P5178; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Li J, 2007, AM J MED GENET A, V143A, P1900, DOI 10.1002/ajmg.a.31855; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sugiura T, 2007, EXP CELL RES, V313, P782, DOI 10.1016/j.yexcr.2006.11.014; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000; Zukerberg LR, 2004, CANCER RES, V64, P202, DOI 10.1158/0008-5472.CAN-03-2833	30	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2926	10.1371/journal.pone.0002926	http://dx.doi.org/10.1371/journal.pone.0002926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698352	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600012
J	Doublet, V; Souty-Grosset, C; Bouchon, D; Cordaux, R; Marcade, I				Doublet, Vincent; Souty-Grosset, Catherine; Bouchon, Didier; Cordaux, Richard; Marcade, Isabelle			A Thirty Million Year-Old Inherited Heteroplasmy	PLOS ONE			English	Article								Due to essentially maternal inheritance and a bottleneck effect during early oogenesis, newly arising mitochondrial DNA (mtDNA) mutations segregate rapidly in metazoan female germlines. Consequently, heteroplasmy (i.e. the mixture of mtDNA genotypes within an organism) is generally resolved to homoplasmy within a few generations. Here, we report an exceptional transpecific heteroplasmy (predicting an alanine/valine alloacceptor tRNA change) that has been stably inherited in oniscid crustaceans for at least thirty million years. Our results suggest that this heteroplasmy is stably transmitted across generations because it occurs within mitochondria and therefore escapes the mtDNA bottleneck that usually erases heteroplasmy. Consistently, at least two oniscid species possess an atypical trimeric mitochondrial genome, which provides an adequate substrate for the emergence of a constitutive intra-mitochondrial heteroplasmy. Persistence of a mitochondrial polymorphism on such a deep evolutionary timescale suggests that balancing selection may be shaping mitochondrial sequence evolution in oniscid crustaceans.	[Doublet, Vincent; Souty-Grosset, Catherine; Bouchon, Didier; Cordaux, Richard; Marcade, Isabelle] Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Doublet, V (corresponding author), Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France.	isabelle.marcade@univ-poitiers.fr	Bouchon, Didier/B-2419-2012; Doublet, Vincent/D-8050-2015	Bouchon, Didier/0000-0002-4938-408X; Doublet, Vincent/0000-0002-6313-1222	Centre National de la Recherche Scientifique (CNRS) [Young Investigator ATIP award]; French Ministere de l'Education Nationale; de l'Enseignement Superieur et de la Recherche; Region Poitou-Charentes [fellowship]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale; de l'Enseignement Superieur et de la Recherche; Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This research was funded by the Centre National de la Recherche Scientifique (CNRS) and the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. VD was supported by a Ph.D. fellowship from Region Poitou-Charentes. RC was supported by a CNRS Young Investigator ATIP award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; BENTON MJ, 1993, FOSS REC, V2, P845; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; LEGRAND JJ, 2006, CRUSTACEA, P353; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcade I, 1999, HEREDITY, V83, P71, DOI 10.1038/sj.hdy.6885380; Marcade I, 2007, J MOL EVOL, V65, P651, DOI 10.1007/s00239-007-9037-5; Raimond R, 1999, GENETICS, V151, P203; SCHMALFUSS H, 2003, NATURK A, V654, P1; SOUTYGROSSET C, 1992, CR ACAD SCI III-VIE, V314, P119; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	20	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2938	10.1371/journal.pone.0002938	http://dx.doi.org/10.1371/journal.pone.0002938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698356	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600024
J	Rauchs, G; Orban, P; Schmidt, C; Albouy, G; Balteau, E; Degueldre, C; Schnackers, C; Sterpenich, V; Tinguely, G; Luxen, A; Maquet, P; Peigneux, P				Rauchs, Geraldine; Orban, Pierre; Schmidt, Christina; Albouy, Genevieve; Balteau, Evelyne; Degueldre, Christian; Schnackers, Caroline; Sterpenich, Virginie; Tinguely, Gilberte; Luxen, Andre; Maquet, Pierre; Peigneux, Philippe			Sleep Modulates the Neural Substrates of Both Spatial and Contextual Memory Consolidation	PLOS ONE			English	Article							SLOW-WAVE SLEEP; LATE NOCTURNAL SLEEP; DECLARATIVE MEMORY; RETROGRADE-AMNESIA; HUMAN NAVIGATION; BRAIN; RECOLLECTION; HIPPOCAMPUS; SYSTEMS; TASK	It is known that sleep reshapes the neural representations that subtend the memories acquired while navigating in a virtual environment. However, navigation is not process-pure, as manifold learning components contribute to performance, notably the spatial and contextual memory constituents. In this context, it remains unclear whether post-training sleep globally promotes consolidation of all of the memory components embedded in virtual navigation, or rather favors the development of specific representations. Here, we investigated the effect of post-training sleep on the neural substrates of the consolidation of spatial and contextual memories acquired while navigating in a complex 3D, naturalistic virtual town. Using fMRI, we mapped regional cerebral activity during various tasks designed to tap either the spatial or the contextual memory component, or both, 72 h after encoding with or without sleep deprivation during the first post-training night. Behavioral performance was not dependent upon post-training sleep deprivation, neither in a natural setting that engages both spatial and contextual memory processes nor when looking more specifically at each of these memory representations. At the neuronal level however, analyses that focused on contextual memory revealed distinct correlations between performance and neuronal activity in frontal areas associated with recollection processes after post-training sleep, and in the parahippocampal gyrus associated with familiarity processes in sleep-deprived participants. Likewise, efficient spatial memory was associated with posterior cortical activity after sleep whereas it correlated with parahippocampal/medial temporal activity after sleep deprivation. Finally, variations in place-finding efficiency in a natural setting encompassing spatial and contextual elements were associated with caudate activity after post-training sleep, suggesting the automation of navigation. These data indicate that post-training sleep modulates the neural substrates of the consolidation of both the spatial and contextual memories acquired during virtual navigation.	[Rauchs, Geraldine; Orban, Pierre; Schmidt, Christina; Albouy, Genevieve; Balteau, Evelyne; Degueldre, Christian; Schnackers, Caroline; Sterpenich, Virginie; Tinguely, Gilberte; Luxen, Andre; Maquet, Pierre; Peigneux, Philippe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Rauchs, Geraldine] Univ Caen Basse Normandie, Inserm, EPHE, Unite Rech U923, Caen, France; [Orban, Pierre] Univ Montreal, Funct Neuroimag Unit, Montreal, PQ H3C 3J7, Canada; [Peigneux, Philippe] Free Univ Brussels, Neuropsychol & Funct Neuroimag Res Unit, UR2NF, B-1050 Brussels, Belgium	University of Liege; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; Universite de Montreal; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Rauchs, G (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	Philippe.Peigneux@ulb.ac.be	ALBOUY, Genevieve/K-5350-2015; RAUCHS, Géraldine/L-7921-2015; ALBOUY, Genevieve/P-4723-2019	ALBOUY, Genevieve/0000-0002-5437-023X; RAUCHS, Géraldine/0000-0001-7128-2189; ALBOUY, Genevieve/0000-0002-5437-023X; Peigneux, Philippe/0000-0003-4745-1434; , Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X	Belgian Fonds de la Recherche Scientifique - FNRS; Fondation Medicale Reine Elisabeth; Special Research Funds of the University of Liege; Pole d Attraction Interuniversitaire [PAI/P5_04]; Fondation Fyssen; French Ministere de la Recherche; Belgian Fonds Leon Fredericq	Belgian Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Special Research Funds of the University of Liege; Pole d Attraction Interuniversitaire; Fondation Fyssen; French Ministere de la Recherche(Ministry of Research, France); Belgian Fonds Leon Fredericq	This study was supported by the Belgian Fonds de la Recherche Scientifique - FNRS, the Fondation Medicale Reine Elisabeth, the Special Research Funds of the University of Liege, and the Pole d Attraction Interuniversitaire PAI/P5_04. GR was supported by grants from the Fondation Fyssen and the FNRS. EB, PO, VS, GT, ChS and PM are supported by the FNRS. GA was supported by a PhD grant from the French Ministere de la Recherche. CS was supported by the FNRS and the Belgian Fonds Leon Fredericq. All funders had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Chan AHD, 2004, NEUROIMAGE, V22, P1128, DOI 10.1016/j.neuroimage.2004.02.034; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; DEROVER M, 2007, HUM BRAIN MAPP 1019; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Drummond SPA, 2004, SLEEP, V27, P445; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; ELLIS BW, 1981, SLEEP, V4, P93, DOI 10.1093/sleep/4.1.93; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Gardini S, 2006, NEUROIMAGE, V30, P645, DOI 10.1016/j.neuroimage.2005.10.012; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iaria G, 2003, J NEUROSCI, V23, P5945; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; MAQUET P, 2003, SLEEP BRAIN PLASTICI, P396; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Ojemann GA, 2002, NAT NEUROSCI, V5, P64, DOI 10.1038/nn785; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; PENNY WD, 2003, HUMAN BRAIN FUNCTION, P843; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; RANGANATH C, 2003, COGNITIVE NEUROSCIEN, P83; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rauchs G, 2008, HIPPOCAMPUS, V18, P503, DOI 10.1002/hipo.20411; Rauchs G, 2007, NEUROBIOL AGING, V28, P1410, DOI 10.1016/j.neurobiolaging.2006.06.005; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Woodruff CC, 2005, NEUROPSYCHOLOGIA, V43, P1022, DOI 10.1016/j.neuropsychologia.2004.10.013; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	62	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2949	10.1371/journal.pone.0002949	http://dx.doi.org/10.1371/journal.pone.0002949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698363	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600035
J	Lugo, E; Doti, R; Faubert, J				Lugo, Eduardo; Doti, Rafael; Faubert, Jocelyn			Ubiquitous Crossmodal Stochastic Resonance in Humans: Auditory Noise Facilitates Tactile, Visual and Proprioceptive Sensations	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; HUMAN-BRAIN; SYNCHRONIZATION; SENSITIVITY; STIMULI	Background: Stochastic resonance is a nonlinear phenomenon whereby the addition of noise can improve the detection of weak stimuli. An optimal amount of added noise results in the maximum enhancement, whereas further increases in noise intensity only degrade detection or information content. The phenomenon does not occur in linear systems, where the addition of noise to either the system or the stimulus only degrades the signal quality. Stochastic Resonance (SR) has been extensively studied in different physical systems. It has been extended to human sensory systems where it can be classified as unimodal, central, behavioral and recently crossmodal. However what has not been explored is the extension of this crossmodal SR in humans. For instance, if under the same auditory noise conditions the crossmodal SR persists among different sensory systems. Methodology/Principal Findings: Using physiological and psychophysical techniques we demonstrate that the same auditory noise can enhance the sensitivity of tactile, visual and propioceptive system responses to weak signals. Specifically, we show that the effective auditory noise significantly increased tactile sensations of the finger, decreased luminance and contrast visual thresholds and significantly changed EMG recordings of the leg muscles during posture maintenance. Conclusions/Significance: We conclude that crossmodal SR is a ubiquitous phenomenon in humans that can be interpreted within an energy and frequency model of multisensory neurons spontaneous activity. Initially the energy and frequency content of the multisensory neurons' activity (supplied by the weak signals) is not enough to be detected but when the auditory noise enters the brain, it generates a general activation among multisensory neurons of different regions, modifying their original activity. The result is an integrated activation that promotes sensitivity transitions and the signals are then perceived. A physiologically plausible model for crossmodal stochastic resonance is presented.	[Lugo, Eduardo; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, E (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	jocelyn.faubert@umontreal.ca	Lugo, J. Eduardo Lugo/A-3372-2011; Faubert, Jocelyn/E-2207-2011		NSERC [Essilor Research Chair]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the NSERC-Essilor Research Chair and an NSERC operating grant.	Allard R, 2007, VISION RES, V47, P1129, DOI 10.1016/j.visres.2007.01.010; Allard R, 2006, J VISION, V6, P322, DOI 10.1167/6.4.3; Badzey RL, 2005, NATURE, V437, P995, DOI 10.1038/nature04124; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Calvert G., 2004, HDB MULTISENSORY PRO; Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gobbele R, 2003, NEUROIMAGE, V20, P503, DOI 10.1016/S1053-8119(03)00312-4; Gong YF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031904; GREEN DM, 1966, SIGNAL DETECTION THE, P87; HARPER DW, 1979, PERCEPT MOTOR SKILL, V48, P791, DOI 10.2466/pms.1979.48.3.791; Hidaka I, 2000, PHYS REV LETT, V85, P3740, DOI 10.1103/PhysRevLett.85.3740; Ivey C, 1998, J NEUROPHYSIOL, V79, P1879, DOI 10.1152/jn.1998.79.4.1879; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Laurienti PJ, 2006, NEUROBIOL AGING, V27, P1155, DOI 10.1016/j.neurobiolaging.2005.05.024; LUGO JE, 2008, PSYCHOL SCI IN PRESS; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Ries DT, 2007, HEARING RES, V228, P136, DOI 10.1016/j.heares.2007.01.027; Sato S, 2004, J SOUND VIB, V277, P511, DOI 10.1016/j.jsv.2004.03.012; SHULGIN B, 1995, PHYS REV LETT, V75, P4157, DOI 10.1103/PhysRevLett.75.4157; SIMIU E, 2002, PRIN SER APPL MATH, P1; SIMON A, 1992, PHYS REV LETT, V68, P3375, DOI 10.1103/PhysRevLett.68.3375; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; WALLACE MT, 1992, EXP BRAIN RES, V91, P484; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	35	82	84	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2860	10.1371/journal.pone.0002860	http://dx.doi.org/10.1371/journal.pone.0002860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682745	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600016
J	Fazekas, AJ; Burgess, KS; Kesanakurti, PR; Graham, SW; Newmaster, SG; Husband, BC; Percy, DM; Hajibabaei, M; Barrett, SCH				Fazekas, Aron J.; Burgess, Kevin S.; Kesanakurti, Prasad R.; Graham, Sean W.; Newmaster, Steven G.; Husband, Brian C.; Percy, Diana M.; Hajibabaei, Mehrdad; Barrett, Spencer C. H.			Multiple Multilocus DNA Barcodes from the Plastid Genome Discriminate Plant Species Equally Well	PLOS ONE			English	Article							LAND PLANTS; IDENTIFICATION; REGIONS; PHYLOGENIES; CONFIDENCE; IDENTIFY; TAXONOMY; RBCL	A universal barcode system for land plants would be a valuable resource, with potential utility in fields as diverse as ecology, floristics, law enforcement and industry. However, the application of plant barcoding has been constrained by a lack of consensus regarding the most variable and technically practical DNA region(s). We compared eight candidate plant barcoding regions from the plastome and one from the mitochondrial genome for how well they discriminated the monophyly of 92 species in 32 diverse genera of land plants (N = 251 samples). The plastid markers comprise portions of five coding (rpoB, rpoC1, rbcL, matK and 23S rDNA) and three non-coding (trnH-psbA, atpF-atpH, and psbK-psbI) loci. Our survey included several taxonomically complex groups, and in all cases we examined multiple populations and species. The regions differed in their ability to discriminate species, and in ease of retrieval, in terms of amplification and sequencing success. Single locus resolution ranged from 7% (23S rDNA) to 59% (trnH-psbA) of species with well-supported monophyly. Sequence recovery rates were related primarily to amplification success (85-100% for plastid loci), with matK requiring the greatest effort to achieve reasonable recovery (88% using 10 primer pairs). Several loci (matK, psbK-psbI, trnH-psbA) were problematic for generating fully bidirectional sequences. Setting aside technical issues related to amplification and sequencing, combining the more variable plastid markers provided clear benefits for resolving species, although with diminishing returns, as all combinations assessed using four to seven regions had only marginally different success rates (69-71%; values that were approached by several two-and three-region combinations). This performance plateau may indicate fundamental upper limits on the precision of species discrimination that is possible with DNA barcoding systems that include moderate numbers of plastid markers. Resolution to the contentious debate on plant barcoding should therefore involve increased attention to practical issues related to the ease of sequence recovery, global alignability, and marker redundancy in multilocus plant DNA barcoding systems.	[Fazekas, Aron J.; Kesanakurti, Prasad R.; Newmaster, Steven G.; Husband, Brian C.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Burgess, Kevin S.; Barrett, Spencer C. H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Graham, Sean W.; Percy, Diana M.] Univ British Columbia, UBC Botanical Garden & Ctr Plant Res, Dept Bot, Vancouver, BC, Canada; [Hajibabaei, Mehrdad] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON, Canada	University of Guelph; University of Toronto; University of British Columbia; University of Guelph	Fazekas, AJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	afazekas@uoguelph.ca	Kesanakurti, Prasad/GYQ-5526-2022; Barrett, Spencer C.H./S-5782-2019; Barrett, Spencer CH/M-3751-2013; 赵, 鹏/B-8401-2009; Graham, Sean W/L-3944-2014; Kesanakurti, Prasad/AAO-7478-2021	Barrett, Spencer C.H./0000-0002-7762-3455; Graham, Sean W/0000-0001-8209-5231; 	Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network	Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network(Genome Canada)	This research was funded by a grant from Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Craft KJ, 2006, CAN J FOREST RES, V36, P206, DOI 10.1139/x05-234; Crisp Michael D., 1996, Telopea, V6, P813; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; FELSENSTEIN J, 1993, SYST BIOL, V42, P193, DOI 10.2307/2992541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; HALL T, 2007, IBIS BIOSCIENCES; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; *KEW, 2007, DNA BARC PHAS 2 UPD; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee HL, 2007, 2 INT BARC LIF C TAI; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Noyes RD, 2000, GENETICS, V155, P379; OLMSTEAD RG, 1995, SYST BOT, V20, P623, DOI 10.2307/2419814; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Prance GT, 2001, TAXON, V50, P345, DOI 10.2307/1223885; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; RAMBAUT A, 2002, SE A1 SEQUENCE ALIGN; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Swofford DL, 2001, PAUP PHYLOGENETIC AN; TABERLET P, 2006, NUCLEIC ACIDS RES, V35, pE1; Xiang LL, 2000, AM J BOT, V87, P1175, DOI 10.2307/2656654	43	448	510	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2802	10.1371/journal.pone.0002802	http://dx.doi.org/10.1371/journal.pone.0002802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665273	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300021
J	Melchers, J; Diechtierow, M; Feher, K; Sinning, I; Tews, I; Krauth-Siegel, RL; Muhle-Goll, C				Melchers, Johannes; Diechtierow, Michael; Feher, Krisztina; Sinning, Irmgard; Tews, Ivo; Krauth-Siegel, R. Luise; Muhle-Goll, Claudia			Structural Basis for a Distinct Catalytic Mechanism in Trypanosoma brucei Tryparedoxin Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; CRYSTAL-STRUCTURE; SEQUENCE IDENTITY; AMINO-ACIDS; PROTEIN; TRYPANOTHIONE; SPECIFICITY; METABOLISM; ASSIGNMENT; DYNAMICS	Trypanosoma brucei, the causative agent of African sleeping sickness, encodes three cysteine homologues (Px I-III) of classical selenocysteine-containing glutathione peroxidases. The enzymes obtain their reducing equivalents from the unique trypanothione (bis(glutathionyl) spermidine)/tryparedoxin system. During catalysis, these tryparedoxin peroxidases cycle between an oxidized form with an intramolecular disulfide bond between Cys(47) and Cys(95) and the reduced peroxidase with both residues in the thiol state. Here we report on the three-dimensional structures of oxidized T. brucei Px III at 1.4 angstrom resolution obtained by x-ray crystallography and of both the oxidized and the reduced protein determined by NMR spectroscopy. Px III is a monomeric protein unlike the homologous poplar thioredoxin peroxidase (TxP). The structures of oxidized and reduced Px III are essentially identical in contrast to what was recently found for TxP. In Px III, Cys(47), Gln(82), and Trp(137) do not form the catalytic triad observed in the selenoenzymes, and related proteins and the latter two residues are unaffected by the redox state of the protein. The mutational analysis of three conserved lysine residues in the vicinity of the catalytic cysteines revealed that exchange of Lys(107) against glutamate abrogates the reduction of hydrogen peroxide, whereas Lys(97) and Lys(99) play a crucial role in the interaction with tryparedoxin.	[Melchers, Johannes; Feher, Krisztina; Muhle-Goll, Claudia] Karlsruhe Inst Technol, Inst Biol Grenzflachen IBG 2, D-76021 Karlsruhe, Germany; [Melchers, Johannes; Diechtierow, Michael; Sinning, Irmgard; Tews, Ivo; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Feher, Krisztina; Muhle-Goll, Claudia] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Max Planck Society	Muhle-Goll, C (corresponding author), Karlsruhe Inst Technol, Inst Biol Grenzflachen IBG 2, POB 3640, D-76021 Karlsruhe, Germany.	claudia.muhle@kit.edu	Tews, Ivo/A-2750-2010; Muhle-Goll, Claudia/AAM-6070-2021	Tews, Ivo/0000-0002-4704-1139; 	Deutsche Forschungsgemeinschaft [SFB 544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 544, project B3 (to L.K.-S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Alphey MS, 2003, J BIOL CHEM, V278, P25919, DOI 10.1074/jbc.M301526200; Aumann KD, 1997, BIOMED ENVIRON SCI, V10, P136; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brigelius-Flohe R, 2003, BIOFACTORS, V17, P93, DOI 10.1002/biof.5520170110; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burley SK, 2002, CURR OPIN STRUC BIOL, V12, P383, DOI 10.1016/S0959-440X(02)00330-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W.L., 2002, DELANO SCI; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Evrard C, 2004, J MOL BIOL, V337, P1079, DOI 10.1016/j.jmb.2004.02.017; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Foloppe N, 2007, J MOL BIOL, V372, P798, DOI 10.1016/j.jmb.2007.05.101; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung BG, 2002, J BIOL CHEM, V277, P12572, DOI 10.1074/jbc.M110791200; Karplus P. Andrew, 2007, V44, P41; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krauth-Siegel Luise R., 2007, V44, P231; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Prabhakar R, 2005, BIOCHEMISTRY-US, V44, P11864, DOI 10.1021/bi050815q; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Scheerer P, 2007, BIOCHEMISTRY-US, V46, P9041, DOI 10.1021/bi700840d; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Utomo A, 2004, J BIOL CHEM, V279, P43522, DOI 10.1074/jbc.M407141200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; YANG YF, 1991, J BIOL CHEM, V266, P12759	57	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30401	30411		10.1074/jbc.M803563200	http://dx.doi.org/10.1074/jbc.M803563200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18684708	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000260366900083
J	Amano, K; Ichida, F; Sugita, A; Hata, K; Wada, M; Takigawa, Y; Nakanishi, M; Kogo, M; Nishimura, R; Yoneda, T				Amano, Katsuhiko; Ichida, Fumitaka; Sugita, Atsushi; Hata, Kenji; Wada, Masahiro; Takigawa, Yoko; Nakanishi, Masako; Kogo, Mikihiko; Nishimura, Riko; Yoneda, Toshiyuki			Msx2 Stimulates Chondrocyte Maturation by Controlling Ihh Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-DEVELOPMENT; INDIAN-HEDGEHOG; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; MESENCHYMAL CELLS; IN-VITRO; PROTEIN; GROWTH; ROLES; BINDING	Several studies indicated that a homeobox gene, Msx2, is implicated in regulation of skeletal development by controlling enchondral ossification as well as membranous ossification. However, the molecular basis by which Msx2 conducts chondrogenesis is currently unclear. In this study, we examined the role of Msx2 in chondrocyte differentiation using mouse primary chondrocytes and embryonic metatarsal explants. Treatment with BMP2 up-regulated the expression of Msx2 mRNA along with chondrocyte differentiation in murine primary chondrocytes. Overexpression of wild-type Msx2 stimulated calcification of primary chondrocytes in the presence of BMP2. We also found that constitutively active Msx2(caMsx2) enhanced BMP2 dependent calcification more efficiently than wild- type Msx2. Consistently, caMsx2 overexpression up-regulated the expression of alkaline phosphatase and collagen type X induced by BMP2. Furthermore, organ culture experiments using mouse embryonic metatarsals indicated that caMsx2 clearly stimulated the maturation of chondrocytes into the prehypertrophic and hypertrophic stages in the presence of BMP2. In contrast, knockdown of Msx2 inhibited maturation of primary chondrocytes. The stimulatory effect of Msx2 on chondrocyte maturation was enhanced by overexpression of Smad1 and Smad4 but inhibited by Smad6, an inhibitory Smad for BMP2 signaling. These data suggest that Msx2 requires BMP2/Smad signaling for its chondrogenic action. In addition, caMsx2 overexpression induced Ihh (Indian hedgehog) expression in mouse primary chondrocytes. Importantly, treatment with cyclopamine, a specific inhibitor for hedgehogs, blocked Msx2-induced chondrogenesis. Collectively, our results indicated that Msx2 promotes the maturation of chondrocytes, at least in part, through up-regulating Ihh expression.	[Amano, Katsuhiko; Ichida, Fumitaka; Sugita, Atsushi; Hata, Kenji; Wada, Masahiro; Takigawa, Yoko; Nakanishi, Masako; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biol, Suita, Osaka 5650871, Japan; [Amano, Katsuhiko; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg, Suita, Osaka 5650871, Japan; [Sugita, Atsushi] Osaka Univ, Sch Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Nishimura, R (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Science, Sports, Japan; Naito Foundation	Ministry of Education, Science, Sports, Japan; Naito Foundation(Naito Memorial Foundation)	This work was supported by the Ministry of Education, Science, Sports, Japan, a culture grant-in-aid for scientific research, the Naito Foundation, and the Novartis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Carlberg AL, 2001, DIFFERENTIATION, V67, P128, DOI 10.1046/j.1432-0436.2001.670405.x; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Nifuji A, 2004, ENDOCRINOLOGY, V145, P3434, DOI 10.1210/en.2003-0685; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	34	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29513	29521		10.1074/jbc.M803681200	http://dx.doi.org/10.1074/jbc.M803681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682398	Green Published, hybrid			2022-12-25	WOS:000260179900077
J	Choi, CL; Claridge, SA; Garner, EC; Alivisatos, AP; Mullins, RD				Choi, Charina L.; Claridge, Shelley A.; Garner, Ethan C.; Alivisatos, A. Paul; Mullins, R. Dyche			Protein-nanocrystal conjugates support a single filament polymerization model in R1 plasmid segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA SEGREGATION; GOLD; NANOPARTICLE; COMPLEX	To ensure inheritance by daughter cells, many low-copy number bacterial plasmids, including the R1 drug-resistance plasmid, encode their own DNA segregation systems. The par operon of plasmid R1 directs construction of a simple spindle structure that converts free energy of polymerization of an actin-like protein, ParM, into work required to move sister plasmids to opposite poles of rod-shaped cells. The structures of individual components have been solved, but little is known about the ultrastructure of the R1 spindle. To determine the number of ParM filaments in a minimal R1 spindle, we used DNA-gold nanocrystal conjugates as mimics of the R1 plasmid. We found that each end of a single polar ParM filament binds to a single ParR/parC-gold complex, consistent with the idea that ParM filaments bind in the hollow core of the ParR/parC ring complex. Our results further suggest that multifilament spindles observed in vivo are associated with clusters of plasmids segregating as a unit.	[Garner, Ethan C.; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Choi, Charina L.; Claridge, Shelley A.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Choi, Charina L.; Claridge, Shelley A.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mullins, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	dyche@mullinslab.ucsf.edu	Garner, Ethan/J-4025-2014; Alivisatos, Paul/N-8863-2015	Garner, Ethan/0000-0003-0141-3555; Alivisatos, Paul/0000-0001-6895-9048	National Institutes of Health [PN2 EY016546, 5R01GM079556-03]; University of California San Francisco/University of California Berkeley Nanomedicine Development Center; University of California San Francisco; Sandler Family Supporting Foundation; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079556, R01GM061010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco/University of California Berkeley Nanomedicine Development Center; University of California San Francisco(University of California System); Sandler Family Supporting Foundation; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant PN2 EY016546 to the University of California San Francisco/University of California Berkeley Nanomedicine Development Center as administered through the University of California San Francisco. This work was also supported by grants from the Sandler Family Supporting Foundation, National Institutes of Health Grant 5R01GM079556-03, and the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231 (to R. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Claridge SA, 2005, CHEM MATER, V17, P1628, DOI 10.1021/cm0484089; Claridge SA, 2008, NANO LETT, V8, P1202, DOI 10.1021/nl0802032; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; NORDSTROM K, 1972, J BACTERIOL, V110, P562; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e	22	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28081	28086		10.1074/jbc.M803833200	http://dx.doi.org/10.1074/jbc.M803833200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658133	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000259969300010
J	Lewarchik, CM; Peters, KW; Qi, JJ; Frizzell, RA				Lewarchik, Christopher M.; Peters, Kathryn W.; Qi, Juanjuan; Frizzell, Raymond A.			Regulation of CFTR trafficking by its R domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; CHLORIDE CHANNEL; PLASMA-MEMBRANE; XENOPUS-OOCYTES; EPITHELIAL-CELLS; SODIUM-CHANNEL; CL-CHANNELS; G-PROTEINS; HALF-LIFE	Phosphorylation of the R domain is required for cystic fibrosis transmembrane conductance regulator (CFTR) channel gating, and cAMP/protein kinase A (PKA) simulation can also elicit insertion of CFTR into the plasma membrane from intracellular compartments (Bertrand, C. A., and Frizzell, R. A. (2003) Am. J. Physiol. 285, C1-C18). We evaluated the structural basis of regulated CFTR trafficking by determining agonist-evoked increases in plasma membrane capacitance ( Cm) of Xenopus oocytes expressing CFTR deletion mutants. Expression of CFTR as a split construct that omitted the R domain (Delta amino acids 635-834) produced a channel with elevated basal current (I-m) and no Delta I-m or trafficking response (Delta C-m) upon cAMP/PKA stimulation, indicating that the structure(s) required for regulated CFTR trafficking are contained within the R domain. Additional deletions showed that removal of amino acids 817 838, a 22-amino acid conserved helical region having a net charge of -9, termed NEG2 (Xie, J., Adams, L. M., Zhao, J., Gerken, T. A., Davis, P. B., and Ma, J. ( 2002) J. Biol. Chem. 277, 23019-23027), produced a channel with regulated gating that lacked the agonist-induced increase in CFTR trafficking. Injection of NEG2 peptides into oocytes expressing split Delta NEG2 CFTR prior to stimulation restored the agonist-evoked Delta C-m, consistent with the concept that this sequence mediates the regulated trafficking event. In support of this idea, Delta NEG2 CFTR escaped from the inhibition of wild type CFTR trafficking produced by overexpression of syntaxin 1A. These observations suggest that the NEG2 region at the C terminus of the R domain allows stabilization of CFTR in a regulated intracellular compartment from which it traffics to the plasma membrane in response to cAMP/PKA stimulation.	[Lewarchik, Christopher M.; Peters, Kathryn W.; Qi, Juanjuan; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu			National Institutes of Health [DK68196, DK72506]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK68196 and DK72506. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameen NA, 2003, AM J PHYSIOL-CELL PH, V284, pC429, DOI 10.1152/ajpcell.00261.2002; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chambers LA, 2007, RESP PHYSIOL NEUROBI, V159, P256, DOI 10.1016/j.resp.2007.06.005; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Condliffe SB, 2003, J BIOL CHEM, V278, P12796, DOI 10.1074/jbc.M210772200; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; CUNNINGHAM SA, 1992, AM J PHYSIOL, V262, pC783, DOI 10.1152/ajpcell.1992.262.3.C783; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; Lehrich RW, 1998, J CLIN INVEST, V101, P737, DOI 10.1172/JCI803; Liu XH, 2001, J GEN PHYSIOL, V118, P433, DOI 10.1085/jgp.118.4.433; Lukacs GL, 1997, BIOCHEM J, V328, P353; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma JJ, 2000, NEWS PHYSIOL SCI, V15, P154; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Peters KW, 1999, AM J PHYSIOL-CELL PH, V277, pC174, DOI 10.1152/ajpcell.1999.277.1.C174; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; RIORDAN JR, 1989, SCIENCE, V245, P1066; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Schillers H, 2001, J MEMBRANE BIOL, V180, P205, DOI 10.1007/s002320010071; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; SCHWIEBERT EM, 1994, AM J PHYSIOL, V267, pC272, DOI 10.1152/ajpcell.1994.267.1.C272; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Takahashi A, 1996, AM J PHYSIOL-CELL PH, V271, pC1887, DOI 10.1152/ajpcell.1996.271.6.C1887; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Weber WM, 1999, PFLUG ARCH EUR J PHY, V438, P561, DOI 10.1007/s004240051076; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200	60	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28401	28412		10.1074/jbc.M800516200	http://dx.doi.org/10.1074/jbc.M800516200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694937	Green Published, hybrid			2022-12-25	WOS:000259969300042
J	van Hellemond, EW; Mazon, H; Heck, AJ; van den Heuvel, RHH; Heuts, DPHM; Janssen, DB; Fraaije, MW				van Hellemond, Erik W.; Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.; Heuts, Dominic P. H. M.; Janssen, Dick B.; Fraaije, Marco W.			ADP competes with FAD binding in putrescine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN ADENINE-DINUCLEOTIDE; MONOAMINE-OXIDASE; MICROCOCCUS-RUBENS; DRUG TARGET; FLAVINYLATION; POLYAMINES; RECONSTITUTION; FLAVOPROTEINS; DISCOVERY; ENZYME	Putrescine oxidase from Rhodococcus erythropolis NCIMB 11540 (PuORh) is a soluble homodimeric flavoprotein of 100 kDa, which catalyzes the oxidative deamination of putrescine and some other aliphatic amines. The initial characterization of PuORh uncovered an intriguing feature: the enzyme appeared to contain only one noncovalently bound FAD cofactor per dimer. Here we show that this low FAD/protein ratio is the result of tight binding of ADP, thereby competing with FAD binding. MS analysis revealed that the enzyme is isolated as a mixture of dimers containing two molecules of FAD, two molecules ADP, or one FAD and one ADP molecule. In addition, based on a structural model of PuORh that was built using the crystal structure of human monoamine oxidase B (MAO-B), we constructed an active mutant enzyme, PuORh A394C, that contains covalently bound FAD. These findings show that the covalent FAD-protein linkage can be formed autocatalytically and hint to a new-found rationale for covalent flavinylation: covalent flavinylation may have evolved to prevent binding of ADP or related cellular compounds, which would prohibit formation of flavinylated and functional enzyme.	[van Hellemond, Erik W.; Heuts, Dominic P. H. M.; Janssen, Dick B.; Fraaije, Marco W.] Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.] Univ Utrecht, Biomol Mass Spectrometry & Proteom Grp, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University	Fraaije, MW (corresponding author), Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	Fraaije, Marco/E-8421-2014; Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Fraaije, Marco/0000-0001-6346-5014	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Integrated Biosynthesis Organic Synthesis (IBOS) program of the Netherlands Organisation for Scientific Research (NWO). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2004, FEBS LETT, V564, P225, DOI 10.1016/S0014-5793(04)00209-1; Bruckner RC, 2007, BIOCHEMISTRY-US, V46, P819, DOI 10.1021/bi062087s; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; DESA RJ, 1972, J BIOL CHEM, V247, P5527; Edmondson DE, 2004, NEUROTOXICOLOGY, V25, P63, DOI 10.1016/S0161-813X(03)00114-1; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Hassan-Abdallah A, 2006, BIOCHEMISTRY-US, V45, P9454, DOI 10.1021/bi0607352; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Inaba Y, 2004, BIOSENS BIOELECTRON, V20, P833, DOI 10.1016/j.bios.2004.03.022; ISHIZUKA H, 1993, J GEN MICROBIOL, V139, P425, DOI 10.1099/00221287-139-3-425; ISOBE K, 1987, CLIN BIOCHEM, V20, P157, DOI 10.1016/S0009-9120(87)80113-3; Jin JF, 2007, FEBS J, V274, P2311, DOI 10.1111/j.1742-4658.2007.05767.x; Kay CWM, 2007, J AM CHEM SOC, V129, P16091, DOI 10.1021/ja076090q; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Nandigama RK, 2000, J BIOL CHEM, V275, P20527, DOI 10.1074/jbc.M002132200; Rochette JF, 2005, ANAL BIOCHEM, V336, P305, DOI 10.1016/j.ab.2004.10.027; SCHILLING B, 1995, MOL GEN GENET, V247, P430, DOI 10.1007/BF00293144; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; van Hellemond EW, 2008, APPL MICROBIOL BIOT, V78, P455, DOI 10.1007/s00253-007-1310-4; VANBERKEL WJH, 1988, EUR J BIOCHEM, V178, P197; WU HF, 1993, MOL PHARMACOL, V43, P888; YAMADA H, 1965, AGR BIOL CHEM TOKYO, V29, P1148, DOI 10.1080/00021369.1965.10858523; YAMADA H, 1965, AGR BIOL CHEM TOKYO, V29, P260, DOI 10.1080/00021369.1965.10858382; Yamada H., 1971, METHODS ENZYMOL B, V17, P726; ZHOU BP, 1995, J BIOL CHEM, V270, P23653, DOI 10.1074/jbc.270.40.23653; Zhou BP, 1998, J BIOL CHEM, V273, P14862, DOI 10.1074/jbc.273.24.14862	31	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28259	28264		10.1074/jbc.M803255200	http://dx.doi.org/10.1074/jbc.M803255200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678871	hybrid, Green Published			2022-12-25	WOS:000259969300027
J	Dammeyer, T; Hofmann, E; Frankenberg-Dinkel, N				Dammeyer, Thorben; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Phycoerythrobilin synthase (PebS) of a marine virus - Crystal structures of the biliverdin complex and the substrate-free form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOCYANOBILIN-FERREDOXIN OXIDOREDUCTASE; CYANOBACTERIAL PHYCOCYANOBILIN; PHYTOCHROMOBILIN SYNTHASE; DIFFRACTION DATA; BIOSYNTHESIS; BILIN; PCYA; REDUCTION; FAMILY; HY2	The reddish purple open chain tetrapyrrole pigment phycoerythrobilin (PEB; A(lambda max) similar to 550nm) is an essential chromophore of the light-harvesting phycobiliproteins of most cyanobacteria, red algae, and cryptomonads. The enzyme phycoerythrobilin synthase (PebS), recently discovered in a marine virus infecting oceanic cyanobacteria of the genus Prochlorococcus (cyanophage PSSM-2), is a new member of the ferredoxin-dependent bilin reductase (FDBR) family. In a formal four-electron reduction, the substrate biliverdin IX alpha is reduced to yield 3Z-PEB, a reaction that commonly requires the action of two individual FDBRs. The first reaction catalyzed by PebS is the reduction of the 15,16-methine bridge of the biliverdin IX alpha tetrapyrrole system. This reaction is exclusive to PEB biosynthetic enzymes. The second reduction site is the A-ring 2,3,3(1),3(2)-diene system, the most common target of FDBRs. Here, we present the first crystal structures of a PEB biosynthetic enzyme. Structures of the substrate complex were solved at 1.8- and 2.1-angstrom resolution and of the substrate-free form at 1.55-angstrom resolution. The overall folding revealed an alpha/beta/alpha-sandwich with similarity to the structure of phycocyanobilin: ferredoxin oxidoreductase (PcyA). The substrate-binding site is located between the central beta-sheet and C-terminal alpha-helices. Eight refined molecules with bound substrate, from two different crystal forms, revealed a high flexibility of the substrate-binding pocket. The substrate was found to be either in a planar porphyrin-like conformation or in a helical conformation and is coordinated by a conserved aspartate/asparagine pair from the beta-sheet side. From the alpha-helix side, a conserved highly flexible aspartate/proline pair is involved in substrate binding and presumably catalysis.	[Dammeyer, Thorben; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Dept Biol & Biotechnol, D-44780 Bochum, Germany	Ruhr University Bochum	Hofmann, E (corresponding author), Ruhr Univ Bochum, Dept Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	eckhard.hofmann@bph.rub.de; nicole.frankenberg@rub.de	Frankenberg-Dinkel, Nicole/C-1058-2011; Hofmann, Eckhard/GPF-5024-2022	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X; Dammeyer, Thorben/0000-0002-3542-1273	Deutsche Forschungsgemeinschaft [Teilprojekt C6, Teilprojekt C8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 480 from the Deutsche Forschungsgemeinschaft (Teilprojekt C6 and C8; to E. H. and N. F.-D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blankenship RE, 2001, NAT STRUCT BIOL, V8, P94, DOI 10.1038/84191; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2007, FEMS MICROBIOL LETT, V271, P251, DOI 10.1111/j.1574-6968.2007.00715.x; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2006, FEBS LETT, V580, P3823, DOI 10.1016/j.febslet.2006.05.075; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KROIS D, 1995, MONATSH CHEM, V126, P349, DOI 10.1007/BF00816104; KROIS D, 1991, MONATSH CHEM, V122, P495, DOI 10.1007/BF00809802; KRONICK MN, 1983, CLIN CHEM, V29, P1582; LASKOWSKI R, 1993, B ENVIRON CONTAM TOX, V50, P232, DOI 10.1007/BF00191727; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PASTORE A, 1989, EUR BIOPHYS J BIOPHY, V16, P363, DOI 10.1007/BF00257885; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; RUDIGER W, 1980, Z NATURFORSCH C, V35, P763; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TERRY MJ, 1995, J BIOL CHEM, V270, P11111, DOI 10.1074/jbc.270.19.11111; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2006, J BIOL CHEM, V281, P3127, DOI 10.1074/jbc.M510126200; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439	40	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27547	27554		10.1074/jbc.M803765200	http://dx.doi.org/10.1074/jbc.M803765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662988	hybrid, Green Published			2022-12-25	WOS:000259719200025
J	Murai, J; Ikegami, D; Okamoto, M; Yoshikawa, H; Tsumaki, N				Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Yoshikawa, Hideki; Tsumaki, Noriyuki			Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; COLLAGEN GENE; CTCF; EXPRESSION; BINDING; ELEMENTS; GENOME; DOMAIN; ALPHA; LINE	The retinoid X receptor beta gene (Rxrb) is located just upstream of the alpha 2(XI) collagen chain gene (Col11a2) in a head-to-tail manner. However, the domain structures of these genes are unknown. Col11a2 is specifically expressed in cartilage. In the present study, we found Rxrb expression in various tissues with low expression in the cartilage. Col11a2 1st intron enhancer directed cartilage specific expression when linked to the heterologous promoter in transgenic mice. These results suggest the presence of enhancer-blocking elements that insulate Rxrb promoter from the Col11a2 enhancer. So far, most of insulators examined in vertebrates contain a binding site for CTCF. We found two possible CTCF-binding sites: one (11P) in the intergenic region between Rxrb and Col11a2 by electrophoretic mobility shift assays, and the other in the 4th intron of RXRB by data base search. To examine the function of these elements, we prepared bacterial artificial chromosome (BAC) transgene constructs containing a 142-kb genomicDNAinsert with RXRB and COL11A2 sequences in the middle. Mutation of 11P significantly decreased the RXRB promoter activity in muscular cells and significantly increased expression levels of RXRB in chondrosarcoma cells. In transgenic mouse assays, the wild-type BAC transgene partly recapitulated endogenous Rxrb expression patterns. A 507-bp deletion mutation including 11P enhanced the cartilage-specific activity of the RXRB promoter in BACtransgenic mice. Chromatin immunoprecipitation analysis showed that CTCF was associated with RX4, but not with 11P. Our results showed that the intergenic sequence including 11P insulates Rxrb promoter from Col11a2 enhancer, possibly associating with unknown factors that recognize a motif similar to CTCF.	[Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Tsumaki, Noriyuki] Osaka Univ, Dept Bone & Cartilage Biol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Yoshikawa, Hideki] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsumaki, N (corresponding author), Osaka Univ, Dept Bone & Cartilage Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ntsumaki@dbcb.med.osaka-u.ac.jp	Murai, Junko/AAU-9516-2021	Tsumaki, Noriyuki/0000-0002-0520-3654	Ministry of Education, Culture, Sports, Science and Technology of Japan [19659378]; Health and Labor Sciences Research Grants of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants of Japan	This work was supported in part by Scientific Research Grants 18390415 and 19659378 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Health and Labor Sciences Research Grants of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Charron G, 1995, J BIOL CHEM, V270, P30604, DOI 10.1074/jbc.270.51.30604; Davies SR, 2004, GENOMICS, V83, P667, DOI 10.1016/j.ygeno.2003.09.013; DAWES KE, 1993, EUR J CELL BIOL, V61, P126; DPELTON RW, 1990, DEVELOPMENT, V110, P609; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Nagy A., 2003, MANIPULATING MOUSE E; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Tsumaki N, 1998, J BIOL CHEM, V273, P22861, DOI 10.1074/jbc.273.36.22861; TSUMAKI N, 1995, J BIOL CHEM, V270, P2372, DOI 10.1074/jbc.270.5.2372; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	40	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27677	27687		10.1074/jbc.M803657200	http://dx.doi.org/10.1074/jbc.M803657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682388	hybrid			2022-12-25	WOS:000259719200039
J	Taft, MH; Hartmann, FK; Rump, A; Keller, H; Chizhov, I; Manstein, DJ; Tsiavaliaris, G				Taft, Manuel H.; Hartmann, Falk K.; Rump, Agrani; Keller, Heiko; Chizhov, Igor; Manstein, Dietmar J.; Tsiavaliaris, Georgios			Dictyostelium myosin-5b is a conditional processive motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW DUTY RATIO; UNCONVENTIONAL MYOSIN; KINETIC MECHANISM; MOLECULAR MOTOR; BINDING DOMAIN; ACTIN; DISCOIDEUM; MAGNESIUM; PROTEIN; TRAFFICKING	Dictyostelium myosin-5b is the gene product of myoJ and one of two closely related myosin-5 isoenzymes produced in Dictyostelium discoideum. Here we report a detailed investigation of the kinetic and functional properties of the protein. In standard assay buffer conditions, Dictyostelium myosin-5b displays high actin affinity in the presence of ADP, fast ATP hydrolysis, and a high steady-state ATPase activity in the presence of actin that is rate limited by ADP release. These properties are typical for a processive motor that can move over long distances along actin filaments without dissociating. Our results show that a physiological decrease in the concentration of free Mg2+-ions leads to an increased rate of ADP release and shortening of the fraction of time the motor spends in the strong actin binding states. Consistently, the ability of the motor to efficiently translocate actin filaments at very low surface densities decreases with decreasing concentrations of free Mg2+-ions. In addition, we provide evidence that the observed changes in Ddmyosin-5b motor activity are of physiological relevance and propose a mechanism by which this molecular motor can switch between processive and non-processive movement.	[Taft, Manuel H.; Hartmann, Falk K.; Rump, Agrani; Keller, Heiko; Chizhov, Igor; Manstein, Dietmar J.; Tsiavaliaris, Georgios] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School	Tsiavaliaris, G (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350,Carl Neuberg Str 1, D-30625 Hannover, Germany.	gtsiaval@bpc.mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J./AAG-2640-2019	Manstein, Dietmar J. J/0000-0003-0763-0147; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147	Deutsche Forschungsgemeinschaft [TS 169/3-1, MA 1081/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grants TS 169/3-1 (to G.T.) and MA 1081/11 (to D.J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Evans LL, 1998, J CELL SCI, V111, P2055; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gabriel D, 1999, J CELL SCI, V112, P3995; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Hammer JA, 1996, J BIOL CHEM, V271, P7120, DOI 10.1074/jbc.271.12.7120; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Kim HM, 2007, J ORG CHEM, V72, P2088, DOI 10.1021/jo062341m; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; LEVI V, 2006, BIOPHYS J, V90; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Peterson MD, 1996, J MUSCLE RES CELL M, V17, P411, DOI 10.1007/BF00123358; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	50	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26902	26910		10.1074/jbc.M802957200	http://dx.doi.org/10.1074/jbc.M802957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650439	hybrid			2022-12-25	WOS:000259586600010
J	Xie, JJ; Reverdatto, S; Frolov, A; Hoffmann, R; Burz, DS; Shekhtman, A				Xie, Jingjing; Reverdatto, Sergey; Frolov, Andrej; Hoffmann, Ralf; Burz, David S.; Shekhtman, Alexander			Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CELL-SURFACE RECEPTOR; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; GLYCOSYLATION; MECHANISM; ACTIVATION; LIGANDS; BINDING; IDENTIFICATION	The receptor for advanced glycated end products ( RAGE) is a multiligand receptor that is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. The ability of RAGE to recognize advanced glycated end products (AGEs) formed by nonenzymatic glycoxidation of cellular proteins places RAGE in the category of pattern recognition receptors. The structural mechanism of AGE recognition was an enigma due to the diversity of chemical structures found in AGE-modified proteins. Here, using NMR spectroscopy we showed that the immunoglobulin V-type domain of RAGE is responsible for recognizing various classes of AGEs. Three distinct surfaces of the V domain were identified to mediate AGE-V domain interactions. They are located in the positively charged areas of the V domain. The first interaction surface consists of strand C and loop CC', the second interaction surface consists of strand C', strand F, and loop FG, and the third interaction surface consists of strand A' and loop EF. The secondary structure elements of the interaction surfaces exhibit significant flexibility on the ms-mu s time scale. Despite highly specific AGE-V domain interactions, the binding affinity of AGEs for an isolated V domain is low, similar to 10 mu M. Using in-cell fluorescence resonance energy transfer we show that RAGE is a constitutive oligomer on the plasma membrane. We propose that constitutive oligomerization of RAGE is responsible for recognizing patterns of AGE-modified proteins with affinities less than 100 nM.	[Xie, Jingjing; Reverdatto, Sergey; Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Frolov, Andrej; Hoffmann, Ralf] Univ Leipzig, Dept Chem & Mineral, Inst Bioanalyt Chem, D-14103 Leipzig, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Leipzig University	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, 1400 Washington Ave, Albany, NY 12222 USA.	ashekhta@albany.edu	Frolov, Andrej A/V-5550-2018; xie, jing/GRY-1689-2022; Hoffmann, Ralf/ABD-8779-2020	Shekhtman, Alexander/0000-0003-2649-2675	American Diabetes Association Career Development [1-06-CD-23]	American Diabetes Association Career Development(American Diabetes Association)	This work was supported by American Diabetes Association Career Development Award 1-06-CD-23 (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Buetler TM, 2008, MOL NUTR FOOD RES, V52, P370, DOI 10.1002/mnfr.200700101; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; DOMINICZAK MH, 1991, DIABETIC MED, V8, P505, DOI 10.1111/j.1464-5491.1991.tb01643.x; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Frolov A, 2007, J PEPT SCI, V13, P862, DOI 10.1002/psc.901; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Gruber P, 2005, J PEPT RES, V66, P111, DOI 10.1111/j.1399-3011.2005.00279.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hawkins CL, 1998, BIOCHEM J, V332, P617, DOI 10.1042/bj3320617; Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Hinton DJS, 2006, AMINO ACIDS, V30, P425, DOI 10.1007/s00726-006-0269-2; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P443, DOI DOI 10.1007/978-0-387-46312-4_13; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; THORNALLEY PJ, 1999, CLIN LAB, V45, P263; Valencia JV, 2004, DIABETES, V53, P743, DOI 10.2337/diabetes.53.3.743; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908; [No title captured]; [No title captured]; [No title captured]; [No title captured]	76	178	184	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27255	27269		10.1074/jbc.M801622200	http://dx.doi.org/10.1074/jbc.M801622200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667420	hybrid			2022-12-25	WOS:000259586600045
J	Chen, S; Tong, X; Woodard, RW; Du, GC; Wu, J; Chen, J				Chen, Sheng; Tong, Xing; Woodard, Ronald W.; Du, Guocheng; Wu, Jing; Chen, Jian			Identification and characterization of bacterial cutinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTICOLA WINT. HONEY; SOLANI-PISI CUTINASE; POLYETHYLENE TEREPHTHALATE; INTERFACIAL ACTIVATION; THERMOMONOSPORA-FUSCA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; LIPASE; PURIFICATION; ENZYME	Cutinase, which exists in both fungi and bacteria, catalyzes the cleavage of the ester bonds of cutin. Fungal cutinases have been extensively studied, however, reports on bacterial cutinases have been limited due to the lack of knowledge concerning the identity of their open reading frames. In the present study, the cutinase from Thermobifida fusca was induced by cutin and purified to homogeneity by following p-nitrophenyl butyrate hydrolyzing activity. Peptide mass fingerprinting analysis of the wild-type enzyme matched two proteins, Tfu_0883 and Tfu_0882, which are 93% identical in sequence. Both proteins were cloned and overexpressed in their mature form. Recombinant Tfu_0883 and Tfu_0882 display very similar enzymatic properties and were confirmed to be cutinases by their capability to hydrolyze the ester bonds of cutin. Comparative characterization of Fusarium solani pisi and T. fusca cutinases indicated that they have similar substrate specificity and catalytic properties except that the T. fusca enzymes are thermally more stable. Homology modeling revealed that T. fusca cutinases adopt an alpha/beta-hydrolase fold that exhibits both similarities and variations from the fungal cutinase structure. A serine hydrolase catalytic mechanism involving a Ser(170)-His(248)-Asp(216) (Tfu_0883 numbering) catalytic triad was supported by active site-directed inhibition studies and mutational analyses. This is the first report of cutinase encoding genes from bacterial sources.	[Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	Jiangnan University; Jiangnan University; Jiangnan University; University of Michigan System; University of Michigan	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.	jingwu@jiangnan.edu.cn; jchen@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Woodard, Ronald/0000-0002-7472-3653	Program for New Century Excellent Talents in University [NCET-06-0486]; National Science Fund for Distinguished Young Scholars of China [20625619]; 111 Project [11-2-06]; Research Program of State Key Laboratory of Food Science and Technology [SKLF-MB-200802]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 Project(Ministry of Education, China - 111 Project); Research Program of State Key Laboratory of Food Science and Technology	This work was supported by Program for New Century Excellent Talents in University Grant NCET-06-0486, National Science Fund for Distinguished Young Scholars of China Grant 20625619, 111 Project Grant 11-2-06, and Research Program of State Key Laboratory of Food Science and Technology Grant SKLF-MB-200802. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alisch-Mark M, 2006, BIOTECHNOL LETT, V28, P681, DOI 10.1007/s10529-006-9041-7; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Araujo R, 2007, J BIOTECHNOL, V128, P849, DOI 10.1016/j.jbiotec.2006.12.028; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P15071, DOI 10.1021/bi0013905; Carvalho CML, 1999, BIOTECHNOL BIOENG, V66, P17, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;17::AID-BIT2&gt;3.0.CO;2-F; Cunha MT, 2003, J BIOTECHNOL, V100, P55, DOI 10.1016/S0168-1656(02)00225-0; Degani O, 2002, APPL BIOCHEM BIOTECH, V102, P277, DOI 10.1385/ABAB:102-103:1-6:277; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Ferreira BS, 2003, APPL MICROBIOL BIOT, V61, P69, DOI 10.1007/s00253-002-1196-0; Fett WF, 1999, J APPL MICROBIOL, V86, P561, DOI 10.1046/j.1365-2672.1999.00690.x; FETT WF, 1992, CURR MICROBIOL, V25, P165, DOI 10.1007/BF01571025; FETT WF, 1992, APPL ENVIRON MICROB, V58, P2123, DOI 10.1128/AEM.58.7.2123-2130.1992; GERARD HC, 1992, PHYTOCHEM ANALYSIS, V3, P139, DOI 10.1002/pca.2800030310; Gindro K, 1999, FEMS MICROBIOL LETT, V171, P239, DOI 10.1111/j.1574-6968.1999.tb13438.x; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Kleeberg I, 2005, BIOMACROMOLECULES, V6, P262, DOI 10.1021/bm049582t; Lang D, 1996, J MOL BIOL, V259, P704, DOI 10.1006/jmbi.1996.0352; LIN TS, 1980, PHYSIOL PLANT PATHOL, V17, P1, DOI 10.1016/0048-4059(80)90002-8; Longhi S, 1999, BBA-MOL CELL BIOL L, V1441, P185, DOI 10.1016/S1388-1981(99)00159-6; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Osman SF, 1999, J AGR FOOD CHEM, V47, P799, DOI 10.1021/jf980693r; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; PURDY RE, 1973, ARCH BIOCHEM BIOPHYS, V159, P61, DOI 10.1016/0003-9861(73)90429-3; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEBASTIAN J, 1988, ARCH BIOCHEM BIOPHYS, V263, P77, DOI 10.1016/0003-9861(88)90615-7; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; Wang GY, 2000, ARCH BIOCHEM BIOPHYS, V382, P31, DOI 10.1006/abbi.2000.1995; Wang GY, 2002, FUNGAL GENET BIOL, V35, P261, DOI 10.1006/fgbi.2001.1320; Wei YY, 1998, STRUCTURE, V6, P511, DOI 10.1016/S0969-2126(98)00052-5	35	149	176	9	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25854	25862		10.1074/jbc.M800848200	http://dx.doi.org/10.1074/jbc.M800848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658138	hybrid, Green Published			2022-12-25	WOS:000259200100012
J	Cho, C; Reck-Peterson, SL; Vale, RD				Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.			Regulatory ATPase sites of cytoplasmic dynein affect processivity and force generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; NUCLEOTIDE-BINDING; HEAVY-CHAIN; MOTOR; HYDROLYSIS; DOMAINS; COMMUNICATION; COMPLEXES; PROTEINS	The heavy chain of cytoplasmic dynein contains four nucleotide-binding domains referred to as AAA1-AAA4, with the first domain (AAA1) being the main ATP hydrolytic site. Although previous studies have proposed regulatory roles for AAA3 and AAA4, the role of ATP hydrolysis at these sites remains elusive. Here, we have analyzed the single molecule motility properties of yeast cytoplasmic dynein mutants bearing mutations that prevent ATP hydrolysis at AAA3 or AAA4. Both mutants remain processive, but the AAA4 mutant exhibits a surprising increase in processivity due to its tighter affinity for microtubules. In addition to changes in motility characteristics, AAA3 and AAA4 mutants produce less maximal force than wild-type dynein. These results indicate that the nucleotide binding state at AAA3 and AAA4 can allosterically modulate microtubule binding affinity and affect dynein processivity and force production.	[Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), MC 2200,Rm N312E,600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Reck-Peterson, Samara/0000-0002-1553-465X; Cho, Carol/0000-0003-4070-6561	National Institutes of Health [T32 GM07810]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, R01GM097312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM07810 (to C. C.). This work was also supported by the Howard Hughes Medical Institute (to R. D. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GIBBONS BH, 1987, J BIOL CHEM, V262, P8354; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Neuwald AF, 1999, GENOME RES, V9, P27; OGAWA K, 1995, MOL BIOL CELL, V6, P685, DOI 10.1091/mbc.6.6.685; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	33	102	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25839	25845		10.1074/jbc.M802951200	http://dx.doi.org/10.1074/jbc.M802951200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650442	Green Published, hybrid			2022-12-25	WOS:000259200100010
J	Marelja, Z; Stocklein, W; Nimtz, M; Leimkuhler, S				Marelja, Zvonimir; Stoecklein, Walter; Nimtz, Manfred; Leimkuehler, Silke			A novel role for human Nfs1 in the cytoplasm - Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODANESE-LIKE DOMAIN; MOLYBDOPTERIN SYNTHASE; CYSTEINE DESULFURASE; CLUSTER BIOGENESIS; ESCHERICHIA-COLI; IRON; ISD11; GENE; ISCU; NIFS	The human MOCS3 gene encodes a protein involved in activation and sulfuration of the C terminus of MOCS2A, the smaller subunit of the molybdopterin (MPT) synthase. MPT synthase catalyzes the formation of the dithiolene group ofMPT that is required for the coordination of the molybdenum atom in the last step of molybdenum cofactor (Moco) biosynthesis. The two-domain proteinMOCS3catalyzes both the adenylation and the subsequent generation of a thiocarboxylate group at the C terminus of MOCS2A by its C-terminal rhodanese-like domain (RLD). The low activity of MOCS3-RLD with thiosulfate as sulfur donor and detailed mutagenesis studies showed that thiosulfate is most likely not the physiological sulfur source for Moco biosynthesis in eukaryotes. It was suggested that an L-cysteine desulfurase might be involved in the sulfuration of MOCS3 in vivo. In this report, we investigated the involvement of the human L-cysteine desulfurase Nfs1 in sulfur transfer to MOCS3-RLD. A variant of Nfs1 was purified in conjunction with Isd11 in a heterologous expression system in Escherichia coli, and the kinetic parameters of the purified protein were determined. By studying direct protein-protein interactions, we were able to show that Nfs1 interacted specifically with MOCS3-RLD and that sulfur is transferred from L-cysteine to MOCS3-RLD via an Nfs1-bound persulfide intermediate. Because MOCS3 was shown to be located in the cytosol, our results suggest that cytosolic Nfs1 has an important role in sulfur transfer for the biosynthesis of Moco.	[Marelja, Zvonimir; Stoecklein, Walter; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Marelja, Zvonimir/AAL-3557-2020	Leimkuhler, Silke/0000-0003-3238-2122; Marelja, Zvonimir/0000-0002-3702-7528	Deutsche Forschungsgemeinschaft [LE1171/5-3]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Duran M, 1996, INT PEDIAT, V11, P334; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Johnson JL., 2001, METABOLIC MOL BASES, P3163; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; RAJAGOPALAN KV, 1982, FED PROC, V41, P2608; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Reiss J, 2000, HUM GENET, V106, P157, DOI 10.1007/s004390051023; Reiss J, 2003, HUM MUTAT, V21, P569, DOI 10.1002/humu.10223; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	48	97	103	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25178	25185		10.1074/jbc.M804064200	http://dx.doi.org/10.1074/jbc.M804064200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18650437	hybrid			2022-12-25	WOS:000259012700010
J	Grosskurth, SE; Bhattacharya, D; Wang, QC; Lin, JJC				Grosskurth, Shaun E.; Bhattacharya, Debashish; Wang, Qinchuan; Lin, Jim Jung-Ching			Emergence of Xin Demarcates a Key Innovation in Heart Evolution	PLOS ONE			English	Article							INTERCALATED DISK PROTEIN; CARDIAC-HYPERTROPHY; BLOOD-VESSELS; MXIN-ALPHA; VERTEBRATE; REVEALS; COMPLEX; GENES; CARDIOMYOPATHY; DUPLICATIONS	The mouse Xin repeat-containing proteins (mXin alpha and mXin beta) localize to the intercalated disc in the heart. mXin alpha is able to bundle actin filaments and to interact with beta-catenin, suggesting a role in linking the actin cytoskeleton to N-cadherin/beta-catenin adhesion. mXin alpha-null mouse hearts display progressively ultrastructural alterations at the intercalated discs, and develop cardiac hypertrophy and cardiomyopathy with conduction defects. The up-regulation of mXin beta in mXin alpha-deficient mice suggests a partial compensation for the loss of mXin alpha. To elucidate the evolutionary relationship between these proteins and to identify the origin of Xin, a phylogenetic analysis was done with 40 vertebrate Xins. Our results show that the ancestral Xin originated prior to the emergence of lamprey and subsequently underwent gene duplication early in the vertebrate lineage. A subsequent teleost-specific genome duplication resulted in most teleosts encoding at least three genes. All Xins contain a highly conserved beta-catenin-binding domain within the Xin repeat region. Similar to mouse Xins, chicken, frog and zebrafish Xins also co-localized with beta-catenin to structures that appear to be the intercalated disc. A putative DNA-binding domain in the N-terminus of all Xins is strongly conserved, whereas the previously characterized Mena/VASP-binding domain is a derived trait found only in Xin alpha s from placental mammals. In the C-terminus, Xin alpha s and Xin beta s are more divergent relative to each other but each isoform from mammals shows a high degree of within-isoform sequence identity. This suggests different but conserved functions for mammalian Xin alpha and Xin beta. Interestingly, the origin of Xin ca. 550 million years ago coincides with the genesis of heart chambers with complete endothelial and myocardial layers. We postulate that the emergence of the Xin paralogs and their functional differentiation may have played a key role in the evolutionary development of the heart.	[Grosskurth, Shaun E.; Bhattacharya, Debashish; Wang, Qinchuan; Lin, Jim Jung-Ching] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Grosskurth, SE (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	jim-lin@uiowa.edu	Wang, Qinchuan/AAH-5614-2021	Wang, Qinchuan/0000-0002-2359-3262	National Heart, Lung and blood Institute, National Institutes of Health [HL075015, ES013679]; National Science Foundation [EF-0625440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER	National Heart, Lung and blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Heart, Lung and blood Institute grant HL075015 from the National Institutes of Health to JJ-CL and grants from the National Science Foundation (EF-0625440) and the National Institutes of Health (ES013679) to DB.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AUGUSTINSSON KB, 1956, J PHYSIOL-LONDON, V131, P257, DOI 10.1113/jphysiol.1956.sp005461; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; BURNSTOCK G, 1969, PHARMACOL REV, V21, P247; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Choi SJ, 2007, J BIOL CHEM, V282, P36024, DOI 10.1074/jbc.M707639200; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jung-Ching Lin Jim, 2005, J Med Sci, V25, P215; KILARSKI WINCENTY, 1964, ACTA BIOL CRACOV SER ZOOL, V7, P75; KRIEBEL ME, 1970, AM J PHYSIOL, V218, P1194, DOI 10.1152/ajplegacy.1970.218.4.1194; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MOLLER PC, 1973, J MORPHOL, V139, P389, DOI 10.1002/jmor.1051390403; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; NAKAO T, 1981, ANAT RECORD, V199, P555, DOI 10.1002/ar.1091990411; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; PERCY R, 1991, J ZOOL, V223, P49; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; RAHR H, 1981, ZOOMORPHOLOGY, V97, P53, DOI 10.1007/BF00310102; Rambaut A, 1995, SE AL SEQUENCE ALIGN; Randall D.J., 1980, HEARTS HEART LIKE OR, P41, DOI 10.1016/C2013-0-10405-9; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Towbin J A, 2000, Curr Cardiol Rep, V2, P134, DOI 10.1007/s11886-000-0010-9; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; WALSH JB, 1985, GENETICS, V110, P345; Wang DZ, 1999, DEVELOPMENT, V126, P1281; WANG DZ, 1996, FRONT BIOSCI, V1, P15	48	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2857	10.1371/journal.pone.0002857	http://dx.doi.org/10.1371/journal.pone.0002857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682726	gold, Green Published			2022-12-25	WOS:000264366600013
J	Vrticka, P; Andersson, F; Grandjean, D; Sander, D; Vuilleumier, P				Vrticka, Pascal; Andersson, Frederic; Grandjean, Didier; Sander, David; Vuilleumier, Patrik			Individual Attachment Style Modulates Human Amygdala and Striatum Activation during Social Appraisal	PLOS ONE			English	Article							ADULT ATTACHMENT; ROMANTIC LOVE; ORBITOFRONTAL CORTEX; WORKING MODELS; REWARD; REPRESENTATIONS; REJECTION; EMOTION; FMRI; RESPONSIVITY	Adult attachment style refers to individual personality traits that strongly influence emotional bonds and reactions to social partners. Behavioral research has shown that adult attachment style reflects profound differences in sensitivity to social signals of support or conflict, but the neural substrates underlying such differences remain unsettled. Using functional magnetic resonance imaging (fMRI), we examined how the three classic prototypes of attachment style (secure, avoidant, anxious) modulate brain responses to facial expressions conveying either positive or negative feedback about task performance (either supportive or hostile) in a social game context. Activation of striatum and ventral tegmental area was enhanced to positive feedback signaled by a smiling face, but this was reduced in participants with avoidant attachment, indicating relative impassiveness to social reward. Conversely, a left amygdala response was evoked by angry faces associated with negative feedback, and correlated positively with anxious attachment, suggesting an increased sensitivity to social punishment. Secure attachment showed mirror effects in striatum and amygdala, but no other specific correlate. These results reveal a critical role for brain systems implicated in reward and threat processing in the biological underpinnings of adult attachment style, and provide new support to psychological models that have postulated two separate affective dimensions to explain these individual differences, centered on the ventral striatum and amygdala circuits, respectively. These findings also demonstrate that brain responses to face expressions are not driven by facial features alone but determined by the personal significance of expressions in current social context. By linking fundamental psychosocial dimensions of adult attachment with brain function, our results do not only corroborate their biological bases but also help understand their impact on behavior.	[Vrticka, Pascal; Grandjean, Didier; Sander, David; Vuilleumier, Patrik] Univ Geneva, Swiss Natl Ctr Affect Sci, Geneva, Switzerland; [Vrticka, Pascal; Andersson, Frederic; Vuilleumier, Patrik] Univ Med Ctr Geneva, Dept Neurosci Clin Neurol, Lab Neurol & Imaging Cognit, Geneva, Switzerland; [Grandjean, Didier; Sander, David] Univ Geneva, FPSE, Dept Psychol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Vrticka, P (corresponding author), Univ Geneva, Swiss Natl Ctr Affect Sci, Geneva, Switzerland.	pascal.vrticka@medecine.unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Andersson, Frederic/P-6969-2016; Andersson, Frédéric/N-6927-2019; Vrticka, Pascal/U-9166-2018; Vrticka, Pascal/H-2209-2013	Vuilleumier, Patrik/0000-0002-8198-9214; Andersson, Frederic/0000-0002-2343-2450; Andersson, Frédéric/0000-0002-2343-2450; Vrticka, Pascal/0000-0002-8920-5509; Vrticka, Pascal/0000-0002-4806-9037; Grandjean, Didier/0000-0001-6125-4520; Sander, David/0000-0003-1266-9361	National Center of Competence in Research (NCCR); Swiss National Science Foundation [51NF40-104897]; University of Geneva	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva	This research was supported by the National Center of Competence in Research (NCCR). Affective sciences financed by the Swiss National Science Foundation (n 51NF40-104897) and hosted by the University of Geneva, and grants of the Swiss National Science Foundation to DS and PV.	AINSWORTH MDS, 1978, BEHAV BRAIN SCI, V1, P436, DOI 10.1017/S0140525X00075828; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; BALDWIN MW, 1992, PSYCHOL BULL, V112, P461, DOI 10.1037/0033-2909.112.3.461; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Bouthillier D, 1996, CAN J BEHAV SCI, V28, P74, DOI 10.1037/0008-400X.28.1.74; Bowlby J., 1982, ATTACHMENT LOSS, V2nd; Bowlby J., 1969, ATTACHMENT AND LOSS; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chotai J, 2005, EUR PSYCHIAT, V20, P251, DOI 10.1016/j.eurpsy.2004.11.008; Collins NL, 2004, J PERS SOC PSYCHOL, V87, P363, DOI 10.1037/0022-3514.87.3.363; Collins NL., 1994, ATTACHMENT PROCESSES, P53; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DOZIER M, 1992, CHILD DEV, V63, P1473, DOI 10.2307/1131569; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; FEENEY JA, 1994, HEALTH PSYCHOL, V13, P334, DOI 10.1037/0278-6133.13.4.334; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fraley R.C., 1998, ATTACHMENT THEORY CL, P249; Fraley RC, 2006, J PERS, V74, P1163, DOI 10.1111/j.1467-6494.2006.00406.x; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fuendeling JM, 1998, J SOC PERS RELAT, V15, P291, DOI 10.1177/0265407598153001; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Kashdan TB, 2007, CLIN PSYCHOL REV, V27, P348, DOI 10.1016/j.cpr.2006.12.003; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Kurdek LA, 2002, J SOC PERS RELAT, V19, P811, DOI 10.1177/0265407502196005; Lemche E, 2006, HUM BRAIN MAPP, V27, P623, DOI 10.1002/hbm.20206; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Niedenthal PM, 2002, J PERS SOC PSYCHOL, V82, P419, DOI 10.1037//0022-3514.82.3.419; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Overall N, 2003, AUST J PSYCHOL, V55, P57; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Riggs SA, 2007, DEV PSYCHOPATHOL, V19, P263, DOI 10.1017/S0954579407070149; Rom E, 2003, J PERS SOC PSYCHOL, V84, P1220, DOI 10.1037/0022-3514.84.6.1220; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P971, DOI 10.1037/0022-3514.59.5.971; Simpson JA, 2002, PERS SOC PSYCHOL B, V28, P598, DOI 10.1177/0146167202288004; Simpson JA, 1996, J PERS SOC PSYCHOL, V71, P899, DOI 10.1037/0022-3514.71.5.899; Simpson JA, 2007, J PERS SOC PSYCHOL, V92, P355, DOI 10.1037/0022-3514.92.2.355; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Spielberger C. D., 1999, USE PSYCHOL TESTING, P993; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Van Emmichoven IAZ, 2003, DEV PSYCHOPATHOL, V15, P219, DOI 10.1017/S0954579403000129; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	52	177	184	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2868	10.1371/journal.pone.0002868	http://dx.doi.org/10.1371/journal.pone.0002868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682729	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600024
J	Ahlander, J; Chen, XB; Bosco, G				Ahlander, Joseph; Chen, Xiao-Bo; Bosco, Giovanni			The N-Terminal Domain of the Drosophila Retinoblastoma Protein Rbf1 Interacts with ORC and Associates with Chromatin in an E2F Independent Manner	PLOS ONE			English	Article								Background: The retinoblastoma (Rb) tumor suppressor protein can function as a DNA replication inhibitor as well as a transcription factor. Regulation of DNA replication may occur through interaction of Rb with the origin recognition complex (ORC). Principal Findings: We characterized the interaction of Drosophila Rb, Rbf1, with ORC. Using expression of proteins in Drosophila S2 cells, we found that an N-terminal Rbf1 fragment (amino acids 1-345) is sufficient for Rbf1 association with ORC but does not bind to dE2F1. We also found that the C-terminal half of Rbf1 (amino acids 345-845) interacts with ORC. We observed that the amino-terminal domain of Rbf1 localizes to chromatin in vivo and associates with chromosomal regions implicated in replication initiation, including colocalization with Orc2 and acetylated histone H4. Conclusions/Significance: Our results suggest that Rbf1 can associate with ORC and chromatin through domains independent of the E2F binding site. We infer that Rbf1 may play a role in regulating replication directly through its association with ORC and/or chromatin factors other than E2F. Our data suggest an important role for retinoblastoma family proteins in cell proliferation and tumor suppression through interaction with the replication initiation machinery.	[Ahlander, Joseph; Chen, Xiao-Bo; Bosco, Giovanni] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Ahlander, J (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	gbosco@email.arizona.edu			National Institutes of Health [GM069462]; American Cancer Society [IRG7400128]; National Science Foundation [DGE-0638744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grant GM069462 (GB), the American Cancer Society grant IRG7400128 (GB), and the National Science Foundation grant DGE-0638744 (JA).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Cayirlioglu P, 2003, MOL CELL BIOL, V23, P2123, DOI 10.1128/MCB.23.6.2123-2134.2003; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DEMAKOV SA, 1993, MOL GEN GENET, V238, P437, DOI 10.1007/BF00292003; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Doostzadeh-Cizeron J, 1999, MOL BIOL CELL, V10, P3251, DOI 10.1091/mbc.10.10.3251; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Goodrich DW, 2003, J CELL PHYSIOL, V197, P169, DOI 10.1002/jcp.10358; Hartl T, 2007, CHROMOSOMA, V116, P197, DOI 10.1007/s00412-006-0092-2; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; KELLY TJ, 1994, CURR BIOL, V4, P238, DOI 10.1016/S0960-9822(00)00053-1; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kennedy BK, 2001, P NATL ACAD SCI USA, V98, P8720, DOI 10.1073/pnas.151240898; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Knudsen ES, 2006, CURR MOL MED, V6, P749; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; LUND O, 2002, X3M COMPUTER PROGRAM; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Markey MP, 2002, CANCER RES, V62, P6587; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MISHRA A, 1982, CHROMOSOMA, V85, P221, DOI 10.1007/BF00294967; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pennaneach V, 2001, MOL CELL, V7, P715, DOI 10.1016/S1097-2765(01)00217-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riley DJ, 1997, MOL CELL BIOL, V17, P7342, DOI 10.1128/MCB.17.12.7342; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; SASS H, 1982, CHROMOSOMA, V86, P77, DOI 10.1007/BF00330731; Schmitz NMR, 2004, BIOCHEM BIOPH RES CO, V317, P779, DOI 10.1016/j.bbrc.2004.03.109; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHAO ZH, 1995, P NATL ACAD SCI USA, V92, P3115, DOI 10.1073/pnas.92.8.3115; Shao ZH, 1997, ONCOGENE, V15, P385, DOI 10.1038/sj.onc.1201204; SRINIVASAN SV, 2007, J BIOL CHEM; STAJICH J, 2006, PAIRWISE KAKS PERL S; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stevaux O, 2002, EMBO J, V21, P4927, DOI 10.1093/emboj/cdf501; Takemura M, 1997, ONCOGENE, V15, P2483, DOI 10.1038/sj.onc.1201431; Takemura M, 2006, BBA-PROTEINS PROTEOM, V1764, P1447, DOI 10.1016/j.bbapap.2006.06.015; Tanny RE, 2006, MOL BIOL CELL, V17, P2415, DOI 10.1091/mbc.E05-11-1037; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; VLASSOVA IE, 1985, CHROMOSOMA, V91, P251, DOI 10.1007/BF00328220; Wang JYJ, 2001, ACTA ONCOL, V40, P689; WANG NP, 1990, CELL GROWTH DIFFER, V1, P233; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Whitaker LL, 1997, ONCOGENE, V15, P1069, DOI 10.1038/sj.onc.1201277; Xin SJ, 2002, DEVELOPMENT, V129, P1345; Yamane K, 2000, ONCOGENE, V19, P1982, DOI 10.1038/sj.onc.1203528; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3	85	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2831	10.1371/journal.pone.0002831	http://dx.doi.org/10.1371/journal.pone.0002831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665226	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300050
J	Weis, JJ; Madrigal, DS; Cardinale, BJ				Weis, Jerome J.; Madrigal, Daniel S.; Cardinale, Bradley J.			Effects of Algal Diversity on the Production of Biomass in Homogeneous and Heterogeneous Nutrient Environments: A Microcosm Experiment	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOSYSTEM FUNCTION; PLANT DIVERSITY; COMPETITIVE COEXISTENCE; FRESH-WATER; LONG-TERM; BIODIVERSITY; NITROGEN; CONSEQUENCES; N-2-FIXATION	Background: One of the most common questions addressed by ecologists over the past decade has been-how does species richness impact the production of community biomass? Recent summaries of experiments have shown that species richness tends to enhance the production of biomass across a wide range of trophic groups and ecosystems; however, the biomass of diverse polycultures only rarely exceeds that of the single most productive species in a community ( a phenomenon called 'transgressive overyielding'). Some have hypothesized that the lack of transgressive overyielding is because experiments have generally been performed in overly-simplified, homogeneous environments where species have little opportunity to express the niche differences that lead to 'complementary' use of resources that can enhance biomass production. We tested this hypothesis in a laboratory experiment where we manipulated the richness of freshwater algae in homogeneous and heterogeneous nutrient environments. Methodology/Principal Findings: Experimental units were comprised of patches containing either homogeneous nutrient ratios (16:1 nitrogen to phosphorus (N:P) in all patches) or heterogeneous nutrient ratios ( ranging from 4:1 to 64:1 N:P across patches). After allowing 6-10 generations of algal growth, we found that algal species richness had similar impacts on biomass production in both homo- and heterogeneous environments. Although four of the five algal species showed a strong response to nutrient heterogeneity, a single species dominated algal communities in both types of environments. As a result, a 'selection effect'-where diversity maximizes the chance that a competitively superior species will be included in, and dominate the biomass of a community-was the primary mechanism by which richness influenced biomass in both homo- and heterogeneous environments. Conclusions/Significance: Our study suggests that spatial heterogeneity, by itself, is not sufficient to generate strong effects of biodiversity on productivity. Rather, heterogeneity must be coupled with variation in the relative fitness of species across patches in order for spatial niche differentiation to generate complementary resource use.	[Weis, Jerome J.; Madrigal, Daniel S.; Cardinale, Bradley J.] Univ Calif Santa Barbara, Dept Ecol, Evolution & Marine Biol, Santa Barbara, CA USA	University of California System; University of California Santa Barbara	Weis, JJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol, Evolution & Marine Biol, Santa Barbara, CA USA.	jerome.weis@yale.edu	Cardinale, Bradley J/I-7076-2013; Madrigal, Daniel/AHA-0013-2022		National Science Foundation [DEB 0614428]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation to BJC (DEB 0614428). The National Science Foundation did not play any role in carrying out this experiment or preparing this manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bengtsson J, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P209; BOLD HC, 1978, INTRO ALGAE STRUCTUR, pR14; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2006, J ANIM ECOL, V75, P497, DOI 10.1111/j.1365-2656.2006.01070.x; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; DAILY GC, 1997, NATURES SERVICES SOC, pR20; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; FINDLAY DL, 1994, CAN J FISH AQUAT SCI, V51, P2254, DOI 10.1139/f94-229; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Gause G.F., 1936, STRUGGLE EXISTENCE; Graham LE, 2000, ALGAE; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HENDZEL LL, 1994, CAN J FISH AQUAT SCI, V51, P2247, DOI 10.1139/f94-228; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KALFF J, 2002, LIMNOLOGY INLAND WAT, pR12; KINZIG AP, 2001, FUNCTIONAL CONSEQUEN; KOLASA J, ECOLOGICAL HETEROGEN, pR11; Loreau M., 2002, Biodiversity and ecosystem functioning: synthesis and perspectives; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; REDFIELD AC, 1958, AM SCI, V46, P205; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; SCHMID B, 2002, BIODIVERSITY ECOSYST, pR12; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Symstad AJ, 2003, BIOSCIENCE, V53, P89, DOI 10.1641/0006-3568(2003)053[0089:LTALSP]2.0.CO;2; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D., 1997, SPATIAL ECOLOGY ROLE; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Weis JJ, 2007, ECOLOGY, V88, P929, DOI 10.1890/06-0943	58	54	55	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2825	10.1371/journal.pone.0002825	http://dx.doi.org/10.1371/journal.pone.0002825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665221	Green Published, gold			2022-12-25	WOS:000264304300044
J	Duan, H; Xiang, H; Ma, L; Boxer, LM				Duan, H.; Xiang, H.; Ma, L.; Boxer, L. M.			Functional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells	ONCOGENE			English	Article						t(14;18) lymphoma; bcl-2; IgH enhancer; spatial interactions	CHROMOSOME CONFORMATION; CREB PROTEINS; IN-VIVO; EXPRESSION; GENE; APOPTOSIS; CHEMORESISTANCE; LOCUS	To better understand the mechanisms underlying the role of the immunoglobulin heavy-chain gene (IgH) 3' enhancers on bcl-2 transcriptional deregulation in t(14; 18) lymphoma, we characterized the physical interactions of the IgH 3' enhancer region with the bcl-2 promoters. Using the chromosome conformation capture technique, we found that the IgH 3' enhancers physically interact with the bcl-2 promoter region over a 350 kb genomic region in t( 14; 18) lymphoma cells. No interactions of the bcl-2 promoter region with sequences distant to the IgH enhancers were observed. The physical interactions of the IgH enhancers with the bcl-2 5' region are functionally involved in the transcriptional control of bcl-2. The histone deacetylase inhibitor, trichostatin A, repressed bcl-2 transcription and decreased the IgH enhancer-bcl-2 promoter region interactions. We showed by chromatin immunoprecipitation assay and small interference RNA transfection studies that the POU2 family transcription factor Oct-2 and its cofactor Bob-1 have an important function in mediating the IgH enhancer-bcl-2 promoter region interactions. This study reveals a new aspect of the regulatory role of the IgH 3' enhancers on bcl-2 transcription in t(14; 18) lymphomas.	[Duan, H.; Xiang, H.; Ma, L.; Boxer, L. M.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Duan, H.; Xiang, H.; Ma, L.; Boxer, L. M.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol Med, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Boxer, LM (corresponding author), Stanford Univ, Sch Med, Dept Med, CCSR 1155,269 Campus Dr, Stanford, CA 94305 USA.	lboxer@stanford.edu			National Institutes of Health [CA56764]; NATIONAL CANCER INSTITUTE [R01CA056764, R56CA056764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grant CA56764. We are grateful to Dr Job Dekker (U Mass) for advice and for providing the 3C protocol, and to Drs Tao Li, Jianqun Lin and Xinwen Qiu in Dr Andrew Hoffman's laboratory at Stanford University for expert assistance with the 3C analysis.	Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DESOIZE B, 1994, ANTICANCER RES, V14, P2291; Duan H, 2007, ONCOGENE, V26, P2635, DOI 10.1038/sj.onc.1210061; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heckman CA, 2006, ONCOGENE, V25, P888, DOI 10.1038/sj.onc.1209127; Heckman CA, 2000, J BIOL CHEM, V275, P6499, DOI 10.1074/jbc.275.9.6499; Heckman CA, 2003, CANCER RES, V63, P6666; Heckman CA, 2003, ONCOGENE, V22, P7891, DOI 10.1038/sj.onc.1206639; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MIELE A, 2006, CURRENT PROTOCOLS MO; Mills FC, 1997, J EXP MED, V186, P845, DOI 10.1084/jem.186.6.845; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; REED JC, 1994, ANN ONCOL, V5, pS61, DOI 10.1093/annonc/5.suppl_1.S61; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wilson BE, 1996, MOL CELL BIOL, V16, P5546	26	29	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 13	2008	27	53					6720	6728		10.1038/onc.2008.286	http://dx.doi.org/10.1038/onc.2008.286			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18695675	Green Accepted			2022-12-25	WOS:000260866200002
J	Cerra, MC; Gallo, MP; Angelone, T; Quintieri, AM; Pulera, E; Filice, E; Guerold, B; Shooshtarizadeh, P; Levi, R; Ramella, R; Brero, A; Boero, O; Metz-Boutigue, MH; Tota, B; Alloatti, G				Cerra, M. C.; Gallo, M. P.; Angelone, T.; Quintieri, A. M.; Pulera, E.; Filice, E.; Guerold, B.; Shooshtarizadeh, P.; Levi, R.; Ramella, R.; Brero, A.; Boero, O.; Metz-Boutigue, M. H.; Tota, B.; Alloatti, G.			The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide	FASEB JOURNAL			English	Article						endocrine heart; peptide hormones; endothelial cells; stress response	N-TERMINAL DOMAIN; SECRETORY GRANULES; PEPTIDES; PROTEIN; VASOSTATIN-1; PROHORMONE; CELLS; IDENTIFICATION; EXPRESSION; FRAGMENTS	Chromogranin A (CGA), produced by human and rat myocardium, generates several biologically active peptides processed at specific proteolytic cleavage sites. A highly conserved cleavage N-terminal site is the bond 64-65 that reproduces the native rat CGA sequence (rCGA1-64), corresponding to human N-terminal CGA-derived vasostatin-1. rCGA1-64 cardiotropic activity has been explored in rat cardiac preparations. In Langendorff perfused rat heart, rCGA1-64 (from 33 nM) induced negative inotropism and lusitropism as well as coronary dilation, counteracting isoproterenol (Iso) - and endothelin-1 (ET-1) - induced positive inotropic effects and ET-1-dependent coronary constriction. rCGA1-64 also depressed basal and Iso-induced contractility on rat papillary muscles, without affecting calcium transients on isolated ventricular cells. Structure-function analysis using three modified peptides on both rat heart and papillary muscles revealed the disulfide bridge requirement for the cardiotropic action. A decline in Iso intrinsic activity in the presence of the peptides indicates a noncompetitive antagonistic action. Experiments on rat isolated cardiomyocytes and bovine aortic endothelial cells indicate that the negative inotropism observed in rat papillary muscle is probably due to an endothelial phosphatidylinositol 3-kinase-dependent nitric oxide release, rather than to a direct action on cardiomyocytes. Taken together, our data strongly suggest that in the rat heart the homologous rCGA1-64 fragment exerts an autocrine/paracrine modulation of myocardial and coronary performance acting as stabilizer against intense excitatory stimuli.-Cerra, M. C., Gallo, M. P., Angelone, T., Quintieri, A. M., Pulera, E., Filice, E., Guerold, B., Shooshtarizadeh, P., Levi, R., Ramella, R., Brero, A., Boero, O., Metz-Boutigue, M. H., Tota, B., Alloatti, G. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB J. 22, 3992 - 4004 (2008)	[Cerra, M. C.; Angelone, T.; Tota, B.] Univ Calabria, Dept Cell Biol, I-87030 Calabria, Italy; [Cerra, M. C.; Quintieri, A. M.; Pulera, E.; Filice, E.] Univ Calabria, Dept Pharmacobiol, I-87030 Calabria, Italy; [Gallo, M. P.; Levi, R.; Ramella, R.; Brero, A.; Boero, O.; Alloatti, G.] Univ Turin, Dept Anim & Human Biol, Turin, Italy; [Guerold, B.; Shooshtarizadeh, P.; Metz-Boutigue, M. H.] Univ Strasbourg, Unity INSERM 575, Strasbourg, France	University of Calabria; University of Calabria; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Alloatti, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87030 Calabria, Italy.	giuseppe.alloatti@unito.it	Gallo, Mariana C/J-2832-2014; Angelone, Tommaso/AAM-1230-2020	Angelone, Tommaso/0000-0001-7797-7862; Gallo, Maria Pia/0000-0002-0382-7607; Cerra, Maria Carmela/0000-0002-2091-928X	Fondazione Cassa di Risparmio di Calabria e Lucania; Italian Ministry of University and Research; Dottorato di Fisiologia, University of Turin; Istituto Nazionale di Ricerca Cardiovascolare, and Compagnia San Paolo, Italy; Regione Piemonte	Fondazione Cassa di Risparmio di Calabria e Lucania; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Dottorato di Fisiologia, University of Turin; Istituto Nazionale di Ricerca Cardiovascolare, and Compagnia San Paolo, Italy(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte)	This work was supported by Fondazione Cassa di Risparmio di Calabria e Lucania, research project Cuore-cervello: nuovi orizzonti biomedici nello studio di neuropeptidi ad attivita cardiovascolare (B. T., M. C. C., and T. A.); the Italian Ministry of University and Research (MURST ex 60%: B. T., G. A., and M. C. C.); and the Dottorato di Fisiologia, University of Turin, the Istituto Nazionale di Ricerca Cardiovascolare, and Compagnia San Paolo, Italy (A. M. Q.). O.B. was the recipient of research funds from Regione Piemonte (2004).	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Abi-Gerges N, 2001, J PHYSIOL-LONDON, V531, P117, DOI 10.1111/j.1469-7793.2001.0117j.x; Angelone T, 2006, J PHARMACOL EXP THER, V318, P336, DOI 10.1124/jpet.106.102103; Atherton E., 1990, SOLID PHASE PEPTIDE; BAYDOUN AR, 1989, J CARDIOVASC PHARM, V13, pS193, DOI 10.1097/00005344-198900135-00054; Beinfeld MC, 1998, ENDOCRINE, V8, P1, DOI 10.1385/ENDO:8:1:1; Brekke JF, 2002, REGUL PEPTIDES, V105, P93, DOI 10.1016/S0167-0115(02)00004-6; BRUNNER F, 2006, PHARMACOL THERAPEUT, V26, P364; BRUTSAERT DL, 1989, PHYSIOL REV, V69, P1228, DOI 10.1152/physrev.1989.69.4.1228; Cappello S, 2007, AM J PHYSIOL-HEART C, V293, pH719, DOI 10.1152/ajpheart.01352.2006; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Cerra MC, 2006, BASIC RES CARDIOL, V101, P43, DOI 10.1007/s00395-005-0547-2; Corti A, 2000, ADV EXP MED BIOL, V482, P351; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; Danser AHJ, 2002, J MOL CELL CARDIOL, V34, P1463, DOI 10.1006/jmcc.2002.2078; DEAKIN H, 1963, BIOCHEM J, V89, P296, DOI 10.1042/bj0890296; EIDEN LE, 1987, NATURE, V325, P301, DOI 10.1038/325301a0; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Gallo MP, 2007, AM J PHYSIOL-HEART C, V292, pH2906, DOI 10.1152/ajpheart.01253.2006; Georget M, 2003, FASEB J, V17, P1380, DOI 10.1096/fj.02-0784com; Glattard E, 2006, FEBS J, V273, P3311, DOI 10.1111/j.1742-4658.2006.05334.x; Goumon Y, 2000, J BIOL CHEM, V275, P38355, DOI 10.1074/jbc.M007557200; HALBAN PA, 1994, BIOCHEM J, V299, P1; Hartell NA, 2005, BIOCHEM PHARMACOL, V69, P781, DOI 10.1016/j.bcp.2004.11.022; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Helle KB, 2000, ADV EXP MED BIOL, V482, P389; Hong SJ, 1998, BRIT J PHARMACOL, V124, P849, DOI 10.1038/sj.bjp.0701898; HoveMadsen L, 1996, BASIC RES CARDIOL, V91, P1, DOI 10.1007/BF00795355; HSIAO RJ, 1990, KIDNEY INT, V37, P955, DOI 10.1038/ki.1990.71; HUTTON JC, 1988, ENDOCRINOLOGY, V122, P1014, DOI 10.1210/endo-122-3-1014; IACANGELO A, 1988, FEBS LETT, V227, P115, DOI 10.1016/0014-5793(88)80880-9; Koeslag JH, 1999, J PHYSIOL-LONDON, V517, P643, DOI 10.1111/j.1469-7793.1999.0643s.x; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Mahapatra NR, 2006, J HYPERTENS, V24, P895, DOI 10.1097/01.hjh.0000222760.99852.e0; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Maniatis NA, 2006, CIRC RES, V99, P870, DOI 10.1161/01.RES.0000245187.08026.47; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; MISEREZ B, 1992, FEBS LETT, V314, P122, DOI 10.1016/0014-5793(92)80956-H; Muth E, 2004, BBA-PROTEINS PROTEOM, V1699, P263, DOI 10.1016/j.bbapap.2004.03.007; NOBELS FRE, 1994, EUR J ENDOCRINOL, V131, P589, DOI 10.1530/eje.0.1310589; O'Connor DT, 1999, BLOOD PRESSURE, V8, P285, DOI 10.1080/080370599439508; Omland T, 2003, AM J MED, V114, P25, DOI 10.1016/S0002-9343(02)01425-0; PIERONI M, 2007, EUR HEART J, V28, P1052; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Shah AM, 1996, CARDIOVASC RES, V31, P847; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 2002, AM J PHYSIOL-LUNG C, V283, pL1192, DOI 10.1152/ajplung.00112.2002; STEINER HJ, 1990, J HISTOCHEM CYTOCHEM, V38, P845, DOI 10.1177/38.6.2139887; STRIDSBERG M, 1995, J ENDOCRINOL, V144, P49, DOI 10.1677/joe.0.1440049; Tota B, 2003, REGUL PEPTIDES, V114, P123, DOI 10.1016/S0167-0115(03)00112-5; Tota B, 2007, COMP BIOCHEM PHYS A, V147, P11, DOI 10.1016/j.cbpa.2006.05.016; VITTONE L, 1994, J PHARMACOL TOX MET, V32, P7, DOI 10.1016/1056-8719(94)90011-6; Weiergraber M, 2000, J HISTOCHEM CYTOCHEM, V48, P807, DOI 10.1177/002215540004800609	53	41	42	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3992	4004		10.1096/fj.08-110239	http://dx.doi.org/10.1096/fj.08-110239			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18697842				2022-12-25	WOS:000260503000027
J	Yang, JL; Siqueira, MF; Behl, Y; Alikhani, M; Graves, DT				Yang, Julia; Siqueira, Michelle F.; Behl, Yugal; Alikhani, Mani; Graves, Dana T.			The transcription factor ST18 regulates proapoptotic and proinflammatory gene expression in fibroblasts	FASEB JOURNAL			English	Article						cytokines; cell death; inflammation; mRNA profiling; microarray	FACTOR-KAPPA-B; TUMOR-NECROSIS-FACTOR; PRO-APOPTOTIC GENES; RHEUMATOID-ARTHRITIS; CHEMOTHERAPY; THERAPY; CANCER; P53; IDENTIFICATION; NETWORKS	Suppression of tumorigenicity 18 (ST18) and the homologues neural zinc-finger protein-3 (NZF3) and myelin transcription factor 3 (Myt3) are transcription factors with unknown function. Previous studies have established that they repress transcription of a synthetic reporter construct consisting of the consensus sequence AAAGTTT linked to the thymidine kinase promoter. In addition, ST18 exhibits significantly reduced expression in breast cancer and breast cancer cell lines. We report here for the first time evidence that ST18 mediates tumor necrosis factor (TNF) -alpha induced mRNA levels of proapoptotic and proinflammatory genes in fibroblasts by mRNA profiling and silencing with ST18 small interfering RNA ( siRNA). Gene set enrichment analysis and mRNA profiling support this conclusion by identifying several apoptotic and inflammatory pathways that are down-regulated by ST18 siRNA. In addition, ST18 siRNA reduces TNF-induced fibroblast apoptosis and caspase3/7 activity. Fibroblasts that overexpress ST18 by transient transfection exhibit significantly increased apoptosis and increased expression of TNF-alpha, interleukin (IL) -1 alpha, and IL-6. In addition, cotransfection of ST18 and a TNF-alpha or IL-1 alpha reporter construct demonstrates that ST18 overexpression in fibroblasts significantly enhanced promoter activity of these genes. Taken together, these studies demonstrate that the transcription factor ST18/NZF3 regulates the mRNA levels of proapoptotic and proinflammatory genes in revealing a previously unrecognized function. -Yang, J., Siqueira, M. F., Behl, Y., Alikhani, M., and Graves, D. T. The transcription factor ST18 regulates proapoptotic and proinflammatory gene expression in fibroblasts. FASEB J. 22, 3956-3967 (2008)	[Yang, Julia; Siqueira, Michelle F.; Behl, Yugal; Graves, Dana T.] Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA; [Alikhani, Mani] NYU, Coll Dent, Dept Orthodont, New York, NY USA	Boston University; New York University	Graves, DT (corresponding author), Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St W-202 D, Boston, MA 02118 USA.	dgraves@bu.edu			U. S. National Institute of Health [DE07559, DE17732]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011254, R01DE007559, R23DE007559] Funding Source: NIH RePORTER	U. S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Alicia Ruff for help in preparing this manuscript. This work was supported by U. S. National Institute of Health grants DE07559 and DE17732.	Alikhani M, 2004, J CELL PHYSIOL, V201, P341, DOI 10.1002/jcp.20067; Alikhani ZB, 2005, J BIOL CHEM, V280, P12087, DOI 10.1074/jbc.M406313200; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Chen F, 1999, CLIN CHEM, V45, P7; Choisy-Rossi C, 1998, TOXICOL LETT, V103, P491, DOI 10.1016/S0378-4274(98)00238-0; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Graves DT, 2001, J DENT RES, V80, P1875, DOI 10.1177/00220345010800100301; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Kane CD, 2000, WOUND REPAIR REGEN, V8, P45, DOI 10.1046/j.1524-475x.2000.00045.x; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; Lavon I, 2003, CANCER RES, V63, P25; Liu HT, 2003, CURR OPIN PHARMACOL, V3, P317, DOI 10.1016/S1471-4892(03)00037-7; Matt T, 2002, ACTA MED AUST, V29, P77, DOI 10.1046/j.1563-2571.2002.02010.x; Monks NR, 2004, J CELL BIOCHEM, V92, P646, DOI 10.1002/jcb.20080; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Steinbach D, 2006, CLIN CANCER RES, V12, P2434, DOI 10.1158/1078-0432.CCR-05-2552; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Taylor PC, 2001, MOL BIOTECHNOL, V19, P153, DOI 10.1385/MB:19:2:153; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wong DJ, 2005, J INVEST DERMATOL, V125, P175, DOI 10.1111/j.0022-202X.2005.23827.x; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231	33	55	57	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3956	3967		10.1096/fj.08-111013	http://dx.doi.org/10.1096/fj.08-111013			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18676404	Green Published			2022-12-25	WOS:000260503000024
J	Fan, W; Luo, JY				Fan, Wei; Luo, Jianyuan			RecQ4 Facilitates UV Light-induced DNA Damage Repair through Interaction with Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A (XPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; WERNER-SYNDROME; GENE-PRODUCT; PROTEIN; REPLICATION; INVOLVEMENT; PATHWAY; IRRADIATION; EUKARYOTES; INITIATION	Mutations in the RECQL4 helicase gene have been linked to Rothmund-Thomson syndrome, which is characterized by genome instability, cancer susceptibility, and premature aging. To better define the cellular function of the RecQ4 protein, we investigated the subcellular localization of RecQ4 upon treatment of cells with different DNA-damaging agents including-UV irradiation, 4-nitroquinoline 1-oxide, camptothecin, etoposide, hydroxyurea, and H2O2. We found that RecQ4 formed discrete nuclear foci specifically in response to UV irradiation and 4-nitroquinoline 1-oxide. We demonstrated that functional RecQ4 was required for the efficient removal of UV lesions and could rescue UV sensitivity of RecQ4-deficient Rothmund-Thomson syndrome cells. Furthermore, UV treatment also resulted in the colocalization of the nuclear foci formed with RecQ4 and xeroderma pigmentosum group A in human cells. Consistently, RecQ4 could directly interact with xeroderma pigmentosum group A, and this interaction was stimulated by UV irradiation. By fractionating whole cell extracts into cytoplasmic, soluble nuclear, and chromatin-bound fractions, we observed that RecQ4 protein bound more tightly to chromatin upon UV irradiation. Taken together, our findings suggest a role of RecQ4 in the repair of UV-induced DNA damages in human cells.	[Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luo, JY (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 422 LRB,364 Plantat St, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health [R01AG026534]; Worcester Foundation Annual Research Award; NATIONAL INSTITUTE ON AGING [R01AG026534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worcester Foundation Annual Research Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG026534 (to J. L.) through the NIA. This work was also supported in part by grants from Worcester Foundation Annual Research Award. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ababou M, 2002, ONCOGENE, V21, P2079, DOI 10.1038/sj.onc.1205246; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BERG E, 1987, J AM ACAD DERMATOL, V17, P332, DOI 10.1016/S0190-9622(87)70207-2; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kumata Y, 2007, BBA-MOL CELL RES, V1773, P556, DOI 10.1016/j.bbamcr.2007.01.005; Li G, 1998, BRIT J DERMATOL, V139, P3; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Vasseur F, 1999, ACTA DERM-VENEREOL, V79, P150; VENNOS EM, 1995, DERMATOL CLIN, V13, P143, DOI 10.1016/S0733-8635(18)30117-7; VENNOS EM, 1992, J AM ACAD DERMATOL, V27, P750, DOI 10.1016/0190-9622(92)70249-F; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	30	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29037	29044		10.1074/jbc.M801928200	http://dx.doi.org/10.1074/jbc.M801928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18693251	Green Published, hybrid			2022-12-25	WOS:000260179900030
J	Ulrich, M; Petre, A; Youhnovski, N; Promm, F; Schirle, M; Schumm, M; Pero, RS; Doyle, A; Checkel, J; Kita, H; Thiyagarajan, N; Acharya, KR; Schmid-Grendelmeier, P; Simon, HU; Schwarz, H; Tsutsui, M; Shimokawa, H; Bellon, G; Lee, JJ; Przybylski, M; Doring, G				Ulrich, Martina; Petre, Alina; Youhnovski, Nikolay; Proemm, Franziska; Schirle, Markus; Schumm, Michael; Pero, Ralph S.; Doyle, Alfred; Checkel, James; Kita, Hirohito; Thiyagarajan, Nethaji; Acharya, K. Ravi; Schmid-Grendelmeier, Peter; Simon, Hans-Uwe; Schwarz, Heinz; Tsutsui, Masato; Shimokawa, Hiroaki; Bellon, Gabriel; Lee, James J.; Przybylski, Michael; Doering, Gerd			Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BASIC-PROTEIN; NITRIC-OXIDE SYNTHASE; RIBONUCLEOLYTIC ACTIVE-SITE; TRYPANOSOMA-CRUZI; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; CATIONIC PROTEIN; IN-VITRO; IDENTIFICATION; CLONING	Nitration of tyrosine residues has been observed during various acute and chronic inflammatory diseases. However, the mechanism of tyrosine nitration and the nature of the proteins that become tyrosine nitrated during inflammation remain unclear. Here we show that eosinophils but not other cell types including neutrophils contain nitrotyrosine-positive proteins in specific granules. Furthermore, we demonstrate that the human eosinophil toxins, eosinophil peroxidase (EPO), major basic protein, eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP), and the respective murine toxins, are post-translationally modified by nitration at tyrosine residues during cell maturation. High resolution affinity-mass spectrometry identified specific single nitration sites at Tyr(349) in EPO and Tyr(33) in both ECP and EDN. ECP and EDN crystal structures revealed and EPO structure modeling suggested that the nitrated tyrosine residues in the toxins are surface exposed. Studies in EPO-/-, gp91(phox-/-), and NOS-/- mice revealed that tyrosine nitration of these toxins is mediated by EPO in the presence of hydrogen peroxide and minute amounts of NOx. Tyrosine nitration of eosinophil granule toxins occurs during maturation of eosinophils, independent of inflammation. These results provide evidence that post-translational tyrosine nitration is unique to eosinophils.	[Ulrich, Martina; Proemm, Franziska; Doering, Gerd] Univ Klinikum Tubingen, Inst Med Microbiol & Hyg, D-72074 Tubingen, Germany; [Petre, Alina; Youhnovski, Nikolay; Przybylski, Michael] Univ Konstanz, Dept Chem, Analyt Chem Lab, D-78457 Constance, Germany; [Schirle, Markus] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Schumm, Michael] Univ Klinikum Tubingen, Childrens Clin, D-72076 Tubingen, Germany; [Pero, Ralph S.; Doyle, Alfred; Lee, James J.] Mayo Clin, Scottsdale, AZ 85259 USA; [Checkel, James; Kita, Hirohito] Mayo Clin, Rochester, MN 55905 USA; [Thiyagarajan, Nethaji; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Schmid-Grendelmeier, Peter] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8004 Zurich, Switzerland; [Simon, Hans-Uwe] Univ Bern, Inst Pharmakol, CH-3010 Bern, Switzerland; [Schwarz, Heinz] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Tsutsui, Masato] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Kitakyushu, Fukuoka 8078555, Japan; [Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Sendai, Miyagi 9808974, Japan; [Bellon, Gabriel] Univ Lyon, Hosp Civils Lyon, F-69600 Lyon, France	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Konstanz; Novartis; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; University of Bath; University of Zurich; University Zurich Hospital; University of Bern; Max Planck Society; University of Occupational & Environmental Health - Japan; Tohoku University; CHU Lyon	Doring, G (corresponding author), Wilhelmstr 31, D-72074 Tubingen, Germany.	gerd.doering@med.uni-tuebingen.de	Simon, Hans-Uwe/AAU-7410-2020; Petre, Brindusa-Alina/C-2793-2011	Simon, Hans-Uwe/0000-0002-9404-7736; Acharya, K. Ravi/0000-0002-3009-4058; Shimokawa, Hiroaki/0000-0001-7534-4826	Deutsche Forschungs-gemeinschaft, Bonn, Germany; European Union	Deutsche Forschungs-gemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Union(European Commission)	This work was supported in part by grants from the Deutsche Forschungs-gemeinschaft, Bonn, Germany, and the European Union (to M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTTERWORTH AE, 1984, ADV PARASIT, V23, P143, DOI 10.1016/S0065-308X(08)60287-0; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; delPozo V, 1997, J IMMUNOL, V158, P859; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Duguet A, 2001, AM J RESP CRIT CARE, V164, P1119, DOI 10.1164/ajrccm.164.7.2010085; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Giembycz MA, 1999, PHARMACOL REV, V51, P213; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; GOLDSTEIN W, 1986, AM REV RESPIR DIS, V134, P49; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jiang Q, 1997, J BIOL CHEM, V272, P32767, DOI 10.1074/jbc.272.52.32767; KOBZIK L, 1997, AM J RESP CRIT CARE, V155, pA60; KOIZUMI C, 1971, J FOOD SCI, V36, P1105; Kurashima K, 1996, LAB INVEST, V75, P689; LARSON KA, 1995, J IMMUNOL, V155, P3002; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee NA, 1997, J IMMUNOL, V158, P1332; Leonidas DD, 2001, J BIOL CHEM, V276, P15009, DOI 10.1074/jbc.M010585200; Macht M, 2004, ANAL BIOANAL CHEM, V378, P1102, DOI 10.1007/s00216-003-2159-8; Macias MP, 2000, J LEUKOCYTE BIOL, V67, P567, DOI 10.1002/jlb.67.4.567; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; METCALF JA, 1986, LABORATORY MANUAL NE, P1; Mohan CG, 2002, BIOCHEMISTRY-US, V41, P12100, DOI 10.1021/bi0264521; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; MOLINA HA, 1989, IMMUNOLOGY, V66, P289; Morishita T, 2005, P NATL ACAD SCI USA, V102, P10616, DOI 10.1073/pnas.0502236102; MOTOJIMA S, 1989, AM REV RESPIR DIS, V139, P801, DOI 10.1164/ajrccm/139.3.801; NICHOLLS P, 1964, BIOCHEM J, V90, P331, DOI 10.1042/bj0900331; NOGUEIRA NM, 1982, J IMMUNOL, V128, P1705; Ohmori J, 1996, INT ARCH ALLERGY IMM, V111, P30, DOI 10.1159/000237341; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Pfeiffer S, 2001, FASEB J, V15, P2355, DOI 10.1096/fj.01-0295com; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; RAPPOPORY Z, 1984, CRC HDB TABLES ORGAN, P20; ROSENBERG HF, 1995, J BIOL CHEM, V270, P30234; Saleh D, 1997, AM J RESP CRIT CARE, V155, P1763, DOI 10.1164/ajrccm.155.5.9154889; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TEN RM, 1989, J EXP MED, V169, P1757, DOI 10.1084/jem.169.5.1757; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; VILLALTA F, 1987, J PROTOZOOL, V34, P285, DOI 10.1111/j.1550-7408.1987.tb03176.x; Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008; WASMOEN TL, 1988, J BIOL CHEM, V263, P12559; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111	60	39	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28629	28640		10.1074/jbc.M801196200	http://dx.doi.org/10.1074/jbc.M801196200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694936	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000259969300065
J	Eisenberg, S; Giehl, K; Henis, YI; Ehrlich, M				Eisenberg, Sharon; Giehl, Klaudia; Henis, Yoav I.; Ehrlich, Marcelo			Differential interference of chlorpromazine with the membrane interactions of oncogenic K-Ras and its effects on cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; RECEPTOR ACTIVATION; PROTEINS; SURFACE; CANCER; DRUGS; PALMITOYLATION; INHIBITORS; PATHWAY; GOLGI	Membrane anchorage of Ras proteins is important for their signaling and oncogenic potential. K-Ras4B (K-Ras), the Ras isoform most often mutated in human cancers, is the only Ras isoform where a polybasic motif contributes essential electrostatic interactions with the negatively charged cytoplasmic leaflet. Here we studied the effects of the cationic amphiphilic drug chlorpromazine (CPZ) on the membrane association of oncogenic K-Ras(G12V), cell proliferation, and apoptosis. Combining live cell microscopy, FRAP beam size analysis, and cell fractionation studies, we show that CPZ reduces the association of GFP-K-Ras(G12V) with the plasma membrane and increases its exchange between plasma membrane and cytoplasmic pools. These effects appear to depend on electrostatic interactions because the membrane association of another related protein that has a membrane-interacting polybasic cluster (Rac1(G12V)) was also affected, whereas that of H-Ras was not. The weakened association with the plasma membrane led to a higher fraction of GFP-K-Ras(G12V) in the cytoplasm and in internal membranes, accompanied by either cell cycle arrest (PANC-1 cells) or apoptosis (Rat-1 fibroblasts), the latter being in correlation with the targeting of K-Ras(G12V) to mitochondria. In accord with these results, CPZ compromised the transformed phenotype of PANC-1 cells, as indicated by inhibition of cell migration and growth in soft agar.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Eisenberg, Sharon; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Giehl, Klaudia] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-98070 Ulm, Germany; [Giehl, Klaudia] Univ Ulm, Med Ctr, Dept Internal Med 1, D-98070 Ulm, Germany	Tel Aviv University; Tel Aviv University; Ulm University; Ulm University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	henis@post.tau.ac; marceloe@tauex.tau.ac.il		Henis, Yoav/0000-0002-1408-3877; Ehrlich, Marcelo/0000-0002-2352-1808	Jacqueline Seroussi Memorial Foundation for Cancer Research	Jacqueline Seroussi Memorial Foundation for Cancer Research	This work was supported in part by an award from the Jacqueline Seroussi Memorial Foundation for Cancer Research (to Y. I. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGARD DA, 1989, METHOD CELL BIOL, V30, P353; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOS JL, 1989, CANCER RES, V49, P4682; Chen JY, 2003, BBA-BIOMEMBRANES, V1616, P95, DOI 10.1016/S0005-2736(03)00229-3; Chen LM, 2005, WORLD J GASTROENTERO, V11, P831, DOI 10.3748/wjg.v11.i6.831; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Dreissigacker U, 2006, CELL SIGNAL, V18, P1156, DOI 10.1016/j.cellsig.2005.09.004; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; FORD JM, 1989, MOL PHARMACOL, V35, P105; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; FUJITA K, 1958, NATURE, V181, P54, DOI 10.1038/181054a0; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Lopez-Munoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Motohashi Noboru, 2000, Current Drug Targets, V1, P237, DOI 10.2174/1389450003349191; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 1999, J BIOL CHEM, V274, P1606, DOI 10.1074/jbc.274.3.1606; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Nordenberg J, 1999, BIOCHEM PHARMACOL, V58, P1229, DOI 10.1016/S0006-2952(99)00156-2; OLIVER MH, 1989, J CELL SCI, V92, P513; POLLIACK A, 1972, CANCER RES, V32, P1912; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; SCHRIER SL, 1992, BLOOD, V79, P782; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Welman A, 2000, ONCOGENE, V19, P4582, DOI 10.1038/sj.onc.1203818; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	52	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27279	27288		10.1074/jbc.M804589200	http://dx.doi.org/10.1074/jbc.M804589200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18693247	hybrid			2022-12-25	WOS:000259586600047
J	Zhang, YY; Mei, ZQ; Wu, JW; Wang, ZX				Zhang, Yuan-Yuan; Mei, Zi-Qing; Wu, Jia-Wei; Wang, Zhi-Xin			Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38 alpha in different phosphorylation states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-2; CONTINUOUS SPECTROPHOTOMETRIC ASSAY; MAP-KINASE; TYROSINE-PHOSPHATASE; KINETIC-MECHANISM; STRESS; P38; PATHWAYS; DEPHOSPHORYLATION; INACTIVATION	The mitogen-activated protein (MAP) kinases are essential signaling molecules that mediate many cellular effects of growth factors, cytokines, and stress stimuli. Full activation of the MAP kinases requires dual phosphorylation of the Thr and Tyr residues in the TXY motif of the activation loop by MAP kinase kinases. Down-regulation of MAP kinase activity can be initiated by multiple serine/threonine phosphatases, tyrosine-specific phosphatases, and dual specificity phosphatases (MAP kinase phosphatases). This would inevitably lead to the formation of monophosphorylated MAP kinases. However, the biological functions of these monophosphorylated MAP kinases are currently not clear. In this study, we have prepared MAP kinase p38 alpha, a member of the MAP kinase family, in all phosphorylated forms and characterized their biochemical properties. Our results indicated the following: (i) p38 alpha phosphorylated at both Thr-180 and Tyr-182 was 10-20-fold more active than p38 alpha phosphorylated at Thr-180 only, whereas p38 alpha phosphorylated at Tyr-182 alone was inactive; (ii) the dual-specific MKP5, the tyrosine-specific hematopoietic protein-tyrosine phosphatase, and the serine/threonine-specific PP2C alpha are all highly specific for the dephosphorylation of p38 alpha, and the dephosphorylation rates were significantly affected by different phosphorylated states of p38 alpha; (iii) the N-terminal domain of MPK5 has no effect on enzyme catalysis, whereas deletion of the MAP kinase-binding domain in MKP5 leads to a 370-fold decrease in kcat/Km for the dephosphorylation of p38 alpha. This study has thus revealed the quantitative contributions of phosphorylation of Thr, Tyr, or both to the activation of p38 alpha and to the substrate specificity for various phosphatases.	[Zhang, Yuan-Yuan; Mei, Zi-Qing; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ Bioinformat, Key Lab, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Acad Sinica, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, JW (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ Bioinformat, Key Lab, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn; zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Ministry of Science and Technology of China [2006CB503900-2007CB914400]; National Natural Science Foundation of China [30425005-30770476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grants 2006CB503900-2007CB914400 from the Ministry of Science and Technology of China and Grants 30425005-30770476 from National Natural Science Foundation of China. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHN NG, 1991, J BIOL CHEM, V266, P4220; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cha HJ, 2001, J CELL BIOL, V153, P1355, DOI 10.1083/jcb.153.7.1355; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Killilea SD, 1998, METH MOL B, V93, P23; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Ogata M, 1999, BIOCHEM BIOPH RES CO, V256, P52, DOI 10.1006/bbrc.1999.0278; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pettiford SM, 2000, ONCOGENE, V19, P858, DOI 10.1038/sj.onc.1203408; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; SEGEL IH, 1975, ENZYME KINETICS, P73; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Szafranska AE, 2005, FEBS J, V272, P4631, DOI 10.1111/j.1742-4658.2005.04827.x; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yao Z, 2000, FEBS LETT, V468, P37, DOI 10.1016/S0014-5793(00)01191-1; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; Zhang HM, 1999, TRANSPORT RES B-METH, V33, P1, DOI 10.1016/S0191-2615(98)00022-8; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	51	63	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26591	26601		10.1074/jbc.M801703200	http://dx.doi.org/10.1074/jbc.M801703200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18669639	Green Published, hybrid			2022-12-25	WOS:000259341600035
J	Carattino, MD; Hughey, RP; Kleyman, TR				Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.			Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNELS; XENOPUS-OOCYTES; ELASTASE ACTIVATION; MEMBRANE TOPOLOGY; FURIN; ENAC; TRANSPORT; CLEAVAGE; PEPTIDE; MCAP2	Maturation of the epithelial sodium channel (ENaC) involves furin-dependent cleavage at two extracellular sites within the alpha subunit and at a single extracellular site within the gamma subunit. Channels lacking furin processing of the alpha subunit have very low activity. We recently identified a prostasin-dependent cleavage site (RKRK186) in the gamma subunit. We also demonstrated that the tract alpha D206-R231, between the two furin cleavage sites in the alpha subunit, as well as the tract gamma E144-K186, between the furin and prostasin cleavage sites in the gamma subunit, are inhibitory domains. ENaC cleavage by furin, and subsequently by prostasin, leads to a stepwise increase in the open probability of the channel as a result of release of the alpha and gamma subunit inhibitory tracts, respectively. We examined whether release of either the alpha or gamma inhibitory tract has a dominant role in activating the channel. Co-expression of prostasin and either wild type channels or mutant channels lacking furin cleavage of the alpha subunit (alpha R205A, R208A, R231A beta gamma) in Xenopus laevis oocytes led to increases in whole cell currents to similar levels. In an analogous manner and independent of the proteolytic processing of the alpha subunit, amiloride-sensitive currents in oocytes expressing channels carrying gamma subunits with both a mutation in the furin cleavage site and a deletion of the inhibitory tract (alpha beta gamma R143A, Delta E144-K186 and alpha R205A, R208A, R231A beta gamma R143A, Delta E144-K186) were significantly higher than those from oocytes expressing wild type ENaC. When channels lacked the alpha and gamma subunitinhibitorytracts, alpha subunitcleavage was required for channels to be fully active. Channels lacking both furin cleavage and the inhibitory tract in the gamma subunit(alpha beta gamma R143A, Delta E144-K186) showed a significant reduction in the efficacy of block by the synthetic alpha-26 inhibitory peptide representing the tract alpha D206-R231. Our data indicate that removal of the inhibitory tract from the gamma subunit, in the absence of alpha subunit cleavage, results in nearly full activation of the channel.	[Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughey, RP (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, S933 Scaife Hall, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu			National Institutes of Health [R01/R56 DK065161, P30 DK079307]; Cystic Fibrosis Foundation [R883CR02, Kleyma08P0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01/R56 DK065161 and P30 DK079307. This work was also supported by the Cystic Fibrosis Foundation (R883CR02 and Kleyma08P0). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; RENARD S, 1994, J BIOL CHEM, V269, P12981; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598	20	96	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25290	25295		10.1074/jbc.M803931200	http://dx.doi.org/10.1074/jbc.M803931200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18650438	Green Published, hybrid			2022-12-25	WOS:000259012700022
J	Kring, SII; Holst, C; Zimmermann, E; Jess, T; Berentzen, T; Toubro, S; Hansen, T; Astrup, A; Pedersen, O; Sorensen, TIA				Kring, Sofia I. I.; Holst, Claus; Zimmermann, Esther; Jess, Tine; Berentzen, Tina; Toubro, Soren; Hansen, Torben; Astrup, Arne; Pedersen, Oluf; Sorensen, Thorkild I. A.			FTO Gene Associated Fatness in Relation to Body Fat Distribution and Metabolic Traits throughout a Broad Range of Fatness	PLOS ONE			English	Article							INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; ADULT OBESITY; MASS INDEX; CHILDHOOD; VARIANTS; DISEASE; CLONING; WEIGHT; RISK	Background: A common single nucleotide polymorphism (SNP) of FTO (rs9939609, T/A) is associated with total body fatness. We investigated the association of this SNP with abdominal and peripheral fatness and obesity-related metabolic traits in middle-aged men through a broad range of fatness present already in adolescence. Methodology/Principal Findings: Obese young Danish men (n = 753, BMI >= 31.0 kg/m(2)) and a randomly selected group (n = 879) from the same population were examined in three surveys (mean age 35, 46 and 49 years, respectively). The traits included anthropometrics, body composition, oral glucose tolerance test, blood lipids, blood pressure, fibrinogen and aspartate aminotransferase. Logistic regression analysis was used to assess the age-adjusted association between the phenotypes and the odds ratios for the FTO rs9939609 (TT and TA genotype versus the AA genotype), for anthropometrics and body composition estimated per unit z-score. BMI was strongly associated with the AA genotype in all three surveys: OR = 1.17, p = 1.1*10(-6), OR = 1.20, p = 1.7*10(-7), OR = 1.17, p = 3.4*10(-3), respectively. Fat body mass index was also associated with the AA genotype (OR = 1.21, p = 4.6*10(-7) and OR = 1.21, p = 1.0*10(-3)). Increased abdominal fatness was associated with the AA genotype when measured as waist circumference (OR = 1.21, p = 2.2*10(-6) and OR = 1.19, p = 5.9*10(-3)), sagittal abdominal diameter (OR = 1.17, p = 1.3*10(-4) and OR = 1.18, p = 0.011) and intra-abdominal adipose tissue (OR = 1.21, p = 0.005). Increased peripheral fatness measured as hip circumference (OR = 1.19, p = 1.3*10(-5) and OR = 1.18, p = 0.004) and lower body fat mass (OR = 1.26, p = 0.002) was associated with the AA genotype. The AA genotype was significantly associated with decreased Stumvoll insulin sensitivity index (OR = 0.93, p = 0.02) and with decreased non-fasting plasma HDL-cholesterol (OR = 0.57, p = 0.037), but not with any other of the metabolic traits. However, all significant results for both body fat distribution and metabolic traits were explained by a mediating effect of total fat mass. Conclusion: The association of the examined FTO SNP to general fatness throughout the range of fatness was confirmed, and this association explains the relation between the SNP and body fat distribution and decreased insulin sensitivity and HDL-cholesterol. The SNP was not significantly associated with other metabolic traits suggesting that they are not derived from the general accumulation of body fat.	[Kring, Sofia I. I.; Holst, Claus; Zimmermann, Esther; Jess, Tine; Berentzen, Tina; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Kring, Sofia I. I.] Univ Copenhagen, Panum Inst, Ctr Pharmacogenom, DK-1168 Copenhagen, Denmark; [Toubro, Soren] Hvidovre Univ Hosp, Reduce Res Clin Nutr, Hvidovre, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Astrup, Arne] Univ Copenhagen, Fac Life Sci, Inst Human Nutr, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; Aarhus University; University of Copenhagen	Kring, SII (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	si@ipm.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Palmer, David/E-6824-2010; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Astrup, Arne/0000-0001-8968-8996; Hansen, Torben/0000-0001-8748-3831; Zimmermann, Esther/0000-0001-5854-0542	Center for Pharmacogenomics at the University of Copenhagen, Denmark	Center for Pharmacogenomics at the University of Copenhagen, Denmark	This study is financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Buemann B, 2005, INT J OBESITY, V29, P624, DOI 10.1038/sj.ijo.0802929; CLEMENT K, 2007, OBESITY GENOMICS POS, P19; CLEMENT K, 2007, OBESITY GENOMICS POS, P221; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Field SF, 2007, DIABETOLOGIA, V50, P2218, DOI 10.1007/s00125-007-0767-0; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HEITMANN BL, 1994, EUR J CLIN NUTR, V48, P228; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; SCHNOHR P, 2001, J EUROPEAN SOC CA SH, V3; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomas DC, 2004, STAT METHODS GENETIC; TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2958	10.1371/journal.pone.0002958	http://dx.doi.org/10.1371/journal.pone.0002958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698412	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600043
J	Christiansen, P				Christiansen, Per			Evolution of Skull and Mandible Shape in Cats (Carnivora: Felidae)	PLOS ONE			English	Article							AFRICAN WILD DOGS; PREDATORY BEHAVIOR; LATE PLEISTOCENE; BITE FORCES; LA-BREA; ECOLOGY; MAMMALS; SABERTOOTHS; CHARACTERS; PATTERNS	The felid family consists of two major subgroups, the sabretoothed and the feline cats, to which all extant species belong, and are the most anatomically derived of all carnivores for predation on large prey with a precision killing bite. There has been much controversy and uncertainty about why the skulls and mandibles of sabretoothed and feline cats evolved to become so anatomically divergent, but previous models have focused on single characters and no unifying hypothesis of evolutionary shape changes has been formulated. Here I show that the shape of the skull and mandible in derived sabrecats occupy entirely different positions within overall morphospace from feline cats, and that the evolution of skull and mandible shape has followed very different paths in the two subgroups. When normalised for body-size differences, evolution of bite forces differ markedly in the two groups, and are much lower in derived sabrecats, and they show a significant relationship with size and cranial shape, whereas no such relationship is present in feline cats. Evolution of skull and mandible shape in modern cats has been governed by the need for uniform powerful biting irrespective of body size, whereas in sabrecats, shape evolution was governed by selective pressures for efficient predation with hypertrophied upper canines at high gape angles, and bite forces were secondary and became progressively weaker during sabrecat evolution. The current study emphasises combinations of new techniques for morphological shape analysis and biomechanical studies to formulate evolutionary hypotheses for difficult groups.	[Christiansen, Per] Zool Museum, Dept Vertibrates, DK-2100 Copenhagen, Denmark		Christiansen, P (corresponding author), Zool Museum, Dept Vertibrates, DK-2100 Copenhagen, Denmark.	p2christiansen@zmuc.ku.dk			Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	Carlsberg Foundation; they had no part of the actual work conducted.	Akersten W.A, 1985, CONTRIB SCI NAT HIST, V356, P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; Bakker R.T., 1983, P350; Biknevicius AR, 1996, CARNIVORE BEHAV ECOL, VII, P393; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1996, P 1993 NATO ASI MORP, P131; Bryant Harold N., 1996, P283; BUCKLANDWRIGHT JC, 1978, J MORPHOL, V155, P35, DOI 10.1002/jmor.1051550104; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CHRISTIANSEN P, 2008, BIOL J LINN SOC, V92; CHRISTIANSEN P, 2008, J MAMMAL EVOL; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; COOPER SM, 1991, AFR J ECOL, V29, P130, DOI 10.1111/j.1365-2028.1991.tb00993.x; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Goswami A, 2006, EVOLUTION, V60, P169; Gray J. E., 1867, Proceedings of the Zoological Society, P258; Haltenorth T., 1936, Zeitschrift fuer Saugetierkunde Berlin, V11, P32; Haltenorth T., 1937, Z SAUGETIERKUNDE, V12, P97; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hunt Jr R. M., 1996, CARNIVORE BEHAV ECOL, V2, P485; KURTEN B, 1954, COMMENT BIOL SOC SCI, V13, P1; LEWIS M, 1996, J HUM EVOL, V32, P257; Leyhausen, 1979, CAT BEHAV; Marean CW, 1995, J HUM EVOL, V29, P515, DOI 10.1006/jhev.1995.1074; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; MILLER GJ, 1984, IMPERIAL VALLEY COLL, V7, P1; MILLS MGL, 1993, MAMMALS PREDATORS, P256; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; RADINSKY L, 1982, NAT HIST, V91, P50; Rawn-Schatzinger V., 1992, ILL STATE MUS REP IN, V47, P1; ROBERTS D, 1979, ACTA ANAT, V103, P422, DOI 10.1159/000145044; ROHLF F.J., 1993, CONTRIBUTIONS MORPHO, V8, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Salles LO., 1992, AM MUS NOVIT, V3047, P1; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1130, P1; Sokal RR, 1995, BIOMETRY; Sunquist ME, 2002, WILD CATS WORLD; Therrien F, 2005, J ZOOL, V267, P249, DOI 10.1017/S0952836905007430; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; TUCKER R, 1954, AUST J ZOOL, V2, P381, DOI 10.1071/ZO9540381; Turner A., 1997, BIG CATS THEIR FOSSI; Van Valkenburgh Blaire, 1998, Illinois State Museum Scientific Papers, V27, P357; Van Valkenhurgh B, 2007, J MORPHOL, V268, P1144; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; WERDELIN L, 1983, BIOL J LINN SOC, V19, P375, DOI 10.1111/j.1095-8312.1983.tb00793.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; ZELDITCH ML, 1995, SYST BIOL, V44, P179, DOI 10.2307/2413705; [No title captured]	60	77	85	0	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2807	10.1371/journal.pone.0002807	http://dx.doi.org/10.1371/journal.pone.0002807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665225	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300026
J	Sun, FJ; Caetano-Anolles, G				Sun, Feng-Jie; Caetano-Anolles, Gustavo			Evolutionary Patterns in the Sequence and Structure of Transfer RNA: A Window into Early Translation and the Genetic Code	PLOS ONE			English	Article							SECONDARY STRUCTURE; AMINO-ACIDS; COEVOLUTION THEORY; CONFIDENCE-LIMITS; ORIGIN; SELENOCYSTEINE; PROTEINS; UGA; PHYLOGENY; SPECULATIONS	Transfer RNA (tRNA) molecules play vital roles during protein synthesis. Their acceptor arms are aminoacylated with specific amino acid residues while their anticodons delimit codon specificity. The history of these two functions has been generally linked in evolutionary studies of the genetic code. However, these functions could have been differentially recruited as evolutionary signatures were left embedded in tRNA molecules. Here we built phylogenies derived from the sequence and structure of tRNA, we forced taxa into monophyletic groups using constraint analyses, tested competing evolutionary hypotheses, and generated timelines of amino acid charging and codon discovery. Charging of Sec, Tyr, Ser and Leu appeared ancient, while specificities related to Asn, Met, and Arg were derived. The timelines also uncovered an early role of the second and then first codon bases, identified codons for Ala and Pro as the most ancient, and revealed important evolutionary take-overs related to the loss of the long variable arm in tRNA. The lack of correlation between ancestries of amino acid charging and encoding indicated that the separate discoveries of these functions reflected independent histories of recruitment. These histories were probably curbed by co-options and important take-overs during early diversification of the living world.	[Sun, Feng-Jie; Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	gca@uiuc.edu			National Science Foundation [MCB-0343126]; University of Illinois Critical Research Initiative	National Science Foundation(National Science Foundation (NSF)); University of Illinois Critical Research Initiative	This work was supported by National Science Foundation grant MCB-0343126 and the University of Illinois Critical Research Initiative.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Amirnovin R, 1997, J MOL EVOL, V44, P473, DOI 10.1007/PL00006170; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; Ashby WR., 1956, INTRO CYBERNETICS, DOI [10.5962/bhl.title.5851, DOI 10.5962/BHL.TITLE.5851]; Billoud B, 2000, MOL BIOL EVOL, V17, P1435, DOI 10.1093/oxfordjournals.molbev.a026244; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Brooks DJ, 2004, BIOINFORMATICS, V20, P2251, DOI 10.1093/bioinformatics/bth235; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Caetano-Anolles G, 2005, J MOL EVOL, V60, P635, DOI 10.1007/s00239-004-0244-z; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Chaley MB, 1999, J MOL EVOL, V48, P168, DOI 10.1007/PL00006455; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Copeland PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-221; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; de Pouplana LR, 1998, P NATL ACAD SCI USA, V95, P11295, DOI 10.1073/pnas.95.19.11295; Di Giulio M, 2004, J THEOR BIOL, V226, P89, DOI 10.1016/j.jtbi.2003.07.001; DIGIULIO M, 1995, ORIGINS LIFE EVOL B, V25, P549, DOI 10.1007/BF01582024; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; Forsdyke DR, 2007, J THEOR BIOL, V248, P745, DOI 10.1016/j.jtbi.2007.07.008; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; GLADYSHEV GP, 1982, J THEOR BIOL, V94, P301, DOI 10.1016/0022-5193(82)90314-9; Gladyshev VN, 2001, BIOFACTORS, V14, P87, DOI 10.1002/biof.5520140112; Gultyaev AP, 2002, J MOL EVOL, V54, P1, DOI 10.1007/s00239-001-0010-4; HAIG D, 1991, J MOL EVOL, V33, P412, DOI 10.1007/BF02103132; HARTMAN H, 1995, J MOL EVOL, V40, P541; HARTMAN H, 1978, ORIGINS LIFE EVOL B, V9, P133, DOI 10.1007/BF00931410; HARTMAN H, 1975, J MOL EVOL, V4, P359, DOI 10.1007/BF01732537; HATFIELD D, 1993, TRENDS GENET, V9, P69, DOI 10.1016/0168-9525(93)90215-4; Hatfield D, 1999, COMPREHENSIVE NATURA, P353; Hauser DL, 1997, CLADISTICS, V13, P97, DOI 10.1111/j.1096-0031.1997.tb00243.x; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; HIGGS PG, 1993, J PHYS I, V3, P43, DOI 10.1051/jp1:1993116; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; HIGGS PG, 1995, J CHEM SOC FARADAY T, V91, P2531, DOI 10.1039/ft9959102531; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; KLUGE AG, 1993, CLADISTICS, V9, P183, DOI 10.1111/j.1096-0031.1993.tb00217.x; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; LOVETT PS, 1991, J BACTERIOL, V173, P1810, DOI 10.1128/jb.173.5.1810-1812.1991; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; MCCLAIN WH, 1993, FASEB J, V7, P72, DOI 10.1096/fasebj.7.1.8422977; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; NIRENBERG M, 1966, COLD SPRING HARB SYM, V31, P11, DOI 10.1101/SQB.1966.031.01.008; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pollock DD, 2003, J MOL EVOL, V56, P375, DOI 10.1007/s00239-002-2456-4; Rodin S, 1996, P NATL ACAD SCI USA, V93, P4537, DOI 10.1073/pnas.93.10.4537; RODIN S, 1993, P NATL ACAD SCI USA, V90, P4723, DOI 10.1073/pnas.90.10.4723; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rodin SN, 2006, DNA CELL BIOL, V25, P365, DOI 10.1089/dna.2006.25.365; Ronneberg TA, 2000, P NATL ACAD SCI USA, V97, P13690, DOI 10.1073/pnas.250403097; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHNEIDER ED, 1994, FUTURES, V26, P626, DOI 10.1016/0016-3287(94)90034-5; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Schrdinger E., 1944; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536; Schultes Erik, 1999, Complexity, V4, P61; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Sherrer RL, 2008, NUCLEIC ACIDS RES, V36, P1247, DOI 10.1093/nar/gkm1134; SJOSTROM M, 1985, J MOL EVOL, V22, P272, DOI 10.1007/BF02099756; SOLL D, 1995, TRNA STRUCTURE BIOSY, P225; Soltis PS, 2003, STAT SCI, V18, P256; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; Steel M, 2004, APPL MATH LETT, V17, P785, DOI 10.1016/j.aml.2004.06.006; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; STEFFENS W, 1999, NUCLEIC ACIDS RES, V27, P1578; STEGER G, 1984, J BIOMOL STRUCT DYN, V2, P543; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Sun FJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000018; Sun FJ, 2008, J MOL EVOL, V66, P21, DOI 10.1007/s00239-007-9050-8; Sun FJ, 2007, TRENDS GENET, V23, P26, DOI 10.1016/j.tig.2006.11.005; Swain TD, 2003, P ROY SOC B-BIOL SCI, V270, P887, DOI 10.1098/rspb.2002.2297; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szathmary E, 1999, TRENDS GENET, V15, P223, DOI 10.1016/S0168-9525(99)01730-8; Teichmann SA, 2001, TRENDS BIOTECHNOL, V19, P482, DOI 10.1016/S0167-7799(01)01813-3; Trifonov EN, 1997, GENE, V205, P1, DOI 10.1016/S0378-1119(97)00479-4; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Watanabe Kimitsuna, 1995, P225; WEINER AM, 1973, J MOL BIOL, V80, P837, DOI 10.1016/0022-2836(73)90213-1; Widmann J, 2005, J MOL EVOL, V61, P524, DOI 10.1007/s00239-004-0315-1; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WOESE CR, 1973, NATURWISSENSCHAFTEN, V60, P447; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; WONG JT, 1981, TRENDS BIOCHEM SCI, V6, P33; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; YARUS M, 1989, BIOCHEMISTRY-US, V28, P980, DOI 10.1021/bi00429a010; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; ZUCKERKANDL E, 1971, J MOL BIOL, V59, P473, DOI 10.1016/0022-2836(71)90311-1	119	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2799	10.1371/journal.pone.0002799	http://dx.doi.org/10.1371/journal.pone.0002799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665254	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300018
J	Akiduki, S; Ikemoto, MJ				Akiduki, Saori; Ikemoto, Mitsushi J.			Modulation of the Neural Glutamate Transporter EAAC1 by the Addicsin-interacting Protein ARL6IP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION PROFILE; FUNCTIONAL-CHARACTERIZATION; MOUSE-BRAIN; C6 GLIOMA; KINASE-C; LOCALIZATION; GENE; ADDICSIN/GTRAP3-18; NEURODEGENERATION; IDENTIFICATION	Addicsin (Arl6ip5) is a murine homologue of rat glutamate transporter-associated protein 3-18 (GTRAP3-18), a putative negative modulator of Na+-dependent neural glutamate transporter-excitatory amino acid carrier 1 (EAAC1). Here we report that ADP-ribosylation factor-like 6 interacting protein 1 (Arl6ip1) is a novel addicsin-associated partner that indirectly promotes EAAC1-mediated glutamate transport activity in a protein kinase C activity-dependent manner. Like addicsin, Arl6ip1 is expressed in numerous tissues and proved likely to be co-localized with addicsin in certain neurons in the matured brain. Arl6ip1 was not translocated from the subcellular compartments under any of the test conditions and had no association with any molecules on the plasma membrane. Immunoprecipitation assay demonstrated that Arl6ip1 bound directly to addicsin and that the hydrophobic region located at amino acids 103-117 of addicsin was crucial to the formation of the Arl6ip1-addicsin heterodimer and addicsin homodimer. Glutamate transport assay revealed that increasing the expression of Arl6ip1 in C6BU-1 cells markedly enhanced Na+-dependent EAAC1-mediated glutamate transport activity in the presence of 100 nM phorbol 12-myristate 13-acetate. Under these conditions, kinetic analyses demonstrated that EAAC1 altered glutamate transport activity by increasing its glutamate affinity but not its maximal velocity. Meanwhile, increasing expression of addicsin Y110A/L112A mutant lacking binding ability for Arl6ip1 showed no enhancement of EAAC1-mediated glutamate transport activity, regardless of phorbol 12-myristate 13-acetate activation, suggesting that association between addicsin and Arl6ip1 causes altered EAAC1-mediated glutamate transport activity. Our findings suggest that Arl6ip1 is a novel addicsin-associated partner that promotes EAAC1-mediated glutamate transport activity by decreasing the number of addicsin molecules available for interaction with EAAC1.	[Akiduki, Saori; Ikemoto, Mitsushi J.] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Ikemoto, Mitsushi J.] Toho Univ, Grad Sch Sci, Chiba 2748510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Toho University	Ikemoto, MJ (corresponding author), Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	m.ikemoto@aist.go.jp	IKEMOTO, Mitsushi J/L-8861-2018	IKEMOTO, Mitsushi J/0000-0001-5799-0672	National Institute of Advanced Industrial Science and Technology, Japan	National Institute of Advanced Industrial Science and Technology, Japan	This work was supported by the National Institute of Advanced Industrial Science and Technology, Japan (to M. J. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiduki S, 2007, NEUROSCI LETT, V426, P149, DOI 10.1016/j.neulet.2007.08.056; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; Huerta B, 2006, SYNAPSE, V59, P394, DOI 10.1002/syn.20250; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Inoue K, 2005, NEUROSCI LETT, V386, P184, DOI 10.1016/j.neulet.2005.06.013; Kanai Y, 1995, NEUROREPORT, V6, P2357, DOI 10.1097/00001756-199511270-00020; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Palos TP, 1996, MOL BRAIN RES, V37, P297, DOI 10.1016/0169-328X(95)00331-L; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	33	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31323	31332		10.1074/jbc.M801570200	http://dx.doi.org/10.1074/jbc.M801570200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18684713	hybrid			2022-12-25	WOS:000260760800009
J	Luthra, R; Singh, RR; Luthra, MG; Li, YX; Hannah, C; Romans, AM; Barkoh, BA; Chen, SS; Ensor, J; Maru, DM; Broaddus, RR; Rashid, A; Albarracin, CT				Luthra, R.; Singh, R. R.; Luthra, M. G.; Li, Y. X.; Hannah, C.; Romans, A. M.; Barkoh, B. A.; Chen, S. S.; Ensor, J.; Maru, D. M.; Broaddus, R. R.; Rashid, A.; Albarracin, C. T.			MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers	ONCOGENE			English	Article						annexin A1; miR-196a; esophageal cancer; breast cancer; endometrial cancer	ACUTE MYELOID-LEUKEMIA; MICROARRAY ANALYSIS; PROSTATE-CANCER; MESSENGER-RNAS; EXPRESSION; CELLS; ESOPHAGEAL; APOPTOSIS; PROTEIN; CARCINOMA	Suppression of annexin A1 (ANXA1), a mediator of apoptosis and inhibitor of cell proliferation, is well documented in various cancers but the underlying mechanism remains unknown. We investigated whether decreased ANXA1 expression was mediated by microRNAs (miRNAs), which are small, non-coding RNAs that negatively regulate gene expression. Using Sanger miR-Base, we identified miR-584, miR-196a and miR-196b as potential miRNAs targeting ANXA1. Only miRNA-196a showed significant inverse correlation with ANXA1 mRNA levels in 12 cancer cell lines of esophageal, breast and endometrial origin (Pearson's correlation -0.66, P=0.019), identifying this as the candidate miRNA targeting ANXA1. Inverse correlation was also observed in 10 esophageal adenocarcinomas (Pearson's correlation -0.64, P=0.047). Analysis of paired normal/tumor tissues from additional 10 patients revealed an increase in miR-196a in the cancers (P=0.003), accompanied by a decrease in ANXA1 mRNA (P=0.004). Increasing miR-196a levels in cells by miR-196a mimics resulted in decreased ANXA1 mRNA and protein. In addition, miR-196a mimics inhibited luciferase expression in luciferase plasmid reporter that included predicted miR-196a recognition sequence from ANXA1 3'-untranslated region conforming that miR-196a directly targets ANXA1. miR-196a promoted cell proliferation, anchorage-independent growth and suppressed apoptosis, suggesting its oncogenic potential. This study demonstrated a novel mechanism of post-transcriptional regulation of ANXA1 expression and identified miR-196a as a marker of esophageal cancer.	[Luthra, R.] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Dept Hematopathol, Houston, TX 77054 USA; [Luthra, M. G.; Li, Y. X.; Maru, D. M.; Broaddus, R. R.; Rashid, A.; Albarracin, C. T.] Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Houston, TX 77054 USA; [Chen, S. S.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77054 USA; [Ensor, J.] Univ Texas MD Anderson Canc Ctr, Dept Quantitat Sci, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Luthra, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Dept Hematopathol, 8515 Fannin St,NAO1-091, Houston, TX 77054 USA.	rluthra@mdanderson.org		Ensor, Joe/0000-0003-3533-4388	Goodwin Fund for Target Molecular Diagnosis; Institutional Research; NIH [1P50CA098258-01]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	Goodwin Fund for Target Molecular Diagnosis; Institutional Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dawn Chalaire for critical editing of the manuscript and James M Gilbert and Kim-Anh Vu for assistance with preparation of the manuscript and illustrations. We also thank Drs Raju, Izzo and Liu of MD Anderson Cancer Center for providing the cell lines used in the study. This study was supported by Goodwin Fund for Target Molecular Diagnosis and Institutional Research Grant (CT Albarracin), NIH 1P50CA098258-01, SPORE in Uterine Cancer (RR Broaddus).	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Debret R, 2003, FEBS LETT, V546, P195, DOI 10.1016/S0014-5793(03)00570-2; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hsiang CH, 2006, PROSTATE, V66, P1413, DOI 10.1002/pros.20457; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; JOHNSON MD, 1989, HUM PATHOL, V20, P772, DOI 10.1016/0046-8177(89)90071-3; Kang JS, 2002, CLIN CANCER RES, V8, P117; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luthra R, 2006, J CLIN ONCOL, V24, P259, DOI 10.1200/JCO.2005.03.3688; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Paweletz CP, 2000, CANCER RES, V60, P6293; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Sakamoto T, 1996, BIOCHEM BIOPH RES CO, V220, P643, DOI 10.1006/bbrc.1996.0457; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Sinha P, 1998, J BIOCHEM BIOPH METH, V37, P105, DOI 10.1016/S0165-022X(98)00020-7; Solito E, 2001, BRIT J PHARMACOL, V133, P217, DOI 10.1038/sj.bjp.0704054; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	30	217	226	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	52					6667	6678		10.1038/onc.2008.256	http://dx.doi.org/10.1038/onc.2008.256			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18663355				2022-12-25	WOS:000260638800005
J	Tang, J; Yang, X; Liu, X				Tang, J.; Yang, X.; Liu, X.			Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression	ONCOGENE			English	Article						Plk1; MK2; mitosis; phosphorylation	POLO-LIKE KINASES; P38 MAP KINASE; SACCHAROMYCES-CEREVISIAE; TOPOISOMERASE-II; CELL-DIVISION; ACTIVATION; CHECKPOINT; EXPRESSION; PATHWAY; CANCER	Polo-like kinase 1 (Plk1), the best characterized member of the mammalian polo-like kinase family, is well regulated throughout the cell cycle at the protein expression level. Moreover, it is known that Plk1 kinase activity is also regulated at the post-translational level through phosphorylation. However, the upstream kinases of Plk1 have not been identified. Although the involvement of the p38 MAP kinase pathway in cellular responses to stress has been well documented, the role of this pathway in normal cell cycle progression is unclear. Here, we show that phosphorylated p38 and MAP kinase-activated protein kinase 2 (MK2) are colocalized with Plk1 to the spindle poles during prophase and metaphase. Specific depletion of various members of the p38 MAP kinase pathway by the use of RNA interference revealed that the pathway is required for mitotic progression under normal growth conditions. Furthermore, MK2 directly phosphorylates Ser326 of Plk1. Ectopic expression of Plk1-S326A completely blocked cells at mitosis, likely due to the defect of bipolar spindle formation and subsequent activation of the spindle checkpoint. Only Plk1-S326E, but not the Plk1-S326A, efficiently rescued the p38 or MK2-depletion-induced mitotic defects, further solidifying the requirement of S326 phosphorylation during mitotic progression.	[Tang, J.; Yang, X.; Liu, X.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tang, J.; Yang, X.; Liu, X.] Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA; [Yang, X.] Sichuan Univ, Dept Chem, Chengdu 610064, Sichuan, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University	Liu, X (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu			National Cancer Institute [K01 CA114401]; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Raymond Erikson, in whose laboratory the preliminary experiments were performed, for generously providing many cell lines and plasmids. We appreciate Eleanor Erikson, Xiaoyi Zhang and Hongchang Li for helpful discussions and critical reading of the paper. XL is a recipient of the Howard Temin Award from the National Cancer Institute (K01 CA114401).	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Fan L, 2005, CELL CYCLE, V4, P1616, DOI 10.4161/cc.4.11.2125; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Knecht R, 1999, CANCER RES, V59, P2794; Knecht R, 2000, INT J CANCER, V89, P535; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tang JB, 2006, CELL CYCLE, V5, P2484, DOI 10.4161/cc.5.21.3411; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	24	40	42	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	52					6635	6645		10.1038/onc.2008.262	http://dx.doi.org/10.1038/onc.2008.262			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18695677	Green Accepted			2022-12-25	WOS:000260638800002
J	Mao, JH; Wu, D; DelRosario, R; Castellanos, A; Balmain, A; Perez-Losada, J				Mao, J. H.; Wu, D.; DelRosario, R.; Castellanos, A.; Balmain, A.; Perez-Losada, J.			Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background	ONCOGENE			English	Article						Ataxia-Telangiectasia; ATM/Atm; P53; lymphoma; loss-of-heterozygosity; genetic-background	ATAXIA-TELANGIECTASIA HETEROZYGOTES; FAMILIAL BREAST-CANCER; INDUCED MAMMARY-TUMORS; DEFICIENT MICE; EARLY-ONSET; GENE; HAPLOINSUFFICIENCY; TUMORIGENESIS; MUTATIONS; RISK	Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer susceptibility is controversial, in both human and mouse. Earlier studies identified deletions near the Atm gene on mouse chromosome 9 in radiation-induced lymphomas from p53 heterozygous mice. To determine whether Atm was the target of these deletions, Atm heterozygous as well as Atm/P53 double heterozygous mice were treated with ionizing radiation. There were no significant differences in tumor latency, progression and lifespan after gamma-radiation in Atm heterozygous mice compared with their wild-type control counterparts. Deletions were found on chromosome 9 near the Atm locus in radiation-induced tumors, but in 50% of the cases the deletion included the knockout allele, and the expression of Atm was maintained in the tumors indicating that loss of heterozygosity on chromosome 9 is not driven by Atm, but by an alternative tumor suppressor gene located near Atm on this chromosome. We conclude that Atm heterozygosity does not confer an increase in tumor susceptibility in this context.	[Castellanos, A.; Perez-Losada, J.] Univ Salamanca, Dept Med, Fac Med, E-37008 Salamanca, Spain; [Mao, J. H.; Wu, D.; DelRosario, R.; Balmain, A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of Salamanca; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Perez-Losada, J (corresponding author), Univ Salamanca, Dept Med, Fac Med, Campus Miguel Unamuno Sn, E-37008 Salamanca, Spain.	jperezlosada@usal.es	2008, Ibsal/A-1268-2012; Pérez-Losada, Jesús/A-5883-2019; Castellanos, Andres/F-3302-2016; Mao, Jian-Hua/EIZ-8595-2022; Castellanos, Antonio/J-4830-2013	Pérez-Losada, Jesús/0000-0003-2400-624X; Castellanos, Andres/0000-0003-2864-7271; Mao, Jian-Hua/0000-0001-9320-6021; Castellanos, Antonio/0000-0001-9291-0930	Spanish 'Ministerio de Educacion y Ciencia; European Community; Fondo de Investigaciones Sanitarias [PI070057]; NCI [U01 CA84244]; DOE [DE-FG02-03ER63630]; UCSF Research-Evaluation Allocation Committee (REAC); NATIONAL CANCER INSTITUTE [U01CA084244] Funding Source: NIH RePORTER	Spanish 'Ministerio de Educacion y Ciencia(Spanish Government); European Community(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE(United States Department of Energy (DOE)); UCSF Research-Evaluation Allocation Committee (REAC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Gonzalez-Sarmiento, Dr Sanchez-Garcia and Dr Cobaleda for useful comments; and Dr Kogan for tumor pathology analysis. Dr Balmain acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. Dr Perez-Losada is an investigator of the 'Programa Ramon y Cajal' from the Spanish 'Ministerio de Educacion y Ciencia' and the European Community, his study is partially supported by the 'Fondo de Investigaciones Sanitarias' (PI070057). Dr Castellanos is supported by the 'Fondo de Investigaciones Sanitarias' ( PI070057). These studies were also supported by NCI grant U01 CA84244 and the DOE (DE-FG02-03ER63630) to Dr Balmain, and the UCSF Research-Evaluation Allocation Committee (REAC) to Dr Mao.	Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Bishop DT, 1997, NAT GENET, V15, P226, DOI 10.1038/ng0397-226; Bowen TJ, 2005, CANCER RES, V65, P8736, DOI 10.1158/0008-5472.CAN-05-1598; BURNS PA, 1991, ENVIRON HEALTH PERSP, V93, P41, DOI 10.2307/3431166; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Chen JD, 1998, CANCER RES, V58, P1376; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Connolly L, 2006, RADIAT RES, V166, P39, DOI 10.1667/RR3578.1; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karabinis ME, 2001, CARCINOGENESIS, V22, P343, DOI 10.1093/carcin/22.2.343; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Lu S, 2006, CARCINOGENESIS, V27, P848, DOI 10.1093/carcin/bgi302; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakamura Y, 1998, NAT MED, V4, P1231, DOI 10.1038/3207; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Teraoka SN, 2001, CANCER-AM CANCER SOC, V92, P479, DOI 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G; Umesako S, 2005, BREAST CANCER RES, V7, pR164, DOI 10.1186/bcr968; Vorechovsky I, 1996, CANCER RES, V56, P2726; Westphal CH, 1998, CANCER RES, V58, P5637; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yu YJ, 2001, CANCER RES, V61, P1820	38	18	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 30	2008	27	51					6596	6600		10.1038/onc.2008.280	http://dx.doi.org/10.1038/onc.2008.280			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18679420				2022-12-25	WOS:000260501700007
J	Bricker, TM; Frankel, LK				Bricker, Terry M.; Frankel, Laurie K.			The psbo1 Mutant of Arabidopsis Cannot Efficiently Use Calcium in Support of Oxygen Evolution by Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-STABILIZING PROTEIN; KDA EXTRINSIC PROTEIN; 33-KDA; BINDING; CHLORIDE; LACKING; SYSTEM; THERMOLUMINESCENCE; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY	The Arabidopsis thaliana mutant psbo1 contains a point mutation in the psbO-1 gene (At5g66570) leading to the loss of expression of the PsbO-1 protein and overexpression of the PsbO-2 protein (Murakami, R., Ifuku, K., Takabayashi, A., Shikanai, T., Endo, T., and Sato, F. (2002) FEBS Lett. 523, 138-142). Previous characterization of fluorescence induction and decay kinetics by our laboratory documented defects on both the oxidizing and reducing sides of Photosystem II. Additionally, anomalous flash oxygen yield patterns indicated that the mutant contains a defective oxygen-evolving complex that appears to exhibit anomalously long-lived S-2 and S-3 oxidation states (Liu, H., Frankel, L. K., and Bricker, T. M. (2007) Biochemistry 46, 7607-7613). In this study, we have documented that the S-2 and S-3 states in psbo1 thylakoids decay very slowly. The total flash oxygen yield of the psbo1 mutant was also significantly reduced, as was its stability. Incubation of psbo1 thylakoids at high NaCl concentrations did not increase the rate of S-2 and S-3 state decay. The oxygen-evolving complexes of the mutant did, however, exhibit somewhat enhanced stability following this treatment. Incubation with CaCl2 had a significantly more dramatic effect. Under this condition, both the S-2 and S-3 states of the mutant decayed at nearly the same rate as the wild type, and the total oxygen yield and its stability following CaCl2 treatment were indistinguishable from that of the wild type. These results strongly suggest that the principal defect in the psbo1 mutant is an inability to effectively utilize the calcium associated with Photosystem II. We hypothesize that the PsbO-2 protein cannot effectively sequester calcium at the oxygen-evolving site.	[Bricker, Terry M.; Frankel, Laurie K.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			National Science Foundation and the Department of Energy	National Science Foundation and the Department of Energy	This work was supported by grants from the National Science Foundation and the Department of Energy (to T. M. B. and L. K. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSSON B, 1984, BIOCHIM BIOPHYS ACTA, V766, P21, DOI 10.1016/0005-2728(84)90212-3; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Betts SD, 1997, BIOCHEMISTRY-US, V36, P4047, DOI 10.1021/bi962413b; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; Bricker TM, 2003, BIOCHEMISTRY-US, V42, P2056, DOI 10.1021/bi020652v; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; Bricker TM, 2001, BIOCHEMISTRY-US, V40, P11483, DOI 10.1021/bi010906x; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; ENGELS DH, 1994, PHOTOSYNTH RES, V42, P227, DOI 10.1007/BF00018265; KAVELAKI K, 1991, PHOTOSYNTH RES, V29, P149, DOI 10.1007/BF00036218; Liu HJ, 2007, BIOCHEMISTRY-US, V46, P7607, DOI 10.1021/bi700107w; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; MURATA N, 1984, BIOCHIM BIOPHYS ACTA, V765, P363, DOI 10.1016/0005-2728(84)90177-4; ONO T, 1985, BIOCHIM BIOPHYS ACTA, V806, P331, DOI 10.1016/0005-2728(85)90240-3; PHILBRICK JB, 1991, J BIOL CHEM, V266, P13370; Popelkova H, 2006, BIOCHEMISTRY-US, V45, P3107, DOI 10.1021/bi0523759; Popelkova H, 2007, PHOTOSYNTH RES, V93, P111, DOI 10.1007/s11120-006-9121-5; PutnamEvans C, 1996, BIOCHEMISTRY-US, V35, P4046, DOI 10.1021/bi952661s; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; VASS I, 1992, BIOCHIM BIOPHYS ACTA, V1102, P195, DOI 10.1016/0005-2728(92)90100-G; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200	30	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29022	29027		10.1074/jbc.M805122200	http://dx.doi.org/10.1074/jbc.M805122200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18667416	Green Published, hybrid			2022-12-25	WOS:000260179900028
J	Tsao, PN; Chen, F; Izvolsky, KI; Walker, J; Kukuruzinska, MA; Lu, JN; Cardoso, WV				Tsao, Po-Nien; Chen, Felicia; Izvolsky, Konstantin I.; Walker, Janice; Kukuruzinska, Maria A.; Lu, Jining; Cardoso, Wellington V.			gamma-Secretase Activation of Notch Signaling Regulates the Balance of Proximal and Distal Fates in Progenitor Cells of the Developing Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; DEVELOPING MOUSE LUNG; EMBRYONIC LETHALITY; MICE LACKING; IN-VIVO; TRANSGENIC MICE; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; PROLIFERATION	Little is known about the mechanisms by which the lung epithelial progenitors are initially patterned and how proximaldistal boundaries are established and maintained when the lung primordium forms and starts to branch. Here we identified a number of Notch pathway components in respiratory progenitors of the early lung, and we investigated the role of Notch in lung pattern formation. By preventing gamma-secretase cleavage of Notch receptors, we have disrupted global Notch signaling in the foregut and in the lung during the initial stages of murine lung morphogenesis. We demonstrate that Notch signaling is not necessary for lung bud initiation; however, Notch is required to maintain a balance of proximal-distal cell fates at these early stages. Disruption of Notch signaling dramatically expands the population of distal progenitors, altering morphogenetic boundaries and preventing formation of proximal structures. Our data suggest a novel mechanism in which Notch and fibroblast growth factor signaling interact to control the proximaldistal pattern of forming airways in the mammalian lung.	[Tsao, Po-Nien; Chen, Felicia; Izvolsky, Konstantin I.; Lu, Jining; Cardoso, Wellington V.] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Kukuruzinska, Maria A.] Boston Univ, Sch Dent Med, Dept Cell & Mol Biol, Boston, MA 02118 USA; [Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Walker, Janice] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Boston University; Boston University; National Taiwan University; Jefferson University	Cardoso, WV (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 715 Albany St,R-304, Boston, MA 02118 USA.	wcardoso@bu.edu	Tsao, Po-Nien/E-5671-2012	Kukukruzinska, Maria/0000-0001-5314-1454; Chen, Felicia/0000-0001-6092-1774; Cardoso, Wellington/0000-0002-2550-3697; TSAO, PO-NIEN/0000-0002-6114-1769; Lu, Jining/0000-0001-9263-9212	National Institutes of Health [PO1 HL47049]; NIH/EE [014798]; National Health Research Institutes-Taiwan Physician Scientist Award [PS9402]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/EE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes-Taiwan Physician Scientist Award(National Health Research Institutes - Taiwan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant PO1 HL47049 (to W. V. C.) and NIH/EE Grant 014798 (to J.W. and M. A. K.). This work was also supported by National Health Research Institutes-Taiwan Physician Scientist Award PS9402 (to P. N. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Heber S, 2000, J NEUROSCI, V20, P7951; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herzog EL, 2006, STEM CELLS, V24, P1986, DOI 10.1634/stemcells.2005-0579; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Ito T, 2000, DEVELOPMENT, V127, P3913; Kong YP, 2004, AM J PHYSIOL-LUNG C, V286, pL1075, DOI 10.1152/ajplung.00438.2002; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; KUBBUTAT MHG, 1994, J CLIN PATHOL, V47, P524, DOI 10.1136/jcp.47.6.524; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lu J, 2004, DEV BIOL, V273, P418, DOI 10.1016/j.ydbio.2004.05.035; Lu JN, 2005, J BIOL CHEM, V280, P4834, DOI 10.1074/jbc.M410714200; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Miralles F, 2006, INT J DEV BIOL, V50, P17, DOI 10.1387/ijdb.052080fm; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakagawa M, 2001, J CELL SCI, V114, P1829; OKA C, 1995, DEVELOPMENT, V121, P3291; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Petit A, 2003, J NEUROSCI RES, V74, P370, DOI 10.1002/jnr.10747; Post LC, 2000, MECH DEVELOP, V98, P95, DOI 10.1016/S0925-4773(00)00432-9; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Radtke F, 2005, EMBO REP, V6, P1120, DOI 10.1038/sj.embor.7400585; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Taichman DB, 2002, DEV DYNAM, V225, P166, DOI 10.1002/dvdy.10146; van Eyll JM, 2004, J CELL SCI, V117, P2077, DOI 10.1242/jcs.01067; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL672, DOI 10.1152/ajplung.00247.2004; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	69	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29532	29544		10.1074/jbc.M801565200	http://dx.doi.org/10.1074/jbc.M801565200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694942	hybrid, Green Published			2022-12-25	WOS:000260179900079
J	Papi, A; Contoli, M; Gasparini, P; Bristot, L; Edwards, MR; Chicca, M; Leis, M; Ciaccia, A; Caramori, G; Johnston, SL; Pinamonti, S				Papi, Alberto; Contoli, Marco; Gasparini, Pierluigi; Bristot, Laura; Edwards, Michael R.; Chicca, Milvia; Leis, Marilena; Ciaccia, Adalberto; Caramori, Gaetano; Johnston, Sebastian L.; Pinamonti, Silvano			Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; OXIDATIVE STRESS; COMMON COLD; AIRWAY INFLAMMATION; GENE-EXPRESSION; ASTHMA; EXACERBATIONS; RECEPTOR	Rhinoviruses are the major cause of the common cold and acute exacerbations of asthma and chronic obstructive pulmonary disease. We previously reported rapid rhinovirus induction of intracellular superoxide anion, resulting in NF-kappa B activation and pro-inflammatory molecule production. The mechanisms of rhinovirus superoxide induction are poorly understood. Here we found that the proteolytic activation of the xanthine dehy-drogenase/xanthine oxidase (XD/XO) system was required because pretreatment with serine protease inhibitors abolished rhinovirus-induced superoxide generation in primary bronchial and A549 respiratory epithelial cells. These findings were confirmed by Western blotting analysis and by silencing experiments. Rhinovirus infection induced intracellular depletion of reduced glutathione (GSH) that was abolished by pretreatment with either XO inhibitor oxypurinol or serine protease inhibitors. Increasing intracellular GSH with exogenous H2S or GSH prevented both rhinovirus-mediated intracellular GSH depletion and rhinovirus-induced superoxide production. We propose that rhinovirus infection proteolytically activates XO initiating a pro-inflammatory vicious circle driven by virus-induced depletion of intracellular reducing power. Inhibition of these pathways has therapeutic potential.	[Papi, Alberto; Contoli, Marco; Bristot, Laura; Ciaccia, Adalberto; Caramori, Gaetano] Univ Ferrara, Res Ctr Asthma & COPD, I-44100 Ferrara, Italy; [Gasparini, Pierluigi; Chicca, Milvia; Leis, Marilena; Pinamonti, Silvano] Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Natl Heart & Lung Inst, Wright Fleming Inst Infect & Immun, London W2 1PG, England; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, London W2 1PG, England; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London W2 1PG, England	University of Ferrara; University of Ferrara; Imperial College London; Imperial College London; Imperial College London; University of London; King's College London	Pinamonti, S (corresponding author), Via Savonarola 9, I-44100 Ferrara, Italy.	ppa@unife.it	Gasparini, Pierluigi/ABA-2811-2021; Papi, alberto/AAC-1888-2019; Contoli, Marco/K-3947-2018; Johnston, Sebastian Lennox/I-2423-2012; Caramori, Gaetano/AAS-8611-2020	Gasparini, Pierluigi/0000-0001-8311-8845; Contoli, Marco/0000-0002-2731-5809; Johnston, Sebastian Lennox/0000-0003-3009-9200; Caramori, Gaetano/0000-0002-9807-327X; Edwards, Michael Robert/0000-0001-6837-0532; PAPI, ALBERTO/0000-0002-6924-4500	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0; BARTL K, 1979, CLIN CHEM, V25, P619; Bhattacharya S, 2001, BMC Struct Biol, V1, P4, DOI 10.1186/1472-6807-1-4; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Caramori G, 2004, THORAX, V59, P170, DOI 10.1136/thorax.2002.002477; Casola A, 2001, J BIOL CHEM, V276, P19715, DOI 10.1074/jbc.M101526200; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Edwards MR, 2007, J BIOL CHEM, V282, P15366, DOI 10.1074/jbc.M701325200; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Halliwell B., 1999, FREE RADICAL BIOL ME; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; HASSOUN PM, 1995, AM J PHYSIOL-LUNG C, V268, pL809, DOI 10.1152/ajplung.1995.268.5.L809; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; JEFFERSON TO, 2007, COCHRANE DB SYST REV, V18, P2743; Jobsis RQ, 2001, MEDIAT INFLAMM, V10, P351; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL., 1997, DIAGNOSTIC PROCEDURE, P553; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kaul P, 2000, J INFECT DIS, V181, P1885, DOI 10.1086/315504; Lee MM, 2004, MOL CELL BIOCHEM, V259, P15, DOI 10.1023/B:MCBI.0000021340.79014.a3; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Mallia P, 2007, CURR PHARM DESIGN, V13, P73, DOI 10.2174/138161207779313777; MCCORD JM, 1973, PHOTOCHEM PHOTOBIOL, V17, P115, DOI 10.1111/j.1751-1097.1973.tb06340.x; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Papi A, 2002, FASEB J, V16, P1934, DOI 10.1096/fj.02-0118fje; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; PETERHANS E, 1997, J NUTR, V127, P962; Pinamonti S, 1996, FREE RADICAL BIO MED, V21, P147, DOI 10.1016/0891-5849(96)00030-5; PRIEST DG, 1972, ANAL BIOCHEM, V50, P195, DOI 10.1016/0003-2697(72)90499-X; Psarras S, 2005, CURR PHARM DESIGN, V11, P2053, DOI 10.2174/1381612054065774; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; SPECTOR T, 1988, BIOCHEM PHARMACOL, V37, P349, DOI 10.1016/0006-2952(88)90739-3; STANWAY G, 1994, ENCY VIROLOGY, V3, P1253; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wegner Julie, 2003, J Extra Corpor Technol, V35, P326; Yeh CT, 2004, BIOCHEM BIOPH RES CO, V323, P32, DOI 10.1016/j.bbrc.2004.08.079; Zsengeller ZK, 2001, AM J PHYSIOL-LUNG C, V280, pL503, DOI 10.1152/ajplung.2001.280.3.L503	54	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28595	28606		10.1074/jbc.M805766200	http://dx.doi.org/10.1074/jbc.M805766200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678861	Green Published, hybrid			2022-12-25	WOS:000259969300062
J	Popowski, M; Ferguson, HA; Sion, AM; Koller, E; Knudsen, E; Van den Berg, CL				Popowski, Melissa; Ferguson, Heather A.; Sion, Amy M.; Koller, Erich; Knudsen, Erik; Van den Berg, Carla L.			Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC RESPONSE; INDUCED APOPTOSIS; INHIBITION; PHOSPHORYLATION; TRANSLATION; ACTIVATION; CANCER; DEPHOSPHORYLATION; KINASE; P53	Significant discoveries have recently contributed to our knowledge of intracellular growth factor and nutrient signaling via mTOR (mammalian target of rapamycin). This signaling pathway is essential in cellular metabolism and cell survival by enhancing protein translation through phosphorylation of 4EBP-1 and p70S6K. Growth factors like insulin-like growth factor-I induce mTOR to prevent cell death during cellular stress. Agents targeting mTOR are of major interest as anticancer agents. We show here, using human breast cancer cells, that certain types of stress activate mTOR leading to 4E-BP1 and p70S6K phosphorylation. UV treatment increased phosphorylation of the translation inhibitor eIF2 alpha, suggesting a potential mechanism for UV activation of Akt and mTOR. c-Myc, a survival protein regulated by cap-dependent protein translation, increased with IGF-I treatment, but this response was not inhibited by rapamycin. Additionally, UV treatment potently increased c-Myc degradation, which was reduced by co-treatment with the proteasomal inhibitor, MG-132. Together, these data suggest that protein translation does not strongly mediate cell survival in these models. In contrast, the phosphorylation status of retinoblastoma protein (pRB) was mediated by mTOR through its inhibitory effects on phosphatase activity. This effect was most notable during DNA damage and rapamycin treatment. Hypophosphorylated pRB was susceptible to inactivation by caspase-mediated cleavage, resulting in cell death. Reduction of pRB expression inhibited IGF-I survival effects. Our data support an important role of phosphatases and pRB in IGF-I/mTOR-mediated cell survival. These studies provide new directions in optimizing anticancer efficacy of m TOR inhibitors when used in combination with DNA-damaging agents.	[Popowski, Melissa; Van den Berg, Carla L.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Ferguson, Heather A.; Sion, Amy M.; Van den Berg, Carla L.] Univ Colorado, Sch Pharm, Hlth Sci Ctr, Denver, CO 80262 USA; [Koller, Erich] Isis Pharmaceut Inc, Carlsbad, CA 92008 USA; [Knudsen, Erik] Univ Cincinnati, Dept Cell Biol, Vontz Ctr Mol Studies, Coll Med, Cincinnati, OH 45267 USA	University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Isis Pharmaceuticals Inc; University System of Ohio; University of Cincinnati	Van den Berg, CL (corresponding author), Univ Texas Austin, Coll Pharm, 1 Univ Ave,A1915, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu			National Institutes of Health [CA 89288]; United States Army Medical Research [DAMD17-99-9142]; NATIONAL CANCER INSTITUTE [R01CA089288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 89288 and the United States Army Medical Research Grant DAMD17-99-9142 (to C.L.V.D.B.). The content of this information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Britton S, 2008, CELL CYCLE, V7, P63, DOI 10.4161/cc.7.1.5111; Chakraborty S, 2007, GENOMICS, V90, P344, DOI 10.1016/j.ygeno.2007.05.002; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Fattman CL, 2001, ONCOGENE, V20, P2918, DOI 10.1038/sj.onc.1204414; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferguson HA, 2003, J BIOL CHEM, V278, P45793, DOI 10.1074/jbc.M307979200; Giles FJ, 2005, CURR MOL MED, V5, P653, DOI 10.2174/156652405774641034; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Mingo-Sion AM, 2005, BREAST CANCER RES TR, V91, P259, DOI 10.1007/s10549-005-0669-0; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; THIMMAIAH KN, 2003, CANCER RES, P364; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	36	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28265	28273		10.1074/jbc.M805724200	http://dx.doi.org/10.1074/jbc.M805724200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697743	Green Published, hybrid			2022-12-25	WOS:000259969300028
J	Ponnusamy, S; Alderson, NL; Hama, H; Bielawski, J; Jiang, JC; Bhandari, R; Snyder, SH; Jazwinski, SM; Ogretmen, B				Ponnusamy, Suriyan; Alderson, Nathan L.; Hama, Hiroko; Bielawski, Jacek; Jiang, James C.; Bhandari, Rashna; Snyder, Solomon H.; Jazwinski, S. Michal; Ogretmen, Besim			Regulation of telomere length by fatty acid elongase 3 in yeast - Involvement of inositol phosphate metabolism and Ku70/80 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME TERMINI; CERAMIDE SYNTHESIS; DNA-REPAIR; ELONGATION; KU; GENE; PYROPHOSPHATES; SPHINGOLIPIDS; PROTEINS	In this study, we investigated the roles of very long-chain fatty acid (VLCFA) synthesis by fatty acid elongase 3 (ELO3) in the regulation of telomere length and life span in the yeast Saccharomyces cerevisiae. Loss of VLCFA synthesis via deletion of ELO3 reduced telomere length, and reconstitution of the expression of wild type ELO3, and not by its mutant with decreased catalytic activity, rescued telomere attrition. Further experiments revealed that alterations of phytoceramide seem to be dispensable for telomere shortening in response to loss of ELO3. Interestingly, telomere shortening in elo3 Delta cells was almost completely prevented by deletion of IPK2 or KCS1, which are involved in the generation of inositol phosphates (IP4, IP5, and inositol pyrophosphates). Deletion of IPK1, which generates IP6, however, did not affect regulation of telomere length. Further data also suggested that elo3 Delta cells exhibit accelerated chronologic aging, and reduced replicative life span compared with wild type cells, and deletion of KCS1 helped recover these biological defects. Importantly, to determine downstream mechanisms, epistasis experiments were performed, and data indicated that ELO3 and YKU70/80 share a common pathway for the regulation of telomere length. More specifically, chromatin immunoprecipitation assays revealed that the telomere binding and protective function of YKu80p in vivo was reduced in elo3 Delta cells, whereas its non-homologues end-joining function was not altered. Deletion of KCS1 in elo3 Delta cells recovered the telomere binding and protective function of Ku, consistent with the role of KCS1 mutation in the rescue of telomere length attrition. Thus, these findings provide initial evidence of a possible link between Elo3-dependent VLCFA synthesis, and IP metabolism by KCS1 and IPK2 in the regulation of telomeres, which play important physiological roles in the control of senescence and aging, via a mechanism involving alterations of the telomere-binding/protection function of Ku.	[Ponnusamy, Suriyan; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Ponnusamy, Suriyan; Alderson, Nathan L.; Hama, Hiroko; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Jiang, James C.; Jazwinski, S. Michal] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70118 USA; [Bhandari, Rashna; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Medical University of South Carolina; Medical University of South Carolina; Tulane University; Johns Hopkins University	Ogretmen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St,Rm HO512A, Charleston, SC 29425 USA.	ogretmen@musc.edu		Bhandari, Rashna/0000-0003-3101-0204	National Institutes of Health [CA88932, DE016572, AG006168]; NATIONAL CANCER INSTITUTE [R01CA088932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006168, R01AG006168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA88932 and DE016572 (to B. O.) and AG006168 (to S. M.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dittrich F, 1998, EUR J BIOCHEM, V252, P477, DOI 10.1046/j.1432-1327.1998.2520477.x; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Jazwinski SM, 2002, INT J BIOCHEM CELL B, V34, P1491, DOI 10.1016/S1357-2725(02)00044-4; Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Li WM, 2007, INT J BIOL SCI, V3, P120; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Obeid L.M., 2003, SCI AGING KNOWLEDGE, V2003, pPE27; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Seeds AM, 2007, BIOCHEM SOC SYMP, V74, P183, DOI 10.1042/BSS2007c16; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	48	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27514	27524		10.1074/jbc.M802980200	http://dx.doi.org/10.1074/jbc.M802980200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694931	Green Published, hybrid			2022-12-25	WOS:000259719200022
J	Yamano, K; Kuroyanagi-Hasegawa, M; Esaki, M; Yokota, M; Endo, T				Yamano, Koji; Kuroyanagi-Hasegawa, Mika; Esaki, Masatoshi; Yokota, Mihoko; Endo, Toshiya			Step-size analyses of the mitochondrial Hsp70 import motor reveal the Brownian ratchet in operation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; PRECURSOR PROTEINS; TRANSLOCATION; PATHWAYS; CHAPERONES; TRANSPORT	Newly synthesized mitochondrial precursor proteins have to become unfolded by the mitochondrial Hsp70 ( mtHsp70) import motor to cross the mitochondrial membranes. To assess the mechanism of unfolding of precursor proteins by mtHsp70, we designed a system to measure step sizes of the mtHsp70 import motor, which are distances at which the motor system moves along polypeptide chains during a single turnover of ATP. We made a series of fusion proteins consisting of a mitochondrial presequence containing the first mtHsp70 binding site, a spacer sequence containing an Hsp70 avoidance segment followed by the second mtHsp70 binding site, and different folded mature domains. Analyses of the dependence of the import rates of those fusion proteins on the lengths of Hsp70 avoidance segments allowed us to estimate the step sizes, which differ for different mature domains and different lengths of the spacers. These results suggest that the mtHsp70 import motor functions at least as a molecular Brownian ratchet to unfold mitochondrial precursor proteins.	[Yamano, Koji; Kuroyanagi-Hasegawa, Mika; Esaki, Masatoshi; Yokota, Mihoko; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Japan Sci & Technol Corp JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/ABS-6645-2022; Esaki, Masatoshi/L-6591-2017		Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); JST	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST))	This work was supported by grants-in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and a grant from the JST. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P183; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Howard J, 2006, CURR BIOL, V16, pR517, DOI 10.1016/j.cub.2006.06.045; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	29	30	30	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27325	27332		10.1074/jbc.M805249200	http://dx.doi.org/10.1074/jbc.M805249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678864	hybrid			2022-12-25	WOS:000259586600051
J	Kotadia, S; Kao, LR; Comerford, SA; Jones, RT; Hammer, RE; Megraw, TL				Kotadia, S.; Kao, L. R.; Comerford, S. A.; Jones, R. T.; Hammer, R. E.; Megraw, T. L.			PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen	ONCOGENE			English	Article						SV40 ST; centriole; centrosome; PP2A; aneuploidy; cyclin E	PROTEIN PHOSPHATASE 2A; SMALL-T-ANTIGEN; HUMAN CELL-TRANSFORMATION; CYCLIN-A PROMOTER; VIRUS TYPE-1 TAX; REGULATORY SUBUNIT; CANCER PROGRESSION; E7 ONCOPROTEIN; GAMMA-TUBULIN; SIMIAN-VIRUS-40	Viruses of the DNA tumor virus family share the ability to transform vertebrate cells through the action of virus-encoded tumor antigens that interfere with normal cell physiology. They accomplish this very efficiently by inhibiting endogenous tumor suppressor proteins that control cell proliferation and apoptosis. Simian virus 40 (SV40) encodes two oncoproteins, large tumor antigen, which directly inhibits the tumor suppressors p53 and Rb, and small tumor antigen (ST), which interferes with serine/threonine protein phosphatase 2A (PP2A). We have constructed a Drosophila model for SV40 ST expression and show that ST induces supernumerary centrosomes, an activity we also demonstrate in human cells. In early Drosophila embryos, ST also caused increased microtubule stability, chromosome segregation errors, defective assembly of actin into cleavage furrows, cleavage failure, a rise in cyclin E levels and embryonic lethality. Using ST mutants and genetic interaction experiments between ST and PP2A subunit mutations, we show that all of these phenotypes are dependent on ST's interaction with PP2A. These analyses demonstrate the validity and utility of Drosophila as a model for viral oncoprotein function in vivo.	[Kotadia, S.; Kao, L. R.; Jones, R. T.; Megraw, T. L.] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Pharmacol, Dallas, TX 75390 USA; [Comerford, S. A.] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, R. E.] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Megraw, TL (corresponding author), Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Pharmacol, 6001 Forest Pk Rd,Room ND11-120, Dallas, TX 75390 USA.	timothy.megraw@utsouthwestern.edu	Megraw, Tim/U-1442-2019; Megraw, Timothy/T-5186-2019	Hammer, Robert E./0000-0001-5487-7551; Megraw, Timothy/0000-0001-7455-7483; Comerford, Sarah Ann/0000-0002-7452-7759	National Institutes of Health [GM068756]; Welch Foundation [I-1610]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Estelle Sontag, Hui Zou, Helena Richardson, Stefan Heidmann and Kristen Johansen for reagents and Marc Mumby for a critical reading of our paper. This work was supported by grants from the National Institutes of Health (GM068756) and the Welch Foundation (I-1610).	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; CALLAINI G, 1990, J CELL SCI, V97, P539; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Comerford SA, 2003, ONCOGENE, V22, P2515, DOI 10.1038/sj.onc.1206259; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; De Luca A, 2003, CANCER RES, V63, P1430; Duensing A, 2007, ONCOGENE, V26, P6280, DOI 10.1038/sj.onc.1210456; Duensing S, 2004, ONCOGENE, V23, P8206, DOI 10.1038/sj.onc.1208012; Duensing S, 2003, J VIROL, V77, P12331, DOI 10.1128/JVI.77.22.12331-12335.2003; FROST JA, 1994, MOL CELL BIOL, V14, P6244, DOI 10.1128/MCB.14.9.6244; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gaillard S, 2001, J VIROL, V75, P9799, DOI 10.1128/JVI.75.20.9799-9807.2001; Goetz F, 2001, ONCOGENE, V20, P2325, DOI 10.1038/sj.onc.1204355; Hannus M, 2002, DEVELOPMENT, V129, P3493; Hong S, 2007, J BIOL CHEM, V282, P12119, DOI 10.1074/jbc.M610392200; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Mateer SC, 1998, J BIOL CHEM, V273, P35339, DOI 10.1074/jbc.273.52.35339; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nitta T, 2006, CANCER SCI, V97, P836, DOI 10.1111/j.1349-7006.2006.00254.x; Nunbhakdi-Craig V, 2003, J VIROL, V77, P2807, DOI 10.1128/JVI.77.5.2807-2818.2003; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pihan GA, 2001, CANCER RES, V61, P2212; Pim D, 2005, ONCOGENE, V24, P7830, DOI 10.1038/sj.onc.1208935; Porras A, 1996, J VIROL, V70, P6902; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; Reed SI, 1997, CANCER SURV, V29, P7; Rothwell WF, 2000, CURR TOP DEV BIOL, V49, P409; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; Schuchner S, 1999, J VIROL, V73, P9266; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Skoczylas C, 2005, VIROLOGY, V332, P596, DOI 10.1016/j.virol.2004.12.017; Skoczylas C, 2004, CELL CYCLE, V3, P606; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Snaith HA, 1996, J CELL SCI, V109, P3001; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Viquez NM, 2006, J NEUROSCI, V26, P9293, DOI 10.1523/JNEUROSCI.1740-06.2006; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	66	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	49					6334	6346		10.1038/onc.2008.254	http://dx.doi.org/10.1038/onc.2008.254			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18663356	Green Accepted			2022-12-25	WOS:000260263400003
J	Karpurapu, M; Wang, D; Singh, NK; Li, QY; Rao, GN				Karpurapu, Manjula; Wang, Dong; Singh, Nikhlesh K.; Li, Quanyi; Rao, Gadiparthi N.			NFATc1 targets cyclin a in the regulation of vascular smooth muscle cell multiplication during restenosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; DEPENDENT KINASE INHIBITOR; RECEPTOR TYROSINE KINASE; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; NEOINTIMA FORMATION; IN-VITRO; NF-ATC; PROTEIN; GROWTH	Platelet-derived growth factor BB (PDGF-BB) induced cyclin A expression and CDK2 activity in vascular smooth muscle cells (VSMC). Inhibition of nuclear factors of activated T cell (NFAT) activation by cyclosporin A (CsA) and VIVIT suppressed PDGF-BB-induced cyclin A expression and CDK2 activity, resulting in blockade of VSMC in the G(1) phase. In addition, CsA- and VIVIT-mediated inhibition of NFATs and small interfering RNA-targeted down-regulation of cyclin A levels suppressed PDGF-BB-induced VSMC DNA synthesis. PDGF-BB also induced cyclin A mRNA levels in VSMC in an NFAT-dependent manner. Cloning and bioinformatic analysis of rat cyclin A promoter revealed the presence of NFAT-binding elements, and PDGF-BB induced the binding of NFATs to these regulatory sequences in a CsA- and VIVIT-sensitive manner. Chromatin immunoprecipitation analysis showed that NFATc1 binds to the cyclin A promoter in response to PDGF-BB in a VIVIT-sensitive manner. Furthermore, PDGF-BB induced cyclin A promoter-luciferase reporter gene activity in VSMC, and it was inhibited by both CsA and VIVIT. Balloon injury induced cyclin A expression and CDK2 activity in rat carotid arteries, and these responses were also blocked by VIVIT. In addition, VIVIT attenuated balloon injury-induced SMC proliferation, resulting in reduced restenosis. Down-regulation of NFATc1 by its small interfering RNA inhibited PDGF-BB-induced cyclin A expression and DNA synthesis both in rat and human VSMC. Together, these findings demonstrate that the cyclin A-CDK2 complex may be a potential effector of NFATs, specifically NFATc1, in mediating SMC multiplication leading to neointima formation. Therefore, NFATs may be used as target molecules for the development of therapeutic agents against vascular diseases such as restenosis.	[Karpurapu, Manjula; Wang, Dong; Singh, Nikhlesh K.; Li, Quanyi; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Singh, Nikhlesh/AAA-4253-2020	Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908 (to G. N. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; HARPER JW, 1993, CELL, V75, P805; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; KATO J, 1993, GENE DEV, V7, P331; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang R, 1997, CANCER RES, V57, P913; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Yu HX, 2006, ARTERIOSCL THROM VAS, V26, P1531, DOI 10.1161/01.ATV.0000225286.30710.af	59	32	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26577	26590		10.1074/jbc.M800423200	http://dx.doi.org/10.1074/jbc.M800423200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667424	Green Published, hybrid			2022-12-25	WOS:000259341600034
J	Uemura, T; Yerushalmi, HF; Tsaprailis, G; Stringer, DE; Pastorian, KE; Hawel, L; Byus, CV; Gerner, EW				Uemura, Takeshi; Yerushalmi, Hagit F.; Tsaprailis, George; Stringer, David E.; Pastorian, Kirk E.; Hawel, Leo, III; Byus, Craig V.; Gerner, Eugene W.			Identification and characterization of a diamine exporter in colon epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTRESCINE TRANSPORT-SYSTEM; HAMSTER OVARY CELLS; ACTIVATED KI-RAS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; POLYAMINE UPTAKE; MAMMALIAN-CELLS; ORNITHINE-DECARBOXYLASE; VACUOLAR MEMBRANE; MASS-SPECTROMETRY	SLC3A2, a member of the solute carrier family, was identified by proteomics methods as a component of a transporter capable of exporting the diamine putrescine in the Chinese hamster ovary (CHO) cells selected for resistance to growth inhibition by high exogenous concentrations of putrescine. Putrescine transport was increased in inverted plasma membrane vesicles prepared from cells resistant to growth inhibition by putrescine compared with transport in inverted vesicles prepared from non-selected cells. Knockdown of SLC3A2 in human cells, using short hairpin RNA, caused an increase in putrescine uptake and a decrease in arginine uptake activity. SLC3A2 knockdown cells accumulated higher polyamine levels and grew faster than control cells. The growth of SLC3A2 knockdown cells was inhibited by high concentrations of putrescine. Knockdown of SLC3A2 reduced export of polyamines from cells. Expression of SLC3A2 was suppressed in human HCT116 colon cancer cells, which have an activated K-RAS, compared with their isogenic clone, Hkh2 cells, which lack an activated K-RAS allele. Spermidine/spermine N1-acetyltransferase (SAT1) was co-immunoprecipitated by an anti-SLC3A2 antibody as was SLC3A2 with an anti-SAT1 antibody. SLC3A2 and SAT1 colocalized on the plasma membrane. These data provide the first molecular characterization of a polyamine exporter in animal cells and indicate that the diamine putrescine is exported by an arginine transporter containing SLC3A2, whose expression is negatively regulated by K-RAS. The interaction between SLC3A2 and SAT1 suggests that these proteins may facilitate excretion of acetylated polyamines.	[Uemura, Takeshi; Stringer, David E.; Gerner, Eugene W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; [Yerushalmi, Hagit F.] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel; [Tsaprailis, George] Coll Pharm, Ctr Toxicol, Tucson, AZ 85721 USA; [Pastorian, Kirk E.; Hawel, Leo, III; Byus, Craig V.] Univ Calif Riverside, Dept Biomed Sci, Riverside, CA 92521 USA	Arizona Center Cancer Care; University of Arizona; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of California System; University of California Riverside	Gerner, EW (corresponding author), Univ Arizona, Arizona Canc Ctr, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	egerner@azcc.arizona.edu		Tsaprailis, George/0000-0003-1239-2358	National Institutes of Health [CA123065]; NATIONAL CANCER INSTITUTE [R01CA123065, P50CA095060, P30CA023074, P01CA072008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA123065. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; BACHRACH U, 1970, ANN NY ACAD SCI, V171, P939, DOI 10.1111/j.1749-6632.1970.tb39400.x; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gerner EW, 2007, BIOCHEM SOC T, V35, P322, DOI 10.1042/BST0350322; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; HAWEL L, 1994, J BIOL CHEM, V269, P7412; HAWEL L, 1994, BBA-MOL CELL RES, V1222, P15, DOI 10.1016/0167-4889(94)90020-5; Heiskala M, 1999, EMBO J, V18, P1214, DOI 10.1093/emboj/18.5.1214; HESSELS J, 1989, INT J CANCER, V43, P1155, DOI 10.1002/ijc.2910430632; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ignatenko NA, 2004, MOL CARCINOGEN, V39, P91, DOI 10.1002/mc.10166; Ignatenko NA, 2006, NUTR CANCER, V56, P172, DOI 10.1207/s15327914nc5602_8; Ignaternko NA, 2004, MOL CARCINOGEN, V39, P221, DOI 10.1002/mc.20008; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Linsalata M, 2004, SCAND J GASTROENTERO, V39, P470, DOI 10.1080/0036552031008755; Loser C, 1999, GUT, V44, P12, DOI 10.1136/gut.44.1.12; Mariadason JM, 2003, CANCER RES, V63, P8791; Pastorian KE, 1997, EXP CELL RES, V231, P284, DOI 10.1006/excr.1996.3467; PEGG AE, 1988, CANCER RES, V48, P759; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414; Sala R, 2002, AM J PHYSIOL-CELL PH, V282, pC134, DOI 10.1152/ajpcell.2002.282.1.C134; SAXENA M, 1995, J BIOL CHEM, V270, P5312, DOI 10.1074/jbc.270.10.5312; SCHAUB T, 1991, FEBS LETT, V279, P83, DOI 10.1016/0014-5793(91)80256-3; SEILER N, 1980, J CHROMATOGR, V221, P227, DOI 10.1016/S0378-4347(00)84307-8; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tahara H, 2006, DRUG METAB DISPOS, V34, P743, DOI 10.1124/dmd.105.008375; TJANDRAWINATA RR, 1994, BIOCHEM PHARMACOL, V48, P2237, DOI 10.1016/0006-2952(94)00420-X; TJANDRAWINATA RR, 1994, J IMMUNOL, V152, P3039; TOME ME, 1994, J CELL PHYSIOL, V158, P237, DOI 10.1002/jcp.1041580205; Tomitori H, 1999, J BIOL CHEM, V274, P3265, DOI 10.1074/jbc.274.6.3265; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2004, BIOCHEM BIOPH RES CO, V315, P1082, DOI 10.1016/j.bbrc.2004.01.162; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Xie XZ, 1997, J BIOL CHEM, V272, P20484, DOI 10.1074/jbc.272.33.20484	54	68	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26428	26435		10.1074/jbc.M804714200	http://dx.doi.org/10.1074/jbc.M804714200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660501	Green Published, hybrid			2022-12-25	WOS:000259341600017
J	Qu, A; Brulc, JM; Wilson, MK; Law, BF; Theoret, JR; Joens, LA; Konkel, ME; Angly, F; Dinsdale, EA; Edwards, RA; Nelson, KE; White, BA				Qu, Ani; Brulc, Jennifer M.; Wilson, Melissa K.; Law, Bibiana F.; Theoret, James R.; Joens, Lynn A.; Konkel, Michael E.; Angly, Florent; Dinsdale, Elizabeth A.; Edwards, Robert A.; Nelson, Karen E.; White, Bryan A.			Comparative Metagenomics Reveals Host Specific Metavirulomes and Horizontal Gene Transfer Elements in the Chicken Cecum Microbiome	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; BROILER-CHICKENS; CAMPYLOBACTER INFECTION; METHANOGENIC ARCHAEA; DIVERSITY; QUANTIFICATION; COLONIZATION; SUCCESSION; VIRUSES; PROJECT	Background: The complex microbiome of the ceca of chickens plays an important role in nutrient utilization, growth and well-being of these animals. Since we have a very limited understanding of the capabilities of most species present in the cecum, we investigated the role of the microbiome by comparative analyses of both the microbial community structure and functional gene content using random sample pyrosequencing. The overall goal of this study was to characterize the chicken cecal microbiome using a pathogen-free chicken and one that had been challenged with Campylobacter jejuni. Methodology/Principal Findings: Comparative metagenomic pyrosequencing was used to generate 55,364,266 bases of random sampled pyrosequence data from two chicken cecal samples. SSU rDNA gene tags and environmental gene tags (EGTs) were identified using SEED subsystems-based annotations. The distribution of phylotypes and EGTs detected within each cecal sample were primarily from the Firmicutes, Bacteroidetes and Proteobacteria, consistent with previous SSU rDNA libraries of the chicken cecum. Carbohydrate metabolism and virulence genes are major components of the EGT content of both of these microbiomes. A comparison of the twelve major pathways in the SEED Virulence Subsystem (metavirulome) represented in the chicken cecum, mouse cecum and human fecal microbiomes showed that the metavirulomes differed between these microbiomes and the metavirulomes clustered by host environment. The chicken cecum microbiomes had the broadest range of EGTs within the SEED Conjugative Transposon Subsystem, however the mouse cecum microbiomes showed a greater abundance of EGTs in this subsystem. Gene assemblies (32 contigs) from one microbiome sample were predominately from the Bacteroidetes, and seven of these showed sequence similarity to transposases, whereas the remaining sequences were most similar to those from catabolic gene families. Conclusion/Significance: This analysis has demonstrated that mobile DNA elements are a major functional component of cecal microbiomes, thus contributing to horizontal gene transfer and functional microbiome evolution. Moreover, the metavirulomes of these microbiomes appear to associate by host environment. These data have implications for defining core and variable microbiome content in a host species. Furthermore, this suggests that the evolution of host specific metavirulomes is a contributing factor in disease resistance to zoonotic pathogens.	[Qu, Ani; Brulc, Jennifer M.; Wilson, Melissa K.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Law, Bibiana F.; Theoret, James R.; Joens, Lynn A.] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ 85721 USA; [Konkel, Michael E.] Washington State Univ, Ctr Biotechnol, Sch Mol Biosci, Seattle, WA USA; [Angly, Florent; Dinsdale, Elizabeth A.; Edwards, Robert A.] San Diego State Univ, Dept Biol, San Diego, CA USA; [Angly, Florent] San Diego State Univ, Dept Computat Sci, San Diego, CA USA; [Dinsdale, Elizabeth A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Edwards, Robert A.] San Diego State Univ, Ctr Microb Sci, San Diego, CA USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Arizona; Washington State University; California State University System; San Diego State University; California State University System; San Diego State University; Flinders University South Australia; California State University System; San Diego State University; California State University System; San Diego State University; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign	Qu, A (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Angly, Florent E/A-7717-2011; Edwards, Robert/Q-1691-2019	Angly, Florent E/0000-0002-8999-0738; Edwards, Robert/0000-0001-8383-8949; dinsdale, elizabeth/0000-0002-2177-203X; Konkel, Michael/0000-0002-8950-0903	Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2005-35212-15287]	Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	These studies were supported by the Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, Grant number ##2005-35212-15287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Apajalahti JHA, 2001, APPL ENVIRON MICROB, V67, P5656, DOI 10.1128/AEM.67.12.5656-5667.2001; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berndtson E, 1996, INT J FOOD MICROBIOL, V32, P35, DOI 10.1016/0168-1605(96)01102-6; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; BRULC JM, 2008, P NATL ACAD IN PRESS; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DOYLE MP, 1992, CAMPLYLOBACTER JEJUNI, P45; Edwards Robert A, 2006, BMC Genomics, V7, P57; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; Fairchild AS, 2005, APPL ENVIRON MICROB, V71, P5865, DOI 10.1128/AEM.71.10.5865-5872.2005; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HAMADY M, 2008, NATURE METHODS 0210, DOI DOI 10.1038/NMETH.1182; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; HYMAN ED, 1988, ANAL BIOCHEM, V174, P423, DOI 10.1016/0003-2697(88)90041-3; Konkel ME, 2007, APPL ENVIRON MICROB, V73, P2297, DOI 10.1128/AEM.02193-06; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Legendre P, 1998, NUMERICAL ECOLOGY; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x; SCUPHAM AJ, 2008, MICROBIAL ECOLO 0108; Scupham AJ, 2007, ENVIRON MICROBIOL, V9, P1801, DOI 10.1111/j.1462-2920.2007.01300.x; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shreeve JE, 2000, AVIAN DIS, V44, P983, DOI 10.2307/1593076; Smirnov A, 2005, J NUTR, V135, P187, DOI 10.1093/jn/135.2.187; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STERN NJ, 1992, CAMPLYLOBACTER JEJUNI, P49; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	64	198	222	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2945	10.1371/journal.pone.0002945	http://dx.doi.org/10.1371/journal.pone.0002945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698407	Green Published, gold			2022-12-25	WOS:000264412600031
J	Coello, Y; Bartolo, A; Amiri, B; Devanne, H; Houdayer, E; Derambure, P				Coello, Yann; Bartolo, Angela; Amiri, Bastien; Devanne, Herve; Houdayer, Elise; Derambure, Philippe			Perceiving What Is Reachable Depends on Motor Representations: Evidence from a Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; NEURAL-NETWORKS; FAR SPACE; PERCEPTION; MOVEMENTS; HAND; LOCALIZATION; SUPPRESSION; INHIBITION; ACTIVATION	Background: Visually determining what is reachable in peripersonal space requires information about the egocentric location of objects but also information about the possibilities of action with the body, which are context dependent. The aim of the present study was to test the role of motor representations in the visual perception of peripersonal space. Methodology: Seven healthy participants underwent a TMS study while performing a right-left decision (control) task or perceptually judging whether a visual target was reachable or not with their right hand. An actual grasping movement task was also included. Single pulse TMS was delivered 80% of the trials on the left motor and premotor cortex and on a control site (the temporo-occipital area), at 90% of the resting motor threshold and at different SOA conditions (50ms, 100ms, 200ms or 300ms). Principal Findings: Results showed a facilitation effect of the TMS on reaction times in all tasks, whatever the site stimulated and until 200ms after stimulus presentation. However, the facilitation effect was on average 34ms lower when stimulating the motor cortex in the perceptual judgement task, especially for stimuli located at the boundary of peripersonal space. Conclusion: This study provides the first evidence that brain motor area participate in the visual determination of what is reachable. We discuss how motor representations may feed the perceptual system with information about possible interactions with nearby objects and thus may contribute to the perception of the boundary of peripersonal space.	[Coello, Yann; Bartolo, Angela; Amiri, Bastien] Univ Lille Nord France, Lab URECA, EA 1059, Lille, France; [Coello, Yann] Univ Lille Nord France, UMR CNRS 8163 STL, Lille, France; [Devanne, Herve; Houdayer, Elise; Derambure, Philippe] Ctr Hosp Regional Univ, Hop Roger Salengro, Dept Neurophysiol Clin, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Coello, Y (corresponding author), Univ Lille Nord France, Lab URECA, EA 1059, Lille, France.	yann.coello@univ-lille3.fr	Devanne, Herve/M-7703-2016; Derambure, Philippe/AAK-8546-2020; Houdayer, Elise/K-1494-2016	Devanne, Herve/0000-0002-0296-9152; Bartolo, Angela/0000-0003-3034-6136; Houdayer, Elise/0000-0003-3153-0365	Region Nord-Pas-de-Calais; University Charles de Gaulle-Lille3; European Science Foundation; Eurocores CNCC CRP	Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); University Charles de Gaulle-Lille3; European Science Foundation(European Science Foundation (ESF)European Commission); Eurocores CNCC CRP	This work was supported by Region Nord-Pas-de-Calais, University Charles de Gaulle-Lille3, European Science Foundation, Eurocores CNCC CRP grant. These organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Barfield W, 1997, INT J AVIAT PSYCHOL, V7, P123, DOI 10.1207/s15327108ijap0702_2; Binsted G, 2007, P NATL ACAD SCI USA, V104, P12669, DOI 10.1073/pnas.0702307104; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOOTH D, 1992, EUR J DEV RES, V4, P1; BOURGEOIS Y, 2008, CONSCIOUS PERC UNPUB; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Coello Y, 2006, PERCEPT PSYCHOPHYS, V68, P278, DOI 10.3758/BF03193675; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; DAVEY NJ, 1992, J PHYSIOL-LONDON, V446, pP447; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; DIEDERICH A, 1992, PERCEPT PSYCHOPHYS, V52, P714, DOI 10.3758/BF03211708; Fischer MH, 2000, HUM MOVEMENT SCI, V19, P297, DOI 10.1016/S0167-9457(00)00016-6; Foltys H, 2000, NEUROREPORT, V11, P147, DOI 10.1097/00001756-200001170-00029; Gabbard C, 2006, J MOTOR BEHAV, V38, P423, DOI 10.3200/JMBR.38.6.423-429; GARDENFORS P, 2007, EUR REV, V15, P223; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grealy MA, 2003, EXP BRAIN RES, V150, P356, DOI 10.1007/s00221-003-1426-4; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HEILMAN KM, 1990, BEHAV BRAIN SCI, V13, P552, DOI 10.1017/S0140525X00080134; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JEANNEROD M, 2006, MOTOR COGNITION, P209; JORDAN MI, 1995, J MOTOR BEHAV, V27, P179, DOI 10.1080/00222895.1995.9941709; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lee ES, 2002, YONSEI MED J, V43, P446, DOI 10.3349/ymj.2002.43.4.446; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Magne P, 2002, BEHAV BRAIN RES, V136, P277, DOI 10.1016/S0166-4328(02)00169-9; MENNEMEIER M, 1992, BRAIN, V115, P37, DOI 10.1093/brain/115.1.37; Milner A. D., 1995, VISUAL BRAIN ACTION; O'Shea J, 2007, CURR BIOL, V17, pR196, DOI 10.1016/j.cub.2007.01.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASCUALLEONE A, 1992, BRAIN, V115, P109, DOI 10.1093/brain/115.1.109; Paterson A, 1944, BRAIN, V67, P331, DOI 10.1093/brain/67.4.331; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Rizzolatti G, 1988, HDB NEUROPSYCHOLOGY, V1, P223; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rochat P, 1997, J EXP PSYCHOL HUMAN, V23, P199, DOI 10.1037/0096-1523.23.1.199; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; SHELTON PA, 1990, BRAIN, V113, P191, DOI 10.1093/brain/113.1.191; Todd J. W., 1912, ARCH PSYCHOL, V25; Walsh V, 2003, BRADFORD BOOKS, P1; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	59	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2862	10.1371/journal.pone.0002862	http://dx.doi.org/10.1371/journal.pone.0002862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682848	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600018
J	Terleph, TA; Lu, K; Vicario, DS				Terleph, Thomas A.; Lu, Kai; Vicario, David S.			Response Properties of the Auditory Telencephalon in Songbirds Change with Recent Experience and Season	PLOS ONE			English	Article							SONG-CONTROL; GENE-EXPRESSION; CAUDAL TELENCEPHALON; ZEBRA FINCHES; BRAIN; SYSTEM; FOREBRAIN; DYNAMICS; NEURONS; BAT	The caudomedial nidopallium (NCM) is a telencephalic auditory area that is selectively activated by conspecific vocalizations in zebra finches and canaries. We recently demonstrated that temporal and spectral dynamics of auditory tuning in NCM differ between these species [1]. In order to determine whether these differences reflect recent experience, we exposed separate groups of each species and sex to different housing conditions. Adult birds were housed either in an aviary with conspecifics (NORM), with heterospecifics (canary subjects in a zebra finch aviary, and vice versa: (CROSS)), or in isolation (ISO) for 9 days prior to testing. We then recorded extracellular multi-unit electrophysiological responses to simple pure tone stimuli (250-5000 Hz) in awake birds from each group and analyzed auditory tuning width using methods from our earlier studies. Relative to NORM birds, tuning was narrower in CROSS birds, and wider in ISO birds. The trend was greater in canaries, especially females. The date of recording was also included as a covariate in ANCOVAs that analyzed a larger set of the canary data, including data from birds tested outside of the breeding season, and treated housing condition and sex as independent variables. These tests show that tuning width was narrower early in the year and broader later. This effect was most pronounced in CROSS males. The degree of the short-term neural plasticity described here differs across sexes and species, and may reflect differences in NCM's anatomical and functional organization related to species differences in song characteristics, adult plasticity and/or social factors. More generally, NCM tuning is labile and may be modulated by recent experience to reflect the auditory processing required for behavioral adaptation to the current acoustic, social or seasonal context.	[Terleph, Thomas A.] Sacred Heart Univ, Dept Biol, Fairfield, CT USA; [Lu, Kai; Vicario, David S.] Rutgers State Univ, Psychol Dept, Piscataway, NJ USA	Sacred Heart University; Rutgers State University New Brunswick	Terleph, TA (corresponding author), Sacred Heart Univ, Dept Biol, Fairfield, CT USA.	terlepht@sacredheart.edu			 [DC 008043-01];  [MH40900];  [DC2853]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002853, R01DC002853, F32DC008043] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	DC 008043-01, MH40900, and DC2853. These funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Leitner S, 2001, BEHAVIOUR, V138, P885, DOI 10.1163/156853901753172700; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Pinaud R, 2007, J CHEM NEUROANAT, V34, P1, DOI 10.1016/j.jchemneu.2007.03.005; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Terleph TA, 2007, DEV NEUROBIOL, V67, P1498, DOI 10.1002/dneu.20524; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760; Zann RA., 1996, ZEBRA FINCH SYNTHESI; ZEIGLER HP, 2004, BEHAV NEUROBIOLOGY B; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	29	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2854	10.1371/journal.pone.0002854	http://dx.doi.org/10.1371/journal.pone.0002854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682724	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600010
J	Yang, JX; Bridges, K; Chen, KY; Liu, AYC				Yang, Jingxian; Bridges, Kristen; Chen, Kuang Yu; Liu, Alice Y. -C.			Riluzole Increases the Amount of Latent HSF1 for an Amplified Heat Shock Response and Cytoprotection	PLOS ONE			English	Article								Background: Induction of the heat shock response (HSR) and increased expression of the heat shock proteins (HSPs) provide mechanisms to ensure proper protein folding, trafficking, and disposition. The importance of HSPs is underscored by the understanding that protein mis-folding and aggregation contribute centrally to the pathogenesis of neurodegenerative diseases. Methodology/Principal Findings: We used a cell-based hsp70-luciferease reporter gene assay system to identify agents that modulate the HSR and show here that clinically relevant concentrations of the FDA-approved ALS drug riluzole significantly increased the heat shock induction of hsp70-luciferse reporter gene. Immuno-Western and -cytochemical analysis of HSF1 show that riluzole increased the amount of cytosolic HSF1 to afford a greater activation of HSF1 upon heat shock. The increased HSF1 contributed centrally to the cytoprotective activity of riluzole as hsf1 gene knockout negated the synergistic activity of riluzole and conditioning heat shock to confer cell survival under oxidative stress. Evidence of a post-transcriptional mechanism for the increase in HSF1 include: quantitation of mRNA hsf1 by RT-PCR showed no effect of either heat shock or riluzole treatment; riluzole also increased the expression of HSF1 from a CMV-promoter; analysis of the turnover of HSF1 by pulse chase and immunoprecipitation show that riluzole slowed the decay of [(35)S] labeled-HSF1. The effect of riluzole on HSF1 was qualitatively different from that of MG132 and chloroquine, inhibitors of the proteasome and lysosome, respectively, and appeared to involve the chaperone-mediated autophagy pathway as RNAi-mediated knockdown of CMA negated its effect. Conclusion/Significance: We show that riluzole increased the amount of HSF1 to amplify the HSR for cytoprotection. Our study provides novel insight into the mechanism that regulates HSF1 turnover, and identifies the degradation of HSF1 as a target for therapeutics intervention.	[Yang, Jingxian; Bridges, Kristen; Liu, Alice Y. -C.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Chen, Kuang Yu] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Yang, JX (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	liu@biology.rutgers.edu		Liu, Alice Y./0000-0002-6984-1671; Chen, Kuang Yu/0000-0002-5629-7785	NSF [MCB0240009]; NJ Commission on Spinal Cord Research [05-3037-SCR-E-0]	NSF(National Science Foundation (NSF)); NJ Commission on Spinal Cord Research	This work was supported in part by grants from the NSF (MCB0240009) and NJ Commission on Spinal Cord Research (05-3037-SCR-E-0).	ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Batulan Z, 2003, J NEUROSCI, V23, P5789; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bush KT, 1997, J BIOL CHEM, V272, P9086; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; HUANG LE, 1994, J BIOL CHEM, V269, P30718; Ishiyama T, 2004, BRAIN RES, V1019, P226, DOI 10.1016/j.brainres.2004.06.002; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lips J, 2000, ANESTHESIOLOGY, V93, P1303, DOI 10.1097/00000542-200011000-00025; Lubbers NL, 2002, EUR J PHARMACOL, V435, P79, DOI 10.1016/S0014-2999(01)01552-7; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MIFFLIN LC, 1994, J BIOL CHEM, V269, P15710; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; NUNES SL, 1995, BIOCHEM BIOPH RES CO, V213, P1, DOI 10.1006/bbrc.1995.2090; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Polakowski JS, 2002, EUR J PHARMACOL, V435, P73, DOI 10.1016/S0014-2999(01)01551-5; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Weng YC, 2007, EXP NEUROL, V204, P433, DOI 10.1016/j.expneurol.2006.12.003; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yanagida Y, 2000, J BIOTECHNOL, V79, P53, DOI 10.1016/S0168-1656(00)00214-5; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082	57	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2864	10.1371/journal.pone.0002864	http://dx.doi.org/10.1371/journal.pone.0002864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682744	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600020
J	Baba, K; Hoosen, AA; Langeland, N; Dyrhol-Riise, AM				Baba, Kamaldeen; Hoosen, Anwar A.; Langeland, Nina; Dyrhol-Riise, Anne M.			Adenosine Deaminase Activity Is a Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in Patients with Very Low CD4 Counts	PLOS ONE			English	Article								Background: Adenosine Deaminase Activity (ADA) is a commonly used marker for the diagnosis of tuberculous pleural effusion. There has been concern about its usefulness in immunocompromised patients, especially HIV positive patients with very low CD4 counts. The objective of this study was to evaluate the sensitivity of ADA in pleural fluid in patients with low CD4 counts. Materials and Methods: This was a retrospective case control study. Medical files of patients with tuberculous pleuritis and non-tuberculous pleuritis were reviewed. Clinical characteristics, CD4 cell counts in blood and biochemical markers in pleural fluid, including ADA were recorded. Results: One ninety seven tuberculous pleuritis and 40 non-tuberculous pleuritis patients were evaluated. Using the cut-off value of 30 U/L, the overall sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of ADA was 94%, 95%, 19, and 0.06 respectively. The mean CD4 cell counts among TB pleuritis patients was 29 and 153 cells/microL in patients with CD4,50 cells/microL and < 50 cells/microL, (p < 0.05) respectively. The corresponding mean ADA values for these patients were 76 U/L and 72 U/L respectively (p > 0.5). There was no correlation between ADA values and CD4 cell counts (r =-0.120, p = 0.369). Conclusion: ADA analysis is a sensitive marker of tuberculous pleuritis even in HIV patients with very low CD4 counts in a high TB endemic region. The ADA assay is inexpensive, rapid, and simple to perform and is of great value for the immediate diagnosis of tuberculous pleuritis while waiting for culture result and this has a positive impact on patient outcome.	[Baba, Kamaldeen; Langeland, Nina; Dyrhol-Riise, Anne M.] Univ Bergen, Inst Med, Bergen, Norway; [Baba, Kamaldeen] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Baba, Kamaldeen; Hoosen, Anwar A.] Univ Limpopo, Dept Microbiol Pathol, Limpopo, South Africa; [Langeland, Nina; Dyrhol-Riise, Anne M.] Haukeland Hosp, Dept Med, Bergen, Norway	University of Bergen; University of Bergen; University of Limpopo; University of Bergen; Haukeland University Hospital	Baba, K (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	adeola12@yahoo.co.uk			University of Bergen, Norway [QUOTA fellowship programme]; Regional Health Authorities of Western Norway	University of Bergen, Norway; Regional Health Authorities of Western Norway	This study was funded by QUOTA fellowship programme at the University of Bergen, Norway and thanks to the Regional Health Authorities of Western Norway who funded the running costs. The funders did not play any role in the study design, data analysis and preparation of manuscript.	Alvarez GG, 2004, INT J TUBERC LUNG D, V8, P1472; BABA K, 2008, AIMM IN PRESS; BABA K, 1998, BMC INFECT IN PRESS; BAGANHA MF, 1990, CHEST, V97, P605, DOI 10.1378/chest.97.3.605; BLAKE J, 1982, S AFR MED J, V62, P19; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; BURGESS LJ, 1995, THORAX, V50, P672, DOI 10.1136/thx.50.6.672; Corral I, 2004, EUR J CLIN MICROBIOL, V23, P471, DOI 10.1007/s10096-004-1110-z; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Gaga M, 2005, RESPIRATION, V72, P160, DOI 10.1159/000084047; GAKIS C, 1991, CHEST, V99, P1555, DOI 10.1378/chest.99.6.1555; Goto M, 2003, ANN CLIN BIOCHEM, V40, P374, DOI 10.1258/000456303766477011; Hsu Wu-Huei, 1993, Journal of the Formosan Medical Association, V92, P668; Ibrahim WH, 2005, RESP MED, V99, P1038, DOI 10.1016/j.rmed.2004.12.012; Lee YCG, 2001, CHEST, V120, P356, DOI 10.1378/chest.120.2.356; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Perez-Rodriguez E, 1999, RESP MED, V93, P816, DOI 10.1016/S0954-6111(99)90267-6; PFALLER MA, 1994, AM J CLIN PATHOL, V101, P329, DOI 10.1093/ajcp/101.3.329; PIRAS MA, 1978, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.6154.1751-a; Reuter Helmuth, 2005, Cardiovasc J S Afr, V16, P143; Riantawan P, 1999, CHEST, V116, P97, DOI 10.1378/chest.116.1.97; Sharma S K, 2001, Indian J Chest Dis Allied Sci, V43, P149; Tarhan G, 2006, J INFECTION, V52, P264, DOI 10.1016/j.jinf.2005.06.009; UNGERER JPJ, 1994, CHEST, V106, P33, DOI 10.1378/chest.106.1.33; VALDES L, 1993, CHEST, V103, P458, DOI 10.1378/chest.103.2.458; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; Villena V, 1996, CLIN CHEM, V42, P218; Villena V, 1996, EUR RESPIR J, V9, P2635, DOI 10.1183/09031936.96.09122635; Villena V, 2003, AM J MED, V115, P365, DOI 10.1016/S0002-9343(03)00423-6; *WHO, 2005, WHOHTMTB2005349	31	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2788	10.1371/journal.pone.0002788	http://dx.doi.org/10.1371/journal.pone.0002788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665218	Green Published, gold			2022-12-25	WOS:000264304300007
J	Chen, L; Zheng, S				Chen, Liang; Zheng, Sika			Identify Alternative Splicing Events Based on Position-Specific Evolutionary Conservation	PLOS ONE			English	Article							SELECTION PRESSURE; IDENTIFICATION; DATABASE; GENOME; EXONS; PREDICTION	The evolution of eukaryotes is accompanied by the increased complexity of alternative splicing which greatly expands genome information. One of the greatest challenges in the post-genome era is a complete revelation of human transcriptome with consideration of alternative splicing. Here, we introduce a comparative genomics approach to systemically identify alternative splicing events based on the differential evolutionary conservation between exons and introns and the high-quality annotation of the ENCODE regions. Specifically, we focus on exons that are included in some transcripts but are completely spliced out for others and we call them conditional exons. First, we characterize distinguishing features among conditional exons, constitutive exons and introns. One of the most important features is the position-specific conservation score. There are dramatic differences in conservation scores between conditional exons and constitutive exons. More importantly, the differences are position-specific. For flanking intronic regions, the differences between conditional exons and constitutive exons are also position-specific. Using the Random Forests algorithm, we can classify conditional exons with high specificities (97% for the identification of conditional exons from intron regions and 95% for the classification of known exons) and fair sensitivities (64% and 32% respectively). We applied the method to the human genome and identified 39,640 introns that actually contain conditional exons and classified 8,813 conditional exons from the current RefSeq exon list. Among those, 31,673 introns containing conditional exons and 5,294 conditional exons classified from known exons cannot be inferred from RefSeq, UCSC or Ensembl annotations. Some of these de novo predictions were experimentally verified.	[Chen, Liang] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zheng, Sika] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of Southern California; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Chen, L (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	liang.chen@usc.edu	Zheng, Sika/ABB-9203-2020	Zheng, Sika/0000-0002-0573-4981	USC	USC	This work was partially supported by the Faculty Setup Grant from USC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cooper TA, 2005, CELL, V120, P1, DOI 10.1016/j.cell.2004.12.030; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dror G, 2005, BIOINFORMATICS, V21, P897, DOI 10.1093/bioinformatics/bti132; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Leparc GG, 2007, NUCLEIC ACIDS RES, V35, P3192, DOI 10.1093/nar/gkm187; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Parmley JL, 2007, PLOS BIOL, V5, P343, DOI 10.1371/journal.pbio.0050014; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	24	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2806	10.1371/journal.pone.0002806	http://dx.doi.org/10.1371/journal.pone.0002806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665247	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300025
J	Li, P; Chaurasia, SS; Gao, Y; Carr, AL; Iuvone, PM; Li, L				Li, Ping; Chaurasia, Shyam S.; Gao, Yan; Carr, Aprell L.; Iuvone, P. Michael; Li, Lei			CLOCK Is Required for Maintaining the Circadian Rhythms of Opsin mRNA Expression in Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSIN PROMOTER EXPRESSION; N-ACETYLTRANSFERASE; MELATONIN; GENETICS; NPAS2; ROLES	In zebrafish, the expression of long-wavelength cone (LC) opsin mRNA fluctuated rhythmically between the day and night. In a 24-h period, expression was high in the afternoon and low in the early morning. This pattern of fluctuation persisted in zebrafish that were kept in constant darkness, suggesting an involvement of circadian clocks. Functional expression of Clock, a circadian clock gene that contributes to the central circadian pacemaker, was found to play an important role in maintaining the circadian rhythms of LC opsin mRNA expression. In zebrafish embryos, in which the translation of Clock was inhibited by anti-Clock morpholinos, the circadian rhythms of LC opsin mRNA expression diminished. CLOCK may regulate the circadian rhythms of LC opsin mRNA expression via cyclic adenosine monophosphate (cAMP)-dependent signaling pathways. In control retinas, the concentration of cAMP was high in the early morning and low in the remainder of the day and night. Inhibition of Clock translation abolished the fluctuation in the concentration of cAMP, thereby diminishing the circadian rhythms of opsin mRNA expression. Transient increase of cAMP concentrations in the early morning (i. e. by treating the embryos with 8-bromo-cAMP) restored the circadian rhythms of LC opsin mRNA expression in morpholino-treated embryos. Together, the data suggest that Clock plays important roles in regulating the circadian rhythms in photoreceptor cells.	[Li, Ping; Gao, Yan; Carr, Aprell L.; Li, Lei] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chaurasia, Shyam S.; Iuvone, P. Michael] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Li, Lei] Nankai Univ, Sch Med, Dept Physiol, Tianjin 300071, Peoples R China	University of Notre Dame; Emory University; Nankai University	Li, L (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Chaurasia, Shyam/AAB-4709-2019; Li, Lei/F-5722-2015	Chaurasia, Shyam/0000-0001-8725-676X; Li, Lei/0000-0001-9703-2102	National Institutes of Health [R01 EY013147, EY004864, EY 014764]; Core Grant for Vision Research [P30 EY03630]; NATIONAL EYE INSTITUTE [R01EY013147, R01EY004864, R01EY014764, P30EY006360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY013147 (to L. L.), EY004864 and EY 014764 (to P. M. I.), and Core Grant for Vision Research P30 EY03630. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alfinito PD, 2001, J NEUROCHEM, V76, P881, DOI 10.1046/j.1471-4159.2001.00109.x; BESHARSE JC, 1977, SCIENCE, V196, P536, DOI 10.1126/science.300504; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Chaurasia SS, 2006, J NEUROCHEM, V99, P1142, DOI 10.1111/j.1471-4159.2006.04154.x; Corey DR, 2001, GENOME BIOL, V2; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Green CB, 2003, J NEUROENDOCRINOL, V15, P350, DOI 10.1046/j.1365-2826.2003.00999.x; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ribelayga C, 2003, J COMP NEUROL, V467, P243, DOI 10.1002/cne.10927; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu CJ, 2007, J EXP BIOL, V210, P676, DOI 10.1242/jeb.02694; Yu CJ, 2007, J NEUROSCI RES, V85, P488, DOI 10.1002/jnr.21157; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007	26	22	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31673	31678		10.1074/jbc.M803875200	http://dx.doi.org/10.1074/jbc.M803875200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18687681	Green Published, hybrid			2022-12-25	WOS:000260760800049
J	Michailidou, Z; Carter, RN; Marshall, E; Sutherland, HG; Brownstein, DG; Owen, E; Cockett, K; Kelly, V; Ramage, L; Al-Dujaili, EAS; Ross, M; Maraki, I; Newton, K; Holmes, MC; Seckl, JR; Morton, NM; Kenyon, CJ; Chapman, KE				Michailidou, Z.; Carter, R. N.; Marshall, E.; Sutherland, H. G.; Brownstein, D. G.; Owen, E.; Cockett, K.; Kelly, V.; Ramage, L.; Al-Dujaili, E. A. S.; Ross, M.; Maraki, I.; Newton, K.; Holmes, M. C.; Seckl, J. R.; Morton, N. M.; Kenyon, C. J.; Chapman, K. E.			Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet	FASEB JOURNAL			English	Article						HPA axis; diet-induced obesity; NR3C1; glucose and lipid homeostasis	BODY-MASS INDEX; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; TRIGLYCERIDE-METABOLISM; TARGETED MUTATIONS; DIABETES-MELLITUS; INDUCED OBESITY; MICE BEARING; GENE; EXPRESSION; SYSTEM	Glucocorticoid hormones are critical to respond and adapt to stress. Genetic variations in the glucocorticoid receptor (GR) gene alter hypothalamic-pituitary-adrenal (HPA) axis activity and associate with hypertension and susceptibility to metabolic disease. Here we test the hypothesis that reduced GR density alters blood pressure and glucose and lipid homeostasis and limits adaption to obesogenic diet. Heterozygous GR(beta geo/+) mice were generated from embryonic stem (ES) cells with a gene trap integration of a beta-galactosidase-neomycin phosphotransferase (beta geo) cassette into the GR gene creating a transcriptionally inactive GR fusion protein. Although GR(beta geo/+) mice have 50% less functional GR, they have normal lipid and glucose homeostasis due to compensatory HPA axis activation but are hypertensive due to activation of the renin-angiotensin-aldosterone system (RAAS). When challenged with a high-fat diet, weight gain, adiposity, and glucose intolerance were similarly increased in control and GR(beta geo/+) mice, suggesting preserved control of intermediary metabolism and energy balance. However, whereas a high-fat diet caused HPA activation and increased blood pressure in control mice, these adaptions were attenuated or abolished in GR(beta geo/+) mice. Thus, reduced GR density balanced by HPA activation leaves glucocorticoid functions unaffected but mineralocorticoid functions increased, causing hypertension. Importantly, reduced GR limits HPA and blood pressure adaptions to obesogenic diet. -Michailidou, Z., Carter, R. N., Marshall, E., Sutherland, H. G., Brownstein, D. G., Owen, E., Cockett, K., Kelly, V., Ramage, L., Al-Dujaili, E. A. S., Ross, M., Maraki, I., Newton, K., Holmes, M. C., Seckl, J. R., Morton, N. M., Kenyon, C. J., Chapman, K. E. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet. FASEB J. 22, 3896-3907 (2008)	[Chapman, K. E.] Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Sutherland, H. G.; Newton, K.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Al-Dujaili, E. A. S.] Queen Margaret Univ, Musselburgh, East Lothian, Scotland	University of Edinburgh; University of Edinburgh; Queen Margaret University	Chapman, KE (corresponding author), Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	karen.chapman@ed.ac.uk	Seckl, Jonathan R/C-3555-2013; Morton, NICHOLAS/ABF-3774-2020	Chapman, Karen/0000-0001-7777-6817; Sutherland, Heidi/0000-0002-8512-1498	Wellcome Trust PhD Studentship; British Heart Foundation; Wellcome Trust Programme; Wellcome Trust Project; Medical Research Council Programme; Wellcome Trust Research Career Development Fellowship; Medical Research Council [G0500026] Funding Source: researchfish; MRC [G0500026] Funding Source: UKRI	Wellcome Trust PhD Studentship(Wellcome Trust); British Heart Foundation(British Heart Foundation); Wellcome Trust Programme(Wellcome Trust); Wellcome Trust Project(Wellcome Trust); Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Mark Danielsen (Georgetown University School of Medicine, Washington, DC, USA) for kindly providing the SV2wrec plasmid encoding mouse GR cDNA and David Pearce (University of California, San Francisco, Department of Medicine, San Francisco, CA, USA) for providing the rPNMT-998/-466 Luc plasmid. We thank the Biomedical Research Resources facility, University of Edinburgh, facility for assistance with animal care and members of the Endocrinology Unit for helpful discussions and advice. This work was supported by a Wellcome Trust PhD Studentship (to Z.M.), a British Heart Foundation Project Grant (to K.E.C., C.J.K., N.M.M., and J.R.S.), a Wellcome Trust Programme Grant (to J.R.S. and K.E.C.), a Wellcome Trust Project Grant (to M.C.H and J.R.S.), and a Medical Research Council Programme Grant (to C.J.K.). N.M.M. is supported by a Wellcome Trust Research Career Development Fellowship.	Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Al-Dujaili EAS, 2006, CLIN CHIM ACTA, V364, P172, DOI 10.1016/j.cccn.2005.06.019; ALDUJAILI EAS, 1981, CLIN CHIM ACTA, V116, P277, DOI 10.1016/0009-8981(81)90047-4; BALLARD PL, 1974, ENDOCRINOLOGY, V94, P998, DOI 10.1210/endo-94-4-998; BARTLETT SM, 1988, BIOCHEM J, V249, P37, DOI 10.1042/bj2490037; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; CARROLL K. K., 1952, ENDOCRINOLOGY, V51, P476; CHAPMAN KE, 2007, NEUROCHEM RES; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Coll AP, 2004, ENDOCRINOLOGY, V145, P4721, DOI 10.1210/en.2004-0491; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; Di Blasio AM, 2003, CLIN ENDOCRINOL, V59, P68, DOI 10.1046/j.1365-2265.2003.01798.x; EVANS AL, 1994, MED BIOL ENG COMPUT, V32, P101, DOI 10.1007/BF02512487; Finotto S, 1999, DEVELOPMENT, V126, P2935; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; Harris HJ, 2001, ENDOCRINOLOGY, V142, P114, DOI 10.1210/en.142.1.114; Harrison PA, 2001, J CHILD ADOLES SUBST, V11, P1, DOI 10.1300/J029v11n02_01; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Howell MP, 2006, FRONT NEUROENDOCRIN, V27, P275, DOI 10.1016/j.yfrne.2006.05.001; KASAI Y, 1990, FEBS LETT, V274, P99, DOI 10.1016/0014-5793(90)81339-P; KAUFMAN LN, 1993, AM J PHYSIOL, V265, pR1, DOI 10.1152/ajpregu.1993.265.1.R1; Kellendonk C, 2002, ENDOCRINOLOGY, V143, P2333, DOI 10.1210/en.143.6.2333; Kino T, 2002, ANN NY ACAD SCI, V970, P101, DOI 10.1111/j.1749-6632.2002.tb04416.x; Kino T, 2001, J ENDOCRINOL, V169, P437, DOI 10.1677/joe.0.1690437; KIRK CJ, 1976, BIOCHEM J, V156, P593, DOI 10.1042/bj1560593; KLAUSNER H, 1967, AM J PHYSIOL, V212, P1236, DOI 10.1152/ajplegacy.1967.212.6.1236; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; Magiakou MA, 2006, BEST PRACT RES CL EN, V20, P467, DOI 10.1016/j.beem.2006.07.006; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mantha L, 1999, AM J PHYSIOL-REG I, V277, pR455, DOI 10.1152/ajpregu.1999.277.2.R455; Mantha L, 2000, AM J PHYSIOL-REG I, V278, pR1424, DOI 10.1152/ajpregu.2000.278.6.R1424; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILLS E, 1993, AM J PHYSIOL, V264, pR73, DOI 10.1152/ajpregu.1993.264.1.R73; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; NAKAMURA N, 1985, HYPERTENSION, V7, P855, DOI 10.1161/01.HYP.7.6.855; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Panarelli M, 1998, J CLIN ENDOCR METAB, V83, P1846, DOI 10.1210/jc.83.6.1846; Pazirandeh A, 2002, FASEB J, V16, P727, DOI 10.1096/fj.01-0891fje; PEPIN MC, 1992, NATURE, V355, P725, DOI 10.1038/355725a0; Ramdas J, 1999, CANCER RES, V59, P1378; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; RICHARD D, 1993, AM J PHYSIOL, V265, pR146, DOI 10.1152/ajpregu.1993.265.1.R146; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; SECKL JR, 1994, J HYPERTENS, V12, P105; SECKL JR, 1990, J NEUROENDOCRINOL, V2, P911, DOI 10.1111/j.1365-2826.1990.tb00659.x; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Takami S, 1999, AM J PHYSIOL-HEART C, V276, pH1379, DOI 10.1152/ajpheart.1999.276.4.H1379; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Yau JLW, 2007, NEUROPSYCHOPHARMACOL, V32, P2520, DOI 10.1038/sj.npp.1301389	63	41	43	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3896	3907		10.1096/fj.08-111914	http://dx.doi.org/10.1096/fj.08-111914			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18697839	Green Published, hybrid			2022-12-25	WOS:000260503000018
J	De Luca, M; Brunetto, L; Asteriti, IA; Giubettini, M; Lavia, P; Guarguaglini, G				De Luca, M.; Brunetto, L.; Asteriti, I. A.; Giubettini, M.; Lavia, P.; Guarguaglini, G.			Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity	ONCOGENE			English	Article						Aurora-A; ch-TOG; MCAK; mitosis; spindle pole	D-TACC; CENTROSOME; KINASE; ORGANIZATION; ANEUPLOIDY; PROTEIN; CANCER; PHOSPHORYLATION; AMPLIFICATION; LOCALIZATION	Mitotic spindle assembly is a highly regulated process, crucial to ensure the correct segregation of duplicated chromosomes in daughter cells and to avoid aneuploidy, a common feature of tumors. Among the most important spindle regulators is Aurora-A, a mitotic centrosomal kinase frequently overexpressed in tumors. Here, we investigated the role of Aurora-A in spindle pole organization in human cells. We show that RNA interference-mediated Aurora-A inactivation causes pericentriolar material fragmentation in prometaphase, yielding the formation of spindles with supernumerary poles. This fragmentation does not necessarily involve centrioles and requires microtubules (MTs). Aurora-A-depleted prometaphases mislocalize the MT-stabilizing protein colonic hepatic tumor-overexpressed gene (ch-TOG), which abnormally accumulates at spindle poles, as well as the mitotic centromere-associated kinesin ( MCAK), the major functional antagonist of ch-TOG, which delocalizes from poles. ch-TOG is required for extrapole formation in prometaphases lacking Aurora-A, because co-depletion of Aurora-A and ch-TOG mitigates the fragmented pole phenotype. These results indicate a novel function of Aurora-A, the regulation of ch-TOG and MCAK localization, and highlight a common pathway involving the three factors in control of spindle pole integrity.	[De Luca, M.; Brunetto, L.; Asteriti, I. A.; Giubettini, M.; Lavia, P.; Guarguaglini, G.] Univ Roma La Sapienza, CNR, Inst Mol Biol & Pathol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Guarguaglini, G (corresponding author), Univ Roma La Sapienza, CNR, IBPM, Via Apuli 4, I-00185 Rome, Italy.	giulia.guarguaglini@uniroma1.it	Lavia, Patrizia/J-5793-2019; Lavia, Patrizia/AAL-3982-2021	Lavia, Patrizia/0000-0003-3310-6701; DE LUCA, Maria/0000-0003-2329-776X; Giubettini, Maria/0000-0001-5863-1911	AIRC (Italian Association for Cancer Research)	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	We thank M Ciciarello and R Mangiacasale for helpful discussions and JL Salisbury and C Walczak for reagents. This work was supported by AIRC ( Italian Association for Cancer Research) grants ( to PL).	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; De Luca M, 2006, CELL CYCLE, V5, P296; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holmfeldt P, 2005, EMBO J, V24, P1256, DOI 10.1038/sj.emboj.7600601; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198	36	43	43	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2008	27	51					6539	6549		10.1038/onc.2008.252	http://dx.doi.org/10.1038/onc.2008.252			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18663358				2022-12-25	WOS:000260501700001
J	Choi, WI; Jeon, BN; Park, H; Yoo, JY; Kim, YS; Koh, DI; Kim, MH; Kim, YR; Lee, CE; Kim, KS; Osborne, TF; Hur, MW				Choi, Won-Il; Jeon, Bu-Nam; Park, Hyejin; Yoo, Jung-Yoon; Kim, Yeon-Sook; Koh, Dong-In; Kim, Myung-Hwa; Kim, Yu-Ri; Lee, Choong-Eun; Kim, Kyung-Sup; Osborne, Timothy F.; Hur, Man-Wook			Proto-oncogene FBI-1 (Pokemon) and SREBP-1 Synergistically Activate Transcription of Fatty-acid Synthase Gene (FASN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; LIPOPROTEIN RECEPTOR GENE; BINDING PROTEIN; POZ DOMAIN; INSULIN REGULATION; PROMOTER; CANCER; SP1; CHOLESTEROL; HOMEOSTASIS	FBI-1 (Pokemon/ZBTB7A) is a proto-oncogenic transcription factor of the BTB/POZ (bric-a-brac, tramtrack, and broad complex and pox virus zinc finger) domain family. Recent evidence suggested that FBI-1 might be involved in adipogenic gene expression. Coincidentally, expression of FBI-1 and fatty-acid synthase (FASN) genes are often increased in cancer and immortalized cells. Both FBI-1 and FASN are important in cancer cell proliferation. SREBP-1 is a major regulator of many adipogenic genes, and FBI-1 and SREBP-1 (sterol-responsive element (SRE)-binding protein 1) interact with each other directly via their DNA binding domains. FBI-1 enhanced the transcriptional activation of SREBP-1 on responsive promoters, pGL2-6x(SRE)-Luc and FASN gene. FBI-1 and SREBP-1 synergistically activate transcription of the FASN gene by acting on the proximal GC-box and SRE/E-box. FBI-1, Sp1, and SREBP-1 can bind to all three SRE, GC-box, and SRE/E-box. Binding competition among the three transcription factors on the GC-box and SRE/E-box appears important in the transcription regulation. FBI-1 is apparently changing the binding pattern of Sp1 and SREBP-1 on the two elements in the presence of induced SREBP-1 and drives more Sp1 binding to the proximal promoter with less of an effect on SREBP-1 binding. The changes induced by FBI-1 appear critical in the synergistic transcription activation. The molecular mechanism revealed provides insight into how proto-oncogene FBI-1 may attack the cellular regulatory mechanism of FASN gene expression to provide more phospholipid membrane components needed for rapid cancer cell proliferation.	[Choi, Won-Il; Jeon, Bu-Nam; Park, Hyejin; Yoo, Jung-Yoon; Kim, Yeon-Sook; Koh, Dong-In; Kim, Myung-Hwa; Kim, Yu-Ri; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Inst Genet Sci,Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Lee, Choong-Eun] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Osborne, Timothy F.] Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Yonsei University; Sungkyunkwan University (SKKU); University of California System; University of California Irvine	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Inst Genet Sci,Brain Korea Project Med Sci 21, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		CHOI, WONIL/0000-0002-4837-0436; Hur, Man-Wook/0000-0002-3416-1334; Kim, Yeon-Sook/0000-0003-1142-5488; Kim, Kyung-sup/0000-0001-8483-8537; Yoo, Jung-Yoon/0000-0001-9366-3863	Korea Research Foundation [E00046]; Korea Ministry of Education; Korea Science and Engineering Foundation [R0A-2003-000-10318-0 from]; Korea Ministry of Science and Technology	Korea Research Foundation(National Research Foundation of Korea); Korea Ministry of Education(Ministry of Education (MOE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a Korea Research Foundation Grant E00046 (2005), Korea Ministry of Education, and National Research Laboratory Grant R0A-2003-000-10318-0 from Korea Science and Engineering Foundation, Korea Ministry of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Wolf Siegmund S., 1998, Biochemical Society Transactions, V26, pS95; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	38	60	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29341	29354		10.1074/jbc.M802477200	http://dx.doi.org/10.1074/jbc.M802477200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682402	Green Published, hybrid			2022-12-25	WOS:000260179900061
J	Balan, V; Miller, GS; Kaplun, L; Balan, K; Chong, ZZ; Li, FQ; Kaplun, A; VanBerkum, MFA; Arking, R; Freeman, DC; Maiese, K; Tzivion, G				Balan, Vitaly; Miller, Gregory S.; Kaplun, Ludmila; Balan, Karina; Chong, Zhao-Zhong; Li, Faqi; Kaplun, Alexander; VanBerkum, Mark F. A.; Arking, Robert; Freeman, D. Carl; Maiese, Kenneth; Tzivion, Guri			Life span extension and neuronal cell protection by Drosophila nicotinamidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; NAD BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; SIR2 FAMILY; SIRTUINS; PATHWAY; FOXO; METABOLISM; ACTIVATION; REGULATOR	The life span of model organisms can be modulated by environmental conditions that influence cellular metabolism, oxidation, or DNA integrity. The yeast nicotinamidase gene pnc1 was identified as a key transcriptional target and mediator of calorie restriction and stress-induced life span extension. PNC1 is thought to exert its effect on yeast life span by modulating cellular nicotinamide and NAD levels, resulting in increased activity of Sir2 family class III histone deacetylases. In Caenorhabditis elegans, knockdown of a pnc1 homolog was shown recently to shorten the worm life span, whereas its overexpression increased survival under conditions of oxidative stress. The function and regulation of nicotinamidases in higher organisms has not been determined. Here, we report the identification and biochemical characterization of the Drosophila nicotinamidase, D-NAAM, and demonstrate that its overexpression significantly increases median and maximal fly life span. The life span extension was reversed in Sir2 mutant flies, suggesting Sir2 dependence. Testing for physiological effectors of D-NAAM in Drosophila S2 cells, we identified oxidative stress as a primary regulator, both at the transcription level and protein activity. In contrast to the yeast model, stress factors such as high osmolarity and heat shock, calorie restriction, or inhibitors of TOR and phosphatidylinositol 3-kinase pathways do not appear to regulate D-NAAM in S2 cells. Interestingly, the expression of D-NAAM in human neuronal cells conferred protection from oxidative stress-induced cell death in a sirtuin-dependent manner. Together, our findings establish a life span extending the ability of nicotinamidase in flies and offer a role for nicotina-mide-modulating genes in oxidative stress regulated pathways influencing longevity and neuronal cell survival.	[Balan, Vitaly; Kaplun, Ludmila; Balan, Karina; Kaplun, Alexander; Tzivion, Guri] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Balan, Vitaly; Kaplun, Ludmila; Balan, Karina; Kaplun, Alexander; Tzivion, Guri] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; [Miller, Gregory S.; VanBerkum, Mark F. A.; Arking, Robert; Freeman, D. Carl] Wayne State Univ, Dept Biol Sci, Detroit, MI 48201 USA; [Chong, Zhao-Zhong; Li, Faqi; Maiese, Kenneth] Wayne State Univ, Dept Neurol Anat & Cell Biol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Tzivion, G (corresponding author), Wayne State Univ, Karmanos Canc Inst, 4100 John R,HWCRC-716, Detroit, MI 48201 USA.	tziviong@karmanos.org	Kaplun, Alexander/AAH-5033-2020; Tzivion, Guri/D-8954-2011		National Institutes of Health [R01-GM067134, NS053946]; American Diabetes Association; American Heart Association Bugher Foundation Award; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association Bugher Foundation Award(American Heart Association); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM067134 (to G. T.) and NS053946 (to K. M.). This work was also supported by the American Diabetes Association, the American Heart Association Bugher Foundation Award, and Wayne State University institutional support (to M. V. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; CHAYKIN S, 1969, ANAL BIOCHEM, V31, P375, DOI 10.1016/0003-2697(69)90278-4; Chonga ZZ, 2004, EXP CELL RES, V296, P196, DOI 10.1016/j.yexcr.2004.01.021; Csiszar Anna, 2005, Current Vascular Pharmacology, V3, P285, DOI 10.2174/1570161054368616; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Denu JM, 2007, CELL, V129, P453, DOI 10.1016/j.cell.2007.04.023; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Newman BL, 2002, GENETICS, V162, P1675; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sandmeier JJ, 2002, GENETICS, V160, P877; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003	64	125	130	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27810	27819		10.1074/jbc.M804681200	http://dx.doi.org/10.1074/jbc.M804681200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18678867	Green Published, hybrid			2022-12-25	WOS:000259719200052
J	Xia, R; Mei, ZZ; Mao, HJ; Yang, W; Dong, L; Bradley, H; Beech, DJ; Jiang, LH				Xia, Rong; Mei, Zhu-Zhong; Mao, Hong-Ju; Yang, Wei; Dong, Li; Bradley, Helen; Beech, David J.; Jiang, Lin-Hua			Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; EPITHELIAL CA2+; TRPM2 CHANNEL; ADP-RIBOSE; SELECTIVITY; MG2+; ACID; SUSCEPTIBILITY; INFLUX; TRPC5	The molecular basis for divalent cationic permeability in transient receptor potential melastatin subtype ( TRPM) channels is not fully understood. Here we studied the roles of all eight acidic residues, glutamate or aspartate, and also the glutamine residue between pore helix and selectivity filter in the pore of TRPM2 channel. Mutants with alanine substitution in each of the acidic residues, except Glu-960 and Asp-987, formed functional channels. These channels exhibited similar Ca2+ and Mg2+ permeability to wild type channel, with the exception of the E1022A mutant, which displayed increased Mg2+ permeability. More conservative E960Q, E960D, and D987N mutations also led to loss of function. The D987E mutant was functional and showed greater Ca2+ permeability along with concentration-dependent inhibition of Na+ carrying currents by Ca2+. Incorporation of negative charge in place of Gln-981 between the pore helix and selectivity filter by changing it to glutamate, which is present in the more Ca2+ -permeable TRPM channels, substantially increased Ca2+ permeability. Expression of concatemers linking wild type and E960D mutant subunits resulted in functional channels that exhibited reduced Ca2+ permeability. These data taken together suggest that Glu-960, Gln-981, Asp-987, and Glu-1022 residues are engaged in determining divalent cationic permeation properties of the TRPM2 channel.	[Xia, Rong; Mei, Zhu-Zhong; Mao, Hong-Ju; Yang, Wei; Dong, Li; Bradley, Helen; Beech, David J.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	h.jiang@leeds.ac.uk	Jiang, Lin-Hua/AAU-1078-2020; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Beech, David/0000-0002-7683-9422	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (to L.-H. Jiang). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hille B., 2001, IONIC CHANNELS EXCIT, P539; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	39	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27426	27432		10.1074/jbc.M801049200	http://dx.doi.org/10.1074/jbc.M801049200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687688	Green Published, hybrid			2022-12-25	WOS:000259719200011
J	Ouellet, YH; Daigle, R; Lague, P; Dantsker, D; Milani, M; Bolognesi, M; Friedman, JM; Guertin, M				Ouellet, Yannick H.; Daigle, Richard; Laguee, Patrick; Dantsker, David; Milani, Mario; Bolognesi, Martino; Friedman, Joel M.; Guertin, Michel			Ligand binding to truncated hemoglobin N from Mycobacterium tuberculosis is strongly modulated by the interplay between the distal heme pocket residues and internal water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; MYOGLOBIN; REACTIVITY; OXYGEN; O-2; DETOXIFICATION	The survival of Mycobacterium tuberculosis requires detoxification of host center dot NO. Oxygenated Mycobacterium tuberculosis truncated hemoglobin N catalyzes the rapid oxidation of nitric oxide to innocuous nitrate with a second-order rate constant (k'NOD approximate to 745 x 10(6) M(-1 center dot)s(-1)), which is similar to 15-fold faster than the reaction of horse heart myoglobin. We ask what aspects of structure and/or dynamics give rise to this enhanced reactivity. A first step is to expose what controls ligand/substrate binding to the heme. We present evidence that the main barrier to ligand binding to deoxy-truncated hemoglobin N (deoxy-trHbN) is the displacement of a distal cavity water molecule, which is mainly stabilized by residue Tyr(B10) but not coordinated to the heme iron. As observed in the Tyr( B10)/Gln(E11) apolar mutants, once this kinetic barrier is lowered, CO and O-2 binding is very rapid with rates approaching 1 - 2 x 10(9) M(-1 center dot)s(-1). These large values almost certainly represent the upper limit for ligand binding to a heme protein and also indicate that the iron atom in trHbN is highly reactive. Kinetic measurements on the photoproduct of the center dot NO derivative of met-trHbN, where both the center dot NO and water can be directly followed, revealed that water rebinding is quite fast (similar to 1.49 x 10(8) s(-1)) and is responsible for the low geminate yield in trHbN. Molecular dynamics simulations, performed with trHbN and its distal mutants, indicated that in the absence of a distal water molecule, ligand access to the heme iron is not hindered. They also showed that a water molecule is stabilized next to the heme iron through hydrogen-bonding with Tyr(B10) and Gln(E11).	[Ouellet, Yannick H.; Daigle, Richard; Laguee, Patrick; Guertin, Michel] Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada; [Dantsker, David; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Milani, Mario; Bolognesi, Martino] Univ Milan, Milano Res Unit, CNR, INFM, I-20131 Milan, Italy; [Milani, Mario; Bolognesi, Martino] Univ Milan, Dept Biomol Sci & Biotechnol, I-20131 Milan, Italy	Laval University; Yeshiva University; Albert Einstein College of Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan; University of Milan	Guertin, M (corresponding author), Univ Laval, Dept Biochem & Microbiol, Pavillon Charles Eugene Marchand,Rm 3145, Quebec City, PQ G1K 7P4, Canada.	Michel.Guertin@rsvs.ulaval.ca	Bolognesi, Martino/B-7924-2017; Milani, Mario/B-6446-2015	Bolognesi, Martino/0000-0002-9253-5170; Milani, Mario/0000-0001-6098-3991; Lague, Patrick/0000-0002-5236-4979	National Institutes of Health [1-R01-AI052258]; National Sciences and Engineering Research Council [46306- 01]; Fonds Que be cois de la Recherche sur la Nature et les Technologies [104897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Que be cois de la Recherche sur la Nature et les Technologies(FQRNT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-AI052258 (to J. M. F.). This work was also supported by National Sciences and Engineering Research Council Grant 46306- 01 (2005- 2010) and Fonds Que be cois de la Recherche sur la Nature et les Technologies Grant 104897 (M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brunori M, 1999, CELL MOL LIFE SCI, V56, P549, DOI 10.1007/s000180050452; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; Christian JF, 1997, BIOCHEMISTRY-US, V36, P11198, DOI 10.1021/bi9710075; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Dantsker D, 2005, J BIOL CHEM, V280, P38740, DOI 10.1074/jbc.M506333200; Dantsker D, 2004, J BIOL CHEM, V279, P38844, DOI 10.1074/jbc.M401513200; Dantsker D, 2005, BBA-PROTEINS PROTEOM, V1749, P234, DOI 10.1016/j.bbapap.2005.04.002; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Feller SE, 1996, J PHYS CHEM-US, V100, P17011, DOI 10.1021/jp9614658; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Ouellet Y, 2006, BIOCHEMISTRY-US, V45, P8770, DOI 10.1021/bi060112o; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; Samuni U, 2007, GENE, V398, P234, DOI 10.1016/j.gene.2007.04.032; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6	45	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27270	27278		10.1074/jbc.M804215200	http://dx.doi.org/10.1074/jbc.M804215200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676995	Green Published, hybrid			2022-12-25	WOS:000259586600046
J	Carbone, M; Rossi, MN; Cavaldesi, M; Notari, A; Amati, P; Maione, R				Carbone, M.; Rossi, M. N.; Cavaldesi, M.; Notari, A.; Amati, P.; Maione, R.			Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells	ONCOGENE			English	Article						c-Fos; c-Myc; G0 exit; poly(ADP-ribosyl)ation	MESSENGER-RNA LEVELS; RIBOSE POLYMERASE; GROWTH-FACTORS; TRANSCRIPTION; EXPRESSION; DIFFERENTIATION; MITOGENESIS; ACTIVATION; DOMAINS; BINDING	Poly(ADP-ribosyl)ation, catalysed by a family of poly (ADP-ribose) polymerases (PARPs), plays an important role in a large variety of physiological processes, including cell proliferation, but its role in cell cycle progression is not yet completely defined. As reported here, the examination of early times following serum stimulation of quiescent fibroblasts suggests that poly(ADP-ribosyl) ation is necessary for the transition from the G0 phase to the G1 phase. We show that PARP activity is involved in this step through the regulation of immediate-early response genes, such as c-Fos and c-Myc. This is supported by the finding that exogenous Myc expression substantially restores cell cycle reactivation in the absence of polymer synthesis. Furthermore, using RNA interference, we show that PARP-1 is the PARP family member playing the most prominent role in the upregulation of c-Fos and c-Myc during G0-G1 transition. We report that even in lectin-stimulated peripheral blood mononucleated cells, the inhibition of PARP activity interferes with the upregulation of immediate-early genes and delays the induction of proliferation, suggesting a general role for PARP-1 in linking growth factor signaling with cell cycle entry.	[Amati, P.; Maione, R.] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Mol Genet Sect, Pasteur Inst Fdn Cenci Bolognetti, I-00161 Rome, Italy	Sapienza University Rome	Amati, P (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Mol Genet Sect, Pasteur Inst Fdn Cenci Bolognetti, Viale Regina Elena 324, I-00161 Rome, Italy.	amati@bce.uniroma1.it; maione@bce.uniroma1.it	Rossi, Marianna Nicoletta/S-5083-2019	Rossi, Marianna Nicoletta/0000-0003-4485-7738	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4179]; AIRC/FIRC	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC/FIRC(Fondazione AIRC per la ricerca sul cancro)	We thank Dr M Crescenzi for human FB 1329 cells, Professor G Palmieri for purified PBMCs and Dr B Amati for the c-MycER-expressing cells and for helpful suggestions. We are grateful to Professor P Caiafa for useful discussions on the 'PARP world'. This work was supported by Grant no. 4179 from Associazione Italiana per la Ricerca sul Cancro (AIRC). MC was supported by a fellowship from AIRC/FIRC.	ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; Carbone M, 2006, J MOL BIOL, V363, P773, DOI 10.1016/j.jmb.2006.05.077; CESARONE CF, 1990, BIOCHIM BIOPHYS ACTA, V1087, P241, DOI 10.1016/0167-4781(90)90211-J; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEAN M, 1986, J BIOL CHEM, V261, P9161; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; ITTEL ME, 1983, BIOCHEM BIOPH RES CO, V116, P428, DOI 10.1016/0006-291X(83)90541-7; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; JOHNSTONE AP, 1982, NATURE, V300, P368, DOI 10.1038/300368a0; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; MARINI M, 1989, FEBS LETT, V253, P146, DOI 10.1016/0014-5793(89)80948-2; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; MENEGAZZI M, 1992, FEBS LETT, V297, P59, DOI 10.1016/0014-5793(92)80327-D; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Simbulan-Rosenthal CM, 1999, ONCOGENE, V18, P5015, DOI 10.1038/sj.onc.1202900; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; SimbulanRosenthal CM, 1996, BIOCHEMISTRY-US, V35, P11622, DOI 10.1021/bi953010z; Treitinger, 1999, Braz J Infect Dis, V3, P1; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; WEIN KH, 1993, BIOCHIM BIOPHYS ACTA, V1176, P69, DOI 10.1016/0167-4889(93)90179-S	34	31	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6083	6092		10.1038/onc.2008.221	http://dx.doi.org/10.1038/onc.2008.221			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18663363				2022-12-25	WOS:000260083100001
J	Sripathy, SP; Chaplin, LJ; Gaikwad, NW; Rogan, EG; Montano, MM				Sripathy, S. P.; Chaplin, L. J.; Gaikwad, N. W.; Rogan, E. G.; Montano, M. M.			hPMC2 is required for recruiting an ER beta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen	ONCOGENE			English	Article						PARP-1; ER beta-dependent transcription; antioxidative enzymes; tamoxifen; breast cancer	ESTROGEN-RECEPTOR-BETA; QUINONE REDUCTASE GENE; BREAST-CANCER; FUNCTIONAL IMPLICATIONS; C-FOS; ALPHA; ACTIVATION; EXPRESSION; ENZYMES; ELEMENT	In the presence of ER beta, trans-hydroxytamoxifen (TOT) protects cells against 17 beta-estradiol(E-2)-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ER beta-mediated protection against ODD. We observe constitutive interaction between ERb and the novelprote in hPMC2. Using a combination of breast epithelial cell lines that are either positive or negative for ER alpha, we demonstrate TOT-dependent recruitment of both ERb and hPMC2 to the EpRE (electrophile response element)- regulated antioxidative enzyme QR. We further demonstrate TOT-dependent corecruitment of the coactivators Nrf2, PARP-1 (poly (ADP-ribose) polymerase 1) and topoisomerase II beta, both in the presence and absence of ER alpha. However, absence of either ER beta or hPMC2 results in nonrecruitment of PARP-1 and topoisomerase IIb, loss of antioxidative enzyme induction and attenuated protection against ODD by TOT even in the presence of Nrf2 and ERa. These findings indicate minor role for Nrf2 and ER alpha in TOT-dependent antioxidative gene regulation. However, downregulation of PARP-1 attenuates TOT-dependent antioxidative gene induction. We conclude that ER beta and hPMC2 are required for TOT-dependent recruitment of coactivators such as PARP-1 to the EpRE resulting in the induction of antioxidative enzymes and subsequent protection against ODD.	[Sripathy, S. P.; Chaplin, L. J.; Montano, M. M.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Gaikwad, N. W.; Rogan, E. G.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	Case Western Reserve University; University of Nebraska System; University of Nebraska Medical Center	Montano, MM (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 2901 Adelbert Rd,W305, Cleveland, OH 44106 USA.	mxm126@case.edu			NIH [CA92440, CA130066]; NATIONAL CANCER INSTITUTE [R01CA092440, R03CA130066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grants (CA92440 and CA130066) to MMM.	Bianco NR, 2003, MOL ENDOCRINOL, V17, P1344, DOI 10.1210/me.2002-0382; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAVALIERI E, 2006, BIOCH BIOPHYS ACTA; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Fabian C, 2007, CANCER EPIDEM BIOMAR, V16, P2210, DOI 10.1158/1055-9965.EPI-06-1065; Gaikwad NW, 2007, FREE RADICAL BIO MED, V43, P1289, DOI 10.1016/j.freeradbiomed.2007.07.021; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Jordan VC, 2007, CANCER EPIDEM BIOMAR, V16, P2207, DOI 10.1158/1055-9965.EPI-07-0629; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li KM, 2004, CARCINOGENESIS, V25, P289, DOI 10.1093/carcin/bgg191; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Lis JT, 2006, CELL, V125, P1225, DOI 10.1016/j.cell.2006.06.016; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Montano MM, 2007, ONCOGENE, V26, P3587, DOI 10.1038/sj.onc.1210144; Montano MM, 2000, J BIOL CHEM, V275, P34306, DOI 10.1074/jbc.M003880200; Montano MM, 2004, ONCOGENE, V23, P2442, DOI 10.1038/sj.onc.1207358; Montano MM, 1998, J BIOL CHEM, V273, P25443, DOI 10.1074/jbc.273.39.25443; Oestergaard MZ, 2006, BRIT J CANCER, V95, P525, DOI 10.1038/sj.bjc.6603272; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKODA LC, 2007, BREAST CANC RES TREA; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Speirs V, 2007, J PATHOL, V211, P499, DOI 10.1002/path.2130; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; TEW KD, 1994, CANCER RES, V54, P4313; Udler M, 2007, J CLIN ONCOL, V25, P3015, DOI 10.1200/JCO.2006.10.0099; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h	37	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	49					6376	6384		10.1038/onc.2008.235	http://dx.doi.org/10.1038/onc.2008.235			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18663360	Green Accepted			2022-12-25	WOS:000260263400007
J	Conn, EM; Madsen, MA; Cravatt, BF; Ruf, W; Deryugina, EI; Quigley, JP				Conn, Erin M.; Madsen, Mark A.; Cravatt, Benjamin F.; Ruf, Wolfram; Deryugina, Elena I.; Quigley, James P.			Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL ADHESION MOLECULE; TISSUE-FACTOR; CANCER METASTASIS; TRANSENDOTHELIAL MIGRATION; MATRIX METALLOPROTEINASES; DOWN-REGULATION; MELANOMA-CELLS; FACTOR-VIIA; IN-VIVO; PROTEIN	In order to better understand the molecular and cellular determinants of tumor cell intravasation, our laboratory has generated a pair of congenic human HT-1080 fibrosarcoma variants (i.e. HT-hi/diss and HT-lo/diss) differing 50-100-fold in their ability to intravasate and disseminate. To investigate the molecular differences underlying the distinct dissemination capacities of these HT-1080 variants, we performed a comparative analysis of the cell surface proteomes of HT-hi/diss and HT-lo/diss. Cell membrane proteins were enriched by biotinylation and avidin precipitation and analyzed by tandem mass spectrometry employing multidimensional protein identification technology. By this approach, 47 cell surface-associated molecules were identified as differentially expressed between the HT-1080 intravasation variants. From these candidates, four targets (i.e. TIMP-2, NCAM-1, JAM-C, and tissue factor (TF)) were selected for further biochemical validation and in vivo functional verification. Western blot analysis of the cell surface enriched fractions confirmed the proteomic array data, demonstrating that, in vitro, TIMP-2 protein was increased in the HT-lo/diss variant, whereas NCAM-1, JAM-C, and TF levels were increased in the HT-hi/diss variant. Corresponding in vivo differences in levels of TIMP-2, JAM-C, and TF were demonstrated in primary tumors grown in the chick embryo. Finally, functional inhibition of one selected protein (i.e. TF) by small interfering RNA silencing or ligation with a function-blocking antibody significantly reduced HT-hi/diss intravasation, thus clearly implicating TF in the early steps of tumor cell dissemination. Overall, our cell surface proteomic analysis provides a powerful tool for identification of specific cell membrane molecules that contribute functionally to intravasation and metastasis in vivo.	[Conn, Erin M.; Madsen, Mark A.; Cravatt, Benjamin F.; Deryugina, Elena I.; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Quigley, JP (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jquigley@scripps.edu			National Institutes of Health [CA55852, CA105412]; National Institutes of Health, NCI [2 T32CA77109- 08]; NATIONAL CANCER INSTITUTE [R01CA055852, R01CA105412, T32CA077109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 ( to J. P. Q.) and National Institutes of Health, NCI, Grant 2 T32CA77109- 08 ( to E. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Blavier L, 1999, ANN NY ACAD SCI, V878, P108, DOI 10.1111/j.1749-6632.1999.tb07677.x; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Bromberg ME, 2001, THROMB HAEMOSTASIS, V86, P1210; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ESUMI N, 1991, CANCER RES, V51, P4549; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hastie C, 2005, ONCOGENE, V24, P5905, DOI 10.1038/sj.onc.1208747; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LIU H, 2002, BIOTECHNIQUES, V32, P902; Liu HB, 2002, BIOTECHNIQUES, V32, P898, DOI 10.2144/02324pt01; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; MUELLER BM, 1992, P NATL ACAD SCI USA, V89, P11832, DOI 10.1073/pnas.89.24.11832; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; RAO LVM, 1992, CANCER METAST REV, V11, P249; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Santoso S, 2005, J BIOL CHEM, V280, P36326, DOI 10.1074/jbc.M505059200; Scheurer SB, 2005, PROTEOMICS, V5, P3035, DOI 10.1002/pmic.200402069; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Voigtlander C, 2002, J CELL BIOCHEM, V85, P54, DOI 10.1002/jcb.10099; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang XL, 2004, INT J CANCER, V112, P994, DOI 10.1002/ijc.20527; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	52	43	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26518	26527		10.1074/jbc.M803337200	http://dx.doi.org/10.1074/jbc.M803337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658134	Green Published, hybrid			2022-12-25	WOS:000259341600028
J	Sai, JQ; Raman, D; Liu, YX; Wikswo, J; Richmond, A				Sai, Jiqing; Raman, Dayanidhi; Liu, Yuxin; Wikswo, John; Richmond, Ann			Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE ACTIVITY; NEUTROPHIL CHEMOTAXIS; FAMILY; PI3K-GAMMA; PROTEINS; POLARITY; DOCK180; CELLS; DICTYOSTELIUM; ELMO1	The requirement for phosphatidylinositol 3-kinase (PI3K) in the establishment of cell polarity and motility in a number of cell types has recently come into question. In this study, we demonstrate that inhibition of PI3K by wortmannin in neutrophil-like differentiated HL60 cells expressing CXCR2 resulted in reduced cell motility but normal chemotaxis in response to a gradient of CXCL8. However, wortmannin inhibition of PI3K did impair the ability of cells to re-orient their polarity and respond quickly to a change in the direction of the CXCL8 gradient. We hypothesized that Src-regulated ELMO-Dock2-Rac2 activation mediates chemotaxis in the absence of PI3K activity. Inhibition of Src with the small molecule inhibitor, PP2, or inhibition of Dock2 by shRNA knockdown confirmed the functional role of Src and Dock2 in regulating chemotaxis when PI3K was inhibited. Moreover, neutrophils isolated from bone marrow of hck(-/-) fgr(-/-) lyn(-/-) mice exhibited much more severe inhibition of chemotaxis when PI3K was blocked with wortmannin as compared with neutrophils isolated from bone marrow of wild-type mice. Thus, PI3K and Src-ELMO-Dock2 pathways work in parallel to activate Rac2 and modulate chemotaxis in response to a CXCL8 gradient in neutrophils.	[Sai, Jiqing; Raman, Dayanidhi; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37232 USA; [Liu, Yuxin; Wikswo, John] Vanderbilt Univ, Sch Engn, VIIBRE & Biomed Engn, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014; liu, yuxin/GRY-3592-2022	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health [CA34590]; NCI [U54CA113007]; Department of Veterans Affairs; Vanderbilt Academic Venture Capital Fund; Vanderbilt Ingram-Cancer Center [CA68485]; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590, U54CA113007, P30CA068485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Academic Venture Capital Fund; Vanderbilt Ingram-Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part by National Institutes of Health Grants CA34590 (to A. R.) and NCI U54CA113007 (to Vito Quaranta). This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs (to A. R.), the Vanderbilt Institute for Integrative Biosystems Research and Education and the Vanderbilt Academic Venture Capital Fund (to J. W.), and the Vanderbilt Ingram-Cancer Center Grant CA68485 (to Jennifer Pietenpol). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu YX, 2008, BIOMED MICRODEVICES, V10, P499, DOI 10.1007/s10544-007-9158-z; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Smith LD, 2007, CELL SIGNAL, V19, P2528, DOI 10.1016/j.cellsig.2007.08.006; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832	47	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26538	26547		10.1074/jbc.M805611200	http://dx.doi.org/10.1074/jbc.M805611200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662984	Green Published, hybrid			2022-12-25	WOS:000259341600030
J	Potzl, J; Botteron, C; Tausch, E; Pedre, X; Mueller, AM; Mannel, DN; Lechner, A				Poetzl, Johann; Botteron, Catherine; Tausch, Eugen; Pedre, Xiomara; Mueller, Andre M.; Maennel, Daniela N.; Lechner, Anja			Tracing Functional Antigen-Specific CCR6(+) Th17 Cells after Vaccination	PLOS ONE			English	Article								Background: The function of T helper cell subsets in vivo depends on their location, and one hallmark of T cell differentiation is the sequential regulation of migration-inducing chemokine receptor expression. CC-chemokine receptor 6 (CCR6) is a trait of tissue-homing effector T cells and has recently been described as a receptor on T helper type 17 (Th17) cells. Th17 cells are associated with autoimmunity and the defence against certain infections. Although, the polarization of Th cells into Th17 cells has been studied extensively in vitro, the development of those cells during the physiological immune response is still elusive. Methodology/Principal Findings: We analysed the development and functionality of Th17 cells in immune-competent mice during an ongoing immune response. In naive and vaccinated animals CCR6(+) Th cells produce IL-17. The robust homeostatic proliferation and the presence of activation markers on CCR6(+) Th cells indicate their activated status. Vaccination induces antigen-specific CCR6(+) Th17 cells that respond to in vitro re-stimulation with cytokine production and proliferation. Furthermore, depletion of CCR6(+) Th cells from donor leukocytes prevents recipients from severe disease in experimental autoimmune encephalomyelitis, a model for multiple sclerosis in mice. Conclusions/Significance: In conclusion, we defined CCR6 as a specific marker for functional antigen-specific Th17 cells during the immune response. Since IL-17 production reaches the highest levels during the immediate early phase of the immune response and the activation of Th17 cells precedes the Th1 cell differentiation we tent to speculate that this particular Th cell subset may represent a first line effector Th cell subpopulation. Interference with the activation of this Th cell subtype provides an interesting strategy to prevent autoimmunity as well as to establish protective immunity against infections.	[Poetzl, Johann; Botteron, Catherine; Tausch, Eugen; Maennel, Daniela N.; Lechner, Anja] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Pedre, Xiomara; Mueller, Andre M.] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Mueller, Andre M.] Multiple Sclerosis Res Ctr New York, New York, NY USA	University of Regensburg; University of Regensburg	Potzl, J (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	anja.lechner@klinik.uni-regensburg.de		Pedreiturria, Xiomara/0000-0002-3024-3826	Deutsche Forschungsgemeinschaft [LE 2435/1-1]; Medical Faculty of the University of Regensburg; Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Regensburg; Bayerische Forschungsstiftung	This work was supported by a project grant of the Deutsche Forschungsgemeinschaft (LE 2435/1-1 to AL) and an intramural ReForM grant of the Medical Faculty of the University of Regensburg. A scholarship of the Bayerische Forschungsstiftung was granted to JP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betti M, 2006, ANN ONCOL, V17, P235; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Cai GF, 2007, EUR J IMMUNOL, V37, P602, DOI 10.1002/eji.200636787; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dorfman JR, 2002, MICROBES INFECT, V4, P547, DOI 10.1016/S1286-4579(02)01571-X; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Laan M, 1999, J IMMUNOL, V162, P2347; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lechner A, 2007, MICROBES INFECT, V9, P291, DOI 10.1016/j.micinf.2006.12.002; Levings AK, 2005, CURR TOP MICROBIOL, V293, P303; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	44	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2951	10.1371/journal.pone.0002951	http://dx.doi.org/10.1371/journal.pone.0002951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698357	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600037
J	Liu, LH; Zhu, SZ; Gong, ZY; Low, BC				Liu, Lihui; Zhu, Shizhen; Gong, Zhiyuan; Low, Boon Chuan			K-ras/PI3K-Akt Signaling Is Essential for Zebrafish Hematopoiesis and Angiogenesis	PLOS ONE			English	Article								The RAS small GTPases orchestrate multiple cellular processes. Studies on knock-out mice showed the essential and sufficient role of K-RAS, but not N-RAS and H-RAS in embryonic development. However, many physiological functions of K-RAS in vivo remain unclear. Using wild-type and fli1:GFP transgenic zebrafish, we showed that K-ras-knockdown resulted in specific hematopoietic and angiogenic defects, including the impaired expression of erythroid-specific gene gata1 and sse3-hemoglobin, reduced blood circulation and disorganized blood vessels. Expression of either K-rasC40 that links to phosphoinositide 3-kinase (PI3K) activation, or Akt2 that acts downstream of PI3K, could rescue both hematopoietic and angiogenic defects in the K-ras knockdown. Consistently, the functional rescue by k-ras mRNA was significantly suppressed by wortmannin, a PI3K-specific inhibitor. Our results provide direct evidence that PI3K-Akt plays a crucial role in mediating K-ras signaling during hematopoiesis and angiogenesis in vivo, thus offering new targets and alternative vertebrate model for studying these processes and their related diseases.	[Liu, Lihui; Zhu, Shizhen; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117548, Singapore; [Zhu, Shizhen; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Mol Biol Lab, Singapore, Singapore	National University of Singapore; National University of Singapore	Liu, LH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117548, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012; Gong, Zhiyuan/H-8794-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Gong, Zhiyuan/0000-0002-9660-5260	Biomedical Research Council of Singapore	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council of Singapore.	Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Cheng R, 1997, MOL MAR BIOL BIOTECH, V6, P40; Choi K, 1998, DEVELOPMENT, V125, P725; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Khalaf WF, 2005, BLOOD, V105, P3538, DOI 10.1182/blood-2004-05-2021; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LUBBERT M, 1992, ONCOGENE, V7, P263; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARSHA JM, 1998, MOL CELL BIOL, V18, P3718; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Parker J, 1996, SEMIN HEMATOL, V33, P206; Prior IA, 2001, J CELL SCI, V114, P1603; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	29	35	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2850	10.1371/journal.pone.0002850	http://dx.doi.org/10.1371/journal.pone.0002850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682746	Green Submitted, gold, Green Published			2022-12-25	WOS:000264366600006
J	VanRullen, R; Pascual-Leone, A; Battelli, L				VanRullen, Rufin; Pascual-Leone, Alvaro; Battelli, Lorella			The Continuous Wagon Wheel Illusion and the 'When' Pathway of the Right Parietal Lobe: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							ILLUSORY MOTION REVERSAL; VISUAL-ATTENTION; RIVALRY; PERCEPTION; NEGLECT	A continuous periodic motion stimulus can sometimes be perceived moving in the wrong direction. These illusory reversals have been taken as evidence that part of the motion perception system samples its inputs as a series of discrete snapshots although other explanations of the phenomenon have been proposed, that rely on the spurious activation of low-level motion detectors in early visual areas. We have hypothesized that the right inferior parietal lobe ('when' pathway) plays a critical role in timing perceptual events relative to one another, and thus we examined the role of the right parietal lobe in the generation of this "continuous Wagon Wheel Illusion'' (c-WWI). Consistent with our hypothesis, we found that the illusion was effectively weakened following disruption of right, but not left, parietal regions by low frequency repetitive transcranial magnetic stimulation (1 Hz, 10 min). These results were independent of whether the motion stimulus was shown in the left or the right visual field. Thus, the c-WWI appears to depend on higher-order attentional mechanisms that are supported by the 'when' pathway of the right parietal lobe.	[VanRullen, Rufin] Univ Toulouse, CerCo, UPS, Toulouse, France; [VanRullen, Rufin] CNRS, Fac Med Rangueil, UMR5549, Toulouse, France; [Pascual-Leone, Alvaro; Battelli, Lorella] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Berenson Allen Ctr Noninvasive Brain Stimulat, Boston, MA USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttmann Neurorehab, Badalona, Spain; [Battelli, Lorella] Harvard Univ, Dept Psychol, Vision Sci Lab, Cambridge, MA USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; Harvard University	VanRullen, R (corresponding author), Univ Toulouse, CerCo, UPS, Toulouse, France.	lbattell@bidmc.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019; VanRullen, Rufin/B-2150-2008	Pascual-Leone, Alvaro/0000-0001-8975-0382; VanRullen, Rufin/0000-0002-3611-7716	Philippe Foundation; Agence Nationale de la Recherche [JCJC06_140102]; Fyssen Foundation; European Science Foundation (EURYI); Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center [NCRR MO1 RR01032]; NEI [EY15960];  [RO1-EY12091];  [R21-EY0116168];  [K24 RR018875]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032, K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091, F32EY015960] Funding Source: NIH RePORTER	Philippe Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fyssen Foundation; European Science Foundation (EURYI)(European Science Foundation (ESF)); Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	R.V. is supported by the Philippe Foundation, the Agence Nationale de la Recherche (project JCJC06_140102), the Fyssen Foundation and the European Science Foundation (EURYI). A.P.L. is supported by RO1-EY12091, R21-EY0116168 and K24 RR018875, and the Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center (NCRR MO1 RR01032). L.B. is supported by NEI EY15960.	Andrews T, 2005, TRENDS COGN SCI, V9, P261, DOI 10.1016/j.tics.2005.04.004; Andrews TJ, 2005, TRENDS COGN SCI, V9, P560, DOI 10.1016/j.tics.2005.10.006; Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; BATTELLI L, 2006, ROLE MT PARIETAL LOB; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bonneh YS, 2004, NEUROREPORT, V15, P473, DOI 10.1097/00001756-200403010-00018; CARMEL D, 2008, CAUSAL ROLE RIGHT PA; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Holcombe AO, 2005, TRENDS COGN SCI, V9, P559, DOI 10.1016/j.tics.2005.10.009; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kline K, 2004, VISION RES, V44, P2653, DOI 10.1016/j.visres.2004.05.030; Kline KA, 2006, VISION RES, V46, P1158, DOI 10.1016/j.visres.2005.08.021; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Mottaghy FM, 2002, EUR J NEUROSCI, V16, P1627, DOI 10.1046/j.1460-9568.2002.02209.x; Pakarian P, 2003, PERCEPTION, V32, P1307, DOI 10.1068/p5133; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Rojas D, 2006, VISION RES, V46, P1155, DOI 10.1016/j.visres.2005.07.023; Schouten J.F., 1967, MODELS PERCEPTION SP, P44; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Van Rullen R, 2007, VISION RES, V47, P2143, DOI 10.1016/j.visres.2007.03.019; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2006, VISION RES, V46, P4091, DOI 10.1016/j.visres.2006.07.030; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	32	30	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2911	10.1371/journal.pone.0002911	http://dx.doi.org/10.1371/journal.pone.0002911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682842	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600067
J	Brenkman, AB; de Keizer, PLJ; van den Broek, NJF; Jochemsen, AG; Burgering, BMT				Brenkman, Arjan B.; de Keizer, Peter L. J.; van den Broek, Niels J. F.; Jochemsen, A. G.; Burgering, Boudewijn M. Th.			Mdm2 Induces Mono-Ubiquitination of FOXO4	PLOS ONE			English	Article								Background: The Forkhead box O (FOXO) class of transcription factors are involved in the regulation of several cellular responses including cell cycle progression and apoptosis. Furthermore, in model organisms FOXOs act as tumor suppressors and affect aging. Previously, we noted that FOXOs and p53 are remarkably similar within their spectrum of regulatory proteins [1]. For example, the de-ubiquitinating enzyme USP7 removes ubiquitin from both FOXO and p53. However, Skp2 has been identified as E3 ligase for FOXO1, whereas Mdm2 is the prime E3 ligase for p53. Principal Findings/Methodology: Here we provide evidence that Mdm2 acts as an E3 ligase for FOXO as well. In vitro incubation of Mdm2 and FOXO results in ATP-dependent (multi) mono-ubiquitination of FOXO similar to p53. Furthermore, in vivo co-expression of Mdm2 and FOXO induces FOXO mono-ubiquitination and consistent with this result, siRNA-mediated depletion of Mdm2 inhibits mono-ubiquitination of FOXO induced by hydrogen peroxide. Regulation of FOXO ubiquitination by Mdm2 is likely to be direct since Mdm2 and FOXO co-immunoprecipitate. In addition, Mdm2-mediated ubiquitination regulates FOXO transcriptional activity. Conclusions/Significance: These data identify Mdm2 as a novel E3 ligase for FOXOs and extend the analogous mode of regulation between FOXO and p53.	[Brenkman, Arjan B.; de Keizer, Peter L. J.; van den Broek, Niels J. F.; Burgering, Boudewijn M. Th.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands; [Jochemsen, A. G.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Burgering, Boudewijn M. Th.] Ctr Biomed Genet Univ, Dept Physiol Chem, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl	de+Keizer, Peter/AAD-5320-2020	de+Keizer, Peter/0000-0002-6948-925X	European Commission Transfog Consortium [LSHC-CT-2004-503438]	European Commission Transfog Consortium(European CommissionEuropean Commission Joint Research Centre)	A.B.B was supported by the European Commission Transfog Consortium (LSHC-CT-2004-503438). The funder only paid for the author's post-doc salary.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Brooks CL, 2004, CELL CYCLE, V3, P436; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; ESSERS MA, 2004, EMBO J; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Winkler GS, 2005, METHOD ENZYMOL, V399, P355, DOI 10.1016/S0076-6879(05)99024-1; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; YANG JY, 2008, NAT CELL BIOL	29	94	101	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2819	10.1371/journal.pone.0002819	http://dx.doi.org/10.1371/journal.pone.0002819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665269	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300038
J	Yang, HJ; Takagi, H; Konishi, Y; Ageta, H; Ikegami, K; Yao, I; Sato, S; Hatanaka, K; Inokuchi, K; Seog, DH; Setou, M				Yang, Hyunjeong; Takagi, Hiroshi; Konishi, Yoshiyuki; Ageta, Hiroshi; Ikegami, Koji; Yao, Ikuko; Sato, Showbu; Hatanaka, Ken; Inokuchi, Kaoru; Seog, Dae-Hyun; Setou, Mitsutoshi			Transmembrane and Ubiquitin-Like Domain-Containing Protein 1 (Tmub1/HOPS) Facilitates Surface Expression of GluR2-Containing AMPA Receptors	PLOS ONE			English	Article							ACID TRANSPORTER ATA2; PLASMA-MEMBRANE; DEGRADATION; TRAFFICKING; GLUR2; ENDOCYTOSIS; INTERACTS; ABP/GRIP; REVEALS; KINESIN	Some ubiquitin-like (UBL) domain-containing proteins are known to play roles in receptor trafficking. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) undergo constitutive cycling between the intracellular compartment and the cell surface in the central nervous system. However, the function of UBL domain-containing proteins in the recycling of the AMPARs to the synaptic surface has not yet been reported. Here, we report that the Transmembrane and ubiquitin-like domain-containing 1 (Tmub1) protein, formerly known as the Hepatocyte Odd Protein Shuttling ( HOPS) protein, which is abundantly expressed in the brain and which exists in a synaptosomal membrane fraction, facilitates the recycling of the AMPAR subunit GluR2 to the cell surface. Neurons transfected with Tmub1/HOPS-RNAi plasmids showed a significant reduction in the AMPAR current as compared to their control neurons. Consistently, the synaptic surface expression of GluR2, but not of GluR1, was significantly decreased in the neurons transfected with the Tmub1/HOPS-RNAi and increased in the neurons overexpressing EGFP-Tmub1/HOPS. The altered surface expression of GluR2 was speculated to be due to the altered surface-recycling of the internalized GluR2 in our recycling assay. Eventually, we found that GluR2 and glutamate receptor interacting protein (GRIP) were coimmunoprecipitated by the anti-Tmub1/HOPS antibody from the mouse brain. Taken together, these observations show that the Tmub1/HOPS plays a role in regulating basal synaptic transmission; it contributes to maintain the synaptic surface number of the GluR2-containing AMPARs by facilitating the recycling of GluR2 to the plasma membrane.	[Yang, Hyunjeong] Tokyo Inst Technol, Dept Biol Informat, Kanagawa, Japan; [Yang, Hyunjeong; Takagi, Hiroshi; Konishi, Yoshiyuki; Ageta, Hiroshi; Ikegami, Koji; Yao, Ikuko; Sato, Showbu; Hatanaka, Ken; Inokuchi, Kaoru; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Seog, Dae-Hyun] Inje Univ, Colle Med, Dept Biochem, Pusan, South Korea; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan	Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Inje University; Hamamatsu University School of Medicine	Yang, HJ (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Kanagawa, Japan.	setou@hama-med.ac.jp	Inokuchi, Kaoru/AAI-9693-2020	Inokuchi, Kaoru/0000-0002-5393-3133	Mitsubishi Kagaku Institute of Life Sciences	Mitsubishi Kagaku Institute of Life Sciences	Mitsubishi Kagaku Institute of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Hatanaka K, 2006, BIOCHEM BIOPH RES CO, V350, P610, DOI 10.1016/j.bbrc.2006.09.093; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hatanaka T, 2006, J BIOL CHEM, V281, P39273, DOI 10.1074/jbc.M604534200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Kulangara K, 2007, J BIOL CHEM, V282, P2395, DOI 10.1074/jbc.M606471200; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Niibori Y, 2007, NEUROSCI RES, V57, P399, DOI 10.1016/j.neures.2006.11.014; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pieroni S, 2008, CELL CYCLE, V7, P1462, DOI 10.4161/cc.7.10.5882; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; SAHARA Y, 1991, NEUROSCI RES, V10, P200, DOI 10.1016/0168-0102(91)90057-6; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Steiner P, 2005, EMBO J, V24, P2873, DOI 10.1038/sj.emboj.7600755; Tanaka K, 1998, MOL CELLS, V8, P503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	51	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2809	10.1371/journal.pone.0002809	http://dx.doi.org/10.1371/journal.pone.0002809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665261	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300028
J	de Jong, EK; Vinet, J; Stanulovic, VS; Meijer, M; Wesseling, E; Sjollema, K; Boddeke, HWGM; Biber, K				de Jong, Eiko K.; Vinet, Jonathan; Stanulovic, Vesna S.; Meijer, Michel; Wesseling, Evelyn; Sjollema, Klaas; Boddeke, Hendrikus W. G. M.; Biber, Knut			Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles	FASEB JOURNAL			English	Article						chemokines; neuroimmunology; vesicles; microglia; neuronal injury; neuron-glia communication	REGULATED SECRETORY PATHWAY; NERVOUS-SYSTEM; GROWTH-FACTOR; PC12 CELLS; RAT-BRAIN; MICROGLIA; CHEMOKINES; GRANULES; NEUROPEPTIDES; MOTOR	Neurons are highly polarized cells, and neuron-neuron communication is based on directed transport and release of neurotransmitters, neuropeptides, and neurotrophins. Directed communication may also be attributed to neuron-microglia signaling, since neuronal damage can induce a microglia reaction at specific sites only. However, the mechanism underlying this site-specific microglia reaction is not yet understood. Neuronal CCL21 is a microglia-activating chemokine, which in brain is solely found in endangered neurons and is therefore a candidate for neuron-microglia signaling. Here we present that neuronal CCL21 is sorted into large dense-core vesicles, the secretory granules of the regulated release pathway of neurons. Live-cell imaging studies show preferential sorting of CCL21-containing vesicles into axons, indicating its directed transport. Thus, mouse neurons express and transport a microglia activating factor very similar to signaling molecules used in neuron-neuron communication. These data show for the first time the directed transport of a microglia activating factor in neurons and corroborate the function of neuronal CCL21 in directed neuron-microglia communication.	[de Jong, Eiko K.; Vinet, Jonathan; Stanulovic, Vesna S.; Meijer, Michel; Wesseling, Evelyn; Boddeke, Hendrikus W. G. M.; Biber, Knut] Univ Groningen, Dept Med Physiol, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Sjollema, Klaas] Univ Groningen, Univ Med Imaging Ctr, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Biber, K (corresponding author), Univ Groningen, Dept Med Physiol, Univ Med Ctr Groningen, Ant Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	k.p.h.biber@med.umcg.nl	Vinet, Jonathan/O-2934-2015; de Jong, Eiko/P-3407-2015	Vinet, Jonathan/0000-0001-9011-6207; de Jong, Eiko/0000-0001-6520-0407; Sjollema, Klaas/0000-0001-8840-2087	NWO-Vidi	NWO-Vidi(Netherlands Organization for Scientific Research (NWO))	The authors thank Dr. R. Toonen and Prof. M. Verhage (VUMC, Amsterdam, The Netherlands) for providing pmRFP-N1, pNPY-mRFP, and pVAMP-mRFP plasmids, and Dr. S. Carra and N. Bouwer for technical support. The work of K.B., J.V., and V.S. is supported by an NWO-Vidi grant to K.B.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adler MW, 2005, AAPS J, V7, pE865, DOI 10.1208/aapsj070484; Banati RB, 2002, J PHYSIOLOGY-PARIS, V96, P289, DOI 10.1016/S0928-4257(02)00018-9; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Biber K, 2006, CURR DRUG TARGETS, V7, P29, DOI 10.2174/138945006775270196; Biber K, 2001, GLIA, V34, P121, DOI 10.1002/glia.1047; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Copray JCVM, 2001, J NEUROIMMUNOL, V118, P203, DOI 10.1016/S0165-5728(01)00324-1; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; de Jong EK, 2005, J NEUROSCI, V25, P7548, DOI 10.1523/JNEUROSCI.1019-05.2005; de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; Dijkstra IM, 2004, J IMMUNOL, V172, P2744, DOI 10.4049/jimmunol.172.5.2744; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kayadjanian N, 2007, MOL CELL NEUROSCI, V34, P219, DOI 10.1016/j.mcn.2006.11.001; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; Minami M, 2005, NEUROMOL MED, V7, P149, DOI 10.1385/NMM:7:1-2:149; Moller JC, 2006, NEUROSCI LETT, V400, P75, DOI 10.1016/j.neulet.2006.02.018; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; PELLETIER G, 1984, NEUROPEPTIDES, V4, P319, DOI 10.1016/0143-4179(84)90006-4; Rappert A, 2002, J IMMUNOL, V168, P3221, DOI 10.4049/jimmunol.168.7.3221; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Rasband W.S., 2006, IMAGEJ; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Specht H, 2003, MOL CELL NEUROSCI, V22, P75, DOI 10.1016/S1044-7431(02)00023-4; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Thomas K, 2005, CURR BIOL, V15, pR262, DOI 10.1016/j.cub.2005.03.023; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	48	45	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4136	4145		10.1096/fj.07-101907	http://dx.doi.org/10.1096/fj.07-101907			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18697841				2022-12-25	WOS:000261254800013
J	Zhang, SS; Park, CG; Zhang, P; Bartra, SS; Plano, GV; Klena, JD; Skurnik, M; Hinnebusch, BJ; Chen, T				Zhang, Shu-sheng; Park, Chae Gyu; Zhang, Pei; Bartra, Sara Schesser; Plano, Gregory V.; Klena, John D.; Skurnik, Mikael; Hinnebusch, B. Joseph; Chen, Tie			Plasminogen Activator Pla of Yersinia pestis Utilizes Murine DEC-205 (CD205) as a Receptor to Promote Dissemination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PNEUMONIC PLAGUE; DENDRITIC CELL SUBSETS; ANTIGEN GENE-CLUSTER; DC-SIGN CD209; O-ANTIGEN; MYCOBACTERIUM-TUBERCULOSIS; CORE LIPOPOLYSACCHARIDE; NEISSERIA-GONORRHOEAE; NONINTEGRIN CD209; ESCHERICHIA-COLI	Yersinia pestis, a Gram-negative bacterium that causes bubonic and pneumonic plague, is able to rapidly disseminate to other parts of its mammalian hosts. Y. pestis expresses plasminogen activator (PLA) on its surface, which has been suggested to play a role in bacterial dissemination. It has been speculated that Y. pestis hijacks antigen-presenting cells, such as macrophages (M phi s) and dendritic cells, to be delivered to lymph nodes to initiate dissemination and infection. Both alveolar M phi s and pulmonary dendritic cells express a C-type lectin receptor, DEC-205 (CD205), which mediates antigen uptake and presentation. However, no ligand has been identified for DEC-205. In this study, we show that the invasion of alveolar M phi s by Y. pestis depends both in vitro and in vivo on the expression of PLA. DEC-205-expressing M phi s and transfectants, but not their negative counterparts, phagocytosed PLA-expressing Y. pestis and Escherichia coli K12 more efficiently than PLA-negative controls. The interactions between PLA-expressing bacteria and DEC-205-expressing transfectants or alveolar M phi s could be inhibited by an anti-DEC-205 antibody. Importantly, the blockage of the PLA-DEC-205 interaction reduced the dissemination of Y. pestis in mice. In conclusion, murine DEC-205 is a receptor for PLA of Y. pestis, and this host-pathogen interaction appears to play a key role in promoting bacterial dissemination.	[Zhang, Shu-sheng; Zhang, Pei; Chen, Tie] Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61107 USA; [Park, Chae Gyu] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, Lab Cellular Physiol & Immunol, New York, NY 10065 USA; [Bartra, Sara Schesser; Plano, Gregory V.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; [Klena, John D.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Bartra, Sara Schesser] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MN 59840 USA; [Skurnik, Mikael] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Skurnik, Mikael] Univ Helsinki, Cent Hosp Lab Diagnost, FIN-00014 Helsinki, Finland	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Rockefeller University; University of Miami; University of Canterbury; Umea University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Helsinki; University of Helsinki	Chen, T (corresponding author), Univ Illinois, Coll Med Rockford, Dept Biomed Sci, 1601 Parkview Ave, Rockford, IL 61107 USA.	tiechen@uic.edu	Zhang, Shusheng/GRO-2963-2022; Skurnik, Mikael/I-8477-2019	Skurnik, Mikael/0000-0001-8791-9260; Park, Chae Gyu/0000-0003-1906-1308	National Institutes of Health [AI 057158]; University of Illinois, College of Medicine, Rockford; Academy of Finland [114075];  [Northeast Biodefense Center]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, Z01AI000919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois, College of Medicine, Rockford; Academy of Finland(Academy of Finland); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants (USPHS). This work was also supported in part by a grant from the University of Illinois, College of Medicine, Rockford (to T. C.), and work in the Skurnik laboratory was supported by Academy of Finland Grant 114075. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant AI 057158 (Northeast Biodefense Center).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; BRUBAKER RR, 1983, REV INFECT DIS, V5, pS748; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 2001, J BIOL CHEM, V276, P17413, DOI 10.1074/jbc.M010609200; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Hammad H, 2007, ADV IMMUNOL, V93, P265, DOI 10.1016/S0065-2776(06)93007-7; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Isberg RR, 2001, J CELL SCI, V114, P21; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; KARLYSHEV AV, 1992, FEBS LETT, V297, P77, DOI 10.1016/0014-5793(92)80331-A; Kato M, 2006, INT IMMUNOL, V18, P857, DOI 10.1093/intimm/dxl022; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; KLENA JD, 1992, J BACTERIOL, V174, P7297, DOI 10.1128/jb.174.22.7297-7307.1992; KLENA JD, 1993, MOL MICROBIOL, V9, P393, DOI 10.1111/j.1365-2958.1993.tb01700.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ordway D, 2006, J IMMUNOL, V176, P4931, DOI 10.4049/jimmunol.176.8.4931; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Oyston PCF, 2003, J MED MICROBIOL, V52, P289, DOI 10.1099/jmm.0.05044-0; Pack M, 2008, IMMUNOLOGY, V123, P438, DOI 10.1111/j.1365-2567.2007.02710.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; PORTNOY DA, 1985, CURR TOP MICROBIOL, V118, P29; Prior JL, 2001, FEMS MICROBIOL LETT, V197, P229, DOI 10.1111/j.1574-6968.2001.tb10608.x; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SIKKEMA DJ, 1987, INFECT IMMUN, V55, P572, DOI 10.1128/IAI.55.3.572-578.1987; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Zhang P, 2008, INFECT IMMUN, V76, P2070, DOI 10.1128/IAI.01246-07; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184	70	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31511	31521		10.1074/jbc.M804646200	http://dx.doi.org/10.1074/jbc.M804646200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18650418	Green Published, hybrid			2022-12-25	WOS:000260760800030
J	Muller, DW; Bosserhoff, AK				Mueller, D. W.; Bosserhoff, A-K			Integrin beta(3) expression is regulated by let-7a miRNA in malignant melanoma	ONCOGENE			English	Article						microRNA; integrins; post-transcriptional silencing; melanoma progression	GENE-EXPRESSION; MICRORNA; PROGRESSION; ALPHA(V)BETA(3); MELANOCYTES; RAS; MIA	Although integrin beta(3) is known to play an important role in melanoma progression and invasion, regulation of integrin beta(3) expression in melanoma has not been analysed in detail until today. As transcriptional regulation of integrin beta(3) was ruled out by our analysis, we concentrated on the regulation by microRNAs (miRNAs). Comparing primary melanocytes and malignant melanoma cell lines, we found that one candidate miRNA, miR-let-7a, was lost in melanoma and sequence analysis suggested an interaction with the 3'-untranslated region (3'-UTR) of integrin beta(3) mRNA. Transfection of melanoma cells with let-7a pre-miR (TM) molecules resulted in the downregulation of integrin beta(3) mRNA and protein expression. In addition, we cloned the 3'-UTR of the integrin beta(3) mRNA containing the let-7a target sequence into a reporter plasmid and revealed that let-7a negatively regulates reporter gene expression. The repressed expression of integrin beta(3) accompanies with reduced invasive potential of melanoma cells transfected with synthetic let-7a molecules observed in Boyden chamber assays. On the other hand, the induction of integrin beta(3) expression was achieved in melanocytes by transfection with let-7 a anti-miRs, resulting in invasive behavior of transfected melanocytes. In summary, we determined miRNA let-7a to be an important regulator of integrin beta(3) expression and showed that the loss of let-7a expression is involved in development and progression of malignant melanoma.	[Mueller, D. W.; Bosserhoff, A-K] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany	University of Regensburg	Bosserhoff, AK (corresponding author), Univ Regensburg, Inst Pathol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X				ALBELDA SM, 1990, CANCER RES, V50, P6757; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; DANEN EHJ, 1995, INT J CANCER, V61, P491, DOI 10.1002/ijc.2910610411; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jin Y, 1998, BLOOD, V92, P2777, DOI 10.1182/blood.V92.8.2777.420k27_2777_2790; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim VN, 2005, MOL CELLS, V19, P1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li XW, 1998, INVAS METAST, V18, P1, DOI 10.1159/000024494; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; Rothhammer T, 2005, CANCER RES, V65, P448; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Van Belle PA, 1999, HUM PATHOL, V30, P562, DOI 10.1016/S0046-8177(99)90202-2; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883	23	173	184	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6698	6706		10.1038/onc.2008.282	http://dx.doi.org/10.1038/onc.2008.282			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18679415				2022-12-25	WOS:000260638800008
J	Marobbio, CMT; Giannuzzi, G; Paradies, E; Pierri, CL; Palmieri, F				Marobbio, Carlo M. T.; Giannuzzi, Giulia; Paradies, Eleonora; Pierri, Ciro L.; Palmieri, Ferdinando			alpha-isopropylmalate, a leucine biosynthesis intermediate in yeast, is transported by the mitochondrial oxalacetate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL RECONSTITUTION; SUBCELLULAR-LOCALIZATION; OXOGLUTARATE CARRIER; BACTERIAL EXPRESSION; BOVINE MITOCHONDRIA; PHOSPHATE CARRIER; GENE-EXPRESSION; STRUCTURAL ROLE	In Saccharomyces cerevisiae, alpha-isopropylmalate (alpha-IPM), which is produced in mitochondria, must be exported to the cytosol where it is required for leucine biosynthesis. Recombinant and reconstituted mitochondrial oxalacetate carrier (Oac1p) efficiently transported alpha-IPM in addition to its known substrates oxalacetate, sulfate, and malonate and in contrast to other di- and tricarboxylate transporters as well as the previously proposed alpha-IPM transporter. Transport was saturable with a half-saturation constant of 75 +/- 4 mu M for alpha-IPM and 0.31 +/- 0.04 mM for alpha-IPM and was inhibited by the substrates of Oac1p. Though not transported, alpha-ketoisocaproate, the immediate precursor of leucine in the biosynthetic pathway, inhibited Oac1p activity competitively. In contrast, leucine, alpha-ketoisovalerate, valine, and isoleucine neither inhibited nor were transported by Oac1p. Consistent with the function of Oac1p as an alpha-IPM transporter, cells lacking the gene for this carrier required leucine for optimal growth on fermentable carbon sources. Single deletions of other mitochondrial carrier genes or of LEU4, which is the only other enzyme that can provide the cytosol with alpha-IPM (in addition to Oac1p) exhibited no growth defect, whereas the double mutant Delta OAC1 Delta LEU4 did not grow at all on fermentable substrates in the absence of leucine. The lack of growth of Delta OAC1 Delta LEU4 cells was partially restored by adding the leucine biosynthetic cytosolic intermediates alpha-ketoisocaproate and alpha-IPM to these cells as well as by complementing them with one of the two unknown human mitochondrial carriers SLC25A34 and SLC25A35. Oac1p is important for leucine biosynthesis on fermentable carbon sources catalyzing the export of alpha-IPM, probably in exchange for oxalacetate.	[Marobbio, Carlo M. T.; Giannuzzi, Giulia; Paradies, Eleonora; Pierri, Ciro L.; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	MAROBBIO, Carlo/G-5775-2015; Pierri, Ciro Leonardo L/G-4753-2013; Paradies, Eleonora/K-4606-2014	MAROBBIO, Carlo/0000-0002-2516-0321; Pierri, Ciro Leonardo L/0000-0003-1816-548X; Paradies, Eleonora/0000-0002-1668-7148	Ministero dell'Universita e della Ricerca (MUR); Center of Excellence in Genomics (CEGBA); European Commission [LSHM-CT-2004503116]; University local funds	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics (CEGBA); European Commission(European CommissionEuropean Commission Joint Research Centre); University local funds	This work was supported by grants from Ministero dell'Universita e della Ricerca (MUR), the Center of Excellence in Genomics (CEGBA) and Apulia Region, a contract from the European Commission (LSHM-CT-2004503116), and University local funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boer VM, 2005, FEMS YEAST RES, V5, P885, DOI 10.1016/j.femsyr.2005.04.003; Brachmann CB, 1998, YEAST, V14, P115; Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; Casalone E, 2000, YEAST, V16, P539, DOI 10.1002/(SICI)1097-0061(200004)16:6<539::AID-YEA547>3.0.CO;2-K; Catoni E, 2003, FEBS LETT, V534, P87, DOI 10.1016/S0014-5793(02)03782-1; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giangregorio N, 2007, BBA-BIOENERGETICS, V1767, P1331, DOI 10.1016/j.bbabio.2007.08.010; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; Klingenberg M, 2005, BIOCHEMISTRY-US, V44, P8563, DOI 10.1021/bi050543r; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kovaleva Galina Yu., 2006, Journal of Bioinformatics and Computational Biology, V4, P981, DOI 10.1142/S0219720006002284; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Miotto G, 2007, FUNGAL GENET BIOL, V44, P740, DOI 10.1016/j.fgb.2006.12.004; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; RYAN ED, 1973, J BACTERIOL, V116, P222, DOI 10.1128/JB.116.1.222-225.1973; Schroers A, 1997, J BIOL CHEM, V272, P10558; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19	37	56	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28445	28453		10.1074/jbc.M804637200	http://dx.doi.org/10.1074/jbc.M804637200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682385	Green Published, hybrid			2022-12-25	WOS:000259969300046
J	Wegener, KM; Welsh, EA; Thornton, LE; Keren, N; Jacobs, JM; Hixson, KK; Monroe, ME; Camp, DG; Smith, RD; Pakrasi, HB				Wegener, Kimberly M.; Welsh, Eric A.; Thornton, Leeann E.; Keren, Nir; Jacobs, Jon M.; Hixson, Kim K.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.; Pakrasi, Himadri B.			High sensitivity proteomics assisted discovery of a novel operon involved in the assembly of photosystem II, a membrane protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTICR MASS-SPECTROMETRY; PSBQ PROTEIN; FUNCTIONAL-CHARACTERIZATION; OXYGEN EVOLUTION; SIGNAL PEPTIDES; CHLOROPHYLL-A; SYNECHOCYSTIS; ARCHITECTURE; LIPOPROTEIN; PREDICTION	Photosystem II (PSII) is a large membrane protein complex that performs the water oxidation reactions of photosynthesis in cyanobacteria, algae, and plants. The unusual redox reactions in PSII often lead to damage, degradation, and reassembly of this molecular machine. To identify novel assembly factors, high sensitivity proteomic analysis of PSII purified from the cyanobacterium Synechocystis sp. PCC6803 was performed. This analysis identified six PSII-associated proteins that are encoded by an operon containing nine genes, slr0144 to slr0152. This operon encodes proteins that are not essential components of the PSII holocomplex but accumulate to high levels in pre-complexes lacking any of the lumenal proteins PsbP, PsbQ, or PsbV. The operon contains genes with putative binding domains for chlorophylls and bilins, suggesting these proteins may function as a reservoir for cofactors needed during the PSII lifecycle. Genetic deletion of this operon shows that removal of these protein products does not alter photoautotrophic growth or PSII fluorescence properties. However, the deletion does result in decreased PSII-mediated oxygen evolution and an altered distribution of the S states of the catalytic manganese cluster. These data demonstrate that the proteins encoded by the genes in this operon are necessary for optimal function of PSII and function as accessory proteins during assembly of the PSII complex. Thus, we have named the products of the slr0144-slr0152 operon Pap (Photosystem II assembly proteins).	[Wegener, Kimberly M.; Welsh, Eric A.; Thornton, Leeann E.; Keren, Nir; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Jacobs, Jon M.; Hixson, Kim K.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Biol Sci Div & Lab, Richland, WA 99352 USA	Washington University (WUSTL); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, CB 1137, St Louis, MO 63130 USA.	Pakrasi@wustl.edu	Monroe, Matthew/L-1157-2019; Hixson, Kim/AAW-2332-2020; Keren, Nir/GON-9181-2022; Hixson, Kim/AAJ-7714-2020; Smith, Richard D/J-3664-2012	Hixson, Kim/0000-0003-3915-7040; Hixson, Kim/0000-0003-3716-0326; Smith, Richard D/0000-0002-2381-2349; Keren, Nir/0000-0002-7356-8831	National Science Foundation [MCB0745611]; W. R. Wiley Environmental Molecular Sciences Laboratory,; United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory; Direct For Biological Sciences [0745611] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); W. R. Wiley Environmental Molecular Sciences Laboratory,; United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0745611 (to H. B. P.) and by funds from a Membrane Biology EMSL Scientific Grand Challenge project at the W. R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bogdanov B, 2005, MASS SPECTROM REV, V24, P168, DOI 10.1002/mas.20015; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Harkewicz R, 2002, J AM SOC MASS SPECTR, V13, P144, DOI 10.1016/S1044-0305(01)00343-9; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Inoue-Kashino N, 2005, BIOCHEMISTRY-US, V44, P12214, DOI 10.1021/bi047539k; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2007, BBA-BIOENERGETICS, V1767, P1269, DOI 10.1016/j.bbabio.2007.08.008; Kashino Y, 2007, J CHROMATOGR B, V849, P282, DOI 10.1016/j.jchromb.2006.10.067; Kashino Y, 2006, J BIOL CHEM, V281, P20834, DOI 10.1074/jbc.M603188200; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; Keren N, 2005, J BIOL CHEM, V280, P6548, DOI 10.1074/jbc.M410218200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Page JS, 2004, CURR OPIN BIOTECH, V15, P3, DOI 10.1016/j.copbio.2004.01.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Singh AK, 2004, PHYSIOL PLANTARUM, V120, P27, DOI 10.1111/j.0031-9317.2004.0232.x; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; THORNTON LE, 2005, LIGHT DRIVEN WATER P; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	41	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27829	27837		10.1074/jbc.M803918200	http://dx.doi.org/10.1074/jbc.M803918200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693241	hybrid			2022-12-25	WOS:000259719200054
J	dos Santos, CO; Dore, LC; Valentine, E; Shelat, SG; Hardison, RC; Ghosh, M; Wang, W; Eisenstein, RS; Costa, FF; Weiss, MJ				dos Santos, Camila O.; Dore, Louis C.; Valentine, Eric; Shelat, Suresh G.; Hardison, Ross C.; Ghosh, Manik; Wang, Wei; Eisenstein, Richard S.; Costa, Fernando F.; Weiss, Mitchell J.			An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BINDING-PROTEIN; BETA-THALASSEMIA; HIGH-AFFINITY; HAIRPIN LOOP; ERYTHROID-DIFFERENTIATION; TRANSLATIONAL REGULATION; 5'-UNTRANSLATED REGION; 3'-UNTRANSLATED REGION; DEPENDENT REGULATION	Hemoglobin production during erythropoiesis is mechanistically coupled to the acquisition and metabolism of iron. We discovered that iron regulates the expression of alpha-hemoglobin-stabilizing protein (AHSP), a molecular chaperone that binds and stabilizes free alpha-globin during hemoglobin synthesis. In primates, the 3 '-untranslated region (UTR) of AHSP mRNA contains a nucleotide sequence resembling iron responsive elements (IREs), stem-loop structures that regulate gene expression post-transcriptionally by binding iron regulatory proteins (IRPs). The AHSP IRE-like stem-loop deviates from classical consensus sequences and binds IRPs poorly in electrophoretic mobility shift assays. However, in cytoplasmic extracts, AHSP mRNA co-immunoprecipitates with IRPs in a fashion that is dependent on the stem-loop structure and inhibited by iron. Moreover, this interaction enhances AHSP mRNA stability in erythroid and heterologous cells. Our findings demonstrate that IRPs can regulate mRNA expression through non-canonical IREs and extend the repertoire of known iron-regulated genes. In addition, we illustrate a new mechanism through which hemoglobin may be modulated according to iron status.	[dos Santos, Camila O.; Dore, Louis C.; Valentine, Eric; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Shelat, Suresh G.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Ghosh, Manik] NICHD, NIH, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; [Wang, Wei] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; [Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Costa, Fernando F.] Univ Estadual Campinas, Ctr Hemotherapy & Hematol, Sao Paulo, Brazil	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wake Forest University; Wake Forest University School of Medicine; University of Wisconsin System; University of Wisconsin Madison; Universidade Estadual de Campinas	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu	Weiss, Mitchell J/W-9814-2018; Costa, Fernando F/D-1566-2012; Weiss, Mitchell J/A-1245-2013; Hardison, Ross C/G-1142-2010; Dore, Louis/A-5689-2009	Weiss, Mitchell J/0000-0003-2460-3036; Costa, Fernando F/0000-0002-4632-572X; Hardison, Ross C/0000-0003-4084-7516; Dore, Louis/0000-0002-7837-5887	National Institutes of Health [R01 DK61692, R01 HL087427, R01 DK65806, R01 DK66600]; American Heart Association Postdoctoral Fellowship Award [4247620608]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [02/13801-7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692, R01DK065806, R01DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship Award(American Heart Association); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK61692 and R01 HL087427 (to M.J.W.), R01 DK65806 (to R. C. H.), and R01 DK66600 (to R. S. E.). This work was also supported by an American Heart Association Postdoctoral Fellowship Award (Grant 4247620608) (to C.O.S.), by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grant 02/13801-7) (to F. F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; BARTON HA, 1990, J BIOL CHEM, V265, P7000; BENBASSA.I, 1974, BLOOD, V44, P551, DOI 10.1182/blood.V44.4.551.551; Beutler Ernest, 2003, Hematology Am Soc Hematol Educ Program, P40; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Friedlich AL, 2007, MOL PSYCHIATR, V12, P222, DOI 10.1038/sj.mp.4001937; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Huang TS, 1999, INSECT BIOCHEM MOLEC, V29, P1, DOI 10.1016/S0965-1748(98)00097-6; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Jeong JS, 2004, J BIOL CHEM, V279, P45450, DOI 10.1074/jbc.M407562200; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; Kong J, 2003, MOL CELL BIOL, V23, P1125, DOI 10.1128/MCB.23.4.1125-1134.2003; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; Meehan HA, 2001, J BIOL CHEM, V276, P14791, DOI 10.1074/jbc.M010295200; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, P3258, DOI 10.1093/nar/gkh650; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Rodgers ND, 2002, RNA, V8, P1526, DOI 10.1017/S1355838202029035; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; ROUAULT T, 1985, J BIOL CHEM, V260, P4862; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sanchez M, 2007, NAT PROTOC, V2, P2033, DOI 10.1038/nprot.2007.293; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schlegl J, 1997, RNA, V3, P1159; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; SEISER C, 1995, J BIOL CHEM, V270, P29400, DOI 10.1074/jbc.270.49.29400; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Solano-Gonzalez E, 2007, FEBS LETT, V581, P2919, DOI 10.1016/j.febslet.2007.05.056; Tahara T, 2004, BIOCHEM BIOPH RES CO, V324, P77, DOI 10.1016/j.bbrc.2004.09.022; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; YIP YK, 1972, J BIOL CHEM, V247, P7237; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	69	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26956	26964		10.1074/jbc.M802421200	http://dx.doi.org/10.1074/jbc.M802421200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676996	Green Published, hybrid			2022-12-25	WOS:000259586600016
J	Leung, AWC; Varanyuwatana, P; Halestrap, AP				Leung, Anna W. C.; Varanyuwatana, Pinadda; Halestrap, Andrew P.			The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; DEPENDENT ANION CHANNEL; RAT-HEART MITOCHONDRIA; CELL-DEATH; OXIDATIVE STRESS; INORGANIC-PHOSPHATE; ADP/ATP CARRIER; MATRIX VOLUME; UBIQUINONE ANALOGS; REPERFUSION INJURY	The mitochondrial permeability transition pore (MPTP) plays a key role in cell death, yet its molecular identity remains uncertain. Although knock-out studies have confirmed critical roles for both cyclophilin-D (CyP-D) and the adenine nucleotide translocase (ANT), given a strong enough stimulus MPTP opening can occur in the absence of either. Here we provide evidence that the mitochondrial phosphate carrier (PiC) may also be a critical component of the MPTP. Phenylarsine oxide (PAO) was found to activate MPTP opening in the presence of carboxyatractyloside (CAT) that prevents ANT binding to immobilized PAO. Only four proteins from solubilized CAT-treated beef heart inner mitochondrial membranes bound to immobilized PAO, one of which was the PiC. GST-CyP-D pull-down and co-immunoprecipitation studies revealed CsA-sensitive binding of PiC to CyP-D; this increased following diamide treatment. Co-immunoprecipitation of the ANT with the PiC was also observed but was insensitive to CsA treatment. N-ethylmaleimide and ubiquinone analogues (UQ(0) and Ro 68-3400) inhibited phosphate transport into rat liver mitochondria with the same concentration dependence as their inhibition of MPTP opening. UQ(0) and Ro 68-3400 also induced the "m" conformation of the ANT, as does NEM, and reduced the binding of both the PiC and ANT to the PAO column. We propose a model for the MPTP in which a calcium-triggered conformational change of the PiC, facilitated by CyP-D, induces pore opening. An interaction of the PiC with the ANT may enable agents that bind to either transporter to modulate pore opening.	[Halestrap, Andrew P.] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ Bristol, Bristol Heart Inst, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Halestrap, AP (corresponding author), Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England.	a.halestrap@bristol.ac.uk	Halestrap, Andrew P/G-7275-2011	Halestrap, Andrew/0000-0001-5374-2778	British Heart Foundation [FS/04/043];  [RG/03/002]	British Heart Foundation(British Heart Foundation); 	This work was supported in part by a Research Studentship (FS/04/043) from the British Heart Foundation (to A. W. C. L.) and Programme Grant support (RG/03/002). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; AQUILA H, 1982, EUR J BIOCHEM, V122, P141, DOI 10.1111/j.1432-1033.1982.tb05859.x; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Brustovetsky N, 2002, BIOCHEMISTRY-US, V41, P11804, DOI 10.1021/bi0200110; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Clarke SJ, 2008, CIRC RES, V102, P1082, DOI 10.1161/CIRCRESAHA.107.167072; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; DOUSSIERE J, 1984, BIOCHIM BIOPHYS ACTA, V766, P492, DOI 10.1016/0005-2728(84)90265-2; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; GUERIN B, 1990, J BIOL CHEM, V265, P19736; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Halestrap AP, 2004, NATURE, V430, DOI 10.1038/nature02816; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HALESTRAP AP, 1987, BIOCHEM J, V244, P159, DOI 10.1042/bj2440159; HALESTRAP AP, 1986, BIOCHEM J, V239, P559, DOI 10.1042/bj2390559; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; HUGHES WA, 1981, BIOCHEM J, V196, P459, DOI 10.1042/bj1960459; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; KLINGENBERG M, 1971, FEBS LETT, V16, P253, DOI 10.1016/0014-5793(71)80363-0; KLINGENBERG M, 2008, BIOCH BIOPH IN PRESS; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kramer R, 1998, EXP PHYSIOL, V83, P259, DOI 10.1113/expphysiol.1998.sp004111; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LEQUOC K, 1988, ARCH BIOCHEM BIOPHYS, V265, P249, DOI 10.1016/0003-9861(88)90125-7; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PEYROULA EP, 2003, NATURE, V426, P39; Phelps A, 2004, BIOCHEMISTRY-US, V43, P6200, DOI 10.1021/bi036148n; ROJO M, 1994, BBA-BIOENERGETICS, V1187, P360, DOI 10.1016/0005-2728(94)90010-8; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Smith VR, 2003, BIOCHEM J, V376, P757, DOI 10.1042/BJ20030942; STONER CD, 1973, J CELL BIOL, V56, P65, DOI 10.1083/jcb.56.1.65; Tafani M, 2001, CANCER RES, V61, P2459; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287	63	251	260	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26312	26323		10.1074/jbc.M805235200	http://dx.doi.org/10.1074/jbc.M805235200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667415	Green Published, hybrid			2022-12-25	WOS:000259341600004
J	Dong, ZF; Han, HL; Cao, J; Zhang, X; Xu, L				Dong, ZhiFang; Han, HuiLi; Cao, Jun; Zhang, Xia; Xu, Lin			Coincident Activity of Converging Pathways Enables Simultaneous Long-Term Potentiation and Long-Term Depression in Hippocampal CA1 Network In Vivo	PLOS ONE			English	Article								Memory is believed to depend on activity-dependent changes in the strength of synapses, e. g. long-term potentiation (LTP) and long-term depression (LTD), which can be determined by the sequence of coincident pre- and postsynaptic activity, respectively. It remains unclear, however, whether and how coincident activity of converging efferent pathways can enable LTP and LTD in the pathways simultaneously. Here, we report that, in pentobarbital-anesthetized rats, stimulation (600 pulses, 5 Hz) to Schaffer preceding to commissural pathway within a 40-ms timing window induced similar magnitudes of LTP in both pathways onto synapses of CA1 neurons, with varied LTP magnitudes after reversal of the stimulation sequence. In contrast, in urethane-anesthetized or freely-moving rats, the stimulation to Schaffer preceding to commissural pathway induced Schaffer LTP and commissural LTD simultaneously within a 40-ms timing window, without affecting synaptic efficacy in the reversed stimulation sequence. Coincident activity of Schaffer pathways confirmed the above findings under pentobarbital and urethane anesthesia. Thus, coincident activity of converging afferent pathways tends to switch the pathways to be LTP only or LTP/LTD depending on the activity states of the hippocampus. This network rule strengthens the view that activity-dependent synaptic plasticity may well contribute to memory process of the hippocampal network with flexibility or stability from one state to another.	[Dong, ZhiFang; Han, HuiLi; Cao, Jun; Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Peoples R China; [Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res, Ottawa, ON, Canada; [Xu, Lin] Cent S Univ, Second Xiangya Hosp, Mental Hlth Inst, Changsha, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; University of Ottawa; Central South University	Dong, ZF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Peoples R China.	Xia.Zhang@rohcg.on.ca; lxu@vip.163.com	Dong, Zhifang/Q-2467-2019; Xu, Lin/T-5531-2017	Xu, Lin/0000-0002-2710-3507	National Natural Science Foundation; Basic Research Program (973) of Ministry of Science and Technology; Chinese Academy of Sciences; National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA [Independent Investigator Award]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Basic Research Program (973) of Ministry of Science and Technology(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA(NARSAD)	This work was supported by grants from the National Natural Science Foundation, the Basic Research Program (973) of Ministry of Science and Technology and Chinese Academy of Sciences (to L.X. and J.C.). X.Z. is the recipient of Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cao J, 2004, NEUROSCI RES, V49, P229, DOI 10.1016/j.neures.2004.03.001; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dong ZF, 2006, HIPPOCAMPUS, V16, P1017, DOI 10.1002/hipo.20234; Dong ZF, 2006, HIPPOCAMPUS, V16, P809, DOI 10.1002/hipo.20216; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FOX SE, 1986, EXP BRAIN RES, V62, P495; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; KAIBARA T, 1993, J NEUROSCI, V13, P2391, DOI 10.1523/JNEUROSCI.13-06-02391.1993; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Wei HM, 2002, NEUROSCI LETT, V324, P181, DOI 10.1016/S0304-3940(02)00183-0; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	30	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2848	10.1371/journal.pone.0002848	http://dx.doi.org/10.1371/journal.pone.0002848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682723	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600004
J	Ofek, G; Revell, CM; Hu, JC; Allison, DD; Grande-Allen, KJ; Athanasiou, KA				Ofek, Gidon; Revell, Christopher M.; Hu, Jerry C.; Allison, David D.; Grande-Allen, K. Jane; Athanasiou, Kyriacos A.			Matrix Development in Self-Assembly of Articular Cartilage	PLOS ONE			English	Article								Background: Articular cartilage is a highly functional tissue which covers the ends of long bones and serves to ensure proper joint movement. A tissue engineering approach that recapitulates the developmental characteristics of articular cartilage can be used to examine the maturation and degeneration of cartilage and produce fully functional neotissue replacements for diseased tissue. Methodology/Principal Findings: This study examined the development of articular cartilage neotissue within a self-assembling process in two phases. In the first phase, articular cartilage constructs were examined at 1, 4, 7, 10, 14, 28, 42, and 56 days immunohistochemically, histologically, and through biochemical analysis for total collagen and glycosaminoglycan (GAG) content. Based on statistical changes in GAG and collagen levels, four time points from the first phase (7, 14, 28, and 56 days) were chosen to carry into the second phase, where the constructs were studied in terms of their mechanical characteristics, relative amounts of collagen types II and VI, and specific GAG types (chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, and hyaluronan). Collagen type VI was present in initial abundance and then localized to a pericellular distribution at 4 wks. N-cadherin activity also spiked at early stages of neotissue development, suggesting that self-assembly is mediated through a minimization of free energy. The percentage of collagen type II to total collagen significantly increased over time, while the proportion of collagen type VI to total collagen decreased between 1 and 2 wks. The chondroitin 6-to 4-sulfate ratio decreased steadily during construct maturation. In addition, the compressive properties reached a plateau and tensile characteristics peaked at 4 wks. Conclusions/Significance: The indices of cartilage formation examined in this study suggest that tissue maturation in self-assembled articular cartilage mirrors known developmental processes for native tissue. In terms of tissue engineering, it is suggested that exogenous stimulation may be necessary after 4 wks to further augment the functionality of developing constructs.	[Ofek, Gidon; Revell, Christopher M.; Hu, Jerry C.; Allison, David D.; Grande-Allen, K. Jane; Athanasiou, Kyriacos A.] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University	Athanasiou, KA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX USA.	athanasiou@rice.edu	Grande-Allen, Kathryn/P-4042-2014; Hu, Jerry/E-7385-2013	Grande-Allen, Kathryn/0000-0003-1533-3767; Hu, Jerry/0000-0003-0651-1461	NIH NIAMS [R0l AR053286]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053286] Funding Source: NIH RePORTER	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH NIAMS R0l AR053286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2005, ACTA BIOMATER, V1, P317, DOI 10.1016/j.actbio.2005.02.001; Alexopoulos LG, 2005, J BIOMECH, V38, P509, DOI 10.1016/j.jbiomech.2004.04.012; Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047; Archer CW, 1996, J ANAT, V189, P23; *ARTHR, 2007, DIS CTR OST; Asanbaeva A., 2007, BIOMECH MODEL MECHAN; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; BAYLISS MT, 1978, BIOCHEM J, V176, P683, DOI 10.1042/bj1760683; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bland YS, 1996, ANAT EMBRYOL, V194, P607; Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; DIMICCO MA, 2007, OSTEOARTHRITIS CARTI; ELDER BD, 2007, J ORTHOP RES; Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fraser SA, 2006, TISSUE ENG, V12, P569, DOI 10.1089/ten.2006.12.569; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; Grande-Allen KJ, 2003, J AM COLL CARDIOL, V42, P271, DOI 10.1016/S0735-1097(03)00626-0; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Haider MA, 2006, BIOMECH MODEL MECHAN, V5, P160, DOI 10.1007/s10237-006-0026-1; Hashimoto K, 2006, INFLAMM RES, V55, P72, DOI 10.1007/s00011-005-0012-6; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Hing WA, 2002, OSTEOARTHR CARTILAGE, V10, P297, DOI 10.1053/joca.2002.0517; Hu J. C., 2003, HDB HISTOLOGY METHOD; Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; KEMPSON GE, 1976, BIOCHIM BIOPHYS ACTA, V428, P741, DOI 10.1016/0304-4165(76)90205-1; KEMPSON GE, 1982, ANN RHEUM DIS, V41, P508, DOI 10.1136/ard.41.5.508; Knight MM, 1998, BBA-MOL CELL RES, V1405, P67, DOI 10.1016/S0167-4889(98)00102-5; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Lewis S, 1999, ANN RHEUM DIS, V58, P441, DOI 10.1136/ard.58.7.441; Morrison EH, 1996, J ANAT, V189, P9; Mow Van C., 1997, P113; MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Oshin AO, 2007, VET COMP ORTHOPAED, V20, P151, DOI 10.1160/VCOT-07-02-0018; Pacifici M, 2000, CONNECT TISSUE RES, V41, P175, DOI 10.3109/03008200009005288; Pavasant P, 1996, MATRIX BIOL, V15, P423, DOI 10.1016/S0945-053X(96)90161-4; Pietila K, 1999, CELLS TISSUES ORGANS, V164, P30, DOI 10.1159/000016640; Platt D, 1998, EQUINE VET J, V30, P43, DOI 10.1111/j.2042-3306.1998.tb04087.x; POOLE CA, 1988, J CELL SCI, V90, P635; POOLE CA, 1992, J CELL SCI, V103, P1101; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Pullig O, 1999, OSTEOARTHR CARTILAGE, V7, P191, DOI 10.1053/joca.1998.0208; QUARTO R, 1993, DEVELOPMENT, V117, P245; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SHAPIRO IM, 1991, AM J CLIN NUTR, V54, pS1209, DOI 10.1093/ajcn/54.6.1209s; Shelton JC, 2003, CELLS TISSUES ORGANS, V175, P140, DOI 10.1159/000074630; Sherwin AF, 1999, HISTOCHEM J, V31, P623, DOI 10.1023/A:1003811310619; SORRELL JM, 1989, DEVELOPMENT, V106, P657; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; YOUN I, 2006, OSTEOARTHRITIS CARTI	64	110	115	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2795	10.1371/journal.pone.0002795	http://dx.doi.org/10.1371/journal.pone.0002795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665220	Green Published, gold			2022-12-25	WOS:000264304300014
J	Walsh, CT; Radeff-Huang, J; Matteo, R; Hsiao, A; Subramaniam, S; Stupack, D; Brown, JH				Walsh, Colin T.; Radeff-Huang, Julie; Matteo, Rosalia; Hsiao, Albert; Subramaniam, Shankar; Stupack, Dwayne; Brown, Joan Heller			Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61	FASEB JOURNAL			English	Article						G-protein; S1P receptor; PAR1; matricellular protein; glioblastoma	IMMEDIATE-EARLY GENE; TISSUE GROWTH-FACTOR; PRO-ANGIOGENIC ACTIVITIES; BREAST-CANCER; EXTRACELLULAR-MATRIX; BINDING-SITE; FAMILY GTPASES; DNA-SYNTHESIS; CCN1 CYR61; C-JUN	A subset of G-protein coupled receptors (GPCRs), including the thrombin receptor (PAR1), elicits mitogenic responses. Thrombin also activates Ras homolog gene family member A (RhoA) and activating protein (AP-1) -mediated gene expression in 1321N1 astrocytoma cells, whereas the nonmitogenic agonist carbachol does not. Transcriptomic analysis was used to explore differential gene induction by these agonists and revealed that the matricellular protein cysteine-rich 61 (Cyr61/CCN1) is selectively induced by thrombin. The ability of GPCR agonists to induce Cyr61 parallels their ability to activate RhoA; agonist-stimulated Cyr61 expression is inhibited by C3 toxin. When Cyr61 is down-regulated using short interfering RNA (siRNA) or short-hairpin RNA (shRNA), thrombin-induced DNA synthesis is significantly attenuated. When Cyr61 expression is induced, it appears in the extracellular compartment and on the cell surface. Extracellular Cyr61 interacts with alpha(5), alpha(6), and beta(1) integrins on these cells, and monoclonal antibodies directed against alpha(5) and beta(1) integrins inhibit thrombin-induced DNA synthesis. Functional blockade of Cyr61 with soluble heparin or anti-Cyr61 antibodies also inhibits thrombin-induced DNA synthesis. Thus Cyr61 is a highly inducible, secreted extracellular factor through which GPCR and RhoA signaling pathways engage integrins that contribute to GPCR-mediated proliferation.-Walsh, C. T., Radeff-Huang, J., Matteo, R., Hsiao, A., Subramaniam, S., Stupack, D., and Brown, J. H. Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61. FASEB J. 22, 4011-4021 (2008)	[Walsh, Colin T.; Radeff-Huang, Julie; Matteo, Rosalia; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hsiao, Albert; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Stupack, Dwayne] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Stupack, Dwayne] Univ Calif San Diego, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr-0636, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu		Hsiao, Albert/0000-0002-9412-1369	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036927] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA218859] Funding Source: Medline; NIGMS NIH HHS [R01 GM036927] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; LATINKIC BV, 1991, NUCLEIC ACIDS RES, V19, P3261, DOI 10.1093/nar/19.12.3261; Lau LF, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P61, DOI 10.1142/9781860946899_0003; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Liang YB, 2003, J BIOL CHEM, V278, P27267, DOI 10.1074/jbc.M301009200; Lin BR, 2007, MOL CANCER RES, V5, P1111, DOI 10.1158/1541-7786.MCR-06-0289; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Pendurthi UR, 2002, ARTERIOSCL THROM VAS, V22, P1421, DOI 10.1161/01.ATV.0000030200.59331.3F; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Post GR, 1996, MOL BIOL CELL, V7, P1679, DOI 10.1091/mbc.7.11.1679; QUI RG, 1995, NATURE, V374, P457; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Schober JM, 2003, J BIOL CHEM, V278, P25808, DOI 10.1074/jbc.M301534200; Schwartz MA, 1996, EMBO J, V15, P6525, DOI 10.1002/j.1460-2075.1996.tb01043.x; Seasholtz TM, 2004, MOL INTERV, V4, P348, DOI 10.1124/mi.4.6.8; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004	77	37	37	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					4011	4021		10.1096/fj.08-113266	http://dx.doi.org/10.1096/fj.08-113266			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18687805	Green Published			2022-12-25	WOS:000260503000029
J	Galdiero, S; Falanga, A; Vitiello, M; Raiola, L; Fattorusso, R; Browne, H; Pedone, C; Isernia, C; Galdiero, M				Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Raiola, Luca; Fattorusso, Roberto; Browne, Helena; Pedone, Carlo; Isernia, Carla; Galdiero, Massimiliano			Analysis of a Membrane Interacting Region of Herpes Simplex Virus Type 1 Glycoprotein H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PEPTIDE; ALPHA-HELIX; CELL-FUSION; TRANSMEMBRANE ORIENTATION; PHOSPHOLIPID-MEMBRANES; FUSOGENIC DOMAINS; CRYSTAL-STRUCTURE; CYTOPLASMIC TAIL; HEPARAN-SULFATE; HEPTAD-REPEAT	Glycoprotein H (gH) of herpes simplex virus type I (HSV-1) is involved in the complex mechanism of membrane fusion of the viral envelope with the host cell. Membrane interacting regions and potential fusion peptides have been identified in HSV-1 gH as well as glycoprotein B (gB). Because of the complex fusion mechanism of HSV-1, which requires four viral glycoproteins, and because there are only structural data for gB and glycoprotein D, many questions regarding the mechanism by which HSV-1 fuses its envelope with the host cell membrane remain unresolved. Previous studies have shown that peptides derived from certain regions of gH have the potential to interact with membranes, and based on these findings we have generated a set of peptides containing mutations in one of these domains, gH-(626-644), to investigate further the functional role of this region. Using a combination of biochemical, spectroscopic, and nuclear magnetic resonance techniques, we showed that the alpha-helical nature of this stretch of amino acids in gH is important for membrane interaction and that the aromatic residues, tryptophan and tyrosine, are critical for induction of fusion.	[Galdiero, Stefania; Pedone, Carlo; Galdiero, Massimiliano] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, I-80134 Naples, Italy; [Galdiero, Stefania; Falanga, Annarita; Pedone, Carlo] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, I-80134 Naples, Italy; [Vitiello, Mariateresa; Galdiero, Massimiliano] Univ Naples Federico II, Dept Expt Med 2, I-80138 Naples, Italy; [Galdiero, Stefania] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Browne, Helena] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QPZ, England; [Raiola, Luca; Fattorusso, Roberto; Isernia, Carla] Univ Naples Federico II, Dept Environm Sci 2, I-81100 Caserta, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Cambridge; University of Naples Federico II	Galdiero, M (corresponding author), Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, Via Mezzocannone 16, I-80134 Naples, Italy.	massimiliano.galdiero@unina2.it	Galdiero, Stefania/M-3225-2019; Isernia, Carla/ABD-8156-2021; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Falanga, Anna/0000-0001-6906-9020; Galdiero, Massimiliano/0000-0002-1576-6290; Isernia, Carla/0000-0002-1504-2479; FALANGA, Annarita/0000-0001-6538-8585; Fattorusso, Roberto/0000-0002-3539-5343				Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Buzon V, 2005, BIOCHEMISTRY-US, V44, P13354, DOI 10.1021/bi050382r; Cairns TM, 2005, VIROLOGY, V332, P550, DOI 10.1016/j.virol.2004.12.006; Cairns TM, 2003, J VIROL, V77, P6731, DOI 10.1128/JVI.77.12.6731-6742.2003; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Delahunty MD, 1996, VIROLOGY, V218, P94, DOI 10.1006/viro.1996.0169; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Fusco D, 2005, P NATL ACAD SCI USA, V102, P9323, DOI 10.1073/pnas.0503907102; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Galdiero M, 1997, J VIROL, V71, P2163, DOI 10.1128/JVI.71.3.2163-2170.1997; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; Hammond K, 2002, BIOCHEMISTRY-US, V41, P3243, DOI 10.1021/bi011163i; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harman A, 2002, J VIROL, V76, P10708, DOI 10.1128/JVI.76.21.10708-10716.2002; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KILLIAN JA, 1994, FEBS LETT, V348, P161, DOI 10.1016/0014-5793(94)00594-X; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P9482, DOI 10.1021/bi00154a022; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Silburn KA, 1998, AIDS RES HUM RETROV, V14, P385, DOI 10.1089/aid.1998.14.385; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; STANKOWSKI S, 1990, BIOCHIM BIOPHYS ACTA, V1025, P164, DOI 10.1016/0005-2736(90)90094-5; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	73	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29993	30009		10.1074/jbc.M803092200	http://dx.doi.org/10.1074/jbc.M803092200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18678872	hybrid, Green Published			2022-12-25	WOS:000260366900044
J	Armand, AS; Bourajjaj, M; Martinez-Martinez, S; el Azzouzi, H; Martins, PAD; Hatzis, P; Seidler, T; Redondo, JM; De Windt, LJ				Armand, Anne-Sophie; Bourajjaj, Meriem; Martinez-Martinez, Sara; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; Seidler, Tim; Miguel Redondo, Juan; De Windt, Leon J.			Cooperative Synergy between NFAT and MyoD Regulates Myogenin Expression and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; DEFICIENT MICE; HEART-FAILURE; CALCINEURIN; GENE; MOUSE; MEF2; SELECTION; POLARITY	Calcineurin/NFAT signaling is involved in multiple aspects of skeletal muscle development and disease. The myogenic basic helix-loop-helix transcription factors, MyoD, myogenin, Myf5, and MRF4 specify the myogenic lineage. Here we show that calcineurin/NFAT (nuclear factor of activated T cells) signaling is required for primary myogenesis by transcriptional cooperation with the basic helix-loop-helix transcription factor MyoD. Calcineurin/NFAT signaling is involved in myogenin expression in differentiating myoblasts, where the myogenic regulatory factor MyoD synergistically cooperates with NFATc2/c3 at the myogenin promoter. Using gel shift and chromatin immunoprecipitation assays, we identified two conserved NFAT binding sites in the myogenin promoter that were occupied by NFATc3 upon skeletal muscle differentiation. The transcriptional integration between NFATc3 and MyoD is crucial for primary myogenesis in vivo, as myogenin expression is weak in myod:nfatc3 double null embryos, whereas myogenin expression is unaffected in embryos with null mutations for either factor alone. Thus, the combined findings provide a novel transcriptional paradigm for the first steps of myogenesis, where a calcineurin/NFATc3 pathway regulates myogenin induction in cooperation with MyoD during myogenesis.	[Bourajjaj, Meriem; da Costa Martins, Paula A.; De Windt, Leon J.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CM Utrecht, Netherlands; [Armand, Anne-Sophie; Bourajjaj, Meriem; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; De Windt, Leon J.] Royal Netherlands Acad Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Armand, Anne-Sophie; Bourajjaj, Meriem; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; De Windt, Leon J.] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3584 CT Utrecht, Netherlands; [Martinez-Martinez, Sara; Miguel Redondo, Juan] Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, Madrid 28029, Spain; [Seidler, Tim] Univ Gottingen, Dept Cardiol, D-37075 Gottingen, Germany	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Gottingen	De Windt, LJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Yalelaan 50, NL-3584 CM Utrecht, Netherlands.	L.J.deWindt@umcutrecht.nl	Redondo, Juan Miguel/H-6351-2015; Seidler, Tim/B-3929-2014; de Windt, Leon/AAO-6395-2020; Seidler, Tim/ABH-8333-2020	Redondo, Juan Miguel/0000-0001-5779-9122; de Windt, Leon/0000-0002-7793-2856; Seidler, Tim/0000-0002-6158-5087; el Azzouzi, Hamid/0000-0003-1242-9691; Armand, Anne-Sophie/0000-0002-0291-6421	Netherlands Organization for Health Research and Development [912-04-054, 912-04-017]; VIDI Award [917-863-72]; Netherlands Heart Foundation Program [NHS2007B167]; European Union [LSHM-CT-2005-018833]; EUGeneHeart	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); VIDI Award; Netherlands Heart Foundation Program(Netherlands Heart Foundation); European Union(European Commission); EUGeneHeart	This work was supported by Netherlands Organization for Health Research and Development Grants 912-04-054 and 912-04-017 and VIDI Award 917-863-72, Netherlands Heart Foundation Program Grant NHS2007B167, and European Union Contract LSHM-CT-2005-018833/EUGeneHeart (to L. J. D. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Gajewski K, 2003, P NATL ACAD SCI USA, V100, P1040, DOI 10.1073/pnas.0337662100; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Johnson J, 2001, DEV BIOL, V229, P176, DOI 10.1006/dbio.2000.9969; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roelen BAJ, 2002, MECH DEVELOP, V119, P81, DOI 10.1016/S0925-4773(02)00329-5; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323	35	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29004	29010		10.1074/jbc.M801297200	http://dx.doi.org/10.1074/jbc.M801297200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18676376	Green Published, hybrid			2022-12-25	WOS:000260179900026
J	Xu, J; Liu, Y; Zhang, GY				Xu, Jie; Liu, Yong; Zhang, Guang-Yi			Neuroprotection of GluR5-containing Kainate Receptor Activation against Ischemic Brain Injury through Decreasing Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptors Mediated by Src Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; SYNAPTIC-TRANSMISSION; GLUR6-DEFICIENT MICE; RAT HIPPOCAMPUS; NMDA RECEPTORS; SUBUNITS; GLUR5; INTERNEURONS; INHIBITION; INCREASES	Previous studies indicate that cerebral ischemia breaks the dynamic balance between excitatory and inhibitory inputs. The neural excitotoxicity induced by ionotropic glutamate receptors gain the upper hand during ischemia-reperfusion. In this paper, we investigate whether GluR5 (glutamate receptor 5)-containing kainate receptor activation could lead to a neuroprotective effect against ischemic brain injury and the related mechanism. The results showed that (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a selective GluR5 agonist, could suppress Src tyrosine phosphorylation and interactions among N-methyl-D-aspartate (NMDA) receptor subunit 2A (NR2A), postsynaptic density protein 95 (PSD-95), and Src and then decrease NMDA receptor activation through attenuating tyrosine phosphorylation of NR2A and NR2B. More importantly, ATPA had a neuroprotective effect against ischemia reperfusion induced neuronal cell death in vivo. However, four separate drugs were found to abolish the effects of ATPA. These were selective GluR5 antagonist NS3763; GluR5 antisense oligodeoxynucleotides; CdCl2, a broad spectrum blocker of voltage-gated calcium channels; and bicuculline, an antagonist of gamma-aminobutyric acid A (GABA(A)) receptor. GABA(A) receptor agonist muscimol could attenuate Src activation and interactions among NR2A, PSD-95 and Src, resulting the suppression of NMDA receptor tyrosine phosphorylation. Moreover, patch clamp recording proved that the activated GABAA receptor could inhibit NMDA receptor-mediated whole-cell currents. Taken together, the results suggest that during ischemia-reperfusion, activated GluR5 may facilitate Ca2+-dependent GABA release from interneurons. The released GABA can activate postsynaptic GABAA receptors, which then attenuates NMDA Src. The final result of this process is that the pyramidal neurons are rescued from hyperexcitability.	[Xu, Jie; Liu, Yong; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Peoples R China	Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, 84 W Huai Hai Rd, Xuzhou 221002, Peoples R China.	gyzhang@xzmc.edu.cn	, lyong74/AEV-2086-2022	LIU, Yong/0000-0003-4079-2156	National Natural Science Foundation of China [90608015]; Natural Science foundation of Jiangsu Province, China [BK2007546]; President Special Grant of Xuzhou Medical College [07KJZ08]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [06KJB180116, 07KJA18030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); President Special Grant of Xuzhou Medical College; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by Great Research Project of the National Natural Science Foundation of China Grant 90608015, Natural Science foundation of Jiangsu Province, China, Grant BK2007546, and the President Special Grant of Xuzhou Medical College 07KJZ08 and Natural Science Foundation of the Jiangsu Higher Education Institutions of China Grants 06KJB180116 and 07KJA18030. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; BAHN S, 1994, J NEUROSCI, V14, P5525; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Bureau I, 1999, J NEUROSCI, V19, P653; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hou XY, 2003, NEUROSCI LETT, V343, P125, DOI 10.1016/S0304-3940(03)00365-3; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Jiang Q, 2000, BRAIN RES, V857, P71, DOI 10.1016/S0006-8993(99)02364-1; Khalilov I, 2002, J NEUROPHYSIOL, V88, P523, DOI 10.1152/jn.2002.88.1.523; Laube B, 1998, J NEUROSCI, V18, P2954; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYDEN PD, 1992, STROKE, V23, P1463, DOI 10.1161/01.STR.23.10.1463; LYDEN PD, 1994, STROKE, V25, P189, DOI 10.1161/01.STR.25.1.189; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; OJA SS, 1990, NEUROCHEM RES, V15, P797, DOI 10.1007/BF00968557; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Pei L, 2000, ACTA PHARMACOL SIN, V21, P695; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHUAIB A, 1993, EXP NEUROL, V123, P284, DOI 10.1006/exnr.1993.1160; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Takagi N, 1997, J NEUROCHEM, V69, P1060; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	42	36	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29355	29366		10.1074/jbc.M800393200	http://dx.doi.org/10.1074/jbc.M800393200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18678878	Green Published, hybrid			2022-12-25	WOS:000260179900062
J	de Agostini, AI; Dong, JC; Arrighi, CD; Ramus, MA; Dentand-Quadri, I; Thalmann, S; Ventura, P; Ibecheole, V; Monge, F; Fischer, AM; HajMohammadi, S; Shworak, NW; Zhang, LJ; Zhang, Z; Linhardt, RJ				de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria; Monge, Felicia; Fischer, Anne-Marie; HajMohammadi, Sassan; Shworak, Nicholas W.; Zhang, Lijuan; Zhang, Zhenqing; Linhardt, Robert J.			Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; ENDOTHELIAL-CELLS; ANTITHROMBIN-BINDING; THROMBIN GENERATION; OVARIAN-FOLLICLES; GRANULOSA-CELLS; RAT OVARY; PROTEOGLYCANS; EXPRESSION; MODULATION	Anticoagulant heparan sulfate proteoglycans bind and activate antithrombin by virtue of a specific 3-O-sulfated pentasaccharide. They not only occur in the vascular wall but also in extravascular tissues, such as the ovary, where their functions remain unknown. The rupture of the ovarian follicle at ovulation is one of the most striking examples of tissue remodeling in adult mammals. It involves tightly controlled inflammation, proteolysis, and fibrin deposition. We hypothesized that ovarian heparan sulfates may modulate these processes through interactions with effector proteins. Our previous work has shown that anticoagulant heparan sulfates are synthesized by rodent ovarian granulosa cells, and we now have set out to characterize heparan sulfates from human follicular fluid. Here we report the first anticoagulant heparan sulfate purified from a natural human extravascular source. Heparan sulfate chains were fractionated according to their affinity for antithrombin, and their structure was analyzed by H-1 NMR and MS/MS. We find that human follicular fluid is a rich source of anticoagulant heparan sulfate, comprising 50.4% of total heparan sulfate. These antithrombin-binding chains contain more than 6% 3-O-sulfated glucosamine residues, convey an anticoagulant activity of 2.5 IU/ml to human follicular fluid, and have an anti-Factor Xa specific activity of 167 IU/mg. The heparan sulfate chains that do not bind antithrombin surprisingly exhibit an extremely high content in 3-O-sulfated glucosamine residues, which suggest that they may exhibit biological activities through interactions with other proteins.	[de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria] Univ Hosp Geneva, Dept Obstet & Gynaecol, Geneva 14, Switzerland; [de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria] Univ Geneva, Geneva 14, Switzerland; [Monge, Felicia; Fischer, Anne-Marie] Univ Paris 05, Fac Med, F-75014 Paris, France; [Monge, Felicia; Fischer, Anne-Marie] INSERM, U765, F-75006 Paris, France; [Monge, Felicia; Fischer, Anne-Marie] Hop Europeen Georges Pompidou, Serv Hematol Biol, AP HP, F-75015 Paris, France; [HajMohammadi, Sassan; Shworak, Nicholas W.] Dartmouth Med Sch, Dept Med, Cardiol Sect, Hanover, NH 03756 USA; [Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA	University of Geneva; University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Dartmouth College; Washington University (WUSTL); Rensselaer Polytechnic Institute	de Agostini, AI (corresponding author), Fdn Rech Med, CH-1205 Geneva, Switzerland.	Ariane.Deagostini@medecine.unige.ch	Shworak, Nicholas/AAJ-6770-2020	Shworak, Nicholas/0000-0001-7783-4634	National Institutes of Health [GM38060]; Swiss National Foundation [3200B0-102148/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38060 (to R. J. L.). This work was also supported by Swiss National Foundation Grant 3200B0-102148/1 (to A. d. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494; Bungay SD, 2006, B MATH BIOL, V68, P2283, DOI 10.1007/s11538-006-9115-7; Carrell R, 1997, THROMB HAEMOSTASIS, V78, P516; Daniels RJ, 2001, HUM MOL GENET, V10, P339, DOI 10.1093/hmg/10.4.339; de Agostini AI, 2006, SWISS MED WKLY, V136, P583; DEAGOSTINI AI, 1994, J CELL BIOCHEM, V54, P174, DOI 10.1002/jcb.240540206; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; ENGLAND BG, 1974, J CLIN ENDOCR METAB, V38, P42, DOI 10.1210/jcem-38-1-42; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Eriksen GV, 1997, FERTIL STERIL, V68, P791, DOI 10.1016/S0015-0282(97)00326-9; Gentry PA, 2000, FERTIL STERIL, V73, P848, DOI 10.1016/S0015-0282(99)00635-4; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Gong F, 2003, J BIOL CHEM, V278, P35152, DOI 10.1074/jbc.M300925200; Haimov-Kochman R, 2005, BIOL REPROD, V73, P20, DOI 10.1095/biolreprod.104.036780; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Hasan S, 2002, BIOL REPROD, V66, P144, DOI 10.1095/biolreprod66.1.144; Hosseini G, 1996, J BIOL CHEM, V271, P22090, DOI 10.1074/jbc.271.36.22090; KAMAT BR, 1995, AM J PATHOL, V146, P157; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; Lawrence R, 2007, MATRIX BIOL, V26, P442, DOI 10.1016/j.matbio.2007.03.002; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; McArthur ME, 2000, BIOL REPROD, V63, P913, DOI 10.1095/biolreprod63.3.913; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Princivalle M, 2001, GLYCOBIOLOGY, V11, P183, DOI 10.1093/glycob/11.3.183; Roach LE, 2002, BIOL REPROD, V66, P1350, DOI 10.1095/biolreprod66.5.1350; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Shimada H, 2001, BIOL REPROD, V64, P1739, DOI 10.1095/biolreprod64.6.1739; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10365, DOI 10.1073/pnas.97.19.10365; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; Therien I, 2005, MOL REPROD DEV, V71, P97, DOI 10.1002/mrd.20287; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Yabe T, 2001, BIOCHEM J, V359, P235, DOI 10.1042/0264-6021:3590235; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zhang LJ, 1999, J BIOL CHEM, V274, P5681, DOI 10.1074/jbc.274.9.5681	41	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28115	28124		10.1074/jbc.M805338200	http://dx.doi.org/10.1074/jbc.M805338200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669628	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000259969300014
J	Galm, U; Wang, LY; Wendt-Pienkowski, E; Yang, RY; Liu, W; Tao, MF; Coughlin, JM; Shen, B				Galm, Ute; Wang, Liyan; Wendt-Pienkowski, Evelyn; Yang, Runying; Liu, Wen; Tao, Meifeng; Coughlin, Jane M.; Shen, Ben			In vivo manipulation of the bleomycin biosynthetic gene cluster in Streptomyces verticillus ATCC15003 revealing new insights into its biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR DRUG BLEOMYCIN; DNA STRAND SCISSION; HETEROLOGOUS EXPRESSION; ESCHERICHIA-COLI; HYBRID PEPTIDE; CONJUGAL TRANSFER; GROUP ANTIBIOTICS; PRODUCER; CLONING; TALLYSOMYCIN	Bleomycin (BLM), an important clinically used antitumor compound, and its analogs are challenging to prepare by chemical synthesis. Genetic engineering of the biosynthetic pathway in the producer strain would provide an efficient and convenient method of generating new derivatives of this complex molecule in vivo. However, the BLM producing Streptomyces verticillus ATCC15003 has been refractory to all means of introducing plasmid DNA into its cells for nearly two decades. Several years after cloning and identification of the bleomycin biosynthetic gene cluster, this study demonstrates, for the first time, genetic accessibility of this pharmaceutically relevant producer strain by intergeneric Escherichia coli-Streptomyces conjugation. Gene replacement and in-frame deletion mutants were created by lambda RED-mediated PCR targeting mutagenesis, and the secondary metabolite profile of the resultant mutants confirmed the identity of the BLM biosynthetic gene cluster and established its boundaries. Ultimately, the in-frame blmD deletion mutant strain S. verticillus SB5 resulted in the production of a bleomycin intermediate. The structure of this compound, decarbamoyl-BLM, was elucidated, and its DNA cleavage activity was compared with the parent compounds.	[Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Yang, Runying; Shen, Ben] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu			National Institutes of Health [CA94426]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94426. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BOGER DL, 1995, J AM CHEM SOC, V117, P7344, DOI 10.1021/ja00133a008; Burke J, 2001, P NATL ACAD SCI USA, V98, P6289, DOI 10.1073/pnas.101589398; Calafat AM, 1997, J AM CHEM SOC, V119, P3656, DOI 10.1021/ja963392b; CALCUTT MJ, 1994, GENE, V151, P17, DOI 10.1016/0378-1119(94)90627-0; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LC, 2003, BIOCHEMISTRY-US, V42, P9731, DOI 10.1021/bi034817r; Du LC, 1999, CHEM BIOL, V6, P507, DOI 10.1016/S1074-5521(99)80083-0; Du LC, 2000, FEMS MICROBIOL LETT, V189, P171, DOI 10.1016/S0378-1097(00)00274-3; EHRENFELD GM, 1987, BIOCHEMISTRY-US, V26, P931, DOI 10.1021/bi00377a038; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Galm U, 2005, CHEM REV, V105, P739, DOI 10.1021/cr030117g; Galm U, 2006, EXPERT OPIN DRUG DIS, V1, P409, DOI 10.1517/17460441.1.5.409; Goodwin KD, 2008, P NATL ACAD SCI USA, V105, P5052, DOI 10.1073/pnas.0708143105; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Katano K, 1998, J AM CHEM SOC, V120, P11285, DOI 10.1021/ja9819458; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; Mutka SC, 2006, BIOCHEMISTRY-US, V45, P1321, DOI 10.1021/bi052075r; NAGANAWA H, 1977, J ANTIBIOT, V30, P388, DOI 10.7164/antibiotics.30.388; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Shen B, 2001, J IND MICROBIOL BIOT, V27, P378, DOI 10.1038/sj.jim.7000194; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; Shen B, 1999, BIOORG CHEM, V27, P155, DOI 10.1006/bioo.1998.1131; Slick B. I., 1985, BLEOMYCIN CHEMOTHERA; SUGIYAMA H, 1985, J NAT PROD, V48, P869, DOI 10.1021/np50042a001; SUGIYAMA H, 1986, J AM CHEM SOC, V108, P3852, DOI 10.1021/ja00273a063; Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361; TAKITA T, 1978, J ANTIBIOT, V31, P801, DOI 10.7164/antibiotics.31.801; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; Wang LY, 2007, J NAT PROD, V70, P402, DOI 10.1021/np060592k; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; Wenzel SC, 2005, CURR OPIN BIOTECH, V16, P594, DOI 10.1016/j.copbio.2005.10.001; YAMAMOTO H, 1986, J ANTIBIOT, V39, P1304, DOI 10.7164/antibiotics.39.1304	42	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28236	28245		10.1074/jbc.M804971200	http://dx.doi.org/10.1074/jbc.M804971200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697737	Green Published, hybrid			2022-12-25	WOS:000259969300025
J	Syson, K; Tomlinson, C; Chapados, BR; Sayers, JR; Tainer, JA; Williams, NH; Grasby, JA				Syson, Karl; Tomlinson, Christopher; Chapados, Brian R.; Sayers, Jon R.; Tainer, John A.; Williams, Nicholas H.; Grasby, Jane A.			Three metal ions participate in the reaction catalyzed by T5 flap endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; T4 RNASE-H; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; BINDING-SITES; RESTRICTION ENDONUCLEASES; BACILLUS-CEREUS; PHOSPHOLIPASE-C; ACTIVE-SITE	Protein nucleases and RNA enzymes depend on divalent metal ions to catalyze the rapid hydrolysis of phosphate diester linkages of nucleic acids during DNA replication, DNA repair, RNA processing, and RNA degradation. These enzymes are widely proposed to catalyze phosphate diester hydrolysis using a "two-metal-ion mechanism." Yet, analyses of flap endonuclease (FEN) family members, which occur in all domains of life and act in DNA replication and repair, exemplify controversies regarding the classical two-metal-ion mechanism for phosphate diester hydrolysis. Whereas substrate-free structures of FENs identify two active site metal ions, their typical separation of >4 A appears incompatible with this mechanism. To clarify the roles played by FEN metal ions, we report here a detailed evaluation of the magnesium ion response of T5FEN. Kinetic investigations reveal that overall the T5FEN-catalyzed reaction requires at least three magnesium ions, implying that an additional metal ion is bound. The presence of at least two ions bound with differing affinity is required to catalyze phosphate diester hydrolysis. Analysis of the inhibition of reactions by calcium ions is consistent with a requirement for two viable cofactors (Mg2+ or Mn2+). The apparent substrate association constant is maximized by binding two magnesium ions. This may reflect a metal-dependent unpairing of duplex substrate required to position the scissile phosphate in contact with metal ion(s). The combined results suggest that T5FEN primarily uses a two-metal-ion mechanism for chemical catalysis, but that its overall metallobiochemistry is more complex and requires three ions.	[Syson, Karl; Tomlinson, Christopher; Williams, Nicholas H.; Grasby, Jane A.] Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; [Sayers, Jon R.] Univ Sheffield, Sch Med & Biomed Sci, Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Chapados, Brian R.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Sheffield; University of Sheffield; Scripps Research Institute	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk	Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020; Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443; Tainer, John/0000-0003-1659-2429; Williams, Nicholas/0000-0002-4457-4220	National Institutes of Health [CA081967]; SBDR [P01 CA92584]; BBSRC [B20079, F0147321]; BBSRC [BB/F014732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [B20079, BB/F014732/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA081967, P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBDR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA081967 (to J. A. T.) and SBDR Program Grant P01 CA92584 (to J. A. T.). This work was also supported by BBSRC Grants B20079 and F0147321 (to J. A. G. and N. H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amyes TL, 2005, J AM CHEM SOC, V127, P15708, DOI 10.1021/ja055493s; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bhagwat M, 1997, J BIOL CHEM, V272, P28531, DOI 10.1074/jbc.272.45.28531; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Gangisetty O, 2005, J BIOL CHEM, V280, P12876, DOI 10.1074/jbc.M414025200; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; GUTFREUND F, 1995, KINETICS LIFE SCI; HAN H, 1991, BIOCHEMISTRY-US, V30, P11104, DOI 10.1021/bi00110a012; HANSEN S, 1993, J MOL BIOL, V234, P179, DOI 10.1006/jmbi.1993.1572; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pickering TJ, 1999, J BIOL CHEM, V274, P17711, DOI 10.1074/jbc.274.25.17711; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SAYERS JR, 1990, J BIOL CHEM, V265, P18311; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s	41	38	38	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28741	28746		10.1074/jbc.M801264200	http://dx.doi.org/10.1074/jbc.M801264200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697748	hybrid, Green Published			2022-12-25	WOS:000259969300076
J	Wang, Y; Boudreaux, DM; Estrada, DF; Egan, CW; Jeor, SC; De Guzman, RN				Wang, Yu; Boudreaux, Daniel M.; Estrada, D. Fernando; Egan, Chet W.; St Jeor, Stephen C.; De Guzman, Roberto N.			NMR structure of the N-terminal coiled coil domain of the Andes hantavirus nucleocapsid protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS CORE PARTICLES; PULMONARY SYNDROME; TULA HANTAVIRUS; UNITED-STATES; OUTBREAK; DISEASE; OLIGOMERIZATION; SPECTROSCOPY; RECOGNITION; ASSOCIATION	The hantaviruses are emerging infectious viruses that in humans can cause a cardiopulmonary syndrome or a hemorrhagic fever with renal syndrome. The nucleocapsid (N) is the most abundant viral protein, and during viral assembly, the N protein forms trimers and packages the viral RNA genome. Here, we report the NMR structure of the N-terminal domain (residues 1-74, called N1-74) of the Andes hantavirus N protein. N1-74 forms two long helices (alpha(1) and alpha(2)) that intertwine into a coiled coil domain. The conserved hydrophobic residues at the helix alpha(1)-alpha(2) interface stabilize the coiled coil; however, there are many conserved surface residues whose function is not known. Site-directed mutagenesis, CD spectroscopy, and immunocytochemistry reveal that a point mutation in the conserved basic surface formed by Arg(22) or Lys(26) lead to antibody recognition based on the subcellular localization of the N protein. Thus, Arg(22) and Lys(26) are likely involved in a conformational change or molecular recognition when the N protein is trafficked from the cytoplasm to the Golgi, the site of viral assembly and maturation.	[Wang, Yu; Estrada, D. Fernando; Egan, Chet W.; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Boudreaux, Daniel M.; St Jeor, Stephen C.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA	University of Kansas; Nevada System of Higher Education (NSHE); University of Nevada Reno	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	wang, yu/A-3473-2011; Pacific-Southwest, RCE/B-6155-2009		National Institutes of Health [AI057160, AI65359]; American Heart Association [0755724Z]; National Science Foundation Program [EF 0326999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057160 and AI65359. This work was also supported by American Heart Association Grant 0755724Z ( to R. N. D.); National Science Foundation Program Grant EF 0326999 ( to S.C.S.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; CASE DA, 2002, AMBER7; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deyde VM, 2005, VIROLOGY, V331, P307, DOI 10.1016/j.virol.2004.11.003; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Geldmacher A, 2005, VACCINE, V23, P3973, DOI 10.1016/j.vaccine.2005.02.025; Geldmacher A, 2004, VIROLOGY, V323, P108, DOI 10.1016/j.virol.2004.02.022; Gott P, 1997, VIRUS GENES, V14, P31, DOI 10.1023/A:1007983306341; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HJELLE B, 1994, J VIROL, V68, P592, DOI 10.1128/JVI.68.2.592-596.1994; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Kaukinen P, 2004, J VIROL, V78, P13669, DOI 10.1128/JVI.78.24.13669-13677.2004; Kaukinen P, 2003, J VIROL, V77, P10910, DOI 10.1128/JVI.77.20.10910-10916.2003; Kaukinen P, 2003, VIRUS RES, V92, P37, DOI 10.1016/S0168-1702(02)00312-X; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Khaiboullina SF, 2005, J MED VIROL, V75, P267, DOI 10.1002/jmv.20266; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; Koster F., 1993, Morbidity and Mortality Weekly Report, V42, P421; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; Li XD, 2002, J GEN VIROL, V83, P759, DOI 10.1099/0022-1317-83-4-759; Lundkvist A, 2002, VIRAL IMMUNOL, V15, P177, DOI 10.1089/088282402317340323; Maeda A, 2003, VIROLOGY, V305, P288, DOI 10.1006/viro.2002.1767; Maes P, 2006, INTERVIROLOGY, V49, P253, DOI 10.1159/000093454; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; PENSIERO MN, 1992, J VIROL, V66, P5929, DOI 10.1128/JVI.66.10.5929-5936.1992; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ravkov EV, 1998, J VIROL, V72, P2865, DOI 10.1128/JVI.72.4.2865-2870.1998; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Spiropoulou CF, 2001, CURR TOP MICROBIOL, V256, P33; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yoshimatsu K, 2003, J VIROL, V77, P943, DOI 10.1128/JVI.77.2.943-952.2003; ZAKI SR, 1995, AM J PATHOL, V146, P552; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	56	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28297	28304		10.1074/jbc.M804869200	http://dx.doi.org/10.1074/jbc.M804869200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687679	Green Published, hybrid			2022-12-25	WOS:000259969300031
J	Krauss, M; Jia, JY; Roux, A; Beck, R; Wieland, FT; De Camilli, P; Haucke, V				Krauss, Michael; Jia, Jun-Yong; Roux, Aurelien; Beck, Rainer; Wieland, Felix T.; De Camilli, Pietro; Haucke, Volker			Arf1-GTP-induced tubule formation suggests a function of Arf family proteins in curvature acquisition at sites of vesicle budding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-1; MEMBRANE CURVATURE; PLASMA-MEMBRANE; TRANSPORT; GOLGI; DYNAMIN; BAR; AMPHIPHYSIN; MECHANISMS; MULTIPLE	ADP-ribosylation factor (Arf) and related small GTPases play crucial roles in membrane traffic within the exo- and endocytic pathways. Arf proteins in their GTP-bound state are associated with curved membrane buds and tubules, frequently together with effector coat proteins to which they bind. Here we report that Arf1 is found on membrane tubules originating from the Golgi complex where it colocalizes with COPI and GGA1 vesicle coat proteins. Arf1 also induces tubulation of liposomes in vitro. Mutations within the amino-terminal amphipathic helix (NTH) of Arf1 affect the number of Arf1-positive tubules in vivo and its property to tubulate liposomes. Moreover, hydrophilic substitutions within the hydrophobic part of its NTH impair Arf1-catalyzed budding of COPI vesicles in vitro. Our data indicate that GTP-controlled local induction of high curvature membranes is an important property of Arf1 that might be shared by a subgroup of Arf/Arl family GTPases.	[Krauss, Michael; Jia, Jun-Yong; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Roux, Aurelien; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Roux, Aurelien] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Beck, Rainer; Wieland, Felix T.] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	Free University of Berlin; Yale University; Howard Hughes Medical Institute; Yale University; Ruprecht Karls University Heidelberg	Haucke, V (corresponding author), Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	v.haucke@biochemie.fu-berlin.de	Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Roux, Aurelien R/0000-0002-6088-0711; Haucke, Volker/0000-0003-3119-6993; Krauss, Michael/0000-0003-1010-9723; Beck, Rainer/0000-0001-9304-2733	German Research Funding Agency DFG [HA2686/4-1, SFB 740/TP C6, SFB 638/TP A10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251] Funding Source: NIH RePORTER	German Research Funding Agency DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by German Research Funding Agency DFG Grants HA2686/4-1, SFB 740/TP C6 (to V. H.), and SFB 638/TP A10 (to F. T. W.) and European Molecular Biology Organization (EMBO) YIP Programme (to V. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Polishchuk RS, 2006, TRAFFIC, V7, P1092, DOI 10.1111/j.1600-0854.2006.00453.x; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sun Z, 2007, TRAFFIC, V8, P582, DOI 10.1111/j.1600-0854.2007.00554.x; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221	29	80	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27717	27723		10.1074/jbc.M804528200	http://dx.doi.org/10.1074/jbc.M804528200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693248	hybrid, Green Published			2022-12-25	WOS:000259719200043
J	Sun, JM; Pedersen, M; Ronnstrand, L				Sun, Jianmin; Pedersen, Malin; Ronnstrand, Lars			Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-kit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; PI 3-KINASE; ADAPTER PROTEINS; CELL-SURVIVAL; ISOFORMS; TRANSDUCTION; ACTIVATION; EXPRESSION; ROLES; PHOSPHORYLATION	The stem cell factor receptor/c-Kit plays an important physiological role in hematopoiesis, melanogenesis, and gametogenesis. It has also been implicated in numerous human malignancies. Signal transduction pathways shown to be of importance for c-Kit-mediated transformation include the phosphoinositide 3-kinase (PI3K)/Akt pathway. We have previously shown that two alternative splice forms of c-Kit, denoted GNNK(-) and GNNK(+), mediate distinctively different signals. In this study, we found that in the hematopoietic cell line Ba/F3, GNNK(-) c-Kit mediates a substantially stronger activation of PI3K/Akt than GNNK(-) c-Kit. This difference in signaling was shown to be dependent on the association of the scaffolding protein Gab2 with c-Kit, and Src-mediated phosphorylation of Gab2 was shown to be to be independent of the direct association of PI3K with c-Kit. Furthermore, proliferation and survival of Ba/F3 cells expressing a mutant of c-Kit that fails to bind to PI3K directly were slightly decreased compared with wild-type c-Kit-expressing cells. Using small interfering RNA technology, we further verified a role of Gab2 in inducing activation of PI3K/ Akt downstream of c-Kit. To summarize, we show that PI3K activation by c-Kit is both splice form-dependent and cell type-specific. Furthermore, activation of PI3K by c-Kit is dependent both on the direct PI3K-binding site in c-Kit and on the phosphorylation of Gab2. The fact that c-Kit has been found mutated in numerous human malignancies, including acute myeloid leukemia, and that Gab2 is often overexpressed in acute myeloid leukemia suggests a potential role of Gab2-mediated PI3K activation in transformation.	[Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Sun, Jianmin/AAX-5094-2021; Ronnstrand, Lars/A-2429-2011	Sun, Jianmin/0000-0003-2327-4285; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society(Royal Society of London)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Gunnar Nilsson Cancer Foundation, the Alfred Osterlund Foundation, the Malmo University Hospital Foundation, the Malmo University Hospital Cancer Foundation, and the Royal Physiographical Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Caruana G, 1998, ONCOGENE, V16, P179, DOI 10.1038/sj.onc.1201494; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; CROSIER PS, 1993, BLOOD, V82, P1151; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; Karlsson R, 2003, J LEUKOCYTE BIOL, V74, P923, DOI 10.1189/jlb.0403142; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Nguyen MHH, 2001, J BIOL CHEM, V276, P32704, DOI 10.1074/jbc.M103100200; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; PIAO XH, 1994, BLOOD, V83, P476; REITH AD, 1991, EMBO J, V10, P2451, DOI 10.1002/j.1460-2075.1991.tb07784.x; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SERVE H, 1994, J BIOL CHEM, V269, P6026; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Young SM, 2007, CELL SIGNAL, V19, P2572, DOI 10.1016/j.cellsig.2007.08.004; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	29	42	43	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27444	27451		10.1074/jbc.M709703200	http://dx.doi.org/10.1074/jbc.M709703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697750	Green Submitted, hybrid			2022-12-25	WOS:000259719200014
J	Chai, SC; Wang, WL; Ye, QZ				Chai, Sergio C.; Wang, Wen-Long; Ye, Qi-Zhuang			Fe(II) is the native cofactor for Escherichia coli methionine aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOFORM-SELECTIVE INHIBITION; PEPTIDE DEFORMYLASE; SACCHAROMYCES-CEREVISIAE; RECOMBINANT PROLIDASE; SUBSTRATE-SPECIFICITY; STRUCTURAL-ANALYSIS; OUTER-MEMBRANE; DRUG DISCOVERY; CELL-GROWTH; PROTEINS	Divalent metal ions play a critical role in the removal of N-terminal methionine from nascent proteins by methionine aminopeptidase (MetAP). Being an essential enzyme for bacteria, MetAP is an appealing target for the development of novel antibacterial drugs. Although purified enzyme can be activated by several divalent metal ions, the exact metal ion used by MetAP in cells is unknown. Many MetAP inhibitors are highly potent on purified enzyme, but they fail to show significant inhibition of bacterial growth. One possibility for the failure is a disparity of the metal used in activation of purified MetAP and the metal actually used by MetAP inside bacterial cells. Therefore, the challenge is to elucidate the physiologically relevant metal for MetAP and discover MetAP inhibitors that can effectively inhibit cellular MetAP. We have recently discovered MetAP inhibitors with selectivity toward different metalloforms of Escherichia coli MetAP, and with these unique inhibitors, we characterized their inhibition of MetAP enzyme activity in a cellular environment. We observed that only inhibitors that are selective for the Fe(II)-form of MetAP were potent in this assay. Further, we found that only these Fe(II)-form selective inhibitors showed significant inhibition of growth of five E. coli strains and two Bacillus strains. We confirmed their cellular target as MetAP by analysis of N-terminal processed and unprocessed recombinant glutathione S-transferase proteins. Therefore, we conclude that Fe(II) is the likely metal used by MetAP in E. coli and other bacterial cells.	[Chai, Sergio C.; Wang, Wen-Long; Ye, Qi-Zhuang] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Ye, QZ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	yeq@iupui.edu	Ye, Qizhuang/B-3147-2009	Chai, Sergio/0000-0002-8257-8599	National Institutes of Health [AI065898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065898, R01AI065898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part by National Institutes of Health Grant AI065898 (to Q.-Z.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; BRASS JM, 1981, J BACTERIOL, V146, P10, DOI 10.1128/JB.146.1.10-17.1981; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Copik AJ, 2003, BIOCHEMISTRY-US, V42, P6283, DOI 10.1021/bi027327s; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; D'souza VM, 1999, BIOCHEMISTRY-US, V38, P11079, DOI 10.1021/bi990872h; D'souza VM, 2002, BIOCHEMISTRY-US, V41, P13096, DOI 10.1021/bi020395u; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Douangamath A, 2004, J MED CHEM, V47, P1325, DOI 10.1021/jm034188j; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Golich FC, 2006, PROTEIN EXPRES PURIF, V47, P634, DOI 10.1016/j.pep.2005.11.012; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Hanzlik RP, 1976, INORGANIC ASPECTS BI; HOOPER NM, 1992, HYPERTENSION, V19, P281, DOI 10.1161/01.HYP.19.3.281; Huang M, 2006, BIOCHEM BIOPH RES CO, V339, P506, DOI 10.1016/j.bbrc.2005.11.042; Huang M, 2007, J MED CHEM, V50, P5735, DOI 10.1021/jm700930k; Huang QQ, 2005, BIOORG MED CHEM LETT, V15, P5386, DOI 10.1016/j.bmcl.2005.09.019; IRVIN RT, 1981, J BACTERIOL, V145, P1397, DOI 10.1128/JB.145.3.1397-1403.1981; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; LATHE R, 1980, P NATL ACAD SCI-BIOL, V77, P3548, DOI 10.1073/pnas.77.6.3548; Leopoldini M, 2007, J AM CHEM SOC, V129, P7776, DOI 10.1021/ja068168t; Li JY, 2003, BIOCHEM BIOPH RES CO, V307, P172, DOI 10.1016/S0006-291X(03)01144-6; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu LF, 1997, BIOCHEM J, V327, P593, DOI 10.1042/bj3270593; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Lowther WT, 1999, BIOCHEMISTRY-US, V38, P14810, DOI 10.1021/bi991711g; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; Lowther WT, 1999, BIOCHEMISTRY-US, V38, P7678, DOI 10.1021/bi990684r; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Luo QL, 2003, J MED CHEM, V46, P2631, DOI 10.1021/jm0300532; Lupi A, 2006, FEBS J, V273, P5466, DOI 10.1111/j.1742-4658.2006.05538.x; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MEINNEL T, 1995, J MOL BIOL, V254, P175, DOI 10.1006/jmbi.1995.0609; MILLER CG, 1989, J BACTERIOL, V171, P5215, DOI 10.1128/jb.171.9.5215-5217.1989; Molinaro G, 2005, BIOCHEM J, V385, P389, DOI 10.1042/BJ20040849; National Committee for Clinical Laboratory Standards, 2000, M7A4 NAT COMM CLIN L; NORMARK S, 1969, J BACTERIOL, V97, P1334, DOI 10.1128/JB.97.3.1334-1342.1969; Oefner C, 2003, J MOL BIOL, V332, P13, DOI 10.1016/S0022-2836(03)00862-3; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Schiffmann R, 2005, ANGEW CHEM INT EDIT, V44, P3620, DOI 10.1002/anie.200500592; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Towbin H, 2003, J BIOL CHEM, V278, P52964, DOI 10.1074/jbc.M309039200; Vaughan MD, 2002, CURR MED CHEM, V9, P385, DOI 10.2174/0929867023371102; Walker KW, 1998, PROTEIN SCI, V7, P2684, DOI 10.1002/pro.5560071224; Wang JY, 2003, BIOCHEMISTRY-US, V42, P5035, DOI 10.1021/bi020670c; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Xie SX, 2006, ACTA CRYSTALLOGR D, V62, P425, DOI 10.1107/S0907444906003878; Yang SI, 2008, FEBS J, V275, P271, DOI 10.1111/j.1742-4658.2007.06197.x; Ye OZ, 2004, J AM CHEM SOC, V126, P13940, DOI 10.1021/ja045864; Ye QZ, 2006, P NATL ACAD SCI USA, V103, P9470, DOI 10.1073/pnas.0602433103; Yocum CF, 1999, CURR OPIN CHEM BIOL, V3, P182, DOI 10.1016/S1367-5931(99)80031-3; You CH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-57; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; ZORZOPULOS J, 1989, FEMS MICROBIOL LETT, V61, P23	65	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26879	26885		10.1074/jbc.M804345200	http://dx.doi.org/10.1074/jbc.M804345200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669631	Green Published, hybrid			2022-12-25	WOS:000259586600007
J	Ofosu, FA; Dewar, L; Craven, SJ; Song, YQ; Cedrone, A; Freedman, J; Fenton, JW				Ofosu, Frederick A.; Dewar, Lori; Craven, Sharon J.; Song, Yingqi; Cedrone, Aisha; Freedman, John; Fenton, John W., II			Coordinate activation of human platelet protease-activated receptor-1 and-4 in response to subnanomolar alpha-thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPIRIN RESISTANCE; ANTIPLATELET THERAPY; DIABETIC-PATIENTS; CLEAVED PEPTIDE; GLUCOSE-LEVELS; N-TERMINUS; IN-VIVO; HEMOSTASIS; BINDING; CLONING	We previously demonstrated that human platelets activated with SFLLRN release PAR-1 activation peptide, PAR-1-(1-41), even in the presence of hirudin. This observation suggests that during their activation, platelets generate a protease that activates PAR-1. In this study, PAR-1 and -4 activation peptides were detected 10 s after <= 1.0 nM alpha-thrombin, 10 mu M SFLLRN, or 100 mu M AYPGKF were added to platelets. When SFLLRN or AYGPKF were added to platelets, generation of PAR-1 and -4 activation peptides was complete at 10 s. Generation of both PAR-1 and -4 activation peptides in response to 1 nM alpha-thrombin was significantly inhibited by affinity-purified anti-PAR-1(35-62) IgY, anti-PAR-4-(34-54) IgY, and by the specific PAR-1 antagonist BMS 200261, but not by the PAR-4 antagonist YD3. Effective inhibition of platelet aggregation in response to 1.0 nM alpha-thrombin occurred only in the presence of both anti-PAR span antibodies. We conclude that platelet activation initiated with <= 1.0 nM alpha-thrombin proceeds via simultaneous PAR-1 and -4 activation. Inhibiting the activation of either PAR inhibits activation of the other. Both PAR-1 and -4 activation must be inhibited to prevent platelet activation subsequent to thrombin binding to platelets. The more efficient generation of PAR activation peptides by platelets activated with SFLLRN or AYGPKF, compared with alpha-thrombin, indicates that a platelet-derived serine protease that is inactivated by soybean trypsin inhibitor propagates PAR-1 and -4 activation.	[Ofosu, Frederick A.; Dewar, Lori; Craven, Sharon J.] Canadian Blood Serv, Hamilton, ON, Canada; [Ofosu, Frederick A.; Song, Yingqi; Cedrone, Aisha] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Freedman, John] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Fenton, John W., II] Albany Coll Pharm, Pharmaceut Res Inst, Rensselaer, NY 12144 USA	Canadian Blood Services; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Albany College of Pharmacy & Health Sciences	Ofosu, FA (corresponding author), 1200 Main St W,HSC 3N26, Hamilton, ON L8N 3Z5, Canada.	ofosuf@mcmaster.ca			Heart and Stroke Foundation of Ontario; Canadian Blood Services, Research and Development	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Blood Services, Research and Development	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of Ontario and operational support funds from the Canadian Blood Services, Research and Development. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn HS, 1997, MOL PHARMACOL, V51, P350, DOI 10.1124/mol.51.2.350; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; BRASS LF, 1992, J BIOL CHEM, V267, P13795; CHUNG I, 2008, ANN MED, V11, P1; Cohen HW, 2008, J DIABETES COMPLICAT, V22, P224, DOI 10.1016/j.jdiacomp.2007.05.002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Day JRS, 2004, CIRCULATION, V110, P2597, DOI 10.1161/01.CIR.0000138027.80056.31; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Furman MI, 2000, THROMB HAEMOSTASIS, V84, P897, DOI 10.1055/s-0037-1614134; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; GouinThibault I, 1996, BRIT J HAEMATOL, V95, P738, DOI 10.1046/j.1365-2141.1996.d01-1963.x; Guthikonda S, 2008, THROMB HAEMOSTASIS, V100, P83, DOI 10.1160/TH07-10-0590; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Liu LB, 1997, J BIOL CHEM, V272, P1997, DOI 10.1074/jbc.272.3.1997; LIU LB, 1994, BRIT J HAEMATOL, V88, P592, DOI 10.1111/j.1365-2141.1994.tb05078.x; LONGENECKER GL, 1985, PLATELETS PHYSL PHAR; Ludwig S, 2005, DIABETES RES CLIN PR, V70, P110, DOI 10.1016/j.diabres.2005.03.025; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ofosu FA, 1996, BRIT J HAEMATOL, V94, P407, DOI 10.1046/j.1365-2141.1996.d01-1793.x; Ofosu FA, 1998, BIOCHEM J, V336, P283, DOI 10.1042/bj3360283; Poullis M, 2000, J THORAC CARDIOV SUR, V120, P370, DOI 10.1067/mtc.2000.108531; Ramachandran R, 1997, THROMB HAEMOSTASIS, V78, P1119; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Shantsila E, 2008, THROMB HAEMOSTASIS, V100, P7, DOI 10.1160/TH08-06-0342; Sudic D, 2006, BRIT J HAEMATOL, V133, P315, DOI 10.1111/j.1365-2141.2006.06012.x; THOMAS AP, 1991, CELLULAR CALCIUM PRA, P33; Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Wu CC, 2002, THROMB HAEMOSTASIS, V87, P1026, DOI 10.1055/s-0037-1613128; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	43	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26886	26893		10.1074/jbc.M802237200	http://dx.doi.org/10.1074/jbc.M802237200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682394	hybrid			2022-12-25	WOS:000259586600008
J	Soragni, E; Kassavetis, GA				Soragni, Elisabetta; Kassavetis, George A.			Absolute gene occupancies by RNA polymerase III, TFIIIB, and TFIIIC in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR TFIIIB; TRANSCRIPTION COMPLEXES; IN-VITRO; YEAST; MAF1; PROMOTER; REPRESSION; PROTEIN; MACHINERY; DEPHOSPHORYLATION	A major limitation of chromatin immunoprecipitation lies in the challenge of measuring the immunoprecipitation effectiveness of different proteins and antibodies and the resultant inability to compare the occupancies of different DNA-binding proteins. Here we present the implementation of a quantitative chromatin immunoprecipitation assay in the RNA polymerase III (pol III) system that allowed us to measure the absolute in vivo occupancy of pol III and its two transcription factors, TFIIIC and TFIIIB, on a subset of pol III genes. The crucial point of our analysis was devising a method that allows the accurate determination of the immunoprecipitation efficiency for each protein. We achieved this by spiking every immunoprecipitation reaction with the formaldehyde cross-linked in vitro counterparts of TFIIIB-, TFIIIC-, and pol III-DNA complexes, measuring the in vitro occupancies of the corresponding factors on a DNA probe and determining probe recovery by quantitative PCR. Analysis of nine pol III-transcribed genes with diverse sequence characteristics showed a very high occupancy by TFIIIB and pol III ( pol III occupancy being generally similar to 70% of TFIIIB occupancy) and a TFIIIC occupancy that ranged between similar to 5 and 25%. Current data suggest that TFIIIC is released during transcription in vitro, and it has been proposed that TFIIIB suffices for pol III recruitment in vivo. Our findings point to the transient nature of the TFIIIC- DNA interaction in vivo, with no significant counter-correlation between pol III and TFIIIC occupancy and instead to a dependence of TFIIIB- DNA and TFIIIC- DNA complex maintenance in vivo on pol III function.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Soragni, E (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB-27, La Jolla, CA 92037 USA.	soragni@scripps.edu; gak@biomail.ucsd.edu			National Institutes of Health [GM018386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018386, R37GM018386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM018386. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrau JC, 2001, EUR J BIOCHEM, V268, P5167, DOI 10.1046/j.0014-2956.2001.02445.x; BAKER RE, 1986, J BIOL CHEM, V261, P5275; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARFORD JP, 1976, EXP CELL RES, V102, P276, DOI 10.1016/0014-4827(76)90043-4; BARTHOLOMEW B, 1990, EMBO J, V9, P2197, DOI 10.1002/j.1460-2075.1990.tb07389.x; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; BURNOL AF, 1993, NATURE, V362, P475, DOI 10.1038/362475a0; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Costanzo G, 2001, MOL CELL BIOL, V21, P3166, DOI 10.1128/MCB.21.9.3166-3178.2001; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 2002, J BIOL CHEM, V277, P6903, DOI 10.1074/jbc.M105036200; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dumay-Odelot H, 2007, J BIOL CHEM, V282, P17179, DOI 10.1074/jbc.M611542200; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Ferrari R, 2004, P NATL ACAD SCI USA, V101, P13442, DOI 10.1073/pnas.0403851101; French SL, 2008, MOL CELL BIOL, V28, P4576, DOI 10.1128/MCB.00127-08; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Giuliodori S, 2003, J MOL BIOL, V333, P1, DOI 10.1016/j.jmb.2003.08.016; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Guffanti E, 2006, J BIOL CHEM, V281, P29155, DOI 10.1074/jbc.M600387200; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Harlow E., 1999, USING ANTIBODIES LAB; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, P3048, DOI 10.1093/nar/gki608; Joazeiro CAP, 1996, GENE DEV, V10, P725, DOI 10.1101/gad.10.6.725; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; KASSAVETIS GA, 1991, P NATL ACAD SCI USA, V88, P7308, DOI 10.1073/pnas.88.16.7308; Kassavetis GA, 1998, MOL CELL BIOL, V18, P5587, DOI 10.1128/MCB.18.9.5587; Kassavetis GA, 2006, J BIOL CHEM, V281, P7445, DOI 10.1074/jbc.M512810200; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARSOLIER MC, 1995, GENE DEV, V9, P410, DOI 10.1101/gad.9.4.410; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; Moir RD, 2004, ADV PROTEIN CHEM, V67, P93; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Nechaev S, 2006, EMBO J, V25, P1700, DOI 10.1038/sj.emboj.7601069; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801	55	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26568	26576		10.1074/jbc.M803769200	http://dx.doi.org/10.1074/jbc.M803769200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667429	Green Published, hybrid			2022-12-25	WOS:000259341600033
J	Takagi, Y; Kobayashi, T; Shiono, M; Wang, L; Piao, X; Sun, G; Zhang, D; Abe, M; Hagiwara, Y; Takahashi, K; Hino, O				Takagi, Y.; Kobayashi, T.; Shiono, M.; Wang, L.; Piao, X.; Sun, G.; Zhang, D.; Abe, M.; Hagiwara, Y.; Takahashi, K.; Hino, O.			Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein	ONCOGENE			English	Article						BHD; S6K1; AMPK; FnipL/Fnip2; Fnip1	NIHON RAT MODEL; UNIDENTIFIED HUMAN GENES; BHD GENE; RENAL CARCINOGENESIS; COMPLETE SEQUENCES; CODING SEQUENCES; NATURAL-HISTORY; CDNA-CLONES; CANCER; MTOR	Birt-Hogg-Dube (BHD) syndrome is characterized by the development of pneumothorax, hair folliculomas and renal tumors and the responsible BHD gene is thought to be a tumor suppressor. The function of folliculin (Flcn), encoded by BHD, is totally unknown, although its interaction with Fnip1 has been reported. In this study, we identified a novel protein binding to Flcn, which is highly homologous to Fnip1, and which we named FnipL (recently reported in an independent study as Fnip2). The interaction between FnipL/Fnip2 and Flcn may be mediated mainly by the C-terminal domains of each protein as is the case for the Flcn-Fnip1 interaction. FnipL/Fnip2 and Flcn were located together in the cytoplasm in a reticular pattern, although solely expressed Flcn was found mainly in the nucleus. Cytoplasmic retention of Flcn was canceled with C-terminal truncation of FnipL/Fnip2, suggesting that FnipL/Fnip2 regulates Flcn distribution through their complex formation. By the employment of siRNA, we observed a decrease in S6K1 phosphorylation in the BHD-suppressed cell. We also observed a decrease in S6K1 phosphorylation in FNIP1- and, to a lesser extent, in FNIPL/FNIP2-suppressed cells. These results suggest that Flcn-FnipL/Fnip2 and Flcn-Fnip1 complexes positively regulate S6K1 phosphorylation and that FnipL/Fnip2 provides an important clue to elucidating the function of Flcn and the pathogenesis of BHD.	[Takagi, Y.; Kobayashi, T.; Shiono, M.; Wang, L.; Piao, X.; Sun, G.; Zhang, D.; Abe, M.; Hagiwara, Y.; Hino, O.] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, Tokyo 1138421, Japan; [Hagiwara, Y.] Immunobiol Labs Co Ltd, Div Mfg Res & Dev, Fujioka, Gunma, Japan	Juntendo University; Immuno-Biological Laboratories Co. Ltd.	Hino, O (corresponding author), Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ohino@juntendo.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank Drs Fujii H, Tsurui H, Matsuoka S, Wakiya M, Kajino K, Mr Sasahara K and Mr Takagaki T in the Department of Pathology and Oncology for helpful discussions and technical supports. We also thank Ms Ochiai K and Mr Matsunami K in the Division of Radioisotope Research for expert support. We appreciate Dr Maeda M (IBL) for production of antibodies, and Drs Okimoto K, Matsumoto I and Kouchi M (Dainippon-Sumitomo Pharma) and Dr Maeda T (Tokyo University) for helpful discussions. We also thank Kazusa DNA Research Institute for cDNA clones. This study was supported by the grants from the Japan Society for the Promotion of Science (JSPS), from the Ministry of Education, Culture, Sports and Technology of Japan, and from the Ministry of Health, Labour and Welfare of Japan.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Fukuda T, 2000, ANAL BIOCHEM, V285, P274, DOI 10.1006/abio.2000.4787; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hino O, 2003, CANCER SCI, V94, P142, DOI 10.1111/j.1349-7006.2003.tb01410.x; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Kouchi M, 2006, VIRCHOWS ARCH, V448, P463, DOI 10.1007/s00428-005-0142-9; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nagase T, 2001, DNA RES, V8, P319, DOI 10.1093/dnares/8.6.319; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okimoto K, 2004, CURR MOL MED, V4, P887, DOI 10.2174/1566524043359737; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Okimoto K, 2000, JPN J CANCER RES, V91, P1096, DOI 10.1111/j.1349-7006.2000.tb00890.x; Roberg KJ, 1997, GENETICS, V147, P1569; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Togashi Y, 2006, ONCOGENE, V25, P2885, DOI 10.1038/sj.onc.1209317; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154	23	95	99	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 11	2008	27	40					5339	5347		10.1038/onc.2008.261	http://dx.doi.org/10.1038/onc.2008.261			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18663353				2022-12-25	WOS:000259096100006
J	Mager, U; Degenhardt, T; Pulkkinen, L; Kolehmainen, M; Tolppanen, AM; Lindstrom, J; Eriksson, JG; Carlberg, C; Tuomilehto, J; Uusitupa, M				Mager, Ursula; Degenhardt, Tatjana; Pulkkinen, Leena; Kolehmainen, Marjukka; Tolppanen, Anna-Maija; Lindstrom, Jaana; Eriksson, Johan G.; Carlberg, Carsten; Tuomilehto, Jaakko; Uusitupa, Matti		Finnish Diabet Prevention Study	Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HORMONE SECRETAGOGUE RECEPTOR; BODY-MASS INDEX; BINDING PROTEIN; MESSENGER-RNA; LIFE-STYLE; FTO GENE; FAT MASS; TRANSCRIPTION; EXPRESSION	Background: Ghrelin may influence the development of obesity through its role in the control of energy balance, food intake, and regulation of body weight. The effects of ghrelin are mediated via the growth hormone secretagogue receptor (GHSR). Methodology/Principal Findings: We genotyped 7 single nucleotide polymorphisms (SNPs) in the GHSR gene and assessed the association between those SNPs and obesity and type 2 diabetes-related phenotypes from 507 middle-aged overweight persons with impaired glucose tolerance participating in the Finnish Diabetes Prevention Study (DPS). Additionally, we performed in silico screening of the 59-regulatory region of GHSR and evaluated SNPs disrupting putative transcription factor (TF) binding sites in vitro with gelshift assays to determine differences in protein binding between different alleles of SNPs. Rs9819506 in the promoter region of GHSR was associated with body weight (p=0.036); persons with rs9819506-AA genotype having the lowest body weight. Individuals with rs490683-CC genotype displayed highest weight loss in the whole study population (p=0.032). The false discovery rate for these results was,10%. Rs490683 and rs509035 were associated with several measures of glucose and insulin metabolism during the follow-up. Rs490683 may be a functional SNP, since gelshift experiments showed differential protein binding between the alleles, with higher binding to the G-allele. Rs490683-C may disrupt a putative binding site for the TF nuclear factor 1 (NF-1), thus rs4906863-GG genotype where the NF-1 site is intact may lead to a higher GHSR gene expression. Conclusion/Significance: Polymorphisms in the GHSR promoter may modify changes in body weight during long-term lifestyle intervention and affect ghrelin receptor signalling through modulation of GHSR gene expression.	[Mager, Ursula; Pulkkinen, Leena; Kolehmainen, Marjukka; Tolppanen, Anna-Maija; Uusitupa, Matti] Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, FIN-70211 Kuopio, Finland; [Degenhardt, Tatjana; Carlberg, Carsten] Univ Kuopio, Dept Biosci Biochem, FIN-70211 Kuopio, Finland; [Lindstrom, Jaana; Eriksson, Johan G.; Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabetes Unit, Helsinki, Finland; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Eriksson, Johan G.; Tuomilehto, Jaakko] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland	University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Luxembourg; University of Helsinki	Mager, U (corresponding author), Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, FIN-70211 Kuopio, Finland.	ursula.mager@uku.fi	Carlberg, Carsten/C-9075-2011; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Carlberg, Carsten/0000-0003-2633-0684; Eriksson, Johan/0000-0002-2516-2060; Griebler, Ursula/0000-0002-9958-3714; Lindstrom, Jaana/0000-0001-9255-020X	Academy of Finland [209445, 40758, 117844, 38387, 46558]; EVO-fund of Kuopio University Hospital [5179, 5198, 5952, 5926]; Ministry of Education of Finland; Finnish Diabetes Foundation; Sigrid Juselius Foundation; Austrian Academy of Sciences; RTN NucSys of the European Union; Finnish Graduate School on Applied Bioscience; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); EVO-fund of Kuopio University Hospital; Ministry of Education of Finland; Finnish Diabetes Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Austrian Academy of Sciences; RTN NucSys of the European Union; Finnish Graduate School on Applied Bioscience; Yrjo Jahnsson Foundation	This work has been financially supported by grants from the Academy of Finland (number 209445 to MK, numbers 40758 and 117844 to MU; numbers 38387 and 46558 to JT), the EVO-fund of Kuopio University Hospital (numbers 5179, 5198, 5952 and 5926 to MU), the Ministry of Education of Finland, the Finnish Diabetes Foundation, Sigrid Juselius Foundation, the Austrian Academy of Sciences, the RTN NucSys of the European Union, the Finnish Graduate School on Applied Bioscience and the Yrjo Jahnsson Foundation.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dossus L, 2008, CARCINOGENESIS, V29, P1360, DOI 10.1093/carcin/bgn083; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; Kim MS, 2003, NEUROREPORT, V14, P1317, DOI [10.1097/01.wnr.0000078703.79393.d2, 10.1097/00001756-200307180-00006]; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Vartiainen J, 2004, EUR J ENDOCRINOL, V150, P457, DOI 10.1530/eje.0.1500457; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; *WHO, 1985, WHO TECH REP SER, V727, pR1; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	42	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2941	10.1371/journal.pone.0002941	http://dx.doi.org/10.1371/journal.pone.0002941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698404	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600027
J	Krishnamoorthy, S				Krishnamoorthy, Srinivasan			Receptor Tyrosine Kinase (RTK) Mediated Tyrosine Phosphor- Proteome from Drosophila S2 (ErbB1) Cells Reveals Novel Signaling Networks	PLOS ONE			English	Article								Protein phosphorylation mediates many critical cellular responses and is essential for many biological functions during development. About one-third of cellular proteins are phosphorylated, representing the phosphor-proteome, and phosphorylation can alter a protein's function, activity, localization and stability. Tyrosine phosphorylation events mediated by aberrant activation of Receptor Tyrosine Kinase (RTK) pathways have been proven to be involved in the development of several diseases including cancer. To understand the systems biology of RTK activation, we have developed a phosphor-proteome focused on tyrosine phosphorylation events under insulin and EGF signaling pathways using the PhosphoScan (R) technique coupled with high-throughput mass spectrometry analysis. Comparative proteomic analyses of all these tyrosine phosphorylation events revealed that around 70% of these pY events are conserved in human orthologs and paralogs. A careful analysis of published in vivo tyrosine phosphorylation events from literature and patents revealed that around 38% of pY events from Drosophila proteins conserved on 185 human proteins are confirmed in vivo tyrosine phosphorylation events. Hence the data are validated partially based on available reports, and the credibility of the remaining 62% of novel conserved sites that are unpublished so far is very high but requires further follow-up studies. The novel pY events found in this study that are conserved on human proteins could potentially lead to the discovery of drug targets and biomarkers for the detection of various cancers and neurodegenerative diseases.	[Krishnamoorthy, Srinivasan] Harvard Univ, Sch Med, Dept Surg, Pediat Surg Res Labs,Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Krishnamoorthy, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Pediat Surg Res Labs,Massachusetts Gen Hosp, Boston, MA 02115 USA.	ksrini10@gmail.com			NIH [R01 GM-61707, P01-HD-39942, Project2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funding for supplies and chemicals used in this study was from grants from NIH R01 GM-61707 and P01-HD-39942, Project2. The author did not receive any salary for this work.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Chang YC, 2008, J PROTEOME RES, V7, P1055, DOI 10.1021/pr700801p; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Nam NH, 2003, CURR DRUG TARGETS, V4, P159, DOI 10.2174/1389450033346966; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schiller JH, 2008, CANCER INVEST, V26, P81, DOI 10.1080/07357900701511847; Schumacher JA, 2007, J MOL DIAGN, V9, P169, DOI 10.2353/jmoldx.2007.060031; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2877	10.1371/journal.pone.0002877	http://dx.doi.org/10.1371/journal.pone.0002877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682802	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600033
J	Zogopoulos, G; Jorgensen, C; Bacani, J; Montpetit, A; Lepage, P; Ferretti, V; Chad, L; Selvarajah, S; Zanke, B; Hudson, TJ; Pawson, T; Gallinger, S				Zogopoulos, George; Jorgensen, Claus; Bacani, Julinor; Montpetit, Alexandre; Lepage, Pierre; Ferretti, Vincent; Chad, Lauren; Selvarajah, Subani; Zanke, Brent; Hudson, Thomas J.; Pawson, Tony; Gallinger, Steven			Germline EPHB2 Receptor Variants in Familial Colorectal Cancer	PLOS ONE			English	Article								Familial clustering of colorectal cancer occurs in 15-20% of cases, however recognized cancer syndromes explain only a small fraction of this disease. Thus, the genetic basis for the majority of hereditary colorectal cancer remains unknown. EPHB2 has recently been implicated as a candidate tumor suppressor gene in colorectal cancer. The aim of this study was to evaluate the contribution of EPHB2 to hereditary colorectal cancer. We screened for germline EPHB2 sequence variants in 116 population-based familial colorectal cancer cases by DNA sequencing. We then estimated the population frequencies and characterized the biological activities of the EPHB2 variants identified. Three novel nonsynonymous missense alterations were detected. Two of these variants (A438T and G787R) result in significant residue changes, while the third leads to a conservative substitution in the carboxy-terminal SAM domain (V945I). The former two variants were found once in the 116 cases, while the V945I variant was present in 2 cases. Genotyping of additional patients with colorectal cancer and control subjects revealed that A438T and G787R represent rare EPHB2 alleles. In vitro functional studies show that the G787R substitution, located in the kinase domain, causes impaired receptor kinase activity and is therefore pathogenic, whereas the A438T variant retains its receptor function and likely represents a neutral polymorphism. Tumor tissue from the G787R variant case manifested loss of heterozygosity, with loss of the wild-type allele, supporting a tumor suppressor role for EPHB2 in rare colorectal cancer cases. Rare germline EPHB2 variants may contribute to a small fraction of hereditary colorectal cancer.	[Zogopoulos, George; Jorgensen, Claus; Bacani, Julinor; Selvarajah, Subani; Pawson, Tony; Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Zogopoulos, George; Gallinger, Steven] Mt Sinai Hosp, Dr Zane Cohen Digestive Dis Clin Res Ctr, Toronto, ON, Canada; [Montpetit, Alexandre; Lepage, Pierre; Ferretti, Vincent; Chad, Lauren] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Zanke, Brent; Hudson, Thomas J.; Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Zanke, Brent; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McGill University; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Zogopoulos, G (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sgallinger@mtsinai.on.ca	Gallinger, Steven/E-4575-2013; Pawson, Tony J/E-4578-2013	Jorgensen, Claus/0000-0002-7841-943X	National Cancer Institute, National Institutes of Health [CA-96-011]; Colon Cancer Family Registry; Ontario Genomics Institute; Genome Quebec; Ministere du Developpement yconomique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; Society of University Surgeons; National Cancer Institute of Canada [Terry Fox Foundation Research Fellowship]; Burroughs Wellcome Fund [Clinician-Scientist Award in Translational Research]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colon Cancer Family Registry; Ontario Genomics Institute; Genome Quebec; Ministere du Developpement yconomique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; Society of University Surgeons; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-96-011 (to SG) and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating institutions or investigators in the Colon CFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the Colon CFR. Cancer Care Ontario, as the host organization to the ARCTIC Genome Project, acknowledges that this Project was partly funded by Genome Canada through the Ontario Genomics Institute, by Genome Quebec, the Ministere du Developpement yconomique et Regional et de la Recherche du Quebec and the Ontario Institute for Cancer Research. GZ is a Scholar of the Society of University Surgeons and a recipient of a Terry Fox Foundation Research Fellowship from the National Cancer Institute of Canada. TJH is a recipient of a Clinician-Scientist Award in Translational Research from the Burroughs Wellcome Fund.	Aasheim HC, 2005, BBA-GEN SUBJECTS, V1723, P1, DOI 10.1016/j.bbagen.2005.01.011; Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Cotterchio M, 2000, Chronic Dis Can, V21, P81; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kokko A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-145; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Oba SM, 2001, CANCER LETT, V164, P97, DOI 10.1016/S0304-3835(00)00716-3; OGUNBIYI OA, 1997, GASTROENTEROLOGY, V113, P76176; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; PRAML C, 1995, ONCOGENE, V11, P1357; Shitoh K, 2001, GENE CHROMOSOME CANC, V30, P32, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1065>3.0.CO;2-I; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; Sparks AB, 1998, CANCER RES, V58, P1130; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	24	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2885	10.1371/journal.pone.0002885	http://dx.doi.org/10.1371/journal.pone.0002885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682749	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600041
J	Arduini, BL; Gallagher, GR; Henion, PD				Arduini, Brigitte L.; Gallagher, Glen R.; Henion, Paul D.			Zebrafish Endzone Regulates Neural Crest-Derived Chromatophore Differentiation and Morphology	PLOS ONE			English	Article								The development of neural crest-derived pigment cells has been studied extensively as a model for cellular differentiation, disease and environmental adaptation. Neural crest-derived chromatophores in the zebrafish (Danio rerio) consist of three types: melanophores, xanthophores and iridiphores. We have identified the zebrafish mutant endzone (enz), that was isolated in a screen for mutants with neural crest development phenotypes, based on an abnormal melanophore pattern. We have found that although wild-type numbers of chromatophore precursors are generated in the first day of development and migrate normally in enz mutants, the numbers of all three chromatophore cell types that ultimately develop are reduced. Further, differentiated melanophores and xanthophores subsequently lose dendricity, and iridiphores are reduced in size. We demonstrate that enz function is required cell autonomously by melanophores and that the enz locus is located on chromosome 7. In addition, zebrafish enz appears to selectively regulate chromatophore development within the neural crest lineage since all other major derivatives develop normally. Our results suggest that enz is required relatively late in the development of all three embryonic chromatophore types and is normally necessary for terminal differentiation and the maintenance of cell size and morphology. Thus, although developmental regulation of different chromatophore sublineages in zebrafish is in part genetically distinct, enz provides an example of a common regulator of neural crest-derived chromatophore differentiation and morphology.	[Arduini, Brigitte L.; Gallagher, Glen R.; Henion, Paul D.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Henion, Paul D.] Ohio State Univ, Dept Neurosci, Columbus, OH USA	Ohio State University; Ohio State University	Arduini, BL (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA.	henion.1@osu.edu		Gallagher, Glen/0000-0001-6837-9473; Arduini, Brigitte/0000-0002-8587-3518	NIH [GM076505, P30-NS045758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant GM076505 with additional support from NIH grant P30-NS045758.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Arduini BL, 2004, MECH DEVELOP, V121, P1353, DOI 10.1016/j.mod.2004.06.006; Bagnara JT, 1973, CHROMATOPHORES COLOR; BAGNARA JT, 1998, COMP ANATOMY PHYSL P, P9; BAKER BI, 1986, GEN COMP ENDOCR, V63, P62, DOI 10.1016/0016-6480(86)90182-6; BARBER LD, 1987, GEN COMP ENDOCR, V65, P79, DOI 10.1016/0016-6480(87)90225-5; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cornell RA, 2004, MECH DEVELOP, V121, P1365, DOI 10.1016/j.mod.2004.06.005; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; EPPERLEIN HH, 1990, ADV ANAT EMBRYOL CEL, V118, P1; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GREEN JA, 1991, J ENDOCRINOL, V128, P267, DOI 10.1677/joe.0.1280267; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Henion PD, 1996, DEV GENET, V18, P11; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Hogben LT, 1922, P R SOC LOND B-CONTA, V93, P318, DOI 10.1098/rspb.1922.0024; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; JOHNSON SL, 1995, DEV BIOL, V167, P27, DOI 10.1006/dbio.1995.1004; Kawauchi H, 2004, PEPTIDES, V25, P1577, DOI 10.1016/j.peptides.2004.03.025; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Kumagai T, 1998, EXP ANIM TOKYO, V47, P265, DOI 10.1538/expanim.47.265; Lahav R, 2005, INT J DEV BIOL, V49, P173, DOI 10.1387/ijdb.041951rl; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Le Guyader S, 2002, PIGM CELL RES, V15, P27; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; LISTER J, 1858, PHILOS T ROY SOC LON, V148, P627; Lister JA, 2002, MICROSC RES TECHNIQ, V58, P435, DOI 10.1002/jemt.10161; Lister JA, 1999, DEVELOPMENT, V126, P3757; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Nagatsu T, 1999, MOL NEUROBIOL, V19, P79, DOI 10.1007/BF02741379; Nakamura M, 2002, J DERMATOL SCI, V28, P1, DOI 10.1016/S0923-1811(01)00158-X; Nataf V, 1996, P NATL ACAD SCI USA, V93, P9645, DOI 10.1073/pnas.93.18.9645; Nechiporuk A, 1999, GENOME RES, V9, P1231, DOI 10.1101/gr.9.12.1231; NORDLUND JJ, 1998, PIGMENTARY SYSTEM PH, pR24; Odenthal J, 1996, DEVELOPMENT, V123, P391; ODONNELL JM, 1989, DEV GENET, V10, P273, DOI 10.1002/dvg.1020100316; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Pickart MA, 2004, PIGM CELL RES, V17, P461, DOI 10.1111/j.1600-0749.2004.00189.x; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; Rawls JF, 2003, GENETICS, V163, P997; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; REAUME AG, 1991, GENETICS, V129, P1099; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; SILVERS W, 1979, COAT COLORS MICE MOD, pR14; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STREISINGER G, 1986, GENETICS, V112, P311; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; WOOD JM, 1995, BIOCHEM BIOPH RES CO, V206, P480, DOI 10.1006/bbrc.1995.1068	78	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2845	10.1371/journal.pone.0002845	http://dx.doi.org/10.1371/journal.pone.0002845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665240	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300064
J	Locke, JB; Aziz, RK; Vicknair, MR; Nizet, V; Buchanan, JT				Locke, Jeffrey B.; Aziz, Ramy K.; Vicknair, Mike R.; Nizet, Victor; Buchanan, John T.			Streptococcus iniae M-Like Protein Contributes to Virulence in Fish and Is a Target for Live Attenuated Vaccine Development	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; GROUP-B STREPTOCOCCI; TROUT ONCORHYNCHUS-MYKISS; HYBRID STRIPED BASS; C5A PEPTIDASE; RAINBOW-TROUT; ANTIMICROBIAL PEPTIDE; COMPLEMENT-SYSTEM; AEROMONAS-SALMONICIDA; SURFACE-PROTEINS	Background: Streptococcus iniae is a significant pathogen in finfish aquaculture, though knowledge of virulence determinants is lacking. Through pyrosequencing of the S. iniae genome we have identified two gene homologues to classical surface-anchored streptococcal virulence factors: M-like protein (simA) and C5a peptidase (scpl). Methodology/Principal Findings: S. iniae possesses a Mga-like locus containing simA and a divergently transcribed putative mga-like regulatory gene, mgx. In contrast to the Mga locus of group A Streptococcus (GAS, S. pyogenes), scpl is located distally in the chromosome. Comparative sequence analysis of the Mgx locus revealed only one significant variant, a strain with an insertion frameshift mutation in simA and a deletion mutation in a region downstream of mgx, generating an ORF which may encode a second putative mga-like gene, mgx2. Allelic exchange mutagenesis of simA and scpl was employed to investigate the potential role of these genes in S. iniae virulence. Our hybrid striped bass (HSB) and zebrafish models of infection revealed that M-like protein contributes significantly to S. iniae pathogenesis whereas C5a peptidase-like protein does not. Further, in vitro cell-based analyses indicate that SiMA, like other M family proteins, contributes to cellular adherence and invasion and provides resistance to phagocytic killing. Attenuation in our virulence models was also observed in the S. iniae isolate possessing a natural simA mutation. Vaccination of HSB with the Delta simA mutant provided 100% protection against subsequent challenge with a lethal dose of wild-type (WT) S. iniae after 1,400 degree days, and shows promise as a target for live attenuated vaccine development. Conclusions/Significance: Analysis of M-like protein and C5a peptidase through allelic replacement revealed that M-like protein plays a significant role in S. iniae virulence, and the Mga-like locus, which may regulate expression of this gene, has an unusual arrangement. The M-like protein mutant created in this research holds promise as live-attenuated vaccine.	[Locke, Jeffrey B.; Nizet, Victor; Buchanan, John T.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Locke, Jeffrey B.; Nizet, Victor] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biotechnol & Biomed, La Jolla, CA USA; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Vicknair, Mike R.] Kent SeaTech Corp, San Diego, CA USA; [Nizet, Victor] Univ Califo San Diego, Skaggs Sch Pharm & Pharm Sci, La Jolla, CA USA; [Buchanan, John T.] Aqua Bounty Technol, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Egyptian Knowledge Bank (EKB); Cairo University; University of California System; University of California San Diego	Locke, JB (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jtbuchanan@gmail.com	Nizet, Victor/AAF-3190-2019; Aziz, Ramy/B-2918-2009	Nizet, Victor/0000-0003-3847-0422; Aziz, Ramy/0000-0002-4448-7100	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration [NA04OAR4170038]; California Sea Grant College Program [59-A-N]; California State Resources Agency; NIH [5 T32 GM067550]; USDA [2006-35600-16569]; Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant College Program; California State Resources Agency; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was supported in part by the National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA Grant #NA04OAR4170038, project #59-A-N, through the California Sea Grant College Program; and in part by the California State Resources Agency. The views expressed herein do not necessarily reflect the views of any of those organizations. Additional funding was provided by the NIH Training Program in Marine Biotechnology grant #5 T32 GM067550. The DNA sequence of S. iniae strain 9117 was supported by USDA grant #2006-35600-16569 at the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC).	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baiano JCF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-67; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Boshra H, 2004, FISH SHELLFISH IMMUN, V17, P293, DOI 10.1016/j.fsi.2004.04.002; Boshra H, 2004, J IMMUNOL, V172, P4381, DOI 10.4049/jimmunol.172.7.4381; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; BUCHANAN JT, 2008, VET MICROBI IN PRESS; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992; COURTNEY HS, 1992, MICROB PATHOGENESIS, V12, P199, DOI 10.1016/0882-4010(92)90054-R; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; DALE JB, 1985, J EXP MED, V162, P583, DOI 10.1084/jem.162.2.583; ELLEN RP, 1972, INFECT IMMUN, V5, P826, DOI 10.1128/IAI.5.5.826-830.1972; Eyngor M, 2007, FEMS MICROBIOL LETT, V277, P238, DOI 10.1111/j.1574-6968.2007.00973.x; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FISCHETTI VA, 1977, J INFECT DIS, V136, pS222, DOI 10.1093/infdis/136.Supplement.S222; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; Fuller JD, 2001, INFECT IMMUN, V69, P1994, DOI 10.1128/IAI.69.4.1994-2000.2001; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Geyer A, 2000, MOL GEN GENET, V262, P965, DOI 10.1007/PL00008665; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HILL HR, 1988, J IMMUNOL, V141, P3551; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holland MCH, 2004, J IMMUNOL, V172, P349, DOI 10.4049/jimmunol.172.1.349; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Husmann LK, 1997, INFECT IMMUN, V65, P1422, DOI 10.1128/IAI.65.4.1422-1430.1997; Jadoun J, 1997, ADV EXP MED BIOL, V418, P511; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; LARSEN SA, 1970, APPL MICROBIOL, V20, P40, DOI 10.1128/AEM.20.1.40-45.1970; Lau SKP, 2003, J CLIN MICROBIOL, V41, P1004, DOI 10.1128/JCM.41.3.1004-1009.2003; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Locke JB, 2007, DIS AQUAT ORGAN, V76, P17, DOI 10.3354/dao076017; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marsden MJ, 1996, INFECT IMMUN, V64, P3863, DOI 10.1128/IAI.64.9.3863-3869.1996; Marsden MJ, 1998, VACCINE, V16, P1087, DOI 10.1016/S0264-410X(98)80103-5; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Moshynskyy I, 2003, MICROB PATHOGENESIS, V35, P203, DOI 10.1016/S0882-4010(03)00150-5; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NONAKA M, 1981, J IMMUNOL, V126, P1495; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; OCONNOR SP, 1987, J INFECT DIS, V156, P495, DOI 10.1093/infdis/156.3.495; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pahlman LI, 2006, J IMMUNOL, V177, P1221, DOI 10.4049/jimmunol.177.2.1221; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; PIER GB, 1976, INT J SYST BACTERIOL, V26, P545, DOI 10.1099/00207713-26-4-545; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Purushothaman SS, 2004, INDIAN J MED RES, V119, P44; RELF WA, 1994, GENE, V144, P25, DOI 10.1016/0378-1119(94)90198-8; Russo R, 2006, AQUACULTURE, V256, P105, DOI 10.1016/j.aquaculture.2006.02.046; Salonius K, 2005, DEV BIOLOGICALS, V121, P189; Shimizu C, 2003, IN VITRO CELL DEV-AN, V39, P29; Shoemaker CA, 2001, AM J VET RES, V62, P174, DOI 10.2460/ajvr.2001.62.174; SIMPSON WJ, 1990, J BACTERIOL, V172, P696, DOI 10.1128/jb.172.2.696-700.1990; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; STOLLERMAN GH, 1991, CLIN IMMUNOL IMMUNOP, V61, P131, DOI 10.1016/S0090-1229(05)80019-4; Subramaniam S, 1998, PROTEINS, V32, P1; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNTON JC, 1991, MICROB PATHOGENESIS, V11, P85, DOI 10.1016/0882-4010(91)90002-R; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Vahling CM, 2006, J BACTERIOL, V188, P863, DOI 10.1128/JB.188.3.863-873.2006; Vasi J, 2000, INFECT IMMUN, V68, P294, DOI 10.1128/IAI.68.1.294-302.2000; Vivas J, 2004, FISH SHELLFISH IMMUN, V16, P193, DOI 10.1016/S1050-4648(03)00078-0; Wang HL, 2002, BIOTECHNIQUES, V33, P26, DOI 10.2144/02331bm02; Weinstein MR, 1997, NEW ENGL J MED, V337, P589, DOI 10.1056/NEJM199708283370902; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; ZABRISKIE JB, 1966, J EXP MED, V124, P661, DOI 10.1084/jem.124.4.661; Zlotkin A, 2003, INFECT IMMUN, V71, P2318, DOI 10.1128/IAI.71.5.2318-2325.2003	101	70	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2824	10.1371/journal.pone.0002824	http://dx.doi.org/10.1371/journal.pone.0002824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665241	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300043
J	Aydin, J; Shabalina, IG; Place, N; Reiken, S; Zhang, SJ; Bellinger, AM; Nedergaard, J; Cannon, B; Marks, AR; Bruton, JD; Westerblad, H				Aydin, Jan; Shabalina, Irina G.; Place, Nicolas; Reiken, Steven; Zhang, Shi-Jin; Bellinger, Andrew M.; Nedergaard, Jan; Cannon, Barbara; Marks, Andrew R.; Bruton, Joseph D.; Westerblad, Hakan			Nonshivering thermogenesis protects against defective calcium handling in muscle	FASEB JOURNAL			English	Article						muscle contraction; ryanodine receptor; temperature control; increased beta-adrenergic activity	SKELETAL-MUSCLE; RYANODINE RECEPTOR; INTACT FIBERS; COLD; MOUSE; SINGLE; MICE; CATECHOLAMINES; ADAPTATION; RELEASE	When acutely exposed to a cold environment, mammals shiver to generate heat. During prolonged cold exposure, shivering is replaced by adaptive adrenergic nonshivering thermogenesis with increased heat production in brown adipose tissue due to activation of uncoupling protein-1 (UCP1). This cold acclimation is associated with chronically increased sympathetic stimulation of skeletal muscle, which may increase the sarcoplasmic reticulum (SR) Ca2+ leak via destabilized ryanodine receptor 1 (RyR1) channel complexes. Here, we use genetically engineered UCP1-deficient (UCP1-KO) mice that rely completely on shivering in the cold. We examine soleus muscle, which participates in shivering, and flexor digitorum brevis (FDB) muscle, a distal and superficial muscle that does not shiver. Soleus muscles of cold-acclimated UCP1-KO mice exhibited severe RyR1 PKA hyperphosphorylation and calstabin1 depletion, as well as markedly decreased SR Ca2+ release and force during contractions. In stark contrast, the RyR1 channel complexes were little affected, and Ca2+ and force were not decreased in FDB muscles of cold-acclimated UCP1-KO mice. These results indicate that activation of UCP1-mediated heat production in brown adipose tissue during cold exposure reduces the necessity for shivering and thus prevents the development of severe dysfunction in shivering muscles. Aydin, J., Shabalina, I. G., Place, N., Reiken, S., Zhang, S.-J., Bellinger, A. M., Nedergaard, J., Cannon, B., Marks, A. R., Bruton, J. D., Westerblad, H. Nonshivering thermogenesis protects against defective calcium handling in muscle. FASEB J. 22, 3919-3924 (2008)	[Aydin, Jan; Place, Nicolas; Zhang, Shi-Jin; Bruton, Joseph D.; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Shabalina, Irina G.; Nedergaard, Jan; Cannon, Barbara] Univ Stockholm, Wenner Gren Inst, Arrhenius Labs, S-11345 Stockholm, Sweden; [Reiken, Steven; Bellinger, Andrew M.; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Karolinska Institutet; Stockholm University; Columbia University	Westerblad, H (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	hakan.westerblad@ki.se	Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Shabalina, Irina G/A-4225-2011; Place, Nicolas/B-3416-2018; Shabalina, Irina/AAC-3720-2019; Cannon, Barbara/B-3089-2016	Shabalina, Irina G/0000-0002-2915-6450; Place, Nicolas/0000-0001-9044-0621; Shabalina, Irina/0000-0002-2915-6450; Cannon, Barbara/0000-0001-6594-2363; Westerblad, Hakan/0000-0002-8180-3029; Nedergaard, Jan/0000-0003-2070-1587; Bruton, Joseph/0000-0002-6985-099X	Swedish Research Council; Swedish National Center for Sports Research; Karolinska Institute; U.S. Defense Advanced Research Projects Agency (DARPA); Swedish Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056180] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Center for Sports Research; Karolinska Institute(Karolinska Institutet); U.S. Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Swedish Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Swedish Research Council, the Swedish National Center for Sports Research, funds from the Karolinska Institute, and the U.S. Defense Advanced Research Projects Agency (DARPA). N.P. was supported by the Swedish Institute.	Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; BROWN GL, 1948, J PHYSIOL-LONDON, V107, P115, DOI 10.1113/jphysiol.1948.sp004255; CAIRNS SP, 1993, PFLUG ARCH EUR J PHY, V425, P150, DOI 10.1007/BF00374515; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DULLOO AG, 1988, AM J PHYSIOL, V255, pE180, DOI 10.1152/ajpendo.1988.255.2.E180; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Harper ME, 2001, BBA-BIOENERGETICS, V1504, P159, DOI 10.1016/S0005-2728(00)00244-9; HEMINGWAY A, 1963, PHYSIOL REV, V43, P397, DOI 10.1152/physrev.1963.43.3.397; LANNERGREN J, 1987, J PHYSIOL-LONDON, V390, P285; LEBLANC J, 1967, AM J PHYSIOL, V213, P1419, DOI 10.1152/ajplegacy.1967.213.6.1419; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; MOTELICA I, 1969, ACTA PHYSIOL SCAND, V76, P393, DOI 10.1111/j.1748-1716.1969.tb04484.x; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; ROTH J, 1988, J COMP PHYSIOL B, V157, P855, DOI 10.1007/BF00691018; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; WILLIAMS JH, 1989, MUSCLE NERVE, V12, P968, DOI 10.1002/mus.880121204; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237	19	51	51	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3919	3924		10.1096/fj.08-113712	http://dx.doi.org/10.1096/fj.08-113712			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18687806	Green Published			2022-12-25	WOS:000260503000020
J	Gourdine, JP; Cioci, G; Miguet, L; Unverzagt, C; Silva, DV; Varrot, A; Gautier, C; Smith-Ravin, EJ; Imberty, A				Gourdine, Jean-Philippe; Cioci, Gianluca; Miguet, Laurence; Unverzagt, Carlo; Silva, Daniel Varon; Varrot, Annabelle; Gautier, Catherine; Smith-Ravin, Emilie Juliette; Imberty, Anne			High Affinity Interaction between a Bivalve C-type Lectin and a Biantennary Complex-type N-Glycan Revealed by Crystallography and Microcalorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; DC-SIGN; 3-DIMENSIONAL STRUCTURES; CRYSTAL-STRUCTURE; E-SELECTIN; DATA-BANK; BINDING; OLIGOSACCHARIDES; DISACCHARIDES; REFINEMENT	Codakine is an abundant 14-kDa mannose-binding C-type lectin isolated from the gills of the sea bivalve Codakia orbicularis. Binding studies using inhibition of hemagglutination indicated specificity for mannose and fucose monosaccharides. Further experiments using a glycan array demonstrated, however, a very fine specificity for N-linked biantennary complex-type glycans. An unusually high affinity was measured by titration microcalorimetry performed with a biantennary Asn-linked nonasaccharide. The crystal structure of the native lectin at 1.3 angstrom resolution revealed a new type of disulfide-bridged homodimer. Each monomer displays three intramolecular disulfide bridges and contains only one calcium ion located in the canonical binding site that is occupied by a glycerol molecule. The structure of the complex between Asn-linked nonasaccharide and codakine has been solved at 1.7 angstrom resolution. All residues could be located in the electron density map, except for the capping beta 1 - 4-linked galactosides. The alpha 1 - 6-linked mannose binds to calcium by coordinating the O3 and O4 hydroxyl groups. The GlcNAc moiety of the alpha 1,6 arm engages in several hydrogen bonds with the protein, whereas the GlcNAc on the other antenna is stacked against Trp(108), forming an extended binding site. This is the first structural report for a bivalve lectin.	[Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Univ Grenoble 1, CERMAV CNRS, F-38041 Grenoble 09, France; [Gourdine, Jean-Philippe; Smith-Ravin, Emilie Juliette] Univ Antilles Guyane, Dept Biol, F-97159 Guadeloupe, France; [Cioci, Gianluca] European Synchrotron Radiat Facil, Expt Div, F-38043 Grenoble, France; [Unverzagt, Carlo; Silva, Daniel Varon] Univ Bayreuth, D-95440 Bayreuth, Germany; [Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble, France; [Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite des Antilles; European Synchrotron Radiation Facility (ESRF); University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Imberty, A (corresponding author), Univ Grenoble 1, CERMAV CNRS, BP53, F-38041 Grenoble 09, France.	imberty@cermav.cnrs.fr	Gourdine, Jean-Philippe/P-4323-2018; Gourdine, Jean-Philippe F/E-3739-2012; Silva, Daniel Varon/D-5819-2014; Imberty, Anne/P-6451-2018	Gourdine, Jean-Philippe/0000-0001-9969-8610; Gourdine, Jean-Philippe F/0000-0001-9969-8610; Silva, Daniel Varon/0000-0003-2804-1923; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS; French Ministry of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS and the French Ministry of Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERG CJ, 1984, AQUACULTURE, V39, P165, DOI 10.1016/0044-8486(84)90264-3; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Bulgheresi S, 2006, APPL ENVIRON MICROB, V72, P2950, DOI 10.1128/AEM.72.4.2950-2956.2006; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Drickamer K, 1996, BIOCHEM SOC T, V24, P146, DOI 10.1042/bst0240146; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Foadi J, 2000, ACTA CRYSTALLOGR D, V56, P1137, DOI 10.1107/S090744490000932X; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V23, P831, DOI 10.1016/j.fsi.2007.03.009; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V22, P498, DOI 10.1016/j.fsi.2006.06.013; Gourdine JP, 2002, PREP BIOCHEM BIOTECH, V32, P341, DOI 10.1081/PB-120015458; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; Gutternigg M, 2007, GLYCOCONJUGATE J, V24, P475, DOI 10.1007/s10719-007-9040-5; IMBERTY A, 1991, GLYCOCONJUGATE J, V8, P456, DOI 10.1007/BF00769847; IMBERTY A, 1990, GLYCOCONJUGATE J, V7, P27, DOI 10.1007/BF01050401; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; JACOB GS, 1995, BIOCHEMISTRY-US, V34, P1210, DOI 10.1021/bi00004a014; Jimbo M, 2005, BIOCHEM BIOPH RES CO, V330, P157, DOI 10.1016/j.bbrc.2005.02.137; Kajihara Y, 2004, CHEM-EUR J, V10, P971, DOI 10.1002/chem.200305115; Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minamikawa M, 2004, FISH SHELLFISH IMMUN, V17, P463, DOI 10.1016/j.fsi.2004.05.001; Moy GW, 2008, P NATL ACAD SCI USA, V105, P1993, DOI 10.1073/pnas.0711862105; MULLER WEG, 1985, ACTA HISTOCHEM, P37; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Quesenberry MS, 1997, BIOCHEMISTRY-US, V36, P2724, DOI 10.1021/bi9622635; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; VASTA GR, 1992, GLYCOCONJUGATES COMP, P593; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamaura K, 2008, COMP BIOCHEM PHYS B, V149, P168, DOI 10.1016/j.cbpb.2007.09.004	56	32	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30112	30120		10.1074/jbc.M804353200	http://dx.doi.org/10.1074/jbc.M804353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687680	Green Published, hybrid			2022-12-25	WOS:000260366900056
J	Pellistri, F; Bucciantini, M; Relini, A; Nosi, D; Gliozzi, A; Robello, M; Stefani, M				Pellistri, Francesca; Bucciantini, Monica; Relini, Annalisa; Nosi, Daniele; Gliozzi, Alessandra; Robello, Mauro; Stefani, Massimo			Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MISFOLDING DISEASES; HIPPOCAMPAL-NEURONS; CALCIUM-CHANNELS; OXIDATIVE DAMAGE; COMMON MECHANISM; MAMMALIAN-CELLS; PRION PROTEIN; IN-VITRO; HYPF-N; BETA	It is widely reported that the Ca2+ increase following nonspecific cell membrane permeabilization is among the earliest biochemical modifications in cells exposed to toxic amyloid aggregates. However, more recently receptors with Ca2+ channel activity such as alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), N-methyl D-aspartate (NMDA), ryanodine, and inositol 1,4,5-trisphosphate receptors have been proposed as mediators of the Ca2+ increase in neuronal cells challenged with beta-amyloid peptides. We previously showed that prefibrillar aggregates of proteins not associated with amyloid diseases are toxic to exposed cells similarly to comparable aggregates of disease-associated proteins. In particular, prefibrillar aggregates of the prokaryotic HypF-N were shown to be toxic to different cultured cell lines by eliciting Ca2+ and reactive oxygen species increases. This study was aimed at assessing whether NMDA and AMPA receptor activations could be considered a generic feature of cell interaction with amyloid aggregates rather than a specific effect of some aggregated protein. Therefore, we investigated whether NMDA and AMPA receptors were involved in the Ca2+ increase following exposure of rat cerebellar granule cells to HypF-N prefibrillar aggregates. We found that the intracellular Ca2+ increase was associated with the early activation of NMDA and AMPA receptors, although some nonspecific membrane permeabilization was also observed at longer times of exposure. This result matched a significant co-localization of the aggregates with both receptors on the plasma membrane. Our data support the possibility that glutamatergic channels are generic sites of interaction with the cell membrane of prefibrillar aggregates of different peptides and proteins as well as the key structures responsible for the resulting early membrane permeabilization to Ca2+.	[Pellistri, Francesca; Relini, Annalisa; Gliozzi, Alessandra; Robello, Mauro] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Pellistri, Francesca; Bucciantini, Monica; Relini, Annalisa; Gliozzi, Alessandra; Robello, Mauro; Stefani, Massimo] Univ Florence, Res Ctr Mol Basis Neurodegenerat, I-50134 Florence, Italy; [Bucciantini, Monica; Stefani, Massimo] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Nosi, Daniele] Univ Florence, Dept Anat Histol & Forens Med, I-50134 Florence, Italy	University of Genoa; University of Florence; University of Florence; University of Florence	Robello, M (corresponding author), Univ Genoa, Dept Phys, Via Dodecaneso 33, I-16146 Genoa, Italy.	robello@fisica.unige.it	Relini, Annalisa/AHC-3105-2022	RELINI, ANNALISA/0000-0002-4040-9279; STEFANI, MASSIMO/0000-0002-4490-1922; bucciantini, monica/0000-0002-5243-9301	Italian MUR [2005053998_001, _005]; Fondazione CARIGE; Ente Cassa di Risparmio di Firenze	Italian MUR(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by Italian MUR Grants 2005053998_001 and _005, Fondazione CARIGE, and Ente Cassa di Risparmio di Firenze. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMICO C, 1995, J NEUROSCI, V15, P2839; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Canale C, 2006, BIOPHYS J, V91, P4575, DOI 10.1529/biophysj.106.089482; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Casagrande S, 2007, NEUROSCI LETT, V414, P273, DOI 10.1016/j.neulet.2006.12.024; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dorningues A, 2007, NEUROCHEM INT, V50, P872, DOI 10.1016/j.neuint.2007.03.001; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hyun DH, 2002, J BIOL CHEM, V277, P28572, DOI 10.1074/jbc.M200666200; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P173, DOI 10.1023/A:1010932603406; Kranenburg O, 2003, FEBS LETT, V539, P149, DOI 10.1016/S0014-5793(03)00218-7; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Relini A, 2004, J MOL BIOL, V338, P943, DOI 10.1016/j.jmb.2004.03.054; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Taddei N, 1996, BIOCHEMISTRY-US, V35, P7077, DOI 10.1021/bi952900b; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244	44	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29950	29960		10.1074/jbc.M803992200	http://dx.doi.org/10.1074/jbc.M803992200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18676369	Green Published, hybrid			2022-12-25	WOS:000260366900040
J	Qi, Z; Shi, WG; Xue, N; Pan, CG; Jing, WG; Liu, KL; Jiang, SB				Qi, Zhi; Shi, Weiguo; Xue, Na; Pan, Chungen; Jing, Weiguo; Liu, Keliang; Jiang, Shibo			Rationally Designed Anti-HIV Peptides Containing Multifunctional Domains as Molecule Probes for Studying the Mechanisms of Action of the First and Second Generation HIV Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL COILED-COIL; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; ATOMIC-STRUCTURE; CORE STRUCTURE; TYPE-1 GP41; VIRUS; ENTRY; PROTEIN	We have previously shown that the first generation human immunodeficiency virus (HIV) fusion inhibitor T20 (Fuzeon) contains a critical lipid-binding domain (LBD), whereas C34, another anti-HIV peptide derived from the gp41 C-terminal heptad repeat, consists of an important pocket-binding domain (PBD), and both share a common 4-3 heptad repeat (HR) sequence (Liu, S., Jing, W., Cheung, B., Lu, H., Sun, J., Yan, X., Niu, J., Farmar, J., Wu, S., and Jiang, S. (2007) J. Biol. Chem. 282, 9612-9620). T1249, the second generation HIV fusion inhibitor, has both LBD and PBD but a different HR sequence, suggesting that these three anti-HIV peptides may have distinct mechanisms of action. Here we rationally designed a set of peptides that contain multiple copies of a predicted HR sequence (5HR) or the HR sequence plus either LBD (4HR-LBD) or PBD (PBD-4HR) or both (PBD-3HR-LBD), and we compared their anti-HIV-1 activity and biophysical properties. We found that the peptide 5HR exhibited low-to-moderate inhibitory activity on HIV-1-mediated cell-cell fusion, whereas addition of LBD and/or PBD to the HR sequence resulted in a significant increase of the anti-HIV-1 activity. The peptides containing PBD, including PBD-4HR and PBD-3HR-LBD, could form a stable six-helix bundle with the N-peptide N46 and effectively blocked the gp41 core formation, whereas the peptides containing LBD, e. g. 4HR-LBD and PBD-3HR-LBD, could interact with the lipid vehicles. These results suggest that the HR sequence in these anti-HIV peptides acts as a structure domain and is responsible for its interaction with the HR sequence in N-terminal heptad repeat, whereas PBD and LBD are critical for interactions with their corresponding targets. T20, C34, and T1249 may function like 4HR-LBD, PBD-4HR, and PBD-3HR-LBD, respectively, to interact with different target sites for inhibiting HIV fusion and entry. Therefore, this study provides important information for understanding the mechanisms of action of the peptic HIV-1 fusion inhibitors and for rational design of novel antiviral peptides against HIV and other viruses with class I fusion proteins.	[Shi, Weiguo; Liu, Keliang] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Qi, Zhi; Xue, Na; Pan, Chungen; Jing, Weiguo; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Pan, Chungen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Academy of Military Medical Sciences - China; New York Blood Center; Peking University	Liu, KL (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China.	keliangliu@yahoo.com; sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health [AI46221]; China Postdoctoral Science Foundation [20070410511]; Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences [2005-2-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46221 (to S. J.). This work was also supported by China Postdoctoral Science Foundation Grant 20070410511 (to W. S.) and Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences Grant 2005-2-6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG S, 2000, P SOC PHOTO-OPT INS, V3926, P212, DOI DOI 10.1117/12.380514; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V270, P153, DOI 10.1006/bbrc.2000.2411; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V269, P641, DOI 10.1006/bbrc.1999.1972; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Lazzarin A, 2005, EXPERT OPIN PHARMACO, V6, P453, DOI 10.1517/14656566.6.3.453; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	32	48	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30376	30384		10.1074/jbc.M804672200	http://dx.doi.org/10.1074/jbc.M804672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18662985	Green Published, hybrid			2022-12-25	WOS:000260366900081
J	Lee, BC; Le, DT; Gladyshev, VN				Lee, Byung Cheon; Le, Dung Tien; Gladyshev, Vadim N.			Mammals reduce methionine-S-sulfoxide with MsrA and are unable to reduce methionine-R-sulfoxide, and this function can be restored with a yeast reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; AMINO-ACIDS; LIFE-SPAN; METABOLISM; PROTEIN; TRANSCRIPTION; CYSTEINE; REVEALS; CELLS; ATF3	Methionine is an essential amino acid in mammals at the junction of methylation, protein synthesis, and sulfur pathways. However, this amino acid is highly susceptible to oxidation, resulting in a mixture of methionine-S-sulfoxide and methionine-R-sulfoxide. Whether methionine is quantitatively regenerated from these compounds is unknown. Here we report that SK-Hep1 hepatocytes grew on methionine-S-sulfoxide and consumed this compound by import and methionine-S-sulfoxide reductase (MsrA)-dependent reduction, but methionine-R-sulfoxide reductases were not involved in this process, and methionine-R-sulfoxide could not be used by the cells. However, SKHep1 cells expressing a yeast free methionine-R-sulfoxide reductase proliferated in the presence of either sulfoxide, reduced them, and showed increased resistance to oxidative stress. Only methionine-R-sulfoxide was detected in the plasma of wild type mice, but both sulfoxides were in the plasma of MsrA knock-out mice. These results show that mammals can support methionine metabolism by reduction of methionine-S-sulfoxide, that this process is dependent on MsrA, that mammals are inherently deficient in the reduction of methionine-R-sulfoxide, and that expression of yeast free methionine-R-sulfoxide reductase can fully compensate for this deficiency.	[Gladyshev, Vadim N.] Univ Nebraska, Beadle Ctr N151, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Univ Nebraska, Beadle Ctr N151, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Le, Dung Tien/A-7276-2008; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Le, Dung Tien/0000-0002-5117-3476; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V. N. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker DH, 2005, P NATL ACAD SCI USA, V102, P17897, DOI 10.1073/pnas.0509317102; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Elmore CL, 2007, ANTIOXID REDOX SIGN, V9, P1911, DOI 10.1089/ars.2007.1795; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Fukushima E, 2007, J BACTERIOL, V189, P7134, DOI 10.1128/JB.00751-06; HAENOLD R, 2007, FREE RADICAL RES, V28, P1; Kim HY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-11; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Oien DB, 2007, BIOCHEM BIOPH RES CO, V352, P556, DOI 10.1016/j.bbrc.2006.11.063; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	27	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28361	28369		10.1074/jbc.M805059200	http://dx.doi.org/10.1074/jbc.M805059200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697736	Green Published, hybrid			2022-12-25	WOS:000259969300038
J	Li, YJ; Wei, YS; Fu, XH; Hao, DL; Xue, Z; Gong, H; Zhang, ZQ; Liu, DP; Liang, CC				Li, Ya-Jun; Wei, Yu-Sheng; Fu, Xiang-Hui; Hao, De-Long; Xue, Zheng; Gong, Huan; Zhang, Zhu-Qin; Liu, De-Pei; Liang, Chih-Chuan			The apolipoprotein CIII enhancer regulates both extensive histone modification and Intergenic transcription of human apolipoprotien AI/CIII/AIV genes but not apolipoprotein AV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; RESPONSE ELEMENT; ACETYLTRANSFERASE ACTIVITY; TARGETED RECRUITMENT; TRANSGENIC MICE; ACTIVE GENES; IN-VIVO; C-III; CHROMATIN	The apolipoprotein (apo) AI/CIII/AIV/AV cluster genes are expressed at different levels in the liver and intestine. The apoCIII enhancer, a common regulatory element, regulates the tissue-specific expression of apoAI, apoCIII, and apoAIV but not apoAV. To study this regulation at the chromatin level, the histone modifications and intergenic transcription in the human apoAI/CIII/AIV/AV cluster were investigated in HepG2 and Caco-2 cells and in the livers of transgenic mice carrying the human gene cluster constructs with or without the apoCIII enhancer. We found that both the promoters and the intergenic regions of the apoAI/CIII/AIV genes were hyperacetylated and formed an open subdomain that did not include the apoAV gene. Hepatic and intestinal intergenic transcripts were identified to transcribe bidirectionally with strand preferences along the cluster. The deletion of the apoCIII enhancer influenced both histone modification and intergenic transcription in the apoAI/CIII/AIV gene region. These results demonstrate that the apoCIII enhancer contributes to the maintenance of an active chromatin subdomain of the apoAI/CIII/AIV genes, but not apoAV.	[Liu, De-Pei] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, DP (corresponding author), Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.	liudp@pumc.edu.cn	fu, xianghui/B-9165-2014	Fu, Xianghui/0000-0001-9808-3892; Liu, De-Pei/0000-0002-2636-4297	National Natural Science Foundation of China [30500297, 30721063]; National Basic Research Program of China [2005CB522402, 2006CB503801]; National High-tech Research and Development Program of China [2006AA02A406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China Grants 30500297 and 30721063, National Basic Research Program of China Grants 2005CB522402 and 2006CB503801, and National High-tech Research and Development Program of China Grant 2006AA02A406. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fu XH, 2005, EXP CELL RES, V309, P174, DOI 10.1016/j.yexcr.2005.05.015; Gao J, 2005, J BIOL CHEM, V280, P12559, DOI 10.1074/jbc.M409883200; Genoux A, 2005, ARTERIOSCL THROM VAS, V25, P1186, DOI 10.1161/01.ATV.0000163841.85333.83; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Jakel H, 2006, ANN MED, V38, P2, DOI 10.1080/07853890500407488; Kan HY, 2000, J BIOL CHEM, V275, P30423, DOI 10.1074/jbc.M005641200; Kardassis D, 2002, BIOCHEMISTRY-US, V41, P1217, DOI 10.1021/bi015618f; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim A, 2007, MOL CELL BIOL, V27, P2980, DOI 10.1128/MCB.02337-06; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Li YJ, 2004, INT J BIOCHEM CELL B, V36, P1411, DOI 10.1016/j.biocel.2003.11.003; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Prieur X, 2005, MOL ENDOCRINOL, V19, P3107, DOI 10.1210/me.2005-0048; Prieur X, 2003, J BIOL CHEM, V278, P25468, DOI 10.1074/jbc.M301302200; Rong JX, 2000, ANN MED, V32, P642, DOI 10.3109/07853890009002035; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zhu XG, 2007, NUCLEIC ACIDS RES, V35, P5532, DOI 10.1093/nar/gkm595	42	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28436	28444		10.1074/jbc.M710289200	http://dx.doi.org/10.1074/jbc.M710289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678879	Green Published, hybrid			2022-12-25	WOS:000259969300045
J	Fulton, Z; McAlister, A; Wilce, MCJ; Brammananth, R; Zaker-Tabrizi, L; Perugini, MA; Bottomley, SP; Coppel, RL; Crellin, PK; Rossjohn, J; Beddoe, T				Fulton, Zara; McAlister, Adrian; Wilce, Matthew C. J.; Brammananth, Rajini; Zaker-Tabrizi, Leyla; Perugini, Matthew A.; Bottomley, Stephen P.; Coppel, Ross L.; Crellin, Paul K.; Rossjohn, Jamie; Beddoe, Travis			Crystal structure of a UDP-glucose-specific glycosyltransferase from a Mycobacterium Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY; COMPLEX; ULTRACENTRIFUGATION; RECOGNITION; ALIGNMENT; DONOR; SPSA	Glycosyltransferases (GTs) are a large and ubiquitous family of enzymes that specifically transfer sugar moieties to a range of substrates. Mycobacterium tuberculosis contains a large number of GTs, many of which are implicated in cell wall synthesis, yet the majority of these GTs remain poorly characterized. Here, we report the high resolution crystal structures of an essential GT (MAP2569c) from Mycobacterium avium subsp. paratuberculosis (a close homologue of Rv1208 from M. tuberculosis) in its apo- and ligand-bound forms. The structure adopted the GT-A fold and possessed the characteristic DXD motif that coordinated an Mn2+ ion. Atypical of most GTs characterized to date, MAP2569c exhibited specificity toward the donor substrate, UDP-glucose. The structure of this ligated complex revealed an induced fit binding mechanism and provided a basis for this unique specificity. Collectively, the structural features suggested that MAP2569c may adopt a "retaining" enzymatic mechanism, which has implications for the classification of other GTs in this large superfamily.	[Fulton, Zara; McAlister, Adrian; Wilce, Matthew C. J.; Zaker-Tabrizi, Leyla; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Prot Crystallog Unit, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Fulton, Zara; Brammananth, Rajini; Zaker-Tabrizi, Leyla; Coppel, Ross L.; Crellin, Paul K.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Perugini, Matthew A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; University of Melbourne; Monash University	Beddoe, T (corresponding author), Monash Univ, Prot Crystallog Unit, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	travis.beddoe@med.monash.edu.au	Rossjohn, Jamie/F-9032-2013; Coppel, Ross L/A-6626-2008; Beddoe, Travis/F-3415-2014	Rossjohn, Jamie/0000-0002-2020-7522; Coppel, Ross L/0000-0002-4476-9124; Beddoe, Travis/0000-0003-4550-2277; Crellin, Paul K/0000-0002-2017-4935	Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council (NHMRC) of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fulton Z, 2008, ACTA CRYSTALLOGR F, V64, P428, DOI 10.1107/S1744309108011196; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wimmerova M, 2003, BIOCHIMIE, V85, P691, DOI 10.1016/S0300-9084(03)00120-2; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	35	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27881	27890		10.1074/jbc.M801853200	http://dx.doi.org/10.1074/jbc.M801853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667419	hybrid			2022-12-25	WOS:000259719200059
J	Liang, XB; Butterworth, MB; Peters, KW; Walker, WH; Frizzell, RA				Liang, Xiubin; Butterworth, Michael B.; Peters, Kathryn W.; Walker, William H.; Frizzell, Raymond A.			An obligatory heterodimer of 14-3-3 beta and 14-3-3 epsilon is required for aldosterone regulation of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; COLLECTING DUCT CELLS; NA+ CHANNEL; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; STRUCTURAL BASIS; BLOOD-PRESSURE; RAT-KIDNEY; PROTEINS; ENAC	Increased distal nephron sodium absorption in response to aldosterone involves Nedd4-2 phosphorylation, which blocks its ability to ubiquitylate ENaC and increases apical membrane channel density by reducing its endocytosis. Our prior work (Liang, X., Peters, K. W., Butterworth, M. B., and Frizzell, R. A. ( 2006) J. Biol. Chem. 281, 16323-16332) showed that aldosterone selectively increased 14-3-3 protein isoform expression and that the association of 14-3-3 with phospho-Nedd4-2 was required for sodium transport stimulation. The knockdown of 14-3-3 beta alone nearly eliminated the response to aldosterone, despite the expression of other 14-3-3 isoforms in cortical collecting duct (CCD) cells. To further examine this marked effect of 14-3-3 knockdown, we evaluated the hypothesis that phospho-Nedd4-2 binding prefers a heterodimer composed of two different 14-3-3 isoforms. We tested this concept in polarized CCD cells using RNA interference and assays of sodium transport and of the interaction of Nedd4-2 with 14-3-3 epsilon, a second aldosterone-induced isoform. As observed previously for 14-3-3 knockdown, small interfering RNA-induced reduction of 14-3-3 markedly attenuated aldosterone-stimulated ENaC expression and sodium transport and increased the interaction of Nedd4-2 with ENaC toward prealdosterone levels. After aldosterone induction, 14-3-3 and 14-3-3 were quantitatively co-immunoprecipitated from CCD cell lysates, and the association of both isoforms with Nedd4-2 increased. Finally, the knockdown of either 14-3-3 or 14-3-3 reduced the association of Nedd4-2 with the other isoform. We conclude that the two aldosterone- induced 14-3-3 isoforms, beta and epsilon, interact with phospho-Nedd4-2 as an obligatory heterodimer, blocking its interaction with ENaC and thereby increasing apical ENaC density and sodium transport.	[Liang, Xiubin; Butterworth, Michael B.; Peters, Kathryn W.; Walker, William H.; Frizzell, Raymond A.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, S362 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu			National Institutes of Health [DK54814, DK72506]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054814, K99DK078917, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54814 and DK72506. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bonny O, 2002, J AM SOC NEPHROL, V13, P2399, DOI 10.1097/01.ASN.0000028641.59030.B2; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; BUTTERWORTH MB, 2008, AM J PHYSL IN PRESS; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hou JH, 2002, J AM SOC NEPHROL, V13, P1190, DOI 10.1097/01.ASN.0000013702.73570.3B; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Naray-Fejes-Toth A, 2004, MOL CELL ENDOCRINOL, V217, P197, DOI 10.1016/j.mce.2003.10.043; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; Sagnella GA, 2006, CURR PHARM DESIGN, V12, P2221, DOI 10.2174/138161206777585157; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Stokes JB, 1999, KIDNEY INT, V56, P2318, DOI 10.1046/j.1523-1755.1999.00803.x; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	44	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27418	27425		10.1074/jbc.M803687200	http://dx.doi.org/10.1074/jbc.M803687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687683	Green Published, hybrid			2022-12-25	WOS:000259719200010
J	Liao, H; Huang, WH; Schachner, M; Guan, Y; Guo, JJ; Yan, J; Qin, J; Bai, XS; Zhang, LY				Liao, Hong; Huang, Wenhui; Schachner, Melitta; Guan, Yue; Guo, Jingjing; Yan, Jun; Qin, Jing; Bai, Xianshu; Zhang, Luyong			beta 1 integrin-mediated effects of tenascin-R domains EGFL and FN6-8 on neural stem/progenitor cell proliferation and differentiation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX GLYCOPROTEIN; SUBVENTRICULAR ZONE; MICE DEFICIENT; MESSENGER-RNA; STEM-CELLS; ADHESION; NEUROGENESIS; J1-160/180; MIGRATION; JANUSIN	Neural stem/progenitor cells (NSCs) have the capacity for self-renewal and differentiation into major classes of central nervous system cell types, such as neurons, astrocytes, and oligodendrocytes. The determination of fate of NSCs appears to be regulated by both intrinsic and extrinsic factors. Mounting evidence has shown that extracellular matrix molecules contribute to NSC proliferation and differentiation as extrinsic factors. Here we explore the effects of the epidermal growth factor-like (EGFL) and fibronectin type III homologous domains 6-8 (FN6-8) of the extracellular matrix molecule tenascin-R on NSC proliferation and differentiation. Our results show that domain FN6-8 inhibited NSC proliferation and promoted NSCs differentiation into astrocytes and less into oligodendrocytes or neurons. The EGFL domain did not affect NSC proliferation, but promoted NSC differentiation into neurons and reduced NSC differentiation into astrocytes and oligodendrocytes. Treatment of NSCs with beta 1 integrin function-blocking antibody resulted in attenuation of inhibition of the effect of FN6-8 on NSC proliferation. The influence of EGFL or FN6-8 on NSCs differentiation was inhibited by beta 1 integrin antibody application, implicating beta 1 integrin in proliferation and differentiation induced by EGFL and FN6-8 mediated triggering of NSCs.	[Liao, Hong; Huang, Wenhui; Guan, Yue; Guo, Jingjing; Yan, Jun; Qin, Jing; Bai, Xianshu] China Pharmaceut Univ, Neurobiol Lab, New Drug Screening Ctr, Nanjing 210038, Peoples R China; [Zhang, Luyong] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210038, Peoples R China; [Huang, Wenhui; Schachner, Melitta] Univ Hamburg, Zentrum Mol Biol, D-20251 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	China Pharmaceutical University; China Pharmaceutical University; University of Hamburg; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Liao, H (corresponding author), 1 Shen Nong Rd, Nanjing 210038, Peoples R China.	liaohong56@hotmail.com; lyzhang@cpu.edu.cn	Huang, Wenhui/M-6227-2013; Bai, Xianshu/ABY-7478-2022	Huang, Wenhui/0000-0001-9865-0375; Bai, Xianshu/0000-0002-4758-1645	National Natural Science Foundation of China [30670793]; Natural Science Foundation of Jiang Su Province [BK2006150]; International Coorperation Projects of Jiang Su Province [BZ2006050]; Pharmacodynamics Research and Evaluation Fund of Jiang Su Province; Initial Fund of China Pharmaceutical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiang Su Province(Natural Science Foundation of Jiangsu Province); International Coorperation Projects of Jiang Su Province; Pharmacodynamics Research and Evaluation Fund of Jiang Su Province; Initial Fund of China Pharmaceutical University	This work was supported by grants from the National Natural Science Foundation of China (30670793), Natural Science Foundation of Jiang Su Province (BK2006150), International Coorperation Projects of Jiang Su Province (BZ2006050), Pharmacodynamics Research and Evaluation Fund of Jiang Su Province, and Initial Fund of China Pharmaceutical University (to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; BARTSCH U, 1993, GLIA, V9, P57, DOI 10.1002/glia.440090108; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2006, CELL TISSUE RES, V326, P647, DOI 10.1007/s00441-006-0217-1; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gurevicius K, 2004, MOL CELL NEUROSCI, V25, P515, DOI 10.1016/j.mcn.2003.12.001; Hargus G, 2008, STEM CELLS, V26, P1973, DOI 10.1634/stemcells.2007-0929; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liao H, 2005, J BIOL CHEM, V280, P8316, DOI 10.1074/jbc.M412730200; LOCHTER A, 1993, J NEUROSCI, V13, P3986; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Norenberg U, 1996, INT J DEV NEUROSCI, V14, P217, DOI 10.1016/0736-5748(96)00009-3; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; PESHEVA P, 1994, J CELL SCI, V107, P2323; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Pesheva P, 1997, J NEUROSCI, V17, P4642; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; Scheffler B, 1999, TRENDS NEUROSCI, V22, P348, DOI 10.1016/S0166-2236(99)01416-2; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Steindler DA, 1996, PROG BRAIN RES, V108, P349, DOI 10.1016/S0079-6123(08)62551-0; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; van Meeteren ME, 2005, DEV BRAIN RES, V156, P78, DOI 10.1016/j.devbrainres.2005.02.005; WINTERGERST ES, 1993, EUR J NEUROSCI, V5, P299, DOI 10.1111/j.1460-9568.1993.tb00497.x; Xiao ZC, 1997, J NEUROSCI RES, V49, P698, DOI 10.1002/(SICI)1097-4547(19970915)49:6<698::AID-JNR4>3.0.CO;2-2; Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x	44	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27927	27936		10.1074/jbc.M804764200	http://dx.doi.org/10.1074/jbc.M804764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658130	hybrid			2022-12-25	WOS:000259719200063
J	Cain, SA; Baldwin, AK; Mahalingam, Y; Raynal, B; Jowitt, TA; Shuttleworth, CA; Couchman, JR; Kielty, CM				Cain, Stuart A.; Baldwin, Andrew K.; Mahalingam, Yashithra; Raynal, Bertrand; Jowitt, Thomas A.; Shuttleworth, C. Adrian; Couchman, John R.; Kielty, Cay M.			Heparan sulfate regulates fibrillin-1 N- and C-terminal interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION FORMATION; MARFAN-SYNDROME; CALCIUM DETERMINES; HUMAN TROPOELASTIN; RICH MICROFIBRILS; CELL-ADHESION; ORGANIZATION; MOLECULES; PROTEINS; DOMAINS	Fibrillin-1 N- and C-terminal heparin binding sites have been characterized. An unprocessed monomeric N- terminal fragment (PF1) induced a very high heparin binding response, indicating heparin-mediated multimerization. Using PF1 deletion and short fragments, a heparin binding site was localized within the domain encoded by exon 7 after the first hybrid domain. Rodent embryonic fibroblasts adhered to PF1 and deletion fragments, and, when cells were plated on fibrillin-1 or fibronectin Arg-Gly-Asp cell-binding fragments, cells showed heparin-dependent spreading and focal contact formation in response to soluble PF1. Within domains encoded by exons 59 - 62 near the fibrillin-1 C terminus are novel conformation-dependent high affinity heparin and tropoelastin binding sites. Heparin disrupted tropoelastin binding but did not disrupt N- and C-terminal fibrillin-1 interactions. Thus, fibrillin-1 N- terminal interactions with heparin/heparan sulfate directly influence cell behavior, whereas C-terminal interactions with heparin/heparan sulfate regulate elastin deposition. These data highlight how heparin/heparan sulfate controls fibrillin-1 interactions.	[Cain, Stuart A.; Baldwin, Andrew K.; Raynal, Bertrand; Jowitt, Thomas A.; Shuttleworth, C. Adrian; Kielty, Cay M.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Mahalingam, Yashithra] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; [Couchman, John R.] Univ Copenhagen, Inst Biomed, Bioctr, DK-2200 Copenhagen, Denmark; [Raynal, Bertrand] Inst Pasteur, F-75724 Paris 15, France	University of Manchester; Imperial College London; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Cain, Stuart A/G-2836-2017	Jowitt, Thomas/0000-0002-4045-0933; Baldwin, Andrew/0000-0002-8331-6769; Cain, Stuart/0000-0001-8417-1058; raynal, Bertrand/0000-0001-5634-0408	British Heart Foundation [PG/04/052/17027]; Wellcome Trust [081930]; Medical Research Council [0200246]; European Union [LSHM-CT-2005-018960]; Medical Research Council [G0200246] Funding Source: researchfish; MRC [G0200246] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by British Heart Foundation Grant PG/04/052/17027, Wellcome Trust Grant 081930, Medical Research Council Grant G0200246, and European Union Grant LSHM-CT-2005-018960. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; BLOOMFIE.V, 1967, BIOPOLYMERS, V5, P135, DOI 10.1002/bip.1967.360050202; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, METHODS, V45, P42, DOI 10.1016/j.ymeth.2008.01.005; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; Nardella C, 2004, ANAL BIOCHEM, V332, P368, DOI 10.1016/j.ab.2004.05.050; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wess TJ, 1998, J CELL BIOL, V141, P829, DOI 10.1083/jcb.141.3.829	32	47	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27017	27027		10.1074/jbc.M803373200	http://dx.doi.org/10.1074/jbc.M803373200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669635	hybrid			2022-12-25	WOS:000259586600022
J	Schutte, M; Elstrodt, F; Bralten, LBC; Nagel, JHA; Duijm, E; Hollestelle, A; Vuerhard, MJ; Wasielewski, M; Peeters, JK; van der Spek, P; Smitt, PAS; French, PJ				Schutte, Mieke; Elstrodt, Fons; Bralten, Linda B. C.; Nagel, Jord H. A.; Duijm, Elza; Hollestelle, Antoinette; Vuerhard, Maartje J.; Wasielewski, Marijke; Peeters, Justine K.; van der Spek, Peter; Smitt, Peter A. Sillevis; French, Pim J.			Exon Expression Arrays as a Tool to Identify New Cancer Genes	PLOS ONE			English	Article								Background: Identification of genes that are causally implicated in oncogenesis is a major goal in cancer research. An estimated 10-20% of cancer-related gene mutations result in skipping of one or more exons in the encoded transcripts. Here we report on a strategy to screen in a global fashion for such exon-skipping events using PAttern based Correlation (PAC). The PAC algorithm has been used previously to identify differentially expressed splice variants between two predefined subgroups. As genetic changes in cancer are sample specific, we tested the ability of PAC to identify aberrantly expressed exons in single samples. Principal Findings: As a proof-of-principle, we tested the PAC strategy on human cancer samples of which the complete coding sequence of eight cancer genes had been screened for mutations. PAC detected all seven exon-skipping mutants among 12 cancer cell lines. PAC also identified exon- skipping mutants in clinical cancer specimens although detection was compromised due to heterogeneous (wild-type) transcript expression. PAC reduced the number of candidate genes/exons for subsequent mutational analysis by two to three orders of magnitude and had a substantial true positive rate. Importantly, of 112 randomly selected outlier exons, sequence analysis identified two novel exon skipping events, two novel base changes and 21 previously reported base changes (SNPs). Conclusions: The ability of PAC to enrich for mutated transcripts and to identify known and novel genetic changes confirms its suitability as a strategy to identify candidate cancer genes.	[Schutte, Mieke; Elstrodt, Fons; Nagel, Jord H. A.; Hollestelle, Antoinette; Wasielewski, Marijke] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Bralten, Linda B. C.; Duijm, Elza; Vuerhard, Maartje J.; Smitt, Peter A. Sillevis; French, Pim J.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Neurol, Rotterdam, Netherlands; [Peeters, Justine K.; van der Spek, Peter] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Bioinformat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Schutte, M (corresponding author), Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands.	a.schutte@erasmusmc.nl; p.french@erasmusmc.nl		French, Pim/0000-0002-0668-9529; Hollestelle, Antoinette/0000-0003-1166-1966	Susan G. Komen Breast Cancer Foundation [BCTR0601309]; Dutch Cancer Society Koningin Wilhelmina Fonds; DDHK [2002-2687]; Erasmus MC Mrace 2005	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); DDHK; Erasmus MC Mrace 2005	This work was supported by the Susan G. Komen Breast Cancer Foundation (BCTR0601309), the Dutch Cancer Society Koningin Wilhelmina Fonds, DDHK 2002-2687 and Erasmus MC Mrace 2005.	BECKER KF, 1994, CANCER RES, V54, P3845; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Frederick L, 2000, CANCER RES, V60, P1383; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Su Gloria H, 2002, Hum Mutat, V19, P81, DOI 10.1002/humu.9002; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van de Wetering M, 2001, CANCER RES, V61, P278; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z	24	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3007	10.1371/journal.pone.0003007	http://dx.doi.org/10.1371/journal.pone.0003007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18688287	gold, Green Published			2022-12-25	WOS:000264420900032
J	Butchar, JP; Cremer, TJ; Clay, CD; Gavrilin, MA; Wewers, MD; Marsh, CB; Schlesinger, LS; Tridandapani, S				Butchar, Jonathan P.; Cremer, Thomas J.; Clay, Corey D.; Gavrilin, Mikhail A.; Wewers, Mark D.; Marsh, Clay B.; Schlesinger, Larry S.; Tridandapani, Susheela			Microarray Analysis of Human Monocytes Infected with Francisella tularensis Identifies New Targets of Host Response Subversion	PLOS ONE			English	Article								Francisella tularensis is a gram-negative facultative bacterium that causes the disease tularemia, even upon exposure to low numbers of bacteria. One critical characteristic of Francisella is its ability to dampen or subvert the host immune response. In order to help understand the mechanisms by which this occurs, we performed Affymetrix microarray analysis on transcripts from blood monocytes infected with the virulent Type A Schu S4 strain. Results showed that expression of several host response genes were reduced such as those associated with interferon signaling, Toll-like receptor signaling, autophagy and phagocytosis. When compared to microarrays from monocytes infected with the less virulent F. tularensis subsp. novicida, we found qualitative differences and also a general pattern of quantitatively reduced pro-inflammatory signaling pathway genes in the Schu S4 strain. Notably, the PI3K/Akt1 pathway appeared specifically down-regulated following Schu S4 infection and a concomitantly lower cytokine response was observed. This study identifies several new factors potentially important in host cell subversion by the virulent Type A F. tularensis that may serve as novel targets for drug discovery.	[Butchar, Jonathan P.; Gavrilin, Mikhail A.; Wewers, Mark D.; Marsh, Clay B.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Div Pulm & Crit Care, Columbus, OH 43210 USA; [Cremer, Thomas J.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH USA; [Clay, Corey D.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microb Interface Biol, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm & Crit Care, Columbus, OH 43210 USA.	jon.butchar@osumc.edu	Wewers, Mark/AAB-6202-2021; Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011	Gavrilin, Mikhail/0000-0003-2003-768X	NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program [1-U54-AI-057153]; NIH [R01 AI059406, P01 CA095426]; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059406, U54AI057153] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V Great Lakes RCE (NIH award 1-U54-AI-057153). This work was also supported by NIH grants R01 AI059406 and P01 CA095426 to ST.	Andersson H, 2006, GENES IMMUN, V7, P503, DOI 10.1038/sj.gene.6364321; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Andersson H, 2006, J MED MICROBIOL, V55, P1023, DOI 10.1099/jmm.0.46553-0; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; CONLAN J, 2008, MOL IMMUNOL; Dudoit S, 2003, BIOTECHNIQUES, P45; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golovliov I, 1996, FEMS IMMUNOL MED MIC, V13, P239, DOI 10.1111/j.1574-695X.1996.tb00244.x; GOLOVLIOV I, 1995, INFECT IMMUN, V63, P534, DOI 10.1128/IAI.63.2.534-538.1995; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; HUNTER S, 1993, EXP HEMATOL, V21, P1492; KARTTUNEN R, 1987, J CLIN MICROBIOL, V25, P1074, DOI 10.1128/JCM.25.6.1074-1078.1987; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; LOFGREN S, 1983, INFECT IMMUN, V39, P715; MALKOVA D, 1986, FOLIA PARASIT, V33, P87; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; PROCTOR RA, 1975, INFECT IMMUN, V11, P146, DOI 10.1128/IAI.11.1.146-151.1975; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Santic M, 2007, CELL MICROBIOL, V9, P2314, DOI 10.1111/j.1462-5822.2007.01021.x; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; SURCEL HM, 1991, INFECT IMMUN, V59, P1948, DOI 10.1128/IAI.59.6.1948-1953.1991; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; WOOLARD M, 2008, INFECT IMMUN; YAMAGATA M, 1994, GENE, V139, P223, DOI 10.1016/0378-1119(94)90760-9; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhao L, 2006, CHEM-ASIAN J, V1, P203, DOI 10.1002/asia.200600097	55	95	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2924	10.1371/journal.pone.0002924	http://dx.doi.org/10.1371/journal.pone.0002924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698339	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600010
J	Doroghazi, JR; Buckley, DH				Doroghazi, James R.; Buckley, Daniel H.			Evidence from GC-TRFLP that Bacterial Communities in Soil Are Lognormally Distributed	PLOS ONE			English	Article							SPECIES-ABUNDANCE; DIVERSITY; MODEL; DNA	The Species Abundance Distribution (SAD) is a fundamental property of ecological communities and the form and formation of SADs have been examined for a wide range of communities including those of microorganisms. Progress in understanding microbial SADs, however, has been limited by the remarkable diversity and vast size of microbial communities. As a result, few microbial systems have been sampled with sufficient depth to generate reliable estimates of the community SAD. We have used a novel approach to characterize the SAD of bacterial communities by coupling genomic DNA fractionation with analysis of terminal restriction fragment length polymorphisms (GC-TRFLP). Examination of a soil microbial community through GC-TRFLP revealed 731 bacterial operational taxonomic units (OTUs) that followed a lognormal distribution. To recover the same 731 OTUs through analysis of DNA sequence data is estimated to require analysis of 86,264 16S rRNA sequences. The approach is examined and validated through construction and analysis of simulated microbial communities in silico. Additional simulations performed to assess the potential effects of PCR bias show that biased amplification can cause a community whose distribution follows a power-law function to appear lognormally distributed. We also show that TRFLP analysis, in contrast to GC-TRFLP, is not able to effectively distinguish between competing SAD models. Our analysis supports use of the lognormal as the null distribution for studying the SAD of bacterial communities as for plant and animal communities.	[Doroghazi, James R.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Buckley, Daniel H.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	Cornell University; Cornell University	Doroghazi, JR (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	dhb28@cornell.edu	Buckley, Daniel H/B-8089-2008	Buckley, Daniel H/0000-0003-1654-2907	National Science Foundation [MCB-0447586]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation under award number MCB-0447586.	Buckley DH, 2007, APPL ENVIRON MICROB, V73, P3196, DOI 10.1128/AEM.02610-06; Buckley DH, 2007, APPL ENVIRON MICROB, V73, P3189, DOI 10.1128/AEM.02609-06; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Bunge J, 2006, SCIENCE, V313, DOI 10.1126/science.1126593; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; Dewdney AK, 2000, BIOL BULL-US, V198, P152, DOI 10.2307/1542811; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Figuerola ELM, 2007, ENVIRON MICROBIOL, V9, P1780, DOI 10.1111/j.1462-2920.2007.01298.x; Frey JC, 2006, J MICROBIOL METH, V67, P9, DOI 10.1016/j.mimet.2006.02.011; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GANS J, 2006, SCIENCE, V313, P918; Gray JS, 2006, J ANIM ECOL, V75, P752, DOI 10.1111/j.1365-2656.2006.01095.x; Holben WE, 2004, APPL ENVIRON MICROB, V70, P2263, DOI 10.1128/AEM.70.4.2263-2270.2004; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Maina GG, 2000, CONSERV BIOL, V14, P1335, DOI 10.1046/j.1523-1739.2000.98510.x; May R.M., 1975, P81; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Narang R, 2004, MICROB ECOL, V47, P396, DOI 10.1007/s00248-003-1026-7; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; R Development Core Team, 2006, R LANG ENV STAT COMP; Sambrook J., MOL CLONING LAB MANU; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Sloan WT, 2007, MICROB ECOL, V53, P443, DOI 10.1007/s00248-006-9141-x; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Volkov I, 2006, SCIENCE, V313, DOI 10.1126/science.1121225; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x	34	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2910	10.1371/journal.pone.0002910	http://dx.doi.org/10.1371/journal.pone.0002910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682841	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600066
J	Efroni, S; Carmel, L; Schaefer, CG; Buetow, KH				Efroni, Sol; Carmel, Liran; Schaefer, Carl G.; Buetow, Kenneth H.			Superposition of Transcriptional Behaviors Determines Gene State	PLOS ONE			English	Article								We introduce a novel technique to determine the expression state of a gene from quantitative information measuring its expression. Adopting a productive abstraction from current thinking in molecular biology, we consider two expression states for a gene-Up or Down. We determine this state by using a statistical model that assumes the data behaves as a combination of two biological distributions. Given a cohort of hybridizations, our algorithm predicts, for the single reading, the probability of each gene's being in an Up or a Down state in each hybridization. Using a series of publicly available gene expression data sets, we demonstrate that our algorithm outperforms the prevalent algorithm. We also show that our algorithm can be used in conjunction with expression adjustment techniques to produce a more biologically sound gene-state call. The technique we present here enables a routine update, where the continuously evolving expression level adjustments feed into gene-state calculations. The technique can be applied in almost any multi-sample gene expression experiment, and holds equal promise for protein abundance experiments.	[Efroni, Sol; Schaefer, Carl G.; Buetow, Kenneth H.] NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA; [Carmel, Liran] Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Efroni, S (corresponding author), NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA.	buetowk@nih.gov	Efroni, Sol/I-6752-2012	Efroni, Sol/0000-0001-7927-6349	NATIONAL CANCER INSTITUTE [Z01BC011059, ZIABC011059] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BITTNER M, 2006, INT GENOMICS CONSORT; Boes T, 2005, METHOD INFORM MED, V44, P414; BOLSTAD B, 2007, RMAEXPRESS; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Duda R. O., 2001, PATTERN CLASSIFICATI, P654, DOI DOI 10.1007/S00357-007-0015-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; HOGG RV, 2005, INTRO MATH STAT, P704; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; IRIZARRY RA, 2007, AFFYCOMP, V2; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; LEE AH, 2007, BIOMETRICS, V63, P10; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mayrose I, 2005, BIOINFORMATICS, V21, P151, DOI 10.1093/bioinformatics/bti1125; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a	15	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2901	10.1371/journal.pone.0002901	http://dx.doi.org/10.1371/journal.pone.0002901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682855	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600057
J	Ueda, S; Kawamata, M; Teratani, T; Shimizu, T; Tamai, Y; Ogawa, H; Hayashi, K; Tsuda, H; Ochiya, T				Ueda, Shinobu; Kawamata, Masaki; Teratani, Takumi; Shimizu, Taku; Tamai, Yoshitaka; Ogawa, Hiromasa; Hayashi, Katsuyuki; Tsuda, Hiroyuki; Ochiya, Takahiro			Establishment of Rat Embryonic Stem Cells and Making of Chimera Rats	PLOS ONE			English	Article								The rat is a reference animal model for physiological studies and for the analysis of multigenic human diseases such as hypertension, diabetes, neurological disorders, and cancer. The rats have long been used in extensive chemical carcinogenesis studies. Thus, the rat embryonic stem (rES) cell is an important resource for the study of disease models. Attempts to derive ES cells from various mammals, including the rat, have not succeeded. Here we have established two independent rES cells from Wister rat blastocysts that have undifferentiated characters such as Nanog and Oct3/4 genes expression and they have stage-specific embryonic antigen (SSEA) -1, -3, -4, and TRA-1-81 expression. The cells were successfully cultured in an undifferentiated state and can be possible over 18 passages with maintaining more than 40% of normal karyotype. Their pluripotent potential was confirmed by the differentiation into derivatives of the endoderm, mesoderm, and ectoderm. Most importantly, the rES cells are capable of producing chimera rats. Therefore, we established pluripotent rES cell lines that are widely used to produce genetically modified experimental rats for study of human diseases.	[Ueda, Shinobu; Kawamata, Masaki; Teratani, Takumi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Tokyo 104, Japan; [Ueda, Shinobu] Waseda Univ, Comprehensive Res Org, Tokyo, Japan; [Shimizu, Taku; Tamai, Yoshitaka] BANYU, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan; [Ogawa, Hiromasa] CLEA Japan Inc, Tokyo, Japan; [Hayashi, Katsuyuki] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Tsuda, Hiroyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan	National Cancer Center - Japan; Waseda University; Novartis; DNA Chip Research Inc.; Nagoya City University	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Tokyo 104, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019; Ogawa, Hiromasa/AAE-2865-2019	Kawamata, Masaki/0000-0002-2607-9672	Ministry of Health, Labour and Welfare of Japan [Grant-in-Aid]; Ministry of Education, Culture, Sports, Science and Technology [Grant-in-Aid]; Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan; Foundation for Promotion of Cancer Research [Research Resident Fellowships]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan; Foundation for Promotion of Cancer Research	This work is supported by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, Health Science Research Grants for Research on the Human Genome and Gene Therapy from the Ministry of Health, Labour and Welfare of Japan, a Grant-in-Aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan. S.U. and M.K. were awardees of Research Resident Fellowships from the Foundation for Promotion of Cancer Research.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; KOMIYA T, 1995, BIOCHEM BIOPH RES CO, V207, P405, DOI 10.1006/bbrc.1995.1202; Liu X, 1997, DEV DYNAM, V209, P85; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stranzinger GF, 1996, INT J EXP PATHOL, V77, P263; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Takahama Y, 1998, ONCOGENE, V16, P3189, DOI 10.1038/sj.onc.1201826; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	34	58	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2800	10.1371/journal.pone.0002800	http://dx.doi.org/10.1371/journal.pone.0002800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665239	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300019
J	Zuin, A; Gabrielli, N; Calvo, IA; Garcia-Santamarina, S; Hoe, KL; Kim, DU; Park, HO; Hayles, J; Ayte, J; Hidalgo, E				Zuin, Alice; Gabrielli, Natalia; Calvo, Isabel A.; Garcia-Santamarina, Sarela; Hoe, Kwang-Lae; Kim, Dong Uk; Park, Han-Oh; Hayles, Jacqueline; Ayte, Jose; Hidalgo, Elena			Mitochondrial Dysfunction Increases Oxidative Stress and Decreases Chronological Life Span in Fission Yeast	PLOS ONE			English	Article								Background: Oxidative stress is a probable cause of aging and associated diseases. Reactive oxygen species (ROS) originate mainly from endogenous sources, namely the mitochondria. Methodology/Principal Findings: We analyzed the effect of aerobic metabolism on oxidative damage in Schizosaccharomyces pombe by global mapping of those genes that are required for growth on both respiratory-proficient media and hydrogen-peroxide-containing fermentable media. Out of a collection of approximately 2700 haploid yeast deletion mutants, 51 were sensitive to both conditions and 19 of these were related to mitochondrial function. Twelve deletion mutants lacked components of the electron transport chain. The growth defects of these mutants can be alleviated by the addition of antioxidants, which points to intrinsic oxidative stress as the origin of the phenotypes observed. These respiration-deficient mutants display elevated steady-state levels of ROS, probably due to enhanced electron leakage from their defective transport chains, which compromises the viability of chronologically-aged cells. Conclusion/Significance: Individual mitochondrial dysfunctions have often been described as the cause of diseases or aging, and our global characterization emphasizes the primacy of oxidative stress in the etiology of such processes.	[Zuin, Alice; Gabrielli, Natalia; Calvo, Isabel A.; Garcia-Santamarina, Sarela; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain; [Hoe, Kwang-Lae; Kim, Dong Uk] KRIBB, Pombe Deletion Project, Taejon, South Korea; [Park, Han-Oh] Bioneer Corp, Taejon, South Korea; [Hayles, Jacqueline] Canc Res UK, London, England	Pompeu Fabra University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cancer Research UK	Zuin, A (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain.	elena.hidalgo@upf.edu	Santamarina, Sarela Garcia/AAA-2261-2021; Garcia Santamarina, Sarela/O-4477-2017; Hidalgo, Elena/K-2919-2014; Ayte, Jose/L-5217-2014	Santamarina, Sarela Garcia/0000-0002-0611-7918; Garcia Santamarina, Sarela/0000-0002-0611-7918; Hidalgo, Elena/0000-0002-3768-6785; Ayte, Jose/0000-0002-6354-0536; Calvo Arnedo, Isabel/0000-0001-6619-4571; Hoe, Kwang Lae/0000-0002-3943-4549	Direccion General de Investigacion of Spain [BFU2006-02610]; Spanish program Consolider-Ingenio 2010 [CSD 2007-0020]	Direccion General de Investigacion of Spain(Spanish Government); Spanish program Consolider-Ingenio 2010	This work was supported by Direccion General de Investigacion of Spain Grant BFU2006-02610, and by the Spanish program Consolider-Ingenio 2010 Grant CSD 2007-0020 to E.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; BRYLA J, 1969, BIOCHIM BIOPHYS ACTA, V189, P327; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P1, DOI 10.1007/BF02046695; BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P442, DOI 10.1007/BF02046758; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P157, DOI 10.1099/00221287-44-2-157; deJongGubbels P, 1996, MICROBIOL-UK, V142, P1399, DOI 10.1099/13500872-142-6-1399; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; HESLOT H, 1970, J BACTERIOL, V104, P473, DOI 10.1128/JB.104.1.473-481.1970; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; POOLE RK, 1973, BIOCHEM J, V136, P195, DOI 10.1042/bj1360195; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Suzuki K, 1997, J BIOCHEM, V121, P496; Swerdlow RH, 2007, ANTIOXID REDOX SIGN, V9, P1591, DOI 10.1089/ars.2007.1676; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	36	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2842	10.1371/journal.pone.0002842	http://dx.doi.org/10.1371/journal.pone.0002842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665268	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300061
J	Anunciado-Koza, R; Ukropec, J; Koza, RA; Kozak, LP				Anunciado-Koza, Rea; Ukropec, Jozef; Koza, Robert A.; Kozak, Leslie P.			Inactivation of UCP1 and the glycerol phosphate cycle synergistically increases energy expenditure to resist diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; BROWN ADIPOSE-TISSUE; COLD-INDUCED THERMOGENESIS; TRANSGENIC MICE LACKING; NONSHIVERING THERMOGENESIS; WHITE FAT; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; BLOOD-FLOW; EXPRESSION; GENE	Our current paradigm for obesity assumes that reduced thermogenic capacity increases susceptibility to obesity, whereas enhanced thermogenic capacity protects against obesity. Here we report that elimination of two major thermogenic pathways encoded by the mitochondrial uncoupling protein (Ucp1) and mitochondrial glycerol-3-phosphate dehydrogenase (Gdm) result in mice with increased resistance to diet-induced obesity when housed at 28 C, provided prior adaptation occurred at 20 C. Obesity resistant Gdm(-/-) .Ucp1(-/-) mice maintained at 28 C have increased energy expenditure, in part through conversion of white to brown adipocytes in inguinal fat. Increased oxygen consumption in inguinal fat cell suspensions and the up-regulation of genes of mitochondrial function and fat metabolism indicated increased thermogenic activity, despite the absence of UCP1, whereas liver and skeletal muscle showed no changes in gene expression. Additionally, comparisons of energy expenditure in UCP1-deficient and wild type mice fed an obesogenic diet indicates that UCP1-based brown fat-based thermogenesis plays no role in so-called diet-induced thermogenesis. Accordingly, a new paradigm for obesity emerges in which the inactivation of major thermogenic pathways force the induction of alternative pathways that increase metabolic inefficiency.	[Anunciado-Koza, Rea; Ukropec, Jozef; Koza, Robert A.; Kozak, Leslie P.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	kozaklp@pbrc.edu	Ukropec, Jozef/AAI-5590-2020; Ukropec, Jozef/D-5960-2018	Ukropec, Jozef/0000-0001-8401-6621	National Institutes of Health [R01-HD08431]; Clinical Nutrition Research Unit (CNRU); COBRE Center [P-30DK072476, P20-RR021945]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008431] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit (CNRU); COBRE Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HD08431. This work was also supported by Clinical Nutrition Research Unit (CNRU) and COBRE Center Grants P-30DK072476 and P20-RR021945, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; BLUNDELL JE, 2004, HDB OBESITY ETIOLOGY, P427; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; Dossantos RA, 2003, ENDOCRINOLOGY, V144, P5469, DOI 10.1210/en.2003-0687; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; DUMONTEIL E, 1993, AM J PHYSIOL, V265, pC507, DOI 10.1152/ajpcell.1993.265.2.C507; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Gambert S, 2007, CURR OPIN CLIN NUTR, V10, P664, DOI 10.1097/MCO.0b013e3282f0b69d; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; HILL J, 2004, HDB OBESITY, P631; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Hirsch J, 1997, NATURE, V387, P27, DOI 10.1038/387027a0; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LARDY H, 1990, ANNU REV BIOCHEM, V59, P689, DOI 10.1146/annurev.biochem.59.1.689; Levin BE, 2007, AM J PHYSIOL-REG I, V293, pR988, DOI 10.1152/ajpregu.00434.2007; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; Marrif H, 2005, ENDOCRINOLOGY, V146, P2872, DOI 10.1210/en.2004-1544; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; RATNER PL, 1981, J BIOL CHEM, V256, P3576; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHUTZ Y, 2004, HDB OBESITY ETIOLOGY, P615; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	55	77	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27688	27697		10.1074/jbc.M804268200	http://dx.doi.org/10.1074/jbc.M804268200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18678870	Green Published, hybrid			2022-12-25	WOS:000259719200040
J	Crawford, DK; Perkins, DI; Trudell, JR; Bertaccini, EJ; Davies, DL; Alkana, RL				Crawford, Daniel K.; Perkins, Daya I.; Trudell, James R.; Bertaccini, Edward J.; Davies, Daryl L.; Alkana, Ronald L.			Roles for Loop 2 residues of alpha 1 glycine receptors in agonist activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; SIGNATURE DISULFIDE LOOP; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; CHARGED RESIDUES; LIGAND-BINDING; A RECEPTOR; SUBUNIT; GABA(A)	The present study tested the hypothesis that several residues in Loop 2 of alpha 1 glycine receptors (GlyRs) play important roles in mediating the transduction of agonist activation to channel gating. This was accomplished by investigating the effect of cysteine point mutations at positions 50 - 60 on glycine responses in alpha 1GlyRs using two-electrode voltage clamp of Xenopus oocytes. Cysteine substitutions produced position-specific changes in glycine sensitivity that were consistent with a beta-turn structure of Loop 2, with odd-numbered residues in the beta-turn interacting with other agonist-activation elements at the interface between extracellular and transmembrane domains. We also tested the hypothesis that the charge at position 53 is important for agonist activation by measuring the glycine response of wild type (WT) and E53C GlyRs exposed to methanethiosulfonate reagents. As earlier, E53C GlyRs have a significantly higher EC50 thanWTGlyRs. Exposing E53C GlyRs to the negatively charged 2-sulfonatoethyl methanethiosulfonate, but not neutral 2-hydroxyethyl methanethiosulfonate, positively charged 2-aminoethyl methanethiosulfonate, or 2-trimethyl-ammonioethyl methanethiosulfonate, decreased the glycine EC50 to resemble WT GlyR responses. Exposure to these reagents did not significantly alter the glycine EC50 for WT GlyRs. The latter findings suggest that the negative charge at position 53 is important for activation of GlyRs through its interaction with positive charge(s) in other neighboring agonist activation elements. Collectively, the findings provide the basis for a refined molecular model of alpha 1GlyRs based on the recent x-ray structure of a prokaryotic pentameric ligand-gated ion channel and offer insight into the structure-function relationships in GlyRs and possibly other ligand-gated ion channels.	[Davies, Daryl L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Lab, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Crawford, Daniel K.; Alkana, Ronald L.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Trudell, James R.; Bertaccini, Edward J.] Stanford Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Trudell, James R.; Bertaccini, Edward J.] Stanford Sch Med, Beckman Program Mol & Genet Med, Stanford, CA 94305 USA; [Bertaccini, Edward J.] Palo Alto Vet Affairs Hlth Care Syst, Dept Anesthesia, Palo Alto, CA 94304 USA	University of Southern California; University of Southern California; Stanford University; Stanford University	Davies, DL (corresponding author), Univ So Calif, Sch Pharm, Alcohol & Brain Res Lab, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave PSC 500, Los Angeles, CA 90089 USA.	ddavies@usc.edu	Davies, Daryl L/P-1137-2016	Davies, Daryl L/0000-0003-2940-7739; Bertaccini, Edward/0000-0002-9062-0566; Crawford, Daniel/0000-0002-0169-8645	National Institutes of Health, NIAAA [AA03972, AA013890, AA013922, AA013378]; University of Southern California School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013378, R01AA003972, R01AA013922, R21AA013890] Funding Source: NIH RePORTER	National Institutes of Health, NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Southern California School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health, NIAAA, Grants AA03972 (to R. L. A.), AA013890 (to D. L. D.), AA013922 (to D. L. D.), and AA013378 (to J. R. T.) and the University of Southern California School of Pharmacy. This work was conducted as partial fulfillment of the requirements for the Ph. D. degree in Neuroscience, University of Southern California (D. K. C.). Portions of these findings were presented at the Annual Meeting of the Society for Neuroscience in Atlanta, GA (Program 233.7/D32, 2006 Neuroscience Meeting Planner, Atlanta, GA, Society for Neuroscience). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Asgary MP, 2007, BIOINFORMATICS, V23, P3125, DOI 10.1093/bioinformatics/btm324; Bertaccini E, 2002, PROTEIN ENG, V15, P443, DOI 10.1093/protein/15.6.443; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen ZW, 2005, MOL PHARMACOL, V68, P152, DOI 10.1124/mol.104.009878; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; Davies DL, 2004, J NEUROCHEM, V89, P1175, DOI 10.1111/j.1471-4159.2004.02390.x; Davies DL, 2003, ALCOHOL CLIN EXP RES, V27, P743, DOI 10.1097/01.ALC.0000065722.31109.A1; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Hales TG, 2006, J BIOL CHEM, V281, P17034, DOI 10.1074/jbc.M603599200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mascia MP, 1996, MOL PHARMACOL, V50, P402; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; Ortells MO, 1997, PROTEIN ENG, V10, P511, DOI 10.1093/protein/10.5.511; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tang P, 2002, BIOPHYS J, V83, P252, DOI 10.1016/S0006-3495(02)75166-7; THEUSCH CM, 2005, SOC NEUR ABSTR; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	47	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27698	27706		10.1074/jbc.M802384200	http://dx.doi.org/10.1074/jbc.M802384200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658152	hybrid, Green Published			2022-12-25	WOS:000259719200041
J	Knight, KK; Wentzlaff, DM; Snyder, PM				Knight, Kristin K.; Wentzlaff, Danielle M.; Snyder, Peter M.			Intracellular sodium regulates proteolytic activation of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; FEEDBACK INHIBITION; CYTOSOLIC NA+; FROG-SKIN; RAT CCT; EXPRESSION; TRANSPORT; FURIN; MEMBRANE; CLEAVAGE	Na+ transport across epithelia is mediated in part by the epithelial Na+ channel ENaC. Previous work indicates that Na+ is an important regulator of ENaC, providing a negative feedback mechanism to maintain Na+ homeostasis. ENaC is synthesized as an inactive precursor, which is activated by proteolytic cleavage of the extracellular domains of the alpha and gamma subunits. Here we found that Na+ regulates ENaC in part by altering proteolytic activation of the channel. When the Na+ concentration was low, we found that the majority of ENaC at the cell surface was in the cleaved/active state. As Na+ increased, there was a dose-dependent decrease in ENaC cleavage and, hence, ENaC activity. This Na+ effect was dependent on Na+ permeation; cleavage was increased by the ENaC blocker amiloride and by a mutation that decreases ENaC activity (alpha(H69A)) and was reduced by a mutation that activates ENaC (beta(S520K)). Moreover, the Na+ ionophore monensin reversed the effect of the inactivating mutation (alpha(H69A)) on ENaC cleavage, suggesting that intracellular Na+ regulates cleavage. Na+ did not alter activity of Nedd4-2, an E3 ubiquitin ligase that modulates ENaC cleavage, but Na+ reduced ENaC cleavage by exogenous trypsin. Our findings support a model in which intracellular Na+ regulates cleavage by altering accessibility of ENaC cleavage sites to proteases and provide a molecular explanation for the earlier observation that intracellular Na+ inhibits Na+ transport via ENaC (Na+ feedback inhibition).	[Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by the National Institutes of Health.	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bengrine A, 2007, FASEB J, V21, P1189, DOI 10.1096/fj.06-6046com; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; FRINDT G, 1993, AM J PHYSIOL, V264, pF565, DOI 10.1152/ajprenal.1993.264.3.F565; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; HARVEY BJ, 1988, J GEN PHYSIOL, V92, P767, DOI 10.1085/jgp.92.6.767; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MACROBBIE E, 1961, ACTA PHYSIOL SCAND, V53, P348, DOI 10.1111/j.1748-1716.1961.tb02293.x; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; PALMER LG, 1986, AM J PHYSIOL, V250, pF273, DOI 10.1152/ajprenal.1986.250.2.F273; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; ROSE BD, 1984, CLIN PHYSL ACID BASE, P125; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	36	35	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27477	27482		10.1074/jbc.M804176200	http://dx.doi.org/10.1074/jbc.M804176200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662987	hybrid, Green Published			2022-12-25	WOS:000259719200018
J	Nomachi, A; Nishita, M; Inaba, D; Enomoto, M; Hamasaki, M; Minami, Y				Nomachi, Akira; Nishita, Michiru; Inaba, Daisuke; Enomoto, Masahiro; Hamasaki, Mayumi; Minami, Yasuhiro			Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK SIGNALING PATHWAY; EXPRESSION; MOTILITY; CDC42; PROLIFERATION; STABILIZATION; DROSOPHILA; MOVEMENTS; EXTENSION; MELANOMA	The receptor tyrosine kinase Ror2 has recently been shown to act as an alternative receptor or coreceptor for Wnt5a and to mediate Wnt5a-induced migration of cultured cells. However, little is known about the molecular mechanism underlying this migratory process. Here we show by wound-healing assays that Ror2 plays critical roles in Wnt5a-induced cell migration by regulating formation of lamellipodia and reorientation of microtubule-organizing center (MTOC). Wnt5a stimulation induces activation of the c-Jun N-terminal kinase JNK at the wound edge in a Ror2-dependent manner, and inhibiting JNK activity abrogates Wnt5a-induced lamellipodia formation and MTOC reorientation. Additionally, the association of Ror2 with the actin-binding protein filamin A is required for Wnt5a-induced JNK activation and polarized cell migration. We further show that Wnt5a-induced JNK activation and MTOC reorientation can be suppressed by inhibiting PKC zeta. Taken together, our findings indicate that Wnt5a/Ror2 activates JNK, through a process involving filamin A and PKC zeta, to regulate polarized cell migration.	[Nomachi, Akira; Nishita, Michiru; Inaba, Daisuke; Enomoto, Masahiro; Hamasaki, Mayumi; Minami, Yasuhiro] Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Enomoto, Masahiro] Kobe Univ, Dept Pediat, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University	Nishita, M (corresponding author), Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nishita@med.kobe-u.ac.jp; minami@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Uehara Memorial Foundation; Naito Foundation; Hyogo Science and Technology Association; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a Grant-in-Aid for Scientific Research in Priority Areas, a Grant-in-Aid for Scientific Research (B), and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Uehara Memorial Foundation, the Naito Foundation, the Hyogo Science and Technology Association, and the Astellas Foundation for Research on Metabolic Disorders. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Paganoni S, 2005, J CELL SCI, V118, P433, DOI 10.1242/jcs.01622; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yoda A, 2003, J RECEPT SIG TRANSD, V23, P1, DOI 10.1081/RRS-120018757	37	150	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27973	27981		10.1074/jbc.M802325200	http://dx.doi.org/10.1074/jbc.M802325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667433	hybrid			2022-12-25	WOS:000259719200067
J	Nye, CK; Hanson, RW; Kalhan, SC				Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.			Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; RESPONSIVE GLUCOSE-TRANSPORTER; ADIPOSE-TISSUE; SKELETAL-MUSCLE; ACID CYCLE; INSULIN-RESISTANCE; FATTY-ACIDS; TRIACYLGLYCEROL SYNTHESIS; TRITIATED-WATER; CYTOSOLIC FORM	Triglyceride synthesis in mammalian tissues requires glycerol 3-phosphate as the source of triglyceride glycerol. In this study the relative contribution of glyceroneogenesis and glycolysis to triglyceride glycerol synthesis was quantified in vivo in adipose tissue, skeletal muscle, and liver of the rat in response to a chow diet (controls), 48-h fast, and lipogenic (high sucrose) diet. The rate of glyceroneogenesis was quantified using the tritium ([H-3(2)]O) labeling of body water, and the contribution of glucose, via glycolysis, was determined using a [U-C-14] glucose tracer. In epididymal and mesenteric adipose tissue of control rats, glyceroneogenesis accounted for similar to 90% of triglyceride glycerol synthesis. Fasting for 48 h did not alter glyceroneogenesis in adipose tissue, whereas the contribution of glucose was negligible. In response to sucrose feeding, the synthesis of triglyceride glycerol via both glyceroneogenesis and glycolysis nearly doubled (versus controls); however, glyceroneogenesis remained quantitatively higher as compared with the contribution of glucose. Enhancement of triglyceride-fatty acid cycling by epinephrine infusion resulted in a higher rate of glyceroneogenesis in adipose tissue, as compared with controls, whereas the contribution of glucose via glycolysis was not measurable. Glyceroneogenesis provided the majority of triglyceride glycerol in the gastrocnemius and soleus. In the liver the fractional contribution of glyceroneogenesis remained constant (similar to 60%) under all conditions and was higher than that of glucose. Thus, glyceroneogenesis, in contrast to glucose, via glycolysis, is quantitatively the predominant source of triglyceride glycerol in adipose tissue, skeletal muscle, and liver of the rat during fasting and high sucrose feeding.	[Nye, Colleen K.; Hanson, Richard W.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kalhan, Satish C.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Med, Cleveland, OH 44106 USA; [Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kalhan, SC (corresponding author), Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave,NE40, Cleveland, OH 44195 USA.	satish.kalhan@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK-58620, DK-25541, HD-11089, HD-042154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042154, P01HD011089, P50HD011089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025541, R01DK021859, R37DK021859, R01DK058620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-58620 and DK-25541 (to R. W. H.) and HD-11089 and HD-042154 (to S. C. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BAY U, 1986, MOL CELL ENDOCRINOL, V47, P217, DOI 10.1016/0303-7207(86)90115-2; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; BERGE RK, 1983, INT J BIOCHEM, V15, P205, DOI 10.1016/0020-711X(83)90066-6; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Bonen A, 2006, APPL PHYSIOL NUTR ME, V31, P31, DOI 10.1139/H05-002; Botion LM, 1998, METABOLISM, V47, P1217, DOI 10.1016/S0026-0495(98)90326-2; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Cadoudal T, 2008, M S-MED SCI, V24, P407, DOI 10.1051/medsci/2008244407; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chaves VE, 2006, J NUTR, V136, P2475, DOI 10.1093/jn/136.10.2475; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Ezaki O, 1997, BIOCHEM BIOPH RES CO, V241, P1, DOI 10.1006/bbrc.1997.7587; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Franckhauser S, 2007, DIABETES, V56, pA458; FRAYN KN, 1994, AM J PHYSIOL, V266, pE308, DOI 10.1152/ajpendo.1994.266.3.E308; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guo ZK, 1998, J APPL PHYSIOL, V84, P1674, DOI 10.1152/jappl.1998.84.5.1674; Guo ZK, 1999, J BIOL CHEM, V274, P23702, DOI 10.1074/jbc.274.34.23702; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HETENYI G, 1982, FED PROC, V41, P104; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JANSSON PA, 1994, J CLIN INVEST, V93, P240, DOI 10.1172/JCI116951; Kalhan SC, 2008, METABOLISM, V57, P305, DOI 10.1016/j.metabol.2007.10.003; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; Karbowska J, 2001, METABOLISM, V50, P734, DOI 10.1053/meta.2001.23309; KASHIWAGI A, 1983, J BIOL CHEM, V258, P3685; KATZ J, 1966, J BIOL CHEM, V241, P3600; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kowalski TJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE613, DOI 10.1152/ajpendo.1997.273.3.E613; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Newsholme E A, 1976, Biochem Soc Symp, P61; NEWSHOLME EA, 1969, BIOCHEM J, V112, P465, DOI 10.1042/bj1120465; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; POSTLE AD, 1980, BIOCHEM J, V192, P65, DOI 10.1042/bj1920065; REEVES RE, 1941, J AM CHEM SOC, V63, P1476; RESHEF L, 1972, ISRAEL J MED SCI, V8, P372; RESHEF L, 1967, J LIPID RES, V8, P688; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; ROBINSON J, 1967, BIOCHEM J, V104, P2; ROGNSTAD R, 1974, EUR J BIOCHEM, V47, P383, DOI 10.1111/j.1432-1033.1974.tb03703.x; SCHNEIBLE PA, 1981, J BIOL CHEM, V256, P4888; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; SHRAGO E, 1971, METABOLISM, V20, P54, DOI 10.1016/0026-0495(71)90059-X; Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010; STAINSBY WN, 1984, J APPL PHYSIOL, V57, P321, DOI 10.1152/jappl.1984.57.2.321; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; TAGLIAFERRO AR, 1990, INT J OBESITY, V14, P957; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; WIELAND O, 1974, METHOD ENZYMAT AN, P1404; WOLFE RR, 1987, AM J PHYSIOL, V252, pE189, DOI 10.1152/ajpendo.1987.252.2.E189; WOLFE RR, 1987, AM J PHYSIOL, V252, pE218, DOI 10.1152/ajpendo.1987.252.2.E218	63	117	118	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27565	27574		10.1074/jbc.M804393200	http://dx.doi.org/10.1074/jbc.M804393200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662986	Green Published, hybrid			2022-12-25	WOS:000259719200027
J	Bilican, B; Fiore-Heriche, C; Compston, A; Allen, ND; Chandran, S				Bilican, Bilada; Fiore-Heriche, Christelle; Compston, Alastair; Allen, Nicholas D.; Chandran, Siddharthan			Induction of Olig2(+) Precursors by FGF Involves BMP Signalling Blockade at the Smad Level	PLOS ONE			English	Article								During normal development oligodendrocyte precursors (OPCs) are generated in the ventral spinal cord in response to Sonic hedgehog (Shh) signalling. There is also a second, late wave of oligodendrogenesis in the dorsal spinal cord independent of Shh activity. Two signalling pathways, controlled by bone morphogenetic protein and fibroblast growth factor (FGF), are active players in dorsal spinal cord specification. In particular, BMP signalling from the roof plate has a crucial role in setting up dorsal neural identity and its inhibition is sufficient to generate OPCs both in vitro and in vivo. In contrast, FGF signalling can induce OPC production from dorsal spinal cord cultures in vitro. In this study, we examined the cross-talk between mitogen-activated protein kinase (MAPK) and BMP signalling in embryonic dorsal spinal cord cultures at the SMAD1/5/8 (SMAD1) transcription factor level, the main effectors of BMP activity. We have previously shown that FGF2 treatment of neural precursor cells (NPCs) derived from rat E14 dorsal spinal cord is sufficient to generate OPCs in vitro. Utilising the same system, we now show that FGF prevents BMP-induced nuclear localisation of SMAD1-phosphorylated at the C-terminus (C-term-pSMAD1). This nuclear exclusion of C-term-pSMAD1 is dependent on MAPK activity and correlates with OLIG2 upregulation, the obligate transcription factor for oligodendrogenesis. Furthermore, inhibition of the MAPK pathway abolishes OLIG2 expression. We also show that SMAD4, which acts as a common partner for receptor-regulated Smads including SMAD1, associates with a Smad binding site in the Olig2 promoter and dissociates from it upon differentiation. Taken together, these results suggest that FGF can promote OPC generation from embryonic NPCs by counteracting BMP signalling at the Smad1 transcription factor level and that Smad-containing transcriptional complexes may be involved in direct regulation of the Olig2 promoter.	[Bilican, Bilada; Compston, Alastair; Chandran, Siddharthan] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Fiore-Heriche, Christelle] Univ Cambridge, MRC Res Ctr, Dept Oncol Hutchison, Cambridge, England; [Allen, Nicholas D.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	University of Cambridge; University of Cambridge; Cardiff University	Bilican, B (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	bb337@cam.ac.uk	Messier, Claude/A-2322-2008; allen, nick d/A-4336-2010	Messier, Claude/0000-0002-4791-1763; Allen, Nicholas/0000-0003-4009-186X	Husky Foundation; Medical Research Council (UK); BBSRC	Husky Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Husky Foundation, Medical Research Council (UK), BBSRC and Sir David Walker. Funding bodies had no input on design and conduct of experiments or interpretation of data.	Attisano L, 2001, GENOME BIOL, V2; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kuroda H, 2005, GENE DEV, V19, P1022, DOI 10.1101/gad.1306605; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Spagnoli FM, 2006, CURR OPIN GENET DEV, V16, P469, DOI 10.1016/j.gde.2006.08.004; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; TSANG M, 2004, SCI STKE, pPE17, DOI DOI 10.1126/STKE.2282004PE17; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; WARF BC, 1991, J NEUROSCI, V11, P2477; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	46	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2863	10.1371/journal.pone.0002863	http://dx.doi.org/10.1371/journal.pone.0002863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682850	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000264366600019
J	Fu, XD; Giretti, MS; Baldacci, C; Garibaldi, S; Flamini, M; Sanchez, AM; Gadducci, A; Genazzani, AR; Simoncini, T				Fu, Xiao-Dong; Giretti, Maria S.; Baldacci, Chiara; Garibaldi, Silvia; Flamini, Marina; Sanchez, Angel Matias; Gadducci, Angiolo; Genazzani, Andrea R.; Simoncini, Tommaso			Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton	PLOS ONE			English	Article								Progesterone plays a role in breast cancer development and progression but the effects on breast cancer cell movement or invasion have not been fully explored. In this study, we investigate the actions of natural progesterone and of the synthetic progestin medroxyprogesterone acetate (MPA) on actin cytoskeleton remodeling and on breast cancer cell movement and invasion. In particular, we characterize the nongenomic signaling cascades implicated in these actions. T47-D breast cancer cells display enhanced horizontal migration and invasion of three-dimensional matrices in the presence of both progestins. Exposure to the hormones triggers a rapid remodeling of the actin cytoskeleton and the formation of membrane ruffles required for cell movement, which are dependent on the rapid phosphorylation of the actin-regulatory protein moesin. The extra-cellular small GTPase RhoA/Rho-associated kinase (ROCK-2) cascade plays central role in progesterone-and MPA-induced moesin activation, cell migration and invasion. In the presence of progesterone, progesterone receptor A (PRA) interacts with the G protein G alpha(13), while MPA drives PR to interact with tyrosine kinase c-Src and to activate phosphatidylinositol-3 kinase, leading to the activation of RhoA/ROCK-2. In conclusion, our findings manifest that progesterone and MPA promote breast cancer cell movement via rapid actin cytoskeleton remodeling, which are mediated by moesin activation. These events are triggered by RhoA/ROCK-2 cascade through partially differing pathways by the two compounds. These results provide original mechanistic explanations for the effects of progestins on breast cancer progression and highlight potential targets to treat endocrine-sensitive breast cancers.	[Fu, Xiao-Dong; Giretti, Maria S.; Baldacci, Chiara; Garibaldi, Silvia; Flamini, Marina; Sanchez, Angel Matias; Gadducci, Angiolo; Genazzani, Andrea R.; Simoncini, Tommaso] Univ Pisa, MCGEL, Dept Reprod Med & Child Dev, Pisa, Italy; [Fu, Xiao-Dong] Sun Yat sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou, Peoples R China	University of Pisa; Sun Yat Sen University	Simoncini, T (corresponding author), Univ Pisa, MCGEL, Dept Reprod Med & Child Dev, Pisa, Italy.	t.simoncini@obgyn.med.unipi.it	Simoncini, Tommaso/AAC-1879-2019; Gadducci, Angiolo/AAC-1332-2019	Simoncini, Tommaso/0000-0002-2971-0079; Gadducci, Angiolo/0000-0002-4404-406X	Italian University and Scientific Research Ministry (MIUR) [2004057090_007]	Italian University and Scientific Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by PRIN grant 2004057090_007 by the Italian University and Scientific Research Ministry (MIUR).	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Fournier A, 2008, J CLIN ONCOL, V26, P1260, DOI 10.1200/JCO.2007.13.4338; Fu XD, 2007, SEMIN REPROD MED, V25, P178, DOI 10.1055/s-2007-973430; Giretti MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002238; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Humphreys RC, 1997, J MAMMARY GLAND BIOL, V2, P343, DOI 10.1023/A:1026343212187; Hyder SM, 2001, INT J CANCER, V92, P469, DOI 10.1002/ijc.1236; Kamps AR, 2005, ANN NY ACAD SCI, V1049, P17, DOI 10.1196/annals.1334.003; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kato S, 2005, J CLIN ENDOCR METAB, V90, P1181, DOI 10.1210/jc.2004-0857; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Machelon V, 1996, J CELL BIOCHEM, V61, P619, DOI 10.1002/(SICI)1097-4644(19960616)61:4<619::AID-JCB16>3.0.CO;2-A; McGowan EM, 2003, J MOL ENDOCRINOL, V31, P241, DOI 10.1677/jme.0.0310241; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Saitoh M, 2005, ENDOCRINOLOGY, V146, P4917, DOI 10.1210/en.2004-1535; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Simoncini T, 2004, ENDOCRINOLOGY, V145, P5745, DOI 10.1210/en.2004-0510; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Sitruk-Ware R, 2003, ANN ENDOCRINOL-PARIS, V64, P178; Stanczyk FZ, 2003, STEROIDS, V68, P879, DOI 10.1016/j.steroids.2003.08.003; Thomas CP, 2006, AM J PHYSIOL-RENAL, V290, pF306, DOI 10.1152/ajprenal.00062.2005; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vanzulli SI, 2005, CARCINOGENESIS, V26, P1055, DOI 10.1093/carcin/bgi060; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	51	76	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2790	10.1371/journal.pone.0002790	http://dx.doi.org/10.1371/journal.pone.0002790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665217	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300009
J	Jaron, B; Maranghi, E; Leclerc, C; Majlessi, L				Jaron, Barbara; Maranghi, Eddie; Leclerc, Claude; Majlessi, Laleh			Effect of Attenuation of Treg during BCG Immunization on Anti-Mycobacterial Th1 Responses and Protection against Mycobacterium tuberculosis	PLOS ONE			English	Article							REGULATORY T-CELLS; CUTTING EDGE; BOVIS BCG; FUNCTIONAL INACTIVATION; ENHANCE PROTECTION; IMMUNE-RESPONSE; CD4(+)CD25(+); MICE; VACCINATION; INFECTION	Background: The functional equilibrium between natural regulatory T cells (Treg) and effector T cells can affect the issue of numerous infections. In unvaccinated mice, the influence of Treg in the control of primary infection with mycobacteria remains controversial. Methodology: Here, we evaluated the role of Treg during prophylactic vaccination with Mycobacterium bovis BCG (Bacillus Calmette-Guerin) on the induction of T cell responses and on the protective effect against subsequent M. tuberculosis challenge in mice. Principal Findings: We demonstrated that, subsequent to BCG injection, Treg were recruited to the draining lymph nodes and negatively control anti-mycobacterial CD4(+) - but not CD8(+) - T-cell responses. Treatment of BCG-immunized mice with an anti-CD25 mAb (PC61) induced an increase IFN-gamma response against both subdominant and immunodominant regions of the protective immunogen TB10.4. In Treg-attenuated, BCG-immunized mice, which were then infected with M. tuberculosis, the lung mycobacterial load was significantly, albeit moderately, reduced compared to the control mice. Conclusions: Our results provide the first demonstration that attenuation of Treg subset concomitant to BCG vaccination has a positive, yet limited, impact on the protective capacity of this vaccine against infection with M. tuberculosis. Thus, for rational design of improved BCG, it should be considered that, although the action of Treg does not represent the major cause of the limited efficiency of BCG, the impact of this cell population on the subsequent control of M. tuberculosis growth is significant and measurable.	[Jaron, Barbara; Leclerc, Claude; Majlessi, Laleh] Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, Paris, France; [Maranghi, Eddie] Inst Pasteur, Animalerie Centrale, Paris, France; [Jaron, Barbara; Leclerc, Claude; Majlessi, Laleh] Inst Natl Sante & Rech Med, U883, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jaron, B (corresponding author), Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, Paris, France.	lmajless@pasteur.fr			European [HEALTH-F3-2007-201762]	European(European Science Foundation (ESF))	European contract HEALTH-F3-2007-201762	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Cohen J, 2006, SCIENCE, V313, P1554; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Doherty TM, 2005, VACCINE, V23, P2109, DOI 10.1016/j.vaccine.2005.01.060; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kursar M, 2002, J EXP MED, V196, P1585, DOI 10.1084/jem.20011347; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; LECLERC C, 1991, J VIROL, V65, P711, DOI 10.1128/JVI.65.2.711-718.1991; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; Majlessi L, 2007, J IMMUNOL, V179, P1825, DOI 10.4049/jimmunol.179.3.1825; Manca C, 1999, J IMMUNOL, V162, P6740; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Preville X, 2005, CANCER RES, V65, P641; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quinn KM, 2008, EUR J IMMUNOL, V38, P695, DOI 10.1002/eji.200737888; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; WHO, 2007, WHO REP 2007; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a	47	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2833	10.1371/journal.pone.0002833	http://dx.doi.org/10.1371/journal.pone.0002833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665224	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300052
J	Johnston, J; Iser, WB; Chow, DK; Goldberg, IG; Wolkow, CA				Johnston, Josiah; Iser, Wendy B.; Chow, David K.; Goldberg, Ilya G.; Wolkow, Catherine A.			Quantitative Image Analysis Reveals Distinct Structural Transitions during Aging in Caenorhabditis elegans Tissues	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; TRANSCRIPTIONAL PROFILE; MUSCLE STRENGTH; MORTALITY; PROTEINS; PATTERNS; CYCLE; MASS	Aging is associated with functional and structural declines in many body systems, even in the absence of underlying disease. In particular, skeletal muscles experience severe declines during aging, a phenomenon termed sarcopenia. Despite the high incidence and severity of sarcopenia, little is known about contributing factors and development. Many studies focus on functional aspects of aging-related tissue decline, while structural details remain understudied. Traditional approaches for quantifying structural changes have assessed individual markers at discrete intervals. Such approaches are inadequate for the complex changes associated with aging. An alternative is to consider changes in overall morphology rather than in specific markers. We have used this approach to quantitatively track tissue architecture during adulthood and aging in the C. elegans pharynx, the neuromuscular feeding organ. Using pattern recognition to analyze aged-grouped pharynx images, we identified discrete step-wise transitions between distinct morphologies. The morphology state transitions were maintained in mutants with pharynx neurotransmission defects, although the pace of the transitions was altered. Longitudinal measurements of pharynx function identified a predictive relationship between mid-life pharynx morphology and function at later ages. These studies demonstrate for the first time that adult tissues undergo distinct structural transitions reflecting postdevelopmental events. The processes that underlie these architectural changes may contribute to increased disease risk during aging, and may be targets for factors that alter the aging rate. This work further demonstrates that pattern analysis of an image series offers a novel and generally accessible approach for quantifying morphological changes and identifying structural biomarkers.	[Johnston, Josiah; Goldberg, Ilya G.] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Iser, Wendy B.; Chow, David K.; Wolkow, Catherine A.] NIA, Lab Neurosci, Intramural Res Program, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Johnston, J (corresponding author), NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	igg@nih.gov; wolkowca@grc.nia.nih.gov	Goldberg, Ilya/H-5307-2011	Goldberg, Ilya/0000-0001-8514-6110	National Institute on Aging, National Institutes of Health; Ellison Medical Foundation [New Scholar in Aging Award]; NATIONAL INSTITUTE ON AGING [ZICAG000685, ZIAAG000320] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Wolkow and Goldberg labs are funded by the National Institute on Aging as part of the National Institutes of Health Intramural Research Program. This work was also supported by a New Scholar in Aging Award from the Ellison Medical Foundation (C.A.W.).	Bishop C.M., 2006, PATTERN RECOGNITION; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Garigan D, 2002, GENETICS, V161, P1101; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Helfrich YR, 2007, ARCH DERMATOL, V143, P397, DOI 10.1001/archderm.143.3.397; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Locke John, 1690, ESSAY HUMANE UNDERST; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Orlov N, 2006, I S BIOMED IMAGING, P1152; ORLOV N, 2007, VISION SYSTEMS SEGME; ORLOV N, 2008, WND CHARM MULTIPURPO; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Wolkow CA, 2006, EXP GERONTOL, V41, P1001, DOI 10.1016/j.exger.2006.06.033; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	35	43	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2821	10.1371/journal.pone.0002821	http://dx.doi.org/10.1371/journal.pone.0002821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665238	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300040
J	Hagelstrom, RT; Askin, KF; Williams, AJ; Ramaiah, L; Desaintes, C; Goodwin, EH; Ullrich, RL; Bailey, SM				Hagelstrom, R. T.; Askin, K. F.; Williams, A. J.; Ramaiah, L.; Desaintes, C.; Goodwin, E. H.; Ullrich, R. L.; Bailey, S. M.			DNA-PKcs and ATM influence generation of ionizing radiation-induced bystander signals	ONCOGENE			English	Article						DNA-PKcs; ATM; ionizing radiation; bystander effect	DEPENDENT PROTEIN-KINASE; SISTER-CHROMATID EXCHANGES; STRAND BREAK REPAIR; CATALYTIC SUBUNIT; INTERCELLULAR COMMUNICATION; V(D)J RECOMBINATION; ALPHA-PARTICLES; LOW FLUENCES; CELLS; DEFICIENCY	The phenomenon by which irradiated cells influence non-irradiated neighboring cells, referred to as the bystander effect (BSE), is not well understood in terms of the underlying pathways involved. We sought to enlighten connections between DNA damage repair and the BSE. Utilizing sister chromatid exchange (SCE) frequencies as a marker of the BSE, we performed cell transfer strategies that enabled us to distinguish between generation versus reception of a bystander signal. We find that DNA-dependent Protein Kinase catalytic subunit (DNA-PKcs) and Ataxia Telangectasia Mutated (ATM) are necessary for the generation of such a bystander signal in normal human cells following gamma (gamma)-ray exposure, but are not required for its reception. Importantly, we also show that directly irradiated human cells do not respond to receipt of a bystander signal, helping to explain why the BSE is a low-dose phenomenon. These studies provide the first evidence for a role of the DNA damage response proteins DNA-PKcs and ATM specifically in the generation of a bystander signal and intercellular signaling.	[Hagelstrom, R. T.; Askin, K. F.; Williams, A. J.; Ramaiah, L.; Ullrich, R. L.; Bailey, S. M.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Desaintes, C.] CEN SCK, Radiobiol Lab, B-2400 Mol, Belgium; [Goodwin, E. H.] KromaTiD Inc, Ft Collins, CO USA	Colorado State University; Belgian Nuclear Research Centre (SCK-CEN)	Bailey, SM (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Campus Delivery 1618, Ft Collins, CO 80523 USA.	sbailey@colostate.edu	Ramaiah, Lila/GPX-6746-2022		NIH/NCI [CA-09236-30, CA-043322-20]; US Department of Energy (DOE) [DE-FG02-01ER63239]; National Aeronautics and Space Administration (NASA) [NNJ04HD83G]; NATIONAL CANCER INSTITUTE [R01CA043322] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy (DOE)(United States Department of Energy (DOE)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dakim Gaines for technical assistance. Support for this research is gratefully acknowledged from the NIH/NCI, Grants CA-09236-30 (RLU) and CA-043322-20 (RLU and SMB), the US Department of Energy (DOE), Grant DE-FG02-01ER63239 (RLU and SMB), and from the National Aeronautics and Space Administration (NASA), Grant NNJ04HD83G (SMB).	ARDITO G, 1980, Bollettino Societa Italiana Biologia Sperimentale, V56, P719; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2004, DNA REPAIR, V3, P225, DOI 10.1016/j.dnarep.2003.10.013; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Banaz-Yasar F, 2008, J CELL BIOCHEM, V103, P149, DOI 10.1002/jcb.21395; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deshpande A, 1996, RADIAT RES, V145, P260, DOI 10.2307/3578980; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Grifalconi M, 2007, MUTAT RES-FUND MOL M, V625, P102, DOI 10.1016/j.mrfmmm.2007.06.004; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Iyer R, 2002, RADIAT RES, V157, P3, DOI 10.1667/0033-7587(2002)157[0003:APIIIT]2.0.CO;2; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Kanasugi Y, 2007, INT J RADIAT BIOL, V83, P73, DOI 10.1080/09553000601121116; Kashino G, 2007, J RADIAT RES, V48, P327, DOI 10.1269/jrr.07008; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lehnert BE, 1997, CANCER RES, V57, P2164; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Morgan WF, 2003, ONCOGENE, V22, P7094, DOI 10.1038/sj.onc.1206992; Mothersill C, 2004, RADIAT RES, V161, P256, DOI 10.1667/RR3136; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Nagasawa H, 2005, RADIAT RES, V164, P141, DOI 10.1667/RR3420; Nagasawa H, 2003, INT J RADIAT BIOL, V79, P35, DOI 10.1080/0955300021000019230; Nagasawa H, 2002, MUTAT RES-FUND MOL M, V508, P121, DOI 10.1016/S0027-5107(02)00193-8; NAGASAWA H, 1992, CANCER RES, V52, P6394; O'Neill-Mehlenbacher A, 2007, INT J RADIAT BIOL, V83, P593, DOI 10.1080/09553000701481782; Okayasu R, 2000, CANCER RES, V60, P4342; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Seymour CB, 2000, RADIAT RES, V153, P508, DOI 10.1667/0033-7587(2000)153[0508:RCOBAT]2.0.CO;2; Shao CL, 2006, RADIAT RES, V166, P479, DOI 10.1667/RR3600.1; Weil MM, 1997, GENETICS, V146, P1061; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006; WOLFF S, 1975, EXP CELL RES, V93, P23, DOI 10.1016/0014-4827(75)90418-8; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Yu YJ, 2001, CANCER RES, V61, P1820; Zhang Y, 2007, CANCER LETT, V250, P63, DOI 10.1016/j.canlet.2006.09.021	45	26	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6761	6769		10.1038/onc.2008.276	http://dx.doi.org/10.1038/onc.2008.276			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18679419				2022-12-25	WOS:000260866200006
J	Pallero, MA; Elzie, CA; Chen, JP; Mosher, DF; Murphy-Ullrich, JE				Pallero, Manuel A.; Elzie, Carrie A.; Chen, Jiping; Mosher, Deane F.; Murphy-Ullrich, Joanne E.			Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis	FASEB JOURNAL			English	Article						apoptosis; fibroblasts; cell adhesion; focal adhesions; Akt	CELL-SURFACE CALRETICULIN; RECEPTOR-RELATED PROTEIN; N-TERMINAL DOMAIN; INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; EXTRACELLULAR-MATRIX; PLASMA-MEMBRANE; CATHEPSIN-G; IN-VITRO; SURVIVAL	Anoikis, apoptotic cell death due to loss of cell adhesion, is critical for regulation of tissue homeostasis in tissue remodeling. Fibrogenesis is associated with reduced fibroblast apoptosis. The matricellular protein thrombospondin 1 (TSP1) regulates cell adhesion and motility during tissue remodeling and in fibrogenesis. The N-terminal domain of TSP1 binds to the calreticulin-LRP1 receptor co-complex to signal down-regulation of cell adhesion and increased cell motility through focal adhesion disassembly. TSP1 signaling through calreticulin-LRP1 activates cell survival signals such as PI3-kinase. Therefore, we tested the hypothesis that TSP1 supports cell survival under adhesion-independent conditions to facilitate tissue remodeling. Here, we show that platelet TSP1, its N-terminal domain (NoC1) as a recombinant protein, or a peptide comprising the calreticulin-LRP1 binding site [amino acids 17-35 (hep I)] in the N-terminal domain promotes fibroblast survival under anchorage-independent conditions. TSP1 activates Akt and decreases apoptotic signaling through caspase 3 and PARP1 in suspended fibroblasts. Inhibition of PI3K/Akt activity blocks TSP1-mediated anchorage-independent survival. Fibroblasts lacking LRP1 or expressing calreticulin lacking the TSP1 binding site do not respond to TSP1 with anchorage-independent survival. These data define a novel role for TSP1 signaling through the calreticulin/LRP1 co-complex in tissue remodeling and fibrotic responses through stimulation of anoikis resistance. -Pallero, M. A., Elzie, C. A., Chen, J., Mosher, D. F., Murphy-Ullrich, J. E. Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J. 22, 3968-3979 (2008)	[Pallero, Manuel A.; Elzie, Carrie A.; Chen, Jiping; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, VH 668 1530 3rd Ave S, Birmingham, AL 35294 USA; [Pallero, Manuel A.; Elzie, Carrie A.; Chen, Jiping; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Pallero, Manuel A.; Elzie, Carrie A.; Chen, Jiping; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, BioMatrix Engn & Regenerat Med Ctr, Birmingham, AL 35294 USA; [Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Murphy-Ullrich, JE (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, VH 668 1530 3rd Ave S, Birmingham, AL 35294 USA.	murphy@uab.edu			bone biology and disease [T32AR47512-01A1]; oral biology [T32DE014300]; National Institutes of Health (NIH) [HL079644]; National Center for Research Resources, NIH [C06 RR 15490]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE014300] Funding Source: NIH RePORTER	bone biology and disease; oral biology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors gratefully acknowledge Marek Michalak ( University of Alberta, Edmonton, AB, Canada) for providing the CRT constructs, K41 and K42 CRT(-/-) MEFs. We also thank Doug Annis (University of Wisconsin, Madison, WI, USA) for assistance with the preparation of recombinant TSP1 proteins. We thank Silvia Goicoechea (University of North Carolina, Chapel Hill, NC, USA) for making the CRT deletion construct. We appreciate the assistance of Mariya T. Sweetwyne in preparation of the figures. This work was supported by a comprehensive training grant in bone biology and disease (T32AR47512-01A1) to C. A. E., a training grant in oral biology (T32DE014300) to J. C., and a National Institutes of Health (NIH) grant (HL079644) to J. E. M. U. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program grant C06 RR 15490 from the National Center for Research Resources, NIH.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Anilkumar N, 2002, J CELL SCI, V115, P2357; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Bruel A, 2005, ANTICANCER RES, V25, P757; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; CONWAY EM, 1995, J BIOL CHEM, V270, P17011, DOI 10.1074/jbc.270.28.17011; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DiPietro LA, 1996, AM J PATHOL, V148, P1851; do Outeiro-Bernstein MAF, 2002, MATRIX BIOL, V21, P311, DOI 10.1016/S0945-053X(02)00010-0; Duus K, 2007, SCAND J IMMUNOL, V66, P501, DOI 10.1111/j.1365-3083.2007.01999.x; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Freyberg MA, 2001, BIOCHEM BIOPH RES CO, V286, P141, DOI 10.1006/bbrc.2001.5314; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Graf R, 2002, APOPTOSIS, V7, P493, DOI 10.1023/A:1020634924760; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; Groenendyk J, 2004, MOL CELLS, V17, P383; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Hasanuzzaman M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-34; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Hou YL, 2006, CELL SIGNAL, V18, P882, DOI 10.1016/j.cellsig.2005.07.015; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Jang JH, 2005, CANCER LETT, V229, P101, DOI 10.1016/j.canlet.2004.12.012; Jinnin M, 2006, J INVEST DERMATOL, V126, P551, DOI 10.1038/sj.jid.5700090; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; MURPHYULLRICH JE, 1993, J BIOL CHEM, V268, P26784; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nor Jacques E, 2005, Oral Biosci Med, V2, P153; Nunes SS, 2008, J CELL PHYSIOL, V214, P828, DOI 10.1002/jcp.21281; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; RabhiSabile S, 1996, FEBS LETT, V386, P82, DOI 10.1016/0014-5793(96)00408-5; Rai Nirendra K, 2005, Int J Low Extrem Wounds, V4, P138, DOI 10.1177/1534734605280018; Rajeswari J, 2006, CELL BIOL INT, V30, P963, DOI 10.1016/j.cellbi.2006.06.022; Rath GM, 2006, INT J BIOCHEM CELL B, V38, P2219, DOI 10.1016/j.biocel.2006.07.004; RAUGI GJ, 1987, J INVEST DERMATOL, V89, P551, DOI 10.1111/1523-1747.ep12461198; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Saumet A, 2005, BLOOD, V106, P658, DOI 10.1182/blood-2004-09-3585; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; SOTTILE J, 1991, BIOCHEMISTRY-US, V30, P6556, DOI 10.1021/bi00240a028; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Szabo E, 2007, J CELL PHYSIOL, V213, P269, DOI 10.1002/jcp.21122; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Wang Y, 2006, PROTEOMICS, V6, P3862, DOI 10.1002/pmic.200500840; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zhang G., 2006, Experimental Oncology, V28, P36; Zvibel I, 2002, CELL TRANSPLANT, V11, P621, DOI 10.3727/000000002783985404	94	64	67	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3968	3979		10.1096/fj.07-104802	http://dx.doi.org/10.1096/fj.07-104802			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18653767	Green Published			2022-12-25	WOS:000260503000025
J	Roche, Y; Gerbeau-Pissot, P; Buhot, B; Thomas, D; Bonneau, L; Gresti, J; Mongrand, S; Perrier-Cornet, JM; Simon-Plas, F				Roche, Yann; Gerbeau-Pissot, Patricia; Buhot, Blandine; Thomas, Dominique; Bonneau, Laurent; Gresti, Joseph; Mongrand, Sebastien; Perrier-Cornet, Jean-Marie; Simon-Plas, Francoise			Depletion of phytosterols from the plant plasma membrane provides evidence for disruption of lipid rafts	FASEB JOURNAL			English	Article						cyclodextrin; detergent-resistant membranes; membrane lateral organization; microdomains; tobacco; spectro-fluorimetry	DETERGENT-RESISTANT MEMBRANES; LAURDAN FLUORESCENCE; CELL-MEMBRANES; GENERALIZED POLARIZATION; PHOSPHOLIPID-BILAYERS; BIOLOGICAL-MEMBRANES; STEROL BIOSYNTHESIS; SURFACE TRANSPORT; BETA-CYCLODEXTRIN; MODEL MEMBRANES	Involvement of sterols in membrane structural properties has been extensively studied in model systems but rarely assessed in natural membranes and never investigated for the plant plasma membrane (PM). Here, we address the question of the role of phytosterols in the organization of the plant PM. The sterol composition of tobacco BY-2 cell PM was determined by gas chromatography. The cyclic oligosaccharide methyl-beta-cyclodextrin, commonly used in animal cells to decrease cholesterol levels, caused a drastic reduction (50%) in the PM total free sterol content of the plant material, without modification in amounts of steryl-conjugates. Fluorescence spectroscopy experiments using DPH, TMA-DPH, Laurdan, and di-4-ANEPPDHQ indicated that such a depletion in sterol content increased lipid acyl chain disorder and reduced the overall liquid-phase heterogeneity in correlation with the disruption of phytosterol-rich domains. Methyl-beta-cyclodextrin also prevented isolation of a PM fraction resistant to solubilization by nonionic detergents, previously characterized in tobacco, and induced redistribution of the proteic marker of this fraction, NtrbohD, within the membrane. Altogether, our results support the role of phytosterols in the lateral structuring of the PM of higher plant cells and suggest that they are key compounds for the formation of plant PM microdomains.-Roche, Y., Gerbeau-Pissot, P., Buhot, B., Thomas, D., Bonneau, L., Gresti, J., Mongrand, S., Perrier-Cornet, J.-M., Simon-Plas, F. Depletion of phytosterols from the plant plasma membrane provides evidence for disruption of lipid rafts. FASEB J. 22, 3980-3991 (2008)	[Roche, Yann; Gerbeau-Pissot, Patricia; Buhot, Blandine; Thomas, Dominique; Bonneau, Laurent; Simon-Plas, Francoise] Univ Bourgogne, CNRS 5184, Lab Plantes Microbe Environm, INRA,UMR 1088, F-21065 Dijon, France; [Gresti, Joseph] Univ Bourgogne, UMR 866 Lipides, Equipe Physiopathol Dyslipidemies, F-21065 Dijon, France; [Mongrand, Sebastien] Univ Victor Segalen Bordeaux 2, CNRS, UMR 5200, Lab Biogenese Membranaire, Bordeaux, France; [Perrier-Cornet, Jean-Marie] Ensbana, Lab Genie Procedes Microbiol & Alimentaires, Dijon, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut Agro; AgroSup Dijon	Gerbeau-Pissot, P (corresponding author), Univ Bourgogne, CNRS 5184, Lab Plantes Microbe Environm, INRA,UMR 1088, 17 Rue Sully,BP 86510, F-21065 Dijon, France.	patricia.gerbeau-pissot@dijon.inra.fr	PERRIER-CORNET, Jean-Marie/D-2456-2014	Perrier-Cornet, Jean-Marie/0000-0002-6547-5731	French Agence Nationale de la Recherche [ANR-JC05-45555, ANR-JC05-50611]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank V. Gianinazzi-Pearson for kind corrections of the manuscript. This work was supported by the French Agence Nationale de la Recherche (ANR-JC05-45555, plant rafts; ANR-JC05-50611, Vegeraft). Fluorescence spectroscopy was performed at the Plateau Imagerie Spectroscopique, IFR92, Burgundy University.	Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bernsdorff C, 2003, J PHYS CHEM B, V107, P10658, DOI 10.1021/jp034922a; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohn M, 2001, ARCH BIOCHEM BIOPHYS, V387, P35, DOI 10.1006/abbi.2000.2224; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bultynck L, 1997, PHYTOCHEMISTRY, V45, P1337, DOI 10.1016/S0031-9422(97)00171-4; Christian AE, 1999, J LIPID RES, V40, P1475; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; dos Santos SM, 2007, BIOCHEM BIOPH RES CO, V354, P216, DOI 10.1016/j.bbrc.2006.12.202; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; GUO DA, 1995, LIPIDS, V30, P203, DOI 10.1007/BF02537823; Hac-Wydro K, 2007, CHEM PHYS LIPIDS, V150, P22, DOI 10.1016/j.chemphyslip.2007.06.211; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Hellgren LI, 2001, PHYSIOL PLANTARUM, V111, P165, DOI 10.1034/j.1399-3054.2001.1110206.x; Hellgren LI, 2001, PHYSIOL PLANTARUM, V113, P23, DOI 10.1034/j.1399-3054.2001.1130104.x; Hodzic A, 2008, BIOPHYS J, V94, P3935, DOI 10.1529/biophysj.107.123224; Hovenkamp E, 2007, LIPIDS, V42, P1125, DOI 10.1007/s11745-007-3119-4; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; MACALA LJ, 1983, J LIPID RES, V24, P1243; Marsan MP, 1998, BIOPHYS CHEM, V75, P45, DOI 10.1016/S0301-4622(98)00188-4; MCKEAN ML, 1977, PHYTOCHEMISTRY, V16, P683, DOI 10.1016/S0031-9422(00)89231-6; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Mora MP, 1999, CHEM PHYS LIPIDS, V101, P255, DOI 10.1016/S0009-3084(99)00067-5; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Mukherjee S, 2005, BBA-BIOMEMBRANES, V1714, P43, DOI 10.1016/j.bbamem.2005.06.010; Ostermeyer AG, 1999, J BIOL CHEM, V274, P34459, DOI 10.1074/jbc.274.48.34459; Palleschi S, 1996, BBA-BIOMEMBRANES, V1279, P197, DOI 10.1016/0005-2736(95)00250-2; PARASASSI T, 1993, BIOCHIM BIOPHYS ACTA, V1153, P143, DOI 10.1016/0005-2736(93)90399-K; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Peskan T, 2000, PLANT MOL BIOL, V42, P915, DOI 10.1023/A:1006477631166; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Reungpatthanaphong P, 2004, J BIOENERG BIOMEMBR, V36, P533, DOI 10.1007/s10863-004-9000-8; Rothblat GH, 1999, J LIPID RES, V40, P781; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; SCHULER I, 1991, P NATL ACAD SCI USA, V88, P6926, DOI 10.1073/pnas.88.16.6926; Shrivastava S, 2007, BIOCHEM BIOPH RES CO, V356, P705, DOI 10.1016/j.bbrc.2007.03.032; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; TRAVIS RL, 1980, PLANT PHYSIOL, V65, P871, DOI 10.1104/pp.65.5.871; Vest R, 2006, J MEMBRANE BIOL, V211, P15, DOI 10.1007/s00232-005-7008-6; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	65	95	95	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3980	3991		10.1096/fj.08-111070	http://dx.doi.org/10.1096/fj.08-111070			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18676403				2022-12-25	WOS:000260503000026
J	Anand, K; Pallares, I; Valnickova, Z; Christensen, T; Vendrell, J; Wendt, KU; Schreuder, HA; Enghild, JJ; Aviles, FX				Anand, Kanchan; Pallares, Irantzu; Valnickova, Zuzana; Christensen, Trine; Vendrell, Josep; Wendt, K. Ulrich; Schreuder, Herman A.; Enghild, Jan J.; Aviles, Francesc X.			The Crystal Structure of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Provides the Structural Basis for Its Intrinsic Activity and the Short Half-life of TAFIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; 3-DIMENSIONAL STRUCTURE; CARBOXYPEPTIDASE-B; THERMAL-STABILITY; U TAFI; ACTIVATION; INACTIVATION; PURIFICATION; INSTABILITY; VARIANTS	Mature thrombin-activable fibrinolysis inhibitor (TAFIa) is a highly unstable metallocarboxypeptidase that stabilizes blood clots by clipping C-terminal lysine residues from partially degraded fibrin. In accordance with its in vitro antifibrinolytic activity, animal studies have reported that inhibition of mature TAFI aids in the prevention of thrombosis. The level of TAFI activity is stringently regulated through (i) controlled proteolytic truncation of the zymogen (TAFI), generating the mature enzyme, TAFIa, and (ii) the short half-life of TAFIa. TAFI itself exhibits an intrinsic enzymatic activity, which is likely required to provide a baseline level of antifibrinolytic activity. The novel crystal structure presented here reveals that the active site of TAFI is accessible, providing the structural explanation for the its intrinsic activity. It also supports the notion that an "instability region" exists, in agreement with site-directed mutagenesis studies. Sulfate ions, bound to this region, point toward a potential heparin-binding site and could explain how heparin stabilizes TAFIa.	[Anand, Kanchan; Wendt, K. Ulrich; Schreuder, Herman A.] Sanofi Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany; [Pallares, Irantzu; Vendrell, Josep; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol Biomed, E-08193 Barcelona, Spain; [Valnickova, Zuzana; Christensen, Trine; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Valnickova, Zuzana; Christensen, Trine; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	Sanofi-Aventis; Autonomous University of Barcelona; Aarhus University; Aarhus University	Schreuder, HA (corresponding author), Sanofi Aventis Pharma Deutschland GmbH, Bldg G877,Ind Pk Hochst, D-65926 Frankfurt, Germany.	herman.schreuder@sanofi-aventis.com; jje@mb.au.dk	Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015; Pallares, Irantzu/N-3687-2014; Vendrell, Josep/A-6731-2010	Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Pallares, Irantzu/0000-0002-8205-2060; Vendrell, Josep/0000-0002-9378-4742; Schreuder, Herman/0000-0003-2249-2782; Enghild, Jan Johannes/0000-0001-9292-9172	EC-European Commission [LSHG 2006-18830-CAMP]; Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona) [BIO2007-68046]; Danish Natural Science Research Council	EC-European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona)(Spanish Government); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by Grants LSHG 2006-18830-CAMP from the EC-European Commission, Directorate F, Grant BIO2007-68046 from Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona), and a grant from the Danish Natural Science Research Council (for Aarhus University). H. A. S. and K. U. W. are employed by Sanofi-Aventis, a publicly held pharmaceutical company. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; Bouma BN, 2001, THROMB RES, V101, P329, DOI 10.1016/S0049-3848(00)00411-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell W, 2001, IMMUNOL REV, V180, P162, DOI 10.1034/j.1600-065X.2001.1800114.x; Ceresa E, 2007, J THROMB HAEMOST, V5, P2105, DOI 10.1111/j.1538-7836.2007.02720.x; Ceresa E, 2006, J BIOL CHEM, V281, P15878, DOI 10.1074/jbc.M509839200; COLL M, 1991, EMBO J, V10, P1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EATON DL, 1991, J BIOL CHEM, V266, P21833; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; HENDRIKS D, 1990, BIOCHIM BIOPHYS ACTA, V1034, P86, DOI 10.1016/0304-4165(90)90157-R; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knecht W, 2006, FEBS J, V273, P778, DOI 10.1111/j.1742-4658.2006.05110.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Marx PF, 2002, BIOCHEMISTRY-US, V41, P1211, DOI 10.1021/bi0115683; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Redlitz A, 1996, CIRCULATION, V93, P1328, DOI 10.1161/01.CIR.93.7.1328; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; Valnickova Z, 1996, J BIOL CHEM, V271, P12937, DOI 10.1074/jbc.271.22.12937; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; VENDRELL J, 2000, BIOCHIM BIOPHYS ACTA, V1477, P2884; WANG W, 1994, J BIOL CHEM, V269, P15937; Willemse JL, 2007, FRONT BIOSCI-LANDMRK, V12, P1973, DOI 10.2741/2203; Willemse JL, 2006, ANAL BIOCHEM, V356, P157, DOI 10.1016/j.ab.2006.05.020; Zirlik A, 2004, THROMB HAEMOSTASIS, V91, P420	34	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29416	29423		10.1074/jbc.M804003200	http://dx.doi.org/10.1074/jbc.M804003200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18669641	Green Published, hybrid			2022-12-25	WOS:000260179900068
J	Rakotomalala, L; Studach, L; Wang, WH; Gregori, G; Hullinger, RL; Andrisani, O				Rakotomalala, Lova; Studach, Leo; Wang, Wen-Horng; Gregori, Gerald; Hullinger, Ronald L.; Andrisani, Ourania			Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LICENSING FACTOR CDT1; GENOMIC INSTABILITY; HEPATOCELLULAR-CARCINOMA; CELL-CYCLE; GENE-EXPRESSION; COMET ASSAY; C-KIT; GEMININ; LIVER; KINASE	Hepatitis B virus X protein (pX) is implicated in hepatocellular carcinoma pathogenesis by an unknown mechanism. Employing the tetracycline-regulated pX-expressing 4pX-1 cell line, derived from the murine AML12 hepatocyte cell line, we demonstrate that pX induces partial polyploidy (> 4N DNA). Depletion of p53 in 4pX-1 cells increases by 5-fold the polyploid cells in response to pX expression, indicating that p53 antagonizes pX-induced polyploidy. Dual-parameter flow cytometric analyses show pX-dependent bromodeoxyuridine (BrdUrd) incorporation in 4pX-1 cells containing 4N and > 4N DNA, suggesting pX induces DNA re-replication. Interestingly, pX increases expression of endogenous replication initiation factors Cdc6 and Cdtl while suppressing geminin expression, a negative regulator of re-replication. In comparison to a geminin knockdown 4pX-1 cell line used as DNA re-replication control, the Cdt1/geminin ratio is greater in 4pX-1 cells expressing pX, indicating that pX promotes DNA re-replication. In support of this conclusion, pX-expressing 4pX-1 cells, similar to the geminin knockdown 4pX-1 cells, continue to incorporate BrdUrd in the G(2) phase and exhibit nuclear Cdc6 and MCM5 co-localization and the absence of geminin. In addition, pX expression activates the ATR kinase, the sensor of DNA re-replication, which in turn phosphorylates RAD17 and H2AX. Interestingly, phospho-H2AX-positive and BrdUrd-positive cells progress through mitosis, demonstrating a link between pX-induced DNA re-replication and polyploidy. Our studies highlight a novel function of pX that likely contributes to hepatocellular carcinoma pathogenesis.	[Rakotomalala, Lova; Studach, Leo; Wang, Wen-Horng; Gregori, Gerald; Hullinger, Ronald L.; Andrisani, Ourania] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, O (corresponding author), Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [044533]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 044533 (to O. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andrisani OM, 1999, INT J ONCOL, V15, P373; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BEASLEY RP, 1981, LANCET, V2, P1129; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Crosby HA, 2001, GASTROENTEROLOGY, V120, P534, DOI 10.1053/gast.2001.21175; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Frenzilli G, 2006, ANN NY ACAD SCI, V1074, P478, DOI 10.1196/annals.1369.048; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Karahashi H, 2000, BBA-MOL BASIS DIS, V1502, P207, DOI 10.1016/S0925-4439(00)00045-4; Kawai H, 2000, HEPATOLOGY, V31, P1246, DOI 10.1053/jhep.2000.7298; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee ES, 2005, AM J CLIN PATHOL, V124, P31, DOI 10.1309/LETTWN3LUF516HR0; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Ohmori S, 2004, INT J MOL MED, V14, P179; Olive Peggy L, 2002, Methods Mol Biol, V203, P179; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weiss RS, 2000, GENE DEV, V14, P1886; Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhang SH, 2004, J CANCER RES CLIN, V130, P757, DOI 10.1007/s00432-004-0613-4; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	68	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28729	28740		10.1074/jbc.M802751200	http://dx.doi.org/10.1074/jbc.M802751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18693245	Green Published, hybrid			2022-12-25	WOS:000259969300075
J	Yokoyama, U; Minamisawa, S; Quan, H; Akaike, T; Suzuki, S; Jin, M; Jiao, Q; Watanabe, M; Otsu, K; Iwasaki, S; Nishimaki, S; Sato, M; Ishikawa, Y				Yokoyama, Utako; Minamisawa, Susumu; Quan, Hong; Akaike, Toru; Suzuki, Sayaka; Jin, Meihua; Jiao, Qibin; Watanabe, Mayumi; Otsu, Koji; Iwasaki, Shiho; Nishimaki, Shigeru; Sato, Motohiko; Ishikawa, Yoshihiro			Prostaglandin E-2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL-MIGRATION; CYCLIC-AMP; ENDOTHELIAL-CELLS; UP-REGULATION; ACTIVATION; EXPRESSION; RECEPTOR; MECHANISMS	We have demonstrated that chronic stimulation of the prostaglandin E-2-cAMP-dependent protein kinase A (PKA) signal pathway plays a critical role in intimal cushion formation in perinatal ductus arteriosus (DA) through promoting synthesis of hyaluronan. We hypothesized that Epac, a newly identified effector of cAMP, may play a role in intimal cushion formation (ICF) in the DA distinct from that of PKA. In the present study, we found that the levels of Epac1 and Epac2 mRNAs were significantly up-regulated in the rat DA during the perinatal period. A specific EP4 agonist, ONO-AE1 -329, increased Rap1 activity in the presence of a PKA inhibitor, PKI-(14-22)-amide, in DA smooth muscle cells. 8-pCPT-2-O-Me-cAMP (O-Me-cAMP), a cAMP analog selective to Epac activator, promoted migration of DA smooth muscle cells (SMC) in a dose-dependent manner. Adenovirus-mediated Epac1 or Epac2 gene transfer further enhanced O-Me-cAMP-induced cell migration, although the effect of Epac1 overexpression on cell migration was stronger than that of Epac2. In addition, transfection of small interfering RNAs for Epac1, but not Epac2, significantly inhibited serum-mediated migration of DA SMCs. In the presence of O-Me-cAMP, actin stress fibers were well organized with enhanced focal adhesion, and cell shape was widely expanded. Adenovirus-mediated Epac1, but not Epac2 gene transfer, induced prominent ICF in the rat DA explants when compared with those with green fluorescent protein gene transfer. The thickness of intimal cushion became significantly greater (1.98-fold) in Epac1-overexpressed DA. O-Me-cAMP did not change hyaluronan production, although it decreased proliferation of DA SMCs. The present study demonstrated that Epac, especially Epac1, plays an important role in promoting SMC migration and thereby ICF in the rat DA.	[Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Yokoyama, Utako; Minamisawa, Susumu; Quan, Hong; Akaike, Toru; Suzuki, Sayaka; Jin, Meihua; Jiao, Qibin; Watanabe, Mayumi; Otsu, Koji; Sato, Motohiko; Ishikawa, Yoshihiro] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanagawa 2360027, Japan; [Iwasaki, Shiho; Nishimaki, Shigeru] Yokohama City Univ, Grad Sch Med, Dept Pediat, Kanagawa 2360027, Japan; [Minamisawa, Susumu] Waseda Univ, Inst Biomed Engn, Consolidated Res Inst Adv Sci & Med Care, Tokyo 1628480, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Med Cardiol, Newark, NJ 07101 USA	Waseda University; Yokohama City University; Yokohama City University; Waseda University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Minamisawa, S (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	sminamis@waseda.jp	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Minamisawa, Susumu/0000-0003-4728-2116	National Institutes of Health Grant [RO1 GM067773]; Yokohama Foundation for Advanced Medical Science; Ministry of Education, Science, Sports and Culture of Japan; Mother and Child Health Foundation; Miyata Cardiology Research Promotion Founds; Takeda Science Foundation; Foundation for Growth Science; JapanCardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Special Coordination Funds for Promoting Science and Technology, MEXT; Waseda University Grant; Yokohama Academic Foundation; Uehara memorial foundation; Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067773] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advanced Medical Science; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mother and Child Health Foundation(Mother and Child Health Foundation); Miyata Cardiology Research Promotion Founds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Growth Science; JapanCardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Special Coordination Funds for Promoting Science and Technology, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University Grant; Yokohama Academic Foundation; Uehara memorial foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant RO1 GM067773 (to Y. I.). This work was also supported by grants from the Yokohama Foundation for Advanced Medical Science (to S. M., U. Y., T. A., and Y. I.), the Ministry of Education, Science, Sports and Culture of Japan (to S. M., Y. I., and S. I.), the Mother and Child Health Foundation (to S. M.), the Miyata Cardiology Research Promotion Founds (to S. M.), the Takeda Science Foundation (to S. M.), the Foundation for Growth Science (to S. M.), the JapanCardiovascular Research Foundation (to S. M.), the Mitsubishi Pharma Research Foundation (to S. M.), the Special Coordination Funds for Promoting Science and Technology, MEXT(to S. M.), the Waseda University Grant for Special Research Projects (to S. M.), the Yokohama Academic Foundation(to H. Q. and S. I.), the Uehara memorial foundation (to U. Y.) the Kitsuen Research Foundation (to Y. I.), and the Japan Space Forum (to Y. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Hu YL, 2007, BIOCHEM BIOPH RES CO, V357, P871, DOI 10.1016/j.bbrc.2007.04.028; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Smith GCS, 1998, PHARMACOL REV, V50, P35; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049	18	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28702	28709		10.1074/jbc.M804223200	http://dx.doi.org/10.1074/jbc.M804223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697745	hybrid, Green Published			2022-12-25	WOS:000259969300072
J	Capendeguy, O; Iwaszkiewicz, J; Michielin, O; Horisberger, JD				Capendeguy, Oihana; Iwaszkiewicz, Justyna; Michielin, Olivier; Horisberger, Jean-Daniel			The fourth extracellular loop of the alpha subunit of Na, K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; CALCIUM-PUMP; BINDING-SITE; SARCOPLASMIC-RETICULUM; XENOPUS OOCYTES; AMINO-ACIDS; SODIUM-PUMP; FUNCTIONAL EXPRESSION; GASTRIC H,K-ATPASE; CRYSTAL-STRUCTURE	Na, K-ATPase is the main active transport system that maintains the large gradients of Na+ and K+ across the plasma membrane of animal cells. The crystal structure of a K+-occluding conformation of this protein has been recently published, but the movements of its different domains allowing for the cation pumping mechanism are not yet known. The structure of many more conformations is known for the related calcium ATPase SERCA, but the reliability of homology modeling is poor for several domains with low sequence identity, in particular the extracellular loops. To better define the structure of the large fourth extracellular loop between the seventh and eighth transmembrane segments of the alpha subunit, we have studied the formation of a disulfide bond between pairs of cysteine residues introduced by site-directed mutagenesis in the second and the fourth extracellular loop. We found a specific pair of cysteine positions (Y308C and D884C) for which extracellular treatment with an oxidizing agent inhibited the Na, K pump function, which could be rapidly restored by a reducing agent. The formation of the disulfide bond occurred preferentially under the E2-P conformation of Na, K-ATPase, in the absence of extracellular cations. Using recently published crystal structure and a distance constraint reproducing the existence of disulfide bond, we performed an extensive conformational space search using simulated annealing and showed that the Tyr(308) and Asp(884) residues can be in close proximity, and simultaneously, the SYGQ motif of the fourth extracellular loop, known to interact with the extracellular domain of the beta subunit, can be exposed to the exterior of the protein and can easily interact with the beta subunit.	[Capendeguy, Oihana; Horisberger, Jean-Daniel] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Iwaszkiewicz, Justyna; Michielin, Olivier] Univ Lausanne, Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Michielin, Olivier] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1005 Lausanne, Switzerland; [Michielin, Olivier] Univ Lausanne, Ctr Pluridisciplinaire Oncol, CH-1005 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne	Horisberger, JD (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Jean-Daniel.Horisberger@unil.ch	Horisberger, Jean-Daniel/A-2538-2009; Michielin, Olivier/ABE-7924-2020		Swiss National Fund [31-65441.01]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Fund Grant 31-65441.01 (to J.-D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; Capendeguy O, 2006, J GEN PHYSIOL, V127, P341, DOI 10.1085/jgp.200509418; Capendeguy O, 2005, J PHYSIOL-LONDON, V565, P207, DOI 10.1113/jphysiol.2004.080218; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Crambert G, 2004, MOL PHARMACOL, V65, P335, DOI 10.1124/mol.65.2.335; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Horisberger JD, 2004, PHYSIOLOGY, V19, P377, DOI 10.1152/physiol.00013.2004; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAISSER F, 1992, J BIOL CHEM, V267, P16895; JAUNIN P, 1992, J BIOL CHEM, V267, P577; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Keenan SM, 2005, J MOL GRAPH MODEL, V23, P465, DOI 10.1016/j.jmgm.2005.02.001; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Qiu LY, 2006, J BIOL CHEM, V281, P13533, DOI 10.1074/jbc.M600551200; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Rakowski RF, 2003, NEWS PHYSIOL SCI, V18, P164, DOI 10.1152/nips.01441.2003; Sanchez R, 2000, METH MOL B, V143, P97; SCHULTHEIS PJ, 1993, BIOCHEMISTRY-US, V32, P544, DOI 10.1021/bi00053a020; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944	37	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27850	27858		10.1074/jbc.M802194200	http://dx.doi.org/10.1074/jbc.M802194200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693246	hybrid			2022-12-25	WOS:000259719200056
J	Rossi, ML; Pike, JE; Wang, W; Burgers, PMJ; Campbell, JL; Bambara, RA				Rossi, Marie L.; Pike, Jason E.; Wang, Wensheng; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			Pif1 helicase directs eukaryotic Okazaki fragments toward the two-nuclease cleavage pathway for primer removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; CALF RTH-1 NUCLEASE; ESSENTIAL IN-VIVO; ENDONUCLEASE ACTIVITY; FLAP ENDONUCLEASE-1; REPLICATION FORK; LIGATABLE NICK; STRANDED DNA; HUMAN FEN1; YEAST	Eukaryotic Okazaki fragment maturation requires complete removal of the initiating RNA primer before ligation occurs. Polymerase delta (Pol delta) extends the upstream Okazaki fragment and displaces the 5'-end of the downstream primer into a single nucleotide flap, which is removed by FEN1 nuclease cleavage. This process is repeated until all RNA is removed. However, a small fraction of flaps escapes cleavage and grows long enough to be coated with RPA and requires the consecutive action of the Dna2 and FEN1 nucleases for processing. Here we tested whether RPA inhibits FEN1 cleavage of long flaps as proposed. Surprisingly, we determined that RPA binding to long flaps made dynamically by polymerase delta only slightly inhibited FEN1 cleavage, apparently obviating the need for Dna2. Therefore, we asked whether other relevant proteins promote long flap cleavage via the Dna2 pathway. The Pif1 helicase, implicated in Okazaki maturation from genetic studies, improved flap displacement and increased RPA inhibition of long flap cleavage by FEN1. These results suggest that Pif1 accelerates long flap growth, allowingRPA to bind before FEN1 can act, thereby inhibiting FEN1 cleavage. Therefore, Pif1 directs long flaps toward the two-nuclease pathway, requiring Dna2 cleavage for primer removal.	[Rossi, Marie L.; Pike, Jason E.; Wang, Wensheng; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441]; NIH [GM087666, GM32431, T32-GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM032431, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant GM024441 (to R. A. B.) with additional support from NIH Grants GM087666 (to J.L.C.) and GM32431 (to P. M. J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Huang L, 1996, BIOCHEMISTRY-US, V35, P9266, DOI 10.1021/bi9603074; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	39	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27483	27493		10.1074/jbc.M804550200	http://dx.doi.org/10.1074/jbc.M804550200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18689797	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000259719200019
J	Sam, KA; Strampraad, MJF; de Vries, S; Ferguson, SJ				Sam, Katharine A.; Strampraad, Marc J. F.; de Vries, Simon; Ferguson, Stuart J.			Very early reaction intermediates detected by microsecond time scale kinetics of cytochrome cd(1)-catalyzed reduction of nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD(1) NITRITE; PARACOCCUS-PANTOTROPHUS; THIOSPHAERA-PANTOTROPHA; DISSIMILATORY NITRITE; ELECTRON-TRANSFER; OXIDASE REACTION; HEME; ENZYME; DENITRIFICANS; PSEUDOAZURIN	Paracoccus pantotrophus cytochrome cd(1) is a nitrite reductase found in the periplasm of many denitrifying bacteria. It catalyzes the reduction of nitrite to nitric oxide during the denitrification part of the biological nitrogen cycle. Previous studies of early millisecond intermediates in the nitrite reduction reaction have shown, by comparison with pH 7.0, that at the optimum pH, approximately pH 6, the earliest intermediates were lost in the dead time of the instrument. Access to early time points (similar to 100 mu s) through use of an ultra-rapid mixing device has identified a spectroscopically novel intermediate, assigned as the Michaelis complex, formed from reaction of fully reduced enzyme with nitrite. Spectroscopic observation of the subsequent transformation of this species has provided data that demand reappraisal of the general belief that the two subunits of the enzyme function independently.	[Sam, Katharine A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Strampraad, Marc J. F.; de Vries, Simon] Delft Univ Technol, NL-2628 BC Delft, Netherlands	University of Oxford; Delft University of Technology	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk			Biotechnology and Biological Sciences Research Council [C19430]; Foundation for Fundamental Research on Matter [D-26]; Netherlands Foundation for Research NWO [700-50-025]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Netherlands Foundation for Research NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by Biotechnology and Biological Sciences Research Council Grant C19430 (to S.J.F.), a studentship (to K. A. S.), the Foundation for Fundamental Research on Matter Grant D-26 (to S.d.V.), and the Netherlands Foundation for Research NWO Grant 700-50-025. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JWA, 2002, BIOCHEM J, V366, P883, DOI 10.1042/BJ20020795; ALLEN JWA, 2001, HDB METALLOPROTEINS, P424; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Das TK, 2001, BIOCHEMISTRY-US, V40, P10774, DOI 10.1021/bi002327i; Farver O, 2003, P NATL ACAD SCI USA, V100, P7622, DOI 10.1073/pnas.0932693100; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; George SJ, 2000, J BIOL CHEM, V275, P33231, DOI 10.1074/jbc.M005033200; Jafferji A, 2000, J BIOL CHEM, V275, P25089, DOI 10.1074/jbc.M001377200; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; KIM CH, 1984, J BIOL CHEM, V259, P2092; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; NEWTON N, 1967, BIOCHEM J, V105, pC21, DOI 10.1042/bj1050021C; Pearson IV, 2003, J BACTERIOL, V185, P6308, DOI 10.1128/JB.185.21.6308-6315.2003; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Richter CD, 2002, J BIOL CHEM, V277, P3093, DOI 10.1074/jbc.M108944200; Rinaldo S, 2007, BIOCHEM BIOPH RES CO, V363, P662, DOI 10.1016/j.bbrc.2007.09.036; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Sam KA, 2008, BIOCHEM BIOPH RES CO, V371, P719, DOI 10.1016/j.bbrc.2008.04.149; Sam KA, 2008, J BIOL CHEM, V283, P12555, DOI 10.1074/jbc.M800954200; Sjogren T, 2001, J BIOL CHEM, V276, P13072, DOI 10.1074/jbc.M011312200; van Wonderen JH, 2007, J BIOL CHEM, V282, P28207, DOI 10.1074/jbc.M701242200; Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; YAMANAKA T, 1963, BIOCHIM BIOPHYS ACTA, V67, P407	29	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27403	27409		10.1074/jbc.M804493200	http://dx.doi.org/10.1074/jbc.M804493200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669629	hybrid			2022-12-25	WOS:000259719200008
J	Fasken, MB; Stewart, M; Corbett, AH				Fasken, Milo B.; Stewart, Murray; Corbett, Anita H.			Functional significance of the interaction between the mRNA-binding protein, Nab2, and the nuclear pore-associated protein, Mlp1, in mRNA export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FG-REPEAT NUCLEOPORINS; HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; POLY(A)(+) RNA; COMPLEX-FORMATION; YEAST; MEX67P; DOMAIN; LOCALIZATION; TAP	Nuclear export of mRNA requires several key mRNA-binding proteins that recognize and remodel the mRNA and target it for export via interactions with the nuclear pore complex. In Saccharomyces cerevisiae, the shuttling heterogeneous nuclear ribonucleoprotein, Nab2, which is essential for mRNA export, specifically recognizes poly( A) RNA and binds to the nuclear pore-associated protein, myosin- like protein 1 (Mlp1), which functions in mRNA export and quality control. Specifically, the N-terminal domain of Nab2 (Nab2-N; residues 1-97) interacts directly with the C-terminal globular domain of Mlp1 (CT-Mlp1: residues 1490-1875). Recent structural and binding studies focused on Nab2-N have shown that Nab2-N contains a hydrophobic patch centered on Phe(73) that is critical for interaction with Mlp1. Engineered amino acid changes within this patch disrupt the Nab2/Mlp1 interaction in vitro. Given the importance of Nab2 and Mlp1 to mRNA export, we have examined the Nab2/Mlp1 interaction in greater detail and analyzed the functional consequences of disrupting the interaction in vivo. We find that the Nab2-binding domain of Mlp1 (Mlp1-NBD) maps to a 183-residue region (residues 1586-1768) within CT-Mlp1, binds directly to Nab2 with micromolar affinity, and confers nuclear accumulation of poly( A) RNA. Furthermore, we show that cells expressing a Nab2 F73D mutant that cannot interact with Mlp1 exhibit nuclear accumulation of poly(A) RNA and that this nab2 F73D mutant genetically interacts with alleles of two essential mRNA export genes, MEX67 and YRA1. These data provide in vivo evidence for a model of mRNA export in which Nab2 is important for targeting mRNAs to the nuclear pore for export.	[Fasken, Milo B.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Emory University; MRC Laboratory Molecular Biology	Corbett, AH (corresponding author), 1510 Clifton Rd, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021; Fasken, Milo/K-2177-2019	Corbett, Anita/0000-0002-0461-6895; Fasken, Milo/0000-0003-4317-7909	National Institutes of Health; Wellcome Trust Programme; Medical Research Council [MC_U105178939] Funding Source: researchfish; MRC [MC_U105178939] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Programme(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. H. C.). This work was also supported by a Wellcome Trust Programme Grant (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams A, 1997, METHODS YEAST GENETI; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Henry M, 1996, GENETICS, V142, P103; Herold A, 2001, RNA, V7, P1768; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Katahira J, 2002, J BIOL CHEM, V277, P9242, DOI 10.1074/jbc.M110007200; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; KOLLING R, 1993, MOL GEN GENET, V237, P359; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; RUSSELL I, 1995, EUR J CELL BIOL, V66, P293; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SINGLETON DR, 1995, J CELL SCI, V108, P265; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Szymczyna BR, 2003, GENE DEV, V17, P461, DOI 10.1101/gad.1060403; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wiegand HL, 2002, MOL CELL BIOL, V22, P245, DOI 10.1128/MCB.22.1.245-256.2002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	73	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27130	27143		10.1074/jbc.M803649200	http://dx.doi.org/10.1074/jbc.M803649200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682389	Green Published, hybrid			2022-12-25	WOS:000259586600034
J	Hao, F; Tan, MQ; Xu, XM; Cui, MZ				Hao, Feng; Tan, Mingqi; Xu, Xuemin; Cui, Mei-Zhen			Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase C delta-dependent ERK activation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TISSUE FACTOR EXPRESSION; EARLY GROWTH RESPONSE-1; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; GENE-EXPRESSION; CORONARY-ARTERY; ATHEROSCLEROSIS; MONOCYTES/MACROPHAGES; CYCLOOXYGENASE-2	Histamine, a potent inflammatory mediator, has multiple effects on the pathogenesis of atherosclerosis. This study investigates the effect of histamine on the expression of early growth response factor 1 (Egr-1), a master transcription factor that regulates the expression of an array of atherogenic genes in atherosclerotic lesions. Histamine markedly and rapidly induces Egr-1 mRNA and protein expression in primary human aortic endothelial cells (HAECs). Histamine-induced Egr-1 expression is dependent on the activation of the H1 receptor. Histamine also rapidly and transiently activates protein kinase C-delta (PKC delta), extracellular signal-regulated kinase (ERK) 1/2, p38 kinase, and c-Jun N-terminal kinase (JNK) prior to Egr-1 induction. Using specific pharmacological inhibitors and small interfering RNA technology, we determined that PKC delta and ERK, but not p38 and JNK, mediate histamine-induced Egr-1 expression. Our data provide the first evidence that histamine regulates expression of Egr-1 in mammalian cells and demonstrate a novel role of PKC delta in up-regulation of Egr-1 expression. The present study reveals the following regulatory mechanism: histamine up-regulates Egr-1 expression in primary HAECs via the H1 receptor and the PKC delta-dependent ERK activation pathway. Our data also imply that CREB, a downstream component of the ERK pathway, regulates Egr-1 expression in HAECs. Importantly, these results suggest a central role of Egr-1 in histamine-induced gene expression and in histamine-induced vascular disease.	[Hao, Feng; Tan, Mingqi; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Cui, MZ (corresponding author), 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu		xu, xuemin/0000-0002-7426-272X; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL074341, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074341 (to M.-Z.C.) and AG026640 (to X. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASAKO H, 1994, J CLIN INVEST, V93, P1508, DOI 10.1172/JCI117129; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Choi EY, 2007, J CELL BIOCHEM, V102, P1442, DOI 10.1002/jcb.21367; Cui MZ, 2006, ARTERIOSCL THROM VAS, V26, P1029, DOI 10.1161/01.ATV.0000214980.90567.b5; Cui MZ, 2003, ARTERIOSCL THROM VAS, V23, P224, DOI 10.1161/01.ATV.0000054660.61191.7D; DELNESTE Y, 1994, CLIN EXP IMMUNOL, V98, P344; Fang YI, 2005, LIFE SCI, V77, P241, DOI 10.1016/j.lfs.2004.05.041; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Haller H, 1996, ARTERIOSCL THROM VAS, V16, P678, DOI 10.1161/01.ATV.16.5.678; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; JEANNIN P, 1994, BLOOD, V84, P2229; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kimura S, 2004, PATHOL INT, V54, P465, DOI 10.1111/j.1440-1827.2004.01653.x; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Lo LW, 2001, J CELL PHYSIOL, V188, P304, DOI 10.1002/jcp.1124; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Miyazawa N, 1998, EUR J PHARMACOL, V362, P53, DOI 10.1016/S0014-2999(98)00716-X; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Prince JM, 2007, SHOCK, V27, P157, DOI 10.1097/01.shk.0000245025.01365.8e; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; Sasaguri Y, 2005, CIRC RES, V96, P974, DOI 10.1161/01.RES.0000166325.00383.ed; SATOH T, 1994, ATHEROSCLEROSIS, V110, P53, DOI 10.1016/0021-9150(94)90067-1; Sayasith K, 2006, J MOL ENDOCRINOL, V37, P239, DOI 10.1677/jme.1.02078; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; TAKAGISHI T, 1995, AM J PATHOL, V146, P981; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tanimoto A, 2007, ARTERIOSCL THROM VAS, V27, P1556, DOI 10.1161/ATVBAHA.106.139089; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wheaton K, 2004, MOL CELL BIOL, V24, P7298, DOI 10.1128/MCB.24.16.7298-7311.2004; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030	36	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26928	26936		10.1074/jbc.M803071200	http://dx.doi.org/10.1074/jbc.M803071200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682391	hybrid, Green Published			2022-12-25	WOS:000259586600013
J	Park, HS; Betzenhauser, MJ; Won, JH; Chen, J; Yule, DI				Park, Hyung Seo; Betzenhauser, Matthew J.; Won, Jong Hak; Chen, Ju; Yule, David I.			The type 2 inositol (1,4,5)-trisphosphate (InsP(3)) receptor determines the sensitivity of InsP(3)-induced Ca2+ release to ATP in pancreatic acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGAND-BINDING AFFINITY; SALIVARY-GLAND CELLS; 1,4,5-TRISPHOSPHATE RECEPTORS; TRISPHOSPHATE RECEPTORS; ADENINE-NUCLEOTIDES; FUNCTIONAL-CHARACTERIZATION; POLARIZED EXPRESSION; RYANODINE-RECEPTORS; EXOCRINE PANCREAS	Calcium release through inositol (1,4,5)-trisphosphate receptors (InsP(3)R) is the primary signal driving digestive enzyme and fluid secretion from pancreatic acinar cells. The type 2 (InsP(3)R2) and type 3 (InsP(3)R3) InsP(3)R are the predominant isoforms expressed in acinar cells and are required for proper exocrine gland function. Both InsP3R2 and InsP3R3 are positively regulated by cytosolic ATP, but InsP(3)R(2) is 10-fold more sensitive than InsP3R3 to this form of modulation. In this study, we examined the role of InsP3R2 in setting the sensitivity of InsP(3)-induced Ca2+ release (IICR) to ATP in pancreatic acinar cells. IICR was measured in permeabilized acinar cells from wild-type (WT) and InsP(3)R2 knock-out (KO) mice. ATP augmented IICR from WT pancreatic cells with an EC50 of 38 mu M. However, the EC50 was 10-fold higher in acinar cells isolated from InsP(3)R2-KO mice, indicating a role for InsP3R2 in setting the sensitivity of IICR to ATP. Consistent with this idea, heterologous expression of InsP(3)R2 in RinM5F cells, which natively express predominately InsP3R3, increased the sensitivity of IICR to ATP. Depletion of ATP attenuated agonist-induced Ca2+ signaling in WT pancreatic acinar cells. This effect was more profound in acinar cells prepared from InsP(3)R2-KO mice. These data suggest that the sensitivity of IICR to ATP depletion is regulated by the particular complement of InsP3R expressed in an individual cell. The effects of metabolic stress on intracellular Ca2+ signals can therefore be determined by the relative amount of InsP(3)R2 expressed in cells.	[Park, Hyung Seo; Betzenhauser, Matthew J.; Won, Jong Hak; Yule, David I.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Park, Hyung Seo] Konyang Univ, Coll Med, Dept Physiol, Taejon 302718, South Korea; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Rochester; Konyang University; Konyang University Hospital; University of California System; University of California San Diego	Betzenhauser, MJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Med Ctr, 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	Matthew_Betzenhauser@urmc.rochester.edu	Chen, Ju/E-5579-2011		National Institutes of Health [T32-DE07202, RO1-DK054568, RO1-DE016999]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016999, T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32-DE07202 from NIDCR (to M.J.B.), National Institutes of Health Grants RO1-DK054568 and RO1-DE016999 (to D.I.Y.), and a National Institutes of Health grant (to J.C). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ashby MC, 2002, PHYSIOL REV, V82, P701, DOI 10.1152/physrev.00006.2002; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Kargacin ME, 1997, AM J PHYSIOL-CELL PH, V273, pC1416; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Missiaen L, 1997, BIOCHEM J, V325, P661, DOI 10.1042/bj3250661; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Padfield PJ, 1998, PFLUG ARCH EUR J PHY, V436, P782, DOI 10.1007/s004240050702; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Williams JA, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1337; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yule DI, 1997, J BIOL CHEM, V272, P9093	54	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26081	26088		10.1074/jbc.M804184200	http://dx.doi.org/10.1074/jbc.M804184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658132	hybrid, Green Published			2022-12-25	WOS:000259200100036
J	Wynn, RM; Kato, M; ChuangO, JL; Tso, SC; Li, J; Chuang, DT				Wynn, R. Max; Kato, Masato; ChuangO, Jacinta L.; Tso, Shih-Chia; Li, Jun; Chuang, David T.			Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOYL-BEARING DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASE; RAT-HEART; DIHYDROLIPOYL ACETYLTRANSFERASE; PHOSPHORYLATION SITES; MAXIMUM-LIKELIHOOD; BLOOD-GLUCOSE; COMPLEX; BINDING	Human pyruvate dehydrogenase complex (PDC) is down-regulated by pyruvate dehydrogenase kinase (PDK) isoforms 1 -4. PDK4 is overexpressed in skeletal muscle in type 2 diabetes, resulting in impaired glucose utilization. Here we show that human PDK4 has robust core-free basal activity, which is considerably higher than activity levels of other PDK isoforms stimulated by thePDCcore. PDK4 binds the L3 lipoyl domain, but its activity is not significantly stimulated by any individual lipoyl domains or the core of PDC. The 2.0-A crystal structures of the PDK4 dimer with bound ADP reveal an open conformation with a wider active-site cleft, compared with that in the closed conformation epitomized by the PDK2-ADP structure. The open conformation in PDK4 shows partially ordered C-terminal cross-tails, in which the conserved DW (Asp(394) -Trp(395)) motif from one subunit anchors to the N-terminal domain of the other subunit. The open conformation fosters a reduced binding affinity for ADP, facilitating the efficient removal of product inhibition by this nucleotide. Alteration or deletion of the DW-motif disrupts the C-terminal cross-tail anchor, resulting in the closed conformation and the nearly complete inactivation of PDK4. Fluorescence quenching and enzyme activity data suggest that compounds AZD7545 and dichloroacetate lock PDK4 in the open and the closed conformational states, respectively. We propose that PDK4 with bound ADP exists in equilibrium between the open and the closed conformations. The favored metastable open conformation is responsible for the robust basal activity of PDK4 in the absence of the PDC core.	[Wynn, R. Max; ChuangO, Jacinta L.; Tso, Shih-Chia; Li, Jun; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Kato, Masato; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Chuang@UTSouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK62306]; Welch Foundation. [Grant I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062306, R56DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation.(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK62306. This work was also supported by Grant I-1286 from the Welch Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aicher TD, 1999, J MED CHEM, V42, P2741, DOI 10.1021/jm9902584; ALEX LA, 1994, TRENDS GENET, V10, P133, DOI 10.1016/0168-9525(94)90215-1; Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13442, DOI 10.1021/bi0494875; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DONG J, 2001, THESIS KANSAS STATE; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Hawes JW, 2000, METHOD ENZYMOL, V324, P200; Hiromasa Y, 2006, J BIOL CHEM, V281, P12568, DOI 10.1074/jbc.M513514200; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hiromasa Y, 2008, BIOCHEMISTRY-US, V47, P2312, DOI 10.1021/bi7014772; Hiromasa Y, 2008, BIOCHEMISTRY-US, V47, P2298, DOI 10.1021/bi701475f; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Klyuyeva A, 2005, BIOCHEMISTRY-US, V44, P13573, DOI 10.1021/bi0505868; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Popov KM, 1997, ADV SEC MESS PHOSPH, V31, P105; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SALE GJ, 1981, BIOCHEM J, V193, P935, DOI 10.1042/bj1930935; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shroads AL, 2008, J PHARMACOL EXP THER, V324, P1163, DOI 10.1124/jpet.107.134593; Smirnova IN, 1998, FEBS LETT, V431, P309, DOI 10.1016/S0014-5793(98)00760-1; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Tuganova A, 2007, BIOCHEMISTRY-US, V46, P8592, DOI 10.1021/bi700650k; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024	66	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25305	25315		10.1074/jbc.M802249200	http://dx.doi.org/10.1074/jbc.M802249200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18658136	Green Published, hybrid			2022-12-25	WOS:000259012700024
J	Antons, AK; Wang, R; Kalams, SA; Unutmaz, D				Antons, Amanda K.; Wang, Rui; Kalams, Spyros A.; Unutmaz, Derya			Suppression of HIV-Specific and Allogeneic T Cell Activation by Human Regulatory T Cells Is Dependent on the Strength of Signals	PLOS ONE			English	Article								Regulatory T cells (Tregs) suppress immune responses against both self and non-self antigens. Tregs require activation through the T cell receptor (TCR) and IL-2 to exert their suppressive functions. However, how strength of TCR signals modulate the potency of Treg-mediated suppression of antigen-specific T cell activation remain unclear. We found that both strength of TCR signals and ratios of Tregs to target cells, either through superantigen, allogeneic antigens or HIV-specific peptides, modified the suppressive ability of Tregs. While human Tregs were able to mediate suppression in the presence of only autologous antigen-presenting cells, this was much less efficient as compared to when Tregs were activated by allogeneic dendritic cells. In another physiologically relevant system, we show that the strength of peptide stimulation, high frequency of responder CD8+ T cells or presence of high IL-2 can override the suppression of HIV-specific CD8+ T cells by Tregs. These findings suggest that ratios and TCR activation of human Tregs, are important parameters to overcome robust immune responses to pathogens or allogeneic antigens. Modulating the strength of T cell signals and selective enhancement or depletion of antigen-specific Tregs thus may have implications for designing potent vaccines and regulating immune responses during allogeneic transplantation and chronic infections.	[Antons, Amanda K.; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Wang, Rui; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY USA	Vanderbilt University; Vanderbilt University; New York University	Antons, AK (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA.	Derya.Unutmaz@nyumc.org			National Institutes of Health [R01 AI065303, AI39966]; Vanderbilt-Meharry Center for AIDS Research [P30 AI54999]; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999, R01AI039966, R01AI065303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Meharry Center for AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant R01 AI065303 to DU and R01 grant AI39966, Vanderbilt-Meharry Center for AIDS Research (P30 AI54999), Elizabeth Glaser Pediatric AIDS Foundation to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kursar M, 2004, J IMMUNOL, V172, P3167, DOI 10.4049/jimmunol.172.5.3167; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miedema F, 1992, Immunodefic Rev, V3, P173; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wood Kathryn J, 2003, Novartis Found Symp, V252, P177; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	54	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2952	10.1371/journal.pone.0002952	http://dx.doi.org/10.1371/journal.pone.0002952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698349	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600038
J	Liang, J; Song, WJ; Tromp, G; Kolattukudy, PE; Fu, MG				Liang, Jian; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui			Genome-Wide Survey and Expression Profiling of CCCH-Zinc Finger Family Reveals a Functional Module in Macrophage Activation	PLOS ONE			English	Article								Previously, we have identified a novel CCCH zinc finger protein family as negative regulators of macrophage activation. To gain an overall insight into the entire CCCH zinc finger gene family and to evaluate their potential role in macrophage activation, here we performed a genome-wide survey of CCCH zinc finger genes in mouse and human. Totally 58 CCCH zinc finger genes in mouse and 55 in human were identified and most of them have not been reported previously. Phylogenetic analysis revealed that the mouse CCCH family was divided into 6 groups. Meanwhile, we employed quantitative real-time PCR to profile their tissue expression patterns in adult mice. Clustering analysis showed that most of CCCH genes were broadly expressed in all of tissues examined with various levels. Interestingly, several CCCH genes Mbnl3, Zfp36l2, Zfp36, Zc3h12a, Zc3h12d, Zc3h7a and Leng9 were enriched in macrophage-related organs such as thymus, spleen, lung, intestine and adipose. Consistently, a comprehensive assessment of changes in expression of the 58 members of the mouse CCCH family during macrophage activation also revealed that these CCCH zinc finger genes were associated with the activation of bone marrow-derived macrophages by lipopolysaccharide. Taken together, this study not only identified a functional module of CCCH zinc finger genes in the regulation of macrophage activation but also provided the framework for future studies to dissect the function of this emerging gene family.	[Liang, Jian; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui] Univ Cent Florida, Coll Med, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Liang, J (corresponding author), Univ Cent Florida, Coll Med, Biomol Sci Ctr, Orlando, FL 32816 USA.	mfu@mail.ucf.edu	kolattukudy, pappachan e/A-1350-2012; Song, Wenjun/HGB-4891-2022	Song, Wenjun/0000-0002-6355-2983	UCF Starting Package; National Institutes of Health [HL69458]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL069458, R01HL069458] Funding Source: NIH RePORTER	UCF Starting Package; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by UCF Starting Package (to M.F) and National Institutes of Health Grant HL69458 (to P.E.K).	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Burke B., 2002, MACROPHAGE; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; NIU J, 2008, J BIOL CHEM IN PRESS; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang M, 2007, CANCER RES, V67, P93, DOI 10.1158/0008-5472.CAN-06-2723; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zhou L, 2006, CIRC RES, V98, P1, DOI DOI 10.1161/01	37	118	124	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2880	10.1371/journal.pone.0002880	http://dx.doi.org/10.1371/journal.pone.0002880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682727	Green Published, gold			2022-12-25	WOS:000264366600036
J	Somorjai, IML; Martinez-Arias, A				Somorjai, Ildiko M. L.; Martinez-Arias, Alfonso			Wingless Signalling Alters the Levels, Subcellular Distribution and Dynamics of Armadillo and E-Cadherin in Third Instar Larval Wing Imaginal Discs	PLOS ONE			English	Article								Background: Armadillo, the Drosophila orthologue of vertebrate beta-catenin, plays a dual role as the key effector of Wingless/Wnt1 signalling, and as a bridge between E-Cadherin and the actin cytoskeleton. In the absence of ligand, Armadillo is phosphorylated and targeted to the proteasome. Upon binding of Wg to its receptors, the "degradation complex'' is inhibited; Armadillo is stabilised and enters the nucleus to transcribe targets. Methodology/Principal Findings: Although the relationship between signalling and adhesion has been extensively studied, few in vivo data exist concerning how the "transcriptional'' and "adhesive'' pools of Armadillo are regulated to orchestrate development. We have therefore addressed how the subcellular distribution of Armadillo and its association with E-Cadherin change in larval wing imaginal discs, under wild type conditions and upon signalling. Using confocal microscopy, we show that Armadillo and E-Cadherin are spatio-temporally regulated during development, and that a punctate species becomes concentrated in a subapical compartment in response to Wingless. In order to further dissect this phenomenon, we overexpressed Armadillo mutants exhibiting different levels of activity and stability, but retaining E-Cadherin binding. Arm(S10) displaces endogenous Armadillo from the AJ and the basolateral membrane, while leaving E-Cadherin relatively undisturbed. Surprisingly, Delta NArm(1-155) caused displacement of both Armadillo and E-Cadherin, results supported by our novel method of quantification. However, only membrane-targeted Myr-Delta NArm(1-155) produced comparable nuclear accumulation of Armadillo and signalling to Arm(S10). These experiments also highlighted a row of cells at the A/P boundary depleted of E-Cadherin at the AJ, but containing actin. Conclusions/Significance: Taken together, our results provide in vivo evidence for a complex non-linear relationship between Armadillo levels, subcellular distribution and Wingless signalling. Moreover, this study highlights the importance of Armadillo in regulating the subcellular distribution of E-Cadherin	[Somorjai, Ildiko M. L.; Martinez-Arias, Alfonso] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Somorjai, IML (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ildiko.somorjai@obs-banyuls.fr; ama11@cus.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010	Somorjai, Ildiko/0000-0001-5243-6664	Wellcome Trust; NSERC; Commonwealth Trust	Wellcome Trust(Wellcome TrustEuropean Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Commonwealth Trust	This work was funded by the Wellcome Trust. I.S. was a student on the 4-year Wellcome Trust PhD Programme in Developmental Biology, and received additional financial assistance from NSERC and the Commonwealth Trust.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cox RT, 1999, DEVELOPMENT, V126, P1327; Cox RT, 1999, GENETICS, V153, P319; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; deCelis JF, 1996, DEVELOPMENT, V122, P359; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hagen T, 2004, BIOCHEM J, V379, P471, DOI 10.1042/BJ20031749; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hayward P, 2006, DEV DYNAM, V235, P2656, DOI 10.1002/dvdy.20902; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Klein T, 1999, DEVELOPMENT, V126, P913; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lawrence N, 2000, INT J DEV BIOL, V44, P749; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Marygold SJ, 2003, MECH DEVELOP, V120, P157, DOI 10.1016/S0925-4773(02)00439-2; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohsugi M, 1999, DEV DYNAM, V216, P168, DOI 10.1002/(SICI)1097-0177(199910)216:2<168::AID-DVDY7>3.0.CO;2-R; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pai LM, 1997, DEVELOPMENT, V124, P2255; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; PEIFER M, 1993, J CELL SCI, V105, P993; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SULLIVAN W, 2000, DROSOPHILA PROTOCOLS, P720; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Wodarz A, 2006, J CELL SCI, V119, P2425, DOI 10.1242/jcs.02973; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	81	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2893	10.1371/journal.pone.0002893	http://dx.doi.org/10.1371/journal.pone.0002893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682750	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600049
J	Tremblay, K; Lemire, M; Potvin, C; Tremblay, A; Hunninghake, GM; Raby, BA; Hudson, TJ; Perez-Iratxeta, C; Andrade-Navarro, MA; Laprise, C				Tremblay, Karine; Lemire, Mathieu; Potvin, Camille; Tremblay, Alexandre; Hunninghake, Gary M.; Raby, Benjamin A.; Hudson, Thomas J.; Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.; Laprise, Catherine			Genes to Diseases (G2D) Computational Method to Identify Asthma Candidate Genes	PLOS ONE			English	Article								Asthma is a complex trait for which different strategies have been used to identify its environmental and genetic predisposing factors. Here, we describe a novel methodological approach to select candidate genes for asthma genetic association studies. In this regard, the Genes to Diseases (G2D) computational tool has been used in combination with a genome-wide scan performed in a sub-sample of the Saguenay-Lac-St-Jean (SLSJ) asthmatic familial collection (n = 609) to identify candidate genes located in two suggestive loci shown to be linked with asthma (6q26) and atopy (10q26.3), and presenting differential parent-of-origin effects. This approach combined gene selection based on the G2D data mining analysis of the bibliographic and protein public databases, or according to the genes already known to be associated with the same or a similar phenotype. Ten genes (LPA, NOX3, SNX9, VIL2, VIP, ADAM8, DOCK1, FANK1, GPR123 and PTPRE) were selected for a subsequent association study performed in a large SLSJ sample (n = 1167) of individuals tested for asthma and atopy related phenotypes. Single nucleotide polymorphisms (n = 91) within the candidate genes were genotyped and analysed using a family-based association test. The results suggest a protective association to allergic asthma for PTPRE rs7081735 in the SLSJ sample (p = 0.000463; corrected p = 0.0478). This association has not been replicated in the Childhood Asthma Management Program (CAMP) cohort. Sequencing of the regions around rs7081735 revealed additional polymorphisms, but additional genotyping did not yield new associations. These results demonstrate that the G2D tool can be useful in the selection of candidate genes located in chromosomal regions linked to a complex trait.	[Tremblay, Karine; Potvin, Camille] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Tremblay, Karine; Potvin, Camille; Tremblay, Alexandre; Laprise, Catherine] Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Saguenay, Canada; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hunninghake, Gary M.; Raby, Benjamin A.] Harvard Med Sch, Brigham & Womens Hosp, Channing Lab, Boston, MA USA; [Hudson, Thomas J.] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.] Ottawa Hlth Res Inst, Mol Med, Ottawa, ON, Canada; [Andrade-Navarro, Miguel A.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Laprise, Catherine] Univ Quebec, Dept Sci Fondamentales, Saguenay, Canada	Laval University; Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Quebec; University of Quebec Chicoutimi	Tremblay, K (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada.	catherine_laprise@uqac.ca	Andrade, Miguel A/B-6565-2008; Raby, Benjamin/AAK-3866-2021	Andrade, Miguel A/0000-0001-6650-1711; Tremblay, Karine/0000-0002-2774-9738; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research; Respiratory Health Network of the Fonds de la recherche en sante du Quebec; National Heart, Lung and Blood Institute, National Institutes of Health [U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, T32 HL07427]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL083069, U01HL065899, U01HL075419, F32HL083634, R01HL086601, T32HL007427] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Respiratory Health Network of the Fonds de la recherche en sante du Quebec; National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Canadian Institutes of Health Research and the Respiratory Health Network of the Fonds de la recherche en sante du Quebec financially supported this work. The Childhood Asthma Management Program Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, and T32 HL07427 from the National Heart, Lung and Blood Institute, National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Begin P, 2007, AM J RESP CRIT CARE, V175, P1109, DOI 10.1164/rccm.200607-1012OC; Blumenthal MN, 2005, CURR OPIN ALLERGY CL, V5, P141, DOI 10.1097/01.all.0000162306.12728.c2; Bouchard G, 1989, Hist Mes, V4, P39, DOI 10.3406/hism.1989.874; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; HEYER E, 1995, AM J HUM GENET, V56, P970; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffjan S, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-14; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Koh MS, 2007, INT J CLIN PRACT, V61, P1371, DOI 10.1111/j.1742-1241.2007.01426.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Labuda M, 1996, AM J HUM GENET, V59, P633; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lemire M, 2004, AM J HUM GENET, V75, P571, DOI 10.1086/424528; Lemire M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S159; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Nakamura K, 1996, BIOCHEM BIOPH RES CO, V218, P726, DOI 10.1006/bbrc.1996.0129; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oeth P., 2005, IPLEX ASSAY INCREASE; Perez-Iratxeta C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-45; Perez-Iratxeta C, 2007, NUCLEIC ACIDS RES, V35, pW212, DOI 10.1093/nar/gkm223; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; Sandford A, 1996, AM J RESP CRIT CARE, V153, P1749, DOI 10.1164/ajrccm.153.6.8665031; Schumann G, 1998, MOL BRAIN RES, V62, P56, DOI 10.1016/S0169-328X(98)00237-X; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Sully V, 2001, BIOCHEM BIOPH RES CO, V286, P184, DOI 10.1006/bbrc.2001.5360; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2907	10.1371/journal.pone.0002907	http://dx.doi.org/10.1371/journal.pone.0002907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682798	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000264366600063
J	Vinci, G; Xia, XH; Veitia, RA				Vinci, Giovanna; Xia, Xuhua; Veitia, Reiner A.			Preservation of Genes Involved in Sterol Metabolism in Cholesterol Auxotrophs: Facts and Hypotheses	PLOS ONE			English	Article							LAMIN-B RECEPTOR; CAENORHABDITIS-ELEGANS; BIOSYNTHETIC PROTEIN; ENZYME; RATES; METHYLTRANSFERASE; ORGANIZATION; REQUIREMENT; EVOLUTION; REDUCTASE	Background: It is known that primary sequences of enzymes involved in sterol biosynthesis are well conserved in organisms that produce sterols de novo. However, we provide evidence for a preservation of the corresponding genes in two animals unable to synthesize cholesterol (auxotrophs): Drosophila melanogaster and Caenorhabditis elegans. Principal Findings: We have been able to detect bona fide orthologs of several ERG genes in both organisms using a series of complementary approaches. We have detected strong sequence divergence between the orthologs of the nematode and of the fruitfly; they are also very divergent with respect to the orthologs in organisms able to synthesize sterols de novo (prototrophs). Interestingly, the orthologs in both the nematode and the fruitfly are still under selective pressure. It is possible that these genes, which are not involved in cholesterol synthesis anymore, have been recruited to perform different new functions. We propose a more parsimonious way to explain their accelerated evolution and subsequent stabilization. The products of ERG genes in prototrophs might be involved in several biological roles, in addition to sterol synthesis. In the case of the nematode and the fruitfly, the relevant genes would have lost their ancestral function in cholesterogenesis but would have retained the other function(s), which keep them under pressure. Conclusions: By exploiting microarray data we have noticed a strong expressional correlation between the orthologs of ERG24 and ERG25 in D. melanogaster and genes encoding factors involved in intracellular protein trafficking and folding and with Start1 involved in ecdysteroid synthesis. These potential functional connections are worth being explored not only in Drosophila, but also in Caenorhabditis as well as in sterol prototrophs.	[Vinci, Giovanna; Veitia, Reiner A.] UM 3, Univ Paris 05,CNRS, Dept Genet & Dev,Inst Cochin,U567, INSERM,Fac Med Paris Descartes,UMR 8104, Paris, France; [Xia, Xuhua] Univ Ottawa, Biol Dept, CAREG, Ottawa, ON, Canada; [Veitia, Reiner A.] Univ Denis Diderot Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; UDICE-French Research Universities; Universite Paris Cite	Vinci, G (corresponding author), UM 3, Univ Paris 05,CNRS, Dept Genet & Dev,Inst Cochin,U567, INSERM,Fac Med Paris Descartes,UMR 8104, Paris, France.	veitia@cochin.inserm.fr	Xia, Xuhua/E-5264-2010; Vinci, Giovanna/M-1311-2017	Xia, Xuhua/0000-0002-3092-7566; 	INSERM; Paris VII university	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris VII university	Supported by the INSERM and Paris VII university.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909; Beckstead RB, 2006, CELL, V124, P1137, DOI 10.1016/j.cell.2006.03.001; Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P199, DOI 10.1016/S0303-7207(00)00416-0; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Freeman MR, 1999, DEVELOPMENT, V126, P4591; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hulsen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-398; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Mo CQ, 2005, J LIPID RES, V46, P1991, DOI 10.1194/jlr.M500153-JLR200; Mo CQ, 2004, BBA-MOL CELL BIOL L, V1686, P30, DOI 10.1016/j.bbalip.2004.08.001; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rosenfeld JM, 1998, J BIOL CHEM, V273, P16112, DOI 10.1074/jbc.273.26.16112; Roth GE, 2004, P NATL ACAD SCI USA, V101, P1601, DOI 10.1073/pnas.0308212100; Scheel J, 1999, NAT CELL BIOL, V1, P127, DOI 10.1038/10100; SCHROEDER F, 1995, MOL MEMBR BIOL, V12, P113, DOI 10.3109/09687689509038505; SCHROEDER F, 1991, P SOC EXP BIOL MED, V196, P235; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SCHULER E, 1994, J BIOL CHEM, V269, P11312; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Veitia RA, 2001, J GENET, V80, P17, DOI 10.1007/BF02811414; Wagner N, 2004, J CELL SCI, V117, P2015, DOI 10.1242/jcs.01052; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Wendler F, 2006, DEVELOPMENT, V133, P3055, DOI 10.1242/dev.02472; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2001, DATA ANAL MOL BIOL E, P277; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Ye Q, 1998, Subcell Biochem, V31, P587; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	50	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2883	10.1371/journal.pone.0002883	http://dx.doi.org/10.1371/journal.pone.0002883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682733	gold, Green Published, Green Submitted			2022-12-25	WOS:000264366600039
J	Reif, KE; Stout, RW; Henry, GC; Foil, LD; Macaluso, KR				Reif, Kathryn E.; Stout, Rhett W.; Henry, Gretchen C.; Foil, Lane D.; Macaluso, Kevin R.			Prevalence and Infection Load Dynamics of Rickettsia felis in Actively Feeding Cat Fleas	PLOS ONE			English	Article							CTENOCEPHALIDES-FELIS; TRANSOVARIAL TRANSMISSION; MOLECULAR-IDENTIFICATION; WOLBACHIA INFECTIONS; MURINE TYPHUS; SIPHONAPTERA; BIOLOGY; ASSOCIATION; HENSELAE; OPOSSUMS	Background: Rickettsia felis is a flea-associated rickettsial pathogen recurrently identified in both colonized and wild-caught cat fleas, Ctenocephalides felis. We hypothesized that within colonized fleas, the intimate relationship between R. felis and C. felis allows for the coordination of rickettsial replication and metabolically active periods during flea bloodmeal acquisition and oogenesis. Methodology/Principal Findings: A quantitative real-time PCR assay was developed to quantify R. felis in actively feeding R. felis-infected fleas. In three separate trials, fleas were allowed to feed on cats, and a mean of 3.9 x 10(6) R. felis 17-kDa gene copies was detected for each flea. A distinct R. felis infection pattern was not observed in fleas during nine consecutive days of bloodfeeding. However, an inverse correlation between the prevalence of R. felis-infection, which ranged from 96% in Trial 1 to 35% in Trial 3, and the R. felis-infection load in individual fleas was identified. Expression of R. felis-infection load as a ratio of R. felis/C. felis genes confirmed that fleas in Trial 3 had significantly greater rickettsial loads than those in Trial 1. Conclusion/Significance: Examining rickettsial infection dynamics in the flea vector will further elucidate the intimate relationship between R. felis and C. felis, and facilitate a more accurate understanding of the ecology and epidemiology of R. felis transmission in nature.	[Reif, Kathryn E.; Stout, Rhett W.; Henry, Gretchen C.; Macaluso, Kevin R.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Foil, Lane D.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Macaluso, KR (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	kmacaluso@vetmed.lsu.edu			Louisiana Board of Regents (LEQSF); National Institutes of Health [P20RR0201595, RR017504-01]; National Institute of Allergy and Infectious Diseases [R21AI70705]; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR017504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070705] Funding Source: NIH RePORTER	Louisiana Board of Regents (LEQSF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Louisiana Board of Regents (LEQSF), the National Institutes of Health (NIH; P20RR0201595), and the National Institute of Allergy and Infectious Diseases (R21AI70705). Gretchen Henry was supported by an NIH T35 (RR017504-01) awarded to LSU-SVM.	ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Bauer O, 2006, AM J TROP MED HYG, V74, P444, DOI 10.4269/ajtmh.2006.74.444; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; DRYDEN MW, 1994, VET PARASITOL, V52, P1, DOI 10.1016/0304-4017(94)90031-0; DRYDEN MW, 1989, VET PARASITOL, V34, P117, DOI 10.1016/0304-4017(89)90171-4; Foil L, 1998, J MED ENTOMOL, V35, P625, DOI 10.1093/jmedent/35.5.625; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Gorham CH, 2003, J PARASITOL, V89, P283, DOI 10.1645/0022-3395(2003)089[0283:WEIFS]2.0.CO;2; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; Horigane M, 2007, ARCH INSECT BIOCHEM, V64, P186, DOI 10.1002/arch.20170; Jiang J, 2006, EMERG INFECT DIS, V12, P1281, DOI 10.3201/eid1708.060327; Macaluso KR, 2001, VECTOR-BORNE ZOONOT, V1, P45, DOI 10.1089/153036601750137660; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Pornwiroon W, 2007, ISME J, V1, P394, DOI 10.1038/ismej.2007.38; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Rust MK, 1997, ANNU REV ENTOMOL, V42, P451, DOI 10.1146/annurev.ento.42.1.451; Schloderer D, 2006, EMERG INFECT DIS, V12, P841, DOI 10.3201/eid1205.051458; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; Stevenson HL, 2005, J MED ENTOMOL, V42, P163, DOI 10.1603/0022-2585(2005)042[0163:DORFIA]2.0.CO;2; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wedincamp J, 2000, J VECTOR ECOL, V25, P123; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Zanetti AS, 2008, J MED ENTOMOL, V45, P267, DOI 10.1603/0022-2585(2008)45[267:CORIIA]2.0.CO;2; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869	38	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2805	10.1371/journal.pone.0002805	http://dx.doi.org/10.1371/journal.pone.0002805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665265	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300024
J	Gaspar, M; Gill, MB; Loesing, JB; May, JS; Stevenson, PG				Gaspar, Miguel; Gill, Michael B.; Loesing, Jens-Bernhard; May, Janet S.; Stevenson, Philip G.			Multiple Functions for ORF75c in Murid Herpesvirus-4 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; COMPLETE SEQUENCE; GENE-EXPRESSION; VIRAL-PROTEINS; GLYCOPROTEIN-M; CELLS; IDENTIFICATION; TRANSCRIPTION; REPLICATION	All gamma-herpesviruses encode at least one homolog of the cellular enzyme formyl-glycineamide-phosphoribosylamidotransferase. Murid herpesvirus-4 (MuHV-4) encodes 3 (ORFs 75a, 75b and 75c), suggesting that at least some copies have acquired new functions. Here we show that the corresponding proteins are all present in virions and localize to infected cell nuclei. Despite these common features, ORFs 75a and 75b did not substitute functionally for a lack of ORF75c, as ORF75c virus knockouts were severely impaired for lytic replication in vitro and for host colonization in vivo. They showed 2 defects: in-coming capsids failed to migrate to the nuclear margin following membrane fusion, and genomes that did reach the nucleus failed to initiate normal gene expression. The latter defect was associated with a failure of in coming virions to disassemble PML bodies. The capsid transport deficit seemed to be functionally more important, since ORF75c(-) MuHV-4 infected both PML+ and PML- cells poorly. The original host enzyme has therefore evolved into a set of distinct and multi-functional viral tegument proteins. One important function is moving incoming capsids to the nuclear margin for viral genome delivery.	[Gaspar, Miguel; Gill, Michael B.; Loesing, Jens-Bernhard; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Gaspar, M (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Bosse, Jens Bernhard/D-7336-2011; Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Bosse, Jens Bernhard/0000-0001-7252-5541; Stevenson, Philip g/0000-0002-3520-5060	Wellcome Trust Senior Clinical Fellow [GR076956MA]; Medical Research Council [G0400427, G0701185, G9800903]; CR-UK [C19612/A6189]; Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany; Studienstiftung des Deutschen Volkes; MRC [G0701185, G0400427, G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust Senior Clinical Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany; Studienstiftung des Deutschen Volkes; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427,G0701185 and G9800903 and by CR-UK grant C19612/A6189. JBL was supported by the Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany and by the Studienstiftung des Deutschen Volkes.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Antinone SE, 2006, J VIROL, V80, P5494, DOI 10.1128/JVI.00026-06; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Davison AJ, 2005, J VIROL, V79, P12880, DOI 10.1128/JVI.79.20.12880-12892.2005; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560; DUSH MK, 1985, P NATL ACAD SCI USA, V82, P2731, DOI 10.1073/pnas.82.9.2731; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Feederle R, 2006, J VIROL, V80, P9435, DOI 10.1128/JVI.00473-06; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Hair JR, 2007, J GEN VIROL, V88, P1689, DOI 10.1099/vir.0.82548-0; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Martinez-Guzman D, 2003, J VIROL, V77, P10488, DOI 10.1128/JVI.77.19.10488-10503.2003; May JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002131; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; OHARE P, 1985, J VIROL, V56, P723, DOI 10.1128/JVI.56.3.723-733.1985; PATTERSON D, 1975, SOMAT CELL GENET, V1, P91, DOI 10.1007/BF01538734; Patterson D, 1999, GENE, V239, P381, DOI 10.1016/S0378-1119(99)00378-9; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Zimmermann W, 2001, J VIROL, V75, P1186, DOI 10.1128/JVI.75.3.1186-1194.2001	47	41	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2781	10.1371/journal.pone.0002781	http://dx.doi.org/10.1371/journal.pone.0002781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648660	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900051
J	Otterstatter, MC; Thomson, JD				Otterstatter, Michael C.; Thomson, James D.			Does Pathogen Spillover from Commercially Reared Bumble Bees Threaten Wild Pollinators?	PLOS ONE			English	Article							ANTHER-SMUT INFECTION; HONEY-BEE; BOMBUS-TERRESTRIS; CROP POLLINATION; PARASITIC MITES; WORLDWIDE MIGRATION; APIDAE ACTIVITY; SPATIAL SPREAD; HYMENOPTERA; DISEASE	The conservation of insect pollinators is drawing attention because of reported declines in bee species and the 'ecosystem services' they provide. This issue has been brought to a head by recent devastating losses of honey bees throughout North America (so called, 'Colony Collapse Disorder'); yet, we still have little understanding of the cause(s) of bee declines. Wild bumble bees (Bombus spp.) have also suffered serious declines and circumstantial evidence suggests that pathogen 'spillover' from commercially reared bumble bees, which are used extensively to pollinate greenhouse crops, is a possible cause. We constructed a spatially explicit model of pathogen spillover in bumble bees and, using laboratory experiments and the literature, estimated parameter values for the spillover of Crithidia bombi, a destructive pathogen commonly found in commercial Bombus. We also monitored wild bumble bee populations near greenhouses for evidence of pathogen spillover, and compared the fit of our model to patterns of C. bombi infection observed in the field. Our model predicts that, during the first three months of spillover, transmission from commercial hives would infect up to 20% of wild bumble bees within 2 km of the greenhouse. However, a travelling wave of disease is predicted to form suddenly, infecting up to 35-100% of wild Bombus, and spread away from the greenhouse at a rate of 2 km/wk. In the field, although we did not observe a large epizootic wave of infection, the prevalences of C. bombi near greenhouses were consistent with our model. Indeed, we found that spillover has allowed C. bombi to invade several wild bumble bee species near greenhouses. Given the available evidence, it is likely that pathogen spillover from commercial bees is contributing to the ongoing decline of wild Bombus in North America. Improved management of domestic bees, for example by reducing their parasite loads and their overlap with wild congeners, could diminish or even eliminate pathogen spillover.	[Otterstatter, Michael C.; Thomson, James D.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Otterstatter, MC (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	michael.otterstatter@utoronto.ca		Otterstatter, Michael/0000-0001-5489-014X	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarships (OGS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarships (OGS)(Ontario Graduate Scholarship)	Funding for this research was provided by grants to the authors by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Ontario Graduate Scholarships (OGS). No funding agencies had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Altizer SM, 1998, AM MIDL NAT, V139, P147, DOI 10.1674/0003-0031(1998)139[0147:VBATTO]2.0.CO;2; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; BANASZAK J, 1992, AGR ECOSYST ENVIRON, V40, P179, DOI 10.1016/0167-8809(92)90091-O; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Buchmann S, 2005, BEE WORLD, V86, P71, DOI 10.1080/0005772X.2005.11417316; Buchmann SL, 1996, SCIENCES, V36, P22, DOI 10.1002/j.2326-1951.1996.tb03254.x; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Diamond J., 2010, RUZHYA MIKROBY STALI; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dwyer G, 1998, AM NAT, V152, P485, DOI 10.1086/286185; DWYER G, 1994, AM NAT, V143, P533, DOI 10.1086/285619; DWYER G, 1995, ECOLOGY, V76, P1262, DOI 10.2307/1940933; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; ENTWISTLE PF, 1983, J APPL ECOL, V20, P473, DOI 10.2307/2403521; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Forup ML, 2005, ECOL ENTOMOL, V30, P47, DOI 10.1111/j.0307-6946.2005.00660.x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; Goka K, 2000, JPN J APPL ENTOMOL Z, V44, P47, DOI 10.1303/jjaez.2000.47; Goka K, 2001, MOL ECOL, V10, P2095, DOI 10.1046/j.0962-1083.2001.01323.x; Goka K, 2006, POPUL ECOL, V48, P285, DOI 10.1007/s10144-006-0010-8; GORBUNOV PS, 1987, ZOOL ZH, V66, P1775; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; KEVAN PG, 1991, P ENTOMOL SOC ONT, V122, P15; KEVAN PG, 1990, BEE WORLD, V71, P119, DOI 10.1080/0005772X.1990.11099048; Kevan PG, 2001, CONSERV ECOL, V5; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LAVERTY TM, 1988, CAN ENTOMOL, V120, P965, DOI 10.4039/Ent120965-11; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; LIU HJ, 1973, THESIS GUELPH U GUEL, P130; Ludwig JA, 1988, STAT ECOLOGY; MACFARLANE RP, 1974, THESIS GUELPH U GUEL, P210; MacPhee Ross D.E., 1997, P169; McCullagh P, 1989, GEN LINEAR MODELS; Morandin LA, 2001, CAN ENTOMOL, V133, P883, DOI 10.4039/Ent133883-6; Morandin LA, 2001, J ECON ENTOMOL, V94, P462, DOI 10.1603/0022-0493-94.2.462; Murray J.D., 2002, MATH BIOL; Niwa S, 2004, JPN J APPL ENTOMOL Z, V48, P60, DOI 10.1303/jjaez.2004.60; *NRC COMM STAT POL, 2006, STAT POLL N AM; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Otterstatter MC, 2004, APIDOLOGIE, V35, P351, DOI 10.1051/apido:2004024; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; ROCHE BM, 1995, ECOLOGY, V76, P1863, DOI 10.2307/1940719; Ruiz-Gonzalez MX, 2006, ECOL ENTOMOL, V31, P616, DOI 10.1111/j.1365-2311.2006.00823.x; Sabara HA, 2004, J ECON ENTOMOL, V97, P727, DOI 10.1603/0022-0493(2004)097[0727:IOBVSA]2.0.CO;2; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Samways MJ, 2006, CONSERV BIOL, V20, P245, DOI 10.1111/j.1523-1739.2006.00349.x; Samways MJ, 1996, BIODIVERS CONSERV, V5, P1047, DOI 10.1007/BF00052715; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Sokal R. R., 2012, BIOMETRY; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; THORP R, 2005, RED LIST POLLINATOR; VANDERSTEEN J, 2006, BIODIVERSITY IMPACT, P105; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; White A, 1999, OIKOS, V85, P487, DOI 10.2307/3546698; White A, 2000, OIKOS, V89, P137, DOI 10.1034/j.1600-0706.2000.890115.x; Whittington R, 2004, J ECON ENTOMOL, V97, P1384, DOI 10.1603/0022-0493-97.4.1384; Whittington R, 2004, CAN J PLANT SCI, V84, P599, DOI 10.4141/P02-192; Whittington R, 2003, J INVERTEBR PATHOL, V84, P54, DOI 10.1016/S0022-2011(03)00123-X; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Winter K, 2006, IMPORTATION NONNATIV; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	82	132	136	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2771	10.1371/journal.pone.0002771	http://dx.doi.org/10.1371/journal.pone.0002771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648661	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900041
J	Pletnev, S; Shcherbo, D; Chudakov, DM; Pletneva, N; Merzlyak, EM; Wlodawer, A; Dauter, Z; Pletnev, V				Pletnev, Sergei; Shcherbo, Dmitry; Chudakov, Dmitry M.; Pletneva, Nadezhda; Merzlyak, Ekaterina M.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Vladimir			A Crystallographic Study of Bright Far-Red Fluorescent Protein mKate Reveals pH-induced cis-trans Isomerization of the Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VIVO; STRUCTURAL BASIS; WHOLE-BODY; GREEN; CHROMOPROTEIN; MATURATION; MECHANISM; EXTENSION; PROGRAM	The far-red fluorescent protein mKate (lambda(ex), 588 nm; lambda(em), 635 nm; chromophore-forming triad Met(63)-Tyr(64)-Gly(65)), originating from wild-type red fluorescent progenitor eqFP578 (sea anemone Entacmaea quadricolor), is monomeric and characterized by the pronounced pH dependence of fluorescence, relatively high brightness, and high photostability. The protein has been crystallized at a pH ranging from 2 to 9 in three space groups, and four structures have been determined by x-ray crystallography at the resolution of 1.75-2.6 angstrom. The pH-dependent fluorescence of mKate has been shown to be due to reversible cis-trans isomerization of the chromophore phenolic ring. In the non-fluorescent state at pH 2.0, the chromophore of mKate is in the trans-isomeric form. The weakly fluorescent state of the protein at pH 4.2 is characterized by a mixture of trans and cis isomers. The chromophore in a highly fluorescent state at pH 7.0/9.0 adopts the cis form. Three key residues, Ser(143), Leu(174), and Arg(197) residing in the vicinity of the chromophore, have been identified as being primarily responsible for the far-red shift in the spectra. A group of residues consisting of Val(93), Arg(122), Glu(155), Arg(157), Asp(159), His(169), Ile(171), Asn(173), Val(192), Tyr(194), and Val(216), are most likely responsible for the observed monomeric state of the protein in solution.	[Pletnev, Sergei] SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletnev, Sergei; Dauter, Zbigniew] NCI, Macromol Crystallog Lab, NIH, Argonne, IL 60439 USA; [Shcherbo, Dmitry; Chudakov, Dmitry M.; Pletneva, Nadezhda; Pletnev, Vladimir] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Merzlyak, Ekaterina M.] Evrogen JSC, Moscow 117997, Russia; [Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA.	svp@ncifcrf.gov	Pletneva, Nadya/F-7839-2014; Shcherbo, Dmitry S/B-3549-2019; Chudakov, Dmitriy M/G-7741-2014; Merzlyak, Ekaterina/AAN-8272-2020; Pletnev, Vladimir/Q-6151-2016	Chudakov, Dmitriy M/0000-0003-0430-790X; Pletneva, Nadya/0000-0001-9681-4022; Merzlyak, Ekaterina/0000-0001-5695-0396	National Institutes of Health Intramural Research Program of the Center for Cancer Research; NCI [NO1-CO-12400]; Russian Foundation for Basic Research [07-04-00054, 07-04-12189]; Russian Federal Agency for Science and Innovations [02.513.12.3013]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Center for Cancer Research, NCI, and with Federal funds from NCI Contract No. NO1-CO-12400. This work was also supported by the Russian Foundation for Basic Research (Grants 07-04-00054 and 07-04-12189), Russian Federal Agency for Science and Innovations (Grant 02.513.12.3013). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Haugwitz M, 2003, GENET ENG NEWS, V23, P36; He X, 2003, FEBS LETT, V549, P35, DOI 10.1016/S0014-5793(03)00761-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1992485; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakhomov AA, 2006, BIOCHEMISTRY-US, V45, P7256, DOI 10.1021/bi060207q; Passamaneck YJ, 2006, MICROSC RES TECHNIQ, V69, P160, DOI 10.1002/jemt.20284; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Quillin ML, 2005, BIOCHEMISTRY-US, V44, P5774, DOI 10.1021/bi047644u; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Seitz G, 2006, J PEDIATR SURG, V41, P1369, DOI 10.1016/j.jpedsurg.2006.04.039; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Stewart CN, 2006, TRENDS BIOTECHNOL, V24, P155, DOI 10.1016/j.tibtech.2006.02.002; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wacker SA, 2007, DEV DYNAM, V236, P473, DOI 10.1002/dvdy.20955; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1; 1998, GREEN FLUORESCENT PR, P120	48	85	88	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28980	28987		10.1074/jbc.M800599200	http://dx.doi.org/10.1074/jbc.M800599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682399	Green Published, hybrid			2022-12-25	WOS:000260179900023
J	Jin, Z; Heinnickel, M; Krebs, C; Shen, G; Golbeck, JH; Bryant, DA				Jin, Zhao; Heinnickel, Mark; Krebs, Carsten; Shen, Gaozhong; Golbeck, John H.; Bryant, Donald A.			Biogenesis of iron-sulfur clusters in photosystem I - HOLO-NfuA from the cyanobacterium synechococcus sp PCC 7002 rapidly and efficiently transfers [4Fe-4S] clusters to apo-PsaC in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOTHIOL GLUTAREDOXINS; SCAFFOLD PROTEIN; CORE PROTEIN; AZOTOBACTER-VINELANDII; SUFBCDS OPERON; SP PCC-7002; NIFU; MITOCHONDRIA; RECONSTITUTION; BIOSYNTHESIS	The NfuA protein has been postulated to act as a scaffolding protein in the biogenesis of photosystem (PS) I and other iron-sulfur (Fe/S) proteins in cyanobacteria and chloroplasts. To determine the properties of NfuA, recombinant NfuA from Synechococcus sp. PCC 7002 was overproduced and purified. In vitro reconstituted NfuA contained oxygen-and EDTA-labile Fe/S cluster(s), which had EPR properties consistent with [4Fe-4S] clusters. After reconstitution with Fe-57(2+), Mossbauer studies of NfuA showed a broad quadrupole doublet that confirmed the presence of [4Fe-4S](2+) clusters. Native gel electrophoresis under anoxic conditions and chemical cross-linking showed that holo-NfuA forms dimers and tetramers harboring Fe/S cluster(s). Combined with iron and sulfide analyses, the results indicated that one [4Fe-4S] cluster was bound per NfuA dimer. Fe/S cluster transfer from holo-NfuA to apo-PsaC of PS I was studied by reconstitution of PS I complexes using P700-FX core complexes, PsaD, apo-PsaC, and holo-NfuA. Electron transfer measurements by time-resolved optical spectroscopy showed that holo-NfuA rapidly and efficiently transferred [4Fe-4S] clusters to PsaC in a reaction that required contact between the two proteins. The NfuA-reconstituted PS I complexes had typical charge recombination kinetics from [FA/FB](-) to P700(+) and light-induced low-temperature EPR spectra. These results establish that cyanobacterial NfuA can act as a scaffolding protein for the insertion of [4Fe-4S] clusters into PsaC of PS I in vitro.	[Jin, Zhao; Heinnickel, Mark; Krebs, Carsten; Shen, Gaozhong; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Krebs, Carsten; Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-235 Frear Bldg, University Pk, PA 16802 USA.	dab14@psu.edu	Jin, Zhao/C-5405-2011; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	U. S. Dept. of Agriculture Contract [2005-35318-15284]; National Science Foundation [MCB-0077586]; Center for the Study of Biometals in Health and Disease [417-12Hy TSF]; Pennsylvania Dept. of Health	U. S. Dept. of Agriculture Contract; National Science Foundation(National Science Foundation (NSF)); Center for the Study of Biometals in Health and Disease; Pennsylvania Dept. of Health	This work was supported by U. S. Dept. of Agriculture Contract 2005-35318-15284 (to J. H. G. and D. A. B.), National Science Foundation Grant MCB-0077586 (to D. A. B. and J. H. G.), and "Center for the Study of Biometals in Health and Disease" Grant 417-12Hy TSF (to C. K.). This work was also supported, in part, under a grant with the Pennsylvania Dept. of Health using Tobacco Settlement Funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Antonkine ML, 2003, J MOL BIOL, V327, P671, DOI 10.1016/S0022-2836(03)00145-1; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BEARDEN AJ, 1976, BIOCHIM BIOPHYS ACTA, V430, P538, DOI 10.1016/0005-2728(76)90029-3; Beinert H, 1978, Methods Enzymol, V54, P435; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; CRANKSHAW MW, 1996, CURRENT PROTOCOLS PR, P2218; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Golbeck J. H., 1995, CRC HDB ORGANIC PHOT, P1407; GOLBECK JH, 1976, BIOCHEM BIOPH RES CO, V71, P452, DOI 10.1016/0006-291X(76)90808-1; GOLBECK JH, 1988, FEBS LETT, V240, P9, DOI 10.1016/0014-5793(88)80331-4; Golbeck JH, 1994, MOL BIOL CYANOBACTER, P319; GOLBECK JH, 2006, PHOTOSYSTEM, V1; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Heinnickel M, 2005, BIOCHEMISTRY-US, V44, P9950, DOI 10.1021/bi050588s; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; LI N, 1991, BIOCHIM BIOPHYS ACTA, V1059, P215, DOI 10.1016/S0005-2728(05)80206-3; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Shen Gaozhong, 2006, V24, P529; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vassiliev IR, 1997, BIOPHYS J, V72, P301, DOI 10.1016/S0006-3495(97)78669-7; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	47	34	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28426	28435		10.1074/jbc.M803395200	http://dx.doi.org/10.1074/jbc.M803395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694929	Green Published, hybrid			2022-12-25	WOS:000259969300044
J	Hannemann, S; Madrid, R; Stastna, J; Kitzing, T; Gasteier, J; Schonichen, A; Bouchet, J; Jimenez, A; Geyer, M; Grosse, R; Benichou, S; Fackler, OT				Hannemann, Sebastian; Madrid, Ricardo; Stastna, Jana; Kitzing, Thomas; Gasteier, Judith; Schoenichen, Andre; Bouchet, Jerome; Jimenez, Alberto; Geyer, Matthias; Grosse, Robert; Benichou, Serge; Fackler, Oliver T.			The diaphanous-related formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELL INVASION; MAMMALIAN FORMIN; RHO-GTPASES; ACTIN; PROTEIN; MIGRATION; ACTIVATION; MECHANISM; PHOSPHORYLATION; IDENTIFICATION	Diaphanous-related formins (DRFs) mediate GTPase-triggered actin rearrangements to regulate central cellular processes, such as cell motility and cytokinesis. The DRF FHOD1 interacts with the Rho-GTPase Rac1 and mediates formation of actin stress fibers in its deregulated form; the physiologically relevant activities and molecular mechanisms of endogenous FHOD1, however, are still unknown. Here we report that FHOD1 physically associates via the N-terminal part of its FH2 domain with the central domain of ROCK1. Although FHOD1 does not affect the kinase activity of ROCK1, the DRF is an efficient substrate for phosphorylation by ROCK1. Co-expression of FHOD1 and ROCK1 results in the generation of nonapoptotic plasma membrane (PM) blebs, to which the DRF is efficiently recruited. Blebbing induced by FHOD1 and ROCK1 depends on F-actin integrity, the Rho-ROCK cascade, and Src activity and is reminiscent of the recently described PM blebs triggered by expression of Src homology 4 (SH4) domain PM targeting signals. Consistently, endogenous FHOD1 is required in SH4 domain expressing cells for efficient PM blebbing and rounded cell morphology in two-dimensional cultures or three-dimensional matrices, respectively. Efficient association of FHOD1 with ROCK1, as well as recruitment of the DRF to blebs, depends on Src activity, suggesting that the functional interaction between both proteins is regulated by Src. These results define a role for endogenous FHOD1 in SH4 domain-induced blebbing and suggest that its activity is regulated by ROCK1 in a Src-dependent manner.	[Hannemann, Sebastian; Stastna, Jana; Gasteier, Judith; Fackler, Oliver T.] Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany; [Kitzing, Thomas; Grosse, Robert] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Madrid, Ricardo; Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Madrid, Ricardo; Bouchet, Jerome; Benichou, Serge] INSERM, U567, F-75014 Paris, France; [Madrid, Ricardo; Jimenez, Alberto] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Madrid, Ricardo; Jimenez, Alberto] CSIC, E-28049 Madrid, Spain; [Schoenichen, Andre; Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Max Planck Society	Fackler, OT (corresponding author), Heidelberg Univ, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	oliver_fackler@med.uni-heidelberg.de	bouchet, jerome/I-7716-2019	bouchet, jerome/0000-0002-6611-4380; Fackler, Oliver Till/0000-0003-2982-4209; Geyer, Matthias/0000-0002-7718-5002; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Grosse, Robert/0000-0002-3380-5273; Benichou, Serge/0000-0003-3602-3530	Deutsche Forschungsgemeinschaft [Fa 378/6-1, Ge 976/4-1, Gr 2111/1-3, GRK1188]; French Agency for AIDS Research; Sidaction; Ministerio de Educacion y Cultura, Ramon y Cajal program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); French Agency for AIDS Research(French National Research Agency (ANR)); Sidaction; Ministerio de Educacion y Cultura, Ramon y Cajal program(Spanish Government)	This work was supported by Deutsche Forschungsgemeinschaft Grants Fa 378/6-1 (to O.T.F.), Ge 976/4-1 (to M. G.), Gr 2111/1-3 (to R. G.), and GRK1188 (to S. H. and J. S.) and grants from the French Agency for AIDS Research (to S. B.), Sidaction (to S. B., R. M., and J. B.), and the Ministerio de Educacion y Cultura, Ramon y Cajal program (to R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Koka S, 2005, BIOCHEM BIOPH RES CO, V336, P1285, DOI 10.1016/j.bbrc.2005.08.257; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Madrid R, 2005, FEBS LETT, V579, P441, DOI 10.1016/j.febslet.2004.12.009; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Rauch S, 2008, J VIROL, V82, P2918, DOI 10.1128/JVI.02185-07; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Torgerson RR, 1998, J CELL SCI, V111, P2911; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	49	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27891	27903		10.1074/jbc.M801800200	http://dx.doi.org/10.1074/jbc.M801800200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694941	hybrid			2022-12-25	WOS:000259719200060
J	Demirci, H; Gregory, ST; Dahlberg, AE; Jogl, G				Demirci, Hasan; Gregory, Steven T.; Dahlberg, Albert E.; Jogl, Gerwald			Crystal structure of the Thermus thermophilus 16 S rRNA methyltransferase RsmC in complex with cofactor and substrate guanosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEVEL STREPTOMYCIN RESISTANCE; ESCHERICHIA-COLI; DEPENDENT METHYLTRANSFERASE; THERMUS-THERMOPHILUS; STRUCTURE ALIGNMENT; MUTATIONS; FOLD; CONTRIBUTES; RECOGNITION; SELECTIVITY	Post-transcriptional modification is a ubiquitous feature of ribosomal-RNA in all kingdoms of life. Modified nucleotides are generally clustered in functionally important regions of the ribosome, but the functional contribution to protein synthesis is not well understood. Here we describe high resolution crystal structures for the N-2-guanine methyltransferase RsmC that modifies residue G1207 in 16 S rRNA near the decoding site of the 30 S ribosomal subunit. RsmC is a class I S-adenosyl-L-methionine-dependent methyltransferase composed of two methyltransferase domains. However, only one S-adenosyl-L-methionine molecule and one substrate molecule, guanosine, bind in the ternary complex. The N-terminal domain does not bind any cofactor. Two structures with bound S-adenosyl-L-methionine and S-adenosyl-L-homocysteine confirm that the cofactor binding mode is highly similar to other class I methyltransferases. Secondary structure elements of the N-terminal domain contribute to cofactor-binding interactions and restrict access to the cofactor-binding site. The orientation of guanosine in the active site reveals that G1207 has to disengage from its Watson-Crick base pairing interaction with C1051 in the 16 S rRNA and flip out into the active site prior to its modification. Inspection of the 30 S crystal structure indicates that access to G1207 by RsmC is incompatible with the native subunit structure, consistent with previous suggestions that this enzyme recognizes a subunit assembly intermediate.	[Demirci, Hasan; Gregory, Steven T.; Dahlberg, Albert E.; Jogl, Gerwald] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Jogl, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315; Demirci, Hasan/0000-0002-9135-5397	National Institutes of Health [GM19756]; Brown University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University	This work was supported, in whole or in part, by National Institutes of Health Grant GM19756 (to A. E. D.). This work was also supported by Brown University (to G. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; [Anonymous], [No title captured]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujnicki JM, 2000, FASEB J, V14, P2365, DOI 10.1096/fj.00-0076com; BUJNICKI JM, 2002, BMC BIOINFORMATICS, V3; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; CUSACK S, 1998, MANY FACES RNA, P55; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Demirci H, 2007, EMBO J, V26, P567, DOI 10.1038/sj.emboj.7601508; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; GORINGER HU, 1991, P NATL ACAD SCI USA, V88, P6603, DOI 10.1073/pnas.88.15.6603; GREGORY ST, 1995, NUCLEIC ACIDS RES, V23, P4234, DOI 10.1093/nar/23.21.4234; Guymon R, 2006, BIOCHEMISTRY-US, V45, P4888, DOI 10.1021/bi052579p; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; JEMIOLO DK, 1991, NUCLEIC ACIDS RES, V19, P4259, DOI 10.1093/nar/19.15.4259; KOZBIAL PZ, 2005, BMC STRUCT BIOL, P5; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lenz T, 2007, J AM CHEM SOC, V129, P6240, DOI 10.1021/ja069366n; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Mengel-Jorgensen J, 2006, J BIOL CHEM, V281, P22108, DOI 10.1074/jbc.M600377200; MOINE H, 1994, J MOL BIOL, V243, P402, DOI 10.1006/jmbi.1994.1668; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimura K, 2007, J BACTERIOL, V189, P6068, DOI 10.1128/JB.00558-07; Nishimura K, 2007, J BACTERIOL, V189, P3876, DOI 10.1128/JB.01776-06; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Sergiev PV, 2007, NUCLEIC ACIDS RES, V35, P2295, DOI 10.1093/nar/gkm104; Shatsky M, 2006, PROTEINS, V62, P209, DOI 10.1002/prot.20665; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Sunita S, 2007, NUCLEIC ACIDS RES, V35, P4264, DOI 10.1093/nar/gkm411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	47	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26548	26556		10.1074/jbc.M804005200	http://dx.doi.org/10.1074/jbc.M804005200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667428	hybrid, Green Published			2022-12-25	WOS:000259341600031
J	Sawada, T; Nishiyama, C; Kishi, T; Sasazuki, T; Komazawa-Sakon, S; Xue, X; Piao, JH; Ogata, H; Nakayama, J; Taki, T; Hayashi, Y; Watanabe, M; Yagita, H; Okumura, K; Nakano, H				Sawada, Taisuke; Nishiyama, Chiharu; Kishi, Takuma; Sasazuki, Tomonari; Komazawa-Sakon, Sachiko; Xue, Xin; Piao, Jiang-Hu; Ogata, Hideko; Nakayama, Jun-ichi; Taki, Tomohiko; Hayashi, Yasuhide; Watanabe, Mamoru; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu			Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MEGAKARYOBLASTIC LEUKEMIA; HISTONE DEACETYLASES; GENE-EXPRESSION; ACTIVATION; MYOCARDIN; CLONING; ALPHA; DIFFERENTIATION; COACTIVATOR	OTT/RBM15-BSAC/MAL/MKL1/MRTF-A was identified as a fusion transcript generated by t(1; 22)(p13; q13) in acute megakaryoblastic leukemia. Previous studies have shown that BSAC (basic, SAP, and coiled-coil domain) activates the promoters containing CArG boxes via interaction with serum response factor, and OTT (one twenty-two) negatively regulates the development of megakaryocytes and myeloid cells. However, the mechanism by which OTT-BSAC promotes leukemia is largely unknown. Here we show that OTT-BSAC, but not BSAC or OTT strongly activates several promoters containing a transcription factor Yin Yang 1-binding sequence. In addition, although BSAC predominantly localizes in the cytoplasm and its nuclear translocation is considered to be regulated by the Rho-actin signaling pathway, OTT-BSAC exclusively localizes in the nucleus. Moreover, OTT interacts with histone deacetylase 3, but this interaction is abolished in OTT-BSAC. Collectively, these functional and spatial changes of OTT and BSAC caused by the fusion might perturb their functions, culminating in the development of acute megakaryoblastic leukemia.	[Sawada, Taisuke; Kishi, Takuma; Sasazuki, Tomonari; Komazawa-Sakon, Sachiko; Xue, Xin; Piao, Jiang-Hu; Ogata, Hideko; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Juntendo Univ, Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Ningxia Med Coll, Sch Basic Med Sci, Dept Immunol, Xingqing Qu 750004, Yinchuan, Peoples R China; [Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Taki, Tomohiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Lab Med, Kamigyo Ku, Kyoto 6028566, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Gunma 3778577, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan	Juntendo University; Juntendo University; Juntendo University; Ningxia Medical University; RIKEN; Kyoto Prefectural University of Medicine; Gunma Children's Medical Centre; Tokyo Medical & Dental University (TMDU)	Nakano, H (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hnakano@juntendo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022; Nakayama, Jun-ichi/C-6003-2011; Watanabe, Mamoru/AHE-0489-2022	Nakayama, Jun-ichi/0000-0002-5597-8239; Nakano, Hiroyasu/0000-0003-4843-1427; Komazawa-Sakon, Sachiko/0000-0002-6244-1974	Grant-in-Aid for a " High-Tech Research Center"; Ministry of Education, Culture, Sports, Science and Technology; Scientific Research (B) and (C) from Japan Society for the Promotion of Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Takeda Science Foundation; Mitsubishi Pharma Foundation; Tokyo Biochemical Research Foundation	Grant-in-Aid for a " High-Tech Research Center"; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research (B) and (C) from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Foundation; Tokyo Biochemical Research Foundation	This work was supported in part by a Grant-in-Aid for a " High-Tech Research Center" Project for Private Universities, matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, and Scientific Research (B) and (C) from Japan Society for the Promotion of Science, and grants from the NOVARTIS Foundation (Japan) for the Promotion of Science, the Takeda Science Foundation, the Mitsubishi Pharma Foundation, and the Tokyo Biochemical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Holmes ML, 2002, J BIOL CHEM, V277, P48333, DOI 10.1074/jbc.M206127200; Jepsen K, 2002, J CELL SCI, V115, P689; Kanada S, 2008, J IMMUNOL, V180, P8204, DOI 10.4049/jimmunol.180.12.8204; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MURAOKA O, 1993, IMMUNOL LETT, V37, P159, DOI 10.1016/0165-2478(93)90026-X; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nguyen N, 2004, J BIOL CHEM, V279, P25927, DOI 10.1074/jbc.M402525200; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; OGURA M, 1985, BLOOD, V66, P1384; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005	28	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26820	26828		10.1074/jbc.M802315200	http://dx.doi.org/10.1074/jbc.M802315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667423	Green Published, hybrid			2022-12-25	WOS:000259341600053
J	Siller-Jackson, AJ; Burra, S; Gu, SM; Xia, XC; Bonewald, LF; Sprague, E; Jiang, JX				Siller-Jackson, Arlene J.; Burra, Sirisha; Gu, Sumin; Xia, Xuechun; Bonewald, Lynda F.; Sprague, Eugene; Jiang, Jean X.			Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; FLUID-FLOW; OSTEOCLAST FORMATION; ATP RELEASE; BONE MASS; OSTEOCYTES; EXPRESSION; INHIBITION; CARTILAGE; PROTEINS	Bone tissues respond to mechanical loading/unloading regimens to accommodate (re) modeling requirements; however, the underlying molecular mechanism responsible for these responses is largely unknown. Previously, we reported that connexin (Cx) 43 hemichannels in mechanosensing osteocytes mediate the release of prostaglandin, PGE(2), a crucial factor for bone formation in response to anabolic loading. We show here that the opening of hemichannels and release of PGE(2) by shear stress were significantly inhibited by a potent antibody we developed that specifically blocks Cx43-hemichannels, but not gap junctions or other channels. The opening of hemichannels and release of PGE(2) are magnitude-dependent on the level of shear stress. Insertion of a rest period between stress enhances this response. Hemichannels gradually close after 24 h of continuous shear stress corresponding with reduced Cx43 expression on the cell surface, thereby reducing any potential negative effects of channels staying open for extended periods. These data suggest that Cx43-hemichannel activity associated with PGE(2) release is adaptively regulated by mechanical loading to provide an effective means of regulating levels of extracellular signaling molecules responsible for initiation of bone (re) modeling.	[Siller-Jackson, Arlene J.; Burra, Sirisha; Gu, Sumin; Xia, Xuechun; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Sprague, Eugene] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Bonewald, Lynda F.] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Kansas City	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Bonewald, Lynda/Q-3638-2019; burra, sirisha/H-2014-2011	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [F31 AR053468, P01 AR46798]; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR053468, P01AR046798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31 AR053468 (to A. J. S.-J.) and P01 AR46798 (to J. X. J., L. F. B., and E. S.). This work was also supported by the Welch Foundation Grant AQ-1507 (to J. X. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Boucher S, 2003, J NEUROSCI RES, V72, P393, DOI 10.1002/jnr.10575; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; COLLINS DA, 1992, J BONE MINER RES, V7, P555; COLLINS DA, 1991, J BONE MINER RES, V6, P157; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; DONAHUE HJ, 1995, J BONE MINER RES, V10, P1359; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; John S, 2003, ACTA PHYSIOL SCAND, V179, P23, DOI 10.1046/j.1365-201X.2003.01197.x; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Mason DJ, 1996, J BONE MINER RES, V11, P350; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; PRASAD ARS, 1993, CIRC RES, V72, P827, DOI 10.1161/01.RES.72.4.827; Presley CA, 2005, CELL COMMUN ADHES, V12, P307, DOI 10.1080/15419060500514200; Raisz LG, 1999, OSTEOARTHR CARTILAGE, V7, P419, DOI 10.1053/joca.1998.0230; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Robling AG, 2000, J BONE MINER RES, V15, P1596, DOI 10.1359/jbmr.2000.15.8.1596; Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P285, DOI 10.1007/BF00334489; Schwab W, 1998, HISTOCHEM J, V30, P413, DOI 10.1023/A:1003220225670; Skerry T. M., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P122; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Tanaka K, 1995, J BONE MINER METAB, V13, P61, DOI DOI 10.1007/BF01771319; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002; THOMPSON DD, 1988, J BONE MINER RES, V3, P409; Wang LY, 2003, J BIOMECH, V36, P1439, DOI 10.1016/S0021-9290(03)00241-0; ZENG Y, 1994, ANN BIOMED ENG, V22, P280, DOI 10.1007/BF02368235	55	120	124	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26374	26382		10.1074/jbc.M803136200	http://dx.doi.org/10.1074/jbc.M803136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676366	Green Published, hybrid			2022-12-25	WOS:000259341600011
J	Bachvaroff, TR; Place, AR				Bachvaroff, Tsvetan R.; Place, Allen R.			From Stop to Start: Tandem Gene Arrangement, Copy Number and Trans-Splicing Sites in the Dinoflagellate Amphidinium carterae	PLOS ONE			English	Article							BINDING-PROTEIN; PLASTID GENOME; FINE-STRUCTURE; ORGANIZATION; DNA; EXPRESSION; PERIDININ; SYMBIODINIUM; DIVERSITY; RUBISCO	Dinoflagellate genomes present unique challenges including large size, modified DNA bases, lack of nucleosomes, and condensed chromosomes. EST sequencing has shown that many genes are found as many slightly different variants implying that many copies are present in the genome. As a preliminary survey of the genome our goal was to obtain genomic sequences for 47 genes from the dinoflagellate Amphidinium carterae. A PCR approach was used to avoid problems with large insert libraries. One primer set was oriented inward to amplify the genomic complement of the cDNA and a second primer set would amplify outward between tandem repeats of the same gene. Each gene was also tested for a spliced leader using cDNA as template. Almost all (14/15) of the highly expressed genes (i.e. those with high representation in the cDNA pool) were shown to be in tandem arrays with short intergenic spacers, and most were trans-spliced. Only two moderately expressed genes were found in tandem arrays. A polyadenylation signal was found in genomic copies containing the sequence AAAAG/C at the exact polyadenylation site and was conserved between species. Four genes were found to have a high intron density (>5 introns) while most either lacked introns, or had only one to three. Actin was selected for deeper sequencing of both genomic and cDNA copies. Two clusters of actin copies were found, separated from each other by many non-coding features such as intron size and sequence. One intron-rich gene was selected for genomic walking using inverse PCR, and was not shown to be in a tandem repeat. The first glimpse of dinoflagellate genome indicates two general categories of genes in dinoflagellates, a highly expressed tandem repeat class and an intron rich less expressed class. This combination of features appears to be unique among eukaryotes.	[Bachvaroff, Tsvetan R.; Place, Allen R.] Univ Maryland, Biotechnol Inst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Bachvaroff, TR (corresponding author), Univ Maryland, Biotechnol Inst, Baltimore, MD USA.	bachvarofft@si.edu	Place, Allen R/F-9267-2013		National Oceanic and Atmospheric Administration Coastal Ocean Program [NA04NOS4780276, NA05NOS4781196, U50/CCU 323376]; Centers for Disease Control and Prevention; Maryland Department of Health and Mental Hygiene; NSF [EF-0626678]	National Oceanic and Atmospheric Administration Coastal Ocean Program(National Oceanic Atmospheric Admin (NOAA) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maryland Department of Health and Mental Hygiene; NSF(National Science Foundation (NSF))	Funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under award #NA04NOS4780276 (to ARP) and #NA05NOS4781196 and Grant # U50/CCU 323376, Centers for Disease Control and Prevention and the Maryland Department of Health and Mental Hygiene (to ARP) and NSF grant EF-0626678. The sponsors and funders had no role in the design and conduct, or collection, analysis, and interpretation of the data, or preparation, review, or approval of the manuscript.	ANDERSEN RA, 1997, J PHYSL S, V33; Bachvaroff TR, 2006, J MOL EVOL, V62, P42, DOI 10.1007/s00239-004-0365-4; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Barbrook AC, 2001, MOL GENET GENOMICS, V266, P632, DOI 10.1007/s004380100582; BJORNLAND T, 1979, J PHYCOL, V15, P457; BUTSCHLI O, 1885, KLASSEN ORDNUNGEN TH, V1, P865; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Chatton E., 1920, Archives de Zoologie Experimentale Paris, V59; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Guillebault D, 2002, J BIOL CHEM, V277, P40881, DOI 10.1074/jbc.M205624200; HAAPALA OK, 1973, NATURE-NEW BIOL, V244, P195, DOI 10.1038/newbio244195a0; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; HARATA M, 1994, P NATL ACAD SCI USA, V91, P8258, DOI 10.1073/pnas.91.17.8258; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Joubes J, 2000, PLANT MOL BIOL, V43, P735, DOI 10.1023/A:1006446417196; Kubota T, 2006, BIOL PHARM BULL, V29, P1314, DOI 10.1248/bpb.29.1314; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; LEE DH, 1993, J BIOL CHEM, V268, P8842; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Liu LY, 2006, J PHYCOL, V42, P96, DOI 10.1111/j.1529-8817.2006.00165.x; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; MADDISON WP, 2000, MACCLADE VERSION 4; MAXSON R, 1983, ANNU REV GENET, V17, P239, DOI 10.1146/annurev.ge.17.120183.001323; MORSE D, 1995, SCIENCE, V268, P1622, DOI 10.1126/science.7777861; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Parrow MW, 2004, J PHYCOL, V40, P664, DOI 10.1111/j.1529-8817.2004.03202.x; RAE PMM, 1976, SCIENCE, V194, P1062, DOI 10.1126/science.988637; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; RIZZO PJ, 1972, SCIENCE, V176, P796, DOI 10.1126/science.176.4036.796; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; WILCOX LW, 1985, SCIENCE, V227, P192, DOI 10.1126/science.227.4683.192; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	45	130	132	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2929	10.1371/journal.pone.0002929	http://dx.doi.org/10.1371/journal.pone.0002929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698341	gold, Green Submitted, Green Published			2022-12-25	WOS:000264412600015
J	Pyron, RA; Burbrink, FT; Guiher, TJ				Pyron, R. Alexander; Burbrink, Frank T.; Guiher, Timothy J.			Claims of Potential Expansion throughout the U.S. by Invasive Python Species Are Contradicted by Ecological Niche Models	PLOS ONE			English	Article							DISTRIBUTIONS; CLIMATE; GECKOS	Background: Recent reports from the United States Geological Survey (USGS) suggested that invasive Burmese pythons in the Everglades may quickly spread into many parts of the U. S. due to putative climatic suitability. Additionally, projected trends of global warming were predicted to significantly increase suitable habitat and promote range expansion by these snakes. However, the ecological limitations of the Burmese python are not known and the possible effects of global warming on the potential expansion of the species are also unclear. Methodology/Principal Findings: Here we show that a predicted continental expansion is unlikely based on the ecology of the organism and the climate of the U. S. Our ecological niche models, which include variables representing climatic extremes as well as averages, indicate that the only suitable habitat in the U. S. for Burmese pythons presently occurs in southern Florida and in extreme southern Texas. Models based on the current distribution of the snake predict suitable habitat in essentially the only region in which the snakes are found in the U. S. Future climate models based on global warming forecasts actually indicate a significant contraction in suitable habitat for Burmese pythons in the U. S. as well as in their native range. Conclusions/Significance: The Burmese python is strongly limited to the small area of suitable environmental conditions in the United States it currently inhabits due to the ecological niche preferences of the snake. The ability of the Burmese python to expand further into the U. S. is severely limited by ecological constraints. Global warming is predicted to significantly reduce the area of suitable habitat worldwide, underscoring the potential negative effects of climate change for many species.	[Pyron, R. Alexander; Guiher, Timothy J.] CUNY, Grad Sch, Dept Biol, New York, NY 10021 USA; [Pyron, R. Alexander; Burbrink, Frank T.; Guiher, Timothy J.] CUNY, Coll Staten Island, Dept Biol, Staten Isl, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Pyron, RA (corresponding author), CUNY, Grad Sch, Dept Biol, New York, NY 10021 USA.	rpyron@gc.cuny.edu	Pyron, Robert/F-1681-2014	Pyron, Robert/0000-0003-2524-1794				Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Grinnell J., 1917, Auk Cambridge Mass, V34; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; MCDIARMID RW, 1999, SNAKE SPECIES WORLD, P511; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Snow R. W., 2007, BIOL BOAS PYTHONS, P417	12	51	54	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2931	10.1371/journal.pone.0002931	http://dx.doi.org/10.1371/journal.pone.0002931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698351	Green Published, gold			2022-12-25	WOS:000264412600017
J	Ban, M; Elson, J; Walton, A; Turnbull, D; Compston, A; Chinnery, P; Sawcer, S				Ban, Maria; Elson, Joanna; Walton, Amie; Turnbull, Douglas; Compston, Alastair; Chinnery, Patrick; Sawcer, Stephen			Investigation of the Role of Mitochondrial DNA in Multiple Sclerosis Susceptibility	PLOS ONE			English	Article								Several lines of evidence suggest that mitochondrial genetic factors may influence susceptibility to multiple sclerosis. To explore this hypothesis further, we re-sequenced the mitochondrial genome (mtDNA) from 159 patients with multiple sclerosis and completed a haplogroup analysis including a further 835 patients and 1,506 controls. A trend towards over-representation of super-haplogroup U was the only evidence for association with mtDNA that we identified in these samples. In a parallel analysis of nuclear encoded mitochondrial genes, we also found a trend towards association with the complex I gene, NDUFS2. These results add to the evidence suggesting that variation in mtDNA and nuclear encoded mitochondrial genes may contribute to disease susceptibility in multiple sclerosis.	[Ban, Maria; Walton, Amie; Compston, Alastair; Sawcer, Stephen] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Elson, Joanna; Turnbull, Douglas; Chinnery, Patrick] Newcastle Univ, Med Sch, Mitochondrial Res Grp, Framlington Place, Newcastle Upon Tyne, Tyne & Wear, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK	Ban, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England.	mb531@medschl.cam.ac.uk		/0000-0002-3551-5624; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust [057097]; Medical Research Council [G0700061]; National Institute of Health [NS 049477-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER; Medical Research Council [G90/63] Funding Source: researchfish; MRC [G90/63, G0700061] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant 057097), the Medical Research Council (G0700061) and the National Institute of Health (NS 049477-01A1). The Funders did not play any role in the design and conduct of the study, in the collection, analysis and interpretation of data, and in the preparation, review, or approval of the manuscript.	Andrews HE, 2005, MED HYPOTHESES, V64, P669, DOI 10.1016/j.mehy.2004.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Chalmers RM, 1996, ANN NEUROL, V40, P239, DOI 10.1002/ana.410400216; CHALMERS RM, 1995, J NEUROL, V242, P332, DOI 10.1007/BF00878877; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Houshmand M, 2005, MULT SCLER J, V11, P728, DOI 10.1191/1352458505ms1228sr; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Kalman B, 1996, J NEUROL SCI, V140, P75, DOI 10.1016/0022-510X(96)00112-8; Kalman B, 1997, Mult Scler, V2, P279; Kalman B, 1995, Mult Scler, V1, P32; Kalman B, 1999, ACTA NEUROL SCAND, V99, P16; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x; Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x; NISHIMURA M, 1995, NEUROLOGY, V45, P1333, DOI 10.1212/WNL.45.7.1333; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Otaegui D, 2004, MULT SCLER J, V10, P532, DOI 10.1191/1352458504ms1069oa; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Torroni A, 1996, GENETICS, V144, P1835; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1191/135245898678919456; Vyshkina T, 2005, J NEUROL SCI, V228, P55, DOI 10.1016/j.jns.2004.09.027; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wilichowski E, 1998, NEUROPEDIATRICS, V29, P307, DOI 10.1055/s-2007-973583	35	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2891	10.1371/journal.pone.0002891	http://dx.doi.org/10.1371/journal.pone.0002891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682780	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600047
J	Bishop, MT; Ritchie, DL; Will, RG; Ironside, JW; Head, MW; Thomson, V; Bruce, M; Manson, JC				Bishop, Matthew T.; Ritchie, Diane L.; Will, Robert G.; Ironside, James W.; Head, Mark W.; Thomson, Val; Bruce, Moira; Manson, Jean C.			No Major Change in vCJD Agent Strain after Secondary Transmission via Blood Transfusion	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PRION STRAIN; MICE; SCRAPIE; BSE; SUSCEPTIBILITY; INFECTIVITY; PRIMATES	Background: The identification of transmission of variant Creutzfeldt-Jakob disease (vCJD) by blood transfusion has prompted investigation to establish whether there has been any alteration in the vCJD agent following this route of secondary transmission. Any increase in virulence or host adaptation would require a reassessment of the risk analyses relating to the possibility of a significant secondary outbreak of vCJD. Since there are likely to be carriers of the vCJD agent in the general population, there is a potential for further infection by routes such as blood transfusion or contaminated surgical instruments. Methodology: We inoculated both wild-type and transgenic mice with material from the first case of transfusion associated vCJD infection. Principal Findings: The strain transmission properties of blood transfusion associated vCJD infection show remarkable similarities to the strain of vCJD associated with transmission from bovine spongiform encephalopathy (BSE). Conclusions: Although it has been hypothesized that adaptation of the BSE agent through secondary passage in humans may result in a greater risk of onward transmission due to an increased virulence of the agent for humans, our data presented here in two murine models suggest no significant alterations to transmission efficiency of the agent following human-to-human transmission of vCJD.	[Bishop, Matthew T.; Ritchie, Diane L.; Will, Robert G.; Ironside, James W.; Head, Mark W.] Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland; [Thomson, Val; Bruce, Moira; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Neuropathogenesis Div, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Bishop, MT (corresponding author), Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland.	Jean.Manson@roslin.ed.ac.uk		Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108; manson, jean/0000-0002-0175-9890	UK Department of Health; Medical Research Council; MRC [G0600953, G0700640, G9721848] Funding Source: UKRI; Medical Research Council [G0700640, G0600953, G9721848] Funding Source: researchfish	UK Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Department of Health and the Medical Research Council. The sponsors had no role in study design, data analysis, or the decision to submit for publication.	Andrews NJ, 2003, LANCET, V361, P751, DOI 10.1016/S0140-6736(03)12632-3; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Baron T, 2002, TRENDS MOL MED, V8, P495, DOI 10.1016/S1471-4914(02)02416-4; Barron RM, 2005, J GEN VIROL, V86, P859, DOI 10.1099/vir.0.80525-0; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bruce ME, 2007, PRIONS IN HUMANS AND ANIMALS, P573; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Cooper JK, 2007, VOX SANG, V92, P302, DOI 10.1111/j.1423-0410.2007.00904.x; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; IRONSIDE JW, 2006, BMJ; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Manson JC, 2006, BIOCHEM SOC T, V34, P1155, DOI 10.1042/BST0341155; MCCUTCHEON S, 2007, TRANSMISSION BSE INF; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; 2006, CDR WEEKLY, V16	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2878	10.1371/journal.pone.0002878	http://dx.doi.org/10.1371/journal.pone.0002878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682737	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600034
J	Coluccio, AE; Rodriguez, RK; Kernan, MJ; Neiman, AM				Coluccio, Alison E.; Rodriguez, Rachael K.; Kernan, Maurice J.; Neiman, Aaron M.			The Yeast Spore Wall Enables Spores to Survive Passage through the Digestive Tract of Drosophila	PLOS ONE			English	Article								In nature, yeasts are subject to predation by flies of the genus Drosophila. In response to nutritional starvation Saccharomyces cerevisiae differentiates into a dormant cell type, termed a spore, which is resistant to many types of environmental stress. The stress resistance of the spore is due primarily to a spore wall that is more elaborate than the vegetative cell wall. We report here that S. cerevisiae spores survive passage through the gut of Drosophila melanogaster. Constituents of the spore wall that distinguish it from the vegetative cell wall are necessary for this resistance. Ascospores of the distantly related yeast Schizosaccharomyces pombe also display resistance to digestion by D. melanogaster. These results suggest that the primary function of the yeast ascospore is as a cell type specialized for dispersion by insect vectors.	[Coluccio, Alison E.; Rodriguez, Rachael K.; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kernan, Maurice J.] SUNY Stony Brook, Ctr Dev Genet, Dept Neurobiol & Behavior, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Coluccio, AE (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Aaron.Neiman@sunysb.edu		Kernan, Maurice/0000-0002-1546-6159; Neiman, Aaron/0000-0002-6600-6996	NIH [GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM072540 to A. M. N.	Arellano M, 2000, MOL MICROBIOL, V35, P79, DOI 10.1046/j.1365-2958.2000.01678.x; BEGON M, 1986, GENET BIOL DROSOPHIL, P345; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P5380, DOI 10.1073/pnas.77.9.5380; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1988, J BIOL CHEM, V263, P11569; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; CARLILE MJ, 1994, FUNGI; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; DAWES IW, 1974, MOL GEN GENET, V131, P281, DOI 10.1007/BF00264859; DOW JAT, 1992, J EXP BIOL, V172, P355; EGEL R, 1977, ARCH MICROBIOL, V112, P109, DOI 10.1007/BF00446662; ELGIN SCR, 1980, GENET BIOL DROSOPHIL, P112; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; House H.L., 1974, P63; Howe H.F., 1986, P123; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KREGERVANRIJ NJW, 1978, ARCH MICROBIOL, V117, P73, DOI 10.1007/BF00689354; KREGERVANRIJ NJW, 1969, YEASTS, P5; Lodder J, 1958, CHEMISTRY BIOLOGY YE, P1; Matsuo Y, 2005, FEBS LETT, V579, P2737, DOI 10.1016/j.febslet.2005.04.008; MILLER MW, 1962, APPL MICROBIOL, V10, P394, DOI 10.1128/AEM.10.5.394-400.1962; MORAIS PB, 1994, ANTON LEEUW INT J G, V66, P313, DOI 10.1007/BF00882766; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; PHAFF H. J., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P145, DOI 10.1007/BF02538322; Prillinger H, 1997, YEAST, V13, P945, DOI 10.1002/(SICI)1097-0061(199708)13:10<945::AID-YEA150>3.0.CO;2-5; Pulvirenti A, 2002, ANN MICROBIOL, V52, P245; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Rose MD., 1990, METHODS YEAST GENETI; SHIHATA AMEA, 1951, AM NAT, V85, P381, DOI 10.1086/281692; SHIMODA C, 1980, CAN J MICROBIOL, V26, P741, DOI 10.1139/m80-129; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Wenny DG, 2001, EVOL ECOL RES, V3, P51; XU LZ, 1995, MOL CELL BIOL, V15, P6572	41	120	125	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2873	10.1371/journal.pone.0002873	http://dx.doi.org/10.1371/journal.pone.0002873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682732	Green Submitted, gold, Green Published			2022-12-25	WOS:000264366600029
J	Harris, D; DeBolt, S				Harris, Darby; DeBolt, Seth			Relative Crystallinity of Plant Biomass: Studies on Assembly, Adaptation and Acclimation	PLOS ONE			English	Article							CELLULOSE CRYSTALLINITY; WOOD; DIFFRACTION; FLEXURE; CELLS	Plant biomechanical design is central to cell shape, morphogenesis, reproductive performance and protection against environmental and mechanical stress. The cell wall forms the central load bearing support structure for plant design, yet a mechanistic understanding of its synthesis is incomplete. A key tool for studying the structure of cellulose polymorphs has been x-ray diffraction and fourier transform infrared spectroscopy (FTIR). Relative crystallinity index (RCI) is based on the x-ray diffraction characteristics of two signature peaks and we used this technique to probe plant assembly, adaptation and acclimation. Confocal microscopy was used to visualize the dynamics of cellulose synthase in transgenic Arabidopsis plants expressing a homozygous YFP::CESA6. Assembly: RCI values for stems and roots were indistinguishable but leaves had 23.4 and 21.6% lower RCI than stems and roots respectively. Adaptation: over 3-fold variability in RCI was apparent in leaves from 35 plant species spanning Ordovician to Cretaceous periods. Within this study, RCI correlated positively with leaf geometric constraints and with mass per unit area, suggestive of allometry. Acclimation: biomass crystallinity was found to decrease under conditions of thigmomorphogenesis in Arabidopsis. Further, in etiolated pea hypocotyls, RCI values also decreased compared to plants that were grown in light, consistent with alterations in FTIR cellulose fingerprint peaks and live cell imaging experiments revealing rapid orientation of the YFP:: cellulose synthase-6 array in response to light. Herein, results and technical challenges associated with the structure of the cell wall that gives rise to sample crystallinity are presented and examined with respect to adaptation, acclimation and assembly in ecosystem-level processes.	[Harris, Darby; DeBolt, Seth] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA	University of Kentucky	Harris, D (corresponding author), Univ Kentucky, Dept Hort, Lexington, KY 40546 USA.	seth.debolt@uky.edu			University of Kentucky	University of Kentucky	University of Kentucky provided startup funds to the author.	Andersson S, 2000, J WOOD SCI, V46, P343, DOI 10.1007/BF00776394; Andersson S, 2003, J WOOD SCI, V49, P531, DOI 10.1007/s10086-003-0518-x; Andersson S, 2004, TREES-STRUCT FUNCT, V18, P346, DOI 10.1007/s00468-003-0312-9; [Anonymous], 1949, PHYS CHEM CELLULOSE; Brett CT, 2000, INT REV CYTOL, V199, P161, DOI 10.1016/S0074-7696(00)99004-1; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; HONJO G, 1958, NATURE, V181, P326, DOI 10.1038/181326a0; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; MANDOLI DF, 1982, P NATL ACAD SCI-BIOL, V79, P2902, DOI 10.1073/pnas.79.9.2902; McCarthy MC, 2007, INT J PLANT SCI, V168, P751, DOI 10.1086/513491; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Newman RH, 2004, HOLZFORSCHUNG, V58, P91, DOI 10.1515/HF.2004.012; Niklas KJ, 2008, AM J BOT, V95, P549, DOI 10.3732/ajb.0800034; Nishiyama Y., 2002, ADV XRAY ANAL, V45, P385; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Saren MP, 2001, J STRUCT BIOL, V136, P101, DOI 10.1006/jsbi.2001.4434; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Smith VC, 2003, J EXP BOT, V54, P845, DOI 10.1093/jxb/erg068; Stubicar N, 1998, HOLZFORSCHUNG, V52, P455, DOI 10.1515/hfsg.1998.52.5.455; Swenson NG, 2008, AM J BOT, V95, P516, DOI 10.3732/ajb.95.4.516; TEEAAR R, 1987, POLYM BULL, V17, P231; TELEWSKI FW, 1989, TREE PHYSIOL, V5, P113, DOI 10.1093/treephys/5.1.113; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; VITOUSEK PM, 1995, ECOLOGY, V76, P712, DOI 10.2307/1939338; WEIMER PJ, 1995, BIOTECHNOL BIOENG, V48, P169, DOI 10.1002/bit.260480211; Woodcock DW, 2003, ANN BOT-LONDON, V91, P529, DOI 10.1093/aob/mcg054; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2000, BIOL J LINN SOC, V69, P521, DOI 10.1111/j.1095-8312.2000.tb01222.x; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	39	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2897	10.1371/journal.pone.0002897	http://dx.doi.org/10.1371/journal.pone.0002897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682826	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600053
J	Wise, RA; Wang, B; You, ZB				Wise, Roy A.; Wang, Bin; You, Zhi-Bing			Cocaine Serves as a Peripheral Interoceptive Conditioned Stimulus for Central Glutamate and Dopamine Release	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; INTRAVENOUS COCAINE; INTRAADMINISTRATION ASSOCIATIONS; EXTRACELLULAR DOPAMINE; TRANSPORTER OCCUPANCY; SODIUM-CHANNELS; ONSET CUES; IN-VIVO; RATS	Intravenous injections of cocaine HCl are habit-forming because, among their many actions, they elevate extracellular dopamine levels in the terminal fields of the mesocorticolimbic dopamine system. This action, thought to be very important for cocaine's strong addiction liability, is believed to have very short latency and is assumed to reflect rapid brain entry and pharmacokinetics of the drug. However, while intravenous cocaine HCl has almost immediate effects on behavior and extracellular dopamine levels, recent evidence suggests that its central pharmacological effects are not evident until 10 or more seconds after IV injection. Thus the immediate effects of a given intravenous cocaine injection on extracellular dopamine concentration and behavior appear to occur before there is sufficient time for cocaine to act centrally as a dopamine uptake inhibitor. To explore the contribution of peripheral effects of cocaine to the early activation of the dopamine system, we used brain microdialysis to measure the effects of cocaine methiodide (MI)-a cocaine analogue that does not cross the blood brain barrier-on glutamate (excitatory) input to the dopamine cells. IP injections of cocaine MI were ineffective in cocaine-naive animals but stimulated ventral tegmental glutamate release in rats previously trained to lever-press for cocaine HCl. This peripherally triggered glutamate input was sufficient to reinstate cocaine-seeking in previously trained animals that had undergone extinction of the habit. These findings offer an explanation for short-latency behavioral responses and immediate dopamine elevations seen following cocaine injections in cocaine-experienced but not cocaine-naive animals.	[Wise, Roy A.; Wang, Bin; You, Zhi-Bing] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wise, RA (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	rwise@intra.nida.nih.gov	Wise, Roy A/A-6465-2012		Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000471, ZIADA000471] Funding Source: NIH RePORTER	Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services	AKIMOTO K, 1989, BRAIN RES, V490, P339, DOI 10.1016/0006-8993(89)90251-5; BLACK J, 1985, BRAIN RES, V359, P113, DOI 10.1016/0006-8993(85)91418-0; BYKOV KM, 1957, CEREBRAL CORRTEX INT; COLPAERT FC, 1976, EUR J PHARMACOL, V40, P195, DOI 10.1016/0014-2999(76)90372-1; CRUMB WJ, 1990, BIOPHYS J, V57, P589, DOI 10.1016/S0006-3495(90)82574-1; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; EIKELBOOM R, 1982, PSYCHOL REV, V89, P507, DOI 10.1037/0033-295X.89.5.507; ETTENBERG A, 1982, PSYCHOPHARMACOLOGY, V78, P204, DOI 10.1007/BF00428151; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; Fowler JS, 1998, SYNAPSE, V28, P111, DOI 10.1002/(SICI)1098-2396(199802)28:2<111::AID-SYN1>3.0.CO;2-E; GERBER GJ, 1975, PHARMACOL BIOCHEM BE, V3, P1055, DOI 10.1016/0091-3057(75)90016-7; GOEDERS NE, 1983, SCIENCE, V221, P773, DOI 10.1126/science.6879176; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; HUANG JT, 1974, PHARMACOL BIOCHEM BE, V2, P669, DOI 10.1016/0091-3057(74)90036-7; Ikemoto S, 2004, NEUROPHARMACOLOGY, V47, P190, DOI 10.1016/j.neuropharm.2004.07.012; Kalivas PW, 1998, J NEUROCHEM, V70, P1497; KALIVAS PW, 1993, J NEUROSCI, V13, P276; Kim JA, 1999, J EXP PSYCHOL ANIM B, V25, P491, DOI 10.1037/0097-7403.25.4.491; Kiyatkin EA, 2000, NEUROSCIENCE, V98, P729, DOI 10.1016/S0306-4522(00)00168-8; KNUEPFER MM, 1992, J PHARMACOL EXP THER, V263, P734; Legault M, 1999, SYNAPSE, V31, P241, DOI 10.1002/(SICI)1098-2396(19990315)31:4<241::AID-SYN1>3.0.CO;2-#; Legault M, 2000, J NEUROSCI, V20, P1635; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Mateo Y, 2004, EUR J NEUROSCI, V20, P2838, DOI 10.1111/j.1460-9568.2004.03736.x; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Premkumar LS, 2005, J MEMBRANE BIOL, V204, P129, DOI 10.1007/s00232-005-0755-6; Rahman MA, 2005, ANAL CHEM, V77, P4854, DOI 10.1021/ac050558v; REITH MEA, 1986, J BIOL CHEM, V261, P7300; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SELLERS EM, 1989, NIDA RES MG, V92, P287; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Siegel S, 1999, ADDICTION, V94, P1113, DOI 10.1046/j.1360-0443.1999.94811132.x; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; Sokolowska M, 2002, J EXP PSYCHOL ANIM B, V28, P309, DOI 10.1037//0097-7403.28.3.309; Stewart J., 1987, HDB PSYCHOPHARMACOLO, P1; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TELLA SR, 1990, J PHARMACOL EXP THER, V252, P491; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Weise-Kelly L, 2001, J EXP PSYCHOL-ANIM B, V27, P125, DOI 10.1037//0097-7403.27.2.125; WISE RA, 1987, PHARMACOL THERAPEUT, V35, P227, DOI 10.1016/0163-7258(87)90108-2; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; You ZB, 2007, J NEUROSCI, V27, P10546, DOI 10.1523/JNEUROSCI.2967-07.2007; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119	48	70	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2846	10.1371/journal.pone.0002846	http://dx.doi.org/10.1371/journal.pone.0002846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682722	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600002
J	Xu, JZ; Knutson, MD; Carter, CS; Leeuwenburgh, C				Xu, Jinze; Knutson, Mitchell D.; Carter, Christy S.; Leeuwenburgh, Christiaan			Iron Accumulation with Age, Oxidative Stress and Functional Decline	PLOS ONE			English	Article							SKELETAL-MUSCLE APOPTOSIS; CALORIE RESTRICTION; NONHEME IRON; PHYSICAL PERFORMANCE; DIFFERENT TISSUES; RAT-LIVER; DAMAGE; RNA; PROTEINS; OVERLOAD	Identification of biological mediators in sarcopenia is pertinent to the development of targeted interventions to alleviate this condition. Iron is recognized as a potent pro-oxidant and a catalyst for the formation of reactive oxygen species in biological systems. It is well accepted that iron accumulates with senescence in several organs, but little is known about iron accumulation in muscle and how it may affect muscle function. In addition, it is unclear if interventions which reduced age-related loss of muscle quality, such as calorie restriction, impact iron accumulation. We investigated non-heme iron concentration, oxidative stress to nucleic acids in gastrocnemius muscle and key indices of sarcopenia (muscle mass and grip strength) in male Fischer 344 X Brown Norway rats fed ad libitum (AL) or a calorie restricted diet (60% of ad libitum food intake starting at 4 months of age) at 8, 18, 29 and 37 months of age. Total non-heme iron levels in the gastrocnemius muscle of AL rats increased progressively with age. Between 29 and 37 months of age, the non-heme iron concentration increased by approximately 200% in AL-fed rats. Most importantly, the levels of oxidized RNA in gastrocnemius muscle of AL rats were significantly increased as well. The striking age-associated increase in non-heme iron and oxidized RNA levels and decrease in sarcopenia indices were all attenuated in the calorie restriction (CR) rats. These findings strongly suggest that the age- related iron accumulation in muscle contributes to increased oxidative damage and sarcopenia, and that CR effectively attenuates these negative effects.	[Xu, Jinze; Carter, Christy S.; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Dept Aging & Geriatr, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32611 USA; [Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA; [Carter, Christy S.] Gainesville VA Geriatr Res, Ed & Clin Ctr GRECC, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xu, JZ (corresponding author), Univ Florida, Inst Aging, Dept Aging & Geriatr, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32611 USA.	mknutson@ufl.edu; cleeuwen@aging.ufl.edu	Xu, Jinze/G-7868-2011; Carter, Christy/E-6630-2011	Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994, AG21042]; CSC [AG024526]; National Institutes of Health [DK065064]; University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center NIH [1 P30 AG028740]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK065064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024526, R01AG021042, R01AG017994, P30AG028740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CSC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to CL from the National Institute on Aging (AG17994 and AG21042) and to CSC (AG024526), a K01 grant (DK065064) to MK from the National Institutes of Health. This work was supported by the University of Florida Institute on Aging and the Claude D. Pepper Older Americans Independence Center NIH Grant # 1 P30 AG028740.	Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; BARKER T, 2007, J PHYSL; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Brewer GJ, 2007, EXP BIOL MED, V232, P323; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Carlini RG, 2006, NEPHROL DIAL TRANSPL, V21, P3055, DOI 10.1093/ndt/gfl341; Carmeli E, 2000, GERONTOLOGY, V46, P249, DOI 10.1159/000022168; Carter CS, 2004, J GERONTOL A-BIOL, V59, P416; Castello L, 2005, FASEB J, V19, P1863, DOI 10.1096/fj.04-2864fje; Childs A, 2001, FREE RADICAL BIO MED, V31, P745, DOI 10.1016/S0891-5849(01)00640-2; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; DEMETRIUMS L, 2004, GERONTOLOGICAL SOC A, V59, pB902; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Focht SJ, 1997, NEUROSCIENCE, V79, P255, DOI 10.1016/S0306-4522(96)00607-0; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Galey Jean-Baptiste, 1997, V38, P167; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063; Kozlov AV, 1996, BIOMETALS, V9, P98, DOI 10.1007/BF00188097; Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661; Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439; Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Marzani B., 2004, BASIC APPL MYOL, V14, P37; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Merry BJ, 2000, ANN NY ACAD SCI, V908, P180; Mumby S, 1998, BBA-GEN SUBJECTS, V1380, P102, DOI 10.1016/S0304-4165(97)00124-4; Nakano M, 2003, FREE RADICAL BIO MED, V35, P826, DOI 10.1016/S0891-5849(03)00432-5; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Okunade GW, 1999, BIOSCIENCE REP, V19, P1, DOI 10.1023/A:1020113121995; Polla AS, 2003, AGEING RES REV, V2, P25, DOI 10.1016/S1568-1637(02)00048-X; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602; Rao KS, 2003, MOL CELL BIOCHEM, V253, P313, DOI 10.1023/A:1026004208822; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; Rikans LE, 1997, ARCH BIOCHEM BIOPHYS, V344, P85, DOI 10.1006/abbi.1997.0172; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; ROBERTS SB, 1995, J GERONTOL A-BIOL, V50, P101; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; ROTHMAN RJ, 1992, MOL PHARMACOL, V42, P703; SHERTZER HG, 1992, BIOCHEM PHARMACOL, V44, P1367, DOI 10.1016/0006-2952(92)90538-T; Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; St Pierre TG, 2000, HYPERFINE INTERACT, V126, P75, DOI 10.1023/A:1012636510472; SWERLICK RA, 2004, J INVEST DERMATOL, V122, pR9; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2; Wang ZJ, 1998, INVEST OPHTH VIS SCI, V39, P631; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Wood JC, 2007, AM J HEMATOL, V82, P1132, DOI 10.1002/ajh.21099; Wood RJ, 2004, AGEING RES REV, V3, P355, DOI 10.1016/j.arr.2004.04.002; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	68	86	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2865	10.1371/journal.pone.0002865	http://dx.doi.org/10.1371/journal.pone.0002865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682742	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600021
J	Chen, S; Owens, GC; Edelman, DB				Chen, Sigeng; Owens, Geoffrey C.; Edelman, David B.			Dopamine Inhibits Mitochondrial Motility in Hippocampal Neurons	PLOS ONE			English	Article							SYNTHASE KINASE-3; AXONAL-TRANSPORT; GROWTH-FACTOR; RECEPTORS; EXPRESSION; AKT; D-2; SYNTAPHILIN; SEROTONIN; MOVEMENT	Background: The trafficking of mitochondria within neurons is a highly regulated process. In an earlier study, we found that serotonin (5-HT), acting through the 5-HT1A receptor subtype, promotes axonal transport of mitochondria in cultured hippocampal neurons by increasing Akt activity, and consequently decreasing glycogen synthase kinase (GSK3 beta) activity. This finding suggests a critical role for neuromodulators in the regulation of mitochondrial trafficking in neurons. In the present study, we investigate the effects of a second important neuromodulator, dopamine, on mitochondrial transport in hippocampal neurons. Methodology/Principal Findings: Here, we show that dopamine, like 5-HT, regulates mitochondrial motility in cultured hippocampal neurons through the Akt-GSK3 beta signaling cascade. But, in contrast to the stimulatory effect of 5-HT, administration of exogenous dopamine or bromocriptine, a dopamine 2 receptor (D2R) agonist, caused an inhibition of mitochondrial movement. Moreover, pretreatment with bromocriptine blocked the stimulatory effect of 5-HT on mitochondrial movement. Conversely, in cells pretreated with 5-HT, no further increases in movement were observed after administration of haloperidol, a D2R antagonist. In contrast to the effect of the D2R agonist, addition of SKF38393, a dopamine 1 receptor (D1R) agonist, promoted mitochondrial transport, indicating that the inhibitory effect of dopamine was actually the net summation of opposing influences of the two receptor subtypes. The most pronounced effect of dopamine signals was on mitochondria that were already moving directionally. Western blot analysis revealed that treatment with either a D2R agonist or a D1R antagonist decreased Akt activity, and conversely, treatment with either a D2R antagonist or a D1R agonist increased Akt activity. Conclusions/Significance: Our observations strongly suggest a role for both dopamine and 5-HT in regulating mitochondrial movement, and indicate that the integrated effects of these two neuromodulators may be important in determining the distribution of energy sources in neurons.	[Chen, Sigeng; Owens, Geoffrey C.; Edelman, David B.] Inst Neurosci, San Diego, CA USA		Edelman, DB (corresponding author), Inst Neurosci, San Diego, CA USA.	david_edelman@nsi.edu	Chen, Sigeng/G-1678-2014		Neurosciences Research Foundation	Neurosciences Research Foundation	Work supported by the Neurosciences Research Foundation. The Neurosciences Research Foundation did not have any role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, INT J NEUROPSYCHOPH, V10, P3, DOI 10.1017/S1461145706006857; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; BRENNERLAVIE H, 2007, BIOCH BIOPHYS ACTA; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Curran MA, 2000, MOL THER, V1, P31, DOI 10.1006/mthe.1999.0007; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; George Susan R, 2007, ScientificWorldJournal, V7, P58; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Inazu M, 1999, NEUROSCI RES, V34, P235, DOI 10.1016/S0168-0102(99)00053-X; Inazu M, 1999, LIFE SCI, V64, P2239, DOI 10.1016/S0024-3205(99)00175-7; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Lee D, 2000, MOL PSYCHIATR, V5, P332, DOI 10.1038/sj.mp.4000723; Lee H, 2002, IEEE T NANOTECHNOL, V1, P219, DOI 10.1109/TNANO.2002.807376; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Malaiyandi LM, 2005, J NEUROSCI, V25, P9507, DOI 10.1523/JNEUROSCI.0868-05.2005; Millan MJ, 2004, EUR J PHARMACOL, V500, P371, DOI 10.1016/j.ejphar.2004.07.038; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mistry SK, 2002, P NATL ACAD SCI USA, V99, P1621, DOI 10.1073/pnas.022646599; Mookherjee P, 2007, J CELL BIOCHEM, V102, P196, DOI 10.1002/jcb.21287; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tremblay P, 2006, CURR DRUG TARGETS, V7, P149, DOI 10.2174/138945006775515464; Trimmer PA, 2005, ANTIOXID REDOX SIGN, V7, P1101, DOI 10.1089/ars.2005.7.1101; Ward MW, 2000, J NEUROSCI, V20, P7208; Weikop P, 2007, J PSYCHOPHARMACOL, V21, P795, DOI 10.1177/0269881107077347; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; ZHANG X, 2008, P NATL ACAD SCI US	48	61	64	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2804	10.1371/journal.pone.0002804	http://dx.doi.org/10.1371/journal.pone.0002804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665222	gold, Green Published			2022-12-25	WOS:000264304300023
J	Gillet, L; Colaco, S; Stevenson, PG				Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.			The Murid Herpesvirus-4 gL Regulates an Entry-Associated Conformation Change in gH	PLOS ONE			English	Article								The glycoprotein H (gH)/gL heterodimer is crucial for herpesvirus membrane fusion. Yet how it functions is not well understood. The Murid Herpesvirus-4 gH, like that of other herpesviruses, adopts its normal virion conformation by associating with gL. However, gH switched back to a gL-independent conformation after virion endocytosis. This switch coincided with a conformation switch in gB and with capsid release. Virions lacking gL constitutively expressed the downstream form of gH, prematurely switched gB to its down-stream form, and showed premature capsid release with poor infectivity. These data argue that gL plays a key role in regulating a gH and gB functional switch from cell binding to membrane fusion.	[Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England	University of Cambridge	Gillet, L (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Fonds National Belge de la Recherche Scientifique; Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; CR-UK [C19612/A6189]; MRC [G0400427] Funding Source: UKRI	Fonds National Belge de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique. PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903 and by CR-UK grant C19612/A6189.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; FITZGERALD D, 1980, CELL, V21, P867, DOI 10.1016/0092-8674(80)90450-X; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, EMBO J, V26, P5131, DOI 10.1038/sj.emboj.7601925; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Klupp BG, 1997, J VIROL, V71, P7687, DOI 10.1128/JVI.71.10.7687-7695.1997; KOZUCH O, 1993, ACTA VIROL, V37, P101; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998	32	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2811	10.1371/journal.pone.0002811	http://dx.doi.org/10.1371/journal.pone.0002811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665235	Green Submitted, gold, Green Published			2022-12-25	WOS:000264304300030
J	Parienti, JJ; Das-Douglas, M; Massari, V; Guzman, D; Deeks, SG; Verdon, R; Bangsberg, DR				Parienti, Jean-Jacques; Das-Douglas, Moupali; Massari, Veronique; Guzman, David; Deeks, Steven G.; Verdon, Renaud; Bangsberg, David R.			Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels	PLOS ONE			English	Article								Background: While the relationship between average adherence to HIV potent antiretroviral therapy is well defined, the relationship between patterns of adherence within adherence strata has not been investigated. We examined medication event monitoring system (MEMS) defined adherence patterns and their relation to subsequent virologic rebound. Methods and Results: We selected subjects with at least 3-months of previous virologic suppression on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen from two prospective cohorts in France and North America. We assessed the risk of virologic rebound, defined as HIV RNA of >400 copies/mL according to several MEMS adherence measurements. Seventy two subjects were studied, five of them experienced virologic rebound. Subjects with and without virologic rebound had similar baseline characteristics including treatment durations, regimen (efavirenz vs nevirapine), and dosing schedule. Each 10% increase in average adherence decreased the risk of virologic rebound (OR = 0.56; 95% confidence interval (CI) [0.37, 0.81], P < 0.002). Each additional consecutive day off therapy for the longest treatment interruption (OR = 1.34; 95% CI [1.15, 1.68], P < 0.0001) and each additional treatment interruption for more than 2 days (OR = 1.38; 95% CI [1.13, 1.77], P < 0.002) increased the risk of virologic rebound. In those with low-to-moderate adherence (i.e.,80%), treatment interruption duration (16.2 days versus 6.1 days in the control group, P < 0.02), but not average adherence (53.1% vs 55.9%, respectively, P = 0.65) was significantly associated with virologic rebound. Conclusions: Sustained treatment interruption may pose a greater risk of virologic rebound on NNRTI therapy than the same number of interspersed missed doses at low-to-moderate adherence.	[Parienti, Jean-Jacques; Verdon, Renaud] Cote Nacre Univ Hosp, Clin Res & Biostat Dept, Caen, France; [Parienti, Jean-Jacques; Massari, Veronique] Pierre Marie Curie Univ Paris 6, INSERM U707, UMR S707, Paris, France; [Das-Douglas, Moupali; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA USA; [Guzman, David] Univ Calif San Francisco, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA	CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Parienti, JJ (corresponding author), Cote Nacre Univ Hosp, Clin Res & Biostat Dept, Caen, France.	parienti-jj@chu-caen.fr	Massari, Veronique/E-6151-2017; Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590	Cote de Nacre University Hospital; NIMH [RO-54907]; NIAAA [K-24 015287]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	Cote de Nacre University Hospital; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by Cote de Nacre University Hospital and NIMH RO-54907. Dr. Bangsberg received additional support from NIAAA K-24 015287.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; DANEL C, 2008, 5 C RETR OPP INF BOS; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Kuss O, 2002, STAT MED, V21, P3789, DOI 10.1002/sim.1421; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2007, AIDS, V21, P2217, DOI 10.1097/QAD.0b013e3282eff388; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Ruiz L, 2007, AIDS, V21, P169, DOI 10.1097/QAD.0b013e328011033a; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2	21	154	155	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2783	10.1371/journal.pone.0002783	http://dx.doi.org/10.1371/journal.pone.0002783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665246	Green Published, gold			2022-12-25	WOS:000264304300002
J	Wiederman, SD; Shoemaker, PA; O'Carroll, DC				Wiederman, Steven D.; Shoemaker, Patrick A.; O'Carroll, David C.			A Model for the Detection of Moving Targets in Visual Clutter Inspired by Insect Physiology	PLOS ONE			English	Article							LARGE MONOPOLAR CELLS; FIRST OPTIC GANGLION; ON-OFF UNITS; MOTION DETECTION; TRANSIENT CELLS; NATURAL IMAGES; NEURONAL BASIS; ORGANIZATION; FLY; SYSTEM	We present a computational model for target discrimination based on intracellular recordings from neurons in the fly visual system. Determining how insects detect and track small moving features, often against cluttered moving backgrounds, is an intriguing challenge, both from a physiological and a computational perspective. Previous research has characterized higher-order neurons within the fly brain, known as 'small target motion detectors' (STMD), that respond robustly to moving features, even when the velocity of the target is matched to the background (i.e. with no relative motion cues). We recorded from intermediate-order neurons in the fly visual system that are well suited as a component along the target detection pathway. This full-wave rectifying, transient cell (RTC) reveals independent adaptation to luminance changes of opposite signs (suggesting separate ON and OFF channels) and fast adaptive temporal mechanisms, similar to other cell types previously described. From this physiological data we have created a numerical model for target discrimination. This model includes nonlinear filtering based on the fly optics, the photoreceptors, the 1(st) order interneurons (Large Monopolar Cells), and the newly derived parameters for the RTC. We show that our RTC-based target detection model is well matched to properties described for the STMDs, such as contrast sensitivity, height tuning and velocity tuning. The model output shows that the spatiotemporal profile of small targets is sufficiently rare within natural scene imagery to allow our highly nonlinear 'matched filter' to successfully detect most targets from the background. Importantly, this model can explain this type of feature discrimination without the need for relative motion cues.	[Wiederman, Steven D.; O'Carroll, David C.] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia; [Shoemaker, Patrick A.] Tanner Res Inc, Monrovia, CA USA	University of Adelaide	Wiederman, SD (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia.	steven.wiederman@adelaide.edu.au	O'Carroll, David C/C-4320-2008; Wiederman, Steven D/G-1556-2012	O'Carroll, David C/0000-0002-2352-4320; Wiederman, Steven D/0000-0002-0902-803X	US Air Force Office of Scientific Research (AFOSR) [FA 9550-04-1-0294, FA 9550-04-1-0283]	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by grants from the US Air Force Office of Scientific Research (AFOSR) FA 9550-04-1-0294, FA 9550-04-1-0283.	ARNETT DW, 1971, SCIENCE, V173, P929, DOI 10.1126/science.173.4000.929; ARNETT DW, 1972, J NEUROPHYSIOL, V35, P429, DOI 10.1152/jn.1972.35.4.429; Barnett PD, 2007, CURR BIOL, V17, P569, DOI 10.1016/j.cub.2007.02.039; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BRINKWORTH RSA, 2007, BIOMIMETIC MOTION DE, P137; BRINKWORTH RSA, 2006, P SPIE, V3; Collett T., 1975, P437; COOMBE PE, 1989, J COMP PHYSIOL A, V166, P23, DOI 10.1007/BF00190206; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; GILBERT C, 1991, J COMP PHYSIOL A, V169, P395, DOI 10.1007/BF00197653; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Higgins CM, 2004, BIOL CYBERN, V91, P417, DOI 10.1007/s00422-004-0518-y; James A. C., 1990, THESIS AUSTR NATL U; JANSONIUS NM, 1993, J COMP PHYSIOL A, V172, P467, DOI 10.1007/BF00213528; JANSONIUS NM, 1991, J COMP PHYSIOL A, V168, P631, DOI 10.1007/BF00224353; JARVILEHTO M, 1970, J COMP PHYSL, V69, P134; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KELLER A, 2002, THESIS BAYERISCHEN J; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Nordstrom K, 2006, PLOS BIOL, V4, P378, DOI 10.1371/journal.pbio.0040054; Nordstrom K, 2006, P ROY SOC B-BIOL SCI, V273, P1211, DOI 10.1098/rspb.2005.3424; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OCARROLL DC, 1992, J COMP PHYSIOL A, V171, P447, DOI 10.1007/BF00194577; OSORIO D, 1987, J COMP PHYSIOL A, V161, P431, DOI 10.1007/BF00603968; OSORIO D, 1991, VISUAL NEUROSCI, V7, P345, DOI 10.1017/S0952523800004831; Rind FC, 1996, J NEUROPHYSIOL, V75, P967, DOI 10.1152/jn.1996.75.3.967; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROWELL CHF, 1977, J EXP BIOL, V68, P157; Shoemaker PA, 2005, BIOL CYBERN, V93, P275, DOI 10.1007/s00422-005-0007-y; SRINIVASAN MV, 1990, PROC R SOC SER B-BIO, V240, P279, DOI 10.1098/rspb.1990.0038; SRINIVASAN MV, 1990, J COMP PHYSIOL A, V166, P287, DOI 10.1007/BF00204803; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; WACHENFELD A, 1994, THESIS U KOLN KOLN; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P581, DOI 10.1098/rstb.1986.0019; WEHRHAHN C, 1979, BIOL CYBERN, V32, P239, DOI 10.1007/BF00337647	44	84	85	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2784	10.1371/journal.pone.0002784	http://dx.doi.org/10.1371/journal.pone.0002784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665213	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300003
J	Baglole, CJ; Maggirwar, SB; Gasiewicz, TA; Thatcher, TH; Phipps, RP; Sime, PJ				Baglole, Carolyn J.; Maggirwar, Sanjay B.; Gasiewicz, Thomas A.; Thatcher, Thomas H.; Phipps, Richard P.; Sime, Patricia J.			The Aryl Hydrocarbon Receptor Attenuates Tobacco Smoke-induced Cyclooxygenase-2 and Prostaglandin Production in Lung Fibroblasts through Regulation of the NF-kappa B Family Member RelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RNA-BINDING PROTEIN; CIGARETTE-SMOKE; MESSENGER-RNA; AH RECEPTOR; TRANSCRIPTIONAL ACTIVITY; DIFFERENTIAL INDUCTION; POTENTIAL MECHANISM; MEDIATED ACTIVATION; OXIDATIVE STRESS	Diseases such as chronic obstructive pulmonary disease and lung cancer caused by cigarette smoke affect millions of people worldwide. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that influences responses to certain environmental pollutants such as tobacco smoke. However, the physiological function(s) of the AhR is unknown. Herein we propose that the physiologic role of the AhR is to limit inflammation. We show that lung fibroblasts from AhR(-/-) mice produce a heightened inflammatory response to cigarette smoke, typified by increased levels of cyclooxygenase-2 (COX-2) and prostaglandins (PGs), when compared with wild type (AhR(+/+)) fibroblasts. This response was dependent on AhR expression as transient transfection of an AhR expression plasmid into AhR(-/-) fibroblasts significantly attenuated the smoke-induced COX-2 and PG production, confirming the anti-inflammatory role of the AhR. The AhR can interact with NF-kappa B. However, the heightened inflammatory response observed in AhR(-/-) fibroblasts was not the result of NF-kappa B (p50/p65) activation. Instead it was coupled with a loss of the NF-kappa B family member RelB in AhR(-/-) fibroblasts. Taken together, these studies provide compelling evidence that AhR expression limits proinflammatory COX-2 and PG production by maintaining RelB expression. The association between RelB and AhR may represent a new therapeutic and more selective target with which to combat inflammation associated diseases.	[Thatcher, Thomas H.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Gasiewicz, Thomas A.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Sime, PJ (corresponding author), Univ Rochester, Sch Med & Dent, Div Pulm & Crit Care Med, 601 Elmwood Ave,Box 692, Rochester, NY 14642 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041	National Institutes of Health [ULIRR024160, T32HL66988, T32ES07026, DE011390, AI071064, ES015775, ES01247, HL075432, HL088325]; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R01HL088325, R01HL075432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015775, T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ULIRR024160, T32HL66988, T32ES07026, DE011390, AI071064, ES015775, ES01247, HL075432, and HL088325. This work was also supported by an American Lung Association research training fellowship and a Parker B. Francis fellowship (to C. J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Brown JR, 2004, CLIN CANCER RES, V10, p4266S, DOI 10.1158/1078-0432.CCR-040014; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Carnevali S, 2006, AM J RESP CRIT CARE, V174, P393, DOI 10.1164/rccm.200512-1835OC; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chen GG, 2006, CANCER LETT, V234, P193, DOI 10.1016/j.canlet.2005.03.032; Chen LJ, 2005, TOXICOL SCI, V83, P372, DOI 10.1093/toxsci/kfi019; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dixon DA, 2003, PROG EXP TUMOR RES, V37, P52; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Harris RE, 2007, INT J BIOL SCI, V3, P328; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Hida T, 1998, CANCER RES, V58, P3761; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; Keith RL, 2006, ANTICANCER RES, V26, P2857; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Kim JH, 2007, LUNG CANCER, V56, P9, DOI 10.1016/j.lungcan.2006.11.010; Knaapen AM, 2007, MUTAT RES-FUND MOL M, V621, P31, DOI 10.1016/j.mrfmmm.2006.12.010; Koumas L, 2002, AM J PHYSIOL-CELL PH, V283, pC599, DOI 10.1152/ajpcell.00065.2002; Kraemer SA, 1996, ARCH BIOCHEM BIOPHYS, V330, P319, DOI 10.1006/abbi.1996.0259; Kreutzer M, 2007, ONCOL REP, V18, P497; Lee MH, 2002, IMMUNOLOGY, V106, P496, DOI 10.1046/j.1365-2567.2002.01451.x; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; MCLEMORE TL, 1988, CANCER RES, V48, P3140; Mineva ND, 2007, J BIOL CHEM, V282, P17475, DOI 10.1074/jbc.M607313200; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murmu N, 2004, P NATL ACAD SCI USA, V101, P13873, DOI 10.1073/pnas.0406066101; Neumann M, 1996, J IMMUNOL, V157, P4862; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; PENNEY DP, 1992, ANAT RECORD, V232, P432, DOI 10.1002/ar.1092320312; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Qualtrough D, 2007, INT J CANCER, V121, P734, DOI 10.1002/ijc.22755; Ravenel JG, 2008, AM J ROENTGENOL, V190, P755, DOI 10.2214/AJR.07.2899; Rodriguez-Sosa M, 2005, FEBS LETT, V579, P6403, DOI 10.1016/j.febslet.2005.10.023; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Sempowski GD, 1997, J PERIODONTOL, V68, P284, DOI 10.1902/jop.1997.68.3.284; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Smith RS, 1997, AM J PATHOL, V151, P317; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; Wolfle D, 2000, CARCINOGENESIS, V21, P15, DOI 10.1093/carcin/21.1.15; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong LS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-13; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Zhang Y, 1998, J IMMUNOL, V160, P1053; Zhou JG, 2003, MOL PHARMACOL, V63, P915, DOI 10.1124/mol.63.4.915; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	99	118	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28944	28957		10.1074/jbc.M800685200	http://dx.doi.org/10.1074/jbc.M800685200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18697742	Green Published, hybrid			2022-12-25	WOS:000260179900020
J	Morla, L; Crambert, G; Mordasini, D; Favre, G; Doucet, A; Imbert-Teboul, M				Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine			Proteinase-activated receptor 2 stimulates Na,K-ATPase and sodium reabsorption in native kidney epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; PROTEINASE-ACTIVATED RECEPTOR-2; CORTICAL COLLECTING DUCT; ION-TRANSPORT; PARACELLULAR PERMEABILITY; SURFACE EXPRESSION; HORMONAL-CONTROL; K+-ATPASE; KINASE-C; CELL	Proteinase-activated receptors 2 (PAR2) are expressed in kidney, but their function is mostly unknown. Since PAR2 control ion transport in several epithelia, we searched for an effect on sodium transport in the cortical thick ascending limb of Henle's loop, a nephron segment that avidly reabsorbs NaCl, and for its signaling. Activation of PAR2, by either trypsin or a specific agonist peptide, increased the maximal activity of Na, K-ATPase, its apparent affinity for sodium, the sodium permeability of the paracellular pathway, and the lumen-positive transepithelial voltage, featuring increased NaCl reabsorption. PAR2 activation induced calcium signaling and phosphorylation of ERK1,2. PAR2-induced stimulation of Na,K-ATPase V-max was fully prevented by inhibition of phospholipase C, of changes in intracellular concentration of calcium, of classical protein kinases C, and of ERK1,2 phosphorylation. PAR2-induced increase in paracellular sodium permeability was mediated by the same signaling cascade. In contrast, increase in the apparent affinity of Na,K-ATPase for sodium, although dependent on phospholipase C, was independent of calcium signaling, was insensitive to inhibitors of classical protein kinases C and of ERK1,2 phosphorylation, but was fully prevented by the nonspecific protein kinase inhibitor staurosporine, as was the increase in transepithelial voltage. In conclusion, PAR2 increases sodium reabsorption in rat thick ascending limb of Henle's loop along both the transcellular and the paracellular pathway. PAR2 effects are mediated in part by a phospholipase C/protein kinase C/ERK1,2 cascade, which increases Na,K-ATPase maximal activity and the paracellular sodium permeability, and by a different phospholipase C-dependent, staurosporine-sensitive cascade that controls the sodium affinity of Na, K-ATPase.	[Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine] Univ Paris 06, UMR 7134, F-75005 Paris, France; [Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine] CNRS, Inst Cordeliers, UMR 7134, Lab Physiol & Genom Renales, F-75006 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Doucet, A (corresponding author), 15 Rue Ecole Med, F-75270 Paris 6, France.	alain.doucet@bhdc.jussieu.fr	Crambert, Gilles/ABF-2753-2020	Crambert, Gilles/0000-0001-7065-9124; Morla, Luciana/0000-0002-1527-4392	Amgen [2005/29-N]	Amgen(Amgen)	This work was supported by a grant from Amgen (2005/29-N). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aristimuno PC, 1997, AM J PHYSIOL-RENAL, V272, pF624, DOI 10.1152/ajprenal.1997.272.5.F624; BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; FERAILLE E, 1995, AM J PHYSIOL-CELL PH, V268, pC1277, DOI 10.1152/ajpcell.1995.268.5.C1277; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Ferreira NCD, 1997, J PHYSIOL-LONDON, V505, P749, DOI 10.1111/j.1469-7793.1997.749ba.x; Fyfe M, 2005, CYTOKINE, V31, P358, DOI 10.1016/j.cyto.2005.06.004; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; Gui Y, 2003, AM J PHYSIOL-RENAL, V285, pF95, DOI 10.1152/ajprenal.00396.2002; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; MARCHETTI J, 1984, PFLUG ARCH EUR J PHY, V401, P27, DOI 10.1007/BF00581529; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; MOREL F, 1986, PHYSIOL REV, V66, P377, DOI 10.1152/physrev.1986.66.2.377; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Ohtomo Y, 1996, DIABETOLOGIA, V39, P199, DOI 10.1007/BF00403963; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rondeau E, 2001, NEPHROL DIAL TRANSPL, V16, P1529, DOI 10.1093/ndt/16.8.1529; Silva GB, 2006, HYPERTENSION, V48, P467, DOI 10.1161/01.HYP.0000236646.83354.51; Tsimaratos M, 2003, DIABETOLOGIA, V46, P124, DOI 10.1007/s00125-002-0996-1; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; XU YC, 1995, AM J PATHOL, V146, P101	37	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28020	28028		10.1074/jbc.M804399200	http://dx.doi.org/10.1074/jbc.M804399200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678869	Green Published, hybrid			2022-12-25	WOS:000259969300003
J	Song, HW; Kong, W; Weatherspoon, N; Qin, GZ; Tyler, W; Turk, J; Curtiss, R; Shi, YX				Song, Haowei; Kong, Wei; Weatherspoon, Natasha; Qin, Guozheng; Tyler, William; Turk, John; Curtiss, Roy, III; Shi, Yixin			Modulation of the regulatory activity of bacterial two-component systems by SlyA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; SENSOR KINASE; PHOP; RESISTANCE; IDENTIFICATION; GENES; EXPRESSION; PHOP/PHOQ	Activation of the transcriptional regulator SlyA by the PhoP/PhoQ two-component system controls intracellular expression of numerous factors influencing Salmonella virulence. By dissecting the SlyA regulon using stable isotope labeling with amino acids in cell culture analysis, we found that SlyA enhances overall transcription of PhoP-activated loci. This amplification of cellular responses to Mg2+ occurs when SlyA binds to the phoPQ promoter thereby activating phoP autoregulation via a positive feedback mechanism. SlyA footprints a DNA region located one helical turn upstream of the PhoP box, which overlaps the H-NS-binding motif required for signal-dependent phoP repression in high Mg2+ conditions. Therefore, binding of SlyA likely antagonizes H-NS and facilitates the interaction of PhoP to its own promoter, subsequently activating the phoPQ operon. Establishment of this regulatory circuit allows SlyA to exert its effect on the PhoP/PhoQ system specifically in Salmonella, which may confer an additional transcriptional regulation. Thus, our results provide a molecular mechanism that determines SlyA-dependent activation of PhoP-regulated genes in modulating Salmonella virulence. Evidence from this study also suggests a function of SlyA as a mediator in signal transduction from the PhoP/PhoQ system to other bacterial two-component systems in Salmonella.	[Weatherspoon, Natasha; Qin, Guozheng; Tyler, William; Curtiss, Roy, III; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Kong, Wei; Curtiss, Roy, III; Shi, Yixin] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Song, Haowei; Turk, John] Washington Univ, Sch Med, Dept Internal Med, Mass Spectrometry Resource,Div Endocrinol Diabet, St Louis, MO 63110 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Washington University (WUSTL)	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	SHI, YIXIN/M-5751-2019; Qin, Guozheng/E-6871-2011; Tyler, William/J-1818-2012	Tyler, William/0000-0002-7758-5022	Arizona State University	Arizona State University	This work was supported by start-up funds from Arizona State University (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Eguchi Y, 2004, J BACTERIOL, V186, P3006, DOI 10.1128/JB.186.10.3006-3014.2004; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gunn JS, 1996, J BACTERIOL, V178, P6369, DOI 10.1128/jb.178.21.6369-6373.1996; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOCH JA, 1995, 2 COMPONENT SIGNAL T, P105; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; KIER LD, 1979, J BACTERIOL, V138, P155, DOI 10.1128/JB.138.1.155-161.1979; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P408; Norte VA, 2003, J BACTERIOL, V185, P3508, DOI 10.1128/JB.185.12.3508-3514.2003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; STEIN MA, 1994, BIOESSAYS, V16, P537, DOI 10.1002/bies.950160805; TAYLOR RK, 1981, J BACTERIOL, V147, P255, DOI 10.1128/JB.147.1.255-258.1981; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	40	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28158	28168		10.1074/jbc.M801058200	http://dx.doi.org/10.1074/jbc.M801058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678876	Green Published, hybrid			2022-12-25	WOS:000259969300018
J	Diaz-Ruiz, R; Averet, N; Araiza, D; Pinson, B; Uribe-Carvajal, S; Devin, A; Rigoulet, M				Diaz-Ruiz, Rodrigo; Averet, Nicole; Araiza, Daniela; Pinson, Benoit; Uribe-Carvajal, Salvador; Devin, Anne; Rigoulet, Michel			Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate - A possible role in Crabtree effect induction?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; EHRLICH ASCITES TUMOR; SACCHAROMYCES-CEREVISIAE; HEXOKINASE-II; OUTER-MEMBRANE; WILD-TYPE; GLUCOSE; GLYCOLYSIS; GROWTH; GENE	In numerous cell types, tumoral cells, proliferating cells, bacteria, and yeast, respiration is inhibited when high concentrations of glucose are added to the culture medium. This phenomenon has been named the "Crabtree effect." We used yeast to investigate (i) the short term event(s) associated with the Crabtree effect and (ii) a putative role of hexose phosphates in the inhibition of respiration. Indeed, yeast divide into "Crabtree-positive," where the Crabtree effect occurs, and "Crabtree-negative," where it does not. In mitochondria isolated from these two categories of yeast, we found that low, physiological concentrations of glucose 6-phosphate and fructose 6-phosphate slightly (20%) stimulated the respiratory flux and that this effect was strongly antagonized by fructose 1,6-bisphosphate (F16bP). On the other hand, F16bP by itself was able to inhibit mitochondrial respiration only in mitochondria isolated from a Crabtree-positive strain. Using permeabilized spheroplasts from Crabtree-positive yeast, we have shown that the sole effect observed at physiological concentrations of hexose phosphates is an inhibition of oxidative phosphorylation by F16bP. This F16bP-mediated inhibition was also observed in isolated rat liver mitochondria, extending this process to mammalian cells. From these results and taking into account that F16bP is able to accumulate in the cell cytoplasm, we propose that F16bP regulates oxidative phosphorylation and thus participates in the establishment of the Crabtree effect.	[Diaz-Ruiz, Rodrigo; Averet, Nicole; Pinson, Benoit; Devin, Anne; Rigoulet, Michel] Univ Bordeaux 2, F-33077 Bordeaux, France; [Diaz-Ruiz, Rodrigo; Averet, Nicole; Araiza, Daniela; Pinson, Benoit; Devin, Anne; Rigoulet, Michel] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Diaz-Ruiz, Rodrigo; Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universidad Nacional Autonoma de Mexico	Rigoulet, M (corresponding author), Univ Bordeaux 2, 1 Rue Camille St Saens, F-33077 Bordeaux, France.		Diaz, Rodrigo/A-9073-2011	Diaz, Rodrigo/0000-0001-5683-8345; Pinson, Benoit/0000-0003-2936-9058; Uribe-Carvajal, Salvador/0000-0002-7028-8121	ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT) [MOS04]	ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the France-Mexico collaboration program ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT) MOS04. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Averet N, 2002, J BIOENERG BIOMEMBR, V34, P499, DOI 10.1023/A:1022526411188; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; CHAPMAN C, 1969, BIOCHEM J, V111, P609, DOI 10.1042/bj1110609; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; DAVIES SEC, 1992, BIOCHEMISTRY-US, V31, P4729, DOI 10.1021/bi00134a028; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; DENHOLLANDER JA, 1981, BIOCHEMISTRY-US, V20, P5871, DOI 10.1021/bi00523a034; Diderich JA, 2002, FEMS YEAST RES, V2, P165, DOI 10.1111/j.1567-1364.2002.tb00081.x; Diderich JA, 2001, APPL ENVIRON MICROB, V67, P1587, DOI 10.1128/AEM.67.4.1587-1593.2001; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N; EVTODIENKO YV, 1994, CELL CALCIUM, V15, P439, DOI 10.1016/0143-4160(94)90108-2; FONTAINE EM, 1995, BIOCHEM BIOPH RES CO, V213, P138, DOI 10.1006/bbrc.1995.2108; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GATT S, 1959, J BIOL CHEM, V234, P1015; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Guerin B, 1979, Methods Enzymol, V55, P149; HESS B, 1961, J BIOL CHEM, V236, P239; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; LEE AC, 1994, J BIOL CHEM, V269, P30974; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; MAZAT JP, 1986, BIOCHIM BIOPHYS ACTA, V849, P7, DOI 10.1016/0005-2728(86)90090-3; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; MULLER S, 1995, J BACTERIOL, V177, P4517; MUSTEA I, 1967, CANCER-AM CANCER SOC, V20, P1499, DOI 10.1002/1097-0142(196709)20:9<1499::AID-CNCR2820200917>3.0.CO;2-Q; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; Noubhani A, 2000, EUR J BIOCHEM, V267, P4566, DOI 10.1046/j.1432-1327.2000.01511.x; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; RIGOULET M, 1987, EUR J BIOCHEM, V168, P275, DOI 10.1111/j.1432-1033.1987.tb13417.x; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; Rodriguez-Enriquez S, 2000, ARCH BIOCHEM BIOPHYS, V375, P21, DOI 10.1006/abbi.1999.1582; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; SAAVEDRAMOLINA A, 1990, BIOCHEM BIOPH RES CO, V167, P148, DOI 10.1016/0006-291X(90)91743-C; SAKS V, 1995, BIOCHEM BIOPH RES CO, V208, P919, DOI 10.1006/bbrc.1995.1422; Sanchez NS, 2006, YEAST, V23, P361, DOI 10.1002/yea.1360; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Tisi R, 2002, FEBS LETT, V520, P133, DOI 10.1016/S0014-5793(02)02806-5; VANAELST L, 1991, EMBO J, V10, P2095, DOI 10.1002/j.1460-2075.1991.tb07742.x; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; VANURK H, 1990, APPL ENVIRON MICROB, V56, P281, DOI 10.1128/AEM.56.1.281-287.1990; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZIZI M, 1994, J BIOL CHEM, V269, P1614	51	106	109	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26948	26955		10.1074/jbc.M800408200	http://dx.doi.org/10.1074/jbc.M800408200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682403	hybrid			2022-12-25	WOS:000259586600015
J	Eaton, SA; Funnell, APW; Sue, N; Nicholas, H; Pearson, RCM; Crossley, M				Eaton, Sally A.; Funnell, Alister P. W.; Sue, Nancy; Nicholas, Hannah; Pearson, Richard C. M.; Crossley, Merlin			A network of Kruppel-like factors (klfs) - Klf8 is repressed by Klf3 and activated by Klf1 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; BOX-BINDING-PROTEIN; EKLF-NULL MICE; TRANSCRIPTION FACTOR; PRIMITIVE ERYTHROPOIESIS; BETA-THALASSEMIA; ERYTHROID-CELLS; GLOBIN GENE; ADIPOGENESIS; INACTIVATION	Transcription factors of the Sp/Klf (Kruppel-like factor) family regulate biological processes such as hematopoiesis, adipogenesis, and stem cell maintenance. Here we show that Bklf or Klf3 ( Basic Kruppel-like factor) represses the Klf8 (Kruppel-like Factor 8) gene in vivo. Conversely, Eklf or Klf1 (Erythroid Kruppel-like factor) activates the Klf8 gene. Klf8 is driven by two promoters, both of which contain multiple CACCC sites. Klf3 can repress Klf1-mediated activation of both promoters. Chromatin immunoprecipitation experiments confirm that Klf3 occupies both Klf8 promoters in vivo. Interestingly, in Klf3 knock-out tissue Klf1 gains access, binds, and activates both Klf8 promoters. These results demonstrate direct competition between activating and repressing Klfs in vivo. Together with previous evidence that Klf1 directly activates the Klf3 gene, the results reveal an elaborate network of cross-talk within the Klf family. The recognition of cross-regulation and potential redundancy between Klf family members is critical to the interpretation of various Klf knock-out mice and the understanding of individual Klfs in particular contexts.	[Eaton, Sally A.; Funnell, Alister P. W.; Sue, Nancy; Nicholas, Hannah; Pearson, Richard C. M.; Crossley, Merlin] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney	Crossley, M (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, G08, Sydney, NSW 2006, Australia.	m.crossley@mmb.usyd.edu.au	Pearson, Richard/J-4411-2012; Crossley, Merlin/D-7888-2011	Pearson, Richard/0000-0002-7918-9111; Crossley, Merlin/0000-0003-2057-3642; Nicholas, Hannah/0000-0002-2239-9249; Eaton, Sally/0000-0003-2036-1607; Funnell, Alister/0000-0002-1062-5296	National Institutes of Health [HL073443]; Australian Research Council; National Health and Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073443. This work was also supported by grants from the Australian Research Council and National Health and Medical Research Council ( to M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; FENG WC, 1994, J BIOL CHEM, V269, P1493; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hu JH, 2007, J MOL BIOL, V366, P1064, DOI 10.1016/j.jmb.2006.12.047; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; PERKINS AC, 1995, NATURE, V375, P318; Rawls A, 1998, DEVELOPMENT, V125, P2349; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sambrook J., 2001, MOL CLONING LAB MANU; Schuierer M, 2001, J BIOL CHEM, V276, P27944, DOI 10.1074/jbc.M100070200; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOGAWA K, 1993, J BIOCHEM, V114, P605, DOI 10.1093/oxfordjournals.jbchem.a124224; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	53	91	107	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26937	26947		10.1074/jbc.M804831200	http://dx.doi.org/10.1074/jbc.M804831200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18687676	Green Published, hybrid			2022-12-25	WOS:000259586600014
J	Paumi, CM; Chuk, M; Chevelev, I; Stagljar, I; Michaelis, S				Paumi, Christian M.; Chuk, Matthew; Chevelev, Igor; Stagljar, Igor; Michaelis, Susan			Negative regulation of the yeast ABC transporter Ycf1p by phosphorylation within its N-terminal extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; BINDING CASSETTE TRANSPORTER; MEMBRANE-SPANNING DOMAIN; CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; R-DOMAIN; SUBSTRATE-SPECIFICITY; CONJUGATE PUMP; CFTR; CADMIUM	The yeast vacuolar membrane protein Ycf1p and its mammalian counterpart, MRP1, belong to the ABCC subfamily of ATP-binding cassette (ABC) transporters that rid cells of toxic endogenous and xenobiotic compounds. Like most members of the ABCC subfamily, Ycf1p contains an N-terminal extension in addition to its ABC "core" domain and transports substrates in the form of glutathione conjugates. Ycf1p is subject to complex regulation to ensure its optimal function. Previous studies showed that Ycf1p activity is stimulated by a guanine nucleotide exchange factor, Tus1p, and is positively regulated by phosphorylation in its ABC core domain at residues Ser-908 and Thr-911. Here we provide evidence that phosphorylation of Ser-251 in the Ycf1p N-terminal extension negatively regulates activity. Mutant Ycf1p- S251A exhibits increased resistance to cadmium in vivo and increased Ycf1p-dependent transport of [H-3] estradiol- beta-17-glucuronide in vitro as compared with wild-type Ycf1p. Activity is restored to the wild-type level for Ycf1-S251E. To identify kinase(s) that negatively regulate Ycf1p function, we conducted an integrated membrane yeast two-hybrid (iMYTH) screen and identified two kinase genes, CKA1 and HAL5, deletion of which increases Ycf1p function. Genetic evidence suggests that Cka1p may regulate Ycf1p function through phosphorylation of Ser 251 either directly or indirectly. Overall, this study provides compelling evidence that negative, as well as positive, regulation of Ycf1p is mediated by phosphorylation.	[Chuk, Matthew; Chevelev, Igor; Stagljar, Igor] Univ Toronto, Dept Biochem, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Chuk, Matthew; Chevelev, Igor; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Paumi, Christian M.; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	University of Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine	Stagljar, I (corresponding author), Univ Toronto, Dept Biochem, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.	igor.stagljar@utoronto.ca; michaelis@jhmi.edu			National Institutes of Health [GM51508, GM077024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508, F32GM077024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51508 (to S. M.) and National Institutes of Health Postdoctoral Award GM077024 (to C. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bakos E, 2000, J CELL SCI, V113, P4451; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Burke D., 2000, METHODS YEAST GENETI; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Chaudhuri B, 1997, GENETICS, V145, P75; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Eraso P, 2004, FEBS LETT, V577, P322, DOI 10.1016/j.febslet.2004.10.030; Fernandez SBM, 2002, J BIOL CHEM, V277, P31048, DOI 10.1074/jbc.M204267200; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; IYER K, 2005, SCI STKE, P13; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Karwatsky J. M., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P19, DOI 10.2174/1568011043482133; Kelm KB, 2004, TRAFFIC, V5, P165, DOI 10.1111/j.1600-0854.2004.00168.x; King SA, 2000, BIOCHEMISTRY-US, V39, P9868, DOI 10.1021/bi992807d; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mason DL, 2003, EUKARYOT CELL, V2, P588, DOI 10.1128/EC.2.3.588-598.2003; Mulet JM, 2004, YEAST, V21, P569, DOI 10.1002/yea.1126; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obenauer John C, 2004, Methods Mol Biol, V261, P445; Pascolo L, 2001, BIOCHEM BIOPH RES CO, V282, P60, DOI 10.1006/bbrc.2001.4318; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Qian YM, 2002, J BIOL CHEM, V277, P35225, DOI 10.1074/jbc.M206058200; Ren XQ, 2006, J BIOCHEM, V140, P313, DOI 10.1093/jb/mvj155; Ren XQ, 2001, J BIOL CHEM, V276, P23197, DOI 10.1074/jbc.M101554200; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sharma KG, 2002, EUKARYOT CELL, V1, P391, DOI 10.1128/EC.1.3.391-400.2002; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Taglicht D, 1998, METHOD ENZYMOL, V292, P130; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wemmie JA, 1997, MOL MICROBIOL, V25, P683, DOI 10.1046/j.1365-2958.1997.5061868.x; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Westlake CJ, 2003, BIOCHEMISTRY-US, V42, P14099, DOI 10.1021/bi035333y; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	57	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27079	27088		10.1074/jbc.M802569200	http://dx.doi.org/10.1074/jbc.M802569200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667437	Green Published, hybrid			2022-12-25	WOS:000259586600029
J	Tzankov, S; Wong, MJH; Shi, K; Nassif, C; Young, JC				Tzankov, Stefan; Wong, Michael J. H.; Shi, Kun; Nassif, Christina; Young, Jason C.			Functional divergence between co-chaperones of Hsc70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP70 NUCLEOTIDE EXCHANGE; MITOCHONDRIAL INNER-MEMBRANE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; MOLECULAR CHAPERONES; UBIQUITIN LIGASE; REACTION CYCLE; DNAJ HOMOLOG; YEAST HSP40; PROTEIN	The ATPase cycle of the chaperone Hsc70 is regulated by co-chaperones; Hsp40/DnaJ-related proteins stimulate ATP hydrolysis by Hsc70 and can bind unfolded polypeptides themselves. Conversely, various nucleotide exchange factors (NEFs) stimulate ADP-ATP exchange by Hsc70. We analyzed the purified Hsp40-related co-chaperones DJA1 (Hdj2) and DJA2 (Hdj3) and found that they had a distinct pattern of binding to a range of polypeptides. DJA2 alone could stimulate Hsc70-mediated refolding of luciferase in the absence of NEF, whereas DJA1 was much less active. The addition of the Bag1 NEF increased refolding by Hsc70 and DJA2, as did the newly characterized NEF Hsp110, but each NEF had a different optimal concentration ratio to Hsc70. Notably, the NEF HspBP1 could not increase refolding by Hsc70 and DJA2 at any concentration, and none of the NEFs improved the refolding activity with DJA1. Instead, DJA1 was inhibitory of refolding with DJA2 and Hsc70. All combinations of DJA1 or DJA2 with the three NEFs stimulated the Hsc70 ATPase rate, although Hsp110 became less effective with increasing concentrations. A chimeric DJA2 having its Hsc70-stimulatory J domain replaced with that of DJA1 was functional for polypeptide binding and ATPase stimulation of Hsc70. However, it could not support efficient Hsc70-mediated refolding and also inhibited refolding with DJA2 and Hsc70. These results suggest a more complex model of Hsc70 mechanism than has been previously thought, with notable functional divergence between Hsc70 co- chaperones.	[Tzankov, Stefan; Wong, Michael J. H.; Shi, Kun; Nassif, Christina; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	jason.young2@mcgill.ca			Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by a Canadian Institutes of Health Research operating grant and the Canadian Foundation for Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Aron R, 2005, GENETICS, V169, P1873, DOI 10.1534/genetics.104.037242; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Hafizur RM, 2004, J BIOCHEM, V135, P193, DOI 10.1093/jb/mvh023; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Palmisano A, 1998, BIOCHEM J, V333, P151, DOI 10.1042/bj3330151; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zara V, 2003, J MOL BIOL, V325, P399, DOI 10.1016/S0022-2836(02)01236-6	45	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27100	27109		10.1074/jbc.M803923200	http://dx.doi.org/10.1074/jbc.M803923200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18684711	Green Accepted, hybrid			2022-12-25	WOS:000259586600031
J	Hasselblatt, P; Gresh, L; Kudo, H; Guinea-Viniegra, J; Wagner, EF				Hasselblatt, P.; Gresh, L.; Kudo, H.; Guinea-Viniegra, J.; Wagner, E. F.			The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice	ONCOGENE			English	Article						colitis-associated cancer; c-Jun; c-Fos; APC; azoxymethane; colorectal carcinoma	DEXTRAN SODIUM-SULFATE; C-JUN; CYCLIN D1; COLON CARCINOGENESIS; COLORECTAL-CANCER; MOUSE INTESTINE; APC LOSS; EXPRESSION; GENE; PROLIFERATION	Chronic inflammation is an important cancer risk factor but the molecular pathways linking inflammation and cancer are incompletely understood. The transcription factor c-Jun/AP-1 (activator protein 1) is involved in inflammatory responses and tumorigenesis and has been proposed as an essential mediator of oncogenic beta-catenin signaling in the intestine. Here, we examined the functions of c-Jun in two distinct mouse models of conditional and intestine-specific activation of beta-catenin. c-Jun is strongly expressed in the small intestine of mutant mice. However, beta-catenin-dependent cell proliferation is surprisingly not affected in mice lacking c-jun in intestinal epithelium, suggesting that c-Jun is not an essential immediate target of beta-catenin signaling in the small intestine. To examine the functions of Jun and Fos proteins during inflammation and cancer in the colon, colitis-associated tumors were induced chemically in the respective knockout mice. Tumors were characterized by activated beta-catenin and strongly expressed c-Jun and JunB. However, tumorigenesis was not affected by inactivation of c-Jun in either intestinal epithelium or myeloid cells. Moreover, tumorigenesis was not altered in mice lacking junB, junD, c-fos, fra-1 or fra-2, suggesting that inhibition of c-Jun or other single AP-1 proteins is not a determining factor in colitis-associated cancer in mice.	[Hasselblatt, P.; Gresh, L.; Kudo, H.; Guinea-Viniegra, J.; Wagner, E. F.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Spanish Natl Canc Ctr CNIO, Canc Cell Biol Program, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	ewagner@cnio.es	Hasselblatt, Peter/AAF-3681-2021	Gresh, Lionel/0000-0002-2333-1748; Wagner, Erwin F/0000-0001-7872-0196; Kudo, Hiromi/0000-0003-4313-7165	Austrian Industrial Research Promotion Fund; WWTF; German Research Foundation; EMBO; Boehringer Ingelheim	Austrian Industrial Research Promotion Fund; WWTF; German Research Foundation(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim(Boehringer Ingelheim)	We are very grateful to Drs L Bakiri, A Behrens, R Eferl and O Sansom for critical reading of the manuscript and helpful discussions, Drs S Robine, C Hartmann, M Taketo and O Sansom for providing mutant mice and V Komnenovic and M Grivej for technical assistance with immunohistochemistry. The IMP is funded by Boehringer Ingelheim and this work was also supported by the Austrian Industrial Research Promotion Fund and by a WWTF grant from the city of Vienna. PH and LG were funded by postdoctoral fellowships of the German Research Foundation and EMBO, respectively.	Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Eferl R, 2007, GENESIS, V45, P447, DOI 10.1002/dvg.20311; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Suzuki R, 2004, CANCER SCI, V95, P721, DOI 10.1111/j.1349-7006.2004.tb03252.x; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thepot D, 2000, DEVELOPMENT, V127, P143; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang HL, 2000, CARCINOGENESIS, V21, P1313, DOI 10.1093/carcin/21.7.1313; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630	38	26	27	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	47					6102	6109		10.1038/onc.2008.211	http://dx.doi.org/10.1038/onc.2008.211			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18679426				2022-12-25	WOS:000260083100003
J	Fenouillet, E; Lavillette, D; Loureiro, S; Krashias, G; Maurin, G; Cosset, FL; Jones, IM; Barbouche, R				Fenouillet, Emmanuel; Lavillette, Dimitri; Loureiro, Silvia; Krashias, George; Maurin, Guillemette; Cosset, Francois-Loic; Jones, Ian M.; Barbouche, Rym			Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; CELL ENTRY; HYPERVARIABLE REGION-1; NEUTRALIZING ANTIBODIES; DISULFIDE BONDS; CD81; GLYCOPROTEIN; BINDING; RECEPTOR; ACTIVATION	Disulfide bonding contributes to the function and antigenicity of many viral envelope glycoproteins. We assessed here its significance for the hepatitis C virus E2 envelope protein and a counterpart deleted for hypervariable region-1 (HVR1). All 18 cysteine residues of the antigens were involved in disulfides. Chemical reduction of up to half of these disulfides was compatible with anti-E2 monoclonal antibody reaction, CD81 receptor binding, and viral entry, whereas complete reduction abrogated these properties. The addition of 5,5'-dithiobis-2-nitrobenzoic acid had no effect on viral entry. Thus, E2 function is only weakly dependent on its redox status, and cell entry does not require redox catalysts, in contrast to a number of enveloped viruses. Because E2 is a major neutralizing antibody target, we examined the effect of disulfide bonding on E2 antigenicity. We show that reduction of three disulfides, as well as deletion of HVR1, improved antibody binding for half of the patient sera tested, whereas it had no effect on the remainder. Small scale immunization of mice with reduced E2 antigens greatly improved serum reactivity with reduced forms of E2 when compared with immunization using native E2, whereas deletion of HVR1 only marginally affected the ability of the serum to bind the redox intermediates. Immunization with reduced E2 also showed an improved neutralizing antibody response, suggesting that potential epitopes are masked on the disulfide-bonded antigen and that mild reduction may increase the breadth of the antibody response. Although E2 function is surprisingly independent of its redox status, its disulfide bonds mask antigenic domains. E2 redox manipulation may contribute to improved vaccine design.	[Fenouillet, Emmanuel; Barbouche, Rym] Univ Aix Marseille 2, CNRS, UMR 6184, F-13015 Marseille, France; [Lavillette, Dimitri] Univ Lyon, F-69000 Lyon, France; [Lavillette, Dimitri; Maurin, Guillemette; Cosset, Francois-Loic] Univ Lyon 1, IFR128, INSERM, Ecole Normale Super Lyon,U758, F-69007 Lyon, France; [Loureiro, Silvia; Krashias, George; Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Reading	Fenouillet, E (corresponding author), Fac Med Nord, Bd Dramard, F-13015 Marseille, France.	emmanuel.fenouillet@univmed.fr	Cosset, François-Loïc/M-5862-2019; Jones, Ian/AAF-4986-2019	Cosset, François-Loïc/0000-0001-8842-3726; Jones, Ian/0000-0002-7738-2516; Lavillette, Dimitri/0000-0002-4706-1519	Agence Nationale de Recherche sur le SIDA (ANRS) [HCV 2006-2007]; Ligue Nationale Contre le Cancer; European Union [LSHB-CT-2004-005246]; Wellcome Trust	Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Agence Nationale de Recherche sur le SIDA (ANRS) Grant HCV 2006-2007 (to E. F. and R. B. (sole support), and I. M. J., and F. L. C.), a grant from the Ligue Nationale Contre le Cancer (to F. L. C.), European Union Grant LSHB-CT-2004-005246 (to F. L. C.), and funds from the Wellcome Trust (to I. M. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Benham AM, 2005, ANTIOXID REDOX SIGN, V7, P835, DOI 10.1089/ars.2005.7.835; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Chan-Fook C, 2000, VIROLOGY, V273, P60, DOI 10.1006/viro.2000.0407; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Diedrich G, 2006, FEBS J, V273, P3871, DOI 10.1111/j.1742-4658.2006.05379.x; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Garry RF, 2003, VIROLOGY, V307, P255, DOI 10.1016/S0042-6822(02)00065-X; Grollo L, 2006, ANTIVIR THER, V11, P1005; Hofmann WP, 2003, J INFECT DIS, V187, P982, DOI 10.1086/368221; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; JENSEN PE, 1995, SEMIN IMMUNOL, V7, P345; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krey T, 2005, J VIROL, V79, P4191, DOI 10.1128/JVI.79.7.4191-4200.2005; Lavillette D, 2006, J BIOL CHEM, V281, P9200, DOI 10.1074/jbc.M512529200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; McCaffrey K, 2007, J VIROL, V81, P9584, DOI 10.1128/JVI.02782-06; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mondelli MU, 2001, ANTIVIR RES, V52, P153, DOI 10.1016/S0166-3542(01)00180-2; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Poumbourios Pantelis, 2007, Antiviral Chemistry & Chemotherapy, V18, P169; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; YOO BJ, 1995, J VIROL, V69, P32, DOI 10.1128/JVI.69.1.32-38.1995; Youn JW, 2005, HEPATOLOGY, V42, P1429, DOI 10.1002/hep.20934; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07	47	14	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26340	26348		10.1074/jbc.M805221200	http://dx.doi.org/10.1074/jbc.M805221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667425	Green Published, hybrid			2022-12-25	WOS:000259341600007
J	Brown, CR; Wolfe, AB; Cui, DY; Chiang, HL				Brown, C. Randell; Wolfe, Allison B.; Cui, Dongying; Chiang, Hui-Ling			The vacuolar import and degradation pathway merges with the endocytic pathway to deliver fructose-1,6-bisphosphatase to the vacuole for degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-GOLGI TRANSPORT; PROTEIN-TRANSPORT; BETA-COP; CATABOLITE DEGRADATION; CYTOSOLIC PROTEIN; COATED VESICLES; YEAST; COATOMER; ER; ENDOSOME	The gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is degraded in the vacuole when glucose is added to glucose-starved cells. Before it is delivered to the vacuole, however, FBPase is imported into intermediate carriers called Vid ( vacuole import and degradation) vesicles. Here, using biochemical and genetic approaches, we identified a requirement for SEC28 in FBPase degradation. SEC28 encodes the alpha-COP subunit of COPI ( coat protein complex I) coatomer proteins. When SEC28 and other coatomer genes were mutated, FBPase degradation was defective and FBPase association with Vid vesicles was impaired. Coatomer proteins were identified as components of Vid vesicles, and they formed a protein complex with a Vid vesicle-specific protein, Vid24p. Furthermore, Vid24p association with Vid vesicles was impaired when coatomer genes were mutated. Kinetic studies indicated that Sec28p traffics to multiple locations. Sec28p was in Vid vesicles, endocytic compartments, and the vacuolar membrane in various mutants that block the FBPase degradation pathway. Sec28p was also found in vesicles adjacent to the vacuolar membrane in the ret2-1 coatomer mutant. We propose that Sec28p resides in Vid vesicles, and these vesicles converge with the endocytic pathway. After fusion, Sec28p is distributed on the vacuolar membrane, where it concentrates on vesicles that pinch off from this organelle. FBPase also utilizes the endocytic pathway for transport to the vacuole, as demonstrated by its presence in endocytic compartments in the Delta vph1 mutant. Taken together, our results indicate a strong connection between the Vid trafficking pathway and the endocytic pathway.	[Brown, C. Randell; Wolfe, Allison B.; Cui, Dongying; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	hlchiang@psu.edu			National Institutes of Health [RO1GM59480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM59480 (to H.-L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bednarek SY, 1996, TRENDS CELL BIOL, V6, P468, DOI 10.1016/0962-8924(96)84943-9; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Haucke V, 2003, TRENDS CELL BIOL, V13, P59, DOI 10.1016/S0962-8924(02)00011-9; Hoffman M, 1996, GENETICS, V143, P1555; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kimata Y, 2000, J BIOL CHEM, V275, P10655, DOI 10.1074/jbc.275.14.10655; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu JJ, 2005, AUTOPHAGY, V1, P146, DOI 10.4161/auto.1.3.2036; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; ORCI L, 1994, P NATL ACAD SCI USA, V91, P11924, DOI 10.1073/pnas.91.25.11924; Owen DJ, 2004, BIOCHEM SOC T, V32, P1, DOI 10.1042/BST0320001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Palmer KJ, 2004, TRENDS CELL BIOL, V14, P57, DOI 10.1016/j.tcb.2003.12.001; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WHITNEY JA, 1995, CELL, V83, P703; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	50	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26116	26127		10.1074/jbc.M709922200	http://dx.doi.org/10.1074/jbc.M709922200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18660504	Green Published, hybrid			2022-12-25	WOS:000259200100040
J	Verhamme, IM; Bock, PE				Verhamme, Ingrid M.; Bock, Paul E.			Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CHLOROMETHYL KETONES; BLOOD-COAGULATION PROTEINASES; LYSINE-BINDING SITES; ACTIVE-SITE; FLUORESCENCE PROBES; CONFORMATIONAL ACTIVATION; EQUIMOLAR COMPLEXES; KRINGLE DOMAINS; GLU-PLASMINOGEN; HIGH-AFFINITY	Binding of the fibrinolytic proteinase plasmin (Pm) to streptokinase (SK) in a tight stoichiometric complex transforms Pm into a potent proteolytic activator of plasminogen. SK binding to the catalytic domain of Pm, with a dissociation constant of 12 pM, is assisted by SK Lys(414) binding to a Pm kringle, which accounts for a 11-20-fold affinity decrease when Pm lysine binding sites are blocked by 6-aminohexanoic acid (6-AHA) or benzamidine. The pathway of SK center dot Pm catalytic complex formation was characterized by stopped-flow kinetics of SK and the Lys(414) deletion mutant (SK Delta K414) binding to Pm labeled at the active site with 5-fluorescein ([5F]FFR-Pm) and the reverse reactions by competitive displacement of [5F]FFR-Pm with active site-blocked Pm. The rate constants for the biexponential fluorescence quenching caused by SK and SK Delta K414 binding to [5F]FFR-Pm were saturable as a function of SK concentration, reporting encounter complex affinities of 62-110 nM in the absence of lysine analogs and 4900 - 6500 and 1430 - 2200 nM in the presence of 6-AHA and benzamidine, respectively. The encounter complex with SK Delta K414 was similar to 10-fold weaker in the absence of lysine analogs but indistinguishable from that of native SK in the presence of 6-AHA and benzamidine. The studies delineate for the first time the sequence of molecular events in the formation of the SK center dot Pm catalytic complex and its regulation by kringle ligands. Analysis of the forward and reverse reactions supports a binding mechanism in which SK Lys414 binding to a Pm kringle accompanies near-diffusion-limited encounter complex formation followed by two slower, tightening conformational changes.	[Verhamme, Ingrid M.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health [RO1 HL056181, RO1 HL 080018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080018, R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL056181 (NHLBI) (to P.E.B.) and RO1 HL 080018 (to I.M.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAJAJ SP, 1977, J BIOL CHEM, V252, P492; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; CHRISTENSEN U, 1985, FEBS LETT, V182, P43, DOI 10.1016/0014-5793(85)81150-9; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; TAYLOR FB, 1968, BIOCHEMISTRY-US, V7, P232, DOI 10.1021/bi00841a028; THEWES T, 1990, J BIOL CHEM, V265, P3906; Tsodikov OV, 1999, BIOPHYS J, V76, P1320, DOI 10.1016/S0006-3495(99)77294-2; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; [No title captured]	55	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26137	26147		10.1074/jbc.M804038200	http://dx.doi.org/10.1074/jbc.M804038200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658146	Green Published, hybrid			2022-12-25	WOS:000259200100042
J	Nicholson, EM; Brunelle, BW; Richt, JA; Kehrli, ME; Greenlee, JJ				Nicholson, Eric M.; Brunelle, Brian W.; Richt, Juergen A.; Kehrli, Marcus E., Jr.; Greenlee, Justin J.			Identification of a Heritable Polymorphism in Bovine PRNP Associated with Genetic Transmissible Spongiform Encephalopathy: Evidence of Heritable BSE	PLOS ONE			English	Article							PRION PROTEIN GENE; TRANSGENIC MICE; PROMOTER REGION; NEURODEGENERATION; DISEASE; CATTLE; INFECTION; VARIANTS; MUTATION; SCRAPIE	Background: Bovine spongiform encephalopathy (BSE) is a transmissible spongiform encephalopathy (TSE) of cattle. Classical BSE is associated with ingestion of BSE-contaminated feedstuffs. H- and L-type BSE, collectively known as atypical BSE, differ from classical BSE by displaying a different disease phenotype and they have not been linked to the consumption of contaminated feed. Interestingly, the 2006 US H- type atypical BSE animal had a polymorphism at codon 211 of the bovine prion gene resulting in a glutamic acid to lysine substitution (E211K). This substitution is analogous a human polymorphism associated with the most prevalent form of heritable TSE in humans, and it is considered to have caused BSE in the 2006 US atypical BSE animal. In order to determine if this amino acid change is a heritable trait in cattle, we sequenced the prion alleles of the only known offspring of this animal, a 2-year-old heifer. Principal Findings: Sequence analysis revealed that both the 2006 US atypical BSE animal and its 2-year-old heifer were heterozygous at bovine prion gene nucleotides 631 through 633 for GAA ( glutamic acid) and AAA ( lysine). Both animals carry the E211K polymorphism, indicating that the allele is heritable and may persist within the cattle population. Conclusions: This is the first evidence that the E211K polymorphism is a germline polymorphism, not a somatic mutation, suggesting BSE may be transmitted genetically in cattle. In the event that E211K proves to result in a genetic form of BSE, this would be the first indication that all 3 etiologic forms of TSEs ( spontaneous, hereditary, and infectious) are present in a non-human species. Atypical BSE arising as both genetic and spontaneous disease, in the context of reports that at least some forms of atypical BSE can convert to classical BSE in mice, suggests a cattle origin for classical BSE.	[Nicholson, Eric M.; Richt, Juergen A.; Kehrli, Marcus E., Jr.; Greenlee, Justin J.] ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Brunelle, Brian W.] ARS, Natl Anim Dis Ctr, Pre Harvest Food Safety & Enter Dis Res Unit, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA.	Eric.Nicholson@ars.usda.gov	Greenlee, Justin/Y-5732-2019; Richt, Juergen/AAL-3632-2020	Greenlee, Justin/0000-0003-2202-3054; Kehrli, Marcus/0000-0003-4850-5211	United States Department of Agriculture, Agriculture Research Service	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the United States Department of Agriculture, Agriculture Research Service.	Arnold ME, 2004, PREV VET MED, V66, P35, DOI 10.1016/j.prevetmed.2004.07.007; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Clawson ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001830; Cutlip RC, 2001, CAN J VET RES, V65, P131; Geldermann H, 2006, ANIM GENET, V37, P469, DOI 10.1111/j.1365-2052.2006.01519.x; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Kashkevich K, 2007, FASEB J, V21, P1547, DOI 10.1096/fj.06-7522com; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Pennington H, 2006, LANCET, V367, P298, DOI 10.1016/S0140-6736(06)68061-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Sauter-Louis C, 2006, SCHWEIZ ARCH TIERH, V148, P245, DOI 10.1024/0036-7281.148.5.245; Seabury CM, 2004, P NATL ACAD SCI USA, V101, P15142, DOI 10.1073/pnas.0406403101; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; *USDA APHIS, 2006, ALB BSE INV FIN EP R	28	55	59	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2912	10.1371/journal.pone.0002912	http://dx.doi.org/10.1371/journal.pone.0002912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698343	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600001
J	O'Brien, CA; Plotkin, LI; Galli, C; Goellner, JJ; Gortazar, AR; Allen, MR; Robling, AG; Bouxsein, M; Schipani, E; Turner, CH; Jilka, RL; Weinstein, RS; Manolagas, SC; Bellido, T				O'Brien, Charles A.; Plotkin, Lilian I.; Galli, Carlo; Goellner, Joseph J.; Gortazar, Arancha R.; Allen, Matthew R.; Robling, Alexander G.; Bouxsein, Mary; Schipani, Ernestina; Turner, Charles H.; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; Bellido, Teresita			Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes	PLOS ONE			English	Article							OSTEOBLAST-DERIVED PTHRP; PARATHYROID-HORMONE; BETA-CATENIN; IN-VIVO; GENE-EXPRESSION; TRABECULAR BONE; PRIMARY HYPERPARATHYROIDISM; DIFFERENTIATED OSTEOBLASTS; OSTEOCLAST DIFFERENTIATION; PTH/PTHRP RECEPTOR	Osteocytes, former osteoblasts buried within bone, are thought to orchestrate skeletal adaptation to mechanical stimuli. However, it remains unknown whether hormones control skeletal homeostasis through actions on osteocytes. Parathyroid hormone (PTH) stimulates bone remodeling and may cause bone loss or bone gain depending on the balance between bone resorption and formation. Herein, we demonstrate that transgenic mice expressing a constitutively active PTH receptor exclusively in osteocytes exhibit increased bone mass and bone remodeling, as well as reduced expression of the osteocyte-derived Wnt antagonist sclerostin, increased Wnt signaling, increased osteoclast and osteoblast number, and decreased osteoblast apoptosis. Deletion of the Wnt co-receptor LDL related receptor 5 (LRP5) attenuates the high bone mass phenotype but not the increase in bone remodeling induced by the transgene. These findings demonstrate that PTH receptor signaling in osteocytes increases bone mass and the rate of bone remodeling through LRP5-dependent and independent mechanisms, respectively.	[O'Brien, Charles A.; Plotkin, Lilian I.; Galli, Carlo; Goellner, Joseph J.; Gortazar, Arancha R.; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; Bellido, Teresita] Univ Arkansas Med Sci, Div Endocrinol, Ctr Osteoporosis & Metab Bone Dis, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Allen, Matthew R.; Robling, Alexander G.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Bloomington, IN 47405 USA; [Bouxsein, Mary] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Orthoped Surg, Orthoped Biomechan Lab, Boston, MA USA; [Schipani, Ernestina] Massachusetts Gen Hosp, Harvard Med Sch, Endocrine Unit, Boston, MA USA; [Turner, Charles H.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Bloomington, IN 47405 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Indiana University System; Indiana University Bloomington; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Div Endocrinol, Ctr Osteoporosis & Metab Bone Dis, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.	caobrien@uams.edu; tbellido@iupui.edu	Allen, Matthew/A-8799-2015; O'Brien, Charles A./AAL-5078-2020; Galli, Carlo/D-4728-2014; Gortazar, Arancha/G-5385-2017; Plotkin, Lilian/H-7188-2019	Allen, Matthew/0000-0002-1174-9004; Galli, Carlo/0000-0001-7476-7181; Gortazar, Arancha/0000-0001-5072-3141; Plotkin, Lilian/0000-0002-9537-4544	National Institutes of Health [R01 DK076007, R01 AR049794, P01 AG13918, S10-RR023710]; Department of Veterans Affairs; University of Arkansas for Medical Sciences Tobacco Settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710, S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237, R01AR049794, R01AR053643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); University of Arkansas for Medical Sciences Tobacco Settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (R01 DK076007, R01 AR049794, P01 AG13918, and S10-RR023710), the Department of Veterans Affairs, and University of Arkansas for Medical Sciences Tobacco Settlement funds.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2004, MECH DEVELOP, V121, P397, DOI 10.1016/j.mod.2004.02.004; Chen XS, 2005, J BONE MINER RES, V20, P1454, DOI 10.1359/jbmr.2005.20.8.1454; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; JILKA RL, 2007, PRINCIPLES BONE BIOL; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KE HZ, 2006, J MUSCULOSKEL NEURON, V6, P359; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kim JS, 2002, CANCER RES, V62, P2744; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2007, MOL CELL BIOL, V27, P1516, DOI 10.1128/MCB.01550-06; Langdahl BL, 1996, BONE, V18, P103, DOI 10.1016/8756-3282(95)00443-2; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu BY, 1998, ENDOCRINOLOGY, V139, P1952, DOI 10.1210/en.139.4.1952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Marotti G, 1996, Ital J Anat Embryol, V101, P25; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; NEUMAN WF, 1975, CALC TISS RES, V18, P263, DOI 10.1007/BF02546245; NIJWEIDE PJ, 2002, PRINCIPLES BONE BIOL, P93; Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Parfitt AM, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P497; PARFITT AM, 1976, METABOLISM, V25, P909, DOI 10.1016/0026-0495(76)90124-4; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM, 1996, J CLIN ENDOCR METAB, V81, P3584, DOI 10.1210/jc.81.10.3584; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; PYRAH LN, 1966, BRIT J SURG, V53, P245, DOI 10.1002/bjs.1800530402; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tomkinson A, 1998, J BONE MINER RES, V13, P1243, DOI 10.1359/jbmr.1998.13.8.1243; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Weinstein R. S, 2002, DISORDERS BONE MINER, P448; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WYSOLMERSKI JJ, 2001, PARATHYROIDS, P275; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	83	274	284	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2942	10.1371/journal.pone.0002942	http://dx.doi.org/10.1371/journal.pone.0002942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698360	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600028
J	Goldar, A; Labit, H; Marheineke, K; Hyrien, O				Goldar, Arach; Labit, Helene; Marheineke, Kathrin; Hyrien, Olivier			A Dynamic Stochastic Model for DNA Replication Initiation in Early Embryos	PLOS ONE			English	Article							XENOPUS EGG EXTRACT; MCM PROTEINS; S-PHASE; YEAST; CHROMATIN; ORIGINS; PHOSPHORYLATION; INCREASES; COMPLEXES; CLUSTERS	Background: Eukaryotic cells seem unable to monitor replication completion during normal S phase, yet must ensure a reliable replication completion time. This is an acute problem in early Xenopus embryos since DNA replication origins are located and activated stochastically, leading to the random completion problem. DNA combing, kinetic modelling and other studies using Xenopus egg extracts have suggested that potential origins are much more abundant than actual initiation events and that the time-dependent rate of initiation, I(t), markedly increases through S phase to ensure the rapid completion of unreplicated gaps and a narrow distribution of completion times. However, the molecular mechanism that underlies this increase has remained obscure. Methodology/Principal Findings: Using both previous and novel DNA combing data we have confirmed that I(t) increases through S phase but have also established that it progressively decreases before the end of S phase. To explore plausible biochemical scenarios that might explain these features, we have performed comparisons between numerical simulations and DNA combing data. Several simple models were tested: i) recycling of a limiting replication fork component from completed replicons; ii) time-dependent increase in origin efficiency; iii) time-dependent increase in availability of an initially limiting factor, e. g. by nuclear import. None of these potential mechanisms could on its own account for the data. We propose a model that combines time-dependent changes in availability of a replication factor and a fork-density dependent affinity of this factor for potential origins. This novel model quantitatively and robustly accounted for the observed changes in initiation rate and fork density. Conclusions/Significance: This work provides a refined temporal profile of replication initiation rates and a robust, dynamic model that quantitatively explains replication origin usage during early embryonic S phase. These results have significant implications for the organisation of replication origins in higher eukaryotes.	[Goldar, Arach] Commissariat Energie Atom, Serv Biol Integrat & Genet Mol, Gif Sur Yvette, France; [Labit, Helene; Marheineke, Kathrin; Hyrien, Olivier] Ecole Normale Superieure, CNRS, UMR 8541, Paris, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Goldar, A (corresponding author), Commissariat Energie Atom, Serv Biol Integrat & Genet Mol, Gif Sur Yvette, France.	arach.goldar@cea.fr; hyrien@biologie.ens.fr	goldar, arach/I-8479-2012; Hyrien, Olivier/R-5108-2017	Hyrien, Olivier/0000-0001-8879-675X; Marheineke, Kathrin/0000-0002-1514-0167	Association pour la Recherche sur le Cancer; Ligue Contre le Cancer (Comite de Paris); Agence Nationale pour la Recherche; Fondation pour la Recherche Medicale; MENESR	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MENESR	The O.H. lab is supported by the Association pour la Recherche sur le Cancer, the Ligue Contre le Cancer (Comite de Paris), the Agence Nationale pour la Recherche and the Fondation pour la Recherche Medicale. H.L. was supported by fellowships from the MENESR and the ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Bechhoefer J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098105; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Bevington P.R., 1969, DATA REDUCTION ERROR, P336; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; CALLAN HG, 1972, PROC R SOC SER B-BIO, V181, P19, DOI 10.1098/rspb.1972.0039; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Jun S, 2004, CELL CYCLE, V3, P223; Jun S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011909; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Legouras I, 2006, YEAST, V23, P951, DOI 10.1002/yea.1416; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Torres-Rosell J, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-19; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhang HY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051903	44	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2919	10.1371/journal.pone.0002919	http://dx.doi.org/10.1371/journal.pone.0002919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682801	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600069
J	Hao, JJ; Daleo, MA; Murphy, CK; Yu, PB; Ho, JN; Hu, JY; Peterson, RT; Hatzopoulos, AK; Hong, CC				Hao, Jijun; Daleo, Marie A.; Murphy, Clare K.; Yu, Paul B.; Ho, Joshua N.; Hu, Jianyong; Peterson, Randall T.; Hatzopoulos, Antonis K.; Hong, Charles C.			Dorsomorphin, a Selective Small Molecule Inhibitor of BMP Signaling, Promotes Cardiomyogenesis in Embryonic Stem Cells	PLOS ONE			English	Article							CARDIAC MESODERM; PROGENITOR CELLS; SMOOTH-MUSCLE; INDUCTION; DIFFERENTIATION; SPECIFICATION; HEART; CARDIOMYOCYTE; FIBROBLASTS; PROTEINS	Background: Pluripotent embryonic stem (ES) cells, which have the capacity to give rise to all tissue types in the body, show great promise as a versatile source of cells for regenerative therapy. However, the basic mechanisms of lineage specification of pluripotent stem cells are largely unknown, and generating sufficient quantities of desired cell types remains a formidable challenge. Small molecules, particularly those that modulate key developmental pathways like the bone morphogenetic protein (BMP) signaling cascade, hold promise as tools to study in vitro lineage specification and to direct differentiation of stem cells toward particular cell types. Methodology/Principal Findings: We describe the use of dorsomorphin, a selective small molecule inhibitor of BMP signaling, to induce myocardial differentiation in mouse ES cells. Cardiac induction is very robust, increasing the yield of spontaneously beating cardiomyocytes by at least 20 fold. Dorsomorphin, unlike the endogenous BMP antagonist Noggin, robustly induces cardiomyogenesis when treatment is limited to the initial 24-hours of ES cell differentiation. Quantitative-PCR analyses of differentiating ES cells indicate that pharmacological inhibition of BMP signaling during the early critical stage promotes the development of the cardiomyocyte lineage, but reduces the differentiation of endothelial, smooth muscle, and hematopoietic cells. Conclusions/Significance: Administration of a selective small molecule BMP inhibitor during the initial stages of ES cell differentiation substantially promotes the differentiation of primitive pluripotent cells toward the cardiomyocytic lineage, apparently at the expense of other mesodermal lineages. Small molecule modulators of developmental pathways like dorsomorphin could become versatile pharmacological tools for stem cell research and regenerative medicine.	[Hao, Jijun; Daleo, Marie A.; Murphy, Clare K.; Ho, Joshua N.; Hu, Jianyong; Hatzopoulos, Antonis K.; Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN USA; [Yu, Paul B.; Peterson, Randall T.] Harvard Univ, Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA USA; [Hu, Jianyong; Hatzopoulos, Antonis K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Vanderbilt University	Hao, JJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	charles.c.hong@vanderbilt.edu	Yu, Paul B./J-7540-2019; Hong, Charles/C-9989-2010; Hatzopoulos, Antonis/D-2049-2010; Hatzopoulos, Antonis/X-2043-2019	Yu, Paul B./0000-0003-2145-4944; Hatzopoulos, Antonis/0000-0001-5610-0017; Peterson, Randall/0000-0003-0727-3469	NIH [HL081535, HL083958]; GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, K08HL081535, R01HL083958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL081535 (CCH) and HL083958 (AKH), and a grant from the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease (CCH).	Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Emre N, 2007, CURR OPIN CHEM BIOL, V11, P252, DOI 10.1016/j.cbpa.2007.04.024; Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olson EN, 2001, SCIENCE, V291, P2327, DOI 10.1126/science.1060063; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu P. B., 2007, NAT CHEM BIOL; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	139	167	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2904	10.1371/journal.pone.0002904	http://dx.doi.org/10.1371/journal.pone.0002904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682835	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600060
J	Gil, M; Menzel, R; De Marco, RJ				Gil, Mariana; Menzel, Randolf; De Marco, Rodrigo J.			Does an Insect's Unconditioned Response to Sucrose Reveal Expectations of Reward?	PLOS ONE			English	Article							APIS-MELLIFERA L.; HONEY-BEE; PROBOSCIS REFLEX; BRAIN; BEHAVIOR; MEMORY; MUSHROOM; NEURONS; PATTERN; BODY	We asked whether and how a sequence of a honeybee's experience with different reward magnitudes changes its subsequent unconditioned proboscis extension response (PER) to sucrose stimulation of the antennae, 24 hours after training, in the absence of reward, and under otherwise similar circumstances. We found that the bees that had experienced an increasing reward schedule extended their probosces earlier and during longer periods in comparison to bees that had experienced either decreasing or constant reward schedules, and that these effects at a later time depend upon the activation of memories formed on the basis of a specific property of the experienced reward, namely, that its magnitude increased over time. An anticipatory response to reward is typically thought of as being rooted in a subject's expectations of reward. Therefore our results make us wonder to what extent a long-term 'anticipatory' adjustment of a honeybee's PER is based upon an expectation of reward. Further experiments will aim to elucidate the neural substrates underlying reward anticipation in harnessed honeybees.	[Gil, Mariana; Menzel, Randolf; De Marco, Rodrigo J.] Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol Neurobiol, D-1000 Berlin, Germany	Free University of Berlin	Gil, M (corresponding author), Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol Neurobiol, D-1000 Berlin, Germany.	mgdm04@yahoo.com.ar; demarco@neurobiologie.fu-berlin.de		De Marco, Rodrigo/0000-0002-2082-4264	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Our study has been supported by funds from the Deutsche Forschungsgemeinschaft.	BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588, DOI 10.1152/jn.1992.67.3.588; ERBER E, 1997, J COMP PHYSL, V181, P1432; Gil M, 2007, LEARN MEMORY, V14, P491, DOI 10.1101/lm.618907; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAMMER M, 1994, SOC NEUR ABSTR, V20, P258; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; HORI S, 2006, J COMP PHYSIOL A, V192, P1432; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; LOGAN FA, 1960, INCENTIVE; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; REHDER V, 1987, J INSECT PHYSIOL, V33, P501, DOI 10.1016/0022-1910(87)90115-6; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SMITH BH, 1989, ETHOLOGY, V82, P68; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tolman E. C., 1959, PSYCHOL STUDY SCI, P92	28	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2810	10.1371/journal.pone.0002810	http://dx.doi.org/10.1371/journal.pone.0002810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665249	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000264304300029
J	Null, B; Liu, CW; Hedehus, M; Conolly, S; Davis, RW				Null, Brian; Liu, Corey W.; Hedehus, Maj; Conolly, Steven; Davis, Ronald W.			High-Resolution, In Vivo Magnetic Resonance Imaging of Drosophila at 18.8 Tesla	PLOS ONE			English	Article								High resolution MRI of live Drosophila was performed at 18.8 Tesla, with a field of view less than 5 mm, and administration of manganese or gadolinium-based contrast agents. This study demonstrates the feasibility of MR methods for imaging the fruit fly Drosophila with an NMR spectrometer, at a resolution relevant for undertaking future studies of the Drosophila brain and other organs. The fruit fly has long been a principal model organism for elucidating biology and disease, but without capabilities like those of MRI. This feasibility marks progress toward the development of new in vivo research approaches in Drosophila without the requirement for light transparency or destructive assays.	[Null, Brian; Davis, Ronald W.] Stanford Genome Technol Ctr, Dept Biochem, Bio X Program, Stanford, CA USA; [Liu, Corey W.] Stanford Magnetic Resonance Lab, Stanford, CA USA; [Hedehus, Maj] Varian Inc, NMR Instruments, Palo Alto, CA USA; [Conolly, Steven] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA USA	Stanford University; University of California System; University of California Berkeley	Null, B (corresponding author), Stanford Genome Technol Ctr, Dept Biochem, Bio X Program, Stanford, CA USA.	zenbonz@gmail.com	Vorobev, Alexander/C-1918-2016; Zhang, Lin/F-6815-2013	Vorobev, Alexander/0000-0002-7324-428X; Zhang, Lin/0000-0002-4394-2685	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	National Science Foundation Major Research Instrumentation Development Grant	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Engstrom Y, 2004, TRENDS BIOTECHNOL, V22, P600, DOI 10.1016/j.tibtech.2004.09.002; GANDHI S, 2007, J VISION, V7, P42; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grant SC, 2000, MAGNET RESON MED, V44, P19, DOI 10.1002/1522-2594(200007)44:1<19::AID-MRM4>3.0.CO;2-F; Haddad D, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.7; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; Jasanoff A, 2002, J MAGN RESON, V158, P79, DOI 10.1016/S1090-7807(02)00063-0; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Lee SC, 2001, J MAGN RESON, V150, P207, DOI 10.1006/jmre.2001.2319; Lilley Kathryn S., 2003, Briefings in Functional Genomics & Proteomics, V2, P106, DOI 10.1093/bfgp/2.2.106; Manev H, 2003, TRENDS PHARMACOL SCI, V24, P41, DOI 10.1016/S0165-6147(02)00004-4; Mason GF, 2006, NMR BIOMED, V19, P690, DOI 10.1002/nbm.1080; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Raghunand N, 2006, MAGN RESON MED, V55, P1272, DOI 10.1002/mrm.20904; Raghunand Natarajan, 2006, Methods Mol Med, V124, P347; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Ruden DM, 2005, ANNU REV NUTR, V25, P499, DOI 10.1146/annurev.nutr.25.050304.092708; Schoofs Liliane, 2003, Briefings in Functional Genomics & Proteomics, V2, P114, DOI 10.1093/bfgp/2.2.114; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Shen J, 2004, J MAGN RESON, V170, P290, DOI 10.1016/j.jmr.2004.05.022; Taraszka JA, 2005, J PROTEOME RES, V4, P1223, DOI 10.1021/pr050038g; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Xun ZY, 2007, J PROTEOME RES, V6, P348, DOI 10.1021/pr060488o	28	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2817	10.1371/journal.pone.0002817	http://dx.doi.org/10.1371/journal.pone.0002817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665264	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300036
J	Taniguchi, E; Nishijo, K; McCleish, AT; Michalek, JE; Grayson, MH; Infante, AJ; Abboud, HE; Legallo, RD; Qualman, SJ; Rubin, BP; Keller, C				Taniguchi, E.; Nishijo, K.; McCleish, A. T.; Michalek, J. E.; Grayson, M. H.; Infante, A. J.; Abboud, H. E.; Legallo, R. D.; Qualman, S. J.; Rubin, B. P.; Keller, C.			PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma	ONCOGENE			English	Article						PDGFR-A; therapeutic target; alveolar rhabdomyosarcoma	GROWTH-FACTOR; IN-VIVO; ALPHA; KINASE; ACTIVATION; EXPRESSION; IMATINIB; RECEPTOR; DISEASE; CELLS	Alveolar rhabdomyosarcoma is an aggressive skeletal muscle cancer of childhood. Our initial studies of rhabdomyosarcoma gene expression for patients enrolled in a national clinical trial suggested that platelet-derived growth factor receptor A (PDGFR-A) may be a mediator of disease progression and metastasis. Using our conditional mouse tumor models that authentically recapitulate the primary mutations and metastatic progression of alveolar rhabdomyosarcomas in humans, we found by immunoblotting and immunokinase assays that PDGFR-A and its downstream effectors, mitogen-activated protein kinase and Akt, were highly activated in both primary and metastatic tumors. Inhibition of PDGFR-A by RNA interference, small molecule inhibitor or neutralizing antibody had a dramatic effect on tumor cell growth both in vitro and in vivo, although resistance evolved in one-third of tumors. These results establish proof-of-principal for PDGFR-A as a therapeutic target in alveolar rhabdomyosarcoma.	[Taniguchi, E.; Nishijo, K.; McCleish, A. T.; Keller, C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Michalek, J. E.; Grayson, M. H.; Infante, A. J.; Keller, C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Michalek, J. E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Abboud, H. E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Legallo, R. D.] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA; [Qualman, S. J.] Ohio State Univ, Dept Pediat, Columbus Childrens Res Inst, Ctr Childhood Canc, Columbus, OH 43210 USA; [Rubin, B. P.] Cleveland Clin, Taussig Canc Ctr, Dept Anat Pathol, Cleveland, OH 44106 USA; [Rubin, B. P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Virginia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Keller, C (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr,MC7784, San Antonio, TX 78229 USA.	kellerc2@uthscsa.edu		Keller, Charles/0000-0003-2505-7487	NIH [RO1CA 133229]; University Research Council (UTHSCSA); Sarcoma Foundation of America; Amschwand Sarcoma Cancer Foundation; National Cancer Institute Center; San Antonio Cancer Center [P30 CA54174]; NATIONAL CANCER INSTITUTE [R01CA133229, P30CA054174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Council (UTHSCSA); Sarcoma Foundation of America; Amschwand Sarcoma Cancer Foundation; National Cancer Institute Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); San Antonio Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Frederic G Barr ( The University of Pennsylvania School of Medicine) for providing Pax3: Fkhr cDNA and Pax7: Fkhr cDNA, and Dr Guillermina Lozano ( University of Texas M. D. Anderson Cancer Center) for providing p53 cDNA. This work was funded in part by grants from NIH RO1CA 133229, the University Research Council (UTHSCSA), the Sarcoma Foundation of America, and the Amschwand Sarcoma Cancer Foundation. Animal care costs for this study were in part defrayed by a National Cancer Institute Center grant to the San Antonio Cancer Center ( Grant number P30 CA54174), of which CK is a member. We thank Dr Sharon B Murphy for critical reading of this article, and Gary Chisholm for statistical support.	Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Blandford MC, 2006, PEDIATR BLOOD CANCER, V46, P329, DOI 10.1002/pbc.20466; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Choudhury GG, 2000, KIDNEY INT, V57, P908, DOI 10.1046/j.1523-1755.2000.00907.x; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Crist WM, 2001, J CLIN ONCOL, V19, P3091, DOI 10.1200/JCO.2001.19.12.3091; DEVARE SG, 1983, P NATL ACAD SCI-BIOL, V80, P731, DOI 10.1073/pnas.80.3.731; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Matei D, 2006, ONCOGENE, V25, P2060, DOI 10.1038/sj.onc.1209232; Mehrotra M, 2004, J CELL BIOCHEM, V93, P741, DOI 10.1002/jcb.20138; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Ricono JM, 2002, AM J PHYSIOL-RENAL, V282, pF211, DOI 10.1152/ajprenal.0323.2000; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Takahashi Y, 2004, MODERN PATHOL, V17, P660, DOI 10.1038/modpathol.3800101; Underwood TJ, 2007, FEBS LETT, V581, P5831, DOI 10.1016/j.febslet.2007.11.056	25	69	74	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 30	2008	27	51					6550	6560		10.1038/onc.2008.255	http://dx.doi.org/10.1038/onc.2008.255			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18679424	Green Accepted			2022-12-25	WOS:000260501700002
J	Mori, M; Yoneda-Kato, N; Yoshida, A; Kato, JY				Mori, Masaaki; Yoneda-Kato, Noriko; Yoshida, Akihiro; Kato, Jun-ya			Stable Form of JAB1 Enhances Proliferation and Maintenance of Hematopoietic Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-1 EXPRESSION; CYCLE INHIBITOR P27(KIP1); COP9 SIGNALOSOME; PROGNOSTIC-SIGNIFICANCE; PANCREATIC-CANCER; UBIQUITIN LIGASES; TUMOR SUPPRESSION; BREAST-CANCER; DEGRADATION; P27	Overexpression of JAB1 is observed in a variety of human cancers, but how JAB1 is involved in tumor development remained to be investigated. Here we analyzed mice with modified Jab1 expression. Mice ectopically expressing a more stable form of JAB1 protein under the control of a constitutive promoter were rescued from the embryonic lethality caused by the Jab1(-/-) allele and developed a myeloproliferative disorder in a gene dosage-dependent manner. Hematopoietic cells from the bone marrow of Jab1 transgenic mice had a significantly larger stem cell population and exhibited higher and transplantable proliferative potential. In contrast, Jab1(-/-) mice, which express similar to 70% as much JAB1 protein as their wild-type littermates, showed inefficient hematopoiesis. Expression of the tumor suppressor p16(INK4a) was inversely correlated with that of JAB1, and the oncoprotein SMYD3, a newly identified JAB1 interactor, suppressed transcription of p16 in cooperation with JAB1. Thus, the expression and function of JAB1 are critical for the proliferation and maintenance of hematopoietic progenitors.	[Mori, Masaaki; Yoneda-Kato, Noriko; Yoshida, Akihiro; Kato, Jun-ya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Kato, JY (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.	jkata@bs.naist.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Bounpheng MA, 2000, GENE, V242, P41, DOI 10.1016/S0378-1119(99)00525-9; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Dong YY, 2005, CLIN CANCER RES, V11, P259; Esteva FJ, 2003, CLIN CANCER RES, V9, P5652; Fukumoto A, 2004, ONCOL REP, V11, P277; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goto A, 2004, PATHOL INT, V54, P675, DOI 10.1111/j.1440-1827.2004.01679.x; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Ito Y, 2003, ANTICANCER RES, V23, P4121; Ito Y, 2003, CANCER LETT, V196, P87, DOI 10.1016/S0304-3835(03)00129-0; Ivan D, 2004, MODERN PATHOL, V17, P811, DOI 10.1038/modpathol.3800123; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Matsumoto N, 2000, LEUKEMIA, V14, P1757, DOI 10.1038/sj.leu.2401897; Osoegawa A, 2004, J CLIN ONCOL, V22, P4165, DOI 10.1200/JCO.2004.01.035; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Seeger M, 2001, CURR BIOL, V11, pR643, DOI 10.1016/S0960-9822(01)00382-7; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sui L, 2001, CLIN CANCER RES, V7, P4130; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656	38	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29011	29021		10.1074/jbc.M804539200	http://dx.doi.org/10.1074/jbc.M804539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18667426	hybrid, Green Published			2022-12-25	WOS:000260179900027
J	Celic, A; Petri, ET; Demeler, B; Ehrlich, BE; Boggon, TJ				Celic, Andjelka; Petri, Edward T.; Demeler, Borries; Ehrlich, Barbara E.; Boggon, Titus J.			Domain mapping of the polycystin-2 C-terminal tail using de novo molecular modeling and biophysical analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; KIDNEY-DISEASE; CATION CHANNEL; PKD2; GENE; PREDICTION; INTERACTS; DICHROWEB	In polycystic kidney disease (PKD), polycystin-2 (PC2) is frequently mutated or truncated in the C-terminal cytoplasmic tail (PC2-C). The currently accepted model of PC2-C consists of an EF-hand motif overlapping with a short coiled coil; however, this model fails to explain the mechanisms by which PC2 truncations C-terminal to this region lead to PKD. Moreover, direct PC2 binding to inositol 1,4,5-trisphosphate receptor, KIF3A, and TRPC1 requires residues in PC2-C outside this region. To address these discrepancies and investigate the role of PC2-C in PC2 function, we performed de novo molecular modeling and biophysical analysis. De novo molecular modeling of PC2-C using the ROBETTA server predicts two domains as follows: an EF-hand motif (PC2-EF) connected by a linker to a previously unidentified C-terminal coiled coil (PC2-CC). This model differs substantially from the current model and correlates with limited proteolysis, matrix-assisted laser desorption/ionization mass spectroscopy, N-terminal sequencing, and improved coiled coil prediction algorithms. PC2-C is elongated and oligomerizes through PC2-CC, as measured by analytical ultracentrifugation and size exclusion chromatography, whereas PC2-EF is globular and monomeric. We show that PC2-C and PC2-EF have micromolar affinity for calcium (Ca2+) by isothermal titration calorimetry and undergo Ca2+-induced conformational changes by circular dichroism. Mutation of predicted EF-hand loop residues in PC2 to alanine abolishes Ca2+ binding. Our results suggest that PC2-CC is involved in PC2 oligomerization, and PC2-EF is a Ca2+-sensitive switch. PKD-associated PC2 mutations are located in regions that may disrupt these functions, providing structural insight into how PC2 mutations lead to disease.	[Celic, Andjelka; Petri, Edward T.; Ehrlich, Barbara E.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Ctr Analyt Ultracentrifugat Macromol Assemblies, San Antonio, TX 78229 USA	Yale University; Yale University; University of Texas System; University of Texas Health San Antonio	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu; titus.boggon@yale.edu	Celic, Andjeka S/AAC-1865-2022; /AAX-8408-2021	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Demeler, Borries/0000-0002-2414-9518; Petri, Edward/0000-0002-3650-1523	National Institutes of Health [DK57328, CA009085, RR022200, CA054174]; PKD Foundation; Robert J. Kleberg Jr., and Helen C. Kleberg Foundation; National Science Foundation [TGMCB070038]; NATIONAL CANCER INSTITUTE [T32CA009085, P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; Robert J. Kleberg Jr., and Helen C. Kleberg Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57328 ( to B. E. E.), CA009085 ( training grant to E. T. P.), RR022200 (UltraScan software development), and CA054174 ( to the Center for Analytical Ultracentrifugation of Macromolecular Assemblies facility). This work was also supported in part by a grant from the PKD Foundation, UltraScan software development was also supported by the Robert J. Kleberg Jr., and Helen C. Kleberg Foundation, and AUC calculations were supported by National Science Foundation Grant TGMCB070038 ( to B. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anyatonwu GI, 2005, J BIOL CHEM, V280, P29488, DOI 10.1074/jbc.M504359200; BROOKES E, 2006, P 2006 ACM IEEE C SU; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Delmas P, 2004, BIOL RES, V37, P681; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LAUE TM, 1992, MODERN ANAL ULTRACEN, P90; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Pei Y, 1998, KIDNEY INT, V53, P1127, DOI 10.1046/j.1523-1755.1998.00890.x; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Somlo S, 2000, CURR OPIN NEPHROL HY, V9, P385, DOI 10.1097/00041552-200007000-00010; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WU G, 1998, CELL, V93, P7; Xu GM, 2002, GENOMICS, V79, P87, DOI 10.1006/geno.2001.6684	44	61	64	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28305	28312		10.1074/jbc.M802743200	http://dx.doi.org/10.1074/jbc.M802743200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694932	hybrid, Green Published			2022-12-25	WOS:000259969300032
J	Jan, A; Gokce, O; Luthi-Carter, R; Lashuel, HA				Jan, Asad; Gokce, Ozgun; Luthi-Carter, Ruth; Lashuel, Hilal A.			The ratio of monomeric to aggregated forms of A beta 40 and A beta 42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PROTEIN A-BETA; IN-VITRO; FIBRIL FORMATION; TRANSGENIC MICE; SENILE PLAQUES; MOUSE MODELS; LEWY BODIES; WILD-TYPE; PEPTIDE	Aggregation and fibril formation of amyloid-beta (A beta) peptides A beta 40 and A beta 42 are central events in the pathogenesis of Alzheimer disease. Previous studies have established the ratio of A beta 40 to A beta 42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of A beta. To better understand the molecular basis underlying the pathologic consequences associated with alterations in the ratio of A beta 40 to A beta 42, we probed the concentration- and ratio-dependent interactions between well defined states of the two peptides at different stages of aggregation along the amyloid formation pathway. We report that monomeric A beta 40 alters the kinetic stability, solubility, and morphological properties of A beta 42 aggregates and prevents their conversion into mature fibrils. A beta 40, at approximately equimolar ratios (A beta 40/A beta 42 similar to 0.5-1), inhibits (> 50%) fibril formation by monomeric A beta 42, whereas inhibition of protofibrillar A beta 42 fibrillogenesis is achieved at lower, substoichiometric ratios (A beta 40/A beta 42 similar to 0.1). The inhibitory effect of A beta 40 on A beta 42 fibrillogenesis is reversed by the introduction of excess A beta 42 monomer. Additionally, monomeric A beta 42 and A beta 40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar A beta aggregates. Whereas the fibrillogenesis of both monomeric species can be seeded by fibrils composed of either peptide, A beta 42 protofibrils selectively seed the fibrillogenesis of monomeric A beta 42 but not monomeric A beta 40. Finally, we also show that the amyloidogenic propensities of different individual and mixed A beta species correlates with their relative neuronal toxicities. These findings, which highlight specific points in the amyloid peptide equilibrium that are highly sensitive to the ratio of A beta 40 to A beta 42, carry important implications for the pathogenesis and current therapeutic strategies of Alzheimer disease.	[Jan, Asad; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Gokce, Ozgun; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Funct Neurogenom, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Jan, Asad/AAZ-2920-2021; Jan, Asad/D-4389-2009	Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; gokce, ozgun/0000-0001-6319-404X	Swiss Federal Institute of Technology [310000-110027]	Swiss Federal Institute of Technology	This work was supported by the Swiss Federal Institute of Technology Lausanne (all investigators) and Grant 310000-110027 from the Swiss National Science Foundation (to H. L. A. and A. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderton BH, 1998, PROG NEUROBIOL, V55, P595, DOI 10.1016/S0301-0082(98)00022-7; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bibl M, 2006, J NEURAL TRANSM, V113, P1771, DOI 10.1007/s00702-006-0537-z; Bibl M, 2006, BRAIN, V129, P1177, DOI 10.1093/brain/awl063; BLOW DM, 1994, PROTEIN SCI, V3, P1638, DOI 10.1002/pro.5560031003; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Frost D, 2003, EUR J BIOCHEM, V270, P654, DOI 10.1046/j.1432-1033.2003.03415.x; Glenner G G, 1984, Appl Pathol, V2, P357; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; JOACHIM CL, 1988, ANN NEUROL, V24, P50, DOI 10.1002/ana.410240110; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Shoji M, 1998, J NEUROL SCI, V158, P134, DOI 10.1016/S0022-510X(98)00122-1; TAMAOKA A, 1994, BIOCHEM BIOPH RES CO, V205, P834, DOI 10.1006/bbrc.1994.2740; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wiltfang J, 2007, J NEUROCHEM, V101, P1053, DOI 10.1111/j.1471-4159.2006.04404.x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yankner BA, 1996, NAT MED, V2, P850, DOI 10.1038/nm0896-850; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x	74	201	203	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28176	28189		10.1074/jbc.M803159200	http://dx.doi.org/10.1074/jbc.M803159200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694930	Green Published, hybrid			2022-12-25	WOS:000259969300020
J	MacLaine, NJ; Oster, B; Bundgaard, B; Fraser, JA; Buckner, C; Lazo, PA; Meek, DW; Hollsberg, P; Hupp, TR				MacLaine, Nicola J.; Oster, Bodil; Bundgaard, Bettina; Fraser, Jennifer A.; Buckner, Carolyn; Lazo, Pedro A.; Meek, David W.; Hoellsberg, Per; Hupp, Ted R.			A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DEPENDENT ACETYLATION; C VIRUS NS5A; COACTIVATOR P300; POINT MUTATION; KINASE; HYPERPHOSPHORYLATION; BINDING; DAMAGE; CELLS; SITE	The tumor suppressor protein p53 is activated by distinct cellular stresses including radiation, hypoxia, type I interferon, and DNA/RNA virus infection. The transactivation domain of p53 contains a phosphorylation site at Ser(20) whose modification stabilizes the binding of the transcriptional co-activator p300 and whose mutation in murine transgenics induces B-cell lymphoma. Although the checkpoint kinase CHK2 is implicated in promoting Ser(20) site phosphorylation after irradiation, the enzyme that triggers this phosphorylation after DNA viral infection is undefined. Using human herpesvirus 6B (HHV-6B) as a virus that induces Ser(20) site phosphorylation of p53 in T-cells, we sought to identify the kinase responsible for this virus-induced p53 modification. The p53 Ser(20) kinase was fractionated and purified using cation, anion, and dye-ligand exchange chromatography. Mass spectrometry identified casein kinase 1 (CK1) and vaccinia-related kinase 1 (VRK1) as enzymes that coeluted with virus-induced Ser(20) site kinase activity. Immunodepletion of CK1 but not VRK1 removed the kinase activity from the peak fraction, and bacterially expressed CK1 exhibited Ser(20) site kinase activity equivalent to that of the virus-induced native CK1. CK1 modified p53 in a docking-dependent manner, which is similar to other known Ser(20) site p53 kinases. Low levels of the CK1 inhibitor D4476 selectively inhibited HHV-6B-induced Ser(20) site phosphorylation of p53. However, x-ray-induced Ser(20) site phosphorylation of p53 was not blocked by D4476. These data highlight a central role for CK1 as the Ser(20) site kinase for p53 in DNA virus-infected cells but also suggest that distinct stresses may selectively trigger different protein kinases to modify the transactivation domain of p53 at Ser(20).	[MacLaine, Nicola J.; Fraser, Jennifer A.; Buckner, Carolyn; Hupp, Ted R.] Univ Edinburgh, Edinburgh EH4 2XR, Midlothian, Scotland; [Oster, Bodil; Bundgaard, Bettina; Hoellsberg, Per] Univ Aarhus, Inst Med Microbiol & Immunol, DK-800 Aarhus, Denmark; [Lazo, Pedro A.] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, Salamanca 37071, Spain; [Meek, David W.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 4HN, Scotland	University of Edinburgh; Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Dundee	Hupp, TR (corresponding author), Univ Edinburgh, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk	Lazo, Pedro A./M-6435-2014; 2008, Ibsal/A-1268-2012; RASOR, Scotland/A-3274-2011	Lazo, Pedro A./0000-0001-8997-3025; Fraser, Jennifer/0000-0001-5546-3916	Biotechnology and Biological Sciences Research Council; Radical Solutions for Researching the Proteome (RASOR); Interdisciplinary Research Collaboration in Proteomic Technologies; Lundbeck Foundation; University of Aarhus, Denmark; Cancer Research UK	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Radical Solutions for Researching the Proteome (RASOR); Interdisciplinary Research Collaboration in Proteomic Technologies; Lundbeck Foundation(Lundbeckfonden); University of Aarhus, Denmark; Cancer Research UK(Cancer Research UK)	Supported by the Biotechnology and Biological Sciences Research Council-Radical Solutions for Researching the Proteome ( RASOR) Interdisciplinary Research Collaboration in Proteomic Technologies. 2 Supported by grants from the Lundbeck Foundation, Edith Stern, and the Faculty of Health Science ( Program on Molecular Medicine), University of Aarhus, Denmark. 3 Supported by Cancer Research UK.	Ahn JW, 2003, J BIOL CHEM, V278, P20480, DOI 10.1074/jbc.M213185200; Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Boutell C, 2004, J VIROL, V78, P8068, DOI 10.1128/JVI.78.15.8068-8077.2004; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Campagna M, 2007, J GEN VIROL, V88, P2800, DOI 10.1099/vir.0.82922-0; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Hupp TR, 2007, NAT STRUCT MOL BIOL, V14, P885, DOI 10.1038/nsmb1007-885; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin PY, 2006, APOPTOSIS, V11, P2179, DOI 10.1007/s10495-006-0291-6; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Oster B, 2008, J GEN VIROL, V89, P87, DOI 10.1099/vir.0.83136-0; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Pedersen SM, 2006, VIROLOGY, V356, P1, DOI 10.1016/j.virol.2006.07.028; Polley S, 2008, J MOL BIOL, V376, P8, DOI 10.1016/j.jmb.2007.11.082; Quintavalle M, 2007, J BIOL CHEM, V282, P5536, DOI 10.1074/jbc.M610486200; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Shieh SY, 2000, GENE DEV, V14, P289; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029	31	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28563	28573		10.1074/jbc.M804433200	http://dx.doi.org/10.1074/jbc.M804433200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669630	hybrid, Green Published			2022-12-25	WOS:000259969300059
J	Del Favero, M; Mazzantini, E; Briani, F; Zangrossi, S; Tortora, P; Deho, G				Del Favero, Marta; Mazzantini, Elisa; Briani, Federica; Zangrossi, Sandro; Tortora, Paolo; Deho, Gianni			Regulation of Escherichia coli polynucleotide phosphorylase by ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; PHOSPHOROLYSIS REACTIONS; BACILLUS-SUBTILIS; LOW-TEMPERATURE; BINDING DOMAIN; ENERGY CHARGE; GENE; DEGRADOSOME; PROTEIN; EXPRESSION	Polynucleotide phosphorylase ( PNPase), an enzyme conserved in bacteria and eukaryotic organelles, processively catalyzes the phosphorolysis of RNA, releasing nucleotide diphosphates, and the reverse polymerization reaction. In Escherichia coli, both reactions are implicated in RNA decay, as addition of either poly( A) or heteropolymeric tails targets RNA to degradation. PNPase may also be associated with the RNA degradosome, a heteromultimeric protein machine that can degrade highly structured RNA. Here, we report that ATP binds to PNPase and allosterically inhibits both its phosphorolytic and polymerization activities. Our data suggest that PNPase-dependent RNA tailing and degradation occur mainly at low ATP concentrations, whereas other enzymes may play a more significant role at high energy charge. These findings connect RNA turnover with the energy charge of the cell and highlight unforeseen metabolic roles of PNPase.	[Briani, Federica; Deho, Gianni] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Del Favero, Marta; Mazzantini, Elisa; Tortora, Paolo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; [Zangrossi, Sandro] Ctr Studio Consiglio Nazl Ric Biol Cellulare & Mo, I-20133 Milan, Italy	University of Milan; University of Milano-Bicocca	Deho, G (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	gianni.deho@unimi.it	Briani, Federica/AAM-5213-2020; BRIANI, FEDERICA/B-4596-2017	Briani, Federica/0000-0002-5876-4463; BRIANI, FEDERICA/0000-0002-5876-4463; Tortora, Paolo/0000-0001-5234-601X; DEHO', GIOVANNI/0000-0001-5492-7766	Ministero dell'Universita e della Ricerca; Universita degli Studi di Milano [PRIN 2006]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Milano	This work was supported in part by joint grants from the Ministero dell'Universita e della Ricerca and the Universita degli Studi di Milano (PRIN 2006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bermudez-Cruz RM, 2005, BIOCHIMIE, V87, P737, DOI 10.1016/j.biochi.2005.03.005; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Danchin A, 1997, DNA Res, V4, P9, DOI 10.1093/dnares/4.1.9; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Fontanella L, 1999, ANAL BIOCHEM, V269, P353, DOI 10.1006/abio.1999.4042; GODEFROY T, 1970, EUR J BIOCHEM, V14, P222, DOI 10.1111/j.1432-1033.1970.tb00281.x; GODEFROY T, 1970, EUR J BIOCHEM, V12, P236, DOI 10.1111/j.1432-1033.1970.tb00843.x; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; GRUNBERGMANAGO M, 1967, BIOCHEM J, V103, pP62; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hurwitz J, 2005, J BIOL CHEM, V280, P42477, DOI 10.1074/jbc.X500006200; KIMHI Y, 1967, BIOCHEMISTRY-US, V6, P2066, DOI 10.1021/bi00859a025; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Mackie GA, 2001, METHOD ENZYMOL, V342, P346, DOI 10.1016/S0076-6879(01)42557-2; Matus-Ortega ME, 2007, BBA-GENE STRUCT EXPR, V1769, P194, DOI 10.1016/j.bbaexp.2007.01.008; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Ochoa S., 1959, NOBEL LECT; Piazza F, 1996, J BACTERIOL, V178, P5513, DOI 10.1128/jb.178.18.5513-5521.1996; PORTIER C, 1975, FEBS LETT, V50, P79, DOI 10.1016/0014-5793(75)81045-3; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; REGNIER P, 1987, J BIOL CHEM, V262, P63; Regonesi ME, 2006, BIOCHIMIE, V88, P151, DOI 10.1016/j.biochi.2005.07.012; Regonesi ME, 2004, NUCLEIC ACIDS RES, V32, P1006, DOI 10.1093/nar/gkh268; Rosenzweig JA, 2007, FEMS MICROBIOL LETT, V270, P255, DOI 10.1111/j.1574-6968.2007.00689.x; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Segel I.H., 1975, ENZYME KINETICS; SHEN LC, 1970, J BIOL CHEM, V245, P5974; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; THANG MN, 1967, J MOL BIOL, V26, P403, DOI 10.1016/0022-2836(67)90312-9; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27355	27359		10.1074/jbc.C800113200	http://dx.doi.org/10.1074/jbc.C800113200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650428	hybrid			2022-12-25	WOS:000259719200003
J	Nakai, Y; Nakai, M; Hayashi, H				Nakai, Yumi; Nakai, Masato; Hayashi, Hideyuki			Thio-modification of yeast cytosolic tRNA requires a ubiquitin-related system that resembles bacterial sulfur transfer systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN CONJUGATION; ELONGATOR COMPLEX; BIOSYNTHESIS; MITOCHONDRIAL; THIAMIN; LOCALIZATION; NFS1P; BIOGENESIS; ACTIVATION	The wobble uridine in yeast cytosolic tRN(UUU)(ALys2) and tRNA(UUC)(Glu3) undergoes a thio- modification at the second position (s(2) modification) and a methoxycarbonylmethyl modification at the fifth position (mcm(5) modification). We previously demonstrated that the cytosolic and mitochondrial iron- sulfur (Fe/S) cluster assembly machineries termed CIA and ISC, including a cysteine desulfurase called Nfs1, were essential for the s(2) modification. However, the cytosolic component that directly participates in this process remains unclear. Wefound that ubiquitinlike protein Urm1 and ubiquitin- activating enzyme- like protein Uba4, as well as Tuc1 and Tuc2, were strictly required for the s(2) modification. The carboxyl- terminal glycine residue of Urm1 was critical for the s(2) modification, indicating direct involvement of the unique ubiquitin- related system in this process. We also demonstrated that the s(2) and mcm(5) modifications in cytosolic tRNAs influence each other's efficiency. Taken together, our data indicate that the s(2) modification of cytosolic tRNAs is a more complex process that requires additional unidentified components.	[Nakai, Yumi; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan; [Nakai, Masato] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka Medical College; Osaka University	Nakai, Y (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigaku Cho, Takatsuki, Osaka 5698686, Japan.	med004@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [19570140]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant- in-aid for Scientific Research 19570140 from the Japan Society for the Promotion of Science (to Y.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BORK P, 1994, PROTEINS, V20, P347, DOI 10.1002/prot.340200407; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Dorrestein PC, 2004, CHEM BIOL, V11, P1373, DOI 10.1016/j.chembiol.2004.08.009; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, MOL BIOL CELL, V14, P1501, DOI 10.1091/mbc.E02-06-0348; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Singh S, 2005, PROTEIN SCI, V14, P2095, DOI 10.1110/ps.051577605; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Xi J, 2001, P NATL ACAD SCI USA, V98, P8513, DOI 10.1073/pnas.141226698; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	30	97	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27469	27476		10.1074/jbc.M804043200	http://dx.doi.org/10.1074/jbc.M804043200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664566	hybrid			2022-12-25	WOS:000259719200017
J	Chang, YM; Bai, L; Liu, S; Yang, JC; Kung, HJ; Evans, CP				Chang, Y-M; Bai, L.; Liu, S.; Yang, J. C.; Kung, H-J; Evans, C. P.			Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530	ONCOGENE			English	Article						Src; FAK; prostate cancer; AZD0530; proliferation; migration	FOCAL ADHESION KINASE; NONRECEPTOR TYROSINE KINASES; ANDROGEN-INDEPENDENT GROWTH; BETA-CATENIN; C-MYC; BREAST-CANCER; CYCLIN D1; NEUROENDOCRINE DIFFERENTIATION; SIGNAL-TRANSDUCTION; CARCINOMA-CELLS	Prostate cancer is the most frequently diagnosed cancer in American men. We have previously demonstrated that Src mediates androgen-independent proliferation in prostate cancer. We sought to investigate the Src-mediated oncogenic pathways and tumor biology using AZD0530, a novel Src family kinase/Abl dual-kinase inhibitor that is entering phase II clinical trials. We show that while both Src and Abl are expressed in all prostate cancer cell lines, Src but not Abl is activated in the prostate. Furthermore, Src activation is inhibited by AZD0530 in a rapid and dose-dependent manner. We show that Src mediates cell proliferation in DU145 and PC3 cells at the G1 phase of cell cycle. Src inhibition resulted in decreased binding of beta-catenin to the promoters of G1 phase cell cycle regulators cyclin D1 and c-Myc. C-Myc may also be regulated at the protein level by extracellular signal-regulated kinase 1/2 and GSK3 beta. Cell motility factors focal adhesion kinase, p130CAS and paxillin activation in DU145 and PC3 cells were also inhibited. Administration of AZD0530 in mice reduced orthotopic DU145 xenograft growth by 45%. We have further delineated the Src-mediated oncogenic growth and migration pathways in prostate cancer and established mechanistic rationale for Src inhibition as novel therapy in the treatment of prostate cancer.	[Evans, C. P.] Univ Calif Davis, Med Ctr, Dept Urol, Sacramento, CA 95817 USA; [Liu, S.; Kung, H-J] Univ Calif Davis, Dept Biol Chem & Mol Med, Sacramento, CA 95817 USA; [Kung, H-J; Evans, C. P.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Evans, CP (corresponding author), Univ Calif Davis, Med Ctr, Dept Urol, 4860 Y St Suite 3500, Sacramento, CA 95817 USA.	kung@ucdavis.edu; cpevans@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013		National Institutes of Health [KO8 DK60748-01, RO1 DK52659]; Department of Defense [PC040161]; NATIONAL CANCER INSTITUTE [R01CA114575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078243, K08DK060748, R01DK052659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grant KO8 DK60748-01 (CPE), RO1 DK52659 (H-JK) and Department of Defense Grant PC040161 (CPE). The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the Department of Defense.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; BJELFMAN C, 1990, MOL CELL BIOL, V10, P361, DOI 10.1128/MCB.10.1.361; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cronauer MV, 2005, INT J ONCOL, V26, P1033; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daaka Y, 2002, BBA-MOL CELL BIOL L, V1582, P265, DOI 10.1016/S1388-1981(02)00180-4; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Devi GR, 2002, PROSTATE, V53, P200, DOI 10.1002/pros.10151; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dominguez-Sola D, 2004, NAT CELL BIOL, V6, P288, DOI 10.1038/ncb0404-288; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; EVANS CP, 1991, INT J CANCER, V49, P109, DOI 10.1002/ijc.2910490120; Farkas A, 2005, J NEUROSCI RES, V80, P855, DOI 10.1002/jnr.20521; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gao LF, 2005, CLIN CANCER RES, V11, P6333, DOI 10.1158/1078-0432.CCR-05-0148; Golas JM, 2003, CANCER RES, V63, P375; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Lee D, 2006, CLIN LUNG CANCER, V7, P381, DOI 10.3816/CLC.2006.n.020; Lee LF, 2004, ONCOGENE, V23, P2197, DOI 10.1038/sj.onc.1207344; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Li GP, 2003, CELL BIOCHEM BIOPHYS, V39, P45, DOI 10.1385/CBB:39:1:45; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rovin JD, 2002, PROSTATE, V53, P124, DOI 10.1002/pros.10114; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Steiner MS, 1998, HUM GENE THER, V9, P747, DOI 10.1089/hum.1998.9.5-747; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Taj MM, 2001, PROSTATE, V47, P194, DOI 10.1002/pros.1063; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Vinall RL, 2006, ONCOGENE, V25, P2082, DOI 10.1038/sj.onc.1209246; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	64	128	132	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	49					6365	6375		10.1038/onc.2008.250	http://dx.doi.org/10.1038/onc.2008.250			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18679417	Green Accepted			2022-12-25	WOS:000260263400006
J	Kao, LY; Sassani, P; Azimov, R; Pushkin, A; Abuladze, N; Peti-Peterdi, J; Liu, WX; Newman, D; Kurtz, I				Kao, Liyo; Sassani, Pakan; Azimov, Rustam; Pushkin, Alexander; Abuladze, Natalia; Peti-Peterdi, Janos; Liu, Weixin; Newman, Debra; Kurtz, Ira			Oligomeric structure and minimal functional unit of the electrogenic sodium bicarbonate cotransporter NBCe1-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; DISULFIDE BOND FORMATION; ERYTHROCYTE ANION-EXCHANGER; CYSTEINE RESIDUES; BAND-3 PROTEIN; AUTOSOMAL-DOMINANT; SLC4A11 MUTATIONS; TRANSPORT PROTEIN; LACTOSE PERMEASE; SELF-ASSOCIATION	The electrogenic sodium bicarbonate cotransporter NBCe1-A mediates the basolateral absorption of sodium and bicarbonate in the proximal tubule. In this study the oligomeric state and minimal functional unit of NBCe1-A were investigated. Wildtype (wt) NBCe1-A isolated from mouse kidney or heterologously expressed in HEK293 cells was predominantly in a dimeric state as was shown using fluorescence energy transfer, pulldown, immunoprecipitation, cross-linking experiments, and nondenaturing perfluorooctanoate-PAGE. NBCe1-A monomers were found to be covalently linked by S-S bonds. When each of the 15 native cysteine residues were individually removed on a wt-NBCe1-A backbone, dimerization of the cotransporter was not affected. In experiments involving multiple native cysteine residue removal, both Cys(630) and Cys(642) in extracellular loop 3 were shown to mediate S-S bond formation between NBCe1-A monomers. When native NBCe1-A cysteine residues were individually reintroduced into a cysteineless NBCe1-A mutant backbone, the finding that a Cys(992) construct that lacked S-S bonds functioned normally indicated that stable covalent linkage of NBCe1-A monomers was not a necessary requirement for functional activity of the cotransporter. Studies using concatameric constructs of wt-NBCe1-A, whose activity is resistant to methanesulfonate reagents, and an NBCe1-A(T442C) mutant, whose activity is completely inhibited by methanesulfonate reagents, confirmed that NBCe1-A monomers are functional. Our results demonstrate that wt-NBCe1-A is predominantly a homodimer, dependent on S-S bond formation that is composed of functionally active monomers.	[Kao, Liyo; Sassani, Pakan; Azimov, Rustam; Pushkin, Alexander; Abuladze, Natalia; Liu, Weixin; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Peti-Peterdi, Janos] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol, Los Angeles, CA 90033 USA; [Peti-Peterdi, Janos] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biophys & Med, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California	Kurtz, I (corresponding author), Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, 10833 Le Conte Ave,Rm 7-155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563, DK063125, ES12935, DK64324, DK74754]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162, R01DK063125, R01DK074754, R01DK064324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162, DK058563, DK063125, ES12935, DK64324, and DK74754. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Azimov R, 2007, FASEB J, V21, pA1283; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Bossi E, 2007, AM J PHYSIOL-CELL PH, V292, pC1379, DOI 10.1152/ajpcell.00473.2006; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; CASEY JR, 1989, METHOD ENZYMOL, V173, P494; CASEY JR, 1991, J BIOL CHEM, V266, P15726; CASEY JR, 1995, J BIOL CHEM, V270, P8521, DOI 10.1074/jbc.270.15.8521; Chang MH, 2007, FASEB J, V21, pA1282; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; CLARKE S, 1975, J BIOL CHEM, V250, P5459; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; DOLDER M, 1993, J MOL BIOL, V231, P119, DOI 10.1006/jmbi.1993.1261; DONCKERWOLCKE RA, 1970, ARCH DIS CHILD, V45, P769, DOI 10.1136/adc.45.244.769; Ducoudret O, 2001, PFLUG ARCH EUR J PHY, V442, P709, DOI 10.1007/s004240100594; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; EMERICK MC, 1993, J BIOL CHEM, V268, P23455; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Gill HS, 2006, ACTA CRYSTALLOGR F, V62, P534, DOI 10.1107/S1744309106015181; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; IGARASHI T, 1994, PEDIATR NEPHROL, V8, P70, DOI 10.1007/BF00868266; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Jha BK, 2002, EUR J BIOCHEM, V269, P298, DOI 10.1046/j.0014-2956.2001.02654.x; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kittanakom S, 2004, J BIOL CHEM, V279, P40960, DOI 10.1074/jbc.M405356200; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; Kohler K, 2003, PFLUG ARCH EUR J PHY, V446, P203, DOI 10.1007/s00424-003-1039-6; KURTZ I, 1994, J CLIN INVEST, V94, P173, DOI 10.1172/JCI117304; Lambert G, 2000, J MEMBRANE BIOL, V176, P133, DOI 10.1007/s002320001082; Lambert G, 2001, J GEN PHYSIOL, V117, P533, DOI 10.1085/jgp.117.6.533; Lemann J, 2000, KIDNEY INT, V58, P1267, DOI 10.1046/j.1523-1755.2000.00282.x; LINDENTHAL S, 1991, P NATL ACAD SCI USA, V88, P6540, DOI 10.1073/pnas.88.15.6540; Makagiansar IT, 2002, J BIOL CHEM, V277, P16002, DOI 10.1074/jbc.M200916200; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mottamal M, 2006, PROTEINS, V62, P996, DOI 10.1002/prot.20844; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; PAPPERT G, 1983, BIOCHIM BIOPHYS ACTA, V730, P32, DOI 10.1016/0005-2736(83)90313-9; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Pushkin Alexander, 2001, Journal of the American Society of Nephrology, V12, p8A; Pushkin AV, 2000, IUBMB LIFE, V50, P397, DOI 10.1080/713803739; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rettig MP, 2001, BBA-BIOMEMBRANES, V1515, P72, DOI 10.1016/S0005-2736(01)00397-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; SAHINTOTH M, 1994, PROTEIN SCI, V3, P2302, DOI 10.1002/pro.5560031215; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Sander T, 2002, EPILEPSY RES, V51, P249, DOI 10.1016/S0920-1211(02)00152-3; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; SCHUBERT D, 1988, MOL ASPECTS MED, V10, P233, DOI 10.1016/0098-2997(88)90009-X; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Tanaka K, 2004, BIOCHEM J, V380, P283, DOI 10.1042/BJ20031724; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Vince JW, 1997, BBA-BIOMEMBRANES, V1326, P295, DOI 10.1016/S0005-2736(97)00033-3; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; WANG DN, 1993, EMBO J, V12, P2233, DOI 10.1002/j.1460-2075.1993.tb05876.x; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; WINSNES A, 1979, ACTA PAEDIATR SCAND, V68, P861; Wittrup K. Dane, 1995, Current Opinion in Biotechnology, V6, P203, DOI 10.1016/0958-1669(95)80033-6; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200	80	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26782	26794		10.1074/jbc.M804006200	http://dx.doi.org/10.1074/jbc.M804006200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658147	hybrid, Green Published			2022-12-25	WOS:000259341600050
J	Nielsen, BS; Egeblad, M; Rank, F; Askautrud, HA; Pennington, CJ; Pedersen, TX; Christensen, IJ; Edwards, DR; Werb, Z; Lund, LR				Nielsen, Boye S.; Egeblad, Mikala; Rank, Fritz; Askautrud, Hanne A.; Pennington, Caroline J.; Pedersen, Tanja X.; Christensen, Ib J.; Edwards, Dylan R.; Werb, Zena; Lund, Leif R.			Matrix Metalloproteinase 13 Is Induced in Fibroblasts in Polyomavirus Middle T Antigen-Driven Mammary Carcinoma without Influencing Tumor Progression	PLOS ONE			English	Article							HUMAN BREAST CARCINOMAS; STROMAL CELLS; COLLAGENASE-3 EXPRESSION; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; GELATINASE-A; CANCER; GROWTH; MODEL; PROTEASES	Matrix metalloproteinase (MMP) 13 (collagenase 3) is an extracellular matrix remodeling enzyme that is induced in myofibroblasts during the earliest invasive stages of human breast carcinoma, suggesting that it is involved in tumor progression. During progression of mammary carcinomas in the polyoma virus middle T oncogene mouse model (MMTV-PyMT), Mmp13 mRNA was strongly upregulated concurrently with the transition to invasive and metastatic carcinomas. As in human tumors, Mmp13 mRNA was found in myofibroblasts of invasive grade II and III carcinomas, but not in benign grade I and II mammary intraepithelial neoplasias. To determine if MMP13 plays a role in tumor progression, we crossed MMTV-PyMT mice with Mmp13 deficient mice. The absence of MMP13 did not influence tumor growth, vascularization, progression to more advanced tumor stages, or metastasis to the lungs, and the absence of MMP13 was not compensated for by expression of other MMPs or tissue inhibitor of metalloproteinases. However, an increased fraction of thin collagen fibrils was identified in MMTV-PyMT; Mmp13(-/-) compared to MMTV-PyMT; Mmp13(+/+) tumors, showing that collagen metabolism was altered in the absence of MMP13. We conclude that the expression pattern of Mmp13 mRNA in myofibroblasts of invasive carcinomas in the MMTV-PyMT breast cancer model recapitulates the expression pattern observed in human breast cancer. Our results suggest that MMP13 is a marker of carcinoma-associated myofibroblasts of invasive carcinoma, even though it does not make a major contribution to tumor progression in the MMTV-PyMT breast cancer model.	[Nielsen, Boye S.; Pedersen, Tanja X.; Christensen, Ib J.; Lund, Leif R.] Rigshospitalet, Finsen Lab, Copenhagen, Denmark; [Egeblad, Mikala; Askautrud, Hanne A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Rank, Fritz] Rigshospitalet, Dept Pathol, Copenhagen, Denmark; [Pennington, Caroline J.; Edwards, Dylan R.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Askautrud, Hanne A.] Ullevaal Univ Hosp, Dept Med Genet, Oslo, Norway; [Askautrud, Hanne A.] Univ Oslo, Fac Med, Oslo, Norway	Rigshospitalet; University of California System; University of California San Francisco; Rigshospitalet; University of East Anglia; University of Oslo; University of Oslo	Nielsen, BS (corresponding author), Exiqon AS, Diagnost Prod Dev, Vedbaek, Denmark.	lund@inet.uni2.dk	Egeblad, Mikala/GNP-0620-2022; Edwards, Dylan R/B-4734-2009	Edwards, Dylan R/0000-0002-3292-2064; Askautrud, Hanne/0000-0002-4404-3622; Egeblad, Mikala/0000-0002-3371-1445; Pedersen, Tanja Xenia/0000-0003-2515-3022	Danish Cancer Society; Meyer Foundation; Danish Medical Research Council; European Commission [LSHC-CT-2003-503297, FP7]; National Cancer Institute [CA057621, CA072006]; Medical Research Council [G0100250] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA057621] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the Danish Cancer Society, the Meyer Foundation, the Danish Medical Research Council (ME), the European Commission: grant number LSHC-CT-2003-503297 (Cancerdegradome) and FP7 grant (Microenvimet), and by the National Cancer Institute (USA) grants CA057621 and CA072006 (ZW). None of these supporting institutions played any role during the study and manuscript preparation.	Almholt K, 2007, J MAMMARY GLAND BIOL, V12, P83, DOI 10.1007/s10911-007-9040-x; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FERGUSON JE, 1992, CELL TISSUE RES, V268, P167, DOI 10.1007/BF00338066; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Green KA, 2006, DEV BIOL, V299, P164, DOI 10.1016/j.ydbio.2006.07.021; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hart R, 2006, J MINIM INVAS GYN, V13, P126, DOI 10.1016/j.jmig.2005.11.015; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Koong AC, 2000, CANCER RES, V60, P883; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LOCHTER A, 1995, SEMIN CANCER BIOL, V6, P165, DOI 10.1006/scbi.1995.0017; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Maglione JE, 2001, CANCER RES, V61, P8298; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Nielsen BS, 2001, CANCER RES, V61, P7091; Nielsen BS, 2001, LAB INVEST, V81, P1485, DOI 10.1038/labinvest.3780363; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Offersen BV, 2003, AM J PATHOL, V163, P1887, DOI 10.1016/S0002-9440(10)63547-X; Olumi AF, 1999, CANCER RES, V59, P5002; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Papakonstantinou E, 2003, CYTOKINE, V24, P25, DOI 10.1016/S1043-4666(03)00253-9; Pedersen TX, 2005, CARCINOGENESIS, V26, P1233, DOI 10.1093/carcin/bgi065; Pedersen TX, 2003, ONCOGENE, V22, P3964, DOI 10.1038/sj.onc.1206614; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; SZABOVA L, 2007, ONCOGENE; Uria JA, 1997, CANCER RES, V57, P4882; Vajner L, 2006, INT J EXP PATHOL, V87, P383, DOI 10.1111/j.1365-2613.2006.00493.x; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	55	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2959	10.1371/journal.pone.0002959	http://dx.doi.org/10.1371/journal.pone.0002959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698413	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000264412600044
J	Zhuo, Y; Chammas, R; Bellis, SL				Zhuo, Ya; Chammas, Roger; Bellis, Susan L.			Sialylation of beta 1 Integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; MYELOID FIBRONECTIN RECEPTORS; BINDING-PROTEINS; N-GLYCOSYLATION; CARCINOMA CELLS; CARCINOEMBRYONIC ANTIGEN; PROSTATE-CANCER; RAT-LIVER; EXPRESSION; DEATH	In previous studies, we determined that beta 1 integrins from human colon tumors have elevated levels of alpha 2-6 sialylation, a modification added by beta-galactosamide alpha-2,6-sialyltranferase I (ST6Gal-I). Intriguingly, the beta 1 integrin is thought to be a ligand for galectin-3 (gal-3), a tumor-associated lectin. The effects of gal-3 are complex; intracellular forms typically protect cells against apoptosis through carbohydrate-independent mechanisms, whereas secreted forms bind to cell surface oligosaccharides and induce apoptosis. In the current study, we tested whether alpha 2-6 sialylation of the beta 1 integrin modulates binding to extracellular gal-3. Herein we report that SW48 colonocytes lacking alpha 2-6 sialylation exhibit beta 1 integrin-dependent binding to gal-3-coated tissue culture plates; however, binding is attenuated upon forced expression of ST6Gal-I. Removal of alpha 2-6 sialic acids from ST6Gal-I expressors by neuraminidase treatment restores gal-3 binding. Additionally, using a blot overlay approach, we determined that gal-3 binds directly and preferentially to unsialylated, as compared with alpha 2-6-sialylated, beta 1 integrins. To understand the physiologic consequences of gal-3 binding, cells were treated with gal-3 and monitored for apoptosis. Galectin-3 was found to induce apoptosis in parental SW48 colonocytes ( unsialylated), whereas ST6Gal-I expressors were protected. Importantly, gal-3-induced apoptosis was inhibited by function blocking antibodies against the beta 1 subunit, suggesting that beta 1 integrins are critical transducers of gal-3-mediated effects on cell survival. Collectively, our results suggest that the coordinate up-regulation of gal-3 and ST6Gal-I, a feature that is characteristic of colon carcinoma, may confer tumor cells with a selective advantage by providing a mechanism for blockade of the pro-apoptotic effects of secreted gal-3.	[Zhuo, Ya; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Chammas, Roger] Univ Sao Paulo, Fac Med, BR-01246903 Sao Paulo, Brazil	University of Alabama System; University of Alabama Birmingham; Universidade de Sao Paulo	Bellis, SL (corresponding author), 982A MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@physiology.uab.edu	Chammas, Roger/A-8004-2011	Chammas, Roger/0000-0003-0342-8726	NCI NIH HHS [R01CA84248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akahani S, 1997, CANCER RES, V57, P5272; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Andre S, 2007, FEBS J, V274, P3233, DOI 10.1111/j.1742-4658.2007.05851.x; Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; BRESALIER RS, 1990, CANCER RES, V50, P1299; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Chammas R, 1996, MOL BIOL CELL, V7, P1691, DOI 10.1091/mbc.7.11.1691; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DALLOLIO F, 1995, BIOCHEM BIOPH RES CO, V211, P554, DOI 10.1006/bbrc.1995.1849; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Fukumori T, 2003, CANCER RES, V63, P8302; Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336; Gorelik E, 2001, CANCER METAST REV, V20, P245, DOI 10.1023/A:1015535427597; Hakomori S, 1996, CANCER RES, V56, P5309; HAY R, 1994, ATCC CELL LINES HYBR; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Holikova Z, 2002, APMIS, V110, P845, DOI 10.1034/j.1600-0463.2002.1101202.x; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Kannicht C, 1999, GLYCOBIOLOGY, V9, P897, DOI 10.1093/glycob/9.9.897; Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; LEMARER N, 1995, GLYCOBIOLOGY, V5, P219, DOI 10.1093/glycob/5.2.219; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OHANNESIAN DW, 1995, CANCER RES, V55, P2191; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Suzuki O, 2006, INT J ONCOL, V28, P155; Suzuki O, 2008, ONCOL REP, V19, P743; Suzuki Y, 2008, BBA-MOL CELL RES, V1783, P924, DOI 10.1016/j.bbamcr.2008.01.025; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	57	118	121	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22177	22185		10.1074/jbc.M8000015200	http://dx.doi.org/10.1074/jbc.M8000015200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18676377	Green Published, Bronze			2022-12-25	WOS:000258114700037
J	Kong, A; Calleja, V; Leboucher, P; Harris, A; Parker, PJ; Larijani, B				Kong, Anthony; Calleja, Veronique; Leboucher, Pierre; Harris, Adrian; Parker, Peter J.; Larijani, Banafshe			HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells	PLOS ONE			English	Article								Background: The response rate to EGFR tyrosine kinase inhibitors (TKIs) may be poor and unpredictable in cancer patients with EGFR expression itself being an inadequate response indicator. There is limited understanding of the mechanisms underlying this resistance. Furthermore, although TKIs suppress the growth of HER2-overexpressing breast tumor cells, they do not fully inhibit HER2 oncogenic function at physiological doses. Methodology and Principal Findings: Here we have provided a molecular mechanism of how HER2 oncogenic function escapes TKIs' inhibition via alternative HER receptor activation as a result of autocrine ligand release. Using both Forster Resonance Energy Transfer (FRET) which monitors in situ HER receptor phosphorylation as well as classical biochemical analysis, we have shown that the specific tyrosine kinase inhibitors (TKIs) of EGFR, AG1478 and Iressa (Gefitinib) decreased EGFR and HER3 phosphorylation through the inhibition of EGFR/HER3 dimerization. Consequent to this, we demonstrate that cleavage of HER4 and dimerization of HER4/HER2 occur together with reactivation of HER3 via HER2/HER3, leading to persistent HER2 phosphorylation in the now resistant, surviving cells. These drug treatment-induced processes were found to be mediated by the release of ligands including heregulin and betacellulin that activate HER3 and HER4 via HER2. Whereas an anti-betacellulin antibody in combination with Iressa increased the anti-proliferative effect in resistant cells, ligands such as heregulin and betacellulin rendered sensitive SKBR3 cells resistant to Iressa. Conclusions and Significance: These results demonstrate the role of drug-induced autocrine events leading to the activation of alternative HER receptors in maintaining HER2 phosphorylation and in mediating resistance to EGFR tyrosine kinase inhibitors (TKIs) in breast cancer cells, and hence specify treatment opportunities to overcome resistance in patients.	[Kong, Anthony; Calleja, Veronique; Larijani, Banafshe] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England; [Kong, Anthony; Parker, Peter J.] Canc Res UK, London Res Inst, Lincolns Inn Fields lab, Protein Phosphorylat Lab, London, England; [Harris, Adrian] Univ Oxford, John Radcliffe Hosp, Canc Res UK, Weatherall Inst Mol Med IMM, Oxford, England; [Leboucher, Pierre] Coll France, Lab Physiol Percept Action, Paris, France; [Parker, Peter J.] Guys Hosp, Kings Coll, Scho Med, Div Canc Studies, London, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; University of Oxford; UDICE-French Research Universities; PSL Research University Paris; College de France; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kong, A (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015; Parker, Peter j/D-5192-2013; Harris, Adrian L/ABA-3343-2020	Larijani, Banafshe/0000-0003-4735-1169; Harris, Adrian L/0000-0003-1376-8409; parker, peter/0000-0002-6218-2933; Kong, Anthony/0000-0002-3989-3948	Cancer Research UK Pilot Project	Cancer Research UK Pilot Project	The work was partially funded by a Cancer Research UK Pilot Project grant awarded to AK.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Anido J, 2003, CLIN CANCER RES, V9, P1274; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Baselga J, 2002, ANN ONCOL, V13, P8, DOI 10.1093/annonc/mdf092; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Britten CD, 2004, MOL CANCER THER, V3, P1335; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kong A, 2006, CANCER RES, V66, P2834, DOI 10.1158/0008-5472.CAN-05-2994; Larijani B, 2003, CURR BIOL, V13, P78, DOI 10.1016/S0960-9822(02)01395-7; Loeffler-Ragy J, 2006, EUR J CANCER, V42, P109, DOI 10.1016/j.ejca.2005.08.034; Menendez JA, 2006, J CLIN ONCOL, V24, P3735, DOI 10.1200/JCO.2005.04.3489; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Moasser MM, 2001, CANCER RES, V61, P7184; Moulder SL, 2001, CANCER RES, V61, P8887; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICHOLSON S, 1989, LANCET, V1, P182; Normanno N, 2002, ANN ONCOL, V13, P65, DOI 10.1093/annonc/mdf020; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Polychronis A, 2005, LANCET ONCOL, V6, P383, DOI 10.1016/S1470-2045(05)70176-5; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Strunk KE, 2007, CANCER RES, V67, P6582, DOI 10.1158/0008-5472.CAN-06-4145; Tan M, 1999, CANCER RES, V59, P1620; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Xu FJ, 1997, CLIN CANCER RES, V3, P1629; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	46	58	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2881	10.1371/journal.pone.0002881	http://dx.doi.org/10.1371/journal.pone.0002881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682844	Green Submitted, gold, Green Published			2022-12-25	WOS:000264366600037
J	Hosu, BG; Mullen, SF; Critser, JK; Forgacs, G				Hosu, Basarab G.; Mullen, Steven F.; Critser, John K.; Forgacs, Gabor			Reversible Disassembly of the Actin Cytoskeleton Improves the Survival Rate and Developmental Competence of Cryopreserved Mouse Oocytes	PLOS ONE			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; MAGNETIC TWEEZERS; PLASMA-MEMBRANE; LIVING CELLS; FERTILIZATION; VITRIFICATION; EMBRYOS; LATRUNCULINS; MICROTUBULES; MATURATION	Effective cryopreservation of oocytes is critically needed in many areas of human reproductive medicine and basic science, such as stem cell research. Currently, oocyte cryopreservation has a low success rate. The goal of this study was to understand the mechanisms associated with oocyte cryopreservation through biophysical means using a mouse model. Specifically, we experimentally investigated the biomechanical properties of the ooplasm prior and after cryopreservation as well as the consequences of reversible dismantling of the F-actin network in mouse oocytes prior to freezing. The study was complemented with the evaluation of post-thaw developmental competence of oocytes after in vitro fertilization. Our results show that the freezing-thawing process markedly alters the physiological viscoelastic properties of the actin cytoskeleton. The reversible depolymerization of the F-actin network prior to freezing preserves normal ooplasm viscoelastic properties, results in high post-thaw survival and significantly improves developmental competence. These findings provide new information on the biophysical characteristics of mammalian oocytes, identify a pathophysiological mechanism underlying cryodamage and suggest a novel cryopreservation method.	[Hosu, Basarab G.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; [Mullen, Steven F.] 21st Century Med, Fontana, CA USA; [Forgacs, Gabor] Univ Missouri, Dept Biol Sci, Columbia, MO USA; [Critser, John K.; Forgacs, Gabor] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Forgacs, Gabor] Univ Missouri, Dept Phys, Columbia, MO USA	Harvard University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Mullen, SF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA.	sfm5ff@mizzou.edu			NSF [IBN0083653]; NASA [NAG2-1211]; NIH [RR014821]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR014821] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was partially supported by grants NSF-IBN0083653, NASA-NAG2-1211 (to G.F.) and NIH-RR014821 (to J.K.C.). The granting agencies had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini D, 2004, ESSENTIAL IVF: BASIC RESEARCH AND CLINICAL APPLICATIONS, P43; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Bernard A, 1996, HUM REPROD UPDATE, V2, P193, DOI 10.1093/humupd/2.3.193; BIGGERS J, 1972, OOGENESIS; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Cobo A, 2001, FERTIL STERIL, V75, P354, DOI 10.1016/S0015-0282(00)01725-8; CRICK FHC, 1950, EXP CELL RES, V1, P37, DOI 10.1016/0014-4827(50)90048-6; de Vries AHB, 2005, BIOPHYS J, V88, P2137, DOI 10.1529/biophysj.104.052035; Dobrinsky JR, 2000, BIOL REPROD, V62, P564, DOI 10.1095/biolreprod62.3.564; Ebner T, 2003, HUM REPROD, V18, P1294, DOI 10.1093/humrep/deg232; Eroglu A, 1998, FERTIL STERIL, V69, P944, DOI 10.1016/S0015-0282(98)00030-2; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Feneberg W, 2001, EUR BIOPHYS J BIOPHY, V30, P284, DOI 10.1007/s002490100135; FUKU E, 1995, MOL REPROD DEV, V40, P177, DOI 10.1002/mrd.1080400206; Fung Y. C., 1993; GALLICANO GI, 1994, MECH DEVELOP, V45, P211; GORBSKY GJ, 1990, P NATL ACAD SCI USA, V87, P6049, DOI 10.1073/pnas.87.16.6049; GRUDZINSKAS JG, 1995, GAMETES OOCYTE, pR13; Guilak F, 2002, BIOPHYS J, V82, P720, DOI 10.1016/S0006-3495(02)75434-9; HIRAMOTO Y, 1969, EXP CELL RES, V56, P201, DOI 10.1016/0014-4827(69)90003-2; Hosu BG, 2003, REV SCI INSTRUM, V74, P4158, DOI 10.1063/1.1599066; Hotamisligil S, 1996, BIOL REPROD, V55, P161, DOI 10.1095/biolreprod55.1.161; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Karlsson JOM, 1996, HUM REPROD, V11, P1296; KAROW AM, 1997, REPROD TISSUE BANKIN, pR18; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lenormand G, 2004, J R SOC INTERFACE, V1, P91, DOI 10.1098/rsif.2004.0010; Mandelbaum J, 1998, HUM REPROD, V13, P161, DOI 10.1093/humrep/13.suppl_3.161; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Miyake K, 2001, J CELL SCI, V114, P3487; Moller W, 2000, BIOPHYS J, V79, P720, DOI 10.1016/S0006-3495(00)76330-2; Nagy ZP, 2003, FERTIL STERIL, V80, P67, DOI 10.1016/S0015-0282(03)00569-7; Park SE, 2001, FERTIL STERIL, V75, P1177, DOI 10.1016/S0015-0282(01)01809-X; PICKERING SJ, 1991, HUM REPROD, V6, P142, DOI 10.1093/oxfordjournals.humrep.a137248; PICKERING SJ, 1990, FERTIL STERIL, V54, P102; POLLARD TD, 1984, J CELL BIOL, V99, pS33, DOI 10.1083/jcb.99.1.33s; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Saunders KM, 1999, BIOL REPROD, V61, P178, DOI 10.1095/biolreprod61.1.178; SCHATTEN G, 1986, EXP CELL RES, V166, P191, DOI 10.1016/0014-4827(86)90519-7; SCHROEDER AC, 1990, J REPROD FERTIL, V89, P43, DOI 10.1530/jrf.0.0890043; Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102; SIMERLY C, 1995, GAMETES OOCYTE, P54; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Togo T, 1999, J CELL SCI, V112, P719; VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130; VANBLERKOM J, 1989, HUM REPROD, V4, P883, DOI 10.1093/oxfordjournals.humrep.a137006; VINCENT C, 1989, J REPROD FERTIL, V87, P809, DOI 10.1530/jrf.0.0870809; VINCENT C, 1990, MOL REPROD DEV, V26, P227, DOI 10.1002/mrd.1080260306; VINCENT C, 1991, MOL REPROD DEV, V28, P394, DOI 10.1002/mrd.1080280412; Vincent C, 1992, Oxf Rev Reprod Biol, V14, P73; Wilmut I, 1998, REPROD FERT DEVELOP, V10, P639, DOI 10.1071/RD98047; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002	59	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2787	10.1371/journal.pone.0002787	http://dx.doi.org/10.1371/journal.pone.0002787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665248	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300006
J	Kohler, B; Anguissola, S; Concannon, CG; Rehm, M; Kogel, D; Prehn, JHM				Koehler, Barbara; Anguissola, Sergio; Concannon, Caoimhin G.; Rehm, Markus; Koegel, Donat; Prehn, Jochen H. M.			Bid Participates in Genotoxic Drug-Induced Apoptosis of HeLa Cells and Is Essential for Death Receptor Ligands' Apoptotic and Synergistic Effects	PLOS ONE			English	Article								Background: The BH3-only protein Bid is an important component of death receptor-mediated caspase activation. Bid is cleaved by caspase-8 or -10 into t-Bid, which translocates to mitochondria and triggers the release of caspase-activating factors. Bid has also been reported to be cleaved by other proteases. Methodology/Principal Findings: To test the hypothesis that Bid is a central mediator of stress-induced apoptosis, we investigated the effects of a small molecule Bid inhibitor on stress-induced apoptosis, and generated HeLa cells deficient for Bid. Stable knockdown of bid lead to a pronounced resistance to Fas/CD95- and TRAIL-induced caspase activation and apoptosis, and significantly increased clonogenic survival. While Bid-deficient cells were equally sensitive to ER stress-induced apoptosis, they showed moderate, but significantly reduced levels of apoptosis, as well as increased clonogenic survival in response to the genotoxic drugs Etoposide, Oxaliplatin, and Doxorubicin. Similar effects were observed using the Bid inhibitor BI6C9. Interestingly, Bid-deficient cells were dramatically protected from apoptosis when subtoxic concentrations of ER stressors, Etoposide or Oxaliplatin were combined with subtoxic TRAIL concentrations. Conclusions/Significance: Our data demonstrate that Bid is central for death receptor-induced cell death and participates in anti-cancer drug-induced apoptosis in human cervical cancer HeLa cells. They also show that the synergistic effects of TRAIL in combination with either ER stressors or genotoxic anti-cancer drugs are nearly exclusively mediated via an increased activation of Bid-induced apoptosis signalling.	[Koehler, Barbara; Anguissola, Sergio; Concannon, Caoimhin G.; Rehm, Markus; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Anguissola, Sergio; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, RCSI Ctr Human Proteom, Dublin, Ireland; [Koehler, Barbara; Koegel, Donat] Johann Wolfgang Goethe Univ Clin, Ctr Neurol & Neurosurg, Frankfurt, Germany	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kohler, B (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	prehn@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Concannon, Caoimhin/B-2075-2010; Rehm, Markus/C-3398-2012	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Kogel, Donat/0000-0003-1209-0210	Science Foundation Ireland [03/RP1/B344]; Higher Education Authority; Health Research Board [RP/2005/206]; Deutsche Forschungsgemeinschaft [PR 338/9-3, PR 338/9-4]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Higher Education Authority; Health Research Board; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from Science Foundation Ireland (03/RP1/B344), the Higher Education Authority (PRTLI Cycle 3, Program of Human Genomics) and Health Research Board (RP/2005/206) to J.H.M.P., and by a grant from the Deutsche Forschungsgemeinschaft (PR 338/9-3 and 9-4) to D.K. and J.H.M.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Becattini B, 2006, P NATL ACAD SCI USA, V103, P12602, DOI 10.1073/pnas.0603460103; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gibson SB, 2000, MOL CELL BIOL, V20, P205, DOI 10.1128/MCB.20.1.205-212.2000; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Gross A, 2006, CELL CYCLE, V5, P582, DOI 10.4161/cc.5.6.2575; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hetschko H, 2008, J NEURO-ONCOL, V86, P265, DOI 10.1007/s11060-007-9472-6; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Miao J, 2004, INT J ONCOL, V25, P651; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Nagane M, 2000, CANCER RES, V60, P847; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Oberkovitz G, 2007, CELL DEATH DIFFER, V14, P1628, DOI 10.1038/sj.cdd.4402181; Onuki R, 2002, P NATL ACAD SCI USA, V99, P14716, DOI 10.1073/pnas.232177599; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheikh MS, 1998, CANCER RES, V58, P1593; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; Singh R, 2002, J BIOL CHEM, V277, P37630, DOI 10.1074/jbc.M203648200; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang XY, 2006, BIOCHEM PHARMACOL, V71, P1540, DOI 10.1016/j.bcp.2006.02.011; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wlodkowic D, 2007, LEUKEMIA RES, V31, P1687, DOI 10.1016/j.leukres.2007.03.008; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	81	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2844	10.1371/journal.pone.0002844	http://dx.doi.org/10.1371/journal.pone.0002844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665234	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300063
J	Mereghetti, L; Sitkiewicz, I; Green, NM; Musser, JM				Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.			Remodeling of the Streptococcus agalactiae Transcriptome in Response to Growth Temperature	PLOS ONE			English	Article								Background: To act as a commensal bacterium and a pathogen in humans and animals, Streptococcus agalactiae (group B streptococcus, GBS) must be able to monitor and adapt to different environmental conditions. Temperature variation is a one of the most commonly encountered variables. Methodology/Principal Findings: To understand the extent to which GBS modify gene expression in response to temperatures encountered in the various hosts, we conducted a whole genome transcriptome analysis of organisms grown at 30 degrees C and 40 degrees C. We identified extensive transcriptome remodeling at various stages of growth, especially in the stationary phase (significant transcript changes occurred for 25% of the genes). A large proportion of genes involved in metabolism was up-regulated at 30 degrees C in stationary phase. Conversely, genes up-regulated at 40 degrees C relative to 30 degrees C include those encoding virulence factors such as hemolysins and extracellular secreted proteins with LPXTG motifs. Over-expression of hemolysins was linked to larger zones of hemolysis and enhanced hemolytic activity at 40 degrees C. A key theme identified by our study was that genes involved in purine metabolism and iron acquisition were significantly up-regulated at 40 degrees C. Conclusion/Significance: Growth of GBS in vitro at different temperatures resulted in extensive remodeling of the transcriptome, including genes encoding proven and putative virulence genes. The data provide extensive new leads for molecular pathogenesis research.	[Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA; [Mereghetti, Laurent] Ctr Hosp Univ Tours, Fac Med, EA3854, Tours, France	The Methodist Hospital System; The Methodist Hospital - Houston; CHU Tours	Musser, JM (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sitkiewicz, Izabela/G-5058-2011	Sitkiewicz, Izabela/0000-0001-8228-9917				Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Berry RJ, 2003, CAN J ANIM SCI, V83, P687, DOI 10.4141/A03-012; Bishop EJ, 2007, EPIDEMIOL INFECT, V135, P1248, DOI 10.1017/S0950268807008515; Clancy A, 2006, MOL MICROBIOL, V59, P707, DOI 10.1111/j.1365-2958.2005.04974.x; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Forquin MP, 2007, INFECT IMMUN, V75, P2063, DOI 10.1128/IAI.01565-06; Gajdos V, 2008, EUR J OBSTET GYN R B, V136, P265, DOI 10.1016/j.ejogrb.2006.10.026; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gottschalk B, 2006, J BACTERIOL, V188, P5984, DOI 10.1128/JB.00768-05; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Herbert MA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-31; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; MARCHLEWICZ BA, 1981, INFECT IMMUN, V34, P787, DOI 10.1128/IAI.34.3.787-794.1981; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Oliveira ICM, 2006, CLIN MICROBIOL INFEC, V12, P887, DOI 10.1111/j.1469-0691.2006.01508.x; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thieringer HA, 1998, BIOESSAYS, V20, P49; Vanberg C, 2007, APPL ENVIRON MICROB, V73, P5501, DOI 10.1128/AEM.00545-07; White-Ziegler CA, 2007, J BACTERIOL, V189, P5429, DOI 10.1128/JB.01929-06; Yildirim AO, 2002, FEMS MICROBIOL LETT, V212, P187, DOI 10.1111/j.1574-6968.2002.tb11265.x	43	39	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2785	10.1371/journal.pone.0002785	http://dx.doi.org/10.1371/journal.pone.0002785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665215	gold, Green Published, Green Submitted			2022-12-25	WOS:000264304300004
J	Strathdee, SA; Lozada, R; Ojeda, VD; Pollini, RA; Brouwer, KC; Vera, A; Cornelius, W; Nguyen, L; Magis-Rodriguez, C; Patterson, TL; El Cuete, P				Strathdee, Steffanie A.; Lozada, Remedios; Ojeda, Victoria D.; Pollini, Robin A.; Brouwer, Kimberly C.; Vera, Alicia; Cornelius, Wayne; Nguyen, Lucie; Magis-Rodriguez, Carlos; Patterson, Thomas L.; El Cuete, Proyecto			Differential Effects of Migration and Deportation on HIV Infection among Male and Female Injection Drug Users in Tijuana, Mexico	PLOS ONE			English	Article							RISK BEHAVIORS; SEX WORKERS; GENDER-DIFFERENCES; SAN-FRANCISCO; UNITED-STATES; TRANSMISSION; PREVALENCE; PREVENTION; MIGRANTS; DISEASES	HIV prevalence is rising, especially among high risk females in Tijuana, Baja California, a Mexico-US border city situated on major migration and drug trafficking routes. We compared factors associated with HIV infection among male and female injection drug users (IDUs) in Tijuana in an effort to inform HIV prevention and treatment programs. IDUs aged >= 18 years were recruited using respondent-driven sampling and underwent testing for HIV, syphilis and structured interviews. Logistic regression identified correlates of HIV infection, stratified by gender. Among 1056 IDUs, most were Mexican-born but 67% were born outside Tijuana. Reasons for moving to Tijuana included deportation from the US (56% for males, 29% for females), and looking for work/better life (34% for females, 15% for males). HIV prevalence was higher in females versus males (10.2% vs. 3.5%, p = 0.001). Among females (N = 158), factors independently associated with higher HIV prevalence included younger age, lifetime syphilis infection and living in Tijuana for longer durations. Among males (N = 898), factors independently associated with higher HIV prevalence were syphilis titers consistent with active infection, being arrested for having 'track-marks', having larger numbers of recent injection partners and living in Tijuana for shorter durations. An interaction between gender and number of years lived in Tijuana regressed on HIV infection was significant (p = 0.03). Upon further analysis, deportation from the U. S. explained the association between shorter duration lived in Tijuana and HIV infection among males; odds of HIV infection were four-fold higher among male injectors deported from the US, compared to other males, adjusting for all other significant correlates (p = 0.002). Geographic mobility has a profound influence on Tijuana's evolving HIV epidemic, and its impact is significantly modified by gender. Future studies are needed to elucidate the context of mobility and HIV acquisition in this region, and whether US immigration policies adversely affect HIV risk.	[Strathdee, Steffanie A.; Ojeda, Victoria D.; Pollini, Robin A.; Brouwer, Kimberly C.; Vera, Alicia; Nguyen, Lucie; Patterson, Thomas L.; El Cuete, Proyecto] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Lozada, Remedios] Patronado Pro COMUSIDA AC, Tijuana, Mexico; [Cornelius, Wayne] Univ Calif San Diego, Dept Political Sci, La Jolla, CA USA; [Magis-Rodriguez, Carlos] Ctr Nacl Prevencion Control VIH SIDA, Mexico City, DF, Mexico; [Patterson, Thomas L.] Dept Vet Affairs Med Ctr, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; HARVEY-VERA, ALICIA/0000-0002-8708-8169	National Institute on Drug Abuse (NIDA) [R01DA019829, R21DA24381];  [K01DA022923];  [K01DA020354];  [DA09829-S2]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019829, K01DA022923, R37DA019829, K01DA020364, R21DA024381] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the National Institute on Drug Abuse (NIDA) (R01DA019829 and R21DA24381). Dr. Pollini is supported by K01DA022923; Dr. Brouwer is supported by K01DA020354 and Dr. Ojeda is supported by DA09829-S2.	Aral SO, 2007, SEX TRANSM INFECT, V83, pI1, DOI 10.1136/sti.2007.027169; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Borges G, 2007, AM J PUBLIC HEALTH, V97, P1847, DOI 10.2105/AJPH.2006.097915; BROUWER K, J IMMIGRANT IN PRESS; Brouwer KC, 2006, SUBST USE MISUSE, V41, P707, DOI 10.1080/10826080500411478; Brouwer KC, 2006, J URBAN HEALTH, V83, P299, DOI 10.1007/s11524-005-9027-0; Bucardo J, 2005, DRUG ALCOHOL DEPEN, V79, P281, DOI 10.1016/j.drugalcdep.2005.02.003; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CORNELIUS W, OAXACALIFOR IN PRESS; CORNELIUS W, 2008, 4 GENERATION NORTENO; Cruz MF, 2007, AIDS BEHAV, V11, P253, DOI 10.1007/s10461-006-9148-9; del Rio C, 2002, AIDS, V16, P1445, DOI 10.1097/00002030-200207260-00001; Deren S, 2003, AIDS BEHAV, V7, P405, DOI 10.1023/B:AIBE.0000004732.74061.3f; Deren S, 2003, AM J PUBLIC HEALTH, V93, P812, DOI 10.2105/AJPH.93.5.812; Ehrlich S., 2006, HIV RISK ASSESSMENT; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1226, DOI 10.1001/archpsyc.61.12.1226; GRUND JPC, 1992, BRIT J ADDICT, V87, P381; Harvey E, 1998, AIDS CARE, V10, P313, DOI 10.1080/713612412; HAWKES SJ, 1993, AIDS CARE, V5, P207, DOI 10.1080/09540129308258601; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; INEGI, 2005, 12 CENS GEN POBL VIV; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Latkin CA, 2003, INT J STD AIDS, V14, P770, DOI 10.1258/09564620360719831; Magis-Rodriguez C, 2005, J PSYCHOACTIVE DRUGS, V37, P333, DOI 10.1080/02791072.2005.10400528; Magis-Rodriguez C, 2004, JAIDS-J ACQ IMM DEF, V37, pS215, DOI 10.1097/01.qai.0000141252.16099.af; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Montgomery SB, 2002, AM J DRUG ALCOHOL AB, V28, P453, DOI 10.1081/ADA-120006736; NUNEZNETO B, 2007, BORDER SECURITY SAN; OJEDA V, AM J PUBL H IN PRESS; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; Parrado EA, 2004, PERSPECT SEX REPRO H, V36, P150, DOI 10.1111/j.1931-2393.2004.tb00016.x; Paschane DM, 2000, SOC SCI MED, V50, P1091, DOI 10.1016/S0277-9536(99)00357-3; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; PHILBIN M, AIDS BEHAV IN PRESS; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; San Diego Association of Governments (SANDAG), 2007, ALL CROSS CAL PORTS; *SEC USDOH, 2006, YB IMM STAT 2005; *SECR SAL, 2007, CONS NAC PREV CONTR; Soskolne V, 2002, SOC SCI MED, V55, P1297, DOI 10.1016/S0277-9536(01)00282-9; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; STRATHDEE SA, JAMA IN PRESS; STRATHDEE SA, 2005, J URBAN HLTH S4, V82, P58; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Viani RM, 2006, JAIDS-J ACQ IMM DEF, V41, P87, DOI 10.1097/01.qai.0000174657.71276.9f	54	89	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2690	10.1371/journal.pone.0002690	http://dx.doi.org/10.1371/journal.pone.0002690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665250	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300001
J	Wong, CCL; Wong, CM; Ko, FCF; Chan, LK; Ching, YP; Yam, JWP; Ng, IOL				Wong, Carmen Chak-Lui; Wong, Chun-Ming; Ko, Frankie Chi-Fat; Chan, Lo-Kong; Ching, Yick-Pang; Yam, Judy Wai-Ping; Ng, Irene Oi-Lin			Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma	PLOS ONE			English	Article								Aims: Deleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity and cancer metastasis. However, the underlying molecular mechanisms of how DLC1 suppresses cell motility have not been fully elucidated. Rho-kinase (ROCK) is an immediate down-stream effector of RhoA in mediating cellular cytoskeletal events and cell motility. In the present study, we aimed to investigate the effects of DLC1 on Rho/ROCK signaling pathway in hepatocellular carcinoma (HCC). Methodology/Principal Findings: We demonstrated that DLC1 negatively regulated ROCK-dependent actomyosin contractility. From immumofluorescence study, we found that ectopic expression of DLC1 abrogated Rho/ROCK-mediated cytoskeletal reorganization including formation of stress fibers and focal adhesions. It also downregulated cortical phosphorylation of myosin light chain 2 (MLC2). These inhibitory events by DLC1 were RhoGAP-dependent, as RhoGAP-deficient mutant of DLC1 (DLC1 K714E) abolished these inhibitory events. In addition, from western study, DLC1 inhibited ROCK-related myosin light chain phosphatase targeting unit 1 (MYPT1) phosphorylation at Threonine 853. By examining cell morphology under microscope, we found that ectopic expression of dominant-active ROCK released cells from DLC1-induced cytoskeletal collapse and cell shrinkage. Conclusion: Our data suggest that DLC1 negatively regulates Rho/ROCK/MLC2. This implicates a ROCK-mediated pathway of DLC1 in suppressing metastasis of HCC cells and enriches our understanding in the molecular mechanisms involved in the progression of hepatocellular carcinoma.	[Wong, Carmen Chak-Lui; Wong, Chun-Ming; Ko, Frankie Chi-Fat; Chan, Lo-Kong; Ching, Yick-Pang; Yam, Judy Wai-Ping; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, SH Ho Fdn Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, CCL (corresponding author), Univ Hong Kong, Dept Pathol, SH Ho Fdn Res Lab, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk	Ko, Frankie Chi Fat/C-4759-2009; WONG, Chun-Ming/A-6739-2009; Kong, Chan Lo/AAI-9300-2020; Yam, Judy Wai Ping/C-4454-2009; Wong, Carmen Chak Lui/C-4660-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; WONG, Chun-Ming/0000-0002-2497-7858; Kong, Chan Lo/0000-0003-3082-1013; Ng, Irene Oi-lin/0000-0001-7532-2029; Yam, Judy Wai Ping/0000-0002-5637-121X; CHING, Yick Pang/0000-0002-6461-8358; Wong, Carmen Chak Lui/0000-0001-5866-4705	Hong Kong Research Grants Council [HKU 7436/04M]; RGC Collaborative Reseaarch Fund [HKU 1/06C]; Michael and Betty Kadoorie Cancer Genetics Research Program 2004	Hong Kong Research Grants Council(Hong Kong Research Grants Council); RGC Collaborative Reseaarch Fund; Michael and Betty Kadoorie Cancer Genetics Research Program 2004	The study was funded by Hong Kong Research Grants Council (HKU 7436/04M), RGC Collaborative Reseaarch Fund (HKU 1/06C), Michael and Betty Kadoorie Cancer Genetics Research Program 2004. I.O.L. Ng is Loke Yew Professor in Pathology.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakagawa H, 2005, MOL CANCER RES, V3, P425, DOI 10.1158/1541-7786.MCR-05-0002; Ng IOL, 2000, CANCER RES, V60, P6581; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Plaumann M, 2003, J CANCER RES CLIN, V129, P349, DOI 10.1007/s00432-003-0440-z; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Song Li-jie, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P428; Sturge J, 2006, J CELL BIOL, V175, P337, DOI 10.1083/jcb.200602125; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Vicari RM, 2005, J AM COLL CARDIOL, V46, P1803, DOI 10.1016/j.jacc.2005.07.047; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yoshioka K, 1999, CANCER RES, V59, P2004; Yoshioka K, 1998, J BIOL CHEM, V273, P5146, DOI 10.1074/jbc.273.9.5146; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	57	50	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2779	10.1371/journal.pone.0002779	http://dx.doi.org/10.1371/journal.pone.0002779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648664	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900049
J	Shen, J; Vakifahmetoglu, H; Stridh, H; Zhivotovsky, B; Wiman, KG				Shen, J.; Vakifahmetoglu, H.; Stridh, H.; Zhivotovsky, B.; Wiman, K. G.			PRIMA-1(MET) induces mitochondrial apoptosis through activation of caspase-2	ONCOGENE			English	Article						apoptosis; cancer therapy; caspase-2; mutant p53; PRIMA-1(MET)	CYTOCHROME-C RELEASE; MUTANT P53; BREAST-CANCER; CELLS; GENE; RESTORATION; DEATH; PUMA; TRANSCRIPTION; INDUCTION	p53 mutations occur frequently in human tumors. The low-molecular-weight compound PRIMA-1(MET) reactivates mutant p53, induces apoptosis in human tumor cells and inhibits tumor xenograft growth in vivo. Here, we show that PRIMA-1(MET) induces mutant p53-dependent mito-chondria-mediated apoptosis through activation of caspase-2 with subsequent cytochrome c release and further activation of downstream caspase-9 and caspase-3. Inhibition of caspase-2 by a selective inhibitor and/or siRNA prevents cytochrome c release on PRIMA-1(MET) treatment and causes a significant reduction in PRIMA-1(MET)-induced cell death. Our findings highlight a chain of cellular events triggered by PRIMA-1(MET) that lead to apoptotic cell death. This should facilitate further development and optimization of eficient PRIMA-1(MET)-based anticancer drugs.	[Wiman, K. G.] Karolinska Univ Hosp, CCK, Karolinska Inst, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Vakifahmetoglu, H.; Zhivotovsky, B.] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wiman, KG (corresponding author), Karolinska Univ Hosp, CCK, Karolinska Inst, Dept Oncol Pathol, R8-04, SE-17176 Stockholm, Sweden.	klas.wiman@ki.se	Wiman, Klas/AAB-8399-2021; Zhivotovsky, Boris/A-4346-2014	Wiman, Klas/0000-0002-7113-524X; Zhivotovsky, Boris/0000-0002-2238-3482	Swedish and Stockholm Cancer Societies; Swedish Research Council; EU 6th and 7th Framework Programs; Karolinska Institutet	Swedish and Stockholm Cancer Societies; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU 6th and 7th Framework Programs(European Commission); Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from the Swedish and Stockholm Cancer Societies, the Swedish Research Council, the EU 6th and 7th Framework Programs, and Karolinska Institutet. This publication reflects the author's views and not necessarily those of the EC partners. The information in this document is provided as is and no guarantee or warranty is given that the information is fit for any particular purpose. The user thereof uses the information at its sole risk and liability. The Community is not liable for any use that may be made of the information contained herein.	ALSHABANAH OA, 1995, CHEMOTHERAPY, V41, P368, DOI 10.1159/000239369; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Guimaraes DP, 2002, BIOCHIMIE, V84, P83, DOI 10.1016/S0300-9084(01)01356-6; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tyagi A, 2006, CARCINOGENESIS, V27, P2269, DOI 10.1093/carcin/bgl098; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	28	49	49	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 30	2008	27	51					6571	6580		10.1038/onc.2008.249	http://dx.doi.org/10.1038/onc.2008.249			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18663359				2022-12-25	WOS:000260501700004
J	Muryoi, N; Tiedemann, MT; Pluym, M; Cheung, J; Heinrichs, DE; Stillman, MJ				Muryoi, Naomi; Tiedemann, Michael T.; Pluym, Mark; Cheung, Johnson; Heinrichs, David E.; Stillman, Martin J.			Demonstration of the iron-regulated surface determinant (Isd) heme transfer pathway in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROPERTIES; UPTAKE SYSTEM; PROTEIN; HEMOGLOBIN; PATHOGENESIS; HAPTOGLOBIN; EXPRESSION; HEMOPHORES; RESISTANCE; SPECTRA	In this study, we report experimental results that provide the first complete challenge of a proposed model for heme acquisition by Staphylococcus aureus via the Isd pathway first put forth by Mazmanian, S. K., Skaar, E. P., Gaspar, A. H., Humayun, M., Gornicki, P., Jelenska, J., Joachmiak, A., Missiakas, D. M., and Schneewind, O. (2003) Science 299, 906-909. The heme-binding NEAT domains of Isd proteins IsdA, IsdB (domain 2), IsdC, and HarA/IsdH (domain 3), and the heme-binding IsdE protein, were overexpressed and purified in apo (heme-free) form. Absorption and magnetic circular dichroism spectral data, together with electrospray ionization mass spectrometry were used to unambiguously identify that heme transfers from NEAT-A through NEAT-C to IsdE. Heme transfer was demonstrated to occur in a unidirectional fashion in the sequence NEAT-B -> NEAT-A -> NEAT-C -> IsdE or, alternatively, initiating from NEAT-H3 instead of NEAT-B2: NEAT-H3 -> NEAT- A -> NEAT-C -> IsdE. Under the conditions of our experiments, only NEAT-H3 and NEAT-B2 could transfer bidirectionally, which is in the reverse direction as well, and only with each other. Whereas apo-IsdE readily accepted heme from holo-NEAT-C, it would not accept heme from holo-NEAT-A. Heme transfer to IsdE requires the presence of holo-NEAT-C, in agreement with the proposal that IsdC serves as the central conduit of the heme transfer pathway. These experimental findings corroborate the heme transfer model first proposed by the Schneewind group. Our data show that heme transport from the wall-anchored IsdH/IsdB proteins proceeds directly to IsdE at the membrane and, for this to occur, we propose that specific protein-protein interactions must take place.	[Muryoi, Naomi; Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Tiedemann, Michael T.; Pluym, Mark; Stillman, Martin J.] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Heinrichs, DE (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	deh@uwo.ca; martin.stillman@uwo.ca	Stillman, Martin/O-3191-2016; Heinrichs, David/ABD-5702-2021	Stillman, Martin/0000-0001-6799-7560; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Ontario Graduate Scholarship program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	This work was supported by a Canadian Institutes of Health Research operating grant (to D. E. H.), operating and equipment grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to M. J. S.), the NSERC Postgraduate Scholarship program (to M. P.), and the Ontario Graduate Scholarship program (to M. T. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEEK J, 2000, MAGNETIC CIRCULAR DI; Clarke SR, 2008, INFECT IMMUN, V76, P1518, DOI 10.1128/IAI.01530-07; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McGowan JE, 2004, NAT REV MICROBIOL, V2, P251, DOI 10.1038/nrmicro845; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Pluym M, 2007, J PORPHYR PHTHALOCYA, V11, P165, DOI 10.1142/S1088424607000217; Pluym M, 2007, BIOCHEMISTRY-US, V46, P12777, DOI 10.1021/bi7009585; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SPRINGALL J, 1976, BIOCHIM BIOPHYS ACTA, V453, P494, DOI 10.1016/0005-2795(76)90145-8; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	34	124	130	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28125	28136		10.1074/jbc.M802171200	http://dx.doi.org/10.1074/jbc.M802171200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18676371	Green Published, hybrid			2022-12-25	WOS:000259969300015
J	Shimamoto, S; Takata, M; Tokuda, M; Oohira, F; Tokumitsu, H; Kobayashi, R				Shimamoto, Seiko; Takata, Maki; Tokuda, Masaaki; Oohira, Fumikazu; Tokumitsu, Hiroshi; Kobayashi, Ryoji			Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; ANTIALLERGIC DRUGS; SCAFFOLD PROTEIN; BINDING; HSP90; IDENTIFICATION; MECHANISMS; TARGET; CARGO; HSP70	S100A2 and S100A6 interact with several target proteins in a Ca2+-regulated manner. However, the exact intracellular roles of the S100 proteins are unclear. In this study we identified Hsp70/Hsp90-organizing protein (Hop) and kinesin light chain (KLC) as novel targets of S100A2 and S100A6. Hop directly associates with Hsp70 and Hsp90 through the tetratricopeptide (TPR) domains andregulates Hop-Hsp70 and Hop-Hsp90 complex formation. We have found that S100A2 and S100A6 bind to the TPR domain of Hop, resulting in inhibition of the Hop-Hsp70 and Hop-Hsp90 interactions in vitro. Although endogenous Hsp70 and Hsp90 interact with Hop in resting Cos-7 cells, but not with S100A6, stimulation of these cells with ionomycin caused a Hop-S100A6 interaction, resulting in the dissociation of Hsp70 and Hsp90 from Hop. Similarly, glutathione S-transferase pulldown and co-immunoprecipitation experiments revealed that S100A6 binds to the TPR domain of KLC, resulting in inhibition of the KLC-c-Jun N-terminal kinase (JNK)-interacting protein 1 (JIP-1) interaction in vitro. The transiently expressed JIP-1 interacts with KLC in resting Cos-7 cells but not with S100A6. Stimulation of these cells with ionomycin also caused a KLC-S100A6 interaction, resulting in dissociation of JIP- 1 from KLC. These results strongly suggest that the S100 proteins modulate Hsp70-Hop-Hsp90 multichaperone complex formation and KLC-cargo interaction via Ca2+-dependent S100 protein-TPR protein complex formation in vivo as well as in vitro. Moreover, we have shown that S100A2 and S100A6 interact with another TPR protein Tom70 and regulate the Tom70-ligand interaction in vitro. Thus, our findings suggest a new intracellular Ca2+-signaling pathway via S100 proteins-TPR motif interactions.	[Shimamoto, Seiko; Takata, Maki; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Shimamoto, Seiko; Oohira, Fumikazu] Kagawa Univ, Fac Engn, Dept Intelligent Mech Syst Engn, Takamatsu, Kagawa 7610396, Japan	Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18300123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in aid for Scientific Research 18300123 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; LASSLE M, 1998, J BIOL CHEM, V273, P3679; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okada M, 2003, BIOCHEM J, V374, P433, DOI 10.1042/BJ20030351; Okada M, 2002, BIOCHEM BIOPH RES CO, V292, P1023, DOI 10.1006/bbrc.2002.6761; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; van der Spuy J, 2000, BIOCHEM J, V345, P645, DOI 10.1042/0264-6021:3450645; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	34	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28246	28258		10.1074/jbc.M801473200	http://dx.doi.org/10.1074/jbc.M801473200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669640	Green Published, hybrid			2022-12-25	WOS:000259969300026
J	Taneva, S; Dennis, MK; Ding, Z; Smith, JL; Cornell, RB				Taneva, Svetla; Dennis, Melissa K.; Ding, Ziwei; Smith, Jillian L.; Cornell, Rosemary B.			Contribution of each membrane binding domain of the CTP : phosphocholine cytidylyltransferase-alpha dimer to its activation, membrane binding, and membrane cross-bridging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CTP; NUCLEAR-LOCALIZATION SIGNAL; PROTEIN-KINASE-C; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PLASMA-MEMBRANE; IDENTIFICATION; LIPIDS; CELLS; PHOSPHATIDYLSERINE; ELECTROSTATICS	CTP:phosphocholine cytidylyltransferase (CCT), a rate-limiting enzyme in phosphatidylcholine synthesis, is regulated by reversible membrane interactions mediated by an amphipathic helical domain ( M) that binds selectively to anionic lipids. CCT is a dimer; thus the functional unit has two M domains. To probe the functional contribution of each domain M we prepared a CCT heterodimer composed of one full-length subunit paired with a CCT subunit truncated before domain M that was also catalytically dead. We compared this heterodimer to the full-length homodimer with respect to activation by anionic vesicles, vesicle binding affinities, and promotion of vesicle aggregation. Surprisingly for all three functions the dimer with just one domain M behaved similarly to the dimer with two M domains. Full activation of the wild-type subunit was not impaired by loss of one domain M in its partner. Membrane binding affinities were the same for dimers with one versus two M domains, suggesting that the two M domains of the dimer do not engage a single bilayer simultaneously. Vesicle cross-bridging was also unhindered by loss of one domain M, suggesting that another motif couples with domain M for cross-bridging anionic membranes. Mutagenesis revealed that the positively charged nuclear localization signal sequence constitutes that second motif for membrane cross-bridging. We propose that the two M domains of the CCT dimer engage a single bilayer via an alternating binding mechanism. The tethering function involves the cooperation of domain M and the nuclear localization signal sequence, each engaging separate membranes. Membrane binding of a single M domain is sufficient to fully activate the enzymatic activity of the CCT dimer while sustaining the low affinity, reversible membrane interaction required for regulation of CCT activity.	[Taneva, Svetla; Dennis, Melissa K.; Ding, Ziwei; Smith, Jillian L.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes of Health [12134]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 12134. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; CORNELL R, 1989, J BIOL CHEM, V264, P9077; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Helmink BA, 2004, BBA-MOL CELL BIOL L, V1683, P78, DOI 10.1016/j.bbalip.2004.04.008; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; POEHLING HM, 1981, ELECTROPHORESIS, V2, P141, DOI 10.1002/elps.1150020304; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vargo MA, 2004, PROTEIN SCI, V13, P1586, DOI 10.1110/ps.04694004; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503	46	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28137	28148		10.1074/jbc.M802595200	http://dx.doi.org/10.1074/jbc.M802595200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694933	Green Published, hybrid			2022-12-25	WOS:000259969300016
J	Nadanaka, S; Ishida, M; Ikegami, M; Kitagawa, H				Nadanaka, Satomi; Ishida, Miho; Ikegami, Masami; Kitagawa, Hiroshi			Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; WNT/BETA-CATENIN; HEPARAN-SULFATE; CROSS-TALK; TGF-BETA; DEVELOPMENTAL REGULATION; MOLECULAR-CLONING; GROWTH-FACTORS; PATHWAYS; PROTEOGLYCANS	Wnt-3a is a ligand that activates the beta-catenin-dependent pathway in Wnt signaling, which is implicated in numerous physiological events such as morphogenesis. So far, heparan sulfate (HS) proteoglycans have been highlighted as a low affinity receptor for morphogens containing Wnts. Here we show the importance of chondroitin sulfate (CS) proteoglycans in the efficient signaling of Wnt-3a and the structural features of CS required for the regulation of Wnt-3a signaling. Wnt-3a signaling was depressed in a mouse L cell mutant, called sog9, which is defective in the EXT1 gene encoding the HS-synthesizing enzyme and the chondroitin 4-O-sulfotransferase (C4ST-1) gene compared with parental L cells. The transfection of sog9 cells with C4ST-1 resulted in the recovery of Wnt-3a signaling, whereas the expression of EXT1 in sog9 cells could not restore Wnt-3a signaling. In addition, the expression level of introduced C4ST-1 correlated with the recovery of Wnt-3a signaling accompanied by the increased expression of the E disaccharide unit of CS. Interestingly, molecular interaction analyses using Biacore revealed that squid CS-E (rich in the E disaccharide unit) bound strongly to Wnt-3a (K-d = 13.2 nM) to the same extent as heparin from bovine lung (K-d = 8.43 nM). In contrast, other CS isoforms as well as HS isolated from bovine kidney showed little binding activity to Wnt-3a. Moreover, exogenously added CS-E potently inhibited the accumulation of beta-catenin induced by Wnt-3a. These results suggest that CS-E-like structures synthesized by C4ST-1 participate in Wnt-3a signaling and modulate the physiological events caused by Wnt-3a signals.	[Nadanaka, Satomi; Ishida, Miho; Ikegami, Masami; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Kitagawa, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp; the Takeda Science Foundation; MEXT, Japan	Japan Private School Promotion Foundation; Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp(Core Research for Evolutional Science and Technology (CREST)); the Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a scientific research promotion fund from the Japan Private School Promotion Foundation, Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp. (to H. K.), the Takeda Science Foundation (to H. K.), and Grant-in-aid for Scientific Research-B 19390025 (to H. K.) from MEXT, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Dao DY, 2007, ANN NY ACAD SCI, V1116, P82, DOI 10.1196/annals.1402.082; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Meyer K, 1941, J BIOL CHEM, V138, P491; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHILLER S, 1961, J BIOL CHEM, V236, P983; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schmidt HH, 2004, ONCOGENE, V23, P6991, DOI 10.1038/sj.onc.1207934; Shibamoto S, 1998, GENES CELLS, V3, P659; Shortkroff S, 2007, OSTEOARTHR CARTILAGE, V15, P147, DOI 10.1016/j.joca.2006.07.004; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tsara ME, 2002, ANTICANCER RES, V22, P2893; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	45	70	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27333	27343		10.1074/jbc.M802997200	http://dx.doi.org/10.1074/jbc.M802997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667431	hybrid			2022-12-25	WOS:000259586600052
J	Jin, JF; Hou, Q; Mullen, TD; Zeidan, YH; Bielawski, J; Kraveka, JM; Bielawska, A; Obeid, LM; Hannun, YA; Hsu, YT				Jin, Junfei; Hou, Qi; Mullen, Thomas D.; Zeidan, Youssef H.; Bielawski, Jacek; Kraveka, Jacqueline M.; Bielawska, Alicja; Obeid, Lina M.; Hannun, Yusuf A.; Hsu, Yi-Te			Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced bax redistribution to mitochondria in NT-2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; DELTA-MEDIATED PHOSPHORYLATION; CYTOCHROME-C RELEASE; ACID SPHINGOMYELINASE; CONFORMATIONAL-CHANGE; TNF-ALPHA; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; SIGNALS APOPTOSIS; HL-60 CELLS	Ceramide functions as an important second messenger in apoptosis signaling pathways. In this report, we show that treatment of NT-2 neuronal precursor cells with hypoxia/reoxygenation (H/R) resulted in ceramide up-regulation. This elevation in ceramide was primarily due to the actions of acid sphingomyelinase and ceramide synthase LASS 5, demonstrating the action of the salvage pathway. Hypoxia/reoxygenation treatment led to Bax translocation from the cytoplasm to mitochondria and cytochrome c release from mitochondria. Down-regulation of either acid sphingomyelinase or LASS 5-attenuated ceramide accumulation and H/R-induced Bax translocation to mitochondria. Overall, we have demonstrated that ceramide upregulation following H/R is pertinent to Bax activation to promote cell death.	[Jin, Junfei; Hou, Qi; Zeidan, Youssef H.; Bielawski, Jacek; Bielawska, Alicja; Hannun, Yusuf A.; Hsu, Yi-Te] Med Univ S Carolina, Dept Biochem & Mol Biol, Div Hematol Oncol, Charleston, SC 29425 USA; [Mullen, Thomas D.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Hematol Oncol, Charleston, SC 29425 USA; [Kraveka, Jacqueline M.] Med Univ S Carolina, Dept Pediat, Div Hematol Oncol, Charleston, SC 29425 USA; [Hou, Qi] Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, Beijing 100050, Peoples R China; [Hou, Qi] Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hsu, YT (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Div Hematol Oncol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hsuy@musc.edu	Zeidan, Youssef H./H-7578-2019	Zeidan, Youssef H./0000-0002-1951-8585; Jin, Junfei/0000-0002-9237-9024; obeid, lina/0000-0002-0734-0847	National Institutes of Health [NS40932, CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132, K01CA100767] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40932 (to Y.-T. H.) and CA97132 ( to Y. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cheng W, 1996, EXP CELL RES, V226, P316, DOI 10.1006/excr.1996.0232; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Garzotto M, 1998, CANCER RES, V58, P2260; Ginis I, 1999, AM J PHYSIOL-CELL PH, V276, pC1171, DOI 10.1152/ajpcell.1999.276.5.C1171; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gulbins Erich, 2002, Subcell Biochem, V36, P229; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kim HJ, 2001, FEBS LETT, V505, P264, DOI 10.1016/S0014-5793(01)02836-8; Kim WH, 2000, CANCER LETT, V151, P39; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Kubota M, 1996, NEUROL RES, V18, P337; Larsen EC, 2007, NEUROSCIENCE, V146, P946, DOI 10.1016/j.neuroscience.2007.02.022; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Misao J, 1996, CIRCULATION, V94, P1506, DOI 10.1161/01.CIR.94.7.1506; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Nakane M, 2000, NEUROSCI LETT, V296, P89, DOI 10.1016/S0304-3940(00)01655-4; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; O'Brien NW, 2003, CIRC RES, V92, P589, DOI 10.1161/01.RES.0000066290.29715.67; Oh HL, 2006, NEUROTOXICOLOGY, V27, P31, DOI 10.1016/j.neuro.2005.05.008; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Perry DK, 2002, BBA-MOL CELL BIOL L, V1585, P146, DOI 10.1016/S1388-1981(02)00335-9; PICKETT CB, 1980, EXP CELL RES, V128, P343, DOI 10.1016/0014-4827(80)90070-1; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang E, 2000, METHOD ENZYMOL, V311, P15; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	71	60	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26509	26517		10.1074/jbc.M801597200	http://dx.doi.org/10.1074/jbc.M801597200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676372	hybrid, Green Published			2022-12-25	WOS:000259341600027
J	Li, Y; Reddy, MA; Miao, F; Shanmugam, N; Yee, JK; Hawkins, D; Ren, B; Natarajan, R				Li, Yan; Reddy, Marpadga A.; Miao, Feng; Shanmugam, Narkunaraja; Yee, Jiing-Kuan; Hawkins, David; Ren, Bing; Natarajan, Rama			Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappa B-dependent inflammatory genes - Relevance to diabetes and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RNA-POLYMERASE-II; GLYCATION END-PRODUCTS; CHROMATIN MODIFICATIONS; LINKS INFLAMMATION; INSULIN-RESISTANCE; STRUCTURAL BASIS; IKK-BETA; METHYLATION; TRANSCRIPTION	Nuclear factor kappa-B (NF-kappa B)-regulated inflammatory genes, such as TNF-alpha(tumor necrosis factor-alpha), play key roles in the pathogenesis of inflammatory diseases, including diabetes and the metabolic syndrome. However, the nuclear chromatin mechanisms are unclear. We report here that the chromatin histone H3-lysine 4 methyltransferase, SET7/9, is a novel coactivator of NF-kappa B. Gene silencing of SET7/9 with small interfering RNAs in monocytes significantly inhibited TNF-alpha-induced inflammatory genes and histone H3-lysine 4 methylation on these promoters, as well as monocyte adhesion to endothelial or smooth muscle cells. Chromatin immunoprecipitation revealed that SET7/9 small interfering RNA could reduce TNF-alpha-induced recruitment of NF-kappa B p65 to inflammatory gene promoters. Inflammatory gene induction by ligands of the receptor for advanced glycation end products was also attenuated in SET7/9 knockdown monocytes. In addition, we also observed increased inflammatory gene expression and SET7/9 recruitment in macrophages from diabetic mice. Microarray profiling revealed that, in TNF-alpha-stimulated monocytes, the induction of 25% NF-kappa B downstream genes, including the histone H3-lysine 27 demethylase JMJD3, was attenuated by SET7/9 depletion. These results demonstrate a novel role for SET7/9 in inflammation and diabetes.	[Li, Yan; Natarajan, Rama] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Yee, Jiing-Kuan] Beckman Res Inst City Hope, Div Virol, Duarte, CA 91010 USA; [Hawkins, David; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Li, Yan; Reddy, Marpadga A.; Miao, Feng; Shanmugam, Narkunaraja; Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Gonda Diabet Ctr, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, Gonda Diabet Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org		Reddy, Marpadga A/0000-0001-9259-7243	National Institutes of Health [R01 DK065073, R01 HL87864]; Juvenile Diabetes Research Foundation; American Heart Association, Western States; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Heart Association, Western States(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065073 and R01 HL87864. This work was also supported by the Juvenile Diabetes Research Foundation (to R. N.) and a Predoctoral fellowship from the American Heart Association, Western States Affiliate (to Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Miao F, 2006, MOL ENDOCRINOL, V20, P1562, DOI 10.1210/me.2005-0365; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Yam P, 2006, MOL THER, V14, P236, DOI 10.1016/j.ymthe.2006.02.017; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	42	261	273	5	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26771	26781		10.1074/jbc.M802800200	http://dx.doi.org/10.1074/jbc.M802800200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650421	hybrid, Green Published			2022-12-25	WOS:000259341600049
J	Zhao, ZZ; Michaely, P				Zhao, Zhenze; Michaely, Peter			The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOUSE PERITONEAL-MACROPHAGES; CELL-SURFACE RECEPTORS; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN-FIBROBLASTS; MEDIATED ENDOCYTOSIS; APOLIPOPROTEIN-E; ADAPTER PROTEIN; CYTOPLASMIC DOMAIN; BINDING DOMAIN	The low density lipoprotein (LDL) receptor (LDLR) mediates efficient endocytosis of VLDL, VLDL remnants, and LDL. As part of the endocytic process, the LDLR releases lipoproteins in endosomes. The release process correlates with an acid-dependent conformational change in the receptor from an extended, "open" state to a compact, "closed" state. The closed state has an intramolecular contact involving H190, H562, and H586. The current model for lipoprotein release holds that protonation of these histidines drives the conformational change that is associated with release. We tested the roles of H190, H562, and H586 on LDLR conformation and on lipoprotein binding, uptake, and release using variants in which the three histidines were replaced with alanine (AAA variant) or in which the histidines were replaced with charged residues that can form ionic contacts at neutral pH (DRK variant). Contrary to expectation, both the AAA and the DRK variants exhibited normal acid-dependent transitions from open to closed conformations. Despite this similarity, both the AAA and DRK mutations modulated lipoprotein release, indicating that H190, H562, and H586 act subsequent to the conformational transition. These observations also suggest that the intramolecular contact does not drive release through a competitive mechanism. In support of this possibility, mutagenesis experiments showed that beta-VLDL binding was inhibited by mutations at D203 and E208, which are exposed in the closed conformation of the LDLR. We propose that H190, H562, and H586 are part of an allosteric mechanism that drives lipoprotein release.	[Zhao, Zhenze; Michaely, Peter] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhao, ZZ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Peter.Michaely@utsouthwestern.edu	Zhao, Zhenze/AAW-5870-2020		National Institutes of Health [HL085218]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085218. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blasiole DA, 2008, J BIOL CHEM, V283, P11374, DOI 10.1074/jbc.M710457200; BRADLEY WA, 1986, J LIPID RES, V27, P40; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; BROWN MS, 1981, COLD SPRING HARB SYM, V46, P713, DOI 10.1101/SQB.1982.046.01.068; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1980, J BIOL CHEM, V255, P1839; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hopkins PN, 1999, J HUM GENET, V44, P364, DOI 10.1007/s100380050179; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jones NL, 2000, J LIPID RES, V41, P1823; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; LOMBARDI P, 1993, J BIOL CHEM, V268, P26113; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MAHLEY RW, 1977, J BIOL CHEM, V252, P3980; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; Prevost M, 2004, PROTEINS, V55, P874, DOI 10.1002/prot.20080; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; Sirinian MI, 2005, J BIOL CHEM, V280, P38416, DOI 10.1074/jbc.M504343200; SUN XM, 1994, ARTERIOSCLER THROMB, V14, P85, DOI 10.1161/01.ATV.14.1.85; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0	53	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26528	26537		10.1074/jbc.M804624200	http://dx.doi.org/10.1074/jbc.M804624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18677035	hybrid, Green Published			2022-12-25	WOS:000259341600029
J	Fuhrman, LE; Shianna, KV; Aballay, A				Fuhrman, Laura E.; Shianna, Kevin V.; Aballay, Alejandro			High-Throughput Isolation and Mapping of C. elegans Mutants Susceptible to Pathogen Infection	PLOS ONE			English	Article								We present a novel strategy that uses high-throughput methods of isolating and mapping C. elegans mutants susceptible to pathogen infection. We show that C. elegans mutants that exhibit an enhanced pathogen accumulation (epa) phenotype can be rapidly identified and isolated using a sorting system that allows automation of the analysis, sorting, and dispensing of C. elegans by measuring fluorescent bacteria inside the animals. Furthermore, we validate the use of Amplifluor (R) as a new single nucleotide polymorphism (SNP) mapping technique in C. elegans. We show that a set of 9 SNPs allows the linkage of C. elegans mutants to a 5-8 megabase sub-chromosomal region.	[Fuhrman, Laura E.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA; [Shianna, Kevin V.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	a.aballay@duke.edu			NIH;  [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM070977, R01GM070977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH GM070977. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; ALEGADO RA, 2008, CELL MICROBIOL; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Bengra C, 2002, CLIN CHEM, V48, P2131; BRENNER S, 1974, GENETICS, V77, P71; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Meneely PM, 2002, GENETICS, V162, P1169; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nairz Knud, 2007, V396, P419; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2882	10.1371/journal.pone.0002882	http://dx.doi.org/10.1371/journal.pone.0002882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682730	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600038
J	Levavasseur, E; Laffont-Proust, I; Morain, E; Faucheux, BA; Privat, N; Peoc'h, K; Sazdovitch, V; Brandel, JP; Hauw, JJ; Haik, S				Levavasseur, Etienne; Laffont-Proust, Isabelle; Morain, Emilie; Faucheux, Baptiste A.; Privat, Nicolas; Peoc'h, Katell; Sazdovitch, Veronique; Brandel, Jean-Philippe; Hauw, Jean-Jacques; Haik, Stephane			Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains	PLOS ONE			English	Article							MOLECULAR-BASIS; BSE AGENT; PROTEIN; HETEROGENEITY; PRPSC; PHENOTYPE; MUTATION; UK	Objective: The glycoprofile of pathological prion protein (PrPres) is widely used as a diagnosis marker in Creutzfeldt-Jakob disease (CJD) and is thought to vary in a strain-specific manner. However, that the same glycoprofile of PrPres always accumulates in the whole brain of one individual has been questioned. We aimed to determine whether and how PrPres glycosylation is regulated in the brain of patients with sporadic and variant Creutzfeldt-Jakob disease. Methods: PrPres glycoprofiles in four brain regions from 134 patients with sporadic or variant CJD were analyzed as a function of the genotype at codon 129 of PRNP and the Western blot type of PrPres. Results: The regional distribution of PrPres glycoforms within one individual was heterogeneous in sporadic but not in variant CJD. PrPres glycoforms ratio significantly correlated with the genotype at codon 129 of the prion protein gene and the Western blot type of PrPres in a region-specific manner. In some cases of sCJD, the glycoprofile of thalamic PrPres was undistinguishable from that observed in variant CJD. Interpretation: Regulations leading to variations of PrPres pattern between brain regions in sCJD patients, involving host genotype and Western blot type of PrPres may contribute to the specific brain targeting of prion strains and have direct implications for the diagnosis of the different forms of CJD.	[Levavasseur, Etienne; Laffont-Proust, Isabelle; Morain, Emilie; Faucheux, Baptiste A.; Privat, Nicolas; Sazdovitch, Veronique; Brandel, Jean-Philippe; Haik, Stephane] INSERM, Avenir Team Human Prion Dis, Paris, France; [Faucheux, Baptiste A.; Sazdovitch, Veronique; Hauw, Jean-Jacques; Haik, Stephane] APHP, R Escourolle Neuropathol Lab, Paris, France; [Hauw, Jean-Jacques; Haik, Stephane] French Natl Ctr Reference Unconvention Transmiss, InVS, Paris, France; [Peoc'h, Katell] Lariboisiere Hosp, Biochem & Mol Biol Dept, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Haik, S (corresponding author), INSERM, Avenir Team Human Prion Dis, Paris, France.	haik@chups.jussieu.fr	Haik, Stephane/M-7247-2018; Peoc'h, Katell/V-1604-2017; Peoc'h, Katell/D-5261-2014	Peoc'h, Katell/0000-0002-8203-1243; 	Region Ile-de-France; INVS; Assistance Publique-Hapitaux de Paris	Region Ile-de-France(Region Ile-de-France); INVS; Assistance Publique-Hapitaux de Paris	This work was supported by grants from Region Ile-de-France and INVS. B.A.F. acknowledges funding from the Assistance Publique-Hapitaux de Paris (Delegation a la Recherche Clinique et au Developpement).	Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Chadeau-Hyam M, 2003, STAT METHODS MED RES, V12, P247, DOI 10.1191/0962280203sm330ra; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Peoc'h K, 2000, HUM MUTAT, V15; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Somerville RA, 1999, J GEN VIROL, V80, P1865, DOI 10.1099/0022-1317-80-7-1865; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200	30	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2786	10.1371/journal.pone.0002786	http://dx.doi.org/10.1371/journal.pone.0002786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665216	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300005
J	Maibach, EW; Chadwick, A; McBride, D; Chuk, M; Ebi, KL; Balbus, J				Maibach, Edward W.; Chadwick, Amy; McBride, Dennis; Chuk, Michelle; Ebi, Kristie L.; Balbus, John			Climate Change and Local Public Health in the United States: Preparedness, Programs and Perceptions of Local Public Health Department Directors	PLOS ONE			English	Article								While climate change is inherently a global problem, its public health impacts will be experienced most acutely at the local and regional level, with some jurisdictions likely to be more burdened than others. The public health infrastructure in the U. S. is organized largely as an interlocking set of public agencies at the federal, state and local level, with lead responsibility for each city or county often residing at the local level. To understand how directors of local public health departments view and are responding to climate change as a public health issue, we conducted a telephone survey with 133 randomly selected local health department directors, representing a 61% response rate. A majority of respondents perceived climate change to be a problem in their jurisdiction, a problem they viewed as likely to become more common or severe over the next 20 years. Only a small minority of respondents, however, had yet made climate change adaptation or prevention a top priority for their health department. This discrepancy between problem recognition and programmatic responses may be due, in part, to several factors: most respondents felt personnel in their health department-and other key stakeholders in their community-had a lack of knowledge about climate change; relatively few respondents felt their own health department, their state health department, or the Centers for Disease Control and Prevention had the necessary expertise to help them create an effective mitigation or adaptation plan for their jurisdiction; and most respondents felt that their health department needed additional funding, staff and staff training to respond effectively to climate change. These data make clear that climate change adaptation and prevention are not currently major activities at most health departments, and that most, if not all, local health departments will require assistance in making this transition. We conclude by making the case that, through their words and actions, local health departments and their staff can and should play a role in alerting members of their community about the prospect of public health impacts from climate change in their jurisdiction.	[Maibach, Edward W.] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Chadwick, Amy] Penn State Univ, State Coll, PA USA; [McBride, Dennis] Milford Dept Hlth, Milford, MA USA; [Chuk, Michelle] Natl Assoc County & City Hlth Officials, Washington, DC USA; [Ebi, Kristie L.] ESS, LLC, Alexandria, VA USA; [Balbus, John] Environm Defense, Washington, DC USA	George Mason University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Maibach, EW (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	emaibach@gmu.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187				[Anonymous], CLIMATE CHANGE HLTH; Bedsworth L., 2008, CLIMATE CHANGE CALIF; BENJAMIN G, 2008, PUBLIC HLTH COMMUNIT; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P161; CONFALONIERI U, 2007, HUMAN HLTH CLIMATE C, P339; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; FRUMKIN H, 2006, CLIMATE CHANGE PUBLI; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; GODLEE F, 2008, BMJ-BRIT MED J, V336, DOI DOI 10.1136/BMJ.39469.569815.47; Haines A, 2006, PUBLIC HEALTH, V120, P585, DOI 10.1016/j.puhe.2006.01.002; Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; MARYONDAVIS A, 2008, ITS TIME ACT CLIMATE; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; National Research Council, 2007, EV PROGR US CLIM CHA; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; WILKINSON P, 2007, LANCET, DOI DOI 10.1016/S0140-6736(06)61252-5; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9	24	73	75	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2838	10.1371/journal.pone.0002838	http://dx.doi.org/10.1371/journal.pone.0002838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665266	Green Published, gold			2022-12-25	WOS:000264304300057
J	Mantyla, E; Alessio, GA; Blande, JD; Heijari, J; Holopainen, JK; Laaksonen, T; Piirtola, P; Klemola, T				Mantyla, Elina; Alessio, Giorgio A.; Blande, James D.; Heijari, Juha; Holopainen, Jarmo K.; Laaksonen, Toni; Piirtola, Panu; Klemola, Tero			From Plants to Birds: Higher Avian Predation Rates in Trees Responding to Insect Herbivory	PLOS ONE			English	Article							NATURAL ENEMIES; EMISSION; REFLECTANCE; OLFACTION; VOLATILES; INVOLVEMENT; ATTRACTION; EVOLUTION; RESPONSES; ISOPRENE	Background: An understanding of the evolution of potential signals from plants to the predators of their herbivores may provide exciting examples of co-evolution among multiple trophic levels. Understanding the mechanism behind the attraction of predators to plants is crucial to conclusions about co-evolution. For example, insectivorous birds are attracted to herbivore-damaged trees without seeing the herbivores or the defoliated parts, but it is not known whether birds use cues from herbivore-damaged plants with a specific adaptation of plants for this purpose. Methodology: We examined whether signals from damaged trees attract avian predators in the wild and whether birds could use volatile organic compound (VOC) emissions or net photosynthesis of leaves as cues to detect herbivore-rich trees. We conducted a field experiment with mountain birches (Betula pubescens ssp. czerepanovii), their main herbivore (Epirrita autumnata) and insectivorous birds. Half of the trees had herbivore larvae defoliating trees hidden inside branch bags and half had empty bags as controls. We measured predation rate of birds towards artificial larvae on tree branches, and VOC emissions and net photosynthesis of leaves. Principal Findings and Significance: The predation rate was higher in the herbivore trees than in the control trees. This confirms that birds use cues from trees to locate insect-rich trees in the wild. The herbivore trees had decreased photosynthesis and elevated emissions of many VOCs, which suggests that birds could use either one, or both, as cues. There was, however, large variation in how the VOC emission correlated with predation rate. Emissions of (E)-DMNT [(E)-4,8dimethyl-1,3,7-nonatriene], b-ocimene and linalool were positively correlated with predation rate, while those of highly inducible green leaf volatiles were not. These three VOCs are also involved in the attraction of insect parasitoids and predatory mites to herbivore-damaged plants, which suggests that plants may not have specific adaptations to signal only to birds.	[Mantyla, Elina; Laaksonen, Toni; Klemola, Tero] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Alessio, Giorgio A.; Blande, James D.; Heijari, Juha; Holopainen, Jarmo K.; Piirtola, Panu] Dept Environm Sci, Kuopio, Finland	University of Turku	Mantyla, E (corresponding author), Univ Turku, Sect Ecol, Dept Biol, Turku, Finland.	elkuma@utu.fi	Holopainen, Jarmo K./B-1656-2008; Laaksonen, Toni/B-4241-2014; Klemola, Tero/B-9235-2014; Blande, James/Q-9611-2019; Mäntylä, Elina/B-7777-2008	Holopainen, Jarmo K./0000-0001-5026-3245; Laaksonen, Toni/0000-0001-9035-7131; Klemola, Tero/0000-0002-8510-329X; Mäntylä, Elina/0000-0002-2267-7114; Blande, James/0000-0001-6822-0649	Jenny and Antti Wihuri Foundation; European Commission [MRTN-CT-2003-504720]; Finnish Cultural Foundation; EU LAPBIAT programme; Academy of Finland [111195, 209198, 111543]	Jenny and Antti Wihuri Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); EU LAPBIAT programme; Academy of Finland(Academy of Finland)	The study was financially supported by Jenny and Antti Wihuri Foundation (grant to E.M.), European Commission (ISONET, MRTN-CT-2003-504720, J.K.H and J.D.B), Finnish Cultural Foundation (grant to J.D.B), EU LAPBIAT programme (grant to G.A.) and the Academy of Finland (decision no. 111195 to T.K., 209198 to T.L. and 111543 to J.K.H, J.H. and P.P.).	Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; BOEGE K, 2006, OIKOS, V115, P559; Cuthill Innes C., 2006, P3; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Gershenzon J, 2007, P NATL ACAD SCI USA, V104, P5257, DOI 10.1073/pnas.0700906104; Gotelli NJ, 2013, ECOSIMR 1 00; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GUENTHER AB, 1993, J GEOPHYS RES-ATMOS, V98, P12609, DOI 10.1029/93JD00527; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagen SB, 2008, P ROY SOC B-BIOL SCI, V275, P1509, DOI 10.1098/rspb.2008.0122; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Haukioja E., 1988, P163; HEINRICH B, 1983, ECOLOGY, V64, P592, DOI 10.2307/1939978; Helmig D, 2006, ATMOS ENVIRON, V40, P4150, DOI 10.1016/j.atmosenv.2006.02.035; Holopainen Jarmo K., 2004, Trends in Plant Science, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Janssen A, 2002, OIKOS, V97, P134, DOI 10.1034/j.1600-0706.2002.970114.x; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Joutsensaari J, 2005, ATMOS CHEM PHYS, V5, P1489, DOI 10.5194/acp-5-1489-2005; KALLIO P, 1978, REP KEVO SUBARCTIC, V14, P38; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Louis J, 2005, REMOTE SENS ENVIRON, V96, P37, DOI 10.1016/j.rse.2005.01.013; Mantyla E, 2004, ECOL LETT, V7, P915, DOI 10.1111/j.1461-0248.2004.00653.x; Mantyla E, 2008, BEHAV ECOL, V19, P325, DOI 10.1093/beheco/arm135; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; Mennerat A, 2005, BEHAV PROCESS, V70, P264, DOI 10.1016/j.beproc.2005.07.005; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Muller MS, 2006, OIKOS, V114, P507, DOI 10.1111/j.2006.0030-1299.14668.x; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Penuelas J, 2004, TRENDS ECOL EVOL, V19, P402, DOI 10.1016/j.tree.2004.06.002; Penuelas J, 2004, NEW PHYTOL, V162, P115, DOI 10.1046/j.1469-8137.2004.01007.x; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; Shimoda T, 2005, J CHEM ECOL, V31, P2019, DOI 10.1007/s10886-005-6075-6; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; Staudt M, 2007, TREE PHYSIOL, V27, P1433, DOI 10.1093/treephys/27.10.1433; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vuorinen T, 2007, ARTHROPOD-PLANT INTE, V1, P159, DOI 10.1007/s11829-007-9013-4; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; [No title captured]	52	114	116	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2832	10.1371/journal.pone.0002832	http://dx.doi.org/10.1371/journal.pone.0002832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665271	Green Published, Green Submitted, gold			2022-12-25	WOS:000264304300051
J	Brocker, MJ; Watzlich, D; Uliczka, F; Virus, S; Saggu, M; Lendzian, F; Scheer, H; Rudiger, W; Moser, J; Jahn, D				Broecker, Markus J.; Waetzlich, Denise; Uliczka, Frank; Virus, Simone; Saggu, Miguel; Lendzian, Friedhelm; Scheer, Hugo; Ruediger, Wolfhart; Moser, Juergen; Jahn, Dieter			Substrate Recognition of Nitrogenase-like Dark Operative Protochlorophyllide Oxidoreductase from Prochlorococcus marinus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVINYL CHLOROPHYLL-A; VINYL REDUCTASE GENE; ABSOLUTE-CONFIGURATION; BCHN-BCHB; BIOSYNTHESIS; SULFUR; OXYGEN; IDENTIFICATION; EVOLUTION; PHOTOSYNTHESIS	Chlorophyll and bacteriochlorophyll biosynthesis requires the two-electron reduction of protochlorophyllide a ring D by a protochlorophyllide oxidoreductase to form chlorophyllide a. A light-dependent (light-dependent Pchlide oxidoreductase (LPOR)) and an unrelated dark operative enzyme (dark operative Pchlide oxidoreductase (DPOR)) are known. DPOR plays an important role in chlorophyll biosynthesis of gymnosperms, mosses, ferns, algae, and photosynthetic bacteria in the absence of light. Although DPOR shares significant amino acid sequence homologies with nitrogenase, only the initial catalytic steps resemble nitrogenase catalysis. Substrate coordination and subsequent [Fe-S] cluster-dependent catalysis were proposed to be unrelated. Here we characterized the first cyanobacterial DPOR consisting of the homodimeric protein complex ChlL(2) and a heterotetrameric protein complex (ChlNB)(2). The ChlL2 dimer contains one EPR active [4Fe-4S] cluster, whereas the (ChlNB) 2 complex exhibited EPR signals for two [ 4Fe-4S] clusters with differences in their g values and temperature-dependent relaxation behavior. These findings indicate variations in the geometry of the individual [4Fe-4S] clusters found in (ChlNB) 2. For the analysis of DPOR substrate recognition, 11 synthetic derivatives with altered substituents on the four pyrrole rings and the isocyclic ring plus eight chlorophyll biosynthetic intermediates were tested as DPOR substrates. Although DPOR tolerated minor modifications of the ring substituents on rings A-C, the catalytic target ring D was apparently found to be coordinated with high specificity. Furthermore, protochlorophyllide a, the corresponding [8-vinyl]-derivative and protochlorophyllide b were equally utilized as substrates. Distinct differences from substrate binding by LPOR were observed. Alternative biosynthetic routes for cyanobacterial chlorophyll biosynthesis with regard to the reduction of the C8-vinyl group and the interconversion of a chlorophyll a/b type C7 methyl/formyl group were deduced.	[Broecker, Markus J.; Waetzlich, Denise; Uliczka, Frank; Virus, Simone; Moser, Juergen; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany; [Scheer, Hugo; Ruediger, Wolfhart] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Braunschweig University of Technology; Technical University of Berlin; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de	Saggu, Miguel/B-1224-2009	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Apel K, 2001, ADV PHOTOSYNTH, V11, P235; BAZZAZ MB, 1981, PHOTOBIOCH PHOTOBIOP, V2, P199; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; GOERICKE R, 1992, LIMNOL OCEANOGR, V37, P425; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Helfrich M, 2003, BBA-BIOENERGETICS, V1605, P97, DOI 10.1016/S0005-2728(03)00081-1; Helfrich M, 1996, J AM CHEM SOC, V118, P2606, DOI 10.1021/ja953440c; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Huberman A, 2002, ANAL BIOCHEM, V307, P375, DOI 10.1016/S0003-2697(02)00047-7; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Kolossov VL, 2003, J BIOL CHEM, V278, P49675, DOI 10.1074/jbc.C300449200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; LI KWK, 1995, MARINE ECOLOGY PROGR, V122, P1; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOSS GP, 1987, PURE APPL CHEM, V59, P779, DOI 10.1351/pac198759060779; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PETERS JW, 1995, ANNU REV MICROBIOL, V49, P335, DOI 10.1146/annurev.mi.49.100195.002003; PORRA RJ, 1994, EUR J BIOCHEM, V219, P671, DOI 10.1111/j.1432-1033.1994.tb19983.x; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Scheumann V, 1999, FEBS LETT, V445, P445, DOI 10.1016/S0014-5793(99)00169-6; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; SCHOCH S, 1995, EUR J BIOCHEM, V229, P291, DOI 10.1111/j.1432-1033.1995.tb20468.x; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; SHEDBALKAR VP, 1992, ANAL BIOCHEM, V207, P261, DOI 10.1016/0003-2697(92)90010-5; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; Xu H, 2002, J BIOL CHEM, V277, P42726, DOI 10.1074/jbc.M205237200; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990	62	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29873	29881		10.1074/jbc.M805206200	http://dx.doi.org/10.1074/jbc.M805206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18693243	Green Published, hybrid			2022-12-25	WOS:000260366900031
J	Selivanov, VA; Zeak, JA; Roca, J; Cascante, M; Trucco, M; Votyakova, TV				Selivanov, Vitaly A.; Zeak, Jennifer A.; Roca, Josep; Cascante, Marta; Trucco, Massimo; Votyakova, Tatyana V.			The Role of External and Matrix pH in Mitochondrial Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-ELECTROCHEMICAL GRADIENT; BOVINE HEART-MITOCHONDRIA; CYTOCHROME BC(1) COMPLEX; RAT-LIVER MITOCHONDRIA; SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; UNCOUPLING PROTEINS; INNER MEMBRANE	Reactive oxygen species (ROS) generation in mitochondria as a side product of electron and proton transport through the inner membrane is important for normal cell operation as well as development of pathology. Matrix and cytosol alkalization stabilizes semiquinone radical, a potential superoxide producer, and we hypothesized that proton deficiency under the excess of electron donors enhances reactive oxygen species generation. We tested this hypothesis by measuring pH dependence of reactive oxygen species released by mitochondria. The experiments were performed in the media with pH varying from 6 to 8 in the presence of complex II substrate succinate or under more physiological conditions with complex I substrates glutamate and malate. Matrix pH was manipulated by inorganic phosphate, nigericine, and low concentrations of uncoupler or valinomycin. We found that high pH strongly increased the rate of free radical generation in all of the conditions studied, even when Delta pH = 0 in the presence of nigericin. In the absence of inorganic phosphate, when the matrix was the most alkaline, pH shift in the medium above 7 induced permeability transition accompanied by the decrease of ROS production. ROS production increase induced by the alkalization of medium was observed with intact respiring mitochondria as well as in the presence of complex I inhibitor rotenone, which enhanced reactive oxygen species release. The phenomena revealed in this report are important for understanding mechanisms governing mitochondrial production of reactive oxygen species, in particular that related with uncoupling proteins.	[Votyakova, Tatyana V.] Univ Pittsburgh, Sch Med, Inst Diabet, Dept Pediat,Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Dept Biochem & Mol Biol, CSIC, Associated Unit,Inst Biomed, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, Catalan Theoret & Computat Chem Reference Network, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 199899, Russia; [Zeak, Jennifer A.; Trucco, Massimo; Votyakova, Tatyana V.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Selivanov, Vitaly A.; Roca, Josep] Univ Barcelona, IDIBAPS, Hosp Clin Ciberes, E-08036 Barcelona, Catalunya, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; University of Barcelona; Lomonosov Moscow State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Votyakova, TV (corresponding author), Univ Pittsburgh, Sch Med, Inst Diabet, Dept Pediat,Rangos Res Ctr, 3460 5th Ave, Pittsburgh, PA 15213 USA.	tav2@pitt.edu	CASCANTE, MARTA/AAG-4355-2022; Roca, Josep/J-2583-2015; CASCANTE, MARTA/AFK-5991-2022	CASCANTE, MARTA/0000-0002-2062-4633; Roca, Josep/0000-0003-4768-8722; CASCANTE, MARTA/0000-0002-2062-4633; Selivanov, Vitaly/0000-0002-7937-9249	National Institutes of Health, NIA [AG 20899]; European Commission (FP6) BioBridge [LSHG-CT-2006-037939]; Spanish government and European Union FEDER funds ISCIII-RTICC [RD06/0020/0046]; Generalitat de Catalunya [2005SGR00204, 2006ITT-10007]; Ministerio de Ciencia y Tecnologia of the Spanish Government [SAF2008-00164, AGL2004-07579-C04-03/ALI]; NATIONAL INSTITUTE ON AGING [R01AG020899] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Commission (FP6) BioBridge(European CommissionEuropean Commission Joint Research Centre); Spanish government and European Union FEDER funds ISCIII-RTICC; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia y Tecnologia of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant AG 20899. This work was also supported by European Commission (FP6) BioBridge Grant LSHG-CT-2006-037939; Spanish government and European Union FEDER funds ISCIII-RTICC Grant RD06/0020/0046; Generalitat de Catalunya Grants 2005SGR00204 and 2006ITT-10007; and Ministerio de Ciencia y Tecnologia of the Spanish Government Grants SAF2008-00164 and AGL2004-07579-C04-03/ALI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Dlaskova A, 2006, BBA-BIOENERGETICS, V1757, P467, DOI 10.1016/j.bbabio.2006.05.005; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; JONES JG, 1993, BIOCHEMISTRY-US, V32, P12240, DOI 10.1021/bi00096a037; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OGAWA S, 1978, P NATL ACAD SCI USA, V75, P1796, DOI 10.1073/pnas.75.4.1796; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Selivanov VA, 1998, BIOPHYS CHEM, V72, P111, DOI 10.1016/S0301-4622(98)00127-6; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	42	93	94	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29292	29300		10.1074/jbc.M801019200	http://dx.doi.org/10.1074/jbc.M801019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18687689	Green Published, hybrid			2022-12-25	WOS:000260179900056
J	Watanabe, M; Tanaka, Y; Suenaga, A; Kuroda, M; Yao, M; Watanabe, N; Arisaka, F; Ohta, T; Tanaka, I; Tsumoto, K				Watanabe, Masato; Tanaka, Yoshikazu; Suenaga, Ayuko; Kuroda, Makoto; Yao, Min; Watanabe, Nobuhisa; Arisaka, Fumio; Ohta, Toshiko; Tanaka, Isao; Tsumoto, Kouhei			Structural basis for multimeric heme complexation through a specific protein-heme interaction - The case of the third neat domain of IsdH from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; IRON; ULTRACENTRIFUGATION; REFINEMENT; METABOLISM; SOFTWARE; SEQUENCE; VACCINE	To elucidate the heme acquisition system in pathogenic bacteria, we investigated the heme-binding properties of the third NEAT domain of IsdH (IsdH-NEAT3), a receptor for heme located on the surfaces of pathogenic bacterial cells, by using x-ray crystallography, isothermal titration calorimetry, examination of absorbance spectra, mutation analysis, size-exclusion chromatography, and analytical ultracentrifugation. We found the following: 1) IsdH-NEAT3 can bind with multiple heme molecules by two modes; 2) heme was bound at the surface of IsdH-NEAT3; 3) candidate residues proposed from the crystal structure were not essential for binding with heme; and 4) IsdH-NEAT3 was associated into a multimeric heme complex by the addition of excess heme. From these observations, we propose a heme-binding mechanism for IsdH-NEAT3 that involves multimerization and discuss the biological importance of this mechanism.	[Watanabe, Masato; Tanaka, Yoshikazu; Suenaga, Ayuko; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan; [Tanaka, Yoshikazu] Hokkaido Univ, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan; [Tanaka, Yoshikazu; Yao, Min; Watanabe, Nobuhisa; Tanaka, Isao] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Kuroda, Makoto; Ohta, Toshiko] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Dept Microbiol, Tsukuba, Ibaraki 3058575, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Tokyo; Hokkaido University; Hokkaido University; University of Tsukuba; Tokyo Institute of Technology	Tanaka, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan.	tanaka@cris.hokudai.ac.jp; tsumoto@k.u-tokyo.ac.jp	Tanaka, Yoshikazu/B-7056-2009; Watanabe, Masato/J-5256-2013; Watanabe, Nobuhisa/B-1187-2008; yao, min/F-5287-2011	Watanabe, Nobuhisa/0000-0002-0118-5815; yao, min/0000-0003-1687-5904	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by grants-in-aid for younger scientists ( to Y. T.) and general research ( to K. T.) from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade MA, 2002, GENOME BIOL, V3; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; GILLAM EMJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P540, DOI 10.1006/abbi.1995.1329; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Riggs A., 1981, Methods in Enzymology, V76, P5; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	39	75	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28649	28659		10.1074/jbc.M803383200	http://dx.doi.org/10.1074/jbc.M803383200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667422	hybrid, Green Published			2022-12-25	WOS:000259969300067
J	Schack, VR; Morth, JP; Toustrup-Jensen, MS; Anthonisen, AN; Nissen, P; Andersen, JP; Vilsen, B				Schack, Vivien Rodacker; Morth, Jens Preben; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente			Identification and function of a cytoplasmic K+ site of the Na+,K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT M1; CATION-BINDING; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; ATP HYDROLYSIS; ALPHA-SUBUNIT; SODIUM-PUMP; POTASSIUM; NA+; TRANSPORT	A cytoplasmic nontransport K+/Rb+ site in the P-domain of the Na+, K+ -ATPase has been identified by anomalous difference Fourier map analysis of crystals of the [Rb-2] center dot E-2 center dot MgF42-form of the enzyme. The functional roles of this third K+/Rb+ binding site were studied by site-directed mutagenesis, replacing the side chain of Asp(742) donating oxygen ligand(s) to the site with alanine, glutamate, and lysine. Unlike the wild-type Na+, K+ -ATPase, the mutants display a biphasic K+ concentration dependence of E2P dephosphorylation, indicating that the cytoplasmic K+ site is involved in activation of dephosphorylation. The affinity of the site is lowered significantly (30-200-fold) by the mutations, the lysine mutation being most disruptive. Moreover, the mutations accelerate the E-2 to E-1 conformational transition, again with the lysine substitution resulting in the largest effect. Hence, occupation of the cytoplasmic K+/Rb+ site not only enhances E2P dephosphorylation but also stabilizes the E-2 dephosphoenzyme. These characteristics of the previously unrecognized nontransport site make it possible to account for the hitherto poorly understood trans-effects of cytoplasmic K+ by the consecutive transport model, without implicating a simultaneous exposure of the transport sites toward the cytoplasmic and extracellular sides of the membrane. The cytoplasmic K+/Rb+ site appears to be conserved among Na+, K+ -ATPases and P-type ATPases in general, and its mode of operation may be associated with stabilizing the loop structure at the C-terminal end of the P6 helix of the P-domain, thereby affecting the function of highly conserved catalytic residues and promoting helix-helix interactions between the P- and A-domains in the E-2 state.	[Schack, Vivien Rodacker; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Andersen, Jens Peter; Vilsen, Bente] Univ Aarhus, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Morth, Jens Preben; Nissen, Poul] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Schack, Vivien Rodacker; Morth, Jens Preben; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente] Univ Aarhus, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Danmarks Grundforskningsfond	Vilsen, B (corresponding author), Univ Aarhus, Inst Physiol & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk	Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013; Nissen, Poul/D-5774-2014	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Schack, Vivien/0000-0002-1365-3938; Andersen, Jens Peter/0000-0003-0654-4300; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Vilsen, Bente/0000-0002-4727-9382	Lundbeck Foundation, Denmark; Danish Medical Research Council; Novo Nordisk Foundation, Denmark; Danish National Research Foundation (PUMPKIN Centre)	Lundbeck Foundation, Denmark(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond)	This study was funded in part by grants from the Lundbeck Foundation, Denmark, the Danish Medical Research Council, the Novo Nordisk Foundation, Denmark, and the Danish National Research Foundation (PUMPKIN Centre). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; BEAUGE LA, 1980, J PHYSIOL-LONDON, V299, P367, DOI 10.1113/jphysiol.1980.sp013130; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; BLOSTEIN R, 1977, J BIOL CHEM, V252, P3035; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P19, DOI 10.1016/0304-4157(91)90011-K; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1067, P227, DOI 10.1016/0005-2736(91)90048-D; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Gropp T, 1998, BBA-BIOMEMBRANES, V1368, P184, DOI 10.1016/S0005-2736(97)00162-4; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; POST RL, 1972, J BIOL CHEM, V247, P6530; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SACHS JR, 1981, J PHYSIOL-LONDON, V319, P515, DOI 10.1113/jphysiol.1981.sp013923; SACHS JR, 1991, SOC GEN PHY, V46, P249; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; SKOU JC, 1985, SODIUM PUMP, P575; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toustrup-Jensen M, 2005, J BIOL CHEM, V280, P10210, DOI 10.1074/jbc.M411214200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VARA F, 1982, J BIOL CHEM, V257, P2826; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; YODA A, 1988, J BIOL CHEM, V263, P10320	44	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27982	27990		10.1074/jbc.M803506200	http://dx.doi.org/10.1074/jbc.M803506200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669634	hybrid, Green Published			2022-12-25	WOS:000259719200068
J	Baljuls, A; Schmitz, W; Mueller, T; Zahedi, RP; Sickmann, A; Hekman, M; Rapp, UR				Baljuls, Angela; Schmitz, Werner; Mueller, Thomas; Zahedi, Rene P.; Sickmann, Albert; Hekman, Mirko; Rapp, Ulf R.			Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; C-RAF; KINASE-ACTIVITY; NEGATIVE REGULATION; PROTEIN-KINASE; FEEDBACK PHOSPHORYLATION; DIFFERENTIAL REGULATION; BINDING-SPECIFICITY; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY	In mammals the RAF family of serine/threonine kinases consists of three members, A-, B-, and C- RAF. Activation of RAF kinases involves a complex series of phosphorylations. Although the most prominent phosphorylation sites of B-and C-RAF are well characterized, little is known about regulatory phosphorylation of A-RAF. Using mass spectrometry, we identified here a number of novel in vivo phosphorylation sites in A-RAF. In particular, we found that Ser-432 participates in MEK binding and is indispensable for A-RAF signaling. On the other hand, phosphorylation within the activation segment does not contribute to epidermal growth factor-mediated activation. Furthermore, we show that the potential 14-3-3 binding domains in A-RAF are phosphorylated independently of its activation status. Of importance, we identified a novel regulatory domain in A-RAF (referred to as IH-segment) positioned between amino acids 248 and 267 that contains seven putative phosphorylation sites. Three of these sites, serines 257, 262, and 264, regulate A-RAF activation in a stimulatory manner. The spatial model of the A-RAF fragment, including residues between Ser-246 and Glu-277, revealed a switch of charge at the molecular surface of the IH-region upon phosphorylation, suggesting a mechanism in which the high accumulation of negative charges may lead to an electrostatic destabilization of protein-membrane interaction resulting in depletion of A-RAF from the plasma membrane. Together, we provide here for the first time a detailed analysis of in vivo A-RAF phosphorylation status and demonstrate that regulation of A-RAF by phosphorylation exhibits unique features compared with B-and C-RAF.	[Baljuls, Angela; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res, D-97078 Wurzburg, Germany; [Schmitz, Werner] Univ Wurzburg, Inst Physiol Chem, D-97078 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Julius von Sachs Inst Biosci, D-97078 Wurzburg, Germany; [Zahedi, Rene P.; Sickmann, Albert] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res, Versbacher Str 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Zahedi, René/A-9148-2012; Sickmann, Albert/A-1010-2011; Zahedi, Rene/HGU-5710-2022	Zahedi, René/0000-0002-4960-5460; Sickmann, Albert/0000-0002-2388-5265; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, projects C3 and B2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARK GE, 1987, MOL CELL BIOL, V7, P2134, DOI 10.1128/MCB.7.6.2134; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mazurek S, 2007, ANTICANCER RES, V27, P3963; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUEN KL, 1995, ONCOGENE, V11, P825; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Xia F, 2008, PLOS BIOL, V6, P1115, DOI 10.1371/journal.pbio.0060128; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	75	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27239	27254		10.1074/jbc.M801782200	http://dx.doi.org/10.1074/jbc.M801782200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662992	hybrid			2022-12-25	WOS:000259586600044
J	Collard, F; Zhang, J; Nemet, I; Qanungo, KR; Monnier, VM; Yee, VC				Collard, Francois; Zhang, Jianye; Nemet, Ina; Qanungo, Kaustubha R.; Monnier, Vincent M.; Yee, Vivien C.			Crystal structure of the deglycating enzyme fructosamine oxidase (Amadoriase II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; MONOMERIC SARCOSINE OXIDASE; PROTEIN CROSS-LINK; EC 1.5.3; EXTRACELLULAR-MATRIX; FUNCTIONAL-ANALYSIS; ASPERGILLUS-ORYZAE; MOLECULAR-CLONING; MAILLARD REACTION; EXPRESSION	Fructosamine oxidases (FAOX) catalyze the oxidative deglycation of low molecular weight fructosamines (Amadori products). These proteins are of interest in developing an enzyme to deglycate proteins implicated in diabetic complications. We report here the crystal structures of FAOX-II from the fungi Aspergillus fumigatus, in free form and in complex with the inhibitor fructosyl-thioacetate, at 1.75 and 1.6 angstrom resolution, respectively. FAOX-II is a two domain FAD-enzyme with an overall topology that is most similar to that of monomeric sarcosine oxidase. Active site residues Tyr-60, Arg-112 and Lys-368 bind the carboxylic portion of the fructosamine, whereas Glu-280 and Arg-411 bind the fructosyl portion. From structure-guided sequence comparison, Glu-280 was identified as a signature residue for FAOX activity. Two flexible surface loops become ordered upon binding of the inhibitor in a catalytic site that is about 12 A deep, providing an explanation for the very low activity of FAOX enzymes toward protein-bound fructosamines, which would have difficulty accessing the active site. Structure-based mutagenesis showed that substitution of Glu-280 and Arg-411 eliminates enzyme activity. In contrast, modification of other active site residues or of amino acids in the flexible active site loops has little effect, highlighting these regions as potential targets in designing an enzyme that will accept larger substrates.	[Collard, Francois; Zhang, Jianye; Nemet, Ina; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Qanungo, Kaustubha R.; Monnier, Vincent M.; Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zhang, Jianye] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Monnier, VM (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd, Cleveland, OH 44106 USA.	vmm3@cwru.edu	Nemet, Ina/ABG-2855-2021; Monnier, Vincent M/B-1371-2009	Nemet, Ina/0000-0002-0657-7121	National Institutes of Health [AG 18436, EY07099, DK075897]; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 18436 and EY07099 (to V. M. M.) and DK075897 (to V.C.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akazawa S, 2004, APPL ENVIRON MICROB, V70, P5882, DOI 10.1128/AEM.70.10.5882-5890.2004; Beksan E, 2003, J AGR FOOD CHEM, V51, P5428, DOI 10.1021/jf0344441; Davidek T, 2005, ANAL CHEM, V77, P140, DOI 10.1021/ac048925a; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferri S, 2004, MAR BIOTECHNOL, V6, P625, DOI 10.1007/s10126-004-0001-8; Fujiwara M, 2006, J BIOSCI BIOENG, V102, P241, DOI 10.1263/jbb.102.241; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Hirokawa K, 2003, BIOCHEM BIOPH RES CO, V311, P104, DOI 10.1016/j.bbrc.2003.09.169; HORIUCHI T, 1989, AGR BIOL CHEM TOKYO, V53, P103, DOI 10.1080/00021369.1989.10869245; KOYAMA Y, 1991, AGR BIOL CHEM TOKYO, V55, P1259, DOI 10.1080/00021369.1991.10870758; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Miura S, 2008, PROTEIN ENG DES SEL, V21, P233, DOI 10.1093/protein/gzm047; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROPER H, 1983, CARBOHYD RES, V116, P183, DOI 10.1016/0008-6215(83)88108-7; Saxena AK, 1996, J BIOL CHEM, V271, P32803, DOI 10.1074/jbc.271.51.32803; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; Tagami U, 2000, J MASS SPECTROM, V35, P131, DOI 10.1002/(SICI)1096-9888(200002)35:2<131::AID-JMS920>3.0.CO;2-0; Takahashi M, 1997, J BIOL CHEM, V272, P12505, DOI 10.1074/jbc.272.19.12505; Takahashi M, 1997, J BIOL CHEM, V272, P3437, DOI 10.1074/jbc.272.6.3437; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Wendt T, 2003, J AM SOC NEPHROL, V14, P1383, DOI 10.1097/01.ASN.0000065100.17349.CA; Wiame E, 2002, J BIOL CHEM, V277, P42523, DOI 10.1074/jbc.M200863200; Wu XL, 2002, BIOCHEMISTRY-US, V41, P4453, DOI 10.1021/bi025539j; Wu XL, 2000, BIOCHEMISTRY-US, V39, P1515, DOI 10.1021/bi992031g; Yoshida N, 2005, FEMS MICROBIOL LETT, V248, P141, DOI 10.1016/j.femsle.2005.05.035; Yoshida N, 2004, J BIOSCI BIOENG, V97, P278, DOI 10.1263/jbb.97.278; Yoshida N, 1996, EUR J BIOCHEM, V242, P499, DOI 10.1111/j.1432-1033.1996.0499r.x; Yoshida N, 2007, J BIOSCI BIOENG, V104, P424, DOI 10.1263/jbb.104.424; Zhao GH, 2002, BIOCHEMISTRY-US, V41, P9751, DOI 10.1021/bi020286f	40	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27007	27016		10.1074/jbc.M804885200	http://dx.doi.org/10.1074/jbc.M804885200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667417	Green Published, hybrid			2022-12-25	WOS:000259586600021
J	Leng, X; Lin, H; Ding, T; Wang, Y; Wu, Y; Klumpp, S; Sun, T; Zhou, Y; Monaco, P; Belmont, J; Aderem, A; Akira, S; Strong, R; Arlinghaus, R				Leng, X.; Lin, H.; Ding, T.; Wang, Y.; Wu, Y.; Klumpp, S.; Sun, T.; Zhou, Y.; Monaco, P.; Belmont, J.; Aderem, A.; Akira, S.; Strong, R.; Arlinghaus, R.			Lipocalin 2 is required for BCR-ABL-induced tumorigenesis	ONCOGENE			English	Article						lipocalin 2; CML; tumorigenesis; BCR-ABL; apoptosis	GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC MYELOGENOUS LEUKEMIA; NGAL; MICE; INDUCTION; CANCER; INFECTION; APOPTOSIS; COMPLEX; GROWTH	Our previous studies indicate that reduction of lipocalin 2 (mouse 24p3) expression by either anti-sense or siRNA approaches strongly reduces the overgrowth of BCR-ABL + mouse myeloid 32D in marrow and spleen of NOD/SCID mice. In this study, we used the mouse bone marrow transplant model to further explore the role of 24p3 in BCR-ABL-induced leukemia. Consistent with our previous findings, when using non-irradiated mice as recipient, donor marrow cells expressing BCR-ABL but lacking 24p3 did not cause leukemia or any disease after 75 days, whereas all mice receiving wild type BCR-ABL donor cells died with CML-like disease. An agar clone of the BCR-ABL + human CML cell line K562 (C5) that secretes relatively high levels of lipocalin 2 (human NGAL) induced suppression of hematopoiesis in spleen and marrow of mice, leading to early death in contrast to parental K562 or K562 clone (C6) expressing low amounts of NGAL. Compared with K562 cells, overexpressing NGAL in K562 led to a higher apoptosis rate and an atrophy phenotype in the spleen of the inoculated mice. Plasma from both leukemic mice and CML patients showed elevated lipocalin 2 levels compared with healthy individuals. Moreover, we found that a primary stable cell line from wild-type mouse marrow cells expressing BCR-ABL caused solid tumors in nude mice whereas a similar BCR-ABL + cell line from 24p3 null mice did not. These findings demonstrate that lipocalin 2 has at least two functions related to tumorigenesis, one involving apoptosis induction of normal hematopoietic cells and the other being tissue invasion by leukemia cells.	[Leng, X.; Lin, H.; Ding, T.; Wang, Y.; Sun, T.; Zhou, Y.; Arlinghaus, R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Wu, Y.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Klumpp, S.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med, Houston, TX 77030 USA; [Monaco, P.; Belmont, J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aderem, A.] Inst Syst Biol, Seattle, WA USA; [Akira, S.] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan; [Akira, S.] Japan Sci & Technol Corp, Exploratory Res Adv Technol ERAYO, Osaka, Japan; [Strong, R.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Institute for Systems Biology (ISB); Osaka University; Japan Science & Technology Agency (JST); Fred Hutchinson Cancer Center	Arlinghaus, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 7435 Fannin St,Unit 951, Houston, TX 77030 USA.	rarlingh@mdanderson.org	Belmont, John W/AAI-2494-2019; Akira, Shizuo/C-3134-2009; Belmont, John/AAH-6084-2021	Belmont, John W/0000-0001-7409-3578; 	NIH [PO1 CA49639]; NATIONAL CANCER INSTITUTE [P01CA049639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We also want to thank Dr Bastinaella Perazzona for critically reading the paper. This research was supported in part by a grant from NIH (PO1 CA49639).	BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Furutani M, 1998, CANCER LETT, V122, P209, DOI 10.1016/S0304-3835(97)00391-1; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Guo JQ, 2002, LEUKEMIA, V16, P2447, DOI 10.1038/sj.leu.2402730; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin F, 2001, ONCOGENE, V20, P1873, DOI 10.1038/sj.onc.1204409; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; Miharada K, 2005, FASEB J, V19, P1881, DOI 10.1096/fj.05-3809fje; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Rudd PM, 1999, BIOCHEMISTRY-US, V38, P13937, DOI 10.1021/bi991162e; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297	26	75	76	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6110	6119		10.1038/onc.2008.209	http://dx.doi.org/10.1038/onc.2008.209			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18663364	Green Accepted			2022-12-25	WOS:000260083100004
J	Tong, Y; Ben-Shlomo, A; Zhou, C; Wawrowsky, K; Melmed, S				Tong, Y.; Ben-Shlomo, A.; Zhou, C.; Wawrowsky, K.; Melmed, S.			Pituitary tumor transforming gene 1 regulates Aurora kinase A activity	ONCOGENE			English	Article						PTTG1; Aurora kinase A; drug response	HUMAN-CELLS; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; OVARIAN-CANCER; HUMAN SECURIN; HISTONE H3; A KINASE; PTTG; CHECKPOINT; EXPRESSION	Pituitary tumor transforming gene 1 (PTTG1), a transforming gene highly expressed in several cancers, is a mammalian securin protein regulating both G1/S and G2/M phases. Using protein array screening, we showed PTTG1 interacting with Aurora kinase A (Aurora-A), and confirmed the interaction using co-immunoprecipitation, His-tagged pull-down assays and intracellular immunofluorescence colocalization. PTTG1 transfection into HCT116 cells prevented Aurora-A T288 autophosphorylation, inhibited phosphorylation of the histone H3 Aurora-A substrate and resulted in abnormally condensed chromatin. PTTG1-null cell proliferation was more sensitive to Aurora-A knock down and to Aurora kinase Inhibitor III treatment. The results indicate that PTTG1 and Aurora-A interact to regulate cellular responses to anti-neoplastic drugs. PTTG1 knockdown is therefore a potential approach to improve the efficacy of tumor Aurora kinase inhibitors.	[Tong, Y.; Ben-Shlomo, A.; Zhou, C.; Wawrowsky, K.; Melmed, S.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, David Geffen Sch Med,Cedars Sinai Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melmed, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, David Geffen Sch Med,Cedars Sinai Res Inst, 8700 Beverly Blvd,Acad Affairs,Room 2015, Los Angeles, CA 90048 USA.	melmed@csmc.edu	Zhou, Cuiqi/B-1568-2010; Ben-Shlomo, Anat/AAH-6009-2021		NIH [CA 75979, T32 DK007770]; The Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [R01CA075979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PTTG1 WT and KO HCT116 cells were kindly provided by Dr Bert Vogelstein, Johns Hopkins University. PTTG1-GFP and PTTG1-PCDNA3.1 plasmids were kindly provided by Dr Run Yu. Supported by NIH Grant CA 75979 (SM), T32 DK007770, and The Doris Factor Molecular Endocrinology Laboratory.	Akino K, 2005, J SURG RES, V129, P142, DOI 10.1016/j.jss.2005.04.019; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bernal JA, 2007, J BIOCHEM, V141, P737, DOI 10.1093/jb/mvm076; Boelaert K, 2003, FASEB J, V17, P1631, DOI 10.1096/fj.02-0948com; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Chien WW, 2000, J BIOL CHEM, V275, P19422, DOI 10.1074/jbc.M910105199; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; El-Naggar SM, 2007, INT J ONCOL, V31, P137; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Kakar SS, 2006, INT J ONCOL, V29, P387; Kim D, 2006, CLIN OTOLARYNGOL, V31, P246; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Lai YQ, 2007, J BIOCHEM MOL BIOL, V40, P966; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; McCabe CJ, 2003, CLIN ENDOCRINOL, V58, P141, DOI 10.1046/j.1365-2265.2003.01598.x; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Pascreau Gaetan, 2003, Prog Cell Cycle Res, V5, P369; Pei L, 1999, J BIOL CHEM, V274, P3151, DOI 10.1074/jbc.274.5.3151; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Pei L, 2000, J BIOL CHEM, V275, P31191, DOI 10.1074/jbc.M002451200; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Sheleg SV, 2007, J VIROL, V81, P7894, DOI 10.1128/JVI.00555-07; Solbach C, 2004, BREAST, V13, P80, DOI 10.1016/j.breast.2003.09.008; Sun CB, 2007, BIOCHEM BIOPH RES CO, V352, P220, DOI 10.1016/j.bbrc.2006.11.004; Tarabykin V, 2000, MECH DEVELOP, V92, P301, DOI 10.1016/S0925-4773(00)00243-4; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang ZY, 2000, J BIOL CHEM, V275, P7459, DOI 10.1074/jbc.275.11.7459; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; XUE Y, 2008, MOL CELL PROTEOMICS; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; ZHANG D, 2008, ONCOGENE; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhang Y, 2007, BIOCHEM BIOPH RES CO, V357, P347, DOI 10.1016/j.bbrc.2007.03.129; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	63	21	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	49					6385	6395		10.1038/onc.2008.234	http://dx.doi.org/10.1038/onc.2008.234			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18663361				2022-12-25	WOS:000260263400008
J	Bendz, H; Marincek, BC; Momburg, F; Ellwart, JW; Issels, RD; Nelson, PJ; Noessner, E				Bendz, Henriette; Marincek, Boris-Christian; Momburg, Frank; Ellwart, Joachim W.; Issels, Rolf D.; Nelson, Peter J.; Noessner, Elfriede			Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INNATE IMMUNE-SYSTEM; CD8(+) T-CELLS; CHEMOKINE RECEPTORS; ANTIGEN DELIVERY; STRESS-PROTEINS; HEAT-SHOCK-PROTEIN-70; PATHWAY; BINDING; CCR5	Extracellular heat shock proteins (HSPs) can stimulate antigen-specific immune responses. Using recombinant human (rhu) Hsp70, we previously demonstrated that through complex formation with exogenous antigenic peptides, rhuHsp70 can enhance cross-presentation by antigen-presenting cells (APCs) resulting in stronger T cell stimulation. T cell stimulatory activity has also been described for mycobacterial (myc) Hsp70. MycHsp70-assisted T cell activation has been reported to act through the binding of mycHsp70 to chemokine receptor 5 (CCR5), calcium signaling, phenotypic maturation, and cytokine secretion by dendritic cells (DCs). We report that highly purified rhuHsp70 and mycHsp70 proteins both strongly enhance cross-presentation of exogenous antigens. Augmentation of cross-presentation was seen for different APCs, irrespective of CCR5 expression. Moreover, neither of the purified Hsp70 proteins induced calcium signals in APCs. Instead, calcium signaling activity was found to be caused by contaminating nucleotides present in Hsp70 protein preparations. These results refute the hypothesis that mycHsp70 proteins require CCR5 expression and calcium signaling by APCs for enhanced antigen cross-presentation for T cell stimulation.	[Bendz, Henriette; Ellwart, Joachim W.; Issels, Rolf D.; Noessner, Elfriede] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Bendz, Henriette; Issels, Rolf D.] Univ Munich, Clin Cooperat Grp Hyperthermia, Dept Internal Med 3, Klinikum Grosshadern, D-81377 Munich, Germany; [Marincek, Boris-Christian; Momburg, Frank] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany; [Nelson, Peter J.] Univ Munich, Med Poliklin, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich	Noessner, E (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, Marchioninistr 25, D-81377 Munich, Germany.	noessner@helmholtz-muenchen.de		Issels, Rolf/0000-0002-3494-6561	Deutsche Forschungsgemeinschaft [SFB455, SFB-TR36]; EU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported in part by Grants SFB455 (to E. N. and R. D. I.) and SFB-TR36 (to P. J. N.) from the Deutsche Forschungsgemeinschaft and EU Grant INNOCHEM (to P. J. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea A, 2007, J BIOSCIENCES, V32, P579, DOI 10.1007/s12038-007-0057-5; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bausinger H, 2002, TRENDS IMMUNOL, V23, P342, DOI 10.1016/S1471-4906(02)02249-4; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Javid B, 2007, J IMMUNOL, V179, P2035, DOI 10.4049/jimmunol.179.4.2035; Kim CH, 2003, J IMMUNOL, V171, P152, DOI 10.4049/jimmunol.171.1.152; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tobian AAR, 2005, J IMMUNOL, V174, P5209, DOI 10.4049/jimmunol.174.9.5209; Tobian AAR, 2004, J IMMUNOL, V172, P5277, DOI 10.4049/jimmunol.172.9.5277; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Udono H, 2004, METHODS, V32, P21, DOI 10.1016/S1046-2023(03)00182-8; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Whittall T, 2006, EUR J IMMUNOL, V36, P2304, DOI 10.1002/eji.200635953; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200	39	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26477	26483		10.1074/jbc.M803310200	http://dx.doi.org/10.1074/jbc.M803310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658155	Green Published, hybrid			2022-12-25	WOS:000259341600023
J	Newberry, KJ; Huffman, JL; Miller, MC; Vazquez-Laslop, N; Neyfakh, AA; Brennan, RG				Newberry, Kate J.; Huffman, Joy L.; Miller, Marshall C.; Vazquez-Laslop, Nora; Neyfakh, Alex A.; Brennan, Richard G.			Structures of BmrR-Drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-MECHANISMS; LIGAND-BINDING; EFFLUX PUMPS; MERR FAMILY; DNA; PROTEIN; REGULATOR; TRANSPORTER; RECOGNITION	BmrR is a member of the MerR family and a multidrug binding transcription factor that up-regulates the expression of the bmr multidrug efflux transporter gene in response to myriad lipophilic cationic compounds. The structural mechanism by which BmrR binds these chemically and structurally different drugs and subsequently activates transcription is poorly understood. Here, we describe the crystal structures of BmrR bound to rhodamine 6G (R6G) orberberine(Ber) and cognate DNA. These structures reveal each drug stacks against multiple aromatic residues with their positive charges most proximal to the carboxylate group of Glu-253 and that, unlike other multidrug binding pockets, that of BmrR is rigid. Substitution of Glu-253 with either alanine (E253A) or glutamine (E253Q) results in unpredictable binding affinities for R6G, Ber, and tetraphenylphosphonium. Moreover, these drug binding studies reveal that the negative charge of Glu-253 is not important for high affinity binding to Ber and tetraphenylphosphonium but plays a more significant, but unpredictable, role in R6G binding. In vitro transcription data show that E253A and E253Q are constitutively active, and structures of the drug-free E253A-DNA and E253Q-DNA complexes support a transcription activation mechanism requiring the expulsion of Tyr152 from the multidrug binding pocket. In sum, these data delineate the mechanism by which BmrR binds lipophilic, monovalent cationic compounds and suggest the importance of the redundant negative electrostatic nature of this rigid drug binding pocket that can be used to discriminate against molecules that are not substrates of the Bmr multidrug efflux pump.	[Newberry, Kate J.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Huffman, Joy L.; Miller, Marshall C.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Vazquez-Laslop, Nora; Neyfakh, Alex A.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Brennan, RG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rgbrenna@mdanderson.org		Brennan, Richard/0000-0001-7647-485X	National Institutes of Health [A1048593]; National Science Foundation [MCB- 9816983]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant A1048593 (to R. G. B.). This work was also supported by National Science Foundation Grant MCB- 9816983 (to A. A. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0; ANSARI AZ, 1995, NATURE, V374, P371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Rajan SS, 2006, PROTEINS, V65, P255, DOI 10.1002/prot.21073; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P30; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	34	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26795	26804		10.1074/jbc.M804191200	http://dx.doi.org/10.1074/jbc.M804191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658145	Green Published, hybrid			2022-12-25	WOS:000259341600051
J	Qu, SG; Kanner, BI				Qu, Shaogang; Kanner, Baruch I.			Substrates and non-transportable analogues induce structural rearrangements at the extracellular entrance of the glial glutamate transporter GLT-1/EAAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED CYSTEINE MUTAGENESIS; RAT-BRAIN; ACID TRANSPORTER; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; REENTRANT LOOP; GLT-1; SODIUM; PORE; RESIDUES	To explore rearrangements of the reentrant loop HP2 relative to transmembrane domains (TMs) 7 and 8 during transport by the glial glutamate transporter GLT-1/EAAT2, cysteine pairs were introduced at the extracellular ends of these structural elements. The pairs were introduced around 10-15 angstrom "above" the residues, which make contact with substrate in the related archaeal homologue Glt(Ph). Transport by the double mutants M449C/L466C (HP2/TM 8), L453C/I463C (HP2/TM 8), and I411C/I463C (TM 7/TM 8) was inhibited by copper(II)(1,10-phenanthroline) (3) (CuPh) and by Cd2+. Inhibition was only observed when the two cysteines were present in the same construct, but not with the respective single cysteine mutants or when only one cysteine was paired with a mutation to another residue. Glutamate and potassium, both expected to increase the proportion of inward-facing transporters, significantly protected against the inhibition of transport activity of M449C/L466C by CuPh. The non-transportable analogues kainate and D,L-threo-beta-benzyloxyaspartate are expected to stabilize an outward-facing conformation, but only the latter potentiated the effect of CuPh on M449C/L466C. However, both analogues increased the aqueous accessibility of the cysteines introduced at positions 449 and 466 to a membrane-impermeant sulfhydryl reagent. Inhibition of L453C/I463C by CuPh was protected not only by glutamate but also by the two analogues. In contrast, these ligands had very little effect on the inhibition of I411C/I463C by CuPh. Our results are consistent with the proposal that HP2 serves as the extracellular gate of the transporter and indicate that glutamate and the two analogues induce distinct conformations of HP2.	[Qu, Shaogang; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			NINDS, National Institutes of Health [NS16708]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant NS16708. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	38	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26391	26400		10.1074/jbc.M802401200	http://dx.doi.org/10.1074/jbc.M802401200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658151	Green Published, hybrid			2022-12-25	WOS:000259341600013
J	Sastre, AP; Grossmann, S; Reusch, HP; Schaefer, M				Sastre, Alejandra Perez; Grossmann, Solveig; Reusch, H. Peter; Schaefer, Michael			Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; EARLY RESPONSE GENE; GROWTH-FACTOR; TRANSCRIPTION FACTOR; RECEPTOR TRANSACTIVATION; ANGIOTENSIN-II; MAP KINASES; PROHB-EGF; IN-VIVO; HB-EGF	The expression of contractile proteins in vascular smooth muscle cells is controlled by still poorly defined mechanisms. A thrombin-inducible expression of smooth muscle-specific alpha-actin and myosin heavy chain requires transactivation of the epidermal growth factor (EGF) receptor and a biphasic activation of ERK1/2. Here we demonstrate that the sustained second phase of ERK1/2 phosphorylation requires de novo RNA and protein synthesis. Depolymerization of the actin cytoskeleton by cytochalasin D or disruption of transit between the endoplasmic reticulum and the Golgi apparatus by brefeldin A prevented the second phase of ERK1/2 phosphorylation. We thus conclude that synthesis and trafficking of a plasma membrane-resident protein may be critical intermediates. Analysis of the expression of protease-activated receptor 1, heparin-binding EGF (HB-EGF), and the EGF receptor revealed that pro-HB-EGF is significantly up-regulated upon thrombin stimulation. The kinetic of HB-EGF expression closely matched that of the second phase of ERK1/2 phosphorylation. Because inhibition of matrix metalloproteases or of the EGF receptor strongly attenuated the late phase of ERK1/2 phosphorylation, the second phase of ERK1/2 activation is primarily relayed by shedding of EGF receptor ligands. The small interfering RNA-mediated knockdown of HB-EGF expression confirmed an important role of HB-EGF expression in triggering the second phase of ERK1/2 activation. Confocal imaging of a yellow fluorescent protein-tagged HB-EGF construct demonstrates the rapid plasma membrane integration of the newly synthesized protein. These data imply that the hormonal control of contractile protein expression relies on an intermediate HB-EGF expression to sustain the signaling strength within the Ras/Raf/MEK/ERK cascade.	[Sastre, Alejandra Perez; Grossmann, Solveig; Schaefer, Michael] Charite, Div Mol Pharmacol & Cell Biol, D-14195 Berlin, Germany; [Reusch, H. Peter] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44780 Bochum, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharm & Toxikol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft [GRK865, Scha941/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants GRK865 and Scha941/2-1 from Deutsche Forschungsgemeinschaft (to A. P. S., S. G., and M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEAUCHAMP RD, 1991, CANCER RES, V51, P5253; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Delaney J, 2008, NEUROCHEM RES, V33, P545, DOI 10.1007/s11064-007-9474-y; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; IVES HE, 1978, J EXP MED, V148, P1400, DOI 10.1084/jem.148.5.1400; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Kaperonis EA, 2006, EUR J VASC ENDOVASC, V31, P386, DOI 10.1016/j.ejvs.2005.11.001; Koh YH, 2001, J BIOCHEM-TOKYO, V130, P351, DOI 10.1093/oxfordjournals.jbchem.a002993; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Liu AY, 1997, PROSTATE, V30, P145, DOI 10.1002/(SICI)1097-0045(19970215)30:3<145::AID-PROS1>3.0.CO;2-L; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Naito S, 1998, AM J PHYSIOL-CELL PH, V274, pC472, DOI 10.1152/ajpcell.1998.274.2.C472; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Oettgen P, 2006, CIRC RES, V99, P1159, DOI 10.1161/01.RES.0000251056.85990.db; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park JM, 1999, AM J PHYSIOL-CELL PH, V277, pC294, DOI 10.1152/ajpcell.1999.277.2.C294; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; *WHO, 1985, TECH REP SERV, V143, P1; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	40	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25871	25878		10.1074/jbc.M800949200	http://dx.doi.org/10.1074/jbc.M800949200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650426	hybrid, Green Published			2022-12-25	WOS:000259200100014
J	Boasso, A; Hardy, AW; Anderson, SA; Dolan, MJ; Shearer, GM				Boasso, Adriano; Hardy, Andrew W.; Anderson, Stephanie A.; Dolan, Matthew J.; Shearer, Gene M.			HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation	PLOS ONE			English	Article								Infection by the human immunodeficiency virus (HIV) is characterized by functional impairment and chronic activation of T lymphocytes, the causes of which are largely unexplained. We cultured peripheral blood mononuclear cells (PBMC) from HIV-uninfected donors in the presence or absence of HIV. HIV exposure increased expression of the activation markers CD69 and CD38 on CD4 and CD8 T cells. IFN-alpha/beta, produced by HIV-activated plasmacytoid dendritic cells (pDC), was necessary and sufficient for CD69 and CD38 upregulation, as the HIV-induced effect was inhibited by blockade of IFN-alpha/beta receptor and mimicked by recombinant IFN-alpha/beta. T cells from HIV-exposed PBMC showed reduced proliferation after T cell receptor stimulation, partially prevented by 1-methyl tryptophan, a competitive inhibitor of the immunesuppressive enzyme indoleamine (2,3)-dioxygenase (IDO), expressed by HIV-activated pDC. HIV-induced IDO inhibited CD4 T cell proliferation by cell cycle arrest in G1/S, and prevented CD8 T cell from entering the cell cycle by downmodulating the costimulatory receptor CD28. Finally, the expression of CHOP, a marker of the stress response activated by IDO, was upregulated by HIV in T cells in vitro and is increased in T cells from HIV-infected patients. Our data provide an in vitro model for HIV-induced T cell dysregulation and support the hypothesis that activation of pDC concomitantly contribute to phenotypic T cell activation and inhibition of T cell proliferative capacity during HIV infection.	[Boasso, Adriano; Hardy, Andrew W.; Shearer, Gene M.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Boasso, Adriano] Imperial Coll, Fac Med, Dept Immunol, London, England; [Boasso, Adriano] Westminster Med Sch & Hosp, London, England; [Anderson, Stephanie A.] Henry M Jackson Fdn, Wilford Hall Med Ctr, Infect Dis Clin Res Program IDCRP, Lackland AFB, TX USA; [Dolan, Matthew J.] Henry M Jackson Fdn, San Antonio Mil Med Ctr SAMMC, Infect Dis Clin Res Program IDCRP, Ft Sam Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Imperial College London; San Antonio Military Medical Center	Boasso, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	a.boasso@imperial.ac.uk		Boasso, Adriano/0000-0001-9673-6319	Intramural research Program of the CCR, NCI; Intramural AIDS Targeted Antiviral Program (IATAP); NATIONAL CANCER INSTITUTE [Z01BC009267, ZIABC009267] Funding Source: NIH RePORTER	Intramural research Program of the CCR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural research Program of the CCR, NCI and by the Intramural AIDS Targeted Antiviral Program (IATAP).	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; BOASSO A, 2008, CLIN IMMUNO IN PRESS; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Boasso A, 2007, CURR DRUG METAB, V8, P217, DOI 10.2174/138920007780362527; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Chen LG, 2007, J IMMUNOL, V178, P6634, DOI 10.4049/jimmunol.178.10.6634; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; DICKMEISS E, 1990, Tokai Journal of Experimental and Clinical Medicine, V15, P263; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Douek Daniel, 2007, Top HIV Med, V15, P114; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Dyrhol-Riise AM, 1999, AIDS, V13, P2365, DOI 10.1097/00002030-199912030-00008; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Foli A, 2007, J INFECT DIS, V196, P1409, DOI 10.1086/521832; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; Fowke KR, 1997, AIDS, V11, P1013, DOI 10.1097/00002030-199708000-00010; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; GONG V, 1984, AM J EMERG MED, V2, P336, DOI 10.1016/0735-6757(84)90131-1; Gougeon M L, 1995, Curr Top Microbiol Immunol, V200, P177; GOUGEON ML, 1995, ADV EXP MED BIOL, V374, P121; Gougeon ML, 1997, J IMMUNOL, V158, P2964; Grant RS, 2000, REDOX REP, V5, P105, DOI 10.1179/135100000101535366; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; Grundstrom Susanna, 2006, Curr HIV/AIDS Rep, V3, P32, DOI 10.1007/s11904-006-0006-1; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Hosmalin A, 2006, J LEUKOCYTE BIOL, V80, P984, DOI 10.1189/jlb.0306154; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Martinson JA, 2007, IMMUNOLOGY, V120, P526, DOI 10.1111/j.1365-2567.2007.02530.x; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moanna Abeer, 2005, Curr HIV/AIDS Rep, V2, P16, DOI 10.1007/s11904-996-0004-3; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Paiardini M, 2006, J VIROL, V80, P634, DOI 10.1128/JVI.80.2.634-642.2006; Paiardini M, 2004, IMMUNOL RES, V29, P253, DOI 10.1385/IR:29:1-3:253; Paiardini M, 2001, J VIROL, V75, P10843, DOI 10.1128/JVI.75.22.10843-10855.2001; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Silvestri G, 2005, J MED PRIMATOL, V34, P243, DOI 10.1111/j.1600-0684.2005.00122.x; Smith DG, 2001, J NEUROVIROL, V7, P56; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Trimble LA, 2000, BLOOD, V96, P1021, DOI 10.1182/blood.V96.3.1021.015k37_1021_1029; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Vigano A, 2000, CHEM IMMUNOL, V75, P207; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; ZACK JA, 1995, ADV EXP MED BIOL, V374, P27; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	86	97	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2961	10.1371/journal.pone.0002961	http://dx.doi.org/10.1371/journal.pone.0002961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698365	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600046
J	Chamberlain, G; Wright, K; Rot, A; Ashton, B; Middleton, J				Chamberlain, Giselle; Wright, Karina; Rot, Antal; Ashton, Brian; Middleton, Jim			Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human	PLOS ONE			English	Article							MARROW STROMAL CELLS; INFLAMED JOINTS; BONE; EXPRESS; DIFFERENTIATION; RECRUITMENT; ENGRAFTMENT; PHENOTYPE; MIGRATION; EXPOSURE	Mesenchymal stem cells (MSCs) are non-haematopoeitic, stromal cells that are capable of differentiating into mesenchymal tissues such as bone and cartilage. They are rare in bone marrow, but have the ability to expand many-fold in culture, and retain their growth and multi-lineage potential. The properties of MSCs make them ideal candidates for tissue engineering. It has been shown that MSCs, when transplanted systemically, can home to sites of injury, suggesting that MSCs possess migratory capacity; however, mechanisms underlying migration of these cells remain unclear. Chemokine receptors and their ligands play an important role in tissue-specific homing of leukocytes. Here we define the cell surface chemokine receptor repertoire of murine MSCs from bone marrow, with a view to determining their migratory activity. We also define the chemokine receptor repertoire of human MSCs from bone marrow as a comparison. We isolated murine MSCs from the long bones of Balb/c mice by density gradient centrifugation and adherent cell culture. Human MSCs were isolated from the bonemarrow of patients undergoing hip replacement by density gradient centrifugation and adherent cell culture. The expression of chemokine receptors on the surface of MSCs was studied using flow cytometry. Primary murine MSCs expressed CCR6, CCR9, CXCR3 and CXCR6 on a large proportion of cells (73 +/- 11%, 44 +/- 25%, 55 +/- 18% and 96 +/- 2% respectively). Chemotaxis assays were used to verify functionality of these chemokine receptors. We have also demonstrated expression of these receptors on human MSCs, revealing some similarity in chemokine receptor expression between the two species. Consequently, these murine MSCs would be a useful model to further study the role of chemokine receptors in in vivo models of disease and injury, for example in recruitment of MSCs to inflamed tissues for repair or immunosupression.	[Chamberlain, Giselle; Ashton, Brian; Middleton, Jim] Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Wright, Karina] Keele Univ, Med Sch, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Rot, Antal] Novartis Inst BioMed Res, Vienna, Austria	Keele University; Keele University; Novartis	Chamberlain, G (corresponding author), Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England.	jim.middleton@rjah.nhs.uk		Rot, Antal/0000-0002-9730-6166	Keele University (UK); The Biotechnology and Biological Science Research Council (UK); BBSRC [BB/D014905/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014905/1] Funding Source: researchfish	Keele University (UK); The Biotechnology and Biological Science Research Council (UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was from Keele University (UK) and The Biotechnology and Biological Science Research Council (UK).	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LOPEZ PA, 2007, STEM CELLS, V25, P1737; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Saruta M, 2007, J IMMUNOL, V178, P3293, DOI 10.4049/jimmunol.178.5.3293; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C	33	96	99	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2934	10.1371/journal.pone.0002934	http://dx.doi.org/10.1371/journal.pone.0002934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698345	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000264412600020
J	Kanerva, A; Lavilla-Alonso, S; Raki, M; Kangasniemi, L; Bauerschmitz, GJ; Takayama, K; Ristimaki, A; Desmond, RA; Hemminki, A				Kanerva, Anna; Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Takayama, Koichi; Ristimaki, Ari; Desmond, Renee A.; Hemminki, Akseli			Systemic Therapy for Cervical Cancer with Potentially Regulatable Oncolytic Adenoviruses	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONDITIONALLY REPLICATIVE ADENOVIRUS; OVARIAN-CANCER; CYCLOOXYGENASE-2 PROMOTER; ENHANCED INFECTIVITY; GENE-TRANSCRIPTION; FACTOR VEGF; EXPRESSION; VECTOR; CARCINOMA	Clinical trials have confirmed the safety of selectively oncolytic adenoviruses for treatment of advanced cancers. However, increasingly effective viruses could result in more toxicity and therefore it would be useful if replication could be abrogated if necessary. We analyzed viruses containing the cyclooxygenase-2 (Cox-2) or vascular endothelial growth factor (VEGF) promoter for controlling replication. Anti-inflammatory agents can lower Cox-2 protein levels and therefore we hypothesized that also the promoter might be affected. As Cox-2 modulates expression of VEGF, also the VEGF promoter might be controllable. First, we evaluated the effect of anti-inflammatory agents on promoter activity or adenovirus infectivity in vitro. Further, we analyzed the oncolytic potency of the viruses in vitro and in vivo with and without the reagents. Moreover, the effect of on virus replication was analyzed. We found that RGD-4C or Ad5/3 modified fibers improved the oncolytic potency of the viruses in vitro and in vivo. We found that both promoters could be downregulated with dexamethasone, sodium salicylate, or salicylic acid. Oncolytic efficacy correlated with the promoter activity and in vitro virus production could be abrogated with the substances. In vivo, we saw good therapeutic efficacy of the viruses in a model of intravenous therapy of metastatic cervical cancer, but the inhibitory effect of dexamethasone was not strong enough to provide significant differences in a complex in vivo environment. Our results suggest that anti-inflammatory drugs may affect the replication of adenovirus, which might be relevant in case of replication associated side effects.	[Kanerva, Anna; Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland; [Kanerva, Anna] Helsinki Univ Cent Hosp HUCH, Dept Obstet & Gynecol, Helsinki, Finland; [Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Hemminki, Akseli] Helsinki Univ Cent Hosp HUCH, HUSLAB, Transplantation Lab, Helsinki, Finland; [Bauerschmitz, Gerd J.] Univ Dusseldorf, Dept Obstet & Gynecol, Dusseldorf, Germany; [Takayama, Koichi] Kyushu Univ, Res Inst Dis Chest, Fukuoka, Japan; [Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Program, Helsinki Univ Cent Hosp, HUSLAB, Helsinki, Finland; [Desmond, Renee A.] Univ Alabama Birmingham, Biostat & Bioinformat Unit, Comprehensive Canc Ctr, Birmingham, AL USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Heinrich Heine University Dusseldorf; Kyushu University; University of Helsinki; Helsinki University Central Hospital; University of Alabama System; University of Alabama Birmingham	Kanerva, A (corresponding author), Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland.	akseli.hemminki@helsinki.fi		Takayama, Koichi/0000-0002-7723-8960	EU FP6 THERADPOX; APOTHERAPY; HUCH Research Funds (EVO); Sigrid Juselius Foundation; Academy of Finland; Emil Aaltonen Foundation; Finnish Cancer Society; University of Helsinki; Sohlberg Foundation; Instrumentarium Research Fund; Finnish Oncology Association; Helsinki Biomedical Graduate School; Helsinki Graduate School in Biotechnology and Molecular Biology; Finnish Cultural Foundation; Research Foundation of Bayer Schering Pharma; Deutsche Forschungsgemeinschaft/DFG; Biocentrum Helsinki; Finnish Cancer Institute	EU FP6 THERADPOX(European Commission); APOTHERAPY; HUCH Research Funds (EVO); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Cancer Society; University of Helsinki; Sohlberg Foundation; Instrumentarium Research Fund; Finnish Oncology Association; Helsinki Biomedical Graduate School; Helsinki Graduate School in Biotechnology and Molecular Biology; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Research Foundation of Bayer Schering Pharma; Deutsche Forschungsgemeinschaft/DFG(German Research Foundation (DFG)); Biocentrum Helsinki; Finnish Cancer Institute	This work was supported by EU FP6 THERADPOX and APOTHERAPY, HUCH Research Funds (EVO), Sigrid Juselius Foundation, Academy of Finland, Emil Aaltonen Foundation, Finnish Cancer Society, University of Helsinki, Sohlberg Foundation, Instrumentarium Research Fund, Finnish Oncology Association, Helsinki Biomedical Graduate School, Helsinki Graduate School in Biotechnology and Molecular Biology, Finnish Cultural Foundation, Research Foundation of Bayer Schering Pharma, Deutsche Forschungsgemeinschaft/DFG and Biocentrum Helsinki. A.H. is K. Albin Johansson Research Professor of the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 2007, MOL THER, V15, P1410, DOI 10.1038/sj.mt.6300206; Barker SD, 2003, J GENE MED, V5, P300, DOI 10.1002/jgm.341; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bauerschmitz GJ, 2004, INT J CANCER, V111, P303, DOI 10.1002/ijc.20217; Benckert C, 2003, CANCER RES, V63, P1083; Binley K, 2003, GENE THER, V10, P540, DOI 10.1038/sj.gt.3301944; BLAIR GE, 1989, VIRUS RES, V14, P339, DOI 10.1016/0168-1702(89)90026-9; Bruning A, 2001, HUM GENE THER, V12, P391, DOI 10.1089/10430340150504019; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Casado E, 2001, CLIN CANCER RES, V7, P2496; Cheng WF, 1999, OBSTET GYNECOL, V93, P761, DOI 10.1016/S0029-7844(98)00505-5; Chow NH, 1997, HUM PATHOL, V28, P698, DOI 10.1016/S0046-8177(97)90179-9; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eibl G, 2005, CANCER RES, V65, P982; Fechner H, 2003, GENE THER, V10, P1680, DOI 10.1038/sj.gt.3302051; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Fujimoto J, 1999, BRIT J CANCER, V80, P827, DOI 10.1038/sj.bjc.6690428; Gralla RJ, 1999, J CLIN ONCOL, V17, P2971, DOI 10.1200/JCO.1999.17.9.2971; Hemminki A, 2003, CANCER RES, V63, P847; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; Insel PA, 1996, PHARMACOL BASIS THER, P617; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2004, INT J CANCER, V110, P475, DOI 10.1002/ijc.20129; Kanerva A, 2004, GENE THER, V11, P552, DOI 10.1038/sj.gt.3302181; Kanerva A, 2007, EXPERT OPIN BIOL TH, V7, P1347, DOI 10.1517/14712598.7.9.1347; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Lam JT, 2004, J GENE MED, V6, P1333, DOI 10.1002/jgm.635; Loncaster JA, 2000, BRIT J CANCER, V83, P620, DOI 10.1054/bjoc.2000.1319; Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Nagi P, 2003, J GASTROINTEST SURG, V7, P364, DOI 10.1016/S1091-255X(02)00437-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; Rein DT, 2004, J GENE MED, V6, P1281, DOI 10.1002/jgm.606; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sarkioja M, 2008, J GENE MED, V10, P744, DOI 10.1002/jgm.1193; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Symensma TL, 2003, J VIROL, V77, P12753, DOI 10.1128/JVI.77.23.12753-12763.2003; TORDJMAN C, 1995, BBA-LIPID LIPID MET, V1256, P249, DOI 10.1016/0005-2760(95)00026-9; WALSH D, 1992, CLEV CLIN J MED, V59, P505, DOI 10.3949/ccjm.59.5.505; Wesseling JG, 2001, CANCER GENE THER, V8, P990, DOI 10.1038/sj.cgt.7700403; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1016/S0016-5085(03)01196-X; Yamamoto M, 2001, MOL THER, V3, P385, DOI 10.1006/mthe.2001.0275; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	56	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2917	10.1371/journal.pone.0002917	http://dx.doi.org/10.1371/journal.pone.0002917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698374	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600005
J	Cook, BL; Ernberg, KE; Chung, HY; Zhang, SG				Cook, Brian L.; Ernberg, Karin E.; Chung, Hyeyoun; Zhang, Shuguang			Study of a Synthetic Human Olfactory Receptor 17-4: Expression and Purification from an Inducible Mammalian Cell Line	PLOS ONE			English	Article								In order to begin to study the structural and functional mechanisms of olfactory receptors, methods for milligram-scale purification are required. Here we demonstrate the production and expression of a synthetically engineered human olfactory receptor hOR17-4 gene in a stable tetracycline-inducible mammalian cell line (HEK293S). The olfactory receptor gene was fabricated from scratch using PCR-based gene-assembly, which facilitated codon optimization and attachment of a 9-residue bovine rhodopsin affinity tag for detection and purification. Induction of adherent cultures with tetracycline together with sodium butyrate led to hOR17-4 expression levels of similar to 30 mu g per 150 mm tissue culture plate. Fos-choline-based detergents proved highly capable of extracting the receptors, and fos-choline-14 (N-tetradecylphosphocholine) was selected for optimal solubilization and subsequent purification. Analysis by SDS-PAGE revealed both monomeric and dimeric receptor forms, as well as higher MW oligomeric species. A two-step purification method of immunoaffinity and size exclusion chromatography was optimized which enabled 0.13 milligrams of hOR17-4 monomer to be obtained at >90% purity. This high purity of hOR17-4 is not only suitable for secondary structural and functional analyses but also for subsequent crystallization trials. Thus, this system demonstrates the feasibility of purifying milligram quantities of the GPCR membrane protein hOR17-4 for fabrication of olfactory receptor-based bionic sensing device.	[Cook, Brian L.; Ernberg, Karin E.; Chung, Hyeyoun; Zhang, Shuguang] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cook, BL (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	John Simon Guggenheim Fellowship; NSF-CCR-0122419 MIT Center for Bits & Atoms; MIT-UROP program; ROHM Corporation, Kyoto, Japan	John Simon Guggenheim Fellowship; NSF-CCR-0122419 MIT Center for Bits & Atoms; MIT-UROP program; ROHM Corporation, Kyoto, Japan	SZ gratefully acknowledges a John Simon Guggenheim Fellowship to provide freedom to pursue new frontiers of research of membrane proteins. BC was partly supported from the NSF-CCR-0122419 MIT Center for Bits & Atoms. HC was supported by MIT-UROP program. This work was also supported in part from a generous grant from ROHM Corporation, Kyoto, Japan.	Breer H, 2003, ANAL BIOANAL CHEM, V377, P427, DOI 10.1007/s00216-003-2113-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ebrahimi FAW, 1998, CURR BIOL, V8, pR431, DOI 10.1016/S0960-9822(98)70271-4; Farrens DL, 2002, J PEPT RES, V60, P336, DOI 10.1034/j.1399-3011.2002.21066.x; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; GAT U, 1994, EUR J BIOCHEM, V225, P1157, DOI 10.1111/j.1432-1033.1994.1157b.x; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Ivic L, 2002, J NEUROBIOL, V50, P56, DOI 10.1002/neu.10016; Jayadev S, 1999, ENDOCRINOLOGY, V140, P2010, DOI 10.1210/en.140.5.2010; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Katada S, 2004, J NEUROCHEM, V90, P1453, DOI 10.1111/j.1471-4159.2004.02619.x; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Levasseur G, 2003, EUR J BIOCHEM, V270, P2905, DOI 10.1046/j.1432-1033.2003.03672.x; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu AH, 2003, GENOMICS, V81, P443, DOI 10.1016/S0888-7543(03)00022-3; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Nekrasova E, 1996, EUR J BIOCHEM, V238, P28, DOI 10.1111/j.1432-1033.1996.0028q.x; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Olender T, 2004, GENOMICS, V83, P361, DOI 10.1016/j.ygeno.2003.08.009; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Shimada M, 2002, J BIOL CHEM, V277, P31774, DOI 10.1074/jbc.M204166200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200	46	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2920	10.1371/journal.pone.0002920	http://dx.doi.org/10.1371/journal.pone.0002920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682799	Green Published, gold			2022-12-25	WOS:000264366600070
J	Dube, S; Qin, J; Ramakrishnan, R				Dube, Simant; Qin, Jian; Ramakrishnan, Ramesh			Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device	PLOS ONE			English	Article							TRANSCRIPTION; GENE	Copy Number Variations (CNVs) of regions of the human genome have been associated with multiple diseases. We present an algorithm which is mathematically sound and computationally efficient to accurately analyze CNV in a DNA sample utilizing a nanofluidic device, known as the digital array. This numerical algorithm is utilized to compute copy number variation and the associated statistical confidence interval and is based on results from probability theory and statistics. We also provide formulas which can be used as close approximations.	[Dube, Simant; Qin, Jian; Ramakrishnan, Ramesh] Fluidigm Corp, San Francisco, CA USA		Dube, S (corresponding author), Fluidigm Corp, San Francisco, CA USA.	simant.dube@fluidigm.com		Dube, Simant/0000-0002-8059-531X	Fludigim Corporation	Fludigim Corporation	The authors are employees of Fludigim Corporation and this work was undertaken at Fluidigm.	BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; Fieller EC, 1932, BIOMETRIKA, V24, P428, DOI 10.2307/2331976; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KAPADIA AS, 2005, MATHEMATICAL STAT AP, P617; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P408; PAPOULIS A, 1965, PROBABILITY RANDOM V, P583; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; SCHEAFFER RL, 1990, INTRO PROBABILITY IT, P363; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sheskin D. J, 2000, HDB PARAMETRIC NONPA, P982; Sindelka R, 2008, NUCLEIC ACIDS RES, V36, P387, DOI 10.1093/nar/gkm1024; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; VONLUXBURG U, 2002, TR133 MAX PLANK I BI; VONLUXBURG U, 2007, ARXIV07110198V1; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	22	198	244	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2876	10.1371/journal.pone.0002876	http://dx.doi.org/10.1371/journal.pone.0002876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682853	Green Published, Green Submitted, gold			2022-12-25	WOS:000264366600032
J	Morel, AP; Lievre, M; Thomas, C; Hinkal, G; Ansieau, S; Puisieux, A				Morel, Anne-Pierre; Lievre, Marjory; Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain			Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Recently, two novel concepts have emerged in cancer biology: the role of so-called "cancer stem cells'' in tumor initiation, and the involvement of an epithelial-mesenchymal transition (EMT) in the metastatic dissemination of epithelial cancer cells. Using a mammary tumor progression model, we show that cells possessing both stem and tumorigenic characteristics of "cancer stem cells'' can be derived from human mammary epithelial cells following the activation of the Ras-MAPK pathway. The acquisition of these stem and tumorigenic characters is driven by EMT induction.	[Morel, Anne-Pierre; Lievre, Marjory; Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain] Ctr Leon Berard, F-69373 Lyon, France; [Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain] Inserm, U590, Lyon, France; [Puisieux, Alain] Univ Lyon, ISPB, Lyon, France	UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm)	Morel, AP (corresponding author), Ctr Leon Berard, F-69373 Lyon, France.	puisieux@lyon.fnclcc.fr	Ansieau, Stephane/I-6195-2016; MOREL, Anne-Pierre/AAN-7072-2021	ANSIEAU, Stephane/0000-0003-0989-2108; PUISIEUX, Alain/0000-0002-9938-3798	Institut National du Cancer; Ligue contre le Cancer; Breast Cancer Research Foundation	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue contre le Cancer(Ligue nationale contre le cancer); Breast Cancer Research Foundation	This work was granted by the Institut National du Cancer, the Ligue contre le Cancer and the Breast Cancer Research Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cobaleda C, 2000, BLOOD, V95, P1007, DOI 10.1182/blood.V95.3.1007.003k35_1007_1013; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; HAY JG, 1995, HUM GENE THER, V6, P1487, DOI 10.1089/hum.1995.6.11-1487; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vermeulen L, 2008, CELL DEATH DIFFER; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	40	1195	1244	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2888	10.1371/journal.pone.0002888	http://dx.doi.org/10.1371/journal.pone.0002888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682804	Green Published, gold, Green Submitted			2022-12-25	WOS:000264366600044
J	Ham, TS; Lee, SK; Keasling, JD; Arkin, AP				Ham, Timothy S.; Lee, Sung K.; Keasling, Jay D.; Arkin, Adam P.			Design and Construction of a Double Inversion Recombination Switch for Heritable Sequential Genetic Memory	PLOS ONE			English	Article								Background: Inversion recombination elements present unique opportunities for computing and information encoding in biological systems. They provide distinct binary states that are encoded into the DNA sequence itself, allowing us to overcome limitations posed by other biological memory or logic gate systems. Further, it is in theory possible to create complex sequential logics by careful positioning of recombinase recognition sites in the sequence. Methodology/Principal Findings: In this work, we describe the design and synthesis of an inversion switch using the fim and hin inversion recombination systems to create a heritable sequential memory switch. We have integrated the two inversion systems in an overlapping manner, creating a switch that can have multiple states. The switch is capable of transitioning from state to state in a manner analogous to a finite state machine, while encoding the state information into DNA. This switch does not require protein expression to maintain its state, and "remembers'' its state even upon cell death. We were able to demonstrate transition into three out of the five possible states showing the feasibility of such a switch. Conclusions/Significance: We demonstrate that a heritable memory system that encodes its state into DNA is possible, and that inversion recombination system could be a starting point for more complex memory circuits. Although the circuit did not fully behave as expected, we showed that a multi-state, temporal memory is achievable.	[Ham, Timothy S.; Keasling, Jay D.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Lee, Sung K.; Keasling, Jay D.; Arkin, Adam P.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif, Dept Chem Engn, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Ham, TS (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Lee, Sung K/HGC-6832-2022; Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Lee, Sung K/E-6525-2010	Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; 	National Science Foundation; NIH [5R01-GM63525-03]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063525] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Science Foundation supported Synthetic Biology Engineering Research Center. APA would like to acknowledge NIH grant # 5R01-GM63525-03 for allowing the initiation of this project and the Howard Hughes Medical Institute for partial support during its progress. We authors declare that no competing interests exist.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; ANDERSON JC, 2006, ADDRESSABLE CONJUGAT; ARKIN A, 1994, BIOPHYS J, V67, P560, DOI 10.1016/S0006-3495(94)80516-8; BARRICK D, 1994, NUCLEIC ACIDS RES, V22, P1287, DOI 10.1093/nar/22.7.1287; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Blomfield IC, 1997, MOL MICROBIOL, V23, P705, DOI 10.1046/j.1365-2958.1997.2241615.x; Carrier TA, 1997, BIOTECHNOL PROGR, V13, P699, DOI 10.1021/bp970095h; DAY A, 2007, BACTOBLOOD; Dworkin J, 1997, P NATL ACAD SCI USA, V94, P985, DOI 10.1073/pnas.94.3.985; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; HAYNES KA, 2008, IET SYNTHETIC BIOL, V1, P44; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; JOHNSON RC, 2002, BACTERIAL SITE SPECI; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KOMANO T, 1987, NUCLEIC ACIDS RES, V15, P1165, DOI 10.1093/nar/15.3.1165; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; MOSKOWITZ IPG, 1991, GENE DEV, V5, P1635, DOI 10.1101/gad.5.9.1635; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Parker J, 2003, EMBO REP, V4, P7, DOI 10.1038/sj.embor.embor719; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDMEIER H, 1990, P NATL ACAD SCI USA, V87, P1109, DOI 10.1073/pnas.87.3.1109; VANPUTTE P, 1992, TRENDS GENET, V8, P457; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700	35	102	107	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2815	10.1371/journal.pone.0002815	http://dx.doi.org/10.1371/journal.pone.0002815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665232	Green Submitted, Green Published, gold			2022-12-25	WOS:000264304300034
J	Ibanez-Ventoso, C; Vora, M; Driscoll, M				Ibanez-Ventoso, Carolina; Vora, Mehul; Driscoll, Monica			Sequence Relationships among C-elegans, D-melanogaster and Human microRNAs Highlight the Extensive Conservation of microRNAs in Biology	PLOS ONE			English	Article							BRAIN-EXPRESSED MICRORNAS; TARGET PREDICTIONS; SMALL RNAS; IDENTIFICATION; GENES; MOUSE; INHIBITION; PATTERNS; TESTIS; ROLES	microRNAs act in a prevalent and conserved post-transcriptional gene regulatory mechanism that impacts development, homeostasis and disease, yet biological functions for the vast majority of miRNAs remain unknown. Given the power of invertebrate genetics to promote rapid evaluation of miRNA function, recently expanded miRNA identifications (miRBase 10.1), and the importance of assessing potential functional redundancies within and between species, we evaluated miRNA sequence relationships by 59 end match and overall homology criteria to compile a snapshot overview of miRNA families within the C. elegans and D. melanogaster genomes that includes their identified human counterparts. This compilation expands literature documentation of both the number of families and the number of family members, within and between nematode and fly models, and highlights sequences conserved between species pairs or among nematodes, flies and humans. Themes that emerge include the substantial potential for functional redundancy of miRNA sequences within species (84/139 C. elegans miRNAs and 70/152 D. melanogaster miRNAs share significant homology with other miRNAs encoded by their respective genomes), and the striking extent to which miRNAs are conserved across species-over half (73/139) C. elegans miRNAs share sequence homology with miRNAs encoded also in both fly and human genomes. This summary analysis of mature miRNA sequence relationships provides a quickly accessible resource that should facilitate functional and evolutionary analyses of miRNAs and miRNA families.	[Ibanez-Ventoso, Carolina; Vora, Mehul; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Ibanez-Ventoso, C (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	driscoll@biology.rutgers.edu	Vora, Mehul/P-4848-2016	Vora, Mehul/0000-0002-1239-6458	NIH [R01 AG024882, R21 AG029376]; NATIONAL INSTITUTE ON AGING [R01AG024882, R21AG029376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work has been supported by NIH grant R01 AG024882 and R21 AG029376.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; GREY F, 2007, MED MICROBIOL IMMUNO; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; HE L, 2004, NAT REV GENET, V5, P522; Huang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-66; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Novotny GW, 2007, INT J ANDROL, V30, P316, DOI 10.1111/j.1365-2605.2007.00773.x; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; NATL BIORESOURCE PRO; MIRBASE	85	122	137	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2818	10.1371/journal.pone.0002818	http://dx.doi.org/10.1371/journal.pone.0002818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665242	Green Submitted, gold, Green Published			2022-12-25	WOS:000264304300037
J	Ostermeier, GC; Wiles, MV; Farley, JS; Taft, RA				Ostermeier, G. Charles; Wiles, Michael V.; Farley, Jane S.; Taft, Robert A.			Conserving, Distributing and Managing Genetically Modified Mouse Lines by Sperm Cryopreservation	PLOS ONE			English	Article								Background: Sperm from C57BL/6 mice are difficult to cryopreserve and recover. Yet, the majority of genetically modified (GM) lines are maintained on this genetic background. Methodology/Principal Findings: Reported here is the development of an easily implemented method that consistently yields fertilization rates of 70 +/- 5% with this strain. This six-fold increase is achieved by collecting sperm from the vas deferens and epididymis into a cryoprotective medium of 18% raffinose (w/v), 3% skim milk (w/v) and 477 mu M monothioglycerol. The sperm suspension is loaded into 0.25 mL French straws and cooled at 37 +/- 1 degrees C/min before being plunged and then stored in LN2. Subsequent to storage, the sperm are warmed at 2,232 +/- 162 degrees C/min and incubated in in vitro fertilization media for an hour prior to the addition of oocyte cumulus masses from superovulated females. Sperm from 735 GM mouse lines on 12 common genetic backgrounds including C57BL/6J, BALB/cJ, 129S1/SvImJ, FVB/NJ and NOD/ShiLtJ were cryopreserved and recovered. C57BL/6J and BALB/cByJ fertilization rates, using frozen sperm, were slightly reduced compared to rates involving fresh sperm; fertilization rates using fresh or frozen sperm were equivalent in all other lines. Developmental capacity of embryos produced using cryopreserved sperm was equivalent, or superior to, cryopreserved IVF-derived embryos. Conclusions/Significance: Combined, these results demonstrate the broad applicability of our approach as an economical and efficient option for archiving and distributing mice.	[Ostermeier, G. Charles; Farley, Jane S.; Taft, Robert A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Ostermeier, G. Charles; Wiles, Michael V.] Jackson Lab, Technol Eval & Dev, Bar Harbor, ME USA	Jackson Laboratory; Jackson Laboratory	Taft, RA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	rob.taft@jax.org	Ostermeier, G. Charles/Y-1172-2019	Ostermeier, G. Charles/0000-0002-3951-512X; wiles, michael/0000-0002-3620-8386; Taft, Robert/0000-0002-3634-3342	Ellison Medical Foundation; NIH [RR01262]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001262] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded in part by: The Ellison Medical Foundation; NIH grant RR01262; and Howard Hughes Medical Institute.	ALVAREZ JG, 1984, BIOL REPROD, V30, P833, DOI 10.1095/biolreprod30.4.833; Amann RP, 2005, THERIOGENOLOGY, V63, P698, DOI 10.1016/j.theriogenology.2004.04.010; Bailey JL, 2000, J ANDROL, V21, P1; Bath ML, 2003, BIOL REPROD, V68, P19, DOI 10.1095/biolreprod.102.007344; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Clark J.D., 1996, GUIDE CARE USE LAB A; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Critser J K, 2000, ILAR J, V41, P197; DELAMIRANDE E, 1995, FREE RADICAL BIO MED, V18, P487, DOI 10.1016/0891-5849(94)00169-K; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ecroyd HW, 2003, BIOL REPROD, V69, P347, DOI 10.1095/biolreprod.102.012716; Fuller SJ, 1997, MOL REPROD DEV, V46, P318, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;318::AID-MRD10&gt;3.0.CO;2-V; GIANFORTONI JG, 1985, GAMETE RES, V11, P59, DOI 10.1002/mrd.1120110107; GLENISTER PH, 1999, MOUSE GENETICS TRANS; Jiang MX, 2005, MOL REPROD DEV, V72, P129, DOI 10.1002/mrd.20328; Kaneko T, 2006, THERIOGENOLOGY, V66, P1098, DOI 10.1016/j.theriogenology.2006.02.049; Kito S, 2005, ZYGOTE, V13, P145, DOI 10.1017/S0967199405003205; Koshimoto C, 2002, BIOL REPROD, V66, P1477, DOI 10.1095/biolreprod66.5.1477; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; Mammoto A, 1996, BIOL REPROD, V55, P1063, DOI 10.1095/biolreprod55.5.1063; NAGY A, 2003, MANIPULATING MOUSE E, P175; NAKAGATA N, 1993, EXP ANIM TOKYO, V42, P317, DOI 10.1538/expanim1978.42.3_317; Songsasen N, 1997, CRYOBIOLOGY, V35, P255, DOI 10.1006/cryo.1997.2047; Stacy R, 2006, CRYOBIOLOGY, V52, P99, DOI 10.1016/j.cryobiol.2005.10.006; Szczygiel MA, 2002, BIOL REPROD, V67, P287, DOI 10.1095/biolreprod67.1.287; Sztein JM, 2000, BIOL REPROD, V63, P1774, DOI 10.1095/biolreprod63.6.1774; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WOLF DP, 1976, J REPROD FERTIL, V48, P213, DOI 10.1530/jrf.0.0480213; Yildiz C, 2007, REPRODUCTION, V133, P585, DOI 10.1530/REP-06-0256	32	77	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2792	10.1371/journal.pone.0002792	http://dx.doi.org/10.1371/journal.pone.0002792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665210	Green Published, gold, Green Submitted			2022-12-25	WOS:000264304300011
J	Hasler, U; Leroy, V; Jeon, US; Bouley, R; Dimitrov, M; Kim, JA; Brown, D; Kwon, HM; Martin, PY; Feraille, E				Hasler, Udo; Leroy, Valeeie; Jeon, Un Sil; Bouley, Richard; Dimitrov, Mitko; Kim, Jeong Ah; Brown, Dennis; Kwon, H. Moo; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B modulates aquaporin-2 transcription in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEPHROTIC SYNDROME; ENHANCER-BINDING PROTEIN; WATER CHANNEL EXPRESSION; DOWN-REGULATION; NULL MICE; ACTIVATION; MECHANISM; GENE; HYPERTONICITY; PERMEABILITY	Renal tubulo-interstitial inflammation is frequently associated with polyuria and urine concentration defects. This led us to investigate the effects of the major pro-inflammatory nuclear factor kappa B (NF-kappa B) pathway on aquaporin 2 (AQP2) expression by the collecting duct. Using immortalized collecting duct principal cells (mpkCCD(c14)), we found that, acting independently of vasopressin, activation of NF-kappa B by lipopolysaccharide (LPS) decreased AQP2 mRNA and protein levels in a time-and dose-dependent manner but did not decrease AQP2 mRNA stability. Consistently, constitutively active I kappa B kinase beta decreased AQP2 expression. The LPS-induced decrease in AQP2 mRNA levels was confirmed in rat kidney slices and was reproduced both under conditions of elevated cAMP concentration and V-2 receptor antagonism. Computer analysis of the AQP2 promoter revealed two putative kappa B elements. Mutation of either kappa B element abolished the LPS-induced decrease of luciferase activity in cells expressing AQP2 promoter-luciferase plasmid constructs. Chromatin immunoprecipitation revealed that LPS challenge decreased p65, increased p50 and p52, and had no effect on RelB and c-Rel binding to kappa B elements of the AQP2 promoter. RNA-mediated interference silencing of p65, p50, and p52 confirmed controlled AQP2 transcription by these NF-kappa B subunits. We additionally found that hypertonicity activated NF-kappa B in mpkCCD(c14) cells, an effect that may counteract the Tonicity-responsive enhancer binding protein (TonEBP)-dependent increase in AQP2 gene transcription. Taken together, these findings indicate that NF-kappa B is an important physiological regulator of AQP2 transcription.	[Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Jeon, Un Sil; Kim, Jeong Ah; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Bouley, Richard; Brown, Dennis] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA	University of Geneva; University of Geneva; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch	Dimitrov, Mitko/C-9822-2009; Lee-Kwon, Whaseon/D-6021-2011; Nunes-Hasler, Paula/N-4337-2015	Nunes-Hasler, Paula/0000-0002-4598-685X; Feraille, Eric/0000-0003-1656-8365	National Institutes of Health [R01-DK-42479, DK38452]; Swiss National Foundation [31-67878.02, 31-109473]; Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-42479 (to H. M. K.) and DK38452 (to D. B). This work was also supported in part by Swiss National Foundation Grants 31-67878.02 and 31-109473, a Carlos and Elsie de Reuter Foundation grant, a Ernest Boninchi Foundation grant (to E. F.), and a Fondation pour la Recherche Medicale grant (to U. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bouley R, 2008, SEMIN NEPHROL, V28, P266, DOI 10.1016/j.semnephrol.2008.03.010; Breton S, 1998, J AM SOC NEPHROL, V9, P155; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Frokiaer J, 1997, AM J PHYSIOL-RENAL, V273, pF213, DOI 10.1152/ajprenal.1997.273.2.F213; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; KLAHR S, 1988, PEDIATR NEPHROL, V2, P34, DOI 10.1007/BF00870378; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Kumar A, 2001, NEPHROL DIAL TRANSPL, V16, P1062, DOI 10.1093/ndt/16.5.1062; LEROY V, J AM SOC NE IN PRESS; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li CL, 2001, AM J PHYSIOL-RENAL, V281, pF163, DOI 10.1152/ajprenal.2001.281.1.F163; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mordasini D, 2005, AM J PHYSIOL-RENAL, V289, pF1031, DOI 10.1152/ajprenal.00128.2005; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Oyama T, 1998, J IMMUNOL, V160, P1224; Ping DS, 1999, J IMMUNOL, V162, P727; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Zhang LP, 2005, CANCER RES, V65, P457	54	104	107	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28095	28105		10.1074/jbc.M708350200	http://dx.doi.org/10.1074/jbc.M708350200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664568	Green Published, hybrid			2022-12-25	WOS:000259969300012
